Citrus Sinensis ID: 002892
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 870 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.991 | 0.854 | 0.385 | 1e-165 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.981 | 0.828 | 0.378 | 1e-155 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.993 | 0.842 | 0.376 | 1e-142 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.975 | 0.723 | 0.337 | 1e-128 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.926 | 0.822 | 0.340 | 1e-121 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.957 | 0.743 | 0.335 | 1e-118 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.954 | 0.794 | 0.326 | 1e-118 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.954 | 0.662 | 0.321 | 1e-117 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.970 | 0.739 | 0.329 | 1e-115 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.954 | 0.664 | 0.301 | 1e-113 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 584 bits (1505), Expect = e-165, Method: Compositional matrix adjust.
Identities = 359/931 (38%), Positives = 530/931 (56%), Gaps = 68/931 (7%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ LGG + P IGNLSFL+ LD+ EN F G +P E+GQL RL++L N L G P +
Sbjct: 76 LQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLY 135
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
S+L L L +N G +P+ L +L++LV+L+ N++ G +P+ +GNLT L L +
Sbjct: 136 NCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSH 195
Query: 121 NNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMG 180
NNL GEIP+++ L + L L NN G P ++N+S++ ++ + N SG +G
Sbjct: 196 NNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLG 255
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
LPN + N TG+IP +++N S L L +N N+L+G IP TFGN+ +L L +
Sbjct: 256 ILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLH 314
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
N L +++S + E FL+SLTNC +L L +G N L LP I N SA
Sbjct: 315 TNSLGSDSSRDLE--FLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTL 372
Query: 301 LKGSIPKEIGNLRGLIA------------------------LSLFTNDLNGTIPTTLGRL 336
+ GSIP +IGNL L LSLF+N L+G IP +G +
Sbjct: 373 ISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNM 432
Query: 337 QQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNS 395
L+ L L N G +PT L + L +L +G N+L +IP ++ +LR+D+S NS
Sbjct: 433 TMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNS 492
Query: 396 LSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSL 455
L GSLP DI L+ L L+L N+LSG +P T+G + +L L N F IPD G L
Sbjct: 493 LIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-L 551
Query: 456 TSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYA 515
++ +DLSNN+LSG IP+ F S L+ LN+S N LEGK+P G F N S + N
Sbjct: 552 VGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNND 611
Query: 516 LCGPPR-LQVPPCKEDDTKGSKKAAPIFLKYVLPLIISTTLIVILIILCI-------RYR 567
LCG Q+ PC KK + K V+ + + TL+++L + + R +
Sbjct: 612 LCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKK 671
Query: 568 NRTT-----------WRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIK 615
N+ T + SY D++ AT+GF+ N++G+GSFG+VYK L + VA+K
Sbjct: 672 NKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVK 731
Query: 616 VFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-----FKALVLEFMPNGSLEK 670
V N+Q A +SF +ECE L+++RHRNL+K+ ++C ++D F+AL+ EFMPNGSL+
Sbjct: 732 VLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDM 791
Query: 671 WLYSHNY--------FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722
WL+ L +LERLNI IDV L+YLH P+ HC+LKP+N+LLD ++
Sbjct: 792 WLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDL 851
Query: 723 TARVSDFGISKLLGE-DDDSVTQTMTMA----TIGYMAPEYASDGIISPKCDVYSYGVLL 777
TA VSDFG+++LL + D++S ++ A TIGY APEY G S DVYS+G+LL
Sbjct: 852 TAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILL 911
Query: 778 METFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR-EVQPSYAKMDCLLRIMH 836
+E FT K+PT+E+F G +L + K +LP + ++VD S++ ++ + ++CL +
Sbjct: 912 LEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFE 971
Query: 837 LALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
+ L CC +SP R+ + VV +L I++ F
Sbjct: 972 VGLRCCEESPMNRLATSIVVKELISIRERFF 1002
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 549 bits (1415), Expect = e-155, Method: Compositional matrix adjust.
Identities = 353/932 (37%), Positives = 512/932 (54%), Gaps = 78/932 (8%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G + P IGNLSFL L++++N+F +P ++G+L RL++L +YN L G PS +
Sbjct: 85 LTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNC 144
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
S+L + L +N +P+ L +LS L LD N+++GN P+ +GNLT L L+FA N
Sbjct: 145 SRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQ 204
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
+RGEIP+E+ L + +ALN+ G P ++NIS++ ++L N SG+ + G+
Sbjct: 205 MRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYL 264
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
LPN + LLL N+ TG IP ++ N S L D++SN LSG IP +FG LR+L L IR N
Sbjct: 265 LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNN 324
Query: 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK 302
L +SS E F+ ++ NC +L L +G N L LP I N S + + + +
Sbjct: 325 SLGNNSSSGLE--FIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382
Query: 303 GSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLIS 361
G+IP +IGNL L LSL TN L+G +P + G+L LQ + L N ++G IP+ ++
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILR------------------------IDLSSNSLS 397
L++LHL SN IP S Y+L IDLS+N L+
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502
Query: 398 GSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTS 457
G P ++ L++L+ L S N+LSG +P IGG + L + N F +IPD L S
Sbjct: 503 GHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVS 561
Query: 458 LEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALC 517
L+ +D SNNNLSG IP+ L L+ LN+S N+ EG++PT G FRN A S N +C
Sbjct: 562 LKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNIC 621
Query: 518 GPPR-LQVPPCKEDDTKGSKKAAPIFLKYVLPL---IISTTLIVILIILCIRYRNRTT-- 571
G R +Q+ PC + +K + K V + I S LI+I+ LC + +
Sbjct: 622 GGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNN 681
Query: 572 ---------------WRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIK 615
+ SY ++ AT F+ NL+G+G+FG+V+KG L + VA+K
Sbjct: 682 ASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVK 741
Query: 616 VFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-----DFKALVLEFMPNGSLEK 670
V NL A +SF +ECE + +RHRNL+K+ + C +L DF+ALV EFMP GSL+
Sbjct: 742 VLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDM 801
Query: 671 WLY--------SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722
WL H+ L E+LNI IDV ALEYLH PV HC++KP+NILLD ++
Sbjct: 802 WLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDL 861
Query: 723 TARVSDFGISKLLGEDD-----DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLL 777
TA VSDFG+++LL + D + + TIGY APEY G S + DVYS+G+LL
Sbjct: 862 TAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILL 921
Query: 778 METFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHL 837
+E F+ KKPTDE F G+ +L + K S+ G T ++ + E L ++ +
Sbjct: 922 LEMFSGKKPTDESFAGDYNLHSYTK-SILSGCTSSGGSNAIDE---------GLRLVLQV 971
Query: 838 ALGCCMDSPEQRMCMTDVVVKLQKIKQTFLVS 869
+ C + P RM + V +L I+ F S
Sbjct: 972 GIKCSEEYPRDRMRTDEAVRELISIRSKFFSS 1003
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 508 bits (1307), Expect = e-142, Method: Compositional matrix adjust.
Identities = 351/933 (37%), Positives = 509/933 (54%), Gaps = 69/933 (7%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ L G V P +GNLSFL L++++N F G +P+E+G L RL++L + N G P +
Sbjct: 91 LKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLS 150
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
S L L L +N +P +LS LV L N+++G P+ +GNLT L L+F
Sbjct: 151 NCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIY 210
Query: 121 NNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMG 180
N + GEIP +I LK + +ALN G P I+N+S++I +++ GN SG G
Sbjct: 211 NQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFG 270
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
LPN Q L + N TGTIP +++N S L LD+ SN L+G+IP +FG R + L +
Sbjct: 271 SLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFG--RLQNLLLLG 328
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
N + S+G+ FL +LTNC++L+ L++G N L LP I N S +
Sbjct: 329 LNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNL 388
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQL-QALLQRNNLNGPIPTCLSSL 359
+ GSIP IGNL L L L N L G +P +LG L +L + LL N L+G IP+ L ++
Sbjct: 389 ISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNI 448
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLP------------------ 401
L L+L +N SIPSS S Y+L ++L +N L+GS+P
Sbjct: 449 SGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNL 508
Query: 402 ------SDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSL 455
DI LK L+ L++S N+LSG IP T+ L L L N F IPD G L
Sbjct: 509 LVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-L 567
Query: 456 TSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYA 515
T L +LDLS NNLSG IP+ S L+ LN+S N +G +PT G FRN A S N
Sbjct: 568 TGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNIN 627
Query: 516 LCGP-PRLQVPPCKEDDTKGSKKAAPIFLKYVLPLIISTTLIVI---------LIILCIR 565
LCG P LQ+ PC + + I V ++ + L+ + L + +R
Sbjct: 628 LCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVR 687
Query: 566 YRN----------RTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTN-VAI 614
N ++ + + SY ++ + T GF+ NL+G+G+FG+V+KG L VAI
Sbjct: 688 ANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAI 747
Query: 615 KVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-----DFKALVLEFMPNGSLE 669
KV NL A +SF +ECE L +RHRNL+K+ + C + DF+ALV EFMPNG+L+
Sbjct: 748 KVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLD 807
Query: 670 KWLYSH--------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN 721
WL+ + L + RLNI IDV AL YLH P+ HC++KP+NILLDK+
Sbjct: 808 MWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKD 867
Query: 722 MTARVSDFGISKLLGE-DDDSVTQTMTMA----TIGYMAPEYASDGIISPKCDVYSYGVL 776
+TA VSDFG+++LL + D D+ + A TIGY APEY G S DVYS+G++
Sbjct: 868 LTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIV 927
Query: 777 LMETFTRKKPTDEMFTGEMSLKHWIKLSL-PRGLTEVVDASLVREVQPSYAKM-DCLLRI 834
L+E FT K+PT+++F ++L + K +L R ++ D +++R + M +CL +
Sbjct: 928 LLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLV 987
Query: 835 MHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
+ + C +SP R+ M + + KL I+++F
Sbjct: 988 FRVGVSCSEESPVNRISMAEAISKLVSIRESFF 1020
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-128, Method: Compositional matrix adjust.
Identities = 326/966 (33%), Positives = 498/966 (51%), Gaps = 117/966 (12%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G++P IG L+ L LD+S N G +P + G L L+ L N L G P+ IG
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
S L L L +N TG IP L NL L L N ++ +IPS + LT+L HL ++N+
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
L G I EIG L++L L L NN G P +I N+ + ++ + N +SG P+ +G
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL- 382
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
L N + L N LTG IP+SI+N + L LDL+ N ++G+IP FG + +L+ ++I N
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRN 441
Query: 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSA------------- 289
+ T E + + NC+ L LS+ N L L PLIG
Sbjct: 442 HFTGEIPDD--------IFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTG 493
Query: 290 ----------SFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQL 339
Y H G IP+E+ NL L L +++NDL G IP + ++ L
Sbjct: 494 PIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLL 553
Query: 340 QAL-------------------------LQRNNLNGPIPTCLSSL--------------- 359
L LQ N NG IP L SL
Sbjct: 554 SVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTG 613
Query: 360 -------ISLRQLHL----GSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLK 408
SL+ + L +N LT +IP LE + IDLS+N SGS+P +Q K
Sbjct: 614 TIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACK 673
Query: 409 VLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNN 467
+ L+ S+N LSG+IP + G+ +I+L+L+RN F IP SFG++T L LDLS+NN
Sbjct: 674 NVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNN 733
Query: 468 LSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPC 527
L+GEIP+S LS LK L ++ N L+G +P +G F+N A + N LCG + + PC
Sbjct: 734 LTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPC 792
Query: 528 --KEDDTKGSKKAAPIFLKYVLPLIISTTLIVILIILC-------IRYRNRTT------- 571
K+ + SK+ I + + L+++LI+ C I + ++
Sbjct: 793 TIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSA 852
Query: 572 --WRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRS 627
+R +++QATD FN N++G+ S +VYKG L DGT +A+KV NL+ + +
Sbjct: 853 LKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKW 912
Query: 628 FESECEVLRNVRHRNLIKIFS-SCCNLDFKALVLEFMPNGSLEKWLY-SHNYFLDMLERL 685
F +E + L ++HRNL+KI + + KALVL FM NG+LE ++ S +LE++
Sbjct: 913 FYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKI 972
Query: 686 NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745
++ + + ++YLH + P+VHC+LKP NILLD + A VSDFG +++LG +D T
Sbjct: 973 DLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTA 1032
Query: 746 MTMA---TIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPT--DEMFTGEMSLKHW 800
T A TIGY+APE+A ++ K DV+S+G+++ME T+++PT ++ + +M+L+
Sbjct: 1033 STSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQL 1092
Query: 801 IKLSLP---RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857
++ S+ +G+ V+D L + S + + + + L L C PE R M +++
Sbjct: 1093 VEKSIGNGRKGMVRVLDMELGDSIV-SLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILT 1151
Query: 858 KLQKIK 863
L K++
Sbjct: 1152 HLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-121, Method: Compositional matrix adjust.
Identities = 308/904 (34%), Positives = 459/904 (50%), Gaps = 98/904 (10%)
Query: 58 WIGV-----FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTK 112
W GV +++ L + G I S+ NL+ L LD N G IP +IG+L +
Sbjct: 56 WSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHE 115
Query: 113 -LVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF---NISTIIIINLVG 168
L L+ ++N L G IP E+G L L L L N L G IP +F + S++ I+L
Sbjct: 116 TLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSN 175
Query: 169 NQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPN-T 227
N L+G P L +FLLLW+N+LTGT+P+S++N++ L +DL SN LSG++P+
Sbjct: 176 NSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQV 235
Query: 228 FGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287
+ L L + N+ + ++ F +SL N + L+ L L N L + + +
Sbjct: 236 ISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHL 295
Query: 288 SASFQQFYAHECKLKGSIPKEI-------------------------------------- 309
S + Q + + ++ GSIP EI
Sbjct: 296 SVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNN 355
Query: 310 ----------GNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALL-QRNNLNGPIPTCLSS 358
G++ L L + N+L+G+IP + G L QL+ LL N+L+G +P L
Sbjct: 356 HLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGK 415
Query: 359 LISLRQLHLGSNQLTSSIPSSFWS--LEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLS 416
I+L L L N LT +IP S L ++LSSN LSG +P ++ + +++ ++LS
Sbjct: 416 CINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLS 475
Query: 417 RNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSF 476
N+LSG IP +G L L+L+RN F ++P S G L L+ LD+S N L+G IP SF
Sbjct: 476 SNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSF 535
Query: 477 EILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCKEDDTKGSK 536
+ S LK LN S N L G + G F +SFL + LCG + + CK+ S
Sbjct: 536 QQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSV 594
Query: 537 K--------AAPIFLKYVLPLIISTTLIVILIILCIRY--------RNRTTWRRTSYLDI 580
A P+ + PL+ + L + +N + R SY +
Sbjct: 595 LLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQL 654
Query: 581 QQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFR-SFESECEVLRNVR 639
AT GFN +L+G+G FG VYKG L + T VA+KV + + F SF+ EC++L+ R
Sbjct: 655 IAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTR 714
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---LDMLERLNIMIDVGLALE 696
HRNLI+I ++C F ALVL MPNGSLE+ LY Y LD+++ +NI DV +
Sbjct: 715 HRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIA 774
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG------EDDDSV----TQTM 746
YLHH VVHC+LKP+NILLD MTA V+DFGIS+L+ DDSV T +
Sbjct: 775 YLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGL 834
Query: 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP 806
++GY+APEY S DVYS+GVLL+E + ++PTD + SL ++K P
Sbjct: 835 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYP 894
Query: 807 RGLTEVVDASLVR---EVQPSYAKM---DCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860
L +++ +L R + +P + + +L ++ L L C +P R M DV ++
Sbjct: 895 DSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMG 954
Query: 861 KIKQ 864
++K+
Sbjct: 955 RLKE 958
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1096), Expect = e-118, Method: Compositional matrix adjust.
Identities = 311/926 (33%), Positives = 473/926 (51%), Gaps = 93/926 (10%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G +PP +GN+ + L +S+N G +P+ LG L+ L L N LTG P IG
Sbjct: 210 LTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNM 269
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
+ L+L N TG IP+SL NL +L L N ++G IP K+GN+ ++ L ++N
Sbjct: 270 ESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNK 329
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
L G IP+ +GNLKNL L L N L G IP + N+ ++I + L N+L+G PS+ G+
Sbjct: 330 LTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGN- 388
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
L N +L L+ N LTG IP + N +I LDL+ N L+G +P++FGN L +L +R N
Sbjct: 389 LKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVN 448
Query: 243 YLTTE----------------TSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPP---- 282
+L+ ++N F ++ KL+ +SL N L+ +P
Sbjct: 449 HLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRD 508
Query: 283 --------LIGN-FSAS-FQQF----------YAHECKLKGSIPKEIGNLRGLIALSLFT 322
+GN F+ F+ F ++H K G I L AL +
Sbjct: 509 CKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHN-KFHGEISSNWEKSPKLGALIMSN 567
Query: 323 NDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFW 381
N++ G IPT + + QL L L NNL G +P + +L +L +L L NQL+ +P+
Sbjct: 568 NNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLS 627
Query: 382 SLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR 441
L + +DLSSN+ S +P + L +NLSRN+ G+IP + L L L L+
Sbjct: 628 FLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSH 686
Query: 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGP 501
N+ IP SL SL+ LDLS+NNLSG IP +FE + L +++S+N+LEG +P
Sbjct: 687 NQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPT 746
Query: 502 FRNFLAQSFLWNYALCGP-PRLQVPPCKEDDTKGSKKAAPIFLKYVLPLIISTTLIVILI 560
FR A + N LC P+ ++ PC+E K KK + + ++P++ ++VIL
Sbjct: 747 FRKATADALEENIGLCSNIPKQRLKPCRE--LKKPKKNGNLVVWILVPIL---GVLVILS 801
Query: 561 I------LCIRYRNRTTWRRTS-----------------YLDIQQATDGFNECNLLGAGS 597
I CIR R R T Y DI ++T+ F+ +L+G G
Sbjct: 802 ICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGG 861
Query: 598 FGSVYKGTLFDGTNVAIKVFNLQLERAF------RSFESECEVLRNVRHRNLIKIFSSCC 651
+ VY+ L D T +A+K + ++ + F +E + L +RHRN++K+F C
Sbjct: 862 YSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCS 920
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYF--LDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
+ L+ E+M GSL K L + L +R+N++ V AL Y+HH TP+VH
Sbjct: 921 HRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHR 980
Query: 710 NLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCD 769
++ NILLD + TA++SDFG +KLL DS + T GY+APE+A ++ KCD
Sbjct: 981 DISSGNILLDNDYTAKISDFGTAKLL--KTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCD 1038
Query: 770 VYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMD 829
VYS+GVL++E K P D +S LSL R +++ R ++P +
Sbjct: 1039 VYSFGVLILELIIGKHPGD--LVSSLSSSPGEALSL-RSISD------ERVLEPRGQNRE 1089
Query: 830 CLLRIMHLALGCCMDSPEQRMCMTDV 855
LL+++ +AL C +PE R M +
Sbjct: 1090 KLLKMVEMALLCLQANPESRPTMLSI 1115
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 425 bits (1093), Expect = e-118, Method: Compositional matrix adjust.
Identities = 304/930 (32%), Positives = 456/930 (49%), Gaps = 100/930 (10%)
Query: 5 GTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSK 64
GT+ P G S L Y D+S N G +P ELG L L L N L GS PS IG +K
Sbjct: 132 GTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTK 191
Query: 65 LQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLR 124
+ +++ +N TGPIP+S NL+ LV L NS+SG+IPS+IGNL L L NNL
Sbjct: 192 VTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLT 251
Query: 125 GEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLP 184
G+IP+ GNLKN+ L + N L G IP I N++ + ++L N+L+G PST+G+ +
Sbjct: 252 GKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGN-IK 310
Query: 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244
L L+ N+L G+IP + +I L+++ N L+G +P++FG L L L +R N L
Sbjct: 311 TLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQL 370
Query: 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS 304
+ + N +L L L +N LP I + + +G
Sbjct: 371 SGPIP--------PGIANSTELTVLQLDTNNFTGFLPDTICR-GGKLENLTLDDNHFEGP 421
Query: 305 IPKEIGNLRGLIALSLFTNDLNGTIPTTLG------------------------RLQQLQ 340
+PK + + + LI + N +G I G + Q+L
Sbjct: 422 VPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLV 481
Query: 341 A-LLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGS 399
A +L N++ G IP + ++ L QL L SN++T +P S ++ I ++ L+ N LSG
Sbjct: 482 AFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGK 541
Query: 400 LPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD--------- 450
+PS I+ L L YL+LS N+ S IP T+ L L ++L+RN +IP+
Sbjct: 542 IPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQ 601
Query: 451 ---------------SFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGK 495
F SL +LE LDLS+NNLSG+IP SF+ + L ++VSHN L+G
Sbjct: 602 MLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGP 661
Query: 496 IPTNGPFRNFLAQSFLWNYALCGPPRLQ--VPPCKEDDTKGSKKAAPIFLKYVLPLIIST 553
IP N FRN +F N LCG + PC +K S K + + ++P+I +
Sbjct: 662 IPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAI 721
Query: 554 TLIVIL--IILCIRYRNRTTWRRTS------------------YLDIQQATDGFNECNLL 593
++ + I +C R R + T Y +I +AT F+ L+
Sbjct: 722 IILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLI 781
Query: 594 GAGSFGSVYKGTLFDGTNVAIKVFNLQLERAF------RSFESECEVLRNVRHRNLIKIF 647
G G G VYK L + +A+K N + + + F +E L +RHRN++K+F
Sbjct: 782 GTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLF 840
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYF--LDMLERLNIMIDVGLALEYLHHSHSTP 705
C + LV E+M GSL K L + + LD +R+N++ V AL Y+HH S
Sbjct: 841 GFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPA 900
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
+VH ++ NILL ++ A++SDFG +KLL DS + T GY+APE A ++
Sbjct: 901 IVHRDISSGNILLGEDYEAKISDFGTAKLL--KPDSSNWSAVAGTYGYVAPELAYAMKVT 958
Query: 766 PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
KCDVYS+GVL +E + P D + T + S P + S R +P+
Sbjct: 959 EKCDVYSFGVLTLEVIKGEHPGDLVST--------LSSSPPDATLSLKSISDHRLPEPTP 1010
Query: 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
+ +L I+ +AL C P+ R M +
Sbjct: 1011 EIKEEVLEILKVALLCLHSDPQARPTMLSI 1040
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 422 bits (1086), Expect = e-117, Method: Compositional matrix adjust.
Identities = 310/964 (32%), Positives = 461/964 (47%), Gaps = 134/964 (13%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFP------ 56
L G +P + L+ L LD+S NN G + E ++ +L+FL A N L+GS P
Sbjct: 276 LQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSN 335
Query: 57 -------------------SWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFN 97
+ I L++L L NN+ TG IP+SLF L L L N
Sbjct: 336 NTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNN 395
Query: 98 SISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFN 157
S+ G + S I NLT L NNL G++P EIG L L + L N G +P I N
Sbjct: 396 SLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGN 455
Query: 158 ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNS 217
+ + I+ GN+LSG PS++G L + L L N L G IP S+ N ++ +DL
Sbjct: 456 CTRLQEIDWYGNRLSGEIPSSIGR-LKDLTRLHLRENELVGNIPASLGNCHQMTVIDLAD 514
Query: 218 NSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
N LSG IP++FG L L I N L + + SL N L ++ SN +
Sbjct: 515 NQLSGSIPSSFGFLTALELFMIYNNSL--------QGNLPDSLINLKNLTRINFSSNKFN 566
Query: 278 SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQ 337
+ PL G S+S+ F E +G IP E+G L L L N G IP T G++
Sbjct: 567 GSISPLCG--SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKIS 624
Query: 338 QLQAL-------------------------LQRNNLNGPIPTCLSSLISLRQLHLGSNQL 372
+L L L N L+G IPT L L L +L L SN+
Sbjct: 625 ELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKF 684
Query: 373 TSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLK 432
S+P+ +SL IL + L NSL+GS+P +I NL+ L LNL NQLSG +P TIG L
Sbjct: 685 VGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLS 744
Query: 433 DLITLSLARNRFQDSIPDSFGSLTSLE-YLDLSNNNLSGEIPKSFEILSHLKRLNVSHNR 491
L L L+RN IP G L L+ LDLS NN +G IP + L L+ L++SHN+
Sbjct: 745 KLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQ 804
Query: 492 LEGKIPTN----------------------GPFRNFLAQSFLWNYALCGPPRLQVPPCKE 529
L G++P F + A +F+ N LCG P + C
Sbjct: 805 LVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSP---LSHCNR 861
Query: 530 DDTKGSKKAAP--IFLKYVLPLIISTTLIVILIILCIR---------------------- 565
+K + +P + + + + + L+V++IIL +
Sbjct: 862 AGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSS 921
Query: 566 -----YRNRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ 620
+ N + DI +AT NE ++G+G G VYK L +G +A+K +
Sbjct: 922 SQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWK 981
Query: 621 LE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKALVLEFMPNGSLEKWLYSHN- 676
+ + +SF E + L +RHR+L+K+ C + L+ E+M NGS+ WL+++
Sbjct: 982 DDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANEN 1041
Query: 677 ----YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732
L RL I + + +EYLH+ P+VH ++K +N+LLD N+ A + DFG++
Sbjct: 1042 TKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLA 1101
Query: 733 KLLGEDDDSVTQTMTM--ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
K+L + D+ T++ TM + GY+APEYA + K DVYS G++LME T K PT+ M
Sbjct: 1102 KILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAM 1161
Query: 791 FTGEMSLKHWIK--LSLPRG---LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDS 845
F E + W++ L P G +++D+ L + + P + + +++ +AL C
Sbjct: 1162 FDEETDMVRWVETVLDTPPGSEAREKLIDSEL-KSLLP--CEEEAAYQVLEIALQCTKSY 1218
Query: 846 PEQR 849
P++R
Sbjct: 1219 PQER 1222
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1068), Expect = e-115, Method: Compositional matrix adjust.
Identities = 304/922 (32%), Positives = 458/922 (49%), Gaps = 78/922 (8%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYN-DLTGSFPSWIGV 61
L G +PP I S L L + +N G +P ELG+L L+ + N +++G PS IG
Sbjct: 165 LTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGD 224
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
S L VL L S +G +P+SL L L L ISG IPS +GN ++LV L +N
Sbjct: 225 CSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYEN 284
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
+L G IP EIG L L L L N+L+G IP I N S + +I+L N LSG PS++G
Sbjct: 285 SLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGR 344
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
L + ++ N+ +G+IP +I+N S L+ L L+ N +SG IP+ G L L+ +
Sbjct: 345 -LSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWS 403
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPP------------LIGNFSA 289
N L E S L +C L+AL L N L +P LI N +
Sbjct: 404 NQL--------EGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLS 455
Query: 290 SFQQFYAHEC-----------KLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQ 338
F C ++ G IP IG+L+ + L +N L+G +P +G +
Sbjct: 456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515
Query: 339 LQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLS 397
LQ + L N+L G +P +SSL L+ L + +NQ + IP+S L + ++ LS N S
Sbjct: 516 LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFS 575
Query: 398 GSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDL-ITLSLARNRFQDSIPDSFGSLT 456
GS+P+ + L L+L N+LSG IP +G +++L I L+L+ NR IP SL
Sbjct: 576 GSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLN 635
Query: 457 SLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYAL 516
L LDLS+N L G++ I +L LN+S+N G +P N FR Q N L
Sbjct: 636 KLSILDLSHNMLEGDLAPLANI-ENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKL 694
Query: 517 CGPPRLQVPPC----KEDDTKGSKKAAPIFLKYVLPLIISTTLIVILIIL----CIRYRN 568
C + C ++ + G A K L L + TL V+L+IL IR R
Sbjct: 695 CSSTQ---DSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARR 751
Query: 569 RT------------TWRRTSYLDIQQATDGFNEC----NLLGAGSFGSVYKGTLFDGTNV 612
W+ T + + + D C N++G G G VY+ + +G +
Sbjct: 752 NIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVI 811
Query: 613 AIKVF---------NLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663
A+K + + + SF +E + L +RH+N+++ C N + + L+ ++M
Sbjct: 812 AVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYM 871
Query: 664 PNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722
PNGSL L+ LD R I++ L YLHH P+VH ++K NNIL+ +
Sbjct: 872 PNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDF 931
Query: 723 TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
++DFG++KL+ E D + GY+APEY I+ K DVYSYGV+++E T
Sbjct: 932 EPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLT 991
Query: 783 RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCC 842
K+P D + L W++ + RG EV+D++L + A+ D +++++ AL C
Sbjct: 992 GKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTLRSRTE---AEADEMMQVLGTALLCV 1046
Query: 843 MDSPEQRMCMTDVVVKLQKIKQ 864
SP++R M DV L++IKQ
Sbjct: 1047 NSSPDERPTMKDVAAMLKEIKQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 314/1040 (30%), Positives = 470/1040 (45%), Gaps = 210/1040 (20%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G +P +GN S L +EN G +P ELG+L L+ L A N LTG PS +G
Sbjct: 203 LEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEM 262
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
S+LQ LSL N G IP SL +L +L LD N+++G IP + N+++L+ L A+N+
Sbjct: 263 SQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNH 322
Query: 123 LRG-------------------------EIPNEIGNLKNLADLVLALNNLIGPIPTTIF- 156
L G EIP E+ ++L L L+ N+L G IP +F
Sbjct: 323 LSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFE 382
Query: 157 -----------------------NISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWA 193
N++ + + L N L G P + +L + L L+
Sbjct: 383 LVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEIS-ALRKLEVLFLYE 441
Query: 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGE 253
NR +G IP I N + L +D+ N G+IP + G L+ L+ L++R N L
Sbjct: 442 NRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVG------- 494
Query: 254 WSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLR 313
+SL NC++L L L N L +P G F +Q + L+G++P + +LR
Sbjct: 495 -GLPASLGNCHQLNILDLADNQLSGSIPSSFG-FLKGLEQLMLYNNSLQGNLPDSLISLR 552
Query: 314 GLIALSLFTNDLNGTI-----------------------PTTLGRLQQLQAL-LQRNNLN 349
L ++L N LNGTI P LG Q L L L +N L
Sbjct: 553 NLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLT 612
Query: 350 GPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSS---------------- 393
G IP L + L L + SN LT +IP + + IDL++
Sbjct: 613 GKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQ 672
Query: 394 --------------------------------NSLSGSLPSDIQNLKVLIYLNL------ 415
NSL+GS+P +I NL L LNL
Sbjct: 673 LGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFS 732
Query: 416 ------------------SRNQLSGNIPITIGGLKDLIT-LSLARNRFQDSIPDSFGSLT 456
SRN L+G IP+ IG L+DL + L L+ N F IP + G+L+
Sbjct: 733 GSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLS 792
Query: 457 SLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYAL 516
LE LDLS+N L+GE+P S + L LNVS N L GK+ F + A SFL N L
Sbjct: 793 KLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGL 850
Query: 517 CGPPRLQVPPCKEDDTKGSKKAAPIFLKYVLPLIISTTLIVILIILCIR----------- 565
CG P + + ++ + A + + + + + L++++I L +
Sbjct: 851 CGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGH 910
Query: 566 -------------------YRNRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTL 606
+RN + + DI +AT +E ++G+G G VYK L
Sbjct: 911 GSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAEL 970
Query: 607 FDGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLD--FKALVLEFM 663
+G VA+K + + + +SF E + L +RHR+L+K+ C + L+ E+M
Sbjct: 971 ENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYM 1030
Query: 664 PNGSLEKWLYS-------HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716
NGS+ WL+ LD RL I + + +EYLHH P+VH ++K +N+
Sbjct: 1031 KNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNV 1090
Query: 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGYMAPEYASDGIISPKCDVYSYG 774
LLD NM A + DFG++K+L E+ D+ T + T + GY+APEYA + K DVYS G
Sbjct: 1091 LLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMG 1150
Query: 775 VLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM-----D 829
++LME T K PTD +F EM + W++ L EV ++ + + P + D
Sbjct: 1151 IVLMEIVTGKMPTDSVFGAEMDMVRWVETHL-----EVAGSARDKLIDPKLKPLLPFEED 1205
Query: 830 CLLRIMHLALGCCMDSPEQR 849
+++ +AL C SP++R
Sbjct: 1206 AACQVLEIALQCTKTSPQER 1225
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 870 | ||||||
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.975 | 0.800 | 0.523 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.790 | 0.523 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.991 | 0.792 | 0.511 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.993 | 0.847 | 0.487 | 0.0 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.991 | 0.593 | 0.475 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.991 | 0.827 | 0.486 | 0.0 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.991 | 0.716 | 0.490 | 0.0 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.991 | 0.702 | 0.483 | 0.0 | |
| 147769371 | 1241 | hypothetical protein VITISV_010511 [Viti | 0.993 | 0.696 | 0.469 | 0.0 | |
| 359483683 | 1228 | PREDICTED: LRR receptor-like serine/thre | 0.975 | 0.691 | 0.478 | 0.0 |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2240), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/890 (52%), Positives = 607/890 (68%), Gaps = 41/890 (4%)
Query: 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNS 74
S L L++ N G +P+ L + L+ L N TGS P I +KL+ L L N+
Sbjct: 163 STLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKNN 222
Query: 75 FTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNL 134
TG IP + L SL +L N ++GNIP +IGN T L+ ++ +NNL G IPNE+GNL
Sbjct: 223 LTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEIHVENNNLTGVIPNEMGNL 282
Query: 135 KNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWAN 194
L +L L NN+ G IP+T FN S + +N+ N LSGH PS G LPN + L L N
Sbjct: 283 HTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLEELYLEKN 342
Query: 195 RLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254
L+G IP+SI NASKLI LDL+ NS SG+IP+ GNLR+L LN+ N LT+++ + E
Sbjct: 343 ELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRS-EL 401
Query: 255 SFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRG 314
SFLSSL+NC L L NPL LP IGN SAS ++ YA +C++ G+IP+ IGNL
Sbjct: 402 SFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLSN 461
Query: 315 LIALSLFTNDLNGTIPTTLGRLQQLQAL-------------------------LQRNNLN 349
LI L L N+L G IP+ +GRL+ LQ L N +
Sbjct: 462 LIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFS 521
Query: 350 GPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKV 409
G +P CLS++ SLR+L+LGSN+ TS IP++FWSL+ +L+I+LS NSL+G+LP +I NLKV
Sbjct: 522 GSLPACLSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKV 580
Query: 410 LIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469
+ ++ S NQLSG+IP +I L++L SL+ NR Q IP SFG L SLE+LDLS N+LS
Sbjct: 581 VTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLS 640
Query: 470 GEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCKE 529
G IPKS E L HLK NVS NRL+G+I GPF NF +SF+ N ALCGP R+QVPPCK
Sbjct: 641 GAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKS 700
Query: 530 DDT-KGSKKAAPIFLKYVLPLIISTTLIVILIILCIRYRNR------------TTWRRTS 576
T + SK+ ++Y++P I L++ L ++ R ++ TWR+ S
Sbjct: 701 ISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPATWRKIS 760
Query: 577 YLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLR 636
Y ++ +AT+GFNE NLLG GS GSVYKGTL DG +A+KVF+LQLE F+SECEVLR
Sbjct: 761 YHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLR 820
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
+RHRNL+KI SSCCNLDFKAL+LEF+P+GSLEKWLYSHNY+LD+L+RLNIMIDV ALE
Sbjct: 821 MLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALE 880
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YLHH + PVVHC+LKP+N+L++++M A VSDFGIS+LLGE D+VTQT+T+ATIGYMAP
Sbjct: 881 YLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGE-GDAVTQTLTLATIGYMAP 939
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
EY +GI+S K DVYSYG+ LMETFTRKKPTD+MF GEMSLK+W+K SLP+ +TEV+DA+
Sbjct: 940 EYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDAN 999
Query: 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866
L+ E + AK DC+ I++LAL C D P +R+CM DV+ L+KIK +
Sbjct: 1000 LLIEEEHFVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIKLKY 1049
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2216), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/929 (52%), Positives = 615/929 (66%), Gaps = 70/929 (7%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV 61
S GT+PP IGN+S L L + N+ +G +P E+G+L +K L N L G+ PS I
Sbjct: 157 SFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQLVGAIPSAIFN 216
Query: 62 FSKLQVLSLRNNS--------------------------FTGPIPNSLFNLSSLVRLDSR 95
S LQ ++L NS FTGPIP++L L L
Sbjct: 217 ISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSKCGELQTLYLS 276
Query: 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTI 155
FN +G IP I +LTKL L+ A N+L GE+P EIG+L L L + N+L G IP I
Sbjct: 277 FNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQI 336
Query: 156 FNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDL 215
FNIS+++ +L N LSG+ P G LPN + L+L N L+G IP+SI NASKL LD
Sbjct: 337 FNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDF 396
Query: 216 NSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNP 275
N L+G IP+ G+LR L LN+ N L E+ E SFL+SLTNC +LR L L NP
Sbjct: 397 GYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQ-ELSFLTSLTNCKRLRILYLSFNP 455
Query: 276 LDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGR 335
L ILP IGN S S Q+F A+ CKLKG+IP EIGNL L LSL NDL GTIP ++G+
Sbjct: 456 LIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQ 515
Query: 336 LQQLQAL-------------------------LQRNNLNGPIPTCLSSLISLRQLHLGSN 370
LQ+LQ L L N L+G IP CL L LR L+LGSN
Sbjct: 516 LQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSN 575
Query: 371 QLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGG 430
+L S+IPS+ WSL +IL +D+SSN L G LPSD+ NLKVL+ ++LSRNQLSG IP IGG
Sbjct: 576 KLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGG 635
Query: 431 LKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
L+DL +LSLA NRF+ I SF +L SLE++DLS+N L GEIPKS E L +LK L+VS N
Sbjct: 636 LQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFN 695
Query: 491 RLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCKEDDTKGSKKAAPIFLKYVLPLI 550
L G+IP GPF NF A+SF+ N ALCG PRL++PPC+ T+ S + + LKY+LP I
Sbjct: 696 GLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCR-TGTRWSTTISWLLLKYILPAI 754
Query: 551 ISTTLIVILIILCIRYRNR-------------TTWRRTSYLDIQQATDGFNECNLLGAGS 597
+ST L + LI + R R R TWRR SY +I QAT+GF+ NLLG GS
Sbjct: 755 LSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGS 814
Query: 598 FGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDF 655
GSVY+GTL DG N AIKVFNLQ E AF+SF++ECEV+ ++RHRNLIKI SSC N +DF
Sbjct: 815 LGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDF 874
Query: 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNN 715
KALVLE++PNGSLE+WLYSHNY LD+L+RLNIMIDV LA+EYLHH STPVVHC+LKP+N
Sbjct: 875 KALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSN 934
Query: 716 ILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGV 775
ILLD++ V DFGI+KLL E ++S+ +T T+ATIGYMAP+Y S+GI++ DVYSYG+
Sbjct: 935 ILLDEDFGGHVGDFGIAKLLRE-EESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGI 993
Query: 776 LLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR-EVQPSYAKMDCLLRI 834
+LMETFTR++PTDE+F+ EMS+K+W+ L +TEVVDA+L+R E + AK C+ I
Sbjct: 994 VLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLI 1053
Query: 835 MHLALGCCMDSPEQRMCMTDVVVKLQKIK 863
+ LA+ C DSPE+R+ M DVV L+KIK
Sbjct: 1054 LGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2176), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/907 (51%), Positives = 610/907 (67%), Gaps = 44/907 (4%)
Query: 3 LGGTVPPHIG-NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWI-G 60
LGG + +IG NLS L L++ N G P ++ L LKF+ N+L+G+ +
Sbjct: 178 LGGNILDNIGGNLSNLQVLNMGLNQLSGSFPPKILDLPSLKFIYLQVNNLSGNLKEILCN 237
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
SKLQ+L+L N G IP+ L+ L L N +G+IP IGNLTKL L+
Sbjct: 238 QNSKLQLLNLAGNQLYGQIPSDLYKCKELRSLALHANKFTGSIPRTIGNLTKLKWLSLGR 297
Query: 121 NNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMG 180
NNL G IP EIGNL+NL + L+ NNL G IP +FNIST+ I + N L G+ P+++G
Sbjct: 298 NNLTGRIPLEIGNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLG 357
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
LPN +L L N+L+G IP+ I+NASKL L+L SNS +G IP++ G+LR+L TL +
Sbjct: 358 LHLPNLIWLYLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLG 417
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
AN L+++ +S E + SSL NC L+ L L NPLD LP +GN S S + F A +
Sbjct: 418 ANLLSSKKTSQ-ELTIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGL 476
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL------------------ 342
+KGS+ + IGNL L L+L NDL G IPTT+G L+ LQ L
Sbjct: 477 IKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDL 536
Query: 343 -------LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNS 395
L N L+G IPTC S+L SLR L L SN+ S+I S+ W+L+ IL+++L+SN
Sbjct: 537 RTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNY 596
Query: 396 LSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSL 455
L+GSLPS+I+NL+ + +N+S+NQLSG IPI+IGGL+DL L L+ N+ Q IP S G +
Sbjct: 597 LTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDI 656
Query: 456 TSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYA 515
SLE+LDLS+NNLSG IPKS + L +LK NVS N L+G+IP G F NF AQSF+ N A
Sbjct: 657 KSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEA 716
Query: 516 LCGPPRLQVPPCKEDDTKGSKK-AAPIFLKYVLPLIISTTLIVILIILCIRYRNR----- 569
LCG RLQV PCK+D+++ ++ + I L+YVLP I+ ++ +I+ RY R
Sbjct: 717 LCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFS 776
Query: 570 --------TTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL 621
TT RR SY ++Q AT+GF E N LG GSFGSVYKGTL DGT +A KVFNLQL
Sbjct: 777 IEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQL 836
Query: 622 ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDM 681
ERAF+SF++ECEVLRN+RHRNL+KI +SC +FKALVLEFMPN SLEKWLYS +YFL+
Sbjct: 837 ERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNN 896
Query: 682 LERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741
L+RLNIM+DV LEYLHH ++ P+ HC++KP+N+LL+++M A ++DFGISKLLGE + S
Sbjct: 897 LQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLGE-EGS 955
Query: 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWI 801
V QTMT+ATIGYMAPEY S+GI+S + DVYSYGVLLMETFT+KKPTD+MFT ++SLK W+
Sbjct: 956 VMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWV 1015
Query: 802 KLSLPRGLTEVVDASLVR-EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860
+ SL +T+V+DA+L+ E AK DC++ I+ LAL C D P R+ M VV LQ
Sbjct: 1016 EQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQ 1075
Query: 861 KIKQTFL 867
KIK FL
Sbjct: 1076 KIKTKFL 1082
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2132), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/932 (48%), Positives = 602/932 (64%), Gaps = 68/932 (7%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSF-PSWI 59
M L GT+PP +GNLSFL YL + N+F G LP+E+G LRRL+ + N L+ P
Sbjct: 83 MGLLGTIPPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESF 142
Query: 60 GVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFN---------------------- 97
G +L+ L N+ TG IP+++FN+SSL LD FN
Sbjct: 143 GNLHRLEELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLPKNMCDHLPRLEMLLL 202
Query: 98 ---SISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTT 154
+SG IPS + +L L NN G IP E+G L L L L +N L G +P +
Sbjct: 203 SSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEVLNLGVNMLSGDLPRS 262
Query: 155 IFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLD 214
IFN++++ + + N LSG P LPN + L L N +TG++P + N S+L LD
Sbjct: 263 IFNMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILD 322
Query: 215 LNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSN 274
L+ N ++G + FGNLR L L++++N T SS +F++SLTN +L+ L +G N
Sbjct: 323 LSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQ-TLNFITSLTNSRQLKELHIGDN 381
Query: 275 PLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLG 334
PLD +LP +GN S+ +FY + KLKG+IP EIGNL LI LSL N L G IPTT+G
Sbjct: 382 PLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVG 441
Query: 335 RLQQLQAL-LQRNNLNG------------------------PIPTCLSSLISLRQLHLGS 369
L+++Q L L +NNLNG IP+C+ +L SLR L+L
Sbjct: 442 GLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHF 501
Query: 370 NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIG 429
N L+S+IP + WSL+ +L ++L SN L GSLPS + ++ I + LS NQLSGNIP TIG
Sbjct: 502 NILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIG 561
Query: 430 GLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSH 489
L++LI SL++N FQ SIP++FG L SLE LDLS NNLSGEIPKS E L +L+ +VS
Sbjct: 562 SLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSF 621
Query: 490 NRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCKEDDTKGSKKAAPIFLKYVLPL 549
N L+G+IP GPF NF A+SF+ N LCGP RLQVPPC + K SK + + L++ LP
Sbjct: 622 NGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRL-LRFSLPT 680
Query: 550 IISTTLIVILIILCIRYRNR-------------TTWRRTSYLDIQQATDGFNECNLLGAG 596
+ S L+V I L + R R RR SYL++ AT+ F+E NLLG G
Sbjct: 681 VASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIG 740
Query: 597 SFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656
SFGSVY+G L DG NVA+K+FNLQL+RAFRSF++ECE++RN+RHRNL+KI SC NLDFK
Sbjct: 741 SFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFK 800
Query: 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716
ALVLE+MP GSLEKWLYSHNY LD+++R+NIMIDV ALEYLHH + +PVVHC+LKP+N+
Sbjct: 801 ALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNV 860
Query: 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVL 776
LLD++M A V DFGI+KLLGE ++S QT T+ATIGYMAPEY DG++S K DVYS+G++
Sbjct: 861 LLDEDMVAHVCDFGIAKLLGE-NESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIM 919
Query: 777 LMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV-REVQPSYAKMDCLLRIM 835
LME TRK+PTDEMF GEMSLK +K SLP + ++VD++++ R S K C+ IM
Sbjct: 920 LMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIM 979
Query: 836 HLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
LAL C +SP +RM M +++ +L+ IK FL
Sbjct: 980 ELALQCVNESPGERMAMVEILARLKNIKAEFL 1011
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/953 (47%), Positives = 591/953 (62%), Gaps = 90/953 (9%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G +P + + L L +S N F G +P +G L L+ L AYN+L G P IG
Sbjct: 505 LKGEIPSSLSHCPHLRGLSLSLNQFTGGIPQAIGSLSNLEELYLAYNNLVGGIPREIGNL 564
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSI----------------------- 99
S L +L ++ +GPIP +FN+SSL D NS+
Sbjct: 565 SNLNILDFGSSGISGPIPPEIFNISSLQIFDLTDNSLLGSLPMDIYKHLPNLQELYLSWN 624
Query: 100 --------------------------SGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGN 133
+GNIP GNLT L L DNN++G IPNE+GN
Sbjct: 625 KLSGQLPSTLSLCGQLQSLSLWGNRFTGNIPPSFGNLTALQDLELGDNNIQGNIPNELGN 684
Query: 134 LKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWA 193
L NL +L L+ NNL G IP IFNIS + ++L N SG PS++G LP+ + L +
Sbjct: 685 LINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGTQLPDLEGLAIGR 744
Query: 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGE 253
N +G IP SI+N S+L LD+ N +G +P GNLR L LN+ +N LT E S++ E
Sbjct: 745 NEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTDEHSAS-E 803
Query: 254 WSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLR 313
FL+SLTNCN LR L + NPL ILP +GN S S + F A C+ +G+IP IGNL
Sbjct: 804 VGFLTSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDASACQFRGTIPTGIGNLT 863
Query: 314 GLIALSLFTNDLNGTIPTTLGRLQQLQAL-------------------------LQRNNL 348
LI+L L NDL G IPTTLG+L++LQ L L N L
Sbjct: 864 SLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQL 923
Query: 349 NGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLK 408
G IP+CL L LR+L+L SN L S+IP S W+L +L ++LSSN L+G LP ++ N+K
Sbjct: 924 TGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIK 983
Query: 409 VLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNL 468
+ L+LS+NQ+SG+IP T+G L++L LSL++NR Q IP FG L SL++LDLS NNL
Sbjct: 984 SIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNL 1043
Query: 469 SGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCK 528
SG IPKS + L++LK LNVS N+L+G+IP GPF NF A+SF++N ALCG P QV C
Sbjct: 1044 SGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACD 1103
Query: 529 EDDTKGSKKAAPIFLKYVLPLIISTTLIVILIILCIRYRNR-------TTW-----RRTS 576
+ S + LKY+LP +IS +V+ ++L IR R +W + S
Sbjct: 1104 KSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLPGSHEKIS 1163
Query: 577 YLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLR 636
+ + AT+ F E NL+G GS VYKG L +G VA+KVFNL+ + AFRSF+SECEV++
Sbjct: 1164 HQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQ 1223
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
++RHRNL+KI + C NLDFKALVLE+MP GSL+KWLYSHNYFLD+++RLNIMIDV ALE
Sbjct: 1224 SIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALE 1283
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YLHH + VVHC+LKPNNILLD +M A V DFGI++LL E +S+ QT T+ TIGYMAP
Sbjct: 1284 YLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLTE-TESMQQTKTLGTIGYMAP 1342
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
EY SDGI+S K DV+SYG++LME F RKKP DEMF G+++LK W++ SL + EVVDA+
Sbjct: 1343 EYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWVE-SLADSMIEVVDAN 1401
Query: 817 LVREVQPSYA-KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFLV 868
L+R +A K+ CL IM LAL C DSPE+R+ M DVVV L+KIK L
Sbjct: 1402 LLRREDEDFATKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELLT 1454
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2078), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/958 (48%), Positives = 604/958 (63%), Gaps = 95/958 (9%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
M L GT+PPH+GNLSFL ++ N F G LP+EL +LRR+K G + N +G PSWIG
Sbjct: 86 MGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNYFSGEIPSWIG 145
Query: 61 VFSKLQVLSLRNNSFT-------------------------------------------- 76
F++LQ LSL +N FT
Sbjct: 146 SFTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRALY 205
Query: 77 -------GPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPN 129
GPIP++L L L FN G+I IGNLT L L NN G IP+
Sbjct: 206 LNSNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSGTIPD 265
Query: 130 EIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFL 189
EIG+L +L +++L +N L G +P+ I+N S + I L NQLSG+ PS+ +LPN +F
Sbjct: 266 EIGDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGYLPSS--SNLPNLEFF 323
Query: 190 LLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETS 249
++ N TG IP S+ NASKL +DL NS G IP+ GNL+ L + N+LT ++S
Sbjct: 324 IIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLTVKSS 383
Query: 250 SNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEI 309
S+G S SSLT C LR L +NPL+ LP +GN S+S + +C + G+IPKEI
Sbjct: 384 SSGL-SLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGITGTIPKEI 442
Query: 310 GNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-------------------------LQ 344
GNL L L L NDL GTIPTT+ +L +LQ L L+
Sbjct: 443 GNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLYLE 502
Query: 345 RNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI 404
N L+G IP+CL ++ SLR L +G N+ +S+IPS+ W L IL ++LSSNSLSGSL DI
Sbjct: 503 VNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAVDI 562
Query: 405 QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLS 464
NLK + ++LS NQLSG+IP +IGGLK L+ LSLA NR + SIP FG SL+ LDLS
Sbjct: 563 GNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLS 622
Query: 465 NNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQV 524
NNNLSGEIPKS E L +L NVS N L+G+IP F N A+SF+ N LCG +LQV
Sbjct: 623 NNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQV 682
Query: 525 PPCKEDDTKGSKKAAPIFLKYVLPLIISTTLIVILI-ILCIRYRNR-----------TTW 572
PC+ +GSK A+ + L+Y L T L V + I+ IR R R T
Sbjct: 683 QPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMRITEGLLPLATL 742
Query: 573 RRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESEC 632
+R SY +++QATD FNE NLLG GSFGSVYKGT DG++VA+KVFNLQ+E AF+SF+ EC
Sbjct: 743 KRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDVEC 802
Query: 633 EVLRNVRHRNLIKIFSSCC--NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMID 690
EVLR +RHRNL+KI +SC N+DFKALVLEFMPN SLEKWL S +FL++LERLNIM+D
Sbjct: 803 EVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIMLD 862
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
V A+EYLHH ++ P+VHC+LKP+NILLD+NM A V+DFGI+KLLG D+ S QT+T+AT
Sbjct: 863 VASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLG-DEHSFIQTITLAT 921
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810
+GYMAPEY S+G++S D+YS+G+LLMETFTRKKPTD+MF E+S+K W++ S+P G+T
Sbjct: 922 VGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWVQESVPGGVT 981
Query: 811 EVVDASLVR-EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
++ D L+R E Q AK DC+L +M +AL C D PE+R + DV+ L K FL
Sbjct: 982 QITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTLNHTKVKFL 1039
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/905 (49%), Positives = 579/905 (63%), Gaps = 42/905 (4%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV- 61
L G +P IGNLS L L + N G +P E+ + L+ + F N L+GS P I
Sbjct: 304 LTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNISSLQVIDFTNNSLSGSLPMGICKH 363
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
LQ L L N +G +P +L L+ L FN G+IP +IGNL+KL H++ N
Sbjct: 364 LPNLQGLYLAQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPREIGNLSKLEHIDLRSN 423
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
+L G IP GNLK L L L +N L G +P IFNIS + + LV N LSG PS++G
Sbjct: 424 SLVGSIPTSFGNLKALKFLNLGINFLTGTVPEAIFNISELQNLALVQNHLSGSLPSSIGT 483
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
LP+ + L + AN +GTIP SI+N SKL L L+ NS +G +P NL L LN+
Sbjct: 484 WLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAH 543
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N LT E ++G FL+SLTNC LR L +G NPL LP +GN + + F A+ C+
Sbjct: 544 NQLTDEHLASGV-GFLTSLTNCKFLRYLWIGYNPLKGTLPNSLGNLPIALESFTAYACQF 602
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL------------------- 342
+G+IP IGNL LI L L NDL G+IPTTLGRLQ+LQ L
Sbjct: 603 RGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLK 662
Query: 343 ------LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSL 396
L N L+G P+C L++LR+L L SN L +IP+S WSL +L ++LSSN L
Sbjct: 663 NLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFL 722
Query: 397 SGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLT 456
+G+LP ++ N+K + L+LS+N +SG IP +G L+ LITLSL++NR Q I FG L
Sbjct: 723 TGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLV 782
Query: 457 SLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYAL 516
SLE LDLS+NNLSG IPKS E L +LK LNVS N+L+G+IP GPF F A+SF++N AL
Sbjct: 783 SLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEAL 842
Query: 517 CGPPRLQVPPCKEDDTKGSKKAAPIFLKYVLPLIISTTLIVILIILCIRYRNRT------ 570
CG P QV C +++ S K LKY+L + ST +V+ I+L IR R+
Sbjct: 843 CGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPI 902
Query: 571 ------TWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERA 624
T + S+ + AT+ F E NL+G GS G VYKG L +G NVAIKVFNL+ + A
Sbjct: 903 DSWLLGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGA 962
Query: 625 FRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER 684
RSF+SECEV++ +RHRNL++I + C NLDFKALVLE+MPNGSLEKWLYSHNYFLD+++R
Sbjct: 963 LRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQR 1022
Query: 685 LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
LNIMIDV ALEYLHH S+ VVHC+LKP+N+LLD +M A V+DFGI+KLL E +S+ Q
Sbjct: 1023 LNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLTE-TESMQQ 1081
Query: 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804
T T+ TIGYMAPE+ S GI+S K DVYSYG+LLME F RKKP DEMFTG+++LK W++ S
Sbjct: 1082 TKTLGTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWVE-S 1140
Query: 805 LPRGLTEVVDASLVREVQPSYA-KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863
L + +VVD +L+R A K+ CL IM LAL C DSP++R+ M D VV+L+K +
Sbjct: 1141 LSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTTDSPKERIDMKDAVVELKKSR 1200
Query: 864 QTFLV 868
L+
Sbjct: 1201 IKLLM 1205
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/905 (48%), Positives = 579/905 (63%), Gaps = 42/905 (4%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWI-GV 61
L G +P IGNLS L L +S N G +P E+ + L+ + F N L+GS P I
Sbjct: 328 LTGGIPREIGNLSNLNILQLSSNGISGPIPAEIFNVSSLQVIAFTDNSLSGSLPKDICKH 387
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
LQ LSL N +G +P +L L+ L FN G+IP +IGNL+KL + N
Sbjct: 388 LPNLQGLSLSQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEKIYLGTN 447
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
+L G IP GNLK L L L +NNL G +P IFNIS + + +V N LSG PS++G
Sbjct: 448 SLIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGT 507
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
L + + L + N +G IP SI+N SKL L L++NS +G +P GNL L L++
Sbjct: 508 WLSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAG 567
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N LT E ++ E FL+SLTNC L+ L +G+NP LP +GN + + F A C+
Sbjct: 568 NQLTDEHVAS-EVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQF 626
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL------------------- 342
+G+IP IGNL LI L L NDL G+IPTTLGRL++LQ L
Sbjct: 627 RGTIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLK 686
Query: 343 ------LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSL 396
L N L+G IP+C L +L++L L SN L +IP+S WSL +L ++LSSN L
Sbjct: 687 NLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFL 746
Query: 397 SGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLT 456
+G+LP ++ N+K + L+LS+N +SG+IP +G ++L LSL++N+ Q IP FG L
Sbjct: 747 TGNLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLV 806
Query: 457 SLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYAL 516
SLE LDLS NNLSG IPKS E L +LK LNVS N+L+G+IP GPF NF A+SF++N AL
Sbjct: 807 SLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEAL 866
Query: 517 CGPPRLQVPPCKEDDTKGSKKAAPIFLKYVLPLIISTTLIVILIILCIRYRNRT------ 570
CG P QV C +++ S K LKY+L + S +V+ I+L IR R+
Sbjct: 867 CGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPI 926
Query: 571 ------TWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERA 624
T + S+ + AT+ F E NL+G GS G VYKG L +G VAIKVFNL+ + A
Sbjct: 927 DSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGA 986
Query: 625 FRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER 684
RSF+SECEV++ +RHRNL++I + C NLDFKALVLE+MPNGSLEKWLYSHNYFLD+++R
Sbjct: 987 LRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQR 1046
Query: 685 LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
LNIMIDV ALEYLHH S+ VVHC+LKPNN+LLD +M A V+DFGI+KLL + +S+ Q
Sbjct: 1047 LNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTK-TESMQQ 1105
Query: 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804
T T+ TIGYMAPE+ SDGI+S K DVYSYG+LLME F+RKKP DEMFTG+++LK W++ S
Sbjct: 1106 TKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWVE-S 1164
Query: 805 LPRGLTEVVDASLVREVQPSYA-KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863
L + +VVDA+L+R A K+ CL IM LAL C DSPE+R+ M D VV+L+K +
Sbjct: 1165 LSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTDSPEERLNMKDAVVELKKSR 1224
Query: 864 QTFLV 868
L+
Sbjct: 1225 MKLLM 1229
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2050), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/954 (46%), Positives = 591/954 (61%), Gaps = 90/954 (9%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV 61
SL G +P ++ + L L +S N F G +P +G L L+ L +YN LTG P IG
Sbjct: 291 SLTGEIPSNLSHCRELRVLSLSFNQFTGGIPQAIGSLSNLEGLYLSYNKLTGGIPREIGN 350
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-------------- 107
S L +L L +N +GPIP +FN+SSL +D NS+SG++P I
Sbjct: 351 LSNLNILQLGSNGISGPIPAEIFNISSLQIIDFSNNSLSGSLPMDICKHLPNLQGLYLLQ 410
Query: 108 ----GNLT-------KLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTT-- 154
G L +L++L+ A N RG IP EIGNL L D+ L N+L+G IPT+
Sbjct: 411 NHLSGQLPTTLSLCGELLYLSLAVNKFRGSIPREIGNLSKLEDISLRSNSLVGSIPTSFG 470
Query: 155 ----------------------IFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLW 192
IFNIS + I+ LV N LSG P ++G LP+ + L +
Sbjct: 471 NLMALKYLDLGMNFLTGTVPEAIFNISELQILVLVQNHLSGSLPPSIGTWLPDLEGLYIG 530
Query: 193 ANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNG 252
+N+ +GTIP SI+N SKLI L + NS +G +P GNL L LN+ AN LT E ++G
Sbjct: 531 SNKFSGTIPMSISNMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLAANQLTNEHLASG 590
Query: 253 EWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNL 312
FL+SLTNC LR L + NP LP +GN + + F A C+ +G+IP IGNL
Sbjct: 591 -VGFLTSLTNCKFLRHLWIDDNPFKGTLPNSLGNLPIALESFTASACQFRGTIPTGIGNL 649
Query: 313 RGLIALSLFTNDLNGTIPTTLGRLQQLQAL-------------------------LQRNN 347
LI L L NDL +IPTTLGRLQ+LQ L L N
Sbjct: 650 TNLIELDLGANDLTRSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLHLXSNK 709
Query: 348 LNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNL 407
L+G IP+C L +L++L L SN L +IP+S WSL +L ++LSSN L+G+LP ++ N+
Sbjct: 710 LSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNM 769
Query: 408 KVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNN 467
K + L+LS+N +SG IP +G ++L LSL++NR Q IP FG L SLE LDLS NN
Sbjct: 770 KSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNN 829
Query: 468 LSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPC 527
LSG IPKS E L +LK LNVS N+L+G+IP GPF NF A+SF++N ALCG P QV C
Sbjct: 830 LSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPHFQVMAC 889
Query: 528 KEDDTKGSKKAAPIFLKYVLPLIISTTLIVILIILCIRYRNRT------------TWRRT 575
+++ S K LKY+L + ST +V+ I+L IR R+ T +
Sbjct: 890 DKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLWIRRRDNMEIXTPIDSWLPGTHEKI 949
Query: 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVL 635
S+ + AT+ F E NL+G GS G VYKG L +G VAIKVFNL+ + A RSF+SECEV+
Sbjct: 950 SHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVM 1009
Query: 636 RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
+ +RHRNL++I + C NLDFKALVL++MPNGSLEKWLYSHNYFLD+++RLNIMIDV AL
Sbjct: 1010 QGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASAL 1069
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755
EYLHH S+ VVHC+LKP+N+LLD BM A V+DFGI+KLL + +S+ QT T+ TIGYMA
Sbjct: 1070 EYLHHDCSSLVVHCDLKPSNVLLDDBMVAHVTDFGIAKLLTK-TESMQQTKTLGTIGYMA 1128
Query: 756 PEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815
PE+ SDGI+S K DVYSYG+LLME F RKKP DEMFTG+++LK W++ SL + +VVD
Sbjct: 1129 PEHGSDGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWVE-SLSNSVIQVVDV 1187
Query: 816 SLVREVQPSYA-KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFLV 868
+L+R A K+ CL IM LAL C DSPE+R+ M D VV+L+K + L+
Sbjct: 1188 NLLRREDEDLATKLSCLSSIMALALACTNDSPEERLDMKDAVVELKKSRMKLLM 1241
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 792 bits (2045), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/939 (47%), Positives = 574/939 (61%), Gaps = 90/939 (9%)
Query: 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFT 76
L L +S N F G +P LG L L+ L YN LTG P IG S L +L L ++
Sbjct: 293 LRVLKLSINQFTGGIPKALGSLSDLEELYLGYNKLTGGIPREIGNLSNLNILHLASSGIN 352
Query: 77 GPIPNSLFNLSSLVRLDSRFNSISG----------------------------------- 101
GPIP +FN+SSL R+D NS+SG
Sbjct: 353 GPIPAEIFNISSLHRIDFTNNSLSGGLPMDICKHLPNLQGLYLSQNHLSGQLPTTLFLCG 412
Query: 102 --------------NIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNL 147
+IP IGNL+KL + + N+L G IP GNLK L L L NNL
Sbjct: 413 ELLLLSLSINKFTGSIPRDIGNLSKLEKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNL 472
Query: 148 IGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNA 207
G IP IFNIS + + L N LSG PS++G LP+ + L + N +GTIP SI+N
Sbjct: 473 TGTIPEDIFNISKLQTLALAQNHLSGGLPSSIGTWLPDLEGLFIGGNEFSGTIPVSISNM 532
Query: 208 SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLR 267
SKLI L ++ N +G +P NLR L LN+ N LT E ++ E FL+SLTNC LR
Sbjct: 533 SKLIRLHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTDEHLTS-EVGFLTSLTNCKFLR 591
Query: 268 ALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNG 327
L + NPL LP +GN S + + F A C +G+IP IGNL LI L L NDL G
Sbjct: 592 TLWIDYNPLKGTLPNSLGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTG 651
Query: 328 TIPTTLGRLQQLQAL-------------------------LQRNNLNGPIPTCLSSLISL 362
+IPTTLG LQ+LQ L L N L+G IP+C L +L
Sbjct: 652 SIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPAL 711
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
R+L L SN L +IP SFWSL ++ + LSSN L+G+LP ++ N+K + L+LS+N +SG
Sbjct: 712 RELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISG 771
Query: 423 NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHL 482
IP +G L++L+ L L++N+ Q SIP FG L SLE +DLS NNL G IPKS E L +L
Sbjct: 772 YIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLEALIYL 831
Query: 483 KRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCKEDDTKGSKKAAPIF 542
K LNVS N+L+G+IP GPF NF A+SF++N ALCG P QV C +++ S K
Sbjct: 832 KHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNRTQSWKTKSFI 891
Query: 543 LKYVLPLIISTTLIVILIILCIRYRNRT-------TWRRTSYLDIQQ-----ATDGFNEC 590
LKY+L + S +V I+L IR R+ T +W ++ I Q AT+GF E
Sbjct: 892 LKYILLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLPGAHEKISQQQLLYATNGFGED 951
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
NL+G GS G VYKG L +G VAIKVFNL+ + A RSF+SECEV++ + HRNLI+I + C
Sbjct: 952 NLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCC 1011
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
NLDFKALVLE+MP GSL+KWLYSHNYFLD+ +RLNIMIDV ALEYLHH S+ VVHC+
Sbjct: 1012 SNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHCD 1071
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDV 770
LKP+N+LLD NM A V+DFGI++LL E +S+ QT T+ TIGYMAPEY SDGI+S K DV
Sbjct: 1072 LKPSNVLLDNNMVAHVADFGIARLLTE-TESMQQTKTLGTIGYMAPEYGSDGIVSTKGDV 1130
Query: 771 YSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA-KMD 829
YSYG+LLME F RKKP DEMFTG+++LK W++ SL + EVVDA+L+R A K+
Sbjct: 1131 YSYGILLMEVFARKKPMDEMFTGDVTLKTWVE-SLSSSVIEVVDANLLRRDDEDLATKLS 1189
Query: 830 CLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFLV 868
L +M LAL C DSPE+R+ M DVVV+L+KIK L+
Sbjct: 1190 YLSSLMALALACTADSPEERINMKDVVVELKKIKIKLLM 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 870 | ||||||
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.581 | 0.501 | 0.330 | 1.4e-132 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.564 | 0.486 | 0.334 | 1.6e-131 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.565 | 0.477 | 0.342 | 1.5e-128 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.567 | 0.481 | 0.339 | 1.7e-122 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.581 | 0.500 | 0.332 | 2.5e-112 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.932 | 0.791 | 0.338 | 3.6e-112 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.565 | 0.431 | 0.327 | 6.6e-98 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.6 | 0.466 | 0.321 | 5e-97 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.758 | 0.673 | 0.309 | 7.4e-68 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.559 | 0.389 | 0.323 | 3.9e-96 |
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 1.4e-132, Sum P(2) = 1.4e-132
Identities = 169/512 (33%), Positives = 245/512 (47%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ LGG + P IGNLSFL+YLD+S N+F G +P E+G L RLK+L +N L G P+ +
Sbjct: 76 LQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLS 135
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
S+L L L +N+ +P+ L +L L+ L N + G P I NLT L+ LN
Sbjct: 136 NCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGY 195
Query: 121 NNLRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPSTMG 180
N+L GEIP++I G L+GN SG+ G
Sbjct: 196 NHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFG 255
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
+ LPN L L N LTG IP ++ N S L + N ++G I FG L +L L +
Sbjct: 256 NLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELA 315
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
N L + S G+ +FL +LTNC+ L LS+ N L LP I N S
Sbjct: 316 NNSLGSY--SFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNL 373
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTXXXXXXXXXXXXXXXXXX-PIPTCLSSL 359
+ GSIP +IGNL GL +L L N L G +PT+ IP+ + +L
Sbjct: 374 IYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNL 433
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDXXXXXXXXXXXXDIQNLKVLIYLNLSRNQ 419
L +L+L +N +P S ++L + +I + L++LN+ N
Sbjct: 434 TQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNS 493
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479
LSG++P IG L++L+ L L N +P + G S+E + L N+ G IP + L
Sbjct: 494 LSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIP-DIKGL 552
Query: 480 SHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFL 511
+K +++S+N L G I F NF +L
Sbjct: 553 MGVKNVDLSNNNLSGSISEY--FENFSKLEYL 582
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 1.6e-131, Sum P(2) = 1.6e-131
Identities = 167/500 (33%), Positives = 257/500 (51%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ LGG + P IGNLSFL+ LD+ EN F G +P E+GQL RL++L N L G P +G
Sbjct: 76 LQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIP--LG 133
Query: 61 VFSKLQVLSLR--NNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNF 118
+++ ++L+LR +N G +P+ L +L++LV+L+ N++ G +P+ +GNLT L L
Sbjct: 134 LYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLAL 193
Query: 119 ADNNLRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPST 178
+ NNL GEIP+++ G + N SG
Sbjct: 194 SHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPD 253
Query: 179 MGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLN 238
+G LPN + N TG+IP +++N S L L +N N+L+G IP TFGN+ +L L
Sbjct: 254 LGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLF 312
Query: 239 IRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHE 298
+ N L +++S + E FL+SLTNC +L L +G N L LP I N SA
Sbjct: 313 LHTNSLGSDSSRDLE--FLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGG 370
Query: 299 CKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTXXXXXXXXXXXXXXXXXXP-IPTCLS 357
+ GSIP +IGNL L L L N L+G +PT+ IP +
Sbjct: 371 TLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIG 430
Query: 358 SLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDXXXXXXXXXXXXDIQNLKVLIYLNLSR 417
++ L L L +N +P+S + ++L + +I ++ L+ L++S
Sbjct: 431 NMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSG 490
Query: 418 NQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFE 477
N L G++P IG L++L TLSL N+ +P + G+ ++E L L N G+IP +
Sbjct: 491 NSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLK 549
Query: 478 ILSHLKRLNVSHNRLEGKIP 497
L +K +++S+N L G IP
Sbjct: 550 GLVGVKEVDLSNNDLSGSIP 569
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 1.5e-128, Sum P(2) = 1.5e-128
Identities = 170/496 (34%), Positives = 255/496 (51%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G + P IGNLSFL L++++N+F +P ++G+L RL++L +YN L G PS +
Sbjct: 85 LTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNC 144
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
S+L + L +N +P+ L +LS L LD N+++GN P+ +GNLT L L+FA N
Sbjct: 145 SRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQ 204
Query: 123 LRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPSTMGHS 182
+RGEIP+E+ G L N SG+ + G+
Sbjct: 205 MRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYL 264
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
LPN + LLL N+ TG IP ++ N S L D++SN LSG IP +FG LR+L L IR N
Sbjct: 265 LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNN 324
Query: 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK 302
L +SS E F+ ++ NC +L L +G N L LP I N S + + + +
Sbjct: 325 SLGNNSSSGLE--FIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382
Query: 303 GSIPKEIGNLRGLIALSLFTNDLNGTIPTTXXXXXXXXXXXXXXXXXX-PIPTCLSSLIS 361
G+IP +IGNL L LSL TN L+G +P + IP+ ++
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDXXXXXXXXXXXXDIQNLKVLIYLNLSRNQLS 421
L++LHL SN IP S Y+L + +I + L Y++LS N L+
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502
Query: 422 GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSH 481
G+ P +G L+ L+ L + N+ +P + G S+E+L + N+ G IP ++S
Sbjct: 503 GHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVS- 561
Query: 482 LKRLNVSHNRLEGKIP 497
LK ++ S+N L G+IP
Sbjct: 562 LKNVDFSNNNLSGRIP 577
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
Identities = 169/498 (33%), Positives = 242/498 (48%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ L G V P +GNLSFL L++++N F G +P+E+G L RL++L + N G P +
Sbjct: 91 LKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLS 150
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
S L L L +N +P +LS LV L N+++G P+ +GNLT L L+F
Sbjct: 151 NCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIY 210
Query: 121 NNLRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPSTMG 180
N + GEIP +I G + GN SG G
Sbjct: 211 NQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFG 270
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
LPN Q L + N TGTIP +++N S L LD+ SN L+G+IP +FG L++L L +
Sbjct: 271 SLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLN 330
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
N L +S G+ FL +LTNC++L+ L++G N L LP I N S +
Sbjct: 331 NNSLGNYSS--GDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNL 388
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTXXXXXXXXXXXXXXXXXX-PIPTCLSSL 359
+ GSIP IGNL L L L N L G +P + IP+ L ++
Sbjct: 389 ISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNI 448
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDXXXXXXXXXXXXDIQNLKVLIYLNLSRNQ 419
L L+L +N SIPSS S Y+L ++ ++ L L+ LN+S N
Sbjct: 449 SGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNL 508
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479
L G + IG LK L+ L ++ N+ IP + + SLE+L L N+ G IP L
Sbjct: 509 LVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGL 567
Query: 480 SHLKRLNVSHNRLEGKIP 497
+ L+ L++S N L G IP
Sbjct: 568 TGLRFLDLSKNNLSGTIP 585
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 2.5e-112, Sum P(2) = 2.5e-112
Identities = 170/512 (33%), Positives = 250/512 (48%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ LGG V P IGN+SFL+ LD+S+N F G +P E+G L RL+ L A+N L G P+ +
Sbjct: 76 LQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLS 135
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
S+L L L +N +P+ L +L+ LV LD N++ G +P +GNLT L L F D
Sbjct: 136 NCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTD 195
Query: 121 NNLRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPSTMG 180
NN+ GE+P+E+ G L G+ SG G
Sbjct: 196 NNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFG 255
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
+ LPN + L L N L G IP +++N S L +N N ++G I FG + L L++
Sbjct: 256 NLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLS 315
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
N L + T G+ F+ SLTNC L+ LS+G L LP I N S
Sbjct: 316 ENPLGSYTF--GDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNH 373
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTXXXXXXXXXXXXXXXXXX-PIPTCLSSL 359
GSIP++IGNL GL L L N L G +PT+ IP+ + +L
Sbjct: 374 FFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNL 433
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDXXXXXXXXXXXXDIQNLKVLIYLNLSRNQ 419
L L+L +N +P S ++L + +I + L+ L++ N
Sbjct: 434 TQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNS 493
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479
LSG++P IG L++L+ LSL N+F +P + G+ ++E L L N+ G IP + L
Sbjct: 494 LSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGL 552
Query: 480 SHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFL 511
++R+++S+N L G IP F NF +L
Sbjct: 553 MGVRRVDLSNNDLSGSIPEY--FANFSKLEYL 582
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 286/845 (33%), Positives = 424/845 (50%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G +PP + LS L L++S+N+ +G +P +G +L L ++N L G P IG
Sbjct: 115 LSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGAS 174
Query: 63 SK-LQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
K L L L N +G IP++L NL+SL D FN +SG IPS +G L+ L+ +N N
Sbjct: 175 LKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQN 234
Query: 122 NLRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVG-NQLSGHRPSTMG 180
NL G IPN I G +G N+ G P+++
Sbjct: 235 NLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVA 294
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
++ + + ++ N +G I + L L L N + + +G +S L
Sbjct: 295 NA-SHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWG---FISDLTNC 350
Query: 241 ANYLTTETSSNGEWSFL-SSLTNCN-KLRALSLGSNPLDSILPPLIGNFSASFQQFYAHE 298
+ T N L +S +N + L L+L N + +P IGN Q Y
Sbjct: 351 SKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNL-IGLQHLYLCN 409
Query: 299 CKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTXXXXXXXXXXXXXXXXXXP-IPTCLS 357
+GS+P +G L+ L L + N+L+G+IP IP LS
Sbjct: 410 NNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLS 469
Query: 358 SLISLRQLHLGSNQLTSSIPSSFWSLEYI-LRIDXXXXXXXXXXXXDIQNLKVLIYLNLS 416
+L +L L L +N L+ IPS ++++ + + I+ +I +LK L+ +
Sbjct: 470 NLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAE 529
Query: 417 RNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSF 476
N+LSG IP T+G + L L L N SIP + G L LE LDLS+NNLSG+IP S
Sbjct: 530 SNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSL 589
Query: 477 EILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGP-PRLQVPPCKED-DTKG 534
++ L LN+S N G++PT G F S N LCG P L +P C + +
Sbjct: 590 ADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRK 649
Query: 535 SKKAAPIFLKYXXXXXXXXXXXXXXXXXXXRYR---NRTTWRR---TSYLDIQQATDGFN 588
PI + + +RT+ + SY + +ATDGF
Sbjct: 650 HFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLVSYSQLVKATDGFA 709
Query: 589 ECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
NLLG+GSFGSVYKG L +VA+KV L+ +A +SF +ECE LRN+RHRNL+KI +
Sbjct: 710 PTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVT 769
Query: 649 SCCNLD-----FKALVLEFMPNGSLEKWLY------SHNYFLDMLERLNIMIDVGLALEY 697
C ++D FKA+V +FMPNGSLE W++ + L++ R+ I++DV AL+Y
Sbjct: 770 ICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDY 829
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ-TMTMA---TIGY 753
LH PVVHC++K +N+LLD +M A V DFG++++L + + Q T +M TIGY
Sbjct: 830 LHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGY 889
Query: 754 MAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813
APEY I S D+YSYG+L++E T K+PTD F ++ L+ +++L L +T+VV
Sbjct: 890 AAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVV 949
Query: 814 DASLV 818
D L+
Sbjct: 950 DTKLI 954
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 596 (214.9 bits), Expect = 6.6e-98, Sum P(2) = 6.6e-98
Identities = 166/507 (32%), Positives = 237/507 (46%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV 61
+L GT+P +G+ L LD+S N G +P L +LR L+ L N LTG P I
Sbjct: 116 NLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISK 175
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSL--VRLDSRFNSISGNIPSKIGNLTKLVHLNFA 119
SKL+ L L +N TG IP L LS L +R+ ISG IPS+IG+ + L L A
Sbjct: 176 CSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGN-KEISGQIPSEIGDCSNLTVLGLA 234
Query: 120 DNNLRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPSTM 179
+ ++ G +P+ +G G L N LSG P +
Sbjct: 235 ETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREI 294
Query: 180 GHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNI 239
G L + L LW N L G IP I N S L +DL+ N LSG IP++ G L L
Sbjct: 295 GQ-LTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLE---- 349
Query: 240 RANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHEC 299
++ ++ +G S ++++NC+ L L L N + ++P +G + F+A
Sbjct: 350 --EFMISDNKFSG--SIPTTISNCSSLVQLQLDKNQISGLIPSELGTLT-KLTLFFAWSN 404
Query: 300 KLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTXXXXXXXXXXXXXXXXXXP-IPTCLSS 358
+L+GSIP + + L AL L N L GTIP+ IP + +
Sbjct: 405 QLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGN 464
Query: 359 LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDXXXXXXXXXXXXDIQNLKVLIYLNLSRN 418
SL +L LG N++T IPS SL+ I +D +I + L ++LS N
Sbjct: 465 CSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNN 524
Query: 419 QLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEI 478
L G++P + L L L ++ N+F IP S G L SL L LS N SG IP S +
Sbjct: 525 SLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGM 584
Query: 479 LSHLKRLNVSHNRLEGKIPTN-GPFRN 504
S L+ L++ N L G+IP+ G N
Sbjct: 585 CSGLQLLDLGSNELSGEIPSELGDIEN 611
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 599 (215.9 bits), Expect = 5.0e-97, Sum P(2) = 5.0e-97
Identities = 176/547 (32%), Positives = 252/547 (46%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G++P +GNL LM L + EN G +P E+G + + L + N LTGS PS +G
Sbjct: 234 LTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNL 293
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
L +LSL N TG IP L N+ S++ L+ N ++G+IPS +GNL L L +N
Sbjct: 294 KNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENY 353
Query: 123 LRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPSTMGHS 182
L G IP E+G G L N L+G P +G+
Sbjct: 354 LTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGN- 412
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
+ + L L N+LTG++P+S N +KL L L N LSG IP N HL+TL + N
Sbjct: 413 MESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTN 472
Query: 243 YLT---TETSSNG--------EWSFLS-----SLTNCNKL-RALSLGSNPLDSILPPLIG 285
T ET G +++ L SL +C L RA LG+ I G
Sbjct: 473 NFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAF-G 531
Query: 286 NF-SASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTX-XXXXXXXXXX 343
+ +F F +H K G I L AL + N++ G IPT
Sbjct: 532 IYPDLNFIDF-SHN-KFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDL 589
Query: 344 XXXXXXXPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDXXXXXXXXXXXXD 403
+P + +L +L +L L NQL+ +P+ L + +D
Sbjct: 590 STNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQT 649
Query: 404 IQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDL 463
+ L +NLSRN+ G+IP + L L L L+ N+ IP SL SL+ LDL
Sbjct: 650 FDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDL 708
Query: 464 SNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGP-PRL 522
S+NNLSG IP +FE + L +++S+N+LEG +P FR A + N LC P+
Sbjct: 709 SHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQ 768
Query: 523 QVPPCKE 529
++ PC+E
Sbjct: 769 RLKPCRE 775
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 7.4e-68, P = 7.4e-68
Identities = 217/702 (30%), Positives = 321/702 (45%)
Query: 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG-VFSKLQVLSLRNNSFTGP 78
LDIS + G + + L L L + N G P IG + L+ LSL N G
Sbjct: 71 LDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGN 130
Query: 79 IPNSLFNLSSLVRLDSRFNSISGNIPSKI---GNLTKLVHLNFADNNLRGEIP-NEIGXX 134
IP L L+ LV LD N ++G+IP ++ G+ + L +++ ++N+L GEIP N
Sbjct: 131 IPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHL 190
Query: 135 XXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPSTMGHSLPNRQFLLLWAN 194
G L N LSG PS + +P QFL L N
Sbjct: 191 KELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYN 250
Query: 195 RLTGTIPN--------SITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246
N S+ N+S L L+L NSL G+I ++ +RHLS +N+ +L
Sbjct: 251 HFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSS---VRHLS-VNLVQIHLD- 305
Query: 247 ETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIP 306
+ +G S ++N L L+L SN L +P + S ++ Y L G IP
Sbjct: 306 QNRIHG--SIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLS-KLERVYLSNNHLTGEIP 362
Query: 307 KEIGNLRGLIALSLFTNDLNGTIPTTXXXXXXXXXXXXXXXXXX-PIPTCLSSLISLRQL 365
E+G++ L L + N+L+G+IP + +P L I+L L
Sbjct: 363 MELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEIL 422
Query: 366 HLGSNQLTSSIPSSFWS-LEYI-LRIDXXXXXXXXXXXXDIQNLKVLIYLNLSRNQLSGN 423
L N LT +IP S L + L ++ ++ + +++ ++LS N+LSG
Sbjct: 423 DLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGK 482
Query: 424 IPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLK 483
IP +G L L+L+RN F ++P S G L L+ LD+S N L+G IP SF+ S LK
Sbjct: 483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542
Query: 484 RLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCKEDDTKGSKK------ 537
LN S N L G + G F +SFL + LCG + + CK+ S
Sbjct: 543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLS 601
Query: 538 --AAPIFLKYXXXXXXXXXXXXXXXXXXX--------RYRNRTTWRRTSYLDIQQATDGF 587
A P+ + + +N + R SY + AT GF
Sbjct: 602 LIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGF 661
Query: 588 NECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFR-SFESECEVLRNVRHRNLIKI 646
N +L+G+G FG VYKG L + T VA+KV + + F SF+ EC++L+ RHRNLI+I
Sbjct: 662 NASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRI 721
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIM 688
++C F ALVL MPNGSLE+ LY Y L+ + ++
Sbjct: 722 ITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLV 763
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 3.9e-96, Sum P(2) = 3.9e-96
Identities = 161/497 (32%), Positives = 226/497 (45%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ L G++ P G L++LD+S NN G +P L L L+ L N LTG PS +G
Sbjct: 81 LGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLG 140
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
++ L + +N G IP +L NL +L L ++G IPS++G L ++ L D
Sbjct: 141 SLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQD 200
Query: 121 NNLRGEIPNEIGXXXXXXXXXXXXXXXIGXXXXXXXXXXXXXXXXLVGNQLSGHRPSTMG 180
N L G IP E+G G L N L+G PS +G
Sbjct: 201 NYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLG 260
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
+ Q+L L AN+L G IP S+ + L LDL++N+L+G+IP F N+ L L +
Sbjct: 261 E-MSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLA 319
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
N+L+ S S+ TN L L L L +P + S +Q
Sbjct: 320 NNHLSGSLPK----SICSNNTN---LEQLVLSGTQLSGEIPVELSKCQ-SLKQLDLSNNS 371
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTI-PTTXXXXXXXXXXXXXXXXXXPIPTCLSSL 359
L GSIP+ + L L L L N L GT+ P+ +P +S+L
Sbjct: 372 LAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISAL 431
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDXXXXXXXXXXXXDIQNLKVLIYLNLSRNQ 419
L L L N+ + IP + + ID I LK L L+L +N+
Sbjct: 432 RKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNE 491
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479
L G +P ++G L L LA N+ SIP SFG L LE L L NN+L G +P S L
Sbjct: 492 LVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISL 551
Query: 480 SHLKRLNVSHNRLEGKI 496
+L R+N+SHNRL G I
Sbjct: 552 RNLTRINLSHNRLNGTI 568
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3856 | 0.9919 | 0.8544 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00110705 | hypothetical protein (1061 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 870 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-105 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-69 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-42 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 348 bits (894), Expect = e-105
Identities = 270/873 (30%), Positives = 404/873 (46%), Gaps = 84/873 (9%)
Query: 12 GNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLR 71
G++ L LD+S N G +PN++G LK L N L G P+ + + L+ L+L
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196
Query: 72 NNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEI 131
+N G IP L + SL + +N++SG IP +IG LT L HL+ NNL G IP+ +
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
Query: 132 GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLL 191
GNLKNL L L N L GPIP +IF++ +I ++L N LSG P + L N + L L
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ-LQNLEILHL 315
Query: 192 WANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSN 251
++N TG IP ++T+ +L L L SN SG+IP G +L+ L++ N LT E
Sbjct: 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP-- 373
Query: 252 GEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGN 311
L + L L L SN L+ G IPK +G
Sbjct: 374 ------EGLCSSGNLFKLILFSNSLE-------------------------GEIPKSLGA 402
Query: 312 LRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSN 370
R L + L N +G +P+ +L + L + NNL G I + + SL+ L L N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 371 QLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGG 430
+ +P SF S + + +DLS N SG++P + +L L+ L LS N+LSG IP +
Sbjct: 463 KFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS 521
Query: 431 LKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
K L++L L+ N+ IP SF + L LDLS N LSGEIPK+ + L ++N+SHN
Sbjct: 522 CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN 581
Query: 491 RLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQ-VPPCKEDDTKGSKKAAPIFLKYVLPL 549
L G +P+ G F A + N LCG +PPCK + P + Y+
Sbjct: 582 HLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR------VRKTPSWWFYITCT 635
Query: 550 IIS--TTLIVILIILCIRYRNRTTWRRTSYLDIQQATDGFN-----------------EC 590
+ + +V + IR RN +R D F+ E
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEE 695
Query: 591 NLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSF-ESECEVLRNVRHRNLIKIFS 648
N++ G G+ YKG ++ +G +K N S SE + ++H N++K+
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
C + L+ E++ +L + L + L R I I + AL +LH S VV
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
NL P I++D + L T T + Y+APE I+ K
Sbjct: 807 GNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKS 859
Query: 769 DVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR-GLTEVVDASLVREVQPSYAK 827
D+Y +G++L+E T K P D F S+ W + L +D S+ +V + +
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919
Query: 828 MDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860
+ + +M+LAL C P R C DV+ L+
Sbjct: 920 I---VEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 7e-69
Identities = 164/460 (35%), Positives = 247/460 (53%), Gaps = 15/460 (3%)
Query: 40 RLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVR-LDSRFNS 98
R+ + + +++G S I +Q ++L NN +GPIP+ +F SS +R L+ N+
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129
Query: 99 ISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNI 158
+G+IP G++ L L+ ++N L GEIPN+IG+ +L L L N L+G IP ++ N+
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 159 STIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSN 218
+++ + L NQL G P +G + + +++ L N L+G IP I + L LDL N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 219 SLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDS 278
+L+G IP++ GNL++L L + N L+ S+ + KL +L L N L
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP--------PSIFSLQKLISLDLSDNSLSG 298
Query: 279 ILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQ 338
+P L+ + + + G IP + +L L L L++N +G IP LG+
Sbjct: 299 EIPELVIQLQ-NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357
Query: 339 LQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLS 397
L L L NNL G IP L S +L +L L SN L IP S + + R+ L NS S
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 398 GSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTS 457
G LPS+ L ++ +L++S N L G I + L LSLARN+F +PDSFGS
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KR 476
Query: 458 LEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIP 497
LE LDLS N SG +P+ LS L +L +S N+L G+IP
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 3e-55
Identities = 148/416 (35%), Positives = 217/416 (52%), Gaps = 16/416 (3%)
Query: 85 NLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNL-KNLADLVLA 143
N S +V +D +ISG I S I L + +N ++N L G IP++I +L L L+
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 144 LNNLIGPIPT-TIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPN 202
NN G IP +I N+ T ++L N LSG P+ +G S + + L L N L G IPN
Sbjct: 127 NNNFTGSIPRGSIPNLET---LDLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIPN 182
Query: 203 SITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTN 262
S+TN + L L L SN L GQIP G ++ L + + N L+ E E L+SL +
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY--EIGGLTSLNH 240
Query: 263 CNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFT 322
L L N L +P +GN + Q + ++ KL G IP I +L+ LI+L L
Sbjct: 241 ------LDLVYNNLTGPIPSSLGNLK-NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293
Query: 323 NDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFW 381
N L+G IP + +LQ L+ L L NN G IP L+SL L+ L L SN+ + IP +
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353
Query: 382 SLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR 441
+ +DLS+N+L+G +P + + L L L N L G IP ++G + L + L
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413
Query: 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIP 497
N F +P F L + +LD+SNNNL G I + L+ L+++ N+ G +P
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 9e-45
Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 593 LGAGSFGSVYKGTLFD-----GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FG VYKGTL T VA+K E F E +++ + H N+++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR- 65
Query: 647 FSSCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
C +V E+MP G L +L H L + + L + + + +EYL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN--- 122
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
VH +L N L+ +N+ ++SDFG+S+ + EDD + I +MAPE DG +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 766 PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
K DV+S+GVLL E FT GE EV++ L+ +
Sbjct: 183 SKSDVWSFGVLLWEIFTL---------GEQPYPGMS-------NEEVLE--LLEDGYRLP 224
Query: 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859
+C + L L C PE R +++V L
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 79/274 (28%), Positives = 125/274 (45%), Gaps = 30/274 (10%)
Query: 593 LGAGSFGSVYKGTLFD-----GTNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FG VYKG L VA+K E+ F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
C + +V+E+M G L +L + L + + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
+H +L N L+ +N+ ++SDFG+S+ L DDD + I +MAPE +G +
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
K DV+S+GVLL E FT ++P MS + + E + QP
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYP-----GMSNEE---------VLEYLKNGYRLP-QPPN 227
Query: 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859
C + L L C + PE R +++V L
Sbjct: 228 ----CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 68/191 (35%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSC 650
LG G FG+VY G VAIK+ + E E+L+ + H N++K++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+ + LV+E+ GSL+ L + L E L I++ + LEYL HS ++H +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117
Query: 711 LKPNNILLDK-NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YASDGIISPKC 768
LKP NILLD N +++DFG+SKLL D + + T YMAPE G S K
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 769 DVYSYGVLLME 779
D++S GV+L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 80/275 (29%), Positives = 125/275 (45%), Gaps = 31/275 (11%)
Query: 593 LGAGSFGSVYKGTLFDG-----TNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FG VYKGTL VA+K E+ F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWL-YSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
C + +V+E+MP G L +L + L + + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
+H +L N L+ +N+ ++SDFG+S+ L DDD I +MAPE +G +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 766 PKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824
K DV+S+GVLL E FT ++P MS + E + +P
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYP-----GMSNAE---------VLEYLKKGYRLP-KPP 227
Query: 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859
C + L L C + PE R +++V L
Sbjct: 228 N----CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 13/215 (6%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFR-SFESECEVLRNVRHRNLIKIFS 648
LG GSFG VY G VAIKV + + R E ++L+ ++H N+++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
+ D LV+E+ G L L E + + ALEYLH +VH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+LKP NILLD++ +++DFG+++ L D T + T YMAPE
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTF-VGTPEYMAPEVLLGKGYGKAV 177
Query: 769 DVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803
D++S GV+L E T K P F G+ L K
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKK 208
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 70/198 (35%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER--AFRSFESECEVLRNVRHRNLIKIFSS 649
LG+GSFG+VYK G VA+K+ + E+ ++ E +LR + H N++++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
+ D LV+E+ G L +L E I + + LEYLH S+ ++H
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH-SNG--IIHR 122
Query: 710 NLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI-ISPKC 768
+LKP NILLD+N +++DFG++K L + S T T YMAPE G PK
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLK-SSSSLTTFV-GTPWYMAPEVLLGGNGYGPKV 180
Query: 769 DVYSYGVLLMETFTRKKP 786
DV+S GV+L E T K P
Sbjct: 181 DVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 85/285 (29%), Positives = 130/285 (45%), Gaps = 38/285 (13%)
Query: 591 NLLGAGSFGSVYKGTLFDGTN----VAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIK 645
LG G+FG VYKG L VA+K R F E V++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 646 IFSSCCNLDFK-ALVLEFMPNGSLEKWLYSH--------NYFLDMLERLNIMIDVGLALE 696
+ C + LVLE+M G L +L L + + L+ I + +E
Sbjct: 61 LLG-VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YL S VH +L N L+ +++ ++SDFG+S+ + +DD +T I +MAP
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815
E DGI + K DV+S+GVLL E FT P + E+ L++ L +G
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY-----LRKGY------ 224
Query: 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860
R +P Y D L +M L C PE R +++V +L+
Sbjct: 225 ---RLPKPEYCP-DELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 9e-39
Identities = 111/309 (35%), Positives = 164/309 (53%), Gaps = 17/309 (5%)
Query: 205 TNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLS----SL 260
N+S+++ +DL+ ++SG+I + L ++ T+N+ N L+ + + S +L
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 261 TNCN-----------KLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEI 309
+N N L L L +N L +P IG+FS S + L G IP +
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFS-SLKVLDLGGNVLVGKIPNSL 184
Query: 310 GNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLG 368
NL L L+L +N L G IP LG+++ L+ + L NNL+G IP + L SL L L
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244
Query: 369 SNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITI 428
N LT IPSS +L+ + + L N LSG +P I +L+ LI L+LS N LSG IP +
Sbjct: 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304
Query: 429 GGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVS 488
L++L L L N F IP + SL L+ L L +N SGEIPK+ ++L L++S
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 489 HNRLEGKIP 497
N L G+IP
Sbjct: 365 TNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 591 NLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIF 647
LLG GSFGSVY D G +A+K L E + E E +L +++H N+++ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 648 SSCCNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDMLERLNI------MIDVGLALEYLH 699
S + + L LE++ GSL L +L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEY 758
S+ +VH ++K NIL+D + +++DFG +K LG D ++ T ++ T +MAPE
Sbjct: 119 -SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLG-DIETGEGTGSVRGTPYWMAPEV 174
Query: 759 ASDGIISPKCDVYSYGVLLMETFTRKKP 786
D++S G ++E T K P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 26/278 (9%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
F LG+G FG V++G + VAIK+ + F+ E + L+ +RH++LI +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
F+ C + ++ E M GSL +L S L + +++ V + YL +S
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS-- 125
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
+H +L NIL+ +++ +V+DFG+++L+ +D + + APE AS G S
Sbjct: 126 -IHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 766 PKCDVYSYGVLLMETFTRKK-PTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824
K DV+S+G+LL E FT + P M E+ + +P P+
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC---------------PA 227
Query: 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
C I + L C PE R + +L I
Sbjct: 228 ----KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 80/292 (27%), Positives = 125/292 (42%), Gaps = 47/292 (16%)
Query: 593 LGAGSFGSVYKGTLF------DGTNVAIKVF-NLQLERAFRSFESECEVLRNVRHRNLIK 645
LG G+FG V+ G + D VA+K A + FE E E+L N +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHN-------------YFLDMLERLNIMIDVG 692
+ C D +V E+M +G L K+L SH L + + L I + +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
+ YL H VH +L N L+ ++ ++ DFG+S+ + D TM I
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 753 YMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMS--LKHWIKLSLPRGL 809
+M PE + + DV+S+GV+L E FT K+P + E+ + L PR
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRT- 248
Query: 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861
C + + LGC P+QR+ + D+ +LQK
Sbjct: 249 --------------------CPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G G FG VYK G VAIKV L+ + +E ++L+ +H N++K + S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
D +V+EF GSL+ L S N L + + ++ LEYLH + ++H ++
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDI 124
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
K NILL + ++ DFG+S L D TM + T +MAPE + K D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL--SDTKARNTM-VGTPYWMAPEVINGKPYDYKADIW 181
Query: 772 SYGVLLMETFTRKKP 786
S G+ +E K P
Sbjct: 182 SLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 591 NLLGAGSFGSVYKGT---LFDGTN--VAIKVFNLQLERAFRS-FESECEVLRNVRHRNLI 644
LG G FG V L D T VA+K N E RS FE E E+LR + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 645 KIFSSCCNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
K + C L++E++P+GSL +L H +++ L + ++YL
Sbjct: 70 K-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT-QTMTMATIGYMAPEYAS 760
+H +L NIL++ ++SDFG++K+L ED D + + I + APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPT 787
S DV+S+GV L E FT P+
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 73/239 (30%), Positives = 106/239 (44%), Gaps = 41/239 (17%)
Query: 593 LGAGSFGSVYK------GTLFDGTNVAIKVFNLQLERAFRSFE---SECEVLRNVRHRNL 643
LG GSFG V G L+ A+KV + + E +E +L + H +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 644 IKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYL 698
+K+ + F+ LVLE+ P G L L F + R ++ LALEYL
Sbjct: 56 VKLHYA-----FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYL 109
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPE 757
H S +++ +LKP NILLD + +++DFG++K L + +T T T Y+APE
Sbjct: 110 H-SLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPE 163
Query: 758 YASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGLTE 811
D +S GVLL E T K P E++ E LK L P L+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY--EKILK--DPLRFPEFLSP 218
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFNL-QLERAFRSF-ESECEVLRNVRHRNLIKIF 647
+G GSFG VY DG +K +L + R +E ++L+ + H N+IK +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 648 SSCCNLDFKA-----LVLEFMPNGSLEKWLYSHN----YFLDMLERLNIMIDVGLALEYL 698
S F+ +V+E+ G L + + F + + L+ + + LAL+YL
Sbjct: 66 ES-----FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQLCLALKYL 119
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE- 757
H ++H ++KP NI L N ++ DFGISK+L D + +T+ T Y++PE
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTVV-GTPYYLSPEL 174
Query: 758 -----YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
Y + K D++S G +L E T K P F GE
Sbjct: 175 CQNKPY------NYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 592 LLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G G FG V G + G VA+K A ++F +E V+ +RH NL+++
Sbjct: 13 TIGKGEFGDVMLGD-YRGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 652 NLDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+ +V E+M GSL +L S + + ++L +DV +EYL VH +
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDV 770
L N+L+ +++ A+VSDFG++K + S Q + + APE + S K DV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 771 YSYGVLLMETFT 782
+S+G+LL E ++
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 591 NLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIF 647
+L+G G+FG VYKG L G VAIK +L+ E A +S E ++L+N++H N++K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
S D ++LE+ NGSL + + F + L + V L YLH V+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVLQGLAYLHEQG---VI 121
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
H ++K NIL K+ +++DFG++ L + + T +MAPE S
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGASTA 179
Query: 768 CDVYSYGVLLMETFTRKKP 786
D++S G ++E T P
Sbjct: 180 SDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 593 LGAGSFGSVYKGTLFDGTN--VAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIK---I 646
LG GS G VYK T A+K ++ + FR E + LR+ ++K
Sbjct: 9 LGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLD-MLERLNIMIDVGLALEYLHHSHSTP 705
F + ++VLE+M GSL L + +L + I GL YLH
Sbjct: 68 FYKEGEI---SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD--YLHTKRH-- 120
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-MATIGYMAPEYASDGII 764
++H ++KP+N+L++ +++DFGISK+L ++++ Q T + T+ YM+PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGESY 177
Query: 765 SPKCDVYSYGVLLMETFTRKKP 786
S D++S G+ L+E K P
Sbjct: 178 SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 592 LLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFR-SFESECEVLRNVRHRNLIKIFSSC 650
+G G+FG VYKG L T VA+K L + F E E+L+ H N++K+ C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+V+E +P GSL +L L + + L + +D +EYL S +H +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDD---SVTQTMTMATIGYMAPEYASDGIISPK 767
L N L+ +N ++SDFG+S+ E++ +V+ + I + APE + G + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 768 CDVYSYGVLLMETFT 782
DV+SYG+LL ETF+
Sbjct: 176 SDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 59/194 (30%), Positives = 105/194 (54%), Gaps = 12/194 (6%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVF---NLQLERAFRSFESECEVLRNVRHRNLIKIFSS 649
LGAG FG V+ GT T VA+K + E +F E ++++ +RH L+++++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
C + +V E+M GSL +L S L + + +++ + + YL + +H
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+L NIL+ +N+ +++DFG+++L+ EDD+ + I + APE A+ G + K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 769 DVYSYGVLLMETFT 782
DV+S+G+LL E T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 63/194 (32%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 592 LLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFR-SFESECEVLRNVRHRNLIKIFSSC 650
LLG G+FG V+KGTL D T VA+K L + + F SE +L+ H N++K+ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+V+E +P G +L L + + +D + YL S +H +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRD 118
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSV--TQTMTMATIGYMAPEYASDGIISPKC 768
L N L+ +N ++SDFG+S+ ++DD + + + I + APE + G S +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 769 DVYSYGVLLMETFT 782
DV+SYG+LL ETF+
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 22/238 (9%)
Query: 586 GFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER---AFRSFESECEVLRNVRH-R 641
+ LG GSFG VY D VA+KV +LE F E ++L ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN--IMIDVGLALEYLH 699
N++K++ + LV+E++ GSLE L + E I+ + ALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 700 HSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQTMTMA----TIGYM 754
++H ++KP NILLD++ ++ DFG++KLL + + + + T GYM
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 755 APEYA---SDGIISPKCDVYSYGVLLMETFTRKKP---TDEMFTGEMSLKHWIKLSLP 806
APE S S D++S G+ L E T P +LK ++L P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
|
Length = 384 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRS---FESECEVLRNVRHRNLIKIFSS 649
+G+G FG V+ G + VAIK + S F E +V+ + H L++++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT----IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
C LV EFM +G L +L + L + +DV + YL S+ V+H
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 710 NLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCD 769
+L N L+ +N +VSDFG+++ + DD + T T + + +PE S S K D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 770 VYSYGVLLMETFTR-KKPTDEMFTGEM 795
V+S+GVL+ E F+ K P + E+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 66/221 (29%), Positives = 116/221 (52%), Gaps = 18/221 (8%)
Query: 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRN 637
L++Q+ T G ++G G FG+V +G + G VA+K N++ + ++F E V+
Sbjct: 3 LNLQKLTLG----EIIGEGEFGAVLQGE-YTGQKVAVK--NIKCDVTAQAFLEETAVMTK 55
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFL-DMLERLNIMIDVGLALE 696
+ H+NL+++ + +V+E M G+L +L + L +++ L +DV +E
Sbjct: 56 LHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YL S +VH +L NIL+ ++ A+VSDFG++++ D+ + + + AP
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAP 166
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMS 796
E S K DV+SYGVLL E F+ + P +M E+
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 593 LGAGSFGSVYKGT-LFDGTN----VAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKI 646
LG+G+FG+VYKG + +G VAIKV + A + E V+ +V H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
C + L+ + MP G L ++ +H + LN + + + YL +
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---L 130
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
VH +L N+L+ +++DFG++KLL D+ I +MA E I +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 767 KCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 796
K DV+SYGV + E T KP + + E+
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 37/228 (16%)
Query: 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFN---LQLERAFRSFESECEVL-RNVRHR 641
F ++G GSF +V AIK+ + L E+ + + E EVL R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 642 NLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
+IK++ + F+ VLE+ PNG L +++ LD ++ LALE
Sbjct: 63 GIIKLYYT-----FQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALE 116
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---- 752
YLH S ++H +LKP NILLDK+M +++DFG +K+L + + I
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 753 --------------YMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
Y++PE ++ D+++ G ++ + T K P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 42/284 (14%)
Query: 593 LGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FG V+ + D VA+K A + F+ E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNIMIDV 691
+ C + D +V E+M +G L K+L +H L + + L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI 751
+ YL H VH +L N L+ N+ ++ DFG+S+ + D TM I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811
+M PE + + DV+S+GV+L E FT K + W +LS + E
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLS-NTEVIE 236
Query: 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
+ V E +P C + + LGC P+QR+ + ++
Sbjct: 237 CITQGRVLE-RPRV----CPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 591 NLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER--AFRSFESECEVLRNVRHRNLIKIF 647
N +G G+FG VY L G +A+K +Q + E +VL ++H NL+K +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLD--MLERLNIMIDVGLALEYLHHSHSTP 705
+ + + +E+ G+LE+ L H LD ++ + + GLA YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLA--YLHSHG--- 119
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM--TMATIGYMAPEYASDGI 763
+VH ++KP NI LD N ++ DFG + L + ++ + + T YMAPE + G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 764 ISPK---CDVYSYGVLLMETFTRKKPTDEM 790
D++S G +++E T K+P E+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 74/290 (25%), Positives = 125/290 (43%), Gaps = 43/290 (14%)
Query: 593 LGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FG V+ D VA+K E A + F+ E E+L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--------------LNIMIDVG 692
+ C +V E+M +G L ++L SH +L L I +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
+ YL H VH +L N L+ + + ++ DFG+S+ + D TM I
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 753 YMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812
+M PE + + D++S+GV+L E FT K + W +LS TE
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQLS----NTEA 233
Query: 813 VDA-SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861
++ + RE++ C + + GC P+QRM + D+ +LQ
Sbjct: 234 IECITQGRELERPRT---CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 84/294 (28%), Positives = 131/294 (44%), Gaps = 42/294 (14%)
Query: 592 LLGAGSFGSVYK---GTLFDGTN--VAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FGSV L D T VA+K R FE E E+L++++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 647 FSSCC-----NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
C NL LV+E++P GSL +L H LD + L + +EYL
Sbjct: 71 KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYAS 760
S VH +L NIL++ ++ DFG++K+L +D + + + I + APE +
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 761 DGIISPKCDVYSYGVLLMETFT----RKKPTDEMFT-------GEMSLKHWIKLSLPRGL 809
+ S DV+S+GV+L E FT P E G+M + H I+L L
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL-LKNNG 243
Query: 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863
R P C I + C + P QR +++ ++++ I+
Sbjct: 244 ---------RLPAPP----GCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 68/277 (24%), Positives = 108/277 (38%), Gaps = 32/277 (11%)
Query: 592 LLGAGSFGSVYKGT----LFDGTNVAIKVF-NLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG GSFG V +G VA+K + +L F E ++ ++ H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 647 FSSCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERL-NIMIDVGLALEYLHHSHST 704
+ L +V E P GSL L ++ L + + + + YL
Sbjct: 62 YGVV--LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-- 117
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT-IGYMAPEYASDGI 763
+H +L NILL + ++ DFG+ + L +++D + + APE
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFT-GEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822
S DV+ +GV L EMFT GE W LS + + +D R +
Sbjct: 177 FSHASDVWMFGVTLW----------EMFTYGEEP---WAGLS-GSQILKKIDKEGERLER 222
Query: 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859
P C I ++ L C +P R + L
Sbjct: 223 PE----ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 593 LGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIK 645
LG G+FG VYKG L T+VAIK E + F E E++ +++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMID 690
+ C ++ E++ +G L ++L ++ LD + L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ +EYL H VH +L N L+ + +T ++SDFG+S+ + D Q+ ++
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +M PE G + + D++S+GV+L E F+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 592 LLGAGSFGSVYKGTL-FDG---TNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKI 646
++GAG FG V++G L G VAIK E+ + F SE ++ H N+I++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
++ E+M NG+L+K+L H+ + + ++ + ++YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---Y 128
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG--YMAPEYASDGII 764
VH +L NIL++ N+ +VSDFG+S++L EDD T T + I + APE +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 765 SPKCDVYSYGVLLMETFTR-KKPTDEMFTGEM--SLKHWIKLSLPRGLTEVVDASLVREV 821
+ DV+S+G+++ E + ++P +M E+ ++ +L P
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP--------------- 232
Query: 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
MDC + L L C +R D+V L K+
Sbjct: 233 ------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 5/207 (2%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LG G FG V G +VAIK+ + + F E +V+ + H L++++ C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLK 712
+V E+M NG L +L H + L + DV + YL S +H +L
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 713 PNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYS 772
N L+D +VSDFG+S+ + DD+ + + + + PE S K DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 773 YGVLLMETFTRKKPTDEMFTGEMSLKH 799
+GVL+ E ++ K E F +++
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 48/293 (16%)
Query: 592 LLGAGSFGSVYKGTLF--DGTNVAIKVFNLQLE----RAFRSFESECEVLRNVRHRNLIK 645
+LG G FGSV +G L DG+ + + V ++L+ F SE +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 646 IFSSCCNLDFKA------LVLEFMPNGSLEKWLYS-------HNYFLDMLERLNIMIDVG 692
+ C ++L FM +G L +L L L L M+D+
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL--LKFMVDIA 123
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
L +EYL + +H +L N +L ++MT V+DFG+SK + D + +
Sbjct: 124 LGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 753 YMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMS--LKHWIKLSLPRGL 809
++A E +D + + K DV+++GV + E TR + P + E+ L+H +L P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE-- 238
Query: 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
DCL + L C P+ R T + L+ I
Sbjct: 239 -------------------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 592 LLGAGSFGSVY------KGTLFDGTNVAIKVFNLQLERAFRS----FESECEVLRNVRHR 641
L+G+GSFGSVY G L V + + + RS E +L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
N+++ S + D + LE++P GS+ L ++ F + L R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-----MATIGYMAP 756
+ ++H ++K NIL+D ++SDFGISK L E + T+T ++ +MAP
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWMAP 181
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKP 786
E + K D++S G L++E T K P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 65/205 (31%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 593 LGAGSFGSVYKGTLF--DGT--NVAIKVF-NLQLERAFRSFESECEVLRNVRHRNLIKIF 647
LG G+FGSV KG G VA+K + + F E V+ + H ++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
C LV+E P G L K+L + + V + + YL H V
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPV-SDLKELAHQVAMGMAYLESKH---FV 117
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT-QTMTMATIGYMAPEYASDGIISP 766
H +L N+LL A++SDFG+S+ LG D T + + APE + G S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEM 790
K DV+SYGV L E F+ KP EM
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 75/261 (28%), Positives = 118/261 (45%), Gaps = 31/261 (11%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRS--FESECEVLRNVRHRNLIKIFSSC 650
LG+G FG V+ G +VAIK+ E A F E +V+ + H NL++++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+V E+M NG L +L L L++ DV A+EYL S +H +
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDV 770
L N L+ ++ +VSDFG+++ + DD + T + + PE S K DV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 771 YSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL--VREVQPSYAKM 828
+S+GVL+ E F+ K E F+ +EVV++ R +P A
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSN----------------SEVVESVSAGYRLYRPKLAPT 228
Query: 829 DCLLRIMHLALGCCMDSPEQR 849
+ + IM+ C + PE R
Sbjct: 229 E-VYTIMYS---CWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 75/280 (26%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 592 LLGAGSFGSVYKGTL-FDGTN---VAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKI 646
++GAG FG V G L G VAIK E+ R F SE ++ H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+V E+M NGSL+ +L H+ +++ + ++ + ++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGY 127
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV-TQTMTMATIGYMAPEYASDGIIS 765
VH +L NIL++ N+ +VSDFG+S++L +D ++ T I + APE + +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 766 PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
DV+SYG+++ E M GE +W E+ + +++ ++ Y
Sbjct: 188 SASDVWSYGIVMWEV---------MSYGERP--YW----------EMSNQDVIKAIEEGY 226
Query: 826 ---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
A MDC + L L C +R +V L K+
Sbjct: 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 591 NLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQ-LERAFRSFE-SECEVLRNVRHRNLIKIF 647
N +G GSFG V+K D A+K +L + R R E VL + +I+ +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHN---YFLDMLERLNIMIDVGLALEYLHHSHST 704
S + +V+E+ NG L K L D + R I I +GLA H HS
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA-----HLHSK 120
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII 764
++H ++K N+ LD ++ D G++KLL D+ + T+ + T Y++PE D
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTI-VGTPYYLSPELCEDKPY 178
Query: 765 SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798
+ K DV++ GV+L E T K P D G + LK
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 36/213 (16%)
Query: 592 LLGAGSFGSVYKG-TLFDGTNVAIKVFNL-----QLERAFRSFESECEVLRNVRHRNLIK 645
LLG+GSFGSVY+G L DG A+K +L + A + E E +L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL---NIMIDVGLALEYLHHSH 702
+ D + LE +P GSL K L + F + + RL I+ L LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYA 759
VH ++K NIL+D N +++DFG++K V + + G +MAPE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPE-- 171
Query: 760 SDGIISPK------CDVYSYGVLLMETFTRKKP 786
+I+ + D++S G ++E T K P
Sbjct: 172 ---VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 593 LGAGSFGSVY----KGTLFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIK 645
+ G++G V+ K T G AIKV + + +E ++L + ++K
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
++ S LV+E++P G L L + + + R + ++ LALEYLH S+
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLH-SNG-- 113
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKL------LGEDDDSVTQTMTMATIGYMAPEYA 759
++H +LKP+NIL+D N +++DFG+SK+ + +DD + T Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-- 171
Query: 760 SDGII-----SPKCDVYSYGVLLMETFT 782
+I S D +S G +L E
Sbjct: 172 ---VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 73/290 (25%), Positives = 124/290 (42%), Gaps = 39/290 (13%)
Query: 593 LGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FG V+ + D VA+K + A + F E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHN------------YFLDMLERLNIMIDVGLA 694
+ C D +V E+M +G L K+L +H L + L+I +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
+ YL H VH +L N L+ +N+ ++ DFG+S+ + D TM I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814
PE + + DV+S GV+L E FT K + W +LS + +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQLSNNEVIECITQ 237
Query: 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+++ + C + L LGC P R+ + ++ LQ + +
Sbjct: 238 GRVLQRPR------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 21/195 (10%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQ---LERAFRSFESECEVLRNVRHRNLIKIFS 648
+G G+ G VYK T G VAIK L+ E E ++++ +H N++ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82
Query: 649 SCCNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDMLERL--NIMIDVGLALEYLHHSHST 704
L L V+E+M GSL + F+ M E + +V LEYLH S
Sbjct: 83 --SYLVGDELWVVMEYMDGGSLTDIIT--QNFVRMNEPQIAYVCREVLQGLEYLH---SQ 135
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII 764
V+H ++K +NILL K+ + +++DFG + L ++ ++ + T +MAPE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN-SV-VGTPYWMAPEVIKRKDY 193
Query: 765 SPKCDVYSYGVLLME 779
PK D++S G++ +E
Sbjct: 194 GPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 65/280 (23%), Positives = 123/280 (43%), Gaps = 34/280 (12%)
Query: 591 NLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645
++G G FG V +G L +VAIK ++ F +E ++ H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ ++ E+M NGSL+K+L ++ + + + ++ + ++YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
VH +L NIL++ N+ +VSDFG+S+ L + + + T I + APE + +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 766 PKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824
DV+S+G+++ E + ++P +M + + +K V+
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIK---------------------AVEDG 224
Query: 825 Y---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861
Y MDC + L L C +R + +V L K
Sbjct: 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 593 LGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIKIFSSC 650
+G G+FG V+ G L D T VA+K L ++ F E +L+ H N++++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+V+E + G +L + L + E + ++ + +EYL H +H +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSV---TQTMTMATIGYMAPEYASDGIISPK 767
L N L+ + ++SDFG+S+ E++D V T M + + APE + G S +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 768 CDVYSYGVLLMETFT 782
DV+S+G+LL E F+
Sbjct: 177 SDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 56/191 (29%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LGAG FG V++G + T VA+K + F +E ++++ +RH LI++++ C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 653 LDFKALVLEFMPNGSLEKWLY-SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+ +V E M GSL ++L L + + +++ V + YL + +H +L
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
N+L+ +N +V+DFG+++++ ED + I + APE A S K DV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 772 SYGVLLMETFT 782
S+G+LL E T
Sbjct: 189 SFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LG G FG V+ GT T VAIK + +F E +V++ +RH L+++++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 653 LDFKALVLEFMPNGSLEKWLY-SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+V E+M GSL +L +L + + +++ + + Y+ + VH +L
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
+ NIL+ +N+ +V+DFG+++L+ ED++ + I + APE A G + K DV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 772 SYGVLLMETFTRKK 785
S+G+LL E T+ +
Sbjct: 188 SFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 17/194 (8%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
+G G FG V G + G VA+K ++ + ++F +E V+ +RH NL+++
Sbjct: 14 IGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 653 LDFKA---LVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
++ K +V E+M GSL +L S L L +DV A+EYL + VH
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+L N+L+ ++ A+VSDFG++K + S TQ + + APE + S K
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 769 DVYSYGVLLMETFT 782
DV+S+G+LL E ++
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 65/205 (31%), Positives = 113/205 (55%), Gaps = 17/205 (8%)
Query: 592 LLGAGSFGSVY--KGTLFDGTNVAIKVFNL-QLERAFR-SFESECEVLRNVRHRNLIKIF 647
++G G+FG V+ + D V IK + Q+ + R + ++EC+VL+ + H N+I+ +
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 648 SSCCNLDFKAL--VLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ L+ KAL V+E+ P G+L +++ N LD L+ + + LAL HH H+
Sbjct: 66 ENF--LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL---HHVHTK 120
Query: 705 PVVHCNLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
++H +LK NILLDK+ M ++ DFGISK+L + T + T Y++PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKP 177
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTD 788
+ K D+++ G +L E + K+ +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 593 LGAGSFGSVYKGTL---FDGTNVAIKVFNLQLERAFR-SFESECEVLRNVRHRNLIKIFS 648
LG+G+FG V KG +VAIKV + E++ R E E++ + + ++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
C + LV+E G L K+L + + + +M V + ++YL + VH
Sbjct: 63 -VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT-QTMTMATIGYMAPEYASDGIISPK 767
+L N+LL A++SDFG+SK LG DD ++ + + APE + S +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 768 CDVYSYGVLLMETFTR-KKPTDEM 790
DV+SYG+ + E F+ +KP +M
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 591 NLLGAGSFGSVYKGTLFD----GTN---VAIKVFNL-QLERAFRSFESECEVLRNVRHRN 642
N LG+G+FG VY+GT D G+ VA+K ++ + F E ++ N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYS------HNYFLDMLERLNIMIDVGLALE 696
++K+ C + + +++E M G L +L L + E L+I +DV
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 697 YLHHSHSTPVVHCNLKPNNILL-----DKNMTARVSDFGISKLLGEDDDSVTQTMTMATI 751
YL H +H +L N L+ D + ++ DFG+++ + + D + + +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+MAPE DG + + DV+S+GVL+ E T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 29/201 (14%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G+G++G VYK + G VAIKV L+ F + E +L+ RH N++ F S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI---DVGLALEYLHHSHSTPVVH 708
D +V+E+ GSL+ +Y L L I + L YLH + +H
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IY--QVTRGPLSELQIAYVCRETLKGLAYLHETG---KIH 124
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT----IG---YMAPEYASD 761
++K NILL ++ +++DFG+S L T T+A IG +MAPE A+
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQL---------TATIAKRKSFIGTPYWMAPEVAAV 175
Query: 762 GIISP---KCDVYSYGVLLME 779
KCD+++ G+ +E
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 593 LGAGSFGSVYKGTLFD------GTNVAIK-VFNLQLERAFRSFESECEVLRNVRHRNLIK 645
LG GSFG VY+G T VAIK V R F +E V++ ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH------NYFLDMLERLNIM-----IDVGLA 694
+ +V+E M G L+ +L S N L + I G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
YL VH +L N ++ +++T ++ DFG+++ + E D + + +M
Sbjct: 134 --YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFT 782
APE DG+ + K DV+S+GV+L E T
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 593 LGAGSFGSVYKGTLFD------GTNVAIKVFNLQLERA-FRSFESECEVLRNVRHRNLIK 645
LG G FG V K T F T VA+K+ + R SE +L+ V H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWL-----------------YSHNYFLDMLERLNIM 688
++ +C L++E+ GSL +L S L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 689 IDVGLA------LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742
+ A ++YL +VH +L N+L+ + ++SDFG+S+ + E+D V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
++ + +MA E D I + + DV+S+GVLL E T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNV-AIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKI 646
++G G+FG V D + A+K N Q + + R+ +E +L+ + H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN------IMIDVGLALEYLHH 700
+ S + + LV++ + G L Y L + + + ++ LALEYLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
S ++H ++KP+NILLD+ ++DF I+ + D++T + + T GYMAPE
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTS-GTPGYMAPEVLC 172
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKP 786
S D +S GV E K+P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVFNL-----QLERAFRSFESECEVLRNVRHRNLIK 645
LLG G+FG VY D G +A+K + ++ + E E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 646 IFSSCCNLDFK-ALVLEFMPNGSLEKWLYSHNYFLDMLER-LNIMIDVGLALEYLHHSHS 703
+ C D ++ +E+MP GS++ L ++ + + R I LE + + HS
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI-----LEGVEYLHS 122
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---------YM 754
+VH ++K NIL D ++ DFG SK L QT+ + G +M
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICSSGTGMKSVTGTPYWM 174
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
+PE S K DV+S G ++E T K P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 35/282 (12%)
Query: 592 LLGAGSFGSVYKGTL----FDGTNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKI 646
++GAG FG V +G L VAIK E+ R F SE ++ H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
++ EFM NG+L+ +L ++ +++ + ++ + ++YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---Y 127
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA---TIGYMAPEYASDGI 763
VH +L NIL++ N+ +VSDFG+S+ L +D T T ++ I + APE +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823
+ DV+SYG+++ E M GE R ++ + ++ ++
Sbjct: 188 FTSASDVWSYGIVMWEV---------MSYGE------------RPYWDMSNQDVINAIEQ 226
Query: 824 SY---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
Y MDC + L L C R +V L K+
Sbjct: 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 593 LGAGSFGSVYKGTLFDGTN--VAIKVFNLQLERA-FRSFESECEVLRNVRHRNLIKIFSS 649
LGAG+ G V K L T +A+K L++ A + E ++L ++ + +
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 650 CCNLDFKALVLEFMPNGSLEKWL--YSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
N ++ +E+M GSL+K L +L + I + V L YLH H ++
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK--II 123
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
H ++KP+NIL++ ++ DFG+S G+ +S+ +T T YMAPE S K
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS---GQLVNSLAKTFV-GTSSYMAPERIQGNDYSVK 179
Query: 768 CDVYSYGVLLMETFTRKKP 786
D++S G+ L+E T + P
Sbjct: 180 SDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 61/223 (27%), Positives = 113/223 (50%), Gaps = 10/223 (4%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LG G FG V+ GT T VAIK +F E ++++ +RH L+ +++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 653 LDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+V EFM GSL +L + +L + + +++ + + Y+ + +H +L
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDL 128
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
+ NIL+ N+ +++DFG+++L+ ED++ + I + APE A G + K DV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 772 SYGVLLMETFTRKK-PTDEMFTGEM--SLKHWIKLSLPRGLTE 811
S+G+LL E T+ + P M E+ ++ ++ P+G E
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 4e-18
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 53/223 (23%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLE------RAFRSFESECEVLRNVRHRNL 643
+G+G++G V G VAIK + + R R E ++LR++RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 644 IK---IFSSCCNLDFKAL--VLEFMPNGSLEKWLYS--------HNYFL-DMLERLNIMI 689
I I DF + V E M L K + S YFL +L
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL------- 113
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-- 747
L+YLH ++ V+H +LKP+NIL++ N ++ DFG+++ + D+D +T
Sbjct: 114 ---RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-LTEY 166
Query: 748 MATIGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
+ T Y APE ++ + D++S G + E TRK
Sbjct: 167 VVTRWYRAPE-----LLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSS 649
+ LG G +G VY+G ++ ++ + V L+ + F E V++ ++H NL+++
Sbjct: 12 HKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
C ++ EFM G+L +L N ++ + L + + A+EYL + +H
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+L N L+ +N +V+DFG+S+L+ D I + APE + S K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 769 DVYSYGVLLMETFT 782
DV+++GVLL E T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 67/212 (31%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 586 GFNECNLLGAGSFGSVYK-GTLFDGTNVAIKVFNL----QLERAFRSFESECEVLRNVRH 640
F LG GS+GSVYK L D A+K +L Q ER +E +L +V H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE--DAVNEIRILASVNH 58
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER---LNIMIDVGLALEY 697
N+I + + + +V+E+ P G L K + ++ I I + L+
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YM 754
LH ++H +LK NILL N ++ D GISK+L + M IG YM
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIGTPHYM 168
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
APE S K D++S G LL E T P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 7e-18
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER---------AFRSFESECEVLRNVRH 640
LG G++ VYK G VAIK L + A R E ++L+ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELKH 61
Query: 641 RNLIK---IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
N+I +F N++ LV EFM LEK + + L + + M+ LEY
Sbjct: 62 PNIIGLLDVFGHKSNIN---LVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
LH + ++H +LKPNN+L+ + +++DFG+++ G + T + T Y APE
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG--SPNRKMTHQVVTRWYRAPE 172
Query: 758 -------YASDGIISPKCDVYSYGVLLMETFTRK 784
Y D++S G + E R
Sbjct: 173 LLFGARHY------GVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 11/201 (5%)
Query: 592 LLGAGSFGSVYKGTLFD----GTNVAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIKI 646
+G G FG VY+G VA+K + R F E ++R H +++K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ +V+E P G L +L + Y LD+ + + AL YL S
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRF 128
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
VH ++ N+L+ ++ DFG+S+ L ED+ + I +MAPE + +
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 767 KCDVYSYGVLLMETFTR-KKP 786
DV+ +GV + E KP
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ------LERAFRSFESECEVLRNVRHRNLI 644
+LG G++G+VY G G +A+K L E+ + + E ++L++++H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDM-LERLNIMIDVGLALEYLHHSHS 703
+ +C + + ++ +EF+P GS+ L + + I G+A YLH++
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YLHNNC- 122
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG----YMAPEYA 759
VVH ++K NN++L N ++ DFG ++ L T + + ++ +MAPE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
++ K D++S G + E T K P M
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNL-QLERAFRS-FESECEVLRNVRHRNLIKIFSS 649
+G GSFG+V K DG + K + + + SE +LR ++H N+++ +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 650 CCNLDFKAL--VLEFMPNGSLEKWL---YSHNYFLDMLERLNIMIDVGLALEYLHH-SHS 703
+ + L V+E+ G L + + +++ I+ + LAL H+ S
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 704 TPVV-HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
V H +LKP NI LD N ++ DFG++K+LG D S +T + T YM+PE +
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTY-VGTPYYMSPEQLNHM 185
Query: 763 IISPKCDVYSYGVLLMETFTRKKP 786
K D++S G L+ E P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 67/300 (22%), Positives = 124/300 (41%), Gaps = 62/300 (20%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNLIK 645
+G G++G VYK G VA+K ++ E+ A R E ++L+ +RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 646 ---IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
I +S +V E+M + L L S + M + L+YLH +
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE----- 757
++H ++K +NIL++ + +++DFG+++ +S T + T+ Y PE
Sbjct: 121 ---ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLGA 176
Query: 758 --YASDGIISPKCDVYSYGVLLMETFTRK--------------------KPTDEMFTGEM 795
Y P+ D++S G +L E F K PTDE + G
Sbjct: 177 TRY------GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230
Query: 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
L + L + + + + A +D L +++ +D P++R+
Sbjct: 231 KLPWFENLKPKKPYKRRL-REFFKHLIDPSA-LDLLDKLL------TLD-PKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-17
Identities = 42/103 (40%), Positives = 60/103 (58%), Gaps = 1/103 (0%)
Query: 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSI 448
+ L + L G +P+DI L+ L +NLS N + GNIP ++G + L L L+ N F SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 449 PDSFGSLTSLEYLDLSNNNLSGEIPKSF-EILSHLKRLNVSHN 490
P+S G LTSL L+L+ N+LSG +P + L H N + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LG G FG V+ GT T VA+K + SF E ++++ +RH L+++++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 653 LDFKALVLEFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+V E+M GSL +L L + +++ V + Y+ + +H +L
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 128
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
+ NIL+ + +++DFG+++L+ ED++ + I + APE A G + K DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 772 SYGVLLMETFTRKK 785
S+G+LL E T+ +
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 52/194 (26%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LGAG FG V+ G + T VA+K + ++F E +++ ++H L+++++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL-EYLHHSHSTPVVHCNL 711
+ ++ E+M GSL +L S +L +L ID + E + + +H +L
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHRDL 129
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
+ N+L+ +++ +++DFG+++++ ED++ + I + APE + G + K DV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 772 SYGVLLMETFTRKK 785
S+G+LL E T K
Sbjct: 189 SFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 23/217 (10%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFR----------SFESECEVLRNVRH 640
L+G G++G VY G +A+K L A R + SE E L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLH 699
N+++ ++ ++ LE++P GS+ L ++ F ++ + GLA YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA--YLH 125
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPE- 757
S ++H +LK +N+L+D + ++SDFGISK +D Q M+M ++ +MAPE
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 758 -YASDGIISPKCDVYSYGVLLMETFTRKKP--TDEMF 791
++ S K D++S G +++E F ++P +E
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 46/295 (15%)
Query: 591 NLLGAGSFGSVYKGTLF-DGT--NVAIKVFN-LQLERAFRSFESECEVLRNV-RHRNLIK 645
+++G G+FG V + + DG N AIK+ E R F E EVL + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDMLERLNIMID 690
+ +C N + + +E+ P G+L +L L + L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
V ++YL +H +L N+L+ +N+ ++++DFG+S+ GE + V +TM
Sbjct: 128 VATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVKKTMGRLP 181
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGL 809
+ +MA E + + + K DV+S+GVLL E + P M E+ K LP+G
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK------LPQGY 235
Query: 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
R +P +C + L C D P +R + V+L ++ +
Sbjct: 236 ---------RMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 52/218 (23%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
LG GS+GSVYK G VAIKV + E + E +L+ ++K + S
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 651 CNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDMLERLN----------IMIDVGLALE 696
FK +V+E+ GS D+++ N I+ LE
Sbjct: 68 ----FKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---Y 753
YLH + +H ++K NILL++ A+++DFG+S L D++ + T+ IG +
Sbjct: 114 YLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT---DTMAKRNTV--IGTPFW 165
Query: 754 MAPEYASDGIISP-----KCDVYSYGVLLMETFTRKKP 786
MAPE +I K D++S G+ +E K P
Sbjct: 166 MAPE-----VIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 12/226 (5%)
Query: 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-----RAFRSFESE 631
L I + T+ F + +LG+G+FG+VYKG +G V I V +L +A + E
Sbjct: 1 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59
Query: 632 CEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDV 691
V+ +V + ++ ++ C + L+ + MP G L ++ H + LN + +
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI 751
+ YL +VH +L N+L+ +++DFG++KLLG D+ I
Sbjct: 119 AKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 796
+MA E I + + DV+SYGV + E T KP D + E+S
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 63/197 (31%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAF--RSFESECEVLRNVRHRNLIKIFSSC 650
LG+G FG V+ G VAIK N E A F E +V+ + H L++++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFL--DMLERLNIMIDVGLALEYLHHSHSTPVVH 708
+V EFM NG L +L L DML L++ DV +EYL + +H
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS---FIH 123
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+L N L+ +VSDFG+++ + DD+ + + + + PE + S K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 769 DVYSYGVLLMETFTRKK 785
DV+S+GVL+ E FT K
Sbjct: 183 DVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 70/265 (26%), Positives = 125/265 (47%), Gaps = 39/265 (14%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LGAG FG V+ G T VAIK Q + +F +E +++ ++H L+++++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 653 LDFKALVLEFMPNGSLEKWLYSH-------NYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
++ E+M NGSL +L + N +DM + I G+A ++ +
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ----IAEGMA--FIERKNY-- 123
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
+H +L+ NIL+ + + +++DFG+++L+ ED++ + I + APE + G +
Sbjct: 124 -IHRDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 766 PKCDVYSYGVLLMETFTRKK-PTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824
K DV+S+G+LL E T + P M E + +L RG R +P
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNLERGY---------RMPRPD 226
Query: 825 YAKMDCLLRIMHLALGCCMDSPEQR 849
+C + L C + PE+R
Sbjct: 227 ----NCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-17
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 53/221 (23%)
Query: 591 NLLGAGSFGSVYK------GTLFDGTNVAIKVFNLQLERAFR-SFESECEVLRNVRHRNL 643
N +G+G+ G+VYK G L+ A+KV E R E E+LR+V H N+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLY-----ALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 644 IKIFSSCCNLDFK-----ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYL 698
+K C+ F ++LEFM GSLE + FL + R I G+A YL
Sbjct: 135 VK-----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIA--YL 184
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM-----TMATIGY 753
H H +VH ++KP+N+L++ +++DFG+S++L QTM ++ TI Y
Sbjct: 185 HRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA-------QTMDPCNSSVGTIAY 234
Query: 754 MAPEY--------ASDGIISPKCDVYSYGVLLMETFTRKKP 786
M+PE A DG D++S GV ++E + + P
Sbjct: 235 MSPERINTDLNHGAYDGYAG---DIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 79/301 (26%), Positives = 127/301 (42%), Gaps = 62/301 (20%)
Query: 593 LGAGSFGSVYKGTLF------DGTN--VAIKVFNLQLERAFRS-FESECEVLRNVRHRNL 643
LG G FG V +L+ DGT VA+K + + S ++ E +L+ + H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 644 IKIFSSCCNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
+K + CC+ L++E++P GSL +L H L L I G+A YLH
Sbjct: 69 VK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA--YLHS 125
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL---------GEDDDSVTQTMTMATI 751
H +H +L N+LLD + ++ DFG++K + ED DS +
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS--------PV 174
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPT-------DEMF---TGEMSLKHWI 801
+ A E + S DV+S+GV L E T +EM G+M++ I
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234
Query: 802 KLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861
+L L RG+ R P +C + L C + R ++ L++
Sbjct: 235 EL-LERGM---------RLPCPK----NCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280
Query: 862 I 862
+
Sbjct: 281 M 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 9/218 (4%)
Query: 578 LDIQQATDGFNECNLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFESECEVLR 636
L+ + D E +LG G++G VY L +AIK + R + E +
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLA-L 695
++HRN+++ S F + +E +P GSL L S + + + +I L
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQIL 118
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
E L + H +VH ++K +N+L++ + ++SDFG SK L + T+T T T+ YM
Sbjct: 119 EGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFT-GTLQYM 176
Query: 755 APEYASDGI--ISPKCDVYSYGVLLMETFTRKKPTDEM 790
APE G D++S G ++E T K P E+
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 47/117 (40%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 413 LNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEI 472
L L L G IP I L+ L +++L+ N + +IP S GS+TSLE LDLS N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 473 PKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLW--NYALCGPPRLQVPPC 527
P+S L+ L+ LN++ N L G++P R SF + N LCG P L C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RAC 537
|
Length = 623 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 71/290 (24%), Positives = 125/290 (43%), Gaps = 43/290 (14%)
Query: 593 LGAGSFGSVYKGTLF-----DGTNVAIKVF-NLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG +FG +YKG L+ VAIK ++ + + F+ E ++ + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHN----------------YFLDMLERLNIMID 690
++ E++ G L ++L + LD + L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ +EYL SH VH +L NIL+ + + ++SD G+S+ + D Q ++
Sbjct: 133 IAAGMEYLS-SHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810
I +M PE G S D++S+GV+L E F+ L+ + S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------FGLQPYYGFS----NQ 233
Query: 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860
EV++ +VR+ Q DC R+ L C + P +R D+ +L+
Sbjct: 234 EVIE--MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLE------RAFRSFESECEVLRNVRHRNLIK 645
+G G++G VYK G VAIK L+ E A R E ++L+ + H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ + LV EFM + L K + L + + + L + H SH
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHG-- 118
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YASDGII 764
++H +LKP N+L++ +++DFG+++ G T + T Y APE D
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH--YVVTRWYRAPELLLGDKGY 176
Query: 765 SPKCDVYSYGVLLMETFTRK 784
S D++S G + E +R+
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 59/229 (25%), Positives = 114/229 (49%), Gaps = 14/229 (6%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LGAG FG V+ T T VA+K + +F +E V++ ++H L+K+ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKL-HAVVT 71
Query: 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL-NIMIDVGLALEYLHHSHSTPVVHCNL 711
+ ++ EFM GSL +L S L +L + + + ++ + +H +L
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 128
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
+ NIL+ ++ +++DFG+++++ ED++ + I + APE + G + K DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 772 SYGVLLMETFTR-KKPTDEMFTGEM--SLKHWIKL----SLPRGLTEVV 813
S+G+LLME T + P M E+ +L+ ++ + P L ++
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 7e-16
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 11/211 (5%)
Query: 592 LLGAGSFGSVYKGTLF-DGTNV----AIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645
+LG+G+FG+VYKG +G V AIK+ N +A F E ++ ++ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ C + + LV + MP+G L +++ H + LN + + + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
+VH +L N+L+ +++DFG+++LL D+ I +MA E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 766 PKCDVYSYGVLLMETFT-RKKPTDEMFTGEM 795
+ DV+SYGV + E T KP D + T E+
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 592 LLGAGSFGSVYKGTLF-DGTN----VAIKVF-NLQLERAFRSFESECEVLRNVRHRNLIK 645
LLG+G FG+V+KG +G + VAIK + + F+ + ++ H +++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ C + LV + P GSL + H LD LN + + + YL
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
+VH NL NILL + +++DFG++ LL DD + I +MA E G +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 766 PKCDVYSYGVLLMETFT 782
+ DV+SYGV + E +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 592 LLGAGSFGSVYK--GTLFDGTNVAIKVFNL----------QLERAFRSFESECEVLR-NV 638
LG+G+FG VYK +A+K N+ + +++ SE +++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 639 RHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYS----HNYFLDMLERL-NIMIDVGL 693
RH N+++ + + D +V++ + L + S F + ER+ NI + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
AL YLH +VH +L PNNI+L ++ ++DFG++K + T + TI Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILY 179
Query: 754 MAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
PE + K DV+++G +L + T + P
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 37/217 (17%)
Query: 593 LGAGSFGSVYKGTL-FDGTNVAIK------VFNLQLERAFRSFESECEVLRNVRHRNLIK 645
LG G FG V + A+K + + S E E+L H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNI--MIDVGLALEYLHHSHS 703
++ + + + +++E+ G L L F + R I ++ LA EYLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG- 113
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEYASDG 762
+++ +LKP N+LLD N ++ DFG +K L S +T T T Y+APE
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK----SGQKTWTFCGTPEYVAPE----- 162
Query: 763 IISPK-----CDVYSYGVLLMETFTRKKPTDEMFTGE 794
II K D +S G+LL E T + P F +
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 591 NLLGAGSFGSVYKGTLF-DG--TNVAIKVFN-LQLERAFRSFESECEVLRNV-RHRNLIK 645
+++G G+FG V K + DG + AIK + R F E EVL + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDMLERLNIMID 690
+ +C + + L +E+ P+G+L +L L + L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
V ++YL +H +L NIL+ +N A+++DFG+S+ G+ + V +TM
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRLP 174
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGL 809
+ +MA E + + + DV+SYGVLL E + P M E+ K LP+G
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LPQGY 228
Query: 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
R +P +C + L C + P +R ++V L ++
Sbjct: 229 ---------RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 591 NLLGAGSFGSVYKGTL--FDGTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNL 643
LG G+FG VY+G DG V ++V L E+ F E ++ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLY------SHNYFLDMLERLNIMIDVGLALEY 697
+++ + ++LE M G L+ +L L M + L DV +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARV---SDFGISKLLGEDDDSVTQTMTMATIGYM 754
L +H +H ++ N LL RV +DFG+++ + M I +M
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFT 782
PE DGI + K DV+S+GVLL E F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 55/212 (25%)
Query: 593 LGAGSFGSV----YKGTLFDGTNVAIKVFNL-------QLERAFRSFESECEVLRNVRHR 641
LG GSFG V +KG+ G A+K+ + Q+E +E +L+++RH
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHV----LNEKRILQSIRHP 61
Query: 642 NLIKIFSSCCNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDMLERLNIMI------DVGL 693
L+ ++ S D L V+E++P G L +SH L R + V L
Sbjct: 62 FLVNLYGS--FQDDSNLYLVMEYVPGGEL----FSH---LRKSGRFPEPVARFYAAQVVL 112
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIG 752
ALEYLH +V+ +LKP N+LLD + +++DFG +K + T T+ T
Sbjct: 113 ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPE 163
Query: 753 YMAPEYASDGIISPK-----CDVYSYGVLLME 779
Y+APE II K D ++ G+L+ E
Sbjct: 164 YLAPE-----IILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 39/287 (13%)
Query: 593 LGAGSFGSVYKGTLFDGTN---VAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIF 647
LG G FGSV +G L + VA+K + + F SE ++ H N++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 648 SSCC----NLDFKA--LVLEFMPNGSLEKWL-YSH----NYFLDMLERLNIMIDVGLALE 696
C + + + ++L FM +G L +L YS +L + M D+ +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YL S +H +L N +L++NM V+DFG+SK + D + + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815
E +D + + K DV+S+GV + E TR + P + E I L +G
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDYLRQG------- 230
Query: 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
R QP DCL + L C + +P+ R + +L+K
Sbjct: 231 --NRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 587 FNECNLLGAGSFGSVYKGTLFD-GTN--VAIKVFNL-QLERAFRSFESECEVLRNVRHRN 642
F +G GSFG VYK D TN VAIKV +L + E + E + L R
Sbjct: 3 FTLLECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 643 LIKIFSSCCNLDFK-ALVLEFMPNGSLEKWLYSHNYFLDMLE--RLN------IMIDVGL 693
+ K + S K +++E+ GS LD+L+ +L+ I+ +V L
Sbjct: 61 ITKYYGSFLK-GSKLWIIMEYCGGGSC----------LDLLKPGKLDETYIAFILREVLL 109
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIG 752
LEYLH +H ++K NILL + +++DFG+S G+ ++++ T T
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSKRNTFVGTPF 163
Query: 753 YMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
+MAPE K D++S G+ +E + P
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 29/215 (13%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLE-----RAFRSFESECEVLRNVRHRNLIK 645
LLG G+FG VY D G +A K E + + E E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 646 IFSSCCNLDFKALV--LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ + K L +E+MP GS++ L ++ + + R LE + + HS
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR----QILEGMSYLHS 124
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---------YM 754
+VH ++K NIL D ++ DFG SK L QT+ M+ G +M
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL--------QTICMSGTGIRSVTGTPYWM 176
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKPTDE 789
+PE S K DV+S G ++E T K P E
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 37/223 (16%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLER------AFRSFESECEVLRN 637
D F+ +G G++G VYK D G VA+K L E+ A R E ++LR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIKILRQ 62
Query: 638 VRHRNLIKIFSSCCN----LDFKA------LVLEFMPN---GSLEKWL--YSHNYFLDML 682
+ HRN++ + + LDFK LV E+M + G LE L +S ++ +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 683 ERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742
++L LE L++ H +H ++K +NILL+ +++DFG+++L ++S
Sbjct: 123 KQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESR 172
Query: 743 TQTMTMATIGYMAPE-YASDGIISPKCDVYSYGVLLMETFTRK 784
T + T+ Y PE + P DV+S G +L E FT+K
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 593 LGAGSFGSVYKGTLF--DGTNVAIKVFNLQLERAFRSFE-----SECEVLRNV-RHRNLI 644
LGAG+FG V + T + ++ +KV L+ S E SE +++ ++ H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNY-FLDMLERLNIMIDVGLALEYLHHSHS 703
+ +C ++ E+ G L +L FL + + L+ V + +L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---S 159
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
+H +L N+LL ++ DFG+++ + D + V + + +MAPE + +
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 764 ISPKCDVYSYGVLLMETFT 782
+ + DV+SYG+LL E F+
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
LG G+FG VYK + G A K+ ++ E F E ++L +H N++ ++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+ +++EF G+L+ + L + + + AL +LH S V+H +L
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 712 KPNNILLDKNMTARVSDFGIS-KLLGEDDDSVTQTMTMATIGYMAPEYA-----SDGIIS 765
K NILL + +++DFG+S K T + T +MAPE D
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETFKDNPYD 186
Query: 766 PKCDVYSYGVLLMETFTRKKPTDEM 790
K D++S G+ L+E + P E+
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 75/293 (25%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 591 NLLGAGSFGSVYKGTLF-DG--TNVAIK-VFNLQLERAFRSFESECEVL-RNVRHRNLIK 645
+++G G+FG V K + DG + AIK + + R F E EVL + H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDMLERLNIMID 690
+ +C + + L +E+ P+G+L +L L + L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
V ++YL +H +L NIL+ +N A+++DFG+S+ + V +TM
Sbjct: 133 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGL 809
+ +MA E + + + DV+SYGVLL E + P M E+ K LP+G
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LPQGY 240
Query: 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
R +P ++C + L C + P +R ++V L ++
Sbjct: 241 ---------RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-14
Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 16/186 (8%)
Query: 609 GTNVAIKVF---NLQLERAFRSFESECEVLRNVRHRNLIKIFSS-CCNLDFKALVLEFMP 664
G VAIK+ + E F E + + H N++ + S V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKN 721
+L + L + L E +M+ V L+ L +H+ +VH +LKP NI++
Sbjct: 63 GRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
Query: 722 MTARVSDFGISKLLGEDDDSVTQTMTMAT--IG---YMAPEYASDGIISPKCDVYSYGVL 776
A+V DFGI LL D+ T+T T +G Y APE ++P D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 777 LMETFT 782
+E T
Sbjct: 179 FLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLE-----RAFRSFESECEVLRNVRHRNLIK 645
LLG G+FG VY D G +A+K E + + E E ++L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 646 IFSSCCNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ + + L +E MP GS++ L S+ + + R LE + + HS
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR----QILEGVSYLHS 124
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY-MAPEYASDG 762
+VH ++K NIL D ++ DFG SK L S T ++ Y M+PE S
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDE 789
K D++S G ++E T K P E
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFE---SECEVLRNVRH 640
D +G G+FG V+ A+KV + + + +E VL+ V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
+I++F + + F +++E++P G L +L + F + ++ ALEYLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH- 118
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEYA 759
S +V+ +LKP NILLDK +++DFG +K L +T T+ T Y+APE
Sbjct: 119 --SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAPE-- 168
Query: 760 SDGIISPK-----CDVYSYGVLLMETFTRKKP 786
+I K D ++ G+L+ E P
Sbjct: 169 ---VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 74/233 (31%), Positives = 117/233 (50%), Gaps = 27/233 (11%)
Query: 592 LLGAGSFGSVY---KGTLFD-GTNVAIKVF---NLQLERAFRSFESECEVLRNVRHRNLI 644
+LG GSFG V+ K T D G A+KV L++ R+ + E ++L V H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 645 KI---FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
K+ F + L L+L+F+ G L L F + + + ++ LAL++LH
Sbjct: 62 KLHYAFQTEGKL---YLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH-- 115
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEYAS 760
S +++ +LKP NILLD+ +++DFG+SK E D + + T+ YMAPE +
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKP---TDEMFTGEMSLKHWIKLSLPRGLT 810
+ D +S+GVL+ E T P D T M LK KL +P+ L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGMPQFLS 222
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESEC--EV--LRNVRHR 641
+ + LG G++G VYK G VA+K ++L+ S E+ L+ ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHP 58
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
N++K+ LV E+ L+K+L L +IM + L Y H S
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH-S 116
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
H ++H +LKP NIL++++ +++DFG+++ G + T + T+ Y APE
Sbjct: 117 HR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH--EVVTLWYRAPE---- 168
Query: 762 GIISPKCDVYSYGV 775
I YS V
Sbjct: 169 --ILLGSKHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 56/223 (25%)
Query: 585 DGFNECNLLGAGSFGSVYK------GTLFDGTNVAIKVFNL--------QLERAFRSFES 630
+ E + LG G+ GSV K G +F A+K Q+ R
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIF-----ALKTITTDPNPDLQKQILR------- 48
Query: 631 ECEVLRNVRHRNLIKIFSSC-----CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER- 684
E E+ ++ + ++K + + ++ + +E+ GSL+ +Y + +R
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSI---GIAMEYCEGGSLDS-IYK-----KVKKRG 99
Query: 685 --------LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736
I V L YLH S ++H ++KP+NILL + ++ DFG+S G
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---G 153
Query: 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLME 779
E +S+ T T T YMAPE S DV+S G+ L+E
Sbjct: 154 ELVNSLAGTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 55/241 (22%), Positives = 108/241 (44%), Gaps = 27/241 (11%)
Query: 589 ECNLLGAGSFGSVY----KGTLFDGTN--VAIKVFN-LQLERAFRSFESECEVLRNVRHR 641
E LG G FG V+ KG +G V +K + E F E ++ R + H+
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDML--------ERLNIMIDVGL 693
N++++ C + ++LE+ G L+++L + + L +++ + + L
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
+++L ++ VH +L N L+ +VS +SK + + + + + +
Sbjct: 129 GMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNALIPLRW 184
Query: 754 MAPEYASDGIISPKCDVYSYGVLLMETFTR------KKPTDEMFTGEMSLKHWIKLSLPR 807
+APE + S K DV+S+GVL+ E FT+ +E+ + K ++L +P
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--LELPVPE 242
Query: 808 G 808
G
Sbjct: 243 G 243
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 13/222 (5%)
Query: 590 CNLLGAGSFGSVY----KGTLFDG--TNVAIKVFNLQLERAFR-SFESECEVLRNVRHRN 642
LG GSFG VY KG + D T VAIK N R F +E V++ +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYS-----HNYFLDMLERLNIMIDV-GLALE 696
++++ +++E M G L+ +L S N + L MI + G +
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
+ + ++ VH +L N ++ ++ T ++ DFG+++ + E D + + +M+P
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798
E DG+ + DV+S+GV+L E T + + + E L+
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G G+ G+VY + G VAIK NLQ + +E V+R +H N++ S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
D +V+E++ GSL + +D + + + ALE+LH + V+H ++
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
K +NILL + + +++DFG + + + TM + T +MAPE + PK D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 772 SYGVLLMETFTRKKP 786
S G++ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-14
Identities = 40/105 (38%), Positives = 61/105 (58%), Gaps = 5/105 (4%)
Query: 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPI 79
L + RG++PN++ +LR L+ + + N + G+ P +G + L+VL L NSF G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 80 PNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVH---LNFADN 121
P SL L+SL L+ NS+SG +P+ +G L+H NF DN
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR--LLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVFNL-----QLERAFRSFESECEVLRNVRHRNLIK 645
LLG G+FG VY D G +A+K + + + E E ++L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 646 IFSSCCNLDFKALVL--EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ + + K L + E+MP GS++ L ++ + + R + + YLH S
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---------YM 754
+VH ++K NIL D ++ DFG SK + QT+ M+ G +M
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRI--------QTICMSGTGIKSVTGTPYWM 176
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKPTDE 789
+PE S K DV+S ++E T K P E
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 31/184 (16%)
Query: 627 SFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN 686
F E ++L + N+ ++ C +++E+M NG L ++L H
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH----------- 113
Query: 687 IMIDVGLALEYLHHSHSTPV------------------VHCNLKPNNILLDKNMTARVSD 728
+ GLA S ST + VH +L N L+ KN T +++D
Sbjct: 114 VAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 729 FGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT--RKKP 786
FG+S+ L D Q I +MA E G + K DV+++GV L E T R++P
Sbjct: 174 FGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233
Query: 787 TDEM 790
+ +
Sbjct: 234 YEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 66/304 (21%), Positives = 120/304 (39%), Gaps = 64/304 (21%)
Query: 592 LLGAGSFGSVYKGTLFD------GTNVAIKVFNLQ-LERAFRSFESECEVLRNV-RHRNL 643
LG G+FG V K + VA+K+ E+ SE E+++ + +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH-------NYFLDMLERLNIMI------- 689
I + C +V+E+ +G+L +L + + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 690 -DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748
V +E+L S +H +L N+L+ ++ +++DFG+++ + D T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK------PTDEMFTGEMSLKHWIK 802
+ +MAPE D + + + DV+S+GVLL E FT P +E+F
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF----------- 244
Query: 803 LSLPRGLTEVVDASLVRE----VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858
L++E +P C + HL C + P QR +V
Sbjct: 245 -------------KLLKEGYRMEKPQN----CTQELYHLMRDCWHEVPSQRPTFKQLVED 287
Query: 859 LQKI 862
L ++
Sbjct: 288 LDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
LG G+FG VYK + G A KV + E + E E+L H ++K+ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDM-LERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+++EF P G+++ + LD L I + LE L + HS ++H +
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 711 LKPNNILLDKNMTARVSDFGIS----KLLGEDDDSVTQTMTMATIGYMAPEYA-----SD 761
LK N+LL + +++DFG+S K L D + T +MAPE D
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCETMKD 189
Query: 762 GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810
K D++S G+ L+E + P E+ + LK I S P L+
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSEPPTLS 236
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 593 LGAGSFGSVYKGTLFDGT------NVAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIK 645
LG FG VYKG LF VAIK + E R F+ E + ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDM------------LER---LNIMID 690
+ +++ + + L ++L + D+ LE ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ +E+L H VVH +L N+L+ + ++SD G+ + + D ++
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
I +M+PE G S D++SYGV+L E F+
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 12/211 (5%)
Query: 593 LGAGSFGSVYKG---TLFDGTNVAIKVF-NLQLERAFR-SFESECEVLRNVRHRNLIKIF 647
LG+G+FG+V KG VA+K+ N + A + E V++ + + ++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
C + LV+E G L K+L + + + ++ V + ++YL ++ V
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQKNKHVTEK-NITELVHQVSMGMKYLEETN---FV 117
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV-TQTMTMATIGYMAPEYASDGIISP 766
H +L N+LL A++SDFG+SK LG D++ +T + + APE + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMS 796
K DV+S+GVL+ E F+ +KP M E++
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKV---FNLQL--ERAFRSFESECEVLRNVRHRNLI 644
+ +G G++G V T G VAIK F Q +R R E ++LR +H N+I
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 645 KIF-----SSCCNLDFKALVLEFMPNGSLEKWLYSHN-------YFLDMLERLNIMIDVG 692
I S + + +V E M L K + + + YFL + R
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------- 117
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MAT 750
L+Y+H S V+H +LKP+N+LL+ N ++ DFG++++ + D T +T +AT
Sbjct: 118 -GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLTEYVAT 172
Query: 751 IGYMAPE--YASDGIISPKCDVYSYGVLLMETFTRK 784
Y APE S G + D++S G +L E + +
Sbjct: 173 RWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 593 LGAGSFGSVYKGTLFDGTNVA-IKVFNLQLERAF---RSFESECEVLRNVRHRNLIKIFS 648
+G G FG V G + G A + V L++ + F E + R+++H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDM------LERLNIMIDVGLALEYLHHSH 702
C + LV+EF P G L+ +L S M L+R+ I +GL H H
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL-----HLH 117
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD- 761
+H +L N LL ++T ++ D+G+S ++D VT + ++APE +
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 762 -GII-----SPKCDVYSYGVLLMETF 781
G + + + +V+S GV + E F
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 591 NLLGAGSFGSVYKGTLFDG----TNVAIKVFN--LQLERAFRSFESECEVLRNVRHRNLI 644
++G G FG VY GTL D + A+K N LE F E ++++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVL 59
Query: 645 KIFSSCCNLDFKALV-LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ C + LV L +M +G L ++ S + + + + + V +EYL S
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---S 116
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISK-LLGEDDDSVTQ-TMTMATIGYMAPEYASD 761
VH +L N +LD++ T +V+DFG+++ + ++ SV T + +MA E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 762 GIISPKCDVYSYGVLLMETFTRKKP 786
+ K DV+S+GVLL E TR P
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 36/89 (40%), Positives = 49/89 (55%)
Query: 44 LGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNI 103
LG L G P+ I LQ ++L NS G IP SL +++SL LD +NS +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 104 PSKIGNLTKLVHLNFADNNLRGEIPNEIG 132
P +G LT L LN N+L G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQ------LERAFRSFESECEVLRNVRHRNLI 644
LG G+F S Y+ + GT +A+K E + E ++ + H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
++ + C L +E+M GS+ L + F + + +N + L YLH +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHENQ-- 123
Query: 705 PVVHCNLKPNNILLDKN-MTARVSDFGI-----SKLLGEDDDSVTQTMTMATIGYMAPEY 758
++H ++K N+L+D R++DFG +K G + Q + TI +MAPE
Sbjct: 124 -IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFMAPEV 179
Query: 759 ASDGIISPKCDVYSYGVLLMETFTRKKP 786
CDV+S G +++E T K P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 73/250 (29%), Positives = 111/250 (44%), Gaps = 59/250 (23%)
Query: 592 LLGAGSFGSVYKGTLFDGTN----VAIKVFNLQLERAFRS------FESECEVLRNVRHR 641
+LG G +G V++ G + A+KV L+ R+ ++E +L V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 642 ---NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMID-------- 690
+LI F + L L+LE++ G L + H LER I ++
Sbjct: 61 FIVDLIYAFQTGGKL---YLILEYLSGGEL----FMH------LEREGIFMEDTACFYLS 107
Query: 691 -VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
+ LALE+LH +++ +LKP NILLD +++DFG+ K + +VT T
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-G 162
Query: 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFT---------RKKPTDEMFTGEMSLKHW 800
TI YMAPE D +S G L+ + T RKK D++ G
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG------- 215
Query: 801 IKLSLPRGLT 810
KL+LP LT
Sbjct: 216 -KLNLPPYLT 224
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G+G++G VYK + G AIKV L+ F + E ++++ +H N++ F S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
D + +EF GSL+ +Y + L I L+ L++ HS +H ++
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IY---HVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYAS---DGIIS 765
K NILL N +++DFG+S + + T + IG +MAPE A+ G +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 766 PKCDVYSYGVLLMETFTRKKP 786
CD+++ G+ +E + P
Sbjct: 188 QLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 592 LLGAGSFGSVYKGTLF--DGT--NVAIKVFNLQLERA--FRSFESECEVLRNVRHRNLIK 645
+LG G FGSV + L DG+ VA+K+ + + F E ++ H N+IK
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 646 IFSSCCN------LDFKALVLEFMPNGSLEKWLYSHN-----YFLDMLERLNIMIDVGLA 694
+ L ++L FM +G L +L + L + + MID+
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
+EYL S +H +L N +L++NMT V+DFG+SK + D + + ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTR 783
A E +D + + DV+++GV + E TR
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 31/240 (12%)
Query: 600 SVYKGTLFDGTNVAIKVF---NLQLERAFRSFESECEVLRNVRHRNLIKIFS----SCCN 652
S+YKG +F+ V I+ F + + E+E + LR + N++KI+ +
Sbjct: 35 SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLK 712
L +L+LE+ G L + L L +L++ ID L L+ + P + NL
Sbjct: 94 LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 713 PNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP---KCD 769
+ L+ +N ++ G+ K+L S + + Y + + +D I S K D
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLND-IFSEYTIKDD 204
Query: 770 VYSYGVLLMETFTRKKPTDEMFTGEM---------SLKHWIKLSLPRGLTEVVDASLVRE 820
+YS GV+L E FT K P + + T E+ SLK + L P + +V+A +
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--LPLDCPLEIKCIVEACTSHD 262
|
Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 12/201 (5%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK---VFNLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
+G G F VY+ T L DG VA+K +F+L +A E ++L+ + H N+IK ++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
S + +VLE G L + + ++ + L H HS V+H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYASDGIIS 765
++KP N+ + ++ D G+ + S T + +G YM+PE + +
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 766 PKCDVYSYGVLLMETFTRKKP 786
K D++S G LL E + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 593 LGAGSFGSVYK-GTLFDGTNVAIKVFNLQLERAFR-SFESECEVLRNVRHRNLIKIFSSC 650
LGAG+ GSV K + GT +A KV ++ + + R E +++ R ++ + +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
N + + +EFM GSL++ +++L + I + V L YL++ H ++H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHR 128
Query: 710 NLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCD 769
++KP+NIL++ ++ DFG+S GE +S+ T + T YM+PE G + K D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQGGKYTVKSD 184
Query: 770 VYSYGVLLMETFTRKKPTDE 789
V+S G+ ++E K P
Sbjct: 185 VWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 593 LGAGSFGSVYKGTLFD------GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645
LG G FG V + +D G VA+K + + E E+LRN+ H N++K
Sbjct: 12 LGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 646 IFSSCCNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
+ C D L++EF+P+GSL+++L + +++ ++L + + ++YL
Sbjct: 71 -YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---G 126
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEYASD 761
S VH +L N+L++ ++ DFG++K + D + T + + + + APE
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 762 GIISPKCDVYSYGVLLMETFT 782
DV+S+GV L E T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRS-FESECEVLRNVRH---R 641
+ L+G G++G+VY+G + G VA+K+ NL S + E +L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
N+ K + S +++E+ GS+ + + + I+ +V +AL+Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVALKYIHKV 120
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
V+H ++K NIL+ ++ DFG++ LL + + S T T +MAPE ++
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-NSSKRSTFV-GTPYWMAPEVITE 175
Query: 762 GII-SPKCDVYSYGVLLMETFTRKKP 786
G K D++S G+ + E T P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 593 LGAGSFGSVYKGTLF----DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKI 646
+G GS+G V +L DG IK NL+ R ++ E E ++L ++H N++
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 647 FSSCCNLD-FKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHS 703
S D +V+ F G L L L + E + + + +AL+YLH H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH- 122
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
++H +LK N+ L + +V D GI+++L E+ + T+ + T YM+PE S+
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTL-IGTPYYMSPELFSNKP 178
Query: 764 ISPKCDVYSYGVLLMETFTRK 784
+ K DV++ G + E T K
Sbjct: 179 YNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 34/230 (14%)
Query: 593 LGAGSFGSVY--------KGTLFDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRN 642
LG G FG V K T VA+K+ E+ SE E+++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWL---------YSHNYFLDMLERLNI------ 687
+I + +C +++E+ G+L ++L Y +N E+L+
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
V +EYL S +H +L N+L+ ++ +++DFG+++ + D T
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK------PTDEMF 791
+ +MAPE D I + + DV+S+GVLL E FT P +E+F
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 32/281 (11%)
Query: 592 LLGAGSFGSVYKGTLF-DGTN----VAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIK 645
+LG+G+FG+VYKG DG N VAIKV +A + E V+ V + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ C + LV + MP G L ++ + + + LN + + + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
+VH +L N+L+ +++DFG+++LL D+ I +MA E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 766 PKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLP-RGLTEVVDASLVREVQP 823
+ DV+SYGV + E T KP D +P R + ++++ R QP
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYD---------------GIPAREIPDLLEKG-ERLPQP 233
Query: 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
C + + + + C M E R ++V + ++ +
Sbjct: 234 P----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 592 LLGAGSFGSV-YKGTLFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFS 648
+LG+G+ G+V + DG A+KV +++ E ++E L N +++K
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95
Query: 649 SCCNLDFK-------------ALVLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVG 692
C+ DF ALVL++ G L + + S N E + I V
Sbjct: 96 --CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED-DDSVTQTMTMATI 751
LA+ HH HS ++H ++K NILL N ++ DFG SK+ D V +T T
Sbjct: 154 LAV---HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTP 209
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTD 788
Y+APE S K D++S GVLL E T K+P D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 593 LGAGSFGSVY----KGTLFDGTNVAIKVFN----LQLERAFRSFESECEVLRNVRHR--- 641
LG G++G V+ G G A+KV +Q + +E +VL VR
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 642 -NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI-DVGLALEYLH 699
L F + L L+L+++ G L LY +F + + I ++ LAL++LH
Sbjct: 68 VTLHYAFQTDTKLH---LILDYVNGGELFTHLYQREHF--TESEVRVYIAEIVLALDHLH 122
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY- 758
+++ ++K NILLD ++DFG+SK +++ + TI YMAPE
Sbjct: 123 Q---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVI 178
Query: 759 -ASDGIISPKCDVYSYGVLLMETFTRKKP 786
G D +S GVL E T P
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 40/233 (17%)
Query: 593 LGAGSFGSVYKGTLF--------DGTNVAIKVF-NLQLERAFRSFESECEVLRNV-RHRN 642
LG G FG V + VA+K+ + E+ SE E+++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWL---------YSHNY---------FLDMLER 684
+I + +C +++E+ G+L ++L YS++ F D++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV-- 140
Query: 685 LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
+ V +EYL S +H +L N+L+ +N +++DFG+++ + D
Sbjct: 141 -SCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK------PTDEMF 791
T + +MAPE D + + + DV+S+GVL+ E FT P +E+F
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 593 LGAGSFGSVYKGTLFD------GTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIK 645
LG GSFG VY+G D T VA+K N R F +E V++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYS-----HNYFLDMLERLNIMI----DVGLALE 696
+ +V+E M +G L+ +L S N L MI ++ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YL+ + VH +L N ++ + T ++ DFG+++ + E D + + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798
E DG+ + D++S+GV+L E + + + + E LK
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 39/238 (16%)
Query: 593 LGAGSFGSVY-------------KGTLFDGTNVAIKVFNLQLE---RAFRSFESECEVLR 636
LG G FG V+ FDG V + V L+ + A F E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWL--------YSHNYFLDMLERLNIM 688
+++ N+I++ C + D ++ E+M NG L ++L ++H + + N++
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 689 ---IDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745
+ + ++YL S VH +L N L+ + T +++DFG+S+ L D Q
Sbjct: 133 YMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT--RKKP----TDEMF---TGE 794
+ I +MA E G + DV+++GV L E FT +++P +DE TGE
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 51/234 (21%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNV-AIKVFN--LQLERAFRS-FESECEVLRNVRH 640
D F ++G G+FG V+ D V A+KV ++R + +E ++L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNI--MIDVGLALEYL 698
++K++ S + + LV+E+MP G L L + F + R I ++ LAL+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LALDSV 117
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV---------------- 742
H +H ++KP+NIL+D + +++DFG+ K + + D
Sbjct: 118 HKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 743 ------TQTMTMA--TIG---YMAPE------YASDGIISPKCDVYSYGVLLME 779
Q A T+G Y+APE Y +CD +S GV+L E
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY------GLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFES---ECEVLRNVRHRNLIKIFS 648
+G G+ VY L + VAIK +L E+ S + E + + H N++K ++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNI---MIDVGLALEYLH-HSHST 704
S D LV+ ++ GSL + +Y L+ I + +V LEYLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGYMAPEYASDG 762
+H ++K NILL ++ + +++DFG+S L + D + + T +MAPE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE----- 176
Query: 763 IISP------KCDVYSYGVLLMETFTRKKP 786
++ K D++S+G+ +E T P
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 69/257 (26%), Positives = 115/257 (44%), Gaps = 54/257 (21%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAF-------RSFESECEVLRNVRHRNLI 644
+G+G++G V G VAIK ++ AF R+ E ++LR+ +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLR-ELKILRHFKHDNII 67
Query: 645 ---KIFSSCCNLDFKA--LVLEFMPNGSLEKWLYSH--------NYFLDMLERLNIMIDV 691
I DFK +V++ M + L ++S YFL L R
Sbjct: 68 AIRDILRPPGA-DFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------- 118
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MA 749
L+Y+H S V+H +LKP+N+L++++ R+ DFG+++ L MT +A
Sbjct: 119 --GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 750 TIGYMAPEYA-SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL--- 805
T Y APE S + D++S G + E R+ ++F G+ + H +KL L
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPGKNYV-HQLKLILSVL 228
Query: 806 ---PRGLTEVVDASLVR 819
+ + + VR
Sbjct: 229 GSPSEEVLNRIGSDRVR 245
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G G+ G+VY + G VAI+ NLQ + +E V+R ++ N++ S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
D +V+E++ GSL + +D + + + ALE+LH S V+H ++
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
K +NILL + + +++DFG + + + + T +MAPE + PK D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 772 SYGVLLMETFTRKKP 786
S G++ +E + P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 593 LGAGSFGS--VYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFS 648
LG G+FG +Y+ T D + V K NL E+ R +E +L ++H N+I ++
Sbjct: 8 LGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 649 SCCNLDFKALV--LEFMPNGSL-------EKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
+D L+ +E+ G+L + L+ L L + + A+ Y+H
Sbjct: 67 HF--MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ------IVSAVSYIH 118
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
++H ++K NI L K ++ DFGISK+LG + S+ +T+ + T YM+PE
Sbjct: 119 ---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETV-VGTPYYMSPELC 173
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKK 785
+ K D+++ G +L E T K+
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 49/195 (25%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G G+ G+V+ + G VAIK NLQ + +E V++ +++ N++ S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
D +V+E++ GSL + +D + + + ALE+LH + V+H ++
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
K +N+LL + + +++DFG + + ++ + T +MAPE + PK D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 772 SYGVLLMETFTRKKP 786
S G++ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 8/195 (4%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G G+ G+VY + G VAIK NLQ + +E V+R ++ N++ S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
D +V+E++ GSL + +D + + + AL++LH S V+H ++
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
K +NILL + + +++DFG + + ++ + T +MAPE + PK D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 772 SYGVLLMETFTRKKP 786
S G++ +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 23/250 (9%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTN---VAIKVFNLQ-LERAFRSFESECEVLRNVRHRN 642
F + +G GSFG V+KG D VAIK+ +L+ E + E VL
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
+ K + S +++E++ GS L + + D + ++ ++ L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH--- 118
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
S +H ++K N+LL + +++DFG++ L D + + + T +MAPE
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP-------RGLTEVVDA 815
K D++S G+ +E + P +M + L K + P + E +DA
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-LFLIPKNNPPTLTGEFSKPFKEFIDA 235
Query: 816 SLVREVQPSY 825
L ++ PS+
Sbjct: 236 CLNKD--PSF 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 34/248 (13%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G GS G V T G VA+K +L+ ++ +E ++R+ +H N+++++SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN------IMIDVGLALEYLHHSHSTP 705
D +V+EF+ G+L + +H R+N + + V AL +LH +
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIATVCLAVLKALSFLH---AQG 135
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY-MAPEYASDGII 764
V+H ++K ++ILL + ++SDFG + ++ V + ++ Y MAPE S
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPY 192
Query: 765 SPKCDVYSYGVLLMET------FTRKKPTDEMF----TGEMSLKHWIKLSLPRGLTEVVD 814
+ D++S G++++E + + P M LK+ K+S PR L +D
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVS-PR-LRSFLD 250
Query: 815 ASLVREVQ 822
LVR+
Sbjct: 251 RMLVRDPA 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 593 LGAGSFGSVY--KGTLFDGTNVAIKVFNLQLERAFRSFESECEV--LRNVRHRNLIKIFS 648
+G GSFG +Y K D + IK +L S+ EV L ++H N++ F+
Sbjct: 8 IGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 649 SCCNLDFKALVLEFMPNGSLEKWL-YSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
S +V+E+ G L K + + L+ + + L L+ H H ++
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK---HIHDRKIL 123
Query: 708 HCNLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEYASDGIIS 765
H ++K NI L KN M A++ DFGI++ L +DS+ T T Y++PE + +
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 766 PKCDVYSYGVLLMETFTRKKP 786
K D++S G +L E T K P
Sbjct: 181 NKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNL---QLERAFRSFESECEVLRNVRHRNLIKIFS 648
+G GSFG+VY + VAIK + Q ++ E L+ +RH N I+ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 649 SCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
C + A LV+E+ GS L H L +E I L YLH SH +
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH-SHER--I 137
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE--YASD-GII 764
H ++K NILL + T +++DFG + L+ + V T +MAPE A D G
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQY 191
Query: 765 SPKCDVYSYGVLLMETFTRKKPTDEM 790
K DV+S G+ +E RK P M
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 62/252 (24%), Positives = 109/252 (43%), Gaps = 40/252 (15%)
Query: 593 LGAGSFGSVY------------KGTLFDGTN-----VAIKVFNLQLERAFRS-FESECEV 634
LG G FG V+ K D + VA+K+ + R+ F E ++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 635 LRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNY----------FLDMLER 684
+ ++ N+I++ + C D ++ E+M NG L ++L H +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 685 LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
+ + + ++YL S VH +L N L+ KN T +++DFG+S+ L D Q
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT--RKKP----TDEMF---TGEM 795
+ I +M+ E G + DV+++GV L E T +++P +DE TGE
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEF 249
Query: 796 SLKHWIKLSLPR 807
++ LP+
Sbjct: 250 FRDQGRQVYLPK 261
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 66/251 (26%), Positives = 112/251 (44%), Gaps = 25/251 (9%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTN---VAIKVFNLQ-LERAFRSFESECEVLRNVRHRN 642
F + +G GSFG V+KG D VAIK+ +L+ E + E VL
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
+ K + S +++E++ GS L LD + I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
S +H ++K N+LL ++ +++DFG++ L D + + + T +MAPE
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP--------RGLTEVVD 814
K D++S G+ +E + P E+ M + I + P + L E V+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPKNNPPTLEGNYSKPLKEFVE 234
Query: 815 ASLVREVQPSY 825
A L +E PS+
Sbjct: 235 ACLNKE--PSF 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIF-- 647
++G G++G VYK G VAIK+ ++ + + E +LR H N+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71
Query: 648 ----SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN------IMIDVGLALEY 697
+ N D LV+E GS+ + +RL I+ + L Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YM 754
LH + V+H ++K NILL KN ++ DFG+S L D ++ + T IG +M
Sbjct: 129 LHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNT--FIGTPYWM 180
Query: 755 APE-----YASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
APE D + DV+S G+ +E K P +M
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 59/230 (25%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERA------FRSFESECEVLRNVR 639
+ E +G G++G+VYK L G VA+K + L R E +L+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56
Query: 640 ---HRNLIKIFSSCCNLDFK-----ALVLEFM-----------PNGSLEKWLYSHNYFLD 680
H N++++ C LV E + P L
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI------- 109
Query: 681 MLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740
++M + +++LH SH +VH +LKP NIL+ + +++DFG++++ +
Sbjct: 110 ----KDLMRQLLRGVDFLH-SHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-- 160
Query: 741 SVTQTMTMATIGYMAPE------YASDGIISPKCDVYSYGVLLMETFTRK 784
+ T + T+ Y APE YA+ D++S G + E F R+
Sbjct: 161 -MALTSVVVTLWYRAPEVLLQSSYAT------PVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 587 FNECNLLGAGSFGSVY---KGTLFD-GTNVAIKVFN----LQLERAFRSFESECEVLRNV 638
F +LG G++G V+ K T D G A+KV +Q + +E VL +V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 639 RHRNLIKIFSSCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
R + + K L+L+++ G + LY + F + R ++ LALE+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEH 120
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
LH +V+ ++K NILLD ++DFG+SK ++ T + TI YMAPE
Sbjct: 121 LH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAPE 176
Query: 758 YASDGIISPK------CDVYSYGVLLMETFTRKKP 786
II K D +S G+L+ E T P
Sbjct: 177 -----IIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 596 GSFGSVY----KGTLFDGTNVAIKVF------------NLQLERAFRSFESECEVLRNVR 639
G+FGSVY + T G AIKV N++ ERA + E
Sbjct: 7 GAFGSVYLAKKRST---GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP------ 57
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
+ K++ S + D+ LV+E++ G + + + + + +V L +E LH
Sbjct: 58 --YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH 114
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
++H ++KP N+L+D+ +++DFG+S+ E+ V T Y+APE
Sbjct: 115 QRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETI 165
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKP 786
D +S G ++ E P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 32/194 (16%)
Query: 678 FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737
L + + ++ V +E+L S +H +L NILL +N ++ DFG+++ + +
Sbjct: 169 PLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKP-----TDEMF 791
D D V + + +MAPE D + + + DV+S+GVLL E F+ P DE F
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285
Query: 792 TGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC 851
LK ++ P T + IM L C ++PE R
Sbjct: 286 CRR--LKEGTRMRAPEYATPEI------------------YSIM---LDCWHNNPEDRPT 322
Query: 852 MTDVVVKLQKIKQT 865
+++V L + Q
Sbjct: 323 FSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 27/162 (16%)
Query: 660 LEFMPNGSLEKW---LYSHNYFL--DMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPN 714
+E M + SL+K+ +Y + D+L + I + + ALEYLH S V+H ++KP+
Sbjct: 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSKLS--VIHRDVKPS 133
Query: 715 NILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP-------- 766
N+L+++N ++ DFGIS G DSV +T+ YMAPE I+P
Sbjct: 134 NVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKPYMAPER-----INPELNQKGYD 185
Query: 767 -KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807
K DV+S G+ ++E T + P D T LK ++ P+
Sbjct: 186 VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ 227
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 66/258 (25%), Positives = 116/258 (44%), Gaps = 64/258 (24%)
Query: 575 TSYLDIQQATDGFNECNLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERA--FRSFESE 631
TSYL++++ LG GS+ +VYKG + +G VA+KV +++ E F + E
Sbjct: 5 TSYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-E 53
Query: 632 CEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM-----------PNGSLEKWLYSHNYFLD 680
+L+ ++H N++ + + V E+M P G L+ +N L
Sbjct: 54 ASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLF 108
Query: 681 MLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740
M + L GLA Y+H H ++H +LKP N+L+ +++DFG+++ +
Sbjct: 109 MFQLLR-----GLA--YIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIP 156
Query: 741 SVTQTMTMATIGYMAP-------EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTG 793
S T + + T+ Y P +Y+S D++ G + +E + +P F G
Sbjct: 157 SQTYSSEVVTLWYRPPDVLLGATDYSSA------LDIWGAGCIFIEML-QGQP---AFPG 206
Query: 794 -----EMSLKHWIKLSLP 806
E K W L +P
Sbjct: 207 VSDVFEQLEKIWTVLGVP 224
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 68/246 (27%)
Query: 568 NRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFR 626
N+T W + D + + +G+G++G V G VAIK +L R F+
Sbjct: 7 NKTVW---------EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----KLSRPFQ 53
Query: 627 SFE------SECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLD 680
S E +L+++ H N+I LD F P SLE + Y +
Sbjct: 54 SAIHAKRTYRELRLLKHMDHENVI------GLLDV------FTPASSLED--FQDVYLVT 99
Query: 681 ML-----------ERLN---IMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARV 726
L ++L+ I V L L + HS ++H +LKP+NI ++++ ++
Sbjct: 100 HLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 159
Query: 727 SDFGISKLLGEDDDSVTQTMT--MATIGYMAPEYASDGII------SPKCDVYSYGVLLM 778
DFG+++ ++ MT +AT Y APE I+ + D++S G ++
Sbjct: 160 LDFGLARHTDDE-------MTGYVATRWYRAPE-----IMLNWMHYNQTVDIWSVGCIMA 207
Query: 779 ETFTRK 784
E T K
Sbjct: 208 ELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFR-----SFESECEVLRNVRHRNLIKIF 647
+G G FG V G G + A +V +L + F E + R + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFL------DMLERLNIMIDVGLALEYLHHS 701
C LVLEF P G L+ +L S+ + D+L+R+ + GL +LH +
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL--WLHQA 119
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS- 760
+H +L N L +++ ++ D+G++ +D +T+ + ++APE
Sbjct: 120 D---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 761 --DGI----ISPKCDVYSYGVLLMETFT 782
+ + K +++S GV + E FT
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G+G++G VYK L G A+K+ L+ F + E +++ +H N++ F S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+ + + +E+ GSL+ +Y + L L I L+ L + HS +H ++
Sbjct: 77 SREKLWICMEYCGGGSLQD-IY---HVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDI 132
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-----MATIGYMAPEYAS---DGI 763
K NILL N +++DFG++ +T T+ + T +MAPE A+ +G
Sbjct: 133 KGANILLTDNGDVKLADFGVAA-------KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 764 ISPKCDVYSYGVLLMETFTRKKP 786
+ CD+++ G+ +E + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 55/230 (23%), Positives = 104/230 (45%), Gaps = 34/230 (14%)
Query: 593 LGAGSFGSVY--------KGTLFDGTNVAIKVF-NLQLERAFRSFESECEVLRNV-RHRN 642
LG G FG V K VA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH-----NYFLDML----------ERLNI 687
+I + +C +++E+ G+L ++L + +Y D + ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
V +EYL S +H +L N+L+ ++ +++DFG+++ + D T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK------PTDEMF 791
+ +MAPE D + + + DV+S+GVLL E FT P +E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNV-AIKVFNL--QLERAFRS-FESECEVLRNVRH 640
D F ++G G+FG V + + A+K+ N L+RA + F E VL N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
+ + + + + ++ LV+++ G L L + F D L + + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY-- 758
H VH ++KP+N+LLD N R++DFG S L D +V ++ + T Y++PE
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 759 -ASDGI--ISPKCDVYSYGVLLMETFTRKKP 786
DG+ P+CD +S GV + E + P
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 24/153 (15%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-------HRNLI 644
LG G+FGSVY G VAIK ++++ F S+E EC LR V+ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 645 KIFSSCCNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDMLERL--NIMIDVGLALEYLHH 700
K+ + L V E+M G+L + L E + +I+ + L ++H
Sbjct: 62 KLKEVF--RENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733
H +LKP N+L+ +++DFG+++
Sbjct: 118 HG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-11
Identities = 30/80 (37%), Positives = 50/80 (62%)
Query: 101 GNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIST 160
G IP+ I L L +N + N++RG IP +G++ +L L L+ N+ G IP ++ +++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 161 IIIINLVGNQLSGHRPSTMG 180
+ I+NL GN LSG P+ +G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 37/221 (16%)
Query: 593 LGAGSFGSVYKGTLF------DGTNVAIKVF----NLQLERAFRSFESECEVLRNVRHRN 642
+G G+FG V++ T VA+K+ + ++ F+ E ++ H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEFDHPN 69
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWL--------------------YSHNYF-LDM 681
++K+ C L+ E+M G L ++L N L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 682 LERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741
E+L I V + YL VH +L N L+ +NM +++DFG+S+ + D
Sbjct: 130 TEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
I +M PE + + DV++YGV+L E F+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 11/199 (5%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIKIFS 648
LG G FG V + G A K + L+ + + +E ++L V R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+ D LV+ M G L+ +Y+ + + LE+LH +V
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
+ +LKP N+LLD + R+SD G L E T GYMAPE +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLG---LAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 768 CDVYSYGVLLMETFTRKKP 786
D ++ G L E + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 30/179 (16%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQL------ERAFRSFESECEVLRNVRHRNLIK 645
+G G+ G V+K G VA+K L+ +A R E + L+ +H ++K
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63
Query: 646 IFS-----SCCNLDFKALVLEFMPNGSLEKWL--YSHNYFLDMLERLNIMIDVGLALEYL 698
+ S LV+E+MP L + L ++ M+ L+ +
Sbjct: 64 LLDVFPHGSGF-----VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML-----LKGV 112
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
+ H+ ++H +LKP N+L+ + +++DFG+++L E++ + + +AT Y APE
Sbjct: 113 AYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-YSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLER---------AFRSFESECEVLRNVRHR 641
L+G GS+G V K + G VAIK F LE A R E +L+ +RH
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60
Query: 642 NLIKIFSSCCNLDFKALVLEFMPN---GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYL 698
NL+ + LV EF+ + LEK Y + + + + + +E+
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK--YPNGLDESRVRK--YLFQILRGIEFC 116
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY 758
H SH+ ++H ++KP NIL+ ++ ++ DFG ++ L + T +AT Y APE
Sbjct: 117 H-SHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATRWYRAPEL 171
Query: 759 -ASDGIISPKCDVYSYGVLLMETFT 782
D D+++ G L+ E T
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 33/80 (41%), Positives = 48/80 (60%), Gaps = 1/80 (1%)
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSL 359
L+G IP +I LR L +++L N + G IP +LG + L+ L L N+ NG IP L L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 360 ISLRQLHLGSNQLTSSIPSS 379
SLR L+L N L+ +P++
Sbjct: 490 TSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAF-RSFESECEVLRNVRHRNLIKIFSSC 650
LG G+ G+VYK L +A+KV L + + SE E+L +I + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 651 CNLDFKALVLEFMPNGSLEKW--LYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
+ ++ EFM GSL+ + + H +L R+ + + GL YL S ++H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEH-----VLGRIAVAVVKGLT--YLW---SLKILH 118
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
++KP+N+L++ ++ DFG+S L +S+ +T + T YMAPE S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTY-VGTNAYMAPERISGEQYGIHS 174
Query: 769 DVYSYGVLLMETFTRKKPTDEMFTGEMSL 797
DV+S G+ ME + P ++ + SL
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVA---IKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
+G G F VYK L DG VA +++F + +A + E ++L+ + H N+IK +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 649 SCCNLDFKALVLEFMPNGSLE---KWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
S + +VLE G L K + + + ALE H HS
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE---HMHSKR 126
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT----MATIGYMAPEYASD 761
++H ++KP N+ + ++ D G+ + +T + T YM+PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSLVGTPYYMSPERIHE 180
Query: 762 GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE-MSL 797
+ K D++S G LL E + P F G+ M+L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 50/195 (25%), Positives = 102/195 (52%), Gaps = 8/195 (4%)
Query: 593 LGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G GS G V T+ G VA+K +L+ ++ +E ++R+ +H N++++++S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
D +V+EF+ G+L + +H ++ + + + V AL L H+ V+H ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIAAVCLAVLKALSVL---HAQGVIHRDI 142
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
K ++ILL + ++SDFG + ++ + + T +MAPE S P+ D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 772 SYGVLLMETFTRKKP 786
S G++++E + P
Sbjct: 201 SLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 46/226 (20%)
Query: 589 ECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
+ +G G+FG+V K L + + V + RS E E R + +++ S
Sbjct: 8 DLGEIGRGAFGTVNK-MLHKPSGTIMAV------KRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 649 SCCNL-DFKALV---------LEFMPNGSLEKWLYSHNYFLDMLERL---NIMIDVGL-- 693
C + F + +E M + SL+K Y + Y ++L+ + I+ + +
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVY--EVLKSVIPEEILGKIAVAT 116
Query: 694 --ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI 751
AL YL ++H ++KP+NILLD+N ++ DFGIS G+ DS+ +T
Sbjct: 117 VKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCR 171
Query: 752 GYMAPEYASDGIISP--------KCDVYSYGVLLMETFTRKKPTDE 789
YMAPE I P + DV+S G+ L E T K P +
Sbjct: 172 PYMAPER-----IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK---VFNLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
+G G F VY+ T L D VA+K +F + +A + E ++L+ + H N+IK
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNI---MIDVGLALEYLHHSHSTP 705
S + +VLE G L + + ++ + + + A+E H HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE---HMHSRR 126
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYASDG 762
V+H ++KP N+ + ++ D G+ + S T + +G YM+PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 763 IISPKCDVYSYGVLLMETFTRKKP--TDEM 790
+ K D++S G LL E + P D+M
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 587 FNECNLLGAGSFGSVY---KGTLFD-GTNVAIKVFN----LQLERAFRSFESECEVLRNV 638
F +LG G++G V+ K + D G A+KV +Q + +E +VL ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 639 RHRNLIKIFSSCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
R + D K L+L+++ G L ++H + + + I G +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVLA 117
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
L H H +++ ++K NILLD N ++DFG+SK ED+ + TI YMAP+
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMAPD 176
Query: 758 Y--ASDGIISPKCDVYSYGVLLMETFTRKKP 786
DG D +S GVL+ E T P
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 41/218 (18%)
Query: 587 FNECNLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER------AFRSFESECEVLRNVR 639
F + +G G++G VYK G VA+K L E A R E +L+ +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
H N++K+ + LV EF+ + L+K F+D I + L YL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGI--PLPLIKSYLF 107
Query: 700 H-------SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
HS V+H +LKP N+L++ +++DFG+++ G T T + T+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLW 165
Query: 753 YMAPE------YASDGIISPKCDVYSYGVLLMETFTRK 784
Y APE Y S + D++S G + E TR+
Sbjct: 166 YRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 579 DIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRN 637
D ++ D F + +G GS G V T G VA+K +L+ ++ +E ++R+
Sbjct: 19 DPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRD 75
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
H N++ +++S D +V+EF+ G+L + +H ++ + + + V AL Y
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSY 133
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
L H+ V+H ++K ++ILL + ++SDFG + + + + + T +MAPE
Sbjct: 134 L---HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPE 188
Query: 758 YASDGIISPKCDVYSYGVLLMETFTRKKP 786
S + D++S G++++E + P
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHR 641
TD + +G G++G VYK T DG+ A+K+ + + E+E +L+++ H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHP 79
Query: 642 NLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLN-IMIDVGL-- 693
N++K + D LVLE GS+ + + L +RL+ MI L
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYG 136
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
AL L H H+ ++H ++K NNILL ++ DFG+S L + + ++ T +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFW 194
Query: 754 MAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
MAPE + D +CDV+S G+ +E P +M
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 39/243 (16%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFN---LQLERAFRSFESECEVLRN 637
F+ +L+G G FG V K T G A+KV L + FE E ++L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
+ ++ + + D LV+E+ P G L L +L R D +A Y
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL----------LSLLNRYEDQFDEDMAQFY 107
Query: 698 L-------HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
L H H VH ++KP N+L+D+ +++DFG + L + V + + T
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGT 166
Query: 751 IGYMAPEY------ASDGIISPKCDVYSYGVLLMETFTRKKPTDE-----MFTGEMSLKH 799
Y+APE G +CD +S GV+ E + P E + M+ +
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR 226
Query: 800 WIK 802
++K
Sbjct: 227 FLK 229
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTNV-AIKVFNLQ-LERAFRSFESECEVLRNVRHRNLI 644
F + +G GSFG VYKG V AIK+ +L+ E + E VL +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--------LNIMIDVGLALE 696
+ + S +++E++ GS LD+L+ I+ ++ L+
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----------LDLLKPGPLEETYIATILREILKGLD 115
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YLH S +H ++K N+LL + +++DFG++ L D + + + T +MAP
Sbjct: 116 YLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAP 170
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
E K D++S G+ +E + P ++
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 31/202 (15%)
Query: 591 NLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLERAFRSFE---SECEVLRNVRHRNL 643
LG GSFG V +KGT G AIK + + + E +L + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ + S + + +LEF+ G L L F + + + ++ LA EYLH S
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLH---S 136
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEYASDG 762
+++ +LKP N+LLD +V+DFG +K + + +T T+ T Y+APE
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE----- 185
Query: 763 IISPK-----CDVYSYGVLLME 779
+I K D ++ GVLL E
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYE 207
|
Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 34/89 (38%), Positives = 49/89 (55%)
Query: 343 LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPS 402
L L G IP +S L L+ ++L N + +IP S S+ + +DLS NS +GS+P
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 403 DIQNLKVLIYLNLSRNQLSGNIPITIGGL 431
+ L L LNL+ N LSG +P +GG
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
LG G+FG VYK + G A KV + + E + E ++L + H N++K+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL----NIMIDVGLALEYLHHSHSTPVV 707
+ +++EF G+++ + LER I + LE L++ H ++
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLE-------LERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-----MATIGYMAPEY---- 758
H +LK NIL + +++DFG+S T+T+ + T +MAPE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA-------KNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 759 -ASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
+ D K DV+S G+ L+E + P E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
AL YL H V+H ++KP+NILLD + ++ DFGIS G DS +T + Y
Sbjct: 126 ALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCAAY 180
Query: 754 MAPEYASDGIISPK----CDVYSYGVLLMETFTRKKP 786
MAPE +PK DV+S G+ L+E T + P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 592 LLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFE---SECEVLRNVRHRNLI 644
LLG G+FG V K + G A+K+ ++ A +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAS---GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ S D V+E++ G L L F + R ++ AL+YLH S
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SG 114
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI----GYMAPEYAS 760
+V+ +LK N++LDK+ +++DFG+ K + +T TM T Y+APE
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKTFCGTPEYLAPEVLE 168
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKP 786
D D + GV++ E + P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 50/230 (21%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 593 LGAGSFGSVYKGTLF--------DGTNVAIKVF-NLQLERAFRSFESECEVLRNV-RHRN 642
LG G FG V + + VA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLY---------------SHNYFLDMLERLNI 687
+I + C +++E+ G+L ++L L + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
V +EYL S +H +L N+L+ ++ +++DFG+++ + + D +
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK------PTDEMF 791
+ +MAPE D + + + DV+S+G+L+ E FT P +E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 593 LGAGSFGSVYK-GTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSC 650
+G G++G V+K +G+ A+K+ + + E+E +L+ + H N++K +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 651 CNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGL---ALEYLHHSH 702
D K LVLE GS+ + FL ER+ I + AL L H H
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS-- 760
+H ++K NNILL ++ DFG+S L + + ++ T +MAPE +
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 761 ---DGIISPKCDVYSYGVLLME 779
D +CDV+S G+ +E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 13/211 (6%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNV-AIKVFNL--QLERAFRS-FESECEVLRNVRH 640
+ F ++G G+FG V L + V A+K+ N L+RA + F E +VL N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
+ + + + + + LV+++ G L L L + ++ +A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
H VH ++KP+NIL+D N R++DFG S L +D +V ++ + T Y++PE
Sbjct: 121 LH---YVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 761 -----DGIISPKCDVYSYGVLLMETFTRKKP 786
G P+CD +S GV + E + P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 30/204 (14%)
Query: 593 LGAGSFGSVYKGTLFDGTNV--AIKVFNLQLERA-FRSFESECEVLRNVRHRNLIKIFSS 649
LG G++GSVYK L T V A+K L+L+ + F E ++L ++ + +
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFL-----DMLERLNIMIDVGLALEYLHHSHST 704
+ +E+M GSL+K LY+ D+L R+ + GL ++L H+
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGL--KFLKEEHN- 123
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYASD 761
++H ++KP N+L++ N ++ DFG+S G S+ +T IG YMAPE
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKT----NIGCQSYMAPERIKS 175
Query: 762 G------IISPKCDVYSYGVLLME 779
G + + DV+S G+ ++E
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 50/234 (21%)
Query: 593 LGAGSFGSV----YKGTLFDGTNVAIK----VFN--LQLERAFRSFESECEVLRNVR-HR 641
LG G++G V T + VAIK VF+ + +RA R E ++LR+ R H+
Sbjct: 8 LGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH-- 699
N+ ++ ++D P E +LY M L+ +I G L H
Sbjct: 63 NITCLY----DMDI------VFPGNFNELYLYEEL----MEADLHQIIRSGQPLTDAHFQ 108
Query: 700 -----------HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT- 747
+ HS V+H +LKP N+L++ + ++ DFG+++ E+ MT
Sbjct: 109 SFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168
Query: 748 -MATIGYMAPEYA-SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH 799
+AT Y APE S + DV+S G +L E RK +F G+ +
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP----VFKGKDYVDQ 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGT--NVAIKVF-------NLQLERAFRSFESECEVL 635
+ FN LG GSFG V T + VAIK F Q++ F SE ++L
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF----SERKIL 85
Query: 636 RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVG--- 692
+ H + ++ S + + LVLEF+ G +L + F + DVG
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---------DVGCFY 136
Query: 693 -----LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
L EYL S +V+ +LKP N+LLDK+ +++DFG +K++ T+T T
Sbjct: 137 AAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYT 187
Query: 748 M-ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
+ T Y+APE + D ++ G+ + E P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 580 IQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAF----RS----FESE 631
+Q + ++ ++G G+FG V + KV+ ++L F RS F E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQ----LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 632 CEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN--IMI 689
+++ ++++F + + + +V+E+MP G L + NY D+ E+
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTA 149
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
+V LAL+ +H S ++H ++KP+N+LLDK+ +++DFG + E V +
Sbjct: 150 EVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-TGMVRCDTAVG 205
Query: 750 TIGYMAPEY----ASDGIISPKCDVYSYGVLLMETFTRKKP 786
T Y++PE DG +CD +S GV L E P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 579 DIQQATDGFNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLERAF----RS--- 627
D++ + + ++G G+FG V +K T KV+ ++L F RS
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR--------KVYAMKLLSKFEMIKRSDSA 88
Query: 628 -FESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN 686
F E +++ ++++F + + + +V+E+MP G L + NY D+ E+
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWA 144
Query: 687 --IMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
+V LAL+ +H S +H ++KP+N+LLDK+ +++DFG + + + V
Sbjct: 145 RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRC 200
Query: 745 TMTMATIGYMAPEY----ASDGIISPKCDVYSYGVLLMETFTRKKP 786
+ T Y++PE DG +CD +S GV L E P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 592 LLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFE---SECEVLRNVRHRNLI 644
LLG G+FG V K T G A+K+ ++ A +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ + D V+E+ G L L F + R ++ ALEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SR 114
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI----GYMAPEYAS 760
VV+ ++K N++LDK+ +++DFG+ K + ++ TM T Y+APE
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKP 786
D D + GV++ E + P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 585 DGFNECNLLGAGSFGSVYK-GTLFDGTNVAIKVFNLQLERAFRS-FESECEVLRNVRHRN 642
D F + LGAG+ G V K G +A K+ +L+++ A R+ E +VL
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHHS 701
++ + + + ++ +E M GSL++ L ++L +++I + GLA YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 122
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
H ++H ++KP+NIL++ ++ DFG+S G+ DS+ + + T YM+PE
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQG 176
Query: 762 GIISPKCDVYSYGVLLMETFTRKKP 786
S + D++S G+ L+E + P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 593 LGAGSFGSVYKGTLFDGTN--VAIKVFNL---QLERAFRSFESECEVLRNVRHRNLIKIF 647
+G GSFG+VY T TN VA+K + Q ++ E + L+ ++H N I+ +
Sbjct: 29 IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-Y 86
Query: 648 SSCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
C + A LV+E+ GS L H L +E I L YLH SH+ +
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHN--M 142
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY---ASDGI 763
+H ++K NILL + +++DFG + + V T +MAPE +G
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQ 196
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEM 790
K DV+S G+ +E RK P M
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVF------NLQLERAFRSFESECEVLRNVRHRNLI 644
++G G++G V K G VAIK F + A R E +VLR +RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ + LV E++ LE L + L + + + L+ + + HS
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQL---LQAIAYCHSH 119
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YASDGI 763
++H ++KP NIL+ ++ ++ DFG ++ L S T +AT Y APE D
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTN 178
Query: 764 ISPKCDVYSYGVLLMETFT 782
DV++ G ++ E
Sbjct: 179 YGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRS-FESECEVLRNVRHRN 642
D F + + LGAG+ G V+K + G +A K+ +L+++ A R+ E +VL
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLD-MLERLNIMIDVGLALEYLHHS 701
++ + + + ++ +E M GSL++ L + +L +++I + GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT--YLREK 122
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
H ++H ++KP+NIL++ ++ DFG+S G+ DS+ + + T YM+PE
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQG 176
Query: 762 GIISPKCDVYSYGVLLMETFTRKKP 786
S + D++S G+ L+E + P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 50/196 (25%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 593 LGAGSFGSV-YKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G GS G V G VA+K+ +L+ ++ +E ++R+ +H+N+++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+ +++EF+ G+L + L+ + + V AL YLH S V+H ++
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY-MAPEYASDGIISPKCDV 770
K ++ILL + ++SDFG + +D V + ++ Y MAPE S + D+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200
Query: 771 YSYGVLLMETFTRKKP 786
+S G++++E + P
Sbjct: 201 WSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 32/289 (11%)
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
+ L L L NN+ T P S+L LD N I ++PS + NL L +L+ + N
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
+L ++P + NL NL +L L+ N I +P I +S + ++L N +
Sbjct: 174 DLS-DLPKLLSNLSNLNNLDLS-GNKISDLPPEIELLSALEELDLSNNSII--------- 222
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
+ +S++N L GL+L++N L +P + GNL +L TL++
Sbjct: 223 -----------------ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSN 264
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N + + SS G + L L + +L L +L L+ N + + +
Sbjct: 265 NQI-SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSI 323
Query: 302 KGSIPKEIGNLRGLI-ALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLN 349
+ ALS+ + N L + +N
Sbjct: 324 LLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNA 372
|
Length = 394 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 25/228 (10%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRN------VRHRNLIKI 646
+G G FG V ++ T VA +V +L+ S E E L+ ++H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVA-RVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQC 60
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF-----LDMLERLNIMIDVGLALEYLHHS 701
C LV E+ G L+ +L + L +L+R+ I G+ H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT-----HM 115
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS- 760
H +H +L N L ++T +V D+GI ++D T+ + ++APE
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 761 --DGIISPK----CDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802
G+I+ + +V++ GV L E F + L H IK
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 30/204 (14%)
Query: 612 VAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEK 670
VA+K+ + R+ F E ++L ++ N+I++ C + D ++ E+M NG L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 671 WLYSHNYFLDMLER-------------------LNIMIDVGLALEYLHHSHSTPVVHCNL 711
+L S ++ D E L++ + + ++YL S VH +L
Sbjct: 109 FL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDL 164
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
N L+ +N+T +++DFG+S+ L D Q + I +MA E G + DV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 772 SYGVLLMETFT--RKKP----TDE 789
++GV L E +++P TDE
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 579 DIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNV-AIKVFNLQLERAFRS----FESECE 633
++ + F+ ++G G+FG V V A+K+ + + E RS F E +
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERD 95
Query: 634 VLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL----------EKWLYSHNYFLDMLE 683
++ + ++++ + + + +V+E+MP G L EKW
Sbjct: 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-----------A 144
Query: 684 RLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743
R +V LAL+ +H S +H ++KP+N+LLDK+ +++DFG + +
Sbjct: 145 RFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200
Query: 744 QTMTMATIGYMAPEY----ASDGIISPKCDVYSYGVLLME 779
T + T Y++PE DG +CD +S GV L E
Sbjct: 201 DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNV-AIKVFNL--QLERAFRS-FESECEVLRNVRH 640
D F ++G G+FG V + + V A+K+ N L+RA + F E +VL N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYL-- 698
R + + + + + LV+++ G L L +L + + +A YL
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDL----------LTLLSKFEDRLPEDMARFYLAE 110
Query: 699 -----HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
H VH ++KP+N+LLDKN R++DFG S L D +V + + T Y
Sbjct: 111 MVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDY 169
Query: 754 MAPEY-----ASDGIISPKCDVYSYGVLLMETFTRKKP 786
++PE G P+CD +S GV + E + P
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 23/225 (10%)
Query: 592 LLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECE-VLRNV-----RHRNLIK 645
+LG GSFG V+ GTN + L+ + + EC V + V H L
Sbjct: 2 MLGKGSFGKVFLAE-LKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
++ + + V+E++ G L + S + F D+ ++ L++LH S
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH---SKG 116
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISK--LLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
+V+ +LK +NILLD + +++DFG+ K +LG D+ T T T Y+APE
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG---DAKTCTFC-GTPDYIAPEILLGQK 172
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTG--EMSLKHWIKLSLP 806
+ D +S+GVLL E + P F G E L I++ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP----FHGHDEEELFQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 49/238 (20%)
Query: 591 NLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFES--------------ECEVL 635
LG G++G V K G VAIK + + + E +++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 636 RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
++H N++ + DF LV++ M L+K + L + I++ + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT---------- 745
LH + +H +L P NI ++ +++DFG+++ G S T +
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 746 MT--MATIGYMAPE-------YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
MT + T+ Y APE Y D++S G + E T K +F GE
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHF------AVDMWSVGCIFAELLTGKP----LFPGE 237
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 34/206 (16%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFE-----SECEVLRNVR-HRNLIK 645
+G G+F V K + G AIK +++ F+S E E + LR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 646 IFSSCCNLDFK----ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
+ D K ALV E M + +L + + L + M + +L+++H +
Sbjct: 63 LIE--VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ----TMTMATIGYMAPE 757
+ H ++KP NIL+ + +++DFG + + T ++T Y APE
Sbjct: 120 G---IFHRDIKPENILIKDD-ILKLADFGSCR-------GIYSKPPYTEYISTRWYRAPE 168
Query: 758 -YASDGIISPKCDVYSYGVLLMETFT 782
+DG PK D+++ G + E +
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 72/254 (28%), Positives = 109/254 (42%), Gaps = 42/254 (16%)
Query: 587 FNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLER-AFRSFES----ECEVLRN 637
F + +LG G FG V + T G A K L+ +R R ES E ++L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRAT---GKMYACK--KLEKKRIKKRKGESMALNEKQILEK 56
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIM--IDVGLAL 695
V R ++ + + D LVL M G L+ +Y H E + ++ L
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGL 115
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGY 753
E LH +V+ +LKP NILLD + R+SD G++ + E QT+ + T+GY
Sbjct: 116 EDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTIKGRVGTVGY 167
Query: 754 MAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813
MAPE + + D ++ G LL E + P + K + R E
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR-----------KKKIKREEVE-- 214
Query: 814 DASLVREVQPSYAK 827
LV+EVQ Y++
Sbjct: 215 --RLVKEVQEEYSE 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 69/260 (26%), Positives = 108/260 (41%), Gaps = 31/260 (11%)
Query: 592 LLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI---- 646
++G G FG VY D G A+K + ++ + + E L +L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 647 FSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
F C F +L+ M G L L H F + R ++ L LE++H+
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNR 116
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
VV+ +LKP NILLD++ R+SD G L D ++ T GYMAPE
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 762 GII-SPKCDVYSYGVLLME------TFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814
G D +S G +L + F + K D+ M+L + + LP + +
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELPDSFSPELK 227
Query: 815 ASLVREVQPSYAK-MDCLLR 833
+ L +Q +K + CL R
Sbjct: 228 SLLEGLLQRDVSKRLGCLGR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 46/196 (23%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 592 LLGAGSFGSVYKGTLFDGTN----VAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKI 646
+LG G FG + +G L + VAI ++ R F +E L H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ +V E+M NG+L+ +L H L + + ++ + ++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGY 128
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM---ATIGYMAPEYASDGI 763
VH L + +L++ ++ ++S F ++D S TM + + + APE
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 764 ISPKCDVYSYGVLLME 779
S DV+S+G+++ E
Sbjct: 185 FSSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 593 LGAGSFGSVYKGTLF----DGTNVAIKVFNLQLERAFRSFES--ECEVLRNVRHRNLIKI 646
+G GSFG K L DG IK N+ ES E VL N++H N+++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER-LNIMIDVGLALEYLHHSHSTP 705
S +V+++ G L K + + L ++ L+ + + LAL+ H H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK---HVHDRK 121
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYASDG 762
++H ++K NI L K+ T ++ DFGI+++L T + IG Y++PE +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEICENR 176
Query: 763 IISPKCDVYSYGVLLMETFTRK 784
+ K D+++ G +L E T K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 3/104 (2%)
Query: 679 LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738
L L+ L+ V +E+L S VH +L N+LL + ++ DFG+++ + D
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ V++ T + +MAPE D + + DV+SYG+LL E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNLIK 645
+G G++G VYKG G VA+K L+ E A R E +L+ ++H N++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH----- 700
+ L+ EF+ + L+K +LD L +D L YL+
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKK-------YLDSL-PKGQYMDAELVKSYLYQILQGI 114
Query: 701 --SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY 758
HS V+H +LKP N+L+D +++DFG+++ G T + T+ Y APE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEV 172
Query: 759 ASDGI-ISPKCDVYSYGVLLMETFTRK 784
S D++S G + E T+K
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVF-----NLQLER-AFRSFESECEVLRNVRHRNL-- 643
+G GS+G V+K + G VAIK F + +++ A R E +L+ ++H NL
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 644 -IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
I++F L LV E+ + L + L + + I+ A+ + H +
Sbjct: 65 LIEVFRRKRKLH---LVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY-ASD 761
+H ++KP NIL+ K ++ DFG +++L D T +AT Y APE D
Sbjct: 121 ---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVATRWYRAPELLVGD 175
Query: 762 GIISPKCDVYSYGVLLMETFT 782
P DV++ G + E T
Sbjct: 176 TQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 56/173 (32%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFE-----SECEVL-RNVRHRNLIK 645
+G GSFG V DG A+KV LQ + + E +E VL +NV+H L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ S D VL+++ G L L F + R ++ AL YLH S
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPE 757
+++ +LKP NILLD ++DFG+ K E + T T T Y+APE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 58/241 (24%)
Query: 568 NRTTWR-RTSYLDIQQATDGFNECNLLGAGSFGSV-YKGTLFDGTNVAIKVF------NL 619
N+T W Y D++Q +G+G++G+V G VAIK L
Sbjct: 7 NKTIWEVPDRYRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL 56
Query: 620 QLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFL 679
+RA+R E +L++++H N+I L+ F P+ SL+++ H+++L
Sbjct: 57 FAKRAYR----ELRLLKHMKHENVI------------GLLDVFTPDLSLDRF---HDFYL 97
Query: 680 DM------------LERLN---IMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA 724
M E+L+ I V L+ L + H+ ++H +LKP N+ ++++
Sbjct: 98 VMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL 157
Query: 725 RVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTR 783
++ DFG+++ DS T + T Y APE + + + D++S G ++ E T
Sbjct: 158 KILDFGLAR----QTDS-EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
Query: 784 K 784
K
Sbjct: 213 K 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-09
Identities = 29/81 (35%), Positives = 46/81 (56%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
L G +P I L L +++S N+ RG +P LG + L+ L +YN GS P +G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 63 SKLQVLSLRNNSFTGPIPNSL 83
+ L++L+L NS +G +P +L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 592 LLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFE---SECEVLRNVRHRNLI 644
LLG G+FG V K T G A+K+ ++ A +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ S D V+E+ G L L F + R ++ AL+YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHSEKN- 116
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII 764
VV+ +LK N++LDK+ +++DFG+ K G D + +T T Y+APE D
Sbjct: 117 -VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDY 173
Query: 765 SPKCDVYSYGVLLMETFTRKKP 786
D + GV++ E + P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 28/89 (31%), Positives = 54/89 (60%), Gaps = 1/89 (1%)
Query: 116 LNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHR 175
L + LRG IPN+I L++L + L+ N++ G IP ++ +I+++ +++L N +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 176 PSTMGHSLPNRQFLLLWANRLTGTIPNSI 204
P ++G L + + L L N L+G +P ++
Sbjct: 483 PESLGQ-LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 54/188 (28%), Positives = 79/188 (42%), Gaps = 19/188 (10%)
Query: 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716
+ +L+ M G L L H F + R ++ L LE H H+ VV+ +LKP NI
Sbjct: 73 SFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLE---HMHNRFVVYRDLKPANI 128
Query: 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGV 775
LLD++ R+SD G L D ++ T GYMAPE G+ D +S G
Sbjct: 129 LLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 184
Query: 776 LLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM--DCLLR 833
+L + P + T + KH I +T + L P + L R
Sbjct: 185 MLFKLLRGHSPFRQHKTKD---KHEID-----RMTLTMAVELPDSFSPELRSLLEGLLQR 236
Query: 834 IMHLALGC 841
++ LGC
Sbjct: 237 DVNRRLGC 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
V +E+L S +H +L NILL +N ++ DFG+++ + +D D V +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +MAPE D + + + DV+S+GVLL E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLI 644
F L+G G++G VYKG + G AIKV ++ + + E +L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 645 KIFSSCCNL------DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYL 698
+ + D LV+EF GS+ + N + L+ I L L
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 124
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-MATIGYMAPE 757
H H V+H ++K N+LL +N ++ DFG+S L D +V + T + T +MAPE
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPE 181
Query: 758 YAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
+ D K D++S G+ +E P +M
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 59/236 (25%), Positives = 104/236 (44%), Gaps = 26/236 (11%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNLIKI 646
+G G +G V+ D G VA+K L E R +E ++L + L+K+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTTKSEWLVKL 66
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ + ++ L +E++P G L ++ L M ++ A++ LH
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHE---LGY 122
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
+H +LKP N L+D + +++DFG+SK + +SV + + YMAPE
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDF 177
Query: 767 KCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817
D +S G +L E P +E + +LK+W K +L R + + +L
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRPVYDDPRFNL 229
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLI 644
F ++G G++G VYKG + G AIKV ++ E + E +L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76
Query: 645 KIF------SSCCNLDFKALVLEFMPNGS---LEKWLYSHNYFLDMLERLNIMIDVGLAL 695
+ S + D LV+EF GS L K + D + + I GLA
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA- 135
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-MATIGYM 754
H H+ V+H ++K N+LL +N ++ DFG+S L D +V + T + T +M
Sbjct: 136 ----HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWM 188
Query: 755 APEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
APE + D + D++S G+ +E P +M
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 587 FNECNLLGAGSFGSVYKG-TLFDGTNVAIKVFNL---QLERAFRSFESECEVLRNVRHRN 642
F++ +G GSFG+VY + + VAIK + Q ++ E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 643 LIKIFSSCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
I+ + C + A LV+E+ GS L H L +E + L YLH S
Sbjct: 77 TIQ-YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH-S 133
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY--- 758
H+ ++H ++K NILL + ++ DFG + ++ + V T +MAPE
Sbjct: 134 HN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 185
Query: 759 ASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
+G K DV+S G+ +E RK P M
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 3/105 (2%)
Query: 678 FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737
L + + + V +E+L S +H +L NILL +N ++ DFG+++ + +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
D D V + + +MAPE D + + + DV+S+GVLL E F+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 11/209 (5%)
Query: 592 LLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVL-RNVRHRNLIKI 646
++G GSFG V DG A+KV ++ + + +E VL +NV+H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
S + VL+F+ G L L F + R ++ AL YLH S +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
V+ +LKP NILLD ++DFG+ K D T T T Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 767 KCDVYSYGVLLMETFTRKKPTDEMFTGEM 795
D + G +L E P EM
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 592 LLGAGSFGSVYKGTLFDGTN--VAIKVFNLQLERAFRSFESECEVLRN------VRHRNL 643
+LG GSFG V L GT+ AIKV L+ + + + +C + +H L
Sbjct: 2 VLGKGSFGKVMLAEL-KGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ D V+E++ G L + F + R +V LAL +LH
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG- 116
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
V++ +LK +NILLD +++DFG+ K G + T T T Y+APE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFC-GTPDYIAPEILQELE 172
Query: 764 ISPKCDVYSYGVLLMETFTRKKP-----TDEMF 791
P D ++ GVL+ E + P D++F
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 33/88 (37%), Positives = 47/88 (53%)
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEI 127
L L N G IPN + L L ++ NSI GNIP +G++T L L+ + N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 128 PNEIGNLKNLADLVLALNNLIGPIPTTI 155
P +G L +L L L N+L G +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 44/163 (26%), Positives = 61/163 (37%), Gaps = 62/163 (38%)
Query: 212 GLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSL 271
GL L++ L G IPN LRHL ++N
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSIN--------------------------------- 448
Query: 272 GSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPT 331
L GN ++G+IP +G++ L L L N NG+IP
Sbjct: 449 -----------LSGNS-------------IRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 332 TLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLT 373
+LG+L L+ L L N+L+G +P L R LH S T
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGG----RLLHRASFNFT 523
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 587 FNECNLLGAGSFGSVY-KGTLFDGTNVAIKVFNL---QLERAFRSFESECEVLRNVRHRN 642
F + +G GSFG+VY + VAIK + Q ++ E + L+ ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 643 LIKIFSSCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
I+ + C + A LV+E+ GS L H L +E I L YLH S
Sbjct: 87 SIE-YKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-S 143
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY--- 758
H+ ++H ++K NILL + +++DFG + + + V T +MAPE
Sbjct: 144 HN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILA 195
Query: 759 ASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
+G K DV+S G+ +E RK P M
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 63/205 (30%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 592 LLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFE-----SECEVLRNVRHRN 642
LLG G+FG V K T G A+K+ L+ E E +E VL+N RH
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKI--LKKEVIIAKDEVAHTLTESRVLQNTRHPF 56
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
L + S D V+E+ G L L F + R ++ AL YLH
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH--- 112
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED-DDSVTQTMTMATIGYMAPEYASD 761
S VV+ +LK N++LDK+ +++DFG+ K E D T T Y+APE D
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 762 GIISPKCDVYSYGVLLMETFTRKKP 786
D + GV++ E + P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 39/211 (18%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNLIK 645
+G G++G VYK G VA+K L+ E A R E +L+ + H N+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 646 IFS---SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
+ S L LV EF+ + L+K++ S L L+ I + L+ + + H
Sbjct: 63 LLDVVHSENKL---YLVFEFL-DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV---TQTMTMATIGYMAPE-- 757
S V+H +LKP N+L+D+ +++DFG+++ G V T T + T+ Y APE
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG-----VPVRTYTHEVVTLWYRAPEIL 171
Query: 758 ----YASDGIISPKCDVYSYGVLLMETFTRK 784
S + D++S G + E R+
Sbjct: 172 LGSRQYSTPV-----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 587 FNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLER-AFRSFES----ECEVLRNVRH 640
F + +LG G FG V + G A K L+ +R R ES E ++L V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLH 699
+ ++ + + D LVL M G L+ +Y+ N + L ++ LE LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
+ V+ +LKP NILLD R+SD G++ + E + + + T+GYMAPE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVL 173
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKP 786
++ + D + G L+ E + P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 43/192 (22%)
Query: 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVF------NLQLERAFRSFESECEVLR 636
T+ + + +G G+FG V G NVAIK + +R +R E ++L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLK 64
Query: 637 NVRHRNLI---KIFSSCCNLDFKALVLEFM--------PNGSLEKWLYSHNYFLDMLERL 685
++RH N+I IF S L+ V E + + LEK YFL + R
Sbjct: 65 HLRHENIISLSDIFIS--PLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILR- 119
Query: 686 NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745
L+Y+H S VVH +LKP+NIL+++N ++ DFG++++ D T
Sbjct: 120 --------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDP-QMT 163
Query: 746 MTMATIGYMAPE 757
++T Y APE
Sbjct: 164 GYVSTRYYRAPE 175
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 592 LLGAGSFGSVYKGTLFDGTNV-AIKVFNLQLERAFRSFESEC-----EVLRNVR-HRNLI 644
+LG GSFG V L + + A+KV L+ + + + EC +L R H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 645 KIFSSCC--NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
+++ CC D V+EF+ G L + F + R ++ AL +LH
Sbjct: 60 QLY--CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH--- 113
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
+++ +LK +N+LLD +++DFG+ K + T + T Y+APE +
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 763 IISPKCDVYSYGVLLMETFTRKKP-----TDEMF 791
+ P D ++ GVLL E P D++F
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 585 DGFNECNLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERA--FRSFESECEVLRNVRHR 641
D + + LG GS+ +VYKG + +G VA+KV LQ E F + E +L+ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
N++ + + LV E++ + L +++ H L N+ + + L L +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYI 119
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
H ++H +LKP N+L+ +++DFG+++ + S T + + T+ Y P+
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 762 GIISPKC-DVYSYGVLLME 779
C D++ G + +E
Sbjct: 178 STEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 57/208 (27%), Positives = 82/208 (39%), Gaps = 26/208 (12%)
Query: 593 LGAGSFGSVY----KGTLFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIK 645
LG G FG V + T G A K N L+ + + E +L V R
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF--- 54
Query: 646 IFSSCCNLDFKA---LVLEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLH 699
I S K LV+ M G L +Y+ N + LE+LH
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEY 758
+++ +LKP N+LLD + R+SD G++ E D ++T A T G+MAPE
Sbjct: 115 QRR---IIYRDLKPENVLLDNDGNVRISDLGLAV---ELKDGQSKTKGYAGTPGFMAPEL 168
Query: 759 ASDGIISPKCDVYSYGVLLMETFTRKKP 786
D ++ GV L E + P
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 67/279 (24%), Positives = 126/279 (45%), Gaps = 55/279 (19%)
Query: 568 NRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRS 627
N+T W + + + + +G+G++GSV FD T ++V +L R F+S
Sbjct: 9 NKTIW---------EVPERYQNLSPVGSGAYGSVCAA--FD-TKTGLRVAVKKLSRPFQS 56
Query: 628 F------ESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEK----WLYSHNY 677
E +L++++H N+I + LD F P SLE+ +L +H
Sbjct: 57 IIHAKRTYRELRLLKHMKHENVIGL------LDV------FTPARSLEEFNDVYLVTHLM 104
Query: 678 FLDM--------LERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729
D+ L ++ + L L + HS ++H +LKP+N+ ++++ ++ DF
Sbjct: 105 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 164
Query: 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKPTD 788
G+++ DD +T +AT Y APE + + + D++S G ++ E T +
Sbjct: 165 GLAR---HTDDEMTG--YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT--- 216
Query: 789 EMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAK 827
+F G H +L L L A L++++ A+
Sbjct: 217 -LFPGT---DHIDQLKLILRLVGTPGAELLKKISSESAR 251
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 593 LGAGSFGSVYKGTLFD--GTNVAIKVFNLQLERAFRSFES--ECEVLRNVR---HRNLIK 645
+G G++G V+K G VA+K +Q + E VLR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 646 IFSSCC----NLDFK-ALVLEFMPNGSLEKWLYSHNYFLDMLERL-NIMIDVGLALEYLH 699
+F C + + K LV E + + L +L E + ++M + L++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
SH VVH +LKP NIL+ + +++DFG++++ + T + T+ Y APE
Sbjct: 128 -SHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVL 181
Query: 760 SDGIISPKCDVYSYGVLLMETFTRK 784
+ D++S G + E F RK
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFE-SECEVLRNVRHRNLIKIFSSC 650
LG G++ +VYKG G VA+K +L E S E +++ ++H N++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYF--LDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
+ LV E+M + L+K++ +H LD + + L+ + H V+H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YASDGIISPK 767
+LKP N+L++K +++DFG+++ G + T + + T+ Y AP+ S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 768 CDVYSYGVLLMETFT 782
D++S G ++ E T
Sbjct: 182 IDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 587 FNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLER-AFRSFES----ECEVLRN 637
F +LG G FG V + T G A K L+ +R R E+ E ++L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT---GKMYACK--KLEKKRIKKRKGEAMALNEKQILEK 56
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALE 696
V R ++ + + D LVL M G L+ +Y+ N D + ++ LE
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
LH +V+ +LKP NILLD R+SD G++ + E + T + T+GYMAP
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAP 170
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKP 786
E + + D + G L+ E K P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 6e-08
Identities = 59/188 (31%), Positives = 95/188 (50%), Gaps = 43/188 (22%)
Query: 593 LGAGSFGSVYKGTLFD---GTNVAIK-VF----NLQ-LERAFRSFESECEVLRNVR-HRN 642
LG G++G V+K D VA+K +F N +R FR E L+ + H N
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPN 68
Query: 643 LIKIFSSCCNLDFKA-------LVLEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVG 692
++K+ + KA LV E+M E L++ N D+ +R IM +
Sbjct: 69 IVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLL 117
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT-QTMT--MA 749
AL+Y+H S V+H +LKP+NILL+ + +++DFG+++ L E +++ +T +A
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 750 TIGYMAPE 757
T Y APE
Sbjct: 175 TRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 6e-08
Identities = 23/59 (38%), Positives = 34/59 (57%)
Query: 434 LITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
L +L L+ NR +F L +L+ LDLS NNL+ P++F L L+ L++S N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 28/165 (16%)
Query: 587 FNECNLLGAGSFGSVY----KGT--LFDGTNVAIKVFNLQ-------LERAFRSFESECE 633
F + LLG G G V+ KGT LF A+KV + + ++R +E E
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLF-----ALKVLDKKEMIKRNKVKRV----LTEQE 53
Query: 634 VLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWL--YSHNYFLDMLERLNIMIDV 691
+L + H L +++S + LV+++ P G L + L + + R +V
Sbjct: 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EV 112
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736
LALEYLH +V+ +LKP NILL ++ +SDF +SK
Sbjct: 113 LLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 41/167 (24%), Positives = 70/167 (41%), Gaps = 17/167 (10%)
Query: 626 RSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF--LDMLE 683
++ E ++L+ + HR +I + + K+ V MP Y + F +D
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-------YKCDLFTYVDRSG 180
Query: 684 RLN----IMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739
L I I L LE L + H ++H ++K NI LD+ A + DFG + L
Sbjct: 181 PLPLEQAITIQRRL-LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
D+ T+ +PE + K D++S G++L E +
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 41/151 (27%), Positives = 79/151 (52%), Gaps = 15/151 (9%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQLE------RAFRSFESECEVLRNVRHRNLIK 645
+G G++G+V+K + VA+K L + A R E +L+ ++H+N+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
++ + LV E+ + L+K+ S N +D + M + L+ L HS
Sbjct: 64 LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL---LKGLAFCHSHN 119
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLG 736
V+H +LKP N+L++KN +++DFG+++ G
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 49/141 (34%), Positives = 63/141 (44%), Gaps = 6/141 (4%)
Query: 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717
LVL F+ G L L F R ++ ALE LH V++ +LKP NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH---KFNVIYRDLKPENIL 125
Query: 718 LDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLL 777
LD + DFG+ KL +DDD T T T Y+APE + D ++ GVLL
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDDK-TNTFC-GTPEYLAPELLLGHGYTKAVDWWTLGVLL 183
Query: 778 METFTRKKPTDEMFTGEMSLK 798
E T P + EM K
Sbjct: 184 YEMLTGLPPFYDENVNEMYRK 204
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 592 LLGAGSFGSV----YKGT--LFDGTNVAIKVFNLQLERAFRSFESEC-----EVLRNV-R 639
+LG GSFG V KGT L+ A+KV L+ + + + EC VL +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELY-----AVKV--LKKDVILQDDDVECTMTEKRVLALAGK 54
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
H L ++ S D V+E++ G L + F + R ++ L L++LH
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLH 113
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
+++ +LK +N+LLD +++DFG+ K G T T T Y+APE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFC-GTPDYIAPEIL 168
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMF 791
S P D ++ GVLL E + P DE+F
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 593 LGAGSFGSV---YKGTLFDGTNVAIKVFNLQLE------RAFRSFESECEVLRNVRHRNL 643
+G+G+ G V Y L NVAIK + + RA+R E +++ V H+N+
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 78
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY------ 697
I + + F P SLE+ + Y + L N+ + + L++
Sbjct: 79 ISLLNV------------FTPQKSLEE--FQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 698 -------LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ H HS ++H +LKP+NI++ + T ++ DFG+++ G S T + T
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 181
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803
Y APE D++S G ++ E K +F G + W K+
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNKV 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLE------RAFRSFESECEVLRNVRHRNLI 644
++G GS+G V G VAIK N E R R E ++LR +RH +++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62
Query: 645 KIFS---SCCNLDFKAL--VLEFM---------PNGSLEKWLYSHNYFLDMLERLNIMID 690
+I +FK + V E M N L H +FL L R
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP--EHHQFFLYQLLR------ 114
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMA 749
AL+Y+H + V H +LKP NIL + + ++ DFG++++ D + + T +A
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 750 TIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRK 784
T Y APE +P D++S G + E T K
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 51/283 (18%)
Query: 592 LLGAGSFGSVYKGTLFD---GTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIK 645
L+G G G VY +D VA+K L + F E ++ ++ H ++
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 646 IFSSCCNLDFKALVLEFMP--NGSLEKWLYSHNYFLDMLER-----------LNIMIDVG 692
++S C + D V MP G K L + + L + L+I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG--ISKLLGEDD---------DS 741
+EY+H S V+H +LKP+NILL + D+G I K L E+D +
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 742 VTQTMT-----MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMS 796
+MT + T YMAPE S D+Y+ GV+L + T P ++S
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240
Query: 797 LKHWIK--------LSLPRGLTEVVDASLVREVQPSYAKMDCL 831
+ I +P L+++ +L + Y+ + L
Sbjct: 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 26/201 (12%)
Query: 593 LGAGSFGSVYKGTLFDGTNV-AIKVFNLQLERAFRSFESECEVLRNVRHRNLI--KIFSS 649
+G G+FG VY+ D + A+KV + + A + EV + RN++ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 650 C---CNLDFK-------ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
L F LV ++M G L L F + + I ++ LALE+LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-Y 758
+V+ +LKP NILLD + DFG+SK D+ + T T T Y+APE
Sbjct: 114 KYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-TNTFC-GTTEYLAPEVL 168
Query: 759 ASDGIISPKCDVYSYGVLLME 779
+ + D +S GVL+ E
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 592 LLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFE-----SECEVL-RNVRHRNLI 644
++G GSFG V DG+ A+KV LQ + + E +E VL +N++H L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ S + VL+++ G L L FL+ R +V A+ YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII 764
+++ +LKP NILLD ++DFG+ K G + + T T T Y+APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFC-GTPEYLAPEVLRKEPY 173
Query: 765 SPKCDVYSYGVLLME 779
D + G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFESECEV-----LRNVRHRNLIKI 646
+G G++G+VYK G VA+K +Q + EV L H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 647 FSSCCNLDFK-----ALVLEFMPNGSLEKWLYSHNYFLDMLERL-NIMIDVGLALEYLHH 700
C LV E + + L +L E + ++M L++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
+ +VH +LKP NIL+ +++DFG++++ + T + T+ Y APE
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPEVLL 180
Query: 761 DGIISPKCDVYSYGVLLMETFTRK 784
+ D++S G + E F RK
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 587 FNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLER-AFRSFES----ECEVLRN 637
F +LG G FG V + T G A K L+ +R R E+ E +L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT---GKMYACK--KLEKKRIKKRKGEAMALNEKRILEK 56
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALE 696
V R ++ + + D LVL M G L+ +Y+ N D + ++ LE
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
L +V+ +LKP NILLD R+SD G++ + E + T + T+GYMAP
Sbjct: 117 DLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAP 170
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKP 786
E ++ + D + G L+ E + P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNLIK 645
+G G+FG V+K VA+K ++ E+ A R E ++L+ ++H N++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75
Query: 646 IFSSCCNL-----DFKA---LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
+ C +K LV EF + L L + N + E +M + L Y
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK--LLGEDDDSVTQTMTMATIGYMA 755
+H ++H ++K NIL+ K+ +++DFG+++ L ++ T + T+ Y
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191
Query: 756 PE-YASDGIISPKCDVYSYGVLLMETFTR 783
PE + P D++ G ++ E +TR
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 587 FNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQ--LER-AFRSFESE---CEVLR 636
F +LG G FG V YK T G AIK + R S E E
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
+ RH L+ +F+ D V+E+ G L ++ H + V L L+
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQ 115
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMA 755
YLH +V+ +LK +N+LLD +++DFG+ K E +T T T ++A
Sbjct: 116 YLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLA 169
Query: 756 PEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
PE ++ + D + GVL+ E + P F G+
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 592 LLGAGSFGSVYKGTLFDGTN--VAIKVFNLQLERAFRSFESECE-VLRNV-----RHRNL 643
+LG GSFG V L GTN AIK L+ + + EC V R V H L
Sbjct: 2 VLGKGSFGKVMLAEL-KGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+F + + V+E++ G L + S F + R ++ L++LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLH---K 114
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISK--LLGEDDDSVTQTMTMATIGYMAPEYASD 761
+++ +LK +N+LLDK+ +++DFG+ K + GE + T Y+APE
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG----KASTFCGTPDYIAPEILKG 170
Query: 762 GIISPKCDVYSYGVLLMETFTRKKP-----TDEMF 791
+ D +S+GVLL E + P DE+F
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 19/198 (9%)
Query: 593 LGAGSFGSVY-----KGTLFDGTNV--AIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
LG GSFG+VY K + V I V L ++ E ++L + H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNI---MIDVGLALEYLHHSH 702
+S D ++ E+ L+ L + L + I + L + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLL-GEDDDSVTQTMTMATIGYMAPEYASD 761
++H +LK NI L N+ ++ DFG+S+LL G D + T T T YM+PE
Sbjct: 127 ---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEALKH 179
Query: 762 GIISPKCDVYSYGVLLME 779
K D++S G +L E
Sbjct: 180 QGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFE-----SECEVL-RNVRHRNLI 644
++G GSFG V + A+KV LQ + + E SE VL +NV+H L+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ S D VL+++ G L L FL+ R ++ AL YLH S
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEYASDGI 763
+V+ +LKP NILLD ++DFG+ K E+ + T T T Y+APE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM 795
D + G +L E P T EM
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 593 LGAGSFGSVYKGTLFDG-TNVAIKVFNLQLERAFRSFES----ECEVLRNVRHRNLIKIF 647
+G G++G VYK D TN I + ++LE+ S E +L+ ++H N++++
Sbjct: 10 IGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---LDMLERLNIMIDVGLALEYLHHSHST 704
+ LV E++ + L+K + S F +++ I G+A + HS
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA-----YCHSH 121
Query: 705 PVVHCNLKPNNILLDKNMTA-RVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE--YASD 761
V+H +LKP N+L+D+ A +++DFG+++ G T T + T+ Y APE S
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG--IPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 762 GIISPKCDVYSYGVLLMETFTRK 784
+P D++S G + E +K
Sbjct: 180 HYSTP-VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 11/176 (6%)
Query: 587 FNECNLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFES--ECEVLRNVRHRNL 643
F + N +G G++G VY+ G VA+K + ER S E +L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 644 IKIFSSCC--NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
+++ +LD LV+E+ L L + + +M+ + L+YLH +
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
++H +LK +N+LL +++DFG+++ G +T + T+ Y APE
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 17/217 (7%)
Query: 580 IQQATDGFNECNLLGAGSFGSVYKGTLFDGTN-----VAIK-VFNLQLERAFRSFESECE 633
I + D +LL G+FG ++ G L D V +K V + E E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 634 VLRNVRHRNLIKIFSSCCNLDFKALVLE-FMPNGSLEKWLYSHNYF-------LDMLERL 685
+L + H+N++ I C VL +M G+L+ +L L + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 686 NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745
++ I + + YLH V+H ++ N ++D+ + +++D +S+ L D
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +MA E + S DV+S+GVLL E T
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 56/184 (30%), Positives = 79/184 (42%), Gaps = 18/184 (9%)
Query: 612 VAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKW 671
V K L ER SE L H ++K F + D L++E+ G L K
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 672 LYSHNYFLDMLERLNIM-IDVGLALEY-----LHHSHSTPVVHCNLKPNNILLDKNMTAR 725
+ + E L +VGL L Y L HS ++H +LK NI L +
Sbjct: 156 IKQR-----LKEHLPFQEYEVGL-LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIK 209
Query: 726 VSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ DFG SK + DSV+ + + G Y+APE S K D++S GV+L E T
Sbjct: 210 LGDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
Query: 783 RKKP 786
+P
Sbjct: 267 LHRP 270
|
Length = 478 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 52/219 (23%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIK----VFNLQLE--RAFRSFESECEVLRNVRHRNLIK 645
+G G++G V + VAIK F+ +++ R R E ++LR++ H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68
Query: 646 ---IFSSCCNLDFKA--LVLEFMPNGSLEKWLYS-------H-NYFLDMLERLNIMIDVG 692
I F +V E M + L + + S H YFL L R
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------- 119
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
L+Y+H S V+H +LKP+N+LL+ N ++ DFG+++ E D +T+ + T
Sbjct: 120 -GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTRW 173
Query: 753 YMAPE-------YASDGIISPKCDVYSYGVLLMETFTRK 784
Y APE Y + DV+S G + E RK
Sbjct: 174 YRAPELLLNCSEYTT------AIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 49/233 (21%)
Query: 593 LGAGSFGSVYKGTLFDGT---NVAIKVFNLQLE------RAFRSFESECEVLRNVRHRNL 643
+G+G+ G V +D NVAIK + + RA+R E +++ V H+N+
Sbjct: 32 IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 85
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY------ 697
I + + F P SLE+ + Y + L N+ + + L++
Sbjct: 86 IGLLNV------------FTPQKSLEE--FQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 698 -------LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ H HS ++H +LKP+NI++ + T ++ DFG+++ G S T + T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 188
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803
Y APE D++S G ++ E +F G + W K+
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTN-VAIKVF--NLQLERAFRSFESECEVLRNVRHRNL 643
F ++G G++G V K + VAIK F + + E + E ++LR ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 644 IKIFSSCCNLDFKALVLEF-----------MPNGSLEKWLYSHNYFLDMLERLNIMIDVG 692
+++ + LV E+ MPNG + + S+ Y L
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------------- 109
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
++ +H H +VH ++KP N+L+ N ++ DFG ++ L E ++ T +AT
Sbjct: 110 --IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRW 166
Query: 753 YMAPEYASDGIISPKCDVYSYGVLLME------TFTRKKPTDEMFT 792
Y +PE D++S G +L E F + D++FT
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 47/207 (22%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 593 LGAGSFGSVYKGT---LFDG-----TNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI 644
LG G+F ++KG + D T V +KV + SF ++ + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ C D +V E++ GSL+ +L + +++ +L + + AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG-- 120
Query: 705 PVVHCNLKPNNILLDKNMTA--------RVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
+ H N+ N+LL + ++SD GIS + + + + + I ++ P
Sbjct: 121 -LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV------LPKEILLERIPWVPP 173
Query: 757 EYASDG-IISPKCDVYSYGVLLMETFT 782
E + +S D +S+G L E F+
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
H HS +V+ ++KP N+LLD R+SD G++ L +D ++TQ T GYMAPE
Sbjct: 110 HLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQ--RAGTNGYMAPEIL 166
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKP 786
+ S D ++ G + E + P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-07
Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 1/84 (1%)
Query: 164 INLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQ 223
+ L L G P+ + L + Q + L N + G IP S+ + + L LDL+ NS +G
Sbjct: 423 LGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 224 IPNTFGNLRHLSTLNIRANYLTTE 247
IP + G L L LN+ N L+
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGR 505
|
Length = 623 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 30/104 (28%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 679 LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738
LD + L+ V + +L S +H +L NILL ++ DFG+++ + D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ V + + +MAPE + + + + DV+SYG+LL E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 38/181 (20%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723
P + L + + L ++ + V +E+L S VH +L N+L+ +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 724 ARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT- 782
++ DFG+++ + D + +++ T + +MAPE + + + DV+S+G+LL E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337
Query: 783 -----RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR------EVQPSYAKMDCL 831
+ P +E F ++K +++ P ++ + + + E++P ++++ L
Sbjct: 338 GGTPYPELPMNEQFYN--AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395
Query: 832 L 832
+
Sbjct: 396 V 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 30/104 (28%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 679 LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738
LD+ + L V +++L S +H ++ N+LL A++ DFG+++ + D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ V + + +MAPE D + + + DV+SYG+LL E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 39/147 (26%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER-----AFRSFESECEVLRNVRHRNLIKI 646
LG GS+ +VYKG + G VA+K L+ E A R E +L++++H N++ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVTL 68
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
LV E++ + L++++ L M + + L Y H V
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---V 124
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISK 733
+H +LKP N+L+ + +++DFG+++
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 592 LLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLR---------NVRHRN 642
+LG GSFG V L G V L+ + + EC ++ N +
Sbjct: 2 VLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
L F + +L F V+EF+ G L + F D+ ++ L++LH
Sbjct: 61 LYCTFQTKEHLFF---VMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH--- 113
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISK--LLGEDDDSVTQTMTMATIGYMAPEYAS 760
S +++ +LK +N++LD++ +++DFG+ K + G++ S T Y+APE
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTPDYIAPEILQ 169
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKP-----TDEMF 791
+ D +S+GVLL E + P DE+F
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 585 DGFNECNLLGAGSFGSVYKG----TLFDGTNVAIKVFNLQLERAFRSFE----SECEVLR 636
D + + N + G++G VY+ T G VA+K L++E+ F E +L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKT---GEIVALK--KLKMEKEKEGFPITSLREINILL 59
Query: 637 NVRHRNLIKI----FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVG 692
++H N++ + S NLD +V+E++ + L+ + + E +M+ +
Sbjct: 60 KLQHPNIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
+ +LH + ++H +LK +N+LL+ ++ DFG+++ G TQ + T+
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLW 171
Query: 753 YMAPE-YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
Y APE S D++S G + E KKP +F G+
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/213 (25%), Positives = 103/213 (48%), Gaps = 43/213 (20%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSF------ESECEVLRNVRHRNLIKI 646
+G+G++GSV + +D T + KV +L R F+S E +L++++H N+I +
Sbjct: 23 VGSGAYGSV--CSAYD-TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDML-----------ERL---NIMIDVG 692
LD F P S+E ++ Y + L ++L ++ +
Sbjct: 80 ------LDV------FTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY 125
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
L L + HS ++H +LKP+N+ ++++ R+ DFG+++ + DD +T +AT
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTG--YVATRW 180
Query: 753 YMAPEYASDGI-ISPKCDVYSYGVLLMETFTRK 784
Y APE + + + D++S G ++ E K
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 38/230 (16%)
Query: 587 FNECNLLGAGSFGSVY----KGT--LFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-- 638
FN +LG GSFG V KGT L+ AIK+ L+ + + + EC ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELY-----AIKI--LKKDVVIQDDDVECTMVEKRVL 54
Query: 639 ----RHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLA 694
+ L ++ S +D V+E++ G L Y + + R V A
Sbjct: 55 ALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-------YQIQQVGRFKEPHAVFYA 107
Query: 695 LEY---LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD-DSVTQTMTMAT 750
E L HS +++ +LK +N++LD +++DFG+ K E+ D VT T
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEM 795
Y+APE + D +++GVLL E + P DE+F M
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 30/240 (12%)
Query: 587 FNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESECEVL--RNVRH 640
FN +LG GSFG V KGT AIK+ L+ + + + EC ++ R +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGT---DELYAIKI--LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 641 RN----LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
++ L ++ S +D V+E++ G L + F + + + ++ + L
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLF 115
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
+LH +++ +LK +N++LD +++DFG+ K D VT T Y+AP
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP 170
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGLTE 811
E + D ++YGVLL E + P DE+F M +H +S P+ L++
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EH--NVSYPKSLSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 68/250 (27%), Positives = 121/250 (48%), Gaps = 32/250 (12%)
Query: 591 NLLGAGSFGSVYKGTLFDGT-NVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI--- 646
N++G GSFG VY+ D + VAIK + R E +++N+ H N+I +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDY 127
Query: 647 -FSSCCNLD----FKALVLEFMPNGSLEKWL--YS-HNYFLDMLERLNIMIDVGLALEYL 698
++ C + F +V+EF+P ++ K++ Y+ +N+ L + + AL Y+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 699 HHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
H S + H +LKP N+L+D N T ++ DFG +K L SV+ + + Y APE
Sbjct: 187 H---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPE 240
Query: 758 YASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
+ D++S G ++ E +F+G+ S+ +++ G T D
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLVRIIQVLG-TPTEDQ- 294
Query: 817 LVREVQPSYA 826
++E+ P+YA
Sbjct: 295 -LKEMNPNYA 303
|
Length = 440 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 54/199 (27%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNV--AIKVFNLQLERAFRS-FESECEVLRNVRHR 641
D F + LGAG+ G V K L + + A K+ +L+++ A R+ E +VL
Sbjct: 1 DDFEKLGELGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSP 59
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHH 700
++ + + + ++ +E M GSL++ L ++L +++I + GL YL
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLT--YLRE 117
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
H ++H ++KP+NIL++ ++ DFG+S G+ DS+ + + T YM+PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 171
Query: 761 DGIISPKCDVYSYGVLLME 779
+ + D++S G+ L+E
Sbjct: 172 GTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 52/250 (20%)
Query: 587 FNECNLLGAGSFGSVY----KGT--LFDGTNVAIKVFNLQLERAFRSFESECEVL-RNV- 638
FN +LG GSFG V KGT L+ AIK+ L+ + + + EC ++ + V
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELY-----AIKI--LKKDVIIQDDDVECTMVEKRVL 54
Query: 639 ----RHRNLIKIFSSCCNLDFKALVLEFMPNGSLE-------KWLYSHNYFLDMLERLNI 687
+ L ++ S +D V+E++ G L K+ H F
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY-------- 106
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED--DDSVTQT 745
++ + L +LH S +++ +LK +N++LD +++DFG+ K E+ T+T
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160
Query: 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHW 800
T Y+APE + D +++GVLL E + P DE+F M +H
Sbjct: 161 FC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EH- 216
Query: 801 IKLSLPRGLT 810
+S P+ L+
Sbjct: 217 -NVSYPKSLS 225
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 24/59 (40%), Positives = 37/59 (62%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
S+ G +PP +G+++ L LD+S N+F G +P LGQL L+ L N L+G P+ +G
Sbjct: 453 SIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 2e-06
Identities = 24/59 (40%), Positives = 31/59 (52%)
Query: 410 LIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNL 468
L L+LS N+L+ GL +L L L+ N P++F L SL LDLS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 54/235 (22%), Positives = 103/235 (43%), Gaps = 32/235 (13%)
Query: 593 LGAGSFGSVYKGTLF---DGTN--------VAIKVFNLQLERAFRSFESECEVLRNVRHR 641
LG G+F ++YKG L D V +KV R +F ++ + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
+L+K++ C + +V E++ G L+ +L+ + + +L++ + AL YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--- 117
Query: 702 HSTPVVHCNLKPNNILLDKN-------MTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
+VH N+ NIL+ + ++SD GI + ++ V + I ++
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWI 171
Query: 755 APEYASDGIISPK--CDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLP 806
APE +G S D +S+G L+E + ++P + + E + + LP
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 57/229 (24%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNLIK 645
LG G+FG VYK + G VA+K + E+ A R E ++L+ ++H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 646 I----FSSCCNLDFKA----LVLEFMP---NGSLE----KWLYSH--NYFLDMLERLNIM 688
+ K +V +M +G LE K S Y L +LE +N
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN-- 129
Query: 689 IDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748
YLH +H ++H ++K NIL+D +++DFG+++ D
Sbjct: 130 --------YLHENH---ILHRDIKAANILIDNQGILKIADFGLARPY---DGPPPNPKGG 175
Query: 749 ATIG------------YMAPEY-ASDGIISPKCDVYSYGVLLMETFTRK 784
G Y PE + + D++ G + E FTR+
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 587 FNECNLLGAGSFGSVYKGTLFD---GTNVAIKVF------NLQLERAFRSFESECEVLRN 637
+ + +G+G+ G V FD G NVA+K +RA+R E +L+
Sbjct: 23 YQQLKPIGSGAQGIVCAA--FDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELVLLKC 76
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
V H+N+I + + F P SLE+ + Y + L N+ + + L++
Sbjct: 77 VNHKNIISLLNV------------FTPQKSLEE--FQDVYLVMELMDANLCQVIHMELDH 122
Query: 698 -------------LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
+ H HS ++H +LKP+NI++ + T ++ DFG+++ +
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMM 179
Query: 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLME 779
T + T Y APE D++S G ++ E
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
L+YLH + ++H ++KP N+L++ N ++ DFG+++ + E D+S T + T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYR 171
Query: 755 APE-------YASDGIISPKCDVYSYGVLLMETFTRK 784
APE Y S D++S G + E R+
Sbjct: 172 APEILMGSRHYTS------AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 45/234 (19%)
Query: 568 NRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFN--LQLE-- 622
N+T W + + + +G+G++GSV G VAIK + Q E
Sbjct: 7 NKTVW---------ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIF 57
Query: 623 --RAFRSFESECEVLRNVRHRNLIK---IFSSCCNL----DFKALVLEFMPNGSLEKWLY 673
RA+R E +L++++H N+I +F+S + DF LV+ +M L+K +
Sbjct: 58 AKRAYR----ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF-YLVMPYMQT-DLQK-IM 110
Query: 674 SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733
H D ++ L V L L + HS ++H +LKP N+ ++++ ++ DFG+++
Sbjct: 111 GHPLSEDKVQYL-----VYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
Query: 734 LLGEDDDSVTQTMT--MATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRK 784
MT + T Y APE + + + D++S G ++ E T K
Sbjct: 166 -------HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 35/139 (25%), Positives = 58/139 (41%), Gaps = 11/139 (7%)
Query: 596 GSFGSVYKGTLFDGTNVAIKVFNL--QLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653
+ K T VA+K NL + + + E R ++H N++ +S
Sbjct: 13 LMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERL---NIMIDVGLALEYLHHSHSTPVVHCN 710
+V M GS E L +H F + L L I+ DV AL+Y+H +H +
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRS 126
Query: 711 LKPNNILLDKNMTARVSDF 729
+K ++ILL + +S
Sbjct: 127 VKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 55/244 (22%), Positives = 113/244 (46%), Gaps = 41/244 (16%)
Query: 593 LGAGSFGSVYKGTLFDGTN-VAIKVFNLQLER-----AFRSFESECEVLRNVRHRNLIKI 646
LG G++ +VYKG N VA+K L+ E A R E +L++++H N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
LV E++ + L+++L ++M N+ + + L L++ H V
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKV 125
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY---ASDGI 763
+H +LKP N+L+++ +++DFG+++ + + T + + T+ Y P+ ++D
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTD-- 181
Query: 764 ISPKCDVYSYGVLLMETFTRK--------------------KPTDEMFTGEMSLKHWIKL 803
S + D++ G + E T + PT+E + G +S + +
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241
Query: 804 SLPR 807
+ P+
Sbjct: 242 NYPK 245
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 585 DGFNECNLLGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER------AFRSFESECEVLRN 637
D + + +G G++G VYK G VA+K L+++ A R E +L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56
Query: 638 VRHRNLIKIFSSCCNLDFKA------LVLEFMPNGSLEKWLYSHNYFL------DMLERL 685
+ I +++ K LV E++ + L+K++ S+ ++
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 686 NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQ 744
+ G+A H H V+H +LKP N+L+DK +++D G+ + S T
Sbjct: 116 MYQLLKGVA-----HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 745 TMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803
+ T+ Y APE S D++S G + E +RK+P +F G+ L+ + +
Sbjct: 171 EIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQQLLHI 224
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 49/182 (26%)
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
++ ++ S + + L++EF+P G L L ++ F + + R M + LA+E +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH--- 118
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGIS-------------KLLGEDD---------- 739
+H ++KP+NIL+D+ ++SDFG+S KLL
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 740 ---DSVTQTMT--------------MA--TIG---YMAPEYASDGIISPKCDVYSYGVLL 777
DS+ TM+ MA T+G Y+APE +CD +S G ++
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 778 ME 779
E
Sbjct: 239 FE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-06
Identities = 27/77 (35%), Positives = 49/77 (63%), Gaps = 4/77 (5%)
Query: 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717
LV+E++ G ++ L+ + YF + + I +V LAL+YLH H ++H +LKP+N+L
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHR-HG--IIHRDLKPDNML 136
Query: 718 LDKNMTARVSDFGISKL 734
+ +++DFG+SK+
Sbjct: 137 ISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 45/209 (21%)
Query: 593 LGAGSFGSV---YKGTLFDGTNVAIKV----FNLQL--ERAFRSFESECEVLRNVRHRNL 643
+G+G+ G V Y G NVAIK F +RA+R +++ V H+N+
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNI 77
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNI--MIDVGL---ALEYL 698
I + + F P SLE+ + Y + L N+ +I + L + YL
Sbjct: 78 IGLLNV------------FTPQKSLEE--FQDVYLVMELMDANLCQVIQMDLDHERMSYL 123
Query: 699 --------HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
H HS ++H +LKP+NI++ + T ++ DFG+++ G S T + T
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 180
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLME 779
Y APE D++S G ++ E
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLER-----AFRSFESECEVLRNVRHRNLIKI 646
LG G++ +V+KG + VA+K L+ E A R E +L+N++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
LV E++ + L+++L + + M N+ I + L L + H +
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCHKRKI 124
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE--YASDGII 764
+H +LKP N+L+++ +++DFG+++ + + T + + T+ Y P+ S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 765 SPKCDVYSYGVLLMETFTRKKPTDEMFTG 793
+P D++ G +L E T + MF G
Sbjct: 183 TP-IDMWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 69/304 (22%), Positives = 118/304 (38%), Gaps = 32/304 (10%)
Query: 216 NSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNP 275
SL P+ +L L + + + N S +S L L +L L +N
Sbjct: 68 RLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNN 127
Query: 276 LDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLN--------- 326
+ I PPLIG ++ ++ + K++ S+P + NL L L L NDL+
Sbjct: 128 ITDI-PPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNL 185
Query: 327 -------------GTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLT 373
+P + L L+ L NN + + LS+L +L L L +N+L
Sbjct: 186 SNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE 245
Query: 374 SSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKD 433
+P S +L + +DLS+N +S S+ S + +L L L+LS N LS +P+ L
Sbjct: 246 -DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALLLLL 302
Query: 434 LITLSLARN-----RFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVS 488
L L + + ++ S E + L + +
Sbjct: 303 LELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNL 362
Query: 489 HNRL 492
+ +
Sbjct: 363 NRYI 366
|
Length = 394 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 61/267 (22%), Positives = 114/267 (42%), Gaps = 52/267 (19%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIF---- 647
LG GS G V+ D VA+K L ++ + E +++R + H N++K++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 648 ----------SSCCNLDFKALVLEFMPNG---SLEKWLYSHNY---FLDMLERLNIMIDV 691
S L+ +V E+M LE+ S + F+ L R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARVSDFGISKLLGED-DDSVTQTMTMA 749
L+Y+ HS V+H +LKP N+ ++ +++ ++ DFG+++++ + +
Sbjct: 126 --GLKYI---HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 750 TIGYMAPEYASDGIISPK-----CDVYSYGVLLMETFTRKKPTDEMFTG--EMSLKHWIK 802
T Y +P ++SP D+++ G + E T K +F G E+ I
Sbjct: 181 TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLIL 232
Query: 803 LSLPRGLTEVVDASLVREVQPSYAKMD 829
S+P + D + + V PS+ + D
Sbjct: 233 ESVP--VVREEDRNELLNVIPSFVRND 257
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 45/238 (18%)
Query: 580 IQQATDGFNECNLLGA-----GSFGSVY----KGT--LFDGTNVAIKVFNLQLERAFRSF 628
+ + C ++ G FG V K T LF + K FN
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---------- 55
Query: 629 ESECEV---LRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL 685
E V +++ + N IK++ S L L+++++ +G L L L E
Sbjct: 56 AIEPMVHQLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVK 112
Query: 686 NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT-ARVSDFGISKLLGEDDDSVTQ 744
I+ + AL LH + ++H ++K N+L D+ + D+G+ K++G T
Sbjct: 113 KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TP 163
Query: 745 TMTMATIGYMAPEYASDGIISPKCDV----YSYGVLLMETFTRKKPTDEMFTGEMSLK 798
+ T+ Y +PE I DV ++ GVL E T K P E E+ L+
Sbjct: 164 SCYDGTLDYFSPE----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 41/176 (23%), Positives = 70/176 (39%), Gaps = 48/176 (27%)
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
NL F V++++P G + L F + L R I ++ A+E +H +H ++
Sbjct: 75 NLYF---VMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH---KMGFIHRDI 127
Query: 712 KPNNILLDKNMTARVSDFGI---------SKLLGEDDDSVTQTMT--------------- 747
KP+NIL+D++ +++DFG+ SK + D +M
Sbjct: 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187
Query: 748 -----------------MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
+ T Y+APE + CD +S GV+L E + P
Sbjct: 188 LERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 51/191 (26%), Positives = 79/191 (41%), Gaps = 41/191 (21%)
Query: 594 GAGSFGSVYKG---TLFDGTNVAIKVFNLQLER-------AFRSFESECEVLRNVRHRNL 643
G G++G VYK DG AIK F E+ A R E +LR ++H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHENV 64
Query: 644 IKIFSSCCNLDFKA--LVLEFMPNGSLE--KWLYSHN--YFLD-MLERLNIMIDVGLALE 696
+ + K+ L+ ++ + + K+ M++ L I L
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI-----LN 119
Query: 697 YLHHSHSTPVVHCNLKPNNILL--DKNMTARV--SDFGISKLLGE------DDDSVTQTM 746
+H+ HS V+H +LKP NIL+ + V D G+++L D D V
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV---- 175
Query: 747 TMATIGYMAPE 757
+ TI Y APE
Sbjct: 176 -VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 46/194 (23%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 593 LGAGSFGSVYKGTLFDGTN-VAIKVFNLQLER-----AFRSFESECEVLRNVRHRNLIKI 646
LG G++ +V+KG N VA+K L+ E A R E +L++++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
LV E++ + L++++ + M N+ I + L L + H V
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKV 125
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YASDGIIS 765
+H +LKP N+L+++ +++DFG+++ + + T + + T+ Y P+ S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 766 PKCDVYSYGVLLME 779
+ D++ G + E
Sbjct: 184 TQIDMWGVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 54/239 (22%), Positives = 96/239 (40%), Gaps = 41/239 (17%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNV-AIKVF---NLQLERAFRSFESECEVLRNVRH 640
+ F ++G G+FG V D +V A+K+ ++ + +E ++L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
++K+F S + L++EF+P G + L + + + I V LA++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQ 119
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE--------------DDDSVTQTM 746
+H ++KP+N+LLD ++SDFG+ L + D Q M
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 747 -------------------TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
T+ T Y+APE + CD +S GV++ E P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-05
Identities = 19/58 (32%), Positives = 27/58 (46%)
Query: 187 QFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244
+ L L NRLT + L LDL+ N+L+ P F L L +L++ N L
Sbjct: 3 KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 43/240 (17%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNV-AIKVFN----LQLERAFRSFESECEVLRNVR 639
D F ++G G+FG V D ++ A+K+ L+ E+ +E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQV-AHIRAERDILVEAD 59
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
++K+F S + L++EF+P G + L + + + I V LA++ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAIH 118
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGI---------------------------- 731
+H ++KP+N+LLD ++SDFG+
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 732 --SKLLGEDDDSVTQTMTMATIG---YMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
SK E + + +T+G Y+APE + CD +S GV++ E P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 39/149 (26%), Positives = 74/149 (49%), Gaps = 8/149 (5%)
Query: 587 FNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQ--LER-AFRSFESECEVLRNVRHRN 642
F + LG G+FG V D A+K + L R ++E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
++K++ S + D V++++P G + L F ++L R I ++ LA+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGI 731
+H ++KP+NIL+D + +++DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 587 FNECNLLGAGSFGSVYKGTLFD-GTNVAIKVF---NLQLERAFRSFESECEVLRNVRHRN 642
F + LG G+FG V D A+K ++ L ++E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
+++++ S + D V++++P G + L F + L R I ++ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGI 731
+H ++KP+NIL+D++ +++DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 42/187 (22%), Positives = 83/187 (44%), Gaps = 42/187 (22%)
Query: 630 SECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI 689
+E ++L + ++K++ S + ++ L++E++P G + L + F + R I
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK---------------- 733
+ LA++ +H +H ++KP+N+LLD ++SDFG+
Sbjct: 110 TI-LAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 734 -LLGEDDDSVTQTM-------------------TMATIGYMAPE-YASDGIISPKCDVYS 772
L D +++ M T+ T Y+APE + G + +CD +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWS 224
Query: 773 YGVLLME 779
GV++ E
Sbjct: 225 LGVIMYE 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 45/222 (20%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 631 ECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMID 690
E +L+NV H ++I++ + + +VL + L +L + L + + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ L YLH ++H ++K NI ++ + D G ++ + T+ T
Sbjct: 166 ILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK---------PTDEMFTGEMSLKHWI 801
APE + + K D++S G++L E P + + + L I
Sbjct: 223 ---NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 802 -KLSL-PRGLTEVVDASLVRE-------VQPSYAKMDCLLRI 834
L + P + LVR + Y + C R+
Sbjct: 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRV 321
|
Length = 357 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFES---ECEVLRNVRHRNL 643
+N ++G GSFG ++ + ++L ++ + E E +L ++H N+
Sbjct: 2 YNVLRVVGEGSFGRALL-VQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFL---DMLERLNIMIDVGLALEYLHH 700
+ S +V+E+ G L + + L D + L + + L ++ H
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFVQMCLGVQ---H 115
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-MATIGYMAPEYA 759
H V+H ++K NI L +N ++ DFG ++LL T + T Y+ PE
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGAYACTYVGTPYYVPPEIW 172
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKP 786
+ + K D++S G +L E T K P
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 48/160 (30%), Positives = 69/160 (43%), Gaps = 5/160 (3%)
Query: 7 VPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQ 66
+P + NLS L LD+S N LP E+ L L+ L + N + S + L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 67 VLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGE 126
L L NN +P S+ NLS+L LD N IS S +G+LT L L+ + N+L
Sbjct: 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNA 292
Query: 127 IPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINL 166
+P L L L+ L L + I++
Sbjct: 293 LPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 21/60 (35%), Positives = 31/60 (51%)
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
+L+ L L +N+LT +F L + +DLS N+L+ P L L L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-04
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 593 LGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
+G G FG V+ K T AI L+ ER E V+R ++H+N+++
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 649 SCCNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDMLER---LNIMIDVGLALEYLHHSHS 703
N + L ++EF G L + + +E ++I + AL Y H+
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 704 TP----VVHCNLKPNNILLDKNM-----------------TARVSDFGISKLLGEDDDSV 742
P V+H +LKP NI L + A++ DFG+SK +G
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG------ 193
Query: 743 TQTMTMATIG---YMAPEYASDGIIS--PKCDVYSYGVLLMETFTRKKP 786
++M + +G Y +PE S K D+++ G ++ E + K P
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 34/164 (20%)
Query: 592 LLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIF 647
L+G G FG VY K+ NL+ E + E V N+ + I ++
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL--------------------NI 687
+ N+D + + GS ++ + + L LE+L NI
Sbjct: 75 KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFIL--LEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731
M D+ LEY+H + H ++KP NI++D N + D+GI
Sbjct: 132 MKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 5/99 (5%)
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
++ LAL YLH +++ +LK +N+LLD +++D+G+ K D T +
Sbjct: 104 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCG 158
Query: 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTD 788
T Y+APE D ++ GVL+ E + P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNL-------QLERAFRSFESECE 633
+ F L+ G++G+VY K T A+K N Q+++ F E +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVF----VERD 53
Query: 634 VLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGL 693
+L + ++ +F S +V+E++ G L + + R+ V L
Sbjct: 54 ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV-L 112
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL----------LGEDDDSVT 743
ALEYLH + +VH +LKP+N+L+ +++DFG+SK+ G +
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 744 QTMTMATIG---YMAPEYASDGIISPKCDVYSYGVLLME 779
+ + G Y+APE D ++ G++L E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 593 LGAGSFGSVYKGTLFD---------GTNVAIKVFNLQLERAFR----SFESECEVLRNVR 639
LG G+ +Y G L IKV L+ + R +F ++R V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
H++++ ++ C +V EF+ G L+ +++ + L + + + AL YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL- 121
Query: 700 HSHSTPVVHCNLKPNNILLDKNMT-------ARVSDFGISKLLGEDDDSVTQTMTMATIG 752
+VH N+ NILL + ++SD GI + + V + I
Sbjct: 122 --EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------IP 173
Query: 753 YMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798
++APE D +S D +S+G L E + GE+ LK
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 8/154 (5%)
Query: 630 SECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLY-SHNYFLDMLERLNIM 688
+E +LR + H ++I++ + F L+L P + + Y + + + + L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 689 IDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748
V A++YLH + ++H ++K NI ++ + DFG + D ++
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
TI APE + P D++S G++L E T
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL-LGEDDDSVTQTMTM 748
++ +AL +LH +++ +LK +N+LLD + +++D+G+ K LG D T +
Sbjct: 104 EICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFC 157
Query: 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTD 788
T Y+APE D ++ GVL+ E + P D
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
++P + NL L LD+S N+ LP L L L L + N ++ P I + S L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
+ L L NNS + +SL NL +L L+ N + ++P IGNL+ L L+ ++N +
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI-- 267
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTI 155
+ +G+L NL +L L+ N+L +P
Sbjct: 268 SSISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 24/73 (32%), Positives = 37/73 (50%), Gaps = 1/73 (1%)
Query: 426 ITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKS-FEILSHLKR 484
IT ++++ L+ I + L ++ ++LSNN LSG IP F S L+
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 485 LNVSHNRLEGKIP 497
LN+S+N G IP
Sbjct: 123 LNLSNNNFTGSIP 135
|
Length = 968 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 5/99 (5%)
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
++ LAL +LH +++ +LK +N+LLD +++D+G+ K G T T
Sbjct: 104 EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFC-G 158
Query: 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTD 788
T Y+APE D ++ GVL+ E + P D
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 63/271 (23%), Positives = 93/271 (34%), Gaps = 63/271 (23%)
Query: 234 LSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASF-- 291
L L + N S L LT L+ L L N L ++ + S
Sbjct: 53 LKELCLSLNETGRIPRGLQ--SLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110
Query: 292 QQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNG- 350
Q+ + L + L+A L L +L L RN L G
Sbjct: 111 QELKLNNNGLGDRGLR-------LLAKGLKDLPPA------LEKLV-----LGRNRLEGA 152
Query: 351 ---PIPTCLSSLISLRQLHLGSNQLTSS-IPS------SFWSLEYILRIDLSSNS----- 395
+ L + L++L+L +N + + I + + +LE +DL++N
Sbjct: 153 SCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE---VLDLNNNGLTDEG 209
Query: 396 ---LSGSLPSDIQNLKVLIYLNLSRNQLSGNI-----PITIGGLKDLITLSLARNRFQDS 447
L+ +L S LK L LNL N L+ + L+TLSL+ N D
Sbjct: 210 ASALAETLAS----LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITD- 264
Query: 448 IPDSFGSL-------TSLEYLDLSNNNLSGE 471
D L SL LDL N E
Sbjct: 265 --DGAKDLAEVLAEKESLLELDLRGNKFGEE 293
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 8/64 (12%)
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
LDL++N L+ F L +L L++ N LT+ + + + LR+L L
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISP--------EAFSGLPSLRSLDLS 56
Query: 273 SNPL 276
N L
Sbjct: 57 GNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 870 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.49 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.28 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.23 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.22 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.21 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.2 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.18 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.18 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.94 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.85 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.7 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.5 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-102 Score=958.13 Aligned_cols=835 Identities=32% Similarity=0.527 Sum_probs=611.8
Q ss_pred CCccCCCCCCCCCCCCeecCCCCccccCCCcccc-CCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCC
Q 002892 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELG-QLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPN 81 (870)
Q Consensus 3 ~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 81 (870)
++|.+|+.+..+++|+.|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|.
T Consensus 81 i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~ 158 (968)
T PLN00113 81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPN 158 (968)
T ss_pred ccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCCh
Confidence 5677888888888888888888888777776654 778888888888877766664 4466777777777777666666
Q ss_pred CCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccc
Q 002892 82 SLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTI 161 (870)
Q Consensus 82 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 161 (870)
.++++++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++++++|+.|+|++|++++.+|..+.++++|
T Consensus 159 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 238 (968)
T PLN00113 159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238 (968)
T ss_pred HHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCC
Confidence 67777777777777777766666667777777777777777766666667777777777777777766666666677777
Q ss_pred eEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccc
Q 002892 162 IIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241 (870)
Q Consensus 162 ~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~ 241 (870)
++|++++|++++..|..+. .+++|+.|++++|++++..|..+.++++|++|++++|.+.+.+|..+.++++|+.|++++
T Consensus 239 ~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~ 317 (968)
T PLN00113 239 NHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317 (968)
T ss_pred CEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCC
Confidence 7777777766666665554 356666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccccCCC--------------C--CcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccC
Q 002892 242 NYLTTETSSN--------------G--EWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSI 305 (870)
Q Consensus 242 N~l~~~~~~~--------------~--~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~ 305 (870)
|.+....+.. . ....+..+..+++|+.|++++|++.+..|..++.. ..++.+++.+|++.+.+
T Consensus 318 n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~-~~L~~L~l~~n~l~~~~ 396 (968)
T PLN00113 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS-GNLFKLILFSNSLEGEI 396 (968)
T ss_pred CccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCc-CCCCEEECcCCEecccC
Confidence 6655422100 0 00112334445555555555555555555544443 24566666666666666
Q ss_pred chhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhc-CCCCCCCcccccCccccceeecCCcccCCCCCccccccc
Q 002892 306 PKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR-NNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLE 384 (870)
Q Consensus 306 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 384 (870)
|..+..+++|+.|++++|++++..|..|..++.|+.|+++ |++.+.+|..+..+++|+.|+|++|++.+.+|..+ ..+
T Consensus 397 p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~ 475 (968)
T PLN00113 397 PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSK 475 (968)
T ss_pred CHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccc
Confidence 6667777777777777777777777777777777777766 66666777777777777777777777777766655 357
Q ss_pred ccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecC
Q 002892 385 YILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLS 464 (870)
Q Consensus 385 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 464 (870)
+|+.|++++|++++..|..|.++++|+.|+|++|++++.+|..++++++|+.|+|++|.+++.+|..|..+++|+.|||+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 88899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccccccccccccCCCC-cCCCCCCCCCCCCCCCCcccee
Q 002892 465 NNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPR-LQVPPCKEDDTKGSKKAAPIFL 543 (870)
Q Consensus 465 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~-~~~~~~~~~~~~~~~~~~~~~~ 543 (870)
+|++++.+|..+..+++|+.|++++|+++|.+|..+++..+...++.+|+.+||++. ...++|... .+......
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~~~~~~ 630 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKTPSWWF 630 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----cccceeee
Confidence 999999999999999999999999999999999999999999999999999999652 344566421 11111111
Q ss_pred eehhHHHHHHH--HHHHHHHHhhhhccccc----------cccc-------chhHHHHhhcCCCCCCeeccccceeEEEE
Q 002892 544 KYVLPLIISTT--LIVILIILCIRYRNRTT----------WRRT-------SYLDIQQATDGFNECNLLGAGSFGSVYKG 604 (870)
Q Consensus 544 ~~~~~~~~~~~--~~v~~~~~~~~~~~~~~----------~~~~-------~~~~~~~~~~~~~~~~~lg~G~~g~v~~~ 604 (870)
++..++.++. ++++++++++++|++.. |... ...........|...+.||+|+||.||+|
T Consensus 631 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~ 709 (968)
T PLN00113 631 -YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKG 709 (968)
T ss_pred -ehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEE
Confidence 1111111111 11112222222222110 1000 01122333456778889999999999999
Q ss_pred Ee-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHH
Q 002892 605 TL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLE 683 (870)
Q Consensus 605 ~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 683 (870)
+. .+++.||||.++..... ...|++.+++++|||||++++++.+.+..++||||+++|+|.++++. ++|.+
T Consensus 710 ~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~ 781 (968)
T PLN00113 710 KSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWER 781 (968)
T ss_pred EECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHH
Confidence 96 47899999988643321 23468889999999999999999999999999999999999999963 78999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCC
Q 002892 684 RLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763 (870)
Q Consensus 684 ~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 763 (870)
+.+++.|+++|++|||..++++|+||||||+||+++.++.+++. ||.+..... .....++++|+|||++.+..
T Consensus 782 ~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~ 854 (968)
T PLN00113 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKD 854 (968)
T ss_pred HHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCC
Confidence 99999999999999997777889999999999999999888775 555443211 11235789999999999999
Q ss_pred cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-hhhhcchhhhcccCcchHHHHHHHHHHHHHhhcc
Q 002892 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG-LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCC 842 (870)
Q Consensus 764 ~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 842 (870)
++.++|||||||++|||+||+.||+...........|........ ...++|+.+..... ...++..++.+++.+||
T Consensus 855 ~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~Cl 931 (968)
T PLN00113 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS---VNQNEIVEVMNLALHCT 931 (968)
T ss_pred CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC---ccHHHHHHHHHHHHhhC
Confidence 999999999999999999999999765555566777776544332 44555555433221 12345668899999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 843 MDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 843 ~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
+.+|++||+|.||+++|+++.+..
T Consensus 932 ~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 932 ATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cCCchhCcCHHHHHHHHHHhhccc
Confidence 999999999999999999987743
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-58 Score=572.93 Aligned_cols=491 Identities=35% Similarity=0.516 Sum_probs=396.6
Q ss_pred CCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCcccc-CCCCCCEEEcCCCccccCCCCCCCCCCCCcEE
Q 002892 14 LSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG-VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRL 92 (870)
Q Consensus 14 l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 92 (870)
..+++.|||++|++++.+|..|..+++|+.|+|++|++++.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 35799999999999999999999999999999999999988887765 899999999999999987775 568999999
Q ss_pred eccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccc
Q 002892 93 DSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172 (870)
Q Consensus 93 ~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 172 (870)
+|++|.+++.+|..++.+++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..+.++++|++|+|++|+++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999899999999999999999999999899999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCC
Q 002892 173 GHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNG 252 (870)
Q Consensus 173 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 252 (870)
+..|..+. .+++|++|++++|++++..|..+.++++|++|++++|++.+..|..+.++++|+.|++++|.+....
T Consensus 226 ~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~---- 300 (968)
T PLN00113 226 GEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI---- 300 (968)
T ss_pred CcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC----
Confidence 98888875 5899999999999999999999999999999999999999999999999999999999999987533
Q ss_pred CcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCch
Q 002892 253 EWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTT 332 (870)
Q Consensus 253 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 332 (870)
+..+..+++|+.|++++|.+.+..|..+..++ .|+.|++++|.+.+.+|..+..+++|+.|++++|++.+.+|..
T Consensus 301 ----p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~ 375 (968)
T PLN00113 301 ----PELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375 (968)
T ss_pred ----ChhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChh
Confidence 33456677777777777777766666665543 5666666666666666666666666666666666666656655
Q ss_pred hhchhhHHHHHhc-CCCCCCCcc------------------------cccCccccceeecCCcccCCCCCcccccccccc
Q 002892 333 LGRLQQLQALLQR-NNLNGPIPT------------------------CLSSLISLRQLHLGSNQLTSSIPSSFWSLEYIL 387 (870)
Q Consensus 333 ~~~l~~L~~L~l~-n~~~~~~p~------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 387 (870)
++.+.+|+.|+++ |++.+.+|. .+..+++|+.|++++|++++.+|..+..+++|+
T Consensus 376 ~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 455 (968)
T PLN00113 376 LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455 (968)
T ss_pred HhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc
Confidence 5555555555444 444444444 444455555555555555555555555555555
Q ss_pred eEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCc
Q 002892 388 RIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNN 467 (870)
Q Consensus 388 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 467 (870)
.|+|++|.+.+.+|..+ ..++|+.|+|++|++++..|..|.++++|+.|+|++|.+.+.+|..+.++++|+.|+|++|+
T Consensus 456 ~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 534 (968)
T PLN00113 456 MLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534 (968)
T ss_pred EEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCc
Confidence 55555555555555444 34677788888888888888889999999999999999999999999999999999999999
Q ss_pred ccCCCCcchhhccccceeeccCCcccccCCCC-Cccccccccccccccccc
Q 002892 468 LSGEIPKSFEILSHLKRLNVSHNRLEGKIPTN-GPFRNFLAQSFLWNYALC 517 (870)
Q Consensus 468 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c 517 (870)
+++.+|..|..+++|+.|+|++|+++|.+|.. ..+.......+.+|...+
T Consensus 535 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred ccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 99999999999999999999999999999863 222233333445555443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=411.69 Aligned_cols=289 Identities=42% Similarity=0.677 Sum_probs=248.0
Q ss_pred cccccchhHHHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 002892 571 TWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650 (870)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 650 (870)
..+.+++.++..+|++|....+||+|+||.||+|...+|+.||||++.....+...+|..|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45678999999999999999999999999999999999999999988765433145699999999999999999999999
Q ss_pred eeCC-eeEEEEecCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEec
Q 002892 651 CNLD-FKALVLEFMPNGSLEKWLYSHNY-FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 651 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
.+.+ +.++||||+++|+|.++++.... .++|..+++||.++|+||+|||+...++|+||||||+|||+|+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999997665 799999999999999999999988878899999999999999999999999
Q ss_pred cccccccCCCCCccccccc-ccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccc-cccchHHHHHHHhcC
Q 002892 729 FGISKLLGEDDDSVTQTMT-MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMF-TGEMSLKHWIKLSLP 806 (870)
Q Consensus 729 fg~a~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~ 806 (870)
||+|........ ..... .||.+|+|||+...+..+.|+||||||++++|++||+.|.+... ..+..+..|....+.
T Consensus 221 FGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999965532111 11111 79999999999999999999999999999999999999888644 345558888876665
Q ss_pred C-chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 807 R-GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 807 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
. .+.+++|+.+.... +....+..++..++..|++.+|++||+|.||+++|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~---~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGE---YPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCC---CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 5 58899998876421 1111556779999999999999999999999999977654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=365.37 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=210.2
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-eeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-FKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 661 (870)
.+.+....||+|..|+||++.++ +++.+|+|++.... ....+++.+|+++++..+||+||.++|.|.... ..+++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35556789999999999999976 68999999995544 344678999999999999999999999999988 5999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
||++|+|++++...++ +++....+++.++++||.|||+ .++||||||||+|||+.+.|.|||+|||.+..+...
T Consensus 159 YMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 9999999999987644 8999999999999999999995 255999999999999999999999999999876322
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
....++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+.. ..+.+.++.......
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~------------~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY------------LDIFELLCAIVDEPP 299 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC------------CCHHHHHHHHhcCCC
Confidence 3455789999999999999999999999999999999999999997641111 112233332222221
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+......++.++..++..|++.||.+||+++|+++.
T Consensus 300 -P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 -PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222222467789999999999999999999999763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=385.23 Aligned_cols=263 Identities=29% Similarity=0.488 Sum_probs=216.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-eeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-FKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv 659 (870)
..++..+.+.+|+|+||+||+|.++....||||++..... .....|.+|+.++.+++|||||+++|++.+.. ..++|
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 3444555667999999999999998666699999976542 22568999999999999999999999999887 78999
Q ss_pred EecCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecccCCCceeeCCCC-ceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTP-VVHCNLKPNNILLDKNM-TARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 736 (870)
|||+++|+|.++++. .+..+++..++.++.|||+|+.||| +.+ ||||||||+|||++.++ ++||+|||+++...
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999997 4677999999999999999999999 666 99999999999999997 99999999998764
Q ss_pred CCCCcccccccccccccCCccccc--CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYAS--DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... . .....+..
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-~~~~~v~~----------- 260 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-QVASAVVV----------- 260 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-HHHHHHHh-----------
Confidence 322 2333367999999999999 66899999999999999999999999987544 1 11111110
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhhh
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFLV 868 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~~ 868 (870)
....+ .-+..|+..+..++..||..||++||++.+++..|+.+...+..
T Consensus 261 ----~~~Rp-~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 ----GGLRP-PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ----cCCCC-CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 00000 11123677899999999999999999999999999999886643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=384.75 Aligned_cols=256 Identities=28% Similarity=0.494 Sum_probs=216.8
Q ss_pred CCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
.++.++.||+|.||+||.|.++....||+|.++.. ....+.|.+|+++|++++|++||+++++|..++..||||||++.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 34456789999999999999998889999999765 33346788999999999999999999999998899999999999
Q ss_pred CCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 666 GSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 666 g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
|+|.+|++. .+..+...+.+.++.|||+|++||+ ++++|||||.++||||+++..+||+|||+|+...++ .....
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~ 361 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS 361 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence 999999996 5677999999999999999999999 666999999999999999999999999999955433 33333
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....-+..|+|||.+..+.++.|||||||||++|||+| |+.||......+ ++.. .....+
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----------------v~~~--le~GyR 422 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----------------VLEL--LERGYR 422 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------------HHHH--HhccCc
Confidence 44446789999999999999999999999999999999 888887642211 1111 112223
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
-+.+..||.+++++|..||+.+|++|||+..+...++++...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 445567999999999999999999999999999999887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=346.82 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=206.7
Q ss_pred hcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEee-eeeeCC-eeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFS-SCCNLD-FKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~-~~~l 658 (870)
..+|++.+.||+|.||+||++. ..+|..+|.|.+.... ....+....|+.++++++|||||++++ .+.++. ..++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3457888999999999999998 5689999999887443 456678899999999999999999998 444444 4899
Q ss_pred EEecCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecccCCCceeeCCCCceEEeccccccc
Q 002892 659 VLEFMPNGSLEKWLY---SHNYFLDMLERLNIMIDVGLALEYLHHSHSTP-VVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 659 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
|||||++|+|...++ +.++.+++.++|+++.|++.||.++|..-.++ |.||||||.||+++.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999887 45667999999999999999999999543232 78999999999999999999999999998
Q ss_pred cCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
+.... ......+|||+||+||.+.+..|++||||||+||++|||+.-+.||.+. .-..+..
T Consensus 178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~--------------- 238 (375)
T KOG0591|consen 178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCK--------------- 238 (375)
T ss_pred hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHH---------------
Confidence 85433 2344568999999999999999999999999999999999999999862 1111111
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
+.....+ +......++..+..++..|+..||+.||+...+++.+..
T Consensus 239 KI~qgd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 239 KIEQGDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHcCCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1101111 112224566789999999999999999996555554443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.89 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=211.1
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..|...+.||+|+|+.||+++. ..|+.||+|++.+.. ....+...+|+++.++++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 789999999998743 455678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|+|+.++|..+++ .+..+++.++..+++||+.|+.||| +++|+|||||..|++++++.+|||+|||+|..+..+.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999998 5556999999999999999999999 7779999999999999999999999999999885332
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.+....+|||.|.|||++.....+..+||||+|||+|.|+.|++||+.. .+.+..++.....
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----------------~vkety~~Ik~~~ 234 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----------------TVKETYNKIKLNE 234 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----------------hHHHHHHHHHhcC
Confidence 2344568999999999999999999999999999999999999999752 1222222222111
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+. -+.....++.++|.++++.+|.+|||+++|+.
T Consensus 235 Y~---~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 YS---MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cc---cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 11134567889999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=355.15 Aligned_cols=201 Identities=29% Similarity=0.496 Sum_probs=181.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
..++|...+.||+|+||+||+|+++ ++..||||.+.+. .+...+....|+++++.++|||||.+++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4578999999999999999999965 6899999999776 455667789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC------CceEEecccccc
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN------MTARVSDFGISK 733 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~a~ 733 (870)
||||.||||.+|+++.+. +++.++..++.|+|.|+++|| +++||||||||.|||++.. -.+||+|||+|+
T Consensus 88 MEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999998764 999999999999999999999 6669999999999999764 468999999999
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcc
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~ 790 (870)
.+. ........+|++.|||||++..++|+.|+|+||+|+|+|+|++|+.||+..
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 885 333445678999999999999999999999999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=380.39 Aligned_cols=448 Identities=29% Similarity=0.394 Sum_probs=328.1
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
++|++++.+..++.|+.|+|++. .+|+.+..+.+|+.|++++|.+. .+|+.++.+..|+.|+..+|+|+ ..|.++.+
T Consensus 82 ~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~ 158 (565)
T KOG0472|consen 82 QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVN 158 (565)
T ss_pred hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHH
Confidence 57888888888888888888887 68888888888888888888888 77888888888888888888888 68888888
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEE
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIIN 165 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 165 (870)
+.+|..|++.+|+++ ..|...-.++.|++||..+|-++ .+|..++.+.+|..|+|..|+|. ..| .|..++.|.+|+
T Consensus 159 ~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh 234 (565)
T KOG0472|consen 159 LSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELH 234 (565)
T ss_pred HHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHH
Confidence 888888899999888 45544444888999999999888 78888999999999999999886 455 788889999999
Q ss_pred eecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccc
Q 002892 166 LVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245 (870)
Q Consensus 166 l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 245 (870)
++.|+|. .+|...++.++.+.+|||++|+++ ..|+.++-+++|.+||+|+|.|+ ..|..++++ +|+.|-+.+|.+.
T Consensus 235 ~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 235 VGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred hcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH
Confidence 9999986 677777777889999999999998 78899999999999999999998 578889998 8999999999888
Q ss_pred cccCC---CCCcccccccccccccceEEcCCC-CCC--CCCCccccc--cccchhhhhcccccccccCchhhhCccC---
Q 002892 246 TETSS---NGEWSFLSSLTNCNKLRALSLGSN-PLD--SILPPLIGN--FSASFQQFYAHECKLKGSIPKEIGNLRG--- 314 (870)
Q Consensus 246 ~~~~~---~~~~~~~~~l~~l~~L~~L~L~~N-~l~--~~~~~~~~~--~~~~l~~l~l~~n~l~~~~~~~l~~l~~--- 314 (870)
++... .++...++.++.-..-.-++-+.- .-+ +..+..+.+ ..-+.+.|.++.-+++ .+|+.+..-..
T Consensus 311 TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~ 389 (565)
T KOG0472|consen 311 TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEI 389 (565)
T ss_pred HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcc
Confidence 76532 111111111111000000000000 000 001111111 1124566666666666 55665554444
Q ss_pred CcEEEeeCCCccccCCchhhchhhHHHH-HhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCC
Q 002892 315 LIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSS 393 (870)
Q Consensus 315 L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 393 (870)
.+..++++|++. .+|..+..+..+... .++||..+.+|..++.+++|..|+|++|-+. .+|..+..+..|+.||+|.
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~ 467 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF 467 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence 778889999988 688777777776554 6668888888888888888888888888776 6677777777777777777
Q ss_pred CccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCccc
Q 002892 394 NSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 394 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 469 (870)
|++. .+|..+-.+..|+.+-.++|++....|..+.+|.+|++|||.+|.+. .+|..+++|++|++|+|++|.|.
T Consensus 468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 7777 66776666666666666677777655555777777777777777775 45666777777777777777666
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.24 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=207.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh-------HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE-------RAFRSFESECEVLRNVRHRNLIKIFSSCCNLD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 654 (870)
..+.|.+.+.+|+|+||.|-+|.. ++|+.||||++++... ......++|+++|++++||+||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788999999999999999984 5899999999976531 11234679999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC---CceEEecccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN---MTARVSDFGI 731 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~ 731 (870)
..|+||||++||+|.+++-.++. +.+..-..+++|++.|+.||| +.||+||||||+|||+..+ -.+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999987665 777788889999999999999 7779999999999999765 6799999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCC---cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGI---ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 808 (870)
|...+. ...+...+|||.|.|||++.++. +..+.|+||+||++|-+++|.+||.+.........++.+..+..
T Consensus 326 AK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f- 401 (475)
T KOG0615|consen 326 AKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF- 401 (475)
T ss_pred hhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc-
Confidence 998753 33455678999999999998654 33478999999999999999999987544332222222211111
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
......+..++..++|.+|+..||++||+++|+++.
T Consensus 402 --------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 --------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 112233456789999999999999999999999863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=381.25 Aligned_cols=259 Identities=28% Similarity=0.477 Sum_probs=219.3
Q ss_pred cCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.+.+..+.||+|+||+||+|+.. +...||||.++..... ..++|++|++.++.++|||||+++|.|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34566788999999999999832 3457999999877655 7889999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCce
Q 002892 658 LVLEFMPNGSLEKWLYSHN-------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA 724 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 724 (870)
+|+|||..|||.+|+.... .+++..+.+.||.|||.|++||-.++ +|||||.++|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999998321 23888999999999999999999544 9999999999999999999
Q ss_pred EEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHH
Q 002892 725 RVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKL 803 (870)
Q Consensus 725 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 803 (870)
||+|||+++..-..+++.......-+++|||||.+..+++|.+||||||||++||+++ |+.||.+..+.+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--------- 713 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--------- 713 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---------
Confidence 9999999987755565555555667899999999999999999999999999999999 999998753322
Q ss_pred hcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 804 SLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
++...-.+ .....++.||.+++.+|..||+.+|++||+++||-..|+++.+.
T Consensus 714 --------VIe~i~~g--~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 --------VIECIRAG--QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --------HHHHHHcC--CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 11111111 11234567899999999999999999999999999999988764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=368.30 Aligned_cols=418 Identities=23% Similarity=0.239 Sum_probs=330.7
Q ss_pred CEEEcCCCccccCCCCCCCCC--CCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecc
Q 002892 66 QVLSLRNNSFTGPIPNSLFNL--SSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLA 143 (870)
Q Consensus 66 ~~L~L~~n~i~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~ 143 (870)
..||.+.+.+.......+... +.-+.||+++|+++...+..|.++++|+++++.+|.++ .+|.......+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 456666666653211112111 12345777777777666666777777777777777777 666655555667777777
Q ss_pred cccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCC
Q 002892 144 LNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQ 223 (870)
Q Consensus 144 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 223 (870)
+|.|+..-.+.+..++.|+.||||.|.|+...-..+. .-.++++|+|++|+|+......|..+.+|.+|.|++|+|+..
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp-~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFP-AKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCC-CCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 7777766666777777777777777777654444433 246788888888888888888899999999999999999988
Q ss_pred CccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccc
Q 002892 224 IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303 (870)
Q Consensus 224 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~ 303 (870)
.+..|..|++|+.|+|..|+|..+.- ..|.++++|+.|.|..|.|...
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~irive~--------ltFqgL~Sl~nlklqrN~I~kL------------------------ 260 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIVEG--------LTFQGLPSLQNLKLQRNDISKL------------------------ 260 (873)
T ss_pred CHHHhhhcchhhhhhccccceeeehh--------hhhcCchhhhhhhhhhcCcccc------------------------
Confidence 88889999999999999999886531 2678888888888888887743
Q ss_pred cCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhc-CCCCCCCcccccCccccceeecCCcccCCCCCccccc
Q 002892 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR-NNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWS 382 (870)
Q Consensus 304 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 382 (870)
....|..+.+++.|+|+.|++..+-.+++.+++.|+.|+++ |.+....++++...++|++|+|++|+|+...+..|..
T Consensus 261 -~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~ 339 (873)
T KOG4194|consen 261 -DDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRV 339 (873)
T ss_pred -cCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHH
Confidence 23457788899999999999998889999999999999999 7777778888888999999999999999999999999
Q ss_pred ccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccc---cccCCCCCCEEEcCCCcccCcccccccCCCCCC
Q 002892 383 LEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPI---TIGGLKDLITLSLARNRFQDSIPDSFGSLTSLE 459 (870)
Q Consensus 383 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 459 (870)
+..|++|+|++|.++.+-..+|.++.+|+.|||++|.|+..+.+ .|.+|++|+.|+|.+|+|..+...+|.++++|+
T Consensus 340 L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE 419 (873)
T KOG4194|consen 340 LSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALE 419 (873)
T ss_pred HHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccc
Confidence 99999999999999987788999999999999999999876544 588999999999999999988889999999999
Q ss_pred eEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccccc--cccccccCCC
Q 002892 460 YLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSF--LWNYALCGPP 520 (870)
Q Consensus 460 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~--~~n~~~c~~~ 520 (870)
.|||.+|-|....|.+|..+ .|+.|-++.-.+-|.|-- .++..|....+ ..-..-|+.|
T Consensus 420 ~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql-~Wl~qWl~~~~lq~sv~a~CayP 480 (873)
T KOG4194|consen 420 HLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQL-KWLAQWLYRRKLQSSVIAKCAYP 480 (873)
T ss_pred eecCCCCcceeecccccccc-hhhhhhhcccceEEeccH-HHHHHHHHhcccccceeeeccCC
Confidence 99999999999999999999 999999988888888864 34444433221 2223467766
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=359.08 Aligned_cols=267 Identities=23% Similarity=0.420 Sum_probs=219.1
Q ss_pred hhHHHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 002892 577 YLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD 654 (870)
Q Consensus 577 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 654 (870)
..+..+..+...+.++||+|.||+||+|+|.. .||||+++... .+..+.|+.|+.++++-+|.||+-+.|||..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 34555566778889999999999999999873 79999998764 457889999999999999999999999999887
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
. .||+.||+|-+|+.+++-.+..++..+.+.||+|||+|+.||| .++|||||+|..||+++++++|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceee
Confidence 7 9999999999999999977777999999999999999999999 67799999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCcccccCC---CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDG---IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
-+.-..........|...|||||+++.+ +|++.+||||||+++|||++|..||.. ...+..+ -
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIi-------------f 603 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQII-------------F 603 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheE-------------E
Confidence 6544333334455688899999999753 689999999999999999999999974 2221111 1
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
++.+... ..........|+.++.+++..||..++++||.+.+|+.+|+.+..
T Consensus 604 mVGrG~l-~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 604 MVGRGYL-MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred Eeccccc-CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111100 011112234678899999999999999999999999999988766
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.61 Aligned_cols=243 Identities=27% Similarity=0.350 Sum_probs=201.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.++||+|+||+||.++.+ +++.||+|++++.. ....+...+|..++.+++||.||.++-.|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999854 68999999998764 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
|+||+.||.|.-.+++.+. +++..+.-++.+|+.||.||| ++||||||+||+|||+|.+|+++|+|||++...-.
T Consensus 103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999997766 889989999999999999999 77799999999999999999999999999985422
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.......++||+.|||||++.+..|+..+|.||+|+++|||++|.+||... +...+ .+....
T Consensus 178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~------------~~~I~~ 239 (357)
T KOG0598|consen 178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKM------------YDKILK 239 (357)
T ss_pred -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHH------------HHHHhc
Confidence 222334478999999999999999999999999999999999999999762 11121 222211
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCC
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRM 850 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 850 (870)
.... ..+.-...+..+++.+.+..+|++|.
T Consensus 240 ~k~~--~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 240 GKLP--LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CcCC--CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1100 00111234678999999999999996
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=369.84 Aligned_cols=461 Identities=26% Similarity=0.393 Sum_probs=375.9
Q ss_pred CCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCC
Q 002892 7 VPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNL 86 (870)
Q Consensus 7 ~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 86 (870)
+-+++.++..|+.|++++|++. .+|.+++.+..++.|+.++|+++ .+|++++.+.+|..|+.++|.+. .+|++++.+
T Consensus 60 l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~ 136 (565)
T KOG0472|consen 60 LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRL 136 (565)
T ss_pred ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHH
Confidence 4467888888999999999988 68888999999999999999988 78888999999999999999998 788889999
Q ss_pred CCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEe
Q 002892 87 SSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINL 166 (870)
Q Consensus 87 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 166 (870)
..|..|+..+|++. ..|..+..+.+|..|++.+|+++. .|...-+++.|++||+.+|-++ .+|..++.+.+|..|+|
T Consensus 137 ~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL 213 (565)
T KOG0472|consen 137 LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYL 213 (565)
T ss_pred hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHh
Confidence 99999999999998 788888888889999999999984 4444445899999999888876 78888999999999999
Q ss_pred ecccccccCCCcccCCCCccceeeecccccccccCCc-ccCCCCccEEEccCCcccCCCccccccccccccccccccccc
Q 002892 167 VGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNS-ITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245 (870)
Q Consensus 167 ~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 245 (870)
..|+|. .+| .| .++..|+.+.+..|+|. .+|.. ..++++|..|||..|+++ ..|+.++.+++|..||+|+|.|+
T Consensus 214 ~~Nki~-~lP-ef-~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is 288 (565)
T KOG0472|consen 214 RRNKIR-FLP-EF-PGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS 288 (565)
T ss_pred hhcccc-cCC-CC-CccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc
Confidence 999987 445 33 35778889999999998 45554 458899999999999998 78888999999999999999998
Q ss_pred cccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccc-hhhhhc--c--cccc-cc----------cCchhh
Q 002892 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSAS-FQQFYA--H--ECKL-KG----------SIPKEI 309 (870)
Q Consensus 246 ~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~-l~~l~l--~--~n~l-~~----------~~~~~l 309 (870)
.++ .+++++ +|+.|-+.+|.++++-.+.+....+. +++|.- . +-+- .| ....+.
T Consensus 289 ~Lp---------~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~ 358 (565)
T KOG0472|consen 289 SLP---------YSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDI 358 (565)
T ss_pred cCC---------cccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccch
Confidence 754 467888 89999999999988766655444332 333322 0 0000 00 122344
Q ss_pred hCccCCcEEEeeCCCccccCCchhhchhh---HHHHHhcCCCCCCCcccccCccccce-eecCCcccCCCCCcccccccc
Q 002892 310 GNLRGLIALSLFTNDLNGTIPTTLGRLQQ---LQALLQRNNLNGPIPTCLSSLISLRQ-LHLGSNQLTSSIPSSFWSLEY 385 (870)
Q Consensus 310 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~l~n~~~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~ 385 (870)
..+.+.+.|++++-+++ .+|+....-.. .+..+++.|....+|..+..+..+.+ +.+++|.+ +.+|..++.+++
T Consensus 359 ~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~k 436 (565)
T KOG0472|consen 359 YAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQK 436 (565)
T ss_pred hhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhc
Confidence 56778899999999998 56665554444 34456777777788988888877765 44555555 489999999999
Q ss_pred cceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCC
Q 002892 386 ILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSN 465 (870)
Q Consensus 386 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 465 (870)
|..|+|++|-+. .+|..++.+..|+.||+|.|++. ..|.....+..|+.+-.++|++....|+.+.++.+|..|||.+
T Consensus 437 Lt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~n 514 (565)
T KOG0472|consen 437 LTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQN 514 (565)
T ss_pred ceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCC
Confidence 999999999998 68999999999999999999998 7899888888899998999999987777799999999999999
Q ss_pred CcccCCCCcchhhccccceeeccCCccc
Q 002892 466 NNLSGEIPKSFEILSHLKRLNVSHNRLE 493 (870)
Q Consensus 466 N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 493 (870)
|.|. .+|..++++.+|+.|+++||+|.
T Consensus 515 Ndlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 515 NDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred Cchh-hCChhhccccceeEEEecCCccC
Confidence 9998 89999999999999999999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=324.51 Aligned_cols=266 Identities=21% Similarity=0.247 Sum_probs=203.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
+.|+...++|+|+||+||+++.+ +|+.||||.|.... +...+-..+|++++++++|+|+|.+++.|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788899999999999999966 69999999997654 3445567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
||+..-| +-++......+...+.+++.|++.|+.|+| +++++||||||+||+++.+|.+||||||+|+....+ .
T Consensus 82 ~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--g 155 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--G 155 (396)
T ss_pred ecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--c
Confidence 9977444 445555556899999999999999999999 667999999999999999999999999999988643 2
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH--HhcCCchhhhcchh--
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK--LSLPRGLTEVVDAS-- 816 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-- 816 (870)
..++.-+.|..|.|||.+.+ .+|+...||||.||++.||++|.+-|.+..+-+ ++..+.. ..+.+....++...
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHHHHHHHHcccCHHHHHHhccCCc
Confidence 33444567899999999887 689999999999999999999998876532221 1111111 11222222222110
Q ss_pred h----hccc---Cc-chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 L----VREV---QP-SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~----~~~~---~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ...+ ++ +........-+.+++..|++.||++|++.++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0 0000 00 0011122346889999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.16 Aligned_cols=261 Identities=24% Similarity=0.312 Sum_probs=210.4
Q ss_pred hcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|+..+.||.|..++||+|+ ...++.||||+++.+. ....+.+++|++.|+.++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4689999999999999999998 4467999999998765 3346889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||.+|++.+.++.. +..+++..+..|.+++++||.||| .+|.||||||+.|||++++|.|||+|||.+..+-....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999843 556999999999999999999999 77799999999999999999999999998866533222
Q ss_pred -cccc-cccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 741 -SVTQ-TMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 741 -~~~~-~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.... ..++||+.|||||++.. ..|+.|+||||||++..|+.+|..||....+.. .+..-.....|.-.....+..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-vLl~tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-VLLLTLQNDPPTLLTSGLDKD 260 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-HHHHHhcCCCCCcccccCChH
Confidence 1122 45689999999999543 458999999999999999999999998743322 122212222221112222222
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. ......+.+++..|+..||++|||++++++
T Consensus 261 ~~---------k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 261 ED---------KKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred Hh---------hhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11 223447889999999999999999999975
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=361.90 Aligned_cols=389 Identities=23% Similarity=0.256 Sum_probs=234.5
Q ss_pred eecCCCCccccCCCccccCC--CCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 19 YLDISENNFRGYLPNELGQL--RRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 19 ~L~ls~n~l~~~~p~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
.||++++++....-..+..+ ..-+.|++|+|++....+..|.++++|++++|.+|.++ .+|.......+|+.|+|.+
T Consensus 56 lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~ 134 (873)
T KOG4194|consen 56 LLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRH 134 (873)
T ss_pred eeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeec
Confidence 46666666653222222221 12344666666666555666666666666666666666 5565555555566666666
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCC
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 176 (870)
|.|+.+-.+.++.++.|+.||||.|.|+...-..|..-.++++|+|++|+|+......|.++.+|..|.|+.|+++...+
T Consensus 135 N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~ 214 (873)
T KOG4194|consen 135 NLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQ 214 (873)
T ss_pred cccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCH
Confidence 66664445556666666666666666664444455555566666666666666556666666666666666666653222
Q ss_pred CcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccc
Q 002892 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSF 256 (870)
Q Consensus 177 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 256 (870)
.. ++.+++|+.|+|..|+|.-.---+|.++++|+.|.|..|.|.......|..+.++++|+|+.|+++.+..+
T Consensus 215 r~-Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g------ 287 (873)
T KOG4194|consen 215 RS-FKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG------ 287 (873)
T ss_pred HH-hhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc------
Confidence 22 23344444444444444422233444444444444444444444444444444444444444444443322
Q ss_pred ccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhch
Q 002892 257 LSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRL 336 (870)
Q Consensus 257 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 336 (870)
.+.++++|+.|+||+|.|.. +.++.....++|++|+|++|+|+...
T Consensus 288 --~lfgLt~L~~L~lS~NaI~r-------------------------ih~d~WsftqkL~~LdLs~N~i~~l~------- 333 (873)
T KOG4194|consen 288 --WLFGLTSLEQLDLSYNAIQR-------------------------IHIDSWSFTQKLKELDLSSNRITRLD------- 333 (873)
T ss_pred --cccccchhhhhccchhhhhe-------------------------eecchhhhcccceeEeccccccccCC-------
Confidence 23344444444444444432 22333444455555555555555433
Q ss_pred hhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcc---cccCCccCCEE
Q 002892 337 QQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPS---DIQNLKVLIYL 413 (870)
Q Consensus 337 ~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L 413 (870)
+.+|..+..|++|+|++|.|+.....+|..+.+|+.|||++|.|+..+.+ .|.+|++|+.|
T Consensus 334 ----------------~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 334 ----------------EGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred ----------------hhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 44566666778888888888877777888888888888888888765543 57888899999
Q ss_pred EccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCC
Q 002892 414 NLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466 (870)
Q Consensus 414 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 466 (870)
+|.+|+|+.+.-..|.++.+|+.|||.+|.|..+-|++|..+ .|++|.++.-
T Consensus 398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred eecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 999999987767788999999999999999988888889888 8888877543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=341.23 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=204.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--eeEEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD--FKALVL 660 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 660 (870)
..+|...+.||+|+||.||++... +|+..|||..........+.+.+|++++++++|||||+++|...... ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777899999999999999965 58999999987664333677899999999999999999999854444 688999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceEEeccccccccCC-C
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFGISKLLGE-D 738 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-~ 738 (870)
||+++|+|.+++...+..+++..+..+.+||++||+||| ++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999977656999999999999999999999 888999999999999999 79999999999987643 1
Q ss_pred CCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
..........||+.|||||++..+ ...+++||||+||++.||+||+.||.+.... ............
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---~~~~~~ig~~~~--------- 240 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---AEALLLIGREDS--------- 240 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---HHHHHHHhccCC---------
Confidence 122233456799999999999854 3446999999999999999999999863111 111111100000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
.+ .-+...+..+.+++.+|+..+|++||||.++++.--
T Consensus 241 ----~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 241 ----LP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----CC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 00 011124557889999999999999999999987543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.53 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=209.7
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCe
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 655 (870)
.....+|.+.+.||+|+|++|++|+. +.++.||||++.+.. +...+.+..|-.+|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45567899999999999999999984 478999999997653 33345677888999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
+|+|+||+++|+|.+++++.+. +++.....++.+|+.|++||| +.|||||||||+|||+|++++++|+|||.|..+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999998765 899999999999999999999 888999999999999999999999999999888
Q ss_pred CCCCCc---------ccc--cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccch-HHHHHHH
Q 002892 736 GEDDDS---------VTQ--TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMS-LKHWIKL 803 (870)
Q Consensus 736 ~~~~~~---------~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~ 803 (870)
...... ... ..++||..|.+||++..+..++.+|+|+||||+|+|+.|++||.+. .++. ...+...
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~--NeyliFqkI~~l 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA--NEYLIFQKIQAL 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc--cHHHHHHHHHHh
Confidence 542222 111 4578999999999999999999999999999999999999999762 2222 1122111
Q ss_pred hcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 804 SLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.+ ...+. .+..+.+++.+.+..||.+|++..+|.+.
T Consensus 303 ~y--------------~fp~~-----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 DY--------------EFPEG-----FPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cc--------------cCCCC-----CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 11111 12457889999999999999999888653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.13 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=213.6
Q ss_pred cCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKALV 659 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 659 (870)
+.|+.+++||+|.||.||+|+ ..+|+.||+|.++.+. +.......+|+.+++++.||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456667789999999999998 5689999999998765 45556778999999999999999999999876 689999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
+|||+. ||..++...+..+++.++..++.|++.||+|+| ++||.|||||.+|||++.+|.+||+|||+|+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999965 999999988888999999999999999999999 7889999999999999999999999999999885443
Q ss_pred CcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc--hh--hhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPRG--LT--EVV 813 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~--~~--~~~ 813 (870)
....+..+.|..|.|||.+.+. .|+.+.|+||.|||+.||++|++.|.+.. ...++..+.+.. .|.. |. ++-
T Consensus 273 -~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t-EveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 273 -SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT-EVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred -CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc-HHHHHHHHHHHhCCCChhccccccCC
Confidence 3346777889999999988764 69999999999999999999999988743 334444444322 1221 22 111
Q ss_pred chhhhccc---Cc--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 814 DASLVREV---QP--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 814 ~~~~~~~~---~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....+.. .+ +......+...++++..++..||.+|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111111 11 1112234567889999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.31 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=209.8
Q ss_pred hcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
...|...+.||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4567778899999999999998 457889999999888777777899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++||+|.|.+.... +++.++..|++++++||+||| .+||+|||||.+||+++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 99999999998765 899999999999999999999 67799999999999999999999999999988754432
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
....-+|||+|||||+.....|++|.||||||++++||+.|++||-. +..+...+... ....
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa--------------~ng~ 486 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIA--------------TNGT 486 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHh--------------hcCC
Confidence 33344799999999999999999999999999999999999999853 12222211110 0000
Q ss_pred c-chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 823 P-SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 823 ~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+ -..+......+.+++.+|+..||++||++.|+++.
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 0 01122335578999999999999999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=341.55 Aligned_cols=268 Identities=23% Similarity=0.292 Sum_probs=208.2
Q ss_pred hhcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhhH-HHHHHHHHHHHHHhcC-CCceeEEeeeeeeCC-eeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER-AFRSFESECEVLRNVR-HRNLIKIFSSCCNLD-FKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l 658 (870)
..++|.+.+.||.|.||.||+|+ ..+|+.||||.++..... ..-.-.+|+..++++. ||||+++.+.+.+.+ ..|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34678899999999999999998 457999999998765422 1223457999999998 999999999999888 9999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||| ..+|.+.++.+++.+++..+..|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+|+.+..
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc-
Confidence 99999 56999999988999999999999999999999999 78899999999999999999999999999997743
Q ss_pred CCcccccccccccccCCcccc-cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH-HhcCC--chhh---
Q 002892 739 DDSVTQTMTMATIGYMAPEYA-SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK-LSLPR--GLTE--- 811 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~--- 811 (870)
....+.-+.|..|.|||++ +++.|+.+.|+|++|||++|+.+-++-|.+..+-+. +..+.. ..-|. .+.+
T Consensus 163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHhCCCccccchhHHH
Confidence 3344555789999999987 467899999999999999999999988766322221 212111 11121 1111
Q ss_pred ---hcchhhhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 812 ---VVDASLVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 812 ---~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.+.-.+........ -...+..++.+++..|+++||.+|||+++.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111100000 112366789999999999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=310.55 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=212.0
Q ss_pred cCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|...+++|+|.||.||+|+ .++|+.||||.++.... .......+|++.++.++|+||+.+++.|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999998 45899999999976542 223557889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++ .+|+..++.....++...+.+++.++++|++|+| ++.|+|||+||.|++++++|.+||+|||+|+.++.....
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 995 5999999988888999999999999999999999 666999999999999999999999999999999766654
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-h--cCCc---hhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-S--LPRG---LTEVVD 814 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~--~~~~---~~~~~~ 814 (870)
.... +.|..|.|||.+.+ +.|+...|+||.|||+.||+.|.+-|.+.. ...++..+... . .++. +..+-|
T Consensus 158 ~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 QTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcccCcccccccc
Confidence 4433 67899999998876 569999999999999999999987665522 22233333321 1 1122 222333
Q ss_pred hhhhcccC---cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 815 ASLVREVQ---PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 815 ~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
....+... ...-...+...+.+++.+++..||.+|++++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 22222111 111123356678999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=373.99 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=217.3
Q ss_pred cCCCCCCeeccccceeEEEEEec--CCc----EEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF--DGT----NVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
...+..+.||+|+||.||.|... +|. .||+|.+++.. .+...+|.+|+.+|+.++|||||+++|.+.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34556678999999999999854 343 48999887654 456788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 658 LVLEFMPNGSLEKWLYSH------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
|++|||+||+|..|+++. ...++....+.++.|||+|+.||++ +++|||||.++|+|+++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999977 6679999999999999999999994 4599999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLT 810 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 810 (870)
|+.+-..+.+.......-+..|||||.+..+.++.|+|||||||++||++| |..||....+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----------------- 911 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----------------- 911 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-----------------
Confidence 996544444443333345689999999999999999999999999999999 88888763221
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
+++...+. ..+...+..|+..++++|..||+.+|++||++..+++.+.++.+...
T Consensus 912 ~v~~~~~~--ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 912 EVLLDVLE--GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHHh--CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11111111 11334556789999999999999999999999999999999887654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=351.61 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=205.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC-
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL- 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~- 653 (870)
..++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 457899999999999999999974 235689999987543 23446788999999999 899999999988754
Q ss_pred CeeEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHN--------------------------------------------------------- 676 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 676 (870)
+..++||||+++|+|.+++...+
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45789999999999999987432
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccc
Q 002892 677 ----YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752 (870)
Q Consensus 677 ----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~ 752 (870)
..+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||++................+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23778889999999999999999 67799999999999999999999999999986543322222233446788
Q ss_pred cCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHH
Q 002892 753 YMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCL 831 (870)
Q Consensus 753 y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (870)
|+|||++.+..++.++|||||||++|||++ |..||......+. ...... +... ...+..++
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~-----------~~~~------~~~~~~~~ 303 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLK-----------DGTR------MRAPENAT 303 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHh-----------cCCC------CCCCCCCC
Confidence 999999999999999999999999999997 9999876322111 111000 0000 00011234
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 832 LRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 832 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
..+.+++.+||+.+|++||++.|+++.|+++.+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 578899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.91 Aligned_cols=276 Identities=25% Similarity=0.352 Sum_probs=216.6
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHh--cCCCceeEEeeeeeeCC----eeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRN--VRHRNLIKIFSSCCNLD----FKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~ 657 (870)
....+..+++|+|.||.||+|++. ++.||||+|... ..+.|..|-++++. ++|+||++++++-.... ...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345677889999999999999976 489999999754 44567777777765 58999999998865444 778
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS------HSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
+|+||++.|+|.+|+..+. ++|.+..+|+..+++||+|||+. ++++|+|||||++|||+..|+++.|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999999776 79999999999999999999964 578899999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCC-c-----CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGI-I-----SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL 805 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~-----~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 805 (870)
|..+............+||.+|||||++.+.. . -.+.||||+|.++|||+++...++....+++++..-.....
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99886555555555678999999999997653 1 13699999999999999988766532334444444333334
Q ss_pred CCchhhhcchhhhccc----CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 806 PRGLTEVVDASLVREV----QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
.+.+.++-+-.+.++. ...+.....+.-+.+.+..||.+||+.|.|+.=|-+++.++...
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 4444443333333332 23333344567788999999999999999999999988887654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.76 Aligned_cols=268 Identities=27% Similarity=0.460 Sum_probs=224.2
Q ss_pred ccchhHHHHhhc---------CCCCCCeeccccceeEEEEEec----CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcC
Q 002892 574 RTSYLDIQQATD---------GFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVR 639 (870)
Q Consensus 574 ~~~~~~~~~~~~---------~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~ 639 (870)
+++|+|..++.. ...+.++||.|.||+||+|+++ ....||||.++... +.+..+|..|+.+|.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 345565555433 3456789999999999999865 24569999998654 566788999999999999
Q ss_pred CCceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC
Q 002892 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD 719 (870)
Q Consensus 640 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 719 (870)
||||+++.|.........||+|||++|+|+.|++.+...+++.+...|.++||.|+.||- ..++|||||.++|||++
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVN 765 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeec
Confidence 999999999999999999999999999999999988888999999999999999999999 45599999999999999
Q ss_pred CCCceEEeccccccccCCCCCccccccccc--ccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccch
Q 002892 720 KNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 796 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~ 796 (870)
.+..+|++|||+++...++. ....+...| +.+|.|||.+..+++|.+|||||||++|||.++ |..||.++.+.+
T Consensus 766 snLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-- 842 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-- 842 (996)
T ss_pred cceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--
Confidence 99999999999999774433 222222223 679999999999999999999999999999988 999987754321
Q ss_pred HHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 797 LKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
++. ++... -+.+.+++||..+.++|+.||+.|-.+||.+.+|+..|+++..
T Consensus 843 ---------------VIk-aIe~g-yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 843 ---------------VIK-AIEQG-YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ---------------HHH-HHHhc-cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 111 11111 2345678999999999999999999999999999999999865
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.88 Aligned_cols=260 Identities=29% Similarity=0.433 Sum_probs=213.3
Q ss_pred hcCCCCCCeeccccceeEEEEEecC--C---cEEEEEEeech---hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD--G---TNVAIKVFNLQ---LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
.++....++||+|+||.||+|++.. + ..||||..+.. ......++.+|+++|++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455566899999999999998542 2 23899998752 36677899999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.++|||+|.||+|.+++++.+..++..+...++.+.|+||+||| +++++||||.++|+|++.++.+||+|||+++.-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999999988878999999999999999999999 677999999999999999999999999998754
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHH-HHhcCCchhhhc
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWI-KLSLPRGLTEVV 813 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 813 (870)
. ..........-+..|+|||.+..+.+++++|||||||++||+++ |..||.+.... ++..++ ...++-
T Consensus 313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~------ 382 (474)
T KOG0194|consen 313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRM------ 382 (474)
T ss_pred c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccC------
Confidence 2 11111212345789999999999999999999999999999999 88898764222 222222 111111
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
..+...+..+..++.+||..+|++||+|.++.+.++.+.+...
T Consensus 383 -----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 -----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111346678899999999999999999999999999987654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.90 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=206.8
Q ss_pred HhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeech----hh-HHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCC
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQ----LE-RAFRSFESECEVLRNVR-HRNLIKIFSSCCNLD 654 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 654 (870)
...+.|++.+.||+|+||.|+.|.. .+++.||+|+++.. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999985 47899999987664 11 23456678999999998 999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEecccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISK 733 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~ 733 (870)
..|+||||+.||+|.+++.. ..++.+.+..++++|++.|++|+| ++||+||||||+||+++.+ +.+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999998 555899999999999999999999 7889999999999999999 999999999999
Q ss_pred ccCCCCCcccccccccccccCCcccccCCC-cC-cccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGI-IS-PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
... ..........||+.|+|||++.+.. |+ .++||||+|+++|.|++|+.||++.... .....+....+ .+..
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-~l~~ki~~~~~--~~p~ 244 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-NLYRKIRKGEF--KIPS 244 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-HHHHHHhcCCc--cCCC
Confidence 773 1223344568999999999999877 75 7999999999999999999999872111 11111000000 0000
Q ss_pred hcchhhhcccCcchHHHHH-HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 812 VVDASLVREVQPSYAKMDC-LLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
.. ...+..++.+|+..+|.+|+++.+|+ .-.-++
T Consensus 245 -----------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 245 -----------------YLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred -----------------CcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 11 34688999999999999999999998 444443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.37 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=205.8
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.+...+....++-+|+|+-|.||.|+++ ++.||||.++. .-+.+++-+++++||||+.+.|+|......+||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 3344455556778999999999999976 68899997642 234578889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
||||..|-|...++..+. +.......|..+||.|+.||| .+.|||||||.-||||..+..|||+|||-++...+.
T Consensus 191 MEfCa~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred eeccccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 999999999999987655 788889999999999999999 666999999999999999999999999999866332
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.+.-.+.||..|||||++...+.+.|.|||||||++|||+||..||.+.-.... .| .+..
T Consensus 266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---Iw---------------GVGs 325 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IW---------------GVGS 325 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---EE---------------eccC
Confidence 344457899999999999999999999999999999999999999976311100 00 0000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
..--..-+..|++.+.-+++.||+..|..||++.+++..|+-..
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 00011224468889999999999999999999999999887443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=330.33 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=208.2
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..|+..+.||+|+||.||+|.. +.++.||+|++.... +.....+++|+.++.+++++||.++|+.+.....++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577789999999999999985 478999999998765 34567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
|.||++.+.++.... +++..+..+++++..|+.||| .++.+|||||+.||++..+|.||++|||.+..+.... .
T Consensus 93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--K 166 (467)
T ss_pred hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh--h
Confidence 999999999986553 488889999999999999999 6679999999999999999999999999998775433 2
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
....++||+.|||||++....|+.|+||||+|++.+||.+|.+|+....+... .. .+|. ...
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lf----lIpk------------~~P 228 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LF----LIPK------------SAP 228 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EE----eccC------------CCC
Confidence 33567899999999999988999999999999999999999999977543111 00 0111 111
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+.... .+...+.+++..|+..+|+.||+++++++.
T Consensus 229 P~L~~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDG-DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred Ccccc-ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11111 445568999999999999999999999763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=332.77 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=206.9
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+.. +...+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888899999999999999854 68899999997654 4456779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+.| +|..++...+. +++..+..++.+++.||.||| +.+|.|||+||.||+++..|++|++|||+|+.++. ..
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 9977 99999987665 999999999999999999999 77799999999999999999999999999998754 34
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
...+...|||.|||||...+++|+..+|.||+||++||+++|++||... .+.+.++ .......
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~------------~I~~d~v 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVK------------SILKDPV 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHH------------HHhcCCC
Confidence 4556678999999999999999999999999999999999999999641 1122221 1111111
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. +......+..++...+..||.+|.+-.+++.
T Consensus 218 ~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 KP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CC---cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11 1134556888999999999999999888764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.95 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=199.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|+.+.+||+|+||.||+|+.+ +|+.+|+|++++.. ..+....+.|-.+|....+|.||+++..|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 578999999999999999999854 69999999998875 45566788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC--
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE-- 737 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~-- 737 (870)
|||++||++..++...+. +++.....++.+++.|++.+| +.|+|||||||+|+|+|..|++||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999987765 899999999999999999999 77799999999999999999999999999853211
Q ss_pred --------------------CCCc----ccc-------------------cccccccccCCcccccCCCcCcccchHhHH
Q 002892 738 --------------------DDDS----VTQ-------------------TMTMATIGYMAPEYASDGIISPKCDVYSYG 774 (870)
Q Consensus 738 --------------------~~~~----~~~-------------------~~~~g~~~y~aPE~~~~~~~~~~sDvwslG 774 (870)
.+.. ... ...+|||.|+|||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 000 134699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC
Q 002892 775 VLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC 851 (870)
Q Consensus 775 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 851 (870)
||+|||+.|-+||....+.+ ....+ +.....- ..+....+..++.++|.+|+. ||++|..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~-T~rkI------------~nwr~~l---~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQE-TYRKI------------VNWRETL---KFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHH-HHHHH------------HHHhhhc---cCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999998643222 11111 1111000 011112234678999999999 9999985
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.56 Aligned_cols=266 Identities=25% Similarity=0.420 Sum_probs=214.2
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHh--cCCCceeEEeeeeeeC----CeeEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRN--VRHRNLIKIFSSCCNL----DFKAL 658 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~~~~l 658 (870)
.+.+..+.||+|.||+||+|.|+ |+.||||+|....+ +.+.+|.++++. ++|+||..+++.-..+ .++++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 45777899999999999999987 89999999975543 446667777765 4999999999876433 36789
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH-----SHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
|++|++.|+|.||+.... ++....++++..+|.||+|||. ++++.|+|||||++||++..++.+.|+|+|+|.
T Consensus 287 vTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999999998744 8999999999999999999994 467889999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccccCCcccccCCC----c--CcccchHhHHHHHHHHHhC----------CCCCCccccccc
Q 002892 734 LLGEDDDS--VTQTMTMATIGYMAPEYASDGI----I--SPKCDVYSYGVLLMETFTR----------KKPTDEMFTGEM 795 (870)
Q Consensus 734 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~----~--~~~sDvwslG~il~elltg----------~~p~~~~~~~~~ 795 (870)
........ ......+||.+|||||++.... + -..+||||||.++||+..+ +.||.+..+.+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 77554332 2345678999999999996542 1 2369999999999999764 367776655554
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
+..+..+ -+-.+.+......++...++...+.++|++||..+|..|.|+-.+.+.|.++.+
T Consensus 445 s~eeMrk--------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEMRK--------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHhc--------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 4333211 122344445556677778889999999999999999999999999999999874
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=302.63 Aligned_cols=268 Identities=21% Similarity=0.259 Sum_probs=214.6
Q ss_pred HHHHhhcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC----
Q 002892 579 DIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL---- 653 (870)
Q Consensus 579 ~~~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 653 (870)
++....++|++.+.+|+|+|+.||.++ ..+++.||+|++.....+......+|++..++++|||+++++++...+
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 344566899999999999999999998 567899999999888777778899999999999999999999887443
Q ss_pred -CeeEEEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecc
Q 002892 654 -DFKALVLEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 654 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
...|++++|+..|+|.+.++. .+..+++.++++|+.++++||++||+.. .+++||||||.||++.+++.+++.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 358999999999999999883 3557999999999999999999999543 35999999999999999999999999
Q ss_pred ccccccCCCCCcc-------cccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHH
Q 002892 730 GISKLLGEDDDSV-------TQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH 799 (870)
Q Consensus 730 g~a~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~ 799 (870)
|.++...-..... .......|.-|.|||.+. +...+.++|||||||++|+|+.|..||+.....+.++.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 9998653221111 123445789999999885 456788999999999999999999999865443332222
Q ss_pred HHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 800 WIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
. +....+...... ..+..+.+++.+|++.||.+||++.+++..++.+.
T Consensus 254 A-----------v~n~q~s~P~~~-----~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 A-----------VQNAQISIPNSS-----RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred e-----------eeccccccCCCC-----CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1 111111111111 13567899999999999999999999999998764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.30 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=199.6
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeee----CCeeEEEEecC
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCN----LDFKALVLEFM 663 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 663 (870)
..||+|++|.||+|.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999997 689999999876532 225678899999999999999999999876 34678999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
++|+|.+++...+ .+++.....++.+++.|++|||+. .+++||||||+||++++++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 9999999998654 489999999999999999999942 358899999999999999999999999988653221
Q ss_pred ccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 744 QTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.. ...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~~~~~i~~----------------~~~ 239 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-EIYDLIIN----------------KNN 239 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh----------------cCC
Confidence 23457889999999976 67899999999999999999999999763211 11111100 000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
... .+..++..+.+++.+||+.||++||+++|+++.|+.+..
T Consensus 240 ~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLK-LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCC-CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000 011346679999999999999999999999999998764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.02 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=209.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe-eEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF-KALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv 659 (870)
.++|..++.+|+|+||.++.++.+ ++..||+|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367899999999999999999855 67899999987653 3444578899999999999999999999999888 9999
Q ss_pred EecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 660 LEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
|+|++||++.+.+...+ ..+++..+.+|+.|++.|+.||| ++.|+|||||+.||+++.++.|+|+|||+|+.++..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998554 77999999999999999999999 555999999999999999999999999999988654
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
. ......+||+.|++||.+.+.+|..|+|+||+||++|||++-+++|... +. ...+.+...
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-~m----------------~~Li~ki~~ 220 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-NM----------------SELILKINR 220 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-ch----------------HHHHHHHhh
Confidence 4 2344567999999999999999999999999999999999999999762 11 111111111
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.... +.+..+..++..++..|++.+|+.||++.+++.+
T Consensus 221 ~~~~--Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLYS--PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCC--CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111 1122345678999999999999999999999876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=301.19 Aligned_cols=198 Identities=29% Similarity=0.413 Sum_probs=179.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|+..+.+|.|+||.|.+++.+ +|..+|+|++++.. -.+.+....|..+++.+.||.++++++.+.+.+..|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356888999999999999999965 68899999998764 23456678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||++||-|.+++++.++ +++....-+|.||+.|++||| +.+|++||+||+|||+|++|.+||+|||+|..+..
T Consensus 123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999999998765 899999999999999999999 67799999999999999999999999999997732
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~ 790 (870)
..-..+|||.|+|||++.++.+..++|.|+||+++|||+.|.+||...
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 233457999999999999999999999999999999999999999763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=342.88 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=204.5
Q ss_pred hcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 655 (870)
.++|++.+.||+|+||.||+|++ +++..||||+++... ....+.+.+|+++++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45789999999999999999973 245689999986543 33446788999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcC-----------------------------------------------------------
Q 002892 656 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 676 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 676 (870)
.++||||+++|+|.++++..+
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999987432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 677 ---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 677 ---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
..+++..+.+++.||+.|++||| +++|+||||||+||+++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 24788899999999999999999 677999999999999999999999999999866433322
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....+.......
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~------------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRM------------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccC-------------
Confidence 22223345678999999999999999999999999999998 888886532211 111111111000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
. .+...+.++.+++.+||+.+|++||+++||++.|++.
T Consensus 337 ~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 L----SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 0011245788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.47 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=202.8
Q ss_pred hcCCCCCCeeccccceeEEEEEecC-----------------CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD-----------------GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 645 (870)
.++|++.+.||+|+||.||+|.+++ +..||+|++.... ......+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 3369999987643 334567899999999999999999
Q ss_pred EeeeeeeCCeeEEEEecCCCCCHHHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 002892 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHN------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707 (870)
Q Consensus 646 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~iv 707 (870)
+++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.|++.|++||| +.+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 9999999999999999999999999986431 24678899999999999999999 66799
Q ss_pred ecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh--CCC
Q 002892 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT--RKK 785 (870)
Q Consensus 708 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~ 785 (870)
||||||+||++++++.+||+|||++................++..|+|||++..+.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986643332222333446788999999988899999999999999999987 556
Q ss_pred CCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 786 PTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 786 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
||...... .................. ...+..++..+.+++.+||+.+|++||++.+|.+.|++
T Consensus 241 p~~~~~~~--~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE--QVIENAGEFFRDQGRQVY----------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH--HHHHHHHHHhhhcccccc----------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 77653211 111111110000000000 00111345678999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=314.09 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=208.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
...+|++.+.+|+|.||.|-+|.. ..|+.||||.++++. +++.-.+++|+++|+.++||||+.+++.|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345788899999999999999984 689999999998764 4556678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||..+|.|+||+..++. +++.+...+++||..|+.|+| +++++|||+|.+|||+|.++++||+|||++..+...
T Consensus 131 vMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999987765 999999999999999999999 777999999999999999999999999999887433
Q ss_pred CCcccccccccccccCCcccccCCCcC-cccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIIS-PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
...+.++|++-|.+||+..+.+|. +..|-||+|+++|.+..|..||++. +....+.+ .-
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk~lvrQ----------------Is 266 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHKRLVRQ----------------IS 266 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-hHHHHHHH----------------hh
Confidence 345667899999999999999885 8999999999999999999999872 11111111 11
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
...+.+. +-+....-+|++|+..+|++|.|+.+|...
T Consensus 267 ~GaYrEP----~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 267 RGAYREP----ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cccccCC----CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1111111 113356678999999999999999998754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=325.55 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=216.7
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
....+.++||+|.||.|.++..+.+..||||.++.... ....+|.+|+++|.+++||||+++++.|..++..++++||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 34667889999999999999988889999999987754 44588999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 664 PNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++|+|.+|+.++..+ .....-.+|+.||+.|++||. +-.+||||+.++|+|+++++++||+|||+++-+-..+...
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999977433 356677789999999999999 5559999999999999999999999999999766666666
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh--CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT--RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.+...+-+.+|||||.+.-+++|.+||||+||+++||+++ .+.||.+..+... . +...++++..-...
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--v--------en~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--V--------ENAGEFFRDQGRQV 764 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--H--------HhhhhhcCCCCcce
Confidence 6666777899999999999999999999999999999876 7788876433211 1 11111222111111
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
+ ...+.-|+..++++|..||+.+-++||++.++...|.+.
T Consensus 765 ~--l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 V--LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred e--ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 112345788999999999999999999999999888764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.88 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=205.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... ......+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457889999999999999999753 35689999987653 2334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++|+|.+++......+++..++.++.|++.|++||| +++++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999876666899999999999999999999 666999999999999999999999999987654221
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. .......++..|+|||.+.+..++.++|||||||++||+++ |..||...... .....+.. . .
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~-----------~-~ 225 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED-----------G-F 225 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC-----------C-C
Confidence 11 11112235678999999999999999999999999999875 99998753211 11111100 0 0
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
....+..++..+.+++..||+.+|++||++.+|.+.|+++
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011223566789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.50 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=205.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 654 (870)
..++|++.+.||+|+||.||+|.+. ++..||+|+++... ......+.+|+++++.+ +|+||+++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457999999999999999998742 34579999997543 33456688999999999 8999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcC----------------------------------------------------------
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 676 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 676 (870)
..++||||+++|+|.++++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 677 -----------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 677 -----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
..+++..+.+++.|++.||+||| ++||+||||||+||++++++.+||+|||++.............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 24788899999999999999999 6779999999999999999999999999997654332222222
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....... ............. .
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~-------------~-- 336 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMS-------------R-- 336 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCcc-------------C--
Confidence 2345678999999998999999999999999999997 999987532211 1111111000000 0
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 337 --~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 --PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0012356889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=330.29 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=206.2
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.+-|+..+.||+|+.|.|..|++ .+|+.+|||++.+.. ......+++|+-+|+.+.|||++++++.|....++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35688889999999999999994 589999999997652 23346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
.||++||-|.+++-.++. +++.+..++++||+.|+.|+|..+ |+|||+||+|+++|..+.+||+|||+|..-..
T Consensus 91 lEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-- 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-- 164 (786)
T ss_pred EEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence 999999999999987665 889999999999999999999555 99999999999999999999999999986432
Q ss_pred CcccccccccccccCCcccccCCCcC-cccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIIS-PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.......+|+|+|+|||++.+.+|. .++||||.|||+|.|+||+.||++. .+.... .+-..
T Consensus 165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LL------------lKV~~ 226 (786)
T KOG0588|consen 165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLL------------LKVQR 226 (786)
T ss_pred -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHH------------HHHHc
Confidence 2334556899999999999998875 7999999999999999999999851 121111 11111
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+. -+...+.++.+++.+|+..||++|.|+.||.+.
T Consensus 227 G~f~---MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 227 GVFE---MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred Cccc---CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1000 112345678999999999999999999999764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=327.10 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=218.8
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec---CC--cEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF---DG--TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
.+...+..+..++||.|.||.||+|... .| -.||||..+.+. ....+.|.+|+.+|++++||||++++|.|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 3344455566789999999999999832 23 358999988743 4557789999999999999999999999976
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
...++|||.++-|-|..|++.++..++......++.||+.||+||| ++.+|||||.++||++.+...||++|||+++
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhh
Confidence 4679999999999999999998888999999999999999999999 7779999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
.+..+..+... ...-++.|||||.+.-..++.+||||.||+++||++. |..||.+..+.+-
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------- 601 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------- 601 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------
Confidence 88655544333 3345788999999999999999999999999999987 9999987544321
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
+.. ....++.+-+..||..++.+|.+||..+|.+||.+.++...|.++.+
T Consensus 602 I~~--iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGH--IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEE--ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111 11223344556799999999999999999999999999999998876
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.91 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=207.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCc----EEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGT----NVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.+|+..+.||+|+||.||+|++. +++ .||+|+++... ....+++..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999854 343 38999986543 34456788999999999999999999998764 5679
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
++||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999977667899999999999999999999 677999999999999999999999999999876543
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||++.... ....+.....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~------------ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE------------ 228 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCC------------
Confidence 33222223335678999999999999999999999999999998 99998753211 1111111000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
....+..++..+.+++.+||+.+|++||++.+++..+.++.++.
T Consensus 229 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00001123456889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=326.00 Aligned_cols=257 Identities=27% Similarity=0.484 Sum_probs=207.5
Q ss_pred hcCCCCCCeeccccceeEEEEEecC------CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD------GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578899999999999999998542 2579999986543 33456789999999999999999999999998999
Q ss_pred EEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC
Q 002892 657 ALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN 721 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 721 (870)
+++|||+++++|.+++.... ..+++.++..++.|++.|++||| +++++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 99999999999999997531 34788999999999999999999 6679999999999999999
Q ss_pred CceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHH
Q 002892 722 MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHW 800 (870)
Q Consensus 722 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~ 800 (870)
+.++|+|||++................+++.|+|||.+.++.++.++|||||||++|||++ |..||...... .....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 9999999999986543333333334456889999999988899999999999999999998 99998753221 11111
Q ss_pred HHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
+... .....+..++.++.+++.+||+.+|++||++.||++.|+++
T Consensus 239 i~~~-----------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRSR-----------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcC-----------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1100 00011234567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=325.88 Aligned_cols=249 Identities=34% Similarity=0.560 Sum_probs=195.1
Q ss_pred CCCeeccccceeEEEEEec-----CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 589 ECNLLGAGSFGSVYKGTLF-----DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 589 ~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..+.||+|+||.||+|.+. .+..|+||+++... ....+.+.+|++.+++++||||+++++++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999976 35679999996543 34478899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++|+|.+++... ...+++..+.+|+.||++||+||| +++++||||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999976 666999999999999999999999 556999999999999999999999999999876433333
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
...........|+|||.+....++.++||||||+++||+++ |+.||... .. ..+..... ..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~-~~~~~~~~----------------~~ 221 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DN-EEIIEKLK----------------QG 221 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CH-HHHHHHHH----------------TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-cc-cccccccc----------------cc
Confidence 33344557789999999999889999999999999999999 67888653 11 11111000 00
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
.....+..++..+.+++..||+.+|++||++.+++++|
T Consensus 222 -~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 -QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00111123456789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.62 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=210.9
Q ss_pred hcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
+++|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46788999999999999999974 234568999987766666678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceE
Q 002892 658 LVLEFMPNGSLEKWLYSHN------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR 725 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 725 (870)
+||||+++++|.+++...+ ..+++..+..++.|++.|++||| ++|++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 9999999999999997432 24899999999999999999999 67799999999999999999999
Q ss_pred EeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHh
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 804 (870)
|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......+ ....+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~- 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ- 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-
Confidence 999999986643322222233345778999999998889999999999999999998 888886532211 1111100
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
... .. ....++..+.+++.+||+.+|++||++.+|.+.|+++.+...
T Consensus 238 --~~~------------~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 238 --GRV------------LQ--RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred --CCc------------CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 000 00 001224468999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=336.10 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=206.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 654 (870)
..++|++.++||+|+||.||+|+.. .+..||||+++... ....+.+..|+++++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568999999999999999999853 13469999997543 334567899999999996 999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcC----------------------------------------------------------
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 676 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 676 (870)
..|+||||+++|+|.+++...+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC
Q 002892 677 -------------------------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD 719 (870)
Q Consensus 677 -------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 719 (870)
..+++..+..++.|++.|++||| +.+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 23778888999999999999999 66799999999999999
Q ss_pred CCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHH
Q 002892 720 KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLK 798 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~ 798 (870)
+++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||........ ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HH
Confidence 999999999999986643332222333456788999999998899999999999999999997 8899865322111 11
Q ss_pred HHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 799 HWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
..+.... .......++..+.+++.+||+.+|++||++.+|.+.|+++.+
T Consensus 351 ~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NKIKSGY-----------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHhcCC-----------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1110000 000112345678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.24 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=206.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 658 (870)
.++|+.+.+|++|.||.||+|+++ +++.||+|+++.+.+ ..-....+|+.++.+.+|||||.+.+.... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356788899999999999999954 789999999976542 223346789999999999999999988764 457899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
|||||+. +|.+.+..-+..+...++..++.|+++|++||| ...|+|||+|++|+|+...|.+||+|||+|+.++.+
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999965 999999988888999999999999999999999 555999999999999999999999999999998654
Q ss_pred CCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH-HhcCCc--hhhhcc
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK-LSLPRG--LTEVVD 814 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~ 814 (870)
....+..+.|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+.... .++..+.. ...|.. +..+..
T Consensus 231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCccccCCCccc
Confidence 3345666789999999988764 5899999999999999999999888763322 23333332 222322 221111
Q ss_pred hhhhc---ccCc-------chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVR---EVQP-------SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~---~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....+ .... .+........-++++...+..||.+|-|+.|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11110 0000 1111112356789999999999999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.39 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=205.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999965 68899999987653 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++.... .+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999999998654 389999999999999999999942 35999999999999999999999999998765322
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-------------
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG------------- 808 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 808 (870)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...........
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCcccc
Confidence 12234689999999999999999999999999999999999999965321 11111111100000
Q ss_pred ------------------hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 809 ------------------LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 809 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+..+... ....+.......+..+.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIV-NEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHH-hCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000011000 0000111111235578999999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.28 Aligned_cols=257 Identities=24% Similarity=0.420 Sum_probs=207.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.++|++.+.||+|+||.||+|.+. +...||+|+++... ......+..|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357889999999999999999864 24579999987543 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
+|||+++++|.+++......+++..+.+++.|++.|++||| +.+|+||||+|+||++++++.++++|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999876667899999999999999999999 677999999999999999999999999999877422
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ............
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~---------- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYRL---------- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC----------
Confidence 22222222335678999999998899999999999999999998 99998653211 111111100000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
..+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00113455789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.19 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=198.1
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--------------HHHHHHHHHHHHHHhcCCCceeEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--------------RAFRSFESECEVLRNVRHRNLIKI 646 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~ 646 (870)
...+.|++.+.||+|.||.|-+|+.. +++.||+|++.+... ...+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45678999999999999999999954 799999999976431 112478899999999999999999
Q ss_pred eeeeee--CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCce
Q 002892 647 FSSCCN--LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA 724 (870)
Q Consensus 647 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 724 (870)
+++..+ .+..|+|+|||..|.+... ......+++.+.+++++++..||+||| .+||+||||||+|+|++++|+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 999875 5688999999998876432 222222899999999999999999999 6779999999999999999999
Q ss_pred EEeccccccccCCCCC---cccccccccccccCCcccccCCC----cCcccchHhHHHHHHHHHhCCCCCCccccccchH
Q 002892 725 RVSDFGISKLLGEDDD---SVTQTMTMATIGYMAPEYASDGI----ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL 797 (870)
Q Consensus 725 kl~Dfg~a~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~ 797 (870)
||+|||.+..+..... .......+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||-+.+.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----- 324 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----- 324 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-----
Confidence 9999999987632211 12233468999999999887632 45689999999999999999999865211
Q ss_pred HHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 798 KHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
.+.+++.+..... -....+....+.+++++++..||++|.+..+|....
T Consensus 325 ------------~~l~~KIvn~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 ------------LELFDKIVNDPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ------------HHHHHHHhcCccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1112221111110 001113455789999999999999999999987543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=318.92 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=202.2
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
++|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688889999999999999998888899999886443 223568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+|+|.+++......+++..+..++.|++.|++||| +++++||||+|+||++++++.+|++|||.+........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 99999999865556899999999999999999999 66699999999999999999999999999876532221 112
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+...... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~-------------~-- 221 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRL-------------Y-- 221 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCC-------------C--
Confidence 22335678999999988889999999999999999999 8889865211 1111111110000 0
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
.+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 222 --~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 --RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0011234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.53 Aligned_cols=249 Identities=23% Similarity=0.286 Sum_probs=198.8
Q ss_pred CCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 587 FNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|++++++++|++++++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999985 478999999987543 22234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++|+|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999999888643 345899999999999999999999 6779999999999999999999999999998653222
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ...+.. .+....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~-------------~~~~~~ 221 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDR-------------RVKEDQ 221 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHH-------------Hhhccc
Confidence 12334689999999999999999999999999999999999999976322111 011100 000000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
.. .....+..+.+++.+||+.+|++||+ ++++++
T Consensus 222 ~~--~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EE--YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cc--CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00 00122446889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.68 Aligned_cols=244 Identities=25% Similarity=0.330 Sum_probs=202.5
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCee
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 656 (870)
...++|+..++||+|.||+|++|..+ +++.||||++++.. ..+......|.+++... +||.+++++.+|+..++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999966 68899999998875 34556677888888777 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
|+||||+.||++..+. ....+++..+.-++..|+.||+||| .+||||||||.+|||+|.+|++||+|||+++.--
T Consensus 445 ~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999943333 3344899999999999999999999 7779999999999999999999999999998542
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
......+.+.|||.|+|||++.+..|+.+.|.|||||++|||+.|+.||.+. .+ ++++|..
T Consensus 520 --~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dE---------------ee~FdsI 580 (694)
T KOG0694|consen 520 --GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DE---------------EEVFDSI 580 (694)
T ss_pred --CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CH---------------HHHHHHH
Confidence 2333566789999999999999999999999999999999999999999862 11 2333333
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
+..++ ..+..++.+...|++..+..+|++|.-+
T Consensus 581 ~~d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCCC---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 33222 1122456688999999999999999966
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=326.70 Aligned_cols=268 Identities=21% Similarity=0.308 Sum_probs=201.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999965 689999999875432 223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++ +++.+++......+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 995 6888888776666899999999999999999999 6779999999999999999999999999987543221
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc--hhhh-----
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPRG--LTEV----- 812 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~----- 812 (870)
.......+++.|+|||++.+ ..++.++||||+||++|||++|..||.+..+....+....... .+.. +...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12233467899999998865 4578899999999999999999999986433222222222110 0100 0000
Q ss_pred cchhhhc-----ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLVR-----EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.++.... .....+........+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 00000011112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.16 Aligned_cols=245 Identities=25% Similarity=0.312 Sum_probs=199.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999965 68999999987543 234466889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999998654 4889999999999999999999 677999999999999999999999999999865322
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...... ......... .. .
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~i~~~------------~~--~ 216 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GIYEKILAG------------KL--E 216 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC------------Cc--C
Confidence 12245899999999999988999999999999999999999999753211 101110000 00 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVVK 858 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 858 (870)
. +......+.+++.+|++.||++||+ +.|+++.
T Consensus 217 ~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 F-----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C-----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 0012346889999999999999995 8887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.73 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=203.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCc----EEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGT----NVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
++|++.+.||+|+||+||+|.+. +++ .+++|.+.... .....++..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 57888999999999999999864 444 47777775432 2345678888889999999999999998754 45688
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
++||+++|+|.+++...+..+++..+..++.|++.|++||| +++++||||||+||++++++.+||+|||.+......
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999876667999999999999999999999 667999999999999999999999999999866433
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
..........++..|+|||+..++.++.++||||||+++||+++ |+.||.+.... ....+.......
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~---------- 230 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGERL---------- 230 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCcC----------
Confidence 32222334456788999999998899999999999999999998 99998653211 111111100000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++..+.+++..||..+|++||++.|+++.|..+.++
T Consensus 231 -------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 -------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00111344678899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=330.80 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=203.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+..|++++.+++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 58999999997653 233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997654 4889999999999999999999 66799999999999999999999999999976532
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......||+.|+|||++.+..++.++||||+||++|||++|..||......+ ....... ... .....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~--~~~----~~~~~---- 220 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKY--WKE----TLQRP---- 220 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHh--ccc----cccCC----
Confidence 2233468999999999999999999999999999999999999997532111 1111100 000 00000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
........++..+.+++.+|+..+|++||++.++++.
T Consensus 221 -~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 -VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=338.95 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=209.5
Q ss_pred hcCCCCCCeeccccceeEEEEEecCC-cEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeee-eee------CC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDG-TNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSS-CCN------LD 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~------~~ 654 (870)
..++++.++|.+|||+.||.|+...+ ..||+|++-...+...+.+.+|+++|++|+ |+|||.+++. ... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45667788999999999999997655 999999988888888899999999999997 9999999993 321 23
Q ss_pred eeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
+.+|.||||.||.|-|++..+ ...+++.++++|+.|+++|+++||.. +.+|||||||-+|||+..+|..||||||.|+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 567999999999999999843 33499999999999999999999965 5779999999999999999999999999997
Q ss_pred ccCCCCCccc-------ccccccccccCCcccc---cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 002892 734 LLGEDDDSVT-------QTMTMATIGYMAPEYA---SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803 (870)
Q Consensus 734 ~~~~~~~~~~-------~~~~~g~~~y~aPE~~---~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 803 (870)
-.-....... .-....|+.|+|||++ .+...+.|+|||++||++|-|+....||++...-.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--------- 265 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--------- 265 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence 4422221111 1134578999999987 46789999999999999999999999998731111
Q ss_pred hcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 804 SLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
+++..... +....+...+..||..||+++|.+||++.+|++.+-++..+
T Consensus 266 --------Ilng~Y~~-----P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 --------ILNGNYSF-----PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------EEeccccC-----CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11111000 01124567899999999999999999999999999988765
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.19 Aligned_cols=245 Identities=25% Similarity=0.291 Sum_probs=199.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367889999999999999999965 68999999997643 23446788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999998654 3789999999999999999999 6779999999999999999999999999998663322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
....|++.|+|||++.+..++.++|||||||++|||++|..||..... ........ .....
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~--------~~~~~- 233 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKIL--------AGRLK- 233 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHh--------cCCcC-
Confidence 224689999999999999999999999999999999999999965211 11111000 00000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
. + .....++.+++.+||+.||++||+ +.+++.
T Consensus 234 -~-p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 -F-P----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -C-C----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 0 012346789999999999999997 577764
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.30 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=209.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
..+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 346788899999999999999742 35568999987666666678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC
Q 002892 658 LVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 722 (870)
+||||+++++|.+++...+ ..+++..+++++.|++.|++||| +++++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence 9999999999999997432 34789999999999999999999 67799999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHH
Q 002892 723 TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWI 801 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 801 (870)
.++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECI 238 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 999999999976543332222334456788999999998999999999999999999999 999986532211 11111
Q ss_pred HHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 802 KLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
.. ..... ....++..+.+++.+||+.+|++||++.+|++.|+++.+.
T Consensus 239 ~~---~~~~~--------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQ---GRVLE--------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hC---CCCCC--------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 00 00000 0112345788999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.37 Aligned_cols=241 Identities=26% Similarity=0.292 Sum_probs=194.7
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999997643 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccc
Q 002892 667 SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM 746 (870)
Q Consensus 667 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 746 (870)
+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence 9999987654 4899999999999999999999 677999999999999999999999999998753211 112234
Q ss_pred cccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchH
Q 002892 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826 (870)
Q Consensus 747 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (870)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+. ... . ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~---~~~--------~--~~----- 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELIL---MEE--------I--RF----- 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHHHH---cCC--------C--CC-----
Confidence 5689999999999999999999999999999999999999965211 11111110 000 0 00
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 827 KMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 827 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
+...+..+.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 012245688999999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.75 Aligned_cols=267 Identities=20% Similarity=0.305 Sum_probs=201.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357999999999999999999865 68999999986543 2233467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++ +|.+++...+..+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 9975 999999876666899999999999999999999 67799999999999999999999999999876532221
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcC--Cchhhhcchh-
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLP--RGLTEVVDAS- 816 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~- 816 (870)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+...... ..+ +.+..+.+..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchh
Confidence 2233457899999998865 568899999999999999999999997532211 11111111 001 1111111100
Q ss_pred ----hhcccCc-ch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 ----LVREVQP-SY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ----~~~~~~~-~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....... .. ........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 00 00112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.30 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=197.9
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-----eeEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-----FKALV 659 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 659 (870)
.|+..+++|+|+||.||+|... +++.||||....+.+ .-.+|+++|+.++|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5677889999999999999954 679999998765432 2346899999999999999998885422 33489
Q ss_pred EecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEecccccccc
Q 002892 660 LEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLL 735 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~ 735 (870)
|||++. +|.++++. .+..++...+.-+++||++|++||| +.+|+||||||.|+|+|.+ |.+||+|||.|...
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999965 89988883 3556889999999999999999999 6779999999999999987 99999999999988
Q ss_pred CCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc--hh-
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPRG--LT- 810 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~--~~- 810 (870)
........ -..|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+ ..+..++..+++. ..|.. +.
T Consensus 177 ~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHhh
Confidence 55444332 247889999998876 4699999999999999999999998876 2333445555442 22221 11
Q ss_pred ------hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 811 ------EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 811 ------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+...+.+....-.+......+.++.+++.++++.+|.+|.++.|+++
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111121111111122344668999999999999999999999874
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.39 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=198.8
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 78999999876443 34456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccc
Q 002892 669 EKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748 (870)
Q Consensus 669 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 748 (870)
.+++...+..+++..++.++.|++.||+||| +++++||||+|+||+++.++.+|++|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999876666899999999999999999999 6779999999999999999999999999987653322111112223
Q ss_pred cccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHH
Q 002892 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAK 827 (870)
Q Consensus 749 g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (870)
.+..|+|||.+.++.++.++||||+|+++|||++ |..||...... ..........+. ..+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~~-----------------~~~ 218 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVRL-----------------PCP 218 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCC-----------------CCc
Confidence 3567999999998889999999999999999998 88888643211 111111100000 011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 828 MDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 828 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
..++..+.+++.+|++.+|++||++.+|.++|++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1235578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.09 Aligned_cols=256 Identities=21% Similarity=0.400 Sum_probs=207.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..++|++.++||+|++|.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3467899999999999999999988888999998865432 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999753 455889999999999999999999 566999999999999999999999999999876432211
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......++..|+|||+..++.++.++||||||+++|+|++ |..||...... ..........+.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~------------- 223 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYRM------------- 223 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC-------------
Confidence 1222345678999999988889999999999999999998 99998652211 111111110000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
.....++..+.+++.+||..+|++||+++++.+.|+++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.81 Aligned_cols=250 Identities=23% Similarity=0.246 Sum_probs=203.1
Q ss_pred CCCCCCeeccccceeEEEEEec-C-CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-D-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.|.+.+.||+|++|.||+|... + ++.||+|............+..|+++++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999843 4 6788999876665565677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 664 PNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 664 ~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
++|+|.+++.. ....+++.++..++.|++.||+|+| +++|+||||||+||+++.++.+||+|||++..+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998863 2445889999999999999999999 67799999999999999999999999999987644332
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
........||++|+|||++.+..++.++||||+||++|||++|+.||...... .+.. ......
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~------------~~~~~~ 287 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQ------------QVLYGK 287 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH------------HHHhCC
Confidence 22334456899999999999999999999999999999999999999652111 1111 000000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+ .+..++..+.+++..||..+|++||++.+++.
T Consensus 288 ~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 YDP--FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCC--CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 01123456889999999999999999999875
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=320.02 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=210.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
...+|++.+.||+|+||.||+|...+++.+|+|++..........+..|+++++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44578899999999999999999888999999999877665667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... +..+++..+..++.|++.|++||| ++|++||||+|+||++++++.+||+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999853 445899999999999999999999 667999999999999999999999999999876432221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....++..|+|||....+.++.++||||||+++|+|++ |+.||...... ...........
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~-------------- 222 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGYR-------------- 222 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCCc--------------
Confidence 123345778999999988889999999999999999998 88998653211 11111110000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
...+..++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001123455788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.99 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=205.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.++|.+.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888899999999999999853 3478999998765443 457899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc
Q 002892 657 ALVLEFMPNGSLEKWLYSHN-------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 723 (870)
++||||+++++|.+++...+ ..+++..+..++.|++.|++||| +++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999997542 34788899999999999999999 677999999999999999999
Q ss_pred eEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHH
Q 002892 724 ARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 724 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 802 (870)
++|+|||++................+++.|+|||++.++.++.++||||+|+++|||++ |..||...... .....+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~ 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECIT 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH
Confidence 99999999976533222222233346788999999999999999999999999999998 99998653211 1111111
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
... . ...+..++..+.+++.+||+.+|++||++.||++.|++
T Consensus 239 ~~~---------------~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 QGR---------------L--LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCC---------------c--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 000 0 00011235578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.77 Aligned_cols=261 Identities=25% Similarity=0.430 Sum_probs=205.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeee-C
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCN-L 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~ 653 (870)
..++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+..|++++.++ +|+||+++++++.. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3468999999999999999999632 35789999987543 23345678899999999 79999999998864 4
Q ss_pred CeeEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHN--------------------------------------------------------- 676 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 676 (870)
...+++|||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56789999999999999986321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccccccccccc
Q 002892 677 ---YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753 (870)
Q Consensus 677 ---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y 753 (870)
..+++..+.+++.||+.|++||| +.+|+||||||+||++++++.++|+|||++..+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25789999999999999999999 677999999999999999999999999999876433322233334567789
Q ss_pred CCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHH
Q 002892 754 MAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLL 832 (870)
Q Consensus 754 ~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (870)
+|||++.+..++.++||||+||++|||++ |..||......+ ........... . ..+..++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~------------~-----~~~~~~~~ 303 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTR------------M-----RAPEYATP 303 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCC------------C-----CCCccCCH
Confidence 99999999999999999999999999998 999986532211 11111110000 0 00112345
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 833 RIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 833 ~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
++.+++.+||+.+|++||++.||++.|+++.+
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.57 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=203.0
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
++|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688889999999999999998777789999887543 223668899999999999999999999998888999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+|+|.+++......+++..++.++.|++.|++||| +++++|+||+|+||++++++.+||+|||.+........ ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 99999999876556899999999999999999999 67799999999999999999999999999876533221 122
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....++..|+|||...+..++.++||||||+++|||++ |..||...... ............
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~---------------- 220 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRL---------------- 220 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCC----------------
Confidence 22345678999999988889999999999999999998 99998653221 111111000000
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
+.....+..+.+++.+||+.+|++||++.++++.++
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000112457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.28 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=206.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..++|++.+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3467889999999999999999987788999999875432 345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997543 56899999999999999999999 66799999999999999999999999999987642221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
........+..|+|||+..+..++.++||||||+++|||++ |+.||...... . ....+....+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~-~~~~~~~~~~-------------- 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-E-VLQQVDQGYR-------------- 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-H-HHHHHHcCCC--------------
Confidence 11112223467999999998899999999999999999999 99998653211 1 1111110000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
......++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 000112345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=330.28 Aligned_cols=256 Identities=25% Similarity=0.431 Sum_probs=217.2
Q ss_pred CCCCCeeccccceeEEEEEec-CC----cEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DG----TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
.+..++||+|+||+||+|.|- .| .+||+|++.... .+...++.+|+.+|.+++|||++++++++..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 445679999999999999853 34 358999886554 445678999999999999999999999998766 78999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
+|++.|+|.|+++.++..+.....+.|..|||+|+.||| .+++|||||.++|||+.+-..+|+.|||+++....+..
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999888999999999999999999999 66699999999999999999999999999998876665
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
........-.+.|||-|.+....++.++|||||||++||++| |..||++....+. .+ +.+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------~d-----lle 914 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------PD-----LLE 914 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------------hH-----HHh
Confidence 555444456788999999999999999999999999999999 9999987433221 11 112
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..++..++..|+..++.+|.+||..|+..||+++++..++.++.++
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2233445667889999999999999999999999999999987653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.14 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=201.9
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
.+.|++.+.||+|+|+.||++.. .+|+.+|+|+++... ....+.+++|+++-+.++||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 56788889999999999999874 479999999886543 446788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~ 737 (870)
|+++|++|..-+-.+ ...++..+..+++||+.||.|+| .++|||||+||+|+++.+ ...+|++|||+|..++
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999997544433 33788899999999999999999 777999999999999954 3469999999999886
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.......+.|||+|||||++...+|+..+|||+.|+|+|-++.|..||.+.... .+.. +.+
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye---------------~I~ 225 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYE---------------QIK 225 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHH---------------HHh
Confidence 333455678999999999999999999999999999999999999999762111 1111 111
Q ss_pred hcccC-cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQ-PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+. +.........+..+++++|+..||++|.|++|.+.
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11110 01112233457889999999999999999998764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=286.86 Aligned_cols=248 Identities=25% Similarity=0.310 Sum_probs=207.7
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.+|+|.||.||.|+. +++-.||+|++.+.. .+..+++++|+++-+.++||||.+++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46789999999999999999994 467889999997654 33456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 660 LEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
+||.++|.+...++.. ...+++.....++.|+|.|+.|+| .+.|+||||||+|+|++.++.+|++|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999999843 345899999999999999999999 7779999999999999999999999999987542
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.......+||..|.|||...+..++...|+|++|++.||++.|.+||.... .......+.+..+ .+
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~-------~~---- 241 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDL-------KF---- 241 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccc-------cC----
Confidence 223344579999999999999999999999999999999999999997643 2222222222111 11
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+...+..+.+++..|+..+|.+|.+..|+++.
T Consensus 242 --------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 --------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 12334568899999999999999999998764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=313.69 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=207.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech---hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ---LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|+.. +++.||+|.++.. .......+.+|+++++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999854 7899999987542 2344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
||+++++|.+++.. ....+++..+..++.|++.|++||| +++++||||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988863 2345789999999999999999999 67799999999999999999999999999887643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. .......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||................
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 222 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-------------- 222 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc--------------
Confidence 22 11223457889999999988889999999999999999999999985422111111111110
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
...+.......+..+.+++.+||..+|++||++.+|++.+++++
T Consensus 223 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 --CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00011111234567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.36 Aligned_cols=267 Identities=21% Similarity=0.222 Sum_probs=201.6
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999975 68899999987543 2334667889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++++.+..+.. ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 999877765543 3445899999999999999999999 67799999999999999999999999999987643221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH--hcCCchhhhc--chhh
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL--SLPRGLTEVV--DASL 817 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~ 817 (870)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ ..+....... +...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccchh
Confidence 12233468999999999998889999999999999999999999997532211 11111110 1111100000 0000
Q ss_pred h----cccC--cc---hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 V----REVQ--PS---YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~----~~~~--~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. .... .. ......+..+.+++.+|++.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0000 00 001123557999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.99 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=203.9
Q ss_pred hcCCCCCCeeccccceeEEEEEe-----cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-----FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 35788889999999999999984 246789999987433 344467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC
Q 002892 658 LVLEFMPNGSLEKWLYSH----------------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN 721 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 721 (870)
+||||+++++|.+++... ...+++..+..++.|++.|++||| +++++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence 999999999999998632 124788999999999999999999 6679999999999999999
Q ss_pred CceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHH
Q 002892 722 MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHW 800 (870)
Q Consensus 722 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~ 800 (870)
+.+|++|||++................++..|+|||++.+..++.++||||||+++|||++ |..||..... ......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~ 238 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM 238 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence 9999999999986643333223333446778999999988889999999999999999998 8888865211 111111
Q ss_pred HHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
+.. ... ...+..++.++.+++.+||+.+|++||++.+|.++|++
T Consensus 239 ~~~---~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK---RQL--------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc---CCc--------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 110 000 00111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=324.40 Aligned_cols=199 Identities=25% Similarity=0.357 Sum_probs=174.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|.+. +++.+|+|++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999966 68899999887643 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++|+|.+++...+ .+++..+..++.|++.|++|||+ ..+++||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999998654 38899999999999999999994 236999999999999999999999999998755321
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~ 789 (870)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234588999999999988899999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.49 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=209.9
Q ss_pred CCCCCCeeccccceeEEEEEec--CCc--EEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF--DGT--NVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
+....++||+|.||+|++|.|. +|+ .||||.++..... ....|.+|+.+|.+|+|||++++||...+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3455688999999999999986 343 5899999876543 67899999999999999999999999987 6678999
Q ss_pred ecCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 661 EFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 661 e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|.++.|+|.+.+++ .+..+-......++.|||.|++||. ++++||||+.++|+++.....|||+|||+.+-++...
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999996 5666888899999999999999999 7779999999999999999999999999999887655
Q ss_pred Ccccc-cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 740 DSVTQ-TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 740 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
..... ....-.+.|+|||.+....++.+||||+|||++|||+| |+.||-+.... + +.+.+|
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--q------------IL~~iD--- 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--Q------------ILKNID--- 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--H------------HHHhcc---
Confidence 44333 33455778999999999999999999999999999999 88898763211 1 112223
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
..+....+..|+..++++|+.||.++|++||++..|.+.+-.
T Consensus 330 --~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 --AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred --ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 112233455789999999999999999999999999865543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.96 Aligned_cols=257 Identities=24% Similarity=0.407 Sum_probs=202.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999998743 35679999986432 2344668899999999999999999999999899
Q ss_pred eEEEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEE
Q 002892 656 KALVLEFMPNGSLEKWLYSHN---------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARV 726 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 726 (870)
.++||||+++++|.+++...+ ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999987532 23578899999999999999999 667999999999999999999999
Q ss_pred eccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhc
Q 002892 727 SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSL 805 (870)
Q Consensus 727 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 805 (870)
+|||++................+++.|+|||++.++.++.++||||||+++|||++ |..||..... +...........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCc
Confidence 99999876543322222223345788999999998899999999999999999999 6888865321 111111110000
Q ss_pred CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
+ . .+..++..+.+++.+||+.+|++||++.|+++.|++
T Consensus 240 ~----~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 L----D--------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred C----C--------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 0 011234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.84 Aligned_cols=260 Identities=24% Similarity=0.408 Sum_probs=206.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCc----EEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGT----NVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|++.+.||+|+||+||+|++. +++ .||+|+++... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888999999999999999853 444 48999986543 3445678899999999999999999999875 4568
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+++||+++|+|.+++......+++.++..++.|++.|++||| +++++||||||+||++++++.+||+|||++.....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876666899999999999999999999 67799999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
...........+++.|+|||...+..++.++|||||||++|||++ |..||+.... .....+......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~---------- 229 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGER---------- 229 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCc----------
Confidence 332222222345678999999988889999999999999999998 8888865321 111222111000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...+..++..+.+++.+||..+|++||++.++++.++++.++.
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 -------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0001123457889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=340.04 Aligned_cols=260 Identities=25% Similarity=0.313 Sum_probs=206.4
Q ss_pred hhHHHHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 577 YLDIQQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 577 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
..+.....++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+..+..++|+|++++++.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 344556678999999999999999999985 478999999986542 34456788999999999999999998776533
Q ss_pred C--------eeEEEEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC
Q 002892 654 D--------FKALVLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722 (870)
Q Consensus 654 ~--------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 722 (870)
+ ..++||||+++|+|.+++... ...+++..+..++.|++.||+|+| +++|+||||||+||++++++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCC
Confidence 2 367999999999999998743 345899999999999999999999 67799999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 002892 723 TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 802 (870)
.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~ 255 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMH 255 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHH
Confidence 999999999987643322222334568999999999999999999999999999999999999996521 111111
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
... .....+ .+..++..+.+++.+||+.+|++||++.++++.
T Consensus 256 ~~~------------~~~~~~--~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTL------------AGRYDP--LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHh------------cCCCCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 000000 011234578899999999999999999999764
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=317.64 Aligned_cols=271 Identities=27% Similarity=0.402 Sum_probs=205.8
Q ss_pred cCCCCCCeeccccceeEEEEEe-----cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-----FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 657 (870)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 2578999999977666667789999999999999999999998753 34678
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++++|.+++...+..+++..+..++.|++.||+||| .+|++||||||+||++++++.++|+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999876666899999999999999999999 66799999999999999999999999999987643
Q ss_pred CCCccc-ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC--Cchhhhcc
Q 002892 738 DDDSVT-QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP--RGLTEVVD 814 (870)
Q Consensus 738 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 814 (870)
...... .....++..|+|||+..+..++.++||||||+++|||++|..|+...... .......... .......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence 322111 11122345699999998888999999999999999999988775432110 0000000000 00000000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
.+.. .........++..+.+++.+||+.+|++|||+.||++.|++++
T Consensus 238 -~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 -LLKN-NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred -HHhc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0000 0000111234567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.91 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=202.0
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
.+|++.+.||+|+||.||+|.+++++.+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45888999999999999999988778999999865432 23567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+++|.+++......+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||.+......... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence 99999999876556899999999999999999999 667999999999999999999999999998765322211 11
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....++..|+|||...+..++.++||||||+++||+++ |+.||+.....+ ..........
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~----------------- 219 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGYR----------------- 219 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCCc-----------------
Confidence 12224567999999998899999999999999999999 788886532211 1110000000
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
...+..++.++.+++.+||..+|++||++.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000112456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.88 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=216.0
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEecC-CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.+.+....+..+..+||-|.||.||.|.|+. .-.||||.++.+ .....+|..|+.+|+.++|||+|+++|.|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3344445567778899999999999999874 567999998765 44568899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 657 ALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
|||+|||..|+|.+|+++. +...+....+.++.||+.|++||. .+.+||||+.++|+|+.++..||++|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999954 445777788999999999999999 555999999999999999999999999999999
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
..+.+.. .....-++.|.|||-+....++.|+|||+|||++||+.| |-.||.+. ++.+.+ +++.
T Consensus 416 tgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY---------~LLE 480 (1157)
T KOG4278|consen 416 TGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVY---------GLLE 480 (1157)
T ss_pred cCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHH---------HHHh
Confidence 6554433 333445788999999999999999999999999999999 66777652 222211 1111
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
+ ..+-..+..|+..++++|+.||+++|.+||+++|+-+.++.+-.
T Consensus 481 k-----gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 481 K-----GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred c-----cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1 11122344688999999999999999999999999999997754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.08 Aligned_cols=241 Identities=25% Similarity=0.301 Sum_probs=194.1
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
+.||+|+||.||+|+.. +|+.||+|+++... ......+..|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999854 68999999997653 234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccc
Q 002892 667 SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM 746 (870)
Q Consensus 667 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 746 (870)
+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence 9998887654 4899999999999999999999 6779999999999999999999999999987532211 12233
Q ss_pred cccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchH
Q 002892 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826 (870)
Q Consensus 747 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (870)
..|++.|+|||++.++.++.++|||||||++|||++|+.||..... ......... .. . ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~~~~----~~--------~--~~----- 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM----EE--------I--RF----- 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHhc----CC--------C--CC-----
Confidence 4689999999999999999999999999999999999999865211 111111100 00 0 00
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 827 KMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 827 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
+..++..+.+++.+||+.+|++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 012345688999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=301.19 Aligned_cols=268 Identities=24% Similarity=0.299 Sum_probs=206.3
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCc-eeEEeeeeeeCC-----
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRN-LIKIFSSCCNLD----- 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~----- 654 (870)
...|..+++||+|+||+||+|+. .+|+.||+|.++...+ ..-....+|+.+++.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34466677899999999999995 4789999999987644 23455688999999999999 999999998877
Q ss_pred -eeEEEEecCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 655 -FKALVLEFMPNGSLEKWLYSHN---YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 655 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
..++||||++ -+|..++...+ ...+...+..++.||++|++||| +++|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 7899999994 59999998655 45888999999999999999999 7889999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH-HhcCC-
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK-LSLPR- 807 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~- 807 (870)
+|+.++-+. ...+..++|..|.|||++.+. .|+...|+||+|||++||++++.-|.+..+. .++..+.. ...|.
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCc
Confidence 999664332 235566789999999999876 6899999999999999999999888764432 22333222 22221
Q ss_pred -chhhhc---chh--hhcccCcchHHHHHH---HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 808 -GLTEVV---DAS--LVREVQPSYAKMDCL---LRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 808 -~~~~~~---~~~--~~~~~~~~~~~~~~~---~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.|..+. +.. ......+..-....+ ....+++.+|++.+|.+|.|++.++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222222 111 111110111111111 368899999999999999999999875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.86 Aligned_cols=239 Identities=25% Similarity=0.261 Sum_probs=191.8
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
||+|+||.||+|... +++.||+|++.... ......+..|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 68899999987542 33446678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccc
Q 002892 669 EKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748 (870)
Q Consensus 669 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 748 (870)
.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 99998654 4899999999999999999999 6779999999999999999999999999987542221 1223446
Q ss_pred cccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHH
Q 002892 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM 828 (870)
Q Consensus 749 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (870)
||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... .. .+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~------------~~---~~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP------------LR---FPD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC------------CC---CCC
Confidence 89999999999999999999999999999999999999975211 11111100000 00 001
Q ss_pred HHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 002892 829 DCLLRIMHLALGCCMDSPEQRMC---MTDVVV 857 (870)
Q Consensus 829 ~~~~~l~~l~~~cl~~~P~~RPs---~~evl~ 857 (870)
..+..+.+++.+||+.+|++||+ +.+++.
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 23456889999999999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=318.03 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=204.3
Q ss_pred CCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999843 23568999886543 2345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCc
Q 002892 659 VLEFMPNGSLEKWLYSHN-----------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNN 715 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 715 (870)
++||+++++|.+++.... ..+++.+++.++.|++.|++||| +++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999986421 24788999999999999999999 6679999999999
Q ss_pred eeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCcccccc
Q 002892 716 ILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGE 794 (870)
Q Consensus 716 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~ 794 (870)
|++++++.+||+|||++................++..|+|||+..+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999976533332222233345678999999988889999999999999999998 9999865321
Q ss_pred chHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 795 MSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
..+..+..... ... .+..++..+.+++.+||+.+|++||+++++++.|+++..
T Consensus 236 ~~~~~~~~~~~------------~~~-----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKTGY------------RME-----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhCCC------------CCC-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111111100 000 011234578899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.89 Aligned_cols=247 Identities=23% Similarity=0.276 Sum_probs=199.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC--CcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD--GTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
..++|++.+.||+|+||.||+|.... +..||+|++.... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 45679999999999999999998543 3689999987543 233456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999998654 3899999999999999999999 67799999999999999999999999999986532
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
. .....||+.|+|||++.+..++.++||||+||++|||++|..||...... ....... ....
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~------------~~~~ 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKIL------------EGII 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHh------------cCCC
Confidence 1 12346899999999999888999999999999999999999999752111 1011100 0000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVVK 858 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 858 (870)
. . +...+..+.+++.+|++.+|++|+ +++++++.
T Consensus 246 -~-~-----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -Y-F-----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -C-C-----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 0 011234578999999999999995 78888653
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.63 Aligned_cols=262 Identities=25% Similarity=0.429 Sum_probs=207.9
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeee
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCC 651 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 651 (870)
+....++|++.+.||+|+||.||+|... ....+|+|.+.... ......+.+|+++++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445678899999999999999999854 23679999987542 33456688999999999 7999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCce
Q 002892 652 NLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716 (870)
Q Consensus 652 ~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 716 (870)
..+..+++|||+++|+|.++++.. ...+++..+++++.|++.|++||| +++|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeE
Confidence 999999999999999999999642 345899999999999999999999 66799999999999
Q ss_pred eeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccc
Q 002892 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEM 795 (870)
Q Consensus 717 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~ 795 (870)
+++.++.+|++|||++..+.............++..|+|||+..+..++.++|||||||++||+++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 999999999999999987644332222222335678999999988899999999999999999998 88888652211
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
........ ... . ..+..++..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 242 ~~~~~~~~------------~~~----~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLKE------------GYR----M-EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHc------------CCc----C-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111100 000 0 011123457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.50 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=205.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
+.+|+..+.||+|+||.||+|... ++..+|+|.+..........+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888899999999999999632 35689999987766666778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc
Q 002892 658 LVLEFMPNGSLEKWLYSHN--------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 723 (870)
++|||+++++|.+++...+ ..+++..+..++.|++.|++||| +.+++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 9999999999999997543 24789999999999999999999 677999999999999999999
Q ss_pred eEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHH
Q 002892 724 ARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 724 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 802 (870)
++|+|||++................+++.|+|||...+..++.++|||||||++|||++ |..||......+ ......
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHH
Confidence 99999999976533222222223345688999999998899999999999999999998 888886532211 111000
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
... ....+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus 239 ~~~-----------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 QGR-----------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCc-----------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000 000111345578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.91 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=205.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..+|++.+.||+|++|.||+|... .++.||+|++.... .....+.+|++++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 356888899999999999999865 58899999987543 3346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ...+++..+..++.|+++|++||| +.+++||||||+||++++++.+||+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999754 345899999999999999999999 667999999999999999999999999999876432221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......++..|+|||...+..++.++|||||||++|||++ |..||..... ............ .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~------------~- 224 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKGYR------------M- 224 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC------------C-
Confidence 1122234668999999998899999999999999999998 8888864211 111111110000 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
..+..++..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 225 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00112356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=318.53 Aligned_cols=259 Identities=28% Similarity=0.463 Sum_probs=204.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCc--EEEEEEeech-hhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGT--NVAIKVFNLQ-LERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 658 (870)
+++|++.+.||+|+||.||+|... ++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 478999999999999999999865 333 4788887642 234456788999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc
Q 002892 659 VLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 723 (870)
|+||+++++|.+++.... ..+++..+..++.|++.|++||| ++|++||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCe
Confidence 999999999999997532 24889999999999999999999 677999999999999999999
Q ss_pred eEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHH
Q 002892 724 ARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 724 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 802 (870)
+||+|||++..... .........+..|+|||+..+..++.++|||||||++|||++ |..||...... .+..
T Consensus 158 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYE 229 (297)
T ss_pred EEECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 99999999864321 111111223567999999988889999999999999999997 99998653211 1111
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
. .+.. .... .+..++..+.+++.+||+.+|.+||++.++++.|+.+.+++.
T Consensus 230 ~-~~~~--------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 K-LPQG--------YRME-----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred H-HhcC--------CCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 0000 0000 011234578899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.05 Aligned_cols=267 Identities=22% Similarity=0.357 Sum_probs=203.4
Q ss_pred CCCCCeeccccceeEEEEEe-----cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeEE
Q 002892 587 FNECNLLGAGSFGSVYKGTL-----FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKAL 658 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 658 (870)
|++.+.||+|+||+||++.. .+++.||+|+++... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988652 357889999987653 23456788999999999999999999987653 46789
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
+|||+++++|.+++.... +++..+..++.|++.|++||| +++++||||||+||++++++.++|+|||++......
T Consensus 86 v~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999997644 899999999999999999999 667999999999999999999999999999876432
Q ss_pred CCccc-ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CCchhhhcchh
Q 002892 739 DDSVT-QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PRGLTEVVDAS 816 (870)
Q Consensus 739 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 816 (870)
..... .....++..|+|||......++.++||||||+++|||++|+.||............+..... .....+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 22111 12223566799999998888999999999999999999999998653221111111000000 00111111111
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
.... .+..++..+.+++..||+.+|++||++++|++.|+++.
T Consensus 241 ~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLP-----CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCC-----CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1100 11234568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.25 Aligned_cols=242 Identities=25% Similarity=0.312 Sum_probs=194.8
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 68999999997653 334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccc
Q 002892 667 SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM 746 (870)
Q Consensus 667 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 746 (870)
+|.+++...+ .+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9999887654 4899999999999999999999 6779999999999999999999999999987532211 12233
Q ss_pred cccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchH
Q 002892 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826 (870)
Q Consensus 747 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (870)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... .. .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~------~~----~----- 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMED------IK----F----- 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCC------cc----C-----
Confidence 4689999999999998999999999999999999999999965211 11111000000 00 0
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002892 827 KMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVVK 858 (870)
Q Consensus 827 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 858 (870)
+...+..+.+++.+|++.+|++|| ++.++++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 011234688999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.86 Aligned_cols=271 Identities=23% Similarity=0.299 Sum_probs=206.9
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEee--chhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee-----
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFN--LQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN----- 652 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 652 (870)
......|...+.||+|+||.|+.|... +|+.||+|.+. .......++..+|++.++.++|+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344566777899999999999999854 79999999986 3345566788899999999999999999998855
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
-...|+|+|+| +.+|...++.... ++...+.-++.|+++||.|+| +.+|+|||+||+|++++.+..+||+|||+|
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence 45779999999 6799998886554 889999999999999999999 777999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCccccc-CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc--
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYAS-DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPRG-- 808 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~-- 808 (870)
+...........+.-+.|..|.|||++. ...|+.+.||||.|||+.||++|++-|.+. +.-.++..+... ..|+.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~-d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK-DYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC-chHHHHHHHHHhcCCCCHHH
Confidence 9885443333445667899999999875 567999999999999999999999988663 112222222221 11211
Q ss_pred hhhhcc-------hhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 LTEVVD-------ASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 ~~~~~~-------~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+..+-. +.+.......+. ...+...+.+++.+|+..||.+|+|++|.++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111 111111111111 1234557889999999999999999999876
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=335.12 Aligned_cols=369 Identities=27% Similarity=0.428 Sum_probs=270.0
Q ss_pred CCCEEEcCCCccc-cCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeec
Q 002892 64 KLQVLSLRNNSFT-GPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVL 142 (870)
Q Consensus 64 ~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L 142 (870)
-.+-.|+++|.++ +..|.++..+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+...++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3444566666666 356666777777777777777776 77888888888888888888888 66777888888888888
Q ss_pred cccccc-ccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCccc
Q 002892 143 ALNNLI-GPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLS 221 (870)
Q Consensus 143 ~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 221 (870)
.+|++. ..+|..++.+..|+.||||+|+++ ..|..+...+++..|+||+|+|.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~--------------------------EvP~~LE~AKn~iVLNLS~N~Ie 139 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR--------------------------EVPTNLEYAKNSIVLNLSYNNIE 139 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh--------------------------hcchhhhhhcCcEEEEcccCccc
Confidence 888875 456777777777777777777776 45555555556666666666665
Q ss_pred CCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccc
Q 002892 222 GQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301 (870)
Q Consensus 222 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l 301 (870)
.+.-..|.+|+.|-.|+||+|++..++ +....+..|++|+|++|.+....
T Consensus 140 tIPn~lfinLtDLLfLDLS~NrLe~LP---------PQ~RRL~~LqtL~Ls~NPL~hfQ--------------------- 189 (1255)
T KOG0444|consen 140 TIPNSLFINLTDLLFLDLSNNRLEMLP---------PQIRRLSMLQTLKLSNNPLNHFQ--------------------- 189 (1255)
T ss_pred cCCchHHHhhHhHhhhccccchhhhcC---------HHHHHHhhhhhhhcCCChhhHHH---------------------
Confidence 433344555666666666666665433 33555556666666666554320
Q ss_pred cccCchhhhCccCCcEEEeeCCC-ccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCccc
Q 002892 302 KGSIPKEIGNLRGLIALSLFTND-LNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSF 380 (870)
Q Consensus 302 ~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 380 (870)
-..+..+++|+.|.+++.+ -...+|.++..+.+|..++++.|-...+|+++-.+++|+.|+||+|+|+ .+....
T Consensus 190 ----LrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~ 264 (1255)
T KOG0444|consen 190 ----LRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTE 264 (1255)
T ss_pred ----HhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCcee-eeeccH
Confidence 0122334445555555432 2234666666667777777775555677888888899999999999998 555566
Q ss_pred ccccccceEecCCCccCCCCcccccCCccCCEEEccCCccC-CcccccccCCCCCCEEEcCCCcccCcccccccCCCCCC
Q 002892 381 WSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS-GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLE 459 (870)
Q Consensus 381 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 459 (870)
....+|++|+||.|+++ .+|+++..++.|+.|++.+|+++ .-+|..++.+.+|+.+..++|.+. .+|..++++..|+
T Consensus 265 ~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~ 342 (1255)
T KOG0444|consen 265 GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQ 342 (1255)
T ss_pred HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHH
Confidence 66788999999999999 89999999999999999999986 237889999999999999999997 8999999999999
Q ss_pred eEecCCCcccCCCCcchhhccccceeeccCCcccccCCC
Q 002892 460 YLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 460 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
.|.|++|+|- .+|+.+.-++.|+.|||..|+=---+|.
T Consensus 343 kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 343 KLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred Hhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 9999999998 8999999999999999999985544553
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=320.00 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=206.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEec--------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCN 652 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 652 (870)
..++|.+.+.||+|+||.||+|+.. ++..+|+|.+.... ......+..|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467999999999999999999742 23569999997543 33456788899999999 79999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCcee
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 717 (870)
.+..++||||+++|+|.+++...+ ..+++.++.+++.|++.|++||| +.|++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheE
Confidence 999999999999999999998532 24889999999999999999999 667999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccch
Q 002892 718 LDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 796 (870)
Q Consensus 718 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~ 796 (870)
+++++.++|+|||.+................+++.|+|||++.+..++.++||||+||++|||++ |..||..... ..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~ 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH
Confidence 99999999999999876543222222222234568999999998889999999999999999998 8888764211 11
Q ss_pred HHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 797 LKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
......... . ...+..++..+.+++.+||+.+|++||++.+|++.|+++.+.-
T Consensus 251 ~~~~~~~~~------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 LFKLLKEGH------------R-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHcCC------------C-----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111111000 0 0001123457889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=319.24 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=202.6
Q ss_pred cCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.+|++.+.||+|+||.||+|... ++..||+|+++.... .....+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677889999999999999853 257899999975543 33466889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC
Q 002892 658 LVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 722 (870)
+++||+++++|.+++... ...+++..+..++.|++.|++|+| ++|++||||||.||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 999999999999998522 234788899999999999999999 67799999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHH
Q 002892 723 TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWI 801 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 801 (870)
.+||+|||++................+++.|+|||.+.++.++.++||||+||++|||++ |..||...... .....+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i 239 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMI 239 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999886643333222333456789999999988889999999999999999998 77787652211 111111
Q ss_pred HHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 802 KLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
. .... ...+..++..+.+++..||+.+|++||++++|++.|+.
T Consensus 240 ~---~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 R---NRQV--------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H---cCCc--------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 0000 00112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=315.62 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=202.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
.+++|++.+.||+|++|.||+|.+. .+..||+|.+.... ......+..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567899999999999999999864 35678999886543 3334568889999999999999999999998889
Q ss_pred eEEEEecCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC---ceEE
Q 002892 656 KALVLEFMPNGSLEKWLYSHN------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---TARV 726 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl 726 (870)
.++||||+++++|.+++...+ ..+++..+.+++.||+.|++||| +++++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999997543 25899999999999999999999 66799999999999998754 5999
Q ss_pred eccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhc
Q 002892 727 SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSL 805 (870)
Q Consensus 727 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 805 (870)
+|||++.................+..|+|||++.+..++.++|||||||++|||++ |..||+...... ....+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~ 238 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGG 238 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence 99999986633222222222334568999999998899999999999999999997 999987532211 111110000
Q ss_pred CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
. ...+..++..+.+++.+||+.+|++||++.+|++.|.
T Consensus 239 ------------~-----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 ------------R-----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------------c-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0001123457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=318.89 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=208.0
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec--------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeee
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCC 651 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 651 (870)
...++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888999999999999999731 34579999986543 34456788999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCce
Q 002892 652 NLDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716 (870)
Q Consensus 652 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 716 (870)
.....+++|||+++|+|.+++...+ ..+++.++..++.|++.|++||| ++|++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 9999999999999999999997532 24788899999999999999999 66799999999999
Q ss_pred eeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccc
Q 002892 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEM 795 (870)
Q Consensus 717 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~ 795 (870)
++++++.+||+|||.+................+++.|+|||++.+..++.++||||||+++||+++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 999999999999999987644333322333345678999999988889999999999999999998 7778754211
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..... .. .....+..++..+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 246 --~~~~~~~~-~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 --EELFKLLK-EG-------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred --HHHHHHHH-cC-------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111100 00 00001123456789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.44 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=207.7
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|++|.||+|.. .+++.||||.+.... ......+.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999995 478999999876532 334467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
||+++++|.+++.. ....+++..++.++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998873 2345899999999999999999999 67799999999999999999999999999876643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
... ......++..|+|||+..+..++.++||||||+++|+|++|..||...............
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 221 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------------- 221 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh---------------
Confidence 222 122345888999999998888999999999999999999999998642211111111000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
....+.......+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus 222 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 222 -QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000000111234557899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=341.97 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=203.8
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999865 68999999987542 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 661 EFMPNGSLEKWLYSH----------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 661 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
||++||+|.+++... ....++..+++++.|+++||+||| ++||+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998632 123567788999999999999999 6779999999999999999999999999
Q ss_pred cccccCCCCC----------------cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc
Q 002892 731 ISKLLGEDDD----------------SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794 (870)
Q Consensus 731 ~a~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~ 794 (870)
++........ ........||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 001112468999999999999999999999999999999999999996521111
Q ss_pred chHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHh
Q 002892 795 MSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-CMTDVVVKLQKIKQ 864 (870)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~i~~ 864 (870)
.... ... .++. ......+.+..+.+++.+|++.+|++|| ++.++++.|+.+.+
T Consensus 239 i~~~----~~i-------~~P~------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR----DVI-------LSPI------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh----hhc-------cChh------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1000 000 0000 0000113345688999999999999996 67777888877654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.49 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=209.0
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|++|.||+|... +|+.||+|.++... ....+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999966 78999999886422 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
||+++++|.+++.. ....+++.++..++.+++.|++||| +.|++||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999863 2345899999999999999999999 67799999999999999999999999999876533
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+... ..
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~------------~~ 221 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKK------------IE 221 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhh------------hh
Confidence 221 12234578899999999888899999999999999999999999854221 11111110 00
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
.... ........+..+.+++.+||..+|++||++.+|+++++++.+
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 222 KCDY-PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred cCCC-CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 0000 001111345578899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.49 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=201.2
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999865 68999999998653 234566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999877566999999999999999999999 67799999999999999999999999999987643322
Q ss_pred cccccccccccccCCccccc------CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYAS------DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ......... ..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~---~~------ 226 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNF---QR------ 226 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcC---CC------
Confidence 2 223346899999999986 456788999999999999999999999753211 111111000 00
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... .....+..+.+++..|++ +|++||++.++++
T Consensus 227 --~~~~~----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 --FLKFP----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --ccCCC----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000 001124467889999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=315.13 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=208.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC-----CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeee-CCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD-----GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCN-LDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 655 (870)
..++|++.+.||+|+||.||+|.+.+ +..|++|++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788999999999999999999765 6889999886543 3445678899999999999999999998765 567
Q ss_pred eEEEEecCCCCCHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEec
Q 002892 656 KALVLEFMPNGSLEKWLYSHN-------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
.++++||+++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999987532 45899999999999999999999 66799999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCC
Q 002892 729 FGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 729 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... .....+.......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCCC
Confidence 999986543332222223345678999999988889999999999999999999 9999875311 1122211111000
Q ss_pred chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 808 GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
.....++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 239 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 -----------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00112355789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=299.15 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=204.0
Q ss_pred hcCCCCCCeeccccceeEEEEEecC-CcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.+.|+..+.||.|.-|+||++..++ +..+|+|++.+.. .....+.+.|.++++.++||.++++|+.++.+...++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3557778899999999999999764 5889999998764 34456778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC-
Q 002892 660 LEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE- 737 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~- 737 (870)
||||+||+|....+++ +..+++..+.-++.+++.||+||| -.|||+|||||+|||+.++|++.|+||.++....-
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999854 566999999999999999999999 56699999999999999999999999998753310
Q ss_pred --------------------------------CCC---------------------cccccccccccccCCcccccCCCc
Q 002892 738 --------------------------------DDD---------------------SVTQTMTMATIGYMAPEYASDGII 764 (870)
Q Consensus 738 --------------------------------~~~---------------------~~~~~~~~g~~~y~aPE~~~~~~~ 764 (870)
... ..+...++||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011124578999999999999999
Q ss_pred CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCC
Q 002892 765 SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMD 844 (870)
Q Consensus 765 ~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 844 (870)
+.++|.|+|||++|||+.|..||.+....+ .+..++. +.+.= ....+.+..+.++|++.+..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~------------~~l~F-----p~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVG------------QPLKF-----PEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhc------------CCCcC-----CCCCcchhHHHHHHHHHhcc
Confidence 999999999999999999999998743332 2222221 11100 00113356789999999999
Q ss_pred CCCCCCC----HHHHHH
Q 002892 845 SPEQRMC----MTDVVV 857 (870)
Q Consensus 845 ~P~~RPs----~~evl~ 857 (870)
||++|.. +.||.+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999997 777754
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.94 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=204.5
Q ss_pred cCCCCCCeeccccceeEEEEEec-CC---cEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DG---TNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.+|++.+.||+|+||.||+|... ++ ..||+|++... .......+..|++++++++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788899999999999999864 33 36999998754 244457899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++...+..+++.++..++.|++.|++||| ++|++||||||+||++++++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876666899999999999999999999 6679999999999999999999999999987664322
Q ss_pred Ccccccccc---cccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 740 DSVTQTMTM---ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 740 ~~~~~~~~~---g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
......... .+..|+|||++.+..++.++||||+|+++||+++ |..||..... .....++....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~---------- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDY---------- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC----------
Confidence 221111111 2457999999998999999999999999999887 9999865321 11111111000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
....+.+++..+.+++..||+.+|++||++.+|++.|+++
T Consensus 229 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001123456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.95 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=195.9
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.|+..+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999854 68899999997643 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999997654 3889999999999999999999 677999999999999999999999999997543210000
Q ss_pred ---------------------------------------------ccccccccccccCCcccccCCCcCcccchHhHHHH
Q 002892 742 ---------------------------------------------VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVL 776 (870)
Q Consensus 742 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~i 776 (870)
.......||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00122468999999999998889999999999999
Q ss_pred HHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhh--ccCCCCCCCCCHHH
Q 002892 777 LMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALG--CCMDSPEQRMCMTD 854 (870)
Q Consensus 777 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~RPs~~e 854 (870)
+|||++|+.||......+.. ..... .... .. .. .....+.++.+++.+ |+..+|.+||++.+
T Consensus 238 l~elltG~~Pf~~~~~~~~~-~~i~~--~~~~--------~~--~~---~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQ-LKVIN--WENT--------LH--IP---PQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHH-HHHHc--cccc--------cC--CC---CCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999763221111 11000 0000 00 00 000123456777777 55667777999999
Q ss_pred HHHH
Q 002892 855 VVVK 858 (870)
Q Consensus 855 vl~~ 858 (870)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.24 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=205.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 654 (870)
..++|++.+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467999999999999999999742 34579999987543 33456789999999999 7999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
..++||||+++|+|.++++... ..+++.++..++.|++.|++||| +++++||||||+||+++.++.++++|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997543 34899999999999999999999 6679999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
...............++..|+|||.+.++.++.++||||+||++|||++ |..||......+ ..........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~------- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGY------- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCC-------
Confidence 6643332222223345778999999999999999999999999999998 999986532211 1111111000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
... .+...+.++.+++.+||..+|++||++.|+++.|++.
T Consensus 262 -----~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 -----RMA-----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----cCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 0011234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=320.90 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=192.9
Q ss_pred CCeeccccceeEEEEEe----cCCcEEEEEEeechh----hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 590 CNLLGAGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.+.||+|+||.||+++. .+++.||+|+++... ......+..|++++++++||||+++++++...+..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36799999999999984 357899999997642 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 81 YLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 9999999999976543 788889999999999999999 6679999999999999999999999999987542221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||...... ....... .... ..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~~------------~~~~--~~ 219 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKIL------------KGKL--NL 219 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHHH------------cCCC--CC
Confidence 1222346899999999999888999999999999999999999999752211 1011100 0000 00
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
+...+..+.+++.+||+.+|++|| ++.++++
T Consensus 220 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 -----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 011234688999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.57 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=205.4
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeC
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNL 653 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 653 (870)
...++|.+.+.||+|+||.||+|++. .++.||+|+++... ....+.+..|++++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34467888899999999999999853 34679999997543 333457889999999997 99999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcC---------------------------------------------------------
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHN--------------------------------------------------------- 676 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 676 (870)
+..++||||+++|+|.++++..+
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999997432
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCce
Q 002892 677 ----------------------------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716 (870)
Q Consensus 677 ----------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 716 (870)
..+++..+..++.|++.||+||| +++++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceE
Confidence 13677788999999999999999 67799999999999
Q ss_pred eeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccc
Q 002892 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEM 795 (870)
Q Consensus 717 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~ 795 (870)
++++++.+|++|||++................++..|+|||.+....++.++||||||+++|||++ |+.||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986533222222223356788999999998889999999999999999998 8889865322111
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
.......... . ..+..++..+.+++.+||..+|++||++++|++.|+++.
T Consensus 351 -~~~~~~~~~~----------------~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -FYNAIKRGYR----------------M-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHHHcCCC----------------C-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111110000 0 001123457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=321.24 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=192.0
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHH---HhcCCCceeEEeeeeeeCCeeEEE
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVL---RNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677889999999999999865 68999999997653 22334566666554 566899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|..++... .+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 9999999999888653 4899999999999999999999 677999999999999999999999999998753221
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
........|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. .
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~i~~------------~---- 216 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDSIVN------------D---- 216 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh------------C----
Confidence 11223456899999999999999999999999999999999999999753111 11111000 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
... .+..++..+.+++.+||+.+|++|| ++.++++
T Consensus 217 ~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 EVR---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 000 0012345678999999999999999 4666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.18 Aligned_cols=254 Identities=27% Similarity=0.470 Sum_probs=200.2
Q ss_pred CCCCCeeccccceeEEEEEec-C---CcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe-----
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-D---GTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF----- 655 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 655 (870)
|++.+.||+|+||.||+|... + +..||+|+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999854 2 3679999987542 3445678999999999999999999998865443
Q ss_pred -eEEEEecCCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecc
Q 002892 656 -KALVLEFMPNGSLEKWLYSH-----NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 656 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
.+++|||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999988632 235899999999999999999999 667999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCc
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 808 (870)
|++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~-- 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNR-- 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence 99986643332222222345678999999988889999999999999999999 88888653221 11111110000
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
...+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 234 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ---------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.56 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=196.9
Q ss_pred CCCCeeccccceeEEEEEecC-Cc--EEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------Cee
Q 002892 588 NECNLLGAGSFGSVYKGTLFD-GT--NVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL------DFK 656 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 656 (870)
.+.+.||+|+||.||+|++.+ ++ .||+|.++... ......+..|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 466889999999999998654 33 68999886542 34456788999999999999999999987432 246
Q ss_pred EEEEecCCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 657 ALVLEFMPNGSLEKWLYS-----HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
+++|||+++|+|.+++.. ....+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998752 2344889999999999999999999 66799999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLT 810 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 810 (870)
+..+.............+++.|+|||+..+..++.++||||||+++|||++ |+.||...... ........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~--~~~-- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ--GNR-- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--CCC--
Confidence 987644332222233346778999999999999999999999999999999 78888652211 11111110 000
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
......++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 233 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 -------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.91 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=196.2
Q ss_pred eeccccceeEEEEEec---CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCC
Q 002892 592 LLGAGSFGSVYKGTLF---DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGS 667 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 667 (870)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 35579999987653 334467889999999999999999999875 456799999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc-ccc
Q 002892 668 LEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT-QTM 746 (870)
Q Consensus 668 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~ 746 (870)
|.+++......+++..+.+++.|++.|++||| ++|++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999866667899999999999999999999 66799999999999999999999999999976543322111 112
Q ss_pred cccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 747 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
..++..|+|||++....++.++||||||+++||+++ |..||....... ....+....+ ..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~-----------------~~ 218 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR-----------------LD 218 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC-----------------CC
Confidence 223578999999988889999999999999999996 999987532211 1111110000 00
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
.+..++..+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1112356788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.80 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=202.7
Q ss_pred eeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHHH
Q 002892 592 LLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEK 670 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 670 (870)
++|+|.||+||-|++. +...+|||.+.....+..+.+.+|+...++++|.|||+++|++.+.++.-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999955 567899999988888888899999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC-CCCceEEeccccccccCCCCCccccccc
Q 002892 671 WLYSHNYFL--DMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARVSDFGISKLLGEDDDSVTQTMT 747 (870)
Q Consensus 671 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 747 (870)
.++..-.++ .+.++--+.+||++||.|||+.+ |||||||-.||++. -.|.+||+|||-++.... .......+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 999765556 78888899999999999999665 99999999999995 579999999999987632 23344556
Q ss_pred ccccccCCcccccCCC--cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 748 MATIGYMAPEYASDGI--ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 748 ~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
.||..|||||++..++ |+.++|||||||++.||.||++||.+...+...... -.+-+...+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---------------VGmyKvHP~-- 799 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---------------VGMYKVHPP-- 799 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---------------hcceecCCC--
Confidence 7999999999998764 788999999999999999999999875443221111 111111001
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
-+.+...+...++.+|+.++|.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 12345667889999999999999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=328.02 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=198.4
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999965 68999999997643 234456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999998654 4899999999999999999999 66799999999999999999999999999875432111
Q ss_pred cc------------------------------------cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCC
Q 002892 741 SV------------------------------------TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRK 784 (870)
Q Consensus 741 ~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~ 784 (870)
.. ......||+.|+|||++....++.++||||+||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011235899999999999999999999999999999999999
Q ss_pred CCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 002892 785 KPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC---MTDVVV 857 (870)
Q Consensus 785 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~ 857 (870)
.||......+ ....... ..... . . ......+..+.+++..|+. +|.+|++ +.++++
T Consensus 237 ~Pf~~~~~~~-~~~~i~~--~~~~~--------~--~---~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQE-TYRKIIN--WKETL--------Q--F---PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHH-HHHHHHc--CCCcc--------C--C---CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997532111 1111100 00000 0 0 0000123467788889986 9999998 888866
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.47 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=205.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CC---cEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DG---TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.++|+..+.||+|+||.||+|... ++ ..+|+|..+... ....+.+..|++++++++|||++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346788899999999999999864 33 379999986553 3445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||++++++.++++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999876666899999999999999999999 667999999999999999999999999999766432
Q ss_pred CCcccc-cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 739 DDSVTQ-TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 739 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
...... .....+..|+|||++..+.++.++||||||+++||+++ |..||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~------------ 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDG------------ 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcC------------
Confidence 221111 11223457999999988889999999999999999998 99998653211 111111100
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
.......+++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00001123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.22 Aligned_cols=266 Identities=22% Similarity=0.284 Sum_probs=195.9
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----CeeE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-----DFKA 657 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 657 (870)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999854 68999999986432 23345688999999999999999999987543 2479
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||++ ++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68999887654 3899999999999999999999 67799999999999999999999999999975532
Q ss_pred CCC-cccccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC------
Q 002892 738 DDD-SVTQTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR------ 807 (870)
Q Consensus 738 ~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~------ 807 (870)
... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......... ..+.
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLLGTPSPETISR 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHH
Confidence 221 112234568999999999865 67899999999999999999999999653211 111111100 0000
Q ss_pred ----chhhhcchhhhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 808 ----GLTEVVDASLVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 808 ----~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
...+.... +........ .....+..+.+++.+||+.+|++||++.|+++.
T Consensus 235 i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00001100 000000000 001124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.62 Aligned_cols=201 Identities=25% Similarity=0.382 Sum_probs=174.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||+||+|... +++.||+|++++.. ......+..|+.++.+++||+|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999855 68999999997643 233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999998654 4899999999999999999999 67799999999999999999999999999875432110
Q ss_pred c---------------------------------ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCC
Q 002892 741 S---------------------------------VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPT 787 (870)
Q Consensus 741 ~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~ 787 (870)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346899999999999999999999999999999999999999
Q ss_pred Cc
Q 002892 788 DE 789 (870)
Q Consensus 788 ~~ 789 (870)
..
T Consensus 237 ~~ 238 (363)
T cd05628 237 CS 238 (363)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.83 Aligned_cols=254 Identities=23% Similarity=0.416 Sum_probs=204.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3567899999999999999999988899999999875443 2457889999999999999999999864 4678999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... +..+++.++..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 9999999998743 456899999999999999999999 67799999999999999999999999999976642221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......++..|+|||++....++.++||||||+++||+++ |+.||....... ...........
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRM------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCCC-------------
Confidence 11223345678999999998889999999999999999999 999987532211 11111000000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
..+..++.++.+++.+||..+|++||+++++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011234579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.48 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=203.6
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD 654 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 654 (870)
...++|++.+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34678999999999999999999743 24579999876443 233456788999999999999999999999989
Q ss_pred eeEEEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceE
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN---------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR 725 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 725 (870)
..++||||+++|+|.+++.... ...++..+..++.|++.|++||| +++++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997421 23567788999999999999999 67799999999999999999999
Q ss_pred EeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHh
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 804 (870)
++|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... ......
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~--- 234 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFV--- 234 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---
Confidence 999999876533332222223345678999999998899999999999999999998 78888653211 111111
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
. +..... .+..++..+.+++.+|++.+|++||++.++++.+++..
T Consensus 235 ~--------~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 M--------DGGYLD------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H--------cCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 000000 01123457999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.89 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=202.7
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.++|++.+.||+|+||.||+|++.++..||+|.++.... ....+.+|++++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356999999999999999999987777899999875432 2356889999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 664 PNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 664 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++|+|.+++... ...+++..+..++.|++.||+|+| +.+++||||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999999853 345799999999999999999999 677999999999999999999999999999866433221
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......++..|+|||+..++.++.++||||||+++|||++ |..||......+. ... .. ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~-~~------------~~~---- 220 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQ-VE------------RGY---- 220 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHH-Hh------------cCC----
Confidence 1122346678999999988899999999999999999999 7878865321110 000 00 000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
......+++..+.+++.+|++.+|++||++.++++.|++.
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0001123456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=327.51 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=203.5
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999965 78999999997653 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC-
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD- 739 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 739 (870)
||+++++|.+++... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999876 44899999999999999999999 6779999999999999999999999999998664332
Q ss_pred --------------------------CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccc
Q 002892 740 --------------------------DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTG 793 (870)
Q Consensus 740 --------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~ 793 (870)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001223456899999999999999999999999999999999999999763211
Q ss_pred cchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 002892 794 EMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-MTDVVVK 858 (870)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~ 858 (870)
+ ....... +... ..... ...++..+.+++..|+. +|++||+ +.++++.
T Consensus 237 ~-~~~~i~~--~~~~--------~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E-TYNKIIN--WKES--------LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H-HHHHHhc--cCCc--------ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1111000 0000 00000 00134568899999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.28 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=199.0
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHH
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLE 669 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 669 (870)
++||+|+||.||+|...+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998888999999987553 333456889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccccccc
Q 002892 670 KWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749 (870)
Q Consensus 670 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 749 (870)
+++......+++..+..++.|++.|+.|+| +++++||||+|+||+++.++.++++|||++........ .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 999866666899999999999999999999 67799999999999999999999999999875432211 11122234
Q ss_pred ccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHH
Q 002892 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM 828 (870)
Q Consensus 750 ~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (870)
+..|+|||+..++.++.++||||||+++|++++ |..||...... .....+...... ..+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~-----------------~~~~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYRM-----------------SCPQ 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCCC-----------------CCCC
Confidence 678999999998889999999999999999998 89898653211 111111100000 0011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 829 DCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 829 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
.++..+.+++.+||+.+|++||++.|++++|+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.25 Aligned_cols=421 Identities=31% Similarity=0.368 Sum_probs=258.5
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
-+|+.||||+|++. ..|..+..+.+|+.|+++.|.|. ..|..++.+.+|++|.|.+|.+. .+|.++..+++|++|++
T Consensus 45 v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl 121 (1081)
T KOG0618|consen 45 VKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL 121 (1081)
T ss_pred eeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence 34899999999998 68888999999999999999998 78888899999999999999988 78999999999999999
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccccccccccccc----------------
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNI---------------- 158 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l---------------- 158 (870)
++|++. .+|..+..++.++.+..++|.-....+ ... .+.++|..|.+.+.++..+.++
T Consensus 122 S~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg----~~~-ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dl 195 (1081)
T KOG0618|consen 122 SFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG----QTS-IKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDL 195 (1081)
T ss_pred chhccC-CCchhHHhhhHHHHHhhhcchhhhhhc----ccc-chhhhhhhhhcccchhcchhhhheeeecccchhhhhhh
Confidence 999987 778777777777777777761111111 111 4444444444444444444444
Q ss_pred ---ccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccc
Q 002892 159 ---STIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLS 235 (870)
Q Consensus 159 ---~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 235 (870)
.+|+.|....|++... -...++|+.|+.++|-++...+... -.+|+++|+++|+++ ..|+|++.+.+|+
T Consensus 196 s~~~~l~~l~c~rn~ls~l-----~~~g~~l~~L~a~~n~l~~~~~~p~--p~nl~~~dis~n~l~-~lp~wi~~~~nle 267 (1081)
T KOG0618|consen 196 SNLANLEVLHCERNQLSEL-----EISGPSLTALYADHNPLTTLDVHPV--PLNLQYLDISHNNLS-NLPEWIGACANLE 267 (1081)
T ss_pred hhccchhhhhhhhcccceE-----EecCcchheeeeccCcceeeccccc--cccceeeecchhhhh-cchHHHHhcccce
Confidence 4444444444444321 1223566666666666663322222 245777777777777 3557777777777
Q ss_pred cccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCC
Q 002892 236 TLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGL 315 (870)
Q Consensus 236 ~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L 315 (870)
.|+..+|+++.+ +..+...++|+.|++.+|++..+ |.....++.|
T Consensus 268 ~l~~n~N~l~~l---------p~ri~~~~~L~~l~~~~nel~yi--------------------------p~~le~~~sL 312 (1081)
T KOG0618|consen 268 ALNANHNRLVAL---------PLRISRITSLVSLSAAYNELEYI--------------------------PPFLEGLKSL 312 (1081)
T ss_pred EecccchhHHhh---------HHHHhhhhhHHHHHhhhhhhhhC--------------------------CCccccccee
Confidence 777777777543 33455666677777777766644 4444556666
Q ss_pred cEEEeeCCCccccCCchhhchhh-HHHHHhcCCCCCCCcc-cccCccccceeecCCcccCCCCCcccccccccceEecCC
Q 002892 316 IALSLFTNDLNGTIPTTLGRLQQ-LQALLQRNNLNGPIPT-CLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSS 393 (870)
Q Consensus 316 ~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~n~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 393 (870)
++|+|..|++....+..|.-+.. |..|..+.+.....|. .=..++.|+.|.+.+|.++...-..+.++.+|+.|+|++
T Consensus 313 ~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsy 392 (1081)
T KOG0618|consen 313 RTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSY 392 (1081)
T ss_pred eeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecc
Confidence 66666666665322222222222 4444444333333331 112244566666666666655555566666666666666
Q ss_pred CccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCC-C
Q 002892 394 NSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGE-I 472 (870)
Q Consensus 394 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~ 472 (870)
|+|.......+.++..|++|+||+|+++ .+|.++..+..|++|...+|++. ..| .+..++.|+.+|+|.|+|+.. +
T Consensus 393 NrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l 469 (1081)
T KOG0618|consen 393 NRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTL 469 (1081)
T ss_pred cccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhh
Confidence 6666333334556666666666666666 45566666666666666666665 345 566666666666666666532 2
Q ss_pred CcchhhccccceeeccCCc
Q 002892 473 PKSFEILSHLKRLNVSHNR 491 (870)
Q Consensus 473 p~~~~~l~~L~~L~ls~N~ 491 (870)
|.... -++|+.|||+||.
T Consensus 470 ~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 470 PEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred hhhCC-CcccceeeccCCc
Confidence 22221 1566666666665
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.10 Aligned_cols=240 Identities=23% Similarity=0.292 Sum_probs=188.5
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999997653 22334455566666654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999987654 4899999999999999999999 6779999999999999999999999999997543222 2233
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +....+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~-i~~~~~-------------~----- 214 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDS-ILNDRP-------------H----- 214 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHH-HHcCCC-------------C-----
Confidence 45689999999999998999999999999999999999999975321 110111 000000 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMT-DVV 856 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 856 (870)
.+..++..+.+++.+||+.+|++||++. +++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0011234678999999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.80 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=202.8
Q ss_pred hcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC-C
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL-D 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 654 (870)
.++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 347889999997543 33456788899999999 689999999988654 4
Q ss_pred eeEEEEecCCCCCHHHHHhhcC----------------------------------------------------------
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 676 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 676 (870)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999987421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccc
Q 002892 677 --------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748 (870)
Q Consensus 677 --------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 748 (870)
..+++..+..++.|++.|++||| +++|+||||||+||++++++.+|++|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 23678888999999999999999 6779999999999999999999999999998653332222222334
Q ss_pred cccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHH
Q 002892 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAK 827 (870)
Q Consensus 749 g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (870)
++..|+|||.+.+..++.++||||||+++|||++ |..||........ .......... . ..+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~------------~-~~~---- 304 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTR------------M-RAP---- 304 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCC------------C-CCC----
Confidence 5678999999988899999999999999999997 8888865322111 1111100000 0 000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 828 MDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 828 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
...+..+.+++..||+.+|++||++.||++.|+.+.+.
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 01234688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.55 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=193.0
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999865 68999999986543 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++|+|.+.. ..++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999986532 2567788899999999999999 66799999999999999999999999999986642211
Q ss_pred cccccccccccCCcccccC-----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 743 TQTMTMATIGYMAPEYASD-----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ......... .
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~------------~ 289 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAI------------C 289 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHH------------h
Confidence 1223468999999998743 23456899999999999999999999732111 111111000 0
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
... .......++.++.+++.+||+.+|++||++.|+++.
T Consensus 290 ~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 MSQ--PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccC--CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000111234578999999999999999999999864
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.69 Aligned_cols=253 Identities=25% Similarity=0.442 Sum_probs=202.4
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|++++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 467899999999999999999988888999999875433 2356889999999999999999999875 45678999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 664 PNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 664 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++++|.+++... ...+++.++..++.|++.|++||| +++++||||+|+||++++++.++|+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999999753 345899999999999999999999 666999999999999999999999999999866432211
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......++..|+|||...+..++.++||||||+++|||++ |..||...... . .........+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~-~~~~~~~~~~--------------- 221 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-E-VLEQVERGYR--------------- 221 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-H-HHHHHHcCCC---------------
Confidence 1122235678999999988889999999999999999999 88888653211 1 1111110000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
...+..++..+.+++.+|+..+|++|||+.++.+.|++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 --MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00111334578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=326.43 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=199.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++...+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999865 68899999997542 2234557789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++|+|.+++.... +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999987543 788889999999999999999 677999999999999999999999999999865432
Q ss_pred CCcccccccccccccCCcccccCC----CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDG----IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
.. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ........... ..
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~--~~------ 265 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMDHK--NS------ 265 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HHHHHHHHcCC--Cc------
Confidence 21 122345689999999988653 478899999999999999999999975211 11111110000 00
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQ--RMCMTDVVVK 858 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 858 (870)
+ .. ......+..+.+++..|++.+|++ ||++.|+++.
T Consensus 266 --~--~~---~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --L--TF---PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --C--CC---CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 00 000123456889999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.75 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=194.6
Q ss_pred cCCCCCCeeccccceeEEEEEec--CCcEEEEEEeechh--hHHHHHHHHHHHHHHhc---CCCceeEEeeeeee-----
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF--DGTNVAIKVFNLQL--ERAFRSFESECEVLRNV---RHRNLIKIFSSCCN----- 652 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----- 652 (870)
.+|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999853 46889999986543 12223455677666665 69999999998852
Q ss_pred CCeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
....++||||++ ++|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456789999996 6899998753 345899999999999999999999 67799999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcC--Cc
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLP--RG 808 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~--~~ 808 (870)
+...... .......|++.|+|||++.+..++.++||||+||++|||++|+.||...... ..+...... ..+ ..
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence 9865432 2223446899999999998889999999999999999999999999763221 122222211 111 11
Q ss_pred hhhh---cchhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 LTEV---VDASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 ~~~~---~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+... .............. ....+..+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1100 00000000000000 0123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.34 Aligned_cols=256 Identities=28% Similarity=0.450 Sum_probs=204.8
Q ss_pred cCCCCCCeeccccceeEEEEEec-C---CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-D---GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.+|++.+.||+|+||.||+|.+. + +..+|+|.++... ......+..|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999853 2 3479999886543 33456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||++++++.++++|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999876666899999999999999999999 6679999999999999999999999999998764332
Q ss_pred Cccc-ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 740 DSVT-QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 740 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.... .....++..|+|||.+.++.++.++||||||+++||+++ |..||...... ...........
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~----------- 227 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR----------- 227 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc-----------
Confidence 2111 112223568999999998889999999999999999887 99998653211 11111110000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
......++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.97 Aligned_cols=263 Identities=26% Similarity=0.366 Sum_probs=204.7
Q ss_pred hcCCCCCCeeccccceeEEEEEecC-----------------CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD-----------------GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 645 (870)
..+|++.+.||+|+||.||+|+..+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999997542 2458999987653 344577899999999999999999
Q ss_pred EeeeeeeCCeeEEEEecCCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCc
Q 002892 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHN----------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNN 715 (870)
Q Consensus 646 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 715 (870)
+++++...+..+++|||+++++|.+++.... ..+++..++.++.|++.|++||| +.+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999997543 25899999999999999999999 6679999999999
Q ss_pred eeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh--CCCCCCccccc
Q 002892 716 ILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT--RKKPTDEMFTG 793 (870)
Q Consensus 716 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~ 793 (870)
|+++.++.++++|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876543332223334456788999999988889999999999999999998 66777543211
Q ss_pred cchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 794 EMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
............. +.... ...+..++.++.+++.+||+.+|++||++.+|++.|++
T Consensus 241 --~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 --QVIENAGHFFRDD-----GRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHhccccc-----ccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111000000 00000 00111234579999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=297.22 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=208.1
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
-|.+++++|+|+||.||+|.++ .|..+|+|.+... .+.+++..|+.+|++++.|++|++||.|......++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3556788999999999999865 7999999998654 445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
.|+..+.++.++..+++.++..+++..+.||+|||... -+|||||+.||++..+|..|++|||.|-.+. +.-...
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhHHhh
Confidence 99999999998889999999999999999999999554 7999999999999999999999999997653 233344
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
....|||.|||||++..-.|..++||||+|++..||..|++||.+..+.... .-+|.. +.+.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FMIPT~------------PPPT 248 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FMIPTK------------PPPT 248 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------EeccCC------------CCCC
Confidence 5568999999999999888999999999999999999999999764332110 001111 1111
Q ss_pred h-HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 825 Y-AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 825 ~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+ .++....++-+++++|+..+|++|-|+.++.+.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 234456789999999999999999999988764
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.11 Aligned_cols=259 Identities=25% Similarity=0.447 Sum_probs=207.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCc----EEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGT----NVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|++.+.||+|+||.||+|.+. +|+ .||+|+..... ......+.+|++++++++|||++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 357888999999999999999854 333 58999886554 3445678899999999999999999999887 7889
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++......+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||.+.....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999877666999999999999999999999 67799999999999999999999999999987653
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
...........++..|+|||.+....++.++||||||+++||+++ |+.||+.... ..+...+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~----------- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGE----------- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCC-----------
Confidence 332222222334678999999988889999999999999999999 9999876321 11111111000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
....+..+...+.+++.+||..+|++||++.++++.|+++.++
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0000112334688999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.73 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=202.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCc--EEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGT--NVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 658 (870)
+++|++.+.||+|+||.||+|.++ ++. .+|+|.++... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 567889999999999999999864 454 45777765432 34456788899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc
Q 002892 659 VLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 723 (870)
||||+++++|.+++...+ ..+++.+++.++.|++.|++||| ++|++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999997432 24789999999999999999999 677999999999999999999
Q ss_pred eEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHH
Q 002892 724 ARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 724 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 802 (870)
+||+|||++..... ........++..|+|||++.+..++.++|||||||++|||+| |..||...... .......
T Consensus 163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~ 237 (303)
T cd05088 163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLP 237 (303)
T ss_pred EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHHh
Confidence 99999999863311 111112234667999999988889999999999999999998 99998643211 1111110
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
... .. ..+..++..+.+++.+||+.+|++||++.++++.++++.+.-
T Consensus 238 ----~~~--------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 238 ----QGY--------RL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred ----cCC--------cC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 00 001123446889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.39 Aligned_cols=262 Identities=20% Similarity=0.238 Sum_probs=198.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..+|++.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999854 68999999643 23467899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+. ++|.+++...+ .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... ..
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 95 78888887554 4899999999999999999999 6679999999999999999999999999997543221 11
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccc------ccchHHHHHHHh------cCCchh
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFT------GEMSLKHWIKLS------LPRGLT 810 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~------~~~~~~~~~~~~------~~~~~~ 810 (870)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+...+... ++....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22345689999999999999999999999999999999999988643211 111222222111 111110
Q ss_pred hhcchhh-------hcccCcc--h-HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 811 EVVDASL-------VREVQPS--Y-AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 811 ~~~~~~~-------~~~~~~~--~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+... ......+ + .....+..+.+++.+|++.||++|||+.|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0011000 0000111 1 11234667899999999999999999999985
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.63 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=196.4
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|... +++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999854 78999999987542 234567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999997654 4889999999999999999999 67799999999999999999999999999864321100
Q ss_pred c---------------------------------------------ccccccccccccCCcccccCCCcCcccchHhHHH
Q 002892 741 S---------------------------------------------VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGV 775 (870)
Q Consensus 741 ~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~ 775 (870)
. .......||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001245899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCC---CCH
Q 002892 776 LLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQR---MCM 852 (870)
Q Consensus 776 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~ 852 (870)
++|||++|..||...... ........ ..... .. + ........+.+++.+|+. +|.+| +++
T Consensus 237 il~elltG~~Pf~~~~~~-~~~~~i~~--~~~~~-~~----------p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-ETYRKIIN--WRETL-YF----------P--DDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-HHHHHHHc--cCCcc-CC----------C--CCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999653211 11111110 00000 00 0 000123467889999997 66665 599
Q ss_pred HHHHHH
Q 002892 853 TDVVVK 858 (870)
Q Consensus 853 ~evl~~ 858 (870)
.|+++.
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.00 Aligned_cols=243 Identities=26% Similarity=0.297 Sum_probs=193.6
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
+.||+|+||.||+|... +|+.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 78999999997643 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccc
Q 002892 667 SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM 746 (870)
Q Consensus 667 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 746 (870)
+|.+++...+ .+++..+..++.|++.||+|||+ .+||+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKT 155 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccccc
Confidence 9999887654 48999999999999999999993 1579999999999999999999999999987532211 12223
Q ss_pred cccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchH
Q 002892 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826 (870)
Q Consensus 747 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (870)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... + .....+. ... . ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~-~~~~~i~---~~~--------~--~~----- 215 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-E-KLFELIL---MEE--------I--RF----- 215 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-H-HHHHHHh---cCC--------C--CC-----
Confidence 4689999999999999999999999999999999999999965211 1 1111100 000 0 00
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002892 827 KMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVVK 858 (870)
Q Consensus 827 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 858 (870)
+...+..+.+++.+|++.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 011234688999999999999997 89988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.87 Aligned_cols=236 Identities=23% Similarity=0.305 Sum_probs=189.1
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|+.+ +++.||+|++.+.. ......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999997643 23345667788888876 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 99999987654 4899999999999999999999 6779999999999999999999999999987542211 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~------------~~--- 214 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDE------------VV--- 214 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCC------------CC---
Confidence 356899999999999989999999999999999999999999753211 1111100000 00
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
.+...+..+.+++.+|++.||++||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 000123467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=304.88 Aligned_cols=249 Identities=27% Similarity=0.345 Sum_probs=203.1
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|.+.+.||+|++|.||+|... +++.|++|.+... .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999865 6899999998653 234557788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ...+++..++.++.|++.|++||| +.|++||||+|+||++++++.++++|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999864 456899999999999999999999 66799999999999999999999999999886643222
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......|++.|+|||+..+..++.++||||||+++|+|++|+.||..... ......... ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~---------------~~~ 218 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIR---------------GVF 218 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc---------------CCC
Confidence 22334578899999999999999999999999999999999999975321 111110000 000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.. ....++..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PP--VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CC--CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 011234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.28 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=201.3
Q ss_pred hcCCCCCCeeccccceeEEEEEecC---------------CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD---------------GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIF 647 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~ 647 (870)
.++|++.+.||+|+||.||+|.... ...||+|.++... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4579999999999999999987532 2358999987643 33446789999999999999999999
Q ss_pred eeeeeCCeeEEEEecCCCCCHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCce
Q 002892 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHN-----------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716 (870)
Q Consensus 648 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 716 (870)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.|++||| +.+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 99999999999999999999999986432 23688999999999999999999 67799999999999
Q ss_pred eeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh--CCCCCCcccccc
Q 002892 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT--RKKPTDEMFTGE 794 (870)
Q Consensus 717 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~~ 794 (870)
++++++.+||+|||++................++..|+|||+...+.++.++||||||+++|+|++ +..||..... +
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-E 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-H
Confidence 999999999999999976533322222233345778999999988889999999999999999998 5567654221 1
Q ss_pred chHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 795 MSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
......... ......... .. ....++..+.+++.+||+.+|++||++++|++.|++
T Consensus 240 ~~~~~~~~~-~~~~~~~~~-----~~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEF-FRNQGRQIY-----LS-----QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHh-hhhcccccc-----CC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111100 000000000 00 011134579999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.03 Aligned_cols=261 Identities=23% Similarity=0.412 Sum_probs=205.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEec--------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCN 652 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 652 (870)
..++|.+.+.||+|+||.||+|+.. ....||+|.++... ......+..|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467889999999999999999742 24568999987543 34456788999999999 69999999999998
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCcee
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 717 (870)
.+..+++|||+++|+|.+++.... ..+++.++.+++.|++.|++||| ++|++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence 889999999999999999997532 34889999999999999999999 677999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccch
Q 002892 718 LDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 796 (870)
Q Consensus 718 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~ 796 (870)
+++++.+||+|||.+................++..|+|||++.++.++.++||||||+++|||++ |..||...... .
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~ 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--E 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence 99999999999999986643322222222234567999999988889999999999999999999 88888653211 1
Q ss_pred HHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 797 LKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
......... ....+..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 245 ~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 LFKLLREGH-----------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111111000 0000113345788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.47 Aligned_cols=269 Identities=23% Similarity=0.378 Sum_probs=203.4
Q ss_pred CCCCCCeeccccceeEEEEEe-----cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeE
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-----FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKA 657 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 657 (870)
-|++.+.||+|+||.||+|+. .+++.||+|.++... ......+.+|++++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999973 357889999987543 34456789999999999999999999998765 5678
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++++|.+++......+++.++..++.|++.||+||| ++|++||||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999866556899999999999999999999 67799999999999999999999999999986643
Q ss_pred CCCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC-chhhhcch
Q 002892 738 DDDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR-GLTEVVDA 815 (870)
Q Consensus 738 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 815 (870)
.... .......++..|+|||++.+..++.++||||||+++|||++++.|+........ ......... .......
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~- 237 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL---KMIGPTHGQMTVTRLVR- 237 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh---hhcccccccccHHHHHH-
Confidence 2221 112234467789999999888899999999999999999998876533111000 000000000 0000000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
.+... ........++..+.+++.+||+.+|++||++.++++.++++
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 00001123456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.85 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=195.5
Q ss_pred eeccccceeEEEEEe---cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 592 LLGAGSFGSVYKGTL---FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
.||+|+||.||+|.+ .++..+|+|+++... ....+.+..|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999986543 334567889999999999999999999875 45678999999999
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc-cc
Q 002892 667 SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT-QT 745 (870)
Q Consensus 667 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~ 745 (870)
+|.+++...+ .+++..+..++.|++.|++||| +++++||||||+||++++++.+||+|||++........... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997554 4899999999999999999999 66799999999999999999999999999987643332111 12
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
...++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+.. .....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~------------~~~~~---- 218 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIES------------GERME---- 218 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHC------------CCCCC----
Confidence 2234578999999988889999999999999999998 99998753221 11111110 00000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
.+..++..+.+++.+||+.+|++||++++|.+.|+..
T Consensus 219 -~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 -CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0112455788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.77 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=203.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++++.||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567999999999999999999853 46789999987553 3345678899999999999999999999999899
Q ss_pred eEEEEecCCCCCHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCC
Q 002892 656 KALVLEFMPNGSLEKWLYSHN---------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPN 714 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~ 714 (870)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+||| .++++||||+|+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 999999999999999997421 24788899999999999999999 667999999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccc
Q 002892 715 NILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTG 793 (870)
Q Consensus 715 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~ 793 (870)
||++++++.++++|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543322222223345678999999988899999999999999999998 77887542211
Q ss_pred cchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 794 EMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
.+........ .. ..+..++.++.+++.+||+.+|++||++.|+++.|++
T Consensus 240 -----~~~~~~~~~~--------~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIYYVRDGN--------VL------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHhcCC--------CC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111000000 00 0011234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=310.68 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=202.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++|||++++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999965 5899999999877666677889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++++++..++.+....+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+...... ..
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 9999999988766666899999999999999999999 677999999999999999999999999998754221 11
Q ss_pred cccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 743 TQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
......+++.|+|||++. ...++.++|||||||++|||++|..||..... ......+.....+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~----------- 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPP----------- 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHHhcCCCc-----------
Confidence 223345788999999884 34567899999999999999999999865221 1111111000000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....+..++..+.+++.+||+.+|++||++.++++
T Consensus 234 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 -----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011123446889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.81 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=204.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeech--hhHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 659 (870)
....|++.+.||+||.+.||++...+.+.||+|.+... ..+....|..|+..+.+++ |.+|+++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 44678999999999999999999888888888876433 3566788999999999995 89999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
||| ...+|..+++......+...+..+..|++.|+.++| .+||||.||||.|+++ -.|.+||+|||.|..+..+.
T Consensus 439 mE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 995 467999999977665664588899999999999999 6779999999999998 45789999999999998877
Q ss_pred CcccccccccccccCCcccccCC-----------CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDG-----------IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 808 (870)
........+||+.||+||.+... +.+.+|||||+|||+|+|+.|+.||....+... +
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a------K------ 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA------K------ 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH------H------
Confidence 77777778999999999988532 256789999999999999999999976322211 1
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+..+.|+.....+.... ...++.++|+.|+..||.+||++.++++
T Consensus 582 l~aI~~P~~~Iefp~~~----~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIP----ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCC----CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11222221111111111 1224899999999999999999999986
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.49 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=202.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-----------------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-----------------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 645 (870)
.++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 23468999987543 334567899999999999999999
Q ss_pred EeeeeeeCCeeEEEEecCCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCc
Q 002892 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHN----------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNN 715 (870)
Q Consensus 646 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 715 (870)
+++++...+..++||||+++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 9999999999999999999999999997532 23678899999999999999999 6679999999999
Q ss_pred eeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh--CCCCCCccccc
Q 002892 716 ILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT--RKKPTDEMFTG 793 (870)
Q Consensus 716 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~ 793 (870)
|++++++.++++|||++..+.............+++.|+|||....+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999976533322222223345678999999888889999999999999999998 67787643221
Q ss_pred cchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 794 EMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
+ .... .. +........... ..+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ~-~~~~-~~--------~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q-VIEN-TG--------EFFRDQGRQVYL--PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-HHHH-HH--------HHHhhccccccC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1100 00 000000000000 0111245678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.93 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=205.5
Q ss_pred cCCCCCCeeccccceeEEEEEecC----CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
++|.+.+.||+|+||.||+|...+ ...||+|...... ....+.+.+|++++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 468888999999999999998543 3468999887654 4456788999999999999999999998875 557899
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876666899999999999999999999 6679999999999999999999999999987664332
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
. .......++..|+|||.+....++.++||||||+++||+++ |..||......+. ....... .
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~~--~----------- 225 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIENG--E----------- 225 (270)
T ss_pred c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcC--C-----------
Confidence 1 11222234568999999988889999999999999999986 9999875432211 1111100 0
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
....+..++..+.+++.+|+..+|++||++.++++.|+++++.
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0001123456789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=304.44 Aligned_cols=248 Identities=31% Similarity=0.490 Sum_probs=200.1
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHH
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLE 669 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 669 (870)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999777999999998765433 5567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccccccc
Q 002892 670 KWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749 (870)
Q Consensus 670 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 749 (870)
+++......+++..+..++.+++.|++||| +++++||||+|+||+++.++.++|+|||.+................+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999876556899999999999999999999 66699999999999999999999999999986543222222122234
Q ss_pred ccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHH
Q 002892 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM 828 (870)
Q Consensus 750 ~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (870)
+..|+|||.+.++.++.++||||||+++|||++ |..||...... ........... ...+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~-----------------~~~~~ 218 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYR-----------------MPAPQ 218 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCC-----------------CCCCc
Confidence 567999999988899999999999999999999 78887653211 11111110000 00011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 829 DCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 829 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
.++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 23557899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.80 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=201.1
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999996 47889999999765545556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++.... .+++..+..++.|++.|++||| +++|+|||++|+||+++.++.++|+|||++....... .
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A 161 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence 99999999987544 4899999999999999999999 6679999999999999999999999999998663221 1
Q ss_pred cccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 743 TQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......+++.|+|||.+. ...++.++||||+||++|||++|+.||......+. ...+...... .+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~-------~~~~-- 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQ-------PPKL-- 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCC-------CCCC--
Confidence 122345788999999874 34577899999999999999999999864321110 0000000000 0000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
......+..+.+++..||+.+|++||+++++++.
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 -----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0011234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.81 Aligned_cols=461 Identities=28% Similarity=0.331 Sum_probs=379.5
Q ss_pred eecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCc
Q 002892 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNS 98 (870)
Q Consensus 19 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 98 (870)
.+|+|.++++ .+|..+..-..+..|+++.|.+-..+-+.+...-.|+.|||++|++. ..|..+..+.+|+.|+++.|.
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 4788899998 68877766666999999999877444445555666999999999998 788899999999999999999
Q ss_pred cccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCc
Q 002892 99 ISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPST 178 (870)
Q Consensus 99 i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 178 (870)
|+ ..|.+...+.+|++|+|.+|++. ..|..+..+++|+.|+++.|++. .+|..+..++.++.++.++|.....++.
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~- 155 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ- 155 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc-
Confidence 98 88888899999999999999998 88999999999999999999986 7888999999999999999933322222
Q ss_pred ccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccccc
Q 002892 179 MGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLS 258 (870)
Q Consensus 179 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~ 258 (870)
...+.++|..|.+.+.++..+..+.. .|||++|.+. --.+..+.+|+.|....|+++.+.
T Consensus 156 -----~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~---------- 215 (1081)
T KOG0618|consen 156 -----TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE---------- 215 (1081)
T ss_pred -----ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----------
Confidence 12788899999998888888877766 7999999987 234778899999999999998754
Q ss_pred ccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhh
Q 002892 259 SLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQ 338 (870)
Q Consensus 259 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 338 (870)
...++|+.|+.++|.+....+ ...+..++.++++.|+++ .+|++++.+.+|+.++..+|++. .+|..+...++
T Consensus 216 --~~g~~l~~L~a~~n~l~~~~~---~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~ 288 (1081)
T KOG0618|consen 216 --ISGPSLTALYADHNPLTTLDV---HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITS 288 (1081)
T ss_pred --ecCcchheeeeccCcceeecc---ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhh
Confidence 235789999999999985432 345678899999999998 46699999999999999999996 78999999999
Q ss_pred HHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCccccc-------------------------ccccceEecCC
Q 002892 339 LQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWS-------------------------LEYILRIDLSS 393 (870)
Q Consensus 339 L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-------------------------l~~L~~L~Ls~ 393 (870)
|+.|...+|-...+|....++..|++|+|..|+|...++..|.. +..|+.|++.+
T Consensus 289 L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lylan 368 (1081)
T KOG0618|consen 289 LVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLAN 368 (1081)
T ss_pred HHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhc
Confidence 99999998888899999999999999999999998443322222 22467788889
Q ss_pred CccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCC
Q 002892 394 NSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIP 473 (870)
Q Consensus 394 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 473 (870)
|.++...-..+-+...|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|.+...++.|++|...+|+|. ..|
T Consensus 369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 9988766567788899999999999998655567889999999999999998 68899999999999999999998 777
Q ss_pred cchhhccccceeeccCCccc-ccCCCCCccccccccccccccc
Q 002892 474 KSFEILSHLKRLNVSHNRLE-GKIPTNGPFRNFLAQSFLWNYA 515 (870)
Q Consensus 474 ~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~~~~~~~~~~~n~~ 515 (870)
.+..++.|+.+|+|.|+|+ +.+|...++++.....+.||.+
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 8999999999999999997 4556555544444444556553
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.41 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=208.5
Q ss_pred hcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..-|...+.||+|.|++|-+|+ ..+|+.||||++.+.. .-....+.+|++.|+.++|||||++|+........|+|.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4567788899999999999998 4589999999997754 334456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC-CCCceEEeccccccccCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|.=++|+|.||+.++...+.+....+++.||..|+.|+|+.| +||||+||+||++- .-|-|||.|||++..+..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 999999999999988888999999999999999999999888 99999999998875 569999999999987743
Q ss_pred CcccccccccccccCCcccccCCCcC-cccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIIS-PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
....+..+|+..|-|||++.+..|+ ++.||||+|||+|.+.+|+.||++..+.+.. ..+.|-.
T Consensus 172 -G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-------------TmImDCK-- 235 (864)
T KOG4717|consen 172 -GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-------------TMIMDCK-- 235 (864)
T ss_pred -cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-------------hhhhccc--
Confidence 3345667899999999999998887 6899999999999999999999875444321 1111110
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+ .-+.....+..++|..|+..||++|.+..||..
T Consensus 236 --Y---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 --Y---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --c---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 0 012234567889999999999999999999864
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=306.48 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=199.8
Q ss_pred CeeccccceeEEEEEecC--C--cEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLFD--G--TNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999987655 567789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc-cc
Q 002892 666 GSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VT 743 (870)
Q Consensus 666 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~ 743 (870)
++|.+++.... ..+++..++.++.|++.||+||| +++++||||+|+||+++.++.+||+|||++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998654 56899999999999999999999 677999999999999999999999999999876442221 11
Q ss_pred ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....++..|+|||++.+..++.++|||||||++|||++ |..||......+ ....+.. .. .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~---~~--------------~ 218 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDK---EG--------------E 218 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh---cC--------------C
Confidence 223456788999999998899999999999999999999 999986532211 1111100 00 0
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
....+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00001123557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.17 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=199.2
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.|++.+.||+|+||.||++... +++.||+|++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 689999999875432 223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999988743 345899999999999999999999 6679999999999999999999999999998653222
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+... . ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~-~------------~~~ 220 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERR-V------------KED 220 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHH-h------------hhc
Confidence 122346899999999999889999999999999999999999999752211 111111000 0 000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVVK 858 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 858 (870)
. .. .+...+..+.+++.+||+.||++|| ++.++++.
T Consensus 221 ~-~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 Q-EE-YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred c-cc-cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0 00 0112345688999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.19 Aligned_cols=241 Identities=22% Similarity=0.276 Sum_probs=191.9
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCC-ceeEEeeeeeeCCeeEEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHR-NLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 660 (870)
+|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|.+++..+.|+ +|+.+++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999865 57899999997643 23445677899999999764 6888999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999999999987654 3789999999999999999999 6779999999999999999999999999986432111
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........ ... .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~------------~~~--~ 219 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQSIME------------HNV--S 219 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHc------------CCC--C
Confidence 1223346899999999999999999999999999999999999999753211 11111100 000 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
. +...+..+.+++.+|+..+|++|++.
T Consensus 220 ~-----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 Y-----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C-----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 01123467899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.98 Aligned_cols=251 Identities=23% Similarity=0.271 Sum_probs=196.2
Q ss_pred CCCCCCeeccccceeEEEEEe----cCCcEEEEEEeechh----hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCee
Q 002892 586 GFNECNLLGAGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 656 (870)
+|++.+.||+|+||.||+|+. .+++.||+|++.+.. ......+..|+++++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999874 358899999997542 23345678899999999 589999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999997654 3899999999999999999999 6779999999999999999999999999997653
Q ss_pred CCCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+....... +.
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~~ 228 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------DP 228 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------CC
Confidence 32221 22234689999999998765 478899999999999999999999964322111 11111100000 00
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
.. +...+..+.+++.+||+.||++|| ++.++++
T Consensus 229 ~~---------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 PF---------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC---------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00 011234678999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.59 Aligned_cols=240 Identities=25% Similarity=0.342 Sum_probs=189.8
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|+.. +++.||+|+++... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999997653 23344566677777764 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++.... .+++.++..++.|++.|++||| +++|+||||||+||++++++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence 99999997643 4889999999999999999999 6779999999999999999999999999987432111 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....+ .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~~~-----------------~~ 215 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDNP-----------------CY 215 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-----------------CC
Confidence 34689999999999998999999999999999999999999975321 111111110000 00
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMT-DVV 856 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 856 (870)
+......+.+++.+||+.+|++||++. ++.
T Consensus 216 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 -PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 011234678999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=307.26 Aligned_cols=248 Identities=31% Similarity=0.518 Sum_probs=203.4
Q ss_pred CeeccccceeEEEEEecC----CcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLFD----GTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|.... +..|++|+++..... ..+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 788999999766543 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 666 GSLEKWLYSH--------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 666 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
++|.+++... ...+++..++.++.|++.|++||| +++++||||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 466999999999999999999999 67799999999999999999999999999987754
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
...........++..|+|||.+....++.++||||+|+++|||++ |..||..... ......... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~-----------~- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK-----------G- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc-----------C-
Confidence 433233344557889999999988889999999999999999999 6889876411 111111110 0
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
.....+..++.++.+++.+||+.+|++||++.|+++.|+
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000011223567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.42 Aligned_cols=241 Identities=24% Similarity=0.293 Sum_probs=191.8
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.+++..+ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57899999997653 23345577788888866 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence 99999987654 3889999999999999999999 6779999999999999999999999999987542221 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......... .. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~----~~------------~~--- 214 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILH----DD------------VL--- 214 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHc----CC------------CC---
Confidence 34689999999999998999999999999999999999999975321 111111100 00 00
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRM-------CMTDVVV 857 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RP-------s~~evl~ 857 (870)
.+..++..+.+++..|++.+|++|| ++.++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0001234688999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.12 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=204.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+++++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467889999999999999999854 24689999986543 23446788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEe
Q 002892 657 ALVLEFMPNGSLEKWLYSHN---------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVS 727 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 727 (870)
++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999997432 23688899999999999999999 6779999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcC
Q 002892 728 DFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLP 806 (870)
Q Consensus 728 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 806 (870)
|||+++...............++..|+|||.+.++.++.++|||||||++||+++ |..||..... .....+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~--- 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVID--- 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHhc---
Confidence 9999986644333223333456789999999988889999999999999999998 8888864221 111111110
Q ss_pred CchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 807 RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
.. . ...+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 237 ~~--------~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GG--------H------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CC--------C------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 00 0 00011235578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.95 Aligned_cols=260 Identities=24% Similarity=0.429 Sum_probs=205.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCc----EEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGT----NVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|+..+.||+|+||.||+|.+. +++ .||+|++.... ......+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999854 444 47888886543 23345688999999999999999999998654 467
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+++||+++|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999877666899999999999999999999 66799999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
...........++..|+|||++.+..++.++||||||+++||+++ |+.||..... .....+......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~---------- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGER---------- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC----------
Confidence 322222223345778999999988899999999999999999997 8899865321 111221111000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
......++..+.+++..||..+|++||++.++++.++++.++.
T Consensus 230 -------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 -------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0001123456889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.75 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=199.6
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|||++++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999965 5788999998766556667788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
+++.+++......+++..+..++.|++.||+||| +.|++||||+|+||+++.++.++++|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 9999988765566899999999999999999999 6779999999999999999999999999987553221 1223
Q ss_pred ccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 746 MTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
...+++.|+|||++. +..++.++||||+||++|||++|+.||...... .......... +.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~-~~------------- 226 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSE-PP------------- 226 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-HHHHHHhhcC-CC-------------
Confidence 345889999999873 445778999999999999999999998753211 1111111000 00
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....+..++..+.+++.+||+.+|++||++.++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 --TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011123457899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=308.84 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=192.5
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
||+|+||.||++..+ +|+.||+|++..... .....+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 689999999865321 2234456799999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccccc
Q 002892 669 EKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747 (870)
Q Consensus 669 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 747 (870)
.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 9888643 345899999999999999999999 6779999999999999999999999999987664322 12234
Q ss_pred ccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHH
Q 002892 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAK 827 (870)
Q Consensus 748 ~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (870)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....+........ . . ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~----~--~~~ 219 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE--------V----K--FEH 219 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc--------c----c--ccc
Confidence 6889999999999888999999999999999999999998753211 11111111111100 0 0 000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 828 MDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 828 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
...+.++.+++.+||+.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 1234568899999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.01 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=204.8
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+|++++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 467889999999999999999865 78999999976644 4577899999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 664 PNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 664 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++++|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999998553 35899999999999999999999 67799999999999999999999999999986632211
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
....+..|+|||++..+.++.++||||||+++||+++ |..||..... ..+.........
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~--------------- 217 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGYR--------------- 217 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCCC---------------
Confidence 2234567999999988889999999999999999997 9999865311 111111110000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
. ..+..++..+.+++.+||..+|++||++.|++++|+++
T Consensus 218 -~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -M-EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -C-CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 00112346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.98 Aligned_cols=244 Identities=23% Similarity=0.261 Sum_probs=192.8
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
||+|+||+||++... +++.||+|.+..... .....+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 789999999875432 2335677899999999999999999999999999999999999999
Q ss_pred HHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 669 EKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 669 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
.+++.. ....+++..+..++.|++.|++||| +++|+||||||+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988753 3345899999999999999999999 67799999999999999999999999999976543222 122
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...|++.|+|||++.+..++.++||||+|+++|||++|+.||....... ............ .. .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~--------~~-------~ 219 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND--------SV-------T 219 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc--------CC-------C
Confidence 3468999999999999999999999999999999999999997532111 011111100000 00 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
.+..++..+.+++.+||+.+|++|| +++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0112345688999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.22 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=193.3
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
++||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 68899999998643 23345678899999988 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99999887554 4899999999999999999999 6779999999999999999999999999987432111 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc---chHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE---MSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+...... .....+..... .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~----- 222 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-------LEKQI----- 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-------HcCCC-----
Confidence 3468999999999999999999999999999999999999997432111 11111111100 00000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMC------MTDVVV 857 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~ 857 (870)
. .+..++..+.+++.+|++.+|++||+ +.++++
T Consensus 223 ~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 R--IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0 00122446889999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.94 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=203.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
...+|++.+.||+|++|.||+|.. .+++.||+|.+..........+.+|+.+++.++|||++++++++......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 346899999999999999999985 4689999999987655556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++... .+++.++..++.|++.|++||| +.||+||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred ccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999999998754 3789999999999999999999 67799999999999999999999999999876532221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+.....+. .
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~----~--------- 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE----L--------- 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHHHhcCCCCC----C---------
Confidence 1223458889999999988889999999999999999999999996532211 111110000000 0
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+...+..+.+++.+||..+|++||++.++++.
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0011233468899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.96 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=205.3
Q ss_pred hcCCCCCCeeccccceeEEEEEecC-CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|+..+.||+|+||.||+|...+ ++.|++|.+..... .+.+.+|++++++++|||++++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4679999999999999999999764 78999999876543 57899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++...+..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999999876677899999999999999999999 56699999999999999999999999999987643321
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ ... .... ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~~--~~~~-----------~~~ 217 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IFM--IPNK-----------PPP 217 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hhh--hccC-----------CCC
Confidence 22234578899999999988999999999999999999999999875322111 000 0000 000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...........+.+++.+||+.+|++||++.||++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00011223457899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.23 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=198.0
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
...++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++...+..|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999965 68899999987532 223456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++.... +++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999999997543 789999999999999999999 67799999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCcccccCC----CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDG----IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~~i~------------ 260 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYSKIM------------ 260 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHHHHH------------
Confidence 221 122345699999999998654 378899999999999999999999975211 11111111
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQ--RMCMTDVVVK 858 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 858 (870)
+....... ......+..+.+++..|+..+|.+ ||++.|+++.
T Consensus 261 ~~~~~~~~---p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNSLNF---PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcccCC---CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00000000 001122445778888888755543 8899998775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=327.54 Aligned_cols=388 Identities=27% Similarity=0.387 Sum_probs=262.5
Q ss_pred CCCCCCCCeecCCCCccc-cCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCC
Q 002892 11 IGNLSFLMYLDISENNFR-GYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSL 89 (870)
Q Consensus 11 ~~~l~~L~~L~ls~n~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 89 (870)
-+-|+..+-+|+|+|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|+.|.+++|++. .+-..++.|+.|
T Consensus 3 tgVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~L 80 (1255)
T KOG0444|consen 3 TGVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRL 80 (1255)
T ss_pred ccccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhh
Confidence 355677778888888887 567777888888888888888887 77888888888888888888887 556677777888
Q ss_pred cEEeccCCcccc-ccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeec
Q 002892 90 VRLDSRFNSISG-NIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVG 168 (870)
Q Consensus 90 ~~L~L~~n~i~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 168 (870)
+.+++..|+++. -+|..+-.+..|+.|+||+|+++ ..|..+..-+++-.|+||+|+|..+.-..|.++..|..
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLf----- 154 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLF----- 154 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhh-----
Confidence 888888887762 35666777777777777777777 67777766666666777766665333333334444444
Q ss_pred ccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccccccc
Q 002892 169 NQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTET 248 (870)
Q Consensus 169 N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 248 (870)
|+|++|++. .+|..+..+..|++|+|++|.+...--..+..+++|++|.+++.+=+-..
T Consensus 155 --------------------LDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N 213 (1255)
T KOG0444|consen 155 --------------------LDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDN 213 (1255)
T ss_pred --------------------hccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhc
Confidence 444444444 45556667777777777777766444444555666666666665433221
Q ss_pred CCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCcccc
Q 002892 249 SSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGT 328 (870)
Q Consensus 249 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 328 (870)
+|.++..+.+|..+|+|.|.+. .+|+.+..+++|+.|+||+|+|+.
T Consensus 214 -------~Ptsld~l~NL~dvDlS~N~Lp--------------------------~vPecly~l~~LrrLNLS~N~ite- 259 (1255)
T KOG0444|consen 214 -------IPTSLDDLHNLRDVDLSENNLP--------------------------IVPECLYKLRNLRRLNLSGNKITE- 259 (1255)
T ss_pred -------CCCchhhhhhhhhccccccCCC--------------------------cchHHHhhhhhhheeccCcCceee-
Confidence 3445666666666666666554 456666677777777777777762
Q ss_pred CCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCC-CCcccccCC
Q 002892 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSG-SLPSDIQNL 407 (870)
Q Consensus 329 ~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l 407 (870)
+........+|++|+||+|+++ .+|.+++.+++|+.|++.+|+++- -+|..++.+
T Consensus 260 -----------------------L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 260 -----------------------LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred -----------------------eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 2223334456777777777777 677777777777777777777652 367788888
Q ss_pred ccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeec
Q 002892 408 KVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNV 487 (870)
Q Consensus 408 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 487 (870)
.+|+.+..++|.+. ..|..+..+..|+.|.|++|++- .+|+++.-|+.|+.|||.+|.=--..|.--..-++|+.-++
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 88888888888886 77888888888888888888876 57888888888888888887433233333222344544433
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=316.13 Aligned_cols=242 Identities=20% Similarity=0.293 Sum_probs=189.5
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|+.. +++.||+|++++.. ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999997643 23445677888888877 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence 99999887654 4899999999999999999999 6679999999999999999999999999987532211 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc---chHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE---MSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+..... .. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-------~~----~~~- 222 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LE----KQI- 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-------hc----CCC-
Confidence 3568999999999999999999999999999999999999996422111 11111111100 00 000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
. -+...+..+.+++.+||+.||++||++
T Consensus 223 -~-~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -R-IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -C-CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0 011224467899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=313.18 Aligned_cols=243 Identities=27% Similarity=0.355 Sum_probs=200.7
Q ss_pred CCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 587 FNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
|...+-||.|+||.||.|+. .+.+.||||.+.... .+.++.+..|++.+++++|||++.+.|+|..+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44456799999999999984 478899999987654 34578899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
| -|+-.|.+.-.+.++.+.++..|..+.+.||+||| +++.||||||+.||++++.|.|||+|||.|..+..
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 9 56888888877777999999999999999999999 77799999999999999999999999999987643
Q ss_pred cccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 743 TQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
...++|||+|||||++. .+.|+-|+||||+|+++.|+..+++|+-.+ +....+.++.....
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNes-------------- 242 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNES-------------- 242 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCC--------------
Confidence 33468999999999885 578999999999999999999999996331 11122222222111
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+.....+....+..++..|++.-|.+|||..++++
T Consensus 243 ---PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 ---PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11122344667889999999999999999988765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.53 Aligned_cols=272 Identities=26% Similarity=0.396 Sum_probs=208.9
Q ss_pred cCCCCCCeeccccceeEEEEEec-----CCcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeee--CCee
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-----DGTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFK 656 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 656 (870)
+.|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999853 3688999999766543 56789999999999999999999999877 5578
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
+++|||+++++|.+++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.++++|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999877666999999999999999999999 6679999999999999999999999999998775
Q ss_pred CCCCcc-cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 737 EDDDSV-TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 737 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
...... ......++..|+|||...+..++.++||||||+++|||++|+.|+......... +...............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence 322211 112233456799999998889999999999999999999999997653221110 0000000000000000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
.+... .....+..++.++.+++.+||+.+|++||++.||+++|++++
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEG-ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcC-CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11100 011112234568999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.53 Aligned_cols=200 Identities=22% Similarity=0.356 Sum_probs=172.2
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.|++++.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999854 68899999997643 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC-
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD- 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 740 (870)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997654 4789999999999999999999 66799999999999999999999999999753311000
Q ss_pred --------------------------------------------cccccccccccccCCcccccCCCcCcccchHhHHHH
Q 002892 741 --------------------------------------------SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVL 776 (870)
Q Consensus 741 --------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~i 776 (870)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCc
Q 002892 777 LMETFTRKKPTDE 789 (870)
Q Consensus 777 l~elltg~~p~~~ 789 (870)
+|||++|+.||..
T Consensus 238 l~elltG~~Pf~~ 250 (382)
T cd05625 238 LYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.89 Aligned_cols=241 Identities=24% Similarity=0.287 Sum_probs=192.8
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|... +++.||+|++++.. ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 57899999998653 23345677888888887 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence 99999987654 4899999999999999999999 6779999999999999999999999999986432211 1122
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+. .. .. .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~---~~--------~~------~- 214 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSIL---ED--------EV------R- 214 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHH---cC--------CC------C-
Confidence 34589999999999999999999999999999999999999975221 11111000 00 00 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCM-----TDVVV 857 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~ 857 (870)
.+..++..+.+++.+||+.+|++||++ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 001234568899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.52 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=195.6
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999854 68999999987543 233466888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999998654 3788999999999999999999 67799999999999999999999999999753310000
Q ss_pred -----------------------------------------cccccccccccccCCcccccCCCcCcccchHhHHHHHHH
Q 002892 741 -----------------------------------------SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLME 779 (870)
Q Consensus 741 -----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~e 779 (870)
........||+.|+|||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC---CHHHHH
Q 002892 780 TFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM---CMTDVV 856 (870)
Q Consensus 780 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---s~~evl 856 (870)
|++|+.||......+.. .... ...... ... .....+..+.+++.+|+ .+|++|+ ++.+++
T Consensus 237 ll~G~~Pf~~~~~~~~~-~~i~--~~~~~~----------~~~---~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 237 MLVGQPPFLADTPAETQ-LKVI--NWETTL----------HIP---SQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhhCCCCCCCCCHHHHH-HHHh--ccCccc----------cCC---CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999763221110 0000 000000 000 00112335667777766 4999999 888887
Q ss_pred HH
Q 002892 857 VK 858 (870)
Q Consensus 857 ~~ 858 (870)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=304.90 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=201.3
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
++|++.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999876543 23456888999999999999999998875 456789999999
Q ss_pred CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 665 NGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 665 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
+++|.+++... ...+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 99999999753 345899999999999999999999 667999999999999999999999999999766432211 1
Q ss_pred ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....++..|+|||...++.++.++||||||+++|||++ |..||......+ ...+.....+.
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~--------------- 222 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM--------------- 222 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC---------------
Confidence 122345678999999988889999999999999999999 888987532211 11111110000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
..+...+..+.+++.+||..+|++||++++|++.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=315.05 Aligned_cols=240 Identities=23% Similarity=0.314 Sum_probs=189.7
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|+.. +|+.||+|+++... .........|..++... +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999997653 23345566777777754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence 99999987654 4889999999999999999999 6679999999999999999999999999986432111 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....+ .. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~~-------------~~-~-- 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDTP-------------HY-P-- 216 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC-------------CC-C--
Confidence 45689999999999999999999999999999999999999965211 111111110000 00 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMT-DVV 856 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 856 (870)
..+...+.+++.+||+.||++||++. ++.
T Consensus 217 --~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 --RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01234678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.28 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=200.9
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh-----hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
+.|+..+.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688999999999999999985 468999999986532 2234578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
|+||+++++|.+++...+. +++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.+......
T Consensus 82 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999999876543 789999999999999999999 667999999999999999999999999998765332
Q ss_pred CCccc-ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVT-QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
..... .....++..|+|||+..+..++.++||||+|+++|||++|+.||...... ....... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~---~~~~--------- 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIA---TQPT--------- 224 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-HHHHHHh---ccCC---------
Confidence 11111 12345778999999999988999999999999999999999998653111 1111100 0000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
. ...+..++..+.+++.+||..+|++||++.++++.
T Consensus 225 ~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 N-----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C-----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 00011234568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.50 Aligned_cols=237 Identities=26% Similarity=0.315 Sum_probs=186.4
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHH-HHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECE-VLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||+||+|+.. +|+.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 789999999976431 22233444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence 99999987654 4889999999999999999999 677999999999999999999999999998753221 11223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... +...... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~--------i~~~~~~--~~--- 216 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDN--------ILNKPLR--LK--- 216 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHH--------HHcCCCC--CC---
Confidence 44689999999999999999999999999999999999999965211 111110 0000000 00
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMT 853 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 853 (870)
...+..+.+++.+|++.+|++||++.
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 --PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 01244688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=316.27 Aligned_cols=241 Identities=22% Similarity=0.292 Sum_probs=192.0
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 660 (870)
+|++.+.||+|+||.||+|+.. +++.||+|++.+.. ......+..|..++..+ +|++|+.+++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999865 57899999997653 22334566777887777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 99999999999876543 889999999999999999999 6679999999999999999999999999987542211
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .. .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~------------~~--~ 219 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEH------------NV--A 219 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHHHHHHHhC------------CC--C
Confidence 122345689999999999999999999999999999999999999975321 1111111100 00 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
.+...+.++.+++.+|++.+|++|++.
T Consensus 220 -----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 -----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 001224467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=304.13 Aligned_cols=239 Identities=22% Similarity=0.330 Sum_probs=189.6
Q ss_pred CeeccccceeEEEEEecC-------------CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 591 NLLGAGSFGSVYKGTLFD-------------GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
+.||+|+||.||+|+..+ ...||+|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258999987666555667888999999999999999999999988999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc-------eEEeccc
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT-------ARVSDFG 730 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Dfg 730 (870)
+||||+++|+|..++......+++..+.+++.||++|++||| +++|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998866666899999999999999999999 677999999999999987654 8999999
Q ss_pred cccccCCCCCcccccccccccccCCccccc-CCCcCcccchHhHHHHHHHHH-hCCCCCCccccccchHHHHHHHhcCCc
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYAS-DGIISPKCDVYSYGVLLMETF-TRKKPTDEMFTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 808 (870)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+ .........
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~--- 226 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEGQC--- 226 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhcCc---
Confidence 98754221 2235778899999886 466889999999999999998 5888775421110 000000000
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
. .. ......+.+++.+||+.+|++||++.+|++.+
T Consensus 227 --~--------~~------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 --M--------LV------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --c--------CC------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 00 01134688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=309.36 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=204.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||.||+|... +++.||+|++..........+..|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467899999999999999999864 6899999999876666667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++...+..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+....... .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 9999999999876667999999999999999999999 6679999999999999999999999999987553221 1
Q ss_pred cccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 743 TQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
......+++.|+|||.+. ...++.++||||+|+++|||++|+.||...... .....+.... +. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~--------~~ 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSE-PP--------TL 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCC-CC--------Cc
Confidence 223345889999999874 345778999999999999999999998753211 1111110000 00 00
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+..++..+.+++..||+.+|++||++.++++.
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 -------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011234568899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.06 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=206.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467899999999999999999864 6789999999876665678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++......+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+....... .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 9999999999876556899999999999999999999 6679999999999999999999999999987653221 1
Q ss_pred cccccccccccCCcccccCC---CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 743 TQTMTMATIGYMAPEYASDG---IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......++..|+|||..... .++.++||||||+++|||++|+.||........ .........+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~~------------ 223 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFPP------------ 223 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCC------------
Confidence 22234578899999998776 788999999999999999999999875322111 11100000000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.........+..+.+++.+||..+|++||++.+|+.
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 --PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000011233557899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=313.38 Aligned_cols=266 Identities=18% Similarity=0.296 Sum_probs=200.2
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67899999999999999999865 67889999987543 22234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++ ++.+++...+..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 975 888888876666899999999999999999999 67799999999999999999999999999875532221
Q ss_pred cccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC--chhhhcchhh-
Q 002892 743 TQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR--GLTEVVDASL- 817 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~- 817 (870)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ........ ..+. .+..+.....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457889999998865 468899999999999999999999997532211 11111110 0000 0111100000
Q ss_pred ----hcccCcc---hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 ----VREVQPS---YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ----~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....+. ......+..+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 001123456789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=305.49 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=205.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..++|++.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|+|++++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4578999999999999999999988888999999875432 346788999999999999999999999988899999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 99999999998643 46899999999999999999999 66699999999999999999999999999986643211
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......++..|+|||.+.+..++.++||||+|+++|++++ |+.||...... .....+ ......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~-~~~~~~------------- 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQV-ERGYRM------------- 223 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH-HcCCCC-------------
Confidence 11122234578999999998889999999999999999998 99998653211 111111 000000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
..+..++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011224578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.16 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=201.1
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
+|++.+.||+|+||.||++... +++.||+|.++.. .....+.+..|+.++++++|+|++++++++...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999865 6899999998643 2345567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 664 PNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 664 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++.+++.. ....+++..+..++.|++.|++||| +++++|+||+|+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 99999999874 3445789999999999999999999 67799999999999999999999999999976643221
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
......|++.|+|||++.+..++.++||||||+++|+|++|..||..... .............
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~------------ 218 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSYK------------ 218 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCCC------------
Confidence 12234588899999999988899999999999999999999999975211 1111100000000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+..++..+.+++.+||+.+|++||++.+++..
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0011234468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.23 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=199.6
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeee-eCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC-NLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||.||+|... |+.||+|.++... ..+.+.+|+.++++++|++++++++++. ..+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 457889999999999999999754 7889999986543 2457889999999999999999999764 45678999999
Q ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++.... ..+++..+..++.|++.|++||| ++|++||||||+||++++++.+|++|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999998643 34889999999999999999999 6779999999999999999999999999987543221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
....++..|+|||+..+..++.++|||||||++|||++ |+.||.... .......+....+.
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~------------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYKM------------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCCC-------------
Confidence 12234568999999998889999999999999999998 898886421 11111111111000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
.....++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00112355788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.79 Aligned_cols=238 Identities=26% Similarity=0.318 Sum_probs=191.2
Q ss_pred CeeccccceeEEEEEe----cCCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 591 NLLGAGSFGSVYKGTL----FDGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3688999999976532 234557789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA 155 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence 999999997654 4899999999999999999999 6679999999999999999999999999987653221 122
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ........ .. . ..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~i~~----~~--------~--~~--- 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMTMILK----AK--------L--GM--- 217 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HHHHHHHc----CC--------C--CC---
Confidence 3356899999999999888999999999999999999999999753111 11111000 00 0 00
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTD 854 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 854 (870)
+...+..+.+++.+||+.||++||++.+
T Consensus 218 --p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 --PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0112346789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.17 Aligned_cols=252 Identities=31% Similarity=0.434 Sum_probs=198.5
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHH--HHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAF--RSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
|++.+.||+|+||+||+|+.. +++.||+|++........ .....|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999965 567899999987653322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
++++|.+++... ..+++..+..++.|+++||++|| +.+++||||||+||+++.++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred cccccccccccc-ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence 999999999833 34899999999999999999999 5669999999999999999999999999997641 22233
Q ss_pred ccccccccccCCccccc-CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 744 QTMTMATIGYMAPEYAS-DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||..... ............. .......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~--------~~~~~~~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKR--------PLPSSSQ 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHT--------HHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcccc--------ccccccc
Confidence 44456889999999998 88899999999999999999999999986411 1111111100000 0000000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
........+.+++.+||+.+|++||++.++++
T Consensus 225 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001257999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=303.24 Aligned_cols=249 Identities=29% Similarity=0.450 Sum_probs=197.2
Q ss_pred CeeccccceeEEEEEec--C--CcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF--D--GTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|... + +..||+|.+..... ...+.+.+|+++++++.|||++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999743 2 36899999876543 34567889999999999999999999876 4567999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc-c
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT-Q 744 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 744 (870)
++|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||.+........... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998665 5899999999999999999999 66699999999999999999999999999986643332211 1
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....++..|+|||...+..++.++||||||+++|||++ |..||..... .....+.....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~----------------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER----------------- 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc-----------------
Confidence 11223567999999998899999999999999999998 9999875321 112221111100
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
...+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0011123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=320.12 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=199.2
Q ss_pred HHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 002892 579 DIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD 654 (870)
Q Consensus 579 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 654 (870)
+.....++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++.+...+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455689999999999999999999965 68899999987532 233455788999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..++||||+++|+|.+++.... +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 9999999999999999987543 788899999999999999999 67799999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCcccccCC----CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDG----IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 810 (870)
...... .......||+.|+|||++... .++.++||||+||++|||++|+.||..... ......+... ....
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~---~~~~ 266 (371)
T cd05622 192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNH---KNSL 266 (371)
T ss_pred cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcC---CCcc
Confidence 643221 122345699999999998653 378899999999999999999999975211 1111111000 0000
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQ--RMCMTDVVVK 858 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 858 (870)
. .......+..+.+++..|+..++.+ ||++.|+++.
T Consensus 267 ~------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 T------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred c------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 0001123456788999999844433 7789888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.05 Aligned_cols=248 Identities=29% Similarity=0.494 Sum_probs=194.4
Q ss_pred CeeccccceeEEEEEec-CCc--EEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGT--NVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|... ++. .+++|.++... ......+..|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999965 343 46888886432 34456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 666 GSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 666 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
|+|.+++...+ ..+++.++..++.|++.|++||| +++++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 24789999999999999999999 6779999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCch
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGL 809 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 809 (870)
++..... .........+..|+|||+.....++.++||||||+++|||++ |..||...... ...... +..
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~----~~~- 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL----PQG- 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHH----hCC-
Confidence 9863211 111112234567999999988889999999999999999997 99998652111 111100 000
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
... ..+..++..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 228 -------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 -------YRL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCC-----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 001123456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.58 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=197.8
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.++||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4688899999999999999985 478999999987543 33446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++++++..+. .+++..+..++.|++.|++||| +.||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 9999997653 2678899999999999999999 677999999999999999999999999999765322
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchH--HHHHHHhcCCchhhhcchhhhcc
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL--KHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ..+... +.+..
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~---- 216 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDED---- 216 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH--------HhccC----
Confidence 1223468899999999998899999999999999999999999997533222111 010000 00000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.........+.++.+++.+||+.+|++||++.|+++.
T Consensus 217 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 -PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000001123468899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.20 Aligned_cols=259 Identities=23% Similarity=0.404 Sum_probs=204.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec--------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL 653 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 653 (870)
..+|++.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 356889999999999999999742 12368999887543 33457789999999999 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL 718 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill 718 (870)
+..+++|||+++|+|.+++.... ..+++.++.+++.|++.|++||| ++|++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 99999999999999999997532 34788999999999999999999 6779999999999999
Q ss_pred CCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchH
Q 002892 719 DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSL 797 (870)
Q Consensus 719 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~ 797 (870)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999986643322222222334567999999999999999999999999999998 8888865311
Q ss_pred HHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 798 KHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
..+........ ....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 243 ~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELFKLLKEGH--------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHcCC--------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11111100000 000011234578899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.41 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=194.0
Q ss_pred CeeccccceeEEEEEec----CCcEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeee-eCCeeEEEEecCC
Q 002892 591 NLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCC-NLDFKALVLEFMP 664 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 664 (870)
+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+.+++.++|||++++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988543 2344567888999999999999999999775 4556889999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc--
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV-- 742 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 742 (870)
+++|.+++.......++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||++..........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876555788889999999999999999 6679999999999999999999999999997653322111
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCC-CCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRK-KPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......++..|+|||.+.+..++.++||||||+++|||++|+ .||... .. .......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~-~~~~~~~~~~---------------~- 219 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DS-FDITVYLLQG---------------R- 219 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CH-HHHHHHHhcC---------------C-
Confidence 112234567899999998888999999999999999999965 455431 11 1111111000 0
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
....+..++..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 220 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 -RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000011234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=304.72 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=202.3
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++||+++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46888899999999999999987788999998865432 23568889999999999999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+++|.+++......+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc-cc
Confidence 99999999876666899999999999999999999 666999999999999999999999999998765432211 12
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....++.+|+|||...++.++.++||||+|+++|||++ |..||...... ....... .. . ....+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~----~~--------~-~~~~~ 223 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETIN----AG--------F-RLYKP 223 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHh----CC--------C-CCCCC
Confidence 22335678999999988889999999999999999998 89998652211 1111000 00 0 00000
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ----RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 012356899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.41 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=202.0
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
++.+++.+.....||+|+||.||+|... +++.||+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445666667789999999999999854 678899999877666667789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceEEecccccccc
Q 002892 659 VLEFMPNGSLEKWLYSHNYFL--DMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFGISKLL 735 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~ 735 (870)
|+||+++++|.+++......+ ++..+..++.|++.|++||| +++|+||||||+||+++. ++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998654435 88889999999999999999 677999999999999976 679999999998765
Q ss_pred CCCCCcccccccccccccCCcccccCCC--cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGI--ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
..... ......+++.|+|||++.... ++.++||||+|+++|+|++|+.||........ ..+...
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~---------- 225 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVG---------- 225 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhh----------
Confidence 33221 122235788999999986543 78899999999999999999999865322111 111000
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... .+. .+..+...+.+++.+||+.+|++||++.++++
T Consensus 226 ---~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 ---MFKI-HPE-IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---hhcc-CCC-CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0000 000 01123456889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=315.44 Aligned_cols=241 Identities=26% Similarity=0.293 Sum_probs=187.4
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHH-HHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESEC-EVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 678899999976431 2223333443 456778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+. +++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~ 154 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS 154 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence 999999986543 788888899999999999999 6779999999999999999999999999987542211 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........ .... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~------------~~~~--~---- 215 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILN------------KPLQ--L---- 215 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHHHh------------CCcC--C----
Confidence 456899999999999999999999999999999999999999752211 11111000 0000 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....+..+.+++.+|++.+|++||++.+...
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 -KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0122446889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.46 Aligned_cols=238 Identities=23% Similarity=0.322 Sum_probs=188.0
Q ss_pred eeccccceeEEEEEecC-------------------------CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEE
Q 002892 592 LLGAGSFGSVYKGTLFD-------------------------GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 646 (870)
.||+|+||.||+|.+.. ...||+|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876655555678889999999999999999
Q ss_pred eeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC----
Q 002892 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---- 722 (870)
Q Consensus 647 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---- 722 (870)
++++......++||||+++|+|..++......+++..+..++.|+++|++||| +++|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999876666899999999999999999999 67799999999999997643
Q ss_pred ---ceEEeccccccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHH-hCCCCCCccccccchH
Q 002892 723 ---TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETF-TRKKPTDEMFTGEMSL 797 (870)
Q Consensus 723 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~ell-tg~~p~~~~~~~~~~~ 797 (870)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|..||......+ .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~ 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K 230 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence 4899999987643211 12346788999998865 56889999999999999995 6888886532211 1
Q ss_pred HHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 798 KHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
..+... .. .... .....+.+++.+||+.+|++||++.+|++.|
T Consensus 231 ~~~~~~------------~~-~~~~------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERFYEK------------KH-RLPE------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHh------------cc-CCCC------CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111110 00 0000 0123588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.31 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=190.4
Q ss_pred CeeccccceeEEEEEecC---CcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 591 NLLGAGSFGSVYKGTLFD---GTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45789998865432 33356888999999999999999999999988999999999999
Q ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 667 SLEKWLYSHN----YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 667 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||++++++.++++|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997432 24677788899999999999999 6779999999999999999999999999997554333222
Q ss_pred cccccccccccCCcccccCC-------CcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 743 TQTMTMATIGYMAPEYASDG-------IISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~-------~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
......++..|+|||++... .++.++||||||+++|||++ |+.||......+. ....+. .......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~----~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVR----EQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhh----cccCCCCC
Confidence 23344577889999988642 35789999999999999996 9999975322211 111000 00000111
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
+.+. ...+..+.+++..|| .+|++||+++||.+.|.
T Consensus 233 ~~~~---------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLK---------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccC---------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1110 012345778999999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.49 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=203.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
...+|++.+.||.|++|.||+|.. .+++.||+|.+..........+.+|+.+++.++|||++++++++...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 345699999999999999999985 4789999999976655556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++... .+++.++..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 97 YLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred ecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999999998754 3899999999999999999999 67799999999999999999999999999876543222
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ...+... ....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~-~~~~------------- 234 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATN-GTPE------------- 234 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc-CCcc-------------
Confidence 12233578899999999988899999999999999999999999965322111 1110000 0000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+..++..+.+++.+||..+|++||++.++++
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0011123456889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.32 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=203.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999865 68889999986543 33446688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++...+ .+++..+..++.|+++|++|||+ ..+++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 99999999998653 48899999999999999999994 246999999999999999999999999998755321
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc--------------
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG-------------- 808 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 808 (870)
......++..|+|||++.+..++.++||||||+++|+|++|+.||.... ......+........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCC
Confidence 1223467899999999988889999999999999999999999986422 111111111110000
Q ss_pred -------hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 809 -------LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 809 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+..+.... ...+.......+..+.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVN-EPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhc-CCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111100 000111111234568999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=314.38 Aligned_cols=201 Identities=28% Similarity=0.397 Sum_probs=173.8
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999965 68999999997532 233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999876666899999999999999999999 67799999999999999999999999999876533221
Q ss_pred cccccccccccccCCcccccC-----CCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002892 741 SVTQTMTMATIGYMAPEYASD-----GIISPKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~ 789 (870)
.......||+.|+|||++.. +.++.++||||+||++|||++|+.||..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 12223468999999999863 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=305.52 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=200.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999854 6899999999776555556788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++...+ .+++.++..++.|++.|++||| +.|++|+||||+||+++.++.++|+|||.+....... .
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 99999999987654 4899999999999999999999 6679999999999999999999999999987653221 1
Q ss_pred cccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 743 TQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......|+..|+|||++. .+.++.++||||+||++|+|++|+.||........ ........... ....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~--~~~~------ 232 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQP--PKLK------ 232 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCCC--Cccc------
Confidence 223346889999999874 45688899999999999999999999864322111 11100000000 0000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....++..+.+++.+|++.+|++||++++|++
T Consensus 233 ------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 ------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00112346789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=315.81 Aligned_cols=239 Identities=25% Similarity=0.307 Sum_probs=187.0
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHH-HHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECE-VLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999854 78999999997653 222334455544 46778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence 99998887544 4899999999999999999999 6779999999999999999999999999987532111 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...|++.|+|||++.+..++.++||||+||++|||++|+.||...... ..... +........ +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~--------~~~~~~~~~--~-- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDN--------ILHKPLVLR--P-- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHH--------HHcCCccCC--C--
Confidence 456899999999999999999999999999999999999999652111 11110 000000000 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 855 (870)
..+..+.+++.+|++.+|++||++.+.
T Consensus 218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 218 ---GASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred ---CCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 123467889999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.30 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=210.2
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCee
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 656 (870)
...+.|++.+.||+|.||.||+++.+ +|+.+|+|++.+... .......+|+++|+++. |||||.+.+.++.....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567888899999999999999966 599999999987653 23468999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC----CceEEeccccc
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN----MTARVSDFGIS 732 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a 732 (870)
++|||++.||.|.+.+... .+++.....++.|++.|++|+| +.||+|||+||+|+++... +.+|++|||++
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999999876 3899999999999999999999 6779999999999999543 57999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
..... .......+||++|+|||++....|+..+||||+|+++|.|++|..||.+....+. ...+....+ +
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-~~~i~~~~~-----~- 256 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-FLAILRGDF-----D- 256 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-HHHHHcCCC-----C-
Confidence 98754 3345567899999999999999999999999999999999999999987432221 111111111 0
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
-...........+.+++..|+..||.+|+++.++++.
T Consensus 257 ---------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 ---------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0111222345678899999999999999999999884
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.10 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=202.9
Q ss_pred CCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|+..+.||.|+||.||.++. ++++.+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488899999999999999984 468999999886542 44456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999865 455899999999999999999999 66799999999999999999999999999986643331
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......+++.|+|||...+..++.++||||+|+++|||++|..||...... .....+.. . ..
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~----~------------~~ 218 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-NLVVKIVQ----G------------NY 218 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHc----C------------CC
Confidence 223346889999999998888899999999999999999999998652111 11111110 0 00
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.. ....++..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~--~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 TP--VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC--CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 00 012234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.38 Aligned_cols=254 Identities=22% Similarity=0.411 Sum_probs=204.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 356899999999999999999997778889999886543 334678899999999999999999999887 778999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ....++.++..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 9999999999853 455789999999999999999999 56799999999999999999999999999976533221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......++..|+|||++..+.++.++|+||||+++|++++ |..||..... .....+.......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~------------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRM------------- 222 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCC-------------
Confidence 11222345678999999998889999999999999999999 8888865311 1111111111000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.49 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=204.1
Q ss_pred HhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
....+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|||++++++++...+..++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 3457899999999999999999985 478999999997665555577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++.+.. +++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 96 EYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cccCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999999987543 789999999999999999999 66799999999999999999999999999876533221
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......+++.|+|||...+..++.++||||+|+++|++++|..||........ .........
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~~~~~~~~~--------------- 232 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGT--------------- 232 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-eeeeccCCC---------------
Confidence 12234578899999999988899999999999999999999999965221110 000000000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....+...+..+.+++.+||+.+|++||++.++++
T Consensus 233 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 -PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000011123456789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=300.71 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=200.2
Q ss_pred CCCCCCeeccccceeEEEEEecCCcEEEEEEeechh------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
+|++.+.||+|+||.||+|...+++.+|+|.+.... .+....+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 578899999999999999998889999999886432 23346688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++.+.. .+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997654 3789999999999999999999 6669999999999999999999999999987653211
Q ss_pred C----cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 740 D----SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 740 ~----~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
. ........++..|+|||+..+..++.++||||+|+++|+|++|+.||....... ........ .... +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~---~~~~----~ 228 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAH---RGLM----P 228 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhc---cCCC----C
Confidence 1 111223457889999999998889999999999999999999999996532111 11110000 0000 0
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. +..++..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RL---------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC---------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0123456889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=325.49 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=191.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--------C
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--------D 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~ 654 (870)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999864 68999999885432 2345699999999999999998876432 2
Q ss_pred eeEEEEecCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEeccc
Q 002892 655 FKALVLEFMPNGSLEKWLY---SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFG 730 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg 730 (870)
..++||||+++ ++.+++. .....+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 7777765 23456899999999999999999999 67799999999999998765 79999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPRG 808 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~ 808 (870)
+|..+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|..||.+.... ..+....... .+..
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Confidence 9986643221 223467899999998865 46899999999999999999999999763221 2222222111 1110
Q ss_pred -hhhhcchhhhc----ccCc----chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 -LTEVVDASLVR----EVQP----SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 -~~~~~~~~~~~----~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......+.... .... ..-+...+.++.+++.+||+.+|++|||+.|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000000000 0000 0001123457899999999999999999999974
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=278.72 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=206.2
Q ss_pred HHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--------hHHHHHHHHHHHHHHhc-CCCceeEEee
Q 002892 579 DIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--------ERAFRSFESECEVLRNV-RHRNLIKIFS 648 (870)
Q Consensus 579 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~ 648 (870)
..+.....|...+.+|.|..++|.++..+ +|..+|+|++.... ......-.+|+.+++++ .||+|+.+.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 34555678888999999999999988754 68889999885432 23345567899999998 6999999999
Q ss_pred eeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEec
Q 002892 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 649 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
+++.+...++|+|.|+.|-|.|++.+... +++.+..+|++|+..|++||| .+.|||||+||+||+++++.++||+|
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence 99999999999999999999999986554 899999999999999999999 55599999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCCccccc------CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 002892 729 FGISKLLGEDDDSVTQTMTMATIGYMAPEYAS------DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 729 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 802 (870)
||+|+.+..+ ......+|||+|.|||.+. ...|+...|.|+.|+|+|.++.|++||... .....+..+..
T Consensus 167 FGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-kQmlMLR~Ime 242 (411)
T KOG0599|consen 167 FGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-KQMLMLRMIME 242 (411)
T ss_pred cceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-HHHHHHHHHHh
Confidence 9999977433 3445568999999999884 234788999999999999999999998641 11111111111
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+ .-..++..+......+++.+|++.||++|.|++|+++.
T Consensus 243 Gky---------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 243 GKY---------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccc---------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111 01122344566788999999999999999999999763
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.32 Aligned_cols=266 Identities=18% Similarity=0.235 Sum_probs=199.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
...+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3568999999999999999999965 578999996432 345689999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
++ .++|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++........
T Consensus 241 ~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 99 47999998866566999999999999999999999 677999999999999999999999999999866433222
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccc------cchHHHHHHH-hc-----CCch
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTG------EMSLKHWIKL-SL-----PRGL 809 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~------~~~~~~~~~~-~~-----~~~~ 809 (870)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+-..... ...+...+.. .. +...
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2223456899999999999999999999999999999999988664321111 1122222221 11 1100
Q ss_pred h-hhcc---hhhhcccC-----cchH-HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 810 T-EVVD---ASLVREVQ-----PSYA-KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 810 ~-~~~~---~~~~~~~~-----~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
. .... ........ ..+. .......+.+++.+|++.||++|||+.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000 00000000 0000 00112367889999999999999999999864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=319.93 Aligned_cols=201 Identities=25% Similarity=0.386 Sum_probs=174.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|+..+.||+|+||.||+|... +++.||+|+++... ......+..|+.++.+++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 68999999997543 334567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999997654 3899999999999999999999 77799999999999999999999999999875432110
Q ss_pred c---------------------------------ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCC
Q 002892 741 S---------------------------------VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPT 787 (870)
Q Consensus 741 ~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~ 787 (870)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346899999999999999999999999999999999999999
Q ss_pred Cc
Q 002892 788 DE 789 (870)
Q Consensus 788 ~~ 789 (870)
..
T Consensus 237 ~~ 238 (360)
T cd05627 237 CS 238 (360)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.44 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=202.4
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++++.||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999865 58899999987543 44567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++... .+++.++..++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||++....... .
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence 9999999998754 3789999999999999999999 6779999999999999999999999999997653322 1
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
......++..|+|||++.+..++.++||||||+++|||++|..||........ .... +.. .
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~----~~~-------------~ 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFLI----PKN-------------N 217 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhhh----hcC-------------C
Confidence 22234578899999999888899999999999999999999999875322110 0000 000 0
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.......++..+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001122356678999999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.69 Aligned_cols=249 Identities=26% Similarity=0.465 Sum_probs=197.0
Q ss_pred CeeccccceeEEEEEecC-------CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 591 NLLGAGSFGSVYKGTLFD-------GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998542 2579999876543 24456788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-----ceEEecccc
Q 002892 663 MPNGSLEKWLYSH------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-----TARVSDFGI 731 (870)
Q Consensus 663 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~ 731 (870)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++||||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 234788999999999999999999 66799999999999999877 899999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLT 810 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 810 (870)
+................++..|+|||++.++.++.++||||||+++|||++ |..||...... .....+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~---~--- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTA---G--- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhc---C---
Confidence 976543333222333446788999999999999999999999999999998 99998643211 11111100 0
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
. .......++..+.+++.+||..+|++||++++|.+.|++
T Consensus 230 -----~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 -----G------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----C------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 000111235678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.40 Aligned_cols=267 Identities=19% Similarity=0.275 Sum_probs=201.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357899999999999999999865 68899999987543 2233457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++ ++|.+++......+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||++........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 997 5999998876666899999999999999999999 67799999999999999999999999999976532221
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH---hcCCchhhhcchhh
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL---SLPRGLTEVVDASL 817 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 817 (870)
......+++.|+|||++.+ ..++.++||||+|+++|||++|+.||..... .......... .....+....+...
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1223356889999998865 4578899999999999999999999975322 1111111110 01111111111110
Q ss_pred hcccC-cc-------hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQ-PS-------YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~-~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... +. ......+..+.+++.+|++.+|.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00 000123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.66 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=190.7
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|+.++.++ +||+|+.+++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 67899999998653 23445678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence 99999887554 4899999999999999999999 6779999999999999999999999999987532211 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc-chHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE-MSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+...... .....+.... +.....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~------------~~~~~~~- 221 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV------------ILEKPIR- 221 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH------------HHhCCCC-
Confidence 3568999999999999999999999999999999999999996432211 1111111100 0000000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMT 853 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 853 (870)
.+...+..+.+++.+|++.||++||++.
T Consensus 222 -~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 -IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0111234678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.40 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=198.1
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC------
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL------ 653 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------ 653 (870)
.+.+.|++.+.||+|+||.||+|... +++.||+|++..... ....+..|+.+++++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678899999999999999999854 688999999875532 335678899999998 699999999998653
Q ss_pred CeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
...+++|||+++++|.+++... ...+++..+..++.|++.|++||| +++|+||||+|+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4678999999999999999864 345899999999999999999999 667999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
....... .......|+..|+|||++. ...++.++||||+||++|||++|+.||...... ...... ..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~--~~ 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLI--PR 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHH--hc
Confidence 7653221 1223356889999999886 345788999999999999999999998653211 111100 00
Q ss_pred chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ..+......++..+.+++.+||..+|++||++.++++
T Consensus 231 ~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 0000011123456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.29 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=191.3
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 660 (870)
+|+..+.||+|+||.||+|... +|+.||+|++.... ......+..|..+++.+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999855 68999999997643 233456778888888885 577888999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+. +++.++..++.|++.|++||| ++||+||||||+||++++++.+||+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 99999999999876543 899999999999999999999 6779999999999999999999999999987542221
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... .. .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~~------------~~--~ 219 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELFQSIMEH------------NV--S 219 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC------------CC--C
Confidence 1222345899999999999989999999999999999999999999753211 111111000 00 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
.+...+..+.+++.+|++.+|++|++.
T Consensus 220 -----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 -----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 001123467889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.76 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=202.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||.|++|.||+|... +++.||+|++.... ......+.+|+++++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999965 68999999987653 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++... .+++..+..++.|++.|++||| +++++||||+|+||++++++.++++|||++....... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 9999999999865 5899999999999999999999 6779999999999999999999999999998764332 1
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||....... .........+.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~--------------- 216 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNPP--------------- 216 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCCC---------------
Confidence 2233467889999999998889999999999999999999999996532110 00000000000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......++..+.+++.+||..+|++||++.++++
T Consensus 217 -~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 -SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0000013446889999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.62 Aligned_cols=264 Identities=20% Similarity=0.218 Sum_probs=195.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-----
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD----- 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 654 (870)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 68999999986532 334566788999999999999999999886443
Q ss_pred -eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 655 -FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 655 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999965 56666542 3788899999999999999999 6779999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... .......... ......+..
T Consensus 172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~~~~~-~~~~~~~~~ 246 (359)
T cd07876 172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNKVIEQ-LGTPSAEFM 246 (359)
T ss_pred ccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHh-cCCCcHHHH
Confidence 54321 122334688999999999999999999999999999999999999975321 1111111110 000000000
Q ss_pred c-------hhhhccc-C----------------cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 814 D-------ASLVREV-Q----------------PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 814 ~-------~~~~~~~-~----------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+ ....... . ...........+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000 0 000001123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=313.11 Aligned_cols=237 Identities=24% Similarity=0.290 Sum_probs=185.4
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHH-HHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESEC-EVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
++||+|+||.||+|+.. +++.||+|++.+.. ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999997543 12233444454 467888999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 99998887543 4788999999999999999999 6779999999999999999999999999987532211 1223
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...|++.|+|||++.+..++.++||||+||++|||++|+.||.... ......... .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~--------~~~~~------- 214 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNIL--------HKPLQ------- 214 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHh--------cCCCC-------
Confidence 3468999999999998899999999999999999999999996521 111111100 00000
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMT 853 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 853 (870)
.+......+.+++.+|++.+|++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0011234688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=335.24 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=200.1
Q ss_pred hhHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeee-
Q 002892 577 YLDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCN- 652 (870)
Q Consensus 577 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~- 652 (870)
+.+.....++|++.+.||+|+||+||+|+.. +++.||+|++... .......+..|+.++++++||||++++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3444556689999999999999999999965 5788999998653 23445678899999999999999999998854
Q ss_pred -CCeeEEEEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCcEecccCCCceeeCC----
Q 002892 653 -LDFKALVLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSH----STPVVHCNLKPNNILLDK---- 720 (870)
Q Consensus 653 -~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~----~~~ivH~dlk~~Nill~~---- 720 (870)
....|+||||+++|+|.+++... ...+++..++.|+.||+.||+|||..+ .++||||||||+|||++.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 45689999999999999999742 245899999999999999999999543 156999999999999964
Q ss_pred -------------CCceEEeccccccccCCCCCcccccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCC
Q 002892 721 -------------NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKK 785 (870)
Q Consensus 721 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~ 785 (870)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 3458999999998664322 1233468999999999854 458899999999999999999999
Q ss_pred CCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 786 PTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 786 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
||..... ...+..... ... .......+..+.+++..||..+|.+||++.++++
T Consensus 242 PF~~~~~----~~qli~~lk-------------~~p--~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANN----FSQLISELK-------------RGP--DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCc----HHHHHHHHh-------------cCC--CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9965211 111111000 000 0000112456889999999999999999999984
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=304.00 Aligned_cols=240 Identities=22% Similarity=0.379 Sum_probs=189.8
Q ss_pred CeeccccceeEEEEEecC--------CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 591 NLLGAGSFGSVYKGTLFD--------GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888888766556667788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc--------eEEeccccccc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT--------ARVSDFGISKL 734 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~a~~ 734 (870)
+++|+|.++++..+..+++..+..++.|++.|++||| +++|+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876667899999999999999999999 677999999999999987765 69999998875
Q ss_pred cCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCC-CCCCccccccchHHHHHHHhcCCchhhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRK-KPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
... .....+++.|+|||++.+ ..++.++||||||+++|||++|. .||...... .. .....
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~-~~~~~---------- 219 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KK-LQFYE---------- 219 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HH-HHHHH----------
Confidence 432 122357788999999976 45789999999999999999985 554431111 00 00000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
... ... ......+.+++.+||+.+|++||+++++++.|+
T Consensus 220 --~~~--~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 --DRH--QLP-----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --ccc--cCC-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000 011246889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.91 Aligned_cols=265 Identities=20% Similarity=0.235 Sum_probs=200.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec---CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF---DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..+|++.+.||+|+||.||+|... .++.||+|.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999743 3578999987643 23467999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|++. +++.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.++|+|||++........
T Consensus 166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9995 688888853 345899999999999999999999 67799999999999999999999999999987654433
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccc--cchHHHHHHHh------cCCchhhh
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTG--EMSLKHWIKLS------LPRGLTEV 812 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~~------~~~~~~~~ 812 (870)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ...+....... ++......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 33334457899999999999999999999999999999999999998653322 11222222110 11100000
Q ss_pred cchhh---hcccCcch------HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 813 VDASL---VREVQPSY------AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 813 ~~~~~---~~~~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+.+.. .....+.+ ........+.+++.+|+..+|++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000000 011124467889999999999999999999764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.99 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=197.6
Q ss_pred CCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-----eeE
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-----FKA 657 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 657 (870)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+++.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999985 478999999986432 234467889999999999999999999998766 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+. ++|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 68888876543 4899999999999999999999 67799999999999999999999999999986532
Q ss_pred CCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh----
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV---- 812 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 812 (870)
.. ........+++.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..+....-.....++
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhh
Confidence 22 2222334578999999998764 4789999999999999999999999763221 112111111000000000
Q ss_pred --cchhhhcccC-cc-h-----HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 813 --VDASLVREVQ-PS-Y-----AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 813 --~~~~~~~~~~-~~-~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
....+..... .. . ........+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 00 0 001124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.05 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=198.9
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
+|.+.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999854 68899999886432 1233568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.++||||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997654 4789999999999999999999 667999999999999999999999999999866
Q ss_pred CCCCCc----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 736 GEDDDS----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 736 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
...... .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~--------- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFKIGE--------- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHHHhc---------
Confidence 422111 1111234788999999999888999999999999999999999999753211 11100000
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+. .+...+..+.+++.+||+.+|++||++.+|++
T Consensus 227 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 NASPE---------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCc---------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000 01123457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.41 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=196.0
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+++.+ +++.||+|++.+.. ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999965 57889999986532 223345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++......+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 999999999999876556899999999999999999999 6779999999999999999999999999987553222
Q ss_pred cccccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 741 SVTQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
........||+.|+|||++. .+.++.++|||||||++|||++|+.||...... ......... ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~--~~~~------ 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNH--KERF------ 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-HHHHHHhCC--Cccc------
Confidence 11223346899999999986 346788999999999999999999999752111 111110000 0000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQ--RMCMTDVVVK 858 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 858 (870)
... .....++..+.+++.+|+..+|++ |+++.|+++.
T Consensus 228 ----~~p--~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ----QFP--AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----cCC--CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 001123456788888887654444 7889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=311.26 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=207.8
Q ss_pred hcCCCCCCeeccccceeEEEEEecC-CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.+-|.++.-+|.|+||.||+|..++ +-..|.|++..........|.-|++++..+.||+||.+++.|.-++.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3457778889999999999998653 455688998888788889999999999999999999999999888999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
|+||-++..+-.-+..+.+.++.-+++|++.||.||| ++.|||||+|+.|||++-+|.++|+|||.+.... ....
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence 9999999988877778999999999999999999999 6669999999999999999999999999986432 1223
Q ss_pred cccccccccccCCcccc-----cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 743 TQTMTMATIGYMAPEYA-----SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~-----~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
....+.|||+|||||+. ...+|++++||||||+++.||..+.+|..+..+. .... +..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVll-------------Kia 248 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLL-------------KIA 248 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHH-------------HHh
Confidence 34567899999999976 4678999999999999999999999997663221 1111 111
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+.....+......+.+++..|+..||..||+++++++
T Consensus 249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1122222233445567889999999999999999999875
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.63 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=196.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|..++..++|++|+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 68899999987532 233455788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875556899999999999999999999 67799999999999999999999999999976643222
Q ss_pred cccccccccccccCCcccccC-----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 741 SVTQTMTMATIGYMAPEYASD-----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.......|++.|+|||++.+ +.++.++||||+||++|||++|+.||...... ........ ...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~---~~~------- 225 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMN---HEE------- 225 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHHHHHc---CCC-------
Confidence 12233568999999999875 56788999999999999999999999652111 01111000 000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQ--RMCMTDVVVK 858 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 858 (870)
...... ...+.+.++.+++.+|+...+++ |+++.++++.
T Consensus 226 --~~~~p~--~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 --RFQFPS--HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --cccCCC--ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000000 00123456888899988865544 4578877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.38 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=197.8
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|++++.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999865 68999999986543 22234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999998643 345899999999999999999999 6779999999999999999999999999987653222
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||........ ...... ..+. .....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~---------~~~~-~~~~~ 224 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVER---------LVKE-VQEEY 224 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHh---------hhhh-hhhhc
Confidence 11234689999999999999999999999999999999999999975322110 000000 0000 00000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
...++..+.+++.+||+.+|++||+ +.|+++
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 -----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1123446889999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.99 Aligned_cols=250 Identities=23% Similarity=0.276 Sum_probs=197.4
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|++++++++|++++.+.+++...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 68999999986543 22234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999988743 345899999999999999999999 6779999999999999999999999999987653221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......|+..|+|||++.+..++.++|+||+|+++|||++|+.||...... .....+... ...... ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~~-~~~~~~---------~~ 224 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDRR-VLETEE---------VY 224 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh-hhcccc---------cc
Confidence 122346899999999999889999999999999999999999999753211 111111110 000000 00
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVVK 858 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~ 858 (870)
....+..+.+++..||+.+|++||+ +.+++..
T Consensus 225 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 -----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112346789999999999999999 6676653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=299.50 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=187.3
Q ss_pred eeccccceeEEEEEecC---CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCC
Q 002892 592 LLGAGSFGSVYKGTLFD---GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGS 667 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 667 (870)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|++.++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3568888775443 3334567889999999999999999999999999999999999999
Q ss_pred HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 668 LEKWLYSHN----YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 668 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
|.+++.... ...++.....++.|++.|++||| +.+|+||||||+||++++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999998543 23467788999999999999999 66799999999999999999999999999875433222222
Q ss_pred ccccccccccCCcccccC-------CCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 744 QTMTMATIGYMAPEYASD-------GIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.....+++.|+|||+... ..++.++||||+||++|||++ |..||......+ .+...... ......++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~----~~~~~~~~ 233 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVRE----QDIKLPKP 233 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhc----cCccCCCC
Confidence 233446778999998743 356789999999999999999 777876532211 11111110 00000111
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
.. ...++..+.+++..|| .+|++||++++|++.|
T Consensus 234 ~~---------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 QL---------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cc---------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00 1123446778888999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.41 Aligned_cols=255 Identities=22% Similarity=0.397 Sum_probs=202.3
Q ss_pred cCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999854 3467999988655433 5677899999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecc
Q 002892 658 LVLEFMPNGSLEKWLYSHN--------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
+||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999998544 14899999999999999999999 667999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCc
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 808 (870)
|++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||...... ........ ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~---~~ 235 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA---GK 235 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc---CC
Confidence 9986442221 122233356778999999988888999999999999999999 77888542211 11111110 00
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
.. .. ....++..+.+++.+||+.+|++||++.|+++.|.+
T Consensus 236 ~~--------~~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 236 LE--------LP-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cC--------CC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00 00 011234578999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.27 Aligned_cols=246 Identities=24% Similarity=0.421 Sum_probs=199.8
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEE---EEEeec-hhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe--eEEE
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVA---IKVFNL-QLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF--KALV 659 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~va---vK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv 659 (870)
.+..++||+|+|-+||+|.+. +|..|| ||.-+. ...+..+++..|+.+++.|+||||++++++|.+... ..+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345678999999999999854 465554 222111 124456889999999999999999999999987665 6689
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEeccccccccCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGED 738 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~ 738 (870)
+|.+..|+|..|.++.+. .....+.+|++||++||.|||.++ ++|+|||||=.||||..+ |.|||+|.|+|......
T Consensus 122 TEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999999998766 889999999999999999999864 789999999999999765 99999999999987433
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.. ....|||.|||||+.. ..|+...||||||++++||.|+.+||.+.......+..++....|..+..+-|+
T Consensus 200 ~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP--- 271 (632)
T KOG0584|consen 200 HA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP--- 271 (632)
T ss_pred cc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH---
Confidence 22 2257999999999886 789999999999999999999999998855544434444333344445555443
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
++.++|.+|+.. .++||++.|+++
T Consensus 272 --------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 --------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 477899999999 899999999975
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.48 Aligned_cols=250 Identities=31% Similarity=0.528 Sum_probs=200.7
Q ss_pred CCCCCeeccccceeEEEEEecC-----CcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 587 FNECNLLGAGSFGSVYKGTLFD-----GTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
+++.+.||.|+||.||+|...+ +..||+|++...... ..+.+..|++++++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999653 388999999765433 5678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
||+++++|.+++...... +++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999865444 899999999999999999999 6779999999999999999999999999998765432
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
..... ...+++.|+|||...+..++.++||||+|+++|+|++ |..||..... ............
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~------------ 222 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGYR------------ 222 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCC------------
Confidence 22211 2236789999999988889999999999999999998 7777764211 111111110000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
......++.++.+++.+|+..+|++|||+.++++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000112456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.62 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=198.4
Q ss_pred CCCCCeeccccceeEEEEEec----CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC------
Q 002892 587 FNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD------ 654 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 654 (870)
|++.+.||+|+||.||+|.+. +++.||+|++.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999853 36889999987542 334567889999999999999999999886432
Q ss_pred eeEEEEecCCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecc
Q 002892 655 FKALVLEFMPNGSLEKWLYSH-----NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
..++++||+++|+|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999887532 234789999999999999999999 667999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCc
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 808 (870)
|.+................+++.|++||......++.++||||||+++|||++ |+.||..... .....+.... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~--~~ 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG--NR 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC--Cc
Confidence 99986643332222233345678999999988889999999999999999999 8888765322 1111111100 00
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
. . ....++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 234 ~---------~------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 L---------K------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C---------C------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 0012345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=298.40 Aligned_cols=238 Identities=23% Similarity=0.412 Sum_probs=189.5
Q ss_pred CeeccccceeEEEEEecCCc-----------EEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 591 NLLGAGSFGSVYKGTLFDGT-----------NVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
+.||+|+||.||+|...+.. .+++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 5788887655433 5788899999999999999999999887 778999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-------ceEEeccccc
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-------TARVSDFGIS 732 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfg~a 732 (870)
|||+++|+|.+++...+..+++..+..++.|++.||+||| +++++||||||+||+++.++ .++++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876656899999999999999999999 67799999999999999887 7999999998
Q ss_pred cccCCCCCcccccccccccccCCcccccCC--CcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCch
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDG--IISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGL 809 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 809 (870)
..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||...... ....+... ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~--~~-- 223 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQD--QH-- 223 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhc--CC--
Confidence 86532 2223466789999998876 78899999999999999999 56777553211 11111110 00
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
... .+. ...+.+++.+||..+|++||++.+|++.|+
T Consensus 224 -------~~~--~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -------RLP--MPD------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------CCC--CCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000 146889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.81 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=205.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888999999999999999865 68899999886543 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++...+ .+++..+..++.+++.|++|||+ .++++||||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 999999999987654 48999999999999999999994 2469999999999999999999999999986542211
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
.....|+..|+|||++.++.++.++|||||||++|++++|+.||......... ...+....+.+..... ..
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~-~~ 229 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMGILDLLQQIVQ-EP 229 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhHHHHHHHHHhh-cc
Confidence 12346889999999998888999999999999999999999999754322110 0000011111111111 11
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
.+......++..+.+++.+||+.+|++||++.|+++..
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111223456789999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.34 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=192.7
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhc---CCCceeEEeeeeee-----CC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNV---RHRNLIKIFSSCCN-----LD 654 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 654 (870)
+|++.+.||+|+||+||+|... +++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999865 689999999875421 1223455666666655 69999999998754 34
Q ss_pred eeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
..+++|||++ +++.+++... ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999997 4898888754 345899999999999999999999 6779999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc--hh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPRG--LT 810 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~--~~ 810 (870)
...... ......++..|+|||++.+..++.++||||+||++|||++|+.||...... ..+...... ..+.. +.
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence 664322 122345789999999999889999999999999999999999998653221 112222111 11110 00
Q ss_pred hhc---chhhhcccCcc--hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 811 EVV---DASLVREVQPS--YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 811 ~~~---~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... ........... .....++..+.+++.+|++.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000000 001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.28 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=199.4
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+..|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566778999999999999854 67899999987543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
++++|.+++... .+++..+..++.|++.|++||| +++++|+||+|+||++++++.++++|||++....... ..
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06642 85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence 999999998653 4789999999999999999999 6779999999999999999999999999987654321 12
Q ss_pred ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
.....++..|+|||++.+..++.++||||||+++|||++|+.||....... ...+.....+ +
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~----------------~ 219 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNSP----------------P 219 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCCC----------------C
Confidence 223457889999999998889999999999999999999999986532211 0111000000 0
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ....++..+.+++.+||+.+|++||++.++++
T Consensus 220 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 T-LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred C-CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 01123456889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.94 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=201.0
Q ss_pred chhHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeee--
Q 002892 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCC-- 651 (870)
Q Consensus 576 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-- 651 (870)
.+..+..++++|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556678899999999999999999999864 68899999886532 2235677899999999 6999999999874
Q ss_pred ---eCCeeEEEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceE
Q 002892 652 ---NLDFKALVLEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR 725 (870)
Q Consensus 652 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 725 (870)
..+..++||||+++++|.+++.. ....+++..+..++.|+++|++||| +.+++||||||+||++++++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence 34568999999999999998763 2345889999999999999999999 67799999999999999999999
Q ss_pred EeccccccccCCCCCcccccccccccccCCcccccC-----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHH
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD-----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW 800 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~ 800 (870)
++|||++........ ......|++.|+|||++.. ..++.++||||+||++|||++|+.||...... ..+
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~~ 238 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RAL 238 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HHH
Confidence 999999876533221 2223458899999998753 44788999999999999999999998653211 111
Q ss_pred HHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
... .... .. ....+..+...+.+++.+||+.+|++||++.||++.
T Consensus 239 ~~~--~~~~----~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 FKI--PRNP----PP-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hhc--cccC----CC-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 0000 00 000011123468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=296.53 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=201.3
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|++.+.||+|+||.+|++... +|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999854 68999999987542 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999998754 345789999999999999999999 66799999999999999999999999999976643221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......|++.|+|||+..++.++.++||||||+++|+|++|+.||..... ...+. .......
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~------------~~~~~~~ 218 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVL------------KIIRGSY 218 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHH------------HHhcCCC
Confidence 12234578899999999988899999999999999999999999864211 11111 1100000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.. .+...+..+.+++.+||+.+|++||++.+|++.
T Consensus 219 ~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PP--VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CC--CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 111234568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=304.67 Aligned_cols=255 Identities=21% Similarity=0.249 Sum_probs=198.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999965 57899999987653 233457888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+........
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997654 4899999999999999999999 67799999999999999999999999998864211000
Q ss_pred -------------cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 002892 741 -------------SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 741 -------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
........++..|+|||.+....++.++|+||||+++|||++|+.||.+.... ...........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~~~~~~~~~~~~~ 235 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIEW 235 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCC
Confidence 00111235778899999998888999999999999999999999998642111 1111111000000
Q ss_pred chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 808 GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
+. ....++..+.+++.+||+.+|++||++.++.+.++
T Consensus 236 ---------------~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 236 ---------------PE-GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ---------------CC-ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 00 00123456899999999999999999765555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.37 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=203.8
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|+..+.||+|++|.||+|... +++.||+|++.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999966 68999999987653 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS-TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++......+++..+..++.|++.|++||| + .+++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999999876566899999999999999999999 6 7799999999999999999999999999875532111
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
....++..|+|||...+..++.++||||+|+++|+|++|+.||............... .... ..
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------~~~~-~~ 220 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ------------YIVN-EP 220 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH------------HHhc-CC
Confidence 1156788999999999999999999999999999999999998753221111111111 0000 00
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+......++..+.+++..||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 011111114557899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=298.45 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=199.4
Q ss_pred CCCCCCeeccccceeEEEEEecC--CcEEEEEEeech----------hhHHHHHHHHHHHHHHh-cCCCceeEEeeeeee
Q 002892 586 GFNECNLLGAGSFGSVYKGTLFD--GTNVAIKVFNLQ----------LERAFRSFESECEVLRN-VRHRNLIKIFSSCCN 652 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 652 (870)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 688999987532 12334557778888765 699999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecc
Q 002892 653 LDFKALVLEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
.+..+++|||+++++|.+++.. ....+++..+++++.|++.|++|||+ ..+++||||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998753 34568999999999999999999993 256999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGL 809 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 809 (870)
|.+....... ......++..|+|||...++.++.++||||||+++|+|++|+.||...... .....+. ....
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~---~~~~ 230 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLATKIV---EAVY 230 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHHHHh---hccC
Confidence 9998664332 233456888999999999888999999999999999999999998642111 1111000 0000
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
.. .....++..+.+++.+||+.+|++||++.|+.++++
T Consensus 231 ~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EP-------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred Cc-------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 000112356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.81 Aligned_cols=261 Identities=20% Similarity=0.247 Sum_probs=194.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999965 5788999975432 234689999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+ .++|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+...... .
T Consensus 139 ~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 211 (357)
T PHA03209 139 Y-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---P 211 (357)
T ss_pred c-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---c
Confidence 9 46899998876667999999999999999999999 667999999999999999999999999998754221 1
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCC-Cccccccc--------hHHHHHHH------hcCC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPT-DEMFTGEM--------SLKHWIKL------SLPR 807 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~-~~~~~~~~--------~~~~~~~~------~~~~ 807 (870)
......||+.|+|||++.+..++.++|||||||++|||+++..|+ +....... .+...... .++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 222345899999999999999999999999999999999865554 33211100 11111110 0110
Q ss_pred ch-----hhhcch-hhhcccCcc---hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 GL-----TEVVDA-SLVREVQPS---YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~~-----~~~~~~-~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. ...++. ...+..... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00 001100 000000001 111123445677999999999999999999975
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.98 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=198.5
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee-CCeeEEEEe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN-LDFKALVLE 661 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 661 (870)
+|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5888999999999999999855 57899999986543 3445678899999999999999999988764 446789999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|+++++|.+++... ...+++.++..++.+++.|+++|| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999999853 345899999999999999999999 6679999999999999999999999999997663322
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......+++.|+|||+..+..++.++||||+|+++|+|++|+.||..... ............+ .
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~-------------~ 221 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-NSLVYRIIEGKLP-------------P 221 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCCC-------------C
Confidence 122234578899999999999999999999999999999999999864211 1111110000000 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 -----MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -----CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=314.39 Aligned_cols=265 Identities=18% Similarity=0.197 Sum_probs=196.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL------ 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 653 (870)
..++|++.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++.+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999854 68899999986532 33446678899999999999999999887543
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
...|+||||+++ ++.+++.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 67777653 3788999999999999999999 6779999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC-chhh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPR-GLTE 811 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~ 811 (870)
...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .+. ....
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHH
Confidence 653221 22334689999999999999999999999999999999999999975321 11111111110 000 0000
Q ss_pred hcchhh----hccc---------------C--cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 812 VVDASL----VREV---------------Q--PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 812 ~~~~~~----~~~~---------------~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.+.... .... . ...........+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0000 0 000001123468899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.34 Aligned_cols=269 Identities=21% Similarity=0.339 Sum_probs=199.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++.+++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999854 689999999865432 22345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||++ +++.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 7888777655555788899999999999999999 66799999999999999999999999999875432221
Q ss_pred cccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHH-HHHHhcCCc----------
Q 002892 741 SVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH-WIKLSLPRG---------- 808 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~---------- 808 (870)
......+++.|+|||++.+. .++.++||||+|+++|||++|+.||+...+....+.. |.....+..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12233568899999998754 5788999999999999999999999764332222111 111111110
Q ss_pred --hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 --LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+...................+..+.+++.+|+..||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000000111346789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=302.28 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=197.2
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ......+.+|+.++++++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999965 68999999986542 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 663 MPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 663 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
++ +++.+++.... ..+++..+..++.|++.||+||| +++++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68988887432 56899999999999999999999 6679999999999999999999999999987653322
Q ss_pred cccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcC-C-ch---hhhc
Q 002892 741 SVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLP-R-GL---TEVV 813 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~-~-~~---~~~~ 813 (870)
.......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||......... ...... ..+ . .+ ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL-FRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCChhhhhcchhhH
Confidence 122233568899999988654 4788999999999999999999999753221111 111000 000 0 00 0000
Q ss_pred ch--hhhcccCc--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 814 DA--SLVREVQP--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 814 ~~--~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+. ........ .......+.++.+++.+||..||++|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00000000 0001123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=311.57 Aligned_cols=266 Identities=20% Similarity=0.225 Sum_probs=196.8
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL----- 653 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 653 (870)
...++|++.+.||+|+||.||+|... .++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999854 68899999986532 33446677899999999999999999988543
Q ss_pred -CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 654 -DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 654 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 356899999965 66666643 3788999999999999999999 677999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-C-----
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-P----- 806 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~----- 806 (870)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .......... +
T Consensus 167 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 865322 12233468999999999999899999999999999999999999997532111 1111111000 0
Q ss_pred ----Cchhhhcchh-----------hhcccC--cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 807 ----RGLTEVVDAS-----------LVREVQ--PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 807 ----~~~~~~~~~~-----------~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
......++.. ...... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 000000 000011123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.51 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=200.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999965 68999999986543 2233567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++++++..+..... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999998888776443 4899999999999999999999 66799999999999999999999999999987643321
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH--hcCCchhhhcchh--
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL--SLPRGLTEVVDAS-- 816 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-- 816 (870)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+. ...+... .......+..+..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccccc
Confidence 1223357788999999866 5578999999999999999999999976432211 1111110 0000000000000
Q ss_pred ----hhcccCcc----hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 ----LVREVQPS----YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ----~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
........ ......+..+.+++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 001123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.32 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=194.0
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-----hHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCee
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFK 656 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 656 (870)
.+|+..+.||+|+||.||+|... +++.||+|++.... .+....+.+|++++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999864 68999999886432 2345678899999999999999999998865 3577
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++++||+++++|.+++..... +++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 899999999999999986543 789999999999999999999 6679999999999999999999999999987653
Q ss_pred CCCCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 737 EDDDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 737 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
..... .......++..|+|||++.+..++.++||||+||++|||++|+.||...... ..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~~~~---~~~~~-------- 225 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AAIFK---IATQP-------- 225 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-HHHHH---HhcCC--------
Confidence 22111 1112345788999999999888999999999999999999999999753111 11111 00000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+.. +......+..++ .||..+|++||++.||++
T Consensus 226 -----~~~~~-~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -----TNPQL-PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----CCCCC-chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00000 112233456666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=297.10 Aligned_cols=246 Identities=27% Similarity=0.477 Sum_probs=197.1
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999974 67889999986543 235788999999999999999999998654 4799999999
Q ss_pred CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 665 NGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 665 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
+++|.+++... ...+++..+..++.|++.|++||| +.|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 99999999854 345899999999999999999999 677999999999999999999999999998754321
Q ss_pred ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
......+..|+|||.+.++.++.++||||+|+++|||++ |+.||...... ........ ...
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~------------~~~---- 215 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEK------------GYR---- 215 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhC------------CCC----
Confidence 112234568999999988899999999999999999998 88888653211 11111110 000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
.. ....++..+.+++.+||+.+|++||+++++++.|++
T Consensus 216 ~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 ME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00 011235678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=306.10 Aligned_cols=265 Identities=19% Similarity=0.244 Sum_probs=194.3
Q ss_pred CCCeeccc--cceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 589 ECNLLGAG--SFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 589 ~~~~lg~G--~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
+.++||+| +|++||++.. .+|+.||+|+++... ......+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6789999985 478999999987543 334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 664 PNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 664 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999753 345899999999999999999999 6679999999999999999999999998654332111100
Q ss_pred -----cccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh-----
Q 002892 743 -----TQTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT----- 810 (870)
Q Consensus 743 -----~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 810 (870)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccchh
Confidence 1112346778999999876 4588999999999999999999999975332111 11111111110000
Q ss_pred --hh--------cchhhhc--------c--c--CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 811 --EV--------VDASLVR--------E--V--QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 811 --~~--------~~~~~~~--------~--~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+. .+..... . . ............+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0000000 0 0 000011123457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=302.75 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=198.6
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999965 68999999986542 22234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++ +++.+++......+++..+..++.||++|++||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 96 5888888765556899999999999999999999 66799999999999999999999999999976533221
Q ss_pred cccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CCc--h---hhhcch
Q 002892 743 TQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PRG--L---TEVVDA 815 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--~---~~~~~~ 815 (870)
......++..|+|||++.+. .++.++||||+||++|||++|+.|+....+....+........ +.. + ....+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234578899999988664 4789999999999999999999986443222222222111100 000 0 000010
Q ss_pred hhhcccCcch----HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSY----AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......... .....+..+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000 01123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=296.04 Aligned_cols=247 Identities=27% Similarity=0.362 Sum_probs=199.8
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-----hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
+|+..+.||+|++|.||+|... +++.|++|++.... ++..+.+..|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999966 78999999986543 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999998654 4789999999999999999999 6679999999999999999999999999987653322
Q ss_pred CcccccccccccccCCcccccCCC-cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... .............
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~-------- 221 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----AAVFKIGRSKELP-------- 221 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----HHHHHHHhcccCC--------
Confidence 223445788999999987766 889999999999999999999998763211 1111000000000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+..+...+.+++.+||+.+|++||++.++++
T Consensus 222 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 ------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 001122456788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=300.63 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=201.9
Q ss_pred chhHHHHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeee-
Q 002892 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCN- 652 (870)
Q Consensus 576 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~- 652 (870)
++.++....+.|++.+.+|+|+||.||+|.. .+++.||+|++..... ....+..|+.+++++ +|||++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4555666778999999999999999999996 4689999999876533 335678899999998 69999999999853
Q ss_pred -----CCeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEE
Q 002892 653 -----LDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARV 726 (870)
Q Consensus 653 -----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 726 (870)
.+..+++|||+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999999853 345788889999999999999999 667999999999999999999999
Q ss_pred eccccccccCCCCCcccccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHH
Q 002892 727 SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWI 801 (870)
Q Consensus 727 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 801 (870)
+|||++....... .......|++.|+|||.+. ...++.++||||+||++|||++|+.||........ ..
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----~~ 236 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----LF 236 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----hh
Confidence 9999987553211 1223346889999999875 34578899999999999999999999865321111 00
Q ss_pred HHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 802 KLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. ............++..+.+++.+||+.+|.+||++.|+++
T Consensus 237 ~~--------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LI--------------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hH--------------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 0000011111234557899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.04 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=206.9
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
...++.|+..+.+|+|++|.||+|... +++.|++|++..... ....+.+|++.+++++|+|++++++++...+..+++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 346678999999999999999999976 689999999976654 456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
+||+++++|.+++......+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999976546999999999999999999999 6779999999999999999999999999987653322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
. ......++..|+|||++.+..++.++||||||+++|+|++|..||...... .....+...
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~---------------- 231 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTK---------------- 231 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc----------------
Confidence 1 122334778999999998888999999999999999999999998652111 111111100
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..........++..+.+++.+||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00000111124557889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.15 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=203.9
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999854 68899999986543 33567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 663 MPNGSLEKWLYSH--NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 663 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
+++++|.+++... ...+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999853 245899999999999999999999 67799999999999999999999999999976644332
Q ss_pred cc--cccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 741 SV--TQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 741 ~~--~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. ......|+..|+|||++... .++.++||||||+++|+|++|+.||....... ........ .+...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~-~~~~~-------- 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN-DPPSL-------- 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC-CCCCc--------
Confidence 21 22334578899999998776 78899999999999999999999997532211 11111110 00000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.........+..+.+++.+||..+|++||++.++++
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ----ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ----CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000001133457889999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=298.99 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=200.0
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC-----
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLD----- 654 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----- 654 (870)
.++++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35789999999999999999999965 678999999876543 346788999999999 6999999999996644
Q ss_pred -eeEEEEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 655 -FKALVLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 655 -~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
..++||||+++++|.+++... +..+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998743 356899999999999999999999 6779999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccC-----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASD-----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL 805 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 805 (870)
.+...... ........++..|+|||++.. ..++.++||||+|+++|+|++|+.||...... ......... .
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-~ 234 (275)
T cd06608 159 VSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRN-P 234 (275)
T ss_pred cceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhcc-C
Confidence 98765322 122233458889999998753 34678999999999999999999999653211 111111100 0
Q ss_pred CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..........+..+.+++.+||..||++|||+.++++
T Consensus 235 ---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 ---------------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---------------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000111224557889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.53 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=198.0
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
|.....||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|+|++++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344467999999999999854 6889999998766555567788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
++|.+++... .+++.++..++.|++.|++||| +++++||||||+||+++.++.++|+|||++........ ...
T Consensus 104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 9999988653 3789999999999999999999 66799999999999999999999999999876532221 122
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...|+..|+|||...+..++.++||||+|+++|||++|+.||...... ..... .....+.. ..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~-~~~~~~~~--------~~------- 239 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRR-IRDNLPPR--------VK------- 239 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHhcCCCc--------cc-------
Confidence 345789999999998888999999999999999999999998642111 10110 00001100 00
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.....+..+..++.+||..+|++||++.++++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 001123467889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.84 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=185.7
Q ss_pred eeccccceeEEEEEecCC---cEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCC
Q 002892 592 LLGAGSFGSVYKGTLFDG---TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGS 667 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 667 (870)
.||+|+||.||+|...++ ..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975443 345677665433 3345678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 668 LEKWLYSHN---YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 668 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
|.+++.... ...++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998532 33667788899999999999999 667999999999999999999999999998643222211222
Q ss_pred cccccccccCCcccccC-------CCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 745 TMTMATIGYMAPEYASD-------GIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ......... .......++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~----~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIK----DQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHh----hcccccCCCc
Confidence 34467889999998753 245779999999999999997 5667754221 111111111 1111111111
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
+.. .....+.+++..|| .+|++||++++|++.|.
T Consensus 234 ~~~---------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LEL---------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCC---------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 12345778999999 67999999999988773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.30 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=199.2
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999965 78999999887542 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 663 MPNGSLEKWLYSH--NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 663 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
+++++|.+++... ...+++..+..++.|++.|++|||+ +.+++||||+|+||+++.++.++|+|||.+..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999998764 2358999999999999999999994 2479999999999999999999999999987653221
Q ss_pred cccccccccccccCCcccccCCC------cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGI------ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
.....+++.|+|||.+.+.. ++.++|+||+||++|+|++|+.||....... ..... . .+.+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~-~--------~~~~ 224 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQL-S--------AIVD 224 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHH-H--------HHhh
Confidence 12235788999999986543 4789999999999999999999996521111 00000 0 0000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
... ...+..++..+.+++.+||+.+|++||++.+++..
T Consensus 225 ----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 225 ----GDP--PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----cCC--CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 000 00111245678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.49 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=203.7
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
...++|++.+.||+|+||.||+|... +++.||+|.+........+.+..|+.++++++|||++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 33578999999999999999999854 68899999987655555677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++.+.. +++.++..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 96 EYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred ecCCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999997543 789999999999999999999 67799999999999999999999999998876543222
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......+++.|+|||.+..+.++.++||||||+++|++++|+.||........ ...+.. ..
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~---~~------------- 231 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIAT---NG------------- 231 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhc---CC-------------
Confidence 12234578899999999888899999999999999999999999965321110 000000 00
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..........+..+.+++.+||..+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111234468899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.90 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=201.3
Q ss_pred chhHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 002892 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL 653 (870)
Q Consensus 576 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 653 (870)
+..++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 44566677899999999999999999999864 68899999986542 2235677899999998 799999999998653
Q ss_pred -----CeeEEEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceE
Q 002892 654 -----DFKALVLEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR 725 (870)
Q Consensus 654 -----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 725 (870)
+..++||||+++++|.++++. ....+++..+..++.|++.|++||| +.+++||||||+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 357999999999999998863 3445899999999999999999999 66799999999999999999999
Q ss_pred EeccccccccCCCCCcccccccccccccCCcccccCC-----CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHH
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG-----IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW 800 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~ 800 (870)
|+|||++........ ......|+..|+|||.+... .++.++||||+||++|||++|+.||...... ..+..+
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~ 245 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKI 245 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHH
Confidence 999999876543221 12234578899999987643 2678999999999999999999998653211 111111
Q ss_pred HHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... .+. ... ........+.+++.+||+.+|++||++.|+++
T Consensus 246 ~~~-~~~---~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 PRN-PPP---TLL------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hcC-CCC---CCC------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 100 000 000 01122346889999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.75 Aligned_cols=267 Identities=20% Similarity=0.273 Sum_probs=202.7
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|++.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++|||++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 68999999987654 33356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+ +++|.+++......+++.++..++.|+++|++||| +++++|+||+|+||++++++.++++|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999999866667999999999999999999999 67799999999999999999999999999987643322 1
Q ss_pred cccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC--chhh---hcch
Q 002892 743 TQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR--GLTE---VVDA 815 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~---~~~~ 815 (870)
......++..|+|||++.+. .++.++||||+|+++|||++|..||....+ ...+...... ..+. .+.+ ..+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 22334688899999988654 468999999999999999999877754322 1111111110 0000 0000 0000
Q ss_pred hhh---cccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 816 SLV---REVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 816 ~~~---~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
... ....... ...+....+.+++.+|++.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000 001234678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=320.88 Aligned_cols=266 Identities=22% Similarity=0.265 Sum_probs=191.9
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCC------CceeEEeeeeeeC
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRH------RNLIKIFSSCCNL 653 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~ 653 (870)
....++|++.+.||+|+||+||+|... .++.||||+++... ........|+++++.++| .+++.+++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 345688999999999999999999864 67889999986432 223445667777777654 4588888888754
Q ss_pred -CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC----------
Q 002892 654 -DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---------- 722 (870)
Q Consensus 654 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---------- 722 (870)
.+.++|||++ +++|.+++...+ .+++..+..++.||+.||+|||.. .||+||||||+||+++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccc
Confidence 5788999988 778999887654 489999999999999999999931 4799999999999998765
Q ss_pred ------ceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccch
Q 002892 723 ------TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMS 796 (870)
Q Consensus 723 ------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~ 796 (870)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.... ...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~ 353 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN-LEH 353 (467)
T ss_pred cCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Confidence 499999998764321 22345689999999999999999999999999999999999999975322 111
Q ss_pred HHHHHHH--hcCCchh---------hhcchhhhc--ccCc---------c-hHHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002892 797 LKHWIKL--SLPRGLT---------EVVDASLVR--EVQP---------S-YAKMDCLLRIMHLALGCCMDSPEQRMCMT 853 (870)
Q Consensus 797 ~~~~~~~--~~~~~~~---------~~~~~~~~~--~~~~---------~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 853 (870)
+..+... ..|..+. ++++..... ...+ . .........+.+++.+|++.||++|||+.
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 1111110 1111110 111100000 0000 0 00001134577999999999999999999
Q ss_pred HHHH
Q 002892 854 DVVV 857 (870)
Q Consensus 854 evl~ 857 (870)
|+++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9986
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.97 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=204.6
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|++++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 689999999987665566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+++|.+++......+++..+..++.|+++|+++|| ..+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999876556899999999999999999999 67799999999999999999999999999987654322 2
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ......
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~~~------------ 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-ALFKIAT----NGPPGL------------ 217 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh----cCCCCc------------
Confidence 33457889999999988889999999999999999999999986531110 0000000 000000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....++..+.+++..||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001112456899999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.09 Aligned_cols=195 Identities=22% Similarity=0.272 Sum_probs=159.3
Q ss_pred CCeeccccceeEEEEEec---CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeEEEEecCC
Q 002892 590 CNLLGAGSFGSVYKGTLF---DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKALVLEFMP 664 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 664 (870)
.++||+|+||+||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 458999999999999854 467899999865422 2456789999999999999999998854 456789999985
Q ss_pred CCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee----CCCCceEEeccccc
Q 002892 665 NGSLEKWLYSH--------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL----DKNMTARVSDFGIS 732 (870)
Q Consensus 665 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a 732 (870)
+++.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888877522 234889999999999999999999 6779999999999999 45678999999999
Q ss_pred cccCCCCC-cccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCcc
Q 002892 733 KLLGEDDD-SVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEM 790 (870)
Q Consensus 733 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~ 790 (870)
..+..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643221 122234568999999999876 45889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.49 Aligned_cols=266 Identities=23% Similarity=0.278 Sum_probs=200.3
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhH-----HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLER-----AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
+|++.+.||+|++|.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 6899999999765322 345577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+ +++|.+++......+++..+..++.|+++||+||| +++++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 99999999866546899999999999999999999 6779999999999999999999999999998764332
Q ss_pred CcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC--chh---hh
Q 002892 740 DSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPR--GLT---EV 812 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~---~~ 812 (870)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||..... ........... .+. .+. ..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhcccc
Confidence 1 1222346788999998854 4678899999999999999999877764322 11111111110 000 000 00
Q ss_pred cchhh---hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 813 VDASL---VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 813 ~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.+... .............+..+.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 00000000112235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.11 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=199.8
Q ss_pred CCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
+|+..+.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 578999999986532 2245778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEeccccccccCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLGE 737 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 737 (870)
||||+++++|.+++...+ .+++..+..++.|++.|++||| +++++||||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997654 4889999999999999999999 66799999999999998776 599999999977643
Q ss_pred CCCc--ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 738 DDDS--VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 738 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... .......++..|+|||.+.+..++.++||||+|+++|+|++|..||...... .....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~--------- 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NHLALIFKIASA--------- 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-chHHHHHHHhcc---------
Confidence 3211 1122345788999999998888999999999999999999999998642111 111111100000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......+......+.+++.+|+..+|++||++.++++
T Consensus 227 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 -----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000011123457889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.89 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=197.8
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh----------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL----------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD 654 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 654 (870)
+|...+.||+|++|.||+|... +++.||+|.++... ....+.+..|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999854 68999999886421 112346788999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..++||||+++++|.+++.... .+++..+..++.|++.|+.||| +++++||||+|+||+++.++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999998664 4899999999999999999999 66799999999999999999999999999976
Q ss_pred cCCCCCcccccccccccccCCcccccCCC--cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGI--ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
..............++..|+|||...... ++.++||||+|+++||+++|..||..... ...+.... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKLG-NKRSAPP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHhh-ccccCCc
Confidence 53322222223345788999999987654 78899999999999999999999864211 11111100 0000000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+... ....++..+.+++.+||..+|++||++.+|++
T Consensus 233 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 233 IPPD---------VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcc---------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0000 00123457889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.91 Aligned_cols=240 Identities=24% Similarity=0.234 Sum_probs=183.7
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhc---CCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNV---RHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
||+|+||+||+|+.. +++.||+|++..... ........|..++... .||+|+.+++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 689999999875431 2223344566666655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+ .+++..+..++.||+.|++||| +++|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence 99999987654 4899999999999999999999 6779999999999999999999999999987542211 1223
Q ss_pred ccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 746 MTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
...||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ........... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~--------------~~ 215 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGK--------------VR 215 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCC--------------CC
Confidence 34689999999998754 478999999999999999999999865211 11111000000 00
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMC----MTDVVV 857 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evl~ 857 (870)
......+..+.+++.+||+.+|++||+ +.++++
T Consensus 216 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000112346789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.35 Aligned_cols=248 Identities=26% Similarity=0.339 Sum_probs=198.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
....|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++|||++++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4466889999999999999999865 68999999986432 3344678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||++ |++.+++......+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 999996 5777777755556899999999999999999999 667999999999999999999999999998755322
Q ss_pred CCcccccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 739 DDSVTQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
....+++.|+|||++. .+.++.++||||||+++|||++|..||....... .......
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~~~~~~~---------- 228 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQ---------- 228 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----HHHHHhc----------
Confidence 2235788999999874 4568889999999999999999999986421110 0000000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..........++..+.+++.+||+.+|++||++.+|+..
T Consensus 229 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 ----NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000111112345678999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=302.80 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=198.2
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
.|.....||+|+||.||+|... +++.||+|++..........+.+|+.+++.++|||++++++++...+..+++|||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3444557999999999999854 689999999876554455678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+++|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++....... ...
T Consensus 102 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~ 174 (297)
T cd06659 102 GGALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR 174 (297)
T ss_pred CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence 99999987653 3799999999999999999999 6679999999999999999999999999987553222 122
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...... .....+....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~-~~~~~~~~~~-------------- 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-VQAMKR-LRDSPPPKLK-------------- 238 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH-HhccCCCCcc--------------
Confidence 334588999999999988899999999999999999999999864211 111111 1100000000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.....+..+.+++.+||+.+|++||++.++++.
T Consensus 239 -~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 -NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 001123457899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=308.67 Aligned_cols=267 Identities=20% Similarity=0.265 Sum_probs=196.9
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC---
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--- 653 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--- 653 (870)
.....++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 334567899999999999999999985 468899999987543 22345677899999999999999999887533
Q ss_pred ---CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 654 ---DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 654 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
...|+++|++ +++|.+++... .+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 78998887643 3899999999999999999999 6779999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CC-
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PR- 807 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~- 807 (870)
++...... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ...+..+..... +.
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSP 237 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCH
Confidence 99865322 223468899999999876 5688999999999999999999999965211 111222211110 00
Q ss_pred c-hhhhcch-------hhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 808 G-LTEVVDA-------SLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 808 ~-~~~~~~~-------~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
. ...+... .+......... .......+.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 00000000000 00112357899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=293.11 Aligned_cols=250 Identities=23% Similarity=0.293 Sum_probs=195.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-----hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--Cee
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFK 656 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 656 (870)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999864 68999999885321 23456788999999999999999999988763 467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
+++|||+++++|.+++.... .+++..+.+++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999987654 3788999999999999999999 6669999999999999999999999999987653
Q ss_pred CCCCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 737 EDDDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 737 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
..... .......++..|+|||++.+..++.++||||||+++|||++|+.||...... .... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~---~~~~~~-------- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIF---KIATQP-------- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHH---HHhcCC--------
Confidence 22111 1122345788999999998888999999999999999999999998653111 1111 100000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. ...+......+.+++.+|+. +|++||+++||++
T Consensus 226 -----~~-~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -----TN-PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----CC-CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 00111234467788889985 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=297.91 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=198.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367889999999999999999965 689999999865432 122446789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++ +|.+++......+++..+..++.|+++||+||| +.+++||||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 9975 999998876667899999999999999999999 66799999999999999999999999999875432111
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcC--Cchhhhcchh-
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLP--RGLTEVVDAS- 816 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~- 816 (870)
......++..|+|||+..+ ..++.++||||+|+++|+|++|+.||.........+...... ..+ ..+....+..
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1222346788999998865 457889999999999999999999997543222222211110 000 0010000000
Q ss_pred ----hhcccCcch-----HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 ----LVREVQPSY-----AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ----~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......... ........+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 00001146789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.89 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=205.4
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|++|.||+|+.. +++.||+|++..... .....+..|++.+++++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999966 589999999876643 4457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS-TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++++|.+++... ..+++..++.++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999865 44899999999999999999999 6 77999999999999999999999999999876432221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccc-ccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFT-GEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .......... ..
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------------~~ 218 (264)
T cd06623 157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----------------DG 218 (264)
T ss_pred --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----------------cC
Confidence 1234578899999999999999999999999999999999999976432 1111111111 00
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.........++..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000111145679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=303.19 Aligned_cols=194 Identities=27% Similarity=0.375 Sum_probs=168.0
Q ss_pred CCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CC-----ceeEEeeeeeeCCeeEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HR-----NLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~l 658 (870)
+|.+.+.||+|+||.|.+|.+ ++++.||||+++.. .....+...|+.++..++ |. |+|+++++|.-.++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999985 47999999999765 344466678999999996 43 89999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC--CceEEecccccccc
Q 002892 659 VLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN--MTARVSDFGISKLL 735 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~ 735 (870)
|+|.+ ..+|.++++.++ ..++...+..|+.||+.||.+|| ..+|||+||||+|||+.+. ..|||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99988 669999999553 45899999999999999999999 6669999999999999653 47999999999977
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~ 789 (870)
+.... .-.-+..|.|||++.+.+|+.+.|+||||||++||++|.+-|.+
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 54333 22456789999999999999999999999999999999776654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=294.48 Aligned_cols=255 Identities=24% Similarity=0.267 Sum_probs=198.8
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 660 (870)
++|+..+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999964 689999999875432 3456788999999999999999999988653 4679999
Q ss_pred ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
||+++++|.+++.. ....+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988763 3445889999999999999999999 66799999999999999999999999999875532
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccc---cchHHHHHHHhcCCchhhhcc
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTG---EMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 814 (870)
... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+..... ......+.......
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 226 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP------- 226 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-------
Confidence 211 1234678899999999889999999999999999999999999764221 11111111110000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+..... .....+..+.+++.+||+.+|++||++.|+++
T Consensus 227 -~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 -ELKDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -hhccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000000 00112456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.91 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=201.4
Q ss_pred CCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeEEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKALVL 660 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 660 (870)
+|++.+.+|+|+||.||+|.. .+++.||+|++.... ....+++..|++++++++|||++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 468899999986532 3445678899999999999999999998754 45678999
Q ss_pred ecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 661 EFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSH--STPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 661 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
||+++++|.+++... ...+++..++.++.|++.|++|||..+ +.+++||||+|+||++++++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 456899999999999999999999554 567999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..........
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~------------ 224 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKE------------ 224 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhc------------
Confidence 43322 1223458899999999998889999999999999999999999997532 1111111110
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.... ..+...+..+.+++.+|++.+|++||++.+|++.
T Consensus 225 ~~~~-----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKFR-----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCC-----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 0111234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=272.65 Aligned_cols=251 Identities=23% Similarity=0.276 Sum_probs=199.5
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 661 (870)
++.+.+..+|.|..|.||+++.+ +|...|||.+.... .+..+++...++++..-. .|.||+.+|||.......+.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44556778999999999999965 58899999987654 556677888888877664 8999999999999988999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
.| ....+.++..-..++++.-+-++...+..||.||.+ +++|+|||+||+|||+|+.|.+|++|||.+-++. .+
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv---dS 245 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DS 245 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee---cc
Confidence 88 556777777667779999999999999999999987 5579999999999999999999999999997663 23
Q ss_pred ccccccccccccCCcccccCC---CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 742 VTQTMTMATIGYMAPEYASDG---IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
...+...|-+.|||||.+... .|+-++||||||++++|+.||+.||......-..+..+.. ..|..+.. .
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~----~-- 318 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPG----H-- 318 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCc----c--
Confidence 344556789999999998643 5888999999999999999999999874443333333222 12211110 0
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+..+.+++..|++.|+.+||.+.++++
T Consensus 319 ---------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 ---------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ---------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 012346889999999999999999998875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.43 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=199.1
Q ss_pred CCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
.|...+.||+|++|.||+|.. .+++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455567999999999999985 4789999999876555555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+++|.+++.. ..+++..+..++.|++.|++||| +++++||||+|+||+++.++.++++|||.+........ ..
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~ 172 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR 172 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence 9999999887 34899999999999999999999 67799999999999999999999999998875533221 12
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
....|++.|+|||...+..++.++||||+|+++|||++|+.||...... ..... .....+. ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~-~~~~~~~--------~~~------ 236 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKR-IRDNLPP--------KLK------ 236 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHH-HHhcCCC--------CCc------
Confidence 2345889999999998888999999999999999999999998642110 00100 0000000 000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....++..+.+++.+||+.+|++||++.++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01113457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.82 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=201.8
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|+..+.||+|+||.||+|... +++.||+|+++.... ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999854 789999999876544 3677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++.... .+++..+..++.+++.|++||| +.+++||||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999998654 3789999999999999999999 6679999999999999999999999999998764433221
Q ss_pred c--ccccccccccCCcccccCCC---cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 743 T--QTMTMATIGYMAPEYASDGI---ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 743 ~--~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
. .....+++.|+|||++.+.. .+.++||||||+++||+++|+.||....... ............
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~---------- 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKP---------- 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcCCCC----------
Confidence 1 11245788999999998766 8899999999999999999999997532111 111111100000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......++..+.+++.+||+.+|++||++.+++.
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 -----PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001122456789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.39 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=198.8
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|++|.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 68999999987543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++.... .+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999998664 4899999999999999999999 677999999999999999999999999999866432
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ........ .... .
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~------------~~~~--~ 216 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-IQIYEKIL------------EGKV--R 216 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh------------cCCc--c
Confidence 2234588999999999888889999999999999999999999865321 10011100 0000 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
. +...+..+.+++.+||..+|++|| ++.|+++
T Consensus 217 ~-----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 F-----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred C-----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 011235688999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.55 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=199.1
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|+..+.||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999854 68899999987542 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEeccccccccCCCCC
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 740 (870)
+++++|.+++... ...+++..+.+++.+++.|++||| +++++||||+|+||+++++ +.++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999864 345899999999999999999999 6679999999999999865 4689999999987643321
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... . ........... .
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~-~~~~~~~~~~~---~--------- 220 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-A-LVLKIMSGTFA---P--------- 220 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-H-HHHHHHhcCCC---C---------
Confidence 22245788999999999888999999999999999999999998653111 1 11111000000 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....++..+.+++..||+.+|++||++.|+++
T Consensus 221 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 -----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=294.09 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=200.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+-|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45778889999999999999864 68899999986443 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++....... .
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--h
Confidence 9999999998754 3799999999999999999999 6779999999999999999999999999987653321 1
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+....+. .
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~----~---------- 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNNPP----T---------- 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCCCC----C----------
Confidence 222345788999999998888899999999999999999999998652211 011100000000 0
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
....++..+.+++..||+.+|++||++.++++.
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011234568899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=299.64 Aligned_cols=193 Identities=22% Similarity=0.287 Sum_probs=157.8
Q ss_pred CeeccccceeEEEEEec---CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF---DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 665 (870)
.+||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999864 457899998865432 2457789999999999999999998853 557789999986
Q ss_pred CCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee----CCCCceEEecccccc
Q 002892 666 GSLEKWLYSH--------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL----DKNMTARVSDFGISK 733 (870)
Q Consensus 666 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~ 733 (870)
+++.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 4777776521 234889999999999999999999 6779999999999999 566799999999998
Q ss_pred ccCCCCCc-ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002892 734 LLGEDDDS-VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 734 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~ 789 (870)
........ .......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76433221 12234568899999999876 4578999999999999999999999965
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=295.17 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=192.4
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHH-HHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEV-LRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++.+.||+|+||.||+|... +|+.||+|+++.... .....+..|... ++..+|||++++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999965 699999999876432 222344455554 566789999999999999999999999
Q ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 662 FMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHST-PVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 662 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
|++ |+|.+++.. ....+++..++.++.|++.|++||| ++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 688888763 2346899999999999999999999 54 799999999999999999999999999876532
Q ss_pred CCCcccccccccccccCCcccccC----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASD----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
. .......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||.........+......
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 223 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE---------- 223 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc----------
Confidence 2 12233457889999998865 456889999999999999999999986432211111111110
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.........++..+.+++.+||..+|++||++.++++
T Consensus 224 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -------PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001111123457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.13 Aligned_cols=247 Identities=23% Similarity=0.430 Sum_probs=197.7
Q ss_pred CCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcC---CCceeEEeeeeeeCCeeEEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVR---HRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 660 (870)
.|+..+.||+|+||.||+|.+ .+++.||+|+++... ......+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 478999999987543 344567888999999996 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999998754 4899999999999999999999 6679999999999999999999999999998764433
Q ss_pred cccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 741 SVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||...... ..... ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~-~~~~----------- 217 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML-IPKS----------- 217 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc-cccC-----------
Confidence 222334688899999988654 4688999999999999999999999753211 11100 0000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+.......+..+.+++..||+.+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 -KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0000000013456889999999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.21 Aligned_cols=266 Identities=24% Similarity=0.296 Sum_probs=199.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 589999998865432 234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++++++.++..... .+++.++..++.|+++|++||| +.+++|||++|+||++++++.++++|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 999999988776443 3899999999999999999999 6679999999999999999999999999987653322
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH--hcCCchhhhcchh--
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL--SLPRGLTEVVDAS-- 816 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-- 816 (870)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... ......... .......+..+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccchH
Confidence 12223457889999998865 44778999999999999999999988642211 111111110 0111111111100
Q ss_pred ----hhcccCcc----hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 ----LVREVQPS----YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ----~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
........ ......+..+.+++..||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=298.04 Aligned_cols=267 Identities=20% Similarity=0.279 Sum_probs=199.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 658 (870)
.++|++.+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357889999999999999999975 688999999875432 2233567899999999999999999998877 89999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||++ ++|.+++......+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999997 5999998876656899999999999999999999 667999999999999999999999999999876443
Q ss_pred CCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cC--Cchhhhcc
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LP--RGLTEVVD 814 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~ 814 (870)
. .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...... .......... .+ ..+.....
T Consensus 160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhc
Confidence 2 122234578899999988654 4688999999999999999999998753221 1111111100 00 00000000
Q ss_pred ------hhhhc----ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ------ASLVR----EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ------~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... .....+........+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 00000111112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=323.43 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=213.4
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec----C----CcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeee
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF----D----GTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSC 650 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 650 (870)
+...++..+.+.+|+|+||.||+|... . ...||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 334445566679999999999999843 1 4568999987654 35567899999999999 699999999999
Q ss_pred eeCCeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCc
Q 002892 651 CNLDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNN 715 (870)
Q Consensus 651 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 715 (870)
...+..++|+||+..|+|.++++..+ ..++....+.++.|||.|++||+ +++++|||+.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence 99999999999999999999999777 44889999999999999999999 6779999999999
Q ss_pred eeeCCCCceEEeccccccccCCCCCcccc-cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccc
Q 002892 716 ILLDKNMTARVSDFGISKLLGEDDDSVTQ-TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTG 793 (870)
Q Consensus 716 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~ 793 (870)
|+++++..+||+|||+|+........... +...-+..|||||.+....++.+|||||||+++||++| |..||.+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999976544444322 22113567999999999999999999999999999999 88898762111
Q ss_pred cchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 794 EMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
..+..+ .+...+...+..|..+++++|+.||+.+|++||+++++++.++...+
T Consensus 529 -~~l~~~-----------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 529 -EELLEF-----------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -HHHHHH-----------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111111 12222233455678899999999999999999999999999999654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=304.84 Aligned_cols=276 Identities=26% Similarity=0.362 Sum_probs=209.4
Q ss_pred CCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeee------CCeeE
Q 002892 586 GFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCN------LDFKA 657 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~ 657 (870)
-|...+.+|+|+||.||+|+ -++|+.||||.++... ....+++-+|++++++++|+|||++++.-.+ .+...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 46677899999999999999 4589999999998643 3455778899999999999999999987543 34668
Q ss_pred EEEecCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee--CCCC--ceEEecccc
Q 002892 658 LVLEFMPNGSLEKWLYS--HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL--DKNM--TARVSDFGI 731 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfg~ 731 (870)
+|||||.||||...+.+ +...+++.+++.+..+++.|+.||| .+|||||||||.||++ +++| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999994 3566999999999999999999999 6669999999999998 3334 479999999
Q ss_pred ccccCCCCCcccccccccccccCCccccc-CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchH-HHHH-HHhcCCc
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYAS-DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL-KHWI-KLSLPRG 808 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~-~~~~-~~~~~~~ 808 (870)
|+...++. .....+||..|.+||... .+.|+..+|.|||||++|+++||..||.....+.... ..|. ...-|.+
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99875433 555678999999999998 4889999999999999999999999997643332111 1111 1222322
Q ss_pred hhhhcchhhhcccC-------cchHHHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHhHhHhh
Q 002892 809 LTEVVDASLVREVQ-------PSYAKMDCLLRIMHLALGCCMDSPEQRM--CMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 809 ~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~RP--s~~evl~~L~~i~~~~~ 867 (870)
..-...+....... +.-.......++.++...++..+|++|. ...+.-..+..|....+
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 22222222211111 0001112234566788888899999999 88888888888876543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=296.24 Aligned_cols=267 Identities=22% Similarity=0.268 Sum_probs=200.9
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++.+.||+|++|.||+|... +++.||+|+++... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999865 68899999986543 3334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++++.+..+.... ..+++..+..++.|++.|++||| ..+++|||++|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 99987776665543 44899999999999999999999 66699999999999999999999999999987644332
Q ss_pred ccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH--HhcCCchhhhcc--hh
Q 002892 742 VTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK--LSLPRGLTEVVD--AS 816 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~ 816 (870)
.......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+ .+..... ...+........ ..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCcc
Confidence 122234578889999999887 78999999999999999999999987532211 1111000 001110000000 00
Q ss_pred hhc----ccCcc-----hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 LVR----EVQPS-----YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~~~----~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... ..... ..+..++..+.+++++||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 00000 001123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=320.80 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=193.6
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL----- 653 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 653 (870)
.+...+|+..++||+||||.||+++.+ ||+.||||++.... ......+.+|+.++++++|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345677888899999999999999976 89999999987653 45567788999999999999999987322000
Q ss_pred --------------------------------------------------------------------------------
Q 002892 654 -------------------------------------------------------------------------------- 653 (870)
Q Consensus 654 -------------------------------------------------------------------------------- 653 (870)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 002892 654 ----------------------------------DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699 (870)
Q Consensus 654 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh 699 (870)
...||-||||+..++.++++.+...-.....++++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1347899999999998888866543367888999999999999999
Q ss_pred hcCCCCcEecccCCCceeeCCCCceEEeccccccccC----------------CCCCcccccccccccccCCcccccCC-
Q 002892 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG----------------EDDDSVTQTMTMATIGYMAPEYASDG- 762 (870)
Q Consensus 700 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~~~~- 762 (870)
+.|+|||||||.||++++++.|||+|||+|.... ........+..+||.-|+|||++.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 6779999999999999999999999999998721 01122245667899999999999764
Q ss_pred --CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhh
Q 002892 763 --IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALG 840 (870)
Q Consensus 763 --~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 840 (870)
.|+.|+|+||+|+|++||+. ||...-+....+...-...+|.. ....+. ....-..++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~--------------~~~~e~slI~~ 853 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP--------------EHPEEASLIRW 853 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc--------------cchHHHHHHHH
Confidence 49999999999999999996 55432111111111111222222 111111 12234678999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 002892 841 CCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 841 cl~~~P~~RPs~~evl~ 857 (870)
++++||++|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999975
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.56 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=200.4
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|+..+.||+|++|.||+|... +++.||+|.+..... ...+.+..|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999965 589999999976532 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 661 EFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 661 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
||+.+++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998753 356899999999999999999999 6779999999999999999999999999987553221
Q ss_pred Ccc---------------------------cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccc
Q 002892 740 DSV---------------------------TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFT 792 (870)
Q Consensus 740 ~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~ 792 (870)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 110 11123578899999999988899999999999999999999999975322
Q ss_pred ccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002892 793 GEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC----MTDVVV 857 (870)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evl~ 857 (870)
. ..... +....... ......+..+.+++.+||..+|++||+ +.++++
T Consensus 238 ~-~~~~~------------~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 D-ETFSN------------ILKKEVTF-----PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H-HHHHH------------HhcCCccC-----CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11111 01000000 000113567999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.26 Aligned_cols=247 Identities=25% Similarity=0.300 Sum_probs=200.7
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
+|++.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999965 68999999997643 2445788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++... ..+++..+..++.|+++|++||| ..+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999866 45899999999999999999999 6669999999999999999999999999988664322
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......|+..|+|||++....++.++||||+|+++|+|++|+.||...... ........ ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~-~~~-------------- 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK-QET-------------- 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH-hcc--------------
Confidence 223345788999999998888999999999999999999999998753221 11111110 000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCM--TDVV 856 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~--~evl 856 (870)
.....+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0000111234678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=295.92 Aligned_cols=260 Identities=18% Similarity=0.200 Sum_probs=186.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC----CcEEEEEEeechhhHH-----------HHHHHHHHHHHHhcCCCceeEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD----GTNVAIKVFNLQLERA-----------FRSFESECEVLRNVRHRNLIKIF 647 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~ 647 (870)
..++|++.++||+|+||.||+|...+ +..+|+|+........ ......+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999999654 4566777643222110 01122334455667899999999
Q ss_pred eeeeeCC----eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc
Q 002892 648 SSCCNLD----FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723 (870)
Q Consensus 648 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 723 (870)
+++.... ..++++|++. .++.+.+.... ..++..+..++.|++.|++||| +++|+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence 8765443 4467888774 46666665432 2578889999999999999999 667999999999999999999
Q ss_pred eEEeccccccccCCCCCc-----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHH
Q 002892 724 ARVSDFGISKLLGEDDDS-----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798 (870)
Q Consensus 724 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~ 798 (870)
++|+|||+|+.+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HH
Confidence 999999999866332211 112234689999999999999999999999999999999999999976422221 11
Q ss_pred HHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 799 HWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
...... ...+.. ........++..+.+++..||+.+|++||++.++++.+
T Consensus 244 ~~~~~~-------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCD-------FIKRLH----EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHH-------HHHHhh----hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111100 000000 00111123456799999999999999999999999876
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.70 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=204.6
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeEEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKALVL 660 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 660 (870)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999966 789999999876542 4567889999999999999999999999888 8899999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++.... .+++..++.++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998665 5899999999999999999999 67799999999999999999999999999987754432
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
........++..|+|||...+...+.++||||+|+++|+|++|..||...... ..............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~---------- 223 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGSSGEPP---------- 223 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhccccCCCc----------
Confidence 21233456788999999998888999999999999999999999999764311 11111100000000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+...+..+.+++.+|+..+|++||++.++++
T Consensus 224 ----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 ----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 011122457899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.21 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=197.1
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.|...+.||+|+||.||+|+.. +++.||+|++.... ......+..|++++++++|||++++++++...+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667888999999999999854 68999999986432 3344678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++ |++.+.+......+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 996 5888887766666899999999999999999999 667999999999999999999999999988754321
Q ss_pred ccccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 742 VTQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
....+++.|+|||++. .+.++.++|||||||++|||++|+.||.... .......+.....
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~------------- 241 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNES------------- 241 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccC-------------
Confidence 2335788999999873 4568899999999999999999999986521 1111111111100
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
.......++..+.+++.+||+.+|++||++.++++...
T Consensus 242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00111123456889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=294.40 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=197.1
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|+..+.||+|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999865 68999999886543 22345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
++ ++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6898888743 355899999999999999999999 66799999999999999999999999999876543221
Q ss_pred ccccccccccccCCcccccCCC-cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH-HhcCCc-hh----hhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK-LSLPRG-LT----EVVD 814 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~-~~----~~~~ 814 (870)
......+++.|+|||+..+.. ++.++||||||+++|||+||+.||...... ........ ...+.. .. ....
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 122334678999999886644 688999999999999999999998653211 11111111 111110 00 0000
Q ss_pred --hhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 --ASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 --~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
............ .......+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 0112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.98 Aligned_cols=268 Identities=23% Similarity=0.276 Sum_probs=198.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 657 (870)
..++|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|+|++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999999965 689999999875432 2223456799999999999999999998754 5689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||++ ++|.+++......+++.++..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||.+.....
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999996 5899988866566899999999999999999999 66799999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc--hhhhc
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPRG--LTEVV 813 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~ 813 (870)
... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ..+...... ..+.. +....
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChhhchhhh
Confidence 321 2222345788999998865 45789999999999999999999999753221 111111110 00000 00000
Q ss_pred chh------hhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 814 DAS------LVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 814 ~~~------~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... ......... ........+.+++.+|++.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000000000 00112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.24 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=198.9
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
+|+..+.||+|++|.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999965 689999999876532 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 664 PNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 664 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
++ ++.+++.... ..+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 8988887543 45899999999999999999999 66799999999999999999999999999976532211
Q ss_pred ccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC--chhhhcchh-
Q 002892 742 VTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPR--GLTEVVDAS- 816 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~- 816 (870)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||..... ........... .+. .+..+.+..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-EDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 12233568899999988654 568899999999999999999999976322 12222211110 010 011111000
Q ss_pred hhcccC----c--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 LVREVQ----P--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~~~~~~----~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...... . ......++..+.+++.+|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0 0001123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.28 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=203.1
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|++.+.||+|++|.||+|... +++.||+|++.... ......+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999965 68999999987653 25567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 663 MPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 663 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
+++++|.+++... ...+++..+..++.+++.|++||| +.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999864 366999999999999999999999 6679999999999999999999999999998764433
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... .............
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~--------- 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYP--------- 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCC---------
Confidence 122234678899999999888899999999999999999999999865221 1111110000000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+ .+..++..+.+++.+||..+|++||++.++++
T Consensus 222 ---~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 ---P--IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 01123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=290.12 Aligned_cols=261 Identities=20% Similarity=0.222 Sum_probs=193.5
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcC-CCceeEEeeeeeeC--CeeEEEEe
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVR-HRNLIKIFSSCCNL--DFKALVLE 661 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 661 (870)
|++.+.||+|+||.||+|... +++.||+|+++.... ........|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999854 689999999875421 22223456888888885 99999999999887 88999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|++ +++.+++......+++.++..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||++.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 996 5888888766566899999999999999999999 667999999999999999 99999999999866432221
Q ss_pred ccccccccccccCCccccc-CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh---hcchhh
Q 002892 742 VTQTMTMATIGYMAPEYAS-DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE---VVDASL 817 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 817 (870)
....++..|+|||++. ++.++.++||||+||++|||++|..||...... ....+..........+ ......
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2235788999999764 456788999999999999999999999653211 1111111111111010 000000
Q ss_pred h------cccCc--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 V------REVQP--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~------~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ..... .......+..+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 00000 0001234678999999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.79 Aligned_cols=268 Identities=20% Similarity=0.253 Sum_probs=196.3
Q ss_pred CCCCCCeeccccceeEEEEEec---CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF---DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKA 657 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 657 (870)
+|++.+.||+|++|.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999997633 33345678899999999999999999999887 7899
Q ss_pred EEEecCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC----CCceEEecc
Q 002892 658 LVLEFMPNGSLEKWLYSH----NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK----NMTARVSDF 729 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 729 (870)
+||||+++ ++.+++... ...+++..+..++.|++.|++||| +++++||||||+||+++. ++.+|++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677766522 235899999999999999999999 677999999999999999 999999999
Q ss_pred ccccccCCCCC-cccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccc--------hHHH
Q 002892 730 GISKLLGEDDD-SVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM--------SLKH 799 (870)
Q Consensus 730 g~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~--------~~~~ 799 (870)
|++........ ........+++.|+|||++.+ ..++.++||||||+++|+|++|+.||........ .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112233457889999998765 4578999999999999999999999975432220 1111
Q ss_pred HHHHh-cCC-----------chhhhcchhhhcccC-cchH---HH--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 800 WIKLS-LPR-----------GLTEVVDASLVREVQ-PSYA---KM--DCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 800 ~~~~~-~~~-----------~~~~~~~~~~~~~~~-~~~~---~~--~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+.... .+. ......+........ .... .. ....++.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11100 000 000000000000000 0000 00 23456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=295.24 Aligned_cols=271 Identities=20% Similarity=0.265 Sum_probs=196.5
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD---- 654 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 654 (870)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34567999999999999999999965 68999999886543 222345567999999999999999999886654
Q ss_pred ----eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 655 ----FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 655 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
..++||||++ +++.+++......+++.++..++.|++.|++||| +++++|+||+|+||+++.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 3499999996 5888888766656899999999999999999999 6679999999999999999999999999
Q ss_pred cccccCCCCCc--ccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH--Hhc
Q 002892 731 ISKLLGEDDDS--VTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK--LSL 805 (870)
Q Consensus 731 ~a~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~ 805 (870)
++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|..||..... ......... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQLCGSI 243 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCC
Confidence 99866432221 112234577889999988664 468899999999999999999999865321 111111111 111
Q ss_pred CCch-hhh-----cchh-hhcccC----cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 806 PRGL-TEV-----VDAS-LVREVQ----PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 806 ~~~~-~~~-----~~~~-~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+... ... .+.. ...... ...........+.+++.+||..+|++||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1110 000 0000 000000 00000011345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.67 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=195.8
Q ss_pred CCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 590 CNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
...||+|+||.||+|... +++.||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999864 7899999998655555566788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccc
Q 002892 669 EKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748 (870)
Q Consensus 669 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 748 (870)
.+++... .+++..+..++.|++.|++||| +.|++||||+|+||++++++.++++|||++........ ......
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 9987644 3789999999999999999999 66799999999999999999999999999876533221 122345
Q ss_pred cccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHH
Q 002892 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM 828 (870)
Q Consensus 749 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (870)
+++.|+|||...+..++.++||||+|+++|+|++|..||..... ...........+.... ...
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~---------------~~~ 240 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLK---------------NLH 240 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccC---------------Ccc
Confidence 78899999999888889999999999999999999999864211 1111111111111100 001
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 829 DCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 829 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.++..+.+++.+||+.+|.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 12346788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.02 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=196.9
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
|++.+.||+|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999864 79999999987543 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 664 PNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 664 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+ ++|.+++.... ..+++..+..++.|+++||+||| +++++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 68999987654 45899999999999999999999 66799999999999999999999999999976533221
Q ss_pred cccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc--h---hhhcc-
Q 002892 743 TQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPRG--L---TEVVD- 814 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~--~---~~~~~- 814 (870)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...... .....+... ..+.. + ....+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 12223468899999987654 5788999999999999999999998653221 111111111 00110 0 00000
Q ss_pred -hhhhcccCcc--hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 -ASLVREVQPS--YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 -~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......... ......+..+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 001122357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.63 Aligned_cols=265 Identities=20% Similarity=0.233 Sum_probs=197.3
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCNL------ 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 653 (870)
..++|+..+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999854 7899999998643 233345677899999999999999999988543
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
...|+||||++ +++.+.+... +++..+..++.|++.||+||| +.|++||||||+||++++++.+||+|||.+.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35699999995 5888877643 789999999999999999999 6679999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcC-Cchhh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLP-RGLTE 811 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~ 811 (870)
...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||..... .......... ..+ ..+.+
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHH
Confidence 664322 12234578899999999999999999999999999999999999865311 1111111110 000 00111
Q ss_pred hcchhhh----ccc------------------CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 812 VVDASLV----REV------------------QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 812 ~~~~~~~----~~~------------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+.... ... .........+..+.+++.+|++.||++||++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1100000 000 0000011235568899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=285.25 Aligned_cols=250 Identities=21% Similarity=0.255 Sum_probs=194.3
Q ss_pred hhHHHHhhcCCCCCCee--ccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 002892 577 YLDIQQATDGFNECNLL--GAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCN 652 (870)
Q Consensus 577 ~~~~~~~~~~~~~~~~l--g~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 652 (870)
..++....++|++.+.+ |+|+||.||++... +++.+|+|++....... . |......+ +|||++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556778887777 99999999999854 68899999987542211 1 22222222 69999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEecccc
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGI 731 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~ 731 (870)
.+..++||||+++++|.+++.... .+++.++..++.|+++|++||| +.+++||||+|+||+++.++ .++++|||.
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999999998664 5899999999999999999999 67799999999999999988 999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
+....... ...++..|+|||++.+..++.++||||+|+++|||++|+.||............+.... ...
T Consensus 157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--- 226 (267)
T PHA03390 157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK--- 226 (267)
T ss_pred ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc---
Confidence 87653221 23578899999999988899999999999999999999999975433332222222211 000
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-MTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~ 857 (870)
.......+..+.+++.+||+.+|++||+ ++++++
T Consensus 227 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0001123456899999999999999996 588864
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=286.01 Aligned_cols=242 Identities=24% Similarity=0.300 Sum_probs=193.9
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
||.|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 58999999987543 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccc
Q 002892 669 EKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748 (870)
Q Consensus 669 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 748 (870)
.+++.... .+++..+..++.|++.|++||| +++++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99998654 3899999999999999999999 6779999999999999999999999999998764332 122345
Q ss_pred cccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHH
Q 002892 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM 828 (870)
Q Consensus 749 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (870)
+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ...... +.+.. .... .+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~--------~~~~~----~~~~-~~~ 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYND--------ILKGN----GKLE-FPN 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHH--------HhccC----CCCC-CCc
Confidence 7889999999988889999999999999999999999997643211 111110 00000 0000 011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 829 DCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 829 ~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
.++..+.+++.+||+.+|++||+ +.|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 12457899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=285.23 Aligned_cols=246 Identities=27% Similarity=0.343 Sum_probs=200.9
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|++.+.||+|++|.||+++.. +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999854 68899999987543 33456778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 663 MPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 663 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
+++++|.+++... +..+++..++.++.|+++|++||| +.|++||||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998752 345899999999999999999999 677999999999999999999999999999876433
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||...... .....+.. .
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---------------~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR---------------G 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---------------C
Confidence 122245788999999999988999999999999999999999999753211 11111000 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... ....++..+.+++.+|++.+|++||++.++++
T Consensus 217 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 217 KYPP--IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCC--CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 11134567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.97 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=199.8
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeEEEEe
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKALVLE 661 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 661 (870)
|++.+.||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999966 58899999998763 33446688899999999999999999999887 88999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++ ++.+++......+++..+..++.|+++|++||| ..+++|+||+|+||++++++.++++|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9974 899988766556899999999999999999999 56799999999999999999999999999987644321
Q ss_pred ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-C--Cchhhhcch--
Q 002892 742 VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-P--RGLTEVVDA-- 815 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~-- 815 (870)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ............ + ..+....+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchh
Confidence 12233456788999997764 4578999999999999999999999875322 111222111100 0 001110000
Q ss_pred --hhhccc--Ccc--hHHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 --SLVREV--QPS--YAKMD-CLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 --~~~~~~--~~~--~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...... ... ..... ++..+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 000 00011 2567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=285.50 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=199.0
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|++.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999965 68899999986542 23345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEeccccccccCCCCC
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLGEDDD 740 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 740 (870)
+++++|.+++... +..+++..+..++.|++.|++||| +.+++|+||+|+||++++++ .++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999754 335799999999999999999999 66699999999999999886 469999999986643221
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ...+............
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-------- 222 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPI-------- 222 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCC--------
Confidence 1223457889999999988889999999999999999999999986421 1112111111110000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
. ...+..+.+++.+||..+|++||++.|+++.
T Consensus 223 -~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -S-----PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -C-----CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 1123468899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=298.08 Aligned_cols=268 Identities=21% Similarity=0.279 Sum_probs=196.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----Cee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-----DFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 656 (870)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999854 78999999986432 33446678899999999999999999887543 357
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++|+||++ +++.+.+... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 99999996 4888777543 4899999999999999999999 6779999999999999999999999999997654
Q ss_pred CCCCc-ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh---cCCchhh
Q 002892 737 EDDDS-VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS---LPRGLTE 811 (870)
Q Consensus 737 ~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 811 (870)
..... .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..... ......+.... .++.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHH
Confidence 32211 11223467899999998654 5688999999999999999999999965211 11111111100 0111111
Q ss_pred hcchhhh-------cccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 812 VVDASLV-------REVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 812 ~~~~~~~-------~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+.+.... ........ ......++.+++.+||+.+|++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111100 00000000 01224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=325.14 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=201.1
Q ss_pred hcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
+-+|.....||.|.||.||-|. .++|+-.|+|-++... ....+.+.+|+.++..++|||+|+++|.-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3467778899999999999998 5679999999876543 344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|||++|+|.+.++..+. .++.....+..|++.|++||| .+|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1314 EyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999986543 677777788999999999999 66699999999999999999999999999988754421
Q ss_pred c--ccccccccccccCCcccccCCC---cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 741 S--VTQTMTMATIGYMAPEYASDGI---ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 741 ~--~~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
. .....-.||+.|||||++.+.. ..-++||||+||++.||+||+.||..... +.++..-+.....+.
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-e~aIMy~V~~gh~Pq------- 1461 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-EWAIMYHVAAGHKPQ------- 1461 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-hhHHHhHHhccCCCC-------
Confidence 1 2223457999999999997643 45689999999999999999999987422 222211111111111
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.+.....+-.+++..|+..||++|++++|+++.
T Consensus 1462 ----------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 ----------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111234567889999999999999999988753
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=285.81 Aligned_cols=242 Identities=23% Similarity=0.295 Sum_probs=184.8
Q ss_pred eeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHH---HHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 592 LLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEV---LRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
+||+|+||.||+|... +++.||+|.+..... .....+.+|..+ +....||+++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 689999998865421 111223344433 333479999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+++|.+++...+ .+++..+..++.|++.|++||| +.+++||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 999999987654 3899999999999999999999 6679999999999999999999999999987553221 2
Q ss_pred cccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....|+..|+|||.... ..++.++||||+||++|||++|..||........ ......... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~------~~~-------- 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT------VNV-------- 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhc------CCc--------
Confidence 23458999999998864 5678999999999999999999999975322211 111000000 000
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVVK 858 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 858 (870)
..+...+.++.+++.+|++.+|++|| +++++++.
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00112345788999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=288.50 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=201.1
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
|++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|++++++++|++|+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999864 789999999875532 24567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
++ ++.+++......+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 888888876566899999999999999999999 6669999999999999999999999999998764433 12
Q ss_pred ccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc---CCchhhhcc---hh
Q 002892 744 QTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL---PRGLTEVVD---AS 816 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---~~ 816 (870)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ........... +..+....+ ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 2234577889999998776 7889999999999999999999998653221 11111111100 000000000 00
Q ss_pred ---hhccc--CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 ---LVREV--QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ---~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... ........++..+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 001112245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=283.98 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=201.9
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+.+|++++++++|||++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 678999999976653 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++... ..+++..+..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999865 34899999999999999999999 677999999999999999999999999999876443321
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....++..|+|||...+..++.++|||++|+++|+|++|+.||..... ......... .... .
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~---------~-- 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ-DDHP---------P-- 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-cCCC---------C--
Confidence 2334578899999999888889999999999999999999999865321 111111000 0000 0
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+...+..+.+++.+||..+|++||++.+++.
T Consensus 219 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 ---LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00122456889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=291.86 Aligned_cols=266 Identities=22% Similarity=0.275 Sum_probs=194.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCe-----
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDF----- 655 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 655 (870)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999965 689999999865432 22356788999999995 6999999999877655
Q ss_pred eEEEEecCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceEEeccc
Q 002892 656 KALVLEFMPNGSLEKWLYSH----NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFG 730 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 730 (870)
.|+||||+++ ++.+++... ...+++..+..++.||+.||+||| +++++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898888743 235799999999999999999999 677999999999999998 8999999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPRG 808 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~ 808 (870)
.+..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ ....... ..+..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 9876532211 1222346788999998865 4578999999999999999999999865322111 1111110 01110
Q ss_pred --hhhhcc---hhhhcccCc---chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 --LTEVVD---ASLVREVQP---SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 --~~~~~~---~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+....+ ........+ .......+..+.+++..||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 000000000 0001124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=292.98 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=205.5
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.-...|.+...||+|.|+.|..|++. ++..||+|.+.+.. ....+.+.+|+++|..+.|||||+++++...+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567899999999999999999954 79999999998764 2333558899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+.+|.+.+++.+.++ ..+.+...++.|+.+|++|+| ++.|||||||++||+++.+..+||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec--
Confidence 9999999999999998876 455888999999999999999 6779999999999999999999999999999884
Q ss_pred CCcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.........|++.|+|||++.+..| ++.+|+||+|+++|.|+.|..||++..-. +.-.+.+
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----------------~Lr~rvl 268 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----------------ELRPRVL 268 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----------------cccchhe
Confidence 3334556789999999999998775 58999999999999999999999863111 1111222
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
...+.-.+ ....+..+++++++..+|.+|++++++.+.
T Consensus 269 ~gk~rIp~---~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 269 RGKYRIPF---YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecccc---eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 22211111 112356788899999999999999998653
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=291.55 Aligned_cols=270 Identities=23% Similarity=0.292 Sum_probs=200.1
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD---- 654 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 654 (870)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 68999999987543 223356778999999999999999999887654
Q ss_pred ------eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEec
Q 002892 655 ------FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 655 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
..++|+||+++ ++.+++......+++..+..++.|++.||+||| +.+|+||||+|+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 777777765556899999999999999999999 66799999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh---
Q 002892 729 FGISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS--- 804 (870)
Q Consensus 729 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--- 804 (870)
||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... ....+..+....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-~~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-ELAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCC
Confidence 999986643322 11222346778999998865 457889999999999999999999987532 111122211111
Q ss_pred cCCchhhhcchhhh------ccc--CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 805 LPRGLTEVVDASLV------REV--QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 805 ~~~~~~~~~~~~~~------~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+..+.++...... ... .........+..+.+++..||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01111111000000 000 000011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.20 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=194.2
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++|||++++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 589999999875533 4556788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC------cc
Q 002892 669 EKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD------SV 742 (870)
Q Consensus 669 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~ 742 (870)
.+++...+ .+++..+..++.|+++||+||| +.+++||||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998655 5899999999999999999999 66799999999999999999999999999875532211 11
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
......++..|+|||.......+.++||||||+++|++++|..||...... ..... ......
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~------------~~~~~~- 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQN------------ILNGKI- 218 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH------------HhcCCc-
Confidence 223345788999999998888999999999999999999999998653211 11100 000000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
........+..+.+++.+||+.+|++||++.++.+.+
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0000001245789999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=291.62 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=195.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC-CcEEEEEEeechh-hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQL-ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 659 (870)
..++|++.+.||+|++|.||+|.+++ ++.||||+++... ......+..|+.++.+.. ||||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 45778999999999999999999764 8999999997543 233445666777676664 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||++ +++.++.......+++..+..++.|++.|++|||+ ..+++||||+|+||++++++.++|+|||.+..+....
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99985 57888777655578999999999999999999994 1479999999999999999999999999987653322
Q ss_pred CcccccccccccccCCcccccCCC----cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGI----ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.........+..+.....+ .
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~---- 238 (296)
T cd06618 170 ---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP----S---- 238 (296)
T ss_pred ---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC----C----
Confidence 122235778999999987553 7889999999999999999999986522111111111110000 0
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
. . ....++.++.+++.+||+.+|++||++.++++.
T Consensus 239 -~----~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -L----P---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -C----C---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0 000234568999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=291.27 Aligned_cols=248 Identities=25% Similarity=0.327 Sum_probs=196.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech---hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ---LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.+.|...+.||+|+||.||+|+.. +++.+|+|.+... ......++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344777788999999999999964 6789999988642 233446678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+. |++.+++......+++.++..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99996 6888887755566899999999999999999999 667999999999999999999999999998765322
Q ss_pred CcccccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 740 DSVTQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
....+++.|+|||.+. .+.++.++|||||||++|+|++|+.||...... .....+.....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~----------- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES----------- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCC-----------
Confidence 2235788999999874 356788999999999999999999998652111 11111111000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 859 (870)
.......++..+.+++.+||+.+|++||++.++++.-
T Consensus 232 ------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 ------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0111123345688999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=284.31 Aligned_cols=242 Identities=21% Similarity=0.272 Sum_probs=186.3
Q ss_pred CeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHH-HhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVL-RNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|... +++.||+|+++... ......+..|...+ ...+|+|++++++++...+..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 68999999987543 12223344454443 445899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
++|.+++.... .+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999997654 3899999999999999999999 66799999999999999999999999999875432 22
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
...++..|+|||...+..++.++||||+|+++|||++|..||...... ........... . . +..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~------------~--~-~~~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRRI------------N--W-PEE 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhccc------------C--C-CCc
Confidence 335788999999998888899999999999999999999999653211 11111000000 0 0 000
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 826 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
....++..+.+++.+||+.+|++||++.++.+.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 111345678999999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.76 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=193.0
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666788999999999999865 68999999987543 234567888999999996 9999999999998889999999
Q ss_pred cCCCCCHHHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 662 FMPNGSLEKWLY----SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 662 ~~~~g~L~~~l~----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
|++ +++.++.. .....+++..+..++.|++.|++|||+ ..+++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 46555432 223558999999999999999999994 24699999999999999999999999999976532
Q ss_pred CCCcccccccccccccCCcccccCC---CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDG---IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
.. ......|++.|+|||++.+. .++.++||||+|+++|||++|+.||..... .... .........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~-~~~~~~~~~----- 228 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQ-LTQVVKGDP----- 228 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHH-HhhhcCCCC-----
Confidence 22 11223578899999998766 688999999999999999999999865321 0011 000000000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+.+.. .....++..+.+++.+||+.+|++||++.+|++.
T Consensus 229 ~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSN-----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCC-----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011245578999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=286.48 Aligned_cols=243 Identities=23% Similarity=0.278 Sum_probs=191.1
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
||+|+||+||+|... +|+.||+|++.... ......+..|++++++++|||++++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68999999987543 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccccc
Q 002892 669 EKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747 (870)
Q Consensus 669 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 747 (870)
.+++.... ..+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99998544 35899999999999999999999 6779999999999999999999999999987653311 12234
Q ss_pred ccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHH
Q 002892 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAK 827 (870)
Q Consensus 748 ~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (870)
.++..|+|||++.+..++.++||||+|+++|+|++|+.||...... ............. ....+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---------------~~~~~ 218 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEM---------------AVEYP 218 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccccc---------------cccCC
Confidence 5778999999998888999999999999999999999999653221 1111111000000 00001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 828 MDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 828 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
...+..+.+++.+||+.+|++|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 12245688999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=310.17 Aligned_cols=270 Identities=17% Similarity=0.173 Sum_probs=189.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC--CcEEEEEE--------------eec---hhhHHHHHHHHHHHHHHhcCCCce
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD--GTNVAIKV--------------FNL---QLERAFRSFESECEVLRNVRHRNL 643 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~ni 643 (870)
..++|++.+.||+|+||+||++..+. ++.++.|. +.+ ........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999987532 22222221 100 112334568899999999999999
Q ss_pred eEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC
Q 002892 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHN----YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD 719 (870)
Q Consensus 644 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 719 (870)
+++++++...+..|+|+|++. +++.+++.... .......+..++.|++.||+||| +++|+||||||+||+++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999984 57777775322 22345677889999999999999 67799999999999999
Q ss_pred CCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCC-CCccccc-cchH
Q 002892 720 KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP-TDEMFTG-EMSL 797 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p-~~~~~~~-~~~~ 797 (870)
.++.+||+|||++..+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.+ +...... ...+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987643222 122335689999999999999999999999999999999998864 4322111 1122
Q ss_pred HHHHH------HhcCCchhhhcchhhhccc-------CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 798 KHWIK------LSLPRGLTEVVDASLVREV-------QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 798 ~~~~~------~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... ..++....+..+....... .........+..+.+++.+|++.||++||++.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 22211 1112111111111000000 000111112345778899999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=296.33 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=198.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee----CCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN----LDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 656 (870)
.++|++.+.||+|++|.||+|... +|+.||+|++.... ......+..|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999854 68999999987542 2334667789999999999999999988753 3467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+. ++|.+++..... +++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 689998875544 899999999999999999999 6679999999999999999999999999997654
Q ss_pred CCCCc--ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcC-Cch-h
Q 002892 737 EDDDS--VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLP-RGL-T 810 (870)
Q Consensus 737 ~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~-~~~-~ 810 (870)
..... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ..+..+... ..+ ... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHhhh
Confidence 32221 11223468889999998765 46889999999999999999999999653221 111111110 000 000 0
Q ss_pred hhcchhh-------hcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 811 EVVDASL-------VREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 811 ~~~~~~~-------~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+... .......+. ....+..+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000 000000000 1123567999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=296.23 Aligned_cols=269 Identities=24% Similarity=0.296 Sum_probs=198.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC--Cee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL--DFK 656 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~ 656 (870)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4568889999999999999999865 6889999988542 223345677899999999 999999999988653 367
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||++ ++|.+++... .+++..+..++.|++.||+||| ++||+||||+|+||+++.++.+||+|||.+....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999988765 5789999999999999999999 6779999999999999999999999999998664
Q ss_pred CCCCc---ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC-c-h
Q 002892 737 EDDDS---VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR-G-L 809 (870)
Q Consensus 737 ~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-~-~ 809 (870)
..... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ....... ..+. . +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 33221 12223457889999998754 5578899999999999999999999965322211 1111111 0000 0 0
Q ss_pred h--------hhcchhhhcccCc-chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 810 T--------EVVDASLVREVQP-SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 810 ~--------~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
. .+.+......... ......++..+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 0110000000000 00011135678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=288.64 Aligned_cols=244 Identities=26% Similarity=0.326 Sum_probs=193.4
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
|...+.||+|+||.||+|+.. +++.||+|++.... ......+..|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999854 68999999986532 33446788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+. |++.+++......+++.++..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 5888888766666899999999999999999999 66799999999999999999999999998864321
Q ss_pred cccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 743 TQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.....|+..|+|||++. .+.++.++||||||+++|||++|..||...... ...........+
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~------------- 238 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNDSP------------- 238 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCC-------------
Confidence 12345788999999974 456888999999999999999999998653111 111110000000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.......+..+.+++.+||+.+|++||++.++++.
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 ----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011223458899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=289.39 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=195.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999865 689999999865432 233567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceEEeccccccccCCCC
Q 002892 662 FMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 662 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~ 739 (870)
|++ +++.+++... ....++..+..++.||+.||+||| +++++||||+|+||+++. ++.+|++|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5888877643 333688889999999999999999 667999999999999985 5679999999997653321
Q ss_pred CcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH-HhcCC--chhh---h
Q 002892 740 DSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK-LSLPR--GLTE---V 812 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~---~ 812 (870)
. ......+++.|+|||++.+ ..++.++||||+|+++|+|+||+.||......+ ....... ...+. .+.. .
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhccccccc
Confidence 1 1222356889999998866 457889999999999999999999996532211 1111111 00110 0000 0
Q ss_pred cchhhh-cc-cCc--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLV-RE-VQP--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~-~~-~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+.... .. ... .......+..+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00 000 0001122456889999999999999999999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=291.89 Aligned_cols=263 Identities=20% Similarity=0.281 Sum_probs=192.6
Q ss_pred Ceeccc--cceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAG--SFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+| +||+||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 89999999864 79999999987542 33457788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc--
Q 002892 666 GSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV-- 742 (870)
Q Consensus 666 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 742 (870)
+++.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998854 335899999999999999999999 6779999999999999999999999998654332111110
Q ss_pred ---cccccccccccCCcccccCC--CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hc--------CCc
Q 002892 743 ---TQTMTMATIGYMAPEYASDG--IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SL--------PRG 808 (870)
Q Consensus 743 ---~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~--------~~~ 808 (870)
......++..|+|||++.+. .++.++||||+||++|||++|+.||........ ....... .. +..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence 01112345679999998764 478899999999999999999999976432211 1111100 00 000
Q ss_pred hhhhc----------c-h--------hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 LTEVV----------D-A--------SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 ~~~~~----------~-~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... . . .+............+...+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 0 0 000000011123346678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=266.33 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=196.5
Q ss_pred HhhcCCCCC-CeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeee----CC
Q 002892 582 QATDGFNEC-NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCN----LD 654 (870)
Q Consensus 582 ~~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~ 654 (870)
..+++|++. ++||-|-.|.|..+..+ +|+++|+|++... ...++|++..-.. .|||||.+++.|.. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 345666654 68999999999998855 7999999998533 3456677664444 69999999998854 34
Q ss_pred eeEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEeccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFG 730 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 730 (870)
.+.+|||.++||.|...++.++ ..+++.++..|+.||+.|++||| +..|+||||||+|+|... +..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence 6679999999999999999654 56999999999999999999999 555999999999999964 4579999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 810 (870)
+|..... .........||+|.|||++...+|+...|+||+||++|-|++|-+||....... ++.++.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------ispgMk 276 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGMK 276 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CChhHH
Confidence 9986532 233445578999999999999999999999999999999999999997643321 112222
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+...--. -+..+....++...++|+..+..+|++|.|+.+++.
T Consensus 277 ~rI~~gqy~--FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYE--FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCcc--CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 211111111 122233455778899999999999999999999865
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=281.83 Aligned_cols=250 Identities=22% Similarity=0.267 Sum_probs=196.2
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech-----hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--Cee
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ-----LERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFK 656 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 656 (870)
.+|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999854 6899999987532 234456788999999999999999999998664 467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++++||+++++|.+++..... +++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999999999999986543 789999999999999999999 6679999999999999999999999999998653
Q ss_pred CCCC-cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 737 EDDD-SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 737 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... ........++..|+|||++.+..++.++|||||||++|++++|+.||...... ...........+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~--------- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AAIFKIATQPTK--------- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-HHHHHHHcCCCC---------
Confidence 2111 11122345788999999998888899999999999999999999999753111 111111000000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+......+.+++.+||. +|.+||++.+++.
T Consensus 228 --------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 --------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00111234568899999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=267.64 Aligned_cols=272 Identities=20% Similarity=0.324 Sum_probs=209.7
Q ss_pred ccchhHHHHhhcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeee
Q 002892 574 RTSYLDIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCC 651 (870)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 651 (870)
...+.|+-..++ +.+|+|+|+.|--+. ..+|..||||++.+.......+.-+|++++.+.+ |+||++++++|+
T Consensus 72 ~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 72 SGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred cchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 345777777664 469999999999887 6789999999999887777788999999999995 999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC---ceEEec
Q 002892 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---TARVSD 728 (870)
Q Consensus 652 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 728 (870)
++...|+|||.+.||+|...++++.. +++.+..++..+|+.||.+|| .+||+|||+||+|||-.+.. -|||+|
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeec
Confidence 99999999999999999999997765 899999999999999999999 78899999999999996654 589999
Q ss_pred cccccccCCCC-----CcccccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHH
Q 002892 729 FGISKLLGEDD-----DSVTQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798 (870)
Q Consensus 729 fg~a~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~ 798 (870)
|.++.-..... ........+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+....+-
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--- 299 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--- 299 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---
Confidence 98876442211 222234567888999999763 34588899999999999999999999987654321
Q ss_pred HHHHHhcCC-chhhhcchhhhcccC-cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 799 HWIKLSLPR-GLTEVVDASLVREVQ-PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 799 ~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
-|.+...=+ ....++.......++ +.......+.+..+++...+..++.+|.++.+++.
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 121111101 111222211111111 11123445677889999999999999999988875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=273.33 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=213.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeee-CC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCN-LD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 654 (870)
...+++..-++.+|.||.||.|.|. +.+.|.+|.++... +-+...+..|.-.+..+.|||+.++.+.+.+ .+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3456777778999999999999654 34456667654332 4456778889989999999999999998865 55
Q ss_pred eeEEEEecCCCCCHHHHHh-------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEe
Q 002892 655 FKALVLEFMPNGSLEKWLY-------SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVS 727 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~-------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 727 (870)
.+++++.++.-|+|..|+. +..+.++..+...++.|++.|++||| ++||||.||.++|+++++.-.|||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEec
Confidence 7789999999999999998 22345788889999999999999999 7789999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcC
Q 002892 728 DFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLP 806 (870)
Q Consensus 728 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 806 (870)
|=.+++..-..+...-......+..||+||.+....|+.++||||||+++|||+| |+.||.+.-+-+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------------ 506 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------------ 506 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------------
Confidence 9999988766666666666677899999999999999999999999999999999 999986521111
Q ss_pred CchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 807 RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
+. ...++..+-.++-+||++++.+|.-||...|++||+++++...|.++...
T Consensus 507 --m~-----~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 --ME-----HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --HH-----HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 11 11222233445668999999999999999999999999999999987654
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=284.95 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=195.0
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhc---CCCceeEEeeeeeeCCe-----
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNV---RHRNLIKIFSSCCNLDF----- 655 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 655 (870)
|++.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+.+++++ .|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 589999999975432 2234456677776665 59999999999988776
Q ss_pred eEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
.+++|||+++ ++.+++.... ..+++..+..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999974 8998887543 35899999999999999999999 66799999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCchhhhc
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPRGLTEVV 813 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 813 (870)
+..... .....++..|+|||++.+..++.++||||||+++|||++|..||..... ......+.... .+.......
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence 643321 1223468889999999998999999999999999999999999875322 22222222211 111000000
Q ss_pred c-----hhhhcccCcc--hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 814 D-----ASLVREVQPS--YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 814 ~-----~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. .......... ....+....+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000000 011123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=290.00 Aligned_cols=261 Identities=21% Similarity=0.209 Sum_probs=190.1
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
+.+|.|+++.||++. .+++.||+|++... .......+..|++++++++||||+++++++...+..+++|||+++|++
T Consensus 8 ~~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEec-CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 344455555555544 36899999998765 344567899999999999999999999999999999999999999999
Q ss_pred HHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC-----cc
Q 002892 669 EKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD-----SV 742 (870)
Q Consensus 669 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~ 742 (870)
.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++|||.+........ ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999853 445889999999999999999999 66799999999999999999999999998875532111 11
Q ss_pred cccccccccccCCcccccCC--CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh----h-----
Q 002892 743 TQTMTMATIGYMAPEYASDG--IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT----E----- 811 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~----- 811 (870)
......++..|+|||++... .++.++||||+||++|||++|+.||............ .....+..+. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcCC
Confidence 11233467789999998663 5788999999999999999999999753222111111 1101000000 0
Q ss_pred -------hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 -------VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 -------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+...... ............+.+++..||+.+|++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 243 MSQSRSSNEHPNNRDS-VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCcccccccccchhhh-hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000000 011111233457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=281.36 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=199.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.+.|+.-++||+|+||.||-++.. +|+-||.|.+.+.. +........|-++++++..+.||.+--.|+..+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999998854 69999999886543 22334567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 660 LEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
+..|.||+|.=++.+.+ ..+++..+.-++.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|.|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999998887543 45999999999999999999999 677999999999999999999999999999988543
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
. .....+||.+|||||++..+.|+...|.||+||++|||+.|+.||....... -.+-+|++..
T Consensus 341 ~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~~ 403 (591)
T KOG0986|consen 341 K---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRTL 403 (591)
T ss_pred C---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHHh
Confidence 3 3445589999999999999999999999999999999999999996521110 0112233322
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCC
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC 851 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 851 (870)
..... + +...+.++..+.+..+..||++|..
T Consensus 404 ~~~~e-y-~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 404 EDPEE-Y-SDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cchhh-c-ccccCHHHHHHHHHHHccCHHHhcc
Confidence 22111 1 1233556788888999999999973
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=293.92 Aligned_cols=271 Identities=22% Similarity=0.238 Sum_probs=200.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----Ce
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-----DF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 655 (870)
.++|++.+.||+|+||+||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999854 6899999998653 223345677899999999999999999987643 35
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.++|+||++ ++|.+++...+ .+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999995 68988887654 4899999999999999999999 667999999999999999999999999999866
Q ss_pred CCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh---cCCchhh
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS---LPRGLTE 811 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 811 (870)
.... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ........... .+.....
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhh
Confidence 4322 12223457889999998764 4688999999999999999999999965321 11111111100 0000111
Q ss_pred hcchhhh-------cccCcc--hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHh
Q 002892 812 VVDASLV-------REVQPS--YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK--LQKI 862 (870)
Q Consensus 812 ~~~~~~~-------~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~i 862 (870)
+.+.... ...... .....++..+.+++.+||+.+|++||++.++++. ++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 1111000 000000 0112346678999999999999999999999876 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=279.95 Aligned_cols=241 Identities=23% Similarity=0.310 Sum_probs=184.3
Q ss_pred eeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHH---HHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 592 LLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESEC---EVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
+||+|+||.||+|... +++.||+|.+..... .....+..|. +.++...||+|+.+++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 689999999865421 1112233333 34444579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
|++|.+++...+ .+++..+..++.|+++|++||| +.+++||||+|+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999999887544 4899999999999999999999 6679999999999999999999999999987553221 1
Q ss_pred cccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....|+..|+|||++.++ .++.++||||+|+++|||++|+.||........ ......... ....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~------~~~~------- 217 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT------MAVE------- 217 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhc------cCCC-------
Confidence 234688999999998754 688999999999999999999999976322111 000000000 0000
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
.+..++..+.+++.+|+..+|++|| ++.++++
T Consensus 218 --~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0111245788999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=287.12 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=200.9
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 659 (870)
++|++.+.||+|++|.||+|... +++.||+|++.... ......+..|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999965 78999999987632 233467888999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++.+.+ .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998764 4899999999999999999999 6679999999999999999999999999998664332
Q ss_pred Cc------------------ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHH
Q 002892 740 DS------------------VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWI 801 (870)
Q Consensus 740 ~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~ 801 (870)
.. .......++..|+|||+.....++.++||||+|++++++++|+.||..... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~ 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKIL 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHH
Confidence 21 122234578899999999888899999999999999999999999875321 00000000
Q ss_pred HHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 002892 802 KLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM----TDVVV 857 (870)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~----~evl~ 857 (870)
. ..... +...+..+.+++..||+.+|++||++ .++++
T Consensus 236 ~--------------~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 K--------------LEYSF-----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred h--------------cCCCC-----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 00000 01124568899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=311.51 Aligned_cols=205 Identities=25% Similarity=0.391 Sum_probs=181.8
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
++-..++|.++++||+|+||.|..++.+ +++.||+|++++-. .....-|..|-.+|..-..+-|++++-.|.+..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3444688999999999999999999965 68899999997732 3345678999999998899999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.|+||||++||+|-.++.+.. .+++..+.-++..|..||+-+| +-|+|||||||.|||+|..|++||+|||.+..+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999999999887 6899999999999999999999 666999999999999999999999999999888
Q ss_pred CCCCCcccccccccccccCCccccc----C-CCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYAS----D-GIISPKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~sDvwslG~il~elltg~~p~~~ 789 (870)
..++ .......+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||+.
T Consensus 226 ~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 226 DADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 6443 44556678999999999985 3 6799999999999999999999999975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=266.35 Aligned_cols=270 Identities=20% Similarity=0.272 Sum_probs=197.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec---CC--cEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeee-CCe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF---DG--TNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCN-LDF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~---~~--~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 655 (870)
...|+.+..||+|.||.||+|.-. +. ..+|+|.++...+ ......-+|+..++.++|||++.+...+.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457899999999999999999632 22 3689999875532 233456789999999999999999998877 778
Q ss_pred eEEEEecCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC----CceEEe
Q 002892 656 KALVLEFMPNGSLEKWLYS----HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN----MTARVS 727 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~ 727 (870)
.++++||.+. +|...++. ....++...+..|+.||+.|+.|||+.. |+|||+||.||++..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999965 78777762 2356899999999999999999999655 9999999999999877 999999
Q ss_pred ccccccccCCCCCcc-cccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccc-----c---chH
Q 002892 728 DFGISKLLGEDDDSV-TQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTG-----E---MSL 797 (870)
Q Consensus 728 Dfg~a~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~-----~---~~~ 797 (870)
|+|+++.+..+-... .....+.|+.|.|||.+.+. .||++.|||+.|||+.||+|-++-|.+.... . .++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999886543322 34456789999999998775 5999999999999999999998877543211 1 122
Q ss_pred HHHHHH-hcCCc--hhhhc---ch-hhhcccC----cc------hHHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 798 KHWIKL-SLPRG--LTEVV---DA-SLVREVQ----PS------YAKMD-CLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 798 ~~~~~~-~~~~~--~~~~~---~~-~~~~~~~----~~------~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.++... ..|.. +..+. +. ....... .. +.... .....++++.+++..||.+|.|+.+.++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 222221 11211 11111 10 0001110 00 00000 1234789999999999999999999865
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=288.98 Aligned_cols=269 Identities=20% Similarity=0.244 Sum_probs=195.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLD------ 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 654 (870)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 689999999865432 22345678999999999999999998875433
Q ss_pred --eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 655 --FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 655 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
..++|+||+++ ++.+.+......+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 46899999964 787777766666999999999999999999999 677999999999999999999999999999
Q ss_pred cccCCCCCcc---------cccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 002892 733 KLLGEDDDSV---------TQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 733 ~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 802 (870)
.......... ..+...+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 7654322111 1123356788999998765 45789999999999999999999998753221 11111111
Q ss_pred Hh-c--CCch------hhhcchhhhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 803 LS-L--PRGL------TEVVDASLVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 803 ~~-~--~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. . +..+ ....+........... ........+.+++.+|++.+|++||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 10 0 0000 0000000000000000 01112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=286.12 Aligned_cols=255 Identities=23% Similarity=0.269 Sum_probs=197.4
Q ss_pred CCCCCCeeccccceeEEEEEe----cCCcEEEEEEeechh----hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCee
Q 002892 586 GFNECNLLGAGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 656 (870)
+|++.+.||+|++|.||+|+. .+++.||||+++... ......+..|++++.++ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 357889999987542 22345678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++++|.+++.... .+++..+..++.|+++|++||| +.+++||||+|+||+++.++.++++|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987543 4889999999999999999999 6779999999999999999999999999987653
Q ss_pred CCCCcccccccccccccCCcccccCCC--cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGI--ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
.... .......|+..|+|||...+.. .+.++||||+|+++|||++|..||..... ......+......
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~-------- 226 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILK-------- 226 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHc--------
Confidence 3221 1122345788999999987655 77899999999999999999999853211 1111111111000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
... ..+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 227 ----~~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 ----SKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----cCC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 0011233467899999999999999998888766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=289.09 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=198.6
Q ss_pred HHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee-CC
Q 002892 579 DIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN-LD 654 (870)
Q Consensus 579 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 654 (870)
++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44557889999999999999999999855 78999999875432 2334667889999999999999999998865 56
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..++++||+ +++|.+++.... +++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+..
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 788999998 568988886543 788889999999999999999 67799999999999999999999999999875
Q ss_pred cCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH--hcCCchh-
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL--SLPRGLT- 810 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~- 810 (870)
.... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..... ......+... ..+..+.
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence 4321 122356788999998765 5688999999999999999999999865321 1111111110 0011110
Q ss_pred hhcchh-------hhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 811 EVVDAS-------LVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 811 ~~~~~~-------~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
...+.. ......... ....++..+.+++.+|++.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000000 001234678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=284.01 Aligned_cols=251 Identities=24% Similarity=0.285 Sum_probs=194.2
Q ss_pred CCCCCCeeccccceeEEEEEe----cCCcEEEEEEeechhh----HHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCee
Q 002892 586 GFNECNLLGAGSFGSVYKGTL----FDGTNVAIKVFNLQLE----RAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 656 (870)
.|++.+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+..|+++++++ +|++|+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 3689999999875432 2345678899999999 589999999999998999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++++|.+++.... .+++..+..++.|+++|++||| +.+++||||+|+||++++++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999998654 4789999999999999999999 6779999999999999999999999999997654
Q ss_pred CCCCcccccccccccccCCcccccCC--CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDG--IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
..... ......|+..|+|||..... .++.++||||||+++|+|++|+.||..... ......+......
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~-------- 226 (290)
T cd05613 157 EDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILK-------- 226 (290)
T ss_pred ccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhc--------
Confidence 32211 12234578899999998753 467899999999999999999999864211 1111111111000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
... . .+..+...+.+++.+||+.+|++|| ++.+++.
T Consensus 227 ----~~~--~-~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 ----SEP--P-YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----cCC--C-CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000 0 0112344688999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=282.50 Aligned_cols=263 Identities=21% Similarity=0.253 Sum_probs=194.5
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEEecC
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
|++.+.||+|++|+||+|... +++.||+|++..... .......+|+..+++++ |||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999965 578999999865432 22234456899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 664 PNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 664 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+|++.+++.... ..+++..+..++.|++.|++||| +++++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 889999887653 46899999999999999999999 6679999999999999999999999999997653322
Q ss_pred cccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC--chhh------h
Q 002892 743 TQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR--GLTE------V 812 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~------~ 812 (870)
......++..|+|||++.. ..++.++|+||||+++|||++|+.||........ ....... ..+. .+.+ .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhcc
Confidence 1223457889999998754 4578999999999999999999999865322111 1111000 0000 0000 0
Q ss_pred cchhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+............ ....+..+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000000 0011356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=290.45 Aligned_cols=273 Identities=19% Similarity=0.270 Sum_probs=201.2
Q ss_pred ccchhHHHHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 002892 574 RTSYLDIQQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSC 650 (870)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 650 (870)
.....++....++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 344566777889999999999999999999985 478999999987542 22345677899999999999999999987
Q ss_pred eeC------CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCce
Q 002892 651 CNL------DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA 724 (870)
Q Consensus 651 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 724 (870)
... ...+++++++ +++|.+++... .+++..+..++.|+++|++||| +.+++||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence 543 3467888877 78998888654 3899999999999999999999 6679999999999999999999
Q ss_pred EEeccccccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 002892 725 RVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803 (870)
Q Consensus 725 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 803 (870)
||+|||++...... .....++..|+|||...+ ..++.++||||+||++|||++|+.||..... ..........
T Consensus 160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~ 233 (345)
T cd07877 160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRL 233 (345)
T ss_pred EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Confidence 99999998754321 123357889999998866 5678899999999999999999999864221 1112221111
Q ss_pred hc--CCchh-hhcc-------hhhhcccCcchHH--HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 804 SL--PRGLT-EVVD-------ASLVREVQPSYAK--MDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 804 ~~--~~~~~-~~~~-------~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.. +.... .+.+ ..+.......+.. ..+...+.+++..|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 10 00111 1100 0000000111100 0124568899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=283.23 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=199.1
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
|+..+.||+|++|.||+|+.. +++.||+|++.... ......+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 58999999997653 333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
+ ++|.+++......+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 7 5999999876456999999999999999999999 56699999999999999999999999999986643222 2
Q ss_pred ccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC--chhhhc-----c
Q 002892 744 QTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR--GLTEVV-----D 814 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~-----~ 814 (870)
.....++..|+|||.+.+. .++.++||||+|+++||+++|+.||...... ..+...... ..+. .+.... +
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 2233457789999998766 7889999999999999999999998653211 111111110 0000 011100 0
Q ss_pred hhhhcccCcc--hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVREVQPS--YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......... ......+..+.+++..||..+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 000112457999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=289.62 Aligned_cols=268 Identities=20% Similarity=0.251 Sum_probs=195.5
Q ss_pred hcCCCC-CCeeccccceeEEEEEec-CCcEEEEEEeechhhHH--------------HHHHHHHHHHHHhcCCCceeEEe
Q 002892 584 TDGFNE-CNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERA--------------FRSFESECEVLRNVRHRNLIKIF 647 (870)
Q Consensus 584 ~~~~~~-~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~ 647 (870)
.++|.. .+.||+|+||+||+|... +++.||+|++....... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 577999999999999855 68999999986543211 12467899999999999999999
Q ss_pred eeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEe
Q 002892 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVS 727 (870)
Q Consensus 648 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 727 (870)
+++...+..++||||++ |+|.+++.... .+++.....++.|++.|++||| +.|++||||+|+||+++.++.++++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence 99999999999999996 68999887543 3899999999999999999999 6779999999999999999999999
Q ss_pred ccccccccCCCCC------------cccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCcccccc
Q 002892 728 DFGISKLLGEDDD------------SVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794 (870)
Q Consensus 728 Dfg~a~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~ 794 (870)
|||.+........ ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9999976641110 1111223467889999998764 4688999999999999999999998753221
Q ss_pred chHHHHHHHh-cCC--chhhhcchhh----hcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 795 MSLKHWIKLS-LPR--GLTEVVDASL----VREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 795 ~~~~~~~~~~-~~~--~~~~~~~~~~----~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+....... .+. .+....+... ........ ....++..+.+++..|++.+|++||++.|++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111110 000 0110000000 00000000 01123457889999999999999999999975
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=290.72 Aligned_cols=272 Identities=23% Similarity=0.294 Sum_probs=204.3
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-----eeE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-----FKA 657 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 657 (870)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999965 58999999987643 344567889999999999999999999987765 789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
++|||++ ++|.+++.... .+++..+..++.|++.|++||| ++|++||||||.||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 58988887654 5899999999999999999999 67799999999999999999999999999987644
Q ss_pred CCCc-ccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC-------
Q 002892 738 DDDS-VTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR------- 807 (870)
Q Consensus 738 ~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~------- 807 (870)
.... .......++..|+|||++.+. .++.++||||+|+++|+|++|..||...... ......... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHhcCCCChhHhhhc
Confidence 3210 112334578899999999887 7899999999999999999999999764221 111111110 0000
Q ss_pred ---chhhhcchhhhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhHh
Q 002892 808 ---GLTEVVDASLVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK--LQKIKQ 864 (870)
Q Consensus 808 ---~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~i~~ 864 (870)
...+.+.. ......... .....+..+.+++..||+.+|++||++.++++. ++++.+
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000 000000000 011135678999999999999999999999874 555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=265.67 Aligned_cols=242 Identities=26% Similarity=0.292 Sum_probs=195.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|...+++|+|.||.|-+++-+ +|+.||+|++++.. +...+.-..|-++++..+||.+..+.-.|+..+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999854 78999999998764 3444556778999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||..||.|.-++...+. +++....-+-.+|+.||.||| +++||.||+|.+|.++|.+|++||+|||++..--
T Consensus 246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence 9999999999888876554 778888889999999999999 6779999999999999999999999999997431
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
........++|||.|.|||++....|+.+.|.|.+|+++|||++|+.||... +.+. +.+.+-..-.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-dh~k-------------LFeLIl~ed~ 385 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-DHEK-------------LFELILMEDL 385 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-chhH-------------HHHHHHhhhc
Confidence 2233455688999999999999999999999999999999999999999752 1111 1111111111
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCC
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRM 850 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 850 (870)
+.+. ....++..++...+..||.+|.
T Consensus 386 kFPr------~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPR------TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCc------cCCHHHHHHHHHHhhcChHhhc
Confidence 1111 1233567788888999999997
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=291.15 Aligned_cols=267 Identities=18% Similarity=0.264 Sum_probs=194.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC---------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--------- 653 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 653 (870)
..+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999864 6899999998776555667788999999999999999999776543
Q ss_pred -----CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceEEe
Q 002892 654 -----DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVS 727 (870)
Q Consensus 654 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~ 727 (870)
...++||||++ ++|.+++... .+++..+..++.|++.|++||| +.|++||||||+||+++. ++.++++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 5898888643 3889999999999999999999 667999999999999975 5678999
Q ss_pred ccccccccCCCCCc-ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-h
Q 002892 728 DFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-S 804 (870)
Q Consensus 728 Dfg~a~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~ 804 (870)
|||.+......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......+. ....... .
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 99999765322111 11123357889999997654 5678899999999999999999999975322111 1111110 0
Q ss_pred cCC--chhhh---cchhhhc-ccCcchH----HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 805 LPR--GLTEV---VDASLVR-EVQPSYA----KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 805 ~~~--~~~~~---~~~~~~~-~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... ..... ....... ....... ......++.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 00000 0000000 0000000 0123456889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=289.37 Aligned_cols=267 Identities=20% Similarity=0.290 Sum_probs=194.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD------ 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 654 (870)
.++|...+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999854 68999999986532 223456788999999999999999999886542
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..++|+||+. .++.++.. ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 4589999996 47766652 34889999999999999999999 66799999999999999999999999999875
Q ss_pred cCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC-chhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR-GLTE 811 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~ 811 (870)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+...... ..+. .+.+
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHH
Confidence 4321 122356888999999876 4688999999999999999999999975321 1111111110 0010 0111
Q ss_pred hcchh--------hhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhH
Q 002892 812 VVDAS--------LVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK--LQKIK 863 (870)
Q Consensus 812 ~~~~~--------~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~i~ 863 (870)
..... .......... .......+.+++..||+.+|++||++.++++. +++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000 0000000000 01234568899999999999999999999854 55544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=288.96 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=196.8
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-- 654 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 654 (870)
+....++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344567899999999999999999985 478999999986432 233456788999999999999999999886543
Q ss_pred ----eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 655 ----FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 655 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
..++||||+ ++++.+++... .+++..+..++.|+++|++||| +.||+||||||+||+++.++.++++|||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 77998888653 4899999999999999999999 6779999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc--CC
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL--PR 807 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~ 807 (870)
++...... .....+++.|+|||.+.+ ..++.++||||+|+++|++++|..||...... ........... +.
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCH
Confidence 98765321 122356889999998875 45788999999999999999999999753211 11111111100 00
Q ss_pred chhhhcchh--------hhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 GLTEVVDAS--------LVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~~~~~~~~~--------~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+.+.+... +........ ....+...+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011100000 000000000 01123456889999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=308.46 Aligned_cols=146 Identities=25% Similarity=0.448 Sum_probs=131.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|... +++.||+|+++... ......+..|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467999999999999999999965 68999999987542 33346788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
|||+++++|.+++...+ .+++..++.++.||+.||+||| .++|+||||||+||+++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997654 3789999999999999999999 6679999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-33 Score=264.95 Aligned_cols=251 Identities=23% Similarity=0.270 Sum_probs=193.0
Q ss_pred CCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 588 NECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
+....||.|+||+|++..++ .|+..|||.++.... ...+++..|.++..+- ..|+||+++|.+..++..++.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 34567999999999999865 799999999976543 4556777777765554 6899999999999999999999998
Q ss_pred CCCHHHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 665 NGSLEKWLY----SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 665 ~g~L~~~l~----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
..+++.+-. -....+++.-+-+|......||.||-+. ..|+|||+||+|||++..|.+||+|||.+-.+ ..
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL---v~ 220 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL---VD 220 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhH---HH
Confidence 457765543 2344589999999999999999999863 34999999999999999999999999998655 23
Q ss_pred cccccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 741 SVTQTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
+...+...|-..|||||.+.. ..|+-+|||||+|+++||+.||..||......-.++...+....|.-..
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~-------- 292 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF-------- 292 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC--------
Confidence 444556678889999998864 3488899999999999999999999976333222333322221111100
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....+....+..++-.|+..|-..||.++++++
T Consensus 293 -----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 -----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -----cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1111234557889999999999999999999865
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=277.31 Aligned_cols=247 Identities=21% Similarity=0.258 Sum_probs=192.0
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-----hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
+|.+.+.||+|+||.||++... .+..+++|+.+... ......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999865 34556666654321 22234566789999999999999999999998999999
Q ss_pred EecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
|||+++++|.+++.. ....+++..+..++.|++.|++||| +.|++|+||+|+||++++ +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 3456899999999999999999999 677999999999999975 569999999987663
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.... ......|++.|+|||...+..++.++|+||+|+++|+|++|..||..... ..........
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~--------- 220 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVEG--------- 220 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHcC---------
Confidence 3221 22234578899999999888889999999999999999999999864211 1111100000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+. .+..++..+.+++.+||+.+|++||++.|+++
T Consensus 221 ----~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 ----PTPS-LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCCC-CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0000 11234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.61 Aligned_cols=265 Identities=20% Similarity=0.293 Sum_probs=198.2
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe-
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF- 655 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~- 655 (870)
+....++|++.+.||+|++|.||+|+.. +++.||+|++.... ......+.+|+.++++++|||++++.+++...+.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3445778999999999999999999965 68899999986532 2334567789999999999999999988766554
Q ss_pred -----eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 656 -----KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 656 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
.++|+||+ +++|.+++... .+++..+..++.|+++|++||| +.|++||||+|+||++++++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 67999998753 4899999999999999999999 6679999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC-
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPR- 807 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~- 807 (870)
.+...... .....++..|+|||...+ ..++.++||||+|+++||+++|+.||..... ...+..+.... .+.
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCH
Confidence 99865332 222357788999998865 3678899999999999999999999965321 11111111110 000
Q ss_pred c---------hhhhcchhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 G---------LTEVVDASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~---------~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ....... +.......+. ....+..+.+++.+|++.+|++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQS-LPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHh-ccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 0000000 0000011111 1123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=283.51 Aligned_cols=266 Identities=22% Similarity=0.277 Sum_probs=191.0
Q ss_pred CCCCCCeeccccceeEEEEEec-C--CcEEEEEEeechh--hHHHHHHHHHHHHHHhc-CCCceeEEeeeeee----CCe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-D--GTNVAIKVFNLQL--ERAFRSFESECEVLRNV-RHRNLIKIFSSCCN----LDF 655 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~ 655 (870)
+|++.+.||+|+||.||+|... + +..||+|++.... ....+.+.+|+++++++ .||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999954 4 7789999986432 22345678899999999 59999999987543 245
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.++++||++ ++|.+++.... .+++..+..++.|++.||+||| ..|++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 688999885 68999887543 4899999999999999999999 667999999999999999999999999999865
Q ss_pred CCCCCc--ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC-c-h
Q 002892 736 GEDDDS--VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR-G-L 809 (870)
Q Consensus 736 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-~-~ 809 (870)
...... .......|+..|+|||...+ ..++.++||||+|+++|+|++|+.||..... .......... ..+. . .
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 432211 11223468899999998765 4688999999999999999999999865221 1111111110 0000 0 0
Q ss_pred hhhcch-------hhhcccCcchHH--HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 810 TEVVDA-------SLVREVQPSYAK--MDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 810 ~~~~~~-------~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+.+. .........+.. ..+...+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 000000000000 112457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=271.78 Aligned_cols=236 Identities=28% Similarity=0.317 Sum_probs=191.0
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
||+|+||.||++... +++.||+|++..... .....+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 589999999876532 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccc
Q 002892 669 EKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748 (870)
Q Consensus 669 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 748 (870)
.+++.... .+++..+..++.|++.|+.|+| +.+++|+||+|+||+++.++.++++|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99998654 3899999999999999999999 5679999999999999999999999999998664322 1223345
Q ss_pred cccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHH
Q 002892 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM 828 (870)
Q Consensus 749 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (870)
++..|+|||...+...+.++|+||||+++|++++|+.||..... ......+. .. .. . .+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~---~~--------~~--~-----~~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKIL---KD--------PL--R-----FPE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHh---cC--------CC--C-----CCC
Confidence 78899999999888889999999999999999999999965321 11111000 00 00 0 000
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHH
Q 002892 829 DCLLRIMHLALGCCMDSPEQRMCMTD 854 (870)
Q Consensus 829 ~~~~~l~~l~~~cl~~~P~~RPs~~e 854 (870)
..+..+.+++.+||..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11456889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-33 Score=259.61 Aligned_cols=270 Identities=19% Similarity=0.276 Sum_probs=198.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeee--------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCN-------- 652 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 652 (870)
...|+...+||+|.||+||+|+.+ .|+.||+|..-.. ....-....+|+++++.++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 345666788999999999999854 5788888865332 12233456789999999999999999988743
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
....|+||++|+ .+|...+......++..++.+++.++..||.|+| +..|+|||+||.|++++.+|.+||+|||++
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 235799999996 4899999888777999999999999999999999 666999999999999999999999999999
Q ss_pred cccCCCC--CcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH--Hhc-C
Q 002892 733 KLLGEDD--DSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK--LSL-P 806 (870)
Q Consensus 733 ~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~-~ 806 (870)
+.+.... .....+..+.|..|.+||.+.+ ..|+++.|||..|||+.||+||.+-+++..+. .++..+.. ..+ +
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQLHLISQLCGSITK 250 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HHHHHHHHHhccCCc
Confidence 7664332 2334566778999999998865 57999999999999999999999888763221 12222111 111 1
Q ss_pred Cchhhhcchhhhccc-------------CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 807 RGLTEVVDASLVREV-------------QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 807 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+-|..+..-.+.... ..+..+.....+..+++.+++..||.+|+++++++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 112222221111111 0000111112367899999999999999999998753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=232.59 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=199.0
Q ss_pred CCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+|...++||+|.||+||+|+ +++++.||+|.++.+. +..-....+|+-+++.++|.|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566789999999999999 4578999999987654 33345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
|+ .+|..+...-...++.+.+..++.|+++|+.++| ++.+.|||+||.|.++..+|+.|++|||+++.++-+ ..
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--vr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VR 156 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eE
Confidence 95 4888888877677999999999999999999999 566999999999999999999999999999977533 22
Q ss_pred cccccccccccCCcccccCCC-cCcccchHhHHHHHHHHHhCCCC-CCccccccchHHHHHHH-hcC--Cc---hhhhcc
Q 002892 743 TQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKP-TDEMFTGEMSLKHWIKL-SLP--RG---LTEVVD 814 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~-~~~--~~---~~~~~~ 814 (870)
-.+..+.|..|.+|.++.+.+ |+...|+||.|||+.|+...+.| |.+ .+-..++..+.+. ..| +. +....|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg-~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC-CcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 344566899999999998765 88999999999999999985555 443 2223334443321 111 11 222222
Q ss_pred hhhhcccCcchHHHH----HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVREVQPSYAKMD----CLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~----~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...-..+.......+ ....=.+++.+.+.-+|.+|.++.+.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 211111111111111 1123457778888889999999998765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=286.27 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=206.2
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeee---
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCN--- 652 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--- 652 (870)
...-..++.|++.+.||.|.+|.||+++ .++++.+|+|+.....+.+ .+++.|..+++.. .|||++.+++++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3344567889999999999999999999 4578999999987765443 6678899999988 69999999999853
Q ss_pred --CCeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecc
Q 002892 653 --LDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 653 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
.+.+++|||||.+|+..|+++.. +..+.|..+..|++.++.|+.+||. ..++|||||-.||+++.++.||++||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeee
Confidence 57889999999999999999833 6679999999999999999999994 44999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccC-----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASD-----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 804 (870)
|.+...+ ..........|||.|||||++.- ..|+.++|+||+|++..||..|.+|+-++.+.... ..
T Consensus 168 GvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F~ 239 (953)
T KOG0587|consen 168 GVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FL 239 (953)
T ss_pred eeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------cc
Confidence 9998763 23334456789999999999853 34777999999999999999999998764332110 11
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+|.... ...-.+.....++.++|..|+..|-++||++.++++
T Consensus 240 IpRNPP-----------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 IPRNPP-----------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCC-----------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111100 011123345678999999999999999999998864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.73 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=191.9
Q ss_pred CCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 590 CNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
.+++|+|.||+||-|+.+ +|+.||||++.+-. ......+++|+.+++++.||.||.+-..|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999854 89999999997643 333477899999999999999999999999999999999999554
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC---CceEEeccccccccCCCCCccc
Q 002892 667 SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN---MTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 667 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
-|+-.+.....++++..-.-+..||+.||.||| -++|+|+|+||+||++.+. ..+||+|||+|+++++.. .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence 444445566667999999999999999999999 5569999999999999654 479999999999986543 2
Q ss_pred ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....+|||.|.|||++..+.|...-|+||.|+|+|.-++|..||.+..+ +.+. +-+...+...
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----IndQ-----------IQNAaFMyPp-- 785 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----INDQ-----------IQNAAFMYPP-- 785 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hhHH-----------hhccccccCC--
Confidence 3345799999999999999999999999999999999999999976222 1111 1111221111
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 856 (870)
....+....+.++|...++..-.+|-+.++-+
T Consensus 786 -~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 -NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 11223445677788888888888888776654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=280.65 Aligned_cols=240 Identities=24% Similarity=0.262 Sum_probs=192.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 660 (870)
.++.|.....+|.|+|++|-.+... +++..+||++.+.. ..-.+|+.++... +|||++++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4677888888999999999988854 68889999997652 2234566666655 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee-CCCCceEEeccccccccCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL-DKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|.+.|+-+.+.+...+. ...++..|+.+|+.|+.||| ++|+||||+||.|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999988888876553 22777889999999999999 6779999999999999 68899999999999876433
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
....+-|..|.|||+.....|++++|+||+|+++|+|++|+.||.....+.. +.. +...
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-i~~--~i~~-------------- 528 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-IHT--RIQM-------------- 528 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-HHH--hhcC--------------
Confidence 2233457889999999999999999999999999999999999976433311 100 0000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......+..+.+++.+|++.||++||+|+++..
T Consensus 529 ----~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 ----PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 0011334567899999999999999999999865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=266.03 Aligned_cols=220 Identities=19% Similarity=0.139 Sum_probs=174.9
Q ss_pred ccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhh
Q 002892 596 GSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYS 674 (870)
Q Consensus 596 G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 674 (870)
|.+|.||++... +++.||+|++.... ....|...+....|||++++++++...+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999854 78999999987643 223445555566799999999999999999999999999999999876
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccC
Q 002892 675 HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754 (870)
Q Consensus 675 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~ 754 (870)
.. .+++..+..++.|++.|++||| +++++||||||+||++++++.++++|||.+...... .....++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 54 3899999999999999999999 677999999999999999999999999987655322 12234567799
Q ss_pred CcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHH
Q 002892 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRI 834 (870)
Q Consensus 755 aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 834 (870)
|||...+..++.++||||+|+++|||++|..|+....... ...... .. +...+..+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~----~~-----~~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTL----NI-----PEWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------cccccc----CC-----cccCCHHH
Confidence 9999988889999999999999999999998865321100 000000 00 01123468
Q ss_pred HHHHhhccCCCCCCCCCHH
Q 002892 835 MHLALGCCMDSPEQRMCMT 853 (870)
Q Consensus 835 ~~l~~~cl~~~P~~RPs~~ 853 (870)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=267.38 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=195.1
Q ss_pred hcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh-------hHHHHHHHHHHHHHHhcCCCceeEEeeeee-eCC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL-------ERAFRSFESECEVLRNVRHRNLIKIFSSCC-NLD 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~ 654 (870)
.++|-...++|+|+|+.||+|. +...+.||||+-.... ....+..-+|.++.+.+.||.||++|+++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4578888999999999999998 4567889999864321 122344668999999999999999999996 456
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC---CCCceEEecccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD---KNMTARVSDFGI 731 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~ 731 (870)
..+-|.|||+|.+|+=|++..+. +++.+...|+.||+.||.||.+. +.+|+|-|+||.|||+. .-|.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 77899999999999988887654 89999999999999999999976 57899999999999994 358899999999
Q ss_pred ccccCCCCCccc-----ccccccccccCCcccccCC----CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 002892 732 SKLLGEDDDSVT-----QTMTMATIGYMAPEYASDG----IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 732 a~~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 802 (870)
+.++..+..... .+...||..|.+||++.-+ ..+.|.||||.|||+|+++.|+.||.........+..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe--- 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE--- 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh---
Confidence 999965444322 2356799999999988533 4678999999999999999999999763222111111
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 856 (870)
..++.......+ .......++..+|+.|+.+--++|....++.
T Consensus 697 -------NTIlkAtEVqFP----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 -------NTILKATEVQFP----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------hchhcceeccCC----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 001111100000 0112244678899999999888888777764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=261.39 Aligned_cols=264 Identities=21% Similarity=0.264 Sum_probs=200.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-C-C----ceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVR-H-R----NLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~~~~~ 655 (870)
..++|.++..+|+|.||.|.++.+. .++.||||+++.- ........-|+++++++. + | -+|++.+||.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3789999999999999999999754 5789999998643 444556677999999993 2 3 37888899999999
Q ss_pred eEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC--------------
Q 002892 656 KALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-------------- 720 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------------- 720 (870)
.++|+|.+ |-++.+++.++ -.+++...+..|++|+++++++|| +.+++|-|+||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999987 77999999964 456899999999999999999999 666999999999999931
Q ss_pred ------CCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc
Q 002892 721 ------NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794 (870)
Q Consensus 721 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~ 794 (870)
...+|++|||.|..-.+.. +..+.|..|.|||++.+-.++.++||||+|||++|+.||..-|+.-.+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3358999999998654333 34467899999999999999999999999999999999999887533222
Q ss_pred chHH--HHHHHhcCCchhhhc-----------c----------hhhhcccCcch----HHHHHHHHHHHHHhhccCCCCC
Q 002892 795 MSLK--HWIKLSLPRGLTEVV-----------D----------ASLVREVQPSY----AKMDCLLRIMHLALGCCMDSPE 847 (870)
Q Consensus 795 ~~~~--~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~ 847 (870)
.++ +.+-.++|..+.... | +...+...+.. ....+..++.++++.|+..||.
T Consensus 317 -HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 317 -HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred -HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 111 111123333221111 0 01111111111 1123456799999999999999
Q ss_pred CCCCHHHHHH
Q 002892 848 QRMCMTDVVV 857 (870)
Q Consensus 848 ~RPs~~evl~ 857 (870)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=236.25 Aligned_cols=218 Identities=26% Similarity=0.346 Sum_probs=178.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 659 (870)
..+.....+.||+|++|.|-+.++ .+|...|+|.+.... .+..++...|+.+..+. ..|.+|+++|.+......++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 334455567899999999988875 479999999987654 33446677788776665 689999999999988999999
Q ss_pred EecCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLY---SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
||.| ..+|+.|-. ..+..+++..+-+||..+.+||.|||++ -.++|||+||+|||++.+|.||+||||.+-.+.
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9988 568877665 4567799999999999999999999974 459999999999999999999999999997663
Q ss_pred CCCCcccccccccccccCCcccccC----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASD----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP 806 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 806 (870)
.+...+...|--.|||||.+.. ..|+-||||||+|+++.||.+++.||+...++-.++.+.+....|
T Consensus 201 ---dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 201 ---DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred ---hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 3334454567888999998854 368889999999999999999999999877777777776654433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=261.59 Aligned_cols=238 Identities=28% Similarity=0.346 Sum_probs=192.4
Q ss_pred cceeEEEEEec-CCcEEEEEEeechhhHH-HHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhh
Q 002892 597 SFGSVYKGTLF-DGTNVAIKVFNLQLERA-FRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYS 674 (870)
Q Consensus 597 ~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 674 (870)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|++++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999997665443 67899999999999999999999999998999999999999999999986
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccC
Q 002892 675 HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754 (870)
Q Consensus 675 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~ 754 (870)
... +++..++.++.++++++++|| +.+++|+||+|+||++++++.++++|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 544 899999999999999999999 5679999999999999999999999999998764432 223345788999
Q ss_pred CcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHH
Q 002892 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRI 834 (870)
Q Consensus 755 aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 834 (870)
|||......++.++|||++|+++|++++|..||...... .....+... ...........++.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~---------------~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGK---------------PKPPFPPPEWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhc---------------cCCCCccccccCCHHH
Confidence 999998888899999999999999999999998653111 111111110 0000000000034578
Q ss_pred HHHHhhccCCCCCCCCCHHHHHH
Q 002892 835 MHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 835 ~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=260.96 Aligned_cols=241 Identities=22% Similarity=0.299 Sum_probs=189.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 658 (870)
..+|.++.+||+|+||.|-+|.-+ +.+.||||+++++.. ...+--..|-+++... +-|.++++..+++.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888999999999999999855 568899999987642 2223334566677665 56789999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+.||+|--.++.-+. +-+....-+|.+||-||-+|| ++||++||+|..||+++.+|++||+|||++..--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-- 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 501 (683)
T ss_pred EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc--
Confidence 9999999999998887665 566677779999999999999 8889999999999999999999999999987421
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
....+...+.|||.|+|||++..++|+.++|.||+|+++|||+.|++||++. +.++....+. +....
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-DE~elF~aI~------------ehnvs 568 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-DEDELFQAIM------------EHNVS 568 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHH------------HccCc
Confidence 1223344578999999999999999999999999999999999999999872 1112111111 11110
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCC
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRM 850 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 850 (870)
.+...+.++..+....+...|.+|.
T Consensus 569 -------yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 -------YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------CcccccHHHHHHHHHHhhcCCcccc
Confidence 1112345677778888888888886
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=284.52 Aligned_cols=265 Identities=19% Similarity=0.212 Sum_probs=167.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-C----CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeee------ee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-D----GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSS------CC 651 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~ 651 (870)
..++|++.+.||+|+||.||+|+.. + +..||+|.+...... .....+ .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999965 4 689999987643221 111111 1111122222222111 23
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC
Q 002892 652 NLDFKALVLEFMPNGSLEKWLYSHNYF-------------------LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLK 712 (870)
Q Consensus 652 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 712 (870)
.....++||||+++++|.+++...... .....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 456789999999999999998754311 123346689999999999999 6679999999
Q ss_pred CCceeeCC-CCceEEeccccccccCCCCCcccccccccccccCCcccccCC----------------------CcCcccc
Q 002892 713 PNNILLDK-NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG----------------------IISPKCD 769 (870)
Q Consensus 713 ~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~sD 769 (870)
|+|||++. ++.+||+|||+|..+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 589999999999865332221 22345688999999965322 1334679
Q ss_pred hHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC-chhhhcchhhhcccCcchHHH-HHHHHHHHHHhhccCCCC
Q 002892 770 VYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR-GLTEVVDASLVREVQPSYAKM-DCLLRIMHLALGCCMDSP 846 (870)
Q Consensus 770 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~~P 846 (870)
|||+||++|||+++..|++... ......... ..+. .+...............+... .......+++.+|++.||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 9999999999999877654310 000000000 0000 011111110000000000000 012235689999999999
Q ss_pred CCCCCHHHHHHH
Q 002892 847 EQRMCMTDVVVK 858 (870)
Q Consensus 847 ~~RPs~~evl~~ 858 (870)
++|||+.++++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=237.08 Aligned_cols=261 Identities=18% Similarity=0.315 Sum_probs=199.9
Q ss_pred hcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeC--CeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCNL--DFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 659 (870)
.++|++.+++|+|.|++||.|. ..+.++++||++++- ..+.+.+|+.+++.++ ||||+++++...+. ..+.++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4689999999999999999998 567899999999744 2357889999999997 99999999998764 466799
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEeccccccccCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGED 738 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~ 738 (870)
+||+.+.+....... ++...+..++.+++.||.|+| +.||.|||+||.|++++.. ..++++|||+|.++...
T Consensus 114 FE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 999998877665543 677788899999999999999 8889999999999999865 67999999999988543
Q ss_pred CCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH--------------
Q 002892 739 DDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-------------- 803 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------------- 803 (870)
. .....+.+..|..||.+.. ..|+.+-|+|||||++..|+..+.||-.......++..+.+.
T Consensus 187 ~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 187 K---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred c---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 3 3344566788999998865 568899999999999999999999985433433444444322
Q ss_pred -hcCCchhhhcchhhhcccCc---chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 804 -SLPRGLTEVVDASLVREVQP---SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 804 -~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..++...+++.+...+.... .....-...++.+++.+.+..|-.+|||++|...
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 12233333333222222111 0011112357889999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=264.72 Aligned_cols=207 Identities=22% Similarity=0.348 Sum_probs=176.0
Q ss_pred CCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 586 GFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
-|..++.||-|+||+|.++. .++...||+|.+++.. ..+....+.|-+++..-..+-||++|-.|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47778899999999999997 4456779999987764 4556678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC----
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE---- 737 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~---- 737 (870)
|++||++-+++-+.+. +++....-++.++..|+++.| .-|+|||||||.|||||.+|++||+|||++.-+..
T Consensus 710 YIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999987775 677777778899999999999 77799999999999999999999999999863311
Q ss_pred -----CCCcc-------------------------------cccccccccccCCcccccCCCcCcccchHhHHHHHHHHH
Q 002892 738 -----DDDSV-------------------------------TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETF 781 (870)
Q Consensus 738 -----~~~~~-------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ell 781 (870)
.+... .....+||+.|+|||++....++..+|.||.|||+|||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 11000 001236999999999999999999999999999999999
Q ss_pred hCCCCCCccccccch
Q 002892 782 TRKKPTDEMFTGEMS 796 (870)
Q Consensus 782 tg~~p~~~~~~~~~~ 796 (870)
.|+.||......+.+
T Consensus 866 ~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQ 880 (1034)
T ss_pred hCCCCccCCCCCcce
Confidence 999999886666554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=266.50 Aligned_cols=243 Identities=21% Similarity=0.297 Sum_probs=196.9
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCc-EEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGT-NVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
..+++.+..+|-|+||.|-+++.++.+ .+|+|++++.. ..+...+..|-.+|...+.|.||++|..|.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 456677788999999999998866443 48999887653 33445677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
||-|-||.+...++.++. ++..+..-++.++.+|++||| +++||+||+||+|++++.+|-+||.|||+|..++...
T Consensus 499 mEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999987765 788888889999999999999 7889999999999999999999999999999885433
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
..-.++|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+. ++......+.+ -+|..-
T Consensus 575 ---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-dpmktYn~ILk---------Gid~i~-- 639 (732)
T KOG0614|consen 575 ---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-DPMKTYNLILK---------GIDKIE-- 639 (732)
T ss_pred ---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-chHHHHHHHHh---------hhhhhh--
Confidence 334578999999999999999999999999999999999999999873 22111111111 011100
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCC
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC 851 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 851 (870)
-+........+++++.+..+|.+|..
T Consensus 640 ------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 ------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 01123456788999999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=245.19 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=194.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 658 (870)
..+|...++||+|+|+.|..++++ +.+.||+|++++.. .+..+-.+.|-.++.+- +||.+|-+..+|+.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457899999999999999999854 67899999998754 33445566777777776 69999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
|.||++||+|-=.++..+. ++++...-+..+|+-||.||| ++||+.||+|..|+++|..|++|++|+|++..--
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l-- 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-- 402 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC--
Confidence 9999999999877776555 888888889999999999999 7889999999999999999999999999987532
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccc--cccchHHHHHHHhcCCchhhhcchh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMF--TGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
......+.+.|||.|.|||++.+..|+...|.|++|++++||+.|+.||+... +++.....+.-. -++.+.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq-------vilekq 475 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ-------VILEKQ 475 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH-------HHhhhc
Confidence 22334556789999999999999999999999999999999999999998642 222222222111 111111
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM 850 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 850 (870)
+... ...+.+...+++.-+..||.+|.
T Consensus 476 irip-------rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRIP-------RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccc-------ceeehhhHHHHHHhhcCCcHHhc
Confidence 1110 11233456677778888998876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=268.55 Aligned_cols=257 Identities=19% Similarity=0.226 Sum_probs=178.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-----------------cCCcEEEEEEeechhhHHHH--------------HHHHH
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-----------------FDGTNVAIKVFNLQLERAFR--------------SFESE 631 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~e 631 (870)
..++|++.++||+|+||+||+|.. .+++.||||.+........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 24568999998654332222 23346
Q ss_pred HHHHHhcCCCce-----eEEeeeeee--------CCeeEEEEecCCCCCHHHHHhhcC----------------------
Q 002892 632 CEVLRNVRHRNL-----IKIFSSCCN--------LDFKALVLEFMPNGSLEKWLYSHN---------------------- 676 (870)
Q Consensus 632 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------- 676 (870)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 566777643 356799999999999999987421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCC
Q 002892 677 -YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755 (870)
Q Consensus 677 -~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~a 755 (870)
...++..+..++.|++.|++|+| +.+|+||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 12467788899999999999999 667999999999999999999999999999765332211 1112235789999
Q ss_pred cccccCCCc----------------------CcccchHhHHHHHHHHHhCCC-CCCccc--cc-----cchHHHHHHHhc
Q 002892 756 PEYASDGII----------------------SPKCDVYSYGVLLMETFTRKK-PTDEMF--TG-----EMSLKHWIKLSL 805 (870)
Q Consensus 756 PE~~~~~~~----------------------~~~sDvwslG~il~elltg~~-p~~~~~--~~-----~~~~~~~~~~~~ 805 (870)
||.+..... ..+.||||+||++|+|++|.. |+.... .. ......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 124799999999999999875 664321 10 011111111000
Q ss_pred CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 002892 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSP---EQRMCMTDVVV 857 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPs~~evl~ 857 (870)
.. .+ .. ..........+++.+++..+| .+|+|++|+++
T Consensus 459 ~~-----~~------~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK-----YD------FS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC-----CC------cc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 00 00 011234567889999998765 68999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=269.95 Aligned_cols=241 Identities=27% Similarity=0.410 Sum_probs=185.6
Q ss_pred CCeeccccce-eEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecCCCCC
Q 002892 590 CNLLGAGSFG-SVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPNGS 667 (870)
Q Consensus 590 ~~~lg~G~~g-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 667 (870)
.+++|.|+.| .||+|..+ |+.||||++-. .......+|++.++.- .|||||++++.-.+....||..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 4578999998 56899854 88999998753 3445678899999988 6999999999989999999999999 679
Q ss_pred HHHHHhhcC--CC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---C--CceEEeccccccccCCCC
Q 002892 668 LEKWLYSHN--YF-LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---N--MTARVSDFGISKLLGEDD 739 (870)
Q Consensus 668 L~~~l~~~~--~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~a~~~~~~~ 739 (870)
|.+++...+ .. ......+.+..|++.||++|| +-+|||||+||.||||.. + .+++|+|||++.....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 999998641 11 111455778999999999999 566999999999999965 3 478999999999885544
Q ss_pred Cc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhC-CCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 740 DS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 740 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.+ .......||-+|+|||++....-+.++|+||+||++|+.++| ..||++....+..+.. +....+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~~--- 734 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLVH--- 734 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cccceee---
Confidence 33 234566799999999999998888899999999999999995 8999874333221110 0000000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. ...+| ++.++|.+|+.++|..||++.+|+.
T Consensus 735 ---L~---~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ---LE---PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---ec---cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 01122 6889999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=255.90 Aligned_cols=196 Identities=23% Similarity=0.331 Sum_probs=169.0
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--------HHHHHHHHHHHHHHhcC---CCceeEEeeeeee
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--------RAFRSFESECEVLRNVR---HRNLIKIFSSCCN 652 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 652 (870)
.+|...+.+|+|+||.|+.|.++ +...|++|.+.+..- +..-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999966 467789998876531 11223556999999996 9999999999999
Q ss_pred CCeeEEEEecC-CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 653 LDFKALVLEFM-PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 653 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
++..|++||-. +|.+|.+++..++. +++.+...|++|++.|+++|| +.||||||||-+||.++++|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999987 45588999986654 899999999999999999999 67799999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCC
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTD 788 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~ 788 (870)
|.... ......++||..|+|||++.+.+| +..-|||++|+++|.+.....||.
T Consensus 717 aa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98663 334456789999999999998876 467999999999999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=236.43 Aligned_cols=268 Identities=21% Similarity=0.286 Sum_probs=193.5
Q ss_pred CCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-----eeE
Q 002892 586 GFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-----FKA 657 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 657 (870)
+.+-.+.||-|+||+||-+++ ++|+.||+|.+..-.. ...+++-+|.+++...+|.|+...++...... ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345568999999999999984 5899999998854322 34567888999999999999998887665432 457
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+++|.+ ..+|...+-.. ..++...+.-+..||++||+||| +.+|.||||||.|.++.++..+||+|||+++.-.
T Consensus 134 V~TELm-QSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee- 207 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD- 207 (449)
T ss_pred HHHHHH-HhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-
Confidence 788877 45676665543 34888888899999999999999 7779999999999999999999999999998653
Q ss_pred CCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh----
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV---- 812 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 812 (870)
.+.....+..+.|.+|.|||++.+. .|+.+.||||.|||+.|++.++.-|+.. ....++..+...--....+.+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq-~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA-GPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc-ChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 3334455666789999999999875 5899999999999999999999888753 223333333221111111111
Q ss_pred ---cchhhhcccCcc-----h---HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 813 ---VDASLVREVQPS-----Y---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 813 ---~~~~~~~~~~~~-----~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
-...+.....+. + .....-.+...+.+.++..||.+|.+..+.+....
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 011111111000 0 11122345677888999999999999988876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=234.15 Aligned_cols=210 Identities=34% Similarity=0.520 Sum_probs=183.4
Q ss_pred eccccceeEEEEEec-CCcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHHH
Q 002892 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEK 670 (870)
Q Consensus 593 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~ 670 (870)
||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999999766432 35678999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceEEeccccccccCCCCCccccccccc
Q 002892 671 WLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFGISKLLGEDDDSVTQTMTMA 749 (870)
Q Consensus 671 ~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 749 (870)
++......+++..+..++.++++++++|| +.+++|+||+|.||+++. ++.++++|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 99876445899999999999999999999 667999999999999999 89999999999986643321 2223457
Q ss_pred ccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHH
Q 002892 750 TIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM 828 (870)
Q Consensus 750 ~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (870)
...|++||..... ..+.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999999877 788999999999999998
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 829 DCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 829 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=260.70 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=203.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|+..+++|+|.||.||+|++ ..++..|+|+++........-+++|+-+++..+||||+.+++.+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 457899999999999999999995 4789999999998887888889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
||.||+|.+.-+-.+. +++.++..+.+...+|++||| +.|=+|||||-.||++++.|.+|+.|||.+..++. ..
T Consensus 93 ycgggslQdiy~~Tgp-lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGP-LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred ecCCCcccceeeeccc-chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence 9999999997775543 899999999999999999999 77799999999999999999999999999987642 22
Q ss_pred ccccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 742 VTQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
...-.+.||++|||||+.. .+.|...+|||+.|++..|+-.-+.|.-+..+. ..+.-..+..+. ....-|
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r~l~LmTkS~~q--pp~lkD---- 239 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-RALFLMTKSGFQ--PPTLKD---- 239 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-HHHHHhhccCCC--CCcccC----
Confidence 3334568999999999874 466889999999999999998888774322111 001110111110 000111
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......+-++++.|+..+|++||++..+++
T Consensus 240 --------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 --------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1122345788999999999999999987764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-26 Score=230.52 Aligned_cols=199 Identities=29% Similarity=0.425 Sum_probs=173.1
Q ss_pred CCCCCeeccccceeEEEEEecC-CcEEEEEEeechhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 587 FNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 899999999876544 56789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+++|.+++......+++..+..++.+++.++++|| +.+++|+|++|.||+++.++.++++|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 99999999865543789999999999999999999 56799999999999999999999999999987754321 122
Q ss_pred cccccccccCCcccc-cCCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002892 745 TMTMATIGYMAPEYA-SDGIISPKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~il~elltg~~p~~~ 789 (870)
....++..|++||.. ....++.++|||+||+++++|++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 234567889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=221.27 Aligned_cols=257 Identities=19% Similarity=0.284 Sum_probs=188.1
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeee-eeeCCeeEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSS-CCNLDFKAL 658 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~l 658 (870)
+..+.|.+.+.+|+|.||.+-++.++ +.+.+|+|.+...... .++|.+|...--.+ .|.||+.-++. |+..+..++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 44578999999999999999999976 5788999988765433 36778887665555 58999988764 566778889
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC--CCCceEEeccccccccC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD--KNMTARVSDFGISKLLG 736 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~ 736 (870)
++||++.|+|.+-+...+ +.+....+++.|++.|+.|+| ++.+||||||.+|||+- +..+||++|||..+..+
T Consensus 100 ~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999999998755 788888999999999999999 77799999999999993 33589999999988653
Q ss_pred CCCCcccccccccccccCCcccccCC-----CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDG-----IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
..... .--+..|.+||..... ...+.+|||.||+++|.++||+.||+...-.+.....|....-..
T Consensus 175 ~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk---- 245 (378)
T KOG1345|consen 175 TTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK---- 245 (378)
T ss_pred ceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc----
Confidence 22111 1234568899876432 356789999999999999999999986444444444443321111
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
.+.+.+... ....+++.+.++-+.++|++|=...++.+..++
T Consensus 246 --~~~~P~~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 246 --NPALPKKFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred --CccCchhhc------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 111111111 123467788888899999998555555544443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=229.92 Aligned_cols=131 Identities=24% Similarity=0.303 Sum_probs=111.0
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-----CC---ceeEEeeeeee---
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-----HR---NLIKIFSSCCN--- 652 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~---niv~~~~~~~~--- 652 (870)
.+|.+.++||=|.|++||+|.+ .+.+.||+|+.+.. +...+....|++++++++ |+ .||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999984 46789999998644 444566788999999984 33 69999999965
Q ss_pred -CCeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC
Q 002892 653 -LDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD 719 (870)
Q Consensus 653 -~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 719 (870)
..+.++|+|++ |.+|..++... -+.++...+.+|++||+.||.|||..+ ||||.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45889999999 78999998843 455999999999999999999999755 799999999999993
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=221.88 Aligned_cols=257 Identities=22% Similarity=0.273 Sum_probs=191.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------C
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL------D 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 654 (870)
..+|...+.+|.|+- .|..|.+. .+++||+|...... ....++..+|...+..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777888999988 66666533 58899999764432 33456677899999999999999999998643 3
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..|+|||++ .++|...+.. .++-.++..+..|++.|++||| +.||+|||+||+||++..+..+||.|||+|+.
T Consensus 95 e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence 668999999 4588888772 2577889999999999999999 88899999999999999999999999999985
Q ss_pred cCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc----CCc-h
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL----PRG-L 809 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~-~ 809 (870)
.+ ..-..+..+.|..|.|||++.+-.+...+||||.||++.||++|+.-|. +...+.+|.+..- |+. +
T Consensus 168 e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 168 ED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred cC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHH
Confidence 43 2235556678899999999988889999999999999999999998764 3445555544221 110 0
Q ss_pred hh-----------------------hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 810 TE-----------------------VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 810 ~~-----------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+ .+.........+. ..-....+.+++.+|+..+|++|-+++++++
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~--~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG--SKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccC--CccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 0000000000000 0011345778999999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=227.69 Aligned_cols=269 Identities=25% Similarity=0.328 Sum_probs=200.4
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLD 654 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 654 (870)
+....+.|..+++||+|.|++||+|.+. .++.||+|.+..... ..++..|++++..+ .+.||+.+.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999843 467899998865443 35688999999999 5899999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceEEecccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFGISK 733 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~ 733 (870)
...+|+||++...-.++... ++..++..+++.+..||+++| ..|||||||||+|++... .+.-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999998888865 567899999999999999999 778999999999999975 4788999999997
Q ss_pred ccCCCC-------------Cc-----------------------------ccccccccccccCCcccccC-CCcCcccch
Q 002892 734 LLGEDD-------------DS-----------------------------VTQTMTMATIGYMAPEYASD-GIISPKCDV 770 (870)
Q Consensus 734 ~~~~~~-------------~~-----------------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~sDv 770 (870)
.+.... .. .......||++|.|||++.. ...++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321100 00 00113469999999999875 457889999
Q ss_pred HhHHHHHHHHHhCCCCCCccccccchHHHHHHHh----------cCCc--h-h--------------hhcc-hhhhcccC
Q 002892 771 YSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS----------LPRG--L-T--------------EVVD-ASLVREVQ 822 (870)
Q Consensus 771 wslG~il~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~--~-~--------------~~~~-~~~~~~~~ 822 (870)
||.|+|+.-+++++.||-...+....+.+.+..- .+.. + . +.++ ..+.+...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999866555444444443211 1111 0 0 0000 11111000
Q ss_pred ---cchHHHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 ---PSYAKMD-CLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 ---~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......+ .+..+++++.+|+..||.+|-++.+.++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0111112 2347899999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=233.39 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=199.7
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcC------CCceeEEeeeeeeC
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVR------HRNLIKIFSSCCNL 653 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~ 653 (870)
+....+|.+....|+|-|++|..|... -|..||||++....... +.=..|++++++|. --|+++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 344578999999999999999999854 47799999998764433 34467999999994 23789999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEeccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFG 730 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 730 (870)
.++|+|||-+ ..+|.+.+++.+ ..+....+..++.|+.-||..|- .-||+|.||||.|||+.+. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999987 668999998654 45788899999999999999999 5559999999999999875 678999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHH--HHHhcCCc
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW--IKLSLPRG 808 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~ 808 (870)
.|...+....+. ...+..|.|||++.+-+|+...|+||.||++||+.||+..|.+..+... +..+ ++..+|..
T Consensus 583 SA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M-Lrl~me~KGk~p~K 657 (752)
T KOG0670|consen 583 SASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM-LRLFMELKGKFPNK 657 (752)
T ss_pred cccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH-HHHHHHhcCCCcHH
Confidence 998876544322 2345679999999999999999999999999999999998877543322 2111 11122211
Q ss_pred h-------hhhcch--------------------------------hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCC
Q 002892 809 L-------TEVVDA--------------------------------SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQR 849 (870)
Q Consensus 809 ~-------~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 849 (870)
+ ..-+|. .+.....-.........++.+++.+|+..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 0 000000 0000000011112345678899999999999999
Q ss_pred CCHHHHHH
Q 002892 850 MCMTDVVV 857 (870)
Q Consensus 850 Ps~~evl~ 857 (870)
.+..+.++
T Consensus 738 it~nqAL~ 745 (752)
T KOG0670|consen 738 ITVNQALK 745 (752)
T ss_pred CCHHHHhc
Confidence 99999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-28 Score=241.12 Aligned_cols=411 Identities=24% Similarity=0.271 Sum_probs=216.2
Q ss_pred CeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCC-CccccCCCCCCCCCCCCcEEeccC
Q 002892 18 MYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRN-NSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
.+++|..|+|+...|.+|+.+++|++||||+|+|+..-|..|.++++|..|-+-+ |+|+....+.|.+|.+|+.|.+.-
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa 149 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA 149 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence 4566666777655556666677777777777777666666666666665554433 666644444566677777777776
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccc------------ccccccccccccceEE
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLI------------GPIPTTIFNISTIIII 164 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~------------~~~~~~~~~l~~L~~L 164 (870)
|++.-...+.|..+++|..|.+.+|.+....-..|..+.+++.+.+..|.+. ...|..++...-..-.
T Consensus 150 n~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~ 229 (498)
T KOG4237|consen 150 NHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPY 229 (498)
T ss_pred hhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchH
Confidence 6666455556666677777777777766333336666666666666666621 1122222222222222
Q ss_pred EeecccccccCCCcccCCCCccceeeecccccccc-cCCcccCCCCccEEEccCCcccCCCccccccccccccccccccc
Q 002892 165 NLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGT-IPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243 (870)
Q Consensus 165 ~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~ 243 (870)
.+.++++....+..+...+..+..-..+.+...++ ....|..+++|+.|+|++|+|+.+.+.+|.++..++.|.|..|+
T Consensus 230 rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~ 309 (498)
T KOG4237|consen 230 RLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNK 309 (498)
T ss_pred HHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcch
Confidence 33333333333333333322222211222222222 22346666777777777777776667777777777777777777
Q ss_pred cccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCC
Q 002892 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTN 323 (870)
Q Consensus 244 l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N 323 (870)
|..+... .|.++..|+.|+|.+|+|+.+ .|.+|..+..|.+|+|-.|
T Consensus 310 l~~v~~~--------~f~~ls~L~tL~L~~N~it~~-------------------------~~~aF~~~~~l~~l~l~~N 356 (498)
T KOG4237|consen 310 LEFVSSG--------MFQGLSGLKTLSLYDNQITTV-------------------------APGAFQTLFSLSTLNLLSN 356 (498)
T ss_pred HHHHHHH--------hhhccccceeeeecCCeeEEE-------------------------ecccccccceeeeeehccC
Confidence 6665432 466666666666666666554 3344555566666776666
Q ss_pred CccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCC---CCcccccccccceEecCCCccCCCC
Q 002892 324 DLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS---IPSSFWSLEYILRIDLSSNSLSGSL 400 (870)
Q Consensus 324 ~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~ 400 (870)
.+.-. +++.-|..-.-++...+ .|..- .-..++.+.++++.+... .|+...-. -++.-
T Consensus 357 p~~Cn-----C~l~wl~~Wlr~~~~~~-~~~Cq-~p~~~~~~~~~dv~~~~~~c~~~ee~~~~------------~s~~c 417 (498)
T KOG4237|consen 357 PFNCN-----CRLAWLGEWLRKKSVVG-NPRCQ-SPGFVRQIPISDVAFGDFRCGGPEELGCL------------TSSPC 417 (498)
T ss_pred cccCc-----cchHHHHHHHhhCCCCC-CCCCC-CCchhccccchhccccccccCCccccCCC------------CCCCC
Confidence 66421 12222222222222222 22211 112456666666655422 11111100 00011
Q ss_pred cccccCCccCC-EEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhc
Q 002892 401 PSDIQNLKVLI-YLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479 (870)
Q Consensus 401 p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 479 (870)
| ..++-+. ....|++.++ .+|..+. ..-+.|++.+|.++ .+|.. .+.+| .+||++|+++...-..|.++
T Consensus 418 P---~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~ 487 (498)
T KOG4237|consen 418 P---PPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNM 487 (498)
T ss_pred C---CCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccch
Confidence 1 1122222 2334444444 3343332 24456667777766 35544 45566 67777777775556667777
Q ss_pred cccceeeccCC
Q 002892 480 SHLKRLNVSHN 490 (870)
Q Consensus 480 ~~L~~L~ls~N 490 (870)
++|.+|-||+|
T Consensus 488 tql~tlilsyn 498 (498)
T KOG4237|consen 488 TQLSTLILSYN 498 (498)
T ss_pred hhhheeEEecC
Confidence 77777777765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=263.11 Aligned_cols=346 Identities=20% Similarity=0.263 Sum_probs=188.4
Q ss_pred CCccccCCCCCcEEEccCCc------ccccCCccccCCC-CCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCcccccc
Q 002892 31 LPNELGQLRRLKFLGFAYND------LTGSFPSWIGVFS-KLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNI 103 (870)
Q Consensus 31 ~p~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 103 (870)
.+.+|.++++|+.|.+..+. +...+|..+..++ +|+.|++.++.++ .+|..+ ...+|+.|+|++|++. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 34567778888888776553 2224566665553 5788888888777 667666 4677888888888776 66
Q ss_pred CcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCC
Q 002892 104 PSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSL 183 (870)
Q Consensus 104 ~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l 183 (870)
+..+..+++|+.|+|++|.....+|. ++.+++|++|+|++|.....+|..+.++++|+.|++++|.....+|..+
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i---- 701 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI---- 701 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC----
Confidence 77777778888888877654335553 6777778888887776666777777777777777777764333333322
Q ss_pred CccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccc
Q 002892 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNC 263 (870)
Q Consensus 184 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l 263 (870)
++++|+.|++++|......|+. ..+|+.|++++|.++.++. . ..+
T Consensus 702 ----------------------~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~---------~-~~l 746 (1153)
T PLN03210 702 ----------------------NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPS---------N-LRL 746 (1153)
T ss_pred ----------------------CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccc---------c-ccc
Confidence 3344444444444332222221 2334444454444443221 0 123
Q ss_pred cccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHH
Q 002892 264 NKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALL 343 (870)
Q Consensus 264 ~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 343 (870)
++|++|++.++....+. . .+....+......++|+.|++++|...
T Consensus 747 ~~L~~L~l~~~~~~~l~-~-----------------~~~~l~~~~~~~~~sL~~L~Ls~n~~l----------------- 791 (1153)
T PLN03210 747 ENLDELILCEMKSEKLW-E-----------------RVQPLTPLMTMLSPSLTRLFLSDIPSL----------------- 791 (1153)
T ss_pred cccccccccccchhhcc-c-----------------cccccchhhhhccccchheeCCCCCCc-----------------
Confidence 34444444432211100 0 000000111111233444444444332
Q ss_pred hcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCc
Q 002892 344 QRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGN 423 (870)
Q Consensus 344 l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 423 (870)
+.+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|+|++|..-..+|.. .++|+.|+|++|.|+ .
T Consensus 792 ------~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~ 860 (1153)
T PLN03210 792 ------VELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-E 860 (1153)
T ss_pred ------cccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-c
Confidence 2334445555666666666654333445444 5666666666665433334432 245666666666665 4
Q ss_pred ccccccCCCCCCEEEcCCC-cccCcccccccCCCCCCeEecCCC
Q 002892 424 IPITIGGLKDLITLSLARN-RFQDSIPDSFGSLTSLEYLDLSNN 466 (870)
Q Consensus 424 ~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N 466 (870)
+|..+..+++|+.|+|++| ++. .+|..+..+++|+.|+++++
T Consensus 861 iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 861 VPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 5556666666666666663 333 35555556666666666655
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=260.74 Aligned_cols=343 Identities=23% Similarity=0.285 Sum_probs=243.2
Q ss_pred CCCCCCCCCeecCCCCc------cccCCCccccCCC-CCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCC
Q 002892 10 HIGNLSFLMYLDISENN------FRGYLPNELGQLR-RLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNS 82 (870)
Q Consensus 10 ~~~~l~~L~~L~ls~n~------l~~~~p~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 82 (870)
.|..+++|+.|.+..+. +...+|+.|..++ +|+.|.+.++.++ .+|..+ .+.+|++|+|++|++. .++..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 48889999999997653 3335778887775 6999999999998 788888 4789999999999998 78889
Q ss_pred CCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccce
Q 002892 83 LFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTII 162 (870)
Q Consensus 83 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 162 (870)
+..+++|+.|+|++|.....+| .++.+++|+.|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++|+
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 9999999999999886554676 48889999999999987666899999999999999999987666777766 789999
Q ss_pred EEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccc
Q 002892 163 IINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242 (870)
Q Consensus 163 ~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N 242 (870)
.|++++|.....+|.. ..+|+.|++++|.+. .+|.. + .+++|+.|++.++
T Consensus 708 ~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~------------------------~-~l~~L~~L~l~~~ 757 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSN------------------------L-RLENLDELILCEM 757 (1153)
T ss_pred EEeCCCCCCccccccc----cCCcCeeecCCCccc-ccccc------------------------c-ccccccccccccc
Confidence 9999998654333321 234455555555544 23332 2 3444444444443
Q ss_pred ccccccCCCCCccc-ccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEee
Q 002892 243 YLTTETSSNGEWSF-LSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLF 321 (870)
Q Consensus 243 ~l~~~~~~~~~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~ 321 (870)
....+.... ... +......++|+.|++++|. ..+.+|..++++++|+.|+++
T Consensus 758 ~~~~l~~~~--~~l~~~~~~~~~sL~~L~Ls~n~-------------------------~l~~lP~si~~L~~L~~L~Ls 810 (1153)
T PLN03210 758 KSEKLWERV--QPLTPLMTMLSPSLTRLFLSDIP-------------------------SLVELPSSIQNLHKLEHLEIE 810 (1153)
T ss_pred chhhccccc--cccchhhhhccccchheeCCCCC-------------------------CccccChhhhCCCCCCEEECC
Confidence 221110000 000 0001123455555555554 334567788888999999998
Q ss_pred CCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCc
Q 002892 322 TNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLP 401 (870)
Q Consensus 322 ~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 401 (870)
+|...+.+|. .+ .+++|+.|+|++|.....+|.. .++|+.|+|++|.++ .+|
T Consensus 811 ~C~~L~~LP~-----------------------~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP 862 (1153)
T PLN03210 811 NCINLETLPT-----------------------GI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVP 862 (1153)
T ss_pred CCCCcCeeCC-----------------------CC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cCh
Confidence 8754434443 22 4567888888887654444443 357888888888888 678
Q ss_pred ccccCCccCCEEEccC-CccCCcccccccCCCCCCEEEcCCCc
Q 002892 402 SDIQNLKVLIYLNLSR-NQLSGNIPITIGGLKDLITLSLARNR 443 (870)
Q Consensus 402 ~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~ 443 (870)
..+..+++|+.|+|++ |++. .+|..+..+++|+.|++++|.
T Consensus 863 ~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 863 WWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred HHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 8888888899998888 4555 567778888888888888774
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=208.90 Aligned_cols=170 Identities=19% Similarity=0.167 Sum_probs=130.2
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 745 (870)
|+|.+++...+..+++.+++.++.|++.||+||| +.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999876667999999999999999999999 444 999999999999999 99988664321
Q ss_pred ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcch
Q 002892 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825 (870)
Q Consensus 746 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (870)
..|++.|+|||++.+..++.++|||||||++|||++|+.||............+.....+... ....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 130 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP------------RDRS 130 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc------------cccc
Confidence 257899999999999999999999999999999999999986533222222222211111100 0001
Q ss_pred HHHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 826 AKMDCL--LRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 826 ~~~~~~--~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
...... .++.+++..||..+|++||++.++++.+..+...
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 111222 2689999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-26 Score=230.56 Aligned_cols=302 Identities=23% Similarity=0.275 Sum_probs=224.5
Q ss_pred CccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccc-cccccccCCCCCccccccccc
Q 002892 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA-NYLTTETSSNGEWSFLSSLTN 262 (870)
Q Consensus 184 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~~l~~ 262 (870)
+....++|..|+|+.+.+.+|..+++|+.||||+|+|+.+.|++|.++++|..|.+.+ |+|+.++.. .|.+
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~--------~F~g 138 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKG--------AFGG 138 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhh--------Hhhh
Confidence 4566777777777777777788888888888888888888888888888877776665 777776532 5666
Q ss_pred ccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHH
Q 002892 263 CNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL 342 (870)
Q Consensus 263 l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 342 (870)
+..|+.|.+.-|++.. ...+.|..+++|..|.+..|.+..+--..|..+..++.+
T Consensus 139 L~slqrLllNan~i~C-------------------------ir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tl 193 (498)
T KOG4237|consen 139 LSSLQRLLLNANHINC-------------------------IRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTL 193 (498)
T ss_pred HHHHHHHhcChhhhcc-------------------------hhHHHHHHhhhcchhcccchhhhhhccccccchhccchH
Confidence 6666666666666654 344566677777777777777775444577777777777
Q ss_pred Hhc-CC------------CCCCCcccccCccccceeecCCcccCCCCCcccccc-cccc-eEecCCCccCCCCc-ccccC
Q 002892 343 LQR-NN------------LNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSL-EYIL-RIDLSSNSLSGSLP-SDIQN 406 (870)
Q Consensus 343 ~l~-n~------------~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~-~L~Ls~N~l~~~~p-~~~~~ 406 (870)
.+. |. .....|..+++..-..-..|.++++..+.+..|... ..+. .+....+... +-| ..|..
T Consensus 194 hlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~-~cP~~cf~~ 272 (498)
T KOG4237|consen 194 HLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS-ICPAKCFKK 272 (498)
T ss_pred hhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC-cChHHHHhh
Confidence 665 44 222334556666666777778888876666666443 2222 2223333333 444 47999
Q ss_pred CccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceee
Q 002892 407 LKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLN 486 (870)
Q Consensus 407 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 486 (870)
+++|+.|+|++|+|+++.+.+|.++..++.|+|..|+|..+-...|.++..|+.|+|++|+|+...|.+|..+.+|.+|+
T Consensus 273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence 99999999999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred ccCCcccccCCCCCcccccccccccccccccCCC
Q 002892 487 VSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPP 520 (870)
Q Consensus 487 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 520 (870)
|-.|+|.|.+-- .++..|...+-.....-|+.|
T Consensus 353 l~~Np~~CnC~l-~wl~~Wlr~~~~~~~~~Cq~p 385 (498)
T KOG4237|consen 353 LLSNPFNCNCRL-AWLGEWLRKKSVVGNPRCQSP 385 (498)
T ss_pred hccCcccCccch-HHHHHHHhhCCCCCCCCCCCC
Confidence 999999998874 456677654323333456655
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=258.67 Aligned_cols=195 Identities=21% Similarity=0.262 Sum_probs=136.9
Q ss_pred cCC-CceeEEeeee-------eeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 002892 638 VRH-RNLIKIFSSC-------CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709 (870)
Q Consensus 638 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~ 709 (870)
++| +||+++++++ ...+..+.++||+ +++|.+++......+++.++..++.||++||+||| ++||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 345 5777777766 2234567788987 66999999876666999999999999999999999 7779999
Q ss_pred ccCCCceeeCCCC-------------------ceEEeccccccccCCCCC--------------cccccccccccccCCc
Q 002892 710 NLKPNNILLDKNM-------------------TARVSDFGISKLLGEDDD--------------SVTQTMTMATIGYMAP 756 (870)
Q Consensus 710 dlk~~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~g~~~y~aP 756 (870)
||||+|||++..+ .+|++|||+++....... ........||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 455566666543211000 0001123578899999
Q ss_pred ccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHH
Q 002892 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMH 836 (870)
Q Consensus 757 E~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 836 (870)
|++.+..++.++|||||||++|||++|..|+.... .....+.....+. . ..........
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~----------------~--~~~~~~~~~~ 243 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPP----------------Q--ILLNWPKEAS 243 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcCh----------------h--hhhcCHHHHH
Confidence 99999999999999999999999999888764311 0111111100000 0 0011223567
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 002892 837 LALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 837 l~~~cl~~~P~~RPs~~evl~ 857 (870)
++.+||+++|.+||++.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=236.40 Aligned_cols=265 Identities=25% Similarity=0.310 Sum_probs=211.2
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
..-..|||++|+++ .+|+.+. .+|+.|++++|+++ .+|.. .++|++|+|++|+|+ .+|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 44678999999998 6888775 48999999999999 57753 589999999999999 56653 468999999
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|.++ .+|..+ .+|+.|++++|+|+ .+|.. +++|+.|+|++|++++ +|.. ..+|+.|++++|++++
T Consensus 270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~- 336 (788)
T PRK15387 270 FSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS- 336 (788)
T ss_pred cCCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-
Confidence 999998 566543 56889999999999 56643 4789999999999985 4432 2468889999999985
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 254 (870)
+|. ...+|+.|+|++|+|+. +|.. ..+|+.|++++|+|+. +|.. ..+|+.|++++|.|+.++..
T Consensus 337 LP~----lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~l---- 400 (788)
T PRK15387 337 LPT----LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPVL---- 400 (788)
T ss_pred ccc----cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCCCCc----
Confidence 332 23589999999999994 5653 3578899999999994 5643 35799999999999875521
Q ss_pred ccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchh
Q 002892 255 SFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTL 333 (870)
Q Consensus 255 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 333 (870)
.++|+.|++++|+|.++ |.. ...++.|++++|+++ .+|..+..+++|+.|+|++|.+++..+..+
T Consensus 401 --------~s~L~~LdLS~N~LssI-P~l----~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 401 --------PSELKELMVSGNRLTSL-PML----PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred --------ccCCCEEEccCCcCCCC-Ccc----hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 25799999999999875 332 346788999999998 688999999999999999999987666544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=194.31 Aligned_cols=264 Identities=18% Similarity=0.186 Sum_probs=203.0
Q ss_pred hhcCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRH-RNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 660 (870)
..+.|+++++||+|+||.+|.|. ..+|+.||+|+-...... ..+..|.++++.+++ ..|..+..+..+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 45789999999999999999998 568999999986544332 457788999999976 68889999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~ 737 (870)
|.+ |.+|++...-..+.++..+++-.+.|++.-++|+| .++++||||||+|++.+- ...+.++|||+|..+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 988 88999999977777999999999999999999999 566999999999999953 35789999999987743
Q ss_pred CCCc-----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 738 DDDS-----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 738 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
.... .......||.+|++-....+.+.+.+.|.-|+|.++.++-.|..||++........ . .+.+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-K---------yEkI 236 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-K---------YEKI 236 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-H---------HHHH
Confidence 3221 12234568999999998888888999999999999999999999999854322111 1 0111
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
..+.+... ...-....|.++.-.+..|-..--++-|+..-+-+.+.-+..
T Consensus 237 ~EkK~s~~--ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 237 SEKKMSTP--IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHhhcCCC--HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11111100 001111224567777888888888999998888777765543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=214.58 Aligned_cols=261 Identities=18% Similarity=0.176 Sum_probs=195.6
Q ss_pred CCCCCCeeccccceeEEEEEecCC--cEEEEEEeechhhHHHHHHHHHHHHHHhcCC----CceeEEeeee-eeCCeeEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLFDG--TNVAIKVFNLQLERAFRSFESECEVLRNVRH----RNLIKIFSSC-CNLDFKAL 658 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 658 (870)
+|++.+.||+|+||.||.+...+. +.+|+|+-..........+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999996543 5789998766533322367788888888863 5899999988 47778899
Q ss_pred EEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-----CceEEeccccc
Q 002892 659 VLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-----MTARVSDFGIS 732 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a 732 (870)
||+.+ |.+|.++..... ..++..++..++.|++.+|+++| +.|++||||||.|+.++.. ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 889999886554 67999999999999999999999 7779999999999999765 46999999999
Q ss_pred c--ccCCCCCc----c-c-ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 002892 733 K--LLGEDDDS----V-T-QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 733 ~--~~~~~~~~----~-~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 804 (870)
+ .+...... . . .....||..|++++++.+.+.+.+.|+||++.++.|+..|..||........ ........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 33222111 1 1 2345699999999999999999999999999999999999999966432211 11110000
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
... .... ....++..+.++...+-..+..++|....+...+++....
T Consensus 254 ~~~----~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKL----LTDR----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhh----cccc----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000 0000 0011234566666666668999999999999987766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-22 Score=195.43 Aligned_cols=263 Identities=15% Similarity=0.169 Sum_probs=203.7
Q ss_pred cCCCCCCeeccccceeEEEEE-ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
-.|++.++||+|+||+++.|+ +-+++.||||.-... ....++..|.+.++.|. .++|..++-+..+.-+-.+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468899999999999999998 568999999975433 23366888999999985 68999999888888888999998
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-----CceEEeccccccccCC
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-----MTARVSDFGISKLLGE 737 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a~~~~~ 737 (870)
+ |.+|+|+..-.++.++..++..+|.|++.-++|+|+ +.+|.|||||+|+||+.. ..+.++|||+|..+.+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 889999999888889999999999999999999995 459999999999999754 3589999999998865
Q ss_pred CCCcc-----cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 738 DDDSV-----TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 738 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
+.... ..-...||.+||+-....+.+.+.+.|.-|+|-++++.+.|..||++....- .-..+-+..-......
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-nK~kYeKIGe~Kr~T~- 259 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-NKEKYEKIGETKRSTP- 259 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-hHHHHHHhccccccCC-
Confidence 54322 1223469999999999999999999999999999999999999999853321 1111111111110000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
...-....|.++..-+...-+.+-.+-|+.+-+...+.++.+.
T Consensus 260 ----------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 260 ----------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ----------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 0111122355666777777778888999998888877776543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=231.77 Aligned_cols=267 Identities=25% Similarity=0.315 Sum_probs=187.1
Q ss_pred CCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEe
Q 002892 39 RRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNF 118 (870)
Q Consensus 39 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 118 (870)
..-..|++++|.++ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 34668899999988 7787775 47899999999988 56642 578889999999888 56643 357888899
Q ss_pred ecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeeccccccc
Q 002892 119 ADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTG 198 (870)
Q Consensus 119 ~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 198 (870)
++|.|+ .+|..+ ++|+.|++++|+++. +|. ..++|+.|+|++|++++. |. ...+|+.|++++|++++
T Consensus 270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~----lp~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 270 FSNPLT-HLPALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PA----LPSELCKLWAYNNQLTS 336 (788)
T ss_pred cCCchh-hhhhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CC----CcccccccccccCcccc
Confidence 999888 455433 567788888888874 443 246788888888888753 32 13457778888888874
Q ss_pred ccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCC
Q 002892 199 TIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDS 278 (870)
Q Consensus 199 ~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 278 (870)
+|.. ..+|++|+|++|+|+. +|.. .++|+.|++++|.|+.++. ...+|+.|++++|+|..
T Consensus 337 -LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~------------l~~~L~~LdLs~N~Lt~ 396 (788)
T PRK15387 337 -LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPA------------LPSGLKELIVSGNRLTS 396 (788)
T ss_pred -cccc---ccccceEecCCCccCC-CCCC---CcccceehhhccccccCcc------------cccccceEEecCCcccC
Confidence 4432 1467888888888874 4432 2456777788887776432 12357777777777764
Q ss_pred CCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccC
Q 002892 279 ILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSS 358 (870)
Q Consensus 279 ~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~ 358 (870)
+ |.. .++|+.|++++|++.+ +|..+
T Consensus 397 L--------------------------P~l---~s~L~~LdLS~N~Lss-IP~l~------------------------- 421 (788)
T PRK15387 397 L--------------------------PVL---PSELKELMVSGNRLTS-LPMLP------------------------- 421 (788)
T ss_pred C--------------------------CCc---ccCCCEEEccCCcCCC-CCcch-------------------------
Confidence 3 111 2467788888888873 44311
Q ss_pred ccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccC
Q 002892 359 LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQN 406 (870)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 406 (870)
.+|+.|+|++|+|+ .+|..|..+++|+.|+|++|.|++..|..+..
T Consensus 422 -~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 422 -SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred -hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 24667888888887 67778888888888888888888776666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=213.50 Aligned_cols=166 Identities=20% Similarity=0.224 Sum_probs=129.9
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec--CCcEEEEEEeech-----hhHHHHHHHHHHHHHHhcCCCceeE-EeeeeeeC
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF--DGTNVAIKVFNLQ-----LERAFRSFESECEVLRNVRHRNLIK-IFSSCCNL 653 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~ 653 (870)
...++|++.+.||+|+||+||+|.+. +++.||||+.... .......+.+|++++++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 44578999999999999999999864 5777899986532 1233567899999999999999885 4432
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccc-CCCceeeCCCCceEEeccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL-KPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a 732 (870)
+..|+||||++|++|... ... . ...++.++++||+||| ++||+|||| ||+||+++.++.+||+|||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999632 111 1 1467899999999999 677999999 999999999999999999999
Q ss_pred cccCCCCCccc------ccccccccccCCcccccCC
Q 002892 733 KLLGEDDDSVT------QTMTMATIGYMAPEYASDG 762 (870)
Q Consensus 733 ~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~ 762 (870)
+.+........ .....+++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 87754332211 1345678899999998653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-23 Score=194.80 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=188.3
Q ss_pred CCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
.....+|.+...|+.|+|+|+ |..+++|+++... .+..+.|..|.-.++-..||||..+++.|....+..++..|++
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344567889999999999987 5567777775443 3344678889999988999999999999999999999999999
Q ss_pred CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEe--ccccccccCCCCCc
Q 002892 665 NGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVS--DFGISKLLGEDDDS 741 (870)
Q Consensus 665 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~--Dfg~a~~~~~~~~~ 741 (870)
.|+|...++.. ..-.+..+..+++.++++|++|||... +-|..--+.++.+++|++.+.+|. |--++.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--------
Confidence 99999999954 444778889999999999999999653 223444688999999999888774 322222
Q ss_pred ccccccccccccCCcccccCCCcC---cccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 742 VTQTMTMATIGYMAPEYASDGIIS---PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~---~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
..-...-.|.||+||.++.++.+ .++|.|||++++||+.|+..||.+..+.+....... ..+.
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------------eglr 407 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------------EGLR 407 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------------cccc
Confidence 11123346889999999877644 479999999999999999999988655443322211 1111
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
....+. ....+.++|.-|+.+||.+||.++.|+-.|+++.
T Consensus 408 v~ippg-----is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 408 VHIPPG-----ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccCCCC-----ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111111 2335778889999999999999999999999875
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=225.92 Aligned_cols=265 Identities=22% Similarity=0.345 Sum_probs=152.3
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
.+.+.|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|+|++|+++ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 45667777777777 4665553 46777788887777 5665543 47777777777777 5565543 36777777
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|++. .+|..+. .+|+.|++++|+|+ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|+++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA- 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence 777776 5665553 46777777777777 4555443 467777777777663 333322 345666666666653
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 254 (870)
+|..+ .++|+.|++++|.++. +|..+. ++|+.|++++|+|+ .+|..+. ++
T Consensus 319 LP~~l---~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~--------------------- 368 (754)
T PRK15370 319 LPETL---PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PT--------------------- 368 (754)
T ss_pred CCccc---cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CC---------------------
Confidence 22222 2345555555555552 333332 34555555555554 2333321 34
Q ss_pred ccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCc----hhhhCccCCcEEEeeCCCccccCC
Q 002892 255 SFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIP----KEIGNLRGLIALSLFTNDLNGTIP 330 (870)
Q Consensus 255 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~----~~l~~l~~L~~L~L~~N~l~~~~~ 330 (870)
|+.|++++|++..+++. + ...++.|++++|++. .+| .....++.+..|++.+|.+..
T Consensus 369 -----------L~~LdLs~N~Lt~LP~~-l---~~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~--- 429 (754)
T PRK15370 369 -----------ITTLDVSRNALTNLPEN-L---PAALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE--- 429 (754)
T ss_pred -----------cCEEECCCCcCCCCCHh-H---HHHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH---
Confidence 44455555554433221 1 124555555555554 233 334456788999999999972
Q ss_pred chhhchhhHHHHHhcCCCCC
Q 002892 331 TTLGRLQQLQALLQRNNLNG 350 (870)
Q Consensus 331 ~~~~~l~~L~~L~l~n~~~~ 350 (870)
..+.+|+.|..++...|
T Consensus 430 ---~tl~~L~~Ll~s~~~~g 446 (754)
T PRK15370 430 ---RTIQNMQRLMSSVGYQG 446 (754)
T ss_pred ---HHHHHHHHhhhcccccC
Confidence 45556666544444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-22 Score=222.87 Aligned_cols=254 Identities=20% Similarity=0.231 Sum_probs=188.8
Q ss_pred CCCCeeccccceeEEEEEec-CCcEEEEEEee----c-hhhH-HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 588 NECNLLGAGSFGSVYKGTLF-DGTNVAIKVFN----L-QLER-AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~----~-~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
...+++|.|++|.|+.+... ..+.++.|.+. . .... ....+..|+-+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877632 34444555443 1 1111 1222667777788889999988877776665555569
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|||++ +|..++.... .+...++-.++.|+..|++|+| +.|+.|||+|++|+++..+|.+||+|||.+..+.-+..
T Consensus 401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 9999998653 3888999999999999999999 77799999999999999999999999999977654443
Q ss_pred c--ccccccccccccCCcccccCCCcCc-ccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 741 S--VTQTMTMATIGYMAPEYASDGIISP-KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 741 ~--~~~~~~~g~~~y~aPE~~~~~~~~~-~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
. .......|+..|+|||++.+.+|++ ..||||.|+++..|.+|+.||......+.+... .......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----------~~~~~~~ 544 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----------NNYSDQR 544 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----------hcccccc
Confidence 3 5566778999999999999999886 699999999999999999999765443332200 0000001
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....+..-....+.+-..++..+++.+|.+|-++.+|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1111122222344667788999999999999999999975
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=221.68 Aligned_cols=237 Identities=25% Similarity=0.385 Sum_probs=191.2
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
.+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|++++|+++ .+|..+. .+|+.|+|++|+++ .+|..+.
T Consensus 192 sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~- 261 (754)
T PRK15370 192 TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP- 261 (754)
T ss_pred cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh-
Confidence 3565553 57999999999999 5777664 58999999999999 6787654 58999999999999 7787765
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEE
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIIN 165 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 165 (870)
++|+.|+|++|+++ .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|+
T Consensus 262 -s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~ 331 (754)
T PRK15370 262 -SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLE 331 (754)
T ss_pred -CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceecc
Confidence 58999999999999 6787664 58999999999999 5665554 579999999999985 454443 6899999
Q ss_pred eecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccc
Q 002892 166 LVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245 (870)
Q Consensus 166 l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 245 (870)
+++|.+++ +|..+ .++|+.|++++|+|+ .+|..+. ++|++|+|++|+++. +|..+. ..|+.|++++|+++
T Consensus 332 Ls~N~Lt~-LP~~l---~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~ 401 (754)
T PRK15370 332 AGENALTS-LPASL---PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV 401 (754)
T ss_pred ccCCcccc-CChhh---cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc
Confidence 99999986 45544 368999999999998 5676664 689999999999994 565554 37999999999999
Q ss_pred cccCCCCCcccccccccccccceEEcCCCCCC
Q 002892 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277 (870)
Q Consensus 246 ~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (870)
.++.. ++..+..++++..|++.+|++.
T Consensus 402 ~LP~s-----l~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 402 RLPES-----LPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred cCchh-----HHHHhhcCCCccEEEeeCCCcc
Confidence 76542 3334455688999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-21 Score=186.95 Aligned_cols=171 Identities=14% Similarity=0.131 Sum_probs=132.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHH---H------HHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAF---R------SFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~---~------~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
..++|+..+++|.|+||.||.+.. ++..+|+|+++....... . .+++|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999765 577899999975532221 2 268999999999999999998886543
Q ss_pred --------CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceE
Q 002892 654 --------DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR 725 (870)
Q Consensus 654 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 725 (870)
...+++|||++|.+|.++.. .++ ....+++.+++.+| ..|++|||++|+||+++++| ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988742 222 24568999999999 77799999999999999988 99
Q ss_pred EeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHH
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETF 781 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ell 781 (870)
++|||............ .+.....+..++|+|+||+++....
T Consensus 175 liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 99999876542211110 0233445667999999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-19 Score=195.36 Aligned_cols=258 Identities=29% Similarity=0.396 Sum_probs=197.8
Q ss_pred CCCCCeeccccceeEEEEEecCCcEEEEEEeechhhH---HHHHHHHHHHHHHhcCCC-ceeEEeeeeeeCCeeEEEEec
Q 002892 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER---AFRSFESECEVLRNVRHR-NLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 662 (870)
|...+.+|.|+||.||++... ..+++|.+...... ....+.+|++.++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999866 78999998766532 467889999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEeccccccccCCCC
Q 002892 663 MPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLGEDD 739 (870)
Q Consensus 663 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 739 (870)
+.++++.+++.... ..++......++.|++.+++|+| +.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777554 25899999999999999999999 66699999999999999988 79999999998664433
Q ss_pred Ccc----cccccccccccCCcccccC---CCcCcccchHhHHHHHHHHHhCCCCCCccccc--cchHHHHHHHhcCCchh
Q 002892 740 DSV----TQTMTMATIGYMAPEYASD---GIISPKCDVYSYGVLLMETFTRKKPTDEMFTG--EMSLKHWIKLSLPRGLT 810 (870)
Q Consensus 740 ~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 810 (870)
... ......|+..|+|||...+ ..++...|+|++|++++++++|..||...... .................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2355679999999999987 57889999999999999999999997653321 11111111111111000
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
........ ......+.+++..|+..+|..|.++.+....
T Consensus 237 --------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 --------SPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --------cccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 1223467889999999999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=179.47 Aligned_cols=139 Identities=18% Similarity=0.168 Sum_probs=108.3
Q ss_pred CCeeccccceeEEEEEecCCcEEEEEEeechhhH--H------------------------HHHHHHHHHHHHhcCCCce
Q 002892 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER--A------------------------FRSFESECEVLRNVRHRNL 643 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 643 (870)
.+.||+|++|.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999778999999999764211 0 1123459999999987776
Q ss_pred eEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecccCCCceeeCCCC
Q 002892 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYL-HHSHSTPVVHCNLKPNNILLDKNM 722 (870)
Q Consensus 644 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dlk~~Nill~~~~ 722 (870)
.....+.. ...++||||++|+++....... ..+++..+..++.|++.+++++ | +.||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 43322221 2348999999998776553332 3488999999999999999999 6 56799999999999998 47
Q ss_pred ceEEecccccccc
Q 002892 723 TARVSDFGISKLL 735 (870)
Q Consensus 723 ~~kl~Dfg~a~~~ 735 (870)
.++++|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=195.13 Aligned_cols=220 Identities=25% Similarity=0.360 Sum_probs=165.7
Q ss_pred HHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCC
Q 002892 635 LRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPN 714 (870)
Q Consensus 635 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~ 714 (870)
++.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+......+++.....+.++++.|++|+|+ +..-.|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 356789999999999999999999999999999999999888889999999999999999999995 333389999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCC-------CcCcccchHhHHHHHHHHHhCCCCC
Q 002892 715 NILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG-------IISPKCDVYSYGVLLMETFTRKKPT 787 (870)
Q Consensus 715 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~sDvwslG~il~elltg~~p~ 787 (870)
|++++....+|++|||+.................-..-|.|||.+... ..+.++||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876431111122222234569999998763 1467899999999999999999999
Q ss_pred CccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 788 DEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
+.....+.. ...+..... .....+.+.+.. ..+.+..+..++..||.++|++||++++|...++.+.+.
T Consensus 159 ~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~-------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDP-DEIILRVKK-GGSNPFRPSIEL-------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCCh-HHHHHHHHh-cCCCCcCcchhh-------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 874333322 111111000 011111111110 013344789999999999999999999999988877653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-21 Score=173.73 Aligned_cols=185 Identities=31% Similarity=0.471 Sum_probs=166.5
Q ss_pred hhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccc
Q 002892 308 EIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYIL 387 (870)
Q Consensus 308 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 387 (870)
.+..+...+.|.||+|+++ .+|..+..+.+|+.|.+.||....+|..++++++|++|+++-|++. +.|..|+.++.|+
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 3456778889999999998 7888999999999999999999999999999999999999999998 8999999999999
Q ss_pred eEecCCCccCC-CCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCC
Q 002892 388 RIDLSSNSLSG-SLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466 (870)
Q Consensus 388 ~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 466 (870)
.|||++|++.. .+|..|..++.|+.|+|++|.+. .+|..++.+++|+.|.+..|.+- .+|..++.++.|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999999974 68999999999999999999998 89999999999999999999987 68999999999999999999
Q ss_pred cccCCCCcchhhcc---ccceeeccCCcccccCC
Q 002892 467 NLSGEIPKSFEILS---HLKRLNVSHNRLEGKIP 497 (870)
Q Consensus 467 ~l~~~~p~~~~~l~---~L~~L~ls~N~l~~~~p 497 (870)
+++ .+|.+++++. +-+.+.+..|+|-..|.
T Consensus 184 rl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa 216 (264)
T KOG0617|consen 184 RLT-VLPPELANLDLVGNKQVMRMEENPWVNPIA 216 (264)
T ss_pred eee-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence 999 8888877654 44667788898865554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-20 Score=206.76 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=179.1
Q ss_pred CCCCCCeeccccceeEEEEEecCCcEEEEEEeechhh-HHHHHH---HHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 586 GFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE-RAFRSF---ESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++...+.+|++.|=.|.+|+++.|. |+||+|-+..+ -....+ ..|++ ...++|||++++.-........|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777889999999999999988777 99999976542 122222 33444 556699999999877777777888988
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc--cCCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL--LGEDD 739 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~--~~~~~ 739 (870)
|+ ..+|+|.+..++ ++...+..+|+.|++.|+..+| ..||+|||||.+|||+++=..+.|+||..-+. +.+++
T Consensus 102 yv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 88 458999987655 4888899999999999999999 66699999999999999999999999976532 23332
Q ss_pred Ccccc---cccccccccCCcccccCC----------C-cCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHh
Q 002892 740 DSVTQ---TMTMATIGYMAPEYASDG----------I-ISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 740 ~~~~~---~~~~g~~~y~aPE~~~~~----------~-~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 804 (870)
..... .....-..|.|||.+... . .+++=||||+||+++|+++ |++||.-. ++-.+-...
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~ 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence 22211 122233569999977431 1 5678899999999999998 67777531 111111110
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
.......+. ..+ ...+.+++..|++.||++|.++++.++.-.
T Consensus 252 -~~~~e~~Le-----~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 252 -ADDPEQLLE-----KIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred -ccCHHHHHH-----hCc--------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 000111110 000 125788999999999999999999998743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-19 Score=171.96 Aligned_cols=141 Identities=20% Similarity=0.195 Sum_probs=110.9
Q ss_pred CCeeccccceeEEEEEecCCcEEEEEEeechhhH--------------------------HHHHHHHHHHHHHhcCCCce
Q 002892 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER--------------------------AFRSFESECEVLRNVRHRNL 643 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 643 (870)
.+.||+|++|.||+|...+|+.||||+++..... .......|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999999778999999998764210 01234678999999999987
Q ss_pred eEEeeeeeeCCeeEEEEecCCCCCHHHH-HhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC
Q 002892 644 IKIFSSCCNLDFKALVLEFMPNGSLEKW-LYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722 (870)
Q Consensus 644 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 722 (870)
.....+... ..++||||++|+++... +.. ..++.....+++.|++.++.++|+ ..||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence 544433332 24899999998865443 332 337888999999999999999993 16799999999999998 89
Q ss_pred ceEEeccccccccCC
Q 002892 723 TARVSDFGISKLLGE 737 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~ 737 (870)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=165.70 Aligned_cols=186 Identities=16% Similarity=0.084 Sum_probs=140.3
Q ss_pred CCCCeeccccceeEEEEEecCCcEEEEEEeechhh----HHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEEec
Q 002892 588 NECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE----RAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.+...+++|+||+||.+.. .+++++.+.+..... -....+.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997764 688888887765432 12335889999999995 5789999886 446999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccc-CCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL-KPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
++|.+|...... ....++.|++++++++| +.||+|||| ||.||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754321 12357889999999999 777999999 799999999999999999999865433211
Q ss_pred ----cc-------ccccccccccCCcccccCC-CcC-cccchHhHHHHHHHHHhCCCCCCc
Q 002892 742 ----VT-------QTMTMATIGYMAPEYASDG-IIS-PKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 742 ----~~-------~~~~~g~~~y~aPE~~~~~-~~~-~~sDvwslG~il~elltg~~p~~~ 789 (870)
.. ......++.|++|+....- ..+ .+.+.++-|+-+|.++|++.|.-.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 1123357778888754332 223 567888999999999999988643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.8e-19 Score=201.94 Aligned_cols=198 Identities=22% Similarity=0.238 Sum_probs=158.1
Q ss_pred HhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC---CCceeEEeeeeeeCCeeEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR---HRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 658 (870)
...+.|.+.+.+|+|+||.||+|...+|+.||+|+-+...... |--=.+++.+|+ -+.|..+..++.-.+..++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3456788889999999999999998889999999876543211 111123333443 2345555566666778899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC-------CCCceEEecccc
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-------KNMTARVSDFGI 731 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-------~~~~~kl~Dfg~ 731 (870)
|+||.+.|+|.+++...+ .++|.-+..+..|+++.+++|| ..+||||||||+|+++. ....++|+|||.
T Consensus 772 v~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 999999999999998544 4899999999999999999999 55599999999999994 234689999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCC
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p 786 (870)
+..+.--.........++|-.+-.+|+..++.+++..|.|.++.+++.|+.|+..
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9877544444455567789999999999999999999999999999999999853
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.1e-19 Score=177.51 Aligned_cols=230 Identities=20% Similarity=0.249 Sum_probs=147.4
Q ss_pred CCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCC----------CceeEEeeee--
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRH----------RNLIKIFSSC-- 650 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~-- 650 (870)
+...+.||.|+++.||.+++. +++.+|+|++.... ....+.+++|.-....+.+ -.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999965 58999999986543 3446667777666555322 1222222211
Q ss_pred -------eeC---C-----eeEEEEecCCCCCHHHHHh---hcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 002892 651 -------CNL---D-----FKALVLEFMPNGSLEKWLY---SHNY---FLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709 (870)
Q Consensus 651 -------~~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~ 709 (870)
... . ..+++|+-+ .+||.+++. .... ......+..+..|+++.+++|| +.|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 111 1 235678776 678888766 2221 2344556677799999999999 6779999
Q ss_pred ccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccC--------CCcCcccchHhHHHHHHHHH
Q 002892 710 NLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD--------GIISPKCDVYSYGVLLMETF 781 (870)
Q Consensus 710 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDvwslG~il~ell 781 (870)
||+|+|++++++|.+.|+||+.....+... .. ...+..|.|||.... -.++.+.|.|++|+++|.++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee---ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999887653211 11 235578999997643 24788999999999999999
Q ss_pred hCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCC
Q 002892 782 TRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQR 849 (870)
Q Consensus 782 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 849 (870)
++..||+.......... .+. .. .+.++.+..++..+++.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~~-----------------~f~----~C---~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-----------------DFS----RC---RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-----------------GGT----TS---S---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-----------------cch----hc---CCcCHHHHHHHHHHccCCcccC
Confidence 99999986422211000 111 11 1446789999999999999988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.7e-21 Score=168.87 Aligned_cols=158 Identities=26% Similarity=0.494 Sum_probs=131.8
Q ss_pred CCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCC
Q 002892 10 HIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSL 89 (870)
Q Consensus 10 ~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 89 (870)
.+.++.+.+.|-||+|+++ .+|..+..+.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4667788888888888888 56777888888888888888888 78888888888888888888887 788888888888
Q ss_pred cEEeccCCccc-cccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeec
Q 002892 90 VRLDSRFNSIS-GNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVG 168 (870)
Q Consensus 90 ~~L~L~~n~i~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 168 (870)
+.|||++|++. ..+|..|-.++.|+.|+|++|.++ .+|..++++++|+.|.+.+|.+. .+|..++.+.+|++|++.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 88888888887 357788888888888888888888 77888888888888888888876 6788888888888888888
Q ss_pred cccc
Q 002892 169 NQLS 172 (870)
Q Consensus 169 N~l~ 172 (870)
|+++
T Consensus 183 nrl~ 186 (264)
T KOG0617|consen 183 NRLT 186 (264)
T ss_pred ceee
Confidence 8877
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-19 Score=176.37 Aligned_cols=197 Identities=22% Similarity=0.245 Sum_probs=136.2
Q ss_pred CCCceeEEeeeeeeC---------------------------CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHH
Q 002892 639 RHRNLIKIFSSCCNL---------------------------DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDV 691 (870)
Q Consensus 639 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i 691 (870)
+|||||++.++|.++ ...|+||..+ ..+|.+++..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence 599999998776432 3568999988 459999998655 4566677799999
Q ss_pred HHHHHHHHhcCCCCcEecccCCCceee--CCCC--ceEEeccccccccCC---C-CCcccccccccccccCCcccccCCC
Q 002892 692 GLALEYLHHSHSTPVVHCNLKPNNILL--DKNM--TARVSDFGISKLLGE---D-DDSVTQTMTMATIGYMAPEYASDGI 763 (870)
Q Consensus 692 ~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfg~a~~~~~---~-~~~~~~~~~~g~~~y~aPE~~~~~~ 763 (870)
++|+.||| ++||.|||+|++||++ ++|+ .+.++|||.+---.. . ......-...|.-.-||||+....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 7779999999999999 3443 578899997642111 0 0111112234677789999886432
Q ss_pred ------cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHH
Q 002892 764 ------ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHL 837 (870)
Q Consensus 764 ------~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 837 (870)
.-.|+|.|+.|.+.||+++...||....+.-.+...+-..+.|. -+..|+.-+.++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa------------------lp~~vpp~~rql 489 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA------------------LPSRVPPVARQL 489 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC------------------CcccCChHHHHH
Confidence 22489999999999999999999976211111111111111111 122355678899
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 002892 838 ALGCCMDSPEQRMCMTDVVVKL 859 (870)
Q Consensus 838 ~~~cl~~~P~~RPs~~evl~~L 859 (870)
+...++.||++|+++.-....+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 9999999999999876554443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=8e-21 Score=204.92 Aligned_cols=257 Identities=21% Similarity=0.223 Sum_probs=174.6
Q ss_pred eecCCCCccc-cCCCccccCCCCCcEEEccCCcccc----cCCccccCCCCCCEEEcCCCcccc------CCCCCCCCCC
Q 002892 19 YLDISENNFR-GYLPNELGQLRRLKFLGFAYNDLTG----SFPSWIGVFSKLQVLSLRNNSFTG------PIPNSLFNLS 87 (870)
Q Consensus 19 ~L~ls~n~l~-~~~p~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~ 87 (870)
.|+|+.+.++ ...+..+..+.+|+.|++++|.++. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5677777776 3344556677778888888888753 255566677778888888887762 2234566677
Q ss_pred CCcEEeccCCccccccCcCCCCcCC---ccEEEeecCccce----ecCCcccCC-CCCCeeecccccccc----cccccc
Q 002892 88 SLVRLDSRFNSISGNIPSKIGNLTK---LVHLNFADNNLRG----EIPNEIGNL-KNLADLVLALNNLIG----PIPTTI 155 (870)
Q Consensus 88 ~L~~L~L~~n~i~~~~~~~~~~l~~---L~~L~l~~N~l~~----~~~~~l~~l-~~L~~L~L~~n~l~~----~~~~~~ 155 (870)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++ .++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887555555555544 8888888888773 233345566 788888888888873 234455
Q ss_pred cccccceEEEeecccccccCCCccc---CCCCccceeeecccccccc----cCCcccCCCCccEEEccCCcccCCCcccc
Q 002892 156 FNISTIIIINLVGNQLSGHRPSTMG---HSLPNRQFLLLWANRLTGT----IPNSITNASKLIGLDLNSNSLSGQIPNTF 228 (870)
Q Consensus 156 ~~l~~L~~L~l~~N~l~~~~~~~~~---~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~ 228 (870)
..+.+|++|++++|.+++.....+. ...++|+.|++++|.+++. +...+..+++|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 5667888888888888743222221 1235888888888887643 33456677889999999998876444444
Q ss_pred cc-----ccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCC
Q 002892 229 GN-----LRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSI 279 (870)
Q Consensus 229 ~~-----l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 279 (870)
.. .+.|+.|++++|.++... ...+...+..+++|+++++++|.+...
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~----~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDG----AKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHH----HHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 33 368899999998886321 112344566668888999998888753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-20 Score=200.84 Aligned_cols=137 Identities=26% Similarity=0.350 Sum_probs=86.3
Q ss_pred ccCccccceeecCCcccCCC----CCcccccccccceEecCCCccCCC----CcccccCCccCCEEEccCCccCCccccc
Q 002892 356 LSSLISLRQLHLGSNQLTSS----IPSSFWSLEYILRIDLSSNSLSGS----LPSDIQNLKVLIYLNLSRNQLSGNIPIT 427 (870)
Q Consensus 356 ~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 427 (870)
+..+++|++|+|++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++.....
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~ 240 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence 34445666677777766632 222334445677777777766532 2334556677888888888777533333
Q ss_pred cc-----CCCCCCEEEcCCCcccC----cccccccCCCCCCeEecCCCcccCC----CCcchhhc-cccceeeccCCcc
Q 002892 428 IG-----GLKDLITLSLARNRFQD----SIPDSFGSLTSLEYLDLSNNNLSGE----IPKSFEIL-SHLKRLNVSHNRL 492 (870)
Q Consensus 428 ~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~ls~N~l 492 (870)
+. ..+.|+.|++++|.+++ .++..+..+++|+++++++|+++.. ....+... +.|+.||+.+|+|
T Consensus 241 l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 22 23678888888888762 2344566667888888888888854 33444445 6788888888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-19 Score=189.56 Aligned_cols=186 Identities=27% Similarity=0.324 Sum_probs=155.6
Q ss_pred eeccccceeEEEEE----ecCCcEEEEEEeechhh--HHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEEecCC
Q 002892 592 LLGAGSFGSVYKGT----LFDGTNVAIKVFNLQLE--RAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 592 ~lg~G~~g~v~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
.+|+|+||.|+.+. .+.|..+|+|+.++... ........|..++...+ ||.++++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999775 34577899999876542 11225566778888886 9999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
||++...+..... +++.....+...++-|++++| +.+++|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 9999888876654 677777778888999999999 66799999999999999999999999999986532221
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~ 789 (870)
..||..|||||++. ....++|.||||++++||+||..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 17899999999997 567899999999999999999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.2e-17 Score=159.61 Aligned_cols=135 Identities=18% Similarity=0.252 Sum_probs=104.9
Q ss_pred CCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-----CCCceeEEeeeeeeCC---eeE-
Q 002892 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-----RHRNLIKIFSSCCNLD---FKA- 657 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~- 657 (870)
+...+.||+|+||.||. ...++.. +||+.........+.+.+|+++++.+ .||||+++++++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 3234444 79988765444556789999999999 5799999999998763 333
Q ss_pred EEEec--CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEecccCCCceeeCC----CCceEEeccc
Q 002892 658 LVLEF--MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL-EYLHHSHSTPVVHCNLKPNNILLDK----NMTARVSDFG 730 (870)
Q Consensus 658 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg 730 (870)
+|+|| +++++|.+++.... +++. ..++.+++.++ +||| +++|+||||||+||+++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 55799999997643 5555 35677888777 9999 666999999999999974 3479999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=162.24 Aligned_cols=142 Identities=19% Similarity=0.126 Sum_probs=111.9
Q ss_pred CCCCCCeeccccceeEEEEE--ecCCcEEEEEEeechhh------------------------HHHHHHHHHHHHHHhcC
Q 002892 586 GFNECNLLGAGSFGSVYKGT--LFDGTNVAIKVFNLQLE------------------------RAFRSFESECEVLRNVR 639 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~ 639 (870)
.|++.+.||+|++|.||+|. ..+|+.||+|+++.... .....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 56899999999875421 01134678999999997
Q ss_pred CC--ceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecccCCCce
Q 002892 640 HR--NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP-VVHCNLKPNNI 716 (870)
Q Consensus 640 h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~~Ni 716 (870)
+. .+..++++ ...++||||++|+++..+..... ..+..+...++.|++.++++|| ..| ++||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 53 34445543 23589999999988876653322 3566677899999999999999 788 99999999999
Q ss_pred eeCCCCceEEeccccccccC
Q 002892 717 LLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 717 ll~~~~~~kl~Dfg~a~~~~ 736 (870)
+++ ++.++++|||.+...+
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-17 Score=175.16 Aligned_cols=123 Identities=26% Similarity=0.484 Sum_probs=108.7
Q ss_pred CeeEEEEecCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 654 DFKALVLEFMPNGSLEKWLY--SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
.+.|+.|++|...+|.+|+. ......++.....++.|++.|++| ++.+|+|+||.||++..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 36789999999999999996 334567889999999999999998 5599999999999999999999999999
Q ss_pred ccccCCCC----CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh
Q 002892 732 SKLLGEDD----DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782 (870)
Q Consensus 732 a~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt 782 (870)
........ .....+...||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98775443 2345667789999999999999999999999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.8e-16 Score=156.43 Aligned_cols=134 Identities=20% Similarity=0.327 Sum_probs=112.7
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeechh--------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
+.||+|++|.||+|.. +|..+++|+..... ......+.+|++++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999986 67889999865322 11234578899999999999987777777777788999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
++|++|.+++.... + .+..++.+++.+++++| +.+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 78899999999999999 67799999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.8e-16 Score=153.15 Aligned_cols=138 Identities=18% Similarity=0.159 Sum_probs=109.0
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhh----------------------HHHHHHHHHHHHHHhcCCCc
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE----------------------RAFRSFESECEVLRNVRHRN 642 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~n 642 (870)
.-|.+.+.||+|+||.||+|...+|+.||||+++.... ........|+..+..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34778899999999999999988899999998764320 01123667888888887774
Q ss_pred --eeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC
Q 002892 643 --LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK 720 (870)
Q Consensus 643 --iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 720 (870)
++..++ ....++||||++|+++.+.... .....++.+++.++.++| ..|++||||+|+||++++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcC
Confidence 444443 2455899999999998765431 234678899999999999 577999999999999999
Q ss_pred CCceEEeccccccccC
Q 002892 721 NMTARVSDFGISKLLG 736 (870)
Q Consensus 721 ~~~~kl~Dfg~a~~~~ 736 (870)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.7e-16 Score=152.95 Aligned_cols=130 Identities=22% Similarity=0.323 Sum_probs=106.1
Q ss_pred eeccccceeEEEEEecCCcEEEEEEeechh--------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 592 LLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.||+|++|.||+|.+ ++..|++|+..... .....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999984 57889999864321 122356788999999999887655555555666779999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
+|++|.+++..... .++.+++.+++++| +.|++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998764321 78999999999999 77799999999999999 89999999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-16 Score=178.24 Aligned_cols=209 Identities=25% Similarity=0.281 Sum_probs=142.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..+|..++.|..|+||.||.++++ ..+.+|+|+ +++.-- .+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee------------------
Confidence 468889999999999999999866 467788853 222100 010 22222233222
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
|+....++..+. ++. +++.+++|+| +.||+|||+||.|.+|+.-|++|++|||++..........
T Consensus 136 ---gDc~tllk~~g~-lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP-LPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCCC-Ccc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 566666654332 221 2267899999 7889999999999999999999999999986432111110
Q ss_pred -------------cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH--hcCC
Q 002892 743 -------------TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL--SLPR 807 (870)
Q Consensus 743 -------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~ 807 (870)
.....+||+.|.|||++..+.|+..+|.|++|+|+||.+-|+.||.+. +.++.+.+++.. .+++
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-tpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-CHHHHHhhhhhhhccccc
Confidence 112347999999999999999999999999999999999999999763 223333333321 1111
Q ss_pred chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 808 GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
. .+..+.++.+++.+.++.+|..|--.
T Consensus 280 ~------------------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 280 E------------------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred c------------------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 1 11224467888999999999998733
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.6e-15 Score=170.88 Aligned_cols=137 Identities=20% Similarity=0.267 Sum_probs=110.8
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeech--------hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ--------LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
..|...+.||+|+||+||+|.+.+. .+++|+.... ......++.+|++++++++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456678999999999999986543 3444432211 112235688999999999999998887777777778
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
++||||++|++|.+++. ....++.++++++++|| +.+++|||+||+||++ +++.++++|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999885 34678999999999999 6779999999999999 6789999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=135.71 Aligned_cols=135 Identities=21% Similarity=0.245 Sum_probs=114.8
Q ss_pred CCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCC--CceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 589 ECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRH--RNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 589 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
+.+.+|+|.++.||++...+ ..+++|+...... ...+..|+..++.++| ..+++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999654 7899999866543 4578889999999976 58999998888778899999999988
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 667 SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 667 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
.+..+ +......++.+++++++++|.....+++|||++|.||++++.+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77554 4567778899999999999976556899999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.3e-14 Score=141.20 Aligned_cols=136 Identities=21% Similarity=0.223 Sum_probs=97.5
Q ss_pred CCeeccccceeEEEEEecCCcEEEEEEeechhhH--HHHH----------------------HHHHHHHHHhcCCCc--e
Q 002892 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER--AFRS----------------------FESECEVLRNVRHRN--L 643 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i 643 (870)
.+.||+|+||.||+|...+++.||||+++..... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999998754211 1111 134555666654432 3
Q ss_pred eEEeeeeeeCCeeEEEEecCCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCcEecccCCCceeeCCC
Q 002892 644 IKIFSSCCNLDFKALVLEFMPNGSLEK-WLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS-TPVVHCNLKPNNILLDKN 721 (870)
Q Consensus 644 v~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~-~~ivH~dlk~~Nill~~~ 721 (870)
.+.+++ ...++||||++++++.. .+.... .. .+...++.+++.++.++| . .+++|||++|+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 344432 34589999999954321 111111 11 567789999999999999 5 7799999999999999 9
Q ss_pred CceEEeccccccccC
Q 002892 722 MTARVSDFGISKLLG 736 (870)
Q Consensus 722 ~~~kl~Dfg~a~~~~ 736 (870)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-13 Score=139.48 Aligned_cols=135 Identities=19% Similarity=0.192 Sum_probs=104.6
Q ss_pred Ceec-cccceeEEEEEecCCcEEEEEEeechh-------------hHHHHHHHHHHHHHHhcCCCce--eEEeeeeeeC-
Q 002892 591 NLLG-AGSFGSVYKGTLFDGTNVAIKVFNLQL-------------ERAFRSFESECEVLRNVRHRNL--IKIFSSCCNL- 653 (870)
Q Consensus 591 ~~lg-~G~~g~v~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~- 653 (870)
..|| .|+.|+||.++.. ++.+|||.+.... .....++.+|++++.+++|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999864 7789999885421 1223567889999999998875 6666664332
Q ss_pred C---eeEEEEecCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecc
Q 002892 654 D---FKALVLEFMPN-GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 654 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
. ..++||||++| .+|.+++.... ++.. .+.+++.+++++| .+||+||||||.||+++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 23599999997 69998886532 4443 3568999999999 777999999999999999999999999
Q ss_pred cccccc
Q 002892 730 GISKLL 735 (870)
Q Consensus 730 g~a~~~ 735 (870)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-15 Score=173.00 Aligned_cols=256 Identities=19% Similarity=0.252 Sum_probs=192.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec--CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF--DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 658 (870)
...|...+.||+|+|+.|-.+... ....+|+|.+.... .........|..+-..+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 456778888999999999887643 24456666655442 233344555777766775 9999999999999999999
Q ss_pred EEecCCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEeccccccccC
Q 002892 659 VLEFMPNGSLEKWL-YSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLG 736 (870)
Q Consensus 659 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 736 (870)
+.+|.+|+++.+.+ .......+......++.|+..++.|+|. ..+++|+|+||+|.+++..+ ..++.|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 5443356777788899999999999993 34499999999999999999 99999999999886
Q ss_pred C-CCCccccccccc-ccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 737 E-DDDSVTQTMTMA-TIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 737 ~-~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
. ...........| ++.|+|||...+. ...+..|+||.|+++..+++|..||+...........|.......
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 250 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF------ 250 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc------
Confidence 6 444444555677 9999999999884 556889999999999999999999987544443333333221000
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 856 (870)
... ..........++..+++..+|+.|.+..++.
T Consensus 251 ~~~---------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 TQL---------PWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccC---------ccccCChhhhhcccccccCCchhcccccccc
Confidence 000 0011233567788888889999999888764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.3e-16 Score=164.58 Aligned_cols=199 Identities=25% Similarity=0.367 Sum_probs=158.2
Q ss_pred eecCCCCccccCCCccc--cCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 19 YLDISENNFRGYLPNEL--GQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 19 ~L~ls~n~l~~~~p~~~--~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
.|.|++-++. ..|..- ..+..-...+|+.|++. ++|..++.+..|+.|.|.+|.|. .+|..++++..|++|||+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 4667666666 344222 34666778899999999 89999999999999999999999 7999999999999999999
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCC
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 176 (870)
|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|++. .+|..+.++.+|+.|++..|++... |
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~l-p 205 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDL-P 205 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhC-C
Confidence 9998 8899998887 899999999999 88999998899999999999987 6788899999999999999998743 3
Q ss_pred CcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccc
Q 002892 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFG 229 (870)
Q Consensus 177 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~ 229 (870)
..+. --.|..||+++|++. .+|-.|.+++.|++|-|.+|.++ ..|..++
T Consensus 206 ~El~--~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 206 EELC--SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred HHHh--CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 3333 224566667777766 56666667777777777777666 4454444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.2e-15 Score=158.52 Aligned_cols=177 Identities=31% Similarity=0.498 Sum_probs=155.7
Q ss_pred hCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceE
Q 002892 310 GNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRI 389 (870)
Q Consensus 310 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 389 (870)
..+..-...||+.|++. .+|..++.+..|+.+.++.|-...+|.+++.+..|+.|+|+.|++. ..|..++.++ |+.|
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 34556678889999998 7899999999999999998888899999999999999999999998 7777777765 8888
Q ss_pred ecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCccc
Q 002892 390 DLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 390 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 469 (870)
-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++.. +|..+..| .|..||+|+|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCC-ceeeeecccCcee
Confidence 99999999 78999998899999999999998 688889999999999999999984 67777766 4899999999998
Q ss_pred CCCCcchhhccccceeeccCCcccc
Q 002892 470 GEIPKSFEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 470 ~~~p~~~~~l~~L~~L~ls~N~l~~ 494 (870)
.+|-.|..|..|++|-|.+|+|+.
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCC
Confidence 899999999999999999999975
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.8e-13 Score=146.01 Aligned_cols=140 Identities=22% Similarity=0.259 Sum_probs=99.8
Q ss_pred CCeeccccceeEEEEEecCCcEEEEEEeechhhHHH----------------------------------------HHHH
Q 002892 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAF----------------------------------------RSFE 629 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 629 (870)
.+.||+|++|.||+|++++|+.||||+.++...... -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 478999999999999999999999999865421110 0244
Q ss_pred HHHHHHHhcC----CCceeEEeeee-eeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 002892 630 SECEVLRNVR----HRNLIKIFSSC-CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGL-ALEYLHHSHS 703 (870)
Q Consensus 630 ~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~Lh~~~~ 703 (870)
.|++.+.+++ |.+-+.+-..+ ......++||||++|+++.++........+ ..+++..++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence 5666555552 33223332222 223457899999999999887753322222 3446666655 467778 6
Q ss_pred CCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 704 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.|++|+|++|.||+++.++.++++|||++..+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 77999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=160.16 Aligned_cols=117 Identities=38% Similarity=0.590 Sum_probs=68.6
Q ss_pred CCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccC
Q 002892 410 LIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSH 489 (870)
Q Consensus 410 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 489 (870)
++.|+|++|.+++.+|..++.+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 45566666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CcccccCCCCC--cccccccccccccccccCCCCcCCCCCC
Q 002892 490 NRLEGKIPTNG--PFRNFLAQSFLWNYALCGPPRLQVPPCK 528 (870)
Q Consensus 490 N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~~~~~~~~~ 528 (870)
|+++|.+|..- .+.......+.+|+.+||.|. .+.|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 66666666421 111122334567777887663 34564
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.6e-13 Score=150.57 Aligned_cols=201 Identities=33% Similarity=0.485 Sum_probs=107.2
Q ss_pred EEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcC-CccEEEeecCccceecCCcccCCCCCCeeecccc
Q 002892 67 VLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLT-KLVHLNFADNNLRGEIPNEIGNLKNLADLVLALN 145 (870)
Q Consensus 67 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n 145 (870)
.|+++.|.+. ..+..+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555553 22233444455555555555555 4444444443 5555555555555 44444555555555555555
Q ss_pred cccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCc
Q 002892 146 NLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIP 225 (870)
Q Consensus 146 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~ 225 (870)
+++ .+|......+. |+.|++++|+++ .+|........|++|++++|++. ..+
T Consensus 174 ~l~-~l~~~~~~~~~-------------------------L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~ 225 (394)
T COG4886 174 DLS-DLPKLLSNLSN-------------------------LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELL 225 (394)
T ss_pred hhh-hhhhhhhhhhh-------------------------hhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecc
Confidence 554 23333334444 444444444444 34444344455666666666433 345
Q ss_pred cccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccC
Q 002892 226 NTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSI 305 (870)
Q Consensus 226 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~ 305 (870)
..+.++.++..|.+.+|++... +..+..+..+++|++++|++..+
T Consensus 226 ~~~~~~~~l~~l~l~~n~~~~~---------~~~~~~l~~l~~L~~s~n~i~~i-------------------------- 270 (394)
T COG4886 226 SSLSNLKNLSGLELSNNKLEDL---------PESIGNLSNLETLDLSNNQISSI-------------------------- 270 (394)
T ss_pred hhhhhcccccccccCCceeeec---------cchhccccccceecccccccccc--------------------------
Confidence 5566666666666666666542 22355556666666666666543
Q ss_pred chhhhCccCCcEEEeeCCCccccCCchhh
Q 002892 306 PKEIGNLRGLIALSLFTNDLNGTIPTTLG 334 (870)
Q Consensus 306 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 334 (870)
+. +..+.+++.|++++|.+....|....
T Consensus 271 ~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 271 SS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred cc-ccccCccCEEeccCccccccchhhhc
Confidence 11 55666777777777777755554443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.1e-13 Score=149.96 Aligned_cols=198 Identities=33% Similarity=0.485 Sum_probs=105.5
Q ss_pred EEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCC-CCcEEeccCCccccccCcCCCCcCCccEEEeecC
Q 002892 43 FLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLS-SLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121 (870)
Q Consensus 43 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N 121 (870)
.|.++.|.+. .....+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4566666654 22333444456666666666666 4555555553 6666666666666 55555666666666666666
Q ss_pred ccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccC
Q 002892 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIP 201 (870)
Q Consensus 122 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 201 (870)
+++ .+|...+.+++|+.|++++|++. .+|........|++|.+++|.+. ..+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~--------------------------~~~ 225 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--------------------------ELL 225 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce--------------------------ecc
Confidence 666 45554446666666666666665 34444434444555555555321 223
Q ss_pred CcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCC
Q 002892 202 NSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILP 281 (870)
Q Consensus 202 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 281 (870)
..+.++.++..|.+.+|++. ..+..++.+++++.|++++|.++.+. .+..+.+++.|++++|.+...++
T Consensus 226 ~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~----------~~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 226 SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSIS----------SLGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred hhhhhcccccccccCCceee-eccchhccccccceeccccccccccc----------cccccCccCEEeccCccccccch
Confidence 33444444444444444444 22344444455555555555554422 24444555555555555554444
Q ss_pred c
Q 002892 282 P 282 (870)
Q Consensus 282 ~ 282 (870)
.
T Consensus 295 ~ 295 (394)
T COG4886 295 L 295 (394)
T ss_pred h
Confidence 3
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.9e-11 Score=133.64 Aligned_cols=145 Identities=19% Similarity=0.183 Sum_probs=94.4
Q ss_pred hcCCCCCCeeccccceeEEEEEecC-CcEEEEEEeechhhHH----------------------------------HH--
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERA----------------------------------FR-- 626 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-- 626 (870)
...|.. +.+|+|++|.||+|++++ |+.||||+.++..... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 799999999999999887 9999999997542110 01
Q ss_pred ----HHHHHHHHHHhcC----CCceeEEeeeeee-CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH-HHH
Q 002892 627 ----SFESECEVLRNVR----HRNLIKIFSSCCN-LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGL-ALE 696 (870)
Q Consensus 627 ----~~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~ 696 (870)
.+.+|+..+.+++ +...+.+-..+.+ ....++||||++|+++.+.-.-.....+... ++...+. -+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~ 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence 1344555555542 3333433333322 4567899999999999875321111122222 2222111 122
Q ss_pred HHHhcCCCCcEecccCCCceeeCCCC----ceEEecccccccc
Q 002892 697 YLHHSHSTPVVHCNLKPNNILLDKNM----TARVSDFGISKLL 735 (870)
Q Consensus 697 ~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~~~ 735 (870)
.++ ..|++|+|++|.||+++.++ .++++|||++..+
T Consensus 275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 333 56799999999999999888 9999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-12 Score=140.50 Aligned_cols=247 Identities=19% Similarity=0.218 Sum_probs=181.6
Q ss_pred CCCCCCeecc--ccceeEEEEEe---cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeE
Q 002892 586 GFNECNLLGA--GSFGSVYKGTL---FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 586 ~~~~~~~lg~--G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 657 (870)
.+.+.+.+|. |.+|.+|.+.. .++..+|+|.-+... .....+-.+|+...+.+ .|++.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556678999 99999999985 468889999843322 23333344566666666 4999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEecccCCCceeeCCC-CceEEeccccc
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGL----ALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGIS 732 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a 732 (870)
+-+|++ +.++.++.+.....++....+....+..+ |+.++| +..++|-|+||.||+..++ ...+++|||+.
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence 999998 57999999887777899999999999999 999999 6679999999999999999 88999999999
Q ss_pred cccCCCCCccccc---ccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcc-ccccchHHHHHHHhcCCc
Q 002892 733 KLLGEDDDSVTQT---MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM-FTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 733 ~~~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~ 808 (870)
..++......... ...|...|++||.. .+.++.++|+|++|.++.+..++..++... ......+..++ ++..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e 346 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IPLE 346 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---Cchh
Confidence 9886654322211 22577889999976 456688999999999999999887664321 11111111111 1111
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+ .-..++...+..+++++|-.|++.+.+..
T Consensus 347 ---~~~--------------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 347 ---FCE--------------GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---hhc--------------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 01223444788899999999998877643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.5e-12 Score=125.87 Aligned_cols=204 Identities=18% Similarity=0.260 Sum_probs=140.2
Q ss_pred HHHHHhcCCCceeEEeeeeeeCC-----eeEEEEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 002892 632 CEVLRNVRHRNLIKIFSSCCNLD-----FKALVLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHS 703 (870)
Q Consensus 632 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~ 703 (870)
...+-++-|.|+|+++.||.+.. ...+++||+..|++..++++. ...+......+|+.||..||.|||.. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 44455667999999999997643 467899999999999999843 45578888899999999999999965 5
Q ss_pred CCcEecccCCCceeeCCCCceEEeccccccccC--CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHH
Q 002892 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLG--EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETF 781 (870)
Q Consensus 704 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~--~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ell 781 (870)
++|+|+++.-+-|++..+|-+|++--....... ............+-++|.+||.-.....+.++|||+||+...||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 889999999999999999888875321111100 000111122334678999999887777888999999999999998
Q ss_pred hCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 782 TRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 782 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
-+..--.. .+.... ..+.....+...... .=...+.+|+...|..||+|.+++..
T Consensus 277 ilEiq~tn---seS~~~----------~ee~ia~~i~~len~---------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTN---SESKVE----------VEENIANVIIGLENG---------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCC---Ccceee----------hhhhhhhheeeccCc---------cccCcCcccccCCCCCCcchhhhhcC
Confidence 87653211 110000 000000000000000 11346789999999999999988654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.7e-13 Score=129.99 Aligned_cols=133 Identities=28% Similarity=0.320 Sum_probs=96.9
Q ss_pred cccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccc
Q 002892 156 FNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLS 235 (870)
Q Consensus 156 ~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 235 (870)
...+.|+++|||+|.|+....+. +..|.+++|+++.|.|+.+ +.+..+++|+.||||+|.++ ....|-.++-+.+
T Consensus 281 dTWq~LtelDLS~N~I~~iDESv--KL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLITQIDESV--KLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred chHhhhhhccccccchhhhhhhh--hhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 34456777777777776433221 3467788888888888743 34888899999999999988 5667777888999
Q ss_pred cccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCC
Q 002892 236 TLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGL 315 (870)
Q Consensus 236 ~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L 315 (870)
+|.|+.|.|.++ +.++.+-+|..||+++|+|.... --..+++++-|
T Consensus 356 tL~La~N~iE~L----------SGL~KLYSLvnLDl~~N~Ie~ld------------------------eV~~IG~LPCL 401 (490)
T KOG1259|consen 356 TLKLAQNKIETL----------SGLRKLYSLVNLDLSSNQIEELD------------------------EVNHIGNLPCL 401 (490)
T ss_pred eeehhhhhHhhh----------hhhHhhhhheeccccccchhhHH------------------------HhcccccccHH
Confidence 999999998863 46778888899999999886431 11346677777
Q ss_pred cEEEeeCCCccc
Q 002892 316 IALSLFTNDLNG 327 (870)
Q Consensus 316 ~~L~L~~N~l~~ 327 (870)
+.+.|.+|.+.+
T Consensus 402 E~l~L~~NPl~~ 413 (490)
T KOG1259|consen 402 ETLRLTGNPLAG 413 (490)
T ss_pred HHHhhcCCCccc
Confidence 777777777764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.7e-12 Score=144.39 Aligned_cols=114 Identities=39% Similarity=0.607 Sum_probs=106.8
Q ss_pred ccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecC
Q 002892 385 YILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLS 464 (870)
Q Consensus 385 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 464 (870)
.++.|+|++|.+++.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|++++.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCcchhhc-cccceeeccCCcccccCCC
Q 002892 465 NNNLSGEIPKSFEIL-SHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 465 ~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~ 498 (870)
+|+++|.+|..+..+ .++..+++++|+..|.+|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 999999999998764 5678999999998776664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.1e-11 Score=128.65 Aligned_cols=168 Identities=17% Similarity=0.177 Sum_probs=129.9
Q ss_pred ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHH
Q 002892 606 LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL 685 (870)
Q Consensus 606 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 685 (870)
..++.+|.|++++...........+-++.++.++||+|+++++.+..++..|+|+|.+. .|..++.+.+ ...+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 34688999998877665555667788899999999999999999999999999999884 5777776533 66778
Q ss_pred HHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcC
Q 002892 686 NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765 (870)
Q Consensus 686 ~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 765 (870)
.-+.||+.||.|||+ ..+++|++|....|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 889999999999985 45699999999999999999999999998875532221 111111122466666543322
Q ss_pred cccchHhHHHHHHHHHhCCC
Q 002892 766 PKCDVYSYGVLLMETFTRKK 785 (870)
Q Consensus 766 ~~sDvwslG~il~elltg~~ 785 (870)
-..|.|.|||+++|++.|..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhhHHHHHHHHhCccc
Confidence 34699999999999999943
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.1e-13 Score=128.01 Aligned_cols=208 Identities=23% Similarity=0.286 Sum_probs=108.1
Q ss_pred CCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc-CCccccccCcCCC
Q 002892 30 YLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR-FNSISGNIPSKIG 108 (870)
Q Consensus 30 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~-~n~i~~~~~~~~~ 108 (870)
.+|-.+.-+++|+.+.+|++.-. .+-+....-+.|+++...+..++. .| ++--.+.+..+.-+ .....|.....+.
T Consensus 205 ~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~d 281 (490)
T KOG1259|consen 205 RLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSAD 281 (490)
T ss_pred ccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecc
Confidence 34545566777777878777654 233333334667777777665552 11 12111222111111 1111122222233
Q ss_pred CcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccce
Q 002892 109 NLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQF 188 (870)
Q Consensus 109 ~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 188 (870)
.-..|++||||+|.|+ .+..+..-++.++.|++|+|.|... ..+..+++|+.||||+|.++... .+...+-+.+.
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~--Gwh~KLGNIKt 356 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECV--GWHLKLGNIKT 356 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhh--hhHhhhcCEee
Confidence 3345666666666666 4555555556666666666666422 22555566666666666654221 11122445555
Q ss_pred eeecccccccccCCcccCCCCccEEEccCCcccCCC-ccccccccccccccccccccccc
Q 002892 189 LLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI-PNTFGNLRHLSTLNIRANYLTTE 247 (870)
Q Consensus 189 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~ 247 (870)
|.|+.|.|.. -..+..+.+|..||+++|+|.... ...++++|.|+.|.|.+|.+..+
T Consensus 357 L~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 357 LKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 5555555542 245666667777777777776322 23466666677776666666653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-10 Score=112.34 Aligned_cols=137 Identities=20% Similarity=0.175 Sum_probs=99.7
Q ss_pred CCeeccccceeEEEEEecC-------CcEEEEEEeechh------------h----------HHHHH----HHHHHHHHH
Q 002892 590 CNLLGAGSFGSVYKGTLFD-------GTNVAIKVFNLQL------------E----------RAFRS----FESECEVLR 636 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~----~~~e~~~l~ 636 (870)
...||.|.-+.||.|...+ +..+|||+++... + ..... .++|++.++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 4799999985421 0 01122 338999999
Q ss_pred hcCC--CceeEEeeeeeeCCeeEEEEecCCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecccC
Q 002892 637 NVRH--RNLIKIFSSCCNLDFKALVLEFMPNGSLEK-WLYSHNYFLDMLERLNIMIDVGLALEYL-HHSHSTPVVHCNLK 712 (870)
Q Consensus 637 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dlk 712 (870)
++.. -++...+++ ...++||||+.++.+.. .++.. .++..+...+..+++.++..+ | ..|+||||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 9853 456666654 56789999997654322 22221 245556677889999999998 7 6679999999
Q ss_pred CCceeeCCCCceEEeccccccccC
Q 002892 713 PNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 713 ~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
+.||+++ ++.+.++|||.+...+
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999996 4789999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.3e-11 Score=117.73 Aligned_cols=130 Identities=18% Similarity=0.186 Sum_probs=96.1
Q ss_pred CCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCcee-EEeeeeeeCCeeEEEEecCCCCCH
Q 002892 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI-KIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
++.++.|.++.||+++.. ++.|++|+...... ....+..|+++++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999855 78899999765432 123467899999988655543 444443 2345899999999887
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 669 EKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH--STPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 669 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
.+.- .....++.+++++++.||... ..+++|||++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6430 112345678999999999543 22359999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-12 Score=134.54 Aligned_cols=192 Identities=21% Similarity=0.187 Sum_probs=113.4
Q ss_pred CCCCCcEEeccCCccccccC--cCCCCcCCccEEEeecCccceec--CCcccCCCCCCeeeccccccccccc-ccccccc
Q 002892 85 NLSSLVRLDSRFNSISGNIP--SKIGNLTKLVHLNFADNNLRGEI--PNEIGNLKNLADLVLALNNLIGPIP-TTIFNIS 159 (870)
Q Consensus 85 ~l~~L~~L~L~~n~i~~~~~--~~~~~l~~L~~L~l~~N~l~~~~--~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~ 159 (870)
++.+|+...|.+..+. ..+ .....+++++.||||+|-+.... -.-...|++|+.|+|+.|++..-.. ..-..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 3445555555555544 222 23444555555555555554221 1122345555555555555532111 1112455
Q ss_pred cceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCC-cccccccccccccc
Q 002892 160 TIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI-PNTFGNLRHLSTLN 238 (870)
Q Consensus 160 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~ 238 (870)
.|+.|.|+.|.++...-.++...+|+|+.|+|..|............+..|++|||++|++-... -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 67777777777764444444556788888888888533344555666788999999999886322 13467788999999
Q ss_pred ccccccccccCCCCCcccccccccccccceEEcCCCCCCCC
Q 002892 239 IRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSI 279 (870)
Q Consensus 239 L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 279 (870)
++.+.|+.+....+. ........++|++|+++.|+|..+
T Consensus 278 ls~tgi~si~~~d~~--s~~kt~~f~kL~~L~i~~N~I~~w 316 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVE--SLDKTHTFPKLEYLNISENNIRDW 316 (505)
T ss_pred ccccCcchhcCCCcc--chhhhcccccceeeecccCccccc
Confidence 999988876532211 112245677888888888888654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-12 Score=133.93 Aligned_cols=212 Identities=23% Similarity=0.248 Sum_probs=115.8
Q ss_pred CCCCCcEEEccCCcccccCC--ccccCCCCCCEEEcCCCccccCCC--CCCCCCCCCcEEeccCCccccccCcC-CCCcC
Q 002892 37 QLRRLKFLGFAYNDLTGSFP--SWIGVFSKLQVLSLRNNSFTGPIP--NSLFNLSSLVRLDSRFNSISGNIPSK-IGNLT 111 (870)
Q Consensus 37 ~l~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~L~~n~i~~~~~--~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~ 111 (870)
++.+|+...|.++... ..+ +....|++++.||||+|-+....+ .-...|++|+.|+|+.|++.--.... -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 3445555555555544 222 244455555555555554442111 11234555666666666554111111 12345
Q ss_pred CccEEEeecCcccee-cCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceee
Q 002892 112 KLVHLNFADNNLRGE-IPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190 (870)
Q Consensus 112 ~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~ 190 (870)
+|+.|.|+.|.++.. +...+..+++|+.|+|+.|............++.|+.|||++|++...........++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 666666666666522 1222334566666666666433333444445566666666666665444333334466677777
Q ss_pred eccccccccc-CCc-----ccCCCCccEEEccCCcccCC-CccccccccccccccccccccccccC
Q 002892 191 LWANRLTGTI-PNS-----ITNASKLIGLDLNSNSLSGQ-IPNTFGNLRHLSTLNIRANYLTTETS 249 (870)
Q Consensus 191 L~~n~l~~~~-~~~-----~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~ 249 (870)
++.+.++.+- |+. ...+++|++|+++.|+|.+. .-+.+..+++|+.|....|+++....
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e~~ 343 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKETD 343 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccccc
Confidence 7777766442 333 35668899999999988531 12335567788888888888887543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.3e-13 Score=131.44 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=168.7
Q ss_pred CcccCCCCccEEEccCCcccCCCc----cccccccccccccccccccccccCCC--CCcccccccccccccceEEcCCCC
Q 002892 202 NSITNASKLIGLDLNSNSLSGQIP----NTFGNLRHLSTLNIRANYLTTETSSN--GEWSFLSSLTNCNKLRALSLGSNP 275 (870)
Q Consensus 202 ~~~~~l~~L~~L~Ls~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~~~~~~l~~l~~L~~L~L~~N~ 275 (870)
..+..+.+++.++||+|.+...-. ..+.+.++|+..+++.=......... .-..+.+++..+++|++||||+|.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 345667788899999998863333 33455667777776653322211100 001122445566677777777776
Q ss_pred CCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCccc
Q 002892 276 LDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTC 355 (870)
Q Consensus 276 l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~ 355 (870)
+....++.|.. -+.+...|+.|.|.+|.+.-.-...++ ..|..|. .++ .
T Consensus 104 ~G~~g~~~l~~---------------------ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~-~~k-------k 152 (382)
T KOG1909|consen 104 FGPKGIRGLEE---------------------LLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA-VNK-------K 152 (382)
T ss_pred cCccchHHHHH---------------------HHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH-HHh-------c
Confidence 65433333222 234455666666666655421111111 1122222 111 1
Q ss_pred ccCccccceeecCCcccCCCC----CcccccccccceEecCCCccCC----CCcccccCCccCCEEEccCCccCCc----
Q 002892 356 LSSLISLRQLHLGSNQLTSSI----PSSFWSLEYILRIDLSSNSLSG----SLPSDIQNLKVLIYLNLSRNQLSGN---- 423 (870)
Q Consensus 356 ~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~---- 423 (870)
.++-+.|++++.++|++.... ...|...+.|+.+.++.|.|.. .+..+|..++.|+.|||.+|-++..
T Consensus 153 ~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~ 232 (382)
T KOG1909|consen 153 AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVA 232 (382)
T ss_pred cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHH
Confidence 234578999999999997433 3456777899999999999863 2334688999999999999999843
Q ss_pred ccccccCCCCCCEEEcCCCcccCcccccc-----cCCCCCCeEecCCCcccC----CCCcchhhccccceeeccCCccc
Q 002892 424 IPITIGGLKDLITLSLARNRFQDSIPDSF-----GSLTSLEYLDLSNNNLSG----EIPKSFEILSHLKRLNVSHNRLE 493 (870)
Q Consensus 424 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~ 493 (870)
+...+..+++|+.|+++++.++.....+| ...++|+.|.|.+|.|+. .+...+...+.|..|+|++|.+.
T Consensus 233 LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 233 LAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 34556778899999999999987655444 336899999999999983 23344667899999999999993
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.2e-12 Score=143.03 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=147.6
Q ss_pred cCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccE
Q 002892 36 GQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVH 115 (870)
Q Consensus 36 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 115 (870)
..+..++.+++..|.++ .+-..++.+.+|+.|++.+|+|+ .+...+..+++|++|++++|.|+.. ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhh
Confidence 35566666667777776 33444666777777777777777 3433366777777777777777633 33566666777
Q ss_pred EEeecCccceecCCcccCCCCCCeeeccccccccccc-ccccccccceEEEeecccccccCCCcccCCCCccceeeeccc
Q 002892 116 LNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIP-TTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWAN 194 (870)
Q Consensus 116 L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n 194 (870)
|++++|.|+ .+ ..+..+++|+.+++++|++...-+ . ...+.+++.+++.+|.+....... .+..+..+++..|
T Consensus 145 L~l~~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~---~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 145 LNLSGNLIS-DI-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLD---LLKKLVLLSLLDN 218 (414)
T ss_pred heeccCcch-hc-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchH---HHHHHHHhhcccc
Confidence 777777777 22 235557777777777777764433 2 455666666777777665332222 1233444466666
Q ss_pred ccccccCCcccCCC--CccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcC
Q 002892 195 RLTGTIPNSITNAS--KLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272 (870)
Q Consensus 195 ~l~~~~~~~~~~l~--~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~ 272 (870)
+++... .+..+. .|+.+++++|++. ..+..+..+.++..|++..|++.... .+.....+..+...
T Consensus 219 ~i~~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~----------~~~~~~~~~~~~~~ 285 (414)
T KOG0531|consen 219 KISKLE--GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE----------GLERLPKLSELWLN 285 (414)
T ss_pred cceecc--CcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc----------cccccchHHHhccC
Confidence 665322 122222 2667777777766 33355666666777777777666532 34445555556666
Q ss_pred CCCCCCCCCccccccccchhhhhcccccccccCch-hhhCccCCcEEEeeCCCccccCCch
Q 002892 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPK-EIGNLRGLIALSLFTNDLNGTIPTT 332 (870)
Q Consensus 273 ~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~ 332 (870)
.|++.... ..... .....+.++.+.+..|.+....+..
T Consensus 286 ~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
T KOG0531|consen 286 DNKLALSE----------------------AISQEYITSAAPTLVTLTLELNPIRKISSLD 324 (414)
T ss_pred cchhcchh----------------------hhhccccccccccccccccccCccccccccc
Confidence 66554221 01111 1455667778888888777555433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-11 Score=115.94 Aligned_cols=106 Identities=28% Similarity=0.375 Sum_probs=26.1
Q ss_pred cccceeecCCcccCCCCCcccc-cccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEE
Q 002892 360 ISLRQLHLGSNQLTSSIPSSFW-SLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438 (870)
Q Consensus 360 ~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 438 (870)
.++++|+|++|+|+.+ . .+. .+.+|+.|+||+|.|+.. +.+..++.|+.|++++|+|+...+.....+++|+.|+
T Consensus 19 ~~~~~L~L~~n~I~~I-e-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI-E-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccccc-c-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 3566666666666632 1 232 355566666666666532 2355555666666666666532221112455555666
Q ss_pred cCCCcccCccc-ccccCCCCCCeEecCCCccc
Q 002892 439 LARNRFQDSIP-DSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 439 Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 469 (870)
|++|+|.+... ..++.+++|+.|+|.+|.++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 66555543211 23444555555555555554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-10 Score=105.52 Aligned_cols=131 Identities=21% Similarity=0.298 Sum_probs=102.6
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeech--------hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ--------LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..+++|+-+.+|.+.+. |.++++|.=.++ ..-...+...|++++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999775 445666642211 122345677899999999766666555566677888999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
++|..|.+.+... ...++..+-+-+.-|| ..||+|||+.++||.+..++ +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998764 2567888888899999 77799999999999997765 99999999874
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.3e-13 Score=133.79 Aligned_cols=252 Identities=19% Similarity=0.209 Sum_probs=142.2
Q ss_pred CCCCCCCCCeecCCCCccccC----CCccccCCCCCcEEEccCCc---ccccCCcc-------ccCCCCCCEEEcCCCcc
Q 002892 10 HIGNLSFLMYLDISENNFRGY----LPNELGQLRRLKFLGFAYND---LTGSFPSW-------IGVFSKLQVLSLRNNSF 75 (870)
Q Consensus 10 ~~~~l~~L~~L~ls~n~l~~~----~p~~~~~l~~L~~L~l~~n~---l~~~~~~~-------~~~l~~L~~L~L~~n~i 75 (870)
.+..+..+++|+||+|.+... +-+.+.+.++|+.-++|+-- +...+|+. +-.++.|++||||+|.+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 456677888899999988632 33456777788888887652 23344443 33456888888888877
Q ss_pred ccCCCCC----CCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccc
Q 002892 76 TGPIPNS----LFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPI 151 (870)
Q Consensus 76 ~~~~~~~----~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 151 (870)
....+.. +.++.+|++|.|.+|.+.-.--..++. .|.+|. .|+ ..++-+.|+.+..+.|++.+..
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~g 173 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGG 173 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeecccccccc
Confidence 6444443 345677777777777765111111111 111111 010 1112234555555555554222
Q ss_pred ----cccccccccceEEEeecccccccCC---CcccCCCCccceeeecccccccc----cCCcccCCCCccEEEccCCcc
Q 002892 152 ----PTTIFNISTIIIINLVGNQLSGHRP---STMGHSLPNRQFLLLWANRLTGT----IPNSITNASKLIGLDLNSNSL 220 (870)
Q Consensus 152 ----~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~i 220 (870)
...|...+.|+.+.++.|.|..... ..-+..+++|++|+|++|-++.. +.+.++.+++|++|++++|.+
T Consensus 174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll 253 (382)
T KOG1909|consen 174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL 253 (382)
T ss_pred HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence 2233334455555555555532111 01122345555555555555422 345667777888888888888
Q ss_pred cCCCccccc-----cccccccccccccccccccCCCCCcccccccccccccceEEcCCCCC
Q 002892 221 SGQIPNTFG-----NLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276 (870)
Q Consensus 221 ~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 276 (870)
......+|. ..+.|++|.|.+|.|+.... ..+..+....+.|+.|+|++|++
T Consensus 254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~----~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 254 ENEGAIAFVDALKESAPSLEVLELAGNEITRDAA----LALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccHHHHHHHHhccCCCCceeccCcchhHHHHH----HHHHHHHhcchhhHHhcCCcccc
Confidence 766555543 36778888888888876331 12233455577788888888877
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6e-12 Score=139.57 Aligned_cols=196 Identities=28% Similarity=0.296 Sum_probs=99.9
Q ss_pred ccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccccccccccc
Q 002892 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCN 264 (870)
Q Consensus 185 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~ 264 (870)
.++.+.++.|.+.. .-..+..+.+|..|++.+|+|.. +...+..+++|++|++++|.|+.+. .+..++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~----------~l~~l~ 140 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE----------GLSTLT 140 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc----------chhhcc
Confidence 33444444444442 23446666777777777777763 3333666777777777777777643 355556
Q ss_pred ccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHh
Q 002892 265 KLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQ 344 (870)
Q Consensus 265 ~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 344 (870)
.|+.|++++|.|..+ ..+..++.|+.+++++|++...-+.....+.+++.+.+
T Consensus 141 ~L~~L~l~~N~i~~~---------------------------~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l 193 (414)
T KOG0531|consen 141 LLKELNLSGNLISDI---------------------------SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDL 193 (414)
T ss_pred chhhheeccCcchhc---------------------------cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhc
Confidence 677777777777643 23344667777777777776433310344455555555
Q ss_pred cCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccC
Q 002892 345 RNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421 (870)
Q Consensus 345 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 421 (870)
.+|....+ ..+..+..+..+++..|.++...+-....+..|+.+++++|.+. ..+..+..++.+..|++++|++.
T Consensus 194 ~~n~i~~i-~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 194 GGNSIREI-EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred cCCchhcc-cchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 54433332 12223334444455555554222211111112444555555544 22233344444444444444444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-10 Score=103.17 Aligned_cols=142 Identities=20% Similarity=0.265 Sum_probs=107.0
Q ss_pred CCCeeccccceeEEEEEecCCcEEEEEE-eech-------hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 589 ECNLLGAGSFGSVYKGTLFDGTNVAIKV-FNLQ-------LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 589 ~~~~lg~G~~g~v~~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..+++-+|+-+.|+++.+. |+.++||. +.+. .+-..++..+|++.+.++.--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999865 77777763 3221 1334567889999999987656555555666677778999
Q ss_pred ecCCC-CCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC---ceEEeccccccc
Q 002892 661 EFMPN-GSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---TARVSDFGISKL 734 (870)
Q Consensus 661 e~~~~-g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~ 734 (870)
||++| .++.+++...-.. .+.......+.+|-+.+.-|| ..+|+|||+..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4788888854322 233333788999999999999 66699999999999997654 458999999864
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.7e-11 Score=111.19 Aligned_cols=111 Identities=27% Similarity=0.300 Sum_probs=43.9
Q ss_pred cccccccceEecCCCccCCCCccccc-CCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCC
Q 002892 380 FWSLEYILRIDLSSNSLSGSLPSDIQ-NLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSL 458 (870)
Q Consensus 380 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 458 (870)
+.+..++++|+|++|.|+.+ +.++ .+.+|+.|+||+|.|+.. ..+..+++|+.|++++|.|+...+.....+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence 34445789999999999953 3565 588999999999999954 358889999999999999996533323568999
Q ss_pred CeEecCCCcccCCC-CcchhhccccceeeccCCcccc
Q 002892 459 EYLDLSNNNLSGEI-PKSFEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 459 ~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~ 494 (870)
+.|+|++|+|.... -..+..+++|+.|+|.+||++.
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 99999999998532 2457789999999999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.7e-10 Score=111.61 Aligned_cols=143 Identities=20% Similarity=0.197 Sum_probs=109.9
Q ss_pred CCeeccccceeEEEEEecCCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCC--ceeEEeeeeeeC---CeeEEEEecC
Q 002892 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHR--NLIKIFSSCCNL---DFKALVLEFM 663 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~ 663 (870)
.+.++.|..+.+|++...+|+.+++|+...... .....+..|+++++.+++. .+.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367999999999999877778999999765432 1345688999999999753 456677776553 2568999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH----------------------------------------- 702 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------------- 702 (870)
+|.++.+.+.. ..++......++.+++++++.||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99988775532 23677777888888888888888421
Q ss_pred ------------CCCcEecccCCCceeeCC--CCceEEeccccccc
Q 002892 703 ------------STPVVHCNLKPNNILLDK--NMTARVSDFGISKL 734 (870)
Q Consensus 703 ------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~ 734 (870)
...++|||+.+.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-10 Score=125.13 Aligned_cols=249 Identities=20% Similarity=0.179 Sum_probs=173.3
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEe--cCCcEEEEEEeechhhHHHHH--HHHHHHHHHhc-CCCceeEEeeeeeeCCe
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTL--FDGTNVAIKVFNLQLERAFRS--FESECEVLRNV-RHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 655 (870)
.....+|..+..||.|.|+.|++... .++..|++|...........+ -..|+.+...+ .|.+++..+..|...+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34567788899999999999998873 367889999876554322222 23445555555 58999999999999899
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEeccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKL 734 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~ 734 (870)
.|+--||+++++...... ....+++..++++..|++.++.++| ++.++|+|++|+||++..+ +..++.|||....
T Consensus 341 ~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence 999999999999887763 3334788899999999999999999 7779999999999999886 7889999998864
Q ss_pred cCCCCCcccccccccccccC--CcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 735 LGEDDDSVTQTMTMATIGYM--APEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
+. .........-+++ +++......+..+.|++|||..+.+..++..- ..... .|.. +
T Consensus 417 ~~-----~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l-s~~~~------~~~~---------i 475 (524)
T KOG0601|consen 417 LA-----FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL-SESGV------QSLT---------I 475 (524)
T ss_pred cc-----eecccccccccccccchhhccccccccccccccccccccccccCccc-Ccccc------ccee---------e
Confidence 21 1111112233334 55555667788999999999999999998642 11111 0100 0
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
..... +.. ......+..+...+..+++..||.+.++....+-
T Consensus 476 ~~~~~-----p~~--~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGDT-----PNL--PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ecccc-----cCC--CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00000 000 0111356667778888999999998887655443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.2e-09 Score=106.02 Aligned_cols=266 Identities=12% Similarity=0.060 Sum_probs=167.1
Q ss_pred CCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeee-------eeCCeeEEEE
Q 002892 589 ECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSC-------CNLDFKALVL 660 (870)
Q Consensus 589 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~-------~~~~~~~lv~ 660 (870)
..+.+|+|+-+.+|-.- .-+..+.|++.........+. ...+... .||-+-.-+.+= .......++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45689999999998542 223456788876543322221 2233333 465433211110 1122356788
Q ss_pred ecCCCC-CHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 661 EFMPNG-SLEKWLYS-----HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 661 e~~~~g-~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..+.+. ....+... .-....|...++.++.++.+.+.|| ..|.+-||+.++|+|+.+++.|.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 877664 23333331 1123789999999999999999999 66699999999999999999999998654332
Q ss_pred cCCCCCcccccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhC-CCCCCccccccc---hHH-HHHHHh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEM---SLK-HWIKLS 804 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~---~~~-~~~~~~ 804 (870)
. .......-.+|...|.+||.-. +-..+..+|.|.+|+++++++.| +.||.+..-... ... .+....
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2 2222334456888999999654 33466789999999999999885 899977432211 011 111111
Q ss_pred cCCchhhhcchhhhcccCc-chHHHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHhHhHhhhc
Q 002892 805 LPRGLTEVVDASLVREVQP-SYAKMDCLLRIMHLALGCCMDS--PEQRMCMTDVVVKLQKIKQTFLVS 869 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~--P~~RPs~~evl~~L~~i~~~~~~~ 869 (870)
+....++.......+ .+...-.+..+..+..+|+... +.-||+++..+..|.++++...+|
T Consensus 244 ----f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 244 ----FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred ----eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 111111111111111 2222233556777888888654 567999999999999999998876
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.3e-08 Score=105.64 Aligned_cols=167 Identities=22% Similarity=0.246 Sum_probs=128.9
Q ss_pred cceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee----CCeeEEEEecCCCC-CHHH
Q 002892 597 SFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN----LDFKALVLEFMPNG-SLEK 670 (870)
Q Consensus 597 ~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g-~L~~ 670 (870)
-..+.|++.. .||..|++|+++............-+++++++.|+|+|++.+.+.. +...++||+|+++. +|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899984 4899999999965543333334556889999999999999988763 45678999999864 6766
Q ss_pred HHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 671 WLYS--------------HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 671 ~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
.-.. .+...++..+|.++.|+..||.++| +.|+..+-+.+++|+++++.+++|+.+|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5431 1234788999999999999999999 6779999999999999999999999999877664
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCC
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK 785 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~ 785 (870)
.+.. |.+.+ -.+-|.-.+|.+++.+.||..
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 3331 11111 136799999999999999964
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.2e-10 Score=130.15 Aligned_cols=248 Identities=21% Similarity=0.274 Sum_probs=162.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
+++.+.+.+.+|+++.++.++-. .|...+.|+..... ..+.+....+-.+.-..++|-++.....+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 45666778889999999887633 34444444433221 112222222222222234566666655566678889999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC--
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED-- 738 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~-- 738 (870)
+|+.++++...++..+. .+..........+.++.+||| +..+.|+|++|.|.+...++..++.|||.....+.-
T Consensus 884 ~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999987663 444444556666788999999 555899999999999999999999999844322110
Q ss_pred -----------------------C----CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccc
Q 002892 739 -----------------------D----DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMF 791 (870)
Q Consensus 739 -----------------------~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~ 791 (870)
. .........+|+.|.+||...+......+|.|+.|++++|.++|..||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0011224568999999999999999999999999999999999999997643
Q ss_pred cccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002892 792 TGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMT 853 (870)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 853 (870)
.... . ..+....+.. ...+.....+..+++...+..+|.+|-.+.
T Consensus 1040 pq~~-f------------~ni~~~~~~~----p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQI-F------------ENILNRDIPW----PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhh-h------------hccccCCCCC----CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 3211 0 1111111000 001112234566777777788888887665
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.8e-10 Score=86.02 Aligned_cols=59 Identities=44% Similarity=0.612 Sum_probs=30.3
Q ss_pred cCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCc
Q 002892 409 VLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNN 467 (870)
Q Consensus 409 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 467 (870)
+|++|++++|+|+.+.+..|.++++|+.|++++|.++...|.+|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444455555555555555555554444555555555555555554
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.6e-11 Score=131.47 Aligned_cols=181 Identities=30% Similarity=0.290 Sum_probs=134.2
Q ss_pred chhhhCccCCcEEEeeCCCccccCCchhhch-hhHHHHHhcCCCC----------CCCcccccCccccceeecCCcccCC
Q 002892 306 PKEIGNLRGLIALSLFTNDLNGTIPTTLGRL-QQLQALLQRNNLN----------GPIPTCLSSLISLRQLHLGSNQLTS 374 (870)
Q Consensus 306 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~n~~~----------~~~p~~~~~l~~L~~L~Ls~N~l~~ 374 (870)
|-.+..+++|+.|.|.++.+.. .- .+..+ ..|+.|...|.+. |.+..++. .-.|...+.++|.++
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~~-GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-AK-GLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh-hh-hhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH-
Confidence 4556778889999999998874 22 12222 2344444333221 11111111 136889999999998
Q ss_pred CCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccC
Q 002892 375 SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGS 454 (870)
Q Consensus 375 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 454 (870)
....++.-++.|+.|||++|+++.. +.+..++.|++|||++|.+....-....++. |..|++++|.++.. ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence 7788888899999999999999964 3788999999999999999954334445555 99999999999853 34789
Q ss_pred CCCCCeEecCCCcccCCCC-cchhhccccceeeccCCccccc
Q 002892 455 LTSLEYLDLSNNNLSGEIP-KSFEILSHLKRLNVSHNRLEGK 495 (870)
Q Consensus 455 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~ 495 (870)
|++|+.|||++|-|.+..- ..++.|..|+.|+|.|||+.|.
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 9999999999999986433 3357789999999999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-08 Score=98.40 Aligned_cols=126 Identities=21% Similarity=0.265 Sum_probs=83.5
Q ss_pred eEEEEEecCCcEEEEEEeechh--------------------------hHHHHHHHHHHHHHHhcCCC--ceeEEeeeee
Q 002892 600 SVYKGTLFDGTNVAIKVFNLQL--------------------------ERAFRSFESECEVLRNVRHR--NLIKIFSSCC 651 (870)
Q Consensus 600 ~v~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 651 (870)
.||.|...+|+.+|+|+++... .......++|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998889999999985421 11234577899999999765 45666654
Q ss_pred eCCeeEEEEecCC--CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcEecccCCCceeeCCCCceEEec
Q 002892 652 NLDFKALVLEFMP--NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY-LHHSHSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 652 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
...++||||++ |..+..+.... ++......++.+++..+.. +| ..|++|||+.+.||+++++ .+.++|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred --eCCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 24579999998 65565544322 1123445567777775554 56 7789999999999999887 999999
Q ss_pred cccccccC
Q 002892 729 FGISKLLG 736 (870)
Q Consensus 729 fg~a~~~~ 736 (870)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887553
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-09 Score=84.88 Aligned_cols=59 Identities=41% Similarity=0.573 Sum_probs=29.6
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCc
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQ 419 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 419 (870)
+|++|++++|+|+.+.+..|.++++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444455555555555555555544444444555555555555544
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.3e-09 Score=125.46 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=126.6
Q ss_pred ccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccc
Q 002892 155 IFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHL 234 (870)
Q Consensus 155 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L 234 (870)
|..++.|++|||++|.=.+.+|+.++. +-+|++|+|++..++ .+|..+.+++.|.+|++..+.-...+|.....|.+|
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~-Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~L 644 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGE-LVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSL 644 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhh-hhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccc
Confidence 333444444444444433344444432 444555555555554 456666666666666666655443445555556666
Q ss_pred ccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCC--ccccccccchhhhhcccccccccCchhhhCc
Q 002892 235 STLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILP--PLIGNFSASFQQFYAHECKLKGSIPKEIGNL 312 (870)
Q Consensus 235 ~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~--~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l 312 (870)
++|.+..-..... ...+..+..+.+|+.+....... .+.- .....+....+.+.+..+.. ...+..+..+
T Consensus 645 r~L~l~~s~~~~~------~~~l~el~~Le~L~~ls~~~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~-~~~~~~~~~l 716 (889)
T KOG4658|consen 645 RVLRLPRSALSND------KLLLKELENLEHLENLSITISSV-LLLEDLLGMTRLRSLLQSLSIEGCSK-RTLISSLGSL 716 (889)
T ss_pred cEEEeeccccccc------hhhHHhhhcccchhhheeecchh-HhHhhhhhhHHHHHHhHhhhhccccc-ceeecccccc
Confidence 6666554431110 11223344445555555433222 0000 00111112222333322222 2456778889
Q ss_pred cCCcEEEeeCCCccccCCchhhc------hhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCccccccccc
Q 002892 313 RGLIALSLFTNDLNGTIPTTLGR------LQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYI 386 (870)
Q Consensus 313 ~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 386 (870)
.+|+.|.+.++.+.......+.. ++++..+...+.-.-..+.+.--.++|+.|.+.++.....+......+..+
T Consensus 717 ~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l 796 (889)
T KOG4658|consen 717 GNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLEL 796 (889)
T ss_pred cCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEecccccccCCCHHHHhhhc
Confidence 99999999999997544433332 223333333333333334444455788888888887766666666666666
Q ss_pred ceEecCCCccCCC-CcccccCCccCCEEEcc
Q 002892 387 LRIDLSSNSLSGS-LPSDIQNLKVLIYLNLS 416 (870)
Q Consensus 387 ~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls 416 (870)
..+-+..+.+.+. .-...++++++..+.++
T Consensus 797 ~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~ 827 (889)
T KOG4658|consen 797 KELILPFNKLEGLRMLCSLGGLPQLYWLPLS 827 (889)
T ss_pred ccEEecccccccceeeecCCCCceeEecccC
Confidence 6666666666643 22334444444444433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=4e-08 Score=100.67 Aligned_cols=140 Identities=12% Similarity=0.064 Sum_probs=100.6
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeechhhH-HH----------HHHHHHHHHHHhcCCCce--eEEeeeeee-----
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER-AF----------RSFESECEVLRNVRHRNL--IKIFSSCCN----- 652 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~ni--v~~~~~~~~----- 652 (870)
+.+-......|++..+ +|+.|.||........ .. ..+.+|++.+.++...+| +..+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455555555777655 5788999987543311 11 137789999888854333 344555533
Q ss_pred CCeeEEEEecCCCC-CHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-------CCc
Q 002892 653 LDFKALVLEFMPNG-SLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-------NMT 723 (870)
Q Consensus 653 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------~~~ 723 (870)
....++|||++++. +|.+++... ....+......++.+++..++.|| ..||+|||++++||+++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999886 899988632 233566777889999999999999 777999999999999975 468
Q ss_pred eEEeccccccc
Q 002892 724 ARVSDFGISKL 734 (870)
Q Consensus 724 ~kl~Dfg~a~~ 734 (870)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998863
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.3e-09 Score=128.83 Aligned_cols=127 Identities=27% Similarity=0.313 Sum_probs=70.3
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCc--ccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEE
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYND--LTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRL 92 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 92 (870)
...+...+-+|.+. .++... ..++|+.|-+..|. +.....+.|..++.|++|||++|.=-+.+|.++++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 44555555555554 233222 22256666666664 332333445556666666666655444566666666666666
Q ss_pred eccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccc
Q 002892 93 DSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLAL 144 (870)
Q Consensus 93 ~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~ 144 (870)
+|+++.++ .+|..++++..|.+|++..+.-...+|..+..|++|++|.+-.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeec
Confidence 66666666 5666666666666666666554434455555566666665543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.8e-08 Score=98.94 Aligned_cols=135 Identities=21% Similarity=0.202 Sum_probs=98.4
Q ss_pred CCCCeeccccceeEEEEEecCCcEEEEEEeechh----------------------hHHHHHHHHHHHHHHhcCCC--ce
Q 002892 588 NECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL----------------------ERAFRSFESECEVLRNVRHR--NL 643 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--ni 643 (870)
.+...||-|.-+.||.|....|.++|||.-+... .-.....++|.++|+++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3457899999999999998899999999753321 11234567899999999654 56
Q ss_pred eEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc
Q 002892 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723 (870)
Q Consensus 644 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 723 (870)
...+++ +...+||||++|-.|...- ++....-.++..|++-+..+- ..||||||+.+-||+++++|.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence 666665 5678999999986654432 123334445555555555555 456999999999999999999
Q ss_pred eEEecccccccc
Q 002892 724 ARVSDFGISKLL 735 (870)
Q Consensus 724 ~kl~Dfg~a~~~ 735 (870)
+.++||--+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999766543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.5e-07 Score=104.52 Aligned_cols=140 Identities=19% Similarity=0.212 Sum_probs=95.9
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeechhhHHH----------------------------------------HHHHH
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAF----------------------------------------RSFES 630 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 630 (870)
+.|+.++-|.||+|++++|+.||||+.++...... -.+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 78999999999999999999999999865432110 12445
Q ss_pred HHHHHHhcC-----CCceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 002892 631 ECEVLRNVR-----HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705 (870)
Q Consensus 631 e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ 705 (870)
|+..+.+++ .+.+.-..=|+.-.....++|||++|..+.+.........+...+.....++. +..+- ..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~---~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLL---RDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHH---hcC
Confidence 555555552 34333222233334567899999999999988543333456444433333222 33333 456
Q ss_pred cEecccCCCceeeCCCCceEEecccccccc
Q 002892 706 VVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 706 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
+.|+|..|.||++..+|++.+.|||....+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999999988755
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.5e-10 Score=95.59 Aligned_cols=135 Identities=24% Similarity=0.311 Sum_probs=101.7
Q ss_pred ccceeecCCcccCCCCCcc---cccccccceEecCCCccCCCCccccc-CCccCCEEEccCCccCCcccccccCCCCCCE
Q 002892 361 SLRQLHLGSNQLTSSIPSS---FWSLEYILRIDLSSNSLSGSLPSDIQ-NLKVLIYLNLSRNQLSGNIPITIGGLKDLIT 436 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 436 (870)
.+..++|++|++. .+++. +.....|+.++|++|.+. ..|..|. ..+.++.|+|++|.|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4567788888876 34444 344566777899999998 4555554 4458889999999998 57888999999999
Q ss_pred EEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCC
Q 002892 437 LSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNG 500 (870)
Q Consensus 437 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 500 (870)
|+++.|.+. ..|..+..|.+|-.||..+|.+. .+|..+-.-+.....++.+|+|.+.+|...
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence 999999997 57777877999999999999887 666654444455556778889988888643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.7e-10 Score=123.75 Aligned_cols=128 Identities=27% Similarity=0.250 Sum_probs=80.3
Q ss_pred CccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeee
Q 002892 112 KLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLL 191 (870)
Q Consensus 112 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L 191 (870)
.|...+.+.|++. ....++.-++.|+.|+|++|+++.. ..+..+++|++|||+.|.++...-... .-..|+.|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~--~gc~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSM--VGCKLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccch--hhhhheeeee
Confidence 4555566666665 4445555556666666666666532 255556666666666666652221111 1223777778
Q ss_pred cccccccccCCcccCCCCccEEEccCCcccCCC-cccccccccccccccccccccc
Q 002892 192 WANRLTGTIPNSITNASKLIGLDLNSNSLSGQI-PNTFGNLRHLSTLNIRANYLTT 246 (870)
Q Consensus 192 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~ 246 (870)
++|.++.. ..+.++++|+.||+++|-|.+.- -..++.|..|+.|+|.+|.+-.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 88877733 45788889999999999886432 2335678889999999998764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.4e-07 Score=88.52 Aligned_cols=106 Identities=20% Similarity=0.235 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHhcCCC--ceeEEeeeeeeC----CeeEEEEecCCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 002892 626 RSFESECEVLRNVRHR--NLIKIFSSCCNL----DFKALVLEFMPNG-SLEKWLYSHNYFLDMLERLNIMIDVGLALEYL 698 (870)
Q Consensus 626 ~~~~~e~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L 698 (870)
.+..+|.+.+..+... .++..+++.... ...++|+|++++. +|.+++..... .+......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4577888888887533 345556665542 2458999999885 89999886333 56677888999999999999
Q ss_pred HhcCCCCcEecccCCCceeeCCCC---ceEEecccccccc
Q 002892 699 HHSHSTPVVHCNLKPNNILLDKNM---TARVSDFGISKLL 735 (870)
Q Consensus 699 h~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~ 735 (870)
| ..||+|+|+++.|||++.++ .+.++||+-+...
T Consensus 135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9 67799999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-06 Score=84.86 Aligned_cols=139 Identities=19% Similarity=0.120 Sum_probs=101.4
Q ss_pred eeccccceeEEEEEecCCcEEEEEEeechh------hHHHHHHHHHHHHHHhcCCCc--eeEEeeeeee----CCeeEEE
Q 002892 592 LLGAGSFGSVYKGTLFDGTNVAIKVFNLQL------ERAFRSFESECEVLRNVRHRN--LIKIFSSCCN----LDFKALV 659 (870)
Q Consensus 592 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~----~~~~~lv 659 (870)
=-|+|+.+-|+....+ |..+-+|.-.... +.....|.+|+..+.++...+ +.+++.+... ....+||
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3567899999987755 4468888764221 223467899999999985332 4444422211 2245799
Q ss_pred EecCCC-CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc--eEEeccccccc
Q 002892 660 LEFMPN-GSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT--ARVSDFGISKL 734 (870)
Q Consensus 660 ~e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~ 734 (870)
+|-++| -+|.+++.... ...+......+..+++.+++-|| ..|+.|+|+.++||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 48888886532 24677888899999999999999 777999999999999987677 99999987653
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3e-08 Score=97.09 Aligned_cols=243 Identities=20% Similarity=0.206 Sum_probs=120.6
Q ss_pred CCCCCCCCCCCCeecCCCCccccCCC-ccc-cCCCCCcEEEccCCcccc--cCCccccCCCCCCEEEcCCCccccCCCCC
Q 002892 7 VPPHIGNLSFLMYLDISENNFRGYLP-NEL-GQLRRLKFLGFAYNDLTG--SFPSWIGVFSKLQVLSLRNNSFTGPIPNS 82 (870)
Q Consensus 7 ~p~~~~~l~~L~~L~ls~n~l~~~~p-~~~-~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 82 (870)
-|=.+....-++-|.+.++.|...-. +.| ...+++++|||.+|.|+. ++-..+.+++.|++|+|+.|++...+ ++
T Consensus 37 s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I-~~ 115 (418)
T KOG2982|consen 37 SYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI-KS 115 (418)
T ss_pred ceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc-cc
Confidence 33344455555566666666643211 122 345677777777777763 33444556777777777777776322 23
Q ss_pred C-CCCCCCcEEeccCCcccc-ccCcCCCCcCCccEEEeecCccceec--CCcccCC-CCCCeeecccccccccccccccc
Q 002892 83 L-FNLSSLVRLDSRFNSISG-NIPSKIGNLTKLVHLNFADNNLRGEI--PNEIGNL-KNLADLVLALNNLIGPIPTTIFN 157 (870)
Q Consensus 83 ~-~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~l~~N~l~~~~--~~~l~~l-~~L~~L~L~~n~l~~~~~~~~~~ 157 (870)
+ ..+.+|+.|-|.+..+.- .....+..++.+++|.+|.|.+.... .+..... +.+++|..-.|
T Consensus 116 lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c------------ 183 (418)
T KOG2982|consen 116 LPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPC------------ 183 (418)
T ss_pred CcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCc------------
Confidence 3 355677777777766652 23344566677777777766443111 1111110 11222221111
Q ss_pred cccceEEEeecccccccCCCcccCCCCccceeeecccccccc-cCCcccCCCCccEEEccCCcccCC-Cccccccccccc
Q 002892 158 ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGT-IPNSITNASKLIGLDLNSNSLSGQ-IPNTFGNLRHLS 235 (870)
Q Consensus 158 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~ 235 (870)
+..+.++-|++. ..+|++..+.+..|-+... ..+.+..++.+--|+|+.|+|..- ..+.+.++++|.
T Consensus 184 ---~~~~w~~~~~l~--------r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~ 252 (418)
T KOG2982|consen 184 ---LEQLWLNKNKLS--------RIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLV 252 (418)
T ss_pred ---HHHHHHHHHhHH--------hhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhh
Confidence 111111222221 2244555555555544422 233445555555666666666421 124456666677
Q ss_pred cccccccccccccCCCCCcccccccccccccceEEcCCCCCC
Q 002892 236 TLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277 (870)
Q Consensus 236 ~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (870)
.|.+++|.+..--.. +.-. .--+..+++++.|+=+ +|+
T Consensus 253 dlRv~~~Pl~d~l~~-~err-~llIaRL~~v~vLNGs--kIs 290 (418)
T KOG2982|consen 253 DLRVSENPLSDPLRG-GERR-FLLIARLTKVQVLNGS--KIS 290 (418)
T ss_pred eeeccCCcccccccC-Ccce-EEEEeeccceEEecCc--ccc
Confidence 777777666542211 1111 1134566777776644 444
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.1e-09 Score=91.85 Aligned_cols=110 Identities=28% Similarity=0.420 Sum_probs=83.3
Q ss_pred CCCCeecCCCCccccCCCcc---ccCCCCCcEEEccCCcccccCCccc-cCCCCCCEEEcCCCccccCCCCCCCCCCCCc
Q 002892 15 SFLMYLDISENNFRGYLPNE---LGQLRRLKFLGFAYNDLTGSFPSWI-GVFSKLQVLSLRNNSFTGPIPNSLFNLSSLV 90 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~---~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 90 (870)
..+..+|||+|.+. .+++. +....+|+..+|++|.++ ..|+.| ..++.+++|+|++|+|+ .+|..+..++.|+
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr 103 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR 103 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence 44677899999886 55554 455667777899999988 455444 44568888888888888 6787888888888
Q ss_pred EEeccCCccccccCcCCCCcCCccEEEeecCccceecCC
Q 002892 91 RLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPN 129 (870)
Q Consensus 91 ~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 129 (870)
.|+++.|.+. ..|..+..+.+|..|+..+|.+. .+|.
T Consensus 104 ~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~ 140 (177)
T KOG4579|consen 104 SLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDV 140 (177)
T ss_pred hcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcH
Confidence 8888888887 67777777888888888888877 3443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 870 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-33 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-33 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-32 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 5e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 6e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 7e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 444 bits (1145), Expect = e-144
Identities = 166/543 (30%), Positives = 244/543 (44%), Gaps = 46/543 (8%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNEL-GQLRRLKFLGFAYNDLTGSFPSWIG 60
G +PP L L YL ++EN F G +P+ L G L L + N G+ P + G
Sbjct: 258 QFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 61 VFSKLQVLSLRNNSFTGPIP-NSLFNLSSLVRLDSRFNSISGNIPSKIGNLT-KLVHLNF 118
S L+ L+L +N+F+G +P ++L + L LD FN SG +P + NL+ L+ L+
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 119 ADNNLRGEIPNEIGN--LKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176
+ NN G I + L +L L N G IP T+ N S ++ ++L N LSG P
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLST 236
S++G SL + L LW N L G IP + L L L+ N L+G+IP+ N +L+
Sbjct: 436 SSLG-SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494
Query: 237 LNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYA 296
+++ N LT G + L L L +N
Sbjct: 495 ISLSNNRLT------G--EIPKWIGRLENLAILKLSNN---------------------- 524
Query: 297 HECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCL 356
G+IP E+G+ R LI L L TN NGTIP + + + N + G +
Sbjct: 525 ---SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK---IAANFIAGKRYVYI 578
Query: 357 SSLISLRQLHLGSN--QLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLN 414
+ ++ H N + L +++S G N +++L+
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 415 LSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK 474
+S N LSG IP IG + L L+L N SIPD G L L LDLS+N L G IP+
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 475 SFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCKEDDTKG 534
+ L+ L +++S+N L G IP G F F FL N LCG P + P D
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758
Query: 535 SKK 537
++
Sbjct: 759 HQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-127
Identities = 144/508 (28%), Positives = 224/508 (44%), Gaps = 28/508 (5%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPS--WIG 60
V + +L+ L L +S ++ G + L L + N L+G + +G
Sbjct: 65 GFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI---GNLTKLVHL 116
S L+ L++ +N+ P S L+SL LD NSISG +L HL
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 117 NFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176
+ N + G++ + NL L ++ NN IP + + S + +++ GN+LSG
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFS 240
Query: 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNT-FGNLRHLS 235
+ + + L + +N+ G IP L L L N +G+IP+ G L+
Sbjct: 241 RAIS-TCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 236 TLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPP-LIGNFSASFQQF 294
L++ N+ G + +C+ L +L+L SN LP + +
Sbjct: 298 GLDLSGNHFY------G--AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR-GLKVL 348
Query: 295 YAHECKLKGSIPKEIGNLRG-LIALSLFTNDLNGTIPTTLGR--LQQLQAL-LQRNNLNG 350
+ G +P+ + NL L+ L L +N+ +G I L + LQ L LQ N G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 351 PIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVL 410
IP LS+ L LHL N L+ +IPSS SL + + L N L G +P ++ +K L
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468
Query: 411 IYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG 470
L L N L+G IP + +L +SL+ NR IP G L +L L LSNN+ SG
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528
Query: 471 EIPKSFEILSHLKRLNVSHNRLEGKIPT 498
IP L L+++ N G IP
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-126
Identities = 141/524 (26%), Positives = 218/524 (41%), Gaps = 49/524 (9%)
Query: 2 SLGGTVPP--HIGNLSFLMYLDISENNFRGYLPNELG-QLRRLKFLGFAYNDLTGSFPSW 58
SL G V +G+ S L +L++S N G +L L+ L + N ++G+
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 59 IGVF---SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVH 115
+ +L+ L++ N +G + + +L LD N+ S IP +G+ + L H
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQH 227
Query: 116 LNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHR 175
L+ + N L G+ I L L ++ N +GPIP + ++ ++L N+ +G
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEI 285
Query: 176 PSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLS 235
P + + L L N G +P + S L L L+SN+ SG++P
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM--------- 336
Query: 236 TLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFY 295
+L L+ L L N LP + N SAS
Sbjct: 337 ----------------------DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 296 AHECKLKGSIPKEIGN--LRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPI 352
G I + L L L N G IP TL +L +L L N L+G I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434
Query: 353 PTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIY 412
P+ L SL LR L L N L IP ++ + + L N L+G +PS + N L +
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494
Query: 413 LNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEI 472
++LS N+L+G IP IG L++L L L+ N F +IP G SL +LDL+ N +G I
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554
Query: 473 PKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYAL 516
P + S ++ N + GK + L
Sbjct: 555 PAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-114
Identities = 136/502 (27%), Positives = 218/502 (43%), Gaps = 31/502 (6%)
Query: 13 NLSFLMYLDISENNFR---GYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLS 69
+ +D+S + + L L L+ L + + + GS + L L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLD 106
Query: 70 LRNNSFTGPIP--NSLFNLSSLVRLDSRFNSISGNIP-SKIGNLTKLVHLNFADNNLRGE 126
L NS +GP+ SL + S L L+ N++ S L L L+ + N++ G
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 127 IPNEI---GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSL 183
L L ++ N + G + + + +++ N S P +G
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGD-C 222
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
Q L + N+L+G +I+ ++L L+++SN G IP L+ L L++ N
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENK 280
Query: 244 LTTETSSNGEWSFLSSLT-NCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK 302
T L+ C+ L L L N +PP G+ S +
Sbjct: 281 FT--------GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS-LLESLALSSNNFS 331
Query: 303 GSIPKE-IGNLRGLIALSLFTNDLNGTIPTTLGRL-QQLQAL-LQRNNLNGPIPT--CLS 357
G +P + + +RGL L L N+ +G +P +L L L L L NN +GPI C +
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391
Query: 358 SLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSR 417
+L++L+L +N T IP + + ++ + LS N LSG++PS + +L L L L
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 418 NQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFE 477
N L G IP + +K L TL L N IP + T+L ++ LSNN L+GEIPK
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 478 ILSHLKRLNVSHNRLEGKIPTN 499
L +L L +S+N G IP
Sbjct: 512 RLENLAILKLSNNSFSGNIPAE 533
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-102
Identities = 123/458 (26%), Positives = 205/458 (44%), Gaps = 32/458 (6%)
Query: 57 SWIGVF---SKLQVLSLRNNSFT---GPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNL 110
++ GV K+ + L + + +SL +L+ L L + I+G++
Sbjct: 41 TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCS 99
Query: 111 TKLVHLNFADNNLRGEIP--NEIGNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLV 167
L L+ + N+L G + +G+ L L ++ N L P + ++++ +++L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 168 GNQLSGHRPSTMG--HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIP 225
N +SG + L + N+++G + ++ L LD++SN+ S IP
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217
Query: 226 NTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIG 285
G+ L L+I N L+ F +++ C +L+ L++ SN +PP
Sbjct: 218 -FLGDCSALQHLDISGNKLS--------GDFSRAISTCTELKLLNISSNQFVGPIPP--L 266
Query: 286 NFSASFQQFYAHECKLKGSIPKEI-GNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-L 343
S Q E K G IP + G L L L N G +P G L++L L
Sbjct: 267 PLK-SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 325
Query: 344 QRNNLNGPIPT-CLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR-IDLSSNSLSGSLP 401
NN +G +P L + L+ L L N+ + +P S +L L +DLSSN+ SG +
Sbjct: 326 SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
Query: 402 SDIQN--LKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLE 459
++ L L L N +G IP T+ +L++L L+ N +IP S GSL+ L
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445
Query: 460 YLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIP 497
L L N L GEIP+ + L+ L + N L G+IP
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-09
Identities = 20/74 (27%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 434 LITLSLARNRFQD---SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
+ ++ L+ ++ S SLT LE L LSN++++G + F+ + L L++S N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110
Query: 491 RLEGKIPTNGPFRN 504
L G + T +
Sbjct: 111 SLSGPVTTLTSLGS 124
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = 3e-93
Identities = 88/538 (16%), Positives = 172/538 (31%), Gaps = 63/538 (11%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRG----YLPNELGQLRRLKFLGFAYNDLTGSFP 56
G VP IG L+ L L + + + + P + + +F
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 57 SWIG--VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLV 114
+ FS L + ++ I S ++ N+I+ + + LTKL
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 115 HLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174
++ E E +N N+ + + +
Sbjct: 210 QFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 175 RPSTMGHSLPNRQFLLLWANRLT--------GTIPNSITNASKLIGLDLNSNSL-SGQIP 225
P+ + +LP Q + + NR K+ + + N+L + +
Sbjct: 265 LPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 226 NTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIG 285
+ ++ L L N L L + + KL +L+L N + I G
Sbjct: 324 TSLQKMKKLGMLECLYNQLE---------GKLPAFGSEIKLASLNLAYNQITEIPANFCG 374
Query: 286 NFSASFQQFYAHECKLKGSIPK--EIGNLRGLIALSLFTNDLNG-------TIPTTLGRL 336
+ KLK IP + ++ + A+ N++ + T +
Sbjct: 375 FTE-QVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 337 QQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS-------SIPSSFWSLEYILR 388
+ ++ L N ++ S+ L ++L N LT +F + +
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 389 IDLSSNSLSGSLPSDIQ--NLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSL------A 440
IDL N L+ L D + L L+ ++LS N S P L +
Sbjct: 493 IDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQ 550
Query: 441 RNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498
NR P+ SL L + +N++ + + +I ++ L++ N +
Sbjct: 551 GNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE--KITPNISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 1e-86
Identities = 79/528 (14%), Positives = 162/528 (30%), Gaps = 46/528 (8%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV 61
S G N +F + + + L R+ L +G P IG
Sbjct: 48 SQQGFGTQPGANWNF----NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 62 FSKLQVLSLRNNSFTGP----IPNSLFNLSSLVRLDSRFNSISGNIPSKIG--NLTKLVH 115
++L+VL+L ++ P + S + + + L+
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 116 LNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHR 175
+ + I + NN+ + + ++ + + +
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 176 PSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLS 235
+ + T N L +++ + ++P L +
Sbjct: 223 ICEAW------ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276
Query: 236 TLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSI-LPPLIGNFSASFQQF 294
+N+ N + +W L+ K++ + +G N L + + +
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGML 335
Query: 295 YAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNG-PI 352
+L+G +P G+ L +L+L N + G +Q++ L N L P
Sbjct: 336 ECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPN 394
Query: 353 PTCLSSLISLRQLHLGSNQLTS-------SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQ 405
S+ + + N++ S + + + + I+LS+N +S
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 406 NLKVLIYLNLSRNQLSG-------NIPITIGGLKDLITLSLARNRFQDSIPDS--FGSLT 456
L +NL N L+ + L ++ L N+ + D +L
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLP 513
Query: 457 SLEYLDLSNNNLSGEIPKSFEILSHLKRL------NVSHNRLEGKIPT 498
L +DLS N+ S P S LK + NR + P
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-83
Identities = 76/519 (14%), Positives = 155/519 (29%), Gaps = 63/519 (12%)
Query: 1 MSLGGTVPPHIGNLSF--LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSW 58
M T + F L+ I+ + + + + +G N++T
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKA 201
Query: 59 IGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNF 118
+ +KL+ + N+ F + + + K NL L +
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 119 ADNNLRGEIPNEIGNLKNLADLVLALNNLI--------GPIPTTIFNISTIIIINLVGNQ 170
+ ++P + L + + +A N I I II + N
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 171 L-SGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFG 229
L + +++ + L N+L G +P + + KL L+L N ++ N G
Sbjct: 317 LKTFPVETSLQK-MKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCG 374
Query: 230 NLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSA 289
+ L+ N L + + + + A+ N + S+
Sbjct: 375 FTEQVENLSFAHNKLKYIPNI-------FDAKSVSVMSAIDFSYNEIGSVDGKNFDP--- 424
Query: 290 SFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNL 348
+ + +++L N ++ L ++ L N L
Sbjct: 425 ---------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
Query: 349 NG-------PIPTCLSSLISLRQLHLGSNQLTSSIPS-SFWSLEYILRIDLSSNSLSGSL 400
+ L + L N+LT +L Y++ IDLS NS S
Sbjct: 470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-F 528
Query: 401 PSDIQNLKVLIYL------NLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGS 454
P+ N L + N+ P I L L + N + + +
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI-- 585
Query: 455 LTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
++ LD+ +N + +++ +
Sbjct: 586 TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-63
Identities = 77/455 (16%), Positives = 143/455 (31%), Gaps = 75/455 (16%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLT--------G 53
T NL L +++ LP L L ++ + A N
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 54 SFPSWIGVFSKLQVLSLRNNSF-TGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTK 112
+ V K+Q++ + N+ T P+ SL + L L+ +N + G +P+ G+ K
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIK 354
Query: 113 LVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIG-PIPTTIFNISTIIIINLVGNQL 171
L LN A N + N G + + +L A N L P ++S + I+ N++
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEI 414
Query: 172 SGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNL 231
+ + F + + + ++L++N +S F
Sbjct: 415 GS---------VDGKNF---------DPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456
Query: 232 RHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASF 291
LS++N+ N LT E N + N L ++ L N L +
Sbjct: 457 SPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDF-------- 507
Query: 292 QQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGP 351
L L+ + L N + PT L+ RN +
Sbjct: 508 ----------------RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD-- 548
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLI 411
N+ P + ++ + SN + + I +
Sbjct: 549 ---------------AQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNIS 590
Query: 412 YLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD 446
L++ N + + L ++ QD
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 29/224 (12%), Positives = 64/224 (28%), Gaps = 13/224 (5%)
Query: 297 HECKLKGSIPKEIGNLRGLIALSLFTNDLNG----TIPTTLGRLQQLQAL-LQRNNLNGP 351
G +P IG L L L+L ++ P + + R +
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 352 IPTCLS--SLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKV 409
L + + S+ SI S +I SN+++ + + L
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTK 207
Query: 410 LIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469
L + + + + + + +L L +++ N
Sbjct: 208 LRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262
Query: 470 GEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWN 513
++P + L ++ +NV+ NR ++
Sbjct: 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 2e-88
Identities = 104/550 (18%), Positives = 188/550 (34%), Gaps = 39/550 (7%)
Query: 8 PPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF--SKL 65
L+ LD+S N QL L+ L + N + + +F S L
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIG---NLTKLVHLNFADNN 122
+ L L +N P + L L + ++ K+ T + +L+ +++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 123 LRGEIPNEIGNLK--NLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMG 180
L LK NL L L+ NNL + + + L N + ++
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 181 --------HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLR 232
+ + + L S L L++ N + G N F L
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
Query: 233 HLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQ 292
+L L++ ++ + T +N + L+ + L L+L N + I +
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAH----SPLHILNLTKNKISKIESDAFSWLG-HLE 408
Query: 293 QFYAHECKLKGSIP-KEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNG 350
++ + +E L + + L N + + LQ L L+R L
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 351 --PIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLS--------GSL 400
P+ L +L L L +N + + LE + +DL N+L+ G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 401 PSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEY 460
++ L L LNL N L +L + L N F + SL+
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 461 LDLSNNNLSGEIPKSFE-ILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQS-----FLWNY 514
L+L N ++ K F +L L++ N + + F N++ ++ L ++
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSH 648
Query: 515 ALCG-PPRLQ 523
LC PP
Sbjct: 649 YLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 1e-85
Identities = 108/511 (21%), Positives = 193/511 (37%), Gaps = 34/511 (6%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
VP + + + L+++ N R + +L L +N ++ P L
Sbjct: 18 QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
+VL+L++N + + ++L L NSI + L+ L+ + N L
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 126 EIPNEIGNLKNLADLVLALNNL--IGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSL 183
L+NL +L+L+ N + + IF S++ + L NQ+ P H++
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF-HAI 194
Query: 184 PNRQFLLLWANRLTGTIPNSIT---NASKLIGLDLNSNSLSGQIPNTFGNLR--HLSTLN 238
L L +L ++ + + + L L+++ LS TF L+ +L+ L+
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 239 IRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGN--------FSAS 290
+ N L + S +L L N + + + S
Sbjct: 255 LSYNNLNVVGN--------DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 291 FQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLN 349
F + L L+ L L++ ND+ G L L+ L L + +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 350 --GPIPTCLSSLI--SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSD-I 404
SL L L+L N+++ +F L ++ +DL N + L
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 405 QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQ--DSIPDSFGSLTSLEYLD 462
+ L+ + + LS N+ + + L L L R + DS P F L +L LD
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486
Query: 463 LSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
LSNNN++ E L L+ L++ HN L
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-71
Identities = 101/517 (19%), Positives = 160/517 (30%), Gaps = 68/517 (13%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV 61
L + L L + N+ + N + + L L ++N L+ +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
LQ L L NN L + L L + N
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIF----------------------ANSSLKKLELSSN 181
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF---NISTIIIINLVGNQLSGHRPST 178
++ P + L L L L + + ++I ++L +QLS +T
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 179 MGH-SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTL 237
N L L N L +S +L L N++ ++ L ++ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 238 NIRANYLTTETSSNGEWSF-LSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYA 296
N++ ++ S S L L++ N
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN---------------------- 339
Query: 297 HECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLG----RLQQLQAL-LQRNNLNGP 351
+ G L L LSL + + T L L L +N ++
Sbjct: 340 ---DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIP-SSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVL 410
S L L L LG N++ + + LE I I LS N + + L
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL 456
Query: 411 IYLNLSRNQLSG--NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNL 468
L L R L + P L++L L L+ N + D L LE LDL +NNL
Sbjct: 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
Query: 469 S--------GEIPKSFEILSHLKRLNVSHNRLEGKIP 497
+ G + LSHL LN+ N +
Sbjct: 517 ARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-41
Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 20/293 (6%)
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
D + L+ + N+ LN+ N L + ++ T ++L +L +G
Sbjct: 9 ADCSHLKLTQVPDDLPTNITV---LNLTHNQLRRLPA--------ANFTRYSQLTSLDVG 57
Query: 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTT 332
N + + P L + +L K L L L +N +
Sbjct: 58 FNTISKLEPELCQKLP-MLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 333 LGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSF--WSLEYILRI 389
+ + L L L N L+ L +L++L L +N++ + ++ + ++
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 390 DLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIG---GLKDLITLSLARNRFQD 446
+LSSN + P + L L L+ QL ++ + + LSL+ ++
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 447 SIPDSFGSL--TSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIP 497
+ +F L T+L LDLS NNL+ SF L L+ + +N ++
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 29/138 (21%), Positives = 50/138 (36%), Gaps = 3/138 (2%)
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQ 419
+S +LT ++ ++L+ N L ++ L L++ N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTNITV---LNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479
+S P L L L+L N +F T+L L L +N++ F
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 480 SHLKRLNVSHNRLEGKIP 497
+L L++SHN L
Sbjct: 121 KNLITLDLSHNGLSSTKL 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 3e-87
Identities = 96/515 (18%), Positives = 171/515 (33%), Gaps = 35/515 (6%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV 61
L + L LD+S + L L L N +
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSI-SGNIPSKIGNLTKLVHLNFAD 120
S LQ L + + +L +L L+ N I S +P NLT L HL+ +
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 121 NNLRGEIPNEIGNLKNLADLVLALN---NLIGPIPTTIFNISTIIIINLVGNQLSGHRPS 177
N ++ ++ L + L L+L+ N + I F + + L N S +
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 178 TMGHSLPNRQFLLLWANRLTGT------IPNSITNASKLIGLDLNSNSLS---GQIPNTF 228
T L + L +++ L + L I + F
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 229 GNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFS 288
L ++S+ ++ + + + + + L L + + +
Sbjct: 279 NCLTNVSSFSLVSVTIER----------VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 289 ASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLN--GTIPTTLGRLQQLQAL-LQR 345
KG +L L L L N L+ G + L+ L L
Sbjct: 329 ------RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 346 NNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSS-FWSLEYILRIDLSSNSLSGSLPSDI 404
N + + + L L L + L S F SL ++ +D+S +
Sbjct: 383 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441
Query: 405 QNLKVLIYLNLSRNQLSGNI-PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDL 463
L L L ++ N N P L++L L L++ + + P +F SL+SL+ L++
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501
Query: 464 SNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498
S+NN ++ L+ L+ L+ S N +
Sbjct: 502 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 4e-80
Identities = 114/508 (22%), Positives = 191/508 (37%), Gaps = 35/508 (6%)
Query: 7 VPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQ 66
+P ++ LD+S N R L+ L + ++ S L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 67 VLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG- 125
L L N + LSSL +L + +++ IG+L L LN A N ++
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIS----TIIIINLVGNQLSGHRPSTMGH 181
++P NL NL L L+ N + T + + + ++L N ++ +P
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA--F 197
Query: 182 SLPNRQFLLLWANRLTGTIP-NSITNASKLIGLDLNSNSLSGQ------IPNTFGNLRHL 234
L L N + + I + L L + + L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 235 STLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQF 294
+ R YL + + + LTN + + SL S ++ + +++ +Q
Sbjct: 258 TIEEFRLAYL--DYYLDDIIDLFNCLTN---VSSFSLVSVTIERVKD---FSYNFGWQHL 309
Query: 295 YAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLN--GP 351
CK ++ +L+ L G + L L+ L L RN L+ G
Sbjct: 310 ELVNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
SL+ L L N + ++ S+F LE + +D ++L + +L+ L
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 411 IYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSI-PDSFGSLTSLEYLDLSNNNLS 469
IYL++S GL L L +A N FQ++ PD F L +L +LDLS L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 470 GEIPKSFEILSHLKRLNVSHNRLEGKIP 497
P +F LS L+ LN+SHN
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 4e-64
Identities = 92/464 (19%), Positives = 150/464 (32%), Gaps = 55/464 (11%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
+ P + + L L N S F+ L LD I
Sbjct: 16 ELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 108 GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLV 167
+L+ L L N ++ L +L LV NL I ++ T+ +N+
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 168 GNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL----IGLDLNSNSLSGQ 223
N + + +L N + L L +N++ + ++ + LDL+ N ++
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 224 IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPL 283
P F +R L L +R N+ + + L R L LG + L
Sbjct: 193 QPGAFKEIR-LHKLTLRNNFDSLNVMKT----CIQGLAGLEVHR-LVLGEFRNEGNLEKF 246
Query: 284 IGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLN------GTIPTTLGRLQ 337
L GL L++ L I L
Sbjct: 247 D------------------------KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 338 QLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSL 396
+ + L + S + L L + + SL+ L+ S
Sbjct: 283 NVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKR-----LTFTSN 335
Query: 397 SGSLPSDIQNLKVLIYLNLSRNQLS--GNIPITIGGLKDLITLSLARNRFQDSIPDSFGS 454
G +L L +L+LSRN LS G + G L L L+ N ++ +F
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 455 LTSLEYLDLSNNNLSGEIPKS-FEILSHLKRLNVSHNRLEGKIP 497
L LE+LD ++NL S F L +L L++SH
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-38
Identities = 58/275 (21%), Positives = 100/275 (36%), Gaps = 16/275 (5%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
+L++ F + +L L+RL F G L
Sbjct: 295 ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSL 349
Query: 66 QVLSLRNN--SFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNL 123
+ L L N SF G S F +SL LD FN + + S L +L HL+F +NL
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 124 RGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
+ + +L+NL L ++ + +S++ ++ + GN + +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
L N FL L +L P + + S L L+++ N+ + L L L+ N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
++ T ++ L L+L N
Sbjct: 529 HIMTSKKQ----ELQHFPSS---LAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-32
Identities = 43/236 (18%), Positives = 79/236 (33%), Gaps = 5/236 (2%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWI- 59
+S G + L YLD+S N + + L +L+ L F +++L +
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 60 GVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNI-PSKIGNLTKLVHLNF 118
L L + + LSSL L NS N P L L L+
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 119 ADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPST 178
+ L P +L +L L ++ NN ++++ +++ N + +
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
Query: 179 MGHSLPNRQFLLLWANRLTGTIPNS--ITNASKLIGLDLNSNSLSGQIPNTFGNLR 232
+ H + FL L N T + + L + + P+ +
Sbjct: 538 LQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 4/164 (2%)
Query: 336 LQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNS 395
+ + N IP L S + L L N L SF+S + +DLS
Sbjct: 7 VPNITYQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 396 LSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSL 455
+ Q+L L L L+ N + GL L L G L
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 456 TSLEYLDLSNNNL-SGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498
+L+ L++++N + S ++P+ F L++L+ L++S N+++ T
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 5e-87
Identities = 90/334 (26%), Positives = 142/334 (42%), Gaps = 41/334 (12%)
Query: 200 IPNSITNASKL----IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWS 255
I + N + L D + + G + +T ++ L++ L +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP------KPYP 67
Query: 256 FLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGL 315
SSL N L L +G L G IP I L L
Sbjct: 68 IPSSLANLPYLNFLYIGGIN------------------------NLVGPIPPAIAKLTQL 103
Query: 316 IALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS 374
L + +++G IP L +++ L L N L+G +P +SSL +L + N+++
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 375 SIPSSFWSLEYILR-IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKD 433
+IP S+ S + + +S N L+G +P NL L +++LSRN L G+ + G K+
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKN 222
Query: 434 LITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
+ LA+N + G +L LDL NN + G +P+ L L LNVS N L
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 494 GKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPC 527
G+IP G + F ++ N LCG P +P C
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 4e-66
Identities = 72/246 (29%), Positives = 116/246 (47%), Gaps = 8/246 (3%)
Query: 1 MSLGGT--VPPHIGNLSFLMYLDIS-ENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPS 57
++L +P + NL +L +L I NN G +P + +L +L +L + +++G+ P
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 58 WIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLV-HL 116
++ L L N+ +G +P S+ +L +LV + N ISG IP G+ +KL +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 117 NFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176
+ N L G+IP NL NLA + L+ N L G + I+L N L+
Sbjct: 180 TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLST 236
N L L NR+ GT+P +T L L+++ N+L G+IP GNL+
Sbjct: 239 KVG--LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDV 295
Query: 237 LNIRAN 242
N
Sbjct: 296 SAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 7e-66
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 18/287 (6%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRG--YLPNELGQLRRLKFLGFA-YNDLTGSFPSW 58
+ G + + LD+S N +P+ L L L FL N+L G P
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 59 IGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNF 118
I ++L L + + + +G IP+ L + +LV LD +N++SG +P I +L LV + F
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 119 ADNNLRGEIPNEIGNLKNLA-DLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPS 177
N + G IP+ G+ L + ++ N L G IP T N++ + ++L N L G
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215
Query: 178 TMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTL 237
G S N Q + L N L + + + L GLDL +N + G +P L+ L +L
Sbjct: 216 LFG-SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 238 NIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL--DSILPP 282
N+ N L GE + N + + +N S LP
Sbjct: 274 NVSFNNLC------GE---IPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-64
Identities = 81/316 (25%), Positives = 131/316 (41%), Gaps = 42/316 (13%)
Query: 46 FAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTG--PIPNSLFNLSSLVRLD-SRFNSISGN 102
G ++ L L + PIP+SL NL L L N++ G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 103 IPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTII 162
IP I LT+L +L N+ G IP+ + +K L L + N L G +P +I ++ ++
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 163 IINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG 222
I GN++SG P + G + + NRLTG IP + N + L +DL+ N L G
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG 211
Query: 223 QIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPP 282
FG+ ++ +++ N L + L + L L L +N
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLA------FD---LGKVGLSKNLNGLDLRNN-------- 254
Query: 283 LIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL 342
++ G++P+ + L+ L +L++ N+L G IP G LQ+
Sbjct: 255 -----------------RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 343 LQRNNLN---GPIPTC 355
NN P+P C
Sbjct: 297 AYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 5e-62
Identities = 84/373 (22%), Positives = 138/373 (36%), Gaps = 92/373 (24%)
Query: 79 IPNSLFNLSSLV----RLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGE--IPNEIG 132
I L N ++L D + G + ++ +L+ + NL IP+ +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 133 NLKNLADLVLA-LNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLL 191
NL L L + +NNL+GPIP I ++ + + + +SG P + + L
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-QIKTLVTLDF 132
Query: 192 WANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSN 251
N L+GT+P SI++ L+G+ + N +SG IP+++G+ L T
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS-------------- 178
Query: 252 GEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGN 311
+++ N +L G IP N
Sbjct: 179 -----------------MTISRN-------------------------RLTGKIPPTFAN 196
Query: 312 LRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSN 370
L L + L N L G G + Q + L +N+L + + +L L
Sbjct: 197 LN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGL----- 249
Query: 371 QLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGG 430
DL +N + G+LP + LK L LN+S N L G IP G
Sbjct: 250 -------------------DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289
Query: 431 LKDLITLSLARNR 443
L+ + A N+
Sbjct: 290 LQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 201 bits (515), Expect = 1e-58
Identities = 84/342 (24%), Positives = 131/342 (38%), Gaps = 68/342 (19%)
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISG--NIPSKIGNLTKLVHLNFAD-NNLR 124
N ++ G + ++ + LD ++ IPS + NL L L NNL
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 125 GEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLP 184
G IP I L L L + N+ G IP + I T++ ++ N LSG P ++ LP
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS-LP 149
Query: 185 NRQFLLLWANRLTGTIPNSITNASKLI-GLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
N + NR++G IP+S + SKL + ++ N L+G+IP TF NL
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------------ 197
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
L + L N L+G
Sbjct: 198 ---------------------NLAFVDLSRN-------------------------MLEG 211
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISL 362
G+ + + L N L + +G + L L L+ N + G +P L+ L L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNS-LSGS-LPS 402
L++ N L IP +L+ ++N L GS LP+
Sbjct: 271 HSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSPLPA 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 1e-85
Identities = 97/297 (32%), Positives = 153/297 (51%), Gaps = 13/297 (4%)
Query: 573 RRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESEC 632
R +D+++AT+ F+ L+G G FG VYKG L DG VA+K + + FE+E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 633 EVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLY---SHNYFLDMLERLNIMI 689
E L RH +L+ + C + L+ ++M NG+L++ LY + +RL I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
L YL H+ ++H ++K NILLD+N +++DFGISK E D + T+
Sbjct: 147 GAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMF-TGEMSLKHWIKLSLPRG 808
T+GY+ PEY G ++ K DVYS+GV+L E + + ++L W S G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 809 -LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
L ++VD +L +++P + L + A+ C S E R M DV+ KL+ +
Sbjct: 264 QLEQIVDPNLADKIRP-----ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 5e-83
Identities = 105/300 (35%), Positives = 154/300 (51%), Gaps = 22/300 (7%)
Query: 572 WRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAF-----R 626
+R S ++Q A+D F+ N+LG G FG VYKG L DGT VA+K +L+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----RLKEERTQGGEL 72
Query: 627 SFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLY---SHNYFLDMLE 683
F++E E++ HRNL+++ C + LV +M NGS+ L LD +
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 684 RLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743
R I + L YLH ++H ++K NILLD+ A V DFG++KL+ D VT
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE---MSLKHW 800
T TIG++APEY S G S K DV+ YGV+L+E T ++ D + L W
Sbjct: 193 -TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 801 IKLSLPRG-LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859
+K L L +VD L Q +Y + + +++ +AL C SP +R M++VV L
Sbjct: 252 VKGLLKEKKLEALVDVDL----QGNYKD-EEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 1e-75
Identities = 107/502 (21%), Positives = 172/502 (34%), Gaps = 46/502 (9%)
Query: 8 PPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQV 67
L L +LD++ + RL L N L + + L+
Sbjct: 50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKH 109
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEI 127
L + L N +L L N IS K KL L+F +N +
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 128 PNEIGNLKNLADLVLALN-NLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS-LPN 185
++ +L+ +L L LN N I I F+ + +N G Q + +S + +
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229
Query: 186 RQFLLLWANRLTGTIPNSITN--ASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
P + ++L + NTF L L++ A +
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
L+ S L + L+ L L +N +++
Sbjct: 290 LS---------ELPSGLVGLSTLKKLVLSANKFENL------------------------ 316
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPT-TLGRLQQLQAL-LQRNNLN--GPIPTCLSSL 359
N L LS+ N + T L L+ L+ L L +++ L +L
Sbjct: 317 -CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLP-SDIQNLKVLIYLNLSRN 418
L+ L+L N+ S +F + +DL+ L S QNL +L LNLS +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 419 QLSGNIPITIGGLKDLITLSLARNRFQDSI---PDSFGSLTSLEYLDLSNNNLSGEIPKS 475
L + GL L L+L N F +S +L LE L LS +LS +
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
Query: 476 FEILSHLKRLNVSHNRLEGKIP 497
F L + +++SHNRL
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 5e-71
Identities = 102/510 (20%), Positives = 180/510 (35%), Gaps = 24/510 (4%)
Query: 12 GNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLR 71
+ L L ++ N L + LK L F ++ + L+ L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 72 NNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKL--VHLNFADNNLRGEIPN 129
+N + F L LD + N+I + +L + + LN N++ I
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEP 196
Query: 130 EIGNLKNLADLVLALNNLIGPIPTTIFN--ISTIIIINLVGNQLSGHRPST-MGHSLPNR 186
+ L + I + N I ++ + P+ G +
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 187 QFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246
+ + L + N+ S L LDL + LS ++P+ L L L + AN
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315
Query: 247 ETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS-- 304
S +N L LS+ N L + ++ ++ S
Sbjct: 316 LCQI--------SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC 367
Query: 305 IPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNG-PIPTCLSSLISL 362
++ NL L +L+L N+ QL+ L L L + +L L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSG---SLPSDIQNLKVLIYLNLSRNQ 419
+ L+L + L S F L + ++L N + +Q L L L LS
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479
LS LK + + L+ NR S ++ L + YL+L++N++S +P IL
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPIL 546
Query: 480 SHLKRLNVSHNRLEGKIPTNGPFRNFLAQS 509
S + +N+ N L+ +N F + ++
Sbjct: 547 SQQRTINLRQNPLDC-TCSNIYFLEWYKEN 575
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-44
Identities = 66/378 (17%), Positives = 124/378 (32%), Gaps = 18/378 (4%)
Query: 5 GTVPPHIGNLSFLMYLDISENNFRGYLPNELG--QLRRLKFLGFAYNDLTGSFPSWIGVF 62
+ P + + L+ + L ++ L F D P+
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 63 SK--LQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
+ ++ ++L+ + F N+ S L LD +S +PS + L+ L L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 121 NNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSG-HRPST 178
N N +L L + N + T N+ + ++L + + +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 179 MGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNT-FGNLRHLSTL 237
+L + Q L L N + +L LDL L + + F NL L L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 238 NIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSA--SFQQFY 295
N+ + L + L+ L+L N + +
Sbjct: 431 NLSHSLLDISSEQ--------LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 296 AHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTC 355
C L +L+ + + L N L + L L+ + L N+++ +P+
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSL 542
Query: 356 LSSLISLRQLHLGSNQLT 373
L L R ++L N L
Sbjct: 543 LPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 43/197 (21%), Positives = 69/197 (35%), Gaps = 7/197 (3%)
Query: 327 GTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYI 386
GT+P + L+ N L T S LI+L L L Q+ +F S +
Sbjct: 29 GTLPNSTECLE-----FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 387 LRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD 446
+ L++N L + + K L +L + +S I + K L +L L N
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKR--LNVSHNRLEGKIPTNGPFRN 504
L+ LD NN + + L LN++ N + G P
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 505 FLAQSFLWNYALCGPPR 521
F + +F L +
Sbjct: 204 FQSLNFGGTQNLLVIFK 220
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 1e-74
Identities = 91/568 (16%), Positives = 178/568 (31%), Gaps = 88/568 (15%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSW------------ 58
+ N + L ++ +G +P+ +GQL LK L F + T S +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 59 -------------IGVFSKLQVLSLRNNSFT-----GPIPNSLFNLSSLVRLDSRFNSIS 100
+ +L + L ++ PI ++ + N I+
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 101 GNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIST 160
I I LTKL + FA++ + N + N+
Sbjct: 439 F-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENEELSWSNLKD 492
Query: 161 IIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTG---------TIPNSITNASKLI 211
+ + L P + LP Q L + NR + + K+
Sbjct: 493 LTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 212 GLDLNSNSLSG-QIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
+ N+L + + L L+ N + L + KL L
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH----------LEAFGTNVKLTDLK 601
Query: 271 LGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPK--EIGNLRGLIALSLFTNDLNGT 328
L N ++ I P F+ + KLK IP ++ + ++ N +
Sbjct: 602 LDYNQIEEI-PEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSE 659
Query: 329 IPTTLGRLQQLQAL------LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS-------S 375
+ + + L N + ++ + + L +N +TS
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 376 IPSSFWSLEYILRIDLSSNSLSGSLPSDIQ--NLKVLIYLNLSRNQLSGNIPITIGGLKD 433
++ + + IDL N L+ SL D + L L +++S N S P
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777
Query: 434 LITLSLAR------NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNV 487
L + NR P + SL L + +N++ ++ + ++ L L++
Sbjct: 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE--KLTPQLYILDI 834
Query: 488 SHNRL-EGKIPTNGPFRNFLAQSFLWNY 514
+ N + + P+ L++
Sbjct: 835 ADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 3e-68
Identities = 84/496 (16%), Positives = 155/496 (31%), Gaps = 34/496 (6%)
Query: 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPI 79
+ + + +L R+ L A G P IG ++L+VLS +S T
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 80 PNSLFNLSSLVRLDSRFNSISGNIPSK-IGNLTKLVHLNFADNNLRGE---IPNEIGNLK 135
+ + R + I + + +L + + + P + +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 136 NLADL-VLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWAN 194
+L D + L N I I I ++ + II + + +
Sbjct: 424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWED------ANSDYA 477
Query: 195 RLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254
+ S +N L ++L + Q+P+ +L L +LNI N + +W
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 255 SFL-SSLTNCNKLRALSLGSNPLDSILPPL-IGNFSASFQQFYAHECKLKGSIPKEIGNL 312
+ L K++ +G N L+ + K+ + G
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV-KLGLLDCVHNKV--RHLEAFGTN 594
Query: 313 RGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNG-PIPTCLSSLISLRQLHLGSN 370
L L L N + Q++ L N L P S+ + + N
Sbjct: 595 VKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYN 654
Query: 371 QLTSSIPSSFWSLEYIL-----RIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS---- 421
++ S + S++ + LS N + + + LS N ++
Sbjct: 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPE 714
Query: 422 ---GNIPITIGGLKDLITLSLARNRFQDSIPDS--FGSLTSLEYLDLSNNNLSGEIPKSF 476
L T+ L N+ S+ D +L L +D+S N S P
Sbjct: 715 NSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQP 772
Query: 477 EILSHLKRLNVSHNRL 492
S LK + H R
Sbjct: 773 LNSSQLKAFGIRHQRD 788
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 9e-63
Identities = 62/488 (12%), Positives = 138/488 (28%), Gaps = 47/488 (9%)
Query: 37 QLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96
+L + + + + + + + L +N + N+ + + +
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKEL 308
Query: 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF 156
+ + N ++ L+ A +G +P+ IG L L L ++
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 157 NISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLN 216
T + +++ H L + + + K + L
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLK 426
Query: 217 SNSLSG------QIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
+ I L L + + T +
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFT-------------YDNIAVDWEDAN 473
Query: 271 LGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNG--- 327
N + C +P + +L L +L++ N
Sbjct: 474 SDYAKQYENEELSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 328 ------TIPTTLGRLQQLQAL-LQRNNLNG-PIPTCLSSLISLRQLHLGSNQLTSSIPSS 379
+ ++Q + NNL P L ++ L L N++ +
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--LEA 590
Query: 380 FWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIP--ITIGGLKDLIT 436
F + + + L N + +P D + L S N+L IP + + +
Sbjct: 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGS 648
Query: 437 LSLARNRFQDSIPDSFGSL-----TSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNR 491
+ + N+ + S+ + + LS N + + F S + + +S+N
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 492 LEGKIPTN 499
+ IP N
Sbjct: 709 MT-SIPEN 715
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 3e-51
Identities = 71/433 (16%), Positives = 130/433 (30%), Gaps = 59/433 (13%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTG-------- 53
NL L +++ LP+ L L L+ L A N
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 54 -SFPSWIGVFSKLQVLSLRNNSFTG-PIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLT 111
K+Q+ + N+ P SL + L LD N + ++ + G
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNV 595
Query: 112 KLVHLNFADNNLRGEIPNEIG-NLKNLADLVLALNNLIG-PIPTTIFNISTIIIINLVGN 169
KL L N + EIP + + L + N L P ++ + ++ N
Sbjct: 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYN 654
Query: 170 QLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFG 229
++ + S+ + + + + L+ N + F
Sbjct: 655 KIGSE-GRNISCSMDDYKGI-------------------NASTVTLSYNEIQKFPTELFA 694
Query: 230 NLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSA 289
+ST+ + N + T N + N L + L N L S+
Sbjct: 695 TGSPISTIILSNNLM-TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLP 753
Query: 290 SFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLN 349
S P + N L A + + N +
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ-----------------RDAEGNRIL 795
Query: 350 GPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSL-SGSLPSDIQNLK 408
PT +++ SL QL +GSN + + + +D++ N S + S ++
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852
Query: 409 VLIY-LNLSRNQL 420
+Y L + Q
Sbjct: 853 AGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-29
Identities = 57/400 (14%), Positives = 114/400 (28%), Gaps = 65/400 (16%)
Query: 125 GEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLP 184
E N D+ +A + +P + + + SG + S +
Sbjct: 185 KEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQ-----SGIKRSELETQSV 239
Query: 185 NRQFLLLWANRLTG--TIPNSITNASKLI-----------GLDLNSNSLSGQIPNTFGNL 231
+ + N+LT +P + ++ I LD + N +
Sbjct: 240 RGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHS 299
Query: 232 RHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASF 291
+ + E G+ L N ++ LSL
Sbjct: 300 LNWNF--------NKELDMWGDQPG-VDLDNNGRVTGLSLAGF----------------- 333
Query: 292 QQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP-TTLGRLQQLQALLQRNNLNG 350
KG +P IG L L LS T+ + L + +++ +
Sbjct: 334 --------GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385
Query: 351 PIPTC-LSSLISLRQLHLGSNQLTS-----SIPSSFWSLEYILRIDLSSNSLSGSLPSDI 404
L L L + + I +I +N ++ + I
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAI 444
Query: 405 QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLS 464
Q L L + + + + + D + + ++ S+ +L L ++L
Sbjct: 445 QRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELY 499
Query: 465 NNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRN 504
N ++P L L+ LN++ NR +
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 3e-73
Identities = 80/304 (26%), Positives = 138/304 (45%), Gaps = 26/304 (8%)
Query: 576 SYLDIQQATDGFNE------CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERA----F 625
S+ +++ T+ F+E N +G G FG VYKG + + T VA+K ++
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 626 RSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF--LDMLE 683
+ F+ E +V+ +H NL+++ + D LV +MPNGSL L + L
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 684 RLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743
R I + +LH +H ++K NILLD+ TA++SDFG+++ + +V
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK- 802
+ + T YMAPE G I+PK D+YS+GV+L+E T DE L +
Sbjct: 192 TSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEE 249
Query: 803 -LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861
+ + + +D + + + +A C + +R + V LQ+
Sbjct: 250 IEDEEKTIEDYIDKKM--NDAD----STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 862 IKQT 865
+ +
Sbjct: 304 MTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 5e-67
Identities = 63/309 (20%), Positives = 117/309 (37%), Gaps = 23/309 (7%)
Query: 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVL 635
++ + + G FG V+K VA+K+F +Q +++++ E E L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72
Query: 636 RNVRHRNLIKIFSSCCNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDV 691
++H N+++ + L+ F GSL +L + E +I +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETM 130
Query: 692 GLALEYLHHSHST-------PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
L YLH + H ++K N+LL N+TA ++DFG++ +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 745 TMTMATIGYMAPEYASDGII-----SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH 799
+ T YMAPE I + D+Y+ G++L E +R D M
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 800 WIKLSLP--RGLTEVVDASLVR-EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856
P + EVV R ++ + K + + C E R+ V
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 857 VKLQKIKQT 865
++ ++++
Sbjct: 311 ERITQMQRL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 7e-65
Identities = 116/533 (21%), Positives = 178/533 (33%), Gaps = 84/533 (15%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
VP I S +D+S N + L++L + ++ L
Sbjct: 25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
L L N P S L+SL L + ++ IG L L LN A N +
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 126 -EIPNEIGNLKNLADLVLALNNL---------------------------IGPIPTTIFN 157
++P NL NL + L+ N + I I F
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQ 202
Query: 158 ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGL---- 213
+ + L GN S + T +L L I S + GL
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 214 ----DLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRAL 269
L + F L ++S +++ + L + K ++L
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY----------LEDVPKHFKWQSL 312
Query: 270 SLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTI 329
S+ L +L L +L+L N G+I
Sbjct: 313 SIIRCQLKQF----------------------------PTLDLPFLKSLTLTMN--KGSI 342
Query: 330 PTTLGRLQQLQAL-LQRNNLNGPIPTCLSSL--ISLRQLHLGSNQLTSSIPSSFWSLEYI 386
L L L L RN L+ S L SLR L L N + ++F LE +
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL 401
Query: 387 LRIDLSSNSLSGSLP-SDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQ 445
+D ++L S +L+ L+YL++S + GL L TL +A N F+
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461
Query: 446 DSIP-DSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIP 497
D+ + F + T+L +LDLS L F+ L L+ LN+SHN L
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 6e-62
Identities = 91/529 (17%), Positives = 162/529 (30%), Gaps = 55/529 (10%)
Query: 8 PPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQV 67
L L L ++ N + + P L L+ L L IG L+
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132
Query: 68 LSLRNNSFTG-PIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKL----VHLNFADNN 122
L++ +N +P NL++LV +D +N I + + L + + L+ + N
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPSTMGH 181
+ I ++ L +L L N I T N++ + + L+ + R +
Sbjct: 193 ID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 182 -----SLPNRQF--LLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHL 234
L + L + + + L S+ + +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLED-VPKHFKW 309
Query: 235 STLNIRANYLTTETSSNGEW-----------SFLSSLTNCNKLRALSLGSNPLDSILPPL 283
+L+I L + + + S L L L N L
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFS---- 365
Query: 284 IGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL- 342
G L L L N + L++LQ L
Sbjct: 366 -------------------GCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLD 405
Query: 343 LQRNNLNGPIPT-CLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLP 401
Q + L SL L L + F L + + ++ NS +
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 402 SDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEY 460
S++ N L +L+LS+ QL L L L+++ N + L SL
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525
Query: 461 LDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQS 509
LD S N + L N+++N + I + F ++ +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQ 573
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-56
Identities = 96/461 (20%), Positives = 159/461 (34%), Gaps = 22/461 (4%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
L+ P I S + + L N S N S L LD I
Sbjct: 20 DQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW 76
Query: 108 GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLV 167
L L +L N ++ P L +L +LV L I + T+ +N+
Sbjct: 77 HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA 136
Query: 168 GNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL----IGLDLNSNSLSGQ 223
N + + +L N + L N + N + + + LD++ N +
Sbjct: 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFI 196
Query: 224 IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPL 283
F + L L +R N+ ++ + L+ L + L+ P +
Sbjct: 197 QDQAFQGI-KLHELTLRGNFNSSNIMKTCLQN-LAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 284 IGNFSA-SFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP-TTLGRLQQLQA 341
+ + +F + L + A+SL + + Q L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLS- 313
Query: 342 LLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLP 401
+ R L PT L L+ L L N+ SI +L + +DLS N+LS S
Sbjct: 314 -IIRCQLKQ-FPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGC 367
Query: 402 SDIQNLKV--LIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDS-FGSLTSL 458
+L L +L+LS N + GL++L L + + S F SL L
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 459 EYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTN 499
YLD+S N + F L+ L L ++ N + +N
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 60/414 (14%), Positives = 119/414 (28%), Gaps = 39/414 (9%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
+ + NL+ L + F+ E+ + ++ L
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL----------------CD 260
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
+ L + L+++ + SI + K L+
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQ 318
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSG-HRPSTMGH 181
L+ +L L L L +N I + ++ ++L N LS S
Sbjct: 319 LKQ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIP-NTFGNLRHLSTLNIR 240
+ + L L N + + +L LD ++L + F +L L L+I
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
F L L + N + + + +C+
Sbjct: 433 YTNTKI--------DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSL 359
L+ L L L++ N+L + +L L L N +
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSG---SLPSDIQNLKVL 410
SL +L +N + I L+++ ++ + P ++ VL
Sbjct: 545 KSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVL 597
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 44/156 (28%), Positives = 61/156 (39%), Gaps = 7/156 (4%)
Query: 350 GPIPTCLSSLISLRQLHLGSNQLTSSIPSS-FWSLEYILRIDLSSNSLSGSLPSDIQNLK 408
G + C+ + ++ +L+ +P S + I DLS N L N
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIPSSTKNI---DLSFNPLKILKSYSFSNFS 56
Query: 409 VLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNL 468
L +L+LSR ++ GL L L L N Q P SF LTSLE L L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 469 SGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRN 504
+ L LK+LNV+HN + F N
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-59
Identities = 74/279 (26%), Positives = 134/279 (48%), Gaps = 26/279 (9%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+GAGSFG+V++ + G++VA+K+ Q F E +++ +RH N++ +
Sbjct: 45 IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
++V E++ GSL + L+ LD RL++ DV + YLH + + P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
NLK N+L+DK T +V DFG+S+L + ++ T +MAPE D + K
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 769 DVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKM 828
DVYS+GV+L E T ++P + +VV A + + +
Sbjct: 221 DVYSFGVILWELATLQQPWGNL-----------------NPAQVVAAVGFKCKRLEIPR- 262
Query: 829 DCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
+ ++ + GC + P +R ++ L+ + ++ +
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-57
Identities = 74/279 (26%), Positives = 115/279 (41%), Gaps = 34/279 (12%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
+G G+FG V K + +VAIK + ER ++F E L V H N++K C
Sbjct: 16 VGRGAFGVVCKAK-WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK-LYGACL 71
Query: 653 LDFKALVLEFMPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
LV+E+ GSL L+ + ++ + + YLH ++H +
Sbjct: 72 NPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 711 LKPNNILLDKNMT-ARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPEYASDGIISPK 767
LKP N+LL T ++ DFG + + MT + +MAPE S K
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACD-------IQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 768 CDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAK 827
CDV+S+G++L E TR+KP DE+ I ++ G R
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHNGT---------RPPLIK--- 227
Query: 828 MDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866
+ I L C P QR M ++V + + + F
Sbjct: 228 -NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-56
Identities = 96/520 (18%), Positives = 178/520 (34%), Gaps = 35/520 (6%)
Query: 8 PPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQV 67
+ L LD+S + L L L N + S LQ
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 104
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSI-SGNIPSKIGNLTKLVHLNFADNNLRGE 126
L + + +L +L L+ N I S +P NLT L HL+ + N ++
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 127 IPNEIGNLKNLADLVLALN---NLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSL 183
++ L + L L+L+ N + I F + + L N S + T L
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGL 224
Query: 184 PNRQFLLLW------ANRLTGTIPNSITNASKLIGLDLNSNSLSG---QIPNTFGNLRHL 234
+ L L +++ L + L I + F L ++
Sbjct: 225 AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNV 284
Query: 235 STLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQF 294
S+ ++ + + + + + L L + S ++
Sbjct: 285 SSFSLVSVTIER----------VKDFSYNFGWQHLELVNCKFGQ----FPTLKLKSLKRL 330
Query: 295 YAHECKLKGSIPKEIGNLRGLIALSLFTNDLN--GTIPTTLGRLQQLQAL-LQRNNLNGP 351
K + + +L L L L N L+ G + L+ L L N +
Sbjct: 331 TFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSS-FWSLEYILRIDLSSNSLSGSLPSDIQNLKVL 410
+ + L L L + L S F SL ++ +D+S + L L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 411 IYLNLSRNQLSGNI-PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469
L ++ N N P L++L L L++ + + P +F SL+SL+ L++++N L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
Query: 470 GEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQS 509
F+ L+ L+++ + N + P +L ++
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 547
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-52
Identities = 111/503 (22%), Positives = 189/503 (37%), Gaps = 35/503 (6%)
Query: 7 VPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQ 66
+P ++ LD+S N R L+ L + ++ S L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 67 VLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLR-G 125
L L N + LSSL +L + +++ IG+L L LN A N ++
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIS----TIIIINLVGNQLSGHRPSTMGH 181
++P NL NL L L+ N + T + + + ++L N ++
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 182 SLPNRQFLLLWANRLTGTIP-NSITNASKLIGLDL------NSNSLSGQIPNTFGNLRHL 234
+ L L N + + I + L L N +L + L +L
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 235 STLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQF 294
+ R YL + + + SL S ++ + +++ +Q
Sbjct: 258 TIEEFRLAYLDYYLD-----DIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQHL 309
Query: 295 YAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLN--GP 351
CK ++ +L+ L S + + L L+ L L RN L+ G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF-----SEVDLPSLEFLDLSRNGLSFKGC 364
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
SL+ L L N + ++ S+F LE + +D ++L + +L+ L
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 411 IYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSI-PDSFGSLTSLEYLDLSNNNLS 469
IYL++S GL L L +A N FQ++ PD F L +L +LDLS L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 470 GEIPKSFEILSHLKRLNVSHNRL 492
P +F LS L+ LN++ N+L
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-49
Identities = 91/477 (19%), Positives = 158/477 (33%), Gaps = 40/477 (8%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
+ P + + L L N S F+ L LD I
Sbjct: 16 ELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 108 GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLV 167
+L+ L L N ++ L +L LV NL I ++ T+ +N+
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 168 GNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL----IGLDLNSNSLSGQ 223
N + + +L N + L L +N++ + ++ + LDL+ N ++
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 224 IPNTFGNLRHLSTLNIRANYLTTETSSNG---------EWSFLSSLTNCNKLRALSLGS- 273
P F +R L L +R N+ + L N L +
Sbjct: 193 QPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 274 -------------NPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSL 320
LD L +I F+ + K+ G L L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311
Query: 321 FTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLT--SSIPS 378
L L++L N L SL L L N L+
Sbjct: 312 VNCKFGQFPTLKLKSLKRLT--FTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 379 SFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITL 437
S + + +DLS N + ++ S+ L+ L +L+ + L ++ L++LI L
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 438 SLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK-SFEILSHLKRLNVSHNRLE 493
++ + + F L+SLE L ++ N+ F L +L L++S +LE
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 4/159 (2%)
Query: 336 LQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNS 395
+ + N IP L S + L L N L SF+S + +DLS
Sbjct: 7 VPNITYQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 396 LSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSL 455
+ Q+L L L L+ N + GL L L G L
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 456 TSLEYLDLSNNNL-SGEIPKSFEILSHLKRLNVSHNRLE 493
+L+ L++++N + S ++P+ F L++L+ L++S N+++
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 37/140 (26%), Positives = 52/140 (37%), Gaps = 6/140 (4%)
Query: 366 HLGSNQLTSSIPSS-FWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNI 424
IP + +S + + DLS N L + L L+LSR ++
Sbjct: 13 QCMELNFYK-IPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 425 PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKR 484
L L TL L N Q +F L+SL+ L NL+ L LK
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 485 LNVSHNRLEGKIPTNGPFRN 504
LNV+HN ++ F N
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 49/210 (23%), Positives = 74/210 (35%), Gaps = 17/210 (8%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+S G + L YLD+S N + + L +L+ L F +++L
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF--S 415
Query: 61 VF---SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHL 116
VF L L + + LSSL L NS N I L L L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 117 NFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHR 175
+ + L P +L +L L +A N L +P IF ++++ I L N
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDC-- 532
Query: 176 PSTMGHSLPNRQFLLLWANRLTGTIPNSIT 205
S P +L W N+ + S
Sbjct: 533 ------SCPRIDYLSRWLNKNSQKEQGSAK 556
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-56
Identities = 65/283 (22%), Positives = 110/283 (38%), Gaps = 39/283 (13%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQ----LERAFRSFESECEVLRNVRHRNLIKIFS 648
+G G FG VY+ + G VA+K + + + E ++ ++H N+I +
Sbjct: 15 IGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
C LV+EF G L + L + +N + + + YLH P++H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 709 CNLKPNNILLDK--------NMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEYA 759
+LK +NIL+ + N +++DFG+++ T M+ A +MAPE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVI 186
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819
+ S DV+SYGVLL E T + P + V +
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGI-----------------DGLAVAYGVAMN 229
Query: 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
++ C L C P R T+++ +L I
Sbjct: 230 KLALPIPS-TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-56
Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 37/281 (13%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSC 650
L G ++KG + G ++ +KV ++ R R F EC LR H N++
Sbjct: 18 LNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP-VLGA 75
Query: 651 CN---LDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
C L+ +MP GSL L+ N+ +D + + +D+ + +LH + +
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLI 134
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE---YASDGI 763
L ++++D++MTAR+S + S M ++APE +
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823
D++S+ VLL E TR+ P ++ E+ +K V L R P
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-------------VALEGL-RPTIP 233
Query: 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ L C + P +R +V L+K++
Sbjct: 234 P----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-56
Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 53/292 (18%)
Query: 593 LGAGSFGSVYKGTLF-DGTNVAIKVFNLQ-------LERAFRSFESECEVLRNVRHRNLI 644
+G G FG V+KG L D + VAIK L + F+ F+ E ++ N+ H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
K++ + +V+EF+P G L L + + +L +M+D+ L +EY+ + +
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNP 143
Query: 705 PVVHCNLKPNNILLDK-----NMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPE 757
P+VH +L+ NI L + A+V+DFG+S+ +++ +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLLGNFQWMAPE 196
Query: 758 --YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK-----LSLPRGLT 810
A + + K D YS+ ++L T + P DE G++ + I+ ++P
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE--- 253
Query: 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
DC R+ ++ C P++R + +V +L ++
Sbjct: 254 ------------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 6e-55
Identities = 66/277 (23%), Positives = 126/277 (45%), Gaps = 25/277 (9%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G+GSFG+VYKG + G VA+K+ N+ + ++F++E VLR RH N++ F
Sbjct: 32 IGSGSFGTVYKGK-WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL-FMGY 88
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
A+V ++ SL L++ +M + ++I ++YLH + ++H +
Sbjct: 89 STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE---YASDGIISPK 767
LK NNI L ++ T ++ DFG++ S +I +MAPE S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 768 CDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAK 827
DVY++G++L E T + P + + + E+V +
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLSPDLSKVRS 252
Query: 828 MDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+C R+ L C ++R ++ +++++ +
Sbjct: 253 -NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-53
Identities = 61/285 (21%), Positives = 115/285 (40%), Gaps = 33/285 (11%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
LG G FG K T + G + +K E R+F E +V+R + H N++K
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+ E++ G+L + S + +R++ D+ + YLH + ++H +L
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDL 134
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA------------TIGYMAPEYA 759
+N L+ +N V+DFG+++L+ ++ ++ +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819
+ K DV+S+G++L E R + LPR T ++
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDY--------------LPR--TMDFGLNVRG 238
Query: 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ Y +C + + CC PE+R + L+ ++
Sbjct: 239 FLDR-YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-52
Identities = 67/324 (20%), Positives = 118/324 (36%), Gaps = 38/324 (11%)
Query: 575 TSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEV 634
+ + D L+G G +G+VYKG+L D VA+KVF+ + +F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 635 --LRNVRHRNLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNI 687
+ + H N+ + + LV+E+ PNGSL K+L H D + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 688 MIDVGLALEYLHHSHST------PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741
V L YLH + H +L N+L+ + T +SDFG+S L +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 742 VTQTMTMA------TIGYMAPEYASDGI-------ISPKCDVYSYGVLLMETFTRKKPTD 788
A TI YMAPE + + D+Y+ G++ E F R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 789 E-MFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS-----YAKMDCLLRIMHLALGCC 842
E + ++ ++ + +P + + C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 843 MDSPEQRMCMTDVVVKLQKIKQTF 866
E R+ ++ ++ +
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIW 320
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-52
Identities = 66/297 (22%), Positives = 122/297 (41%), Gaps = 29/297 (9%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G G +G V+ G + G VA+KVF E ++ E+E +RH N++ ++
Sbjct: 43 KQIGKGRYGEVWMGK-WRGEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAAD 100
Query: 651 CNLDFK----ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH-----HS 701
L+ ++ NGSL +L + LD L + L +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPEYA 759
+ H +LK NIL+ KN T ++D G++ D + V T YM PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-V 217
Query: 760 SDGIISP-------KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812
D ++ D+YS+G++L E R + ++ + ++
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS--YEDM 275
Query: 813 VDASLVREVQPS----YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
+ +++++PS ++ +CL ++ L C +P R+ V L K+ ++
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-51
Identities = 58/288 (20%), Positives = 113/288 (39%), Gaps = 38/288 (13%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFS 648
L+G G FG VY G + G VAI++ +++ E ++F+ E R RH N++
Sbjct: 39 ELIGKGRFGQVYHGR-WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
+C + A++ +L + LD+ + I ++ + YL H+ ++H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA---TIGYMAPE-------- 757
+LK N+ D N ++DFG+ + G + + ++APE
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 758 -YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
S DV++ G + E R+ P E +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ------------------PAEAIIWQ 254
Query: 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ ++P+ +++ I + L C E+R T ++ L+K+ +
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 61/293 (20%), Positives = 119/293 (40%), Gaps = 27/293 (9%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G G +G V++G+ + G NVA+K+F+ + E+++ E+E +RH N++ +S
Sbjct: 14 ECVGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71
Query: 651 CNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH-----HS 701
+ L+ + GSL +L LD + L I++ + L +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPE-- 757
+ H +LK NIL+ KN ++D G++ + + + + T YMAPE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 758 ----YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813
+ D++++G++L E R + + + + ++
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--EDYKPPFYDVVPNDPSFEDMR 247
Query: 814 DASLVREVQP----SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
V + +P + L + L C +P R+ + L KI
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-49
Identities = 59/296 (19%), Positives = 120/296 (40%), Gaps = 27/296 (9%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G G FG V++G + G VA+K+F+ + ER++ E+E +RH N++ ++
Sbjct: 48 ESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105
Query: 651 CNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH-----HS 701
+ LV ++ +GSL +L + Y + + + + + L +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPE-- 757
+ H +LK NIL+ KN T ++D G++ D++ T YMAPE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 758 ----YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813
+ D+Y+ G++ E R + L ++ + + E+
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH--EDYQLPYYDLVPSDPSVEEMR 281
Query: 814 DASLVREVQP----SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
++++P + + L + + C + R+ + L ++ Q
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 9e-48
Identities = 96/486 (19%), Positives = 179/486 (36%), Gaps = 70/486 (14%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
L+ M + + N + L ++ L + + + L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
NN T P L NL+ LV + N I+ P + NLT L L +N + P
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-- 129
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
+ NL NL L L+ N + + ++++ ++ GNQ++ +P +L + L
Sbjct: 130 LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKPLA---NLTTLERLD 183
Query: 191 LWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS 250
+ +N+++ + + + L L +N +S P G L +L L++ N L
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD---- 235
Query: 251 NGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIG 310
+ +L + L L L +N + ++ P +
Sbjct: 236 ------IGTLASLTNLTDLDLANNQISNLAP---------------------------LS 262
Query: 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGS 369
L L L L N ++ P L L L L L N L P +S+L +L L L
Sbjct: 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318
Query: 370 NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIG 429
N ++ P SL + R+ +N +S S + NL + +L+ NQ+S P +
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LA 372
Query: 430 GLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSH 489
L + L L + ++ + +++ + L P + +++
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITW 430
Query: 490 NRLEGK 495
N
Sbjct: 431 NLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-45
Identities = 99/473 (20%), Positives = 190/473 (40%), Gaps = 45/473 (9%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
T +L + L + + + L L + F+ N LT P + +KL
Sbjct: 37 TDTVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKL 92
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
+ + NN P L NL++L L N I+ P + NLT L L + N +
Sbjct: 93 VDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPN 185
+ + L +L L N + P + N++T+ +++ N++S S + L N
Sbjct: 149 --ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAK-LTN 200
Query: 186 RQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245
+ L+ N+++ P + + L L LN N L T +L +L+ L++ N ++
Sbjct: 201 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS 256
Query: 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSI 305
L+ L+ KL L LG+N + +I P + + + +E +L+
Sbjct: 257 N----------LAPLSGLTKLTELKLGANQISNISP--LAGLT-ALTNLELNENQLEDIS 303
Query: 306 PKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQ 364
P I NL+ L L+L+ N+++ P + L +LQ L N ++ L++L ++
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINW 357
Query: 365 LHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNI 424
L G NQ++ P +L I ++ L+ + + + + N+ + + L
Sbjct: 358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--A 413
Query: 425 PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFE 477
P TI + N + + + + SG + + +
Sbjct: 414 PATISDGGSYTEPDITWN-LPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-42
Identities = 109/497 (21%), Positives = 179/497 (36%), Gaps = 91/497 (18%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV 61
LG + L+ L ++ S N P L L +L + N + P +
Sbjct: 55 RLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN 110
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
+ L L+L NN T P L NL++L RL+ N+IS S + LT L L+F N
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GN 165
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
+ P + NL L L ++ N + + I ++
Sbjct: 166 QVTDLKP--LANLTTLERLDISSNKV-----SDISVLA---------------------- 196
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
L N + L+ N+++ P + + L L LN N L T +L +L+ L++
Sbjct: 197 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 252
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N ++ L+ L+ KL L LG+N + +I P
Sbjct: 253 NQISN----------LAPLSGLTKLTELKLGANQISNISP-------------------- 282
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLI 360
+ L L L L N L P + L+ L L L NN++ P +SSL
Sbjct: 283 -------LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLT 331
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
L++L +N+++ SS +L I + N +S P + NL + L L+
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILS 480
+ N P+ + P + S D++ N S S+ S
Sbjct: 388 T-NAPVNYKANVSIPNTVKNVTG-ALIAPATISDGGSYTEPDITWNLPSYTNEVSYT-FS 444
Query: 481 HLKRLNVSHNRLEGKIP 497
+ G +
Sbjct: 445 QPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-20
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 43/242 (17%)
Query: 257 LSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLI 316
+ + T + LG + + +L +
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVS---------------------------QTDLDQVT 49
Query: 317 ALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS 375
L + + L L + N L P L +L L + + +NQ+
Sbjct: 50 TLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI 105
Query: 376 IPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLI 435
P +L + + L +N ++ ++NL L L LS N +S + GL L
Sbjct: 106 TP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQ 159
Query: 436 TLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGK 495
LS N+ D P +LT+LE LD+S+N +S L++L+ L ++N++
Sbjct: 160 QLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDI 214
Query: 496 IP 497
P
Sbjct: 215 TP 216
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-46
Identities = 92/506 (18%), Positives = 171/506 (33%), Gaps = 34/506 (6%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
++P + + + LD+S N +L L+ L + + L
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 66 QVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISG-NIPSKIGNLTKLVHLNFADNNL 123
+ L L +N + + +S F LSSL L+ N + S NLT L L +
Sbjct: 77 EHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 124 RGEIPNE-IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
EI L +L +L + +L ++ +I I + L ++ +
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL-LEIFADI 194
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG----------QIPNTFGNLR 232
L + ++L L L + + + + S ++ L
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
Query: 233 HLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQ 292
+ + N L S + +R L + L L + +
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE-KVK 313
Query: 293 QFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTT---LGRLQQLQAL-LQRNNL 348
+ K+ +L+ L L L N + G LQ L L +N+L
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 349 N--GPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQN 406
L +L +L L + N +P S E + ++LSS + + + I
Sbjct: 374 RSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCI-- 429
Query: 407 LKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466
+ L L++S N L + + L L L ++RN+ + S L + +S N
Sbjct: 430 PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRN 483
Query: 467 NLSGEIPKSFEILSHLKRLNVSHNRL 492
L F+ L+ L+++ + N
Sbjct: 484 QLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-43
Identities = 87/452 (19%), Positives = 161/452 (35%), Gaps = 48/452 (10%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
T S PS G+ + ++ L L N T L ++L L + + I+
Sbjct: 14 SRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70
Query: 108 GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIG-PIPTTIFNISTIIIINL 166
+L L HL+ +DN+L + G L +L L L N + + N++ + + +
Sbjct: 71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130
Query: 167 VGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPN 226
+ L + L + A L S+ + + L L+ + + +
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190
Query: 227 TFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGN 286
L + L +R L S +SS R L + +L L
Sbjct: 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250
Query: 287 FSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRN 346
S +F +C L G D N + + L +++
Sbjct: 251 LELSEVEFD--DCTLNG------------------LGDFNPSESDVVSELGKVE------ 284
Query: 347 NLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQN 406
+++R+LH+ L + + + LE + RI + ++ + S Q+
Sbjct: 285 ------------TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQH 332
Query: 407 LKVLIYLNLSRNQLSGNIPIT---IGGLKDLITLSLARNRFQD--SIPDSFGSLTSLEYL 461
LK L +L+LS N + G L TL L++N + + +L +L L
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392
Query: 462 DLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
D+S N +P S + ++ LN+S +
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-31
Identities = 69/377 (18%), Positives = 139/377 (36%), Gaps = 32/377 (8%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
IP+ + + + ++L N+++ + + N Q L+L ++R+ ++ + L
Sbjct: 20 IPSGLT--AAMKSLDLSFNKITYIGHGDL-RACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 211 IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
LDL+ N LS + FG L L LN+ N T + S +LTN L+ L
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT----SLFPNLTN---LQTLR 129
Query: 271 LGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP 330
+G+ S + + S + L+ + + ++R + L+L ++ +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 331 TTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS----------SIPSS 379
L ++ L L+ NL + L + + + + +
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249
Query: 380 FWSLEYILRIDLSSNSLSGSLPSDIQNLK--------VLIYLNLSRNQLSGNIPITIGGL 431
L + D + N L PS+ + + L++ + L ++ L
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309
Query: 432 KDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKS---FEILSHLKRLNVS 488
+ + +++ ++ L SLE+LDLS N + E K+ L+ L +S
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 489 HNRLEGKIPTNGPFRNF 505
N L T
Sbjct: 370 QNHLRSMQKTGEILLTL 386
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 65/393 (16%), Positives = 131/393 (33%), Gaps = 44/393 (11%)
Query: 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRN 72
L+ L L+I + R Y L +R + L ++ + + S ++ L LR+
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 73 NSFTGPIPNSLFNLSSLVRLDSRFNSIS-------GNIPSKIGNLTKLVHLNFADNNLRG 125
+ + L + S + + + +L + F D L G
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 126 ---------EIPNEIGNLKNLADLVLAL-NNLIGPIPTTIF-NISTIIIINLVGNQLSGH 174
++ +E+G ++ + L + + +T++ + + I + +++
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-L 324
Query: 175 RPSTMGHSLPNRQFLLLWANRLTGTI---PNSITNASKLIGLDLNSNSLS--GQIPNTFG 229
P + L + +FL L N + L L L+ N L +
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
Query: 230 NLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSA 289
L++L++L+I N S K+R L+L S + +
Sbjct: 385 TLKNLTSLDISRNTFH---------PMPDSCQWPEKMRFLNLSSTGIRVVKT---CIPQ- 431
Query: 290 SFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNL 348
+ + L S + L+ L + N L +L L + + RN L
Sbjct: 432 TLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLKTLPDASL--FPVLLVMKISRNQL 485
Query: 349 NGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFW 381
L SL+++ L +N S P +
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 518
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-20
Identities = 43/234 (18%), Positives = 84/234 (35%), Gaps = 7/234 (2%)
Query: 262 NCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLF 321
+C+ S SI P +A+ + K+ ++ L L L
Sbjct: 3 SCDASGVCDGRSRSFTSI-PS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 322 TNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS-SIPSS 379
++ +N L L+ L L N+L+ + L SL+ L+L N + + S
Sbjct: 59 SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 380 FWSLEYILRIDLSS-NSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438
F +L + + + + + S D L L L + L ++ ++D+ L+
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 439 LARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
L + + L+S+ YL+L + NL+ + + R
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 34/145 (23%), Positives = 56/145 (38%), Gaps = 5/145 (3%)
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
+ S TS IPS + +DLS N ++ D++ L L L +++
Sbjct: 6 ASGVCDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG-EIPKSFEIL 479
+ L L L L+ N FG L+SL+YL+L N + F L
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 480 SHLKRLNVSHNRLEGKIPTNGPFRN 504
++L+ L + + +I F
Sbjct: 123 TNLQTLRIGNVETFSEIR-RIDFAG 146
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 43/217 (19%), Positives = 75/217 (34%), Gaps = 37/217 (17%)
Query: 13 NLSFLMYLDISENNF---RGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFS---KLQ 66
+L L +LD+SEN G L+ L + N L S + L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLT 390
Query: 67 VLSLRNNSFTGPIPNSLFNLSSLVRLD---SRFNSISGNIPSKI--------------GN 109
L + N+F P+P+S + L+ + + IP +
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLF 449
Query: 110 LTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVG 168
L +L L + N L+ +P + L + ++ N + +P IF ++++ I L
Sbjct: 450 LPRLQELYISRNKLK-TLP-DASLFPVLLVMKIS-RNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 169 NQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSIT 205
N S P +L W N+ + S
Sbjct: 507 NPWDC--------SCPRIDYLSRWLNKNSQKEQGSAK 535
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-45
Identities = 99/511 (19%), Positives = 178/511 (34%), Gaps = 47/511 (9%)
Query: 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF---SKLQVLS 69
L+ L +S N R + L +L+ L + F L++L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK--EAFRNLPNLRILD 79
Query: 70 LRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNI--PSKIGNLTKLVHLNFADNNLRG-E 126
L ++ P++ L L L F +S + NL L L+ + N +R
Sbjct: 80 LGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139
Query: 127 IPNEIGNLKNLADLVLALNNLIGPIPTTIFNIS--TIIIINLVGNQLSGHRPSTMGHSLP 184
+ G L +L + + N + + + T+ +L N L G +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244
+ ++L ++G N + SN++S + H+ + +
Sbjct: 200 PFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252
Query: 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS 304
+ + L + +R L L + S+ + + K+
Sbjct: 253 KDPDQN-----TFAGLARSS-VRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKI 305
Query: 305 IPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLR 363
+ L L L+L N L + L ++ + LQ+N++ L L+
Sbjct: 306 ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365
Query: 364 QLHLGSNQLT-----SSIPSSFWSLEYILRI----------DLSSNSLSG-SLPSDIQNL 407
L L N LT SIP F S ++ + LS N L + + +
Sbjct: 366 TLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRV 425
Query: 408 KVLIYLNLSRNQLSG-NIPITIGGLKDLITLSLARNRFQDSI-----PDSFGSLTSLEYL 461
L L L++N+ S + T L L L N Q + D F L+ L+ L
Sbjct: 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485
Query: 462 DLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
L++N L+ P F L+ L+ L+++ NRL
Sbjct: 486 YLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-43
Identities = 108/620 (17%), Positives = 193/620 (31%), Gaps = 78/620 (12%)
Query: 13 NLSFLMYLDISENNFRGYLPNE-LGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLR 71
L L L++ + E L L+ L + + P L L L
Sbjct: 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105
Query: 72 NNSFTGPI--PNSLFNLSSLVRLDSRFNSISG-NIPSKIGNLTKLVHLNFADNNLRGEIP 128
+ + NL +L RLD N I + G L L ++F+ N +
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE 165
Query: 129 NEIGNL--KNLADLVLALNNLIGPIPTTIFNISTII------IINLVGNQLSGHRPSTMG 180
+E+ L K L+ LA N+L + I+++ GN +
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225
Query: 181 HSL-----------PNRQFLLLWANRLTGTIPNSITN--ASKLIGLDLNSNSLSGQIPNT 227
+++ + + + N+ S + LDL+ +
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285
Query: 228 FGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287
F L+ L LN+ N + L N L+ L+L N L +
Sbjct: 286 FETLKDLKVLNLAYNKINKIADE-----AFYGLDN---LQVLNLSYNLLGELYSSNFYGL 337
Query: 288 SASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNN 347
+ + + L L L L N L TT+ + + + N
Sbjct: 338 P-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGN 391
Query: 348 LNGPIPTCLSSLISLRQLHLGSNQLTS-SIPSSFWSLEYILRIDLSSNSLSGSLPSDI-Q 405
+ T ++ +HL N+L + I + ++ + L+ N S
Sbjct: 392 ---KLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 406 NLKVLIYLNLSRNQLSGNIPITI-----GGLKDLITLSLARNRFQDSIPDSFGSLTSLEY 460
L L L N L + GL L L L N P F LT+L
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 461 LDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT--------------------NG 500
L L++N L+ + + + ++L+ L++S N+L P
Sbjct: 509 LSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELS 566
Query: 501 PFRNFLAQSFLW------NYALCGPPRLQVPPCKE-DDTKGSKKAAPIFLKYVLPLIIST 553
F N+L + + + P ++ LK+ L ++ +
Sbjct: 567 TFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626
Query: 554 TLIVILIILCIRYRNRTTWR 573
TL + L+ + + R
Sbjct: 627 TLTLFLMTILTVTKFRGFCF 646
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-41
Identities = 78/408 (19%), Positives = 143/408 (35%), Gaps = 47/408 (11%)
Query: 92 LDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPI 151
RF +++ +P L L + N +R + L+ L L L I
Sbjct: 9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 152 PTTIF-NISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTI--PNSITNAS 208
F N+ + I++L +++ P L + L L+ L+ + N
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAF-QGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 209 KLIGLDLNSNSLSG-QIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLR 267
L LDL+ N + + +FG L L +++ +N + L L L
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE-----LEPLQGKT-LS 177
Query: 268 ALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNG 327
SL +N L S + G F+ + L D++G
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRN------------------------MVLEILDVSG 213
Query: 328 TIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLE--Y 385
N ++ L + G + + ++F L
Sbjct: 214 N------GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS 267
Query: 386 ILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQ 445
+ +DLS + + LK L LNL+ N+++ GL +L L+L+ N
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 446 DSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
+ +F L + Y+DL N+++ ++F+ L L+ L++ N L
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 27/159 (16%), Positives = 54/159 (33%), Gaps = 4/159 (2%)
Query: 8 PPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQV 67
LS L L ++ N P L L+ L N LT + + + L++
Sbjct: 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEI 530
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEI 127
L + N P P+ +LS L ++F V + ++
Sbjct: 531 LDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVY 590
Query: 128 PNEIGN--LKNLADLVLALNNLIGPIPTTIFNISTIIII 164
P+ L +L+ ++ + ++F + T+ +
Sbjct: 591 PDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLT 629
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-45
Identities = 93/512 (18%), Positives = 169/512 (33%), Gaps = 88/512 (17%)
Query: 7 VPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQ 66
+ P + +FL +N +P E ++ A+++ + P G ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 67 VLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGE 126
V LR+ L+ +S ++P +L L + N+L E
Sbjct: 62 VSRLRDCLDR-----------QAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-E 105
Query: 127 IPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNR 186
+P +LK+L L L + + + NQL P +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLE-KLPE--LQNSSFL 155
Query: 187 QFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246
+ + + N L +P+ + L + +N L ++P NL L+ + N L
Sbjct: 156 KIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKK 209
Query: 247 ETS----------SNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYA 296
N L L N L + +N L + LP L + +
Sbjct: 210 LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSL----EALNV 264
Query: 297 HECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCL 356
+ L +P+ +L L + L L L N + +
Sbjct: 265 RDNYLT-DLPELPQSLTFLDVSENIFSGL----SELPPNLYYLN--ASSNEIRS-LCDLP 316
Query: 357 SSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLS 416
SL +L++ +N+L +P+ LE R+ S N L+ +P QNLK L ++
Sbjct: 317 PSL---EELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQNLKQL---HVE 365
Query: 417 RNQLSGNIPITIGGLKD----------------LITLSLARNRFQDSIPDSFGSLTSLEY 460
N L P ++D L L + N + PD S+E
Sbjct: 366 YNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDI---PESVED 420
Query: 461 LDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
L +++ + + E L+ H+
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-41
Identities = 91/493 (18%), Positives = 170/493 (34%), Gaps = 93/493 (18%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLR-------------RLKFLGFAYNDLT 52
+P N+ + + + P G+ R + L L+
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 53 GSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPS------- 105
S P L+ L NS T +P +L SL+ ++ ++S P
Sbjct: 85 -SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVS 139
Query: 106 --------KIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFN 157
++ N + L ++ +N+L+ ++P+ +L+ + NN + +P + N
Sbjct: 140 NNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI-AA---GNNQLEELPE-LQN 193
Query: 158 ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNS 217
+ + I N L + + + ++ N L + N L + ++
Sbjct: 194 LPFLTAIYADNNSLK-----KLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADN 246
Query: 218 NSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
N L +P+ +L L+ + NYLT + L + L
Sbjct: 247 NLLK-TLPDLPPSLEALNVRD---NYLT---------DLPELPQSLTFLDVSENIFSGLS 293
Query: 278 SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQ 337
+ P L A +++ S+ +L L++ N L +P RL+
Sbjct: 294 ELPPNL--------YYLNASSNEIR-SLCDLPPSLE---ELNVSNNKLI-ELPALPPRLE 340
Query: 338 QLQALLQRNNLNGPIPTCLSSLI-SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSL 396
+L N+L + L +L+QLH+ N L P S+E DL NS
Sbjct: 341 RLI--ASFNHL-----AEVPELPQNLKQLHVEYNPLRE-FPDIPESVE-----DLRMNSH 387
Query: 397 SGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLT 456
+P QNLK L ++ N L P ++DL + R D + +
Sbjct: 388 LAEVPELPQNLKQL---HVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTD 440
Query: 457 SLEYLDLSNNNLS 469
LE +++
Sbjct: 441 KLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-37
Identities = 88/428 (20%), Positives = 152/428 (35%), Gaps = 73/428 (17%)
Query: 79 IPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLA 138
I + + L ++++ +P + N+ A + P G + +A
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 139 DLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTG 198
L + L L S++ P+ + L+ N LT
Sbjct: 62 VSRLRDCLD-----------RQAHELELNNLGL-----SSLPELPPHLESLVASCNSLT- 104
Query: 199 TIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLS 258
+P + L+ + N +LS P L L + N L L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEK----------LP 147
Query: 259 SLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIAL 318
L N + L+ + + +N L LP L + + A +L+ +P E+ NL L A+
Sbjct: 148 ELQNSSFLKIIDVDNNSL-KKLPDLPPS----LEFIAAGNNQLE-ELP-ELQNLPFLTAI 200
Query: 319 SLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPS 378
N L +P L+ + N L L +L L ++ +N L ++P
Sbjct: 201 YADNNSLK-KLPDLPLSLESIV--AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPD 254
Query: 379 SFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIP-----------IT 427
SLE +++ N L+ LP Q+L L + LS P I
Sbjct: 255 LPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 310
Query: 428 --IGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRL 485
L L+++ N+ +P LE L S N+L+ E+P+ +LK+L
Sbjct: 311 SLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQL 362
Query: 486 NVSHNRLE 493
+V +N L
Sbjct: 363 HVEYNPLR 370
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-45
Identities = 85/409 (20%), Positives = 157/409 (38%), Gaps = 84/409 (20%)
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
++ L+ S T + L S+ +L ++ +I I LT L +LN N
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGN 76
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
+ P + NL L +L + N + T I +
Sbjct: 77 QITDISP--LSNLVKLTNLYIGTNKI-----TDISALQ---------------------- 107
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
+L N + L L + ++ P + N +K+ L+L +N + N+ L+ L +
Sbjct: 108 NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTE 164
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
+ + ++ + N L +LSL N ++ I
Sbjct: 165 SKVKD----------VTPIANLTDLYSLSLNYNQIEDI---------------------- 192
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLI 360
+ +L L + + N + P + + +L +L + N + P L++L
Sbjct: 193 -----SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLS 243
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
L L +G+NQ++ ++ L + +++ SN +S S + NL L L L+ NQL
Sbjct: 244 QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
Query: 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469
IGGL +L TL L++N D P SL+ ++ D +N +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-42
Identities = 84/410 (20%), Positives = 155/410 (37%), Gaps = 84/410 (20%)
Query: 89 LVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLI 148
L + I+ P +L + + ++ + L+++ LV+A +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 149 GPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNAS 208
+I I L N ++L L N++T P ++N
Sbjct: 57 ----ASIQGIE----------------------YLTNLEYLNLNGNQITDISP--LSNLV 88
Query: 209 KLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRA 268
KL L + +N ++ + NL +L L + + ++ +S L N K+ +
Sbjct: 89 KLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD----------ISPLANLTKMYS 136
Query: 269 LSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGT 328
L+LG+N S + N+ GL L++ + +
Sbjct: 137 LNLGANHN--------------------------LSDLSPLSNMTGLNYLTVTESKVKDV 170
Query: 329 IPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYIL 387
P + L L +L L N + P L+SL SL NQ+T P ++ +
Sbjct: 171 TP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN 224
Query: 388 RIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447
+ + +N ++ P + NL L +L + NQ+S +I + L L L++ N+ D
Sbjct: 225 SLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD- 279
Query: 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIP 497
+L+ L L L+NN L E + L++L L +S N + P
Sbjct: 280 -ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 74/412 (17%), Positives = 144/412 (34%), Gaps = 84/412 (20%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
+L+ + + + + + +L + L A + I + L+ L+L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNL 73
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
N T P L NL L L N I+ S + NLT L L ++N+ P
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP-- 127
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
+ NL + L L N+ + + + N++ + + + +++
Sbjct: 128 LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD----------------- 169
Query: 191 LWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS 250
+ I N + L L LN N + P +L L N +T
Sbjct: 170 ---------VTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD---- 213
Query: 251 NGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIG 310
++ + N +L +L +G+N + + P +
Sbjct: 214 ------ITPVANMTRLNSLKIGNNKITDLSP---------------------------LA 240
Query: 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGS 369
NL L L + TN + + + L +L+ L + N ++ L++L L L L +
Sbjct: 241 NLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNN 296
Query: 370 NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421
NQL + L + + LS N ++ P + +L + + + +
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 58/271 (21%), Positives = 113/271 (41%), Gaps = 26/271 (9%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
T + NL+ L L ++E+N + L L ++ L N S S + + L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGL 157
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
L++ + P + NL+ L L +N I P + +LT L + N +
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPN 185
P + N+ L L + N + P + N+S + + + NQ+S + + L
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKD-LTK 266
Query: 186 RQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245
+ L + +N+++ + + N S+L L LN+N L + G L +L+TL + N++T
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
+ L + +K+ + + +
Sbjct: 325 D----------IRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 47/240 (19%), Positives = 84/240 (35%), Gaps = 39/240 (16%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
+ + N++ L YL ++E+ + + L L L YN + P + + L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
+ N T P + N++ L L N I+ P + NL++L L N +
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPN 185
N + +L L L + N IS I ++N +L
Sbjct: 258 --INAVKDLTKLKMLNVGSN-----------QISDISVLN----------------NLSQ 288
Query: 186 RQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245
L L N+L I + L L L+ N ++ P +L + + + +
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 68/398 (17%), Positives = 119/398 (29%), Gaps = 85/398 (21%)
Query: 107 IGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINL 166
+ + +L F + + + + + +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-------------- 53
Query: 167 VGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNAS--KLIGLDLNSNSLSGQI 224
+ N Q L + + +A+ + L+L S L Q
Sbjct: 54 ---------------NSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QF 96
Query: 225 PNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLI 284
P+ L HL + I A L ++ L L+L NPL ++
Sbjct: 97 PDQAFRLSHLQHMTIDAAGLM---------ELPDTMQQFAGLETLTLARNPLRAL----- 142
Query: 285 GNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQ 344
P I +L L LS+ +P L
Sbjct: 143 ---------------------PASIASLNRLRELSIRACPELTELPEPLASTD------- 174
Query: 345 RNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI 404
L++L+ L L + S +P+S +L+ + + + ++ LS +L I
Sbjct: 175 -------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAI 225
Query: 405 QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLS 464
+L L L+L N P GG L L L ++P LT LE LDL
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285
Query: 465 NNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPF 502
+P L + V + L+ ++ + P
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 57/311 (18%), Positives = 105/311 (33%), Gaps = 29/311 (9%)
Query: 198 GTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFL 257
G+ + ++S L ++ + + + W
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNAD------------RNRWHSA 49
Query: 258 SSLTNCNKLRALSLGSNPLDSILPPLIGNFSASF-QQFYAHECKLKGSIPKEIGNLRGLI 316
N N + + L L+ + + L P + L L
Sbjct: 50 WRQANSNNPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQ 107
Query: 317 ALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHL-GSNQLTS 374
+++ L +P T+ + L+ L L RN L +P ++SL LR+L + +LT
Sbjct: 108 HMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTE 165
Query: 375 --------SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPI 426
L + + L + SLP+ I NL+ L L + + LS +
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGP 223
Query: 427 TIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLN 486
I L L L L + P FG L+ L L + + +P L+ L++L+
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283
Query: 487 VSHNRLEGKIP 497
+ ++P
Sbjct: 284 LRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 57/353 (16%), Positives = 102/353 (28%), Gaps = 61/353 (17%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFS-- 63
+ D + + + L + + +
Sbjct: 27 PYHDVLSQWQRHYNADRNRWH----SAWRQANSNNPQIETRTGRALK-ATADLLEDATQP 81
Query: 64 KLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNL 123
L LR+ P+ F LS L + + +P + L L A N L
Sbjct: 82 GRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL 139
Query: 124 RGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSL 183
R +P I +L L +L + + +P + + L
Sbjct: 140 R-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ----------------GL 182
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
N Q L L + ++P SI N L L + ++ LS + +L L L+
Sbjct: 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD----- 235
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
L C LR PP+ G + ++ +C
Sbjct: 236 ----------------LRGCTALRN-----------YPPIFGGRA-PLKRLILKDCSNLL 267
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCL 356
++P +I L L L L +P+ + +L +L +L +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 57/363 (15%), Positives = 109/363 (30%), Gaps = 64/363 (17%)
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
S + L + ++ P + L D + N
Sbjct: 12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSNNPQIETRTGRA 67
Query: 123 LRGEIPNEIGNLKNLADLVLAL-NNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
L+ + + + + L L + + P F +S + + + L
Sbjct: 68 LK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM--------- 117
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
+P+++ + L L L N L +P + +L L L+IRA
Sbjct: 118 -----------------ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159
Query: 242 -NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
LT L++L L +
Sbjct: 160 CPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR----------------------- 196
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSL 359
S+P I NL+ L +L + + L+ + + L +L+ L L+ P
Sbjct: 197 ---SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 360 ISLRQLHL-GSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRN 418
L++L L + L ++P L + ++DL LPS I L + + +
Sbjct: 253 APLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 419 QLS 421
+
Sbjct: 312 LQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 45/187 (24%), Positives = 70/187 (37%), Gaps = 14/187 (7%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQ---------LRRLKFLGFAYNDLTGSFP 56
+P I +L+ L L I LP L L L+ L + + S P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 57 SWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHL 116
+ I L+ L +RN+ + + ++ +L L LD R + N P G L L
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 117 NFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGN---QLSG 173
D + +P +I L L L L + +P+ I + II + + QL
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
Query: 174 HRPSTMG 180
HRP
Sbjct: 319 HRPVARP 325
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-41
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 39/282 (13%)
Query: 593 LGAGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G G+FG V+ G L D T VA+K L F E +L+ H N++++ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+V+E + G +L + L + L ++ D +EYL +H +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDV 770
L N L+ + ++SDFG+S+ + + + + + + APE + G S + DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 771 YSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMD 829
+S+G+LL ETF+ P + +S + + V+ ++
Sbjct: 299 WSFGILLWETFSLGASP----YPN-LSNQ------------QTR-----EFVEKGG-RLP 335
Query: 830 C-------LLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
C + R+M C P QR + + +LQ I++
Sbjct: 336 CPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-41
Identities = 74/437 (16%), Positives = 146/437 (33%), Gaps = 32/437 (7%)
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
++ ++ + ++S + + + ++ LD N +S + + TKL LN + N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
L ++ +L L L L N + + +I ++ N +S S
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSR---- 118
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG-QIPNTFGNLRHLSTLNIRA 241
++ + L N++T S++ LDL N + + L LN++
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N++ + KL+ L L SN L + P + + KL
Sbjct: 179 NFIYD----------VKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAA-GVTWISLRNNKL 226
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLN-GTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLI 360
I K + + L L N + GT+ + Q++Q + + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVKKLTGQNEEECT 284
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGS----LPSDIQNLKVLIYLNLS 416
H G+ L + R + + S GS L + +N ++
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 417 RNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSF 476
+ Q I + ITL + + + + + L+ E+ +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHAT 403
Query: 477 EILSHLKRLNVSHNRLE 493
E S L+ L R E
Sbjct: 404 EEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-40
Identities = 68/463 (14%), Positives = 155/463 (33%), Gaps = 27/463 (5%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
N + +++++ + L + +K L + N L+ + + F+KL++L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
+N + L +LS+L LD ++ N ++ + L+ A+NN+ +
Sbjct: 66 SSNVLYETLD--LESLSTLRTLD-----LNNNYVQELLVGPSIETLHAANNNIS-RVS-- 115
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
+ ++ LA N + S + ++L N++ + + S + L
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 191 LWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS 250
L N + + + +KL LDL+SN L+ + F + ++ +++R N L
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV----- 227
Query: 251 NGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK-LKGSIPKEI 309
+L L L N + + Q K L G +E
Sbjct: 228 ----LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 310 GNLRGLIALSLFTNDLNGTIPTTLGRL--QQLQALLQRNNLNGPIPTCLSSLISLRQLHL 367
+ DL L L ++ L + + + + R++
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343
Query: 368 GSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPIT 427
Q + I + + ++ +L + + + L +
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHA 402
Query: 428 IGGLKDLITLSLARNRFQD-SIPDSFGSLTSLEYLDLSNNNLS 469
L L R+++ + ++ D+ + +
Sbjct: 403 TEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 35/192 (18%), Positives = 71/192 (36%), Gaps = 12/192 (6%)
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISL 362
+I + N + + L + + ++ L L N L+ L+ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
L+L SN L SL + +DL++N + ++ + L+ + N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 423 NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG-EIPKSFEILSH 481
++ + + LA N+ G + ++YLDL N + +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 482 LKRLNVSHNRLE 493
L+ LN+ +N +
Sbjct: 171 LEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 7/51 (13%), Positives = 22/51 (43%)
Query: 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIP 497
+I + + + +++++L + + ++K L++S N L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA 51
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 78/444 (17%), Positives = 136/444 (30%), Gaps = 80/444 (18%)
Query: 79 IPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLA 138
I ++L + + + L + F ++ +R + + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 139 DLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTG 198
L L + I I T F Q L + N +
Sbjct: 73 LLNLN-DLQIEEIDTYAFA------------------------YAHTIQKLYMGFNAIRY 107
Query: 199 TIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLS 258
P+ N L L L N LS F N L+TL++ N L
Sbjct: 108 LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED--------D 159
Query: 259 SLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIAL 318
+ L+ L L SN L + ++ + L
Sbjct: 160 TFQATTSLQNLQLSSNRLTHV----------------------------DLSLIPSLFHA 191
Query: 319 SLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIP 377
++ N L +TL ++ L N++N + + L L L N LT
Sbjct: 192 NVSYNLL-----STLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLTD--T 241
Query: 378 SSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLIT 436
+ + ++ +DLS N L + ++ L L +S N+L + + + L
Sbjct: 242 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 437 LSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKI 496
L L+ N + + LE L L +N++ + LK L +SHN +
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-N 354
Query: 497 PTNGPFRNFLAQSFLWNYALCGPP 520
FRN + C
Sbjct: 355 SLRALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-29
Identities = 73/422 (17%), Positives = 145/422 (34%), Gaps = 66/422 (15%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
+ ++ + I Y E L K + F + + + + F ++
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNLR 124
++L+L + + ++ +L FN+I +P + N+ L L N+L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 125 GEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPSTMGHS 182
+P I N L L ++ NN + I F +++ + L N+L+ S
Sbjct: 131 -SLPRGIFHNTPKLTTLSMS-NNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSL---- 184
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
+P+ + N L+ ++ + LD + NS++ + L+ L ++ N
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHN 236
Query: 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK 302
LT + L N L + L N L+ I+ F
Sbjct: 237 NLTD----------TAWLLNYPGLVEVDLSYNELEKIMY-------HPFV---------- 269
Query: 303 GSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLIS 361
++ L L + N L + + L+ L L N+L +
Sbjct: 270 --------KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDR 319
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421
L L+L N + + S+ +L+ + LS N N ++ N++R +
Sbjct: 320 LENLYLDHNSIVTLKLSTHHTLK---NLTLSHNDWDC-------NSLRALFRNVARPAVD 369
Query: 422 GN 423
Sbjct: 370 DA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 58/297 (19%), Positives = 107/297 (36%), Gaps = 25/297 (8%)
Query: 199 TIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLS 258
I +++ + ++ + L + + + + + ++
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA-------- 63
Query: 259 SLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEI-GNLRGLIA 317
L + ++ L+L ++ I + Q+ Y ++ +P + N+ L
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPHVFQNVPLLTV 121
Query: 318 LSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSI 376
L L NDL+ +L L + NNL + SL+ L L SN+LT
Sbjct: 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD 181
Query: 377 PSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLIT 436
S SL ++S N LS + + L+ S N ++ + +L
Sbjct: 182 LSLIPSLF---HANVSYNLLS-----TLAIPIAVEELDASHNSINV---VRGPVNVELTI 230
Query: 437 LSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
L L N D + L +DLS N L + F + L+RL +S+NRL
Sbjct: 231 LKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 14/120 (11%), Positives = 38/120 (31%)
Query: 374 SSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKD 433
I S+ + + + + L + + + + +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 434 LITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
+ L+L + ++ +F +++ L + N + P F+ + L L + N L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 26/288 (9%)
Query: 593 LGAGSFGSVYKGTLF-----DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIF 647
LG G+FGSV G VA+K E R FE E E+L++++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 648 SSCCNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
C + + L++E++P GSL +L H +D ++ L + +EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASDGII 764
+H +L NIL++ ++ DFG++K+L +D + + + I + APE ++
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 765 SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT---EVVDASLVREV 821
S DV+S+GV+L E FT E S + G +++ L+ +
Sbjct: 195 SVASDVWSFGVVLYELFTY---------IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 822 QPSY---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866
+ + C I + C ++ QR D+ +++ +I+
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 26/288 (9%)
Query: 593 LGAGSFGSVYKGTLF-----DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIF 647
LG G+FGSV G VA+K E R FE E E+L++++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 648 SSCCNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
C + + L++E++P GSL +L H +D ++ L + +EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASDGII 764
+H +L NIL++ ++ DFG++K+L +D + + + I + APE ++
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 765 SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT---EVVDASLVREV 821
S DV+S+GV+L E FT E S + G +++ L+ +
Sbjct: 226 SVASDVWSFGVVLYELFTY---------IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 822 QPSY---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866
+ + C I + C ++ QR D+ +++ +I+
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 60/286 (20%), Positives = 112/286 (39%), Gaps = 26/286 (9%)
Query: 593 LGAGSFGSVYKGTLF-----DGTNVAIKVF-NLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G FG V G VA+K + E E+LRN+ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 647 FSSCCNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
C L++EF+P+GSL+++L + +++ ++L + + ++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ-- 146
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASDGI 763
VH +L N+L++ ++ DFG++K + D + + + + + APE
Sbjct: 147 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT--EVVDASLVREV 821
DV+S+GV L E T + G T ++ LV +
Sbjct: 206 FYIASDVWSFGVTLHELLTY---------CDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
Query: 822 QPSY---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ +C + L C P R +++ + + +
Sbjct: 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 69/282 (24%), Positives = 107/282 (37%), Gaps = 31/282 (10%)
Query: 593 LGAGSFGSVYKGTL----FDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIK 645
LG GSFG V +G +VA+K L A F E + ++ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
++ K +V E P GSL L H + + V + YL
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--- 141
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASDGII 764
+H +L N+LL ++ DFG+ + L ++DD V Q + APE
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201
Query: 765 SPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823
S D + +GV L E FT ++P + ++ +D R +P
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDKEGERLPRP 247
Query: 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
DC I ++ + C PE R + L + + T
Sbjct: 248 ----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 30/279 (10%)
Query: 593 LGAGSFGSVYKGTLFDG-----TNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKI 646
LG+G+FG+VYKG VAIK +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
C L+ + MP G L ++ H + LN + + + YL +
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
VH +L N+L+ +++DFG++KLLG ++ I +MA E I +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
+ DV+SYGV + E T KP D + E+ + L +G R QP
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSI-LEKGE---------RLPQP-- 241
Query: 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
C + + + C M + R +++++ K+ +
Sbjct: 242 --PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 74/284 (26%), Positives = 120/284 (42%), Gaps = 27/284 (9%)
Query: 593 LGAGSFGSVYKGTLF-----DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIF 647
LG G+FGSV G VA+K R F+ E ++L+ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 648 SSCCNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
++ LV+E++P+G L +L H LD L + +EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASDGII 764
VH +L NIL++ +++DFG++KLL D D V + + I + APE SD I
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 765 SPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPR-GLTEVVDASLVRE-- 820
S + DV+S+GV+L E FT K + + L+ +++ L+ E
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLLE--LLEEGQ 261
Query: 821 --VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
P C + L C SP+ R + + +L +
Sbjct: 262 RLPAP----PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 35/281 (12%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVF--NLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G+G FG V+ G + VAIK E F E EV+ + H L++++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
LV EFM +G L +L + L + +DV + YL + V+H +
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 129
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDV 770
L N L+ +N +VSDFG+++ + DD + T T + + +PE S S K DV
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 771 YSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY---A 826
+S+GVL+ E F+ K P + +EVV+ + +
Sbjct: 189 WSFGVLMWEVFSEGKIPYENR-----------------SNSEVVED-----ISTGFRLYK 226
Query: 827 KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
+ + C + PE R + ++ +L +I ++ L
Sbjct: 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 593 LGAGSFGSVYKGTLFDG---TNVAIKVF-NLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
LG G+FGSV +G +VAIKV + E +++ + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
C LV+E G L K+L + + ++ V + ++YL + VH
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 133
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASDGIISPK 767
+L N+LL A++SDFG+SK LG DD ++ + + APE + S +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 768 CDVYSYGVLLMETFTR-KKPTDEM 790
DV+SYGV + E + +KP +M
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKM 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 593 LGAGSFGSVYKGTLFDGTN----VAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKIF 647
+G+G G V G L VAIK ER R F SE ++ H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+V E+M NGSL+ +L +H+ +++ + ++ VG + YL V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV-TQTMTMATIGYMAPEYASDGIISP 766
H +L N+L+D N+ +VSDFG+S++L +D D+ T T I + APE + S
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
DV+S+GV++ E ++P M +V+ + V+ Y
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNM-----------------TNRDVISS-----VEEGY 271
Query: 826 ---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
A M C + L L C QR + +V L + ++
Sbjct: 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 31/276 (11%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LG+G FG V G +VA+K+ + + F E + + + H L+K + C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLK 712
+V E++ NG L +L SH L+ + L + DV + +L +H +L
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLA 131
Query: 713 PNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYS 772
N L+D+++ +VSDFG+++ + DD V+ T + + APE S K DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 773 YGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY---AKM 828
+G+L+ E F+ K P D +EVV V +
Sbjct: 191 FGILMWEVFSLGKMPYDLY-----------------TNSEVVLK-----VSQGHRLYRPH 228
Query: 829 DCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
I + C + PE+R ++ ++ +++
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 35/282 (12%)
Query: 593 LGAGSFGSVYKGTL----FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIF 647
+GAG FG V G L +VAIK + E+ R F E ++ H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+V E+M NGSL+ +L H+ +++ + ++ + ++YL V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV-TQTMTMATIGYMAPEYASDGIISP 766
H +L NIL++ N+ +VSDFG+ ++L +D ++ T I + +PE + +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
DV+SYG++L E + ++P EM +V+ A V Y
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA-----VDEGY 267
Query: 826 ---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
MDC + L L C R +V L K+ +
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 30/280 (10%)
Query: 593 LGAGSFGSVYKGTLFDG-----TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKI 646
LG+G FG+V+KG V IKV + ++F++ + ++ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
C LV +++P GSL + H L LN + + + YL +
Sbjct: 81 LG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---M 136
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
VH NL N+LL +V+DFG++ LL DD + + I +MA E G +
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
+ DV+SYGV + E T +P + E+ L L +G R QP
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAEV-----PDL-LEKGE---------RLAQP-- 239
Query: 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
C + + + + C M R ++ + ++ +
Sbjct: 240 --QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 52/296 (17%), Positives = 103/296 (34%), Gaps = 49/296 (16%)
Query: 200 IPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSS 259
I N ++ + +SL + + + ++ L++ N L+ +++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA--------D 53
Query: 260 LTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALS 319
L KL L+L SN L L + +L L L
Sbjct: 54 LAPFTKLELLNLSSNVLYETLD---------------------------LESLSTLRTLD 86
Query: 320 LFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPS 378
L N + L ++ L NN++ + S + ++L +N++T
Sbjct: 87 LNNNYV-----QELLVGPSIETLHAANNNISR-VS--CSRGQGKKNIYLANNKITMLRDL 138
Query: 379 SFWSLEYILRIDLSSNSLSG-SLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITL 437
+ +DL N + + + L +LNL N + ++ + L TL
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTL 196
Query: 438 SLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
L+ N+ + F S + ++ L NN L I K+ +L+ ++ N
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 53/309 (17%), Positives = 106/309 (34%), Gaps = 26/309 (8%)
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
+ + + + L + + +A + LDL+ N LS L LN+
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECK 300
+N L L + + LR L L +N + L S + +A
Sbjct: 67 SNVLYE----------TLDLESLSTLRTLDLNNNYVQE-LLVG-----PSIETLHAANNN 110
Query: 301 LKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNG-PIPTCLSS 358
+ + +G + L N + G ++Q L L+ N ++ +S
Sbjct: 111 IS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 359 LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRN 418
+L L+L N + + + +DLSSN L+ + + Q+ + +++L N
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 419 QLSGNIPITIGGLKDLITLSLARNRFQ-DSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFE 477
+L I + ++L L N F ++ D F ++ + +
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 478 ILSHLKRLN 486
+ L
Sbjct: 284 TVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 57/350 (16%), Positives = 115/350 (32%), Gaps = 52/350 (14%)
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
++ ++ + ++S + + + ++ LD N +S + + TKL LN + N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
L E ++ +L L L L N + + +I ++ N +S + G
Sbjct: 70 LY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQG 121
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG-QIPNTFGNLRHLSTLNIRA 241
+ + L N++T S++ LDL N + + L LN++
Sbjct: 122 K---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N++ + KL+ L L SN L
Sbjct: 179 NFIYD----------VKGQVVFAKLKTLDLSSNKLA------------------------ 204
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLN-GPIPTCLSSL 359
+ E + G+ +SL N L I L Q L+ L+ N + G + S
Sbjct: 205 --FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
Query: 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRID-LSSNSLSGSLPSDIQNLK 408
++ + + + + ++ + L + L
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 49/272 (18%), Positives = 105/272 (38%), Gaps = 22/272 (8%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
N + +++++ + L + +K L + N L+ + + F+KL++L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
+N + L +LS+L LD ++ N ++ + L+ A+NN+ +
Sbjct: 66 SSNVLYETLD--LESLSTLRTLD-----LNNNYVQELLVGPSIETLHAANNNIS-RVSCS 117
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
+ ++ LA N + S + ++L N++ + + S + L
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 191 LWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS 250
L N + + + +KL LDL+SN L+ + F + ++ +++R N L
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV----- 227
Query: 251 NGEWSFLSSLTNCNKLRALSLGSNPLDSILPP 282
+L L L N
Sbjct: 228 ----LIEKALRFSQNLEHFDLRGNGFHCGTLR 255
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 36/203 (17%), Positives = 73/203 (35%), Gaps = 13/203 (6%)
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISL 362
+I + N + + L + + ++ L L N L+ L+ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
L+L SN L SL + +DL++N + ++ + L+ + N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 423 NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG-EIPKSFEILSH 481
++ + + LA N+ G + ++YLDL N + +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 482 LKRLNVSHNRLEGKIPTNGPFRN 504
L+ LN+ +N + + F
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAK 192
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 41/274 (14%), Positives = 87/274 (31%), Gaps = 17/274 (6%)
Query: 8 PPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQV 67
+ + L L++S N +L L L+ L N + + V ++
Sbjct: 51 AADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIET 103
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG-E 126
L NN+ + + S + N I+ G +++ +L+ N +
Sbjct: 104 LHAANNNISR-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160
Query: 127 IPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNR 186
+ L L L N I + + + + ++L N+L+
Sbjct: 161 FAELAASSDTLEHLNLQ-YNFIYDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQS-AAGV 216
Query: 187 QFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246
++ L N+L I ++ + L DL N ++ + +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK 274
Query: 247 ETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSIL 280
T N E + +L + L + D ++
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 8/90 (8%), Positives = 28/90 (31%), Gaps = 2/90 (2%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLT-GSFPSWIGVFSK 64
+ P + + + ++ + N + L + L+ N G+ + +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 65 LQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94
+Q ++ + + +L +
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-36
Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSS 649
LG G FG V+ GT T VAIK +F E +V++ +RH L+++++
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA- 246
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
+ + +V E+M GSL +L +L + + +++ + + Y+ + VH
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+L+ NIL+ +N+ +V+DFG+++L+ ED++ + I + APE A G + K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 769 DVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY-- 825
DV+S+G+LL E T+ + P M EV+D V+ Y
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGM-----------------VNREVLDQ-----VERGYRM 400
Query: 826 -AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
+C + L C PE+R + L+ +
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 593 LGAGSFGSVYKGTLFDG-----TNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKI 646
LG+G+FG+VYKG VAIK +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
C L+ + MP G L ++ H + LN + + + YL +
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---L 138
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
VH +L N+L+ +++DFG++KLLG ++ I +MA E I +
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
+ DV+SYGV + E T KP D + E+ + L +G R QP
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSI-LEKGE---------RLPQP-- 241
Query: 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
C + + + + C M + R +++++ K+ +
Sbjct: 242 --PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 57/276 (20%), Positives = 109/276 (39%), Gaps = 31/276 (11%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LG G FG V G +VAIK+ + F E +V+ N+ H L++++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLK 712
++ E+M NG L +L + + L + DV A+EYL +H +L
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 147
Query: 713 PNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYS 772
N L++ +VSDFG+S+ + DD+ + + + + PE S K D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 773 YGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY---AKM 828
+GVL+ E ++ K P + +E + +
Sbjct: 207 FGVLMWEIYSLGKMPYERF-----------------TNSETAEH-----IAQGLRLYRPH 244
Query: 829 DCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
++ + C + ++R ++ + +
Sbjct: 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-36
Identities = 67/287 (23%), Positives = 121/287 (42%), Gaps = 35/287 (12%)
Query: 591 NLLGAGSFGSVYKGTLFDG----TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645
++G G FG VY GTL D + A+K N F +E ++++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 646 IFSSCCNLDFKAL-VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ C + L VL +M +G L ++ + + + + + + V +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT--IGYMAPEYASDG 762
VH +L N +LD+ T +V+DFG+++ + + + T A + +MA E
Sbjct: 213 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 763 IISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEM--SLKHWIKLSLPRGLTEVVDASLVR 819
+ K DV+S+GVLL E TR P ++ T ++ L +L P
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP------------- 318
Query: 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866
C + + L C E R +++V ++ I TF
Sbjct: 319 --------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 11/204 (5%)
Query: 593 LGAGSFGSVYKGTLFDGTN----VAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIF 647
+G G FG V++G N VAIK + F E +R H +++K+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+++E G L +L Y LD+ + + AL YL V
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 138
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
H ++ N+L+ N ++ DFG+S+ + ED + I +MAPE + +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 768 CDVYSYGVLLMETFTR-KKPTDEM 790
DV+ +GV + E KP +
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGV 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 36/283 (12%)
Query: 593 LGAGSFGSVYKGTLFDGTN-----VAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKI 646
+GAG FG VYKG L + VAIK E+ F E ++ H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
++ E+M NG+L+K+L + +L+ + ++ + ++YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM-TMATIGYMAPEYASDGIIS 765
VH +L NIL++ N+ +VSDFG+S++L +D ++ T I + APE S +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 766 PKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824
DV+S+G+++ E T ++P E+ EV+ A +
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWEL-----------------SNHEVMKA-----INDG 266
Query: 825 Y---AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ MDC I L + C +R D+V L K+ +
Sbjct: 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 51/194 (26%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSS 649
LGAG FG V+ T T VA+K + +F +E V++ ++H L+K+ +
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHA- 250
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNY-FLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
+ ++ EFM GSL +L S + + ++ + + ++ + +H
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+L+ NIL+ ++ +++DFG+++++ ED++ + I + APE + G + K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 769 DVYSYGVLLMETFT 782
DV+S+G+LLME T
Sbjct: 367 DVWSFGILLMEIVT 380
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 66/283 (23%), Positives = 119/283 (42%), Gaps = 35/283 (12%)
Query: 591 NLLGAGSFGSVYKGTLFDG----TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645
++G G FG VY GTL D + A+K N F +E ++++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 646 IFSSCCNLDFKAL-VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ C + L VL +M +G L ++ + + + + + + V ++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-- 148
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT--IGYMAPEYASDG 762
VH +L N +LD+ T +V+DFG+++ + + + T A + +MA E
Sbjct: 149 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 763 IISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEM--SLKHWIKLSLPRGLTEVVDASLVR 819
+ K DV+S+GVLL E TR P ++ T ++ L +L P
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP------------- 254
Query: 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
C + + L C E R +++V ++ I
Sbjct: 255 --------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 31/220 (14%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
F E +LG G+FG V K D AIK E + SE +L ++ H+ +++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVR 66
Query: 646 IFSSCCNLDFKA-------------LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVG 692
+++ + +E+ NG+L ++S N E + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT-- 750
AL Y+H ++H +LKP NI +D++ ++ DFG++K + D +
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 751 -------IG---YMAPE-YASDGIISPKCDVYSYGVLLME 779
IG Y+A E G + K D+YS G++ E
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 65/292 (22%), Positives = 122/292 (41%), Gaps = 36/292 (12%)
Query: 593 LGAGSFGSVYKGTL-----FDGTNVAIKVFNLQ---LERAFRSFESECEVLRNVRHRNLI 644
LG G FG V G VA+K L+ + ++ E ++LR + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 645 KIFSSCCNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
K C + + LV+E++P GSL +L H+ + + + L + + YLH H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH 154
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASD 761
+H +L N+LLD + ++ DFG++K + E + + + + + APE +
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 762 GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG---LTEVVDASLV 818
DV+S+GV L E T + T + L + + +G + + + L+
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----IGIAQGQMTVLRLTE--LL 264
Query: 819 RE----VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866
+P C + HL C R +++ L+ + + +
Sbjct: 265 ERGERLPRP----DKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 3e-35
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 593 LGAGSFGSVYKGTLFDG---TNVAIKVF-NLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
LG G+FGSV +G +VAIKV + E +++ + + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
C LV+E G L K+L + + ++ V + ++YL + VH
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 459
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASDGIISPK 767
NL N+LL A++SDFG+SK LG DD ++ + + APE + S +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 768 CDVYSYGVLLMETFTR-KKPTDEM 790
DV+SYGV + E + +KP +M
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKM 543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 49/204 (24%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNL--QLERAFRSFESECEVLRNVRHRNLIKIFS 648
+G GSF +VYKG VA + + F+ E E+L+ ++H N+++ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 649 SCCNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
S + LV E M +G+L+ +L + R + + L++LH + +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLH-TRTP 150
Query: 705 PVVHCNLKPNNILLD-KNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEYASDG 762
P++H +LK +NI + + ++ D G++ L + + T +MAPE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEFMAPEMYEEK 205
Query: 763 IISPKCDVYSYGVLLMETFTRKKP 786
DVY++G+ ++E T + P
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYP 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-35
Identities = 73/285 (25%), Positives = 128/285 (44%), Gaps = 41/285 (14%)
Query: 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSS 649
LG G FG V+ GT T VAIK +F E +V++ +RH L+++++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA- 329
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
+ + +V E+M GSL +L +L + + +++ + + Y+ + VH
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+L+ NIL+ +N+ +V+DFG+++L+ ED++ + I + APE A G + K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 769 DVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAK 827
DV+S+G+LL E T+ + P M EV+D V+ Y +
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGM-----------------VNREVLDQ-----VERGY-R 482
Query: 828 MDC-------LLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
M C L +M C PE+R + L+ +
Sbjct: 483 MPCPPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 593 LGAGSFGSVYKGTL---FDGTNVAIKVF--NLQLERAFRSFESECEVLRNVRHRNLIKIF 647
LG+G+FG+V KG VA+K+ +E V++ + + ++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
C + LV+E G L K+L + + + + ++ V + ++YL S+ V
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN---FV 139
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAPEYASDGIISP 766
H +L N+LL A++SDFG+SK L D++ QT + + APE + S
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 767 KCDVYSYGVLLMETFTR-KKPTDEM 790
K DV+S+GVL+ E F+ +KP M
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 50/191 (26%), Positives = 103/191 (53%), Gaps = 7/191 (3%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
LGAG FG V+ G T VA+K +F +E +++ ++H+ L+++++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 653 LDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+ ++ E+M NGSL +L + + L + + L++ + + ++ + +H +L
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVY 771
+ NIL+ ++ +++DFG+++L+ ED++ + I + APE + G + K DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 772 SYGVLLMETFT 782
S+G+LL E T
Sbjct: 195 SFGILLTEIVT 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 591 NLLGAGSFGSVYKGTLFDG----TNVAIKVFN-LQLERAFRSFESECEVLRNVRHRNLIK 645
++G G FG VY G D AIK + + + +F E ++R + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 646 IFSSCCNLD-FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ + ++L +M +G L +++ S + + ++ + V +EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK-- 144
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT--IGYMAPEYASDG 762
VH +L N +LD++ T +V+DFG+++ + + + Q A + + A E
Sbjct: 145 -FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 763 IISPKCDVYSYGVLLMETFTR 783
+ K DV+S+GVLL E TR
Sbjct: 204 RFTTKSDVWSFGVLLWELLTR 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 593 LGAGSFGSVYKGTLFDG----TNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKIF 647
LG G FG VY+G + NVA+K F SE +++N+ H +++K+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+ +++E P G L +L + L +L + + + A+ YL + V
Sbjct: 80 GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CV 135
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
H ++ NIL+ ++ DFG+S+ + ED+D ++T I +M+PE + +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 768 CDVYSYGVLLMETFTR-KKPTDEM 790
DV+ + V + E + K+P +
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWL 218
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 50/210 (23%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIK 645
F ++LG G+ G++ +FD +VA+K + F + E ++LR H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
F + + F+ + +E +L++++ ++ LE + ++ L +LH +
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--- 138
Query: 706 VVHCNLKPNNILL-----DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEY- 758
+VH +LKP+NIL+ + A +SDFG+ K L S ++ + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 759 --ASDGIISPKCDVYSYGVLLMETFTRKKP 786
+ D++S G + +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 593 LGAGSFGSVYKGTLFDG----TNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKI 646
LG G FGSV +G L VA+K L +R F SE +++ H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 647 FSSCCNLDFKA-----LVLEFMPNGSLEKWLYSH-----NYFLDMLERLNIMIDVGLALE 696
C + + ++L FM G L +L + + L M+D+ L +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YL + + +H +L N +L +MT V+DFG+SK + D + + ++A
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTR 783
E +D + + K DV+++GV + E TR
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-34
Identities = 71/344 (20%), Positives = 124/344 (36%), Gaps = 39/344 (11%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
+P I + +++L N++ P+ + L L N ++ P + N L
Sbjct: 26 VPEGIP--TETRLLDLGKNRIKTLNQDEFAS-FPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 211 IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
L L SN L F L +L+ L+I N + + L++L
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDY--------MFQDLYNLKSLE 134
Query: 271 LGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP 330
+G N L I FS L L L+L +L
Sbjct: 135 VGDNDLVYISH---RAFS----------------------GLNSLEQLTLEKCNLTSIPT 169
Query: 331 TTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRI 389
L L L L L+ N+N L L+ L + ++ + + +
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 390 DLSSNSLSGSLPSD-IQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSI 448
++ +L+ ++P +++L L +LNLS N +S + L L + L +
Sbjct: 230 SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288
Query: 449 PDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
P +F L L L++S N L+ F + +L+ L + N L
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-29
Identities = 63/311 (20%), Positives = 104/311 (33%), Gaps = 58/311 (18%)
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
+ L L NR+ + + L L+LN N +S P F NL +L TL +R+N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
L T + L L + N + +L FQ
Sbjct: 92 LKLIPLG--------VFTGLSNLTKLDISENKIVILLD-------YMFQ----------- 125
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISL 362
+L L +L + NDL L L+ L L++ NL LS L L
Sbjct: 126 -------DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGL 178
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
L L + + SF L + +++S ++ + L L+++ L+
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT- 237
Query: 423 NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHL 482
+P + L L +L+LS N +S L L
Sbjct: 238 AVP-----------------------YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274
Query: 483 KRLNVSHNRLE 493
+ + + +L
Sbjct: 275 QEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 76/362 (20%), Positives = 133/362 (36%), Gaps = 41/362 (11%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLT----GSFPSWIGV 61
VP I + LD+ +N + +E L+ L N ++ G+F +
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN---- 78
Query: 62 FSKLQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFA 119
L+ L LR+N IP +F LS+L +LD N I + + +L L L
Sbjct: 79 LFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136
Query: 120 DNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPS 177
DN+L I + L +L L L + IPT ++ +I++ L ++ R
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLE-KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 178 TMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTL 237
+ L + L + T+ + L L + +L+ +L +L L
Sbjct: 195 SF-KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFL 253
Query: 238 NIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAH 297
N+ N ++T S L +L+ + L L + P + +
Sbjct: 254 NLSYNPISTIEG--------SMLHELLRLQEIQLVGGQLAVVEPYAFRGLN-YLRVLNVS 304
Query: 298 ECKLKGSIPKEI-GNLRGLIALSLFTNDLNGTIPTTLG---RLQQLQALLQRNNLNGPIP 353
+L ++ + + ++ L L L +N L RL + R N N P
Sbjct: 305 GNQLT-TLEESVFHSVGNLETLILDSNPLA--------CDCRLLWVFRRRWRLNFNRQQP 355
Query: 354 TC 355
TC
Sbjct: 356 TC 357
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
F E L+G+G FG V+K DG IK E+A R E + L + H N++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 646 IFSSCCNLDFKA----------------LVLEFMPNGSLEKWLYSHN-YFLDMLERLNIM 688
D+ + +EF G+LE+W+ LD + L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 689 IDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748
+ ++Y+H +++ +LKP+NI L ++ DFG+ L D
Sbjct: 129 EQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--- 182
Query: 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790
T+ YM+PE S + D+Y+ G++L E E
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 593 LGAGSFGSVYKGTLFDG----TNVAIKVF--NLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G FGSV + L VA+K+ ++ F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 647 FSSCCNLDFKA------LVLEFMPNGSLEKWLYSH-----NYFLDMLERLNIMIDVGLAL 695
K ++L FM +G L +L + + L + + M+D+ +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755
EYL + +H +L N +L ++MT V+DFG+S+ + D + + ++A
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 756 PEYASDGIISPKCDVYSYGVLLMETFTR 783
E +D + + DV+++GV + E TR
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-34
Identities = 79/331 (23%), Positives = 134/331 (40%), Gaps = 58/331 (17%)
Query: 163 IINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG 222
++N+ + L+ P + + L++ N LT ++P L L+++ N L+
Sbjct: 44 VLNVGESGLT-TLPDCLPAHI---TTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLT- 94
Query: 223 QIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPP 282
+P L LS + +L S L L + N L S LP
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPSG---------------LCKLWIFGNQLTS-LPV 138
Query: 283 LIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL 342
L Q+ + +L S+P L L + N L ++P LQ+L
Sbjct: 139 LPPGL----QELSVSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQELS-- 187
Query: 343 LQRNNLNGPIPTCLSSLI-SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLP 401
+ N L L +L L +L +N+LTS +P+ L+ + +S N L+ SLP
Sbjct: 188 VSDNQL-----ASLPTLPSELYKLWAYNNRLTS-LPALPSGLK---ELIVSGNRLT-SLP 237
Query: 402 SDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYL 461
LK L +S N+L+ ++P+ GL +LS+ RN+ +P+S L+S +
Sbjct: 238 VLPSELK---ELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTV 289
Query: 462 DLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
+L N LS E + L + +
Sbjct: 290 NLEGNPLS-ERT--LQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 78/415 (18%), Positives = 134/415 (32%), Gaps = 84/415 (20%)
Query: 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALN 145
+ L+ + ++ +P + + L DNNL +P L+ L ++
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL-EV---SG 90
Query: 146 NLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSIT 205
N + +P + + I + L L ++ N+LT ++P
Sbjct: 91 NQLTSLPVLPPGLLELSIFSNPLTHLPA--------LPSGLCKLWIFGNQLT-SLPVLPP 141
Query: 206 NASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNK 265
L L ++ N L+ +P L L N N LT S +
Sbjct: 142 G---LQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT---------SLPMLPSG--- 182
Query: 266 LRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDL 325
L+ LS+ N L S+P L L A + N L
Sbjct: 183 LQELSVSDNQL--------------------------ASLPTLPSELYKLWAYN---NRL 213
Query: 326 NGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEY 385
++P L++L + N L +P S L ++L + N+LTS +P L
Sbjct: 214 T-SLPALPSGLKELI--VSGNRLTS-LPVLPSEL---KELMVSGNRLTS-LPMLPSGLL- 264
Query: 386 ILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQ 445
+ + N L+ LP + +L +NL N LS + + S RF
Sbjct: 265 --SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
Query: 446 ---DSIPDSFGSLTSLEYLDLSNNNLSG----EIPKSFEILSHLKRLNVSHNRLE 493
S P +L L + F + ++ +RL
Sbjct: 322 MAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 73/417 (17%), Positives = 134/417 (32%), Gaps = 84/417 (20%)
Query: 38 LRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFN 97
L + LT + P + + + L + +N+ T +P L + L+ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPALPPELRT---LEVSGN 91
Query: 98 SISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFN 157
++ ++P L +L + +L P L L + N + +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL-WI---FGNQLTSLPVLPPG 142
Query: 158 ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNS 217
+ +++ NQL +++ L + N+LT ++P + L L ++
Sbjct: 143 LQE---LSVSDNQL-----ASLPALPSELCKLWAYNNQLT-SLPMLPSG---LQELSVSD 190
Query: 218 NSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
N L+ +P L L N N LT S + + L+ L + N L
Sbjct: 191 NQLA-SLPTLPSELYKLWAYN---NRLT---------SLPALPSG---LKELIVSGNRL- 233
Query: 278 SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQ 337
S+P L+ L + N L ++P L
Sbjct: 234 -------------------------TSLPVLPSELK---ELMVSGNRLT-SLPMLPSGLL 264
Query: 338 QLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS---SIPSSFWSLEYILRIDLSSN 394
L + RN L +P L L S ++L N L+ S + +
Sbjct: 265 SLS--VYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
Query: 395 SLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPIT----IGGLKDLITLSLARNRFQDS 447
S P + + L + L + P G + SL +R ++
Sbjct: 322 MAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 68/378 (17%), Positives = 123/378 (32%), Gaps = 66/378 (17%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
++P L L++S N LP L L L L
Sbjct: 75 SLPALPPELR---TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------L 123
Query: 66 QVLSLRNNSFTGPIPNSLFNL-----------------SSLVRLDSRFNSISGNIPSKIG 108
L + N T +P L S L +L + N ++ ++P
Sbjct: 124 CKLWIFGNQLTS-LPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLT-SLPMLPS 181
Query: 109 NLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVG 168
L L+ +DN L +P L L A NN + +P + +I+
Sbjct: 182 GLQ---ELSVSDNQLA-SLPTLPSELYKLW----AYNNRLTSLPALPSGLKELIVSG--- 230
Query: 169 NQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTF 228
N+L +++ + L++ NRLT ++P + L+ L + N L+ ++P +
Sbjct: 231 NRL-----TSLPVLPSELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESL 280
Query: 229 GNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFS 288
+L +T+N+ N L+ T ++ + S P+
Sbjct: 281 IHLSSETTVNLEGNPLSERTLQ-----------ALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 289 ASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLN-GTIPTTLGRLQQLQALLQRNN 347
+ A L +P G +F + N L RL + + ++
Sbjct: 330 ETRALHLAAADWL---VPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAG 386
Query: 348 LNGPIPTCLSSLISLRQL 365
I + L+ L L
Sbjct: 387 FKAQISSWLAQLAEDEAL 404
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-34
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 7/195 (3%)
Query: 590 CNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFS 648
+ LG G +G VY+G VA+K F E V++ ++H NL+++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLG 283
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
C ++ EFM G+L +L N + + L + + A+EYL + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
H NL N L+ +N +V+DFG+S+L+ D I + APE + S K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 768 CDVYSYGVLLMETFT 782
DV+++GVLL E T
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-33
Identities = 83/482 (17%), Positives = 161/482 (33%), Gaps = 58/482 (12%)
Query: 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSK---LQVLSLRNNSF 75
L+IS+N +++ L +L+ L ++N + VF L+ L L +N
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDI--SVFKFNQELEYLDLSHNKL 81
Query: 76 TGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLK 135
+ NL L + F+++ I + GN+++L L + +L I +L
Sbjct: 82 VKISCHPTVNLKHLDLSFNAFDALP--ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 136 NLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANR 195
L++ +++V N++F +
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIV--------------FPTNKEFHFILDVS 185
Query: 196 LTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWS 255
+ ++N ++ + S LS I LS L + T +
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLS--ILAKLQTNPKLSNLTLNNIETTWNSFIR---- 239
Query: 256 FLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGL 315
+ L + S+ + L +F S +L+ L
Sbjct: 240 -ILQLVWHTTVWYFSISNVKLQG--QLDFRDFDYSGT------------------SLKAL 278
Query: 316 IALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS 374
+ ++ + + C S + L +N LT
Sbjct: 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338
Query: 375 SIPSSFWSLEYILRIDLSSNSLSGSLPSDI---QNLKVLIYLNLSRNQLSGNIPITI-GG 430
++ + L + + L N L L +K L L++S+N +S +
Sbjct: 339 TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 431 LKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
K L++L+++ N D+I ++ LDL +N + IPK L L+ LNV+ N
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN 454
Query: 491 RL 492
+L
Sbjct: 455 QL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 4e-21
Identities = 56/382 (14%), Positives = 122/382 (31%), Gaps = 36/382 (9%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
+P + I+N+ N +S S + SL + L++ NR+ + +L
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDI-LSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 211 IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
LDL+ N L I +L L++ N + +++ L+ L
Sbjct: 72 EYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFD----ALPICKEFGNMSQ---LKFLG 121
Query: 271 LGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP 330
L + L+ I + + S E + ++ L+ SL
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 331 TTLGR----------LQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPS-- 378
+ L ++ +L+ N + + + + +L N + ++ S
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 379 ---SFWSLEYILRIDLSSNSLSGSLPSDI-----QNLKVLIYLNLSRNQLSGNIPITIGG 430
+ +S+ L G L +LK L + +
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298
Query: 431 LKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
++ + + + ++ +LD SNN L+ + ++ L+ L+ L + N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358
Query: 491 RLEGKIPTNGPFRNFLAQSFLW 512
+L+ + L
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLD 380
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 42/239 (17%), Positives = 85/239 (35%), Gaps = 14/239 (5%)
Query: 13 NLSFLMYLDISENNFRGYLPNELG-----QLRRLKFLGFAYNDLTGSFPSWIGVFSKLQV 67
+ + Y IS +G L L+ L + +FS + +
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEI 127
+ + +S + LD N ++ + G+LT+L L N L+ E+
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 128 PNEIG---NLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPSTMGHSL 183
+K+L L ++ N++ +++ +N+ N L+ + +
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI 423
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
+ L L +N++ +IP + L L++ SN L F L L + + N
Sbjct: 424 ---KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 13/192 (6%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC- 651
+G G FG V G + G VA+K ++ + ++F +E V+ +RH NL+++
Sbjct: 201 IGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+V E+M GSL +L S L L +DV A+EYL ++ VH +
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDV 770
L N+L+ ++ A+VSDFG++K + S TQ + + APE + S K DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 771 YSYGVLLMETFT 782
+S+G+LL E ++
Sbjct: 370 WSFGILLWEIYS 381
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 592 LLGAGSFGSVYKGTLFD---GTNVAIKVFNLQLER--AFRS-FESECEVLRNVRHRNLIK 645
L+G G G VY+ D VA+K+ + L FR+ + E ++ +++
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 646 IFSSCCNLDFKA------LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
I DF + + + L L L + I+ +G AL+ H
Sbjct: 99 IH------DFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH 151
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT-MTMATIGYMAPEY 758
+ H ++KP NIL+ + A + DFGI+ D+ +TQ T+ T+ YMAPE
Sbjct: 152 AAG---ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPER 206
Query: 759 ASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE---MSLKH 799
S+ + + D+Y+ +L E T P + G+ + H
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAH 246
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 7/193 (3%)
Query: 593 LGAGSFGSVYKGTLFDG-TNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
LG G +G VY+G VA+K F E V++ ++H NL+++ C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
++ EFM G+L +L N + + L + + A+EYL + +H +
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 711 LKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDV 770
L N L+ +N +V+DFG+S+L+ D I + APE + S K DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 771 YSYGVLLMETFTR 783
+++GVLL E T
Sbjct: 196 WAFGVLLWEIATY 208
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 29/248 (11%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIF 647
LG G +VY VAIK + E + FE E + H+N++ +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
D LV+E++ +L +++ SH L + +N + +++ H +V
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMR---IV 133
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT-MTMATIGYMAPEYASDGIISP 766
H ++KP NIL+D N T ++ DFGI+K L + S+TQT + T+ Y +PE A
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 767 KCDVYSYGVLLMETFTRKKPTDEMFTGE----MSLKH----------WIKLSLPRGLTEV 812
D+YS G++L E + P F GE +++KH ++ +P+ L+ V
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247
Query: 813 VDASLVRE 820
+ + ++
Sbjct: 248 ILRATEKD 255
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 10/195 (5%)
Query: 593 LGAGSFGSVYKGTLFDGTN----VAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIF 647
+G G FG V++G N VAIK + F E +R H +++K+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+ +++E G L +L + LD+ + + AL YL V
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FV 513
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
H ++ N+L+ N ++ DFG+S+ + ED + I +MAPE + +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 768 CDVYSYGVLLMETFT 782
DV+ +GV + E
Sbjct: 573 SDVWMFGVCMWEILM 587
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 16/213 (7%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFS 648
+G GS+G K DG + K + E + SE +LR ++H N+++ +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 649 SCCNLDFKAL--VLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ L V+E+ G L + +LD L +M + LAL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 704 TP--VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
V+H +LKP N+ LD ++ DFG++++L D +T T YM+PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFV-GTPYYMSPEQMNR 190
Query: 762 GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
+ K D++S G LL E P FT
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNL--IKI 646
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ + +V+E N L WL D ER + ++ A+ +H +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---I 148
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE--------- 757
VH +LKP N L+ M ++ DFGI+ + D SV + + T+ YM PE
Sbjct: 149 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 758 --YASDGIISPKCDVYSYGVLLMETFTRKKP 786
S ISPK DV+S G +L K P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G G FG V G G VA+K ++ + ++F +E V+ +RH NL+++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLG-V 82
Query: 651 CNLDFKAL--VLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+ L V E+M GSL +L S L L +DV A+EYL ++ V
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
H +L N+L+ ++ A+VSDFG++K + S TQ + + APE + S K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 768 CDVYSYGVLLMETFT 782
DV+S+G+LL E ++
Sbjct: 195 SDVWSFGILLWEIYS 209
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-32
Identities = 83/393 (21%), Positives = 142/393 (36%), Gaps = 26/393 (6%)
Query: 87 SSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALN 145
+ + +D NSI+ + L L L I N L +L L L
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD-Y 88
Query: 146 NLIGPIPTTIF-NISTIIIINLVGNQLSGHR-PSTMGHSLPNRQFLLLWANRLTGTIPNS 203
N + T F ++ + ++ L L G L + + L+L N + P S
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 204 I-TNASKLIGLDLNSNSLSGQIPNTFGNL--RHLSTLNIRANYLTTETSSNGEWSFLSSL 260
N + LDL N + N +H + L + + L W +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 261 TNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSL 320
+ L L N + F + L + + S
Sbjct: 209 FKNTSITTLDLSGNGFKESMA---KRFFDAIAGTKIQSLIL---------SNSYNMGSSF 256
Query: 321 FTNDLNGTIPTTLGRLQ--QLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIP 377
+ T L+ ++ L ++ + + + S L QL L N++
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDD 316
Query: 378 SSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLIT 436
++FW L ++L+++LS N L S+ S + +NL L L+LS N + + GL +L
Sbjct: 317 NAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375
Query: 437 LSLARNRFQDSIPDS-FGSLTSLEYLDLSNNNL 468
L+L N+ + S+PD F LTSL+ + L N
Sbjct: 376 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 70/363 (19%), Positives = 117/363 (32%), Gaps = 60/363 (16%)
Query: 159 STIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIP-NSITNASKLIGLDLNS 217
+ + ++L N ++ T L + QFL + I N+ S LI L L+
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 218 NSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
N F L +L L + L S + L+SL L L N +
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM------LVLRDNNIK 142
Query: 278 SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQ 337
I P ++ F N+R L L N + L Q
Sbjct: 143 KIQP------ASFFL------------------NMRRFHVLDLTFNKVKSICEEDLLNFQ 178
Query: 338 QLQAL-----------LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYI 386
+ L S+ L L N S+ F+
Sbjct: 179 GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238
Query: 387 LRI-------------DLSSNSLSGSLPSDIQNLKV--LIYLNLSRNQLSGNIPITI-GG 430
+I + + L+ + +LS++++ + ++
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSH 297
Query: 431 LKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
DL L+LA+N ++F LT L L+LS N L + FE L L+ L++S+N
Sbjct: 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYN 357
Query: 491 RLE 493
+
Sbjct: 358 HIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 72/396 (18%), Positives = 134/396 (33%), Gaps = 36/396 (9%)
Query: 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF---SKLQVLSLRNN 73
+ Y+D+S N+ +L+ L+FL + F S L +L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRGLSSLIILKLDYN 89
Query: 74 SFTGPIPNSLF-NLSSLVRLDSRFNSI-SGNIPSKI-GNLTKLVHLNFADNNLRGEIPNE 130
F + F L++L L ++ + LT L L DNN++ P
Sbjct: 90 QFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 131 I-GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFL 189
N++ L L N + I N G + R L +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKS-ICEEDLL-------NFQGKHFTLLR-------LSSITLQ 193
Query: 190 LLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTF---GNLRHLSTLNIRANYLTT 246
+ L + + + LDL+ N + F + +L + +Y
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 247 ETSSNGEWSFLSSLT----NCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK 302
+ + + + T + ++ L + + ++ + + +Q + ++
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFAL-LKSVFSHFTDLEQLTLAQNEIN 312
Query: 303 GSIPKEI-GNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLI 360
I L L+ L+L N L L +L+ L L N++ L
Sbjct: 313 -KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP 371
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSL 396
+L++L L +NQL S F L + +I L +N
Sbjct: 372 NLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 35/172 (20%), Positives = 58/172 (33%), Gaps = 13/172 (7%)
Query: 328 TIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPS-SFWSLEYI 386
+P + + L N++ T S L L+ L + I + +F L +
Sbjct: 27 ELPAHVNYVD-----LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 387 LRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQL-SGNIPITI-GGLKDLITLSLARNR 443
+ + L N L + L L L L++ L + L L L L N
Sbjct: 82 IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 444 FQDSIPDS-FGSLTSLEYLDLSNNNLSGEIPKSFEIL--SHLKRLNVSHNRL 492
+ P S F ++ LDL+ N + + H L +S L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL 192
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 6e-16
Identities = 40/223 (17%), Positives = 74/223 (33%), Gaps = 18/223 (8%)
Query: 306 PKEIGNLRGLIALSLFTNDLNGTIPT-TLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLR 363
L+ L L + I T L L L L N + L +L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLE 106
Query: 364 QLHLGSNQLTSSI--PSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQL 420
L L L ++ + F L + + L N++ P+ N++ L+L+ N++
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166
Query: 421 S----------GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG 470
T+ L + + + TS+ LDLS N
Sbjct: 167 KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 471 EIPKSF---EILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSF 510
+ K F + ++ L +S++ G + F++ +F
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 50/294 (17%), Positives = 93/294 (31%), Gaps = 41/294 (13%)
Query: 13 NLSFLMYLDISENNFRGYLPNEL-GQLRRLKFLGFAYNDLTGSFPSWIGVFSKL------ 65
L+ L L + +NN + P +RR L +N + S
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICE--EDLLNFQGKHFT 183
Query: 66 -------QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLV---- 114
+ + + F +S+ LD N ++ + +
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 115 -HLNFADNNLRGEIPNEIGNLKNLADLVLALNNL---------IGPIPTTIF-NISTIII 163
L+ + N + N L + + I + ++F + + +
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQ 303
Query: 164 INLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQ 223
+ L N+++ L + L L N L N KL LDL+ N +
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRAL 362
Query: 224 IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
+F L +L L + N L + +G + L+SL + L +NP D
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKS--VPDGIFDRLTSLQK------IWLHTNPWD 408
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 51/295 (17%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFN-LQLERAFRSFESECEVLRNVRHRNLIK 645
LG G+FG VY+G + VA+K + E+ F E ++ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH------NYFLDMLERLNIMIDVGLALEYLH 699
+ +++E M G L+ +L L ML+ L++ D+ +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 700 HSHSTPVVHCNLKPNNILLDK---NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
+H +H ++ N LL A++ DFG+++ + M + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP-RGLT--EVV 813
E +GI + K D +S+GVLL E F+ G M P + EV+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PYPSKSNQEVL 255
Query: 814 DASLVREV----QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ V P +C + + C PE R ++ +++ Q
Sbjct: 256 E--FVTSGGRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 593 LGAGSFGSVYKGTL--------FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI 644
LG G+F ++KG T V +KV + SF ++ + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ C D LV EF+ GSL+ +L + +++L +L + + A+ +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 705 PVVHCNLKPNNILLDK--------NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
++H N+ NILL + ++SD GIS + D + I ++ P
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPP 186
Query: 757 EYASDGII-SPKCDVYSYGVLLMETFTR-KKP 786
E + + D +S+G L E + KP
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-32
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 581 QQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFN-LQLERAFRSFESECEVLRNV 638
+ + ++LG G+ +V++G G AIKVFN + R E EVL+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 639 RHRNLIKIFS--SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLA 694
H+N++K+F+ K L++EF P GSL L + + E L ++ DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 695 LEYLHHSHSTPVVHCNLKPNNILL----DKNMTARVSDFGISKLLGEDDDSVTQTMTMA- 749
+ +L + +VH N+KP NI+ D +++DFG ++ L +D Q +++
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD----EQFVSLYG 177
Query: 750 TIGYMAPEYASDGII--------SPKCDVYSYGVLL 777
T Y+ P+ ++ D++S GV
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-32
Identities = 88/461 (19%), Positives = 160/461 (34%), Gaps = 28/461 (6%)
Query: 60 GVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNF 118
+ + + LSL NS + + LS L L N I ++ + L +L+
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107
Query: 119 ADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPS 177
+ N L+ I + +L L L+ N+ F N++ + + L +
Sbjct: 108 SHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLL 164
Query: 178 TMGHSLPNRQFLLLWANRLTGTIPNSITN-ASKLIGLDLNSNSLSGQIPNT-FGNLRHLS 235
+ H + L L + + G S+ + ++ L + NSL N L HL
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 236 TLNIRANYLTTETSSNGEWSFLSSLTNCN-KLRALSLGSNPLDSILPPLIGNFSASFQQF 294
NI+ N + T N L+ + + + +
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF---WPRPVEYL 281
Query: 295 YAHECKLKGSIPKEIGN-----LRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNL 348
+ + I +E L+ L+ + + ++ L ++
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 349 NGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSD---IQ 405
C S S L+ N T S+ +L+ + + L N L + +
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTK 400
Query: 406 NLKVLIYLNLSRNQL-SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLS 464
N+ L L++S N L S T + ++ L+L+ N S+ ++ LDL
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLH 458
Query: 465 NNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNF 505
NN + IPK L L+ LNV+ N+L K +G F
Sbjct: 459 NNRIM-SIPKDVTHLQALQELNVASNQL--KSVPDGVFDRL 496
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 90/493 (18%), Positives = 166/493 (33%), Gaps = 84/493 (17%)
Query: 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSK---LQVLSLRNNSF 75
L +S+N+ ++ L L+ L ++N + S VF L+ L + +N
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF--HVFLFNQDLEYLDVSHNRL 112
Query: 76 TGPIPNSLFNLSSLVRLDSRFNSI-SGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNL 134
I ++SL LD FN + + GNLTKL L + R + +L
Sbjct: 113 QN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169
Query: 135 KNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS---------------------- 172
L+ ++ I T I +++LV + S
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 173 -GHRPSTMGHSLPNRQFLLLWANRLTGTIPN----------SITNASKLIGLDLNSNSLS 221
+ + +T + L++ + +++
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 222 GQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILP 281
+I + ++ ++ + + + S + L + I
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE---MNIKMLSISDTPFIHM 346
Query: 282 PLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQA 341
+ S SF + S+ + L+ L L L N L + + +
Sbjct: 347 VCPPSPS-SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSS 404
Query: 342 L----LQRNNLN-GPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRI-DLSSNS 395
L + N+LN + S+ L+L SN LT S+ F L +++ DL +N
Sbjct: 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNR 461
Query: 396 LSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD-SFGS 454
+ S+P D+ +L+ L LN++ NQL S+PD F
Sbjct: 462 IM-SIPKDVTHLQALQELNVASNQLK-------------------------SVPDGVFDR 495
Query: 455 LTSLEYLDLSNNN 467
LTSL+Y+ L +N
Sbjct: 496 LTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-18
Identities = 54/371 (14%), Positives = 112/371 (30%), Gaps = 28/371 (7%)
Query: 159 STIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI-TNASKLIGLDLNS 217
++L N +S L + L L NR+ ++ + L LD++
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH 109
Query: 218 NSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
N L I + L L++ N E+ L+ LT L L +
Sbjct: 110 NRLQN-IS--CCPMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTF------LGLSAAKFR 159
Query: 278 SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNL-RGLIALSLFTNDLNGTI------P 330
+ + + S +KG + + ++ L N L
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 331 TTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS----SIPSSFW--SLE 384
+L ++ + + L+ +L + L + T + FW +E
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 385 Y--ILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARN 442
Y I + ++ LK L+ ++ + ++ L+ +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 443 RFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPF 502
S +S +L+ + N + + + L L+ L + N L+
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMT 399
Query: 503 RNFLAQSFLWN 513
+N + L
Sbjct: 400 KNMSSLETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 49/270 (18%), Positives = 85/270 (31%), Gaps = 38/270 (14%)
Query: 13 NLSFLMYLDISENNFRG-----YLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQV 67
+ YL+I L+ L S + VF+++ +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEI 127
L + + SS L+ N + ++ L +L L N L+
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392
Query: 128 PNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQ 187
KN++ L +L N L+ H +
Sbjct: 393 FKVALMTKNMSSLETLDVSL---------------------NSLNSHAYDRTCAWAESIL 431
Query: 188 FLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTE 247
L L +N LTG++ + K+ LDL++N + IP +L+ L LN+ +N L +
Sbjct: 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV 488
Query: 248 TSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
L+ + L NP D
Sbjct: 489 PD--------GVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 39/214 (18%), Positives = 66/214 (30%), Gaps = 7/214 (3%)
Query: 306 PKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQ 364
+I L L L L N + Q L+ L + N L I + SLR
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRH 125
Query: 365 LHLGSNQLTS-SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLK-VLIYLNLSRNQLSG 422
L L N + F +L + + LS+ + +L I L+L + G
Sbjct: 126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG 185
Query: 423 NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHL 482
++ L L + S+ +L +L LSN L+ E +
Sbjct: 186 GETESLQIPN-TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244
Query: 483 KRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYAL 516
+ + + + F W +
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 28/140 (20%), Positives = 59/140 (42%), Gaps = 8/140 (5%)
Query: 12 GNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLR 71
+ S +L+ ++N F + L+RL+ L N L +F + + L
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408
Query: 72 NNSFT----GPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEI 127
+ S + S++ L+ N ++G++ + K+ L+ +N + I
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SI 465
Query: 128 PNEIGNLKNLADLVLALNNL 147
P ++ +L+ L +L +A N L
Sbjct: 466 PKDVTHLQALQELNVASNQL 485
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+LG G++G VY G L + +AIK + R + E + ++++H+N+++ S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL--NIMIDVGLALEYLHHSHSTPVVH 708
F + +E +P GSL L S L E+ + L+YLH + +VH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 709 CNLKPNNILLD-KNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPE--YASDGII 764
++K +N+L++ + ++SDFG SK L T T T+ YMAPE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL---AGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 765 SPKCDVYSYGVLLMETFTRKKP 786
D++S G ++E T K P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNL--IKI 646
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ + +V+E N L WL D ER + ++ A+ +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---I 129
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE--------- 757
VH +LKP N L+ M ++ DFGI+ + D SV + + T+ YM PE
Sbjct: 130 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 758 --YASDGIISPKCDVYSYGVLLMETFTRKKP 786
S ISPK DV+S G +L K P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FG V+ ++ VA+K A + F+ E E+L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNIMIDV 691
+ C + D +V E+M +G L K+L +H L + + L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI 751
+ YL H VH +L N L+ N+ ++ DFG+S+ + D TM I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+M PE + + DV+S+GV+L E FT
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 66/295 (22%), Positives = 116/295 (39%), Gaps = 51/295 (17%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFN-LQLERAFRSFESECEVLRNVRHRNLIK 645
LG G+FG VY+G + VA+K + E+ F E ++ H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH------NYFLDMLERLNIMIDVGLALEYLH 699
+ ++LE M G L+ +L L ML+ L++ D+ +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 700 HSHSTPVVHCNLKPNNILLDK---NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
+H +H ++ N LL A++ DFG+++ + M + +M P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP-RGLT--EVV 813
E +GI + K D +S+GVLL E F+ G M P + EV+
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PYPSKSNQEVL 296
Query: 814 DASLVREV----QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ V P +C + + C PE R ++ +++ Q
Sbjct: 297 E--FVTSGGRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFS 648
+G GSFG DG IK N+ + E VL N++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
S +V+++ G L K + + + L+ + + LAL+++H ++
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---IL 147
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPK 767
H ++K NI L K+ T ++ DFGI+++L + + + T Y++PE + + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACI-GTPYYLSPEICENKPYNNK 205
Query: 768 CDVYSYGVLLMETFTRKKP 786
D+++ G +L E T K
Sbjct: 206 SDIWALGCVLYELCTLKHA 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645
LG GSFG VY+G T VAIK N R F +E V++ ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDMLERLNIMIDVGLALE 696
+ +++E M G L+ +L S + + + + ++ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YL+ + VH +L N ++ ++ T ++ DFG+++ + E D + + +M+P
Sbjct: 153 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTR 783
E DG+ + DV+S+GV+L E T
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 62/253 (24%), Positives = 114/253 (45%), Gaps = 34/253 (13%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER--AFRS-FESECEVLRNVRHRNLIKIF 647
+LG G V+ L D +VA+KV L R +F F E + + H ++ ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 648 ------SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
+ L + +V+E++ +L +++ + + ++ D AL + H +
Sbjct: 79 DTGEAETPAGPLPY--IVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN 135
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT-MTMATIGYMAPEYAS 760
++H ++KP NI++ +V DFGI++ + + +SVTQT + T Y++PE A
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE----MSLKH---------WIKLSLPR 807
+ + DVYS G +L E T + P FTG+ ++ +H L
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSARHEGLSA 248
Query: 808 GLTEVVDASLVRE 820
L VV +L +
Sbjct: 249 DLDAVVLKALAKN 261
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 29/221 (13%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNL-QLERAFRSFESECEVLRNVRHRN 642
F LG G FG V++ D N AIK L E A E + L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 643 LIKIFSSCCNLDFKA------------LVLEFMPNGSLEKWLYSHNYFLDMLER--LNIM 688
+++ F++ + + ++ +L+ W+ + L+I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 689 IDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748
+ + A+E+LH ++H +LKP+NI + +V DFG+ + +D++ T M
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 749 ATIG----------YMAPEYASDGIISPKCDVYSYGVLLME 779
YM+PE S K D++S G++L E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+FG V+ + VA+K E A + F+ E E+L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF--------------LDMLERLNIMIDVG 692
F C +V E+M +G L ++L SH L + + L + V
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG 752
+ YL H VH +L N L+ + + ++ DFG+S+ + D TM I
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 753 YMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+M PE + + DV+S+GV+L E FT
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNL--IKI 646
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ + +V+E N L WL D ER + ++ A+ +H +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE--------- 757
VH +LKP N L+ M ++ DFGI+ + D SV + + + YM PE
Sbjct: 177 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 758 --YASDGIISPKCDVYSYGVLLMETFTRKKP 786
S ISPK DV+S G +L K P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 55/225 (24%), Positives = 88/225 (39%), Gaps = 21/225 (9%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
LG G F V L DG A+K ++ + E ++ R H N++++ + C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 651 CNLDFKA----LVLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHS 703
L+L F G+L + FL + L +++ + LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-------TIGYMAP 756
H +LKP NILL + D G + Q +T+ TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 757 E---YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798
E S +I + DV+S G +L + P D +F S+
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIK---VFNLQLERAFRSFESECEVLRNVRH 640
F +G G F VY+ L DG VA+K +F+L +A E ++L+ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDML-ER--LNIMIDVGLALEY 697
N+IK ++S + +VLE G L + + ++ ER + + ALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
+H V+H ++KP N+ + ++ D G+ + + ++ T YM+PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSPE 206
Query: 758 YASDGIISPKCDVYSYGVLLMETFTRKKP 786
+ + K D++S G LL E + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-31
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN-LQLERAFRSFESECEVLRNVRHRNLIKIFS- 648
+LG G+ +V++G G AIKVFN + R E EVL+ + H+N++K+F+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 649 -SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHSTP 705
K L++EF P GSL L + + E L ++ DV + +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 706 VVHCNLKPNNILL----DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEYAS 760
+VH N+KP NI+ D +++DFG ++ L +D Q +++ T Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD----EQFVSLYGTEEYLHPDMYE 188
Query: 761 DGII--------SPKCDVYSYGVLL 777
++ D++S GV
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-31
Identities = 44/244 (18%), Positives = 89/244 (36%), Gaps = 37/244 (15%)
Query: 592 LLGAGSFGSVYKG--TLFDGTNVAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIKIF- 647
+ G G +Y +G V +K + ++ +E + L V H ++++IF
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 648 ------SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
+ + +V+E++ SL++ L + E + ++++ AL YLH
Sbjct: 147 FVEHTDRHGDPVGY--IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI 201
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT-MTMATIGYMAPEYAS 760
+V+ +LKP NI+L + ++ D G + T G+ APE
Sbjct: 202 G---LVYNDLKPENIMLTEE-QLKLIDLGAVS-------RINSFGYLYGTPGFQAPEIVR 250
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW----IKLSLPRGLTEVVDAS 816
G + D+Y+ G L G + L ++ +
Sbjct: 251 TG-PTVATDIYTVGRTLAALTLDLPT----RNGR-YVDGLPEDDPVLKTYDSYGRLLRRA 304
Query: 817 LVRE 820
+ +
Sbjct: 305 IDPD 308
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 38/217 (17%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ-LERAFRSFESECEVLR-NVRHRNLIKIFS 648
+LG GS G+V F G VA+K + + A E ++L + H N+I+ +
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPNVIRYYC 76
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL------NIMIDVGLALEYLHHSH 702
S F + LE N +L+ + S N + L+ +++ + + +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 703 STPVVHCNLKPNNILLD-------------KNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
++H +LKP NIL+ +N+ +SDFG+ K L S +
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 750 --TIGYMAPEYASDGII-------SPKCDVYSYGVLL 777
T G+ APE + + D++S G +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 40/206 (19%), Positives = 77/206 (37%), Gaps = 24/206 (11%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSS 649
+G GSFG V++ G A+K L+ E + ++ ++ +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGA 118
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
+ + +E + GSL + + + + LEYLH ++H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLHTRR---ILHG 174
Query: 710 NLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYASDGII- 764
++K +N+LL + A + DFG + L D + G +MAPE ++
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-----VVM 229
Query: 765 ----SPKCDVYSYGVLLMETFTRKKP 786
K D++S +++ P
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645
LG FG VYKG LF VAIK + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNIMID 690
+ +++ + +G L ++L L+ + ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ +EYL H VVH +L N+L+ + ++SD G+ + + D ++
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
I +MAPE G S D++SYGV+L E F+
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 65/319 (20%), Positives = 121/319 (37%), Gaps = 32/319 (10%)
Query: 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244
+ + + L +P + LDL +N ++ F NL++L TL + N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS 304
+ + + KL L L N L + + + Q+ HE ++
Sbjct: 89 SKISPG--------AFAPLVKLERLYLSKNQLKELPEKM---PK-TLQELRVHENEIT-K 135
Query: 305 IPKEI-GNLRGLIALSLFTNDLNGTI--PTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLI 360
+ K + L +I + L TN L + +++L + + N+ IP
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ--GLPP 192
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
SL +LHL N++T +S L + ++ LS NS+S + N L L+L+ N+L
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 421 SGNIPITIGGLKDLITLSLARNRFQD------SIPDSFGSLTSLEYLDLSNNNLS-GEIP 473
+P + K + + L N P S + L +N + EI
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311
Query: 474 KS-FEILSHLKRLNVSHNR 491
S F + + + + +
Sbjct: 312 PSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 58/324 (17%), Positives = 112/324 (34%), Gaps = 48/324 (14%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
+P + +++L N+++ + + L N L+L N+++ P + KL
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKN-LKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 211 IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
L L+ N L L+ L + N +T S N++ +
Sbjct: 103 ERLYLSKNQLKELPEKMPKTLQEL---RVHENEITKVRKS--------VFNGLNQMIVVE 151
Query: 271 LGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP 330
LG+NPL S + +FQ ++ L + + ++
Sbjct: 152 LGTNPLKSSGIE-----NGAFQ------------------GMKKLSYIRIADTNITTIPQ 188
Query: 331 TTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRID 390
L +L L N + L L +L +L L N +++ S + ++ +
Sbjct: 189 GLPPSLTELH--LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 391 LSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG------NIPITIGGLKDLITLSLARNRF 444
L++N L +P + + K + + L N +S P +SL N
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
Query: 445 QDSI--PDSFGSLTSLEYLDLSNN 466
Q P +F + + L N
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 9/186 (4%)
Query: 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGS 369
NL+ L L L N ++ P L +L+ L L +N L +P + +L++L +
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHE 130
Query: 370 NQLTSSIPSSFWSLEYILRIDLSSNSL-SGSLPSDI-QNLKVLIYLNLSRNQLSGNIPIT 427
N++T S F L ++ ++L +N L S + + Q +K L Y+ ++ ++ I
Sbjct: 131 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IP 187
Query: 428 IGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNV 487
G L L L N+ S L +L L LS N++S S HL+ L++
Sbjct: 188 QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 488 SHNRLE 493
++N+L
Sbjct: 248 NNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 66/326 (20%), Positives = 110/326 (33%), Gaps = 64/326 (19%)
Query: 49 NDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI- 107
L P + +L L+NN T NL +L L N IS I
Sbjct: 41 LGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAF 96
Query: 108 GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINL 166
L KL L + N L+ E+P ++ K L +L + N I + ++F ++ +I++ L
Sbjct: 97 APLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH-ENEITKVRKSVFNGLNQMIVVEL 152
Query: 167 VGNQLSGHR-PSTMGHSLPNRQFLLLWANRLTGTIP--------------NSIT------ 205
N L + + ++ + +T TIP N IT
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAAS 211
Query: 206 --NASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNC 263
+ L L L+ NS+S + N HL L++ N L L +
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV---------KVPGGLADH 262
Query: 264 NKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTN 323
++ + L +N + +I F P +SLF+N
Sbjct: 263 KYIQVVYLHNNNISAIGS-------NDFCP------------PGYNTKKASYSGVSLFSN 303
Query: 324 DLNGTI--PTTLGRLQQLQALLQRNN 347
+ P+T + A+ N
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 413 LNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEI 472
+ S L +P + D L L N+ + F +L +L L L NN +S
Sbjct: 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92
Query: 473 PKSFEILSHLKRLNVSHNRLEGKIPTNGP 501
P +F L L+RL +S N+L+ ++P P
Sbjct: 93 PGAFAPLVKLERLYLSKNQLK-ELPEKMP 120
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 18/230 (7%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNV-RH 640
F + LG GS+G V+K DG A+K + +E V +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
+++ + L E SL++ + L + + D LAL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
+VH ++KP NI L ++ DFG+ LG Q YMAPE
Sbjct: 176 QG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQ 229
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKP------TDEMFTGEMSLKHWIKLS 804
DV+S G+ ++E + ++ G + + LS
Sbjct: 230 GS-YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLS 278
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 68/322 (21%), Positives = 108/322 (33%), Gaps = 43/322 (13%)
Query: 199 TIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLS 258
+I I N L + N++SG + F + +S
Sbjct: 2 SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQAL---------PGENRNEAVS 51
Query: 259 SLTNC--NKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLI 316
L C N+ L L L S LP + + L S+P+ +L
Sbjct: 52 LLKECLINQFSELQLNRLNLSS-LPDNLPP---QITVLEITQNALI-SLPELPASLE--- 103
Query: 317 ALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLI-SLRQLHLGSNQLTSS 375
L N L+ T+P L+ L + N L T L L L ++ +NQLT
Sbjct: 104 YLDACDNRLS-TLPELPASLKHLD--VDNNQL-----TMLPELPALLEYINADNNQLTM- 154
Query: 376 IPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDL- 434
+P SLE + + +N L+ LP ++L+ L ++S N L ++P
Sbjct: 155 LPELPTSLE---VLSVRNNQLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSE 206
Query: 435 ---ITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNR 491
I NR IP++ SL + L +N LS I +S + +
Sbjct: 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265
Query: 492 LEGKIPTNGPFRNFLAQSFLWN 513
LA +
Sbjct: 266 FSMSDGQQNTLHRPLADAVTAW 287
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 7e-20
Identities = 66/451 (14%), Positives = 142/451 (31%), Gaps = 73/451 (16%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSF---TGPIPNSLFNLSSLVRLDSRFNSISGNIP 104
YN ++G++ + + K + +L + + L ++ L ++S ++P
Sbjct: 19 YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLP 75
Query: 105 SKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIII 164
+ ++ L N L +P +L+ L
Sbjct: 76 DNLP--PQITVLEITQNALI-SLPELPASLEYL--------------------------- 105
Query: 165 NLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI 224
+ N+L ST+ + + L + N+LT +P L ++ ++N L+ +
Sbjct: 106 DACDNRL-----STLPELPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-ML 155
Query: 225 PNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLI 284
P +L L++R N LT + L AL + +N L+S LP +
Sbjct: 156 PELPTSLE---VLSVRNNQLT---------FLPELPES---LEALDVSTNLLES-LPAVP 199
Query: 285 G---NFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQA 341
+ + F E ++ IP+ I +L + L N L+ + Q Q
Sbjct: 200 VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQP 257
Query: 342 LLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLP 401
+ + + + + + S + + + +N+ S L
Sbjct: 258 DYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL- 316
Query: 402 SDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYL 461
+ + + R Q++ + L L +S +L +
Sbjct: 317 DRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATESCEDRVALTWN 372
Query: 462 DLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
+L L + L +
Sbjct: 373 NLRKTLLV-HQASEGLFDNDTGALLSLGREM 402
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 5e-19
Identities = 49/268 (18%), Positives = 85/268 (31%), Gaps = 34/268 (12%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
T+P +L +LD+ N LP L + N LT P L
Sbjct: 114 TLPELPASLK---HLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPT---SL 162
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKL----VHLNFADN 121
+VLS+RNN T +P SL LD N + ++P+ + +N
Sbjct: 163 EVLSVRNNQLTF-LPELP---ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCREN 217
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
+ IP I +L ++L N L I ++ + + S
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
P + W + ++ + ++N+ S L L+
Sbjct: 277 HRPLADAVTAW---FPENKQSDVSQIWHAFEHEEHANTFS----------AFLDRLSDTV 323
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRAL 269
+ T ++L L+ +LR
Sbjct: 324 SARNTSGFREQVAAWLEKLSASAELRQQ 351
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 19/220 (8%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIF--- 647
LG G FG V + G VAIK +L + + E ++++ + H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 648 ---SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSH 702
D L +E+ G L K+L + E ++ D+ AL YLH +
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 703 STPVVHCNLKPNNILLDKN---MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
++H +LKP NI+L + ++ D G +K L D + + T+ Y+APE
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH 799
+ D +S+G L E T +P +
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-29
Identities = 76/506 (15%), Positives = 163/506 (32%), Gaps = 71/506 (14%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
+ ++ + I Y E L K + F + + + + F ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNLR 124
++L+L + + ++ +L FN+I +P + N+ L L N+L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136
Query: 125 GEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPSTMGHS 182
+P I N L L ++ NN + I F +++ + L N+L+
Sbjct: 137 -SLPRGIFHNTPKLTTLSMS-NNNLERIEDDTFQATTSLQNLQLSSNRLT----HVDLSL 190
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
+P+ + N L+ ++ + LD + NS++ L L ++ N
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQHN 242
Query: 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK 302
LT + L N L + L N L+ I+
Sbjct: 243 NLTD----------TAWLLNYPGLVEVDLSYNELEKIMYHPFVK---------------- 276
Query: 303 GSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLIS 361
++ L L + N L + + L+ L L N+L +
Sbjct: 277 ---------MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDR 325
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421
L L+L N + + S+ +L+ + LS N + + + + +
Sbjct: 326 LENLYLDHNSIVTLKLSTHHTLK---NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 380
Query: 422 GNIPITIGG----------LKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGE 471
I + D + +A + + + G ++ + ++ +
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYI 440
Query: 472 IPKSFEILSHLKRLNVSHNRLEGKIP 497
+ L ++L N L ++
Sbjct: 441 TQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-22
Identities = 44/200 (22%), Positives = 79/200 (39%), Gaps = 8/200 (4%)
Query: 297 HECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTC 355
I + + + + L + + + + +
Sbjct: 11 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL 70
Query: 356 LSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLN 414
L S + L+L Q+ +F I ++ + N++ LP + QN+ +L L
Sbjct: 71 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 129
Query: 415 LSRNQLSGNIPITI-GGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIP 473
L RN LS ++P I L TLS++ N + D+F + TSL+ L LS+N L+ +
Sbjct: 130 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD 187
Query: 474 KSFEILSHLKRLNVSHNRLE 493
++ L NVS+N L
Sbjct: 188 --LSLIPSLFHANVSYNLLS 205
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 593 LGAGSFGSVYKGTLFD------GTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLI 644
LG G+FG V + F VA+K+ R+ SE ++L ++ H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 645 KIFSSCCNLDFKALV-LEFMPNGSLEKWLYSH---------------NYFLDMLERLNIM 688
+ +C +V +EF G+L +L S FL + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 689 IDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748
V +E+L +H +L NILL + ++ DFG+++ + +D D V +
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 749 ATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +MAPE D + + + DV+S+GVLL E F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIK 645
LG G FG V K T F T VA+K+ R SE VL+ V H ++IK
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLDML 682
++ +C L++E+ GSL +L L M
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 683 ERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742
+ ++ + ++YL +VH +L NIL+ + ++SDFG+S+ + E+D V
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
++ + +MA E D I + + DV+S+GVLL E T
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 68/309 (22%), Positives = 113/309 (36%), Gaps = 65/309 (21%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFN-LQLERAFRSFESECEVLRNVRHRNLIK 645
+G G+FG V++ T VA+K+ F+ E ++ + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLDML 682
+ C L+ E+M G L ++L S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 683 ERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742
E+L I V + YL VH +L N L+ +NM +++DFG+S+ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802
I +M PE + + DV++YGV+L E F+ G
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY---------GLQ------- 275
Query: 803 LSLP-RGLT--EVVDASLVRE----VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
P G+ EV+ VR+ P +C L + +L C P R +
Sbjct: 276 ---PYYGMAHEEVIY--YVRDGNILACP----ENCPLELYNLMRLCWSKLPADRPSFCSI 326
Query: 856 VVKLQKIKQ 864
LQ++ +
Sbjct: 327 HRILQRMCE 335
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 48/215 (22%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 593 LGAGSFGSVYKGTLFD--------GTNVAIKVFN-LQLERAFRSFESECEVLRNV-RHRN 642
LG G+FG V VA+K+ E+ SE E+++ + +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNI 687
+I + +C +++E+ G+L ++L + + + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
+ +EYL +H +L N+L+ +N +++DFG+++ + D T
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +MAPE D + + + DV+S+GVL+ E FT
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 593 LGAGSFGSVYKGTLFD------GTNVAIKVFNLQ-LERAFRSFESECEVLRNV-RHRNLI 644
LGAG+FG V + T + VA+K+ + SE +VL + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSH-----------------NYFLDMLERLNI 687
+ +C ++ E+ G L +L LD+ + L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
V + +L + +H +L NILL ++ DFG+++ + D + V +
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +MAPE + + + + DV+SYG+ L E F+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 48/213 (22%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 591 NLLGAGSFGSVYKGTLFD------GTNVAIKVFNLQ-LERAFRSFESECEVLRNV-RHRN 642
LGAG+FG V + T F VA+K+ + SE +++ ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH-------------NYFLDMLERLNIMI 689
++ + +C + ++ E+ G L +L N + L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
V + +L + +H ++ N+LL A++ DFG+++ + D + + +
Sbjct: 172 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +MAPE D + + + DV+SYG+LL E F+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 591 NLLGAGSFGSVYKGTLFDG---TNVAIKVFNLQL-----ERAFRSFESECEVLRNV-RHR 641
+++G G+FG V K + + AIK ++ + R F E EVL + H
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIK----RMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDMLERLN 686
N+I + +C + + L +E+ P+G+L +L L + L+
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 687 IMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM 746
DV ++YL +H +L NIL+ +N A+++DFG+S+ + V +TM
Sbjct: 147 FAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 200
Query: 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +MA E + + + DV+SYGVLL E +
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 41/246 (16%), Positives = 81/246 (32%), Gaps = 24/246 (9%)
Query: 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTN------VAIKVFNLQLERAFRSFESE 631
+ Q + +LLG G+F VY+ T D + +KV F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 632 CEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL----EKWLYSHNYFLDMLERLNI 687
E L+ +K +S+ + LV E G+L + + + ++
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILL-----------DKNMTARVSDFGISKLLG 736
+ + +E + H ++H ++KP+N +L D + + D G S +
Sbjct: 178 AMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMS 796
T T G+ E S+ + + D + + + GE
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 797 LKHWIK 802
+ +
Sbjct: 295 PEGLFR 300
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-28
Identities = 41/279 (14%), Positives = 87/279 (31%), Gaps = 64/279 (22%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIF 647
+LG + + T G + + V A + + E LR +R K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 648 SSCCNLDFKALVLE------FMPNGSLEKWLYSHNYFLDML------------------- 682
F +++ + E+ ++ + F
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 683 -------ERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735
RL + + V L LHH +VH L+P +I+LD+ ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 736 GEDDDSVTQTMTMATIGYMAPEYAS----------DGIISPKCDVYSYGVLLMETFTRKK 785
G ++ G+ PE + +++ D ++ G+ + +
Sbjct: 262 GAS------AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 786 PTDEMFTGE--MSLKHWI---KLSLPRGLTEVVDASLVR 819
P T + + WI ++P+ + +++ L
Sbjct: 316 P----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRY 350
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 16/195 (8%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G FG+VY +A+KV L+ E E+ ++RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ + L+LE+ P G++ + L + F + + ++ AL Y H V
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKR---V 130
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM--TMATIGYMAPEYASDGII 764
+H ++KP N+LL +++DFG S S + T+ Y+ PE +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLD---YLPPEMIEGRMH 184
Query: 765 SPKCDVYSYGVLLME 779
K D++S GVL E
Sbjct: 185 DEKVDLWSLGVLCYE 199
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-28
Identities = 64/299 (21%), Positives = 121/299 (40%), Gaps = 48/299 (16%)
Query: 593 LGAGSFGSVYKGTLFD--------GTNVAIKVFN-LQLERAFRSFESECEVLRNV-RHRN 642
LG G FG V VA+K+ E+ SE E+++ + +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNI 687
+I + +C +++E+ G+L ++L + + + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
+ +EYL +H +L N+L+ +N +++DFG+++ + D T
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLP 806
+ +MAPE D + + + DV+S+GVL+ E FT P + G + ++ KL L
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP----YPG-IPVEELFKL-LK 319
Query: 807 RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
G R +P+ +C + + C P QR +V L +I
Sbjct: 320 EG---------HRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 593 LGAGSFGSVYKGTLFD--------GTNVAIKVFN-LQLERAFRSFESECEVLRNV-RHRN 642
LG G+FG V T VA+K+ E+ SE E+++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNI 687
+I + +C +++E+ G+L ++L + L + ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
V +EYL +H +L N+L+ ++ +++DFG+++ + D T
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 748 MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ +MAPE D I + + DV+S+GVLL E FT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 49/299 (16%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSS 649
+L G F VY+ + G A+K E R+ E ++ + H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 650 CCNL-------DFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHH 700
+ L+L + G L ++L + L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA----------T 750
P++H +LK N+LL T ++ DFG + + D A T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 751 IGYMAPE---YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807
Y PE S+ I K D+++ G +L R+ P F L+
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR--------- 260
Query: 808 GLTEVVDASLVREVQPSY-AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
+V+ + L+R M L + +PE+R+ + +VV +LQ+I
Sbjct: 261 ----IVNGKYSIPPHDTQYTVFHSLIRAM-LQV-----NPEERLSIAEVVHQLQEIAAA 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 49/194 (25%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIK-- 645
LLG GSF VY+ + G VAIK+ + + + ++E ++ ++H ++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 646 -IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
F + LVLE NG + ++L + E + M + + YLH
Sbjct: 78 NYFEDSNYV---YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEYASDGI 763
++H +L +N+LL +NM +++DFG++ L + + T+ T Y++PE A+
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTPNYISPEIATRSA 188
Query: 764 ISPKCDVYSYGVLL 777
+ DV+S G +
Sbjct: 189 HGLESDVWSLGCMF 202
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 41/224 (18%)
Query: 593 LGAGSFGSVYKGTLFDG------TNVAIKVFNLQL-----ERAFRSFESECEVLRNV-RH 640
LG+G+FG V T + VA+K L + SE +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK----MLKEKADSSEREALMSELKMMTQLGSH 108
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH----------------------NYF 678
N++ + +C L+ E+ G L +L S
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 679 LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738
L + L V +E+L VH +L N+L+ ++ DFG+++ + D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT 782
+ V + + +MAPE +GI + K DV+SYG+LL E F+
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-27
Identities = 69/430 (16%), Positives = 131/430 (30%), Gaps = 74/430 (17%)
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN 122
S L++L LD +SI+ ++ I LT L L NN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
+ + + NL L +N + + + ++ + +N N+L+ S
Sbjct: 76 IT-TLD--LSQNTNLTYLACD-SNKLTNLD--VTPLTKLTYLNCDTNKLTKLDVS----Q 125
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
P +L N LT I +++ ++L LD + N ++ L+TL+ N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180
Query: 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK 302
+T ++ L L+ +N + +
Sbjct: 181 KITE-----------LDVSQNKLLNRLNCDTNNITKL----------------------- 206
Query: 303 GSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISL 362
++ L L +N L I + L QL N + +S+L L
Sbjct: 207 -----DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELD--VSTLSKL 256
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
LH L + L Y + D+ + L L+ ++
Sbjct: 257 TTLHCIQTDLLEIDLTHNTQLIY-----FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT- 310
Query: 423 NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHL 482
+ + L+ L L + T L+ L N ++ + S + L
Sbjct: 311 --ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPAL 363
Query: 483 KRLNVSHNRL 492
+ +
Sbjct: 364 NNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 75/482 (15%), Positives = 152/482 (31%), Gaps = 100/482 (20%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
L+ L LD ++ + +L L L N++T + + + L L+
Sbjct: 38 EEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
+N T + L+ L L+ N ++ + + L +LN A N L EI
Sbjct: 93 DSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID-- 143
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
+ + L +L LN I + + + + ++ N+++ L
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT---------ELD------ 186
Query: 191 LWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS 250
++ L L+ ++N+++ ++ L+ L+ +N LT
Sbjct: 187 -------------VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---- 226
Query: 251 NGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIG 310
+T +L NPL + ++
Sbjct: 227 -------IDVTPLTQLTYFDCSVNPLTEL----------------------------DVS 251
Query: 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSN 370
L L L DL T +L QA ++ L L +
Sbjct: 252 TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA----EGCRKIKELDVTHNTQLYLLDCQAA 307
Query: 371 QLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGG 430
+T S L Y + L++ L+ L D+ + L L+ + + ++G
Sbjct: 308 GITELDLSQNPKLVY---LYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQ-DFS-SVGK 359
Query: 431 LKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
+ L A + ++P + SL + +S + L + + N
Sbjct: 360 IPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417
Query: 491 RL 492
+
Sbjct: 418 TI 419
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-20
Identities = 66/327 (20%), Positives = 110/327 (33%), Gaps = 62/327 (18%)
Query: 169 NQLSGHRPSTMGHSLPNRQF--LLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPN 226
N L + + P+ F + A + T S + L LD +++S++ +
Sbjct: 1 NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG 59
Query: 227 TFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGN 286
L L+ L +N +TT L+ L L+ SN L ++
Sbjct: 60 -IEKLTGLTKLICTSNNITTL-----------DLSQNTNLTYLACDSNKLTNL------- 100
Query: 287 FSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRN 346
++ L L L+ TN L + L L RN
Sbjct: 101 ---------------------DVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLN--CARN 137
Query: 347 NLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQN 406
L I +S L +L N+ + + + +D S N ++ D+
Sbjct: 138 TLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQ 189
Query: 407 LKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466
K+L LN N ++ + + L L + N+ + LT L Y D S N
Sbjct: 190 NKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVN 243
Query: 467 NLSGEIPKSFEILSHLKRLNVSHNRLE 493
L+ E+ S LS L L+ L
Sbjct: 244 PLT-ELDVS--TLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 47/285 (16%), Positives = 95/285 (33%), Gaps = 30/285 (10%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
+ + L LD S N ++ Q + L L N++T + +L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQL 214
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
L +N T + L+ L D N ++ + + L+KL L+ +L
Sbjct: 215 TFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL- 267
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPN 185
EI + + L I + + + + + +++ ++ P
Sbjct: 268 EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT----ELDLSQNPK 319
Query: 186 RQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245
+L L LT + +++ +KL L + + ++ G + L+
Sbjct: 320 LVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI 374
Query: 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSAS 290
T +SLT L NP+ +I P G + +
Sbjct: 375 TMPKETLT---NNSLTIAVSPDLLDQFGNPM-NIEPGDGGVYDQA 415
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 39/246 (15%), Positives = 74/246 (30%), Gaps = 29/246 (11%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
+ L +LD S N ++ L +L + + N LT SKL L
Sbjct: 208 LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELDVST--LSKLTTLHC 261
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
L + + L+ + + T+L L+ + E+
Sbjct: 262 IQTDLLE---IDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD-- 313
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNIST---IIIINLVGNQLSGHRPSTMGHSLPNRQ 187
+ L L L L T ++S + ++ V + + +P
Sbjct: 314 LSQNPKLVYLYLNNTEL------TELDVSHNTKLKSLSCVNAHIQD---FSSVGKIPALN 364
Query: 188 FLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG---QIPNTFGNLRHLSTLNIRANYL 244
+ ++TN S I + + G I G + +T I L
Sbjct: 365 NNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENL 424
Query: 245 TTETSS 250
+T+ +
Sbjct: 425 STDNPA 430
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 22/197 (11%)
Query: 592 LLGAGSFGSVY----KGTLFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLI 644
LG G FG+VY K +A+KV L+ E E E+ ++RH N++
Sbjct: 21 PLGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
++++ + L+LEF P G L K L H F + M ++ AL Y H
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHERK-- 134
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM--TMATIGYMAPEYASDG 762
V+H ++KP N+L+ +++DFG S +TM T+ Y+ PE
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLD---YLPPEMIEGK 187
Query: 763 IISPKCDVYSYGVLLME 779
K D++ GVL E
Sbjct: 188 THDEKVDLWCAGVLCYE 204
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 37/263 (14%), Positives = 83/263 (31%), Gaps = 59/263 (22%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNL----------------QLERAFRSFESECEV 634
+LG + + T G + + V R R +++ +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 635 LRNVR------------HRNLIKIFSSCCNLDFKALVLEFM----PNGSLEKWLYSH--- 675
++R + +I++ ++ + + + + L SH
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 676 NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735
+ L RL + + V L LHH +VH L+P +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 736 GEDDDSVTQTMTMATIGYMAPEYASD-----------GIISPKCDVYSYGVLLMETFTRK 784
G S + G+ PE + +++ D ++ G+++ +
Sbjct: 257 GARVVSSV------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 785 KP---TDEMFTGEMSLKHWIKLS 804
P + E + +
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIP 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 36/302 (11%), Positives = 79/302 (26%), Gaps = 56/302 (18%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIKIF 647
L G V+ + + A+KVF + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 648 SSC-CNLDFKALVLEFMPN----GSLEKWLYSHNYFLDM--------------------- 681
L A+ ++ P + NY L M
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 682 -----LERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736
L + + L +VH + P+N+ + + + D +G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 737 EDDDSVTQTMTMATIGYMAPEY--ASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
+ + Y E+ AS + + + G+ + + P + G
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 795 MSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTD 854
L +P T+ + + P + K + R ++ +R+ +
Sbjct: 301 KGSWKRPSLRVPG--TDSLAFGSCTPL-PDFVK-TLIGRFLNF-------DRRRRLLPLE 349
Query: 855 VV 856
+
Sbjct: 350 AM 351
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 43/191 (22%), Positives = 82/191 (42%), Gaps = 12/191 (6%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIKIF 647
LG G F ++ + A K+ L E + R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+ DF +VLE SL + + R + + L +YLH + V+
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 137
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEYASDGIISP 766
H +LK N+ L++++ ++ DFG++ + D + + + T Y+APE S S
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 767 KCDVYSYGVLL 777
+ DV+S G ++
Sbjct: 195 EVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 44/192 (22%), Positives = 82/192 (42%), Gaps = 14/192 (7%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIKIF 647
LG G F ++ + A K+ L E + R++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707
+ DF +VLE SL + + R + + L +YLH + V+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 163
Query: 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM--TMATIGYMAPEYASDGIIS 765
H +LK N+ L++++ ++ DFG++ + E D + + T Y+APE S S
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSKKGHS 219
Query: 766 PKCDVYSYGVLL 777
+ DV+S G ++
Sbjct: 220 FEVDVWSIGCIM 231
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-26
Identities = 55/232 (23%), Positives = 87/232 (37%), Gaps = 8/232 (3%)
Query: 264 NKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTN 323
N+ + L + P S + + HE +++ +LR L L L N
Sbjct: 43 NQFSKVICVRKNLREV-PD---GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 324 DLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWS 382
+ L L L L N L L L++L L +N + S +F
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 383 LEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR 441
+ + R+DL + + L L YLNL+ L IP + L L L L+
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG 216
Query: 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
N P SF L L+ L + + + +F+ L L +N++HN L
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 73/310 (23%), Positives = 116/310 (37%), Gaps = 66/310 (21%)
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
++ L +P+ I+ ++L L+L+ N + N+F +LRHL L + N+
Sbjct: 43 NQFSKVICVRKNLR-EVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
+ T + L L L N L +I G F
Sbjct: 100 IRTIEIG--------AFNGLANLNTLELFDNRLTTIPN---GAFV--------------- 133
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPT-TLGRLQQLQAL-LQRNNLNGPIPT-CLSSLI 360
L L L L N + +IP+ R+ L+ L L I L
Sbjct: 134 -------YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
+LR L+L L IP+ L + +DLS N LS P Q L L L + ++Q+
Sbjct: 186 NLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILS 480
I ++F +L SL ++L++NNL+ F L
Sbjct: 244 Q-VIE-----------------------RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279
Query: 481 HLKRLNVSHN 490
HL+R+++ HN
Sbjct: 280 HLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 6e-22
Identities = 67/287 (23%), Positives = 105/287 (36%), Gaps = 61/287 (21%)
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
N + L L N++ NS + L L L+ N + F L +L+TL + N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
LTT + L+ L+ L L +NP++SI F+
Sbjct: 124 LTTIPNG-----AFVYLSK---LKELWLRNNPIESIPS---YAFN--------------- 157
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPT-TLGRLQQLQAL-LQRNNLNGPIPTCLSSLIS 361
+ L L L I L L+ L L NL IP L+ LI
Sbjct: 158 -------RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIK 208
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421
L +L L N L++ P SF L ++ ++ + + + + NL+ L+ +NL+ N L+
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
Query: 422 GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNL 468
+P D F L LE + L +N
Sbjct: 269 -LLP-----------------------HDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-21
Identities = 52/242 (21%), Positives = 86/242 (35%), Gaps = 16/242 (6%)
Query: 39 RRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNS 98
+ L N + + L++L L N + L++L L+ N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 99 ISGNIPSKI-GNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF 156
++ IP+ L+KL L +N + IP+ + +L L L + I F
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 157 -NISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDL 215
+S + +NL L P+ L L L N L+ P S L L +
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 216 NSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNP 275
+ + N F NL+ L +N+ N LT + L + L + L NP
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLTLL-----PHDLFTPLHH---LERIHLHHNP 290
Query: 276 LD 277
+
Sbjct: 291 WN 292
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 49/194 (25%), Positives = 71/194 (36%), Gaps = 8/194 (4%)
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISL 362
++P I + L N ++ + + L L L N L + L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 363 RQLHLGSNQLTSSIPSS-FWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQL 420
QL L N S+ + F L + + L L L + + L L YL L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 421 SGNIPITI-GGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479
+P L +L L L NR +F L SL+ L L N ++ P +F L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 480 SHLKRLNVSHNRLE 493
L L + N L
Sbjct: 201 GRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 51/233 (21%), Positives = 82/233 (35%), Gaps = 17/233 (7%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
L + P G+ + Q + L N + S +L L N ++ I +
Sbjct: 20 QQGLQ-AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAA 75
Query: 108 -GNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF-NISTIIII 164
L L L+ +DN + L L L L + + +F ++ + +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD-RCGLQELGPGLFRGLAALQYL 134
Query: 165 NLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI 224
L N L P L N L L NR++ + L L L+ N ++
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 225 PNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
P+ F +L L TL + AN L+ L+ L L+ L L NP
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSAL-----PTEALAPLRA---LQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 59/276 (21%), Positives = 96/276 (34%), Gaps = 60/276 (21%)
Query: 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGE 253
L +P I + + L+ N +S +F R+L+ L + +N L ++
Sbjct: 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA--- 74
Query: 254 WSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLR 313
+ T L L L N + P A+F L
Sbjct: 75 -----AFTGLALLEQLDLSDNAQLRSVDP------ATFH------------------GLG 105
Query: 314 GLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLT 373
L L L LQ+L P L +L+ L+L N L
Sbjct: 106 RLHTLHLDRC-----------GLQELG------------PGLFRGLAALQYLYLQDNALQ 142
Query: 374 SSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLK 432
+ +F L + + L N +S S+P + L L L L +N+++ P L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 433 DLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNL 468
L+TL L N ++ L +L+YL L++N
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 51/248 (20%), Positives = 84/248 (33%), Gaps = 38/248 (15%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
+P I + I L GN++S ++ + N L L +N L + T + L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASF-RACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 211 IGLDLNSNSLSGQIP-NTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRAL 269
LDL+ N+ + TF L L TL++ L L+ L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG--------LFRGLAALQYL 134
Query: 270 SLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTI 329
L N L ++ +F+ +L L L L N ++
Sbjct: 135 YLQDNALQALPD-------DTFR------------------DLGNLTHLFLHGNRISSVP 169
Query: 330 PTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
L L L L +N + P L L L+L +N L++ + L +
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229
Query: 389 IDLSSNSL 396
+ L+ N
Sbjct: 230 LRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 51/240 (21%), Positives = 81/240 (33%), Gaps = 32/240 (13%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
VP I + + + N R L L N L + + L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 66 QVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNL 123
+ L L +N+ + + F L L L + + + L L +L DN L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 124 RGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
+ +P++ +L NL L L N I +P F
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLH-GNRISSVPERAFR------------------------G 175
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
L + LLL NR+ P++ + +L+ L L +N+LS LR L L + N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 28/198 (14%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+LG+G+F V+ G A+K S E+E VL+ ++H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 651 CNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLERL--NIMIDVGLALEYLHHSHS 703
+ LV++ + G L E+ +Y+ E+ ++ V A++YLH +
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYT--------EKDASLVIQQVLSAVKYLHENG- 126
Query: 704 TPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEYA 759
+VH +LKP N+L ++N ++DFG+SK+ T T GY+APE
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVL 179
Query: 760 SDGIISPKCDVYSYGVLL 777
+ S D +S GV+
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 8/189 (4%)
Query: 311 NLRGLIALSLFTNDLN--GTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHL 367
L L LSL +N L+ G + L+ L L N + + + L L L
Sbjct: 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 108
Query: 368 GSNQLTSSIPSS-FWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIP 425
+ L S F SL ++ +D+S + I L L L ++ N N
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL 167
Query: 426 ITI-GGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKR 484
I L++L L L++ + + P +F SL+SL+ L++S+NN ++ L+ L+
Sbjct: 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 485 LNVSHNRLE 493
L+ S N +
Sbjct: 228 LDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/290 (19%), Positives = 92/290 (31%), Gaps = 41/290 (14%)
Query: 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244
+ + + LT ++P I S L+L SN L F L L+ L++ +N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS 304
+ + + +SL L L N + +
Sbjct: 65 SFKGCCSQSDFGTTSLKY------LDLSFNGV--------------------------IT 92
Query: 305 IPKEIGNLRGLIALSLFTNDLNGTIPT-TLGRLQQLQAL-LQRNNLNGPIPTCLSSLISL 362
+ L L L ++L L+ L L + + + L SL
Sbjct: 93 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152
Query: 363 RQLHLGSNQLTSSIPS-SFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQL 420
L + N + F L + +DLS L L +L L LN+S N
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNF 211
Query: 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSL-TSLEYLDLSNNNLS 469
L L L + N S +SL +L+L+ N+ +
Sbjct: 212 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 52/277 (18%), Positives = 93/277 (33%), Gaps = 41/277 (14%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF--- 62
+VP I S L++ N + +L +L L + N L+
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGT 77
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADN 121
+ L+ L L N + ++ L L LD + +++ + +L L++L+ +
Sbjct: 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 122 NLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMG 180
+ R N I L +L L +A N+ IF
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF------------------------ 171
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
L N FL L +L P + + S L L+++ N+ + L L L+
Sbjct: 172 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 231
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
N++ T ++ L L+L N
Sbjct: 232 LNHIMTSKKQ----ELQHFPSS---LAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 57/252 (22%), Positives = 86/252 (34%), Gaps = 17/252 (6%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLT--GTIPNSITNAS 208
+PT I S+ + L N+L L L L +N L+ G S +
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVF-DKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 209 KLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRA 268
L LDL+ N + + + F L L L+ + + L E+S SL N L
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK----QMSEFSVFLSLRN---LIY 130
Query: 269 LSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEI-GNLRGLIALSLFTNDLNG 327
L + + S S + + + +I LR L L L L
Sbjct: 131 LDISHTHTRVAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 189
Query: 328 TIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYI 386
PT L LQ L + NN L SL+ L N + +S
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 387 LR-IDLSSNSLS 397
L ++L+ N +
Sbjct: 250 LAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 24/82 (29%), Positives = 36/82 (43%), Gaps = 5/82 (6%)
Query: 413 LNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS--G 470
+ + L+ ++P I L L N+ Q F LT L L LS+N LS G
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 471 EIPKSFEILSHLKRLNVSHNRL 492
+S + LK L++S N +
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGV 90
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 15/69 (21%), Positives = 26/69 (37%), Gaps = 3/69 (4%)
Query: 436 TLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGK 495
+ S+P +S L+L +N L F+ L+ L +L++S N L K
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 496 IPTNGPFRN 504
+
Sbjct: 68 GCCSQSDFG 76
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 63/319 (19%), Positives = 104/319 (32%), Gaps = 52/319 (16%)
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
P+ L L N ++ + L L L +N +S F LR L L I N+
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
L + SSL L + N + + G FS
Sbjct: 114 LVEIPP-----NLPSSLVE------LRIHDNRIRKVPK---GVFS--------------- 144
Query: 304 SIPKEIGNLRGLIALSLFTNDL-NGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLIS 361
LR + + + N L N +L L + L G IP +
Sbjct: 145 -------GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPET 194
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQL 420
L +LHL N++ + + R+ L N + + + L L L+L N+L
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL 253
Query: 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSL------TSLEYLDLSNNNLSGEI-- 472
S +P + LK L + L N + F + + L NN +
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312
Query: 473 PKSFEILSHLKRLNVSHNR 491
P +F ++ + + +
Sbjct: 313 PATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/325 (18%), Positives = 104/325 (32%), Gaps = 51/325 (15%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
+P I +++L N +S R L + L+L N+++ + + KL
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKG-LQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 211 IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
L ++ N L PN +L L I N + + + +
Sbjct: 105 QKLYISKNHLVEIPPNLPSSLVE---LRIHDNRIRKVPK--------GVFSGLRNMNCIE 153
Query: 271 LGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP 330
+G NPL++ + L L + L G
Sbjct: 154 MGGNPLENS------------------------GFEPGAFDGLKLNYLRISEAKLTGIPK 189
Query: 331 TTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRID 390
L +L L N + L L +L LG NQ+ S L + +
Sbjct: 190 DLPETLNELH--LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247
Query: 391 LSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITI-------GGLKDLITLSLARNR 443
L +N LS +P+ + +LK+L + L N ++ + + +SL N
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305
Query: 444 FQDSI--PDSFGSLTSLEYLDLSNN 466
P +F +T + N
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 59/276 (21%), Positives = 101/276 (36%), Gaps = 21/276 (7%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFS-- 63
VP I LD+ N+ ++ L+ L L N ++ FS
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHE---KAFSPL 101
Query: 64 -KLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADN 121
KLQ L + N IP +L SSLV L N I +P + L + + N
Sbjct: 102 RKLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGN 157
Query: 122 NLR-GEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMG 180
L + L L ++ L G IP + T+ ++L N++ +
Sbjct: 158 PLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLL 214
Query: 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
L L N++ S++ L L L++N LS ++P +L+ L + +
Sbjct: 215 R-YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
N +T ++ + +SL +NP+
Sbjct: 273 TNNIT--KVGVNDFCPVGFGVKRAYYNGISLFNNPV 306
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 11/192 (5%)
Query: 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGS 369
L+ L AL L N ++ L++LQ L + +N+L IP L S SL +L +
Sbjct: 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLPS--SLVELRIHD 132
Query: 370 NQLTSSIPSSFWSLEYILRIDLSSNSL-SGSLPSDI-QNLKVLIYLNLSRNQLSGNIPIT 427
N++ F L + I++ N L + LK L YL +S +L+G I
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTG---IP 188
Query: 428 IGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNV 487
+ L L L N+ Q + + L L L +N + S L L+ L++
Sbjct: 189 KDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 488 SHNRLEGKIPTN 499
+N+L ++P
Sbjct: 249 DNNKLS-RVPAG 259
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 63/339 (18%), Positives = 106/339 (31%), Gaps = 63/339 (18%)
Query: 60 GVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNF 118
+ +L L+NN + + L L L N IS I K L KL L
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYI 109
Query: 119 ADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPS 177
+ N+L EIP + +L +L + +N I +P +F + + I + GN L
Sbjct: 110 SKNHLV-EIPPNL--PSSLVELRIH-DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 178 TMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTL 237
+L + +LT IP + L L L+ N + L L
Sbjct: 166 PGAFDGLKLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRL 222
Query: 238 NIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAH 297
+ N + + SL+ LR L L +N L
Sbjct: 223 GLGHNQIRMIEN--------GSLSFLPTLRELHLDNNKLS-------------------- 254
Query: 298 ECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLS 357
+P + +L+ L + L TN++ +
Sbjct: 255 ------RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA-------------- 294
Query: 358 SLISLRQLHLGSNQLTSSI--PSSFWSLEYILRIDLSSN 394
+ L +N + P++F + L I +
Sbjct: 295 ---YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 50/205 (24%), Positives = 100/205 (48%), Gaps = 30/205 (14%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
+ +G GS G V G VA+K+ +L+ ++ +E ++R+ +H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLE--RLN------IMIDVGLALEY 697
++ S + +++EF+ G+L D++ RLN + V AL Y
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALAY 156
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YM 754
LH V+H ++K ++ILL + ++SDFG + V + ++ +G +M
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWM 208
Query: 755 APEYASDGIISPKCDVYSYGVLLME 779
APE S + + + D++S G++++E
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIE 233
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 34/228 (14%)
Query: 574 RTSYLDIQQATDGFNE----CNLLGAGSFGSVYKGT-LFDGTNVAIKVFN---------L 619
R + L +T GF E +LG G V + A+K+ +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 620 QLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF 678
+++ + E ++LR V H N+I++ + F LV + M G L +L
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 679 LDMLER--LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736
E+ IM + + LH + +VH +LKP NILLD +M +++DFG S L
Sbjct: 122 S---EKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 737 EDDDSVTQTMTMA-TIGYMAPE------YASDGIISPKCDVYSYGVLL 777
+ + + T Y+APE + + D++S GV++
Sbjct: 176 PGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 61/264 (23%), Positives = 114/264 (43%), Gaps = 9/264 (3%)
Query: 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSF-ESECEVLRNVRHRN 642
D F + + LGAG+ G V+K + G +A K+ +L+++ A R+ E +VL
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
++ + + + ++ +E M GSL++ + + + I V L YL H
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
++H ++KP+NIL++ ++ DFG+S G+ DS+ + T YM+PE
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV-GTRSYMSPERLQGT 205
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822
S + D++S G+ L+E + P E+ L ++ T + R +
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 823 PSYAKMDCLLRIMHLALGCCMDSP 846
+ I L + P
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPP 289
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 43/219 (19%), Positives = 89/219 (40%), Gaps = 49/219 (22%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFN-----------------LQLERAFRSFESECEVL 635
L G F + D A+K + + ++ + F++E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 636 RNVRHRNLIK---IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL------- 685
++++ + I ++ + + ++ E+M N S+ K+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEV-Y--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 686 NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745
I+ V + Y+H+ + + H ++KP+NIL+DKN ++SDFG S+ + D +
Sbjct: 155 CIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG 209
Query: 746 MTMATIGYMAPEYASDGIIS-------PKCDVYSYGVLL 777
+ T +M PE S K D++S G+ L
Sbjct: 210 -SRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICL 242
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 62/308 (20%), Positives = 105/308 (34%), Gaps = 62/308 (20%)
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
++ L+ +P I S L+L N++ +TF +L HL L + N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
+ + L L L N L I
Sbjct: 111 IRQIEVG--------AFNGLASLNTLELFDNWLTVIPS---------------------- 140
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLR 363
F L +L++L L+ N + + + SL
Sbjct: 141 ---------------GAFEY---------LSKLRELW--LRNNPIESIPSYAFNRVPSLM 174
Query: 364 QLHLGS-NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
+L LG +L +F L + ++L ++ +P ++ L L L +S N
Sbjct: 175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPE 232
Query: 423 NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHL 482
P + GL L L + ++ ++F L SL L+L++NNLS F L +L
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL 292
Query: 483 KRLNVSHN 490
L++ HN
Sbjct: 293 VELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 66/278 (23%), Positives = 94/278 (33%), Gaps = 48/278 (17%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF--- 62
VP I S YL++ ENN + + L L+ L N + G F
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV--GAFNGL 122
Query: 63 SKLQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFAD 120
+ L L L +N T IP+ F LS L L R N I +IPS + L+ L+ +
Sbjct: 123 ASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGE 180
Query: 121 NNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTM 179
I L NL L L + N+ +P
Sbjct: 181 LKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-------------------------- 213
Query: 180 GHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNI 239
L + L + N P S S L L + ++ +S N F L L LN+
Sbjct: 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273
Query: 240 RANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
N L++ + L L L L NP +
Sbjct: 274 AHNNLSSL-----PHDLFTPLRY---LVELHLHHNPWN 303
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
+ +G G+ G+VY + G VAI+ NLQ + +E V+R ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
S D +V+E++ GSL + +D + + + ALE+LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYASDG 762
V+H ++K +NILL + + +++DFG + ++ TM +G +MAPE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTM--VGTPYWMAPEVVTRK 191
Query: 763 IISPKCDVYSYGVLLME 779
PK D++S G++ +E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 60/296 (20%), Positives = 107/296 (36%), Gaps = 45/296 (15%)
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
+ L L NR+T + + L L L SN ++ ++F +L L L++ NY
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
L+ +SS + L++ L L+L NP ++ FS
Sbjct: 112 LSNLSSS-----WFKPLSS---LTFLNLLGNPYKTLGET--SLFS--------------- 146
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPT-TLGRLQQLQAL-LQRNNLNGPIPTCLSSLIS 361
+L L L + D I L L+ L + ++L P L S+ +
Sbjct: 147 -------HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQ--------NLKVLIYL 413
+ L L Q + + ++L L S++ +
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 414 NLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDS-FGSLTSLEYLDLSNNNL 468
++ L + + + L+ L +RN+ + S+PD F LTSL+ + L N
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 9/167 (5%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
+ + L L N + + L ++L+ L L SN + + SF SL +
Sbjct: 50 LTEAVKSLD-----LSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104
Query: 389 IDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQD 446
+DLS N LS +L S + L L +LNL N ++ L L L +
Sbjct: 105 LDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163
Query: 447 SIPD-SFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
I F LT LE L++ ++L PKS + + ++ L + +
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 52/287 (18%), Positives = 96/287 (33%), Gaps = 32/287 (11%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSK- 64
++P + + LD+S N ++L + L+ L N + + FS
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEE--DSFSSL 99
Query: 65 --LQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFAD 120
L+ L L N + + +S F LSSL L+ N + + +LTKL L +
Sbjct: 100 GSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 121 NNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPST 178
+ +I + L L +L + ++ + +I + + L Q
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASD-LQSYEPKSLKSIQNVSHLILHMKQHI-LLLEI 216
Query: 179 MGHSLPNRQFLLLWANRLTGTIPNSI--------TNASKLIGLDLNSNSLSGQIPNTFGN 230
+ + L L L + + + + SL Q+
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQ 275
Query: 231 LRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
+ L L N L + LT+ L+ + L +NP D
Sbjct: 276 ISGLLELEFSRNQLKSV-----PDGIFDRLTS---LQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 61/353 (17%), Positives = 98/353 (27%), Gaps = 94/353 (26%)
Query: 54 SFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTK 112
S PS G+ ++ L L NN T + L +L L N I+ I +L
Sbjct: 45 SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 113 LVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQL 171
L HL+ + N L + + L +L L NL+GN
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFL------------------------NLLGNPY 136
Query: 172 SGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNL 231
+++ L Q L + I F L
Sbjct: 137 KTLGETSLFSHLTKLQILRVGNMDTFTKIQ-----------------------RKDFAGL 173
Query: 232 RHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASF 291
L L I A+ L + SL + + L L +L
Sbjct: 174 TFLEELEIDASDLQSYEPK--------SLKSIQNVSHLILHMKQHILLLE---IFVD--- 219
Query: 292 QQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPT--------TLGRLQQLQALL 343
+ L L DL+ + +L + + +
Sbjct: 220 -------------------VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260
Query: 344 QRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSL 396
+ + L+ + L +L NQL S F L + +I L +N
Sbjct: 261 ITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 19/194 (9%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIKIFS 648
LG GSFG V G A+KV + ++ + S E ++L+ + H N++K++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL--NIMIDVGLALEYLHHSHSTPV 706
+ + LV E G L + S F E I+ V + Y+H + +
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFS---EVDAARIIRQVLSGITYMHKNK---I 147
Query: 707 VHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
VH +LKP N+LL K+ R+ DFG+S + T Y+APE G
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPE-VLHGT 203
Query: 764 ISPKCDVYSYGVLL 777
KCDV+S GV+L
Sbjct: 204 YDEKCDVWSTGVIL 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 44/235 (18%), Positives = 89/235 (37%), Gaps = 52/235 (22%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNV-RHRN 642
F+E +G+G FGSV+K DG AIK L ++ E + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDML---ERLNIMIDVGLALEYLH 699
+++ FS+ D + E+ GSL + + + E ++++ VG L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 700 HSHSTPVVHCNLKPNNILLDKN-------------------MTARVSDFGISKLLGEDDD 740
+VH ++KP+NI + + + ++ D G +
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----- 184
Query: 741 SVTQTMTMATIG---YMAPEYASDGII------SPKCDVYSYGVLLMETFTRKKP 786
+ G ++A E ++ PK D+++ + ++ +
Sbjct: 185 ----SSPQVEEGDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
F+ LG GS+GSVYK G VAIK + E + E +++ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ S +V+E+ GS+ + N L E I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--- 145
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYASDG 762
+H ++K NILL+ A+++DFG++ L D++ + T+ IG +MAPE +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEVIQEI 200
Query: 763 IISPKCDVYSYGVLLME 779
+ D++S G+ +E
Sbjct: 201 GYNCVADIWSLGITAIE 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 30/198 (15%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
+G GS+G V A K F+ E E+++++ H N+I+++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHSTPVVHC 709
+ LV+E G L + + F E IM DV A+ Y H + V H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVF---RESDAARIMKDVLSAVAYCHKLN---VAHR 130
Query: 710 NLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPE-----YA 759
+LKP N L + ++ DFG++ + M T Y++P+ Y
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-----KMMRTKVGTPYYVSPQVLEGLY- 184
Query: 760 SDGIISPKCDVYSYGVLL 777
P+CD +S GV++
Sbjct: 185 -----GPECDEWSAGVMM 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN--------LQLERAFRSFESECEVLRNVRHRNL 643
LG+G+ G V VAI++ + + + E+E E+L+ + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL--NIMIDVGLALEYLHHS 701
IKI + D+ +VLE M G L + + E + LA++YLH +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLHEN 258
Query: 702 HSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE- 757
++H +LKP N+LL +++ +++DFG SK+LGE S+ +T+ T Y+APE
Sbjct: 259 G---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTL-CGTPTYLAPEV 312
Query: 758 --YASDGIISPKCDVYSYGVLL 777
+ D +S GV+L
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVIL 334
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
+ LG G+FG VYK G A KV + E + E E+L H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ + + +++EF P G+++ + + L + + + AL +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--- 137
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPE----- 757
++H +LK N+L+ R++DFG+S ++ ++ + + IG +MAPE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSF--IGTPYWMAPEVVMCE 192
Query: 758 YASDGIISPKCDVYSYGVLLME 779
D K D++S G+ L+E
Sbjct: 193 TMKDTPYDYKADIWSLGITLIE 214
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 51/168 (30%), Positives = 73/168 (43%), Gaps = 14/168 (8%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
+P L L N L L L QL+L +LT +L +
Sbjct: 29 LPKDTTILH-----LSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGT 81
Query: 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDS 447
+DLS N L SLP Q L L L++S N+L+ ++P+ GL +L L L N + +
Sbjct: 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-T 138
Query: 448 IPDS-FGSLTSLEYLDLSNNNLSGEIPKS-FEILSHLKRLNVSHNRLE 493
+P LE L L+NNNL+ E+P L +L L + N L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 52/190 (27%), Positives = 75/190 (39%), Gaps = 11/190 (5%)
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLR 363
++P ++ + L L N L TL +L L + +L L
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLG 80
Query: 364 QLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSG 422
L L NQL S +P +L + +D+S N L+ SLP + L L L L N+L
Sbjct: 81 TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK- 137
Query: 423 NIPITI-GGLKDLITLSLARNRFQDSIPDS-FGSLTSLEYLDLSNNNLSGEIPKSFEILS 480
+P + L LSLA N +P L +L+ L L N+L IPK F
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSH 195
Query: 481 HLKRLNVSHN 490
L + N
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 48/231 (20%), Positives = 76/231 (32%), Gaps = 42/231 (18%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
+LT + P + +L L N +L + L +L+ ++ +
Sbjct: 19 KRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD- 73
Query: 108 GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLV 167
G L L L+ + N L+ +P L L L ++ N + +P
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS-FNRLTSLPLGAL----------- 120
Query: 168 GNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI-TNASKLIGLDLNSNSLSGQIPN 226
L Q L L N L T+P + T KL L L +N+L+
Sbjct: 121 -------------RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAG 166
Query: 227 TFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
L +L TL ++ N L T G + L L NP
Sbjct: 167 LLNGLENLDTLLLQENSLY--TIPKGFFGSHL-------LPFAFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 34/120 (28%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF--- 62
++P L L LD+S N L L L+ L N+L + P G+
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPP--GLLTPT 147
Query: 63 SKLQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
KL+ LSL NN+ T +P L L +L L + NS+ IP L N
Sbjct: 148 PKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKV-------------FNLQLERAFRSFESECEVLR 636
LG+G++G V + AIKV N +E+ +E +L+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLA 694
++ H N+IK+F + + LV EF G L + + + + F E NIM +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD---ECDAANIMKQILSG 158
Query: 695 LEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMATI 751
+ YLH + +VH ++KP NILL + + ++ DFG+S +D + + T
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTA 212
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLL 777
Y+APE + KCDV+S GV++
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 37/207 (17%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN--------LQLERAFRSFESECEVLRNVRHRNL 643
LG+G+ G V VAIK+ + + + E+E E+L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 644 IKIFSSCCNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDMLERL--NIMIDVGLALEY 697
IKI + F A +VLE M G L + + E + LA++Y
Sbjct: 78 IKIKNF-----FDAEDYYIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQY 129
Query: 698 LHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGY 753
LH + ++H +LKP N+LL +++ +++DFG SK+LGE T+ T Y
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTY 182
Query: 754 MAPE---YASDGIISPKCDVYSYGVLL 777
+APE + D +S GV+L
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 58/200 (29%), Positives = 86/200 (43%), Gaps = 32/200 (16%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN--LQLERAFRSFESECEVLRNVRHRNLIKIFSS 649
LG GSFG V K A+KV N + + E E+L+ + H N++K+F
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHSTPVV 707
+ +V E G L + F E I+ V + Y+H + +V
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAARIIKQVFSGITYMHKHN---IV 143
Query: 708 HCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPE----- 757
H +LKP NILL +K+ ++ DFG+S ++ M T Y+APE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKDRIGTAYYIAPEVLRGT 198
Query: 758 YASDGIISPKCDVYSYGVLL 777
Y KCDV+S GV+L
Sbjct: 199 Y------DEKCDVWSAGVIL 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 52/193 (26%), Positives = 83/193 (43%), Gaps = 18/193 (9%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSS 649
LG+G++G V AIK+ + E VL+ + H N++K++
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHSTPVV 707
+ LV+E G L + F E I+ V + YLH + +V
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFN---EVDAAVIIKQVLSGVTYLHKHN---IV 158
Query: 708 HCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII 764
H +LKP N+LL +K+ ++ DFG+S + + + T Y+APE
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---LGTAYYIAPE-VLRKKY 214
Query: 765 SPKCDVYSYGVLL 777
KCDV+S GV+L
Sbjct: 215 DEKCDVWSIGVIL 227
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 22/195 (11%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSS 649
LG GSFG V K A+KV N + + E E+L+ + H N++K+F
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHSTPVV 707
+ +V E G L + F E I+ V + Y+H + +V
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFS---EHDAARIIKQVFSGITYMHKHN---IV 143
Query: 708 HCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPEYASDG 762
H +LKP NILL +K+ ++ DFG+S ++ M T Y+APE G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMKDRIGTAYYIAPE-VLRG 197
Query: 763 IISPKCDVYSYGVLL 777
KCDV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 37/204 (18%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN-LQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
LG+G+FG V+ G IK N + + E+E EVL+++ H N+IKIF
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 651 CNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHS 703
+ +V+E G L E +M + AL Y H H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQH- 144
Query: 704 TPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPE- 757
VVH +LKP NIL + ++ DFG+++L D + T A T YMAPE
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-----EHSTNAAGTALYMAPEV 197
Query: 758 ----YASDGIISPKCDVYSYGVLL 777
+ KCD++S GV++
Sbjct: 198 FKRDV------TFKCDIWSAGVVM 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 45/212 (21%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNL--------QLERAFRSFESECEVLRNVR-HRN 642
+G G V + G A+K+ + QLE + E +LR V H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLAL 695
+I + S + F LV + M G L EK S E+ +IM + A+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS--------EKETRSIMRSLLEAV 213
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI---- 751
+LH ++ +VH +LKP NILLD NM R+SDFG S L + + +
Sbjct: 214 SFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-------KLRELCGTP 263
Query: 752 GYMAPE------YASDGIISPKCDVYSYGVLL 777
GY+APE + + D+++ GV+L
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLI 644
F + +G GSFG V+KG VAIK+ +L + E + E VL +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLE--RLN------IMIDVGLALE 696
K + S +++E++ GS LD+LE L+ I+ ++ L+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILKGLD 133
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---Y 753
YLH +H ++K N+LL ++ +++DFG++ L D+ + T +G +
Sbjct: 134 YLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFW 185
Query: 754 MAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
MAPE K D++S G+ +E + P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 48/216 (22%), Positives = 92/216 (42%), Gaps = 13/216 (6%)
Query: 569 RTTWRRTSYLDIQQATDGFNE----CNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER 623
W++ ++ + LG+G+FG V++ G K N
Sbjct: 31 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL 90
Query: 624 AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLE 683
+ ++E ++ + H LI + + + L+LEF+ G L + + +Y + E
Sbjct: 91 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE 150
Query: 684 RLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL--DKNMTARVSDFGISKLLGEDDDS 741
+N M L+++H +VH ++KP NI+ K + ++ DFG++ L D+
Sbjct: 151 VINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 205
Query: 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLL 777
+T AT + APE + D+++ GVL
Sbjct: 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 41/205 (20%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSS 649
LG G+F V + G A K+ N + R F+ E E + R ++H N++++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 650 CCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSH 702
F LV + + G L + YS E + + + ++ Y H +
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQILESIAYCHSNG 125
Query: 703 STPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPE- 757
+VH NLKP N+LL K +++DFG++ + + + A T GY++PE
Sbjct: 126 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEV 178
Query: 758 -----YASDGIISPKCDVYSYGVLL 777
Y S D+++ GV+L
Sbjct: 179 LKKDPY------SKPVDIWACGVIL 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 56/267 (20%), Positives = 99/267 (37%), Gaps = 59/267 (22%)
Query: 566 YRNRTTWRRTSYLDIQQATDGFNE----CNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQ 620
+ + ++ R Y + + +G GS+G V AIK+ N
Sbjct: 4 HHHHSSGRENLYFQGGSLLE-LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 621 LERAF-----RSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL------- 668
R ++E +++ + H N+ +++ + + LV+E G L
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 669 ------------------------------EKWLYSHNYFLDMLERL--NIMIDVGLALE 696
+ + E+L NIM + AL
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 697 YLHHSHSTPVVHCNLKPNNILL--DKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIG 752
YLH+ + H ++KP N L +K+ ++ DFG+SK + ++ MT T
Sbjct: 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 753 YMAPE--YASDGIISPKCDVYSYGVLL 777
++APE ++ PKCD +S GVLL
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQL-ERAFRSFESECEV-LRNVRHRNLIKIFSS 649
+G G++GSV K G +A+K + E+ + + +V +R+ +++ + +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN------IMIDVGLALEYLHHSHS 703
+ +E M + S +K+ + + + + I + AL +L +
Sbjct: 90 LFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE----YA 759
++H ++KP+NILLD++ ++ DFGIS G+ DS+ +T YMAPE A
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 760 SDGIISPKCDVYSYGVLLME 779
S + DV+S G+ L E
Sbjct: 202 SRQGYDVRSDVWSLGITLYE 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 40/198 (20%), Positives = 74/198 (37%), Gaps = 16/198 (8%)
Query: 594 GAGSFGSVYKGT-LFDGTNVAIKVFNL--QLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
G +V G V ++ NL + E V + H N++ ++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERL--NIMIDVGLALEYLHHSHSTPVVH 708
+ +V FM GS + L ++ M E I+ V AL+Y+HH VH
Sbjct: 96 IADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVH 151
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDD--SVTQTMTMATIG---YMAPEYASDGI 763
++K ++IL+ + +S + + V ++ +++PE +
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 764 I--SPKCDVYSYGVLLME 779
K D+YS G+ E
Sbjct: 212 QGYDAKSDIYSVGITACE 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 30/198 (15%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSC 650
LG GSF K A+K+ + +R + + E L+ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 651 CNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHS 703
+ LV+E + G L +K +S E IM + A+ ++H
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFS--------ETEASYIMRKLVSAVSHMH---D 124
Query: 704 TPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEYA 759
VVH +LKP N+L + N+ ++ DFG ++L D+ + T T+ Y APE
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL---KTPCFTLHYAAPELL 181
Query: 760 SDGIISPKCDVYSYGVLL 777
+ CD++S GV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSS 649
+LG G+ V L A+K+ Q E E+L + HRN++++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 650 CCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSH 702
D LV E M GS+ ++ ++ E ++ DV AL++LH+
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFN--------ELEASVVVQDVASALDFLHNKG 131
Query: 703 STPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDD-SVTQTMTMATI----GYM 754
+ H +LKP NIL ++ ++ DF + + + D S T + T YM
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 755 APE-----YASDGIISPKCDVYSYGVLL 777
APE I +CD++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 46/221 (20%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 578 LDIQQATDGFNE----CNLLGAGSFGSVYKGT-LFDGTNVAIKV-----FNLQLERAFRS 627
LD+ F + C ++G G F V + G A+K+ F +
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 628 FESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDML 682
+ E + ++H +++++ + + +V EFM L ++ Y
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS---- 128
Query: 683 ERL--NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGE 737
E + + M + AL Y H ++ ++H ++KP+ +LL + + ++ FG++ LGE
Sbjct: 129 EAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185
Query: 738 DDDSVTQTMTMA-TIGYMAPEYASDGIISPKCDVYSYGVLL 777
T +MAPE DV+ GV+L
Sbjct: 186 SGLVAG---GRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-22
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 40/208 (19%)
Query: 590 CNLLGAGSFGSVYKGT-LFDGTNVAIKVFN--LQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G+F V + + G A + N R + E E + R ++H N++++
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 647 FSSCCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLH 699
S L+ + + G L + YS E + + + A+ + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--------EADASHCIQQILEAVLHCH 127
Query: 700 HSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMA 755
VVH NLKP N+LL K +++DFG++ + + + A T GY++
Sbjct: 128 -QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLS 181
Query: 756 PE------YASDGIISPKCDVYSYGVLL 777
PE Y D+++ GV+L
Sbjct: 182 PEVLRKDPY------GKPVDLWACGVIL 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 45/194 (23%), Positives = 92/194 (47%), Gaps = 9/194 (4%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
++ +LG G FG V+K G +A K+ + + ++E V+ + H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
++ + + + LV+E++ G L + +Y L L+ + M + + ++H +
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--- 207
Query: 706 VVHCNLKPNNILLDKNMTARV--SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
++H +LKP NIL ++ DFG+++ + + T ++APE +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDF 264
Query: 764 ISPKCDVYSYGVLL 777
+S D++S GV+
Sbjct: 265 VSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN 642
D ++ LG G+FG V++ T G N A K E + E + + +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
L+ + + + + ++ EFM G L + + + + E + M V L ++H ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 703 STPVVHCNLKPNNILLDKNMTARV--SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
VH +LKP NI+ + + DFG++ L + SV T A + APE A
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTA--EFAAPEVAE 329
Query: 761 DGIISPKCDVYSYGVLL 777
+ D++S GVL
Sbjct: 330 GKPVGYYTDMWSVGVLS 346
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 590 CNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKI 646
LG G+F V + G A K+ N + R F+ E E + R ++H N++++
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 647 FSSCCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLH 699
S F LV + + G L + YS E + + + ++ Y H
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYS--------EADASHCIQQILESIAYCH 145
Query: 700 HSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYM 754
+ +VH NLKP N+LL K +++DFG++ + + + T GY+
Sbjct: 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----EAWHGFAGTPGYL 197
Query: 755 APE------YASDGIISPKCDVYSYGVLL 777
+PE Y S D+++ GV+L
Sbjct: 198 SPEVLKKDPY------SKPVDIWACGVIL 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-21
Identities = 37/181 (20%), Positives = 69/181 (38%), Gaps = 15/181 (8%)
Query: 622 ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDM 681
+ + + +N + + + ++ +L+ W+ D
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 682 LER--LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739
L+I I + A+E+LH ++H +LKP+NI + +V DFG+ + +D+
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 740 DSVTQTMTMA----------TIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDE 789
+ T M T YM+PE S K D++S G++L E E
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
Query: 790 M 790
Sbjct: 279 R 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 18/71 (25%), Positives = 28/71 (39%), Gaps = 2/71 (2%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLI 644
F +G G FG V++ D N AIK L E A E + L + H ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 645 KIFSSCCNLDF 655
+ F++
Sbjct: 68 RYFNAWLETPP 78
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 38/208 (18%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN----LQLERAFRSFESECEVLRNVRHRNLIKI 646
LLG GS+G V + A+K+ ++ + + E ++LR +RH+N+I++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 647 FSSCCNLDFKA--LVLEFMPNGSLEKWLY----------SHNYFLDMLERLNIMIDVGLA 694
N + + +V+E+ G E +H YF +++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----------G 121
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
LEYLH +VH ++KP N+LL T ++S G+++ L T + + +
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 755 APEYAS-----DGIISPKCDVYSYGVLL 777
PE A+ G K D++S GV L
Sbjct: 179 PPEIANGLDTFSG---FKVDIWSAGVTL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 19/220 (8%)
Query: 573 RRTSYLDIQQAT-----DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL-ERAF 625
++T YL I + +G+G+ G V+K G +A+K +
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN 67
Query: 626 RSFESECEVL-RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER 684
+ + +V+ ++ +++ F + + +E M EK +
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERIL 126
Query: 685 LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
+ + + AL YL H V+H ++KP+NILLD+ ++ DFGIS G D +
Sbjct: 127 GKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAK 181
Query: 745 TMTMATIGYMAPE-----YASDGIISPKCDVYSYGVLLME 779
+ YMAPE + + DV+S G+ L+E
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 31/199 (15%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
LG G+ VY+ A+KV +++ +E VL + H N+IK+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 651 CNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHS 703
+LVLE + G L EK YS ER + + + A+ YLH +
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYS--------ERDAADAVKQILEAVAYLHENG- 168
Query: 704 TPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPEY 758
+VH +LKP N+L + +++DFG+SK++ M T GY APE
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-----VLMKTVCGTPGYCAPEI 221
Query: 759 ASDGIISPKCDVYSYGVLL 777
P+ D++S G++
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 49/254 (19%)
Query: 567 RNRTTWRRTSYLDIQQATD---GFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLE 622
+ + R +D+ D F L+G G++G VYKG + G AIKV ++ +
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 623 RAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKA------LVLEFMPNGSLEKWLYSH 675
+ E +L+ HRN+ + + + LV+EF GS+
Sbjct: 63 E-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV------- 114
Query: 676 NYFLDMLERLN-----------IMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA 724
D+++ I ++ L +LH V+H ++K N+LL +N
Sbjct: 115 ---TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168
Query: 725 RVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPE-----YASDGIISPKCDVYSYGVL 776
++ DFG+S L D +V + T IG +MAPE D K D++S G+
Sbjct: 169 KLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223
Query: 777 LMETFTRKKPTDEM 790
+E P +M
Sbjct: 224 AIEMAEGAPPLCDM 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERA-FRSFESECEV-LRNVRHR 641
D LG G++G V K + G +A+K + + + ++ +R V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN------IMIDVGLAL 695
+ + + + +E M + SL+K Y +D + + I + + AL
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKAL 122
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755
E+LH S V+H ++KP+N+L++ ++ DFGIS G D V + + YMA
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPYMA 177
Query: 756 PE----YASDGIISPKCDVYSYGVLLME 779
PE + S K D++S G+ ++E
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERA---FRSFESECEVLRNVRHRN 642
F++ +G GSFG+VY + + VAIK + +++ ++ E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
I+ LV+E+ GS L H L +E + L YLH +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPE-- 757
++H ++K NILL + ++ DFG + ++ + +G +MAPE
Sbjct: 175 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSF--VGTPYWMAPEVI 222
Query: 758 -YASDGIISPKCDVYSYGVLLME 779
+G K DV+S G+ +E
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIE 245
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 41/188 (21%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
LG G FG V++ K ++ + E +L RHRN++ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 652 NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711
+++ ++ EF+ + + + + + L+ E ++ + V AL++LH + + H ++
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDI 128
Query: 712 KPNNILL--DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCD 769
+P NI+ ++ T ++ +FG ++ L D + Y APE ++S D
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 770 VYSYGVLL 777
++S G L+
Sbjct: 186 MWSLGTLV 193
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 44/205 (21%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVL-RNVRHRNLIKIFSSC 650
+G GS+ + A+K+ + E E+L R +H N+I +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 651 CNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHS 703
+ + +V E M G L + +S ER ++ + +EYLH
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFS--------EREASAVLFTITKTVEYLHAQG- 136
Query: 704 TPVVHCNLKPNNILL----DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPE- 757
VVH +LKP+NIL + R+ DFG +K L ++ MT T ++APE
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPCYTANFVAPEV 191
Query: 758 -----YASDGIISPKCDVYSYGVLL 777
Y CD++S GVLL
Sbjct: 192 LERQGY------DAACDIWSLGVLL 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 49/198 (24%), Positives = 78/198 (39%), Gaps = 22/198 (11%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFR------SFESECEVLRNVRHRNLIK 645
LG+G F V K G A K + RA R E E +LR V H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER--LNIMIDVGLALEYLHHSHS 703
+ N L+LE + G L +L E + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS---EEEATSFIKQILDGVNYLHTKK- 135
Query: 704 TPVVHCNLKPNNILL----DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
+ H +LKP NI+L ++ DFG++ + + T ++APE
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIV 190
Query: 760 SDGIISPKCDVYSYGVLL 777
+ + + D++S GV+
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 32/203 (15%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRS------FESECEVLRNVRHRNLIK 645
LG+G F V K G A K + RA R E E +LR V H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 646 IFSSCCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYL 698
+ N L+LE + G L +K S E + + + + YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS--------EEEATSFIKQILDGVNYL 131
Query: 699 HHSHSTPVVHCNLKPNNILL----DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
H + H +LKP NI+L ++ DFG++ + +D + + T ++
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNI-FGTPEFV 185
Query: 755 APEYASDGIISPKCDVYSYGVLL 777
APE + + + D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 32/203 (15%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN------LQLERAFRSFESECEVLRNVRHRNLIK 645
LG+G F V K G A K + + E E +LR +RH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 646 IFSSCCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYL 698
+ N L+LE + G L EK + E + + + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT--------EDEATQFLKQILDGVHYL 124
Query: 699 HHSHSTPVVHCNLKPNNILL----DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
H + H +LKP NI+L N ++ DFGI+ + + + + + T ++
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNI-FGTPEFV 178
Query: 755 APEYASDGIISPKCDVYSYGVLL 777
APE + + + D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 59/228 (25%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN-LQLERAFRSFES------------------- 630
+G GS+G V D T A+KV + +L R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 631 ------ECEVLRNVRHRNLIKIFS--SCCNLDFKALVLEFMPNGSL----------EKWL 672
E +L+ + H N++K+ N D +V E + G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 673 YSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732
+ YF D++ +EYLH+ ++H ++KP+N+L+ ++ +++DFG+S
Sbjct: 138 QARFYFQDLI----------KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 733 KLLGEDDDSVTQTMTMATIGYMAPE---YASDGIISPKCDVYSYGVLL 777
+ D++ T+ T +MAPE DV++ GV L
Sbjct: 185 NEF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 587 FNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVR 639
F +LG GSF +V T AIK+ + E E +V+ +
Sbjct: 32 FKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
H +K++ + + + L + NG L K++ F + R ++ ALEYLH
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH 147
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAPEY 758
++H +LKP NILL+++M +++DFG +K+L + + T Y++PE
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSPE- 202
Query: 759 ASDGIISPK-----CDVYSYGVLLME 779
+++ K D+++ G ++ +
Sbjct: 203 ----LLTEKSACKSSDLWALGCIIYQ 224
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 59/187 (31%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
IP +L LQ N L+ L LR L+L N+L + F L+ +
Sbjct: 35 IPADTKKLD-----LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET 89
Query: 389 IDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQD 446
+ ++ N L +LP + L L L L RNQL ++P + L L LSL N Q
Sbjct: 90 LWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ- 146
Query: 447 SIPD-SFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNF 505
S+P F LTSL+ L L NN L +F+ L+ LK L + +N+L+ ++P G F +
Sbjct: 147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP-EGAFDSL 204
Query: 506 LAQSFLW 512
L
Sbjct: 205 EKLKMLQ 211
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 318 LSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSI 376
L L +N L+ RL +L+ L L N L L +L L + N+L + +
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-L 100
Query: 377 PSS-FWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKD 433
P F L + + L N L SLP + +L L YL+L N+L ++P + L
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158
Query: 434 LITLSLARNRFQDSIPDS-FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
L L L N+ + +P+ F LT L+ L L NN L +F+ L LK L + N
Sbjct: 159 LKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 10/198 (5%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
LT + PS + + + L L++N + + L+ L L N + +P+ I
Sbjct: 25 SKKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI 80
Query: 108 -GNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF-NISTIIII 164
L L L DN L+ +P + L NLA+L L N + +P +F +++ + +
Sbjct: 81 FKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLD-RNQLKSLPPRVFDSLTKLTYL 138
Query: 165 NLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI 224
+L N+L P + L + + L L+ N+L + ++L L L++N L
Sbjct: 139 SLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 225 PNTFGNLRHLSTLNIRAN 242
F +L L L ++ N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 57/212 (26%), Positives = 81/212 (38%), Gaps = 36/212 (16%)
Query: 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244
+ + L L +N+L+ + +KL L LN N L F L++L TL + N L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS 304
G + L +L L L N L S LPP F
Sbjct: 98 Q--ALPIGVFDQLVNLAE------LRLDRNQLKS-LPP--RVFD---------------- 130
Query: 305 IPKEIGNLRGLIALSLFTNDLNGTIPTTL-GRLQQLQAL-LQRNNLNGPIPTCLSSLISL 362
+L L LSL N+L ++P + +L L+ L L N L L L
Sbjct: 131 ------SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSN 394
+ L L +NQL +F SLE + + L N
Sbjct: 184 KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 47/206 (22%), Positives = 79/206 (38%), Gaps = 37/206 (17%)
Query: 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF---SKLQVLSLRNNSF 75
LD+ N +L +L+ L N L + P+ G+F L+ L + +N
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA--GIFKELKNLETLWVTDNKL 97
Query: 76 TGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNLRGEIPNEI-G 132
+P +F L +L L N + ++P ++ +LTKL +L+ N L+ +P +
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 133 NLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLW 192
L +L +L L NN + +P F L + L L
Sbjct: 155 KLTSLKELRLY-NNQLKRVPEGAF------------------------DKLTELKTLKLD 189
Query: 193 ANRLTGTIPNSITNASKLIGLDLNSN 218
N+L + + KL L L N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 60/255 (23%), Positives = 103/255 (40%), Gaps = 50/255 (19%)
Query: 587 FNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFN----LQL-ERAFRSFESECEVLRN 637
F ++G G+FG V K A+K+ N L+ E A F E +VL N
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETAC--FREERDVLVN 130
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMID------- 690
+ + + + + + LV+++ G L + L + +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDL----LTL------LSKFEDRLPEEMARFY 180
Query: 691 ---VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT 747
+ +A++ +H H VH ++KP+NIL+D N R++DFG L ED +
Sbjct: 181 LAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA- 236
Query: 748 MATIGYMAPE-----YASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSL 797
+ T Y++PE G P+CD +S GV + E + P E + +
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY--GKIM 294
Query: 798 KHWIKLSLPRGLTEV 812
H + P +T+V
Sbjct: 295 NHKERFQFPTQVTDV 309
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 46/205 (22%), Positives = 78/205 (38%), Gaps = 36/205 (17%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRS------FESECEVLRNVRHRNLIK 645
LG+G F V K G A K + ++ R E E +L+ ++H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 646 IFSSCCNLDFKALVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYL 698
+ N L+LE + G L EK + E + + + YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLT--------EEEATEFLKQILNGVYYL 130
Query: 699 HHSHSTPVVHCNLKPNNILL----DKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIG 752
H + H +LKP NI+L ++ DFG++ + T
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-----NEFKNIFGTPE 182
Query: 753 YMAPEYASDGIISPKCDVYSYGVLL 777
++APE + + + D++S GV+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 50/193 (25%), Positives = 86/193 (44%), Gaps = 19/193 (9%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN------LQLERAFRSFESECEVLRNVRHRNLIK 645
+G G+F V + G VAIK+ + L++ FR E +++ + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+F L++E+ G + +L +H + E + + A++Y H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YASDGII 764
+VH +LK N+LLD +M +++DFG S Y APE +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDA-FCGAPPYAAPELFQGKKYD 191
Query: 765 SPKCDVYSYGVLL 777
P+ DV+S GV+L
Sbjct: 192 GPEVDVWSLGVIL 204
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 42/208 (20%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN------------LQLERAFRSFESECEVLRNVR 639
LG+G+FG V+ V +K +L + E +L V
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLN------IMIDVGL 693
H N+IK+ N F LV+E +G L+ L++ F+D RL+ I +
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSG-LD--LFA---FIDRHPRLDEPLASYIFRQLVS 141
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
A+ YL ++H ++K NI++ ++ T ++ DFG + L + + T TI Y
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEY 195
Query: 754 MAPEYAS----DGIISPKCDVYSYGVLL 777
APE G P+ +++S GV L
Sbjct: 196 CAPEVLMGNPYRG---PELEMWSLGVTL 220
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNL-QLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G+G+ V VAIK NL + + + E + + H N++ ++S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 651 CNLDFKALVLEFMPNGSLE---KWLYSHNYFLD-MLERLNIMI---DVGLALEYLHHSHS 703
D LV++ + GS+ K + + +L+ I +V LEYLH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG---YMAPEYAS 760
+H ++K NILL ++ + +++DFG+S L D + +G +MAPE
Sbjct: 142 --QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE--- 196
Query: 761 DGIIS------PKCDVYSYGVLLME 779
++ K D++S+G+ +E
Sbjct: 197 --VMEQVRGYDFKADIWSFGITAIE 219
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 40/280 (14%), Positives = 78/280 (27%), Gaps = 33/280 (11%)
Query: 224 IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPL 283
+ + +L+++ + + + + L+ L+L + + PP
Sbjct: 55 EADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114
Query: 284 IGNFS-ASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL 342
+ + + L+ + L +
Sbjct: 115 LLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQ--------------- 158
Query: 343 LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSI-------PSSFWSLEYILRIDLSSNS 395
+ + +L L L N P F +L+ + + +
Sbjct: 159 ---AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 396 LSGSLPSDIQNLKVLIYLNLSRNQLSGNIP-ITIGGLKDLITLSLARNRFQDSIPDSFGS 454
SG + L L+LS N L + L +L+L+ +P G
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPK--GL 272
Query: 455 LTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEG 494
L LDLS N L P E L + L++ N
Sbjct: 273 PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 45/230 (19%), Positives = 66/230 (28%), Gaps = 19/230 (8%)
Query: 203 SITNASKLIGLDLNSNSLSGQIPNTFGNLRH--LSTLNIRANYLTTETSSNGEWSFLSSL 260
+ S L L L + ++G P L+ LN+R T + E
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 261 TNCNKLRALSLGSNPLDSILPPLIGNFSA------SFQQFYAHECKLKGSIPKEIGNLRG 314
L+ LS+ + + F A S + P + L+
Sbjct: 150 G----LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV 205
Query: 315 LIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNG-PIPTCLSSLISLRQLHLGSNQL 372
L + +G QLQ L L N+L L L+L L
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
Query: 373 TSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
L +DLS N L PS L + L+L N
Sbjct: 266 KQVPKGLPAKLSV---LDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 46/239 (19%), Positives = 76/239 (31%), Gaps = 20/239 (8%)
Query: 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG--VFSKLQVLSLRNNSFTG 77
I G L + + L+ L ++TG+ P + L +L+LRN S+
Sbjct: 78 ARIPSRILFGAL--RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 78 --PIPNSLFNLS--SLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEI------ 127
L L L ++ L L+ +DN GE
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 128 -PNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNR 186
P + L+ LA + G + ++L N L +
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 187 QFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245
L L L +P + +KL LDL+ N L P+ L + L+++ N
Sbjct: 256 NSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFL 309
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 32/176 (18%), Positives = 66/176 (37%), Gaps = 15/176 (8%)
Query: 333 LGRLQQLQALLQRNNLNGPIPTCLSSL--ISLRQLHLGSNQLTSSIPSS---FWSLEYIL 387
G + L+ LL+R + + + +SL++L + + ++ S I + +
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 388 RIDLSSNSLSGSLPSDIQNLKV--LIYLNLSRNQLSGNIP----ITIGGLKDLITLSLAR 441
+ L + ++G+ P + L LNL + + L LS+A+
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEI----LSHLKRLNVSHNRLE 493
+ + +L LDLS+N GE + L+ L + + +E
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 47/324 (14%), Positives = 82/324 (25%), Gaps = 61/324 (18%)
Query: 60 GVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPS---KIGNLTKLVHL 116
G S +L + + SL RL R I I ++ ++ L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 117 NFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176
+ + G P + +++ + + N+
Sbjct: 101 TLENLEVTGTAPPPLLEATGP-------------------DLNILNLRNVSWATRDAWLA 141
Query: 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNT----FGNLR 232
P + L + + L LDL+ N G+
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 233 HLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQ 292
L L +R + T + +L+ L L N L ++ +
Sbjct: 202 TLQVLALRNAGMET-----PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 293 QFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGP 351
LK +PK + +L L L N L+
Sbjct: 257 SLNLSFTGLK-QVPKGL--------------------------PAKLSVLDLSYNRLDR- 288
Query: 352 IPTCLSSLISLRQLHLGSNQLTSS 375
P+ L + L L N S
Sbjct: 289 NPSPD-ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 42/212 (19%), Positives = 70/212 (33%), Gaps = 22/212 (10%)
Query: 2 SLGGTVPPHIGNLSF--LMYLDISENNFRGYLPNELGQL-----RRLKFLGFAYNDLTGS 54
+ GT PP + + L L++ ++ L +L LK L A
Sbjct: 106 EVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNF 164
Query: 55 FPSWIGVFSKLQVLSLRNNSFTGPI-------PNSLFNLSSLVRLDSRFNSISGNIPSKI 107
+ VF L L L +N G P L L ++ + SG +
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 108 GNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINL 166
+L L+ + N+LR L L L+ L +P + + + +++L
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDL 281
Query: 167 VGNQLSGHRPSTMGHSLPNRQFLLLWANRLTG 198
N+L + LP L L N
Sbjct: 282 SYNRLDRNPSPD---ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 31/151 (20%), Positives = 49/151 (32%), Gaps = 13/151 (8%)
Query: 8 PPHIGNLSFLMYLDISENNFRGYL-------PNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ L LD+S+N G P + L+ L +G +
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFA 119
+LQ L L +NS S L L+ F + +P + KL L+ +
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLS 282
Query: 120 DNNLRGEIPNEIGNLKNLADLVLALNNLIGP 150
N L P L + +L L N +
Sbjct: 283 YNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 36/245 (14%)
Query: 587 FNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVLRN 637
F + +LG G FG V + T G A K L+ +R + ++L
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKK--LEKKRIKKRKGEAMALNEKQILEK 240
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI-DVGLALE 696
V R ++ + + D LVL M G L+ +Y R ++ LE
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMA 755
LH +V+ +LKP NILLD + R+SD G++ + E T+GYMA
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMA 353
Query: 756 PEYASDGIISPKCDVYSYGVLLMETFT---------RKKPTDEMFTGEMSLKHWIKLSLP 806
PE + + D ++ G LL E +K +E+ + +
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--RLVKEV--PEEYS 409
Query: 807 RGLTE 811
+
Sbjct: 410 ERFSP 414
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-19
Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 40/247 (16%)
Query: 587 FNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC--------EV 634
F+ ++G G FG VY T G A+K L +R +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADT---GKMYAMKC--LDKKRIKMKQGETLALNERIMLSL 245
Query: 635 LRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLA 694
+ ++ + + D + +L+ M G L L H F + R ++ L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILG 304
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGY 753
LE++H + VV+ +LKP NILLD++ R+SD G++ + + T GY
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGY 356
Query: 754 MAPEYASDGII-SPKCDVYSYGVLLMETFT--------RKKPTDEMFTGEMSLKHWIKLS 804
MAPE G+ D +S G +L + + K E+ M+L +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTM--AVE 412
Query: 805 LPRGLTE 811
LP +
Sbjct: 413 LPDSFSP 419
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 30/248 (12%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQ--LERA-FRSFESECEVLRN 637
D F ++G G+F V K T G A+K+ N L+R F E +VL N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI-DVGLALE 696
R + ++ + + ++ LV+E+ G L L + E + ++ +A++
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAID 176
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
+H VH ++KP+NILLD+ R++DFG L D + + T Y++P
Sbjct: 177 SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA-VGTPDYLSP 232
Query: 757 E-------YASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLS 804
E G P+CD ++ GV E F + P T E + + + LS
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY--GKIVHYKEHLS 290
Query: 805 LPRGLTEV 812
LP V
Sbjct: 291 LPLVDEGV 298
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 28/241 (11%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL 635
+ F LLG G+FG V K T G A+K+ L+ E E VL
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKI--LKKEVIVAKDEVAHTLTENRVL 202
Query: 636 RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
+N RH L + S D V+E+ G L L F + R ++ AL
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSAL 261
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755
+YLH + VV+ +LK N++LDK+ +++DFG+ K G D + +T T Y+A
Sbjct: 262 DYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLA 317
Query: 756 PEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGLT 810
PE D D + GV++ E + P +++F E+ L ++ PR L
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--ELILME--EIRFPRTLG 373
Query: 811 E 811
Sbjct: 374 P 374
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 44/207 (21%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQ-------LERAFRSFESECEVLRNVRHRNL 643
LG G+FG V G G VA+K+ N Q + + R E + L+ RH ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDMLERLNIMIDVGLA 694
IK++ +V+E++ G L ++ H F +L A
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS----------A 123
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
++Y H VVH +LKP N+LLD +M A+++DFG+S + D +T + + Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRT-SCGSPNYA 177
Query: 755 APEYAS----DGIISPKCDVYSYGVLL 777
APE S G P+ D++S GV+L
Sbjct: 178 APEVISGRLYAG---PEVDIWSCGVIL 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 44/201 (21%), Positives = 78/201 (38%), Gaps = 30/201 (14%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFN--LQLERAFRSFESECEVLRNVRHR-NLIKIFS 648
LG G F V + G A K + + E VL + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 649 SCCNLDFKALVLEFMPNGSL-----EKWL--YSHNYFLDMLER--LNIMIDVGLALEYLH 699
N L+LE+ G + + S E + ++ + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVS--------ENDVIRLIKQILEGVYYLH 148
Query: 700 HSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
++ +VH +LKP NILL ++ DFG+S+ + + + M T Y+AP
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREI-MGTPEYLAP 202
Query: 757 EYASDGIISPKCDVYSYGVLL 777
E + I+ D+++ G++
Sbjct: 203 EILNYDPITTATDMWNIGIIA 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 36/203 (17%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVL-RNVRHRNLIKIFSS 649
+LG G G V + G A+K+ +A + E + + +++ I
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 650 CCNLDFKA----LVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYL 698
N+ +++E M G L E+ F ER IM D+G A+++L
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQER---GDQAFT---EREAAEIMRDIGTAIQFL 144
Query: 699 HHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYM 754
H + + H ++KP N+L +K+ +++DFG +K ++ T T Y+
Sbjct: 145 HSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYTPYYV 196
Query: 755 APEYASDGIISPKCDVYSYGVLL 777
APE CD++S GV++
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIM 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 43/205 (20%), Positives = 82/205 (40%), Gaps = 39/205 (19%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQ-----LERAFRSFESECEVLRNVRHRNLIK 645
LG G++G V VA+K+ +++ E + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDMLERLNIMIDVGLALE 696
+ + + L LE+ G L + +F ++ +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVV 119
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YLH + H ++KP N+LLD+ ++SDFG++ + ++ T+ Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 757 EYAS----DGIISPKCDVYSYGVLL 777
E DV+S G++L
Sbjct: 177 ELLKRREFHA---EPVDVWSCGIVL 198
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 36/145 (24%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
+P S + L L N L SF+S + +DLS + ++ Q+L L
Sbjct: 26 LPF------STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 411 IYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDSIPD-SFGSLTSLEYLDLSNNNL 468
L L+ N + ++ + GL L L S+ + G L +L+ L++++N +
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 469 -SGEIPKSFEILSHLKRLNVSHNRL 492
S ++P+ F L++L+ L++S N++
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 43/189 (22%), Positives = 75/189 (39%), Gaps = 13/189 (6%)
Query: 311 NLRGLIALSLFTNDLNGTIPT-TLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLG 368
+ L L L ++ TI L L L L N + S L SL++L
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 369 SNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSD--IQNLKVLIYLNLSRNQLSGNIPI 426
L S L+ + ++++ N + S NL L +L+LS N++ +I
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC 166
Query: 427 -TIGGLKDL----ITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSH 481
+ L + ++L L+ N P +F + L+ L L N L F+ L+
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTS 225
Query: 482 LKRLNVSHN 490
L+++ + N
Sbjct: 226 LQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 57/250 (22%), Positives = 84/250 (33%), Gaps = 43/250 (17%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI-TNASK 209
IP + + ++L N L + S P Q L L + TI + + S
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSF-FSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 210 LIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRAL 269
L L L N + F L L L L + + + + L+ L
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF--------PIGHLKTLKEL 129
Query: 270 SLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTI 329
++ N + S L FS NL L L L +N +
Sbjct: 130 NVAHNLIQSF--KLPEYFS----------------------NLTNLEHLDLSSNKIQSIY 165
Query: 330 PTTLGRLQQLQAL-----LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLE 384
T L L Q+ L L N +N I I L++L L +NQL S F L
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLT 224
Query: 385 YILRIDLSSN 394
+ +I L +N
Sbjct: 225 SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 45/231 (19%), Positives = 81/231 (35%), Gaps = 21/231 (9%)
Query: 54 SFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTK 112
P + + L L N S F+ L LD I I +L+
Sbjct: 21 KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 113 LVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNI-STIIIINLVGNQ 170
L L N ++ + L +L LV + + T+ +N+ N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV-ETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 171 LSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL----IGLDLNSNSLSGQIPN 226
+ + +L N + L L +N++ + ++ + LDL+ N ++ P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 227 TFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
F + L L + N L + +G + L+SL + L +NP D
Sbjct: 196 AFKEI-RLKELALDTNQLK--SVPDGIFDRLTSLQK------IWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 51/230 (22%), Positives = 82/230 (35%), Gaps = 33/230 (14%)
Query: 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSK---LQVLSLRNNSF 75
LD+S N R L+ L + ++ + G + L L L N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIED--GAYQSLSHLSTLILTGNPI 88
Query: 76 TGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNLRG-EIPNEIG 132
+ F LSSL +L + +++ ++ + G+L L LN A N ++ ++P
Sbjct: 89 QS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 133 NLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLW 192
NL NL L L+ +N I I T + + LS L L
Sbjct: 147 NLTNLEHLDLS-SNKIQSIYCTDLRVLH----QMPLLNLS----------------LDLS 185
Query: 193 ANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
N + I +L L L++N L F L L + + N
Sbjct: 186 LNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 7/118 (5%)
Query: 388 RIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD 446
+ +P ++ + K L+LS N L + +L L L+R Q
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRN 504
++ SL+ L L L+ N + +F LS L++L L + N P +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLE-NFPIGH 122
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 50/205 (24%), Positives = 78/205 (38%), Gaps = 42/205 (20%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRHRNLIKIF 647
+G+G+FG VA+K E R E R++RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 648 SSCCNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDMLERLNIMIDVGLALEYL 698
A+++E+ G L + + + +F +L + Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGVSYC 132
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTAR--VSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
H + H +LK N LLD + R + DFG SK S ++ T+ T Y+AP
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKS-TVGTPAYIAP 186
Query: 757 EYAS----DGIISPKCDVYSYGVLL 777
E DG DV+S GV L
Sbjct: 187 EVLLRQEYDG---KIADVWSCGVTL 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 61/252 (24%), Positives = 109/252 (43%), Gaps = 50/252 (19%)
Query: 587 FNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVR 639
F +G GSFG V T A+K N Q R+ E ++++ +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 640 HRNLIKI---FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
H L+ + F ++ F +V++ + G L L + +F + +L I ++ +AL+
Sbjct: 74 HPFLVNLWYSFQDEEDM-F--MVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALD 129
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMA 755
YL + ++H ++KP+NILLD++ ++DF I+ +L + TQ TMA T YMA
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMA 182
Query: 756 PEYASDGIISPKC--------DVYSYGVLLMETFTRKKP--------TDEMFTGEMSLKH 799
PE + S + D +S GV E ++P + E+
Sbjct: 183 PE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV--HTFETT 235
Query: 800 WIKLSLPRGLTE 811
++ P ++
Sbjct: 236 --VVTYPSAWSQ 245
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 55/293 (18%), Positives = 107/293 (36%), Gaps = 58/293 (19%)
Query: 201 PNSIT------NASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254
P +I + I + ++++ T +L ++TL+ +TT
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-------- 55
Query: 255 SFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRG 314
+ + N L L L N + + P + NL
Sbjct: 56 --IEGVQYLNNLIGLELKDNQITDLAP---------------------------LKNLTK 86
Query: 315 LIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLT 373
+ L L N L + + LQ ++ L L + P L+ L +L+ L+L NQ+T
Sbjct: 87 ITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT 142
Query: 374 SSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKD 433
+ S L + + + + +S + + NL L L N++S +I + L +
Sbjct: 143 NI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DIS-PLASLPN 196
Query: 434 LITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLN 486
LI + L N+ D P + ++L + L+N ++ + L +
Sbjct: 197 LIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 33/162 (20%), Positives = 69/162 (42%), Gaps = 13/162 (8%)
Query: 333 LGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDL 391
L + ++N+ + + L + L +T+ L ++ ++L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 392 SSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDS 451
N ++ + ++NL + L LS N L N+ I GL+ + TL L + D P
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 452 FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
L++L+ L L N ++ I L++L+ L++ + ++
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 58/338 (17%), Positives = 110/338 (32%), Gaps = 79/338 (23%)
Query: 85 NLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLAL 144
L++ +++ + ++++ +L + L+ + I + L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 145 NNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI 204
N + T + + +L L L N L + I
Sbjct: 73 NQI-----TDLAPLK----------------------NLTKITELELSGNPLK-NVSA-I 103
Query: 205 TNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCN 264
+ LDL S ++ P L +L L + N +T +S L
Sbjct: 104 AGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN----------ISPLAGLT 151
Query: 265 KLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTND 324
L+ LS+G+ + + P + NL L L N
Sbjct: 152 NLQYLSIGNAQVSDLTP---------------------------LANLSKLTTLKADDNK 184
Query: 325 LNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSL 383
++ P L L L + L+ N ++ P L++ +L + L + +T+ +L
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 384 EYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421
+ S + P+ I + NL+ N S
Sbjct: 241 VVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 43/223 (19%), Positives = 86/223 (38%), Gaps = 31/223 (13%)
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
+ ++ ++ T + +L + L + ++ I + L L+ L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIST---IIIINLVGNQLSGHRPST 178
+ ++ + NL + +L L+ N L + I+ I ++L Q++ P
Sbjct: 74 QIT-DLAP-LKNLTKITELELSGNPL-----KNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 179 MGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLN 238
L N Q L L N++T P + + L L + + +S + NL L+TL
Sbjct: 127 ---GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLK 179
Query: 239 IRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILP 281
N ++ +S L + L + L +N + + P
Sbjct: 180 ADDNKISD----------ISPLASLPNLIEVHLKNNQISDVSP 212
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 50/248 (20%), Positives = 86/248 (34%), Gaps = 18/248 (7%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
T +L + L + L L L N +T P + +K+
Sbjct: 32 TDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKI 87
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
L L N + L S+ LD I+ P + L+ L L N +
Sbjct: 88 TELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT- 142
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPN 185
I + L NL L + + P + N+S + + N++S P SLPN
Sbjct: 143 NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISPLA---SLPN 196
Query: 186 RQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTL-NIRANYL 244
+ L N+++ P + N S L + L + +++ Q NL + + +
Sbjct: 197 LIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254
Query: 245 TTETSSNG 252
T S+
Sbjct: 255 APATISDN 262
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 58/335 (17%), Positives = 114/335 (34%), Gaps = 79/335 (23%)
Query: 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF 156
+I+ P L + + +N+ + +L + L + TTI
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-----TTIE 57
Query: 157 NISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLN 216
+ L N L L N++T + + N +K+ L+L+
Sbjct: 58 GVQ----------------------YLNNLIGLELKDNQIT-DLAP-LKNLTKITELELS 93
Query: 217 SNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
N L + L+ + TL++ + +T ++ L + L+ L L N +
Sbjct: 94 GNPLK-NVSA-IAGLQSIKTLDLTSTQITD----------VTPLAGLSNLQVLYLDLNQI 141
Query: 277 DSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRL 336
+I P + L L LS+ ++ P L L
Sbjct: 142 TNISP---------------------------LAGLTNLQYLSIGNAQVSDLTP--LANL 172
Query: 337 QQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNS 395
+L L N ++ P L+SL +L ++HL +NQ++ S + + + L++ +
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQT 228
Query: 396 LSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGG 430
++ NL V + I+ G
Sbjct: 229 ITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNG 263
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 24/124 (19%), Positives = 50/124 (40%), Gaps = 10/124 (8%)
Query: 369 SNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITI 428
+ P +L ++I ++++ +L + L+ ++ I +
Sbjct: 6 PTAINVIFPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-V 59
Query: 429 GGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVS 488
L +LI L L N+ D P +LT + L+LS N L + L +K L+++
Sbjct: 60 QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLT 115
Query: 489 HNRL 492
++
Sbjct: 116 STQI 119
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 37/164 (22%), Positives = 59/164 (35%), Gaps = 10/164 (6%)
Query: 9 PHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVL 68
+ LS L L + N P L L L++L ++ P + SKL L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 69 SLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIP 128
+N + P L +L +L+ + + N IS P + N + L + + + +
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
Query: 129 NEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172
NL + I P TI + T NL N S
Sbjct: 235 FYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWNLTS 276
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 57/249 (22%), Positives = 94/249 (37%), Gaps = 37/249 (14%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL 635
D F + +LG G FG V+ K T G A K L +R + + ++L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKK--LNKKRLKKRKGYQGAMVEKKIL 239
Query: 636 RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDML--ERLNIMI-DVG 692
V R ++ + + LV+ M G + +Y+ + R +
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TI 751
LE+LH +++ +LKP N+LLD + R+SD G++ L T A T
Sbjct: 300 SGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTP 353
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFT---------RKKPTDEMFTGEMSLKHWIK 802
G+MAPE D ++ GV L E K E+ + L+
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRVLEQ--A 409
Query: 803 LSLPRGLTE 811
++ P +
Sbjct: 410 VTYPDKFSP 418
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 43/205 (20%), Positives = 82/205 (40%), Gaps = 39/205 (19%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQ-----LERAFRSFESECEVLRNVRHRNLIK 645
LG G++G V VA+K+ +++ E + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDMLERLNIMIDVGLALE 696
+ + + L LE+ G L + +F ++ +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVV 119
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
YLH + H ++KP N+LLD+ ++SDFG++ + ++ T+ Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 757 EYAS----DGIISPKCDVYSYGVLL 777
E DV+S G++L
Sbjct: 177 ELLKRREFHA---EPVDVWSCGIVL 198
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 56/207 (27%), Positives = 81/207 (39%), Gaps = 38/207 (18%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN----------LQLERAFRSFESECEVLRNVRH 640
LLG+G FGSVY G + D VAIK R E +L+ V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105
Query: 641 R--NLIKIFSSCCNLDFKALVLEF-MPNGSLEKWLYSHNYFLDMLERL--NIMIDVGLAL 695
+I++ D L+LE P L ++ + E L + V A+
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAV 162
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
+ H+ V+H ++K NIL+D N ++ DFG LL D+V T Y
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYS 215
Query: 755 APEYAS----DGIISPKCDVYSYGVLL 777
PE+ G V+S G+LL
Sbjct: 216 PPEWIRYHRYHG---RSAAVWSLGILL 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 54/212 (25%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQ-------LERAFRSFESECEVLRNVRHRNL 643
LG G+FG V G G VA+K+ N Q + + R E + L+ RH ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDMLERLNIMIDVGLA 694
IK++ +V+E++ G L ++ + F +L
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS----------G 128
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG-- 752
++Y H VVH +LKP N+LLD +M A+++DFG+S + D +T + G
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRT----SCGSP 179
Query: 753 -YMAPEYASDGIIS------PKCDVYSYGVLL 777
Y APE +IS P+ D++S GV+L
Sbjct: 180 NYAAPE-----VISGRLYAGPEVDIWSSGVIL 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 587 FNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQ--LERA-FRSFESECEVLRNVR 639
+ ++G G+FG V K T A+K+ + ++R+ F E +++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
++++F + + + +V+E+MP G L + +++ + R +V LAL+ +H
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA-EVVLALDAIH 185
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-- 757
+H ++KP+N+LLDK+ +++DFG + ++ T T Y++PE
Sbjct: 186 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241
Query: 758 --YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
DG +CD +S GV L EM G+
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLY----------EMLVGD 270
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 41/205 (20%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSC 650
LG G G V + A+K+ +A R E E+ + ++++I
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 651 CNLDFKA----LVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLH 699
NL +V+E + G L ++ F ER IM +G A++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT---EREASEIMKSIGEAIQYLH 178
Query: 700 HSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGEDDDSVTQTMTMATI----G 752
+ + H ++KP N+L N +++DFG +K + ++ T
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------SLTTPCYTPY 228
Query: 753 YMAPEYASDGIISPKCDVYSYGVLL 777
Y+APE CD++S GV++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 27/183 (14%), Positives = 65/183 (35%), Gaps = 11/183 (6%)
Query: 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGS 369
+ + L + T T ++ L + L N+ + +++ L + +
Sbjct: 21 TFKAYLNGLL---GQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 370 NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIG 429
T+ P S L + R+ + ++ ++ L L L++S + +I I
Sbjct: 76 IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 430 GLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSH 489
L + ++ L+ N + +L L+ L++ + + E L +L
Sbjct: 134 TLPKVNSIDLSYNG-AITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 490 NRL 492
+
Sbjct: 191 QTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 27/165 (16%), Positives = 63/165 (38%), Gaps = 8/165 (4%)
Query: 308 EIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLH 366
+ L ++L ++ + ++ L + + P +S L +L +L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 367 LGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPI 426
+ +TS + L + +D+S ++ S+ + I L + ++LS N +I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM- 153
Query: 427 TIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGE 471
+ L +L +L++ + D L L + + G+
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 30/195 (15%), Positives = 66/195 (33%), Gaps = 19/195 (9%)
Query: 85 NLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLAL 144
+ + +S + + L ++ A+ N+ ++ I N+ DL +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTIN- 74
Query: 145 NNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI 204
N I +S + + ++G ++ + + L + L + + +I I
Sbjct: 75 NIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKI 132
Query: 205 TNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCN 264
K+ +DL+ N I L L +LNI+ + + + +
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD----------YRGIEDFP 181
Query: 265 KLRALSLGSNPLDSI 279
KL L S +
Sbjct: 182 KLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 36/210 (17%), Positives = 70/210 (33%), Gaps = 35/210 (16%)
Query: 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRN 72
+ + +++ ++ L + DLTG I ++ L++ N
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 73 NSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIG 132
T P + LS+L RL ++ + + LT L L+ + + I +I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 133 NLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLW 192
L + + L+ N I T I + +LP + L +
Sbjct: 134 TLPKVNSIDLSYNGAI----TDIMPLK----------------------TLPELKSLNIQ 167
Query: 193 ANRLTGTIPNSITNASKLIGLDLNSNSLSG 222
+ + I + KL L S ++ G
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 24/137 (17%), Positives = 48/137 (35%), Gaps = 5/137 (3%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
I + L I+ + Y P + L L+ L D+T + + L +L +
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
+++ I + L + +D +N +I + L +L LN + +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG-- 176
Query: 131 IGNLKNLADLVLALNNL 147
I + L L +
Sbjct: 177 IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 27/215 (12%), Positives = 67/215 (31%), Gaps = 44/215 (20%)
Query: 209 KLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRA 268
+ L +S + T + L+ + + +T L+ + + ++
Sbjct: 24 AYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD----------LTGIEYAHNIKD 70
Query: 269 LSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGT 328
L++ + + P I S + ++ + + L L L + + + +
Sbjct: 71 LTINNIHATNYNP--ISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 329 IPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYIL 387
I T + L ++ ++ L N I L +L L+ L++ + +
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY------------ 174
Query: 388 RIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
I++ L L + G
Sbjct: 175 --------------RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 20/118 (16%), Positives = 49/118 (41%), Gaps = 7/118 (5%)
Query: 382 SLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR 441
+ + L L +S + + + +L Y+ L+ ++ I ++ L++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVTDLTGI--EYAHNIKDLTINN 75
Query: 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTN 499
+ P L++LE L + +++ + + L+ L L++SH+ + I T
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 25/178 (14%), Positives = 65/178 (36%), Gaps = 30/178 (16%)
Query: 117 NFADNNLRGEIPNEIG----------NLKNLADLVLALNNLIGPIPTTIFNIST---III 163
N D+ + + +G + +L + LA N+ T + I I
Sbjct: 16 NIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-----TDLTGIEYAHNIKD 70
Query: 164 INLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQ 223
+ + + + P + L N + L + +T +++ + L LD++ ++
Sbjct: 71 LTINNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 224 IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILP 281
I L ++++++ N T+ + L +L++L++ + +
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITD---------IMPLKTLPELKSLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 26/116 (22%), Positives = 41/116 (35%), Gaps = 3/116 (2%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
I LS L L I + L L L L +++ S + I K+ + L
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGE 126
N I L L L L+ +F+ + + I + KL L + G+
Sbjct: 144 SYNGAITDIMP-LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/99 (16%), Positives = 40/99 (40%), Gaps = 3/99 (3%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
+ P++ L+ L LDIS + + ++ L ++ + +YN +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTL 158
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISG 101
+L+ L+++ + + + L +L + +I G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 57/215 (26%), Positives = 79/215 (36%), Gaps = 52/215 (24%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFN----------LQLERAFRSFESECEVLRNVR- 639
LLG G FG+V+ G L D VAIKV E +L V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVGA 93
Query: 640 ---HRNLIKIFSSCCNLDFKA------LVLEF-MPNGSLEKWLYSHNYFLDMLERL--NI 687
H +I++ LD+ LVLE +P L ++ + E
Sbjct: 94 GGGHPGVIRL------LDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCF 144
Query: 688 MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLGEDDDSVTQTM 746
V A+++ H VVH ++K NIL+D A++ DFG LL D
Sbjct: 145 FGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD- 197
Query: 747 TMATIGYMAPEYAS----DGIISPKCDVYSYGVLL 777
T Y PE+ S V+S G+LL
Sbjct: 198 FDGTRVYSPPEWISRHQYHA---LPATVWSLGILL 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 56/280 (20%)
Query: 564 IRYRNRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLER 623
+ + + + R + L Q + + + +G G++G VYK G VA+K L E
Sbjct: 1 MHHHHHHSSGREN-LYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED 59
Query: 624 ------AFRSFESECEVLRNVRHRN---LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYS 674
A R E +L+ + H N LI + S L LV EFM L+K L
Sbjct: 60 EGIPSTAIR----EISLLKELHHPNIVSLIDVIHSERCL---TLVFEFMEK-DLKKVLDE 111
Query: 675 HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734
+ L + + + + + H ++H +LKP N+L++ + +++DFG+++
Sbjct: 112 NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA 168
Query: 735 LGEDDDSVTQTMTMATIGYMAPE-------YASDGIISPKCDVYSYGVLLMETFTRK--- 784
G S T + T+ Y AP+ Y S D++S G + E T K
Sbjct: 169 FGIPVRSYTH--EVVTLWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGKPLF 220
Query: 785 -----------------KPTDEMFTGEMSLKHWIKLSLPR 807
P + L W + +
Sbjct: 221 PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQV 260
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 44/245 (17%)
Query: 587 FNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVLRN 637
F LG GSFG V+ + G A+KV L+ E R + E +L
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSI 62
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
V H +I+++ + + ++++++ G L L F + + + +V LALEY
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEY 121
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAP 756
LH +++ +LKP NILLDKN +++DFG +K D T T+ T Y+AP
Sbjct: 122 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---YVPD---VTYTLCGTPDYIAP 172
Query: 757 EYASDGIISPK-----CDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLP 806
E ++S K D +S+G+L+ E P T + + E L +L P
Sbjct: 173 E-----VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY--EKILNA--ELRFP 223
Query: 807 RGLTE 811
E
Sbjct: 224 PFFNE 228
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 39/227 (17%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER------AFRSFESECEVLRN 637
+ + +G G++G+V+K VA+K L + A R E +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 638 VRHRN---LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLA 694
++H+N L + S L LV EF L+K+ S N LD + + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKL---TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
L + H + V+H +LKP N+L+++N ++++FG+++ G + + T+ Y
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVVTLWYR 168
Query: 755 APE-------YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
P+ Y S D++S G + E +P +F G
Sbjct: 169 PPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 2e-17
Identities = 50/281 (17%), Positives = 90/281 (32%), Gaps = 52/281 (18%)
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
S + QI N++ +T + N + +
Sbjct: 4 TITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTD----------AVTQNELNSIDQIIAN 51
Query: 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTT 332
++ + S+ + I L + L L N L P
Sbjct: 52 NSDIKSV---------------------------QGIQYLPNVTKLFLNGNKLTDIKP-- 82
Query: 333 LGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDL 391
L L+ L L L N + L L L+ L L N ++ + L + + L
Sbjct: 83 LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYL 138
Query: 392 SSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDS 451
+N ++ + + L L L+L NQ+S +I + GL L L L++N D +
Sbjct: 139 GNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD--LRA 192
Query: 452 FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
L +L+ L+L + + L + + L
Sbjct: 193 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 51/325 (15%), Positives = 104/325 (32%), Gaps = 75/325 (23%)
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
F++ +L+ S T + + L+S+ ++ + + I ++ I L + L N
Sbjct: 20 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 75
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
L +I + NLKNL L L N + + ++
Sbjct: 76 KLT-DIKP-LTNLKNLGWLFLDENKI-----KDLSSLK---------------------- 106
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
L + L L N ++ I + + +L L L +N ++ I L L TL++
Sbjct: 107 DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLED 162
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N ++ + L KL+ L L N + +
Sbjct: 163 NQISD----------IVPLAGLTKLQNLYLSKNHISDL---------------------- 190
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLIS 361
+ + L+ L L LF+ + L + + +S
Sbjct: 191 -----RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI-ISDDGD 244
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYI 386
+ ++ + + SF + +
Sbjct: 245 YEKPNVKWHLPEFTNEVSFIFYQPV 269
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 8e-15
Identities = 35/162 (21%), Positives = 69/162 (42%), Gaps = 13/162 (8%)
Query: 333 LGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDL 391
+ L++ ++ + + L S+ Q+ ++ + S L + ++ L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 72
Query: 392 SSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDS 451
+ N L+ + NLK L +L L N++ ++ ++ LK L +LSL N D +
Sbjct: 73 NGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISD--ING 126
Query: 452 FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
L LE L L NN ++ L+ L L++ N++
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 2e-13
Identities = 58/305 (19%), Positives = 102/305 (33%), Gaps = 27/305 (8%)
Query: 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRN 72
+ + ++ + + + +L + + +D+ I + L L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 74
Query: 73 NSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIG 132
N T I L NL +L L N I ++ S + +L KL L+ N + +I +
Sbjct: 75 NKLTD-IKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LV 128
Query: 133 NLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLW 192
+L L L L NN I I T + ++ + ++L NQ+S P L Q L L
Sbjct: 129 HLPQLESLYLG-NNKITDI-TVLSRLTKLDTLSLEDNQISDIVPL---AGLTKLQNLYLS 183
Query: 193 ANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNG 252
N ++ + + L L+L S + N NL +T+ L T
Sbjct: 184 KNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI--- 238
Query: 253 EWSFLSSLTNCNKLRALSLGSNPLDSILPPLI------GNFSASFQQFYAHECKLKGSIP 306
S N L +N + I + F Q + +
Sbjct: 239 -ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVD 297
Query: 307 KEIGN 311
+
Sbjct: 298 GTVIK 302
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 1e-11
Identities = 59/294 (20%), Positives = 104/294 (35%), Gaps = 59/294 (20%)
Query: 137 LADLVLALNNLIGPIPTTIFNIST---IIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWA 193
+ + + + I IF I NL ++ L + ++
Sbjct: 1 MGETITV-STPI----KQIFPDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANN 52
Query: 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGE 253
+ + ++ I + L LN N L+ I NL++L L + N +
Sbjct: 53 SDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD------- 101
Query: 254 WSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLR 313
LSSL + KL++LSL N + I + +L
Sbjct: 102 ---LSSLKDLKKLKSLSLEHNGISDING---------------------------LVHLP 131
Query: 314 GLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQL 372
L +L L N + T T L RL +L L L+ N ++ +P L+ L L+ L+L N +
Sbjct: 132 QLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 187
Query: 373 TSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPI 426
+ + L+ + ++L S + NL V + + L I
Sbjct: 188 SD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 46/245 (18%), Positives = 89/245 (36%), Gaps = 15/245 (6%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
I L + L ++ N P L L+ L +L N + + KL+ LSL
Sbjct: 61 IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSL 116
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
+N + I L +L L L N I+ +I + LTKL L+ DN + +I
Sbjct: 117 EHNGISD-ING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP- 170
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
+ L L +L L+ N I + + + + ++ L + + + +
Sbjct: 171 LAGLTKLQNLYLS-KNHISDLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228
Query: 191 LWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS 250
+ +T P I++ ++ + +F + ++ +A + T
Sbjct: 229 TDGSLVT---PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQP 285
Query: 251 NGEWS 255
E
Sbjct: 286 LKEVY 290
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 27/161 (16%), Positives = 49/161 (30%), Gaps = 8/161 (4%)
Query: 9 PHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVL 68
+ +L L L + N L +L +L L N ++ P + +KLQ L
Sbjct: 125 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 180
Query: 69 SLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIP 128
L N + +L L +L L+ + NL + D +L P
Sbjct: 181 YLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TP 236
Query: 129 NEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGN 169
I + + + + + + I
Sbjct: 237 EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 40/245 (16%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFE---SECEVLRN 637
D F+ LG GSFG V K + G + A+K+ + Q + E +E +L+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
V L+K+ S + +V+E++ G + L F + R + L EY
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEY 156
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM-ATIGYMAP 756
LH +++ +LKP N+L+D+ +V+DFG +K + +T T+ T +AP
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAP 207
Query: 757 EYASDGIISPK-----CDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLP 806
E II K D ++ GVL+ E P +++ E + K+ P
Sbjct: 208 E-----IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY--EKIVSG--KVRFP 258
Query: 807 RGLTE 811
+
Sbjct: 259 SHFSS 263
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 51/210 (24%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQ-------LERAFRSFESECEVLRNVRHRNL 643
LG GSFG V T VA+K + Q R R E L+ +RH ++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH---------NYFLDMLERLNIMIDVGLA 694
IK++ +V+E+ G L ++ +F ++ A
Sbjct: 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC----------A 120
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIG-- 752
+EY H +VH +LKP N+LLD N+ +++DFG+S + D + +T + G
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKT----SCGSP 171
Query: 753 -YMAPEYAS----DGIISPKCDVYSYGVLL 777
Y APE + G P+ DV+S G++L
Sbjct: 172 NYAAPEVINGKLYAG---PEVDVWSCGIVL 198
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 29/240 (12%)
Query: 585 DGFNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL 635
+ F+ LLG G+FG V K T G A+K+ L+ E E VL
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKI--LRKEVIIAKDEVAHTVTESRVL 59
Query: 636 RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
+N RH L + + D V+E+ G L L F + R ++ AL
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSAL 118
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755
EYLH S VV+ ++K N++LDK+ +++DFG+ K G D + +T T Y+A
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLA 173
Query: 756 PEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGLT 810
PE D D + GV++ E + P + +F E+ L ++ PR L+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF--ELILME--EIRFPRTLS 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 38/216 (17%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIK--VFNLQLERAFRSFES---------ECEVLRNVRHR 641
+ +GS+G+V G +G VAIK + R E +L + H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 642 NLIK---IFSSCCNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
N++ IF LV E M L + ++ + M + L L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGYM 754
LH VVH +L P NILL N + DF +++ D + T + Y
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVTHRWYR 200
Query: 755 APEYASDGII------SPKCDVYSYGVLLMETFTRK 784
APE ++ + D++S G ++ E F RK
Sbjct: 201 APE-----LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 83.7 bits (206), Expect = 9e-17
Identities = 49/333 (14%), Positives = 98/333 (29%), Gaps = 22/333 (6%)
Query: 167 VGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI-P 225
H + + L+ +T S++ L L + +
Sbjct: 228 AWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEW 287
Query: 226 NTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIG 285
T S + + + + +F T + + L
Sbjct: 288 RTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVL-LKDRPECWCRDSA 346
Query: 286 NFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR 345
F+ + E + E+ + + L L TI + L L +
Sbjct: 347 TDEQLFRCELSVEKSTV--LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET 404
Query: 346 NNLNGPIPTCLSSLISLRQLHLGSNQLTSSI-----PSSFWSLEYILRIDLSSNSLSGSL 400
S+L ++ + S + + L+ L+ L
Sbjct: 405 LQY-------FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL 456
Query: 401 PSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEY 460
++ L ++ +L+LS N+L +P + L+ L L + N + ++ +L L+
Sbjct: 457 CH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQE 512
Query: 461 LDLSNNNLSG-EIPKSFEILSHLKRLNVSHNRL 492
L L NN L + L LN+ N L
Sbjct: 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 76.7 bits (188), Expect = 1e-14
Identities = 53/307 (17%), Positives = 92/307 (29%), Gaps = 38/307 (12%)
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
+ +W L N + S+S +
Sbjct: 292 GRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQL 351
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNP--LDSILPPLIGNFSASFQQFYAHECKL 301
E S S L +C +L+ L + L IL + ++ + L
Sbjct: 352 FRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL 411
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLIS 361
K P L L + L N + + L L +L L L+
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH-----LAHKDLTVLCH--LEQLLL 464
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421
+ L L N+L + +P + +L + + S N+L ++ + NL L L L N+L
Sbjct: 465 VTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
Query: 422 GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS---GEIPKSFEI 478
++ L S L L+L N+L G + E+
Sbjct: 522 -----QSAAIQPL------------------VSCPRLVLLNLQGNSLCQEEGIQERLAEM 558
Query: 479 LSHLKRL 485
L + +
Sbjct: 559 LPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 5e-11
Identities = 47/291 (16%), Positives = 81/291 (27%), Gaps = 10/291 (3%)
Query: 207 ASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKL 266
D N S G L S L+ + L
Sbjct: 215 VQNAFFTDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTL 274
Query: 267 RALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDL- 325
+ + P N + L +P+ + + S L
Sbjct: 275 LLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL 334
Query: 326 ---NGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWS 382
+QL + + + L S L++L + +I +
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRA 394
Query: 383 LEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARN 442
L+ +L + S D YL+ R++ + D+ L LA
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRA---AYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451
Query: 443 RFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
++ L + +LDLS+N L +P + L L+ L S N LE
Sbjct: 452 DL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 32/132 (24%), Positives = 49/132 (37%), Gaps = 27/132 (20%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
TV H+ L + +LD+S N R LP L LR L+ L + N L + + +L
Sbjct: 454 TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRL 510
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
Q L L NN +++ L + +LV LN N+L
Sbjct: 511 QELLLCNNRLQ--------QSAAIQPL---------------VSCPRLVLLNLQGNSLC- 546
Query: 126 EIPNEIGNLKNL 137
+ L +
Sbjct: 547 QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 41/237 (17%), Positives = 74/237 (31%), Gaps = 51/237 (21%)
Query: 14 LSFLMYLDISENNFRGYLPNELGQLRRLKFLGF------AYNDLTGSFPSWIGVFSKLQV 67
L L E + L + +R L L + ++ L P L+
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427
Query: 68 LSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEI 127
L N + + L ++ + + L + HL+ + N LR +
Sbjct: 428 KFLLEN------SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-AL 478
Query: 128 PNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQ 187
P + L+ L L + N L + + +LP Q
Sbjct: 479 PPALAALRCLEVLQASDNAL-----ENVDGV----------------------ANLPRLQ 511
Query: 188 FLLLWANRLTGTIPN--SITNASKLIGLDLNSNSLS------GQIPNTFGNLRHLST 236
LLL NRL + + +L+ L+L NSL ++ ++ + T
Sbjct: 512 ELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 29/187 (15%), Positives = 64/187 (34%), Gaps = 7/187 (3%)
Query: 311 NLRGLIALSLFTNDLNGTIPTT----LGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLH 366
L + + ND+ I L +L +++ + + NNL P +L +L+ L
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR-IEKANNLLYINPEAFQNLPNLQYLL 110
Query: 367 LGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSD-IQNLKV-LIYLNLSRNQLSGNI 424
+ + + + +D+ N ++ + L + L L++N +
Sbjct: 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH 170
Query: 425 PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKR 484
G + N ++ D F + LD+S + E L L+
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 230
Query: 485 LNVSHNR 491
+ + +
Sbjct: 231 RSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 45/246 (18%), Positives = 79/246 (32%), Gaps = 29/246 (11%)
Query: 39 RRLKFLGFAYNDLT----GSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLF-NLSSLVRLD 93
R L F L G+F F L+ + + N I +F NL L +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSG----FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85
Query: 94 -SRFNSISGNIPSKI-GNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGP 150
+ N++ I + NL L +L ++ ++ +P+ + L + N I
Sbjct: 86 IEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 151 IPTTIFN--ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNAS 208
I F +I+ L N + ++ + + L N L + AS
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 209 KLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRA 268
+ LD++ + NL+ L + L L +L L
Sbjct: 203 GPVILDISRTRIHSLPSYGLENLKKLRARS--TYNLKK----------LPTLEKLVALME 250
Query: 269 LSLGSN 274
SL
Sbjct: 251 ASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 47/285 (16%), Positives = 87/285 (30%), Gaps = 47/285 (16%)
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
+ ++ +IP+ R+ L L + + L + +
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKG--------AFSGFGDLEKIEIS 62
Query: 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLF-TNDLNGTIPT 331
N + ++ FS NL L + + N+L P
Sbjct: 63 QNDVLEVIEA--DVFS----------------------NLPKLHEIRIEKANNLLYINPE 98
Query: 332 TLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPS-SFWSLEYILR- 388
L LQ L + + + L + N +I SF L +
Sbjct: 99 AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI 158
Query: 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSR-NQLSGNIPITI-GGLKDLITLSLARNRFQD 446
+ L+ N + + + N L LNLS N L +P + G + L ++R R
Sbjct: 159 LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHS 216
Query: 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNR 491
+L L N ++P + E L L ++++
Sbjct: 217 LPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 51/282 (18%), Positives = 86/282 (30%), Gaps = 43/282 (15%)
Query: 189 LLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTET 248
L +++T IP+ + I L L F L + I N +
Sbjct: 14 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 249 SSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKE 308
++ F S+L +++R +N L I P F
Sbjct: 71 EAD---VF-SNLPKLHEIR--IEKANNLLYINP---EAFQ-------------------- 101
Query: 309 IGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPT-CLSSL-ISLRQL 365
NL L L + + Q L +Q N I L L
Sbjct: 102 --NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159
Query: 366 HLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNI 424
L N + S+F + +N+L LP+D+ + L++SR ++
Sbjct: 160 WLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLP 218
Query: 425 PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466
+ LK L S + +P + L +L L+
Sbjct: 219 SYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 51/241 (21%), Positives = 83/241 (34%), Gaps = 21/241 (8%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
+ +T PS + L + L +++ N + I + +
Sbjct: 18 ESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 108 -GNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNIST-IIII 164
NL KL + N I E NL NL L+++ N I +P S +++
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS-NTGIKHLPDVHKIHSLQKVLL 133
Query: 165 NLVGNQLSGHRPSTMGHSLPNR-QFLLLWANRLTGTIPNSITNASKLIGLDL-NSNSLSG 222
++ N L L L N + I NS N ++L L+L ++N+L
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE 192
Query: 223 QIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPP 282
+ F L+I + + S L N KLRA S + LP
Sbjct: 193 LPNDVFHGASGPVILDISRTRIHSLPS--------YGLENLKKLRARSTYNL---KKLPT 241
Query: 283 L 283
L
Sbjct: 242 L 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 48/312 (15%), Positives = 91/312 (29%), Gaps = 50/312 (16%)
Query: 13 NLSFLMYLDISENNFRGYLPNE----LGQLRRLKFLGFAYNDLTGSFPSWIGVF---SKL 65
L ++IS+N+ + + L +L ++ N+L F L
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK--ANNLL-YINP--EAFQNLPNL 106
Query: 66 QVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI--GNLTKLVHLNFADNN 122
Q L + N +P+ + V LD + N I G + V L N
Sbjct: 107 QYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 123 LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHS 182
++ EI N N L +L L+ NN + +P +F H
Sbjct: 166 IQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVF------------------------HG 200
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
L + R+ + N KL + ++P T L L ++
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
Query: 243 Y-----LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAH 297
+ + ++ ++ S+ ++S F Y
Sbjct: 257 SHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTE 316
Query: 298 ECKLKGSIPKEI 309
+ ++
Sbjct: 317 FDYDLCNEVVDV 328
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 31/147 (21%), Positives = 58/147 (39%), Gaps = 8/147 (5%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
IP+ L + +L +L +F + +I++S N + + +D+ NL L
Sbjct: 24 IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 411 IYLNLSR-NQLSGNIPITIGGLKDLITLSLARNRFQDSIPD-SFGSLTSLEYLDLSNNNL 468
+ + + N L P L +L L ++ + +PD LD+ +N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNIN 140
Query: 469 SGEIP-KSFEILSH-LKRLNVSHNRLE 493
I SF LS L ++ N ++
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 33/150 (22%), Positives = 54/150 (36%), Gaps = 15/150 (10%)
Query: 6 TVPPHI-GNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF-- 62
+ P NL L YL IS + + L N + F
Sbjct: 94 YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER--NSFVG 151
Query: 63 --SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLD-SRFNSISGNIPSKI-GNLTKLVHLNF 118
+ +L L N I NS FN + L L+ S N++ +P+ + + V L+
Sbjct: 152 LSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDI 209
Query: 119 ADNNLRGEIPNEIGNLKNLADL-VLALNNL 147
+ + +P+ L+NL L + NL
Sbjct: 210 SRTRIH-SLPSYG--LENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 15/83 (18%), Positives = 32/83 (38%), Gaps = 5/83 (6%)
Query: 413 LNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEI 472
++++ IP + ++ I L + + +F LE +++S N++ I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 473 PKS-FEILSHLKRLNVSH-NRLE 493
F L L + + N L
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLL 93
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 12/142 (8%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
+P ++ ++ L N + P +F + + RIDLS+N +S L D Q L+ L
Sbjct: 30 LPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 411 IYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDSIP-DSFGSLTSLEYLDLSNNNL 468
L L N+++ +P ++ GL L L L N+ + D+F L +L L L +N L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
Query: 469 SGEIPKSFEILSHLKRLNVSHN 490
+F L ++ ++++ N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 34/140 (24%), Positives = 67/140 (47%), Gaps = 9/140 (6%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
+P T+ ++ L++N + P S LR++ L +NQ++ P +F L +
Sbjct: 30 LPETITEIR-----LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84
Query: 389 IDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPI-TIGGLKDLITLSLARNRFQD 446
+ L N ++ LP + + L L L L+ N+++ + + L +L LSL N+ Q
Sbjct: 85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT 142
Query: 447 SIPDSFGSLTSLEYLDLSNN 466
+F L +++ + L+ N
Sbjct: 143 IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 15/149 (10%)
Query: 369 SNQLTS---SIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNI 424
LT ++P + I I L N++ +P K L ++LS NQ+S
Sbjct: 20 GKGLTEIPTNLPET------ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELA 72
Query: 425 PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK-SFEILSHLK 483
P GL+ L +L L N+ + F L SL+ L L+ N ++ + +F+ L +L
Sbjct: 73 PDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131
Query: 484 RLNVSHNRLEGKIPTNGPFRNFLAQSFLW 512
L++ N+L+ I G F A +
Sbjct: 132 LLSLYDNKLQ-TIA-KGTFSPLRAIQTMH 158
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 35/164 (21%), Positives = 58/164 (35%), Gaps = 33/164 (20%)
Query: 184 PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY 243
+ L N + P + + KL +DL++N +S P+ F LR L++L + N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 244 LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKG 303
+T S L L+ L L +N ++ + F
Sbjct: 92 ITEL-----PKSLFEGLF---SLQLLLLNANKINCLRV---DAFQ--------------- 125
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNN 347
+L L LSL+ N L T L+ +Q + N
Sbjct: 126 -------DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 31/132 (23%), Positives = 51/132 (38%), Gaps = 12/132 (9%)
Query: 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSK---LQVLSLRNNSFT 76
+ + +N + P ++L+ + + N ++ F L L L N T
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQGLRSLNSLVLYGNKIT 93
Query: 77 GPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNLRGEIPNEI-GN 133
+P SLF L SL L N I+ + +L L L+ DN L+ I
Sbjct: 94 E-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSP 150
Query: 134 LKNLADLVLALN 145
L+ + + LA N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 39/196 (19%), Positives = 67/196 (34%), Gaps = 54/196 (27%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
LT P+ + + + L N+ IP F+
Sbjct: 20 GKGLT-EIPT--NLPETITEIRLEQNTIKV-IPPGAFS---------------------- 53
Query: 108 GNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFNISTIIIINL 166
KL ++ ++N + E+ + L++L LVL N I +P ++F
Sbjct: 54 -PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLY-GNKITELPKSLF---------- 100
Query: 167 VGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPN 226
L + Q LLL AN++ ++ + L L L N L
Sbjct: 101 --------------EGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146
Query: 227 TFGNLRHLSTLNIRAN 242
TF LR + T+++ N
Sbjct: 147 TFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 32/152 (21%), Positives = 54/152 (35%), Gaps = 37/152 (24%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIP--------- 201
IPT + TI I L N + P + + L N+++ +
Sbjct: 26 IPTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 202 --------NSIT--------NASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245
N IT L L LN+N ++ + F +L +L+ L++ N L
Sbjct: 82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
T + G +S L ++ + L NP
Sbjct: 142 --TIAKGTFSPLRAIQT------MHLAQNPFI 165
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 47/215 (21%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTN--VAIKVFNLQLER------AFRSFESECEVLR 636
+ ++ +G G++G VYK + A+K L+ E R E +L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTTIR----EISILK 55
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
++H N++K++ LV E + L+K L L+ + + ++ + +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
Y H V+H +LKP N+L+++ +++DFG+++ G T + T+ Y AP
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAP 169
Query: 757 E-------YASDGIISPKCDVYSYGVLLMETFTRK 784
+ Y S D++S G + E
Sbjct: 170 DVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 585 DGFNECNLLGAGSFGSVY---KGTLFDGTNV-AIKVFN----LQLERAFRSFESECEVLR 636
+ F +LG G +G V+ K T + + A+KV ++ + ++E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 637 NVRHRNLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI-D 690
V+H ++ + + F+ L+LE++ G L L F M + + +
Sbjct: 77 EVKHPFIVDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIF--MEDTACFYLAE 129
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ +AL +LH +++ +LKP NI+L+ +++DFG+ K D +VT T T
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFC-GT 184
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSL 805
I YMAPE + D +S G L+ + T P + + LK KL+L
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI--DKILKC--KLNL 240
Query: 806 PRGLTE 811
P LT+
Sbjct: 241 PPYLTQ 246
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 39/167 (23%), Positives = 62/167 (37%), Gaps = 15/167 (8%)
Query: 329 IPTTLGRLQQLQALLQRNNLNG-PIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYIL 387
+P+ L L NNL+ + L +L L L N L +F + +
Sbjct: 37 LPSYTALLD-----LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR 91
Query: 388 RIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQ 445
+DLSSN L +L + +L+ L L L N + + + L L L++N+
Sbjct: 92 YLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 446 DSIP----DSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVS 488
P L L LDLS+N L + L + +
Sbjct: 150 -RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 40/148 (27%), Positives = 60/148 (40%), Gaps = 10/148 (6%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIP-SSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKV 409
+P L S L L N L+ + L + + LS N L+ + S+ +
Sbjct: 33 VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 410 LIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469
L YL+LS N L L+ L L L N ++F + L+ L LS N +S
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 470 GEIP----KSFEILSHLKRLNVSHNRLE 493
P K L L L++S N+L+
Sbjct: 150 -RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 10/146 (6%)
Query: 331 TTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRI 389
T RL L +L L N+LN + +LR L L SN L + F L+ + +
Sbjct: 58 WTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVL 117
Query: 390 DLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIP----ITIGGLKDLITLSLARNRF 444
L +N + + + +++ L L LS+NQ+S P L L+ L L+ N+
Sbjct: 118 LLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL 175
Query: 445 QDSIPDSFGSLTSL--EYLDLSNNNL 468
+ L + L L NN L
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 38/169 (22%), Positives = 71/169 (42%), Gaps = 11/169 (6%)
Query: 60 GVFSKLQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLN 117
+ S +L L +N+ + L++L L N ++ I S+ + L +L+
Sbjct: 36 SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94
Query: 118 FADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHR 175
+ N+L + + +L+ L L+L NN I + F +++ + + L NQ+S
Sbjct: 95 LSSNHLH-TLDEFLFSDLQALEVLLLY-NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152
Query: 176 PST--MGHSLPNRQFLLLWANRLTGTIPNSITNASKL--IGLDLNSNSL 220
G+ LP L L +N+L + GL L++N L
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 34/143 (23%), Positives = 60/143 (41%), Gaps = 15/143 (10%)
Query: 13 NLSFLMYLDISENNFRGYLPNE-LGQLRRLKFLGFAYNDLTGSFPSWIGVF---SKLQVL 68
L+ L L +S N+ ++ +E + L++L + N L + +F L+VL
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDE--FLFSDLQALEVL 117
Query: 69 SLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIP----SKIGNLTKLVHLNFADNNL 123
L NN + + F +++ L +L N IS P L KL+ L+ + N L
Sbjct: 118 LLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL 175
Query: 124 RGEIPNEIGNLKNLADLVLALNN 146
+ ++ L L L+N
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 55/273 (20%), Positives = 83/273 (30%), Gaps = 57/273 (20%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI-TNASK 209
+P ++ S +++L N LS R L N LLL N L I +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 210 LIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRAL 269
L LDL+SN L F +L+ L L + N++ + ++ L L
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV--VVDRNAFEDMAQLQK------L 141
Query: 270 SLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTI 329
L N + LI + + L L+ L L +N L
Sbjct: 142 YLSQNQISRFPVELIKDGN----------------------KLPKLMLLDLSSNKLKKLP 179
Query: 330 PTTLGRLQQLQAL---LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYI 386
T L +L L N L C L L S W +
Sbjct: 180 LTDLQKLPAWVKNGLYLHNNPLE-----CDCKLYQLF---------------SHWQYRQL 219
Query: 387 LRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQ 419
+ L + N+ L + N S +
Sbjct: 220 SSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYK 252
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-16
Identities = 53/254 (20%), Positives = 95/254 (37%), Gaps = 60/254 (23%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNLIK 645
+G GS+G V+K G VAIK F + A R E +L+ ++H NL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 646 ---IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
+F L LV E+ + ++ L + + +I A+ + H H
Sbjct: 67 LLEVFRRKRRL---HLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-KH 121
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGYMAPE--- 757
+ +H ++KP NIL+ K+ ++ DFG ++LL + +AT Y +PE
Sbjct: 122 N--CIHRDVKPENILITKHSVIKLCDFGFARLLT----GPSDYYDDEVATRWYRSPELLV 175
Query: 758 ----YASDGIISPKCDVYSYGVLLMETFTRK--------------------KPTDEMFTG 793
Y P DV++ G + E +
Sbjct: 176 GDTQY------GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229
Query: 794 EMSLKHWIKLSLPR 807
+ +++ + +P
Sbjct: 230 FSTNQYFSGVKIPD 243
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 30/254 (11%), Positives = 66/254 (25%), Gaps = 57/254 (22%)
Query: 592 LLGAGSFGSVYKGTLFD---GTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIK 645
G ++ D VA+ + Q + + S L + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 646 IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ +V E++ GSL++ + + + M + A + H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--- 149
Query: 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS 765
V P+ + + + ++ M +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA-------N 180
Query: 766 PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK-------------HWIKLSLPRGLTEV 812
P+ D+ G L + P E L I +P ++ V
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 813 VDASLVREVQPSYA 826
S+ + A
Sbjct: 240 AARSVQGDGGIRSA 253
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 51/165 (30%), Positives = 71/165 (43%), Gaps = 11/165 (6%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
IP +L LQ L L L L+L NQL + F L +
Sbjct: 33 IPADTEKLD-----LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGT 87
Query: 389 IDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQD 446
+ L++N L+ SLP + +L L L L NQL +P + L L L L N+ Q
Sbjct: 88 LGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ- 144
Query: 447 SIPDS-FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
SIP F LT+L+ L LS N L +F+ L L+ + + N
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
IP +L L S L + ++F L + ++L N L +L + + +L L
Sbjct: 33 IPA------DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 411 IYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDSIPDS-FGSLTSLEYLDLSNNNL 468
L L+ NQL+ ++P+ + L L L L N+ + S+P F LT L+ L L+ N L
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143
Query: 469 SGEIPKS-FEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLW 512
IP F+ L++L+ L++S N+L+ +P +G F +
Sbjct: 144 Q-SIPAGAFDKLTNLQTLSLSTNQLQS-VP-HGAFDRLGKLQTIT 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 51/153 (33%), Positives = 67/153 (43%), Gaps = 7/153 (4%)
Query: 318 LSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSI 376
L L + L T L +L L L N L L L L L +NQL S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 377 PSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKDL 434
F L + ++ L N L SLPS + L L L L+ NQL +IP L +L
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 435 ITLSLARNRFQDSIPD-SFGSLTSLEYLDLSNN 466
TLSL+ N+ Q S+P +F L L+ + L N
Sbjct: 158 QTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 52/188 (27%), Positives = 76/188 (40%), Gaps = 35/188 (18%)
Query: 91 RLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGP 150
+LD + ++ + LTKL LN N L+ +L L L LA NN +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA-NNQLAS 97
Query: 151 IPTTIFNIST-IIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASK 209
+P +F+ T + + L GNQL SLP+ F +RLT K
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK---------SLPSGVF-----DRLT-----------K 132
Query: 210 LIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRAL 269
L L LN+N L F L +L TL++ N L + +G + L L +
Sbjct: 133 LKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ--SVPHGAFDRLGKLQT------I 184
Query: 270 SLGSNPLD 277
+L N D
Sbjct: 185 TLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 56/208 (26%), Positives = 73/208 (35%), Gaps = 58/208 (27%)
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
LDL S L+ TF L L+ LN+ N L T S G + L+ L L L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT--LSAGVFDDLTELGT------LGLA 91
Query: 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTT 332
+N L S LP + F L L L L N
Sbjct: 92 NNQLAS-LPLGV------FDH------------------LTQLDKLYLGGN--------- 117
Query: 333 LGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSS-FWSLEYILRIDL 391
QL++L P L L++L L +NQL SIP+ F L + + L
Sbjct: 118 -----QLKSL--------P-SGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162
Query: 392 SSNSLSGSLPSDIQNLKVLIYLNLSRNQ 419
S+N L L L + L NQ
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 38/138 (27%), Positives = 56/138 (40%), Gaps = 10/138 (7%)
Query: 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF---SKLQVLS 69
L+ L +L++ N + L L LG A N L S P GVF ++L L
Sbjct: 57 GLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPL--GVFDHLTQLDKLY 113
Query: 70 LRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNLRGEI 127
L N +P+ +F L+ L L N + +IP+ LT L L+ + N L+
Sbjct: 114 LGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVP 171
Query: 128 PNEIGNLKNLADLVLALN 145
L L + L N
Sbjct: 172 HGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 40/180 (22%), Positives = 72/180 (40%), Gaps = 31/180 (17%)
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNLR 124
+ L L++ + L+ L L+ +N + + + + +LT+L L A+N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 125 GEIPNEI-GNLKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPSTMGHS 182
+P + +L L L L N + +P+ +F ++ + + L NQL S
Sbjct: 97 -SLPLGVFDHLTQLDKLYLG-GNQLKSLPSGVFDRLTKLKELRLNTNQLQ---------S 145
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
+P F ++LT L L L++N L F L L T+ + N
Sbjct: 146 IPAGAF-----DKLT-----------NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 52/211 (24%), Positives = 70/211 (33%), Gaps = 58/211 (27%)
Query: 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244
+ + L L + L + +KL L+L+ N L F +L L TL + N L
Sbjct: 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL 95
Query: 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS 304
+ LT +L L LG N L S LP G F
Sbjct: 96 ASLPL-----GVFDHLT---QLDKLYLGGNQLKS-LPS--GVFD---------------- 128
Query: 305 IPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPT-CLSSLISLR 363
L L L L TN QLQ++ P L +L+
Sbjct: 129 ------RLTKLKELRLNTN--------------QLQSI----------PAGAFDKLTNLQ 158
Query: 364 QLHLGSNQLTSSIPSSFWSLEYILRIDLSSN 394
L L +NQL S +F L + I L N
Sbjct: 159 TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 7e-16
Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 30/242 (12%)
Query: 585 DGFNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL 635
FN +LG GSFG V KGT A+K+ L+ + + + EC VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 395
Query: 636 -RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLA 694
+ L ++ S +D V+E++ G L + F + ++ +
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIG 454
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
L +L S +++ +LK +N++LD +++DFG+ K D T+T T Y+
Sbjct: 455 LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFC-GTPDYI 509
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGL 809
APE + D +++GVLL E + P DE+F + ++H ++ P+ +
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--QSIMEH--NVAYPKSM 565
Query: 810 TE 811
++
Sbjct: 566 SK 567
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 69/253 (27%), Positives = 114/253 (45%), Gaps = 51/253 (20%)
Query: 585 DGFNECNLLGAGSFGSVY---KGTLFDGTNV-AIKVFN----LQLERAFRSFESECE--V 634
F +LG GSFG V+ K + D + A+KV +R ++ E +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV----RTKMERDI 79
Query: 635 LRNVRHRNLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI 689
L V H ++K+ + F+ L+L+F+ G L L F E + +
Sbjct: 80 LVEVNHPFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYL 132
Query: 690 -DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTM 748
++ LAL++LH +++ +LKP NILLD+ +++DFG+SK D + +
Sbjct: 133 AELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC- 187
Query: 749 ATIGYMAPEYASDGIISPK-----CDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLK 798
T+ YMAPE +++ + D +S+GVL+ E T P E M LK
Sbjct: 188 GTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM--TMILK 240
Query: 799 HWIKLSLPRGLTE 811
KL +P+ L+
Sbjct: 241 A--KLGMPQFLSP 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 62/253 (24%), Positives = 103/253 (40%), Gaps = 47/253 (18%)
Query: 587 FNECNLLGAGSFGSVY---KGTLFDGTNV-AIKVFN----LQLERAFRSFESECEVLRNV 638
F +LG G++G V+ K + D + A+KV +Q + +E +VL ++
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 639 RHR----NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI-DVGL 693
R L F + L +L+++ G L L F + I + ++ L
Sbjct: 116 RQSPFLVTLHYAFQTETKLHL---ILDYINGGELFTHLSQRERF--TEHEVQIYVGEIVL 170
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
ALE+LH +++ ++K NILLD N ++DFG+SK D+ TI Y
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226
Query: 754 MAPEYASDGIISPK-------CDVYSYGVLLME---------TFTRKKPTDEMFTGEMSL 797
MAP+ I+ D +S GVL+ E K E+ L
Sbjct: 227 MAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRIL 279
Query: 798 KHWIKLSLPRGLT 810
K + P+ ++
Sbjct: 280 KS--EPPYPQEMS 290
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 43/229 (18%)
Query: 578 LDIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER---------AFRS 627
LD++ + + + LG G F +VYK VAIK L A R
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR- 61
Query: 628 FESECEVLRNVRHRNLIK---IFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLER 684
E ++L+ + H N+I F N+ +LV +FM LE + ++ L
Sbjct: 62 ---EIKLLQELSHPNIIGLLDAFGHKSNI---SLVFDFMET-DLEVIIKDNSLVLTPSHI 114
Query: 685 LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
M+ LEYLH ++H +LKPNN+LLD+N +++DFG++K G S +
Sbjct: 115 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----SPNR 167
Query: 745 TMT--MATIGYMAPE-------YASDGIISPKCDVYSYGVLLMETFTRK 784
T + T Y APE Y D+++ G +L E R
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 57/261 (21%), Positives = 110/261 (42%), Gaps = 59/261 (22%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLE-----RAFRSFESECEVLRNV 638
+ + + + LG G++ +VYKG VA+K L+ E A R E +L+++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 639 RHRN---LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
+H N L I + +L LV E++ L+++L ++M + + L
Sbjct: 58 KHANIVTLHDIIHTEKSL---TLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGY 753
Y H V+H +LKP N+L+++ +++DFG+++ T+T + T+ Y
Sbjct: 114 AYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS----IPTKTYDNEVVTLWY 166
Query: 754 MAPE-------YASDGIISPKCDVYSYGVLLMETFTRK--------------------KP 786
P+ Y S + D++ G + E T + P
Sbjct: 167 RPPDILLGSTDY------STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP 220
Query: 787 TDEMFTGEMSLKHWIKLSLPR 807
T+E + G +S + + + P+
Sbjct: 221 TEETWPGILSNEEFKTYNYPK 241
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 50/223 (22%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 581 QQATDGFNECNLLGAGSFGSVYKGTLFD-GTNVAIK-VFNLQLERAFRSFESECEVLRNV 638
++ D F + G G+FG+V G G +VAIK V R + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76
Query: 639 RHRNLIK---IFSSCCNLDFK----ALVLEFMPNGSLEKWLYSHNYFLDMLERLNI---M 688
H N+++ F + D + +V+E++P+ +L + ++ + I +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 689 IDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFGISKLLGEDDDSVTQTMT 747
+ ++ LH S V H ++KP+N+L+++ + T ++ DFG +K L + +V
Sbjct: 136 FQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---Y 191
Query: 748 MATIGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
+ + Y APE +I + D++S G + E +
Sbjct: 192 ICSRYYRAPE-----LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 581 QQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRH 640
+Q + C ++G GSFG V++ L + VAIK R E +++R V+H
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKH 91
Query: 641 RNLIK----IFSSCCNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDMLERLNI---MIDV 691
N++ +S+ D LVLE++P ++ + + + L I M +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA-RVSDFGISKLLGEDDDSVTQTMTMAT 750
+L Y+ HS + H ++KP N+LLD ++ DFG +K+L + +V+ + +
Sbjct: 151 LRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY---ICS 204
Query: 751 IGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
Y APE +I + D++S G ++ E +
Sbjct: 205 RYYRAPE-----LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RAFRSFESECEVLRNVRHRNLIK 645
+G+G+ G V NVAIK F Q RA+R E +++ V H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88
Query: 646 ---IFSSCCNLD-FKA--LVLEFMPNGSLEKWLYS------HNYFLDMLERLNIMIDVGL 693
+F+ +L+ F+ +V+E M +L + + +Y L +
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--------- 138
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATI 751
+++LH S ++H +LKP+NI++ + T ++ DFG+++ G MT + T
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-----MTPYVVTR 190
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFTRK 784
Y APE D++S G ++ E
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 35/144 (24%), Positives = 60/144 (41%), Gaps = 3/144 (2%)
Query: 639 RHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYL 698
+ R S E + FL + + V +E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY 758
S +H +L NILL + ++ DFG+++ + +D D V + + +MAPE
Sbjct: 210 A---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 759 ASDGIISPKCDVYSYGVLLMETFT 782
D + + + DV+S+GVLL E F+
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 593 LGAGSFGSVYKGTLFD------GTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLI 644
LG G+FG V + F VA+K+ R+ SE ++L ++ H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 645 KIFSSCCNLDFKALV-LEFMPNGSLEKWLYSHN 676
+ +C +V +EF G+L +L S
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 55/267 (20%), Positives = 109/267 (40%), Gaps = 58/267 (21%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER------AFRSFESECEVLRN 637
+ + +G G+FG V+K G VA+K ++ E+ A R E ++L+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQL 72
Query: 638 VRHRN---LIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI 689
++H N LI+I + + + LV +F + L L + + E +M
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-- 747
+ L Y+H + ++H ++K N+L+ ++ +++DFG+++ +S T
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 748 MATIGYMAPE-------YASDGIISPKCDVYSYGVLLMETFTRK---------------- 784
+ T+ Y PE Y P D++ G ++ E +TR
Sbjct: 189 VVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 785 ----KPTDEMFTGEMSLKHWIKLSLPR 807
T E++ + + + KL L +
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVK 269
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 587 FNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
+ + ++G GSFG VY+ L D G VAIK R E +++R + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 646 ----IFSSCCNLDFKAL--VLEFMPNGSLEKWLYSHNYFLDMLERLNI---MIDVGLALE 696
+SS D L VL+++P ++ + ++ L + + M + +L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTA-RVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755
Y+H S + H ++KP N+LLD + ++ DFG +K L + +V+ + + Y A
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 224
Query: 756 PEYASDGII------SPKCDVYSYGVLLMETFTRK 784
PE +I + DV+S G +L E +
Sbjct: 225 PE-----LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 55/251 (21%), Positives = 92/251 (36%), Gaps = 50/251 (19%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNL 643
L+G GS+G V K G VAIK F + A R E ++L+ +RH NL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENL 86
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ + C LV EF+ + ++ L LD + + + + H +
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN- 144
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE------ 757
++H ++KP NIL+ ++ ++ DFG ++ L + +AT Y APE
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD--EVATRWYRAPELLVGDV 200
Query: 758 -YASDGIISPKCDVYSYGVLLMETFTRK--------------------KPTDEMFTGEMS 796
Y DV++ G L+ E F +
Sbjct: 201 KY------GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 797 LKHWIKLSLPR 807
+ + LP
Sbjct: 255 NPVFAGVRLPE 265
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 49/218 (22%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK---VFNLQLE--RAFRSFESECEVLRNVRHRNLIK- 645
+G G++G V + VAIK F Q R R E ++L RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 646 --IFSSCCNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDMLERLNIMIDVGLA 694
I + K +V + M L K L + YFL + R
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR---------G 140
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIG 752
L+Y+H S V+H +LKP+N+LL+ ++ DFG++++ D D T +T +AT
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH-TGFLTEYVATRW 196
Query: 753 YMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
Y APE I+ + D++S G +L E + +
Sbjct: 197 YRAPE-----IMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 45/235 (19%), Positives = 91/235 (38%), Gaps = 20/235 (8%)
Query: 263 CNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEI-GNLRGLIALSLF 321
C++ + + I P + S Q E L+ +IP NL + + +
Sbjct: 10 CHQEEDFRVTCKDIQRI--P---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63
Query: 322 TNDLNGTIPT-TLGRLQQLQAL-LQRNNLNGPIPT-CLSSLISLRQLHLGSNQLTSSIP- 377
+ + + + L ++ + ++ I L L L+ L + + L P
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD 122
Query: 378 -SSFWSLEYILRIDLSSNSLSGSLPSDI-QNL-KVLIYLNLSRNQLSGNIPITIGGLKDL 434
+ +S + ++++ N S+P + Q L + L L N + ++ L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 435 ITLSLARNRFQDSIP-DSFGSLTS-LEYLDLSNNNLSGEIP-KSFEILSHLKRLN 486
+ L +N++ I D+FG + S LD+S +++ +P K E L L N
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 43/240 (17%), Positives = 83/240 (34%), Gaps = 40/240 (16%)
Query: 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIP-NTFGNLRHLSTLNIRA 241
P+ Q L L L ++ +N + + ++ + Q+ ++F NL ++ + IR
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
T + +L L+ L + + L P L
Sbjct: 90 TRNLTYIDPD-------ALKELPLLKFLGIFNTGLKMF-PDLTK---------------- 125
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTL--GRLQQLQAL-LQRNNLNGPIPTCLSS 358
+ + L + N +IP G + L L N + +
Sbjct: 126 -------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFN 177
Query: 359 LISLRQLHLGSNQLTSSIPS-SFWSLEYILRI-DLSSNSLSGSLPSDI-QNLKVLIYLNL 415
L ++L N+ + I +F + + D+S S++ +LPS ++LK LI N
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 39/228 (17%), Positives = 66/228 (28%), Gaps = 35/228 (15%)
Query: 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFS---KLQVLSLRNNSF 75
L + E + R + L + + + + S F K+ + +RN
Sbjct: 35 TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLES--HSFYNLSKVTHIEIRNTRN 92
Query: 76 TGPIPNSLF-NLSSLVRLDSRFNSISGNIP--SKIGNLTKLVHLNFADNNLRGEIP-NEI 131
I L L L + P +K+ + L DN IP N
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 132 GNLKN-LADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
L N L L NN + FN + + + L N+ + F
Sbjct: 152 QGLCNETLTLKLY-NNGFTSVQGYAFNGTKLDAVYLNKNKYL--------TVIDKDAFGG 202
Query: 191 LWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLN 238
+ S LD++ S++ +L+ L N
Sbjct: 203 V---------------YSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 26/146 (17%), Positives = 46/146 (31%), Gaps = 15/146 (10%)
Query: 361 SLRQLHLGSNQLTS--SIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSR 417
+ + S+P S +L L L ++PS NL + + +S
Sbjct: 12 QEEDFRVTCKDIQRIPSLPPSTQTL------KLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 418 NQLSGNIPITI-GGLKDLITLSLARNRFQDSIP-DSFGSLTSLEYLDLSNNNLSGEIP-- 473
+ + L + + + R I D+ L L++L + N L P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL 123
Query: 474 KSFEILSHLKRLNVSHNRLEGKIPTN 499
L ++ N IP N
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVN 149
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 27/199 (13%), Positives = 63/199 (31%), Gaps = 13/199 (6%)
Query: 86 LSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLA 143
S L + IPS NL + + + + ++ + NL + + +
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 144 LNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIP- 201
+ I + + + + L T +S L + N +IP
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 202 NSITN-ASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSL 260
N+ ++ + L L +N + + N L + + N T + +F +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKD---AF-GGV 203
Query: 261 TNCNKLRALSLGSNPLDSI 279
+ L + + ++
Sbjct: 204 Y--SGPSLLDVSQTSVTAL 220
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 23/169 (13%), Positives = 49/169 (28%), Gaps = 12/169 (7%)
Query: 13 NLSFLMYLDISENNFRGYLPNEL-GQLRRLKFLGFAYNDLTGSFPSWIGVF---SKLQVL 68
NL + + +S + L + L ++ + L+ L
Sbjct: 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP--DALKELPLLKFL 110
Query: 69 SLRNNSFTG-PIPNSLFNLSSLVRLDSRFNSISGNIPSKI-GNLTK-LVHLNFADNNLRG 125
+ N P +++ L+ N +IP L + L +N
Sbjct: 111 GIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT- 169
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFN--ISTIIIINLVGNQLS 172
+ N L + L N + I F S ++++ ++
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 30/240 (12%)
Query: 587 FNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL-R 636
F +LG GSFG V +K T AIK L+ + + EC VL
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSL 73
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
H L +F + + V+E++ G L + S + F ++ L L+
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQ 132
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
+LH S +V+ +LK +NILLDK+ +++DFG+ K D+ T T T Y+AP
Sbjct: 133 FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFC-GTPDYIAP 187
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGLTE 811
E + D +S+GVLL E + P +E+F PR L +
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF--HSIRMD--NPFYPRWLEK 243
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 54/224 (24%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK---VFNLQLE--RAFRSFESECEVLRNVRHRNLIK- 645
LG G++G V T G VAIK F+ L R R E ++L++ +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 646 --IFSSCCNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDMLERLNIMIDVGLA 694
I +F ++ E M L + + + YF+ R A
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLR---------A 124
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT------MT- 747
++ LH + V+H +LKP+N+L++ N +V DFG+++++ E ++ M
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 748 -MATIGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
+AT Y APE ++ S DV+S G +L E F R+
Sbjct: 182 FVATRWYRAPE-----VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 69/246 (28%), Positives = 101/246 (41%), Gaps = 40/246 (16%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL 635
F+ ++G GSFG V K A+KV LQ + + E + VL
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKV--LQKKAILKKKEEKHIMSERNVL 92
Query: 636 -RNVRHRNLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI 689
+NV+H L+ + S F+ VL+++ G L L FL+ R
Sbjct: 93 LKNVKHPFLVGLHFS-----FQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA- 146
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
++ AL YLH S +V+ +LKP NILLD ++DFG+ K + +S T T
Sbjct: 147 EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFC-G 201
Query: 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLS 804
T Y+APE D + G +L E P T EM+ + L L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY--DNILNK--PLQ 257
Query: 805 LPRGLT 810
L +T
Sbjct: 258 LKPNIT 263
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 8e-15
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 31/207 (14%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RAFRSFESECEVLRNVRHRNLIK 645
+G+G+ G V NVAIK F Q RA+R E +++ V H+N+I
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125
Query: 646 IF------SSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
+ + LV+E M +L + + LD ++ + +++LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLH 181
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGYMAPE 757
S ++H +LKP+NI++ + T ++ DFG+++ G MT + T Y APE
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-----MMTPYVVTRYYRAPE 233
Query: 758 YASDGIISPKCDVYSYGVLLMETFTRK 784
D++S G ++ E K
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 56/219 (25%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RAFRSFESECEVLRNVRHRNLIK 645
+G+G++GSV G VAIK F ++ RA+R E +L++++H N+I
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 646 ---IFSSCCNLD-FKA--LVLEFMPNGSLEKWLYS------HNYFLDMLERLNIMIDVGL 693
+F+ +L F LV+ FM L+K + Y + + +
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK--------- 137
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATI 751
L+Y+H S VVH +LKP N+ ++++ ++ DFG+++ MT + T
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTR 187
Query: 752 GYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
Y APE +I + D++S G ++ E T K
Sbjct: 188 WYRAPE-----VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 47/227 (20%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK--VFNLQLE--RAFRSFESECEVLRNVRHRNLIKIF 647
LG G G V+ VAIK V A R E +++R + H N++K+F
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 648 ------------SSCCNLDFKA--LVLEFMPNGSLEKWLYSHN-------YFLDMLERLN 686
+ + +V E+M L L F+ L R
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR-- 131
Query: 687 IMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARVSDFGISKLLGEDDDSVTQT 745
L+Y+H S V+H +LKP N+ ++ +++ ++ DFG+++++
Sbjct: 132 -------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH-KGH 180
Query: 746 MT--MATIGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
++ + T Y +P ++ + D+++ G + E T K
Sbjct: 181 LSEGLVTKWYRSPR-----LLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 587 FNECNLLGAGSFGSV----YKGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL-R 636
FN +LG GSFG V KGT A+K+ L+ + + + EC VL
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVLAL 76
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI-DVGLAL 695
+ L ++ S +D V+E++ G L + F ++ + L
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF--KEPHAVFYAAEIAIGL 134
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755
+L S +++ +LK +N++LD +++DFG+ K D T+T T Y+A
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFC-GTPDYIA 189
Query: 756 PEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGLT 810
PE + D +++GVLL E + P DE+F + ++H ++ P+ ++
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--QSIMEH--NVAYPKSMS 245
Query: 811 E 811
+
Sbjct: 246 K 246
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 67/242 (27%), Positives = 103/242 (42%), Gaps = 30/242 (12%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL 635
D F +LG GSFG V K T G A+KV L+ + + + EC +L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKV--LKKDVILQDDDVECTMTEKRIL 77
Query: 636 RNV-RHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLA 694
H L ++F D V+EF+ G L + F + R ++ A
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISA 136
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
L +LH +++ +LK +N+LLD +++DFG+ K G + T T T Y+
Sbjct: 137 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFC-GTPDYI 191
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGL 809
APE + + P D ++ GVLL E P D++F E L ++ P L
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF--EAILND--EVVYPTWL 247
Query: 810 TE 811
E
Sbjct: 248 HE 249
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 76.4 bits (187), Expect = 3e-14
Identities = 72/490 (14%), Positives = 146/490 (29%), Gaps = 131/490 (26%)
Query: 332 TLGR-------LQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLE 384
L L+ LQ LL + + N S S+I S++
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPN------------WTSRSDHS----SNIKLRIHSIQ 231
Query: 385 YILRIDLSSNSLSGSLP--SDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARN 442
LR L S L ++QN K NL K L+T R
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL--------------SCKILLT---TRF 274
Query: 443 RFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPF 502
+ + D + T+ ++ L +++++ + +L K L+ L ++ T P
Sbjct: 275 K---QVTDFLSAATT-THISLDHHSMTLTPDEVKSLLL--KYLDCRPQDLPREVLTTNPR 328
Query: 503 ---------RNFLAQSFLWNYALCGPPRLQ------VPPCKEDDTKGSKKAAPIFLKYVL 547
R+ LA W + C +L + + + + +F
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNC--DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 548 PLIISTTLIVILIILCIRYRNRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLF 607
I T L+ ++ W D+ + ++ +L+ S ++
Sbjct: 387 ---IPTILLSLI------------WFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIP 429
Query: 608 DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGS 667
+ LE + + E + HR+++ ++ D L+ ++
Sbjct: 430 S----------IYLE-----LKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQ-- 471
Query: 668 LEKWLYSHNYF------LDMLERLNIMIDVGLALEYLHH--SHSTPVVHCNLKPNNILLD 719
Y +++ ++ ER+ + V L +L H + + + N L
Sbjct: 472 -----YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ 526
Query: 720 -KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDV------YS 772
K + D + + I P+ + I S D+
Sbjct: 527 LKFYKPYICD-----------NDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAE 575
Query: 773 YGVLLMETFT 782
+ E
Sbjct: 576 DEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 73/552 (13%), Positives = 153/552 (27%), Gaps = 165/552 (29%)
Query: 32 PNELGQLRRL-------------KFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGP 78
+ + RL KF+ ++ ++ S ++ +
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI---NYK-FL--MSPIKT---EQRQPSMM 108
Query: 79 IPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEI------- 131
+ L + F + + L + L LR P +
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ--ALL----ELR---PAKNVLIDGVL 159
Query: 132 GNLKN-LADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
G+ K +A V + + IF ++ + N + P T +L
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLN-------LKNC---NSPET----------VL 199
Query: 191 LWANRLTGTI-PNSITNASKLIGLDLNSNSLSGQIPNTFG---------------NLRHL 234
+L I PN + + + L +S+ ++ N +
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 235 STLNIRANYL-TTETSS----------------NGEWSF--------LSSLTNC--NKLR 267
+ N+ L TT + + L +C L
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319
Query: 268 ALSLGSNPLD-SILPPLIGNFSASFQQF--YAHECKLKGSIPKEIGNL-----RGL-IAL 318
L +NP SI+ I + A++ + + KL I + L R + L
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD-KLTTIIESSLNVLEPAEYRKMFDRL 378
Query: 319 SLFTNDLNGTIPT-TLGRL-------------QQLQ--ALLQRNNLNGP--IPTCLSSLI 360
S+F + IPT L + +L +L+++ IP+ L
Sbjct: 379 SVFPPSAH--IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 361 ----SLRQLH---LGSNQLTSSIPSS-----------FWSLEYILRIDLSSNSLSGSLPS 402
+ LH + + + S + + + L
Sbjct: 437 VKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH---------HLKNIEHP 487
Query: 403 DIQNLKVLIYLNLS--RNQL--SGNIPITIGGLKDLIT-LSLARNRFQDSIPDSFGSLTS 457
+ L +++L+ ++ G + + + L + D+ P + +
Sbjct: 488 ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA 547
Query: 458 LE-YLDLSNNNL 468
+ +L NL
Sbjct: 548 ILDFLPKIEENL 559
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 57/220 (25%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RAFRSFESECEVLRNVRHRNLIK 645
+G+G++GSV G VA+K F + R +R E +L++++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 646 ---IFSSCCNLD-FKA--LVLEFMPNGSLEKWLYS-------HNYFLDMLERLNIMIDVG 692
+F+ +L+ F LV M L + + + + R
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR-------- 143
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MAT 750
L+Y+H S ++H +LKP+N+ ++++ ++ DFG+++ MT +AT
Sbjct: 144 -GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVAT 192
Query: 751 IGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
Y APE I+ + D++S G ++ E T +
Sbjct: 193 RWYRAPE-----IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 50/237 (21%), Positives = 88/237 (37%), Gaps = 18/237 (7%)
Query: 257 LSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLI 316
+ S + +L + + + S Q A+ +K S+ + I L +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIK-SV-QGIQYLPNVT 71
Query: 317 ALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS 375
L L N L P L L+ L L L N + L L L+ L L N ++
Sbjct: 72 KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISD- 126
Query: 376 IPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLI 435
+ L + + L +N ++ + + L L L+L NQ+S +I + GL L
Sbjct: 127 -INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQ 181
Query: 436 TLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
L L++N D + L +L+ L+L + + L + + L
Sbjct: 182 NLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 35/162 (21%), Positives = 70/162 (43%), Gaps = 13/162 (8%)
Query: 333 LGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDL 391
+ L++ ++ + + L S+ Q+ ++ + S L + ++ L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 392 SSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDS 451
+ N L+ + + NLK L +L L N++ ++ ++ LK L +LSL N D +
Sbjct: 76 NGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD--ING 129
Query: 452 FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
L LE L L NN ++ L+ L L++ N++
Sbjct: 130 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 54/286 (18%), Positives = 94/286 (32%), Gaps = 32/286 (11%)
Query: 199 TIPNSIT------NASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNG 252
T+P I ++ I +L S++ + L + + + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS------ 60
Query: 253 EWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNL 312
+ + + L L N L I P + N + + E K+K + + +L
Sbjct: 61 ----VQGIQYLPNVTKLFLNGNKLTDIKP--LANLK-NLGWLFLDENKVK-DL-SSLKDL 111
Query: 313 RGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQ 371
+ L +LSL N + + L L QL++L L N + LS L L L L NQ
Sbjct: 112 KKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQ 167
Query: 372 LTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGL 431
++ L + + LS N +S L + LK L L L + L
Sbjct: 168 ISD--IVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNL 223
Query: 432 KDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFE 477
T+ S + + E+ F
Sbjct: 224 VVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 269
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 58/341 (17%), Positives = 114/341 (33%), Gaps = 78/341 (22%)
Query: 105 SKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIII 164
+ + N ++ + L ++ ++ +++ ++ I
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-----KSVQGIQ----- 65
Query: 165 NLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI 224
LPN L L N+LT I + N L L L+ N + +
Sbjct: 66 -----------------YLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DL 105
Query: 225 PNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLI 284
+ +L+ L +L++ N ++ ++ L + +L +L LG+N + I
Sbjct: 106 SS-LKDLKKLKSLSLEHNGISD----------INGLVHLPQLESLYLGNNKITDITV--- 151
Query: 285 GNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-L 343
+ L L LSL N + + L L +LQ L L
Sbjct: 152 ------------------------LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYL 185
Query: 344 QRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSD 403
+N+++ L+ L +L L L S + + + +L + + SL P
Sbjct: 186 SKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEI 241
Query: 404 IQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRF 444
I + N+ + L +T+ A+ RF
Sbjct: 242 ISDDGDYEKPNVKWH-LPEFTNEVSFIFYQPVTIGKAKARF 281
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 42/245 (17%), Positives = 80/245 (32%), Gaps = 49/245 (20%)
Query: 35 LGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94
+T + + + N+ + + L ++ +L
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFL 75
Query: 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTT 154
N ++ +I + NL L L +N ++ ++ + + +LK L L L N + +
Sbjct: 76 NGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGI-----SD 126
Query: 155 IFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLD 214
I + LP + L L N++T I ++ +KL L
Sbjct: 127 INGLV----------------------HLPQLESLYLGNNKIT-DITV-LSRLTKLDTLS 162
Query: 215 LNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSN 274
L N +S I L L L + N+++ L +L L L L S
Sbjct: 163 LEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD----------LRALAGLKNLDVLELFSQ 210
Query: 275 PLDSI 279
+
Sbjct: 211 ECLNK 215
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 47/278 (16%), Positives = 97/278 (34%), Gaps = 26/278 (9%)
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
+ L +T + + + + N++ + + L +++ L +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N LT + L N L L L N + + + + + +
Sbjct: 78 NKLTD----------IKPLANLKNLGWLFLDENKVKDLSS--LKDLK-KLKSLSLEHNGI 124
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLI 360
I + +L L +L L N + T T L RL +L L L+ N ++ +P L+ L
Sbjct: 125 S-DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
L+ L+L N ++ + L+ + ++L S + NL V + + L
Sbjct: 179 KLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
Query: 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSL 458
I+ G + + F + + F ++
Sbjct: 237 VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 274
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 10/161 (6%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
+ NL L +L + EN + L L++LK L +N ++ + +L+ L L
Sbjct: 86 LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYL 141
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
NN T L L+ L L N IS +I + LTKL +L + N++ ++
Sbjct: 142 GNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA- 195
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQL 171
+ LKNL L L + N+ + L
Sbjct: 196 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 32/140 (22%), Positives = 54/140 (38%), Gaps = 8/140 (5%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
+ +L L L + N + L L +L+ L N +T + + +KL LSL
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSL 163
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
+N + +P L L+ L L N IS ++ + + L L L + N
Sbjct: 164 EDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINH 219
Query: 131 IGNLKNLADLVLALNNLIGP 150
NL + +L+ P
Sbjct: 220 QSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 25/139 (17%), Positives = 45/139 (32%), Gaps = 8/139 (5%)
Query: 9 PHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVL 68
+ +L L L + N L +L +L L N ++ + +KLQ L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183
Query: 69 SLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIP 128
L N + +L L +L L+ + NL + D +L P
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTP 239
Query: 129 NEIGNLKNLADLVLALNNL 147
I + + + +
Sbjct: 240 EIISDDGDYEKPNVKWHLP 258
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 335 RLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSN 394
L + ++ N+ + + L ++R L LG N+L S+ L + + L+ N
Sbjct: 39 ELNSIDQIIANNSDIKSVQG-IQYLPNVRYLALGGNKLHD--ISALKELTNLTYLILTGN 95
Query: 395 SLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDSIPDS- 451
L SLP+ + L L L L NQL ++P + L +L L+LA N+ Q S+P
Sbjct: 96 QLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGV 152
Query: 452 FGSLTSLEYLDLSNNNLSGEIPKS-FEILSHLKRLNVSHNRL 492
F LT+L LDLS N L +P+ F+ L+ LK L + N+L
Sbjct: 153 FDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 47/137 (34%), Positives = 67/137 (48%), Gaps = 8/137 (5%)
Query: 358 SLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLS 416
L +L L L NQL S F L + + L N L SLP + L L YLNL+
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 417 RNQLSGNIPITI-GGLKDLITLSLARNRFQDSIPDS-FGSLTSLEYLDLSNNNLSGEIPK 474
NQL ++P + L +L L L+ N+ Q S+P+ F LT L+ L L N L +P
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPD 198
Query: 475 -SFEILSHLKRLNVSHN 490
F+ L+ L+ + + N
Sbjct: 199 GVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 24/106 (22%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 388 RIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447
+ +L S++ + L + + + + + I L ++ L+L N+
Sbjct: 23 KANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQGIQY--LPNVRYLALGGNKLH-D 77
Query: 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
I + LT+L YL L+ N L F+ L++LK L + N+L+
Sbjct: 78 IS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ 122
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 56/260 (21%), Positives = 80/260 (30%), Gaps = 74/260 (28%)
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
+L S++ T L + + + + + L N +R L+LG
Sbjct: 24 ANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQ-------YLPN---VRYLALG 71
Query: 273 SNPLDSILPPLIGNFS--ASFQQFYAHECKLKGSIPKEI-GNLRGLIALSLFTNDLNGTI 329
N L I + +L+ S+P + L L L L N L
Sbjct: 72 GNKLHDI-----SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLP 125
Query: 330 PTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
+L L L L N L L +L +L L NQL
Sbjct: 126 DGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ--------------- 170
Query: 389 IDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447
SLP + L L L L +NQL S
Sbjct: 171 ----------SLPEGVFDKLTQLKDLRLYQNQLK-------------------------S 195
Query: 448 IPD-SFGSLTSLEYLDLSNN 466
+PD F LTSL+Y+ L +N
Sbjct: 196 VPDGVFDRLTSLQYIWLHDN 215
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 57/220 (25%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RAFRSFESECEVLRNVRHRNLIK 645
+G+G++G+V G VAIK F +L RA+R E +L+++RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 646 ---IFSSCCNLD-FKA--LVLEFMPNGSLEKWLYS-------HNYFLDMLERLNIMIDVG 692
+F+ LD F LV+ FM L K + + + + +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK-------- 139
Query: 693 LALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MAT 750
L Y+H + ++H +LKP N+ ++++ ++ DFG+++ MT + T
Sbjct: 140 -GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMTGYVVT 188
Query: 751 IGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
Y APE +I + D++S G ++ E T K
Sbjct: 189 RWYRAPE-----VILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 38/223 (17%)
Query: 582 QATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER-----AFRSFESECEVL 635
++ F + LG G++ +VYKG G VA+K L E A R E ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLM 57
Query: 636 RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF-----LDMLERLNIMID 690
+ ++H N+++++ + LV EFM N L+K++ S L++
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--M 748
+ L + H + ++H +LKP N+L++K ++ DFG+++ G T + +
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG----IPVNTFSSEV 169
Query: 749 ATIGYMAPE-------YASDGIISPKCDVYSYGVLLMETFTRK 784
T+ Y AP+ Y S D++S G +L E T K
Sbjct: 170 VTLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPS-SFWSLEYILRIDLSSNSLSGSLPSDI-QNLKV 409
IP + +L L +N+ T + F L + +I+ S+N ++ + +
Sbjct: 26 IPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 410 LIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDSIP-DSFGSLTSLEYLDLSNNN 467
+ + L+ N+L N+ + GL+ L TL L NR + DSF L+S+ L L +N
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 468 LSGEIPKSFEILSHLKRLNVSHN 490
++ P +F+ L L LN+ N
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 25/107 (23%), Positives = 50/107 (46%), Gaps = 3/107 (2%)
Query: 388 RIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD 446
+ L++N + + I + L L +N S N+++ G + + L NR ++
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPK-SFEILSHLKRLNVSHNRL 492
F L SL+ L L +N ++ + SF LS ++ L++ N++
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 31/153 (20%), Positives = 56/153 (36%), Gaps = 30/153 (19%)
Query: 318 LSLFTNDLNGTIPT-TLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS 375
L L N+ T +L QL+ + N + + ++ L SN+L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96
Query: 376 IPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDL 434
F LE + + L SN ++ + +D L + L+L NQ++
Sbjct: 97 QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT------------- 142
Query: 435 ITLSLARNRFQDSIPD-SFGSLTSLEYLDLSNN 466
++ +F +L SL L+L N
Sbjct: 143 ------------TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 390 DLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDS 447
D S+ L+ +P I Q L L+ N+ + I L L ++ + N+ D
Sbjct: 17 DCSNQKLN-KIPEHIPQYTAEL---RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI 72
Query: 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
+F + + + L++N L K F+ L LK L + NR+
Sbjct: 73 EEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT 118
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 42/143 (29%), Positives = 58/143 (40%), Gaps = 8/143 (5%)
Query: 103 IPSKIGNLTKLVHLNFADNNLRGEIPNEI-GNLKNLADLVLALNNLIGPIPTTIFN-IST 160
IP I T + LN +N I L L + + NN I I F S
Sbjct: 26 IPEHIPQYTAELRLN--NNEFTVLEATGIFKKLPQLRKINFS-NNKITDIEEGAFEGASG 82
Query: 161 IIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI-TNASKLIGLDLNSNS 219
+ I L N+L M L + + L+L +NR+T + N S + L L N
Sbjct: 83 VNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 220 LSGQIPNTFGNLRHLSTLNIRAN 242
++ P F L LSTLN+ AN
Sbjct: 141 ITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 26/114 (22%), Positives = 38/114 (33%), Gaps = 10/114 (8%)
Query: 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF---SKLQVLS 69
L L ++ S N + + N L + +F L+ L
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQH--KMFKGLESLKTLM 111
Query: 70 LRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADN 121
LR+N T + N F LSS+ L N I+ + L L LN N
Sbjct: 112 LRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 31/129 (24%), Positives = 53/129 (41%), Gaps = 10/129 (7%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
IP I + L N+ + + + LP + + N++T + AS +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 211 IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
+ L SN L F L L TL +R+N +T + SF L++ +R LS
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGND----SF-IGLSS---VRLLS 135
Query: 271 LGSNPLDSI 279
L N + ++
Sbjct: 136 LYDNQITTV 144
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 27/165 (16%), Positives = 48/165 (29%), Gaps = 34/165 (20%)
Query: 184 PNRQFLLLWANRLTGTIPNSI-TNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242
L L N T I +L ++ ++N ++ F ++ + + +N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK 302
L + L + L+ L L SN + + +F
Sbjct: 92 RLENV-----QHKMFKGLES---LKTLMLRSNRITCVGN---DSFI-------------- 126
Query: 303 GSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNN 347
L + LSL+ N + P L L L N
Sbjct: 127 --------GLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 39/181 (21%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RAFRSFESECEVLRNVRHRNLIK 645
+G GS+G V + + VAIK VF ++ R R E +L + H +++K
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 646 ---IFSSCCNLDFKA--LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
I F +VLE + +K + Y ++ + ++ ++ + ++Y+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
S ++H +LKP N L++++ + +V DFG+++ + ++ +Q M
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 761 D 761
Sbjct: 232 H 232
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 55/251 (21%), Positives = 98/251 (39%), Gaps = 39/251 (15%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL 635
F+ ++G GS+ V K T A+KV ++ E + + V
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDWVQTEKHVF 63
Query: 636 -RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLA 694
+ H L+ + S V+E++ G L + + R ++ LA
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLA 122
Query: 695 LEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
L YLH +++ +LK +N+LLD +++D+G+ K G T T T Y+
Sbjct: 123 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC-GTPNYI 177
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKP--------------TDEMFTGEMSLKHW 800
APE D ++ GVL+ E + P D +F ++ L+
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--QVILEK- 234
Query: 801 IKLSLPRGLTE 811
++ +PR L+
Sbjct: 235 -QIRIPRSLSV 244
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 54/252 (21%), Positives = 97/252 (38%), Gaps = 41/252 (16%)
Query: 585 DGFNECNLLGAGSFGSVY----KGTLFDGTNVAIKVFNLQLERAFRSFESEC-----EVL 635
F+ ++G GS+ V K T A++V ++ E + + V
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRV--VKKELVNDDEDIDWVQTEKHVF 106
Query: 636 -RNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI-DVGL 693
+ H L+ + S V+E++ G L + E ++ L
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL--PEEHARFYSAEISL 164
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
AL YLH +++ +LK +N+LLD +++D+G+ K G T T T Y
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFC-GTPNY 219
Query: 754 MAPEYASDGIISPKCDVYSYGVLLMETFTRKKP--------------TDEMFTGEMSLKH 799
+APE D ++ GVL+ E + P D +F ++ L+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--QVILEK 277
Query: 800 WIKLSLPRGLTE 811
++ +PR L+
Sbjct: 278 --QIRIPRSLSV 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 44/228 (19%)
Query: 582 QATDGFNECNLLGAGSFGSVYKGTLFDGTN--VAIKVFNLQLER------AFRSFESECE 633
+A + +G G++G V+K VA+K +Q R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 634 V-----LRNVRHRNLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSH-NYFLDML 682
V L H N++++F C LV E + L +L +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 683 ERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742
++M + L++LH VVH +LKP NIL+ + +++DFG++++ +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQM 174
Query: 743 TQTMTMATIGYMAPE------YASDGIISPKCDVYSYGVLLMETFTRK 784
T + T+ Y APE Y + D++S G + E F RK
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRK 216
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 49/140 (35%), Positives = 71/140 (50%), Gaps = 10/140 (7%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
IPT L L N + P SLI+L++L+LGSNQL + F SL +
Sbjct: 38 IPTNAQILY-----LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92
Query: 389 IDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447
+DL +N L+ LPS + L L L + N+L+ +P I L L L+L +N+ + S
Sbjct: 93 LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-S 149
Query: 448 IPD-SFGSLTSLEYLDLSNN 466
IP +F L+SL + L N
Sbjct: 150 IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 43/141 (30%), Positives = 63/141 (44%), Gaps = 11/141 (7%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
IPT + + L+L NQ+T P F SL + + L SN L +LP + +L L
Sbjct: 38 IPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 411 IYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469
L+L NQL+ +P + L L L + N+ +P LT L +L L N L
Sbjct: 91 TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148
Query: 470 GEIPKSFEILSHLKRLNVSHN 490
+F+ LS L + N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 28/81 (34%), Positives = 36/81 (44%)
Query: 412 YLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGE 471
L L NQ++ P L +L L L N+ F SLT L LDL N L+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 472 IPKSFEILSHLKRLNVSHNRL 492
F+ L HLK L + N+L
Sbjct: 104 PSAVFDRLVHLKELFMCCNKL 124
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 41/190 (21%), Positives = 60/190 (31%), Gaps = 64/190 (33%)
Query: 91 RLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLR---GEIPNEIGNLKNLADLVLALNNL 147
L N I+ P +L L L N L + + + L L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL---------- 93
Query: 148 IGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNA 207
+L NQL+ LP+ F +RL
Sbjct: 94 -----------------DLGTNQLT---------VLPSAVF-----DRLV---------- 112
Query: 208 SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLR 267
L L + N L+ +P L HL+ L + N L ++ +G + LSSLT+
Sbjct: 113 -HLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL--KSIPHGAFDRLSSLTH----- 163
Query: 268 ALSLGSNPLD 277
L NP D
Sbjct: 164 -AYLFGNPWD 172
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 38/130 (29%), Positives = 54/130 (41%), Gaps = 7/130 (5%)
Query: 44 LGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN-LSSLVRLDSRFNSISGN 102
L N +T P L+ L L +N +P +F+ L+ L LD N ++
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 103 IPSKI-GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF-NIST 160
+PS + L L L N L E+P I L +L L L N L IP F +S+
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPHGAFDRLSS 160
Query: 161 IIIINLVGNQ 170
+ L GN
Sbjct: 161 LTHAYLFGNP 170
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 51/247 (20%), Positives = 92/247 (37%), Gaps = 61/247 (24%)
Query: 593 LGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK---IFS 648
LG GSFG V + + G A+K R E ++++ + H N+IK F
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY----------- 697
+ + + K N K +N+ ++ + + + +EY
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 698 -----------------------LHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISK 733
+ HS + H ++KP N+L++ T ++ DFG +K
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190
Query: 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRKKPT 787
L + S + + Y APE ++ +P D++S G + E KP
Sbjct: 191 KLIPSEPS---VAYICSRFYRAPE-----LMLGATEYTPSIDLWSIGCVFGELILG-KP- 240
Query: 788 DEMFTGE 794
+F+GE
Sbjct: 241 --LFSGE 245
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 40/193 (20%), Positives = 75/193 (38%), Gaps = 39/193 (20%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RAFRSFESECEVLRNVRHRNLIK 645
+G GS+G VY NVAIK +F ++ R R E +L ++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 646 ---IFSSCCNLDFKA--LVLEFMPNGSLEKWLYSHN--------YFL-DMLERLNIMIDV 691
+ L F +VLE + L+K + L ++L
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL--------- 139
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI 751
L ++H + ++H +LKP N LL+++ + +V DFG+++ + + D+
Sbjct: 140 -LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 752 GYMAPEYASDGII 764
+
Sbjct: 196 EPGPHNKNLKKQL 208
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 56/202 (27%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVL-RNVRHRNLIKIFSSC 650
LG G G V + A+K+ +A R E E+ R + ++++I
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 651 CNLDFKA----LVLEFMPNGSL-----EKWLYSHNYFLDMLER--LNIMIDVGLALEYLH 699
NL +V+E + G L ++ F ER IM +G A++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT---EREASEIMKSIGEAIQYLH 134
Query: 700 HSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISK-LLGEDDDSVTQTMTMATIGYMA 755
S + + H ++KP N+L N +++DFG +K GE Y
Sbjct: 135 -SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE--------------KY-- 175
Query: 756 PEYASDGIISPKCDVYSYGVLL 777
CD++S GV++
Sbjct: 176 ---------DKSCDMWSLGVIM 188
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 40/221 (18%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER------AFRSFESECEVLRN 637
D + LG G++G VYK VAIK L+ E A R E +L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKE 89
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
++HRN+I++ S + L+ E+ N L+K++ + M + + + + +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV-SMRVIKSFLYQLINGVNF 147
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTAR-----VSDFGISKLLGEDDDSVTQTMT--MAT 750
H +H +LKP N+LL + + + DFG+++ G + T + T
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG----IPIRQFTHEIIT 200
Query: 751 IGYMAPE-------YASDGIISPKCDVYSYGVLLMETFTRK 784
+ Y PE Y S D++S + E +
Sbjct: 201 LWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 46/230 (20%)
Query: 582 QATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLER---------AFRSFESE 631
AT + +G G++G+VYK G VA+K + R
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----- 60
Query: 632 CEV-----LRNVRHRNLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHN-YFLD 680
EV L H N++++ C LV E + L +L L
Sbjct: 61 -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 681 MLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740
++M L++LH + +VH +LKP NIL+ T +++DFG++++
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-- 173
Query: 741 SVTQTMTMATIGYMAPE------YASDGIISPKCDVYSYGVLLMETFTRK 784
+ T + T+ Y APE Y + D++S G + E F RK
Sbjct: 174 -MALTPVVVTLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (167), Expect = 2e-12
Identities = 43/251 (17%), Positives = 73/251 (29%), Gaps = 66/251 (26%)
Query: 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKV--------FNLQLERAFRSFESECEV 634
T+ C +G G FG V++ D T VAIK+ N ++ F E +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 635 LRNV---------RHRNLIKIFSSCC------------------------------NLDF 655
+ + R I + S C D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 656 KALVLEFMPNG-SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPN 714
+VLEF G LE+ + +I+ + +L S H +L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191
Query: 715 NILLDKNMTARVSDFGISKLLG---------EDDDSVTQTMTMATIGYMAPEYASD---G 762
N+LL K ++ K D ++++ + + D G
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
Query: 763 IISPKCDVYSY 773
+ D+Y
Sbjct: 252 DGDYQFDIYRL 262
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 45/222 (20%), Positives = 94/222 (42%), Gaps = 50/222 (22%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNL-QLERAFRSFESECEVLRNVR-HRNLIKIFSS 649
LG G + V++ + + V +K+ + ++ R E ++L N+R N+I +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 650 CCNLDFK--ALVLEFMPNGSLEKWLYSHN-----YFLDMLERLNIMIDVGLALEYLHHSH 702
+ + ALV E + N ++ + +++ + + AL+Y H S
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK---------ALDYCH-SM 149
Query: 703 STPVVHCNLKPNNILLD-KNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGYMAPE-- 757
++H ++KP+N+++D ++ R+ D+G+++ Q +A+ + PE
Sbjct: 150 G--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-----QEYNVRVASRYFKGPELL 202
Query: 758 -----YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
Y D++S G +L RK+P F G
Sbjct: 203 VDYQMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 39/237 (16%), Positives = 73/237 (30%), Gaps = 41/237 (17%)
Query: 257 LSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLI 316
+ +LG + ++ L G+
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS---------------------------QKELSGVQ 44
Query: 317 ALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS 375
+ +++ + L+ L L N ++ P L L L +L + N+L +
Sbjct: 45 NFNGDNSNI--QSLAGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL 100
Query: 376 IPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLI 435
L + L +N L + +LK L L++ N+L +I + +G L L
Sbjct: 101 NGIPSACLSRL---FLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLE 153
Query: 436 TLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
L L N + L + ++DL+ E K L + R
Sbjct: 154 VLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 44/309 (14%), Positives = 96/309 (31%), Gaps = 64/309 (20%)
Query: 105 SKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIST---I 161
L V N ++ + L + + +N+ ++ + +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-----QSLAGMQFFTNL 65
Query: 162 IIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLS 221
++L NQ+S P L + L + NRL + ++ L L L++N L
Sbjct: 66 KELHLSHNQISDLSPLK---DLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELR 119
Query: 222 GQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILP 281
++ +L++L L+IR N L + + L +KL L L N + +
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLKS----------IVMLGFLSKLEVLDLHGNEITNT-- 165
Query: 282 PLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQA 341
+ L+ + + L + + +L
Sbjct: 166 -------------------------GGLTRLKKVNWIDLTGQKC---VNEPVKYQPELYI 197
Query: 342 LLQRNNLNGPI--PTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGS 399
+ +G P +S+ S + +L + + + + G+
Sbjct: 198 TNTVKDPDGRWISPYYISNGGSYVDGCV-LWELPVYTDEVSYKFSEYINVGETEAIFDGT 256
Query: 400 LPSDIQNLK 408
+ Q +K
Sbjct: 257 V---TQPIK 262
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 35/236 (14%), Positives = 81/236 (34%), Gaps = 30/236 (12%)
Query: 204 ITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNC 263
+ + +L S++ + L + N + + + L+ +
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS----------LAGMQFF 62
Query: 264 NKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTN 323
L+ L L N + + P + + + ++ + +LK + + LF +
Sbjct: 63 TNLKELHLSHNQISDLSP--LKDLT-KLEELSVNRNRLK-----NLNGIPSACLSRLFLD 114
Query: 324 DLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWS 382
+ +L L+ L+ L ++ N L + L L L L L N++T+
Sbjct: 115 NNELRDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITN--TGGLTR 170
Query: 383 LEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438
L+ + IDL+ ++ L N ++ G I+ + + +
Sbjct: 171 LKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKD-PDGRW-ISPYYISNGGSYV 221
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 41/219 (18%), Positives = 78/219 (35%), Gaps = 17/219 (7%)
Query: 35 LGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94
L +T S +Q + N++ + + ++L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS-LAG-MQFFTNLKELHL 70
Query: 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTT 154
N IS ++ S + +LTKL L+ N L+ + L+ L L N L
Sbjct: 71 SHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRDTDS-- 123
Query: 155 IFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLD 214
+ ++ + I+++ N+L L + L L N +T T +T K+ +D
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVML---GFLSKLEVLDLHGNEITNTGG--LTRLKKVNWID 178
Query: 215 LNSNSLSGQIPNTFGNLRHLSTL-NIRANYLTTETSSNG 252
L + L +T+ + +++ SNG
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNG 217
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 37/213 (17%), Positives = 70/213 (32%), Gaps = 20/213 (9%)
Query: 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSL 70
LS + + +N + + LK L ++N ++ P + +KL+ LS+
Sbjct: 37 QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92
Query: 71 RNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE 130
N + + L RL N + + +L L L+ +N L+ I
Sbjct: 93 NRNRLKNL---NGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM- 145
Query: 131 IGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLL 190
+G L L L L N + + + + I+L G + + P
Sbjct: 146 LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV----NEPVKYQPELYITN 199
Query: 191 LWANRLTGTI--PNSITNASKLIGLDLNSNSLS 221
+ G P I+N + +
Sbjct: 200 TVKD-PDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 64/234 (27%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIK----VFNLQLE--RAFRSFESECEVLRNVR-HRNLI 644
LG G++G V+K G VA+K F + R FR E +L + H N++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 645 KIFSSCCNLDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDMLERLNIMIDVGLAL 695
+ + + + LV ++M L + + Y + L + +
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIK---------VI 122
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG-----------------ISKLLGED 738
+YLH S ++H ++KP+NILL+ +V+DFG E+
Sbjct: 123 KYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 739 DDSVTQTMT--MATIGYMAPEYASDGII------SPKCDVYSYGVLLMETFTRK 784
D +T +AT Y APE I+ + D++S G +L E K
Sbjct: 180 FDDDQPILTDYVATRWYRAPE-----ILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 69/379 (18%), Positives = 119/379 (31%), Gaps = 71/379 (18%)
Query: 159 STIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGT----IPNSITNASKLIGLD 214
I +++ +LS R + + L Q + L LT I +++ L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 215 LNSNSLSG----------QIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCN 264
L SN L Q P+ + L+++ LT G S+L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSC-----KIQKLSLQNCCLTGA----GCGVLSSTLRTLP 113
Query: 265 KLRALSLGSNPLD----SILPPLIGNFSASFQQFYAHECKLK----GSIPKEIGNLRGLI 316
L+ L L N L +L + + ++ C L + +
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 317 ALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLT--- 373
L++ ND+N ++ L L+ + L L L S +T
Sbjct: 174 ELTVSNNDINEAG------VRVLCQGLKDSPCQ------------LEALKLESCGVTSDN 215
Query: 374 -SSIPSSFWSLEYILRIDLSSNSLSGS-----LPSDIQNLKVLIYLNLSRNQLS----GN 423
+ S + + L SN L P + L L + ++ G+
Sbjct: 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD 275
Query: 424 IPITIGGLKDLITLSLARNRFQDSIPDSFGSL-----TSLEYLDLSNNNLSGE----IPK 474
+ + + L LSLA N D LE L + + + +
Sbjct: 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335
Query: 475 SFEILSHLKRLNVSHNRLE 493
L L +S+NRLE
Sbjct: 336 VLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-10
Identities = 80/449 (17%), Positives = 141/449 (31%), Gaps = 79/449 (17%)
Query: 111 TKLVHLNFADNNLRGEIPNEIG-NLKNLADLVLALNNL----IGPIPTTIFNISTIIIIN 165
+ L+ L E+ L+ + L L I + + + +N
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 166 LVGNQLSGHRPSTMGHSL--PNR--QFLLLWANRLTGT----IPNSITNASKLIGLDLNS 217
L N+L + L P+ Q L L LTG + +++ L L L+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 218 NSLSG----------QIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLR 267
N L P L L + L+ S L +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQC-----RLEKLQLEYCSLSAA----SCEPLASVLRAKPDFK 173
Query: 268 ALSLGSNPLD----SILPPLIGNFSASFQQFYAHECKLK----GSIPKEIGNLRGLIALS 319
L++ +N ++ +L + + + C + + + + L L+
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 320 LFTNDLNGT-----IPTTLGRLQQLQAL-LQRNNLNGP----IPTCLSSLISLRQLHLGS 369
L +N L P L +L+ L + + + L + SL++L L
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 370 NQLTSS--------IPSSFWSLEYILRIDLSSNSLSG----SLPSDIQNLKVLIYLNLSR 417
N+L + LE + + S S + S + + L+ L +S
Sbjct: 294 NELGDEGARLLCETLLEPGCQLE---SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISN 350
Query: 418 NQLSGNIPITIG-GLKD----LITLSLARNRFQD----SIPDSFGSLTSLEYLDLSNNNL 468
N+L + GL L L LA D S+ + + SL LDLSNN L
Sbjct: 351 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
Query: 469 SGEIPKSF-EILSH----LKRLNVSHNRL 492
E + L++L +
Sbjct: 411 GDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 76/471 (16%), Positives = 136/471 (28%), Gaps = 143/471 (30%)
Query: 64 KLQVLSLRNNSFT----GPIPNSLFNLSSLVRLDSRFNSISGNIPSKIG----------N 109
K+Q LSL+N T G + ++L L +L L +S N+ G
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH-----LSDNLLGDAGLQLLCEGLLDP 140
Query: 110 LTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGN 169
+L L +L L L + + N
Sbjct: 141 QCRLEKLQLEYCSLSAAS---------CEPLASVLRAK-----------PDFKELTVSNN 180
Query: 170 QLSGHRPSTMGHSLPNR----QFLLLWANRLT----GTIPNSITNASKLIGLDLNSNSLS 221
++ + L + + L L + +T + + + + L L L SN L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 222 GQ-----IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
P L TL I +T + G L L+ LSL N
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAK----GCGDLCRVLRAKESLKELSLAGNE- 295
Query: 277 DSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRL 336
+G+ A L+ +L
Sbjct: 296 -------LGDEGAR------------------------LLCETLLEPGC----------- 313
Query: 337 QQLQAL-LQRNNLNG----PIPTCLSSLISLRQLHLGSNQLTSS--------IPSSFWSL 383
QL++L ++ + + L+ L +L + +N+L + + L
Sbjct: 314 -QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 384 EYILRIDLSSNSLS----GSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSL 439
+ L+ +S SL + + L L+LS N + G+ + S+
Sbjct: 373 R---VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC------LGDAGIL-QLVESV 422
Query: 440 ARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL----SHLKRLN 486
+ LE L L + S E+ + L L+ ++
Sbjct: 423 RQPG------------CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 54/249 (21%), Positives = 98/249 (39%), Gaps = 52/249 (20%)
Query: 566 YRNRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTN---VAIKVFNLQLE 622
++ + + R D+ + E +G G++G VYK DG + A+K Q+E
Sbjct: 7 FKVKLSSERERVEDLFE-----YEGCKVGRGTYGHVYKAKRKDGKDDKDYALK----QIE 57
Query: 623 RAFRSFESECEV--LRNVRHRN---LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNY 677
S + E+ LR ++H N L K+F S + L+ ++ + L + H
Sbjct: 58 GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRA 115
Query: 678 FLDMLERLNIMIDVGL----------ALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR-- 725
+ + + G+ + YLH + V+H +LKP NIL+ R
Sbjct: 116 --SKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170
Query: 726 --VSDFGISKLLGEDDDSVTQ-TMTMATIGYMAPE-------YASDGIISPKCDVYSYGV 775
++D G ++L + + T Y APE Y + D+++ G
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGC 224
Query: 776 LLMETFTRK 784
+ E T +
Sbjct: 225 IFAELLTSE 233
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 24/101 (23%), Positives = 44/101 (43%), Gaps = 2/101 (1%)
Query: 393 SNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIP-ITIGGLKDLITLSLARNRFQDSIPDS 451
+ + + + L L + Q ++ + GL +L L++ ++ + PD+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 452 FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
F L L+LS N L K+ + LS L+ L +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 26/101 (25%), Positives = 37/101 (36%), Gaps = 3/101 (2%)
Query: 322 TNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPT-CLSSLISLRQLHLGSNQLTSSIPSS 379
T D L + L L ++ + L L LR L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 380 FWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
F + R++LS N+L SL L L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 3e-06
Identities = 7/48 (14%), Positives = 13/48 (27%), Gaps = 1/48 (2%)
Query: 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPK-SFEILSHLKRLNVSHNRLE 493
+L L + N + L L+ L + + L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 21/97 (21%), Positives = 34/97 (35%), Gaps = 10/97 (10%)
Query: 182 SLPNRQFLLLWANRLTGTIPN-SITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240
N L + + + + +L L + + L P+ F LS LN+
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
Query: 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
N L + W + L+ L+ L L NPL
Sbjct: 89 FNALES-----LSWKTVQGLS----LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 17/105 (16%), Positives = 33/105 (31%), Gaps = 1/105 (0%)
Query: 141 VLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTI 200
+ + + + + + Q H L + L + + L
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72
Query: 201 PNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245
P++ +L L+L+ N+L T L L L + N L
Sbjct: 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 15/96 (15%), Positives = 27/96 (28%), Gaps = 9/96 (9%)
Query: 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPN-TFGNLRHLSTLNIRANYLTTETSSNG 252
+ + A L L + + + L L L I + L
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP--- 73
Query: 253 EWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFS 288
+ +L L+L N L+S+ + S
Sbjct: 74 -----DAFHFTPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 21/119 (17%), Positives = 36/119 (30%), Gaps = 24/119 (20%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
H+ L L I +L LR L +L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLEL--RDLRGL---------------------GEL 58
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLR 124
+ L++ + P++ L RL+ FN++ ++ K L L + N L
Sbjct: 59 RNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 43/236 (18%), Positives = 93/236 (39%), Gaps = 56/236 (23%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR----------- 639
LG G F +V+ + + T+VA+K+ + + E E ++L+ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 640 HRNLIKIFSSCCNLDFKA-------LVLEFMPNGSLEKWLYSHNYF---LDMLERLNIMI 689
+++K+ + K +V E + +L + + + L +++ I
Sbjct: 85 ANHILKLLDH---FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISK 138
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLD------KNMTARVSDFGISKLLGEDDDSVT 743
+ L L+Y+H ++H ++KP N+L++ + +++D G + E +
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 744 QTMTMATIGYMAPEYASDGII-----SPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794
QT Y +PE ++ D++S L+ E T +F +
Sbjct: 197 QTRE-----YRSPE-----VLLGAPWGCGADIWSTACLIFELITGDF----LFEPD 238
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 56/219 (25%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHR------NLI 644
++G GSFG V K +VA+K+ +R R E +L ++R + N+I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 645 KIFSSCCNLDFKA---LVLEFMPNGSLEKWLYSHNYFLDMLERLN-----------IMID 690
+ + F+ + E L S N + +++++
Sbjct: 163 HMLEN---FTFRNHICMTFE----------LLSMNLY-ELIKKNKFQGFSLPLVRKFAHS 208
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA--RVSDFGISKLLGEDDDSVTQTMTM 748
+ L+ LH + ++HC+LKP NILL + + +V DFG S + + Q+
Sbjct: 209 ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF- 264
Query: 749 ATIGYMAPEYASDGII-----SPKCDVYSYGVLLMETFT 782
Y APE +I D++S G +L E T
Sbjct: 265 ----YRAPE-----VILGARYGMPIDMWSLGCILAELLT 294
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 36/140 (25%), Positives = 55/140 (39%), Gaps = 34/140 (24%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
IP + L L N +P LS+ L + L +N++++ SF
Sbjct: 29 IPRDVTELY-----LDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSF-------- 74
Query: 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQDS 447
N+ L+ L LS N+L IP GLK L LSL N
Sbjct: 75 ----------------SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-V 116
Query: 448 IPD-SFGSLTSLEYLDLSNN 466
+P+ +F L++L +L + N
Sbjct: 117 VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 7/92 (7%)
Query: 401 PSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEY 460
P D+ L L NQ + +P + K L + L+ NR SF ++T L
Sbjct: 30 PRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT 82
Query: 461 LDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
L LS N L P++F+ L L+ L++ N +
Sbjct: 83 LILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 26/98 (26%), Positives = 42/98 (42%), Gaps = 13/98 (13%)
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCL-----S 357
+PKE+ N + L + L N ++ + + QL L L N L C+
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-----RCIPPRTFD 99
Query: 358 SLISLRQLHLGSNQLTSSIP-SSFWSLEYILRIDLSSN 394
L SLR L L N + S +P +F L + + + +N
Sbjct: 100 GLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 9/95 (9%)
Query: 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244
+ L L N+ T +P ++N L +DL++N +S +F N+ L TL + N L
Sbjct: 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSI 279
+F L + LR LSL N + +
Sbjct: 91 R----CIPPRTF-DGLKS---LRLLSLHGNDISVV 117
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 33/129 (25%), Positives = 58/129 (44%), Gaps = 20/129 (15%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
IP + + L GNQ + + + + L NR++ S +N ++L
Sbjct: 29 IPRDVTEL------YLDGNQFT--LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 211 IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS--NGEWSFLSSLTNCNKLRA 268
+ L L+ N L P TF L+ L L++ N + S G ++ LS+L++
Sbjct: 81 LTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI----SVVPEGAFNDLSALSH------ 130
Query: 269 LSLGSNPLD 277
L++G+NPL
Sbjct: 131 LAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 30/107 (28%), Positives = 44/107 (41%), Gaps = 11/107 (10%)
Query: 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFS---KLQVLSLRNNSFT 76
L + N F +P EL + L + + N ++ + + FS +L L L N
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN--QSFSNMTQLLTLILSYNRLR 91
Query: 77 GPIPNSLFN-LSSLVRLDSRFNSISGNIPSKI-GNLTKLVHLNFADN 121
IP F+ L SL L N IS +P +L+ L HL N
Sbjct: 92 C-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 47/142 (33%), Positives = 63/142 (44%), Gaps = 12/142 (8%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
IP L L +N L S F L + ++ L N L SLP+ + L L
Sbjct: 26 IPA------QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 411 IYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD-SFGSLTSLEYLDLSNNNLS 469
YLNLS NQL L L L+L N+ Q S+PD F LT L+ L L N L
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 470 GEIPK-SFEILSHLKRLNVSHN 490
+P F+ L+ L+ + + N
Sbjct: 138 S-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 46/152 (30%), Positives = 59/152 (38%), Gaps = 29/152 (19%)
Query: 318 LSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSI 376
L L TN L L L L L N L + L SL L+L +NQL S
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLP 92
Query: 377 PSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLI 435
F L + + L++N L SLP + L L L L +NQL
Sbjct: 93 NGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-------------- 137
Query: 436 TLSLARNRFQDSIPD-SFGSLTSLEYLDLSNN 466
S+PD F LTSL+Y+ L +N
Sbjct: 138 -----------SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 29/81 (35%), Positives = 37/81 (45%)
Query: 412 YLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGE 471
YL+L N L L L L L N+ Q F LTSL YL+LS N L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 472 IPKSFEILSHLKRLNVSHNRL 492
F+ L+ LK L ++ N+L
Sbjct: 92 PNGVFDKLTQLKELALNTNQL 112
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 33/171 (19%), Positives = 64/171 (37%), Gaps = 21/171 (12%)
Query: 340 QALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGS 399
A+ + T + +LH + + ++ +L+ + LS+N++
Sbjct: 9 DAIRIFEERKSVVATEAEKV----ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-K 62
Query: 400 LPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLI----TLSLARNRFQDSIPDSFGSL 455
+ S + ++ L L+L RN + I L + L ++ N+ L
Sbjct: 63 I-SSLSGMENLRILSLGRNLIK-----KIENLDAVADTLEELWISYNQIAS--LSGIEKL 114
Query: 456 TSLEYLDLSNNNLS--GEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRN 504
+L L +SNN ++ GEI L L+ L ++ N L N
Sbjct: 115 VNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 34/165 (20%), Positives = 56/165 (33%), Gaps = 38/165 (23%)
Query: 112 KLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQL 171
+ V L+ + ++ + LK L L+ N I I ++S
Sbjct: 26 EKVELHGMIPPIE-KMDATLSTLKACKHLALS-TNNI----EKISSLS------------ 67
Query: 172 SGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNL 231
+ N + L L N + I N A L L ++ N ++ + L
Sbjct: 68 ----------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKL 114
Query: 232 RHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
+L L + N +T W + L +KL L L NPL
Sbjct: 115 VNLRVLYMSNNKIT-------NWGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 32/160 (20%), Positives = 54/160 (33%), Gaps = 18/160 (11%)
Query: 44 LGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNI 103
L + + + + L+L N+ + +LS + L R S+ N+
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENL--RILSLGRNL 81
Query: 104 PSKIGNL----TKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIP--TTIFN 157
KI NL L L + N + + I L NL L ++ NN I +
Sbjct: 82 IKKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMS-NNKITNWGEIDKLAA 138
Query: 158 ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLT 197
+ + + L GN L S R ++ L
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSE-YRIEVVKRLPNLK 177
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHR------NL 643
+L+G GSFG V K + VAIK+ + + + E +L + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 644 IKIFSSCCNLDFKA---LVLEFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLH 699
+ + F+ LV E + + +L L + N+ + + + AL +L
Sbjct: 119 VHLKRH---FMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 700 HSHSTPVVHCNLKPNNILL--DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
+ ++HC+LKP NILL K ++ DFG S LG+ Q+ Y +PE
Sbjct: 175 TPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE 228
Query: 758 YASDGII-----SPKCDVYSYGVLLMETFT 782
++ D++S G +L+E T
Sbjct: 229 -----VLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 36/147 (24%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI-KIFSSC 650
+G+GSFG +Y GT + G VAIK+ ++ + E ++ + ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 651 CNLDFKALVLEFMPNG-SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
D+ +V+E + G SLE + + L + + +EY+H + +H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHR 129
Query: 710 NLKPNNILLDKNMTA---RVSDFGISK 733
++KP+N L+ + DFG++K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 388 RIDLSSNSLSGSLPSD--IQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQ 445
+ L+ N L + SD L L+ L L RNQL+G P G + L L N+ +
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 446 DSIPD-SFGSLTSLEYLDLSNNNLSGEIPK-SFEILSHLKRLNVSHN 490
I + F L L+ L+L +N +S + SFE L+ L LN++ N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 36/141 (25%), Positives = 50/141 (35%), Gaps = 34/141 (24%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCL-SSLISLRQLHLGSNQLTSSIPSSFWSLEYIL 387
IP L L N L L L L +L L NQLT P++F +I
Sbjct: 27 IPLHTTELL-----LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81
Query: 388 RIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD 446
+ L N + + + + L L LNL NQ+S
Sbjct: 82 ELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS------------------------- 115
Query: 447 SIPD-SFGSLTSLEYLDLSNN 466
+ SF L SL L+L++N
Sbjct: 116 CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 389 IDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARNRFQD 446
+D + L +P DI + L L+ N+L + G L L+ L L RN+
Sbjct: 13 VDCTGRGLK-EIPRDIPLHTTEL---LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68
Query: 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRL 492
P++F + ++ L L N + K F L LK LN+ N++
Sbjct: 69 IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI 114
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 163 IINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG 222
+ L N+L + LP+ L L N+LTG PN+ AS + L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 223 QIPN-TFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD---S 278
+I N F L L TLN+ N ++ G + L+SLT+ L+L SNP +
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS--CVMPGSFEHLNSLTS------LNLASNPFNCNCH 143
Query: 279 IL 280
+
Sbjct: 144 LA 145
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 33/149 (22%), Positives = 64/149 (42%), Gaps = 15/149 (10%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI-KIFSSC 650
+G G+FG + G L+ VAIK+ ++ E + + + I +++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 651 CNLDFKALVLEFMPNG-SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
+ A+VLE + G SLE + + L I I + +EY+H + +++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129
Query: 710 NLKPNNILLDKNMTARVS-----DFGISK 733
++KP N L+ + DF ++K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 15/149 (10%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI-KIFSSC 650
+G GSFG +++GT L + VAIK + + E + + I ++
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 651 CNLDFKALVLEFMPNG-SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
LV++ + G SLE L + + ++ +H +V+
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYR 130
Query: 710 NLKPNNILLDKNMTAR-----VSDFGISK 733
++KP+N L+ + + V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 39/140 (27%), Positives = 52/140 (37%), Gaps = 33/140 (23%)
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388
IP++ RL+ L+ N L L L +L L NQ+ S F L +
Sbjct: 26 IPSSATRLE-----LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTI 80
Query: 389 IDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447
+ L N L SLP+ + L L L L NQL S
Sbjct: 81 LYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-------------------------S 114
Query: 448 IPD-SFGSLTSLEYLDLSNN 466
+PD F LTSL+ + L N
Sbjct: 115 VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 37/141 (26%), Positives = 55/141 (39%), Gaps = 34/141 (24%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
IP+ S +L L SN+L S F L + ++ LS N + SLP + L L
Sbjct: 26 IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 411 IYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDS-FGSLTSLEYLDLSNNNLS 469
L L N+L S+P+ F LT L+ L L N L
Sbjct: 79 TILYLHENKLQ-------------------------SLPNGVFDKLTQLKELALDTNQLK 113
Query: 470 GEIPKSFEILSHLKRLNVSHN 490
F+ L+ L+++ + N
Sbjct: 114 SVPDGIFDRLTSLQKIWLHTN 134
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.1 bits (134), Expect = 2e-08
Identities = 31/160 (19%), Positives = 61/160 (38%), Gaps = 17/160 (10%)
Query: 349 NGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEY--ILRIDLSSNSLSGSLPSDIQN 406
+ L ++ L L + S +L+ I+ L + + L SD+ N
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 407 LKVLIYLNLSRNQLSGNIPITI-------GGLKDLITLSLARNRFQDSIPDSFGS---LT 456
L+ L+ L + + + + +L L + Q+ + + F L
Sbjct: 221 LEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 457 SLEYLDLSNNNLSGE----IPKSFEILSHLKRLNVSHNRL 492
LE +D+S L+ E + + + HLK +N+ +N L
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 5e-07
Identities = 27/179 (15%), Positives = 56/179 (31%), Gaps = 24/179 (13%)
Query: 326 NGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIP-----SSF 380
+ L + L L + N I +L+ L + S L S+ S
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRP--NLKSLEIISGGLPDSVVEDILGSDL 218
Query: 381 WSLEYILRIDLSSNSLSGSLPSDI------QNLKVLIYLNLSRNQLSGNIPITIGG---L 431
+LE ++ + + L +L + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 432 KDLITLSLARNRFQDS----IPDSFGSLTSLEYLDLSNNNLSGE----IPKSFEILSHL 482
L T+ ++ D + D + L+++++ N LS E + KS + +
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 3e-04
Identities = 26/171 (15%), Positives = 57/171 (33%), Gaps = 25/171 (14%)
Query: 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIG--NLKNLADLVLA 143
L ++ L++ + N+ L L L + +I +L NL LVL
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 144 LNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNS 203
+ + + PN ++L + +
Sbjct: 228 VGVEDYGFDGDMNVFRPLF----------------SKDRFPNLKWLGIVDAEEQNVVVEM 271
Query: 204 ITNA---SKLIGLDLNSNSLSG----QIPNTFGNLRHLSTLNIRANYLTTE 247
+ +L +D+++ L+ + + ++HL +N++ NYL+ E
Sbjct: 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 43/318 (13%), Positives = 89/318 (27%), Gaps = 57/318 (17%)
Query: 203 SITNASKLIGLDLNSNSLSGQ----IPNTFGNLRHLSTLNIRANYL--TTETSSNGEWSF 256
+ + + L+ N++ + + + + L + +
Sbjct: 27 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL 86
Query: 257 LSSLTNCNKLRALSLGSNPLDSILPPLIGNF---SASFQQFYAHECKLKGSIPKEIGNLR 313
L +L C KL + L N + +F + Y H L +I
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR-- 144
Query: 314 GLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGP----IPTCLSSLISLRQLHLGS 369
AL + L + RN L S L + +
Sbjct: 145 ---ALQELAVNKKAKNAPPLRSII-----CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 196
Query: 370 NQLTSS-----IPSSFWSLEYILRIDLSSNSLSG----SLPSDIQNLKVLIYLNLSRNQL 420
N + + + + +DL N+ + +L +++ L L L+
Sbjct: 197 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL- 255
Query: 421 SGNIPITIGGLKDLIT-LSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSF--- 476
++ G ++ S N L+ L L N + + ++
Sbjct: 256 -----LSARGAAAVVDAFSKLEN-------------IGLQTLRLQYNEIELDAVRTLKTV 297
Query: 477 --EILSHLKRLNVSHNRL 492
E + L L ++ NR
Sbjct: 298 IDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 33/168 (19%), Positives = 56/168 (33%), Gaps = 35/168 (20%)
Query: 361 SLRQLHLGSNQLTS----SIPSSFWSLEYILRIDLSSNSLSG----SLPSDIQNLKVLIY 412
S+ L + +T+ S+ + + + I LS N++ L +I + K L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 413 LNLSRNQLSGNIPITIGGLKD----------LITLSLARNRFQDSIPDSFGSL----TSL 458
S L+ L T+ L+ N F + + T L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 459 EYLDLSNNNLSGE-------------IPKSFEILSHLKRLNVSHNRLE 493
E+L L NN L + + K + L+ + NRLE
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 38/258 (14%), Positives = 79/258 (30%), Gaps = 49/258 (18%)
Query: 65 LQVLSLRNNSFTG----PIPNSLFNLSSLVRLDSRFNSISGN----IPSKIGNLTKLVHL 116
++ SL+ ++ T + L S+ + N+I + I + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 117 NFADNNLRGEIPNEIG-----------NLKNLADLVLALNNL----IGPIPTTIFNISTI 161
F+D G + +EI L + L+ N P+ + + +
Sbjct: 66 EFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 162 IIINLVGNQ------------LSGHRPSTMGHSLPNRQFLLLWANRLTG----TIPNSIT 205
+ L N L + + P + ++ NRL +
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 206 NASKLIGLDLNSNSLSGQ-----IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSL 260
+ L + + N + + + + L L+++ N T G + +L
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL----GSSALAIAL 240
Query: 261 TNCNKLRALSLGSNPLDS 278
+ LR L L L +
Sbjct: 241 KSWPNLRELGLNDCLLSA 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 593 LGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI-KIFSSC 650
+G+GSFG +Y GT + VAIK+ N++ + E ++ R ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 651 CNLDFKALVLEFMPNG-SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709
D+ LV++ + G SLE + L + L + + +E++H +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 710 NLKPNNILLDKNMTAR---VSDFGISK 733
++KP+N L+ A + DFG++K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 60/230 (26%)
Query: 592 LLGAGSFGSVYKG--TLFDGTNVAIKVF-NLQLERAFRSFESECEVLRNVRHR------N 642
LG G+FG V + + VA+K+ N + + + E VL+ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 643 LIKIFSSCCNLDFKA---LVLEFMPNGSLEKWLYSHNYF---LDMLERLNIMIDVGLALE 696
+ + +F + E + + ++L +N+ L + + + AL
Sbjct: 84 CVLMSDW---FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH--MAYQLCHALR 137
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTA-------------------RVSDFGISKLLGE 737
+LH + + H +LKP NIL + RV+DFG + E
Sbjct: 138 FLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194
Query: 738 DDDSVTQTMTMATIGYMAPEYASDGII-----SPKCDVYSYGVLLMETFT 782
++ T Y PE +I + CDV+S G +L E +
Sbjct: 195 HHTTIVATRH-----YRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 34/130 (26%), Positives = 59/130 (45%), Gaps = 7/130 (5%)
Query: 361 SLRQLHLGSNQLT-SSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQ 419
++R+L L + + I + + L + L S+ S++ L L L LS N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENR 82
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQD-SIPDSFGSLTSLEYLDLSNN---NLSGEIPKS 475
+ G + + L +L L+L+ N+ +D S + L L+ LDL N NL+
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESV 142
Query: 476 FEILSHLKRL 485
F++L L L
Sbjct: 143 FKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 9e-07
Identities = 25/120 (20%), Positives = 48/120 (40%), Gaps = 9/120 (7%)
Query: 157 NISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLN 216
+ + + L + + + + N +FL L L ++ N + KL L+L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 217 SNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
N + G + L +L+ LN+ N L + S L L L++L L + +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK-------DISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 25/100 (25%), Positives = 41/100 (41%), Gaps = 7/100 (7%)
Query: 394 NSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFG 453
L P+ ++ L L+ ++ G I +L LSL +
Sbjct: 16 LELRNRTPAAVREL----VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISV--SNLP 68
Query: 454 SLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
L L+ L+LS N + G + E L +L LN+S N+L+
Sbjct: 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 27/169 (15%), Positives = 60/169 (35%), Gaps = 35/169 (20%)
Query: 592 LLGAGSFGSVYKGTLFDGTNVAIKVF---------NLQLERAFRSF-----ESECEVLRN 637
+G G FG +Y + +V N L + + + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 638 VRHRNLIKI-------FSSCCNLDFKALVLEFMPNG-SLEKWLYSHNYFLDMLERLNI-- 687
R + + ++ ++++ G L+K ++ L +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 688 -MIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARV--SDFGISK 733
++D+ LEY+H VH ++K +N+LL+ +V D+G++
Sbjct: 160 RILDI---LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 64/234 (27%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVF-NLQLERAFRSFESECEVLRNVRHR-----NLI 644
+G G+FG V + + A+KV N++ + RS + E ++L+ +++ N++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 645 KIFSSCCNLDFKA---LVLEFMPNGSLEKWLYSHNYF---LDMLERLNIMIDVGLALEYL 698
K + L+ E + SL + + +NY ++ ++ I++ AL YL
Sbjct: 100 KYHGK---FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL--YCIEILKALNYL 153
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTA-------------------------RVSDFGISK 733
+ H +LKP NILLD ++ DFG +
Sbjct: 154 RKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGII-----SPKCDVYSYGVLLMETFT 782
+ S+ T Y APE +I D++S+G +L E +T
Sbjct: 211 FKSDYHGSIINTRQ-----YRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-08
Identities = 29/130 (22%), Positives = 60/130 (46%), Gaps = 7/130 (5%)
Query: 361 SLRQLHLGSNQLTS-SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQ 419
+++L L +++ + E + + + L+ S+ +++ L L L LS N+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNR 75
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQD-SIPDSFGSLTSLEYLDLSNNNLSGEI---PKS 475
+SG + + +L L+L+ N+ +D S + L +L+ LDL N ++
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENV 135
Query: 476 FEILSHLKRL 485
F++L L L
Sbjct: 136 FKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 24/120 (20%), Positives = 49/120 (40%), Gaps = 9/120 (7%)
Query: 157 NISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLN 216
S + + L ++ + + + +FL LT +I N + +KL L+L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 217 SNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
N +SG + +L+ LN+ N + + S + L L++L L + +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK-------DLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 22/91 (24%), Positives = 40/91 (43%), Gaps = 4/91 (4%)
Query: 403 DIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLD 462
++K L+ N N+ + ++L LS I + L L+ L+
Sbjct: 15 TPSDVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKKLE 70
Query: 463 LSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
LS+N +SG + E +L LN+S N+++
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 21/89 (23%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 62 FSKLQVLSLRNNSFT-GPIPNSLFNLSSLVRLDSRFNSIS--GNIPSKIGNLTKLVHLNF 118
S ++ L L N+ G + L L + ++ N+P L KL L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLEL 71
Query: 119 ADNNLRGEIPNEIGNLKNLADLVLALNNL 147
+DN + G + NL L L+ N +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 25/114 (21%), Positives = 42/114 (36%), Gaps = 17/114 (14%)
Query: 378 SSFWSLEYILRIDLSSNSLSGSLPSDIQNLKV----LIYLNLSRNQLS--GNIPITIGGL 431
+ + + +DL + I+NL ++ S N++ P L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIRKLDGFP----LL 63
Query: 432 KDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRL 485
+ L TL + NR +L L L L+NN+L + L+ LK L
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSL 115
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 21/113 (18%), Positives = 39/113 (34%), Gaps = 11/113 (9%)
Query: 164 INLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQ 223
++L G ++ +G +L + N + + +L L +N+N +
Sbjct: 24 LDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRI 79
Query: 224 IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
L L+ L + N L E L L + L L + NP+
Sbjct: 80 GEGLDQALPDLTELILTNNSLV-------ELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 3/89 (3%)
Query: 405 QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLS 464
N L+L ++ I L + + N + + D F L L+ L ++
Sbjct: 16 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVN 72
Query: 465 NNNLSGEIPKSFEILSHLKRLNVSHNRLE 493
NN + + L L L +++N L
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 20/87 (22%), Positives = 30/87 (34%), Gaps = 7/87 (8%)
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSIS--GNIPSKIGNLTKLVHLNFAD 120
+ + L LR I N L +D N I P L +L L +
Sbjct: 19 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNN 73
Query: 121 NNLRGEIPNEIGNLKNLADLVLALNNL 147
N + L +L +L+L N+L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 60/230 (26%)
Query: 592 LLGAGSFGSVYKG--TLFDGTNVAIKVF-NLQLERAFRSFESECEVLRNVRHR------N 642
LG G+FG V + G +VA+K+ N+ +R + SE +VL ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 643 LIKIFSSCCNLDFKA---LVLEFMPNGSLEKWLYSHNYF---LDMLERLNIMIDVGLALE 696
+++ + +V E + S ++ + + LD + + + + ++
Sbjct: 79 CVQMLEW---FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK--MAYQICKSVN 132
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTA-------------------RVSDFGISKLLGE 737
+LH + + H +LKP NIL ++ +V DFG + E
Sbjct: 133 FLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189
Query: 738 DDDSVTQTMTMATIGYMAPEYASDGII-----SPKCDVYSYGVLLMETFT 782
++ T Y APE +I S CDV+S G +L+E +
Sbjct: 190 HHSTLVSTRH-----YRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 29/165 (17%), Positives = 58/165 (35%), Gaps = 29/165 (17%)
Query: 593 LGAGSFGSVYKGT---------LFDGTNVAIKV--FNLQLERAFRSFESECEV------- 634
+ G +Y+ ++K+ + +L F+ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 635 -LRNVRHRNLIKIFSSCCNLD-FKALVLEFMPNG-SLEK-WLYSHNYFLDMLERLNIMID 690
L + + + D ++ LVL + G SL+ S + L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARV--SDFGISK 733
+ ALE+LH + VH N+ NI +D ++V + +G +
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 34/167 (20%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G+G FG +Y A V ++ + SE + + V ++ IK +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVE-YQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 651 CNL-------------------DFKALVLEFMPNG-SLEKWLYSHNYF-LDMLERLNI-M 688
L ++ +V+E + G L+K + F + +L I M
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIRM 160
Query: 689 IDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARV--SDFGISK 733
+DV LEY+H + VH ++K N+LL +V +D+G+S
Sbjct: 161 LDV---LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 50/254 (19%), Positives = 83/254 (32%), Gaps = 74/254 (29%)
Query: 593 LGAGSFGSVYKG-TLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC 651
LG G F +V+ + VA+KV E + E +L++VR+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 652 N--LD-FK---------ALVLEFMPNG-SLEKWLYSHNYFLDMLERL-NIMIDVGLALEY 697
LD FK +V E + G L KW+ NY L + I+ V L+Y
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 698 LHHSHSTPVVHCNLKPNNILL--------------------------------------- 718
LH ++H ++KP NILL
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 719 ----------DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
+ + +++D G + + + QT Y + E +
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPA 274
Query: 769 DVYSYGVLLMETFT 782
D++S + E T
Sbjct: 275 DIWSTACMAFELAT 288
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 35/117 (29%), Positives = 51/117 (43%), Gaps = 34/117 (29%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
IPT + + L+L NQ+T P F L + R+DL +N L+ LP+ + L L
Sbjct: 28 IPT------TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 411 IYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD-SFGSLTSLEYLDLSNN 466
L+L+ NQL SIP +F +L SL ++ L NN
Sbjct: 81 TQLSLNDNQLK-------------------------SIPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 31/117 (26%), Positives = 50/117 (42%), Gaps = 34/117 (29%)
Query: 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVL 410
IPT ++L L +NQ+T P F L + ++ +SN L+ ++P+ + L L
Sbjct: 31 IPT------DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 411 IYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD-SFGSLTSLEYLDLSNN 466
L+L+ N L SIP +F +L SL ++ L NN
Sbjct: 84 TQLDLNDNHLK-------------------------SIPRGAFDNLKSLTHIYLYNN 115
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 33/154 (21%), Positives = 57/154 (37%), Gaps = 25/154 (16%)
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILR--------IDLSSNSLSG-SLPSDIQNLKVLI 411
SLRQL+L ++T P + +L ++L+S L L + +
Sbjct: 73 SLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR 129
Query: 412 YLNLSRNQLSGNIPITIG-GLKD----LITLSLARNRFQDS----IPDSFGSLTSLEYLD 462
L L N L + L + TL L+ N + + + TS+ +L
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLS 189
Query: 463 LSNNNLSGE----IPKSFEILSHLKRLNVSHNRL 492
L + L E + + L+ LNV++N
Sbjct: 190 LLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 46/295 (15%), Positives = 94/295 (31%), Gaps = 48/295 (16%)
Query: 208 SKLIGLDLNSNSLSGQIPNTFG-----NLRHLSTLNIRANYLTTETSSNGEWSFLSSLTN 262
+ LDL+ N+L +++LN+ N L + + L
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK----NSDELVQILAA 77
Query: 263 CN-KLRALSLGSNPLD----SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIA 317
+ +L+L N L L + + E +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 318 LSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS-- 375
S+ + +L G +L +L ++ L+L N L S
Sbjct: 138 ASITSLNLRGNDLGIKS-SDELIQILAAIPA------------NVNSLNLRGNNLASKNC 184
Query: 376 --IPSSFWSLEYILR-IDLSSNSLSGSLPSDI-----QNLKVLIYLNLSRNQLSG----N 423
+ S+ + +DLS+N L +++ ++ LNL N L G N
Sbjct: 185 AELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLEN 244
Query: 424 IPITIGGLKDLITLSLARNRFQD-------SIPDSFGSLTSLEYLDLSNNNLSGE 471
+ + LK L T+ L + ++ ++ +F ++ + +D + +
Sbjct: 245 LKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 52/329 (15%), Positives = 98/329 (29%), Gaps = 63/329 (19%)
Query: 206 NASKLIGLDLNSNSLSGQIPNTFG-----NLRHLSTLNIRANYLTTETSSNGEWSFLSSL 260
+ + L+L+ NSL + + ++++LN+ N+L+ + + +L
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYK----SSDELVKTL 104
Query: 261 TNCN-KLRALSLGSNPLD----SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGL 315
+ L LG N S N AS L +
Sbjct: 105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI---------KSS 155
Query: 316 IALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLI-----SLRQLHLGSN 370
L + + +L L+ NNL L+ + S+ L L +N
Sbjct: 156 DELIQILAAIPANV-NSLN--------LRGNNLASKNCAELAKFLASIPASVTSLDLSAN 206
Query: 371 QLT----SSIPSSFWSLEYILR-IDLSSNSLSGS----LPSDIQNLKVLIYLNLSRNQLS 421
L + + F S+ + ++L N L G L +LK L + L + +
Sbjct: 207 LLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266
Query: 422 G-------NIPITIGGLKDLITLSLARNRFQDS----IPDSFGSL-TSLEYLDLSNNNLS 469
+ ++ +I + S I + L + L N L
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326
Query: 470 -----GEIPKSFEILSHLKRLNVSHNRLE 493
+ I L+ + L
Sbjct: 327 FAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 37/165 (22%), Positives = 59/165 (35%), Gaps = 31/165 (18%)
Query: 356 LSSLISLRQLHLGSNQLTSS--------IPSSFWSLEYILRIDLSSNSLSGSLPSDI--- 404
S + L L N L S ++ S+ ++LS NSL ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVT---SLNLSGNSLGFKNSDELVQI 74
Query: 405 --QNLKVLIYLNLSRNQLSGNIPITIG-GLKD----LITLSLARNRFQDS----IPDSFG 453
+ LNLS N LS + L + L L N F +F
Sbjct: 75 LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFS 134
Query: 454 SL-TSLEYLDLSNNNLSGEIPKSF-EIL----SHLKRLNVSHNRL 492
+L S+ L+L N+L + +IL +++ LN+ N L
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 80/479 (16%), Positives = 139/479 (29%), Gaps = 86/479 (17%)
Query: 37 QLRRLKFLGFAYNDLTGSFPSWI--GVFSKLQVLSLRN-NSFT----GPIPNSLFNLSSL 89
LR+LK + F ++ + L+ L L + FT I + +L
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTL 169
Query: 90 VRLDSRFNSISGNIPSKIG-NLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLI 148
+ +S F+ G ++ + T L LNF + K+L + +L
Sbjct: 170 LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKI------SPKDLETIARNCRSL- 222
Query: 149 GPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNAS 208
+ I+ LVG +L L + ++
Sbjct: 223 -----VSVKVGDFEILELVG-------FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270
Query: 209 KLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRA 268
KL L L+ + +P F + L++ L TE + + C L
Sbjct: 271 KLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETE-------DHCTLIQKCPNLEV 322
Query: 269 LSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGT 328
L + D L L A CK L+ L + ++
Sbjct: 323 LETRNVIGDRGLEVL------------AQYCK----------QLKRLR-IERGADEQGME 359
Query: 329 IPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLT----SSIPSSFWSLE 384
L + L AL Q L + + + +T SI + +L
Sbjct: 360 DEEGLVSQRGLIALAQ-------------GCQELEYMAVYVSDITNESLESIGTYLKNLC 406
Query: 385 YILRIDLSSNSLSGSLPSD------IQNLKVLIYLNLSRN--QLSGNIPITIG-GLKDLI 435
+ L LP D + K L L+ IG ++
Sbjct: 407 DFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVR 466
Query: 436 TLSLARNRFQD-SIPDSFGSLTSLEYLDLSNNNLSGE-IPKSFEILSHLKRLNVSHNRL 492
+ L D + + +L+ L++ S I + L L+ L V R
Sbjct: 467 WMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 870 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.59 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.28 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.12 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.12 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.6 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.56 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.56 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.0 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.88 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.55 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.47 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.13 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.04 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.02 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.95 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.86 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.76 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.75 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.06 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.72 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-67 Score=628.49 Aligned_cols=515 Identities=32% Similarity=0.492 Sum_probs=380.2
Q ss_pred CCccCCCCC-CCCCCCCeecCCCCccccCCCcc---ccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccC
Q 002892 3 LGGTVPPHI-GNLSFLMYLDISENNFRGYLPNE---LGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGP 78 (870)
Q Consensus 3 ~~~~~p~~~-~~l~~L~~L~ls~n~l~~~~p~~---~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 78 (870)
+.|.+|..+ .++++|++|||++|++++..|.. +..+++|++|++++|.+++..|. +.+++|++|+|++|.+++.
T Consensus 138 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~ 215 (768)
T 3rgz_A 138 LDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTG 215 (768)
T ss_dssp EECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSC
T ss_pred cCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCC
Confidence 346667665 77777777777777777665554 45555555555555555543332 4445555555555555443
Q ss_pred CCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeec----------------------CccceecCCcccCC-C
Q 002892 79 IPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD----------------------NNLRGEIPNEIGNL-K 135 (870)
Q Consensus 79 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~----------------------N~l~~~~~~~l~~l-~ 135 (870)
+|. ++++++|++|+|++|++++.+|..++.+++|++|++++ |++++.+|..+..+ +
T Consensus 216 ~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~ 294 (768)
T 3rgz_A 216 IPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACD 294 (768)
T ss_dssp CCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCT
T ss_pred Ccc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcC
Confidence 333 45555555555555555444444444444444444444 44444445444443 5
Q ss_pred CCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCC-CccEEE
Q 002892 136 NLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNAS-KLIGLD 214 (870)
Q Consensus 136 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~ 214 (870)
+|++|++++|++++.+|..+.++++|++|++++|++++.+|......+++|++|++++|++++.+|..+.+++ +|++|+
T Consensus 295 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~ 374 (768)
T 3rgz_A 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374 (768)
T ss_dssp TCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEE
T ss_pred cCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEE
Confidence 5555555555555555555555555555555555555555544333455555555555555555555555554 555555
Q ss_pred ccCCcccCCCcccccc--ccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchh
Q 002892 215 LNSNSLSGQIPNTFGN--LRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQ 292 (870)
Q Consensus 215 Ls~N~i~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~ 292 (870)
+++|++++..|..+.. +++|++|++++|.++.. .+..+..+++|++|++++|++.+..|..++.+. .|+
T Consensus 375 Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~--------~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~ 445 (768)
T 3rgz_A 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK--------IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLR 445 (768)
T ss_dssp CCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEE--------CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCC
T ss_pred ccCCCcCCCcChhhhhcccCCccEEECCCCccccc--------cCHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCC
Confidence 5555555555555544 55566666666655532 345688889999999999999988888887774 789
Q ss_pred hhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhc-CCCCCCCcccccCccccceeecCCcc
Q 002892 293 QFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR-NNLNGPIPTCLSSLISLRQLHLGSNQ 371 (870)
Q Consensus 293 ~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-n~~~~~~p~~~~~l~~L~~L~Ls~N~ 371 (870)
.|++++|.+++.+|..+..+++|++|++++|++.+.+|..+..+++|+.|+++ |.+.+.+|.+++.+++|++|+|++|+
T Consensus 446 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 525 (768)
T 3rgz_A 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCc
Confidence 99999999999999999999999999999999998999999999999999888 67777899999999999999999999
Q ss_pred cCCCCCcccccccccceEecCCCccCCCCcccc-----------------------------------------------
Q 002892 372 LTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI----------------------------------------------- 404 (870)
Q Consensus 372 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------------------------------------------- 404 (870)
+++.+|..+..+++|+.|++++|.+++.+|..+
T Consensus 526 l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (768)
T 3rgz_A 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 605 (768)
T ss_dssp CEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGG
T ss_pred ccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhh
Confidence 999999999999999999999999887776543
Q ss_pred -----------------------cCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeE
Q 002892 405 -----------------------QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYL 461 (870)
Q Consensus 405 -----------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 461 (870)
+.+++|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|
T Consensus 606 ~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~L 685 (768)
T 3rgz_A 606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685 (768)
T ss_dssp GGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred ccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEE
Confidence 346789999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccccccccccccCCCCcCCCCCCCCCC
Q 002892 462 DLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPCKEDDT 532 (870)
Q Consensus 462 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~~~~ 532 (870)
||++|+++|.+|..+..+++|+.||||+|+++|.+|..++|.++...+|.+|+.+||+| .++|..+.+
T Consensus 686 dLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~---l~~C~~~~~ 753 (768)
T 3rgz_A 686 DLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNA 753 (768)
T ss_dssp ECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT---SCCCCSCC-
T ss_pred ECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC---CcCCCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999998 447876544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=582.63 Aligned_cols=489 Identities=30% Similarity=0.457 Sum_probs=337.9
Q ss_pred CCCCCCCCCCCCeecCCCCccccCCCc--cccCCCCCcEEEccCCcccccCCccc-cCCCCCCEEEcCCCccccCCCCC-
Q 002892 7 VPPHIGNLSFLMYLDISENNFRGYLPN--ELGQLRRLKFLGFAYNDLTGSFPSWI-GVFSKLQVLSLRNNSFTGPIPNS- 82 (870)
Q Consensus 7 ~p~~~~~l~~L~~L~ls~n~l~~~~p~--~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~~~~- 82 (870)
+|+.++.+++|++|||++|.+++.+|. .++.+++|++|++++|.+++.+|..+ ..+++|++|+|++|++++..|..
T Consensus 92 l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 171 (768)
T 3rgz_A 92 SVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171 (768)
T ss_dssp CCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHH
T ss_pred CchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhh
Confidence 347778888888888888887776776 77777777777777777776666554 56666666666666666544433
Q ss_pred --CC----------------------CCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCC
Q 002892 83 --LF----------------------NLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLA 138 (870)
Q Consensus 83 --~~----------------------~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~ 138 (870)
+. .+++|++|+|++|++++.+|. ++.+++|++|++++|++++.+|..+.++++|+
T Consensus 172 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~ 250 (768)
T 3rgz_A 172 VLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELK 250 (768)
T ss_dssp HHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCC
T ss_pred hhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCC
Confidence 44 445555555555555544444 55555555555555555555555555555555
Q ss_pred eeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCC
Q 002892 139 DLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSN 218 (870)
Q Consensus 139 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 218 (870)
+|++++|++++.+|.. .+++|++|++++|++++..|..++..+++|++|+|++|++++.+|..|.++++|++|++++|
T Consensus 251 ~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 328 (768)
T 3rgz_A 251 LLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328 (768)
T ss_dssp EEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSS
T ss_pred EEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCC
Confidence 5555555555444443 55555666666666655666666555567777777777777666777777777777777777
Q ss_pred cccCCCccc-cccccccccccccccccccc-cCCCCCc----------------cccccccc--ccccceEEcCCCCCCC
Q 002892 219 SLSGQIPNT-FGNLRHLSTLNIRANYLTTE-TSSNGEW----------------SFLSSLTN--CNKLRALSLGSNPLDS 278 (870)
Q Consensus 219 ~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~-~~~~~~~----------------~~~~~l~~--l~~L~~L~L~~N~l~~ 278 (870)
++++.+|.. |.++++|++|++++|.++.. +...... ..+..+.. +++|++|++++|++.+
T Consensus 329 ~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~ 408 (768)
T 3rgz_A 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408 (768)
T ss_dssp EEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEE
T ss_pred cccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccc
Confidence 776555544 66777777777777766532 1110000 00111111 4456666666666655
Q ss_pred CCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhc-CCCCCCCccccc
Q 002892 279 ILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR-NNLNGPIPTCLS 357 (870)
Q Consensus 279 ~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-n~~~~~~p~~~~ 357 (870)
..|..+..+. .|+.|++++|.+++.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+++ |.+.+.+|..+.
T Consensus 409 ~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 487 (768)
T 3rgz_A 409 KIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487 (768)
T ss_dssp ECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred ccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHh
Confidence 5565555543 57777777777777777777777777777777777777777777777777777777 666667777888
Q ss_pred CccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccc---------
Q 002892 358 SLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITI--------- 428 (870)
Q Consensus 358 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--------- 428 (870)
.+++|++|+|++|++++.+|.+|..+++|+.|+|++|++++.+|..++++++|+.|+|++|+++|.+|..+
T Consensus 488 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~ 567 (768)
T 3rgz_A 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAA 567 (768)
T ss_dssp GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCC
T ss_pred cCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhh
Confidence 88888888888888888888888888888888888888887888888888888888888888776666433
Q ss_pred -------------------------------------------------------------cCCCCCCEEEcCCCcccCc
Q 002892 429 -------------------------------------------------------------GGLKDLITLSLARNRFQDS 447 (870)
Q Consensus 429 -------------------------------------------------------------~~l~~L~~L~Ls~N~l~~~ 447 (870)
+.+++|+.|||++|+++|.
T Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ 647 (768)
T 3rgz_A 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647 (768)
T ss_dssp STTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSC
T ss_pred hccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCccccc
Confidence 3356788888899998888
Q ss_pred ccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCC
Q 002892 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTN 499 (870)
Q Consensus 448 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 499 (870)
+|..|+++++|+.|+|++|+++|.+|..|+.+++|+.||||+|+++|.+|..
T Consensus 648 ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~ 699 (768)
T 3rgz_A 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGG
T ss_pred CCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChH
Confidence 9999999999999999999999999999999999999999999999999863
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=527.89 Aligned_cols=487 Identities=21% Similarity=0.198 Sum_probs=432.5
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
++|..+.. ++++|||++|++++..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|..|++
T Consensus 26 ~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 103 (606)
T 3t6q_A 26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG 103 (606)
T ss_dssp SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSS
T ss_pred cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcc
Confidence 56766654 7899999999999888889999999999999999999888999999999999999999999888999999
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccce--E
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTII--I 163 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~ 163 (870)
+++|++|+|++|++++..|..++.+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|+ .
T Consensus 104 l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~ 183 (606)
T 3t6q_A 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183 (606)
T ss_dssp CTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEE
T ss_pred cccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeE
Confidence 99999999999999976678899999999999999999975545566699999999999999988899999999999 8
Q ss_pred EEeecccccccCCCcccCC------------------------------------------------C--Cccceeeecc
Q 002892 164 INLVGNQLSGHRPSTMGHS------------------------------------------------L--PNRQFLLLWA 193 (870)
Q Consensus 164 L~l~~N~l~~~~~~~~~~~------------------------------------------------l--~~L~~L~L~~ 193 (870)
|++++|++++..|..+... + .+|+.|++++
T Consensus 184 L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~ 263 (606)
T 3t6q_A 184 LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263 (606)
T ss_dssp EECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTT
T ss_pred EecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeec
Confidence 9999999998777655321 0 1688899999
Q ss_pred cccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCC
Q 002892 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGS 273 (870)
Q Consensus 194 n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~ 273 (870)
|++++..+..|..+++|++|++++|+++ .+|..+.++++|++|++++|.++.+. +..+..+++|++|++++
T Consensus 264 n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~--------~~~~~~l~~L~~L~l~~ 334 (606)
T 3t6q_A 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC--------QISASNFPSLTHLSIKG 334 (606)
T ss_dssp CCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGG--------GGCGGGCTTCSEEECCS
T ss_pred CccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCc--------hhhhhccCcCCEEECCC
Confidence 9999888888999999999999999999 68888999999999999999998754 34688899999999999
Q ss_pred CCCCCCCCcc-ccccccchhhhhcccccccccC--chhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhc-CCCC
Q 002892 274 NPLDSILPPL-IGNFSASFQQFYAHECKLKGSI--PKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR-NNLN 349 (870)
Q Consensus 274 N~l~~~~~~~-~~~~~~~l~~l~l~~n~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-n~~~ 349 (870)
|.+.+..|.. +..+ ..|+.|++++|.+++.. +..+..+++|+.|++++|++.+..|..|..+++|+.|+++ |.+.
T Consensus 335 n~~~~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 335 NTKRLELGTGCLENL-ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp CSSCCBCCSSTTTTC-TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCcccccchhhhhcc-CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 9998655554 5544 58999999999999776 7889999999999999999999999999999999999998 5666
Q ss_pred CCCcc-cccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCC---CcccccCCccCCEEEccCCccCCccc
Q 002892 350 GPIPT-CLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGS---LPSDIQNLKVLIYLNLSRNQLSGNIP 425 (870)
Q Consensus 350 ~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p 425 (870)
+..+. .+..+++|++|++++|.+++..|..|..+++|++|++++|.+++. .+..+..+++|++|+|++|++++..|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 493 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence 66554 489999999999999999999999999999999999999999862 34679999999999999999999999
Q ss_pred ccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCccccc
Q 002892 426 ITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNF 505 (870)
Q Consensus 426 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~ 505 (870)
..|+++++|+.|+|++|++++..|..|.++++| .|+|++|++++..|..+..+++|+.|++++|+|+|.++.. .|..|
T Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~-~~~~w 571 (606)
T 3t6q_A 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI-YFLEW 571 (606)
T ss_dssp TTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH-HHHHH
T ss_pred hhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH-HHHHH
Confidence 999999999999999999999999999999999 9999999999988999999999999999999999999852 33444
Q ss_pred c
Q 002892 506 L 506 (870)
Q Consensus 506 ~ 506 (870)
.
T Consensus 572 ~ 572 (606)
T 3t6q_A 572 Y 572 (606)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-56 Score=529.03 Aligned_cols=511 Identities=21% Similarity=0.240 Sum_probs=346.6
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
+||+.+. +++++|+|++|++++..+..|.++++|++|++++|.+++..|..++.+++|++|+|++|++++..+..|++
T Consensus 18 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~ 95 (680)
T 1ziw_A 18 QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95 (680)
T ss_dssp SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhcc
Confidence 4666654 67888888888887666667888888888888888888777777888888888888888887544446788
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccccccccccc--ccccceE
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF--NISTIII 163 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~ 163 (870)
+++|++|+|++|++++..|..|+++++|++|++++|.+++..|..++++++|++|++++|++++..+..+. .+++|++
T Consensus 96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 175 (680)
T 1ziw_A 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175 (680)
T ss_dssp CTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESE
T ss_pred CCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccE
Confidence 88888888888888766667788888888888888888877777777888888888888887766666544 4467777
Q ss_pred EEeecccccccCCCcccC--------------------------CCCccceeeecccccccccCCcccCCCC--ccEEEc
Q 002892 164 INLVGNQLSGHRPSTMGH--------------------------SLPNRQFLLLWANRLTGTIPNSITNASK--LIGLDL 215 (870)
Q Consensus 164 L~l~~N~l~~~~~~~~~~--------------------------~l~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L 215 (870)
|++++|++++..|..+.. ..++|+.|++++|++++..|..|..++. |++|++
T Consensus 176 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~L 255 (680)
T 1ziw_A 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255 (680)
T ss_dssp EECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEEC
T ss_pred EECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEEC
Confidence 888777777666554321 1134455555555555555555555433 555555
Q ss_pred cCCcccCCCccccccccccccccccccccccccCCC-CCc--------------------ccc----cccccccccceEE
Q 002892 216 NSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSN-GEW--------------------SFL----SSLTNCNKLRALS 270 (870)
Q Consensus 216 s~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~--------------------~~~----~~l~~l~~L~~L~ 270 (870)
++|++++..|.+|..+++|++|++++|.++.+.+.. +.. .++ ..+..+++|++|+
T Consensus 256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~ 335 (680)
T 1ziw_A 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335 (680)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEE
T ss_pred CCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEE
Confidence 555555555555555555555555555554432210 000 011 1456677788888
Q ss_pred cCCCCCCCCCCccccccc---------------------------cchhhhhcccccccccCchhhhCccCCcEEEeeCC
Q 002892 271 LGSNPLDSILPPLIGNFS---------------------------ASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTN 323 (870)
Q Consensus 271 L~~N~l~~~~~~~~~~~~---------------------------~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N 323 (870)
+++|++.++.+..|..+. ..++.+++++|++++..|.++..+++|+.|++++|
T Consensus 336 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 415 (680)
T 1ziw_A 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415 (680)
T ss_dssp CCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCC
Confidence 888888777666554432 24566666777777777888888888888888888
Q ss_pred CccccCC-chhhchhhHHHHHhc-CCCCCCCcccccCccccceeecCCcccC--CCCCcccccccccceEecCCCccCCC
Q 002892 324 DLNGTIP-TTLGRLQQLQALLQR-NNLNGPIPTCLSSLISLRQLHLGSNQLT--SSIPSSFWSLEYILRIDLSSNSLSGS 399 (870)
Q Consensus 324 ~l~~~~~-~~~~~l~~L~~L~l~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~ 399 (870)
.+.+.+| ..|..+++|+.|+++ |.+.+..+..|..+++|+.|++++|.++ +..|..|..+++|+.|+|++|++++.
T Consensus 416 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i 495 (680)
T 1ziw_A 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495 (680)
T ss_dssp CCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCC
T ss_pred cCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcC
Confidence 8876555 677888888888777 5555555666677777777777777765 45667777777777777777777766
Q ss_pred CcccccCCccCCEEEccCCccCCccc--------ccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCC
Q 002892 400 LPSDIQNLKVLIYLNLSRNQLSGNIP--------ITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGE 471 (870)
Q Consensus 400 ~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 471 (870)
.|..|.++++|++|+|++|++++..+ ..|.++++|+.|+|++|+++.+.+..|.++++|+.|+|++|+|++.
T Consensus 496 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l 575 (680)
T 1ziw_A 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575 (680)
T ss_dssp CTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcC
Confidence 66667777777777777777765422 2366777777777777777755555677777777777777777765
Q ss_pred CCcchhhccccceeeccCCcccccCCCCC--cccccccccccccccccC
Q 002892 472 IPKSFEILSHLKRLNVSHNRLEGKIPTNG--PFRNFLAQSFLWNYALCG 518 (870)
Q Consensus 472 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~ 518 (870)
.+..|..+++|+.|+|++|++++..|..- .+.......+.+|++.|+
T Consensus 576 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred CHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 56666777777777777777776555311 233444445667777765
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=523.22 Aligned_cols=503 Identities=21% Similarity=0.218 Sum_probs=386.9
Q ss_pred CCccCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCC
Q 002892 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNS 82 (870)
Q Consensus 3 ~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 82 (870)
+++-.|..++++++|++|+|++|++++..|..|.++++|++|++++|.+++..+..|+.+++|++|+|++|++++..|..
T Consensus 37 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 116 (680)
T 1ziw_A 37 LRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116 (680)
T ss_dssp CCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCT
T ss_pred CCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhH
Confidence 34444456899999999999999999888888999999999999999999555557999999999999999998766678
Q ss_pred CCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCccc--CCCCCCeeeccccccccccccccccc--
Q 002892 83 LFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIG--NLKNLADLVLALNNLIGPIPTTIFNI-- 158 (870)
Q Consensus 83 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l-- 158 (870)
|+++++|++|+|++|.+++..|..++.+++|++|++++|.+++..+..+. .+++|++|++++|++++..|..+..+
T Consensus 117 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 196 (680)
T 1ziw_A 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196 (680)
T ss_dssp TTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSE
T ss_pred ccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhh
Confidence 99999999999999999888888888999999999999998866655543 45778888888887776666555443
Q ss_pred -------------------------ccceEEEeecccccccCCCcccCCC--CccceeeecccccccccCCcccCCCCcc
Q 002892 159 -------------------------STIIIINLVGNQLSGHRPSTMGHSL--PNRQFLLLWANRLTGTIPNSITNASKLI 211 (870)
Q Consensus 159 -------------------------~~L~~L~l~~N~l~~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 211 (870)
++|+.|++++|.+++..|..+.. + ++|+.|++++|++++..|..|..+++|+
T Consensus 197 L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~-l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 275 (680)
T 1ziw_A 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG-LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275 (680)
T ss_dssp ECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGG-GGGSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhc-cCcCCCCEEECCCCCcCccCcccccCccccc
Confidence 23344444555554444444332 2 2255555555555554455555555555
Q ss_pred EEEccCCcccCCCccc---------------------------------cccccccccccccccccccccCCC-CCccc-
Q 002892 212 GLDLNSNSLSGQIPNT---------------------------------FGNLRHLSTLNIRANYLTTETSSN-GEWSF- 256 (870)
Q Consensus 212 ~L~Ls~N~i~~~~~~~---------------------------------~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~- 256 (870)
+|++++|++.+..|.. |..+++|++|++++|.++.+.... ....-
T Consensus 276 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 355 (680)
T 1ziw_A 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355 (680)
T ss_dssp EEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTC
T ss_pred EeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCC
Confidence 5555555554444433 333444444455555554433210 00000
Q ss_pred ----------------cccccc--ccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCc-hhhhCccCCcE
Q 002892 257 ----------------LSSLTN--CNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIP-KEIGNLRGLIA 317 (870)
Q Consensus 257 ----------------~~~l~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~-~~l~~l~~L~~ 317 (870)
...+.. .++|+.|++++|++.++.|..+..+ ..|+.|++++|.+.+.+| ..+.++++|++
T Consensus 356 ~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 434 (680)
T 1ziw_A 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL-GHLEVLDLGLNEIGQELTGQEWRGLENIFE 434 (680)
T ss_dssp CEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTC-TTCCEEECCSSCCEEECCSGGGTTCTTCCE
T ss_pred cEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCC-CCCCEEeCCCCcCccccCcccccCcccccE
Confidence 001111 1467777778888888878777765 489999999999998766 78999999999
Q ss_pred EEeeCCCccccCCchhhchhhHHHHHhcCC-CC--CCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCC
Q 002892 318 LSLFTNDLNGTIPTTLGRLQQLQALLQRNN-LN--GPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSN 394 (870)
Q Consensus 318 L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~-~~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 394 (870)
|++++|++.+..+..|..+++|+.|+++++ +. +.+|..+..+++|++|+|++|+++++.+..|.++++|++|+|++|
T Consensus 435 L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N 514 (680)
T 1ziw_A 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514 (680)
T ss_dssp EECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCC
Confidence 999999999999999999999999999844 43 678999999999999999999999988999999999999999999
Q ss_pred ccCCCCc--------ccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCC
Q 002892 395 SLSGSLP--------SDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466 (870)
Q Consensus 395 ~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 466 (870)
++++..+ ..|.++++|+.|+|++|+++.+.+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|
T Consensus 515 ~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp CCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 9986422 23789999999999999999766678999999999999999999888888999999999999999
Q ss_pred cccCCCCcchh-hccccceeeccCCcccccCCCCCccccccc
Q 002892 467 NLSGEIPKSFE-ILSHLKRLNVSHNRLEGKIPTNGPFRNFLA 507 (870)
Q Consensus 467 ~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~ 507 (870)
+|++..|..|. .+++|+.|++++|+|.|.|+...+|..|..
T Consensus 595 ~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~~ 636 (680)
T 1ziw_A 595 LITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWIN 636 (680)
T ss_dssp CCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCSS
T ss_pred cCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHHHH
Confidence 99988888888 899999999999999999986456766654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=509.35 Aligned_cols=488 Identities=20% Similarity=0.196 Sum_probs=432.9
Q ss_pred CCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
-+.++.++.+++ .+|..+.. ++++|++++|.+++..|..|+.+++|++|+|++|+|++..|..|+++++|++|+|++
T Consensus 14 ~~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 90 (606)
T 3t6q_A 14 NKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTA 90 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCC
Confidence 457899999998 68877754 799999999999988899999999999999999999988899999999999999999
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCC
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 176 (870)
|++++..|..|+.+++|++|++++|++++..+..++++++|++|++++|++++.....+..+++|++|++++|++++..+
T Consensus 91 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (606)
T 3t6q_A 91 NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170 (606)
T ss_dssp CCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECH
T ss_pred CcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccCh
Confidence 99998889999999999999999999997778889999999999999999997665666669999999999999997777
Q ss_pred CcccCCCCccc--eeeecccccccccCCcccCC-----------------------------------------------
Q 002892 177 STMGHSLPNRQ--FLLLWANRLTGTIPNSITNA----------------------------------------------- 207 (870)
Q Consensus 177 ~~~~~~l~~L~--~L~L~~n~l~~~~~~~~~~l----------------------------------------------- 207 (870)
..+. .+++|+ .|++++|++++..|..+...
T Consensus 171 ~~~~-~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~ 249 (606)
T 3t6q_A 171 EDMS-SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249 (606)
T ss_dssp HHHH-TTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred hhhh-hhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence 6654 478888 89999999998777665432
Q ss_pred ----CCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcc
Q 002892 208 ----SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPL 283 (870)
Q Consensus 208 ----~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 283 (870)
.+|++|++++|.+++..+..|..+++|++|++++|.++.++ ..+..+++|++|++++|++.++.|..
T Consensus 250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp---------~~l~~l~~L~~L~l~~n~l~~~~~~~ 320 (606)
T 3t6q_A 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELP---------SGLVGLSTLKKLVLSANKFENLCQIS 320 (606)
T ss_dssp GGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCC---------SSCCSCTTCCEEECTTCCCSBGGGGC
T ss_pred hhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCC---------hhhcccccCCEEECccCCcCcCchhh
Confidence 16889999999999888888999999999999999998654 45788999999999999999988878
Q ss_pred ccccccchhhhhcccccccccCch-hhhCccCCcEEEeeCCCccccC--CchhhchhhHHHHHhc-CCCCCCCcccccCc
Q 002892 284 IGNFSASFQQFYAHECKLKGSIPK-EIGNLRGLIALSLFTNDLNGTI--PTTLGRLQQLQALLQR-NNLNGPIPTCLSSL 359 (870)
Q Consensus 284 ~~~~~~~l~~l~l~~n~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~-n~~~~~~p~~~~~l 359 (870)
+..++ .|+.|++++|.+.+.+|. .+..+++|++|++++|.+.+.. +..+..+++|+.|+++ |.+.+..|..+..+
T Consensus 321 ~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 399 (606)
T 3t6q_A 321 ASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399 (606)
T ss_dssp GGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTC
T ss_pred hhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCC
Confidence 87774 899999999999977765 4899999999999999999776 7889999999999998 66777778899999
Q ss_pred cccceeecCCcccCCCCCc-ccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCc---ccccccCCCCCC
Q 002892 360 ISLRQLHLGSNQLTSSIPS-SFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGN---IPITIGGLKDLI 435 (870)
Q Consensus 360 ~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~ 435 (870)
++|++|++++|++++..+. .|..+++|+.|++++|.+++..|..|.++++|++|+|++|++++. .+..+..+++|+
T Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence 9999999999999877665 489999999999999999988899999999999999999999873 336789999999
Q ss_pred EEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCC-Ccccccccccccccc
Q 002892 436 TLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTN-GPFRNFLAQSFLWNY 514 (870)
Q Consensus 436 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~ 514 (870)
.|++++|.+++..|..|..+++|+.|+|++|++++..|..|..++.| .|++++|++++.+|.. ..+.......+.+|+
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 558 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence 99999999999999999999999999999999999999999999999 9999999999877753 234444555678888
Q ss_pred cccCC
Q 002892 515 ALCGP 519 (870)
Q Consensus 515 ~~c~~ 519 (870)
+.|.-
T Consensus 559 ~~c~c 563 (606)
T 3t6q_A 559 LDCTC 563 (606)
T ss_dssp EECSG
T ss_pred ccccC
Confidence 87753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=511.17 Aligned_cols=470 Identities=19% Similarity=0.152 Sum_probs=370.1
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
++|+.+. ++|++|+|++|++++..+..|.++++|++|++++|.+++..|..|+.+++|++|+|++|.+++..|..|++
T Consensus 25 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~ 102 (606)
T 3vq2_A 25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102 (606)
T ss_dssp SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTT
T ss_pred cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCC
Confidence 4676665 78999999999999877778999999999999999999878888999999999999999999777889999
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccce-ecCCcccCCCCCCeeecccccccccccccccccccce--
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG-EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTII-- 162 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~-- 162 (870)
+++|++|+|++|++++..+..|+++++|++|++++|++++ .+|..++++++|++|++++|++++..+..+..+.+|+
T Consensus 103 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~ 182 (606)
T 3vq2_A 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182 (606)
T ss_dssp CTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTC
T ss_pred cccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccc
Confidence 9999999999999986666889999999999999999985 4688999999999999999999988888888877765
Q ss_pred --EEEeecccccccCCCcccCCCCccceeeecccccc-------------------------------------------
Q 002892 163 --IINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLT------------------------------------------- 197 (870)
Q Consensus 163 --~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~------------------------------------------- 197 (870)
+|++++|++++..+..+. ..+|+.|++++|.++
T Consensus 183 l~~L~l~~n~l~~~~~~~~~--~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~ 260 (606)
T 3vq2_A 183 NLSLDMSLNPIDFIQDQAFQ--GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260 (606)
T ss_dssp CCEEECTTCCCCEECTTTTT--TCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGG
T ss_pred cceeeccCCCcceeCccccc--CceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhh
Confidence 799999999876665553 238888888888764
Q ss_pred ---------------cccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccccccccc
Q 002892 198 ---------------GTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTN 262 (870)
Q Consensus 198 ---------------~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~ 262 (870)
+..|. +..+++|++|++++|.+.. +| .+..+++|++|++++|.+..++ .+ .
T Consensus 261 l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~~lp----------~~-~ 326 (606)
T 3vq2_A 261 VTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLKQFP----------TL-D 326 (606)
T ss_dssp SEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCSSCC----------CC-C
T ss_pred ccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccCcccc----------cC-C
Confidence 22233 5566777777777777763 44 6777777777777777775432 23 6
Q ss_pred ccccceEEcCCCCCCCCCCccccccccchhhhhccccccccc--CchhhhCccCCcEEEeeCCCccccCCchhhchhhHH
Q 002892 263 CNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS--IPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQ 340 (870)
Q Consensus 263 l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~--~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 340 (870)
+++|++|++++|+..+.. .+.. ...|+.|++++|.+++. .|..+..+++|+.|++++|.+.+ +|..|..+++|+
T Consensus 327 l~~L~~L~l~~n~~~~~~--~~~~-l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~ 402 (606)
T 3vq2_A 327 LPFLKSLTLTMNKGSISF--KKVA-LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQ 402 (606)
T ss_dssp CSSCCEEEEESCSSCEEC--CCCC-CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCC
T ss_pred CCccceeeccCCcCccch--hhcc-CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCC
Confidence 777777777777443322 2222 24677888888887765 47778888888888888888774 557777888888
Q ss_pred HHHhc-CCCCCCCc-ccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCC-CCcccccCCccCCEEEccC
Q 002892 341 ALLQR-NNLNGPIP-TCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSG-SLPSDIQNLKVLIYLNLSR 417 (870)
Q Consensus 341 ~L~l~-n~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~ 417 (870)
.|+++ |.+.+..| ..+..+++|++|++++|++++..|..|..+++|++|++++|.+++ .+|..|+++++|++|+|++
T Consensus 403 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 482 (606)
T 3vq2_A 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482 (606)
T ss_dssp EEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred eeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence 88777 55555555 567788888888888888887778888888888888888888876 3677788888888888888
Q ss_pred CccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhcc-ccceeeccCCcccccC
Q 002892 418 NQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILS-HLKRLNVSHNRLEGKI 496 (870)
Q Consensus 418 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~ 496 (870)
|++++..|..|+++++|+.|+|++|++++..|..|.++++|+.|+|++|+|+ .+|..+..++ +|+.|++++|+|.|.+
T Consensus 483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCC
Confidence 8888777778888888888888888888777888888888888888888887 6676677776 4888888888888877
Q ss_pred CC
Q 002892 497 PT 498 (870)
Q Consensus 497 p~ 498 (870)
+.
T Consensus 562 ~~ 563 (606)
T 3vq2_A 562 EH 563 (606)
T ss_dssp TT
T ss_pred cc
Confidence 75
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=508.67 Aligned_cols=450 Identities=21% Similarity=0.174 Sum_probs=398.6
Q ss_pred CCccCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCC
Q 002892 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNS 82 (870)
Q Consensus 3 ~~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 82 (870)
+.+-.|..+.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|++++..+..
T Consensus 44 l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 123 (606)
T 3vq2_A 44 LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSC
T ss_pred cCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccc
Confidence 45556678999999999999999999888899999999999999999999888999999999999999999999777788
Q ss_pred CCCCCCCcEEeccCCcccc-ccCcCCCCcCCccEEEeecCccceecCCcccCCCCCC----eeecccccccccccccccc
Q 002892 83 LFNLSSLVRLDSRFNSISG-NIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLA----DLVLALNNLIGPIPTTIFN 157 (870)
Q Consensus 83 ~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~----~L~L~~n~l~~~~~~~~~~ 157 (870)
++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+..++.+++|+ +|++++|++++..+..+..
T Consensus 124 ~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~ 203 (606)
T 3vq2_A 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203 (606)
T ss_dssp CTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTT
T ss_pred cCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccC
Confidence 9999999999999999985 5799999999999999999999988888898887776 7999999998666555554
Q ss_pred cccceEEEeecccccc----------------------------------------------------------cCCCcc
Q 002892 158 ISTIIIINLVGNQLSG----------------------------------------------------------HRPSTM 179 (870)
Q Consensus 158 l~~L~~L~l~~N~l~~----------------------------------------------------------~~~~~~ 179 (870)
. +|+.|++++|.+++ ..|.
T Consensus 204 ~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-- 280 (606)
T 3vq2_A 204 I-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-- 280 (606)
T ss_dssp C-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS--
T ss_pred c-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc--
Confidence 4 89999999997641 1222
Q ss_pred cCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccc
Q 002892 180 GHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSS 259 (870)
Q Consensus 180 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~ 259 (870)
...+++|+.|++++|.++. +| .+..+++|++|++++|++. .+| .+ .+++|+.|++++|..... ..
T Consensus 281 ~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~~L~~L~l~~n~~~~~----------~~ 345 (606)
T 3vq2_A 281 FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLK-QFP-TL-DLPFLKSLTLTMNKGSIS----------FK 345 (606)
T ss_dssp CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCS-SCC-CC-CCSSCCEEEEESCSSCEE----------CC
T ss_pred cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccCc-ccc-cC-CCCccceeeccCCcCccc----------hh
Confidence 3457899999999999984 56 8999999999999999995 677 45 999999999999954431 14
Q ss_pred cccccccceEEcCCCCCCCCC--CccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCC-chhhch
Q 002892 260 LTNCNKLRALSLGSNPLDSIL--PPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP-TTLGRL 336 (870)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~~~--~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l 336 (870)
+..+++|++|++++|++.+.. |..+..+ ..|+.|++++|.+++ +|..+..+++|+.|++++|++.+..| ..|..+
T Consensus 346 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~-~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 423 (606)
T 3vq2_A 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGT-NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423 (606)
T ss_dssp CCCCTTCCEEECCSSCEEEEEECCHHHHCC-SCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTC
T ss_pred hccCCCCCEEECcCCccCCCcchhhhhccC-CcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhcc
Confidence 678999999999999998773 6666655 479999999999986 66889999999999999999998887 789999
Q ss_pred hhHHHHHhc-CCCCCCCcccccCccccceeecCCcccCC-CCCcccccccccceEecCCCccCCCCcccccCCccCCEEE
Q 002892 337 QQLQALLQR-NNLNGPIPTCLSSLISLRQLHLGSNQLTS-SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLN 414 (870)
Q Consensus 337 ~~L~~L~l~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 414 (870)
++|+.|+++ |.+.+..|..+..+++|++|+|++|++++ .+|..|..+++|+.|+|++|++++..|..|.++++|++|+
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence 999999998 77788889999999999999999999997 5899999999999999999999998899999999999999
Q ss_pred ccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCC-CCCeEecCCCcccCCCC
Q 002892 415 LSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLT-SLEYLDLSNNNLSGEIP 473 (870)
Q Consensus 415 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p 473 (870)
|++|++++..|..|+++++|+.|+|++|+++ .+|..+..++ +|+.|++++|.+.+..+
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999999999999999999999999998 5777799997 69999999999986544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=518.08 Aligned_cols=473 Identities=21% Similarity=0.221 Sum_probs=334.6
Q ss_pred CCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccC-CccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcE
Q 002892 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSF-PSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVR 91 (870)
Q Consensus 13 ~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 91 (870)
..++|++|||++|.+++..|..|..+++|++|+|++|...+.+ |..|+.+++|++|+|++|.|++..|..|+++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 3467788888888887777777888888888888888554444 677788888888888888887777778888888888
Q ss_pred EeccCCccccccCcC--CCCcCCccEEEeecCccceecC-CcccCCCCCCeeeccccccccccccccccc--ccceEEEe
Q 002892 92 LDSRFNSISGNIPSK--IGNLTKLVHLNFADNNLRGEIP-NEIGNLKNLADLVLALNNLIGPIPTTIFNI--STIIIINL 166 (870)
Q Consensus 92 L~L~~n~i~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~l 166 (870)
|+|++|.+++.+|.. |+.+++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..+ ++|+.|++
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 888888887655554 7778888888888888876544 467788888888888888877777777766 67777777
Q ss_pred ecccccccCCCcccCC-----CCccceeeecccccccccCCcccC-----------------------------------
Q 002892 167 VGNQLSGHRPSTMGHS-----LPNRQFLLLWANRLTGTIPNSITN----------------------------------- 206 (870)
Q Consensus 167 ~~N~l~~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~~~----------------------------------- 206 (870)
++|.+.+..+..+... ...|+.|++++|++++..+..+..
T Consensus 182 ~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~ 261 (844)
T 3j0a_A 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261 (844)
T ss_dssp CCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTT
T ss_pred CCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhh
Confidence 7777776665544321 113677777777665444433322
Q ss_pred ---CCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcc
Q 002892 207 ---ASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPL 283 (870)
Q Consensus 207 ---l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 283 (870)
.++|++|++++|.+.+..+..|..+++|+.|+|++|.++.+.. ..+..+++|++|++++|++.++.|..
T Consensus 262 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~ 333 (844)
T 3j0a_A 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD--------EAFYGLDNLQVLNLSYNLLGELYSSN 333 (844)
T ss_dssp TTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT--------TTTTTCSSCCEEEEESCCCSCCCSCS
T ss_pred ccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh--------HHhcCCCCCCEEECCCCCCCccCHHH
Confidence 1467777777777776666677777777777777777765432 24666677777777777777666666
Q ss_pred ccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcc---------
Q 002892 284 IGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPT--------- 354 (870)
Q Consensus 284 ~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~--------- 354 (870)
+..++ .|+.|++++|.+.+..+..+..+++|+.|++++|.+++. + .+++|+.|.+++|....+|.
T Consensus 334 ~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ 407 (844)
T 3j0a_A 334 FYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLVTLPKINLTANLIH 407 (844)
T ss_dssp CSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCCCCCCCCTTCCEEE
T ss_pred hcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcccccccccccceee
Confidence 66554 567777777777666666677777777777777776632 1 13444444444332223322
Q ss_pred -------------cccCccccceeecCCcccCCCCCc-ccccccccceEecCCCccC-----CCCcccccCCccCCEEEc
Q 002892 355 -------------CLSSLISLRQLHLGSNQLTSSIPS-SFWSLEYILRIDLSSNSLS-----GSLPSDIQNLKVLIYLNL 415 (870)
Q Consensus 355 -------------~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L 415 (870)
.+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|
T Consensus 408 ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L 487 (844)
T 3j0a_A 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487 (844)
T ss_dssp CCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCC
T ss_pred cccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEEC
Confidence 244678888888888888765443 4566788888888888886 344566888888888888
Q ss_pred cCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCccccc
Q 002892 416 SRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGK 495 (870)
Q Consensus 416 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 495 (870)
++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++..|..| .+|+.|++++|++.|.
T Consensus 488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICE 562 (844)
T ss_dssp CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCS
T ss_pred CCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccc
Confidence 88888888888888888888888888888877776666 788888888888888888765 4788888888888888
Q ss_pred CCCCCccccc
Q 002892 496 IPTNGPFRNF 505 (870)
Q Consensus 496 ~p~~~~~~~~ 505 (870)
|+.. .|..|
T Consensus 563 c~~~-~f~~~ 571 (844)
T 3j0a_A 563 CELS-TFINW 571 (844)
T ss_dssp SSCC-SHHHH
T ss_pred cccH-HHHHH
Confidence 8742 34444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=478.37 Aligned_cols=481 Identities=20% Similarity=0.195 Sum_probs=411.9
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
+||+.+. +++++|||++|++++..+..|.++++|++|++++|++++..|..|+.+++|++|+|++|++++..|..|.+
T Consensus 21 ~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (570)
T 2z63_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (570)
T ss_dssp SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence 4676554 57999999999999888889999999999999999999888889999999999999999999877889999
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccce-ecCCcccCCCCCCeeecccccccccccccccccccc---
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG-EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTI--- 161 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--- 161 (870)
+++|++|++++|++++..+..|+.+++|++|++++|.+++ .+|..++++++|++|++++|++++..+..+..+.+|
T Consensus 99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~ 178 (570)
T 2z63_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (570)
T ss_dssp CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTC
T ss_pred ccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchh
Confidence 9999999999999996555579999999999999999996 368999999999999999999998888999999998
Q ss_pred -eEEEeecccccccCCCcccCCCCccceeeecccccc-------------------------------cccCCcccCCC-
Q 002892 162 -IIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLT-------------------------------GTIPNSITNAS- 208 (870)
Q Consensus 162 -~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~-------------------------------~~~~~~~~~l~- 208 (870)
+.|++++|.+++..+..+.. .+|+.|++++|... ......+..+.
T Consensus 179 ~~~L~l~~n~l~~~~~~~~~~--~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~ 256 (570)
T 2z63_A 179 NLSLDLSLNPMNFIQPGAFKE--IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256 (570)
T ss_dssp CCEEECTTCCCCEECTTTTTT--CEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGG
T ss_pred hhhcccCCCCceecCHHHhcc--CcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccc
Confidence 89999999999888877653 38999999987422 11112222222
Q ss_pred -CccEEEccCC-cccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccc
Q 002892 209 -KLIGLDLNSN-SLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGN 286 (870)
Q Consensus 209 -~L~~L~Ls~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 286 (870)
.++.+++++| .+.+..+..|..+++|+.|++++|.++.++ ..+..+ +|++|++++|.+..+...
T Consensus 257 l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~---------~~~~~~-~L~~L~l~~n~~~~l~~~---- 322 (570)
T 2z63_A 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK---------DFSYNF-GWQHLELVNCKFGQFPTL---- 322 (570)
T ss_dssp SEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCC---------BCCSCC-CCSEEEEESCBCSSCCBC----
T ss_pred cchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhh---------hhhccC-CccEEeeccCcccccCcc----
Confidence 3567777777 677788888999999999999999888644 345666 899999999998855432
Q ss_pred cccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccC--CchhhchhhHHHHHhcCCCCCCCcccccCccccce
Q 002892 287 FSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTI--PTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQ 364 (870)
Q Consensus 287 ~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~ 364 (870)
....++.+++.+|.+.+..+. ..+++|+.|++++|++.+.. +..+..+++|+.|++++|....++..+..+++|++
T Consensus 323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~ 400 (570)
T 2z63_A 323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEH 400 (570)
T ss_dssp BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCE
T ss_pred cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCE
Confidence 234788889999988876665 78899999999999998654 77888999999999996655556666999999999
Q ss_pred eecCCcccCCCCC-cccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccC-CcccccccCCCCCCEEEcCCC
Q 002892 365 LHLGSNQLTSSIP-SSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS-GNIPITIGGLKDLITLSLARN 442 (870)
Q Consensus 365 L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N 442 (870)
|++++|++++..+ ..|..+++|+.|++++|.+.+..|..|.++++|++|+|++|+++ +.+|..|..+++|+.|++++|
T Consensus 401 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n 480 (570)
T 2z63_A 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480 (570)
T ss_dssp EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence 9999999997766 57899999999999999999999999999999999999999998 578999999999999999999
Q ss_pred cccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccc
Q 002892 443 RFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFL 506 (870)
Q Consensus 443 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~ 506 (870)
++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|+++|.+|....+..|.
T Consensus 481 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl 544 (570)
T 2z63_A 481 QLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 544 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHH
T ss_pred ccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHH
Confidence 9999889999999999999999999998888889999999999999999999999754443553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=439.27 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=216.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||++++++.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 356888899999999999999863 47789999998776677788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceE
Q 002892 658 LVLEFMPNGSLEKWLYSHN------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR 725 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 725 (870)
+||||+++|+|.++++..+ ..++|.++..|+.||++||+||| +++|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 46999999999999999999999 56699999999999999999999
Q ss_pred EeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHh
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 804 (870)
|+|||+|+...............||++|||||++.++.++.++|||||||++|||+| |+.||.+.... .+...+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~ 246 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQG 246 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence 999999987654443334444568999999999999999999999999999999999 89999764221 111111110
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
. . ...+..|+.++.+++.+||+.||++|||++||.+.|+++.+.
T Consensus 247 ~---------------~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 R---------------V--LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp C---------------C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C---------------C--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0 0 001124566899999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=434.54 Aligned_cols=265 Identities=25% Similarity=0.428 Sum_probs=209.0
Q ss_pred HhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
...+++++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 34578888999999999999999865 36999998643 24556789999999999999999999998764 568999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
||||++|+|.++++..+..+++.++..|+.|||+||+||| +++||||||||+|||+++++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999999877777999999999999999999999 5669999999999999999999999999998765444
Q ss_pred CcccccccccccccCCcccccC---CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 740 DSVTQTMTMATIGYMAPEYASD---GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.........||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+.... ..+...+...... +.
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~~~~~~~~-------p~ 258 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMVGRGYAS-------PD 258 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHTTCCC-------CC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcCCCC-------CC
Confidence 4444455689999999999864 46899999999999999999999999763222 1122211111100 00
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
....+.+|+..+.+++.+||+.+|++|||++||++.|+.++..+
T Consensus 259 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 ------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 00011235667999999999999999999999999999887643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=496.59 Aligned_cols=478 Identities=21% Similarity=0.209 Sum_probs=391.0
Q ss_pred CeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCC-CCCCCCCCCCcEEeccC
Q 002892 18 MYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPI-PNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~ 96 (870)
+..|.++++++ .+|. -.++|++|+|++|.+++..|..|..+++|++|+|++|.+.+.+ |..|.++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 46889999999 5776 4679999999999999888999999999999999999655455 78899999999999999
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCc--ccCCCCCCeeeccccccccccc-ccccccccceEEEeecccccc
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNE--IGNLKNLADLVLALNNLIGPIP-TTIFNISTIIIINLVGNQLSG 173 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~ 173 (870)
|++++..|..|+++++|++|+|++|.+++..|.. +.++++|++|+|++|.+++..+ ..+.++++|++|+|++|.+++
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 9999888999999999999999999999766655 9999999999999999987655 679999999999999999998
Q ss_pred cCCCcccCCC--CccceeeecccccccccCCcccCCCC------ccEEEccCCcccCCCccccccc--------------
Q 002892 174 HRPSTMGHSL--PNRQFLLLWANRLTGTIPNSITNASK------LIGLDLNSNSLSGQIPNTFGNL-------------- 231 (870)
Q Consensus 174 ~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L~~L~Ls~N~i~~~~~~~~~~l-------------- 231 (870)
..+..+.. + ++|+.|++++|.+++..|..+..+.+ |++|++++|.+++..+..+...
T Consensus 163 ~~~~~l~~-l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~ 241 (844)
T 3j0a_A 163 VCEHELEP-LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241 (844)
T ss_dssp CCSGGGHH-HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred eCHHHccc-ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence 88777653 3 78999999999999988888777766 9999999998877666555432
Q ss_pred ------------------------cccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcccccc
Q 002892 232 ------------------------RHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287 (870)
Q Consensus 232 ------------------------~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 287 (870)
++|+.|+|++|.+..+. +..+..+++|+.|+|++|++.++.|..|..+
T Consensus 242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~--------~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 313 (844)
T 3j0a_A 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN--------SRVFETLKDLKVLNLAYNKINKIADEAFYGL 313 (844)
T ss_dssp CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEEC--------SCCSSSCCCCCEEEEESCCCCEECTTTTTTC
T ss_pred cccccccccccCCCChhhhhccccCCccEEECCCCcccccC--------hhhhhcCCCCCEEECCCCcCCCCChHHhcCC
Confidence 56788888888877654 2357778888888888888888777777666
Q ss_pred ccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeec
Q 002892 288 SASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHL 367 (870)
Q Consensus 288 ~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~L 367 (870)
. .|+.|++++|.+++..|..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|....++. +++|+.|++
T Consensus 314 ~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~----~~~L~~L~l 388 (844)
T 3j0a_A 314 D-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF----IPSIPDIFL 388 (844)
T ss_dssp S-SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS----CCSCSEEEE
T ss_pred C-CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC----CCCcchhcc
Confidence 4 78888888888887778888888888888888888887777778888888888888554443332 455666666
Q ss_pred CCcccCCCCCc----------------------ccccccccceEecCCCccCCCCcc-cccCCccCCEEEccCCccC---
Q 002892 368 GSNQLTSSIPS----------------------SFWSLEYILRIDLSSNSLSGSLPS-DIQNLKVLIYLNLSRNQLS--- 421 (870)
Q Consensus 368 s~N~l~~~~~~----------------------~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~--- 421 (870)
++|+++.. |. .+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++
T Consensus 389 ~~N~l~~l-~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 467 (844)
T 3j0a_A 389 SGNKLVTL-PKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467 (844)
T ss_dssp ESCCCCCC-CCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSC
T ss_pred CCCCcccc-cccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccc
Confidence 66655522 22 134678888888888888864433 4566788999999999887
Q ss_pred --CcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCC
Q 002892 422 --GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTN 499 (870)
Q Consensus 422 --~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 499 (870)
+..+..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|++++.+|..
T Consensus 468 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~ 545 (844)
T 3j0a_A 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV 545 (844)
T ss_dssp CSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC
T ss_pred ccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH
Confidence 44456788999999999999999999999999999999999999999977777766 89999999999999988863
Q ss_pred CcccccccccccccccccC
Q 002892 500 GPFRNFLAQSFLWNYALCG 518 (870)
Q Consensus 500 ~~~~~~~~~~~~~n~~~c~ 518 (870)
+.......+.+|++.|+
T Consensus 546 --~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 546 --FVSLSVLDITHNKFICE 562 (844)
T ss_dssp --CSSCCEEEEEEECCCCS
T ss_pred --hCCcCEEEecCCCcccc
Confidence 55555667788998884
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=439.91 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=208.2
Q ss_pred cCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999864 478899999987777777889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCce
Q 002892 659 VLEFMPNGSLEKWLYSHN--------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA 724 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 724 (870)
||||+++|+|.++++..+ ..++|.+++.|+.||++||+||| +++|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 999999999999998532 35899999999999999999999 5669999999999999999999
Q ss_pred EEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHH
Q 002892 725 RVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKL 803 (870)
Q Consensus 725 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 803 (870)
||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... .+...+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~ 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQ 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc
Confidence 9999999987754444444455679999999999999999999999999999999999 89999763221 11111111
Q ss_pred hcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 804 SLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
.. +...+..|+.++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 276 g~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 GR-----------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TC-----------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC-----------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 00 0001123566799999999999999999999999999998764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=472.75 Aligned_cols=486 Identities=19% Similarity=0.186 Sum_probs=406.0
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
+||+.+. ++|++|||++|++++..|..|..+++|++|++++|++++..|..|+.+++|++|+|++|++++..|..+++
T Consensus 19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 96 (549)
T 2z81_A 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96 (549)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTT
T ss_pred cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhcc
Confidence 6787765 79999999999999888899999999999999999999888899999999999999999999766667999
Q ss_pred CCCCcEEeccCCcccc-ccCcCCCCcCCccEEEeecCc-cceecCCcccCCCCCCeeecccccccccccccccccccceE
Q 002892 86 LSSLVRLDSRFNSISG-NIPSKIGNLTKLVHLNFADNN-LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIII 163 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 163 (870)
+++|++|+|++|++++ ..|..++.+++|++|++++|. +....+..+.++++|++|++++|++++..|..+..+++|++
T Consensus 97 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 176 (549)
T 2z81_A 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176 (549)
T ss_dssp CTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred CCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCce
Confidence 9999999999999986 356789999999999999999 55444578999999999999999999999999999999999
Q ss_pred EEeecccccccCCCcccCCCCccceeeeccccccccc---CCcccCCCCccEEEccCCcccCCCccc----ccccccccc
Q 002892 164 INLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTI---PNSITNASKLIGLDLNSNSLSGQIPNT----FGNLRHLST 236 (870)
Q Consensus 164 L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L~Ls~N~i~~~~~~~----~~~l~~L~~ 236 (870)
|++++|.+. ..|..+...+++|++|++++|++++.. ......+++|+.|++++|.+++..+.. +..+++|+.
T Consensus 177 L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~ 255 (549)
T 2z81_A 177 LTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255 (549)
T ss_dssp EEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCE
T ss_pred EecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccc
Confidence 999999986 344455456899999999999999742 223456789999999999998655443 466789999
Q ss_pred ccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCC----ccccccccchhhhhcccccccccCchhh-hC
Q 002892 237 LNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILP----PLIGNFSASFQQFYAHECKLKGSIPKEI-GN 311 (870)
Q Consensus 237 L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~~~~~l~~l~l~~n~l~~~~~~~l-~~ 311 (870)
|++++|.+..+..... .....+..+.+|+.|+++++.+..... +.+......++.+.+++|.+. .+|..+ ..
T Consensus 256 l~l~~~~~~~~~~~~~--~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~ 332 (549)
T 2z81_A 256 VEFDDCTLNGLGDFNP--SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQH 332 (549)
T ss_dssp EEEESCEEECCSCCCC--CTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHH
T ss_pred cccccccccccccccc--cchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhc
Confidence 9999999887542110 112346778899999999998765310 111223357889999999987 677766 57
Q ss_pred ccCCcEEEeeCCCccccCCc---hhhchhhHHHHHhcCCCCCCCc---ccccCccccceeecCCcccCCCCCcccccccc
Q 002892 312 LRGLIALSLFTNDLNGTIPT---TLGRLQQLQALLQRNNLNGPIP---TCLSSLISLRQLHLGSNQLTSSIPSSFWSLEY 385 (870)
Q Consensus 312 l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~l~n~~~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 385 (870)
+++|+.|++++|++.+.+|. .++.+++|+.|++++|....++ ..+..+++|++|+|++|+++ .+|..+..+++
T Consensus 333 l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~ 411 (549)
T 2z81_A 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411 (549)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTT
T ss_pred CccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhccccc
Confidence 99999999999999987643 4788899999999955555544 45889999999999999999 67888999999
Q ss_pred cceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCC
Q 002892 386 ILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSN 465 (870)
Q Consensus 386 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 465 (870)
|++|++++|+++ .+|..+. ++|++|+|++|+|++.+ ..+++|+.|+|++|+++ .+|. ...+++|+.|+|++
T Consensus 412 L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~ 482 (549)
T 2z81_A 412 MRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISR 482 (549)
T ss_dssp CCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCS
T ss_pred ccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCC
Confidence 999999999998 4555442 68999999999999743 57899999999999998 5665 57899999999999
Q ss_pred CcccCCCCcchhhccccceeeccCCcccccCCCCCccccccc
Q 002892 466 NNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLA 507 (870)
Q Consensus 466 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~ 507 (870)
|+|++.+|..|..+++|+.|++++|+|+|.+|....+..|..
T Consensus 483 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l~~~l~ 524 (549)
T 2z81_A 483 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 524 (549)
T ss_dssp SCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHHHHHHH
T ss_pred CccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHHHHHHH
Confidence 999998899999999999999999999999996555555543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=434.49 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=211.6
Q ss_pred cCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++++.+.||+|+||+||+|++. +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667889999999999999863 46789999997543 334578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC
Q 002892 658 LVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 722 (870)
+|||||++|+|.+++... ...++|..+..|+.|||+||+||| +++||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 999999999999999743 235899999999999999999999 56699999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHH
Q 002892 723 TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWI 801 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~ 801 (870)
.+||+|||+|+.....+.....+...||++|||||++.++.++.++|||||||++|||+| |+.||.+... ..+...+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~i 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEMI 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence 999999999987644443344455679999999999999999999999999999999998 8999976322 1111111
Q ss_pred HHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 802 KLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
... .....+.+|+..+.+++.+||+.||++|||++||++.|+++.
T Consensus 261 ~~~-----------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 261 RNR-----------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HcC-----------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 100 001112346678999999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=423.35 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=208.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.+.|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356889999999999999999965 7999999999876555556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
|+||+|.+++...+ +++.++..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||+|+.+.... .
T Consensus 153 ~~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 225 (346)
T 4fih_A 153 LEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 225 (346)
T ss_dssp CTTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--C
Confidence 99999999997643 899999999999999999999 6669999999999999999999999999998774332 2
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ......+....+....
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~~~------------ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPRLK------------ 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCCCS------------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCCCCC------------
Confidence 23456799999999999999999999999999999999999999975211 1111111111111100
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....++..+.+++.+||+.||++|||+.|+++
T Consensus 292 ---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 ---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01123456889999999999999999999976
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=420.84 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=201.9
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999964 79999999997653 3456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+||+|.+++... +..+++.++..++.||+.||+||| ++||+||||||+|||++++|.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 99999999999854 445799999999999999999999 667999999999999999999999999999866321
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ...+..+.....+..
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~~~------------ 245 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNLVLKIISGSFPPV------------ 245 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCCCCC------------
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcCCCCCC------------
Confidence 1223445799999999999999999999999999999999999999976311 111112111111110
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+..++..+.+++.+||+.||++|||+.|+++
T Consensus 246 ------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 ------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0123456889999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=419.52 Aligned_cols=256 Identities=20% Similarity=0.239 Sum_probs=207.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.+.|+..++||+|+||+||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+.+..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356778889999999999999965 699999999976532 24699999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~ 741 (870)
++||+|.++++..+. +++.++..++.||+.||+||| +++|+||||||+|||++.+| .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999986554 999999999999999999999 77799999999999999987 6999999999877543222
Q ss_pred c---cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 742 V---TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 742 ~---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+. ...+.... ....
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~--~~~~-------- 276 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP--PPIR-------- 276 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC--CGGG--------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC--CCch--------
Confidence 1 22345799999999999999999999999999999999999999976433221 22211110 0000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++..+.+++.+||+.||++|||+.|+++.+.+..+.
T Consensus 277 ------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 ------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp ------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 00113455788999999999999999999999999887654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=420.14 Aligned_cols=270 Identities=22% Similarity=0.331 Sum_probs=206.0
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----eeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD----FKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 660 (870)
++|.+.+.||+|+||+||+|++ +|+.||||+++...... ..++.|+..+.+++|||||++++++.+.+ ..|+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577788999999999999997 58999999997654332 33456777778899999999999997654 579999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS-----HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
||+++|+|.++++..+ ++|..+.+++.|+++||+|||+. +.++|+||||||+|||+++++.+||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999998654 89999999999999999999954 2348999999999999999999999999999876
Q ss_pred CCCCCcc--cccccccccccCCcccccCC------CcCcccchHhHHHHHHHHHhCCCCCCccccccc----------hH
Q 002892 736 GEDDDSV--TQTMTMATIGYMAPEYASDG------IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM----------SL 797 (870)
Q Consensus 736 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslG~il~elltg~~p~~~~~~~~~----------~~ 797 (870)
....... ......||+.|||||++.+. .++.++|||||||++|||+||+.||........ ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 4433221 22345799999999998764 467899999999999999999887654222111 11
Q ss_pred HHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 798 KHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..+... +.+..............+++..+.+++.+||+.||++||||.||++.|+++.+.-
T Consensus 239 ~~~~~~--------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 239 EEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHH--------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHH--------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 111111 1111111112223333456778999999999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=414.07 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=208.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999964 79999999997653 334577899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||++||+|.+++.+.+. +++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999986554 899999999999999999999 66799999999999999999999999999998755444
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+....+. +
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~--~----------- 253 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAKIIKLEYD--F----------- 253 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCC--C-----------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC--C-----------
Confidence 4445567899999999999999999999999999999999999999975211 1111111111110 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 856 (870)
. ...+.++.+++.+|++.||++|||+.|+.
T Consensus 254 -p-----~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -P-----EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -C-----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -C-----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 0 01234688999999999999999999864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=472.31 Aligned_cols=439 Identities=21% Similarity=0.267 Sum_probs=271.0
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCccc------c------cCCccccCCCCCCEEEcCCCccccCCCCC
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLT------G------SFPSWIGVFSKLQVLSLRNNSFTGPIPNS 82 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~------~------~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 82 (870)
.+++.|+|++|++.+.+|.+++.+++|++|+|++|.+. + .+|... +..|+ +++++|.+.+..|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 46778888888888888888888888888888888652 1 112111 12223 333333333222222
Q ss_pred CCC-------------------CCCCcEEecc--CCccccccCcCCCCcCCccEEEeecCcccee---------------
Q 002892 83 LFN-------------------LSSLVRLDSR--FNSISGNIPSKIGNLTKLVHLNFADNNLRGE--------------- 126 (870)
Q Consensus 83 ~~~-------------------l~~L~~L~L~--~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~--------------- 126 (870)
+.. ...++.+.+. +|++++ +|..|+++++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~ 236 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ 236 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHH
T ss_pred HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhc
Confidence 221 0011111111 345554 455555555555555555555542
Q ss_pred --cCCccc--CCCCCCeeecccccccccccccccccccceEEEeeccc-ccc-cCCCcccC-----CCCccceeeecccc
Q 002892 127 --IPNEIG--NLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQ-LSG-HRPSTMGH-----SLPNRQFLLLWANR 195 (870)
Q Consensus 127 --~~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~-~~~~~~~~-----~l~~L~~L~L~~n~ 195 (870)
+|..++ ++++|++|+|++|++.+.+|..+.++++|++|++++|+ +++ .+|..++. .+++|++|++++|+
T Consensus 237 ~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~ 316 (636)
T 4eco_A 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316 (636)
T ss_dssp HHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred ccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence 455555 55555555555555555555555555555555555554 444 44443322 12455555555555
Q ss_pred cccccCC--cccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccc-cceEEcC
Q 002892 196 LTGTIPN--SITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNK-LRALSLG 272 (870)
Q Consensus 196 l~~~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~-L~~L~L~ 272 (870)
++ .+|. .+.++++|++|++++|++++.+| .|+.+++|++|++++|.++.++ ..+..+++ |++|+++
T Consensus 317 l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp---------~~l~~l~~~L~~L~Ls 385 (636)
T 4eco_A 317 LK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP---------ANFCGFTEQVENLSFA 385 (636)
T ss_dssp CS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECC---------TTSEEECTTCCEEECC
T ss_pred CC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCcccccc---------HhhhhhcccCcEEEcc
Confidence 55 4555 55555555555555555554455 5555555555555555555322 23455555 5555555
Q ss_pred CCCCCCCCCccccccc-cchhhhhcccccccccCchhhh-------CccCCcEEEeeCCCccccCCchhhchhhHHHHHh
Q 002892 273 SNPLDSILPPLIGNFS-ASFQQFYAHECKLKGSIPKEIG-------NLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQ 344 (870)
Q Consensus 273 ~N~l~~~~~~~~~~~~-~~l~~l~l~~n~l~~~~~~~l~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 344 (870)
+|++.. .|..+.... ..++.|++++|.+++.+|..+. .+++|+.|++++|++.. +|.
T Consensus 386 ~N~l~~-lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~-lp~------------- 450 (636)
T 4eco_A 386 HNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FPK------------- 450 (636)
T ss_dssp SSCCSS-CCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCS-CCT-------------
T ss_pred CCcCcc-cchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCc-CCH-------------
Confidence 555552 233322221 1333444444444444444444 56677777777777763 332
Q ss_pred cCCCCCCCcccccCccccceeecCCcccCCCCCccccccc-------ccceEecCCCccCCCCccccc--CCccCCEEEc
Q 002892 345 RNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLE-------YILRIDLSSNSLSGSLPSDIQ--NLKVLIYLNL 415 (870)
Q Consensus 345 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L 415 (870)
..+..+++|++|+|++|+++.+.+..+.... +|+.|+|++|+++ .+|..+. .+++|+.|+|
T Consensus 451 ---------~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~L 520 (636)
T 4eco_A 451 ---------ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDL 520 (636)
T ss_dssp ---------HHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEEC
T ss_pred ---------HHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEEC
Confidence 2244567899999999999955445555443 8999999999999 6788886 8999999999
Q ss_pred cCCccCCcccccccCCCCCCEEEc------CCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccC
Q 002892 416 SRNQLSGNIPITIGGLKDLITLSL------ARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSH 489 (870)
Q Consensus 416 s~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 489 (870)
++|+|++ +|..+.++++|+.|+| ++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++|+.|+|++
T Consensus 521 s~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~ 596 (636)
T 4eco_A 521 SYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKD 596 (636)
T ss_dssp CSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCS
T ss_pred CCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcC
Confidence 9999997 8889999999999999 56888889999999999999999999999 48888766 8999999999
Q ss_pred CcccccCC
Q 002892 490 NRLEGKIP 497 (870)
Q Consensus 490 N~l~~~~p 497 (870)
|++.+.-+
T Consensus 597 N~l~~~~~ 604 (636)
T 4eco_A 597 NPNISIDL 604 (636)
T ss_dssp CTTCEEEC
T ss_pred CCCccccH
Confidence 99876443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=423.60 Aligned_cols=267 Identities=25% Similarity=0.403 Sum_probs=217.9
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEecC------CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCC-CceeEEeee
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLFD------GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRH-RNLIKIFSS 649 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~~~ 649 (870)
.+.+...++|++.+.||+|+||+||+|++.. ++.||||+++... ....+.+.+|++++++++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3345566889999999999999999998542 3579999997654 3445779999999999965 899999999
Q ss_pred eeeC-CeeEEEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCC
Q 002892 650 CCNL-DFKALVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKP 713 (870)
Q Consensus 650 ~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~ 713 (870)
|.+. +..++|||||++|+|.++++.. +..+++..+..++.|||+||+||| +++||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence 8764 5689999999999999999853 234899999999999999999999 66699999999
Q ss_pred CceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCcccc
Q 002892 714 NNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFT 792 (870)
Q Consensus 714 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~ 792 (870)
+|||+++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755554445556679999999999999999999999999999999998 8999976432
Q ss_pred ccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 793 GEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
.+ .+...+...... ..+..++.++.+++.+||+.||++|||++||++.|+++.+.
T Consensus 294 ~~-~~~~~i~~g~~~-----------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 294 DE-EFCRRLKEGTRM-----------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SH-HHHHHHHHTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-HHHHHHHcCCCC-----------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 22 122211111100 01113456789999999999999999999999999998775
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=453.14 Aligned_cols=463 Identities=20% Similarity=0.222 Sum_probs=281.0
Q ss_pred CCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCC
Q 002892 7 VPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNL 86 (870)
Q Consensus 7 ~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 86 (870)
||+.+. ++|++|+|++|++++..|..|..+++|++|++++|++++..|..|+.+++|++|+|++|+|+ .+|.. .+
T Consensus 15 ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l 89 (520)
T 2z7x_B 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PT 89 (520)
T ss_dssp CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CC
T ss_pred cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--cc
Confidence 444443 45555555555555444445555555555555555555444555555555555555555555 33333 45
Q ss_pred CCCcEEeccCCcccc-ccCcCCCCcCCccEEEeecCccceecCCcccCCCCC--Ceeecccccc--cccccccccccc-c
Q 002892 87 SSLVRLDSRFNSISG-NIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNL--ADLVLALNNL--IGPIPTTIFNIS-T 160 (870)
Q Consensus 87 ~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~ 160 (870)
++|++|+|++|++++ .+|..|+.+++|++|++++|++++ ..+..+++| ++|++++|++ .+..|..+..+. +
T Consensus 90 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~ 166 (520)
T 2z7x_B 90 VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166 (520)
T ss_dssp CCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEE
T ss_pred CCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccc
Confidence 555555555555543 234455555555555555555543 233444444 5555555555 444444444443 2
Q ss_pred ceEEEeecccccccCCCcccCCCCccceeeecccc-------cccccCCcccCCCCccEEEccCCcccCCCccccc---c
Q 002892 161 IIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANR-------LTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFG---N 230 (870)
Q Consensus 161 L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~---~ 230 (870)
...+++++|++.+..+......+++|+.|++++|. +.+.++ .+..+++|+.|++++|.+++..+..+. .
T Consensus 167 ~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~ 245 (520)
T 2z7x_B 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVW 245 (520)
T ss_dssp EEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHH
T ss_pred eEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhh
Confidence 33444455555444444444445555555555554 443333 444555555555555544432211111 1
Q ss_pred ccccccccccccccccccCCCCCccccccc-----ccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccC
Q 002892 231 LRHLSTLNIRANYLTTETSSNGEWSFLSSL-----TNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSI 305 (870)
Q Consensus 231 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~ 305 (870)
.++|++|++++|.++... +..+ ..+++|+.+++++|.+ .+
T Consensus 246 ~~~L~~L~l~~n~l~~~~--------p~~~~~~~~~~l~~L~~l~l~~n~~---------------------------~~ 290 (520)
T 2z7x_B 246 HTTVWYFSISNVKLQGQL--------DFRDFDYSGTSLKALSIHQVVSDVF---------------------------GF 290 (520)
T ss_dssp TSSCSEEEEEEEEEESCC--------CCCCCCCCSCCCCEEEEEEEEECCC---------------------------CS
T ss_pred hCcccEEEeecccccCcc--------ccchhhcccccCceeEeccccccce---------------------------ec
Confidence 234555555555544211 1112 4445555555555544 23
Q ss_pred c-hhhhCc---cCCcEEEeeCCCccccCCchhhchhhHHHHHhc-CCCCCCCcccccCccccceeecCCcccCC--CCCc
Q 002892 306 P-KEIGNL---RGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR-NNLNGPIPTCLSSLISLRQLHLGSNQLTS--SIPS 378 (870)
Q Consensus 306 ~-~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~ 378 (870)
| ..+..+ .+|+.|++++|.+.... .+..+++|+.|+++ |.+.+.+|..+..+++|++|+|++|++++ ..|.
T Consensus 291 p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~ 368 (520)
T 2z7x_B 291 PQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368 (520)
T ss_dssp CTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHH
T ss_pred chhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchH
Confidence 3 333333 45666777776665322 12455666666666 55555677788889999999999999996 4567
Q ss_pred ccccccccceEecCCCccCCCCcc-cccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCC
Q 002892 379 SFWSLEYILRIDLSSNSLSGSLPS-DIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTS 457 (870)
Q Consensus 379 ~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 457 (870)
.|..+++|+.|++++|.+++.+|. .+..+++|++|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++
T Consensus 369 ~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~ 445 (520)
T 2z7x_B 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEA 445 (520)
T ss_dssp HHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTT
T ss_pred HHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCC
Confidence 899999999999999999985665 488999999999999999988887765 79999999999998 67887889999
Q ss_pred CCeEecCCCcccCCCCcc-hhhccccceeeccCCcccccCCCCCcc-cccccccc--cccccccCCC
Q 002892 458 LEYLDLSNNNLSGEIPKS-FEILSHLKRLNVSHNRLEGKIPTNGPF-RNFLAQSF--LWNYALCGPP 520 (870)
Q Consensus 458 L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~-~~~~~~~~--~~n~~~c~~~ 520 (870)
|+.|+|++|+|+ .+|.. |..+++|+.|++++|+++|.|+.. ++ ..|..... ......|..|
T Consensus 446 L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~-~~~~~~~~~~~~~~~~~~~C~~p 510 (520)
T 2z7x_B 446 LQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI-DYLSRWLNKNSQKEQGSAKCSGS 510 (520)
T ss_dssp CCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHHH-HHHHHHHHHTTTTEESCCBBTTT
T ss_pred CCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCch-HHHHHHHHhccccCCCCCCcCCc
Confidence 999999999999 56655 999999999999999999998853 33 44443211 2234567665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=450.38 Aligned_cols=483 Identities=24% Similarity=0.261 Sum_probs=405.3
Q ss_pred CCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc
Q 002892 16 FLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR 95 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 95 (870)
..+.++.++.+++ .+|..+. ++++.|++++|.+++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 8 ~~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 84 (570)
T 2z63_A 8 PNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84 (570)
T ss_dssp TTTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCc
Confidence 3567888888998 5787653 589999999999998888899999999999999999998778889999999999999
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccc-cccccccccccceEEEeeccccccc
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIG-PIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
+|++++..|..|+.+++|++|++++|++++..+..++++++|++|++++|.+++ .+|..+.++++|++|++++|++++.
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~ 164 (570)
T 2z63_A 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (570)
T ss_dssp TCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred CCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence 999997778899999999999999999997666689999999999999999987 4699999999999999999999987
Q ss_pred CCCcccCCCCcc----ceeeecccccccccCCcccCCCCccEEEccCCcccC-CCcccccccccc---------------
Q 002892 175 RPSTMGHSLPNR----QFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG-QIPNTFGNLRHL--------------- 234 (870)
Q Consensus 175 ~~~~~~~~l~~L----~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L--------------- 234 (870)
.+..+. .+.+| +.|++++|.+++..+..+... +|++|++++|.... ..+..+.+++++
T Consensus 165 ~~~~~~-~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~ 242 (570)
T 2z63_A 165 YCTDLR-VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242 (570)
T ss_dssp CGGGGH-HHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS
T ss_pred cHHHcc-chhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchh
Confidence 766554 35666 789999999998888888766 89999999984321 122223333333
Q ss_pred -----------------cccccccc-ccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhc
Q 002892 235 -----------------STLNIRAN-YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYA 296 (870)
Q Consensus 235 -----------------~~L~L~~N-~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l 296 (870)
+.+++++| .+... .+..+..+++|++|++++|.+.. .|+.+... .++.|++
T Consensus 243 l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~--------~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~--~L~~L~l 311 (570)
T 2z63_A 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDD--------IIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF--GWQHLEL 311 (570)
T ss_dssp CEECCTTTTGGGGGSEEEEEEEEETTEEESC--------STTTTGGGTTCSEEEEESCEECS-CCBCCSCC--CCSEEEE
T ss_pred hhhcchhhhccccccchhhhhhhcchhhhhh--------chhhhcCcCcccEEEecCccchh-hhhhhccC--CccEEee
Confidence 33344443 22221 24567889999999999999986 56666665 8999999
Q ss_pred ccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCC-CCCCC--cccccCccccceeecCCcccC
Q 002892 297 HECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNN-LNGPI--PTCLSSLISLRQLHLGSNQLT 373 (870)
Q Consensus 297 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~-~~~~~--p~~~~~l~~L~~L~Ls~N~l~ 373 (870)
++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|+.|++++| +.+.. |..+..+++|++|++++|+++
T Consensus 312 ~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~ 386 (570)
T 2z63_A 312 VNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386 (570)
T ss_dssp ESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE
T ss_pred ccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccc
Confidence 999998 5555 5789999999999999876665 78899999999954 44333 678899999999999999999
Q ss_pred CCCCcccccccccceEecCCCccCCCCc-ccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCccc-Cccccc
Q 002892 374 SSIPSSFWSLEYILRIDLSSNSLSGSLP-SDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQ-DSIPDS 451 (870)
Q Consensus 374 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~ 451 (870)
+..+. |..+++|+.|++++|.+++..| ..|.++++|++|++++|++++..|..|.++++|+.|++++|.+. +.+|..
T Consensus 387 ~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~ 465 (570)
T 2z63_A 387 TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465 (570)
T ss_dssp EEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred ccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhh
Confidence 66555 9999999999999999997666 57899999999999999999999999999999999999999998 578999
Q ss_pred ccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCC-CcccccccccccccccccCCC
Q 002892 452 FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTN-GPFRNFLAQSFLWNYALCGPP 520 (870)
Q Consensus 452 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~ 520 (870)
|..+++|+.|+|++|++++..|..|..+++|+.|++++|++++.+|.. ..+.......+.+|+..|.-|
T Consensus 466 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 999999999999999999888999999999999999999999887752 344455555677887777644
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=404.02 Aligned_cols=244 Identities=22% Similarity=0.378 Sum_probs=195.6
Q ss_pred CCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee----CCeeEEEE
Q 002892 588 NECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN----LDFKALVL 660 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 660 (870)
++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++|||||++++++.. .+..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999965 68999999997543 3456779999999999999999999999865 34679999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecccCCCceeeCC-CCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP--VVHCNLKPNNILLDK-NMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~ 737 (870)
|||+||+|.+++.+.+ .+++..+..++.||+.||+||| +++ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998654 4899999999999999999999 555 999999999999974 79999999999986432
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..... .+...+.....
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~~~~~----------- 247 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK----------- 247 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC-----------
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHHcCCC-----------
Confidence 12334579999999999865 69999999999999999999999997532211 11111110000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+...+..++.++.+++.+||+.||++|||++|+++
T Consensus 248 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001112346889999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=424.32 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=208.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.+.|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999965 6999999999876555556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
|+||+|.+++...+ +++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||+|..+.... .
T Consensus 230 ~~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 302 (423)
T ss_dssp CTTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred CCCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence 99999999997644 899999999999999999999 6679999999999999999999999999998764332 2
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ......+....+....
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~~~------------ 368 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPRLK------------ 368 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCCCS------------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCCCCc------------
Confidence 23456799999999999999999999999999999999999999975211 1111111111111100
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....++..+.+++.+||..||++|||+.|+++
T Consensus 369 ---~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 ---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01123456889999999999999999999976
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=459.81 Aligned_cols=442 Identities=18% Similarity=0.218 Sum_probs=273.7
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEc-cCCcccccCCccc----------------------------------
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGF-AYNDLTGSFPSWI---------------------------------- 59 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l-~~n~l~~~~~~~~---------------------------------- 59 (870)
.+++.|+|++|++.+.+|..|+.|++|++|+| ++|.+.|..|-..
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46888899999998888888899999999999 8887766533110
Q ss_pred -----------------cCCCCCCEEEcCC--CccccCCCCCCCCCCCCcEEeccCCcccc-----------------cc
Q 002892 60 -----------------GVFSKLQVLSLRN--NSFTGPIPNSLFNLSSLVRLDSRFNSISG-----------------NI 103 (870)
Q Consensus 60 -----------------~~l~~L~~L~L~~--n~i~~~~~~~~~~l~~L~~L~L~~n~i~~-----------------~~ 103 (870)
.....++.+.+.. |++++ +|..++++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1112333344433 77775 77777778888888888888776 27
Q ss_pred CcCCC--CcCCccEEEeecCccceecCCcccCCCCCCeeeccccc-ccc-cccccccccc-------cceEEEeeccccc
Q 002892 104 PSKIG--NLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNN-LIG-PIPTTIFNIS-------TIIIINLVGNQLS 172 (870)
Q Consensus 104 ~~~~~--~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~l~~N~l~ 172 (870)
|..++ ++++|++|+|++|++.+.+|..++++++|+.|+|++|+ +++ .+|..+.+++ +|++|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 77766 77778888887777777777777777778888887777 766 6777666665 7777777777777
Q ss_pred ccCCC--cccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccc-cccccccccccccccC
Q 002892 173 GHRPS--TMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRH-LSTLNIRANYLTTETS 249 (870)
Q Consensus 173 ~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~ 249 (870)
.+|. .+. .+++|+.|+|++|+++ .+| .|..+++|++|+|++|+++ .+|..|.++++ |+.|+|++|.++.++
T Consensus 562 -~ip~~~~l~-~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp- 635 (876)
T 4ecn_A 562 -EFPASASLQ-KMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIP- 635 (876)
T ss_dssp -BCCCHHHHT-TCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCC-
T ss_pred -ccCChhhhh-cCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCc-
Confidence 5555 333 4677777777777777 566 6777777777777777777 66667777777 777777777776543
Q ss_pred CCCCcccccccccc--cccceEEcCCCCCCCCCCccccccc----cchhhhhcccccccccCchhh-hCccCCcEEEeeC
Q 002892 250 SNGEWSFLSSLTNC--NKLRALSLGSNPLDSILPPLIGNFS----ASFQQFYAHECKLKGSIPKEI-GNLRGLIALSLFT 322 (870)
Q Consensus 250 ~~~~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~~----~~l~~l~l~~n~l~~~~~~~l-~~l~~L~~L~L~~ 322 (870)
..+..+ ++|+.|++++|++.+.+|....... .+|+.|++++|.++ .+|..+ ..+++|+.|+|++
T Consensus 636 --------~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~ 706 (876)
T 4ecn_A 636 --------NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSN 706 (876)
T ss_dssp --------SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCS
T ss_pred --------hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCC
Confidence 223333 3477777777777665443221110 13444444444444 222222 2344444444444
Q ss_pred CCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccc--cccccceEecCCCccCCCC
Q 002892 323 NDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFW--SLEYILRIDLSSNSLSGSL 400 (870)
Q Consensus 323 N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~ 400 (870)
|++. .+|..+... .+..+.++++|++|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +
T Consensus 707 N~L~-~ip~~~~~~---------------~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-l 768 (876)
T 4ecn_A 707 NLMT-SIPENSLKP---------------KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-F 768 (876)
T ss_dssp CCCS-CCCTTSSSC---------------TTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-C
T ss_pred CcCC-ccChHHhcc---------------ccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-c
Confidence 4444 222211100 0001223346666666666666 4555554 66666666666666664 5
Q ss_pred cccccCCccCCEEEccC------CccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCc
Q 002892 401 PSDIQNLKVLIYLNLSR------NQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK 474 (870)
Q Consensus 401 p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 474 (870)
|..+.++++|+.|+|++ |++.+.+|..|.++++|+.|+|++|++ +.+|..+. ++|+.|||++|++....+.
T Consensus 769 p~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~ 845 (876)
T 4ecn_A 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVT 845 (876)
T ss_dssp CCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECG
T ss_pred chhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChH
Confidence 66666666666666654 555555666666666666666666666 34555444 4566666666666555555
Q ss_pred chhhccccceeeccCCccc
Q 002892 475 SFEILSHLKRLNVSHNRLE 493 (870)
Q Consensus 475 ~~~~l~~L~~L~ls~N~l~ 493 (870)
.+.....+..+.|++|++.
T Consensus 846 ~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 846 SVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp GGHHHHHTTCCEEECCTTS
T ss_pred HccccccchheeecCCCcc
Confidence 5555555555556555544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=463.13 Aligned_cols=434 Identities=19% Similarity=0.253 Sum_probs=347.4
Q ss_pred CCCccCCCCCCCCCCCCeecCCCCccc------c------CCCccccCCCCCcEEEccCCcccccCCccccCC-------
Q 002892 2 SLGGTVPPHIGNLSFLMYLDISENNFR------G------YLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF------- 62 (870)
Q Consensus 2 ~~~~~~p~~~~~l~~L~~L~ls~n~l~------~------~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l------- 62 (870)
.++|++|+++++|++|++|||++|.+. + .+|... +..|+ +++++|.+.+.+|..++.+
T Consensus 92 ~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~ 168 (636)
T 4eco_A 92 GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINS 168 (636)
T ss_dssp CCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHH
T ss_pred ccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhc
Confidence 578999999999999999999999762 2 234333 45566 7778887777666665521
Q ss_pred ------------CCCCEEEcC--CCccccCCCCCCCCCCCCcEEeccCCccccc-----------------cCcCCC--C
Q 002892 63 ------------SKLQVLSLR--NNSFTGPIPNSLFNLSSLVRLDSRFNSISGN-----------------IPSKIG--N 109 (870)
Q Consensus 63 ------------~~L~~L~L~--~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-----------------~~~~~~--~ 109 (870)
..++.+.+. +|++++ +|..++++++|++|+|++|++++. +|..++ +
T Consensus 169 ~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~ 247 (636)
T 4eco_A 169 DPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDN 247 (636)
T ss_dssp CTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGG
T ss_pred CccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcc
Confidence 122222222 578887 888888888899999998888875 888888 8
Q ss_pred cCCccEEEeecCccceecCCcccCCCCCCeeeccccc-ccc-ccccccccc------ccceEEEeecccccccCCC--cc
Q 002892 110 LTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNN-LIG-PIPTTIFNI------STIIIINLVGNQLSGHRPS--TM 179 (870)
Q Consensus 110 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~l~~N~l~~~~~~--~~ 179 (870)
+++|++|+|++|++.+.+|..++++++|++|++++|+ +++ .+|..+.++ ++|++|++++|+++ .+|. .+
T Consensus 248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l 326 (636)
T 4eco_A 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL 326 (636)
T ss_dssp CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH
T ss_pred cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh
Confidence 8899999999998888888888888999999999888 877 788888876 88999999999888 6666 44
Q ss_pred cCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccc-cccccccccccccccCCCCCccccc
Q 002892 180 GHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRH-LSTLNIRANYLTTETSSNGEWSFLS 258 (870)
Q Consensus 180 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~~ 258 (870)
. .+++|++|++++|++++.+| .+..+++|++|++++|+++ .+|..|.++++ |++|++++|.++.++.
T Consensus 327 ~-~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~--------- 394 (636)
T 4eco_A 327 Q-KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPN--------- 394 (636)
T ss_dssp T-TCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCS---------
T ss_pred c-cCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccch---------
Confidence 3 57889999999999988888 8888889999999999888 67888888888 9999999998886542
Q ss_pred cccc--ccccceEEcCCCCCCCCCCccccc------cccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCC
Q 002892 259 SLTN--CNKLRALSLGSNPLDSILPPLIGN------FSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP 330 (870)
Q Consensus 259 ~l~~--l~~L~~L~L~~N~l~~~~~~~~~~------~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 330 (870)
.+.. +++|++|++++|++.+..|..+.. ....++.|++++|+++...+..+..+++|+.|++++|+++ .+|
T Consensus 395 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~ 473 (636)
T 4eco_A 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIP 473 (636)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCC
T ss_pred hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcC
Confidence 3343 348899999999998887777661 1237888899999988544445667999999999999999 455
Q ss_pred ch-hhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccc--cccccceEecCCCccCCCCcccccCC
Q 002892 331 TT-LGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFW--SLEYILRIDLSSNSLSGSLPSDIQNL 407 (870)
Q Consensus 331 ~~-~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l 407 (870)
.. +... +..+..+++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+.++
T Consensus 474 ~~~~~~~----------------~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l 535 (636)
T 4eco_A 474 KNSLKDE----------------NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535 (636)
T ss_dssp SSSSEET----------------TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGC
T ss_pred HHHhccc----------------cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcC
Confidence 43 2211 122445669999999999999 6777776 99999999999999997 89999999
Q ss_pred ccCCEEEc------cCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCc
Q 002892 408 KVLIYLNL------SRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK 474 (870)
Q Consensus 408 ~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 474 (870)
++|+.|+| ++|++.+.+|..|+++++|+.|+|++|++ +.+|..+. ++|+.|+|++|++......
T Consensus 536 ~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~~~ 605 (636)
T 4eco_A 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISIDLS 605 (636)
T ss_dssp SSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEECT
T ss_pred CCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccccHH
Confidence 99999999 56888999999999999999999999999 56787766 8999999999988744433
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=396.70 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=189.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||+||+|+.. +|+.||+|++++.. ......+.+|++++++++|||||++++++.+.+..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999954 79999999997543 23356789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+ +|+|.+++.+.+ .+++.++..++.||+.||+||| +++|+||||||+||++++++.+||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 9999 689999998655 4999999999999999999999 6679999999999999999999999999998664322
Q ss_pred CcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.+... ......+..... . +
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~~~~i~~~~~-~-~--------- 231 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVLFKNISNGVY-T-L--------- 231 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC-C-C---------
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCCC-C-C---------
Confidence 2334679999999999988876 5799999999999999999999975211 111111111100 0 0
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+...+..+.+++.+|++.||++|||+.|+++
T Consensus 232 --------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 --------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0112346889999999999999999999986
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=442.85 Aligned_cols=484 Identities=19% Similarity=0.216 Sum_probs=394.0
Q ss_pred CCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
.-..|+++++++ .+|..+. ++|++|++++|++++..|..|+.+++|++|+|++|+|++..|..|+++++|++|+|++
T Consensus 7 ~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 7 SGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp TSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 344688999998 6787664 7999999999999988899999999999999999999988888999999999999999
Q ss_pred CccccccCcCCCCcCCccEEEeecCcccee-cCCcccCCCCCCeeecccccccccc-cccccccccceEEEeeccccccc
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGE-IPNEIGNLKNLADLVLALNNLIGPI-PTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
|++++..|..|+.+++|++|++++|++++. .|..++++++|++|++++|++.+.+ +..+.++++|++|++++|++++.
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 163 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence 999977777799999999999999999963 5678999999999999999954444 46899999999999999999998
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCC--c-cccccccccccccccccccccccCCC
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI--P-NTFGNLRHLSTLNIRANYLTTETSSN 251 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~--~-~~~~~l~~L~~L~L~~N~l~~~~~~~ 251 (870)
.|..+. .+++|+.|+++.|.+.......+..+++|++|++++|++++.. + .....+++|+.|++++|.++.....
T Consensus 164 ~~~~l~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~- 241 (549)
T 2z81_A 164 QSQSLK-SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN- 241 (549)
T ss_dssp CTTTTT-TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHH-
T ss_pred Chhhhh-ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHH-
Confidence 888776 4899999999999998543334467899999999999998642 2 2345678999999999998763321
Q ss_pred CCcccccccccccccceEEcCCCCCCCCCC------ccccccccchhhhhcccccccc-----cCchhhhCccCCcEEEe
Q 002892 252 GEWSFLSSLTNCNKLRALSLGSNPLDSILP------PLIGNFSASFQQFYAHECKLKG-----SIPKEIGNLRGLIALSL 320 (870)
Q Consensus 252 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~------~~~~~~~~~l~~l~l~~n~l~~-----~~~~~l~~l~~L~~L~L 320 (870)
.+...+..+++|+.|++++|.+.+... ..+. ....++.+.+.++.+.. .++..+....+|+.|++
T Consensus 242 ---~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~-~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l 317 (549)
T 2z81_A 242 ---ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS-ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317 (549)
T ss_dssp ---HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCC-CCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEE
T ss_pred ---HHHHHhhhhccccccccccccccccccccccchhhhh-hhcccccccccccccchhhhcccchhhhhhcccceEEEe
Confidence 233456778899999999998776421 1111 12356677777776543 22333455678999999
Q ss_pred eCCCccccCCchh-hchhhHHHHHhc-CCCCCCCc---ccccCccccceeecCCcccCCCCC--cccccccccceEecCC
Q 002892 321 FTNDLNGTIPTTL-GRLQQLQALLQR-NNLNGPIP---TCLSSLISLRQLHLGSNQLTSSIP--SSFWSLEYILRIDLSS 393 (870)
Q Consensus 321 ~~N~l~~~~~~~~-~~l~~L~~L~l~-n~~~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~ 393 (870)
++|.+. .+|..+ ..+++|+.|+++ |.+.+.+| ..++.+++|++|+|++|++++..+ ..+..+++|++|++++
T Consensus 318 ~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 396 (549)
T 2z81_A 318 ENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR 396 (549)
T ss_dssp ESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTT
T ss_pred ccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCC
Confidence 999998 566665 689999999998 66666554 347889999999999999986643 5689999999999999
Q ss_pred CccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCC
Q 002892 394 NSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIP 473 (870)
Q Consensus 394 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 473 (870)
|+++ .+|..+..+++|++|+|++|++++ +|..+. ++|+.|+|++|++++.. ..+++|++|+|++|+|+ .+|
T Consensus 397 N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip 467 (549)
T 2z81_A 397 NTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLP 467 (549)
T ss_dssp CCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCC
T ss_pred CCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCC
Confidence 9999 688899999999999999999984 444432 68999999999998743 57899999999999999 677
Q ss_pred cchhhccccceeeccCCcccccCCCC-CcccccccccccccccccCCC
Q 002892 474 KSFEILSHLKRLNVSHNRLEGKIPTN-GPFRNFLAQSFLWNYALCGPP 520 (870)
Q Consensus 474 ~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~ 520 (870)
. ...+++|+.|+|++|++++.+|.. ..+.......+.+|++.|+-|
T Consensus 468 ~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 468 D-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp C-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred C-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 6 568999999999999999987752 344445555677888777533
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=444.50 Aligned_cols=493 Identities=20% Similarity=0.209 Sum_probs=377.3
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
+||+.+. +++++|||++|+|++..|.+|.++++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+..|.+
T Consensus 45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~ 122 (635)
T 4g8a_A 45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 122 (635)
T ss_dssp SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTT
T ss_pred ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcC
Confidence 4665543 47899999999998777778999999999999999998777788999999999999999998666667899
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCcccee-cCCcccCCCCCCeeecccccccccccccccccccc---
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGE-IPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTI--- 161 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--- 161 (870)
+++|++|+|++|++++..+..|+++++|++|+|++|.+++. .|..++.+++|++|++++|++++..+..+..+.++
T Consensus 123 L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~ 202 (635)
T 4g8a_A 123 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 202 (635)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhh
Confidence 99999999999999866666789999999999999998753 57778889999999999999988888887776554
Q ss_pred -eEEEeecccccccCCCcccCCCCccceeeecccccccc-----------------------------------------
Q 002892 162 -IIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGT----------------------------------------- 199 (870)
Q Consensus 162 -~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~----------------------------------------- 199 (870)
..++++.|.++...+..+. ...+..+++.+|.....
T Consensus 203 ~~~~~ls~n~l~~i~~~~~~--~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~ 280 (635)
T 4g8a_A 203 NLSLDLSLNPMNFIQPGAFK--EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 280 (635)
T ss_dssp CCEEECTTCCCCEECTTTTT--TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGG
T ss_pred hhhhhcccCcccccCccccc--chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccc
Confidence 3678888888765554432 23444555555432210
Q ss_pred -----------------cCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccccccccc
Q 002892 200 -----------------IPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTN 262 (870)
Q Consensus 200 -----------------~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~ 262 (870)
.+..+....+++.+++.+|.+... ..+.....|+.|++.+|.+..+. ...
T Consensus 281 l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~-----------~~~ 347 (635)
T 4g8a_A 281 LTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFP-----------TLK 347 (635)
T ss_dssp SEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCC-----------CCB
T ss_pred hhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcC-----------ccc
Confidence 111223334455555555554422 12444455666666666655432 123
Q ss_pred ccccceEEcCCCCCCCCCCccccccccchhhhhccccccc--ccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHH
Q 002892 263 CNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLK--GSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQ 340 (870)
Q Consensus 263 l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~--~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 340 (870)
+..|+.++++.|.+...... .. ..+++.++++.|.+. +..+..+..+.+|+.+++..|.+.. .+..+..+++|+
T Consensus 348 l~~L~~l~l~~n~~~~~~~~--~~-l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~ 423 (635)
T 4g8a_A 348 LKSLKRLTFTSNKGGNAFSE--VD-LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLE 423 (635)
T ss_dssp CTTCCEEEEESCCSCCBCCC--CB-CTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCC
T ss_pred chhhhhcccccccCCCCccc--cc-ccccccchhhccccccccccccchhhhhhhhhhhcccccccc-cccccccccccc
Confidence 45666777777766543221 11 246778888888775 3567778888899999999998874 566778888888
Q ss_pred HHHhc-CCCCCCCc-ccccCccccceeecCCcccCCCCCcccccccccceEecCCCcc-CCCCcccccCCccCCEEEccC
Q 002892 341 ALLQR-NNLNGPIP-TCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSL-SGSLPSDIQNLKVLIYLNLSR 417 (870)
Q Consensus 341 ~L~l~-n~~~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~ 417 (870)
.+++. ++.....+ ..+..+++++.+++++|.+.+..+..+..++.|+.|+|++|.+ .+..|..|..+++|++|+|++
T Consensus 424 ~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~ 503 (635)
T 4g8a_A 424 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 503 (635)
T ss_dssp EEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred chhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCC
Confidence 88776 55554443 5688899999999999999999999999999999999999985 446788999999999999999
Q ss_pred CccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhc-cccceeeccCCcccccC
Q 002892 418 NQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL-SHLKRLNVSHNRLEGKI 496 (870)
Q Consensus 418 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~ 496 (870)
|+|++..|..|+++++|+.|+|++|+|++..|..|.++++|+.|||++|+|++..|..|..+ ++|+.|+|++|+|+|.|
T Consensus 504 N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 504 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 99999999999999999999999999999999999999999999999999999999999988 68999999999999999
Q ss_pred CCCCccccccccc----ccccccccCCC
Q 002892 497 PTNGPFRNFLAQS----FLWNYALCGPP 520 (870)
Q Consensus 497 p~~~~~~~~~~~~----~~~n~~~c~~~ 520 (870)
.. .+|..|.... .......|..|
T Consensus 584 ~~-~~~~~wl~~~~~~~~~~~~~~C~~P 610 (635)
T 4g8a_A 584 EH-QSFLQWIKDQRQLLVEVERMECATP 610 (635)
T ss_dssp GG-HHHHHHHHHTTTTBSCGGGCBBCSS
T ss_pred Cc-HHHHHHHHhCCCccCCCCCceeCCc
Confidence 74 4566664321 12234567665
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=437.67 Aligned_cols=454 Identities=20% Similarity=0.239 Sum_probs=355.0
Q ss_pred CeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCC
Q 002892 18 MYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFN 97 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 97 (870)
++||+++|+++ .+|..+. ++|++|++++|.+++..|..|..+++|++|+|++|+|++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57999999998 5787666 89999999999999777788999999999999999999777889999999999999999
Q ss_pred ccccccCcCCCCcCCccEEEeecCccce-ecCCcccCCCCCCeeecccccccccccccccccccc--eEEEeecccc--c
Q 002892 98 SISGNIPSKIGNLTKLVHLNFADNNLRG-EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTI--IIINLVGNQL--S 172 (870)
Q Consensus 98 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~l~~N~l--~ 172 (870)
+|+ .+|.. .+++|++|+|++|++++ .+|..++++++|++|++++|++++ ..+..+++| ++|++++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 998 56665 78999999999999986 367889999999999999999875 456777777 9999999988 6
Q ss_pred ccCCCcccCCCCccceeeecccccccccCC-cccCCCCccEEEccCCc-------ccCCCcccccccccccccccccccc
Q 002892 173 GHRPSTMGHSLPNRQFLLLWANRLTGTIPN-SITNASKLIGLDLNSNS-------LSGQIPNTFGNLRHLSTLNIRANYL 244 (870)
Q Consensus 173 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~-------i~~~~~~~~~~l~~L~~L~L~~N~l 244 (870)
+..|..+..--.....+++++|++.+.++. .+..+++|+.|++++|. +.+.++ .|..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 666666543222344567777777655443 56677778888887776 554444 577777777777777766
Q ss_pred ccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhh-----hCccCCcEEE
Q 002892 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEI-----GNLRGLIALS 319 (870)
Q Consensus 245 ~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l-----~~l~~L~~L~ 319 (870)
+..... .++. ...+++|++|++++|++. +.+|..+ ..+++|+.++
T Consensus 233 ~~~~~~----~~~~-~~~~~~L~~L~l~~n~l~-------------------------~~~p~~~~~~~~~~l~~L~~l~ 282 (520)
T 2z7x_B 233 TWNSFI----RILQ-LVWHTTVWYFSISNVKLQ-------------------------GQLDFRDFDYSGTSLKALSIHQ 282 (520)
T ss_dssp EHHHHH----HHHH-HHHTSSCSEEEEEEEEEE-------------------------SCCCCCCCCCCSCCCCEEEEEE
T ss_pred CHHHHH----HHHH-HhhhCcccEEEeeccccc-------------------------CccccchhhcccccCceeEecc
Confidence 642100 0000 111346666666666555 3455555 7899999999
Q ss_pred eeCCCccccCC-chhhch---hhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCc
Q 002892 320 LFTNDLNGTIP-TTLGRL---QQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNS 395 (870)
Q Consensus 320 L~~N~l~~~~~-~~~~~l---~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 395 (870)
+++|.+ .+| ..+..+ .+|+.|+++++-....+ .+..+++|++|++++|++++..|..+..+++|++|++++|+
T Consensus 283 l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~ 359 (520)
T 2z7x_B 283 VVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359 (520)
T ss_dssp EEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSC
T ss_pred ccccce--ecchhhhhcccccCceeEEEcCCCcccccc-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCc
Confidence 999999 455 566655 56888888855433332 12678999999999999999899999999999999999999
Q ss_pred cCC--CCcccccCCccCCEEEccCCccCCcccc-cccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCC
Q 002892 396 LSG--SLPSDIQNLKVLIYLNLSRNQLSGNIPI-TIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEI 472 (870)
Q Consensus 396 l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 472 (870)
+++ .+|..+..+++|++|+|++|++++.+|. .+..+++|+.|++++|++++..|..+. ++|+.|+|++|+|+ .+
T Consensus 360 l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~i 436 (520)
T 2z7x_B 360 LKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SI 436 (520)
T ss_dssp CCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CC
T ss_pred cCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-cc
Confidence 996 4567899999999999999999984554 589999999999999999988887765 79999999999999 88
Q ss_pred CcchhhccccceeeccCCcccccCCCC--CcccccccccccccccccC
Q 002892 473 PKSFEILSHLKRLNVSHNRLEGKIPTN--GPFRNFLAQSFLWNYALCG 518 (870)
Q Consensus 473 p~~~~~l~~L~~L~ls~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~ 518 (870)
|..+..+++|+.|+|++|++++ +|.. ..+.......+.+|+..|.
T Consensus 437 p~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 437 PKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred chhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence 8888899999999999999995 5543 2333444455677877665
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=403.40 Aligned_cols=247 Identities=25% Similarity=0.306 Sum_probs=194.9
Q ss_pred cCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
++|++.+.||+|+||+||+|+.. +++.||+|++++.. .....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 47889999997543 2223467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||++||+|.+++.+.+. +++.++..++.||+.||+||| +++|+||||||+|||++++|.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999987554 899999999999999999999 667999999999999999999999999999865322
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
. .......||+.|||||++.+..|+.++||||+||++|||+||+.||.+.... .....+.....+ .
T Consensus 180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~--~--------- 245 (304)
T 3ubd_A 180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMILKAKLG--M--------- 245 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC--C---------
T ss_pred C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCCC--C---------
Confidence 2 2233467999999999999999999999999999999999999999763211 111111111000 0
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM-----TDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~ 857 (870)
+..++.++.+++.+||+.||++|||+ +|+++
T Consensus 246 --------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 --------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 01234568899999999999999985 56653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=447.92 Aligned_cols=428 Identities=19% Similarity=0.221 Sum_probs=342.2
Q ss_pred CCCccCCCCCCCCCCCCeecC-CCCccccCCCccc---------------------------------------------
Q 002892 2 SLGGTVPPHIGNLSFLMYLDI-SENNFRGYLPNEL--------------------------------------------- 35 (870)
Q Consensus 2 ~~~~~~p~~~~~l~~L~~L~l-s~n~l~~~~p~~~--------------------------------------------- 35 (870)
.++|++|+++++|++|++||| ++|.+.+..|-..
T Consensus 334 ~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~ 413 (876)
T 4ecn_A 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE 413 (876)
T ss_dssp CCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTT
T ss_pred CCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcc
Confidence 578999999999999999999 8888766533210
Q ss_pred ------cCCCCCcEEEccC--CcccccCCccccCCCCCCEEEcCCCcccc-----------------CCCCCCC--CCCC
Q 002892 36 ------GQLRRLKFLGFAY--NDLTGSFPSWIGVFSKLQVLSLRNNSFTG-----------------PIPNSLF--NLSS 88 (870)
Q Consensus 36 ------~~l~~L~~L~l~~--n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-----------------~~~~~~~--~l~~ 88 (870)
.....++.+.++. |++++ +|..|+.+++|++|+|++|+|++ .+|..++ ++++
T Consensus 414 ~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~ 492 (876)
T 4ecn_A 414 MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD 492 (876)
T ss_dssp SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred ccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCC
Confidence 1112333444443 78886 88889999999999999999987 2888887 9999
Q ss_pred CcEEeccCCccccccCcCCCCcCCccEEEeecCc-cce-ecCCcccCCC-------CCCeeecccccccccccc--cccc
Q 002892 89 LVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN-LRG-EIPNEIGNLK-------NLADLVLALNNLIGPIPT--TIFN 157 (870)
Q Consensus 89 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~-l~~-~~~~~l~~l~-------~L~~L~L~~n~l~~~~~~--~~~~ 157 (870)
|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|+.|+|++|+++ .+|. .+.+
T Consensus 493 L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~ 571 (876)
T 4ecn_A 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQK 571 (876)
T ss_dssp CCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTT
T ss_pred CCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhc
Confidence 9999999999888899999999999999999998 887 6777666655 9999999999998 7787 8899
Q ss_pred cccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCC-ccEEEccCCcccCCCccccccccc--c
Q 002892 158 ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASK-LIGLDLNSNSLSGQIPNTFGNLRH--L 234 (870)
Q Consensus 158 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~i~~~~~~~~~~l~~--L 234 (870)
+++|+.|+|++|+++ .+| . ...+++|+.|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..++. |
T Consensus 572 L~~L~~L~Ls~N~l~-~lp-~-~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L 646 (876)
T 4ecn_A 572 MVKLGLLDCVHNKVR-HLE-A-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646 (876)
T ss_dssp CTTCCEEECTTSCCC-BCC-C-CCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCE
T ss_pred CCCCCEEECCCCCcc-cch-h-hcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCC
Confidence 999999999999998 666 3 346889999999999998 78888999988 999999999998 67888877654 9
Q ss_pred ccccccccccccccCCCCCcccccccc--cccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhC-
Q 002892 235 STLNIRANYLTTETSSNGEWSFLSSLT--NCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGN- 311 (870)
Q Consensus 235 ~~L~L~~N~l~~~~~~~~~~~~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~- 311 (870)
+.|+|++|.++...+. ++..+. .+++|+.|++++|++..+ |..+......|+.|++++|+++ .+|..+..
T Consensus 647 ~~L~Ls~N~l~g~ip~-----l~~~l~~~~~~~L~~L~Ls~N~L~~l-p~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~ 719 (876)
T 4ecn_A 647 GSVDFSYNKIGSEGRN-----ISCSMDDYKGINASTVTLSYNEIQKF-PTELFATGSPISTIILSNNLMT-SIPENSLKP 719 (876)
T ss_dssp EEEECCSSCTTTTSSS-----CSSCTTTCCCCCEEEEECCSSCCCSC-CHHHHHTTCCCSEEECCSCCCS-CCCTTSSSC
T ss_pred CEEECcCCcCCCcccc-----chhhhccccCCCcCEEEccCCcCCcc-CHHHHccCCCCCEEECCCCcCC-ccChHHhcc
Confidence 9999999998764321 111222 345899999999999865 4443333357889999999988 56655443
Q ss_pred -------ccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCccccccc
Q 002892 312 -------LRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLE 384 (870)
Q Consensus 312 -------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 384 (870)
+++|+.|+|++|++. .+|..+. ...+++|+.|+|++|+|++ +|..+..++
T Consensus 720 ~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~---------------------~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~ 776 (876)
T 4ecn_A 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFR---------------------ATTLPYLSNMDVSYNCFSS-FPTQPLNSS 776 (876)
T ss_dssp TTSCCTTGGGCCEEECCSSCCC-CCCGGGS---------------------TTTCTTCCEEECCSSCCSS-CCCGGGGCT
T ss_pred ccccccccCCccEEECCCCCCc-cchHHhh---------------------hccCCCcCEEEeCCCCCCc-cchhhhcCC
Confidence 338999999999998 4444332 0267788888888888886 688888888
Q ss_pred ccceEecCC------CccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCC
Q 002892 385 YILRIDLSS------NSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSL 458 (870)
Q Consensus 385 ~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 458 (870)
+|+.|+|++ |++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|+|++|++....+..|.....+
T Consensus 777 ~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~ 853 (876)
T 4ecn_A 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEA 853 (876)
T ss_dssp TCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHT
T ss_pred CCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccc
Confidence 888888866 888889999999999999999999999 57888776 699999999999998888888877788
Q ss_pred CeEecCCCccc
Q 002892 459 EYLDLSNNNLS 469 (870)
Q Consensus 459 ~~L~L~~N~l~ 469 (870)
..+.|.+|++.
T Consensus 854 ~~~~L~~n~~~ 864 (876)
T 4ecn_A 854 GMYVLLYDKTQ 864 (876)
T ss_dssp TCCEEECCTTS
T ss_pred hheeecCCCcc
Confidence 88899888776
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=392.00 Aligned_cols=249 Identities=22% Similarity=0.371 Sum_probs=188.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--------
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-------- 654 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 654 (870)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999965 78999999997644 344567899999999999999999999987544
Q ss_pred ----eeEEEEecCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEec
Q 002892 655 ----FKALVLEFMPNGSLEKWLYSHNY--FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 655 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
..|+||||+++|+|.+++..... ..++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999986532 3566778899999999999999 66799999999999999999999999
Q ss_pred cccccccCCCCCc----------ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHH
Q 002892 729 FGISKLLGEDDDS----------VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798 (870)
Q Consensus 729 fg~a~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~ 798 (870)
||+|+........ ...+..+||+.|||||++.+..|+.++||||+||++|||++ ||..... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HHH
Confidence 9999877543221 12234579999999999999999999999999999999996 7753111 111
Q ss_pred HHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 799 HWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+.... ..............+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~---------------~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDVR---------------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHH---------------TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHh---------------cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111000 00001112223345678999999999999999999986
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=431.55 Aligned_cols=463 Identities=19% Similarity=0.190 Sum_probs=366.2
Q ss_pred CCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEe
Q 002892 14 LSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLD 93 (870)
Q Consensus 14 l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 93 (870)
....+++|+++|++++ +|..+. ++|++|++++|.+++..|..|+.+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 30 ~~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 106 (562)
T 3a79_B 30 NELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLD 106 (562)
T ss_dssp ---CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEE
Confidence 3445899999999994 787664 8999999999999977778999999999999999999988888999999999999
Q ss_pred ccCCccccccCcCCCCcCCccEEEeecCcccee-cCCcccCCCCCCeeecccccccccccccccccccc--eEEEeeccc
Q 002892 94 SRFNSISGNIPSKIGNLTKLVHLNFADNNLRGE-IPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTI--IIINLVGNQ 170 (870)
Q Consensus 94 L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~l~~N~ 170 (870)
|++|+|+ .+|.. .+++|++|++++|++++. .|..++++++|++|++++|++++. .+..+++| ++|++++|+
T Consensus 107 Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~ 180 (562)
T 3a79_B 107 VSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVS 180 (562)
T ss_dssp CTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESS
T ss_pred CCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccc
Confidence 9999998 67766 899999999999999963 368899999999999999999763 45555555 999999999
Q ss_pred c--cccCCCcccCCCCccceeeecccccccccCC-cccCCCCccEEEccCCc-----ccCCCcccccccccccccccccc
Q 002892 171 L--SGHRPSTMGHSLPNRQFLLLWANRLTGTIPN-SITNASKLIGLDLNSNS-----LSGQIPNTFGNLRHLSTLNIRAN 242 (870)
Q Consensus 171 l--~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~-----i~~~~~~~~~~l~~L~~L~L~~N 242 (870)
+ ++..|..+..--...-.+++++|.+.+.+++ .+..+++|+.|++++|+ +.+ ....|..+++|+.|+++++
T Consensus 181 l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~ 259 (562)
T 3a79_B 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHI 259 (562)
T ss_dssp CCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEE
T ss_pred ccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCC
Confidence 9 7777777654211233668888988875544 46678899999999985 221 2345778888888888888
Q ss_pred ccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcccc----ccccchhhhhcccccccccCc-hhhhCc---cC
Q 002892 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIG----NFSASFQQFYAHECKLKGSIP-KEIGNL---RG 314 (870)
Q Consensus 243 ~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~----~~~~~l~~l~l~~n~l~~~~~-~~l~~l---~~ 314 (870)
.++..... ..+ ......+|++|++++|++.+..|..+. .-...++.+++..+.+ .+| ..+..+ .+
T Consensus 260 ~l~~~~~~----~~~-~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~ 332 (562)
T 3a79_B 260 ETTWKCSV----KLF-QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMN 332 (562)
T ss_dssp EECHHHHH----HHH-HHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCC
T ss_pred cCcHHHHH----HHH-HhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCc
Confidence 77642110 011 122335899999999999876666552 1113444455555555 344 333333 67
Q ss_pred CcEEEeeCCCccccCCchhhchhhHHHHHhc-CCCCCCCcccccCccccceeecCCcccCCCC--CcccccccccceEec
Q 002892 315 LIALSLFTNDLNGTIPTTLGRLQQLQALLQR-NNLNGPIPTCLSSLISLRQLHLGSNQLTSSI--PSSFWSLEYILRIDL 391 (870)
Q Consensus 315 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L 391 (870)
|+.|++++|.+.... .+..+++|++|+++ |.+.+.+|..+..+++|++|+|++|++++.. |..|..+++|+.|++
T Consensus 333 L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l 410 (562)
T 3a79_B 333 IKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410 (562)
T ss_dssp CSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEEC
T ss_pred ceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEEC
Confidence 999999999986432 12678888899888 6677778999999999999999999999743 567999999999999
Q ss_pred CCCccCCCCcc-cccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccC
Q 002892 392 SSNSLSGSLPS-DIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG 470 (870)
Q Consensus 392 s~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 470 (870)
++|.+++.+|. .+..+++|++|+|++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+
T Consensus 411 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~- 486 (562)
T 3a79_B 411 SLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK- 486 (562)
T ss_dssp TTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-
T ss_pred CCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-
Confidence 99999984554 588999999999999999987777665 79999999999998 57777779999999999999999
Q ss_pred CCCcc-hhhccccceeeccCCcccccCCCC
Q 002892 471 EIPKS-FEILSHLKRLNVSHNRLEGKIPTN 499 (870)
Q Consensus 471 ~~p~~-~~~l~~L~~L~ls~N~l~~~~p~~ 499 (870)
.+|.. |..+++|+.|++++|+|+|.||..
T Consensus 487 ~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 487 SVPDGVFDRLTSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp CCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred CCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence 56665 999999999999999999999853
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=404.28 Aligned_cols=401 Identities=18% Similarity=0.217 Sum_probs=249.1
Q ss_pred eecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCC-CCCCCCCCCCcEEeccCC
Q 002892 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPI-PNSLFNLSSLVRLDSRFN 97 (870)
Q Consensus 19 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n 97 (870)
.++.++++++ .+|. + .++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+.+ +..|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 4455555554 3443 1 144555555555555444444555555555555555443222 233444444444444444
Q ss_pred ccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCC
Q 002892 98 SISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPS 177 (870)
Q Consensus 98 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 177 (870)
++++..|..|+++++|++|+|++|++++..+.. ..+..+++|++|+|++|++++..|.
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----------------------~~~~~l~~L~~L~L~~n~l~~~~~~ 147 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG----------------------NFFKPLTSLEMLVLRDNNIKKIQPA 147 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHS----------------------STTTTCTTCCEEECCSSBCCSCCCC
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCc----------------------ccccCcccCCEEECCCCccCccCcc
Confidence 444444444444444444444444444322221 1133444444444444444433333
Q ss_pred cccCCCCccceeeecccccccccCCcccCC--CCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcc
Q 002892 178 TMGHSLPNRQFLLLWANRLTGTIPNSITNA--SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWS 255 (870)
Q Consensus 178 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 255 (870)
.+...+++|++|++++|++++..+..+..+ .+|+.|++++|.+.+..+..++ +.
T Consensus 148 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~------------------------~~ 203 (455)
T 3v47_A 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG------------------------WE 203 (455)
T ss_dssp GGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT------------------------HH
T ss_pred cccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcc------------------------cc
Confidence 222223333333333333333333333333 4555666666655543333221 11
Q ss_pred cccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhC---ccCCcEEEeeCCCccccCCch
Q 002892 256 FLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGN---LRGLIALSLFTNDLNGTIPTT 332 (870)
Q Consensus 256 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~---l~~L~~L~L~~N~l~~~~~~~ 332 (870)
....+..+++|++|++++|++.+..| ..+.. .++|+.|++++|.+.+....
T Consensus 204 ~~~~~~~~~~L~~L~Ls~n~l~~~~~-------------------------~~~~~~~~~~~L~~L~l~~~~~~~~~~~- 257 (455)
T 3v47_A 204 KCGNPFKNTSITTLDLSGNGFKESMA-------------------------KRFFDAIAGTKIQSLILSNSYNMGSSFG- 257 (455)
T ss_dssp HHCCTTTTCEEEEEECTTSCCCHHHH-------------------------HHHHHHTTTCCEEEEECTTCTTTSCCTT-
T ss_pred ccccccccceeeeEecCCCcccccch-------------------------hhhhccccccceeeEeeccccccccccc-
Confidence 12234455667777777776654322 22222 25677777777765532111
Q ss_pred hhchhhHHHHHhcCCCCCCCcccccC--ccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccC
Q 002892 333 LGRLQQLQALLQRNNLNGPIPTCLSS--LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVL 410 (870)
Q Consensus 333 ~~~l~~L~~L~l~n~~~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 410 (870)
.+++....+..+.. .++|++|++++|++++..|..|..+++|++|+|++|++++..|..|.++++|
T Consensus 258 ------------~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 325 (455)
T 3v47_A 258 ------------HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHL 325 (455)
T ss_dssp ------------CCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ------------hhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccC
Confidence 11222222233333 3689999999999999999999999999999999999998889999999999
Q ss_pred CEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCC
Q 002892 411 IYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490 (870)
Q Consensus 411 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 490 (870)
++|+|++|++++..|..|+++++|+.|+|++|++++..|.+|..+++|++|+|++|+|++..+..|..+++|+.|++++|
T Consensus 326 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 405 (455)
T 3v47_A 326 LKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405 (455)
T ss_dssp CEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCC
Confidence 99999999999888999999999999999999999988999999999999999999999877778899999999999999
Q ss_pred cccccCCCCCccccccc
Q 002892 491 RLEGKIPTNGPFRNFLA 507 (870)
Q Consensus 491 ~l~~~~p~~~~~~~~~~ 507 (870)
+++|.+|....+..|..
T Consensus 406 ~l~~~~~~~~~l~~~l~ 422 (455)
T 3v47_A 406 PWDCSCPRIDYLSRWLN 422 (455)
T ss_dssp CBCCCTTTTHHHHHHHH
T ss_pred CcccCCCcchHHHHHHH
Confidence 99999997666666654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=421.94 Aligned_cols=495 Identities=20% Similarity=0.170 Sum_probs=385.0
Q ss_pred CccCCCCCCCCC---CCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCC
Q 002892 4 GGTVPPHIGNLS---FLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIP 80 (870)
Q Consensus 4 ~~~~p~~~~~l~---~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 80 (870)
...+|+....+. .-...+.++.+++ .+|..+. +++++|+|++|+|++..+..|..+++|++|+|++|+|++..|
T Consensus 17 ~~~~p~~~~~c~~~~~~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~ 93 (635)
T 4g8a_A 17 NSSIPESWEPCVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 93 (635)
T ss_dssp --------CCSEEEETTTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred cCCCCCCCCCccccCCCCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcCh
Confidence 345666654442 2346778888898 6886653 489999999999997778899999999999999999997777
Q ss_pred CCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccc-cccccccccc
Q 002892 81 NSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIG-PIPTTIFNIS 159 (870)
Q Consensus 81 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~ 159 (870)
.+|.++++|++|+|++|+|++..+..|+++++|++|+|++|+|++..+..|+++++|++|+|++|++++ ..|..+..++
T Consensus 94 ~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~ 173 (635)
T 4g8a_A 94 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 173 (635)
T ss_dssp TTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred hHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence 789999999999999999996666789999999999999999997777789999999999999999976 4688899999
Q ss_pred cceEEEeecccccccCCCcccC---CCCccceeeecccccccccCCcccCCCCccEEEccCCcccC-CCccccccccccc
Q 002892 160 TIIIINLVGNQLSGHRPSTMGH---SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG-QIPNTFGNLRHLS 235 (870)
Q Consensus 160 ~L~~L~l~~N~l~~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~ 235 (870)
+|++|++++|++++..+..+.. .......++++.|.++...+..+ ....++.+++++|.... ..+..+..+..++
T Consensus 174 ~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~ 252 (635)
T 4g8a_A 174 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 252 (635)
T ss_dssp TCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCE
T ss_pred hhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccc
Confidence 9999999999999887766532 12234478999999996555444 44567788888875431 1122233333333
Q ss_pred cccc---------------------------------------------------------cccccccccCCCCCccccc
Q 002892 236 TLNI---------------------------------------------------------RANYLTTETSSNGEWSFLS 258 (870)
Q Consensus 236 ~L~L---------------------------------------------------------~~N~l~~~~~~~~~~~~~~ 258 (870)
...+ .+|.+.. ..
T Consensus 253 ~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~----------~~ 322 (635)
T 4g8a_A 253 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIER----------VK 322 (635)
T ss_dssp EEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEE----------CG
T ss_pred cccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccc----------cc
Confidence 2222 2222221 12
Q ss_pred ccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccc--cCCchhhch
Q 002892 259 SLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNG--TIPTTLGRL 336 (870)
Q Consensus 259 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l 336 (870)
.+.....|+.|++++|.+..+.+..+ ..++.+.+..|..... .....+++|+.|++++|.+.. ..+..+..+
T Consensus 323 ~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~ 396 (635)
T 4g8a_A 323 DFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 396 (635)
T ss_dssp GGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSC
T ss_pred ccccchhhhhhhcccccccCcCcccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhh
Confidence 34455667778888877766554333 3455666666665533 334578899999999999864 456677788
Q ss_pred hhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCC-CcccccccccceEecCCCccCCCCcccccCCccCCEEEc
Q 002892 337 QQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSI-PSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNL 415 (870)
Q Consensus 337 ~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 415 (870)
.+|+.+++..+.....+..+..+++|+.+++++|+..... +..|..+.+++.+++++|.+.+..|..+..+++|+.|+|
T Consensus 397 ~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~L 476 (635)
T 4g8a_A 397 ISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 476 (635)
T ss_dssp SCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred hhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 8888888886666667778889999999999999886554 457899999999999999999999999999999999999
Q ss_pred cCCcc-CCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccc
Q 002892 416 SRNQL-SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 416 s~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 494 (870)
++|.+ .+..|..|..+++|+.|+|++|+|++..|.+|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++
T Consensus 477 s~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~ 556 (635)
T 4g8a_A 477 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 556 (635)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCB
T ss_pred hhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCC
Confidence 99985 45678899999999999999999999999999999999999999999999889999999999999999999999
Q ss_pred cCCCCC-cc-cccccccccccccccC
Q 002892 495 KIPTNG-PF-RNFLAQSFLWNYALCG 518 (870)
Q Consensus 495 ~~p~~~-~~-~~~~~~~~~~n~~~c~ 518 (870)
.+|..- .+ .........+|++.|+
T Consensus 557 ~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 557 SKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 888632 12 2333446789999885
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=413.56 Aligned_cols=458 Identities=20% Similarity=0.197 Sum_probs=367.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEE
Q 002892 38 LRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLN 117 (870)
Q Consensus 38 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 117 (870)
+...+++++++|+++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|+++++|++|+
T Consensus 30 ~~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 106 (562)
T 3a79_B 30 NELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLD 106 (562)
T ss_dssp ---CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEE
Confidence 444589999999999 5887664 8999999999999977778999999999999999999988899999999999999
Q ss_pred eecCccceecCCcccCCCCCCeeeccccccccc-ccccccccccceEEEeecccccccCCCcccCCCCcc--ceeeeccc
Q 002892 118 FADNNLRGEIPNEIGNLKNLADLVLALNNLIGP-IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNR--QFLLLWAN 194 (870)
Q Consensus 118 l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L--~~L~L~~n 194 (870)
|++|+|+ .+|.. .+++|++|+|++|++++. .|..+.++++|++|++++|++++.... .+++| +.|++++|
T Consensus 107 Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~----~l~~L~L~~L~L~~n 179 (562)
T 3a79_B 107 VSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLL----PVAHLHLSCILLDLV 179 (562)
T ss_dssp CTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTG----GGTTSCEEEEEEEES
T ss_pred CCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchh----hhhhceeeEEEeecc
Confidence 9999999 56665 899999999999999873 468999999999999999999863322 24455 99999999
Q ss_pred cc--ccccCCcccCCC-CccEEEccCCcccCCCcc-ccccccccccccccccccc--cccCCCCCcccccccccccccce
Q 002892 195 RL--TGTIPNSITNAS-KLIGLDLNSNSLSGQIPN-TFGNLRHLSTLNIRANYLT--TETSSNGEWSFLSSLTNCNKLRA 268 (870)
Q Consensus 195 ~l--~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~--~~~~~~~~~~~~~~l~~l~~L~~ 268 (870)
++ ++..|..+..+. ....+++++|.+.+..++ .+..+++|+.|++++|... .+. .....+..+++|+.
T Consensus 180 ~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~------~~~~~l~~l~~L~~ 253 (562)
T 3a79_B 180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM------TFLSELTRGPTLLN 253 (562)
T ss_dssp SCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHH------HHHHHHHSCSSCEE
T ss_pred cccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHH------HHHHHHhccCcceE
Confidence 99 888888888765 233679999998875554 4778999999999998521 111 12345778889999
Q ss_pred EEcCCCCCCCCCCccccc--cccchhhhhcccccccccCchhh-----hCccCCcEEEeeCCCccccCC-chhhch---h
Q 002892 269 LSLGSNPLDSILPPLIGN--FSASFQQFYAHECKLKGSIPKEI-----GNLRGLIALSLFTNDLNGTIP-TTLGRL---Q 337 (870)
Q Consensus 269 L~L~~N~l~~~~~~~~~~--~~~~l~~l~l~~n~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~ 337 (870)
|+++++.+.+.....+.. ....++.|++++|.+++.+|..+ ..++.|..++++.|.+ .+| ..+..+ .
T Consensus 254 L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~ 331 (562)
T 3a79_B 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEM 331 (562)
T ss_dssp EEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTC
T ss_pred EEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccC
Confidence 999888765421111000 11378999999999999999888 7888888888888888 345 333333 4
Q ss_pred hHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCC--CcccccCCccCCEEEc
Q 002892 338 QLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGS--LPSDIQNLKVLIYLNL 415 (870)
Q Consensus 338 ~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L 415 (870)
+|+.|+++++-....+ ....+++|++|+|++|++++..|..|..+++|+.|+|++|++++. +|..|.++++|++|+|
T Consensus 332 ~L~~L~l~~n~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l 410 (562)
T 3a79_B 332 NIKMLSISDTPFIHMV-CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410 (562)
T ss_dssp CCSEEEEESSCCCCCC-CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEEC
T ss_pred cceEEEccCCCccccc-CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEEC
Confidence 5777778854433222 126789999999999999999999999999999999999999963 3567999999999999
Q ss_pred cCCccCCccc-ccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccc
Q 002892 416 SRNQLSGNIP-ITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 416 s~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 494 (870)
++|++++.+| ..+..+++|+.|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++
T Consensus 411 ~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 411 SLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp TTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC
T ss_pred CCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC
Confidence 9999998444 5689999999999999999987777655 79999999999999 788877799999999999999995
Q ss_pred cCCCC--CcccccccccccccccccC
Q 002892 495 KIPTN--GPFRNFLAQSFLWNYALCG 518 (870)
Q Consensus 495 ~~p~~--~~~~~~~~~~~~~n~~~c~ 518 (870)
+|.. ..+.......+.+|++.|+
T Consensus 488 -l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 488 -VPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp -CCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred -CCHHHHhcCCCCCEEEecCCCcCCC
Confidence 5542 3344444455678877775
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=384.15 Aligned_cols=268 Identities=18% Similarity=0.241 Sum_probs=200.9
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCe
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 655 (870)
....+.|++.+.||+|+||+||+|+.+ +++.||+|++..... ..++.+|+++++.+ .||||+++++++.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345688999999999999999999853 467899999865432 35678899999998 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEeccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKL 734 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~ 734 (870)
.|+||||+++|+|.+++. .+++.++..++.|++.||+||| ++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999999984 3899999999999999999999 6679999999999999877 8999999999976
Q ss_pred cCCCCCc--------------------------ccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCC
Q 002892 735 LGEDDDS--------------------------VTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPT 787 (870)
Q Consensus 735 ~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~ 787 (870)
....... ...+..+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432111 112335799999999999775 4899999999999999999999999
Q ss_pred CccccccchHHHHHHHhc---------------------CC-chhhhcchh---------hhccc----CcchHHHHHHH
Q 002892 788 DEMFTGEMSLKHWIKLSL---------------------PR-GLTEVVDAS---------LVREV----QPSYAKMDCLL 832 (870)
Q Consensus 788 ~~~~~~~~~~~~~~~~~~---------------------~~-~~~~~~~~~---------~~~~~----~~~~~~~~~~~ 832 (870)
....+....+..+....- +. ......... ..... .........+.
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 654333333333221100 00 000000000 00000 00000012345
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 833 RIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 833 ~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
++.+++.+|++.||++|||+.|+++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 6889999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=388.55 Aligned_cols=268 Identities=22% Similarity=0.273 Sum_probs=202.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee------CC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN------LD 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 654 (870)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999965 79999999996543 3445678899999999999999999998754 35
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..|+||||++ |+|.+++...+ .+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999995 68999997654 4999999999999999999999 66799999999999999999999999999987
Q ss_pred cCCCC--CcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CCc-h
Q 002892 735 LGEDD--DSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PRG-L 809 (870)
Q Consensus 735 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~-~ 809 (870)
+.... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ...+..+..... +.. .
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-VHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCChHH
Confidence 64322 12233456899999999998775 569999999999999999999999976321 222222222211 110 0
Q ss_pred hhhcc-----h---hhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 810 TEVVD-----A---SLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 810 ~~~~~-----~---~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... . .+.......+. .......+.+++.+||..||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0 00000000000 0112456889999999999999999999876
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=388.63 Aligned_cols=373 Identities=21% Similarity=0.284 Sum_probs=308.4
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccC-CccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEe
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSF-PSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLD 93 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 93 (870)
++|++|||++|++++..|..|.++++|++|++++|.+.+.+ +..|+.+++|++|+|++|++++..|..++++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 78999999999999888999999999999999999997544 67899999999999999999988899999999999999
Q ss_pred ccCCccccccCcC--CCCcCCccEEEeecCccceecCCc-ccCCCCCCeeeccccccccccccccccc--ccceEEEeec
Q 002892 94 SRFNSISGNIPSK--IGNLTKLVHLNFADNNLRGEIPNE-IGNLKNLADLVLALNNLIGPIPTTIFNI--STIIIINLVG 168 (870)
Q Consensus 94 L~~n~i~~~~~~~--~~~l~~L~~L~l~~N~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~l~~ 168 (870)
|++|++++..|.. |+.+++|++|+|++|++++..|.. +.++++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999998755544 999999999999999999877776 8999999999999999998888888876 6888888888
Q ss_pred ccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccc---cccccccccccccc
Q 002892 169 NQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNL---RHLSTLNIRANYLT 245 (870)
Q Consensus 169 N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l---~~L~~L~L~~N~l~ 245 (870)
|.+.+..+..+.. .....+..+++|++|++++|++++..|..+... ++|+.|++++|.+.
T Consensus 190 n~l~~~~~~~~~~-----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 252 (455)
T 3v47_A 190 ITLQDMNEYWLGW-----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252 (455)
T ss_dssp CBCTTCSTTCTTH-----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTT
T ss_pred Ccccccchhhccc-----------------cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccc
Confidence 8887554433221 122334556788888888888887777766554 56666666666544
Q ss_pred cccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhC--ccCCcEEEeeCC
Q 002892 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGN--LRGLIALSLFTN 323 (870)
Q Consensus 246 ~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~--l~~L~~L~L~~N 323 (870)
... +..+.+. ...+..+.. .++|+.|++++|
T Consensus 253 ~~~----------------------~~~~~~~-------------------------~~~~~~~~~~~~~~L~~L~l~~n 285 (455)
T 3v47_A 253 GSS----------------------FGHTNFK-------------------------DPDNFTFKGLEASGVKTCDLSKS 285 (455)
T ss_dssp SCC----------------------TTCCSSC-------------------------CCCTTTTGGGTTSCCCEEECCSS
T ss_pred ccc----------------------cchhhhc-------------------------cCcccccccccccCceEEEecCc
Confidence 311 0111111 111122222 367899999999
Q ss_pred CccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCccc
Q 002892 324 DLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSD 403 (870)
Q Consensus 324 ~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 403 (870)
.+.+..|. .+..+++|++|+|++|++++..|..|..+++|+.|+|++|.+++..|..
T Consensus 286 ~l~~~~~~-----------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 342 (455)
T 3v47_A 286 KIFALLKS-----------------------VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM 342 (455)
T ss_dssp CCCEECTT-----------------------TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGG
T ss_pred cccccchh-----------------------hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhH
Confidence 98865543 4566788999999999999999999999999999999999999888999
Q ss_pred ccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCc
Q 002892 404 IQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK 474 (870)
Q Consensus 404 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 474 (870)
|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++..|.
T Consensus 343 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 343 FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp GTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred hcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 99999999999999999998899999999999999999999988888899999999999999999987763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=391.59 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=198.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHH---HHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERA---FRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.++|++.++||+|+||+||+|+.. +|+.||+|++++.. ... ....+.++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999965 69999999997643 111 22233446677778999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
|+||||++||+|.+++...+. +++..+..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~-l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999987654 899999999999999999999 7779999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccc-hHHHHHHHhcCCchhhhcc
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM-SLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 814 (870)
... ....+||+.|||||++.. ..|+.++|+||+||++|||++|..||.+...... .+...+.. .+...
T Consensus 344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~~~~----- 413 (689)
T 3v5w_A 344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAVEL----- 413 (689)
T ss_dssp SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CCCCC-----
T ss_pred CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CCCCC-----
Confidence 322 234579999999999964 5799999999999999999999999976322211 11111100 00000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
+...+.++.+++.+|++.||++|++ +.||++
T Consensus 414 ------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 414 ------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0112346889999999999999998 677654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=397.87 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=209.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++........+.+.+|+++++.++|||||++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999965 7999999999876666667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC--CceEEeccccccccCCCCC
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN--MTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~ 740 (870)
++||+|.+++......+++.++..++.||+.||+||| +++|+||||||+||+++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999866666999999999999999999999 6669999999999999854 899999999999774332
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......||+.|||||++.+..|+.++||||+||++|||++|..||.+.... ..+..+.......
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~~~i~~~~~~~------------- 375 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNM------------- 375 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCC-------------
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHhCCCCC-------------
Confidence 233457999999999999999999999999999999999999999763221 1111111111100
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||+.||++||++.|+++
T Consensus 376 --~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011123456889999999999999999999986
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=384.80 Aligned_cols=396 Identities=24% Similarity=0.298 Sum_probs=243.3
Q ss_pred CCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCC-------------CEEEcCCC
Q 002892 7 VPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL-------------QVLSLRNN 73 (870)
Q Consensus 7 ~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-------------~~L~L~~n 73 (870)
|.|+-.+.++|++|++++|++ +.+|++++++++|++|++++|.+++.+|..++.+.+| ++|++++|
T Consensus 3 ~~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~ 81 (454)
T 1jl5_A 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNL 81 (454)
T ss_dssp --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTS
T ss_pred ccccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCC
Confidence 345555679999999999999 5899999999999999999999999999999998875 99999999
Q ss_pred ccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccc
Q 002892 74 SFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPT 153 (870)
Q Consensus 74 ~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 153 (870)
.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ ++.. .++|++|++++|++++ +|
T Consensus 82 ~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp- 147 (454)
T 1jl5_A 82 GLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP- 147 (454)
T ss_dssp CCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-
T ss_pred cccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-
Confidence 9984 5552 3789999999999995 6754 3789999999999994 4432 1689999999999986 66
Q ss_pred cccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccc
Q 002892 154 TIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRH 233 (870)
Q Consensus 154 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~ 233 (870)
.+.++++|++|++++|++++ +|.. .++|++|++++|++++ +| .+.++++|++|++++|++++ +|... ++
T Consensus 148 ~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~ 216 (454)
T 1jl5_A 148 ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LS 216 (454)
T ss_dssp CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TT
T ss_pred ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Cc
Confidence 59999999999999999986 3433 4589999999999996 56 68999999999999999985 44432 58
Q ss_pred cccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCcc
Q 002892 234 LSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLR 313 (870)
Q Consensus 234 L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~ 313 (870)
|++|++++|.++.++ .+..+++|++|++++|++.++. + ...+++.|++++|.+++ +|.. ++
T Consensus 217 L~~L~l~~n~l~~lp----------~~~~l~~L~~L~l~~N~l~~l~-~----~~~~L~~L~l~~N~l~~-l~~~---~~ 277 (454)
T 1jl5_A 217 LESIVAGNNILEELP----------ELQNLPFLTTIYADNNLLKTLP-D----LPPSLEALNVRDNYLTD-LPEL---PQ 277 (454)
T ss_dssp CCEEECCSSCCSSCC----------CCTTCTTCCEEECCSSCCSSCC-S----CCTTCCEEECCSSCCSC-CCCC---CT
T ss_pred ccEEECcCCcCCccc----------ccCCCCCCCEEECCCCcCCccc-c----cccccCEEECCCCcccc-cCcc---cC
Confidence 999999999988543 3678899999999999998743 2 12455566666666554 3322 24
Q ss_pred CCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccc-cccceEecC
Q 002892 314 GLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSL-EYILRIDLS 392 (870)
Q Consensus 314 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls 392 (870)
+|+.|++++|++++. |. + .++|++|++++|++++. + .+ ++|+.|+++
T Consensus 278 ~L~~L~ls~N~l~~l-~~--------------------~------~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls 325 (454)
T 1jl5_A 278 SLTFLDVSENIFSGL-SE--------------------L------PPNLYYLNASSNEIRSL-C----DLPPSLEELNVS 325 (454)
T ss_dssp TCCEEECCSSCCSEE-SC--------------------C------CTTCCEEECCSSCCSEE-C----CCCTTCCEEECC
T ss_pred cCCEEECcCCccCcc-cC--------------------c------CCcCCEEECcCCcCCcc-c----CCcCcCCEEECC
Confidence 556666666655531 10 0 13566677777776642 1 22 366677777
Q ss_pred CCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccC--cccccccCCCCCCeEecCCCcccC
Q 002892 393 SNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD--SIPDSFGSLTSLEYLDLSNNNLSG 470 (870)
Q Consensus 393 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~ 470 (870)
+|++++ +|.. +++|++|++++|++++ +|. .+++|+.|++++|++++ .+|.++..+ +.|++.+
T Consensus 326 ~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~ 389 (454)
T 1jl5_A 326 NNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLA 389 (454)
T ss_dssp SSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC---
T ss_pred CCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhccccc
Confidence 777664 4443 3566777777777763 443 35667777777777766 455544432 2344444
Q ss_pred CCCcchhhccccceeeccCCcccc--cCCC
Q 002892 471 EIPKSFEILSHLKRLNVSHNRLEG--KIPT 498 (870)
Q Consensus 471 ~~p~~~~~l~~L~~L~ls~N~l~~--~~p~ 498 (870)
.+|.. +++|+.|++++|++++ .+|.
T Consensus 390 ~i~~~---~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 390 EVPEL---PQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp ------------------------------
T ss_pred ccccc---cCcCCEEECCCCcCCccccchh
Confidence 44442 3677788888888876 5664
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=372.00 Aligned_cols=283 Identities=34% Similarity=0.559 Sum_probs=231.9
Q ss_pred cchhHHHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 002892 575 TSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD 654 (870)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 654 (870)
+.+.++...+++|+..+.||+|+||.||+|++.+++.||+|++........+.+.+|++++++++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34556677889999999999999999999998889999999987766666778999999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN---YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997543 35899999999999999999999 56799999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc-chHHHHHHHhc-CCch
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE-MSLKHWIKLSL-PRGL 809 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~-~~~~ 809 (870)
+................||+.|+|||++.++.++.++||||||+++|||++|+.||......+ .....|..... ....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 987644333333344568999999999988899999999999999999999999997643322 22333332221 1223
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
...+++..... ...+++..+.+++.+||+.||++||++.||++.|+.+.+.
T Consensus 266 ~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTC-----SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccc-----cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 33333322211 1235677899999999999999999999999999988763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=369.51 Aligned_cols=276 Identities=21% Similarity=0.279 Sum_probs=215.3
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----eeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD----FKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l 658 (870)
..++|++.+.||+|+||.||+|+.. ++.||||++...... ....+.|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3468999999999999999999865 799999999765433 345567999999999999999999998744 4699
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CcEecccCCCceeeCCCCceEEec
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST----------PVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~----------~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
||||+++|+|.+++.... +++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999998654 899999999999999999999 55 899999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCCcccccC-----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 002892 729 FGISKLLGEDDDSVTQTMTMATIGYMAPEYASD-----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803 (870)
Q Consensus 729 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 803 (870)
||++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~- 253 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI- 253 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH-
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh-
Confidence 999987755444334444679999999999976 35667899999999999999999999764332211111000
Q ss_pred hcCCchhhhcc----hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 804 SLPRGLTEVVD----ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 804 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
.......++.+ ..........+....++..+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00111111111 1111111222233456778999999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.39 Aligned_cols=263 Identities=22% Similarity=0.391 Sum_probs=216.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467888999999999999999965 6899999998776667778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999987677999999999999999999999 6669999999999999999999999999998764332211
Q ss_pred c------------ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 002892 743 T------------QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810 (870)
Q Consensus 743 ~------------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 810 (870)
. .....||+.|+|||++.+..++.++||||||+++|||++|..||............ ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------~~~ 237 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVR 237 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------CHH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------hhh
Confidence 1 11456899999999999999999999999999999999999998653222111000 000
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...+... +..++..+.+++.+||+.||++||++.++++.|+++++..
T Consensus 238 ~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 238 GFLDRYC---------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHHHHTC---------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccccccC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111100 1123446889999999999999999999999999998765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.92 Aligned_cols=284 Identities=36% Similarity=0.536 Sum_probs=231.0
Q ss_pred ccccchhHHHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeee
Q 002892 572 WRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSC 650 (870)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~ 650 (870)
.+.+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 455788899999999999999999999999999988899999999876532 2223688999999999999999999999
Q ss_pred eeCCeeEEEEecCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEe
Q 002892 651 CNLDFKALVLEFMPNGSLEKWLYSHN---YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVS 727 (870)
Q Consensus 651 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 727 (870)
...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+..||+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998543 348999999999999999999996533489999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcc---ccccchHHHHHHHh
Q 002892 728 DFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM---FTGEMSLKHWIKLS 804 (870)
Q Consensus 728 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~---~~~~~~~~~~~~~~ 804 (870)
|||++........ .......||+.|+|||++.+..++.++||||+|+++|||++|+.||+.. .........|....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987643322 2233456899999999998889999999999999999999999999642 12233344555443
Q ss_pred cCCc-hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 805 LPRG-LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 805 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
.... .....+...... ...+++..+.+++..||+.+|++|||++||++.|++
T Consensus 256 ~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGN-----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTS-----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccc-----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 3332 333444333222 123567789999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=356.94 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=208.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 456899999999999999999985 4789999999987665566778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++|+|.+++.... +++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CCTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 999999999998653 899999999999999999999 66799999999999999999999999999987643322
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........+.
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~-------------- 235 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE-------------- 235 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC--------------
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC--------------
Confidence 2334579999999999999999999999999999999999999997532111 111111111110
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+..++..+.+++.+||+.||++||++.|+++
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0001123456889999999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=369.81 Aligned_cols=262 Identities=23% Similarity=0.409 Sum_probs=215.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec--------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCN 652 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 652 (870)
..++|++.+.||+|+||.||+|++. ++..||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3478899999999999999999852 35679999997653 34567799999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCcee
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 717 (870)
.+..|+||||+++|+|.+++...+ ..+++.+++.++.||+.||+||| +++|+||||||+||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence 999999999999999999998643 34799999999999999999999 667999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccch
Q 002892 718 LDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 796 (870)
Q Consensus 718 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~ 796 (870)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~ 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999987754443333444567889999999999999999999999999999999 99998763221 1
Q ss_pred HHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 797 LKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
+...+..... ...+..++..+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 314 ~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 LFKLLKEGHR-----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHHHTTCC-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCC-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111100 0011134557899999999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=377.54 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=215.3
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..++|++.+.||+|+||.||+|++. +++.||||+++... ......+.+|++++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4567888999999999999999976 78999999987543 334457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999977667999999999999999999999 66699999999999999999999999999986533222
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
........+++.|+|||++.++.++.++|||||||++|||++ |..||...... .....+.....
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------- 333 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGGR------------- 333 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTCC-------------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence 222222345778999999998899999999999999999998 99998763221 11111111000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...+..++..+.+++.+||+.+|++|||+.+|++.|+++++.+
T Consensus 334 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 334 ----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 0011124567899999999999999999999999999998875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.72 Aligned_cols=276 Identities=25% Similarity=0.394 Sum_probs=212.1
Q ss_pred hcCCCCCCeeccccceeEEEEEe-----cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-----FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 656 (870)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 3688999999987777777889999999999999999999999854 3568
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++|+|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999977767999999999999999999999 6679999999999999999999999999998764
Q ss_pred CCCCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch-hhhcc
Q 002892 737 EDDDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGL-TEVVD 814 (870)
Q Consensus 737 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 814 (870)
..... .......++..|+|||++.+..++.++||||||+++|||++|..|+...... ............. .....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence 43222 2223345778899999999999999999999999999999999998652111 0000000000000 00000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..+... .....+..++..+.+++.+||+.+|++|||+.|+++.|+++++.+
T Consensus 243 ~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhcc-CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111111 011112245678999999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=359.51 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=205.5
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
+....++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 344567899999999999999999986 58899999986543 344567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecccCCCceeeCCCCceEEecccccc
Q 002892 658 LVLEFMPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTP--VVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
+||||+++|+|.+++...+ ..+++..++.++.|++.||+||| +++ |+||||||+||+++.++.+||+|||++.
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999998543 23899999999999999999999 777 9999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+......
T Consensus 188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~~------ 257 (309)
T 3p86_A 188 LKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKCKR------ 257 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSCCC------
T ss_pred cccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCC------
Confidence 653221 22334568999999999999999999999999999999999999997632211 11111100000
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
...+..++..+.+++.+||+.+|++||++.++++.|+++.+...
T Consensus 258 ----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 258 ----------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 00011234568899999999999999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=350.47 Aligned_cols=281 Identities=29% Similarity=0.460 Sum_probs=227.1
Q ss_pred ccccchhHHHHhhcCCCCC------CeeccccceeEEEEEecCCcEEEEEEeechh----hHHHHHHHHHHHHHHhcCCC
Q 002892 572 WRRTSYLDIQQATDGFNEC------NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL----ERAFRSFESECEVLRNVRHR 641 (870)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~ 641 (870)
...+++.++..+++.|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567888899998888776 8999999999999985 58899999986532 34467899999999999999
Q ss_pred ceeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC
Q 002892 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH--NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD 719 (870)
Q Consensus 642 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 719 (870)
||+++++++...+..++||||+++++|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999999743 345899999999999999999999 66799999999999999
Q ss_pred CCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHH
Q 002892 720 KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH 799 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~ 799 (870)
+++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||........ ...
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLD 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHH
Confidence 999999999999987654433333444578999999998865 588999999999999999999999986433322 222
Q ss_pred HHHH--hcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 800 WIKL--SLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 800 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
+... .....+.+.++..+. .....++..+.+++.+||+.+|++||++.+|++.|+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMN------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCS------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhcccccc------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2221 112223333333221 1123457789999999999999999999999999999865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=361.61 Aligned_cols=261 Identities=28% Similarity=0.443 Sum_probs=211.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.++|++.+.||+|+||.||+|.+. .+..||||+++.. .....+.+.+|++++++++||||+++++++...+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467889999999999999999964 3456999999765 34455779999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999877667999999999999999999999 666999999999999999999999999999877543
Q ss_pred CCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 739 DDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 739 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .....+.....
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~---------- 272 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGYR---------- 272 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC----------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCC----------
Confidence 222 22233456788999999998999999999999999999999 99999753221 11111110000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...+..++..+.+++..||+.+|++||++.+|++.|+++.+..
T Consensus 273 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 -------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 0011134557899999999999999999999999999987653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=377.39 Aligned_cols=373 Identities=22% Similarity=0.232 Sum_probs=183.3
Q ss_pred CccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCC-------------cEEeccCCc
Q 002892 32 PNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSL-------------VRLDSRFNS 98 (870)
Q Consensus 32 p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~n~ 98 (870)
|+.+ ..++|++|++++|.+ +.+|..++.+++|++|++++|.+++.+|.+++++++| ++|++++|.
T Consensus 5 p~~~-~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~ 82 (454)
T 1jl5_A 5 PRNV-SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG 82 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred cccc-ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence 4444 468899999999999 5899999999999999999999998999999998876 666666666
Q ss_pred cccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCc
Q 002892 99 ISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPST 178 (870)
Q Consensus 99 i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 178 (870)
++ .+|.. .++|++|++++|.+++ +|.. +++|++|++++|++++. +.. .++|++|++++|++++ +| .
T Consensus 83 l~-~lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~ 148 (454)
T 1jl5_A 83 LS-SLPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-E 148 (454)
T ss_dssp CS-CCCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-C
T ss_pred cc-cCCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-c
Confidence 65 33331 2456666666666663 4432 24556666666655531 111 1355555555555554 33 1
Q ss_pred ccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccccc
Q 002892 179 MGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLS 258 (870)
Q Consensus 179 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~ 258 (870)
...+++|++|++++|++++ +|..+ .+|++|++++|++++ +| .|+++++|++|++++|.++.++..
T Consensus 149 -~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~-------- 213 (454)
T 1jl5_A 149 -LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL-------- 213 (454)
T ss_dssp -CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC--------
T ss_pred -cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC--------
Confidence 2335555555555555553 33322 355555555555553 23 355555555555555555443210
Q ss_pred ccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhh
Q 002892 259 SLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQ 338 (870)
Q Consensus 259 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 338 (870)
.++|++|++++|++. .+| .+..+++|+.|++++|++.+ +|.. +++
T Consensus 214 ----~~~L~~L~l~~n~l~--------------------------~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~ 258 (454)
T 1jl5_A 214 ----PLSLESIVAGNNILE--------------------------ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPS 258 (454)
T ss_dssp ----CTTCCEEECCSSCCS--------------------------SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTT
T ss_pred ----cCcccEEECcCCcCC--------------------------ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccc
Confidence 124555555555444 334 36667777777777777764 3332 133
Q ss_pred HHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCC-ccCCEEEccC
Q 002892 339 LQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNL-KVLIYLNLSR 417 (870)
Q Consensus 339 L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~ 417 (870)
|+.|++++|....+|.. .++|++|++++|++++. |.. .++|+.|++++|++++ ++ .+ ++|++|++++
T Consensus 259 L~~L~l~~N~l~~l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~ 326 (454)
T 1jl5_A 259 LEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSN 326 (454)
T ss_dssp CCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCS
T ss_pred cCEEECCCCcccccCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCC
Confidence 44444443322233332 24566666666666642 111 1456666666666663 22 22 3666666666
Q ss_pred CccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccC--CCCcchhhccccceeeccCCccccc
Q 002892 418 NQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG--EIPKSFEILSHLKRLNVSHNRLEGK 495 (870)
Q Consensus 418 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~ 495 (870)
|++++ +|.. +++|+.|++++|++++ +|. .+++|+.|+|++|++++ .+|..+.. ++.|.+.|.
T Consensus 327 N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~ 390 (454)
T 1jl5_A 327 NKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAE 390 (454)
T ss_dssp SCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC----
T ss_pred Ccccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccc
Confidence 66664 3332 3566666666666663 444 35666666666666665 44544332 234555565
Q ss_pred CCC
Q 002892 496 IPT 498 (870)
Q Consensus 496 ~p~ 498 (870)
+|.
T Consensus 391 i~~ 393 (454)
T 1jl5_A 391 VPE 393 (454)
T ss_dssp ---
T ss_pred ccc
Confidence 554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=352.06 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=213.2
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 467889999999999999999988899999999976542 2367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
++++|.+++......+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||++....... ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 163 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence 999999999877777999999999999999999999 6669999999999999999999999999998664321 122
Q ss_pred ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||...... .....+......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~--------------- 226 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL--------------- 226 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC---------------
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccC---------------
Confidence 233456788999999998999999999999999999999 99998753221 111111110000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00011244688999999999999999999999999998864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=351.29 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=213.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..++|++.+.||+|+||.||+|+..++..||+|+++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4568999999999999999999988888999999976543 236688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++++|.+++...+..+++..++.++.|++.|++||| ++||+||||||+||+++.++.+||+|||.+........ .
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V 160 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence 9999999999877667999999999999999999999 66799999999999999999999999999987644332 2
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||........ .........
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~~--------------- 223 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--VLKVSQGHR--------------- 223 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHTTCC---------------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--HHHHHcCCC---------------
Confidence 2334456788999999998899999999999999999999 9999875322111 110000000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
...+..++..+.+++..||+.+|++|||+.++++.|+++++.
T Consensus 224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 --LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000111234688999999999999999999999999998765
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=367.18 Aligned_cols=362 Identities=21% Similarity=0.227 Sum_probs=234.9
Q ss_pred ccCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCC
Q 002892 5 GTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLF 84 (870)
Q Consensus 5 ~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 84 (870)
+..+..++++++|++|++++|++++ +| .+..+++|++|++++|++++ +| ++.+++|++|+|++|+|++ ++ ++
T Consensus 32 ~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~ 103 (457)
T 3bz5_A 32 ATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VT 103 (457)
T ss_dssp TTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CT
T ss_pred cccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cC
Confidence 4444556677777777777777775 34 57777777777777777774 33 6777777777777777774 33 77
Q ss_pred CCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEE
Q 002892 85 NLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIII 164 (870)
Q Consensus 85 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 164 (870)
++++|++|++++|++++ +| ++.+++|++|++++|++++ ++ ++.+++|++|++++|+..+.+ .+..+++|++|
T Consensus 104 ~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L 175 (457)
T 3bz5_A 104 PLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL 175 (457)
T ss_dssp TCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEE
Confidence 77777777777777774 33 6777777777777777774 32 667777777777777544444 35566666666
Q ss_pred EeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccc
Q 002892 165 NLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244 (870)
Q Consensus 165 ~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l 244 (870)
++++|++++. | ...+++|+.|++++|++++. .+..+++|++|++++|++++ +| ++.+++|+.|++++|.+
T Consensus 176 ~ls~n~l~~l-~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l 245 (457)
T 3bz5_A 176 DCSFNKITEL-D---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPL 245 (457)
T ss_dssp ECCSSCCCCC-C---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCC
T ss_pred ECCCCcccee-c---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcC
Confidence 6666666653 2 22345555555555555543 25555555555555555554 23 45555555555555555
Q ss_pred ccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCC
Q 002892 245 TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTND 324 (870)
Q Consensus 245 ~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~ 324 (870)
+.++ +..+++|+.|++++|++ +.|++++|.
T Consensus 246 ~~~~-----------~~~l~~L~~L~l~~n~L---------------------------------------~~L~l~~n~ 275 (457)
T 3bz5_A 246 TELD-----------VSTLSKLTTLHCIQTDL---------------------------------------LEIDLTHNT 275 (457)
T ss_dssp SCCC-----------CTTCTTCCEEECTTCCC---------------------------------------SCCCCTTCT
T ss_pred CCcC-----------HHHCCCCCEEeccCCCC---------------------------------------CEEECCCCc
Confidence 4422 22334444444444322 222333333
Q ss_pred ccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccc
Q 002892 325 LNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI 404 (870)
Q Consensus 325 l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 404 (870)
+ .+.+| ++.+++|+.|+|++|...+.+|. ...+|+.|++++|
T Consensus 276 ~-----------------------~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~---------- 317 (457)
T 3bz5_A 276 Q-----------------------LIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN---------- 317 (457)
T ss_dssp T-----------------------CCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC----------
T ss_pred c-----------------------CCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc----------
Confidence 2 23333 34567788888888877666653 3345555555544
Q ss_pred cCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccce
Q 002892 405 QNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKR 484 (870)
Q Consensus 405 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 484 (870)
++|++|+|++|+|++. .++++++|+.|++++|++++ ++.|+.|++++|+++|. ..+..|..
T Consensus 318 ---~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~ 378 (457)
T 3bz5_A 318 ---PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPK 378 (457)
T ss_dssp ---TTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCC
T ss_pred ---ccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCc
Confidence 6789999999999874 38889999999999999886 35677888999999875 35678888
Q ss_pred eeccCCcccccCCCC
Q 002892 485 LNVSHNRLEGKIPTN 499 (870)
Q Consensus 485 L~ls~N~l~~~~p~~ 499 (870)
+++++|+++|.+|..
T Consensus 379 l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 379 ETLTNNSLTIAVSPD 393 (457)
T ss_dssp BCCBTTBEEEECCTT
T ss_pred cccccCcEEEEcChh
Confidence 999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.46 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=210.5
Q ss_pred ccchhHHHHhhcC----------CCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc
Q 002892 574 RTSYLDIQQATDG----------FNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN 642 (870)
Q Consensus 574 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n 642 (870)
.+++.+++.+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3455565555543 666779999999999999976 79999999998766666678899999999999999
Q ss_pred eeEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC
Q 002892 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722 (870)
Q Consensus 643 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 722 (870)
|+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence 999999999999999999999999999998754 4899999999999999999999 56799999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 002892 723 TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 802 (870)
.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.
T Consensus 179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~ 254 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLR 254 (321)
T ss_dssp CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHH
T ss_pred cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh
Confidence 999999999987643322 22345699999999999999999999999999999999999999975311 11111111
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+.... ....++..+.+++.+||+.||++||++.|+++
T Consensus 255 ~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 255 DSPPPKLK---------------NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HSSCCCCT---------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCCcC---------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111000 01122446889999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.57 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=206.0
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
....++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 33457899999999999999999996 579999999997653 345577889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999999986544 899999999999999999999 66799999999999999999999999999986643
Q ss_pred CCCcccccccccccccCCcccccCCCcC-cccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIIS-PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.. ......||+.|+|||++.+..++ .++||||+||++|||++|+.||+..... .....+..
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~------------- 228 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLR------------- 228 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-------------
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-------------
Confidence 22 33445799999999999887765 7999999999999999999999763211 11111100
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... +..++..+.+++.+||+.||++|||+.|+++
T Consensus 229 --~~~~~---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 229 --GKYRI---PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCCCC---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCC---CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0012346889999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=365.21 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=202.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999864 57789999997653 3455779999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++|+|.+++...+..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999987777999999999999999999999 566999999999999999999999999999876433
Q ss_pred CCcc-cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 739 DDSV-TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 739 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+. ..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~------------~~ 266 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVD------------EG 266 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHH------------TT
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH------------cC
Confidence 2211 1222345778999999999999999999999999999998 99998753211 1111111 00
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
.. ...+..++..+.+++.+||+.+|++||++.+|++.|+++.+..
T Consensus 267 ~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 YR-----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp EE-----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CC-----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 00 0011134567899999999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=351.50 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=208.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4578999999999999999999965 68899999987553 334668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC--CCceEEeccccccccCCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK--NMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~ 739 (870)
|+++|+|.+++......+++.++..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999877667999999999999999999999 667999999999999987 7899999999998764332
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......||+.|+|||++.+..++.++||||+||++|+|++|..||...... .....+.......
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~------------ 222 (321)
T 1tki_A 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTF------------ 222 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCC------------
T ss_pred ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCCC------------
Confidence 233456899999999999988999999999999999999999999763211 1111111111100
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||..||++|||+.|+++
T Consensus 223 ---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111123557899999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=361.55 Aligned_cols=272 Identities=24% Similarity=0.372 Sum_probs=218.7
Q ss_pred ccchhHHHHhhcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeE
Q 002892 574 RTSYLDIQQATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIK 645 (870)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~ 645 (870)
.+.........++|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344555666778999999999999999999973 246789999997643 34456789999999999 7899999
Q ss_pred EeeeeeeCC-eeEEEEecCCCCCHHHHHhhcCC-----------------------------------------------
Q 002892 646 IFSSCCNLD-FKALVLEFMPNGSLEKWLYSHNY----------------------------------------------- 677 (870)
Q Consensus 646 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 677 (870)
+++++.+.+ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999988755 48999999999999999985432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 678 ------------------FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 678 ------------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
.+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 2899999999999999999999 6679999999999999999999999999998775544
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .............
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~--------- 317 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMRA--------- 317 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCCC---------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCCC---------
Confidence 4444555678999999999999999999999999999999998 9999976332221 1111111110000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
+..++..+.+++..||+.+|++||++.||++.|+++.+..
T Consensus 318 --------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 318 --------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0112346889999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.40 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=211.0
Q ss_pred HhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
...++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++...+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 445789999999999999999999988889999999765322 3668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 175 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y 175 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-H
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-c
Confidence 99999999999876666999999999999999999999 6679999999999999999999999999998764321 1
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ....+......
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~------------- 240 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLRL------------- 240 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCCC-------------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhcccCC-------------
Confidence 12233456788999999998899999999999999999998 999997632211 11111100000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 241 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00011234688999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=362.68 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=215.7
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec--------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeee
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCC 651 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 651 (870)
...++|++.+.||+|+||.||+|+.. ++..||||+++... ......+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999852 23579999997653 34457789999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCce
Q 002892 652 NLDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716 (870)
Q Consensus 652 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 716 (870)
..+..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 9999999999999999999998653 35899999999999999999999 66799999999999
Q ss_pred eeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccc
Q 002892 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEM 795 (870)
Q Consensus 717 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~ 795 (870)
+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~ 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--E 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 999999999999999987755444344445567899999999999999999999999999999999 9999875321 1
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
.....+...... . .+..++..+.+++.+||+.+|++||++.||++.|+++.+..
T Consensus 301 ~~~~~~~~~~~~------------~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 301 ELFKLLKEGHRM------------D-----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHTTCCC------------C-----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCCCC------------C-----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 111111111000 0 01123457899999999999999999999999999998653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=356.81 Aligned_cols=259 Identities=24% Similarity=0.443 Sum_probs=203.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcE----EEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTN----VAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357889999999999999999854 4444 5777775433 344577899999999999999999999998754 78
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+|+||+++|+|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 899999999999999987777999999999999999999999 56799999999999999999999999999987765
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||+..... .....+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~--------- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL--------- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC---------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCCCC---------
Confidence 544444445567889999999999999999999999999999999 99999763222 122211111000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 00112345688999999999999999999999999988753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.33 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=211.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.++|++.+.||+|+||.||+|++. +++.||||+++.. .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467889999999999999999843 4678999998654 244456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC---ceEEe
Q 002892 657 ALVLEFMPNGSLEKWLYSHN------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---TARVS 727 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 727 (870)
++||||+++|+|.+++...+ ..+++.+++.++.|++.||+||| ++||+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998543 45899999999999999999999 66799999999999999555 59999
Q ss_pred ccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcC
Q 002892 728 DFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLP 806 (870)
Q Consensus 728 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 806 (870)
|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||..... ......+.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~~ 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGGR 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC
Confidence 9999976533332333344567899999999999999999999999999999998 9999875321 111111111000
Q ss_pred CchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 807 RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
...+..++..+.+++.+||+.+|++||++.+|++.|+.+.+...
T Consensus 305 -----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 305 -----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -----------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 00011234568899999999999999999999999999887543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=347.94 Aligned_cols=264 Identities=25% Similarity=0.437 Sum_probs=199.8
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
+...++|++.+.||+|+||.||+|+.. ..||+|+++... ....+.+.+|++++++++||||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 344678999999999999999999854 469999986543 44567899999999999999999999965 4566899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++++|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999999877777999999999999999999999 666999999999999999999999999999866543
Q ss_pred CCcccccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 739 DDSVTQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
..........||+.|+|||++. +..++.++||||+|+++|||++|+.||......+...........+.....+
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 250 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV--- 250 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS---
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc---
Confidence 3333344456899999999986 5678889999999999999999999997643322211111111111111110
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
...++..+.+++.+||+.+|++||++.++++.|+++.+
T Consensus 251 -----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 251 -----------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11235678999999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=361.30 Aligned_cols=266 Identities=23% Similarity=0.375 Sum_probs=214.1
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 652 (870)
.....++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999964 34889999997653 3445779999999999999999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHN-----------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHC 709 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~ 709 (870)
.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 999999999999999999998632 46899999999999999999999 6679999
Q ss_pred ccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCC
Q 002892 710 NLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTD 788 (870)
Q Consensus 710 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~ 788 (870)
||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987644333333344568899999999998899999999999999999999 999987
Q ss_pred ccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 789 EMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
..... .....+.... .. ..+..++..+.+++..||+.+|++||++.++++.|+++.+.+.
T Consensus 279 ~~~~~--~~~~~~~~~~-----------~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHE--EVIYYVRDGN-----------IL------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHH--HHHHHHHTTC-----------CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChH--HHHHHHhCCC-----------cC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 53211 1111111000 00 0011234578999999999999999999999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=353.15 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=215.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 457889999999999999999985 245789999997643 3455778999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC
Q 002892 656 KALVLEFMPNGSLEKWLYSHN-----------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLK 712 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 712 (870)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+||| +++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence 999999999999999998543 23899999999999999999999 5669999999
Q ss_pred CCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccc
Q 002892 713 PNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMF 791 (870)
Q Consensus 713 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~ 791 (870)
|+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||+|+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755444334444567889999999999899999999999999999999 999997632
Q ss_pred cccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 792 TGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
.. .....+....... .+..++..+.+++.+||+.||++||++.++++.|+++.+.
T Consensus 258 ~~--~~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PE--RLFNLLKTGHRME-----------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG--GHHHHHHTTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH--HHHHHhhcCCcCC-----------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 1111111110000 0112345789999999999999999999999999998765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=352.73 Aligned_cols=253 Identities=19% Similarity=0.311 Sum_probs=204.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 789999999865432 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++..+......
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999987554 3899999999999999999999 667999999999999999999999999999876433333
Q ss_pred ccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||............+.......
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 228 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------- 228 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-------------
Confidence 33345679999999999987765 7799999999999999999999976433333222222111100
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....++..+.+++.+||+.||++|||+.|+++
T Consensus 229 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001123446789999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=346.62 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=207.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech---hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ---LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999864 6899999998543 244567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999998654 4899999999999999999999 6679999999999999999999999999998764322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||............ .....+. ... .
T Consensus 166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~-~~~----~--- 235 (294)
T 4eqm_A 166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDSVPN-VTT----D--- 235 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH-HSSCCCC-HHH----H---
T ss_pred c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hhccCCC-cch----h---
Confidence 1 2223456899999999999999999999999999999999999999763221111000 0000000 000 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHhH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-CMTDVVVKLQKIKQT 865 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~i~~~ 865 (870)
....++..+.+++.+|++.+|++|| +++++.+.|+++...
T Consensus 236 ------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 236 ------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0112345789999999999999999 999999999877543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.52 Aligned_cols=271 Identities=14% Similarity=0.154 Sum_probs=211.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC------CcEEEEEEeechhhHH-----------HHHHHHHHHHHHhcCCCceeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD------GTNVAIKVFNLQLERA-----------FRSFESECEVLRNVRHRNLIK 645 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 645 (870)
..++|++.+.||+|+||.||+|.+.+ ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 4789999987653211 112344566677888999999
Q ss_pred EeeeeeeC----CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC--
Q 002892 646 IFSSCCNL----DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-- 719 (870)
Q Consensus 646 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-- 719 (870)
+++++... ...++||||+ +++|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99998764 4579999999 99999999987677999999999999999999999 66799999999999998
Q ss_pred CCCceEEeccccccccCCCCCc-----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc
Q 002892 720 KNMTARVSDFGISKLLGEDDDS-----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~ 794 (870)
.++.+||+|||++..+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 8899999999999876432211 1113345999999999999999999999999999999999999999863322
Q ss_pred chHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 795 MSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
.....+..........++.+..+.. ..++..+.+++..||+.+|++||++.+|++.|+++.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPA--------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCT--------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhhhHHHHHHHhccc--------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 2222222222223333333333211 123557899999999999999999999999999988764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.96 Aligned_cols=266 Identities=24% Similarity=0.400 Sum_probs=205.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHh--cCCCceeEEeeeeee----CCee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRN--VRHRNLIKIFSSCCN----LDFK 656 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~ 656 (870)
..++|++.+.||+|+||.||+|+. +++.||||++..... ..+..|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999987 689999999875432 344556666655 799999999998654 3467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS-----HSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
++||||+++|+|.++++.. .+++..++.++.|++.||+|||.. ++++|+||||||+||+++.++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 8999999999999999654 489999999999999999999932 245699999999999999999999999999
Q ss_pred ccccCCCCCcc--cccccccccccCCcccccCC------CcCcccchHhHHHHHHHHHhC----------CCCCCccccc
Q 002892 732 SKLLGEDDDSV--TQTMTMATIGYMAPEYASDG------IISPKCDVYSYGVLLMETFTR----------KKPTDEMFTG 793 (870)
Q Consensus 732 a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslG~il~elltg----------~~p~~~~~~~ 793 (870)
+.......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 97664333221 12334789999999999876 456799999999999999999 7887664443
Q ss_pred cchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 794 EMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
......+......... ............++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQ--------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCC--------CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCC--------CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3333332221111110 001111122234677899999999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.34 Aligned_cols=270 Identities=21% Similarity=0.306 Sum_probs=207.9
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
+...++|++.+.||+|+||+||+|+..+|+.||+|++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34567899999999999999999998889999999987543 2234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||++ +++.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...+..
T Consensus 97 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 97 VFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 999997 4898888877777999999999999999999999 667999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh---cCCchhhhcc
Q 002892 739 DDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS---LPRGLTEVVD 814 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 814 (870)
. .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ ....+.... .+..+....+
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTT
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhc
Confidence 2 22334568999999999876 568999999999999999999999998643332 223322211 1111111111
Q ss_pred hhhhc-----ccC-cch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVR-----EVQ-PSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~-----~~~-~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... ... ... ....+..++.+++.+|++.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 000 000 01123456889999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=355.52 Aligned_cols=266 Identities=24% Similarity=0.410 Sum_probs=197.2
Q ss_pred HHHHhhcCCCCCCeeccccceeEEEEEecC-Cc---EEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 002892 579 DIQQATDGFNECNLLGAGSFGSVYKGTLFD-GT---NVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652 (870)
Q Consensus 579 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 652 (870)
+.....++|++.+.||+|+||.||+|+... ++ .||||+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344556789999999999999999998653 32 7999999765 34456789999999999999999999999987
Q ss_pred CCee------EEEEecCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC
Q 002892 653 LDFK------ALVLEFMPNGSLEKWLYSHN-----YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN 721 (870)
Q Consensus 653 ~~~~------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 721 (870)
.... ++||||+++|+|.+++.... ..+++..++.++.|++.||+||| ++||+||||||+||+++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCC
Confidence 6655 89999999999999997432 25899999999999999999999 6679999999999999999
Q ss_pred CceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHH
Q 002892 722 MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHW 800 (870)
Q Consensus 722 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~ 800 (870)
+.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ ....+
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~ 252 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IYNYL 252 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HHHHH
Confidence 9999999999987754443334445567889999999999999999999999999999999 899987632221 11111
Q ss_pred HHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...... ..+..++..+.+++.+||+.||++||++.++++.|+++.+.-
T Consensus 253 ~~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 IGGNRL------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HTTCCC------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCCCC------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 100000 001123457899999999999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.75 Aligned_cols=248 Identities=26% Similarity=0.318 Sum_probs=203.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +|+.||+|++++.. ......+.+|++++++++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999965 68999999997653 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+ .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999998654 4899999999999999999999 6679999999999999999999999999998643221
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. .
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~---------------~ 220 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM---------------E 220 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---------------C
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHc---------------C
Confidence 223345799999999999999999999999999999999999999975211 111111100 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
... + +..++..+.+++.+||+.||++|| ++.|+++
T Consensus 221 ~~~--~-p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 221 EIR--F-PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCC--C-CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCC--C-CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 000 0 012245688999999999999999 8998875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.44 Aligned_cols=265 Identities=15% Similarity=0.127 Sum_probs=214.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+++++++ +|++++++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356799999999999999999995 5789999999865432 24578899999999 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc-----eEEecccccccc
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT-----ARVSDFGISKLL 735 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~a~~~ 735 (870)
||+ +++|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||++...
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 99999999977667999999999999999999999 777999999999999987776 999999999877
Q ss_pred CCCCCc-----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccch--HHHHHHHhcCCc
Q 002892 736 GEDDDS-----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMS--LKHWIKLSLPRG 808 (870)
Q Consensus 736 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~ 808 (870)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543221 1234456899999999999999999999999999999999999999764322111 111111100000
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
.. .....++..+.+++..||+.+|++||++++|++.|+++.+...
T Consensus 242 ~~--------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 242 LR--------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HH--------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HH--------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 00 0011235678999999999999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.24 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=205.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhH------HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
..+.|++.+.||+|+||.||+|... +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999965 6899999999765321 34678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC----ceEEecccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM----TARVSDFGI 731 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~ 731 (870)
.++||||+++|+|.+++...+ .+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999997654 4899999999999999999999 56799999999999998877 799999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
+....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.... .....+......
T Consensus 166 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~----- 236 (361)
T 2yab_A 166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITAVSYD----- 236 (361)
T ss_dssp CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCC-----
T ss_pred ceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCC-----
Confidence 98764322 223456999999999999999999999999999999999999999753211 111111110000
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
++ .......+..+.+++.+||..||++|||+.|+++
T Consensus 237 -~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FD---------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CC---------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CC---------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0011123456889999999999999999999975
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=358.33 Aligned_cols=346 Identities=28% Similarity=0.415 Sum_probs=198.1
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEE
Q 002892 38 LRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLN 117 (870)
Q Consensus 38 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 117 (870)
+++++.|++++|.++ .+|. +..+++|++|+|++|.+++. +. +.++++|++|++++|.+++..+ ++.+++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 445555555555555 3332 44555555555555555532 22 5555555555555555553222 55555555555
Q ss_pred eecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccc
Q 002892 118 FADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLT 197 (870)
Q Consensus 118 l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 197 (870)
+++|++++..+ +..+++|++|++++|++.+. + .+..+++|++|+++ |.+.+..
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~---------------------- 171 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK---------------------- 171 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG----------------------
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch----------------------
Confidence 55555553222 55555555555555555432 1 24555555555553 2222111
Q ss_pred cccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCC
Q 002892 198 GTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277 (870)
Q Consensus 198 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (870)
.+.++++|++|++++|.+++. ..+..+++|++|++++|.++... .+..+++|+.|++++|++.
T Consensus 172 -----~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~----------~~~~l~~L~~L~l~~n~l~ 234 (466)
T 1o6v_A 172 -----PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDIT----------PLGILTNLDELSLNGNQLK 234 (466)
T ss_dssp -----GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG----------GGGGCTTCCEEECCSSCCC
T ss_pred -----hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccc----------cccccCCCCEEECCCCCcc
Confidence 133344444444444444421 12444444444444444444321 1334455555555555544
Q ss_pred CCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCccccc
Q 002892 278 SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLS 357 (870)
Q Consensus 278 ~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~ 357 (870)
++ ..+..+++|+.|++++|.+.+..+ +.
T Consensus 235 ~~---------------------------~~l~~l~~L~~L~l~~n~l~~~~~-------------------------~~ 262 (466)
T 1o6v_A 235 DI---------------------------GTLASLTNLTDLDLANNQISNLAP-------------------------LS 262 (466)
T ss_dssp CC---------------------------GGGGGCTTCSEEECCSSCCCCCGG-------------------------GT
T ss_pred cc---------------------------hhhhcCCCCCEEECCCCccccchh-------------------------hh
Confidence 21 124445566666666666553211 34
Q ss_pred CccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEE
Q 002892 358 SLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITL 437 (870)
Q Consensus 358 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 437 (870)
.+++|++|++++|++++..+ +..+++|+.|++++|++++..| +..+++|+.|+|++|++++..| +..+++|+.|
T Consensus 263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 45667777777777765444 6677777777777777775433 6777788888888888876655 6777888888
Q ss_pred EcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCccccc
Q 002892 438 SLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGK 495 (870)
Q Consensus 438 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 495 (870)
++++|.+++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++.
T Consensus 337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 8888888764 457788888888888888886666 77788888888888888773
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.80 Aligned_cols=274 Identities=25% Similarity=0.396 Sum_probs=208.3
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHh--cCCCceeEEeeeeeeC----
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRN--VRHRNLIKIFSSCCNL---- 653 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~---- 653 (870)
.....++|++.+.||+|+||.||+|+.. ++.||||++..... ..+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445678999999999999999999875 89999999865432 233445555544 4899999999999876
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecccCCCceeeCCCCceEEec
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS-----HSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
...++||||+++|+|.++++... +++..++.++.|++.||+|||.. +..+|+||||||+||+++.++.+||+|
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 68899999999999999997653 89999999999999999999943 112899999999999999999999999
Q ss_pred cccccccCCCCCcc--cccccccccccCCcccccCCCcCcc------cchHhHHHHHHHHHhC----------CCCCCcc
Q 002892 729 FGISKLLGEDDDSV--TQTMTMATIGYMAPEYASDGIISPK------CDVYSYGVLLMETFTR----------KKPTDEM 790 (870)
Q Consensus 729 fg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------sDvwslG~il~elltg----------~~p~~~~ 790 (870)
||++..+....... ......||+.|+|||++.+...+.+ +|||||||++|||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99997664332221 1224568999999999987766655 9999999999999999 5666544
Q ss_pred ccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 791 FTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
.........+....... .........+....++..+.+++.+||+.||++||++.+|++.|+++.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIK--------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SCSSCCHHHHHHHHTTS--------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cCCCCchhhhHHHHhhh--------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 33332222222111111 1111112223334678889999999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.81 Aligned_cols=262 Identities=15% Similarity=0.158 Sum_probs=211.8
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999995 5789999999875432 24578899999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc-----eEEeccccccccC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT-----ARVSDFGISKLLG 736 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~ 736 (870)
|+ +++|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||++..+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 99999999976667999999999999999999999 667999999999999998887 9999999998764
Q ss_pred CCCCcc-----cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccc--hHHHHHHHhcCCch
Q 002892 737 EDDDSV-----TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM--SLKHWIKLSLPRGL 809 (870)
Q Consensus 737 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 809 (870)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+.....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP- 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence 332211 12345799999999999999999999999999999999999999986422211 0111111000000
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
.......++ .+.+++..||+.+|++||++++|.+.|+++.+..
T Consensus 241 -------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 -------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000001124 7899999999999999999999999999887754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=343.18 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=212.8
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 4678899999999999999999888899999999765432 367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
++++|.+++...+..+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 161 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence 999999999977667999999999999999999999 6669999999999999999999999999998664221 112
Q ss_pred ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+......
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~~--------------- 224 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRL--------------- 224 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC---------------
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCcC---------------
Confidence 233456788999999998899999999999999999999 89998753211 111111110000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 225 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00011245688999999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.69 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=216.7
Q ss_pred HhhcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL 653 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 653 (870)
...++|++.+.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999984 356889999997653 23457789999999999 999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCce
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNY-----------------FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNI 716 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 716 (870)
+..++||||+++|+|.+++...+. .+++..++.++.|++.||+||| ++||+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence 999999999999999999986542 4899999999999999999999 66799999999999
Q ss_pred eeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccc
Q 002892 717 LLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEM 795 (870)
Q Consensus 717 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~ 795 (870)
+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 999999999999999987765444334444567889999999998999999999999999999999 999987643221
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
............ . .+..++..+.+++.+||+.+|++||++.|+++.|+++.+..
T Consensus 256 ~~~~~~~~~~~~------------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 KFYKMIKEGFRM------------L-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHHHTCCC------------C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHhccCCCC------------C-----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 111111111100 0 01123457899999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.04 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=201.3
Q ss_pred HhhcCCCCCCeeccccceeEEEEEecC----CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
...++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 445789999999999999999998642 4579999987543 344567899999999999999999999984 4678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++++|.+++...+..+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999999977767999999999999999999999 6679999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... .......+++.|+|||++.+..++.++||||+|+++|||++ |..||......+ ....+......
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~~~-------- 236 (281)
T 1mp8_A 168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERL-------- 236 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCC--------
T ss_pred cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCCCC--------
Confidence 3322 12233456789999999998899999999999999999997 999997632221 11111110000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..+..++..+.+++.+||+.+|++||++.++++.|+++.+..
T Consensus 237 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 001123457889999999999999999999999999998764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=364.12 Aligned_cols=320 Identities=20% Similarity=0.198 Sum_probs=158.6
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecC
Q 002892 42 KFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121 (870)
Q Consensus 42 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N 121 (870)
+.++.+++.++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 34555555555 4454332 35555555555555544555555555555555555555444555555555555555555
Q ss_pred ccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccC
Q 002892 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIP 201 (870)
Q Consensus 122 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 201 (870)
++++..+..|.++++|++|+|++|++++..+..+..+++|++|++++|+ +++..+
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~-------------------------l~~~~~ 145 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND-------------------------LVYISH 145 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTT-------------------------CCEECT
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCc-------------------------cceeCh
Confidence 5554333444555555555555555444333333333333333333333 333334
Q ss_pred CcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCC
Q 002892 202 NSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILP 281 (870)
Q Consensus 202 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 281 (870)
..|..+++|++|+|++|++++..+..|.++++|+.|+|++|.+..+.
T Consensus 146 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~--------------------------------- 192 (477)
T 2id5_A 146 RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR--------------------------------- 192 (477)
T ss_dssp TSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC---------------------------------
T ss_pred hhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC---------------------------------
Confidence 44555555555555555555444444444444444444444443221
Q ss_pred ccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccc
Q 002892 282 PLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLIS 361 (870)
Q Consensus 282 ~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~ 361 (870)
+..+..+++|+.|++++|...+.+|.. .....+
T Consensus 193 ------------------------~~~~~~l~~L~~L~l~~~~~~~~~~~~-----------------------~~~~~~ 225 (477)
T 2id5_A 193 ------------------------DYSFKRLYRLKVLEISHWPYLDTMTPN-----------------------CLYGLN 225 (477)
T ss_dssp ------------------------TTCSCSCTTCCEEEEECCTTCCEECTT-----------------------TTTTCC
T ss_pred ------------------------hhhcccCcccceeeCCCCccccccCcc-----------------------cccCcc
Confidence 122334445555555555443333221 111235
Q ss_pred cceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCC
Q 002892 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR 441 (870)
Q Consensus 362 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 441 (870)
|+.|+|++|++++..+..|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++
T Consensus 226 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 305 (477)
T 2id5_A 226 LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305 (477)
T ss_dssp CSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCS
T ss_pred ccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCC
Confidence 66666666666544444555555555555555555544444455555555555555555554455555555555555555
Q ss_pred CcccCcccccccCCCCCCeEecCCCccc
Q 002892 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 442 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 469 (870)
|++++..+..|..+++|+.|+|++|.++
T Consensus 306 N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp SCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred CcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 5555444444455555555555555544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.75 Aligned_cols=263 Identities=22% Similarity=0.352 Sum_probs=211.5
Q ss_pred HhhcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL 653 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 653 (870)
...++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999985 245689999997543 33456789999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNY----------------------FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl 711 (870)
+..++||||+++|+|.+++...+. .+++..++.++.|++.||+||| ++||+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 999999999999999999986542 3789999999999999999999 667999999
Q ss_pred CCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCcc
Q 002892 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEM 790 (870)
Q Consensus 712 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~ 790 (870)
||+||+++.++.+||+|||++................||+.|+|||++.++.++.++||||||+++|||+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654443334445567889999999998999999999999999999998 99999764
Q ss_pred ccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 791 FTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
... .............. .+..++..+.+++..||+.||++||++.++++.|+.+.+.
T Consensus 279 ~~~-~~~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVD-ANFYKLIQNGFKMD-----------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCS-HHHHHHHHTTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcH-HHHHHHHhcCCCCC-----------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 222 11222111111000 0112345789999999999999999999999999988664
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=353.89 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=208.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3468999999999999999999865 689999999987655556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC--CCceEEeccccccccCCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK--NMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~ 739 (870)
|+++|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||++.......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999999877667999999999999999999999 667999999999999974 4789999999998764332
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......||+.|+|||++.+..++.++||||+||++|||++|..||..... ......+....+.. +.
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~~------~~---- 271 (387)
T 1kob_A 206 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEF------DE---- 271 (387)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHCCCCC------CS----
T ss_pred ---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC------Cc----
Confidence 22334689999999999999999999999999999999999999975321 11111111111000 00
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....++..+.+++.+||+.||++||++.|+++
T Consensus 272 -----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001123456889999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=342.16 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=201.8
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.++|++.+.||+|+||.||+|++. ++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 457888999999999999999865 789999998654 33467899999999999999999999887 4479999999
Q ss_pred CCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc-eEEeccccccccCCCCC
Q 002892 664 PNGSLEKWLYSHNY--FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT-ARVSDFGISKLLGEDDD 740 (870)
Q Consensus 664 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~~ 740 (870)
++|+|.+++..... .+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999985542 4789999999999999999999644478999999999999998886 799999999765322
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+....................
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 224 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP------------ 224 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC------------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC------------
Confidence 22345899999999999999999999999999999999999999764322211111111100000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
....++..+.+++.+||+.+|++||++.++++.|+++.+.+
T Consensus 225 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 225 -----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp -----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred -----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 00123456889999999999999999999999999988754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.13 Aligned_cols=262 Identities=23% Similarity=0.417 Sum_probs=213.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec--------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF--------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCN 652 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 652 (870)
..++|++.+.||+|+||.||+|++. +++.||+|+++... ......+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 46789999997653 34567789999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCcee
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 717 (870)
.+..++||||+++|+|.+++...+ ..+++..++.++.|++.||+||| +++|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence 999999999999999999998643 24899999999999999999999 667999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccch
Q 002892 718 LDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 796 (870)
Q Consensus 718 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~ 796 (870)
++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~ 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--H
Confidence 99999999999999987754443333444567889999999988899999999999999999999 99998753211 1
Q ss_pred HHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 797 LKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
....+...... . .+..++..+.+++.+||+.+|++||++.|+++.|+++.+..
T Consensus 268 ~~~~~~~~~~~------------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 268 LFKLLKEGHRM------------D-----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHHHTCCC------------C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC------------C-----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11111111000 0 01123457899999999999999999999999999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.52 Aligned_cols=270 Identities=22% Similarity=0.374 Sum_probs=209.5
Q ss_pred cCCCCCCeeccccceeEEEEEe-----cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--Cee
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-----FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFK 656 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 656 (870)
+.|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999983 368999999997543 33457789999999999999999999999876 668
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++++|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999876667999999999999999999999 6679999999999999999999999999998775
Q ss_pred CCCCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---hhhh
Q 002892 737 EDDDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG---LTEV 812 (870)
Q Consensus 737 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 812 (870)
..... .......||..|+|||++.+..++.++||||+|+++|||++|+.|+.... ..+.....+.. ....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccCHHH
Confidence 43322 22334567888999999999999999999999999999999999865321 11111111110 0000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
+...+.... ....+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 252 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 252 LVNTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 111111110 001112345679999999999999999999999999998864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=355.08 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=205.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcE----EEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTN----VAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|++.+.||+|+||.||+|.+. +++. ||+|++.... ......+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357889999999999999999864 4554 7777765432 223355778999999999999999999886 46688
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999877667999999999999999999999 66699999999999999999999999999998765
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
...........+++.|+|||++.++.++.++||||||+++|||++ |+.||...... .....+......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~--------- 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERL--------- 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBC---------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCC---------
Confidence 544444455668889999999998999999999999999999999 99999763221 111111111000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 237 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 --------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00011233578899999999999999999999999988653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=348.63 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=203.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-----HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-----RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357899999999999999999865 689999999975431 13567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc---eEEecccc
Q 002892 658 LVLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT---ARVSDFGI 731 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~ 731 (870)
+||||+++++|.+++... +..+++..+..++.||+.||+||| +++|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888643 345899999999999999999999 667999999999999987654 99999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
+....... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ......+.......
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~~---- 251 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKM---- 251 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCCC----
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCCC----
Confidence 98775432 22334579999999999999999999999999999999999999997621 11111111111100
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......++..+.+++.+||+.||++||++.|+++
T Consensus 252 -----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 -----------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -----------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00011123457899999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.23 Aligned_cols=252 Identities=28% Similarity=0.480 Sum_probs=204.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhH-------HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLER-------AFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999964 7899999998654321 1267899999999999999999999986554
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecccCCCceeeCCCCc-----eEEec
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP--VVHCNLKPNNILLDKNMT-----ARVSD 728 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~D 728 (870)
++||||+++|+|.+++......+++..++.++.|++.|++||| +++ |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999999877777999999999999999999999 777 999999999999988776 99999
Q ss_pred cccccccCCCCCcccccccccccccCCcccc--cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hc
Q 002892 729 FGISKLLGEDDDSVTQTMTMATIGYMAPEYA--SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SL 805 (870)
Q Consensus 729 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~ 805 (870)
||++..... ......||+.|+|||++ ....++.++||||+|+++|||++|+.||................ ..
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999975432 23345689999999998 45567899999999999999999999997643332221121111 00
Q ss_pred CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
... .+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 248 ~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RPT-----------------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCC-----------------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 000 0112345789999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=364.08 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=208.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-eeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD-FKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 661 (870)
..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4567888999999999999999875 7899999997654 3467899999999999999999999987655 7899999
Q ss_pred cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSHNY-FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|+++|+|.+++...+. .+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999986543 4799999999999999999999 566999999999999999999999999999854321
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+.....
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~------------- 404 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK------------- 404 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTCC-------------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence 112357889999999999999999999999999999998 999997642221 1111111000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...+..++..+.+++.+||+.+|++||++.++++.|+++....
T Consensus 405 ----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 405 ----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 0011234567999999999999999999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=345.91 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=204.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh------HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE------RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.+.|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456889999999999999999965 689999999976432 1356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC----ceEEeccccc
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM----TARVSDFGIS 732 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a 732 (870)
++||||+++++|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999997644 4899999999999999999999 66799999999999998887 8999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||...... .............
T Consensus 166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~----- 236 (326)
T 2y0a_A 166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYEF----- 236 (326)
T ss_dssp EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHTCCCC-----
T ss_pred eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHhcCCCc-----
Confidence 8764322 223356899999999999999999999999999999999999999653211 1111111100000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||+.||++|||+.|+++
T Consensus 237 ----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 ----------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00011123456889999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.78 Aligned_cols=273 Identities=23% Similarity=0.309 Sum_probs=210.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--eeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD--FKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367899999999999999999966 58999999997543 334567789999999999999999999987655 77999
Q ss_pred EecCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee----CCCCceEEecccccc
Q 002892 660 LEFMPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL----DKNMTARVSDFGISK 733 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~ 733 (870)
|||+++++|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998543 33899999999999999999999 6679999999999999 778889999999998
Q ss_pred ccCCCCCcccccccccccccCCccccc--------CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHH--HH
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYAS--------DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWI--KL 803 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~--~~ 803 (870)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.............. ..
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7644322 23346899999999886 57789999999999999999999999975433222211111 11
Q ss_pred hcCCc-hhhhc---chhhhc--c-cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 804 SLPRG-LTEVV---DASLVR--E-VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 804 ~~~~~-~~~~~---~~~~~~--~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
..+.. +..+. ...+.. . .............+.+++.+||+.||++||+++|+++...+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 12211 11110 000000 0 000111245667899999999999999999999999987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.26 Aligned_cols=266 Identities=20% Similarity=0.296 Sum_probs=202.1
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|+||.||+|+..+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999998889999999986543 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++ +|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence 975 999999876667999999999999999999999 6679999999999999999999999999998764322 1
Q ss_pred cccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC--chhhh-----c
Q 002892 743 TQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPR--GLTEV-----V 813 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~-----~ 813 (870)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+....... .+. .+... .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCChhhchhhhccccc
Confidence 2234468999999999876 45899999999999999999999999764222 1222222211 111 01110 0
Q ss_pred chhhhcccCc--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 814 DASLVREVQP--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 814 ~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
++........ .......+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0000123456889999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=340.46 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=204.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999965 68999999997543 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++ ++.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...+...
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence 9975 676766665566999999999999999999999 6679999999999999999999999999998764322
Q ss_pred ccccccccccccCCcccccCCC-cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CC--chhhhcchhh
Q 002892 742 VTQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PR--GLTEVVDASL 817 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~ 817 (870)
.......||+.|+|||++.+.. ++.++||||+||++|||++|+.||.........+..+..... +. .+.......-
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2233456899999999997765 799999999999999999998886443333333333332211 11 1111110000
Q ss_pred hccc-------CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREV-------QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~-------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... .........+..+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 000001123456889999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.16 Aligned_cols=277 Identities=26% Similarity=0.328 Sum_probs=213.9
Q ss_pred hcCCCCCCeeccccceeEEEEEe-----cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeee--eCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-----FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC--NLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 656 (870)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36789999999999999999984 368899999998776666778999999999999999999999886 45678
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++++|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 8999999999999999876666999999999999999999999 6679999999999999999999999999998775
Q ss_pred CCCCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 737 EDDDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 737 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
..... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ ..+...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCERDVPALSRLLEL 256 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC----CCHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhcccccccccHHHHHHH
Confidence 43322 223345678889999999998999999999999999999999999865211100 000000000011111111
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
.. ... ....+..++..+.+++.+||+.+|++||++.++++.|+++.....
T Consensus 257 ~~-~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LE-EGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HH-TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hh-ccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11 100 001122345679999999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=350.03 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=204.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999865 68999999997643 34457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC---CceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN---MTARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~ 736 (870)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+||+++.+ +.+||+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999997654 4899999999999999999999 6679999999999999865 459999999998764
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... ......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ......+.......
T Consensus 183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~~-------- 249 (362)
T 2bdw_A 183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDY-------- 249 (362)
T ss_dssp TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCC--------
T ss_pred CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCCC--------
Confidence 322 22345699999999999999999999999999999999999999975211 11111111100000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+......++..+.+++.+||+.||++||++.++++.
T Consensus 250 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000111234568899999999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=356.92 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=204.4
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999854 78999999987643 3445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC---CCCceEEecccccccc
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD---KNMTARVSDFGISKLL 735 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~ 735 (870)
||||+++|+|.+++...+. +++..+..++.||+.||+||| ++||+||||||+||+++ .++.+||+|||++...
T Consensus 88 v~E~~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999987654 899999999999999999999 66799999999999998 4688999999999876
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ......+.......
T Consensus 164 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~-------- 232 (444)
T 3soa_A 164 EGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAYDF-------- 232 (444)
T ss_dssp CTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCCCC--------
T ss_pred cCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCCCC--------
Confidence 4332 222345799999999999999999999999999999999999999965211 11111111111100
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||+.||++||++.|+++
T Consensus 233 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 -------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00001123456889999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=369.76 Aligned_cols=259 Identities=22% Similarity=0.400 Sum_probs=211.4
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
+...++|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34557888999999999999999999888999999997653 34578999999999999999999999986 56789999
Q ss_pred ecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 661 EFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 661 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
||+++|+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999854 335899999999999999999999 5669999999999999999999999999998764321
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
........+++.|+|||++..+.++.++|||||||++|||++ |+.||...... .....+.....
T Consensus 339 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~------------ 403 (454)
T 1qcf_A 339 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR------------ 403 (454)
T ss_dssp -HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCC------------
T ss_pred -eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------------
Confidence 111223446788999999998999999999999999999999 99999763221 11111111000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
...+..++..+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 404 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 -----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 00112345679999999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=358.53 Aligned_cols=261 Identities=21% Similarity=0.268 Sum_probs=206.9
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
.++....++|++.++||+|+||+||+|+.. +++.||+|++++... .....+.+|..++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 334455689999999999999999999976 578999999976432 2223488899999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
+..|+||||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|.
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 9999999999999999999876666999999999999999999999 6669999999999999999999999999997
Q ss_pred ccCCCCCcccccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 808 (870)
...... ........||+.|+|||++. .+.++.++||||+||++|||++|+.||...... .....+..
T Consensus 224 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~------ 295 (437)
T 4aw2_A 224 KLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMN------ 295 (437)
T ss_dssp ECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHT------
T ss_pred hcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhh------
Confidence 664332 22233457999999999986 567899999999999999999999999753211 11111110
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQ--RMCMTDVVV 857 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~ 857 (870)
.......... ...++..+.+++.+|+..+|++ ||++.|+++
T Consensus 296 ------~~~~~~~p~~--~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 296 ------HKERFQFPTQ--VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ------HHHHCCCCSS--CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ------ccccccCCcc--cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000000000 0012346889999999988888 999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=349.93 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=198.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 657 (870)
..++|++.+.||+|+||.||+|+.. +++.||+|++++.. ......+..|.++++.+ +||||+++++++...+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999965 68999999998653 33456678899999988 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++...+. +++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999986544 899999999999999999999 66799999999999999999999999999985422
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....
T Consensus 177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~------------ 241 (353)
T 3txo_A 177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAILNDEV------------ 241 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC------------
T ss_pred C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC------------
Confidence 2 22334457999999999999888999999999999999999999999753211 11111111000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM------TDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~ 857 (870)
. . + ...+..+.+++.+|++.+|++||++ .|+++
T Consensus 242 ~--~-p----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 V--Y-P----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp C--C-C----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred C--C-C----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 0 0 0123468899999999999999998 66654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=347.88 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=201.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+++++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 347899999999999999999996 4789999999976432 223578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+ +|+|.+++...+ .+++.++..++.|++.|++||| +.||+||||||+||++++++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99999 789999887654 3899999999999999999999 556999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
. ......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||+....... ... +....
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~-i~~~~ 224 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKK-VNSCV 224 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCC-CCSSC
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHH-HHcCC
Confidence 2 2234569999999999988776 7899999999999999999999976322110 000 00000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. .+...+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 YV------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CC------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CC------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 01112456889999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.86 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=195.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhh----HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE----RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3568899999999999999999965 88999999875432 234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC--------CCceEEeccc
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK--------NMTARVSDFG 730 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfg 730 (870)
||||+++++|.+++... .+++..++.++.|++.|++|||+.+..+|+||||||+||+++. ++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999643 4899999999999999999999543333999999999999986 7789999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchh
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 810 (870)
.+....... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ ...........
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~--- 233 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYGVAMNKLAL--- 233 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-HHHHHTSCCCC---
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHhhhcCCCCC---
Confidence 998664322 2234689999999999999999999999999999999999999975321111 00000000000
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
..+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 234 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 234 --------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00112345789999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.99 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=201.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcE----EEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTN----VAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999854 4554 4666664332 344577899999999999999999999998754 78
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+|+||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999987777999999999999999999999 66699999999999999999999999999987754
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
...........+|+.|+|||++.+..++.++||||+||++|||++ |+.||......+ ....+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~--------- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERL--------- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCC---------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCC---------
Confidence 444444444567889999999999999999999999999999999 999997632221 12211111000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++..+.+++.+||+.+|++||++.|+++.|+++.+.
T Consensus 239 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 --------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 00112344688999999999999999999999999998743
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=344.26 Aligned_cols=270 Identities=23% Similarity=0.376 Sum_probs=211.2
Q ss_pred CCCCCeeccccceeEEEEEec-----CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeEE
Q 002892 587 FNECNLLGAGSFGSVYKGTLF-----DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKAL 658 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 658 (870)
|++.+.||+|+||.||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988642 68899999997654 3446778999999999999999999999987 467899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++|+|.+++...+ +++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999998654 899999999999999999999 666999999999999999999999999999877543
Q ss_pred CCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh--hcch
Q 002892 739 DDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE--VVDA 815 (870)
Q Consensus 739 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 815 (870)
... .......+|+.|+|||++.+..++.++||||+|+++|||++|+.||......... .......... .+..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-----LIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HHCSCCHHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-----hhcccccchhHHHHHH
Confidence 322 2233445788899999999989999999999999999999999998653211000 0001110000 0000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
.+... .....+..++..+.+++.+||+.+|++||++.|+++.|+++.+.+.
T Consensus 263 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 263 LLERG-ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhcc-cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 00000 0111112345679999999999999999999999999999998875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.40 Aligned_cols=277 Identities=25% Similarity=0.391 Sum_probs=215.4
Q ss_pred hcCCCCCCeeccccceeEEEEEe-----cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--ee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-----FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD--FK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 656 (870)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688999999999999999983 368899999998776666788999999999999999999999886543 78
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++++|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999987767999999999999999999999 6679999999999999999999999999998775
Q ss_pred CCCCcc-cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch-hhhcc
Q 002892 737 EDDDSV-TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGL-TEVVD 814 (870)
Q Consensus 737 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 814 (870)
...... ......++..|+|||++.+..++.++||||||+++|||++|..||...... ............. ...+.
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence 433221 122345678899999999888999999999999999999999987642110 0000000000000 00000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
..+.... ....+..++..+.+++.+||+.+|++||++.||++.|+++++.+.
T Consensus 274 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 274 ELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhhcCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0111000 001112345679999999999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=344.83 Aligned_cols=270 Identities=24% Similarity=0.379 Sum_probs=217.1
Q ss_pred chhHHHHhhcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEe
Q 002892 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIF 647 (870)
Q Consensus 576 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~ 647 (870)
.........++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344455668899999999999999999974 356889999997653 33456789999999999 799999999
Q ss_pred eeeeeCC-eeEEEEecCCCCCHHHHHhhcCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccc
Q 002892 648 SSCCNLD-FKALVLEFMPNGSLEKWLYSHNY---------------FLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNL 711 (870)
Q Consensus 648 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl 711 (870)
+++...+ ..++||||+++|+|.+++..... .+++..++.++.|++.||+||| +++|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence 9987654 58999999999999999986543 2789999999999999999999 667999999
Q ss_pred CCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCcc
Q 002892 712 KPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEM 790 (870)
Q Consensus 712 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~ 790 (870)
||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||+|+++|||++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987755444444445567899999999999999999999999999999998 99999764
Q ss_pred ccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 791 FTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..... ............ . +..++..+.+++.+||+.+|++||++.++++.|+++.+..
T Consensus 255 ~~~~~-~~~~~~~~~~~~------------~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDEE-FCRRLKEGTRMR------------A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSHH-HHHHHHHTCCCC------------C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHH-HHHHhccCccCC------------C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 32221 111111111000 0 0112346889999999999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.44 Aligned_cols=278 Identities=23% Similarity=0.327 Sum_probs=201.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee-----CCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN-----LDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~ 657 (870)
..++|++.+.||+|+||.||+|+. +++.||||++....... ...+.|+..+..++||||+++++.+.. ....+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 457899999999999999999975 68999999997554322 222344444556899999999985532 33568
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CcEecccCCCceeeCCCCceEEec
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST---------PVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~---------~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
+||||+++|+|.+++.... .++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 89 lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 9999999999999997655 589999999999999999999 55 899999999999999999999999
Q ss_pred cccccccCCCCC------cccccccccccccCCcccccC-------CCcCcccchHhHHHHHHHHHhCCCCCCccccc-c
Q 002892 729 FGISKLLGEDDD------SVTQTMTMATIGYMAPEYASD-------GIISPKCDVYSYGVLLMETFTRKKPTDEMFTG-E 794 (870)
Q Consensus 729 fg~a~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~il~elltg~~p~~~~~~~-~ 794 (870)
||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987643221 112234468999999999977 45677999999999999999998776432211 1
Q ss_pred chHHHHHHHhcCCchhhh---cchhh-hcccC-cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 795 MSLKHWIKLSLPRGLTEV---VDASL-VREVQ-PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
................++ ..... ..... .......++..+.+++.+||+.||++|||++|+++.|+++...|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 111000000011111110 00000 00000 001112356689999999999999999999999999999988764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=343.48 Aligned_cols=244 Identities=21% Similarity=0.239 Sum_probs=193.5
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||+||+|+.. +++.||||++.... .........|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 79999999986532 23334455556555555 8999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+ +++|.+++...+..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 77999999877777999999999999999999999 5669999999999999999999999999998764322
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+... .....+. . .
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~------------~-----~ 267 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLR------------Q-----G 267 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHT------------T-----T
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHh------------c-----c
Confidence 2334468999999999876 7899999999999999999997765431 1111100 0 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+......++..+.+++.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0001111223567899999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=337.83 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=206.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC--CeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL--DFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 658 (870)
..++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|++++++++||||+++++++... +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3467999999999999999999975 8899999997653 34456799999999999999999999999876 78899
Q ss_pred EEecCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecccCCCceeeCCCCceEEecccccccc
Q 002892 659 VLEFMPNGSLEKWLYSHNY-FLDMLERLNIMIDVGLALEYLHHSHSTP--VVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
||||+++|+|.+++..... .+++..++.++.|++.||+||| +++ ++||||||+||+++.++.++++|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999986543 5899999999999999999999 677 999999999999999999999999987643
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCc---ccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISP---KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
.. ....||+.|+|||++.+..++. ++||||+|+++|||++|+.||........ ............
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~---- 231 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLRPT---- 231 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSCCCCC----
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcCCCCC----
Confidence 21 2245899999999998765544 79999999999999999999975322111 111111100000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
.+..++..+.+++..||+.+|++|||+.++++.|+++.+
T Consensus 232 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 -------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011234568999999999999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.46 Aligned_cols=267 Identities=25% Similarity=0.444 Sum_probs=202.0
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeee
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCC 651 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 651 (870)
.++....++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334445678899999999999999999854 34589999987542 444577899999999999999999999997
Q ss_pred eCC-----eeEEEEecCCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC
Q 002892 652 NLD-----FKALVLEFMPNGSLEKWLYS-----HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN 721 (870)
Q Consensus 652 ~~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 721 (870)
..+ ..++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +++|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence 654 34999999999999999852 2355899999999999999999999 7779999999999999999
Q ss_pred CceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHH
Q 002892 722 MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHW 800 (870)
Q Consensus 722 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~ 800 (870)
+.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~ 261 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDY 261 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHH
Confidence 9999999999987654433333444567889999999999999999999999999999999 888887532211 1111
Q ss_pred HHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
....... ..+..++..+.+++.+||+.+|++||++.++++.|+++.+..
T Consensus 262 ~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 LLHGHRL-----------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHTTCCC-----------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHcCCCC-----------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1110000 001123457899999999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.73 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=212.4
Q ss_pred hcCCCCCC-eeccccceeEEEEEec---CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECN-LLGAGSFGSVYKGTLF---DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.++|.+.+ .||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 8999999999999853 57889999997643 34567789999999999999999999999 5567899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++++|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999999877677999999999999999999999 667999999999999999999999999999877543
Q ss_pred CCcc-cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 739 DDSV-TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 739 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+......
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~~~--------- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKRM--------- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCCC---------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCCcC---------
Confidence 3221 2233456889999999988889999999999999999998 99999763221 111111110000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhhh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFLV 868 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~~ 868 (870)
..+..++..+.+++.+||+.+|++||++.++++.|+++......
T Consensus 233 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 233 --------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 00113355789999999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.23 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=201.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999965 68899999997653 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||++||+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999998654 4899999999999999999999 6679999999999999999999999999998764322
Q ss_pred CcccccccccccccCCcccccC---CCcCcccchHhHHHHHHHHHhCCCCCCccccccc-hHHHHHHHhcCCchhhhcch
Q 002892 740 DSVTQTMTMATIGYMAPEYASD---GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM-SLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 815 (870)
......||+.|+|||++.. ..++.++||||+||++|||++|+.||........ ............
T Consensus 170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 238 (384)
T 4fr4_A 170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT-------- 238 (384)
T ss_dssp ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC--------
T ss_pred ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC--------
Confidence 2344579999999999864 4589999999999999999999999975322111 111111100000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-HHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-MTDVV 856 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl 856 (870)
. +..++..+.+++.+||+.+|++||+ +.+|.
T Consensus 239 -----~-----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 239 -----Y-----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -----C-----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -----C-----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 0 0122456889999999999999998 66654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.89 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=198.6
Q ss_pred CCCCCCeeccccceeEEEEEec--CC--cEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeee-CCeeEEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF--DG--TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCN-LDFKALV 659 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 659 (870)
.|++.+.||+|+||.||+|++. ++ ..||+|.++... ....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999853 22 368999986533 3456789999999999999999999998754 5678999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999977777899999999999999999999 6679999999999999999999999999998664322
Q ss_pred Cc--ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 740 DS--VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 740 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ .........
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~----------- 313 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGR----------- 313 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTC-----------
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCC-----------
Confidence 21 12233457889999999999999999999999999999999 667776532221 111111100
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
....+..++..+.+++.+||+.+|++||++.|+++.|+++...+.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000111245578999999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=349.79 Aligned_cols=246 Identities=20% Similarity=0.305 Sum_probs=198.7
Q ss_pred CCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCCCCH
Q 002892 590 CNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSL 668 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 668 (870)
.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999864 6899999999876656667899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee--CCCCceEEeccccccccCCCCCcccccc
Q 002892 669 EKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL--DKNMTARVSDFGISKLLGEDDDSVTQTM 746 (870)
Q Consensus 669 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 746 (870)
.+++......+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++..+.... ....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cccc
Confidence 9999877667999999999999999999999 6669999999999999 567899999999998774332 2233
Q ss_pred cccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchH
Q 002892 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826 (870)
Q Consensus 747 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (870)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+....++.. ...
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~---------------~~~ 311 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDLE---------------DEE 311 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCSC---------------SGG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCC---------------hhh
Confidence 4689999999999999999999999999999999999999976321 111222221111100 000
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 827 KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 827 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...++..+.+++.+||+.+|++||++.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1123457899999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=338.93 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=207.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC----CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
..++|++.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998542 3459999987653 3456778999999999999999999999865 4568
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++++|.+++...+..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999877767999999999999999999999 66799999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ............
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~~~-------- 234 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDRLP-------- 234 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCCCC--------
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCCCC--------
Confidence 322 22233457889999999998899999999999999999998 999997532221 111111110000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
.+..++..+.+++.+||+.+|++||++.|+++.|+++.+..
T Consensus 235 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 235 ---------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 00123456889999999999999999999999999987653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=346.27 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=205.3
Q ss_pred hcCCCCCCeeccccceeEEEEEecC-----CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD-----GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|+..+.||+|+||.||+|.... +..||+|+++... ......+.+|++++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998542 2359999997643 344567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++......+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999877667999999999999999999999 56799999999999999999999999999987643
Q ss_pred CCCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 738 DDDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 738 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~~--------- 268 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFR--------- 268 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC---------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCCc---------
Confidence 3221 12223346788999999999999999999999999999999 99999653221 11111110000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
...+..++..+.+++.+||+.+|++||++.++++.|+++.+...
T Consensus 269 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 269 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 00011234578999999999999999999999999999887543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.72 Aligned_cols=267 Identities=22% Similarity=0.382 Sum_probs=214.8
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSC 650 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 650 (870)
.+.....++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556788999999999999999999854 36789999997543 34456788999999999999999999999
Q ss_pred eeCCeeEEEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC
Q 002892 651 CNLDFKALVLEFMPNGSLEKWLYSHN---------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN 721 (870)
Q Consensus 651 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 721 (870)
...+..++||||+++|+|.+++...+ ..+++..++.++.|++.||+||| ++||+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence 99999999999999999999998532 34789999999999999999999 6679999999999999999
Q ss_pred CceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHH
Q 002892 722 MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHW 800 (870)
Q Consensus 722 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~ 800 (870)
+.+||+|||++................+|+.|+|||++.+..++.++||||+|+++|||++ |..||...... .....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~ 252 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRF 252 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHHH
Confidence 9999999999986643333333344457889999999998899999999999999999999 88888753211 11111
Q ss_pred HHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
+.. .. ... .+..++..+.+++.+||+.+|++||++.|+++.|+++.+..
T Consensus 253 ~~~---~~--------~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 253 VME---GG--------LLD------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HHT---TC--------CCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHc---CC--------cCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 110 00 000 01123456889999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.28 Aligned_cols=245 Identities=25% Similarity=0.323 Sum_probs=202.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +|+.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467899999999999999999965 78999999997653 23456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.+|.+||+|||++......
T Consensus 85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999998654 3899999999999999999999 777999999999999999999999999999865322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.....
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~-------------- 220 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAEL-------------- 220 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCCC--------------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--------------
Confidence 2235689999999999999999999999999999999999999975311 111111111000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
... ...+..+.+++.+|++.+|++|| ++.|+++
T Consensus 221 ~~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 000 01234688999999999999999 8888864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.73 Aligned_cols=262 Identities=24% Similarity=0.400 Sum_probs=206.3
Q ss_pred hcCCCCCCeeccccceeEEEEEecC----CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeee-eCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCC-NLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~ 657 (870)
...|++.+.||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468888999999999999998542 2358999886533 345577899999999999999999999864 566889
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999877777899999999999999999999 66799999999999999999999999999987643
Q ss_pred CCC--cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhC-CCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 738 DDD--SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 738 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
... ........+|+.|+|||.+.+..++.++||||+|+++|||++| .+||...... . ..........
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~-~~~~~~~~~~-------- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-D-ITVYLLQGRR-------- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-T-HHHHHHTTCC--------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-H-HHHHHhcCCC--------
Confidence 221 1223345678899999999999999999999999999999995 5555442211 1 1111111000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
...+..++..+.+++.+||+.+|++||++.|+++.|+++.+.+.
T Consensus 251 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00011234568999999999999999999999999999988664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.74 Aligned_cols=262 Identities=22% Similarity=0.400 Sum_probs=211.7
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.....++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 344557899999999999999999998888899999987543 23467899999999999999999999886 4568999
Q ss_pred EecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 660 LEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
|||+++++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||.+......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999998542 35899999999999999999999 667999999999999999999999999999876433
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. .......+++.|+|||++.++.++.++||||+|+++|||++ |+.||...... .....+......
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~---------- 229 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRM---------- 229 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC----------
T ss_pred cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccCC----------
Confidence 21 22233456789999999998899999999999999999999 89998753221 111111110000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..+..++..+.+++..||+.+|++||+++++++.|+++....
T Consensus 230 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 230 -------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 001123457899999999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=347.51 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=197.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCC--CceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRH--RNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 346799999999999999999998889999999987543 3445778999999999976 999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||| +.+++|.+++...+ .+++.++..++.|++.||+||| +++|+||||||+||+++ ++.+||+|||++......
T Consensus 87 v~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEe-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999 56889999998754 4899999999999999999999 56699999999999996 678999999999877544
Q ss_pred CCcccccccccccccCCcccccC-----------CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 002892 739 DDSVTQTMTMATIGYMAPEYASD-----------GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------ 234 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------ 234 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh------
Confidence 43334445679999999999864 6788999999999999999999999975332211111111
Q ss_pred chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 808 GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+......... .++..+.+++..||+.||++|||+.|+++.
T Consensus 235 ------~~~~~~~~~~-----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 ------DPNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------CTTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------cCCcccCCcc-----cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1110000000 112468899999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.36 Aligned_cols=252 Identities=20% Similarity=0.270 Sum_probs=197.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 658 (870)
.++|++.++||+|+||.||+|+.. +++.||+|++++.. ......+..|..++.++ +||||+++++++...+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999965 68899999998653 22334578899999887 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++|+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999998654 3899999999999999999999 667999999999999999999999999999853222
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
........||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... .....+......
T Consensus 207 --~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------~~~~~~~~~i~~ 276 (396)
T 4dc2_A 207 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVILE 276 (396)
T ss_dssp --TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHHHH
T ss_pred --CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--------hhHHHHHHHHhc
Confidence 2223446799999999999999999999999999999999999999965321110000 000000000000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
.... .+...+..+.+++.+||+.||++||++
T Consensus 277 ~~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 KQIR---IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCC---CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cccC---CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0000 001134568899999999999999996
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=367.23 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=212.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||.||+|.+. +++.||||+++.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3467888999999999999999976 488999999976533 35778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|+++|+|.+++... +..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 99999999999854 455899999999999999999999 6669999999999999999999999999998764322
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
........+++.|+|||++..+.++.++|||||||++|||++ |..||...... .+...+.....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------- 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR------------- 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC-------------
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence 222233456789999999998999999999999999999999 89998763221 11111111100
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
...+..++..+.+++.+||+.+|++||++.+|++.|+++.+
T Consensus 438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 00112345678999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=342.00 Aligned_cols=264 Identities=23% Similarity=0.376 Sum_probs=216.4
Q ss_pred HHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 579 DIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 579 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
+.....++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 34456678999999999999999999976 58899999997553 34577889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 658 LVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
+||||+++++|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999853 455899999999999999999999 5569999999999999999999999999998775
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... .......+++.|+|||++.+..++.++||||+|+++|+|++ |..||...... ............
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~-------- 231 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRM-------- 231 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCC--------
T ss_pred CCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCCC--------
Confidence 4332 23334457889999999998999999999999999999999 99998753221 111111111000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
. .+..++..+.+++..|++.+|++||++.++++.|+++.+..
T Consensus 232 ----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 ----E-----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ----C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----C-----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 01123457899999999999999999999999999887654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=347.65 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=190.1
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34578999999999999999999976 58899999997653 3356888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~ 737 (870)
||+++|+|.+++...+ .+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++.....
T Consensus 128 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999998654 3899999999999999999999 567999999999999975 88999999999986643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||............+....... .
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-----~---- 271 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-----I---- 271 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----C----
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----C----
Confidence 21 22345689999999999999999999999999999999999999975322221111111110000 0
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......++..+.+++.+||+.||++||++.|+++
T Consensus 272 ------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 ------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000123456889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=353.69 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=206.2
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
.+.....++|++.+.||+|+||.||+|+.+ +|+.||+|++++.. ......+.+|..++.+++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344455789999999999999999999975 79999999997643 22334578899999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
+..|+||||+++|+|.+++...+..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999999876666999999999999999999999 6669999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCccccc-------CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYAS-------DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP 806 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 806 (870)
....... .......||+.|+|||++. .+.++.++|||||||++|||++|+.||...... .....+....
T Consensus 211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~-- 286 (412)
T 2vd5_A 211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHYK-- 286 (412)
T ss_dssp ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHH--
T ss_pred eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc--
Confidence 7643322 2233457999999999987 457899999999999999999999999753211 1111111100
Q ss_pred CchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 002892 807 RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQR---MCMTDVVV 857 (870)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~~evl~ 857 (870)
..... + .....++..+.+++.+||. +|++| |++.|+++
T Consensus 287 ----------~~~~~-p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 ----------EHLSL-P-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ----------HHCCC-C-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ----------cCcCC-C-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00000 0 0011234578999999999 99998 58888864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=345.53 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=201.9
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCe
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 655 (870)
....++|++.+.||+|+||.||+|+.+ +|+.||+|++++.. ......+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999975 68999999997653 23456678899999877 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.|+||||++||+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999998654 3899999999999999999999 667999999999999999999999999999754
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....+.
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~-------- 236 (345)
T 1xjd_A 169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPF-------- 236 (345)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC--------
T ss_pred ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhCCCC--------
Confidence 3221 123445799999999999999999999999999999999999999975321 1111111100000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMT-DVV 856 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 856 (870)
. +..++..+.+++.+||+.+|++||++. +++
T Consensus 237 -----~-----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 -----Y-----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----C-----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----C-----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 001234688999999999999999997 554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.97 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=194.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--------------------------HHHHHHHHHHHHHH
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--------------------------RAFRSFESECEVLR 636 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 636 (870)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999864 689999999875431 12356889999999
Q ss_pred hcCCCceeEEeeeeee--CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCC
Q 002892 637 NVRHRNLIKIFSSCCN--LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPN 714 (870)
Q Consensus 637 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~ 714 (870)
+++||||+++++++.. .+..++||||+++++|.++... ..+++..+..++.|++.||+||| +++|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999986 5688999999999999886543 34899999999999999999999 566999999999
Q ss_pred ceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCC---cCcccchHhHHHHHHHHHhCCCCCCccc
Q 002892 715 NILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI---ISPKCDVYSYGVLLMETFTRKKPTDEMF 791 (870)
Q Consensus 715 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~~ 791 (870)
||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999987643322 223457899999999997665 4788999999999999999999997521
Q ss_pred cccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 792 TGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ......+...... .. ....++..+.+++.+||+.||++||++.|+++
T Consensus 245 ~--~~~~~~~~~~~~~------------~~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 I--MCLHSKIKSQALE------------FP----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H--HHHHHHHHHCCCC------------CC----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H--HHHHHHHhcccCC------------CC----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1111111100000 00 00122456889999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.20 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=201.9
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeech---hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQ---LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999996 47899999998753 244567789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
|||+++++|.+++.. ....+++..++.++.|++.||+||| +++++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999874 3456899999999999999999999 6679999999999999999999999999998664
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.............+... ..
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~------- 255 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DY------- 255 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---CS-------
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---cC-------
Confidence 3221 22334689999999999999999999999999999999999999975322211111111100 00
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
+......++..+.+++.+||+.||++||++.+|++.|+++.+...
T Consensus 256 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 256 ------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 000011234578899999999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.67 Aligned_cols=260 Identities=21% Similarity=0.361 Sum_probs=197.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe---
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF--- 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 655 (870)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999996 578999999997643 3445678999999999999999999999876543
Q ss_pred -eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 656 -KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 656 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
.|+||||+++++|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred ccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 399999999999999998654 4899999999999999999999 56699999999999999999999999999987
Q ss_pred cCCCCCc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 735 LGEDDDS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 735 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ........ +.
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~-~~------ 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRED-PI------ 237 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCC-CC------
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCC-CC------
Confidence 6443222 223345689999999999999999999999999999999999999975322111 11110000 00
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHHHh
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV-VKLQKI 862 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl-~~L~~i 862 (870)
........++..+.+++.+||+.||++||++.+++ +.+.++
T Consensus 238 --------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 --------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00001112355788999999999999999666654 455444
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=355.65 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=205.7
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
.++....++|++.+.||+|+||.||+|+.. +++.||+|++++... .....+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455789999999999999999999965 689999999976431 2234478899999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
+..|+||||++||+|.+++...+ +++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999999997643 899999999999999999999 6679999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCCC----cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGI----ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGL 809 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 809 (870)
...... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ......+...
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~------ 288 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNH------ 288 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTH------
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhHHHHHHhc------
Confidence 764332 22233567999999999997655 78999999999999999999999975211 1111111110
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQ--RMCMTDVVVK 858 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 858 (870)
....... .....+..+.+++.+|+..+|++ ||++.||++.
T Consensus 289 ------~~~~~~p---~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 ------KNSLTFP---DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ------HHHCCCC---TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ------cccccCC---CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000000 00012356889999999999998 9999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=340.18 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=205.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CC-------cEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DG-------TNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
.++|++.+.||+|+||.||+|... ++ ..||+|++........+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467889999999999999999854 33 4799999987766777889999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc--------eEEe
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT--------ARVS 727 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--------~kl~ 727 (870)
.++||||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999987766999999999999999999999 666999999999999998887 9999
Q ss_pred ccccccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 002892 728 DFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP 806 (870)
Q Consensus 728 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 806 (870)
|||.+..... .....|++.|+|||++.+ ..++.++||||+|+++|||++|+.|+.......... ..... .
T Consensus 164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~--~ 234 (289)
T 4fvq_A 164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYED--R 234 (289)
T ss_dssp CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHT--T
T ss_pred cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhc--c
Confidence 9999875421 123357889999999987 678999999999999999999665543321211111 11110 0
Q ss_pred CchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 807 RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
... .. .++..+.+++.+||+.||++||++.++++.|+++...
T Consensus 235 ~~~------------~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 235 HQL------------PA-----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp CCC------------CC-----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred CCC------------CC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000 00 0123578899999999999999999999999987543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.62 Aligned_cols=261 Identities=22% Similarity=0.353 Sum_probs=207.3
Q ss_pred CCCCCCeeccccceeEEEEEec-CC---cEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee-EEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DG---TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK-ALV 659 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv 659 (870)
.|+..+.||+|+||.||+|.+. ++ ..||+|++.... ....+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3555689999999999999853 22 379999987543 34567889999999999999999999999766554 999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+.+|+|.+++......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999987777999999999999999999999 5669999999999999999999999999998664322
Q ss_pred C--cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 740 D--SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 740 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
. ........+++.|+|||.+.+..++.++||||+|+++|+|++|+.|+...... ..............
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~--------- 248 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRRLP--------- 248 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCCCC---------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCCCC---------
Confidence 1 11223346788999999999999999999999999999999966665432222 11222111111000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
.+..++..+.+++.+||+.+|++|||+.++++.|+++.+.+.
T Consensus 249 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 249 --------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 011234568899999999999999999999999999988764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.30 Aligned_cols=272 Identities=18% Similarity=0.237 Sum_probs=205.5
Q ss_pred hhcCCCCCCeeccc--cceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 583 ATDGFNECNLLGAG--SFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
..++|++.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45689999999999 99999999976 79999999997654 345577889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 658 LVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
+||||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999854 345899999999999999999999 6669999999999999999999999999886542
Q ss_pred CCCC-----cccccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-
Q 002892 737 EDDD-----SVTQTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG- 808 (870)
Q Consensus 737 ~~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 808 (870)
.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...... .........+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 258 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLL 258 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC---------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCCCccc
Confidence 2111 111223468899999999987 5789999999999999999999999976432221 111111111000
Q ss_pred ----------------------hhhhcchhhh----cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 809 ----------------------LTEVVDASLV----REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 809 ----------------------~~~~~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
..+....... ...........++..+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000000 0000001112345678999999999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.39 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=197.4
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcC--CCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVR--HRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 660 (870)
+.|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999998889999999997543 445678899999999996 599999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
| +.+++|.+++.... .+++.++..++.||+.||+||| +++|+||||||+||+++ ++.+||+|||++..+.....
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 56889999998765 4899999999999999999999 67799999999999995 58999999999987754433
Q ss_pred cccccccccccccCCcccccC-----------CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCch
Q 002892 741 SVTQTMTMATIGYMAPEYASD-----------GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGL 809 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 809 (870)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~-------- 281 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-------- 281 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--------
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh--------
Confidence 333445679999999999865 4688999999999999999999999975322211111111
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+......... .++..+.+++.+||+.||++||++.|+++.
T Consensus 282 ----~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 ----DPNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----CTTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----CccccCCCCc-----cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1110000000 113468899999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.10 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=197.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD------- 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 654 (870)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999976 79999999997543 345577999999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEecCCCCCHHHHHhhcC--CCCCHH
Q 002892 655 --------------------------------------------------FKALVLEFMPNGSLEKWLYSHN--YFLDML 682 (870)
Q Consensus 655 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~ 682 (870)
..++||||+++++|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3789999999999999998543 335677
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc----------ccccccccccc
Q 002892 683 ERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS----------VTQTMTMATIG 752 (870)
Q Consensus 683 ~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~g~~~ 752 (870)
.++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++......... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999 667999999999999999999999999999877543221 12234569999
Q ss_pred cCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHH
Q 002892 753 YMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLL 832 (870)
Q Consensus 753 y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (870)
|+|||++.+..++.++||||+|+++|||++|..|+... ...... . ..............
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~------------~--~~~~~~~~~~~~~~ 300 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITD------------V--RNLKFPLLFTQKYP 300 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHH------------H--HTTCCCHHHHHHCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHH------------h--hccCCCcccccCCh
Confidence 99999999999999999999999999999987764321 000000 0 00011112233455
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 833 RIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 833 ~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+.+++.+||+.||++||++.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6789999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=363.08 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=204.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 4567888999999999999999988888899999976532 34678999999999999999999999876 678999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++|+|.+++... +..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 9999999999853 345899999999999999999999 66699999999999999999999999999987643221
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......+++.|+|||++.++.++.++||||||+++|||++ |+.||......+ ....+.....
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~-------------- 399 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR-------------- 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC--------------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------------
Confidence 22233457789999999998999999999999999999999 999987532211 1111110000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
...+..++..+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 00112345678999999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.67 Aligned_cols=266 Identities=22% Similarity=0.375 Sum_probs=214.7
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEecC-C-----cEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLFD-G-----TNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCN 652 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 652 (870)
....++|++.+.||+|+||.||+|.... + ..||+|++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445789999999999999999998642 2 479999997653 34457789999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSH-------------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD 719 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 719 (870)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+||| ++||+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence 99999999999999999999843 234799999999999999999999 56799999999999999
Q ss_pred CCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHH
Q 002892 720 KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLK 798 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~ 798 (870)
.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ...
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHH
Confidence 999999999999987644433333444567889999999998899999999999999999999 889987632221 122
Q ss_pred HHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 799 HWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
.......... .+..++..+.+++..||+.+|++||++.+|++.|+++.+...
T Consensus 278 ~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 278 KLVKDGYQMA-----------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHHHHTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCC-----------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 2221111100 001124568899999999999999999999999999887653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=341.48 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=199.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 658 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|..+++++ +||||+++++++...+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357899999999999999999965 68999999997653 34456788999999988 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++|+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999998654 4899999999999999999999 667999999999999999999999999999854222
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||........... .....+......
T Consensus 164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~~~i~~ 233 (345)
T 3a8x_A 164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVILE 233 (345)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHHH
T ss_pred C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--------ccHHHHHHHHHc
Confidence 1 223345799999999999999999999999999999999999999975322110000 000000000000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 852 (870)
.... . +...+..+.+++.+||+.||++||++
T Consensus 234 ~~~~--~-p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 234 KQIR--I-PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCC--C-CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCC--C-CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0000 0 01234568899999999999999996
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=355.38 Aligned_cols=323 Identities=21% Similarity=0.210 Sum_probs=269.8
Q ss_pred CCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
-+.++.++++++ .+|..+. ++++.|+|++|++++..+..|..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 468999999998 5787663 6899999999999988889999999999999999999988899999999999999999
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCC
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 176 (870)
|++++..+..|.++++|++|+|++|++++..+..+..+++|++|++++|++++..+..|.++++|++|++++|++++.
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-- 167 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI-- 167 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC--
T ss_pred CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc--
Confidence 999966566789999999999999999988899999999999999999999988888888888888888888877632
Q ss_pred CcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccc
Q 002892 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSF 256 (870)
Q Consensus 177 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 256 (870)
.+..+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|....
T Consensus 168 -----------------------~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~---------- 214 (477)
T 2id5_A 168 -----------------------PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD---------- 214 (477)
T ss_dssp -----------------------CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCC----------
T ss_pred -----------------------ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccc----------
Confidence 23345666777777777777776666667777777777666654332
Q ss_pred ccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhch
Q 002892 257 LSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRL 336 (870)
Q Consensus 257 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 336 (870)
.+|.......+|+.|++++|++.+ +|.
T Consensus 215 -----------------------------------------------~~~~~~~~~~~L~~L~l~~n~l~~-~~~----- 241 (477)
T 2id5_A 215 -----------------------------------------------TMTPNCLYGLNLTSLSITHCNLTA-VPY----- 241 (477)
T ss_dssp -----------------------------------------------EECTTTTTTCCCSEEEEESSCCCS-CCH-----
T ss_pred -----------------------------------------------ccCcccccCccccEEECcCCcccc-cCH-----
Confidence 111122223367777777777763 221
Q ss_pred hhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEcc
Q 002892 337 QQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLS 416 (870)
Q Consensus 337 ~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 416 (870)
..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|+
T Consensus 242 -----------------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 242 -----------------LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp -----------------HHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred -----------------HHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 245667899999999999999999999999999999999999999889999999999999999
Q ss_pred CCccCCcccccccCCCCCCEEEcCCCcccCc
Q 002892 417 RNQLSGNIPITIGGLKDLITLSLARNRFQDS 447 (870)
Q Consensus 417 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 447 (870)
+|+|++..+..|..+++|+.|+|++|.+...
T Consensus 305 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 305 GNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp SSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred CCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 9999988888999999999999999999854
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.97 Aligned_cols=265 Identities=18% Similarity=0.205 Sum_probs=206.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeee-eeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC-CNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 660 (870)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+|+++++.++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 57899999987654322 4578899999999987766655554 6677889999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee---CCCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~ 737 (870)
||+ +++|.+++......+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 99999999876667999999999999999999999 6669999999999999 7889999999999987654
Q ss_pred CCCc-----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc--chHHHHHHHhcCCchh
Q 002892 738 DDDS-----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE--MSLKHWIKLSLPRGLT 810 (870)
Q Consensus 738 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 810 (870)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...........+...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-
Confidence 3321 12234568999999999999999999999999999999999999997643221 111111111110000
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
......++..+.+++..||+.+|++||++++|++.|+++.+...
T Consensus 240 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 -------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00001224578999999999999999999999999999988654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=340.87 Aligned_cols=273 Identities=22% Similarity=0.361 Sum_probs=214.7
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHh--cCCCceeEEeeeeeeCC----
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRN--VRHRNLIKIFSSCCNLD---- 654 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---- 654 (870)
....++|++.+.||+|+||.||+|+. +++.||||++.... ...+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34557899999999999999999997 58999999997543 3456778888887 78999999999998765
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecccCCCceeeCCCCceEEecc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS-----HSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
..++||||+++|+|.+++...+ +++..++.++.|++.||+|||.. ++++|+||||||+||+++.++.+||+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 7899999999999999998653 89999999999999999999932 1456999999999999999999999999
Q ss_pred ccccccCCCCCcc--cccccccccccCCcccccCC------CcCcccchHhHHHHHHHHHhC----------CCCCCccc
Q 002892 730 GISKLLGEDDDSV--TQTMTMATIGYMAPEYASDG------IISPKCDVYSYGVLLMETFTR----------KKPTDEMF 791 (870)
Q Consensus 730 g~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslG~il~elltg----------~~p~~~~~ 791 (870)
|++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998764433221 22345689999999999775 334689999999999999999 67876644
Q ss_pred cccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 792 TGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
........+....... .........+...+++..+.+++.+||+.+|++||++.+|++.|+++.+...
T Consensus 272 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQ--------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CSSCCHHHHHHHHTTS--------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cCcccHHHHHHHHHHH--------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 4333333332221111 1111112222334667789999999999999999999999999999987653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.17 Aligned_cols=257 Identities=17% Similarity=0.152 Sum_probs=207.7
Q ss_pred HHhhcCCCCCCeeccccceeEEEEE------ecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC---CCceeEEeeeee
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGT------LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR---HRNLIKIFSSCC 651 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~ 651 (870)
....++|++.+.||+|+||+||+|. ..+++.||+|++..... ..+..|++++++++ |+||+.+++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3445789999999999999999994 44689999999976543 35667777777776 999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-------
Q 002892 652 NLDFKALVLEFMPNGSLEKWLYS----HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK------- 720 (870)
Q Consensus 652 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~------- 720 (870)
..+..++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +++|+||||||+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999984 3456999999999999999999999 677999999999999998
Q ss_pred ----CCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccch
Q 002892 721 ----NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMS 796 (870)
Q Consensus 721 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~ 796 (870)
++.+||+|||+|..+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 8999999999997654333344445567999999999999999999999999999999999999998653222110
Q ss_pred HHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHHhHhHhh
Q 002892 797 LKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQR-MCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Ps~~evl~~L~~i~~~~~ 867 (870)
....... . .....+.+++..|+..+|.+| |++.++.+.|+++.+...
T Consensus 295 ----------------~~~~~~~-~-------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 295 ----------------PEGLFRR-L-------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ----------------ECSCCTT-C-------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----------------echhccc-c-------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0000000 0 013357789999999999998 578888999988876643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=332.13 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=205.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567999999999999999999965 578999999987666667789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee---CCCCceEEeccccccccCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~ 738 (870)
|+++++|.+++...+. +++..+..++.|++.|++||| +++|+||||||+||++ +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999886543 899999999999999999999 6679999999999999 78899999999999876433
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
. ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||......+ ....+.......
T Consensus 163 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~----------- 226 (277)
T 3f3z_A 163 K---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTFTF----------- 226 (277)
T ss_dssp S---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCC-----------
T ss_pred c---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC-----------
Confidence 2 22344689999999998654 8999999999999999999999997632211 111111100000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+|++.+|++||++.++++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 ----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011123557899999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.70 Aligned_cols=245 Identities=22% Similarity=0.236 Sum_probs=203.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.+.. ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999965 68999999997653 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+. +++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 120 ~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999986543 899999999999999999999 667999999999999999999999999999876432
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.....+
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~------------- 256 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGKVR------------- 256 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC-------------
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-HHHHHHHHcCCCC-------------
Confidence 2234689999999999999999999999999999999999999975311 1111111110000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
. +..++..+.+++.+||+.||++||+ +.||++
T Consensus 257 -~-----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -F-----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -C-----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -C-----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0 0112456889999999999999998 787764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.48 Aligned_cols=265 Identities=18% Similarity=0.205 Sum_probs=210.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeee-eeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC-CNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 660 (870)
..++|++.+.||+|+||.||+|+. .+++.||+|++...... +.+.+|++++++++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999996 57899999998755432 4578899999999988765555544 6677889999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee---CCCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~ 737 (870)
||+ +++|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 99999999866667999999999999999999999 6679999999999999 4789999999999987654
Q ss_pred CCCcc-----cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc--chHHHHHHHhcCCchh
Q 002892 738 DDDSV-----TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE--MSLKHWIKLSLPRGLT 810 (870)
Q Consensus 738 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 810 (870)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+.....+...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-
Confidence 33211 1234568999999999999999999999999999999999999998643221 111111111110000
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
......++..+.+++..||+.+|++||++.+|++.|+++.+...
T Consensus 240 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 -------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 00011234578999999999999999999999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.57 Aligned_cols=267 Identities=23% Similarity=0.353 Sum_probs=190.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999864 68999999997543 2234667889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 662 FMPNGSLEKWLYSHN-----YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
|++ |+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999987432 45899999999999999999999 6679999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC-c-hhhh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR-G-LTEV 812 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-~-~~~~ 812 (870)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+... ..+. . +..+
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhh
Confidence 3221 2234468999999999876 46899999999999999999999999763222 222222221 1111 1 1110
Q ss_pred cc-----hhhhcccCcc-------hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VD-----ASLVREVQPS-------YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~-----~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. .......... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 0000000000 000113457899999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.85 Aligned_cols=254 Identities=21% Similarity=0.239 Sum_probs=193.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||+||+|+.. +++.||+|++...... ...+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999965 7899999999765332 3567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc--eEEeccccccccCCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT--ARVSDFGISKLLGEDD 739 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~~~~~~ 739 (870)
|+++|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||++......
T Consensus 97 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 999999999997654 3899999999999999999999 667999999999999987765 999999998743221
Q ss_pred CcccccccccccccCCcccccCCCcCcc-cchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPK-CDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ ............
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~---------- 238 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVK---------- 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTC----------
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCC----------
Confidence 12234569999999999988877655 9999999999999999999976433221 111111110000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.. ......++..+.+++.+||+.+|++|||+.|+++.
T Consensus 239 --~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 --YS-IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CC-CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CC-CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 00000123468899999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.27 Aligned_cols=262 Identities=21% Similarity=0.263 Sum_probs=200.5
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999965 68899999997543 334577899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++++|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999998654 4899999999999999999999 56699999999999999999999999999986643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ..........+.
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~---------- 253 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR---------- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC----------
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC----------
Confidence 221 2223456899999999999999999999999999999999999999753211 111111111100
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHhH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-CMTDVVVKLQKIKQT 865 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~i~~~ 865 (870)
.......++..+.+++.+||+.+|++|| ++.++++.|++..+.
T Consensus 254 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 -----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0000112345688999999999999999 999999999877543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.29 Aligned_cols=249 Identities=21% Similarity=0.279 Sum_probs=201.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 657 (870)
..++|++.+.||+|+||.||+|+.. +++.||+|++++.. ......+..|.+++..+ +||+|+++++++...+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999976 47899999998653 23456678899999888 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||++||+|.+++...+. +++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999986543 899999999999999999999 66799999999999999999999999999985422
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+......
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~~~----------- 239 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHNVA----------- 239 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC-----------
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-HHHHHHHHhCCCC-----------
Confidence 21 223345799999999999999999999999999999999999999975211 1111111110000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
. +...+..+.+++.+||+.+|++||+ +.++++
T Consensus 240 ---~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 ---Y-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---C-----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---C-----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 0122456889999999999999995 466654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.53 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=185.3
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|+. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999996 4789999999975432 234678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++++|.+++......+++..++.++.|++.|++||| +++++||||||+||+++.++.+||+|||.+......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999977667999999999999999999999 567999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ . ..+...
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~------------~~~~~~--- 227 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-L------------NKVVLA--- 227 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSS---
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-H------------HHHhhc---
Confidence 21 22234689999999999998999999999999999999999999975321110 0 000000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... .+..++..+.+++.+||+.||++||++.++++
T Consensus 228 -~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 -DYE---MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccC---CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 00112446889999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.75 Aligned_cols=276 Identities=24% Similarity=0.309 Sum_probs=212.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC--eeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD--FKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999966 58999999997543 334567789999999999999999999998755 77999
Q ss_pred EecCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee----CCCCceEEecccccc
Q 002892 660 LEFMPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL----DKNMTARVSDFGISK 733 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~ 733 (870)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998543 33899999999999999999999 6679999999999999 777889999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccC--------CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH--H
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASD--------GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK--L 803 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~ 803 (870)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... .
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 764322 2234568999999998865 56788999999999999999999999754332222222211 1
Q ss_pred hcCCc-hhhhc---chhhhc--c-cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 804 SLPRG-LTEVV---DASLVR--E-VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 804 ~~~~~-~~~~~---~~~~~~--~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..|.. +..+. +..+.. . .............+.+++..||+.||++||+++++++.++++.+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11211 11110 000000 0 000111245677889999999999999999999999999988764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.83 Aligned_cols=253 Identities=19% Similarity=0.308 Sum_probs=206.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999965 78999999997543 3445778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++.... .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||.+.........
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999987543 4899999999999999999999 667999999999999999999999999999866433322
Q ss_pred ccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......|++.|+|||++.+..+ +.++||||+|+++|||++|+.||............|.......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 228 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------- 228 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS-------------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc-------------
Confidence 23344568999999999987765 7799999999999999999999976443333233222110000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......+..+.+++.+||+.+|++||++.|+++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122446889999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=331.20 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=204.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999865 68999999997653 34457788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc---eEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT---ARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~ 736 (870)
|||+++++|.+++...+ .+++..+..++.|++.|++||| +.+|+||||||+||+++.++. +||+|||.+....
T Consensus 84 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999887654 4899999999999999999999 566999999999999986655 9999999998764
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... .............
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~--------- 226 (284)
T 3kk8_A 160 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDY--------- 226 (284)
T ss_dssp SSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCC---------
T ss_pred cCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhccccC---------
Confidence 322 223456899999999999999999999999999999999999999653211 1111111110000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||+.+|++||++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000123456889999999999999999999976
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.88 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=201.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4577999999999999999999865 57899999987543 2234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++++|.+++..... +++..+..++.|++.|++||| ++||+||||||+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999986543 899999999999999999999 777999999999999999999999999998654322
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||...... .......... ..
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~--~~---------- 225 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVE--FT---------- 225 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTC--CC----------
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-HHHHHHHhCC--CC----------
Confidence 223346899999999999999999999999999999999999999753211 1111110000 00
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
. +..++..+.+++.+||+.+|++||++.|+++.
T Consensus 226 --~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 --F-----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --C-----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --C-----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 01123468899999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.65 Aligned_cols=262 Identities=22% Similarity=0.258 Sum_probs=207.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee----CCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN----LDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 657 (870)
..++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346799999999999999999996 5789999999977666677889999999999999999999999863 34778
Q ss_pred EEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 658 LVLEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
+||||+++|+|.+++.. .+..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999985 3556999999999999999999999 56799999999999999999999999999876
Q ss_pred cCCCCCcc-------cccccccccccCCcccccCCC---cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 002892 735 LGEDDDSV-------TQTMTMATIGYMAPEYASDGI---ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 735 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 804 (870)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.................
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 53211110 112345799999999987654 68899999999999999999999965322222121111110
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
. ... ....++..+.+++.+||+.||++||++.++++.|+++..
T Consensus 264 ~------------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 264 L------------SIP-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --------------CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred C------------CCC-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 000 001234568999999999999999999999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.26 Aligned_cols=250 Identities=28% Similarity=0.341 Sum_probs=197.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467899999999999999999964 68999999997654 2345778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee---CCCCceEEecccccccc
Q 002892 662 FMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLL 735 (870)
Q Consensus 662 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~ 735 (870)
|+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998643 356999999999999999999999 6679999999999999 45688999999999866
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... ......||+.|+|||++. +.++.++||||+|+++|||++|+.||...... ..........+..
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~------- 244 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYKEPNY------- 244 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCC-------
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccCCccc-------
Confidence 4322 223456899999999885 56889999999999999999999999763211 1111111100000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......+..+.+++.+||+.||++||++.|+++
T Consensus 245 --------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 --------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000012346889999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.16 Aligned_cols=262 Identities=22% Similarity=0.369 Sum_probs=206.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
..++|++.+.||+|+||.||+|++ .+++.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999983 25778999999644 23445678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEE
Q 002892 656 KALVLEFMPNGSLEKWLYSHN------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARV 726 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl 726 (870)
.++||||+++++|.+++...+ ..+++..++.++.|++.||+||| +++|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999998653 44899999999999999999999 667999999999999984 446999
Q ss_pred eccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhc
Q 002892 727 SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSL 805 (870)
Q Consensus 727 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 805 (870)
+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||..... ......+....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~ 262 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 262 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCC
Confidence 99999976543333333344567899999999988899999999999999999998 8899865321 11111111100
Q ss_pred CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
.. . ....++..+.+++.+||+.+|++||++.++++.++.+.+..
T Consensus 263 ~~------------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 263 RM------------D-----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CC------------C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CC------------C-----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00 0 01123456889999999999999999999999999887643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.92 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=192.9
Q ss_pred hcCCCCCCeeccccceeEEEEEe----cCCcEEEEEEeechh----hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
.++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 478999999997642 2334567889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.|+||||+++++|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999998654 3899999999999999999999 567999999999999999999999999999754
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ...........
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~---------- 238 (327)
T 3a62_A 172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILKCKL---------- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCC----------
T ss_pred ccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCC----------
Confidence 3221 1223456899999999999999999999999999999999999999753211 11111111000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
... ...+..+.+++.+||+.+|++|| ++.|+++
T Consensus 239 ----~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ----NLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 000 01234688999999999999999 6777765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.67 Aligned_cols=246 Identities=26% Similarity=0.324 Sum_probs=200.4
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999996 578999999987542 344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||++ |++.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 6888888766667999999999999999999999 566999999999999999999999999999865322
Q ss_pred cccccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 741 SVTQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||...... ...........+.
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~---------- 272 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPA---------- 272 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCC----------
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCC----------
Confidence 2346899999999884 567899999999999999999999998653211 1111111111000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.....++..+.+++.+||+.+|++||++.++++.
T Consensus 273 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0011224468899999999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.80 Aligned_cols=266 Identities=15% Similarity=0.151 Sum_probs=200.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechhhH-----------HHHHHHHHHHHHHhcCCCceeEEee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQLER-----------AFRSFESECEVLRNVRHRNLIKIFS 648 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~ 648 (870)
.++|++.+.||+|+||.||+|... ++..||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999965 5788999998764321 1123667888899999999999999
Q ss_pred eeee----CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC--
Q 002892 649 SCCN----LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-- 722 (870)
Q Consensus 649 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-- 722 (870)
++.. ....++||||+ +++|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence 9987 67889999999 999999998665 5999999999999999999999 56799999999999998877
Q ss_pred ceEEeccccccccCCCCC-----cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchH
Q 002892 723 TARVSDFGISKLLGEDDD-----SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL 797 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~ 797 (870)
.+||+|||++..+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999987643211 111244578999999999999999999999999999999999999996532222222
Q ss_pred HHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 798 KHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
...... ............. ....++..+.+++..||+.+|++||++.+|++.|+++.
T Consensus 271 ~~~~~~-~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTN-LLDELPQSVLKWA--------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHH-HHHTTTHHHHHHS--------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHh-hcccccHHHHhhc--------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111 0000000000000 00023457999999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=353.54 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=204.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999965 799999999976532 2356789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999997654 4899999999999999999999 7779999999999999999999999999998764332
Q ss_pred CcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.... ......+. +...
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~-----------~~~~- 233 (476)
T 2y94_A 171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLFKKIC-----------DGIF- 233 (476)
T ss_dssp ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHHHHHH-----------TTCC-
T ss_pred ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHHHHHh-----------cCCc-
Confidence 2234569999999999988765 6899999999999999999999975321 11111110 0000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. . +..++..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~--~----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 Y--T----PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp C--C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--C----CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 0 0112346889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=337.31 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=204.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhH------HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLER------AFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
..++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467899999999999999999965 6899999999764321 35678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC----ceEEecccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM----TARVSDFGI 731 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~ 731 (870)
.++||||+++++|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999998654 4899999999999999999999 66799999999999999887 799999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+......
T Consensus 166 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~----- 236 (321)
T 2a2a_A 166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITSVSYD----- 236 (321)
T ss_dssp CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCC-----
T ss_pred ceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcccc-----
Confidence 98764332 223346899999999999999999999999999999999999999753211 111111100000
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+ ......++..+.+++.+||+.||++||++.|+++
T Consensus 237 -~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 -FD---------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CC---------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -cC---------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0001123456889999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.54 Aligned_cols=260 Identities=21% Similarity=0.286 Sum_probs=202.1
Q ss_pred HHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-----hHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 002892 579 DIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652 (870)
Q Consensus 579 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 652 (870)
++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 44566788999999999999999999864 68899999997652 3445788999999999999999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhc---------------------------------------CCCCCHHHHHHHHHHHHH
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSH---------------------------------------NYFLDMLERLNIMIDVGL 693 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~ 693 (870)
.+..++||||+++|+|.+++... ...+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 112467788899999999
Q ss_pred HHHHHHhcCCCCcEecccCCCceeeCCCC--ceEEeccccccccCCCCC--cccccccccccccCCcccccC--CCcCcc
Q 002892 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNM--TARVSDFGISKLLGEDDD--SVTQTMTMATIGYMAPEYASD--GIISPK 767 (870)
Q Consensus 694 ~l~~Lh~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~--~~~~~~ 767 (870)
||+||| +++|+||||||+||+++.++ .+||+|||++..+..... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999 56699999999999998776 899999999986533221 112344568999999999865 678899
Q ss_pred cchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCC
Q 002892 768 CDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPE 847 (870)
Q Consensus 768 sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~ 847 (870)
+||||||+++|||++|+.||......+ ............ .......++..+.+++.+||+.+|+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLCF---------------ENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCT---------------TSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhccccc---------------CCcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999997632211 111111110000 0001112345688999999999999
Q ss_pred CCCCHHHHHH
Q 002892 848 QRMCMTDVVV 857 (870)
Q Consensus 848 ~RPs~~evl~ 857 (870)
+||++.++++
T Consensus 321 ~Rps~~~~l~ 330 (345)
T 3hko_A 321 ERFDAMRALQ 330 (345)
T ss_dssp TSCCHHHHHH
T ss_pred HCCCHHHHhc
Confidence 9999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.90 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=208.0
Q ss_pred HhhcCCCCCC-eeccccceeEEEEEe---cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 582 QATDGFNECN-LLGAGSFGSVYKGTL---FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 582 ~~~~~~~~~~-~lg~G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
...++|++.+ .||+|+||.||+|.+ .+++.||||+++... ....+.+.+|++++++++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788887 999999999999964 246889999997653 23357799999999999999999999998 5677
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.++||||+++++|.+++...+ .+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 899999999999999998754 4899999999999999999999 667999999999999999999999999999877
Q ss_pred CCCCCcc-cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 736 GEDDDSV-TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 736 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~------ 239 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERM------ 239 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCC------
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCC------
Confidence 5433222 2223346789999999988889999999999999999999 9999976322 1111111111000
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
. .+..++..+.+++.+||+.||++||++.++++.|+++...-.
T Consensus 240 ------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 240 ------G-----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ------C-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ------C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0 011234578999999999999999999999999999877654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.01 Aligned_cols=267 Identities=13% Similarity=0.098 Sum_probs=208.1
Q ss_pred hcCCCCCCeeccccceeEEEEEecC---------CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeE---------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFD---------GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK--------- 645 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 645 (870)
.++|++.+.||+|+||.||+|+... ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999653 789999998754 35788999999999999887
Q ss_pred ------Eeeeeee-CCeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCcee
Q 002892 646 ------IFSSCCN-LDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717 (870)
Q Consensus 646 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 717 (870)
+++++.. ....++||||+ +++|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 5666665 67889999999 99999999865 356999999999999999999999 667999999999999
Q ss_pred eCCCC--ceEEeccccccccCCCCCc-----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcc
Q 002892 718 LDKNM--TARVSDFGISKLLGEDDDS-----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790 (870)
Q Consensus 718 l~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~ 790 (870)
++.++ .+||+|||++..+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876432211 1123347899999999999999999999999999999999999999864
Q ss_pred ccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhhh
Q 002892 791 FTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFLV 868 (870)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~~ 868 (870)
............... .......+.... ...++..+.+++..||+.||++||++.+|++.|+++.+....
T Consensus 272 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 272 LPNTEDIMKQKQKFV-DKPGPFVGPCGH--------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TTCHHHHHHHHHHHH-HSCCCEECTTSC--------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CcCHHHHHHHHHhcc-CChhhhhhhccc--------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 323222222211100 000000000000 001235689999999999999999999999999999887543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=343.23 Aligned_cols=271 Identities=21% Similarity=0.263 Sum_probs=206.3
Q ss_pred chhHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-----CCceeEEeee
Q 002892 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVR-----HRNLIKIFSS 649 (870)
Q Consensus 576 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~ 649 (870)
++.+.....++|++.+.||+|+||.||+|+.. +++.||||+++.. ......+..|+++++.++ ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 33444455689999999999999999999964 7899999999753 333456778999999986 9999999999
Q ss_pred eeeCCeeEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC--------
Q 002892 650 CCNLDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-------- 720 (870)
Q Consensus 650 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------- 720 (870)
+...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999 999999998653 45899999999999999999999 667999999999999975
Q ss_pred -----------------CCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhC
Q 002892 721 -----------------NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTR 783 (870)
Q Consensus 721 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg 783 (870)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999865332 2234689999999999999999999999999999999999
Q ss_pred CCCCCccccccchHHHHHHHhc--CCch---------hhhcchhhhc-ccCc---c------------hHHHHHHHHHHH
Q 002892 784 KKPTDEMFTGEMSLKHWIKLSL--PRGL---------TEVVDASLVR-EVQP---S------------YAKMDCLLRIMH 836 (870)
Q Consensus 784 ~~p~~~~~~~~~~~~~~~~~~~--~~~~---------~~~~~~~~~~-~~~~---~------------~~~~~~~~~l~~ 836 (870)
+.||...... ........... +... ...++..... .... . .........+.+
T Consensus 256 ~~pf~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 256 SLLFRTHEHM-EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SCSCCCSSHH-HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCcHH-HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999763221 11211111111 1110 0000000000 0000 0 000111256789
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 002892 837 LALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 837 l~~~cl~~~P~~RPs~~evl~ 857 (870)
++.+||+.||++|||++|+++
T Consensus 335 li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCChhhCCCHHHHhc
Confidence 999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.09 Aligned_cols=247 Identities=22% Similarity=0.305 Sum_probs=179.1
Q ss_pred CCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEEecCCCCC
Q 002892 590 CNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVLEFMPNGS 667 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~ 667 (870)
.+.||+|+||.||+|... +++.||||++.... ...+.+|+.+++++. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999965 68999999997543 356778999999997 9999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC---ceEEeccccccccCCCCCcccc
Q 002892 668 LEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---TARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 668 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
|.+++...+ .+++.++..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||++....... ...
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 166 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL 166 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence 999998754 4899999999999999999999 66799999999999997765 89999999998664322 223
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc--chHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE--MSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
....||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ..... +..........
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------------~~~~i~~~~~~ 234 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE------------IMKKIKKGDFS 234 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH------------HHHHHTTTCCC
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH------------HHHHHHcCCCC
Confidence 34568999999999999999999999999999999999999997632211 01111 11111111110
Q ss_pred -cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 -PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 -~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......++..+.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11111234567899999999999999999998863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=368.75 Aligned_cols=258 Identities=25% Similarity=0.399 Sum_probs=204.5
Q ss_pred CCCCC-eeccccceeEEEEEec---CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 587 FNECN-LLGAGSFGSVYKGTLF---DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 587 ~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
+.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33334 7999999999999864 46679999997643 3356789999999999999999999999876 56899999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++|+|.+++...+..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++.........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 99999999999877777999999999999999999999 667999999999999999999999999999876433221
Q ss_pred -ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 742 -VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 742 -~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.......+++.|+|||++.++.++.++|||||||++|||++ |+.||...... .+...+....
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~-------------- 556 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK-------------- 556 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTC--------------
T ss_pred eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC--------------
Confidence 11223345689999999998999999999999999999998 99999763221 1111111100
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
....+..++..+.+++..||+.+|++||++.+|++.|+.+.....
T Consensus 557 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 557 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 000112355679999999999999999999999999999876653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.71 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=200.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-CeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-DFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 661 (870)
..++|++.+.||+|+||.||+|+.. |+.||+|+++... ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3578999999999999999999864 8899999987543 346789999999999999999999987544 57899999
Q ss_pred cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|+++++|.+++...+ ..+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999998543 23789999999999999999999 667999999999999999999999999998765322
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+..... .
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~------------~ 233 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK------------M 233 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCC------------C
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCC------------C
Confidence 122357889999999998899999999999999999998 99998753221 11111100000 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..+..++..+.+++.+||+.+|++||++.++++.|++++...
T Consensus 234 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 234 -----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 001123457899999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=335.46 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=199.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999975 58999999986543 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||++++++.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+........
T Consensus 82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999999999887544 4899999999999999999999 66799999999999999999999999999987643222
Q ss_pred cccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh--cCCchhhhcch--
Q 002892 741 SVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS--LPRGLTEVVDA-- 815 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-- 815 (870)
......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+. ........ ...........
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHTCG
T ss_pred --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhccccccccccccccc
Confidence 2234568999999999876 6689999999999999999999999976432211 11111110 00000000000
Q ss_pred ----hhhcccC----cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 ----SLVREVQ----PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ----~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....... .......++..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 00001123556889999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=337.79 Aligned_cols=267 Identities=21% Similarity=0.290 Sum_probs=198.7
Q ss_pred hcCCCCC-CeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEE
Q 002892 584 TDGFNEC-NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 584 ~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 660 (870)
.+.|++. +.||+|+||.||+|... +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4568774 78999999999999854 7899999999876555567889999999985 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc---eEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT---ARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~ 737 (870)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999998654 4899999999999999999999 566999999999999988776 99999999976532
Q ss_pred CCC-----cccccccccccccCCcccccC-----CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 002892 738 DDD-----SVTQTMTMATIGYMAPEYASD-----GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 738 ~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+..... .....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~ 243 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEACP 243 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccch
Confidence 211 111223458999999999875 56889999999999999999999999764332210000 00000
Q ss_pred c-hhhhcchhhhcccC-cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 G-LTEVVDASLVREVQ-PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~-~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ...+.......... +......++..+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0 00001100000000 00011123557899999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=348.33 Aligned_cols=270 Identities=22% Similarity=0.310 Sum_probs=194.2
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCC--e
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLD--F 655 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~ 655 (870)
...++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999864 7899999998543 2344567889999999997 999999999997544 6
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.|+||||++ ++|.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+|+.+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999997 6899998764 4899999999999999999999 667999999999999999999999999999865
Q ss_pred CCCC-------------------CcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccc
Q 002892 736 GEDD-------------------DSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM 795 (870)
Q Consensus 736 ~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~ 795 (870)
.... .....+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-MN 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-HH
Confidence 3211 1112234579999999999876 6789999999999999999999999976322 22
Q ss_pred hHHHHHHH-hcCCc--h--------hhhcchhh------hcccCcchH-----------HHHHHHHHHHHHhhccCCCCC
Q 002892 796 SLKHWIKL-SLPRG--L--------TEVVDASL------VREVQPSYA-----------KMDCLLRIMHLALGCCMDSPE 847 (870)
Q Consensus 796 ~~~~~~~~-~~~~~--~--------~~~~~~~~------~~~~~~~~~-----------~~~~~~~l~~l~~~cl~~~P~ 847 (870)
.+..+... ..|.. + ........ .......+. ...++..+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 22222211 11111 0 00000000 000000000 002345789999999999999
Q ss_pred CCCCHHHHHHH
Q 002892 848 QRMCMTDVVVK 858 (870)
Q Consensus 848 ~RPs~~evl~~ 858 (870)
+|||+.|+++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=340.55 Aligned_cols=258 Identities=27% Similarity=0.453 Sum_probs=204.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEE--EEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNV--AIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 658 (870)
.++|++.+.||+|+||.||+|+.. +++.+ |+|++.... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 467999999999999999999854 56644 999887532 33456788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc
Q 002892 659 VLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 723 (870)
||||+++|+|.+++...+ ..+++..++.++.|++.||+||| ++||+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 999999999999998543 46899999999999999999999 667999999999999999999
Q ss_pred eEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHH
Q 002892 724 ARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 724 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 802 (870)
+||+|||++..... ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... ....
T Consensus 181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE 252 (327)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH
T ss_pred EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHHH
Confidence 99999999874321 112233456889999999988889999999999999999998 99999753211 1111
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
. . ....... .+..++..+.+++.+||+.+|++||++.++++.|+++.+..
T Consensus 253 ~-~--------~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 K-L--------PQGYRLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp H-G--------GGTCCCC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred H-h--------hcCCCCC-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 0 0000000 01123457899999999999999999999999999987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=343.72 Aligned_cols=248 Identities=26% Similarity=0.312 Sum_probs=192.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHH-HHhcCCCceeEEeeeeeeCCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEV-LRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
.++|++.+.||+|+||.||+|+.+ +++.||+|++++.. ......+..|..+ ++.++||||+++++++...+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999965 58899999997654 2233455666666 567899999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||++||+|.+++...+ .+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||++......
T Consensus 117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999998654 3889999999999999999999 667999999999999999999999999999864222
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
. .......||+.|+|||++.+..++.++||||+||++|||++|..||...... .....+... ...
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~------------~~~ 257 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNK------------PLQ 257 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHHHHS------------CCC
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhc------------ccC
Confidence 1 2233457999999999999999999999999999999999999999753111 111111110 000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... ..+..+.+++.+||+.||++||++.+..+
T Consensus 258 --~~~-----~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 258 --LKP-----NITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp --CCS-----SSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred --CCC-----CCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 000 12346889999999999999999864433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.95 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=201.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh--------HHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE--------RAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999985 4789999999976531 1234567899999999999999999999999
Q ss_pred CeeEEEEecCCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 654 DFKALVLEFMPNG-SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 654 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
+..++||||+.+| +|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 99999986544 899999999999999999999 667999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------ 236 (335)
T 3dls_A 178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------ 236 (335)
T ss_dssp EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence 87644322 233568999999999988776 78999999999999999999999752110
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
....... +..++..+.+++.+||+.+|++||++.++++.
T Consensus 237 -~~~~~~~-------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAIHP-------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCCCC-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HhhccCC-------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00124468899999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.60 Aligned_cols=267 Identities=24% Similarity=0.314 Sum_probs=198.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh-----HHHHHHHHHHHHHHhc---CCCceeEEeeeeeeC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE-----RAFRSFESECEVLRNV---RHRNLIKIFSSCCNL 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~ 653 (870)
..++|++.+.||+|+||+||+|+. .+++.||+|++..... .....+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 4789999999874321 1123455667666666 499999999999775
Q ss_pred C-----eeEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEe
Q 002892 654 D-----FKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVS 727 (870)
Q Consensus 654 ~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 727 (870)
. ..++||||++ ++|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5789999997 59999998654 34899999999999999999999 6669999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcC
Q 002892 728 DFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLP 806 (870)
Q Consensus 728 Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~ 806 (870)
|||++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... ..+
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 999998764322 233456899999999999999999999999999999999999999763222 222222221 111
Q ss_pred C--chhhhc---chhhhcccCcc--hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 807 R--GLTEVV---DASLVREVQPS--YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 807 ~--~~~~~~---~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. .+.... ........... ....+++..+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1 111000 00000000000 001123457889999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.70 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=204.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee---------
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN--------- 652 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------- 652 (870)
...+|++.+.||+|+||.||+|... +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467899999999999999999976 79999999997654 246789999999999999999998854
Q ss_pred -------CCeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCce
Q 002892 653 -------LDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA 724 (870)
Q Consensus 653 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 724 (870)
....++||||+++++|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence 34578999999999999999854 356899999999999999999999 5679999999999999999999
Q ss_pred EEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 002892 725 RVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 725 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 804 (870)
||+|||++....... ......|++.|+|||++.+..++.++||||||+++|||++|..|+... ..+...
T Consensus 162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~- 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTD- 230 (284)
T ss_dssp EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHH-
T ss_pred EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHH-
Confidence 999999998764332 223346899999999999999999999999999999999999886431 011000
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..... ... .++..+.+++.+||+.||++||++.|+++.++.+.+..
T Consensus 231 -------~~~~~----~~~-----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 231 -------LRDGI----ISD-----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -------HHTTC----CCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -------hhccc----ccc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 00000 000 12345789999999999999999999999999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.07 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=200.8
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
...++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34578999999999999999999976 58999999998766666778999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++......+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999999876666999999999999999999999 567999999999999999999999999987543110
Q ss_pred cccccccccccccCCcccc-----cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 741 SVTQTMTMATIGYMAPEYA-----SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~-----~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
........|++.|+|||++ .+..++.++||||||+++|+|++|+.||...... .....+.....+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-------- 241 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSDPPT-------- 241 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCC--------
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHhccCCcc--------
Confidence 1112234689999999988 4677899999999999999999999999763221 1111111110000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+..++..+.+++.+||+.+|++||++.++++
T Consensus 242 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 --------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0011123456889999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.78 Aligned_cols=266 Identities=18% Similarity=0.256 Sum_probs=198.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHH-HHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERA-FRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999965 78999999987543221 12345799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++ |+|.+++...+..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence 97 5999999887777999999999999999999999 6679999999999999999999999999998653322 2
Q ss_pred cccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-c--CCchhhhcchhhh
Q 002892 743 TQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-L--PRGLTEVVDASLV 818 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~ 818 (870)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+.... . +..+.........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchhh
Confidence 2334568999999999876 56899999999999999999999999763222 2222222211 1 1112221111100
Q ss_pred ccc------Cc--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REV------QP--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~------~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... .. ......++..+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 00 0011123456889999999999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.16 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=204.5
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh------HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE------RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999976 689999999876431 13577899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC----ceEEecccccc
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM----TARVSDFGISK 733 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~ 733 (870)
+||||+++++|.+++.... .+++..+..++.|++.||+||| +++++||||||+||+++.++ .+||+|||.+.
T Consensus 85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999997644 4899999999999999999999 66799999999999998877 89999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
...... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+..... ..
T Consensus 161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~---- 230 (283)
T 3bhy_A 161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAVNY--DF---- 230 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCC--CC----
T ss_pred eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHhHhccc--CC----
Confidence 764322 223346899999999999999999999999999999999999999753211 11111100000 00
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhHh
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV--KLQKIKQ 864 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~i~~ 864 (870)
.......++..+.+++.+||+.+|++||++.++++ .++.+++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 231 ---------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ---------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ---------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 00011123456889999999999999999999987 4555544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.22 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=204.6
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--------hHHHHHHHHHHHHHHhc-CCCceeEEeee
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--------ERAFRSFESECEVLRNV-RHRNLIKIFSS 649 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 649 (870)
.....++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999975 79999999987543 22356788999999999 79999999999
Q ss_pred eeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecc
Q 002892 650 CCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDF 729 (870)
Q Consensus 650 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 729 (870)
+......++||||+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence 999999999999999999999998653 4899999999999999999999 667999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccC------CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASD------GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~ 803 (870)
|++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...
T Consensus 245 G~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~ 320 (365)
T 2y7j_A 245 GFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-ILMLRMIMEG 320 (365)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHT
T ss_pred CcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhC
Confidence 9998764332 2234568999999998853 3588899999999999999999999965211 1111111111
Q ss_pred hcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 804 SLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... .......++..+.+++.+||+.||++||++.++++
T Consensus 321 ~~~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQF---------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCC---------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC---------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 00011123456889999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=353.03 Aligned_cols=249 Identities=25% Similarity=0.296 Sum_probs=194.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999964 68999999997642 33445678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||. .+||+||||||+||+++.++.+||+|||++......
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence 99999999999998654 48999999999999999999993 167999999999999999999999999999754322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+...
T Consensus 303 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~--------------- 364 (446)
T 4ejn_A 303 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME--------------- 364 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC---------------
T ss_pred -CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHhC---------------
Confidence 2223346799999999999999999999999999999999999999965211 1111111100
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
... .+...+..+.+++.+||+.||++|| ++.|+++
T Consensus 365 ~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 EIR---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCC---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 000 0011234688999999999999999 9999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=365.16 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=209.5
Q ss_pred HhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
...++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 34567888999999999999999988888899999976542 34678999999999999999999999876 67899999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|+++|+|.+++... +..+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 99999999999853 345899999999999999999999 6669999999999999999999999999998664221
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
........++..|+|||++..+.++.++|||||||++|||++ |+.||......+ ....+.....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~------------- 482 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR------------- 482 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTCC-------------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence 111223456789999999998999999999999999999999 899987632211 1111110000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
...+..++..+.++|.+||+.+|++||++.+|++.|+++..
T Consensus 483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 00112345678999999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=343.97 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=205.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999965 68999999997653 3445778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+++++|.+++...+. +++..+..++.|++.|++|||+. .||+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 9999999999986543 89999999999999999999942 26999999999999999999999999998754211
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH------------------
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL------------------ 803 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~------------------ 803 (870)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+. ......
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH--HHHHC-------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccCCCCCCCcccCCC
Confidence 12234689999999999999999999999999999999999999975322111 100000
Q ss_pred ---------hcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 804 ---------SLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 804 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+....+..+....... .......++..+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCC-CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCC-CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000011112221111111 11111123557899999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.41 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=199.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec--CCc--EEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF--DGT--NVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.++|++.+.||+|+||.||+|++. +++ .||+|+++... ....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999853 333 68999987542 345678899999999999999999999998755 8
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++++|.+++......+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999876666999999999999999999999 5679999999999999999999999999998775
Q ss_pred CCCCcc-cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 737 EDDDSV-TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 737 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
...... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+.....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~-------- 242 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGE-------- 242 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCC--------
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCC--------
Confidence 433222 2233457889999999998889999999999999999999 99999753211 11111100000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
.......++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 243 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 --------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0000112345789999999999999999999999999988654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=325.12 Aligned_cols=247 Identities=21% Similarity=0.371 Sum_probs=197.2
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee----CCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN----LDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 657 (870)
..|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34778889999999999999864 68899999987543 4456778999999999999999999998865 35689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecccCCCceeeC-CCCceEEeccccccc
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP--VVHCNLKPNNILLD-KNMTARVSDFGISKL 734 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~ 734 (870)
+||||+++++|.+++...+ .+++..+..++.|++.||+||| +.+ |+||||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999998654 3899999999999999999999 666 99999999999997 789999999999976
Q ss_pred cCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
.... ......||+.|+|||++. +.++.++||||+|+++|+|++|+.||............ .....
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~~~--------- 246 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-VTSGV--------- 246 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-HTTTC---------
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH-HhccC---------
Confidence 5332 223346899999999886 45899999999999999999999999753222111111 00000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+......++..+.+++.+||+.+|++||++.|+++
T Consensus 247 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 -------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000001112346889999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=346.73 Aligned_cols=263 Identities=18% Similarity=0.216 Sum_probs=210.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRH-RNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 660 (870)
..++|++.+.||+|+||.||+|+. .+++.||||++...... ..+..|+++++.++| +++..+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999996 47899999998755432 357889999999976 56667777777888999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee---CCCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~ 737 (870)
||+ +++|.+++......+++..++.++.||+.||+||| +++|+||||||+||++ +.++.+||+|||++..+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 99999999876667999999999999999999999 6679999999999999 5889999999999987754
Q ss_pred CCCcc-----cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccch--HHHHHHHhcCCchh
Q 002892 738 DDDSV-----TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMS--LKHWIKLSLPRGLT 810 (870)
Q Consensus 738 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~ 810 (870)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +..+..........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 33211 122457999999999999999999999999999999999999999874332211 11111111111000
Q ss_pred hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
. ....++.++.+++..||+.+|++||++.+|++.|+++.+.
T Consensus 239 ~--------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 239 A--------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp H--------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H--------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0 0112356789999999999999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=350.49 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=205.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|+.. +|+.||+|++.+.. ......+.+|++++++++||||+++++++.+.+..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999965 79999999997643 2334668899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 659 VLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
||||++||+|.+++...+ ..+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999998543 35899999999999999999999 56799999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccc--hHHHHHHHhcCCchhhhcch
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM--SLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 815 (870)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .+...+. ..+..+.
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~p----- 409 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYS----- 409 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-HCCCCCC-----
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-cccccCC-----
Confidence 32 22335799999999999999999999999999999999999999976432211 1111111 0111000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
...+..+.+++.+||+.||++|| ++.||++
T Consensus 410 ------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11234688999999999999999 7788865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=365.38 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=200.4
Q ss_pred CeeccccceeEEEEEec---CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF---DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999643 46789999997653 2345789999999999999999999999864 557899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC-cccc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD-SVTQ 744 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 744 (870)
|+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++..+..... ....
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999997654 4899999999999999999999 56699999999999999999999999999987754332 2223
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+.....
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~----------------- 590 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER----------------- 590 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC-----------------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-----------------
Confidence 33456789999999999999999999999999999998 99999763221 11111111000
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...+..++..+.+++..||+.||++||++.+|++.|+++..+.
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0011234567999999999999999999999999999987764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.53 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=190.6
Q ss_pred hcCCCCC-CeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHh-cCCCceeEEeeeeee----CCee
Q 002892 584 TDGFNEC-NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRN-VRHRNLIKIFSSCCN----LDFK 656 (870)
Q Consensus 584 ~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~ 656 (870)
.++|.+. +.||+|+||+||+|... +++.||||++... ..+.+|++++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4566665 68999999999999965 6899999998643 345677887644 589999999998865 5678
Q ss_pred EEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEeccccc
Q 002892 657 ALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFGIS 732 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a 732 (870)
|+||||+++|+|.+++...+ ..+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999998653 45899999999999999999999 567999999999999987 789999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccc--hHHHHHH-HhcCCch
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM--SLKHWIK-LSLPRGL 809 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~-~~~~~~~ 809 (870)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+. ..+..
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~-- 286 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF-- 286 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC--
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC--
Confidence 8654322 23345689999999999999999999999999999999999999976432211 1111111 10000
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+......++..+.+++.+||+.||++|||+.|+++.
T Consensus 287 -------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 -------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000011234578999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=331.11 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=204.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999966 58899999987653 34557788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++...+ .+++.++..++.|++.|++||| ++|++||||||+||+++.++.+||+|||.+.......
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999987654 4899999999999999999999 6679999999999999999999999999998764322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
. ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+ ....+... . .
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~---~---------~-- 232 (294)
T 2rku_A 170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKN---E---------Y-- 232 (294)
T ss_dssp C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT---C---------C--
T ss_pred c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhc---c---------C--
Confidence 2 2233568999999999999899999999999999999999999997532111 01110000 0 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.. +..++..+.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SI-----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CC-----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CC-----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 01123468899999999999999999999763
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=342.69 Aligned_cols=347 Identities=26% Similarity=0.372 Sum_probs=248.6
Q ss_pred CCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcE
Q 002892 12 GNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVR 91 (870)
Q Consensus 12 ~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 91 (870)
..+++|+.|++++|.+.. +| .+..+++|++|++++|.+++ +|. ++.+++|++|++++|++++..+ +.++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCC-chh-hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 347899999999999984 66 48899999999999999995 454 9999999999999999995444 999999999
Q ss_pred EeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccc
Q 002892 92 LDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQL 171 (870)
Q Consensus 92 L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 171 (870)
|++++|++++. +. +..+++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+.. .+.++++|++|++++|.+
T Consensus 117 L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 117 LTLFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV 189 (466)
T ss_dssp EECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence 99999999854 33 8999999999999999995 44 58999999999997 5665443 388999999999999999
Q ss_pred cccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCC
Q 002892 172 SGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSN 251 (870)
Q Consensus 172 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 251 (870)
++... ...+++|++|++++|++++..+ +..+++|++|++++|++++. ..+..+++|+.|++++|.++...
T Consensus 190 ~~~~~---l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--- 259 (466)
T 1o6v_A 190 SDISV---LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--- 259 (466)
T ss_dssp CCCGG---GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG---
T ss_pred CCChh---hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccch---
Confidence 86532 3468999999999999997655 78899999999999999853 46888888888888888877532
Q ss_pred CCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCc
Q 002892 252 GEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPT 331 (870)
Q Consensus 252 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 331 (870)
.+..+++|++|++++|++.++. . +..+++|+.|++++|++.+..+
T Consensus 260 -------~~~~l~~L~~L~l~~n~l~~~~--------------------------~-~~~l~~L~~L~L~~n~l~~~~~- 304 (466)
T 1o6v_A 260 -------PLSGLTKLTELKLGANQISNIS--------------------------P-LAGLTALTNLELNENQLEDISP- 304 (466)
T ss_dssp -------GGTTCTTCSEEECCSSCCCCCG--------------------------G-GTTCTTCSEEECCSSCCSCCGG-
T ss_pred -------hhhcCCCCCEEECCCCccCccc--------------------------c-ccCCCccCeEEcCCCcccCchh-
Confidence 2556667777777776665321 1 3445555555555555543111
Q ss_pred hhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCC
Q 002892 332 TLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLI 411 (870)
Q Consensus 332 ~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 411 (870)
+..+++|+.|+|++|++++..| +..+++|+.|++++|.+++. ..+..+++|+
T Consensus 305 ------------------------~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~ 356 (466)
T 1o6v_A 305 ------------------------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNIN 356 (466)
T ss_dssp ------------------------GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCC
T ss_pred ------------------------hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCC
Confidence 2334455555555555554433 44445555555555555432 2344444555
Q ss_pred EEEccCCccCCcccccccCCCCCCEEEcCCCcccC
Q 002892 412 YLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD 446 (870)
Q Consensus 412 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 446 (870)
.|++++|++++..| +..+++|+.|++++|.+++
T Consensus 357 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 357 WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp EEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred EEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 55555555444433 4444444444444444443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.36 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=201.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||.||+|+.. +|+.||+|++..........+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467899999999999999999965 789999999987655455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee---CCCCceEEeccccccccCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~ 738 (870)
|+++++|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 999999999987654 3899999999999999999999 6679999999999999 78899999999998754321
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+...... .
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~-~--------- 226 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGYYE-F--------- 226 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCCCC-C---------
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCC-C---------
Confidence 223346899999999999999999999999999999999999999753211 111111110000 0
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||+.||++||++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00001123456889999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.57 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=200.1
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34678999999999999999999965 58999999997643 2366889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++......+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||.+.......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 999999999999866666999999999999999999999 6669999999999999999999999999997664321
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......|++.|+|||++.+..++.++||||+|+++|+|++|+.||....... .........+...
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~----------- 245 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPPTF----------- 245 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCC-----------
T ss_pred -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCccc-----------
Confidence 22334568999999999999999999999999999999999999997532111 0011111100000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+..++..+.+++.+||+.||++||++.++++
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001122456889999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=340.06 Aligned_cols=271 Identities=24% Similarity=0.322 Sum_probs=199.8
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhH-----HHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLER-----AFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
+....++|++.+.||+|+||.||+|+.. +|+.||+|++...... ....+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 4455688999999999999999999965 6899999998754321 124678899999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
+..++||||+++ +|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999999976 899999877767899999999999999999999 6669999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC--ch
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR--GL 809 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~--~~ 809 (870)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|..||...... ..+..+... ..+. .+
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhh
Confidence 764332 223345689999999998764 5889999999999999999999998763221 222222221 1111 11
Q ss_pred hhhc---chhhhcccCc---chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 810 TEVV---DASLVREVQP---SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 810 ~~~~---~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+.. +......... ......++..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1110 0000000000 0001123467899999999999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=347.14 Aligned_cols=262 Identities=21% Similarity=0.226 Sum_probs=196.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCNL------ 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 653 (870)
..++|++.+.||+|+||+||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999855 6899999999764 234457788999999999999999999998654
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 356999999976 46666643 3899999999999999999999 6679999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc--h-
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPRG--L- 809 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~--~- 809 (870)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...+..+.... .+.. +
T Consensus 213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHT
T ss_pred ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHH
Confidence 76432 223445789999999999999999999999999999999999999976321 11222222211 1100 0
Q ss_pred ---------------------hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 810 ---------------------TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 810 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+...... ............+.+++.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFP--ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSC--CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccc--cccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 001112233567899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=337.83 Aligned_cols=267 Identities=22% Similarity=0.292 Sum_probs=200.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999965 58999999986543 334566789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||++++++.++....+ .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999988876444 4899999999999999999999 66799999999999999999999999999986643221
Q ss_pred cccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc--CCchhhhcc---
Q 002892 741 SVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL--PRGLTEVVD--- 814 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--- 814 (870)
......|++.|+|||++.+. .++.++||||+||++|+|++|+.||......+ ....+..... .......+.
T Consensus 180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhcc
Confidence 22345689999999999775 68999999999999999999999997643221 1222111100 000000000
Q ss_pred -------hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 -------ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 -------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+..............++..+.+++.+||+.||++||++.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000111134567999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=338.57 Aligned_cols=258 Identities=22% Similarity=0.265 Sum_probs=191.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeee--------e
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCC--------N 652 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~ 652 (870)
...+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4468999999999999999999964 78999999987776666778899999999996 999999999984 3
Q ss_pred CCeeEEEEecCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecccCCCceeeCCCCceEEec
Q 002892 653 LDFKALVLEFMPNGSLEKWLYS--HNYFLDMLERLNIMIDVGLALEYLHHSHSTP--VVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~D 728 (870)
....++||||++ |+|.+++.. ....+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 445789999995 799998874 3445999999999999999999999 777 99999999999999999999999
Q ss_pred cccccccCCCCCcc----------cccccccccccCCcccc---cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccc
Q 002892 729 FGISKLLGEDDDSV----------TQTMTMATIGYMAPEYA---SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM 795 (870)
Q Consensus 729 fg~a~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~ 795 (870)
||++.......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 99998765432211 11134589999999998 5667889999999999999999999999652111
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
......... ... ..++..+.+++.+||+.+|++||++.|+++.|+++.+..
T Consensus 260 ---~~~~~~~~~------------~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 260 ---RIVNGKYSI------------PPH-----DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ---------CCC------------CTT-----CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---HhhcCcccC------------Ccc-----cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000000 000 011234778999999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.54 Aligned_cols=246 Identities=26% Similarity=0.342 Sum_probs=202.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999965 67899999997643 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++...+ .+++..+..++.|++.|++||| ++|++||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 99999999999998654 3899999999999999999999 777999999999999999999999999998765322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+ ....... ...
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~------------~~~-- 229 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVN------------VDL-- 229 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT------------TCC--
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHhc------------ccc--
Confidence 1233468999999999999999999999999999999999999997532111 0111000 000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... ...+..+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 000 112346889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=339.42 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=197.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..++|++.+.||+|+||.||+|..+ +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999965 6899999999765432 35678888887 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC----CceEEeccccccccC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN----MTARVSDFGISKLLG 736 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~~~ 736 (870)
||+++|+|.+++...+ .+++..+..++.||+.||+||| ++||+||||||+||++..+ +.+||+|||++....
T Consensus 96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999998654 4899999999999999999999 6679999999999998543 359999999998764
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc-chHHHHHH-HhcCCchhhhcc
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE-MSLKHWIK-LSLPRGLTEVVD 814 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~ 814 (870)
.... ......||+.|+|||++.+..++.++||||+||++|||++|..||....... ..+...+. ...+.
T Consensus 172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~------- 242 (342)
T 2qr7_A 172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL------- 242 (342)
T ss_dssp CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC-------
T ss_pred CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc-------
Confidence 3221 2234568999999999988889999999999999999999999997532111 11111111 00000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.......++..+.+++.+||+.||++||++.++++
T Consensus 243 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 --------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000123456889999999999999999999876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=337.82 Aligned_cols=268 Identities=21% Similarity=0.273 Sum_probs=195.6
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
...++|++.+.||+|+||+||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999854 789999999975432 234567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC-----CCCceEEecccccc
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-----KNMTARVSDFGISK 733 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Dfg~a~ 733 (870)
||||++ |+|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||+++ .++.+||+|||++.
T Consensus 111 v~e~~~-~~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCS-EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCC-CCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999997 599999986654 899999999999999999999 56799999999999994 45569999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH-HhcCCc--h
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK-LSLPRG--L 809 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~--~ 809 (870)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..... ...+.. +
T Consensus 186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhh
Confidence 764322 223344689999999999874 4899999999999999999999999763222 12222222 111111 1
Q ss_pred hhhcc-----hhhhcccCc---chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 810 TEVVD-----ASLVREVQP---SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 810 ~~~~~-----~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..... ......... ......++..+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 10000 000000000 0001113457889999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=326.31 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=198.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
++|.....||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44556669999999999999964 68899999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceEEeccccccccCCCCC
Q 002892 664 PNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 664 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 740 (870)
++++|.+++.... ..+++..+..++.|++.||+||| ++|++||||||+||+++. ++.+||+|||.+.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 9999999998653 34678999999999999999999 567999999999999987 8999999999998764322
Q ss_pred cccccccccccccCCcccccCCC--cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 741 SVTQTMTMATIGYMAPEYASDGI--ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.....................
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------- 246 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE---------- 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC----------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc----------
Confidence 1223456899999999987643 789999999999999999999999753221111111000000000
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+..++..+.+++.+||+.+|++||++.++++
T Consensus 247 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 -------IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00123456889999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.95 Aligned_cols=253 Identities=25% Similarity=0.309 Sum_probs=192.7
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--------hHHHHHHHHHHHHHHhcCCCceeEEeeeeee
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--------ERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 652 (870)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999865 68999999997642 1122347899999999999999999999754
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC---ceEEecc
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---TARVSDF 729 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Df 729 (870)
+..++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+||+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 55799999999999999887554 4899999999999999999999 56699999999999997544 5999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccC---CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASD---GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP 806 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 806 (870)
|++...+... ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||........ +...+.....
T Consensus 287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i~~~~~ 362 (419)
T 3i6u_A 287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKY 362 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHHHTTCC
T ss_pred ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHHhcCCC
Confidence 9998764322 2334568999999999853 5678899999999999999999999976332222 2221111100
Q ss_pred CchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 807 RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... ......++..+.+++.+||+.||++||++.|+++
T Consensus 363 ~~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 NFI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC--------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 0011123557899999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.93 Aligned_cols=248 Identities=21% Similarity=0.279 Sum_probs=204.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467889999999999999999965 58899999987653 34557788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999999987654 4899999999999999999999 6679999999999999999999999999998764322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..... .
T Consensus 196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~--~----------- 259 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEY--S----------- 259 (335)
T ss_dssp C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC--C-----------
T ss_pred c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCC--C-----------
Confidence 2 2234568999999999999999999999999999999999999997532111 1111111000 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. +..++..+.+++.+||+.||++||++.|+++
T Consensus 260 -~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 -I-----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -C-----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -C-----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0012346789999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.26 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=205.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467899999999999999999864 68999999997653 344578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++++|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.......
T Consensus 100 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp ECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred EeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 999999999999753 4899999999999999999999 5679999999999999999999999999998764322
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+....+..
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~------------ 238 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPPT------------ 238 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCC------------
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCCC------------
Confidence 1223456899999999999999999999999999999999999999753211 1111111111100
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.. ..++..+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CC-----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred Cc-----cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 1123468899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=348.95 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=204.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh---HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE---RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.+... .....+..|++++++++||||+++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999975 699999999976532 3346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
|||++||+|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999854 345999999999999999999999 6679999999999999999999999999998764
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+..... ...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~--------~~~ 409 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVL--------EQA 409 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHH--------HCC
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHh--------hcc
Confidence 3322 22334799999999999999999999999999999999999999976422111 111111000 000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM-----TDVVV 857 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~ 857 (870)
. .. +...+..+.+++.+||+.||++||++ .+|++
T Consensus 410 ~--~~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 V--TY-----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C--CC-----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred c--CC-----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 00 01224568899999999999999975 55553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=349.91 Aligned_cols=252 Identities=25% Similarity=0.299 Sum_probs=202.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999965 78999999997543 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC---CCCceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD---KNMTARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~ 736 (870)
|||+++|+|.+++...+ .+++..+..++.|++.||+||| ++||+||||||+||+++ .++.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999987654 4899999999999999999999 66799999999999995 45679999999998764
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||..... ......+.....+..
T Consensus 176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~-------- 242 (486)
T 3mwu_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFD-------- 242 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCSC--------
T ss_pred CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCC--------
Confidence 322 2334569999999999875 589999999999999999999999975321 111111111111110
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
......++..+.+++.+||+.+|++|||+.++++.
T Consensus 243 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111234568899999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.33 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=195.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3478999999999999999999976 78999999997653 2335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
||||+++++|.+++...+. +++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999986543 899999999999999999999 556999999999999999999999999999876432
Q ss_pred CCcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
. ......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...... .....+......
T Consensus 165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---------- 229 (276)
T 2h6d_A 165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGVFY---------- 229 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC----------
T ss_pred c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCccc----------
Confidence 2 2233468999999999987765 68999999999999999999999753111 111111110000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
. +..++..+.+++.+||+.||++||++.|+++.
T Consensus 230 ---~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 ---I-----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---C-----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 01123468899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=329.45 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=201.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKAL 658 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 658 (870)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999965 78999999997543 3456778999999999999999999998754 568899
Q ss_pred EEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 659 VLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSH--STPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
||||+++++|.+++... +..+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||.+.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999843 345899999999999999999999432 1239999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+......
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~------ 234 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFR------ 234 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC------
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcccc------
Confidence 764322 122334689999999999998999999999999999999999999976321 1111111110000
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 860 (870)
.. +..++..+.+++.+||+.+|++||++.||++.+.
T Consensus 235 ------~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 ------RI-----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ------CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ------cC-----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 00 0123457889999999999999999999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=332.89 Aligned_cols=261 Identities=19% Similarity=0.280 Sum_probs=201.1
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeeee--CCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCN--LDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... .+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999985 478999999987443 356889999999997 9999999999987 6678999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEeccccccccCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLGED 738 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 738 (870)
|||+++++|.+++.. +++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||++......
T Consensus 112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999854 789999999999999999999 66799999999999999776 8999999999876433
Q ss_pred CCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc---
Q 002892 739 DDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD--- 814 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 814 (870)
. ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.........+.......-.....+.++
T Consensus 185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 2 2234468999999999877 67899999999999999999999999653332222222221111111111110
Q ss_pred ------------hhhhcc---cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ------------ASLVRE---VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ------------~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...... ..........+..+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0000011123567899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.89 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=188.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999996 478999999997543 23334455556667888999999999999999999999
Q ss_pred EecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecccCCCceeeCCCCceEEecccccccc
Q 002892 660 LEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSHST-PVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
|||++ |+|.+++.. .+..+++..+..++.|++.|++||| ++ ||+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 588887763 4556999999999999999999999 44 6999999999999999999999999999866
Q ss_pred CCCCCcccccccccccccCCcccc----cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYA----SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
.... ......||+.|+|||++ .+..++.++||||+|+++|||++|+.||..................+.
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 233 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ---- 233 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC----
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC----
Confidence 4322 22334689999999996 566789999999999999999999999975322222222222111111
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....++..+.+++.+||+.+|++|||+.|+++
T Consensus 234 -------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 -------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 001123456889999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=348.00 Aligned_cols=195 Identities=24% Similarity=0.388 Sum_probs=154.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee-----CCe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN-----LDF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~ 655 (870)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+++.+|++++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999865 78999999986532 3445778999999999999999999999843 357
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.|+||||+ +++|.+++.... .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 579999987654 4899999999999999999999 667999999999999999999999999999876
Q ss_pred CCCCCc-------------------------ccccccccccccCCcccc-cCCCcCcccchHhHHHHHHHHHhC
Q 002892 736 GEDDDS-------------------------VTQTMTMATIGYMAPEYA-SDGIISPKCDVYSYGVLLMETFTR 783 (870)
Q Consensus 736 ~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~il~elltg 783 (870)
...... ......+||+.|+|||++ ....++.++||||+||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 432211 123345789999999976 566799999999999999999993
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=331.95 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=200.0
Q ss_pred cchhHHHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcC--CCceeEEeeee
Q 002892 575 TSYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVR--HRNLIKIFSSC 650 (870)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~ 650 (870)
+.+..+....++|++.+.||+|+||.||+|...+++.||+|++.... ....+.+.+|++++++++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34444555667899999999999999999998889999999996542 445678899999999997 59999999999
Q ss_pred eeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 651 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
...+..++||| +.+++|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++ ++.+||+|||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEeecc
Confidence 99999999999 66889999998654 4899999999999999999999 56799999999999996 4899999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccC-----------CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHH
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASD-----------GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH 799 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~ 799 (870)
++................|++.|+|||++.+ ..++.++||||||+++|||++|+.||............
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 9987754433333345568999999999865 46888999999999999999999999764322111111
Q ss_pred HHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 800 WIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
+. +......... .++..+.+++.+||+.+|++||++.|+++.
T Consensus 252 ~~------------~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 II------------DPNHEIEFPD-----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HH------------CTTSCCCCCC-----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH------------hcccccCCcc-----cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 1110000000 113468899999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.27 Aligned_cols=260 Identities=19% Similarity=0.246 Sum_probs=204.1
Q ss_pred chhHHHHhhcCCCCC-CeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcC-CCceeEEeeee
Q 002892 576 SYLDIQQATDGFNEC-NLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVR-HRNLIKIFSSC 650 (870)
Q Consensus 576 ~~~~~~~~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 650 (870)
.+.......+.|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344555666778877 89999999999999865 68999999987643 233567889999999994 69999999999
Q ss_pred eeCCeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEE
Q 002892 651 CNLDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARV 726 (870)
Q Consensus 651 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl 726 (870)
...+..++||||+++|+|.+++... ...+++..++.++.|++.||+||| ++||+||||||+||+++. ++.+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999999998643 456899999999999999999999 667999999999999987 789999
Q ss_pred eccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC
Q 002892 727 SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP 806 (870)
Q Consensus 727 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 806 (870)
+|||++....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ...........
T Consensus 176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~ 251 (327)
T 3lm5_A 176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TYLNISQVNVD 251 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC
T ss_pred eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhcccc
Confidence 9999998764322 2233568999999999999999999999999999999999999997532211 11111111000
Q ss_pred CchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 807 RGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. .......++..+.+++.+||+.+|++||++.++++
T Consensus 252 ~---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 Y---------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C---------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c---------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 00001123456889999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.61 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=186.3
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 344678999999999999999999854 78999999986543 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 659 VLEFMPNGSLEKWLYS-------HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
||||+++++|.+++.. ....+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999874 2345899999999999999999999 56799999999999999999999999999
Q ss_pred ccccCCCCC---cccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 002892 732 SKLLGEDDD---SVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 732 a~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
+........ ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||........ . .......+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~ 245 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-L-MLTLQNDPP 245 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H-HHHHTSSCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-H-HHHhccCCC
Confidence 976643221 111234568999999999875 5689999999999999999999999976432211 1 111111111
Q ss_pred chh-hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 GLT-EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... ...+..... .++..+.+++.+||+.||++||++.++++
T Consensus 246 ~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLK---------KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhh---------hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111 011111111 12346889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.16 Aligned_cols=274 Identities=20% Similarity=0.248 Sum_probs=203.3
Q ss_pred chhHHHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh-----------hHHHHHHHHHHHHHHhcCCCcee
Q 002892 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL-----------ERAFRSFESECEVLRNVRHRNLI 644 (870)
Q Consensus 576 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv 644 (870)
...++....++|++.+.||+|+||.||+|...+|+.||||++.... ....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4566778889999999999999999999998889999999985432 22347789999999999999999
Q ss_pred EEeeeeee-----CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC
Q 002892 645 KIFSSCCN-----LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD 719 (870)
Q Consensus 645 ~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 719 (870)
++++++.. ....++||||++ |++.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence 99999854 336799999997 6899998877767999999999999999999999 56699999999999999
Q ss_pred CCCceEEeccccccccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHH
Q 002892 720 KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~ 798 (870)
.++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~ 244 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLN 244 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH
T ss_pred CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 99999999999997543222 2334568999999999876 67899999999999999999999999763221 1222
Q ss_pred HHHHHhcCCchh-----------hhcchhhhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 799 HWIKLSLPRGLT-----------EVVDASLVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 799 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
............ +.............+ ....++..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 222211111111 111111111111111 01123456889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=334.48 Aligned_cols=269 Identities=20% Similarity=0.275 Sum_probs=203.0
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee--------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN-------- 652 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 652 (870)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 478999999986543 2223567789999999999999999999876
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
.+..++||||+++ ++.+.+......+++.++..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999975 888888876666999999999999999999999 667999999999999999999999999999
Q ss_pred cccCCCCC--cccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH--hcCC
Q 002892 733 KLLGEDDD--SVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL--SLPR 807 (870)
Q Consensus 733 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~~ 807 (870)
..+..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ......... ..+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCh
Confidence 87643222 222344568999999998876 55899999999999999999999999763222 222222211 1111
Q ss_pred c-hhhhcchhhhc------ccCc----chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 G-LTEVVDASLVR------EVQP----SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~-~~~~~~~~~~~------~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. +.......... .... ..........+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1 11111100000 0000 0011112346889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.34 Aligned_cols=248 Identities=15% Similarity=0.183 Sum_probs=192.1
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeech---hhHHHHHHHHHH---HHHHhcCCCceeEEe-------ee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQ---LERAFRSFESEC---EVLRNVRHRNLIKIF-------SS 649 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 649 (870)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999995 57999999999743 334567788999 555556899999988 55
Q ss_pred eeeCC-----------------eeEEEEecCCCCCHHHHHhhcCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 002892 650 CCNLD-----------------FKALVLEFMPNGSLEKWLYSHNY------FLDMLERLNIMIDVGLALEYLHHSHSTPV 706 (870)
Q Consensus 650 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~Lh~~~~~~i 706 (870)
+...+ ..|+||||+ +|+|.+++...+. .+++..++.++.||+.||+||| +++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 54443 378999999 6899999985432 2335888899999999999999 6679
Q ss_pred EecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCC-----------CcCcccchHhHHH
Q 002892 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG-----------IISPKCDVYSYGV 775 (870)
Q Consensus 707 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~sDvwslG~ 775 (870)
+||||||+||+++.++.+||+|||++...+. ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985422 2234457 999999999877 8999999999999
Q ss_pred HHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 002892 776 LLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855 (870)
Q Consensus 776 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 855 (870)
++|||++|+.||........ ...+.. .. ..++..+.+++.+||+.||++||++.|+
T Consensus 302 il~elltg~~Pf~~~~~~~~-------------~~~~~~-----~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG-------------SEWIFR-----SC------KNIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHHSSCCC------CC-------------SGGGGS-----SC------CCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHHCCCCCcccccccc-------------hhhhhh-----hc------cCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 99999999999965321110 011110 00 1224568899999999999999999999
Q ss_pred HH--HHHHhHhH
Q 002892 856 VV--KLQKIKQT 865 (870)
Q Consensus 856 l~--~L~~i~~~ 865 (870)
++ .++++.+.
T Consensus 358 l~hp~f~~~~~~ 369 (377)
T 3byv_A 358 METPEYEQLRTE 369 (377)
T ss_dssp HTSHHHHHHHHH
T ss_pred hhChHHHHHHHH
Confidence 86 45555443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=348.74 Aligned_cols=251 Identities=24% Similarity=0.299 Sum_probs=200.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh-------------HHHHHHHHHHHHHHhcCCCceeEEee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-------------RAFRSFESECEVLRNVRHRNLIKIFS 648 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~ 648 (870)
..++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999965 688999999875431 23467889999999999999999999
Q ss_pred eeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC---ceE
Q 002892 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM---TAR 725 (870)
Q Consensus 649 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~k 725 (870)
++.+....++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999997654 3899999999999999999999 66799999999999998776 699
Q ss_pred EeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL 805 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 805 (870)
|+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++|..||...... .....+.....
T Consensus 190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~ 264 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKKVEKGKY 264 (504)
T ss_dssp ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC
T ss_pred EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC
Confidence 99999998764332 233456999999999986 46899999999999999999999999763211 11111111100
Q ss_pred CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. +......++..+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~---------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 265 YF---------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CC---------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC---------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00011123457899999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=339.89 Aligned_cols=265 Identities=20% Similarity=0.292 Sum_probs=205.3
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHH-----------------HHHHHHHHHHHHhcCCCceeEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERA-----------------FRSFESECEVLRNVRHRNLIKI 646 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~ 646 (870)
.++|++.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999998 89999999997653221 1778999999999999999999
Q ss_pred eeeeeeCCeeEEEEecCCCCCHHHH------Hhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC
Q 002892 647 FSSCCNLDFKALVLEFMPNGSLEKW------LYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD 719 (870)
Q Consensus 647 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 719 (870)
++++...+..++||||+++++|.++ +... ...+++..++.++.|++.||+|||+ .+|++||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999998 5542 4569999999999999999999994 16799999999999999
Q ss_pred CCCceEEeccccccccCCCCCcccccccccccccCCcccccCC-CcCc-ccchHhHHHHHHHHHhCCCCCCccccccchH
Q 002892 720 KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG-IISP-KCDVYSYGVLLMETFTRKKPTDEMFTGEMSL 797 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~sDvwslG~il~elltg~~p~~~~~~~~~~~ 797 (870)
.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||..........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999999999999876332 23345689999999999877 6666 9999999999999999999997643322211
Q ss_pred HHHHHHh--cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 798 KHWIKLS--LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 798 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+.... .+............. ........++..+.+++.+||+.||++||++.|+++
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNK--KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhccCcCCccchhhhhcccccc--ccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111110 111000000000000 000011234567899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=326.05 Aligned_cols=244 Identities=22% Similarity=0.317 Sum_probs=197.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 658 (870)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567899999999999999999975 79999999997642 34456788899999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC--------------
Q 002892 659 VLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-------------- 721 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-------------- 721 (870)
||||+++++|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999854 245899999999999999999999 6679999999999999844
Q ss_pred -----CceEEeccccccccCCCCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccc
Q 002892 722 -----MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM 795 (870)
Q Consensus 722 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~ 795 (870)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|+|++|..|+... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h
Confidence 479999999998764322 23489999999999776 5668999999999999999998776431 1
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....+.....+. .. ..++..+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~-------------~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QWHEIRQGRLPR-------------IP-----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHHTTCCCC-------------CS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCC-------------CC-----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111111100000 00 112456889999999999999999999975
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=335.16 Aligned_cols=343 Identities=20% Similarity=0.192 Sum_probs=235.5
Q ss_pred CccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccC
Q 002892 25 NNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIP 104 (870)
Q Consensus 25 n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 104 (870)
+......+..++.+++|++|++++|.+++ +| .++.+++|++|+|++|+|++ +| ++.+++|++|+|++|++++ ++
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~ 101 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD 101 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC
T ss_pred cCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee
Confidence 34444455677888888899998888884 45 58888888888888888885 44 8888888888888888885 33
Q ss_pred cCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCC
Q 002892 105 SKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLP 184 (870)
Q Consensus 105 ~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~ 184 (870)
++.+++|++|++++|++++ ++ ++.+++|++|++++|++++. .+..+++|++|++++|+..+..+ ...++
T Consensus 102 --~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~---~~~l~ 170 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD---VTPQT 170 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC---CTTCT
T ss_pred --cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc---cccCC
Confidence 7888888888888888885 44 78888888888888888763 26677777777777775433321 12345
Q ss_pred ccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccccccccccc
Q 002892 185 NRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCN 264 (870)
Q Consensus 185 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~ 264 (870)
+|+.|++++|++++ +| +..+++|++|++++|++++. .++.+++|+.|++++|+++.++ +..++
T Consensus 171 ~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip-----------~~~l~ 233 (457)
T 3bz5_A 171 QLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID-----------VTPLT 233 (457)
T ss_dssp TCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC-----------CTTCT
T ss_pred cCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC-----------ccccC
Confidence 55555555555554 22 45555555555555555532 2445555555555555554321 33344
Q ss_pred ccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHh
Q 002892 265 KLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQ 344 (870)
Q Consensus 265 ~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 344 (870)
+|+.|++++|++.++. +..+++|+.|++++|
T Consensus 234 ~L~~L~l~~N~l~~~~----------------------------~~~l~~L~~L~l~~n--------------------- 264 (457)
T 3bz5_A 234 QLTYFDCSVNPLTELD----------------------------VSTLSKLTTLHCIQT--------------------- 264 (457)
T ss_dssp TCSEEECCSSCCSCCC----------------------------CTTCTTCCEEECTTC---------------------
T ss_pred CCCEEEeeCCcCCCcC----------------------------HHHCCCCCEEeccCC---------------------
Confidence 4444444444444321 122333444443322
Q ss_pred cCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcc
Q 002892 345 RNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNI 424 (870)
Q Consensus 345 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 424 (870)
+|+.|++++|.+.+.+| +..+++|+.|++++|...+.+|. ..++|+.|++++|
T Consensus 265 ----------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~------ 317 (457)
T 3bz5_A 265 ----------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN------ 317 (457)
T ss_dssp ----------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC------
T ss_pred ----------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc------
Confidence 46678888888876666 56788899999999987777664 3455666666555
Q ss_pred cccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCccccc
Q 002892 425 PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGK 495 (870)
Q Consensus 425 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 495 (870)
++|+.|++++|++++. + ++++++|+.|++++|+|++ ++.|..|++++|.++|.
T Consensus 318 -------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~ 370 (457)
T 3bz5_A 318 -------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE 370 (457)
T ss_dssp -------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE
T ss_pred -------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec
Confidence 6899999999999984 3 9999999999999999985 35788889999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=349.41 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=197.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
..++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++......++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457899999999999999999965 68999999997653 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC---CceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN---MTARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~ 736 (870)
|||+++|+|.+++.... .+++..+..++.|++.||+||| ++||+||||||+||+++.. +.+||+|||++..+.
T Consensus 115 ~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999999887654 3899999999999999999999 6679999999999999764 559999999998764
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... ......||+.|+|||++. +.++.++||||+||++|+|++|..||...... .....+........
T Consensus 191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~-------- 257 (494)
T 3lij_A 191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKGKYTFD-------- 257 (494)
T ss_dssp TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCC--------
T ss_pred CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC--------
Confidence 322 233456999999999886 56899999999999999999999999763221 11111111111100
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......++..+.+++.+||+.+|++|||+.|+++
T Consensus 258 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 -------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0001123456889999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=342.69 Aligned_cols=254 Identities=10% Similarity=0.046 Sum_probs=182.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc--CCCceeEEe-------eee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV--RHRNLIKIF-------SSC 650 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~ 650 (870)
...|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +.+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999965 78999999998743 34456677885555555 699988855 333
Q ss_pred eeC-----------------CeeEEEEecCCCCCHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCcE
Q 002892 651 CNL-----------------DFKALVLEFMPNGSLEKWLYSHNYFLDMLER------LNIMIDVGLALEYLHHSHSTPVV 707 (870)
Q Consensus 651 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~Lh~~~~~~iv 707 (870)
... ...++||||++ |+|.+++...+..+++..+ ..++.|++.||+||| +++|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 322 33799999998 8999999865544566666 788899999999999 66799
Q ss_pred ecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCC
Q 002892 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKK 785 (870)
Q Consensus 708 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~ 785 (870)
||||||+||+++.++.+||+|||++...+.. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999866321 113457799999999987 679999999999999999999999
Q ss_pred CCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 786 PTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 786 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
||.......... .....................++..+.+++.+||+.||++||++.++++
T Consensus 292 Pf~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGS-----------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTC-----------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccc-----------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 998643221100 0000000000000000001123557899999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=334.88 Aligned_cols=335 Identities=20% Similarity=0.214 Sum_probs=233.1
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEE
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIIN 165 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 165 (870)
++++++|++++|.++...+..|..+++|++|++++|.+++..+..+..+++|++|+|++|++++..|..+.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 46666777777766633333356666677777777776655555666666666666666666665556666666666666
Q ss_pred eecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccc
Q 002892 166 LVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245 (870)
Q Consensus 166 l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 245 (870)
+++|+++ ...+..|.++++|++|++++|++++..+..|.++++|++|++++|.++
T Consensus 124 L~~n~l~-------------------------~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 124 LERNDLS-------------------------SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCCccC-------------------------cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 6666555 233333455666666666666666555556666666666666666665
Q ss_pred cccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCc
Q 002892 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDL 325 (870)
Q Consensus 246 ~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 325 (870)
.++ +..+++|+.|++++|.+.++ ...++|+.|++++|.+
T Consensus 179 ~~~-----------~~~l~~L~~L~l~~n~l~~~------------------------------~~~~~L~~L~l~~n~l 217 (390)
T 3o6n_A 179 HVD-----------LSLIPSLFHANVSYNLLSTL------------------------------AIPIAVEELDASHNSI 217 (390)
T ss_dssp BCC-----------GGGCTTCSEEECCSSCCSEE------------------------------ECCSSCSEEECCSSCC
T ss_pred ccc-----------cccccccceeeccccccccc------------------------------CCCCcceEEECCCCee
Confidence 431 34456666777776665432 1223577777777777
Q ss_pred cccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCccccc
Q 002892 326 NGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQ 405 (870)
Q Consensus 326 ~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 405 (870)
... |. ...++|+.|+|++|++++. ..+..+++|++|++++|.+++..|..|.
T Consensus 218 ~~~-~~-------------------------~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (390)
T 3o6n_A 218 NVV-RG-------------------------PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 269 (390)
T ss_dssp CEE-EC-------------------------CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred eec-cc-------------------------cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence 632 21 1125788888999988854 5788889999999999999888888999
Q ss_pred CCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhcccccee
Q 002892 406 NLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRL 485 (870)
Q Consensus 406 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 485 (870)
++++|++|+|++|++++ +|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+|++. | +..+++|+.|
T Consensus 270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L 344 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNL 344 (390)
T ss_dssp TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEE
T ss_pred ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCcccee-C--chhhccCCEE
Confidence 99999999999999985 57777889999999999999984 677788899999999999999844 3 6778999999
Q ss_pred eccCCcccccCCCCCcccccccccccccccccCCC
Q 002892 486 NVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPP 520 (870)
Q Consensus 486 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 520 (870)
++++|+|+|.+.. ..+..+....+..+...|+.+
T Consensus 345 ~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 345 TLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp ECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred EcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 9999999986543 344555555566666667644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=326.44 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=198.3
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh----hHHHHHHHHHHHHHHhcCCCceeEEeeeee--eCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL----ERAFRSFESECEVLRNVRHRNLIKIFSSCC--NLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~ 655 (870)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999964 68999999997653 234577899999999999999999999984 4567
Q ss_pred eEEEEecCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
.++||||++++ +.+++.. ....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999876 7777764 3456899999999999999999999 66799999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCcccccCCC--cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGI--ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
..............|++.|+|||++.+.. ++.++||||+|+++|||++|+.||..... ......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~------- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGKGS------- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCC-------
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhcCC-------
Confidence 65433333344556899999999987644 47899999999999999999999975211 11111010000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.. .+..++..+.+++.+||+.||++||++.|+++.
T Consensus 230 --------~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 --------YA---IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------CC---CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------CC---CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 001234568899999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=351.39 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=203.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457899999999999999999965 78999999986543 33457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee---CCCCceEEeccccccccC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---DKNMTARVSDFGISKLLG 736 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~ 736 (870)
|||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++..+.
T Consensus 105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999998654 4899999999999999999999 6679999999999999 567899999999998764
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||...... .....+........
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~-------- 247 (484)
T 3nyv_A 181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFE-------- 247 (484)
T ss_dssp CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCC--------
T ss_pred ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCC--------
Confidence 332 2334569999999999866 6899999999999999999999999763211 11111111111100
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......++..+.+++.+||+.+|++|||+.|+++
T Consensus 248 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 -------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0011123456889999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=341.19 Aligned_cols=201 Identities=25% Similarity=0.375 Sum_probs=167.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----C
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-----D 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 654 (870)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999965 68899999997532 34457789999999999999999999998765 5
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..|+||||++ ++|.+++.... .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 7899999986 59999997653 4899999999999999999999 66799999999999999999999999999987
Q ss_pred cCCCCCc--------------------ccccccccccccCCcccc-cCCCcCcccchHhHHHHHHHHHhCCCCCC
Q 002892 735 LGEDDDS--------------------VTQTMTMATIGYMAPEYA-SDGIISPKCDVYSYGVLLMETFTRKKPTD 788 (870)
Q Consensus 735 ~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~il~elltg~~p~~ 788 (870)
....... .......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6433221 123456789999999986 56679999999999999999998666554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=329.60 Aligned_cols=252 Identities=26% Similarity=0.315 Sum_probs=196.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4467999999999999999999865 68999999986542 12234578999999999999999999998765
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc---eEEeccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT---ARVSDFG 730 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 730 (870)
+ .++||||+++++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 799999999999999987554 4899999999999999999999 667999999999999987664 9999999
Q ss_pred cccccCCCCCcccccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........ +...+......
T Consensus 163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKYN 238 (322)
T ss_dssp TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHHTCCC
T ss_pred cceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHhCccc
Confidence 99876432 1223456899999999873 56788999999999999999999999976432222 22211111000
Q ss_pred chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. ......++..+.+++.+||+.||++||++.++++
T Consensus 239 ~~--------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 FI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC--------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 0001123457899999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=333.01 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=196.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-----
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD----- 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 654 (870)
..++|++.+.||+|+||.||+|... +|+.||||++.... ....+++.+|++++++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3568999999999999999999964 79999999985532 344567889999999999999999999987653
Q ss_pred -eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 655 -FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 655 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
..|+||||+ +++|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 88999999864 3899999999999999999999 6679999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCC-chh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPR-GLT 810 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~-~~~ 810 (870)
..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ...+..+.... .+. ...
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence 75432 233468999999999877 6799999999999999999999999976322 12222222211 111 010
Q ss_pred hhcc--------hhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 811 EVVD--------ASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 811 ~~~~--------~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+. ..+.......+. ...++..+.+++.+|++.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 000000000000 0123457899999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.18 Aligned_cols=266 Identities=21% Similarity=0.341 Sum_probs=203.6
Q ss_pred hhHHHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC
Q 002892 577 YLDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD 654 (870)
Q Consensus 577 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 654 (870)
..+.....++|++.+.||+|+||.||+|+..+ .||+|+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445567889999999999999999998653 59999986542 223355778999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..++||||+++++|.+++...+..+++..++.++.|++.||+||| +++++||||||+||+++ ++.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999999877767999999999999999999999 56799999999999998 68999999999876
Q ss_pred cCCCC---CcccccccccccccCCcccccC---------CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH
Q 002892 735 LGEDD---DSVTQTMTMATIGYMAPEYASD---------GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802 (870)
Q Consensus 735 ~~~~~---~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 802 (870)
..... .........|++.|+|||++.+ ..++.++||||||+++|||++|+.||....... ......
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~ 256 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--IIWQMG 256 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--HHHHHH
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhc
Confidence 53211 1122233458999999999864 457889999999999999999999997532211 111111
Q ss_pred HhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 803 LSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...... .....++..+.+++..||+.+|++||++.++++.|+++.+..
T Consensus 257 ~~~~~~----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 257 TGMKPN----------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TTCCCC----------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cCCCCC----------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 000000 000012345889999999999999999999999999988764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.95 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=198.8
Q ss_pred cchhHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 002892 575 TSYLDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCN 652 (870)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 652 (870)
..+.++....++|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344455567789999999999999999999964 789999999875532 346788999999999 79999999999976
Q ss_pred ------CCeeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceE
Q 002892 653 ------LDFKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR 725 (870)
Q Consensus 653 ------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 725 (870)
.+..++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence 46789999999999999999864 356899999999999999999999 56699999999999999999999
Q ss_pred EeccccccccCCCCCcccccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHH
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW 800 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~ 800 (870)
|+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|+.||....... ....+
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~ 246 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLI 246 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHH
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHh
Confidence 99999998664321 1223446899999999986 5678899999999999999999999996532111 11111
Q ss_pred HHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....+. .....++..+.+++.+||+.+|++||++.++++
T Consensus 247 ~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 247 PRNPAPR-----------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHSCCCC-----------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hcCcccc-----------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1100000 000112346889999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.71 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=203.3
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---------hHHHHHHHHHHHHHHhcC-CCceeEEeeee
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---------ERAFRSFESECEVLRNVR-HRNLIKIFSSC 650 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 650 (870)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 44678999999999999999999975 68999999986542 233567889999999995 99999999999
Q ss_pred eeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 651 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
...+..++||||+++++|.+++.... .+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999998653 4899999999999999999999 6679999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccccCCccccc------CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYAS------DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 804 (870)
.+....... ......|++.|+|||++. ...++.++||||+|+++|+|++|+.||...... ..........
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~ 245 (298)
T 1phk_A 170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGN 245 (298)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTC
T ss_pred chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhcCC
Confidence 998764322 223346899999999885 456889999999999999999999999653211 1111111110
Q ss_pred cCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... .......++..+.+++.+||+.+|++||++.|+++
T Consensus 246 ~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 YQF---------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC---------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccc---------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000 00001123457899999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=360.18 Aligned_cols=262 Identities=21% Similarity=0.331 Sum_probs=208.7
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec----CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
....++|++.+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 344577899999999999999999864 24579999987543 344577899999999999999999999985 466
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.++||||+++|+|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++...
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 89999999999999999977767999999999999999999999 567999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .....+......
T Consensus 542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~~------- 611 (656)
T 2j0j_A 542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERL------- 611 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCCC-------
T ss_pred CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCCC-------
Confidence 43322 22233456789999999998899999999999999999997 99998763221 111111110000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..+..++..+.+++.+||+.||++||++.++++.|+++.+..
T Consensus 612 ----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 ----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 001123557899999999999999999999999999997764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.63 Aligned_cols=260 Identities=19% Similarity=0.209 Sum_probs=193.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD------ 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 654 (870)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999865 68999999997542 344567889999999999999999999987654
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..++||||+++ +|.+++.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 77999999974 78888753 3899999999999999999999 66799999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc------
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG------ 808 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 808 (870)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+..... .....
T Consensus 177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~-~~~~~~~~~~~ 251 (371)
T 2xrw_A 177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIE-QLGTPCPEFMK 251 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC--CCCCCHHHHT
T ss_pred cccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HhCCCCHHHHH
Confidence 5422 1233456899999999999999999999999999999999999999763211 11111111 00000
Q ss_pred --------------------hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 --------------------LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+...+..... ..........+..+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLF--PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGS--CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccC--cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000000 0011122334678999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.93 Aligned_cols=254 Identities=23% Similarity=0.274 Sum_probs=199.9
Q ss_pred hcCCCCCCeeccccceeEEEEEe----cCCcEEEEEEeechh----hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLD 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 654 (870)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ......+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999986 378999999986532 12334567899999999 6999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999998654 4899999999999999999999 66799999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+....
T Consensus 209 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~-------- 278 (355)
T 1vzo_A 209 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRI-------- 278 (355)
T ss_dssp CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHH--------
T ss_pred cccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHH--------
Confidence 53222 222334569999999999986 3478899999999999999999999975322211 11111110
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVVK 858 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 858 (870)
...... .+..++..+.+++.+||+.||++|| ++.|+++.
T Consensus 279 ----~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 ----LKSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----HHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----hccCCC---CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 000000 0012244688999999999999999 89998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=337.81 Aligned_cols=265 Identities=19% Similarity=0.247 Sum_probs=196.0
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee-------
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN------- 652 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 652 (870)
....++|++.+.||+|+||+||+|.. .+|+.||+|++...... ..+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999986 47999999998654322 3469999999999999999999843
Q ss_pred -------------------------------CCeeEEEEecCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHH
Q 002892 653 -------------------------------LDFKALVLEFMPNGSLEKWLY---SHNYFLDMLERLNIMIDVGLALEYL 698 (870)
Q Consensus 653 -------------------------------~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~L 698 (870)
....++||||++ |+|.+.+. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334789999997 58877776 3345699999999999999999999
Q ss_pred HhcCCCCcEecccCCCceeeC-CCCceEEeccccccccCCCCCcccccccccccccCCcccccCC-CcCcccchHhHHHH
Q 002892 699 HHSHSTPVVHCNLKPNNILLD-KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVL 776 (870)
Q Consensus 699 h~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~i 776 (870)
| ++||+||||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9 77799999999999997 68999999999998764332 22334689999999998765 48999999999999
Q ss_pred HHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc--hhhh-----cccCcch---HHHHHHHHHHHHHhhccCCCC
Q 002892 777 LMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD--ASLV-----REVQPSY---AKMDCLLRIMHLALGCCMDSP 846 (870)
Q Consensus 777 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----~~~~~~~---~~~~~~~~l~~l~~~cl~~~P 846 (870)
+|||++|+.||..... ...+..++...-......+.. .... ......+ .+..++..+.+++.+||+.+|
T Consensus 232 l~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 232 FGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999976322 222333322211111110000 0000 0000000 011234568999999999999
Q ss_pred CCCCCHHHHHH
Q 002892 847 EQRMCMTDVVV 857 (870)
Q Consensus 847 ~~RPs~~evl~ 857 (870)
++|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.67 Aligned_cols=198 Identities=23% Similarity=0.300 Sum_probs=171.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhc------CCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNV------RHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~ 655 (870)
...+|++.+.||+|+||.||+|... +++.||||+++... .....+.+|+++++.+ .|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999865 58999999997643 3345677788888877 57799999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc--eEEeccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT--ARVSDFGIS 732 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a 732 (870)
.++||||++ ++|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 69999988654 45899999999999999999999 556999999999999999887 999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcc
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~ 790 (870)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 765322 22346899999999999999999999999999999999999999763
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.63 Aligned_cols=271 Identities=21% Similarity=0.262 Sum_probs=203.9
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC----
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL---- 653 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 653 (870)
+....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 3344578999999999999999999865 68899999997543 34457788999999999999999999998654
Q ss_pred -CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 654 -DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 654 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
...++||||++ |+|.+++.... +++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 36799999997 59999987654 899999999999999999999 667999999999999999999999999999
Q ss_pred cccCCCCCc-ccccccccccccCCccccc-CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc--
Q 002892 733 KLLGEDDDS-VTQTMTMATIGYMAPEYAS-DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG-- 808 (870)
Q Consensus 733 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 808 (870)
......... .......||+.|+|||++. ...++.++||||+||++|||++|+.||...... ..+.......-...
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGILGSPSQE 254 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-GHHHHHHHHHCSCCHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHHHhCCCCHH
Confidence 876432221 1123457899999999865 455899999999999999999999999764322 22222222111110
Q ss_pred -hhhhcchh-------hhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 -LTEVVDAS-------LVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 -~~~~~~~~-------~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+....+.. ........+ ....++..+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 10000000 000000000 00123457899999999999999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=355.67 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=202.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 657 (870)
..++|++.+.||+|+||.||+|+.. +++.||||++++.. ......+..|..++..+ +||+|+.+++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999965 68899999998643 23346678899999887 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|+|.+++...+. +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999986543 899999999999999999999 66799999999999999999999999999986432
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~--------------- 556 (674)
T 3pfq_A 495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIME--------------- 556 (674)
T ss_dssp TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHS---------------
T ss_pred CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-HHHHHHHHh---------------
Confidence 22 223446799999999999999999999999999999999999999976311 111111110
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM-----TDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~ 857 (870)
.... + +...+.++.+++.+||+.||++||++ .||++
T Consensus 557 -~~~~--~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 -HNVA--Y-PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -SCCC--C-CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCCC--C-CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0000 0 01234568999999999999999997 56543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=351.25 Aligned_cols=335 Identities=20% Similarity=0.213 Sum_probs=240.6
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEE
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIIN 165 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 165 (870)
+.+++.|++++|.+....+..|..+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..|.++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 45666677777766644334456666677777777777666666666666676666666666665555566666666666
Q ss_pred eecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccc
Q 002892 166 LVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245 (870)
Q Consensus 166 l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 245 (870)
|++|.++ +..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.++
T Consensus 130 L~~n~l~-------------------------~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 130 LERNDLS-------------------------SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eeCCCCC-------------------------CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 6666555 333344556666666666666666656666666666666666666665
Q ss_pred cccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCc
Q 002892 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDL 325 (870)
Q Consensus 246 ~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 325 (870)
.++ +..+++|+.|++++|.+.++ ....+|+.|++++|.+
T Consensus 185 ~~~-----------~~~l~~L~~L~l~~n~l~~l------------------------------~~~~~L~~L~ls~n~l 223 (597)
T 3oja_B 185 HVD-----------LSLIPSLFHANVSYNLLSTL------------------------------AIPIAVEELDASHNSI 223 (597)
T ss_dssp BCC-----------GGGCTTCSEEECCSSCCSEE------------------------------ECCTTCSEEECCSSCC
T ss_pred CcC-----------hhhhhhhhhhhcccCccccc------------------------------cCCchhheeeccCCcc
Confidence 432 34456666777776665432 1223577777777777
Q ss_pred cccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCccccc
Q 002892 326 NGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQ 405 (870)
Q Consensus 326 ~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 405 (870)
....+. + .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|.
T Consensus 224 ~~~~~~------------------------~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 275 (597)
T 3oja_B 224 NVVRGP------------------------V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFV 275 (597)
T ss_dssp CEEECS------------------------C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred cccccc------------------------c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhc
Confidence 632211 1 1478899999999985 46788899999999999999988899999
Q ss_pred CCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhcccccee
Q 002892 406 NLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRL 485 (870)
Q Consensus 406 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 485 (870)
++++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|
T Consensus 276 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L 350 (597)
T 3oja_B 276 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNL 350 (597)
T ss_dssp TCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEE
T ss_pred CccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEE
Confidence 99999999999999986 5777888999999999999998 5777889999999999999999854 3 6678999999
Q ss_pred eccCCcccccCCCCCcccccccccccccccccCCC
Q 002892 486 NVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPP 520 (870)
Q Consensus 486 ~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 520 (870)
+|++|+|+|.++. ..+..+....+.++...|+.+
T Consensus 351 ~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 351 TLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp ECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred EeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 9999999998653 356666666778888888865
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.79 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=193.1
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee---------
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN--------- 652 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------- 652 (870)
..++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467899999999999999999964 7899999999754 3445778999999999999999999998865
Q ss_pred ----CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEec
Q 002892 653 ----LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 653 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
.+..++||||+++|+|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence 35678999999999999999977667899999999999999999999 56699999999999999999999999
Q ss_pred cccccccCCCCC------------cccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccc
Q 002892 729 FGISKLLGEDDD------------SVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM 795 (870)
Q Consensus 729 fg~a~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~ 795 (870)
||.+........ ........|++.|+|||++.+. .++.++||||+|+++|||++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999987643211 1122345689999999999764 68999999999999999998 5543111111
Q ss_pred hHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 796 SLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... .... ..... ......++..+.+++..||+.||++||++.++++
T Consensus 237 ~~~~-~~~~-~~~~~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 ILKK-LRSV-SIEFP-------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHH-HHST-TCCCC-------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh-cccc-ccccC-------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111 0000 00000 0001123446889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.87 Aligned_cols=264 Identities=21% Similarity=0.269 Sum_probs=199.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcC--------CCceeEEeeeee---
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVR--------HRNLIKIFSSCC--- 651 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~--- 651 (870)
.++|++.+.||+|+||+||+|+.. +++.||||+++.. ......+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999854 6889999999754 334567889999999985 788999999987
Q ss_pred -eCCeeEEEEecCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecccCCCceeeCCCC------
Q 002892 652 -NLDFKALVLEFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHST-PVVHCNLKPNNILLDKNM------ 722 (870)
Q Consensus 652 -~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~------ 722 (870)
.....++||||+ ++++.+++.. ....+++..+..++.||+.||+||| ++ ||+||||||+||+++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence 456889999999 5566666554 3456999999999999999999999 55 799999999999998775
Q ss_pred -------------------------------------------ceEEeccccccccCCCCCcccccccccccccCCcccc
Q 002892 723 -------------------------------------------TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759 (870)
Q Consensus 723 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~ 759 (870)
.+||+|||.+...... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999876432 2334689999999999
Q ss_pred cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccc-----hHHHHHHHh--cCCch-------hhhcchhh-hccc---
Q 002892 760 SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM-----SLKHWIKLS--LPRGL-------TEVVDASL-VREV--- 821 (870)
Q Consensus 760 ~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~--~~~~~-------~~~~~~~~-~~~~--- 821 (870)
.+..++.++|||||||++|||++|+.||........ .+....... .+... .+.+.... ....
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999976433221 111111110 01000 00000000 0000
Q ss_pred ----------CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 822 ----------QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 822 ----------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
........++..+.+++.+||+.||++|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000012345678999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.46 Aligned_cols=266 Identities=20% Similarity=0.280 Sum_probs=195.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeee-----------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCC----------- 651 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----------- 651 (870)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 58999999998776677788999999999999999999998873
Q ss_pred ---eCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC-CCCceEEe
Q 002892 652 ---NLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARVS 727 (870)
Q Consensus 652 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 727 (870)
.....++||||++ |+|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 6999999753 4899999999999999999999 56799999999999997 56799999
Q ss_pred ccccccccCCCCC-cccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 002892 728 DFGISKLLGEDDD-SVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL 805 (870)
Q Consensus 728 Dfg~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 805 (870)
|||++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........ ..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~-~~ 241 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILE-SI 241 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-HS
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hc
Confidence 9999987643211 112233457899999998865 67899999999999999999999999763221 11111111 11
Q ss_pred CCc----hhhh-------cchhhhcccCc-chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 806 PRG----LTEV-------VDASLVREVQP-SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 806 ~~~----~~~~-------~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+.. ..++ ..........+ ......++..+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 110 0000 00000000000 0001124567899999999999999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=333.26 Aligned_cols=263 Identities=20% Similarity=0.294 Sum_probs=184.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL------ 653 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 653 (870)
..++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999985 478999999986532 34456788999999999999999999998654
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
...|+|+||+ +++|.+++... .+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred CeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5679999999 78999988763 4899999999999999999999 6679999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc--h
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPRG--L 809 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~--~ 809 (870)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ...+..+.... .+.. +
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 65322 233568999999999877 6789999999999999999999999976322 12222222211 1110 0
Q ss_pred hhhcc-------hhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 810 TEVVD-------ASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 810 ~~~~~-------~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+.. ..+.......+. ...++..+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 01100 000000011110 0122456899999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.76 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=201.9
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999975 78999999997653 2345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC---CceEEecccccccc
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN---MTARVSDFGISKLL 735 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~ 735 (870)
||||+++++|.+++...+ .+++..++.++.|++.||+||| ++|++||||||+||+++.+ +.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999999999987654 4899999999999999999999 6679999999999999764 47999999999876
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
..... .....|++.|+|||++.+ .++.++||||+|+++|+|++|+.||...... .....+.....+..
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~------- 242 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAFD------- 242 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCC-------
T ss_pred cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCC-------
Confidence 43322 223357899999998865 4889999999999999999999999763211 11111111111000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
......++..+.+++.+||+.+|++||++.|+++
T Consensus 243 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 --------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0011123456889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.56 Aligned_cols=265 Identities=20% Similarity=0.284 Sum_probs=203.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-c-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc------eeEEeeeeeeCC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-F-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN------LIKIFSSCCNLD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~ 654 (870)
..++|++.+.||+|+||.||+|.. . +++.||+|+++.. ......+.+|+++++.++|++ ++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999986 3 6889999999754 344567889999999987654 999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-------------
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK------------- 720 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~------------- 720 (870)
..++||||+ +++|.+++...+ ..+++..+..++.|++.||+||| +++|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 899999998654 35899999999999999999999 667999999999999987
Q ss_pred ------CCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc
Q 002892 721 ------NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE 794 (870)
Q Consensus 721 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~ 794 (870)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|||++|..||......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK- 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-
Confidence 668999999999865332 22346899999999999999999999999999999999999999763221
Q ss_pred chHHHHHHH--hcCCchhhhc-----------------------chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCC
Q 002892 795 MSLKHWIKL--SLPRGLTEVV-----------------------DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQR 849 (870)
Q Consensus 795 ~~~~~~~~~--~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 849 (870)
.....+... ..+..+.... ................++..+.+++.+||+.||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 111111111 1111110000 000000000000112346789999999999999999
Q ss_pred CCHHHHHHH
Q 002892 850 MCMTDVVVK 858 (870)
Q Consensus 850 Ps~~evl~~ 858 (870)
||+.|+++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.82 Aligned_cols=268 Identities=23% Similarity=0.269 Sum_probs=200.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----Ce
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-----DF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 655 (870)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999965 68999999986533 34456788999999999999999999987654 67
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.++||||++ ++|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 899999996 6999998764 4899999999999999999999 667999999999999999999999999999876
Q ss_pred CCCCCcc--------cccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH-Hhc
Q 002892 736 GEDDDSV--------TQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK-LSL 805 (870)
Q Consensus 736 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~ 805 (870)
....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence 4322111 1223468999999998754 778999999999999999999999997632211 1111111 111
Q ss_pred CCc---hhhhcchh-------hhcccCcc--hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 806 PRG---LTEVVDAS-------LVREVQPS--YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 806 ~~~---~~~~~~~~-------~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+.. ........ +....... .....++..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110 00000000 00000000 001134567899999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.64 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=193.7
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC------eeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD------FKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~ 657 (870)
..+|++.+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457999999999999999999987777799998765432 2246999999999999999999985433 378
Q ss_pred EEEecCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC-CCCceEEeccccccc
Q 002892 658 LVLEFMPNGSLEKWLY--SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARVSDFGISKL 734 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~ 734 (870)
+||||++++.+..... .....+++..+..++.|+++||+||| ++||+||||||+||+++ .++.+||+|||++..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998754443332 23456999999999999999999999 66799999999999998 789999999999987
Q ss_pred cCCCCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc-hhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPRG-LTE 811 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~ 811 (870)
...... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ...+..+.... .+.. ...
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence 643322 2234689999999998765 589999999999999999999999976322 22233332211 1111 000
Q ss_pred hcchhhhcc-----cCcchH---HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVRE-----VQPSYA---KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~-----~~~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..++..... ....+. ...++..+.+++.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000000 000000 0113457899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.19 Aligned_cols=268 Identities=24% Similarity=0.330 Sum_probs=200.0
Q ss_pred HhhcCCCCCCeeccccceeEEEEEe--cCCcEEEEEEeechhh--HHHHHHHHHHHHHHhc---CCCceeEEeeeee---
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTL--FDGTNVAIKVFNLQLE--RAFRSFESECEVLRNV---RHRNLIKIFSSCC--- 651 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~--- 651 (870)
...++|++.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+++++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999997 3688999999875432 1123455677766666 8999999999987
Q ss_pred --eCCeeEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEec
Q 002892 652 --NLDFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSD 728 (870)
Q Consensus 652 --~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 728 (870)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 69999998643 44899999999999999999999 66799999999999999999999999
Q ss_pred cccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC
Q 002892 729 FGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR 807 (870)
Q Consensus 729 fg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~ 807 (870)
||++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+...... ..+.
T Consensus 164 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred CcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCC
Confidence 999986532 12233456899999999999999999999999999999999999999763221 122222211 1111
Q ss_pred c--hhhhc---chhhhcccCc--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 G--LTEVV---DASLVREVQP--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~--~~~~~---~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. +.... .......... ......++..+.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000 0000000000 0001123457889999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.18 Aligned_cols=202 Identities=25% Similarity=0.312 Sum_probs=172.3
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CC-----ceeEEeeeeeeC
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HR-----NLIKIFSSCCNL 653 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~ 653 (870)
....++|++.+.||+|+||.||+|... +++.||||+++... .....+..|+++++.++ |+ +++++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344678999999999999999999865 68899999997543 33466778888888875 44 499999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC--CCCceEEeccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD--KNMTARVSDFG 730 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg 730 (870)
+..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||.. ..||+||||||+||+++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999999996 59999998653 4589999999999999999999942 36799999999999995 47889999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcc
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEM 790 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~ 790 (870)
++...+.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99876432 22346899999999999999999999999999999999999999763
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=325.35 Aligned_cols=336 Identities=21% Similarity=0.208 Sum_probs=207.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEE
Q 002892 38 LRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLN 117 (870)
Q Consensus 38 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 117 (870)
+.+++.|++++|.++...+..+..+++|++|+|++|.|++..+..+..+++|++|+|++|++++..|..|+.+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 45666666666666643334456666666666666666655555666666666666666666655555566666666666
Q ss_pred eecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccc
Q 002892 118 FADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLT 197 (870)
Q Consensus 118 l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 197 (870)
+++|+++...+..+.++++|++|++++|++++..+..+..+++|++|++++|+++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------------- 178 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT------------------------- 178 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS-------------------------
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC-------------------------
Confidence 6666666333333455566666666555555444444444444444444444433
Q ss_pred cccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCC
Q 002892 198 GTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277 (870)
Q Consensus 198 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (870)
+. .+..+++|+.|++++|.++.+ ...++|++|++++|++.
T Consensus 179 ------------------------~~---~~~~l~~L~~L~l~~n~l~~~-------------~~~~~L~~L~l~~n~l~ 218 (390)
T 3o6n_A 179 ------------------------HV---DLSLIPSLFHANVSYNLLSTL-------------AIPIAVEELDASHNSIN 218 (390)
T ss_dssp ------------------------BC---CGGGCTTCSEEECCSSCCSEE-------------ECCSSCSEEECCSSCCC
T ss_pred ------------------------cc---ccccccccceeeccccccccc-------------CCCCcceEEECCCCeee
Confidence 21 122333344444444433321 11234555555555544
Q ss_pred CCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCccccc
Q 002892 278 SILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLS 357 (870)
Q Consensus 278 ~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~ 357 (870)
.+.. ...++|+.|++++|.+.+. ..+.
T Consensus 219 ~~~~----------------------------~~~~~L~~L~l~~n~l~~~-------------------------~~l~ 245 (390)
T 3o6n_A 219 VVRG----------------------------PVNVELTILKLQHNNLTDT-------------------------AWLL 245 (390)
T ss_dssp EEEC----------------------------CCCSSCCEEECCSSCCCCC-------------------------GGGG
T ss_pred eccc----------------------------cccccccEEECCCCCCccc-------------------------HHHc
Confidence 3210 0124566777777766531 1245
Q ss_pred CccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEE
Q 002892 358 SLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITL 437 (870)
Q Consensus 358 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 437 (870)
.+++|++|+|++|++++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 56778888888888887778888888888888888888884 5667778889999999999988 466678888899999
Q ss_pred EcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCC
Q 002892 438 SLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 438 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
+|++|.+++. | +..+++|+.|+|++|.+++.- ...-+..+....+.++...|..|.
T Consensus 324 ~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~--~~~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 324 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS--LRALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH--HHHHTTTCCTTTBCCCCSCCCTTC
T ss_pred ECCCCcccee-C--chhhccCCEEEcCCCCccchh--HHHHHHHHHhhcccccCceecccc
Confidence 9999998764 3 778889999999999988532 223345566666777776666553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=327.09 Aligned_cols=262 Identities=21% Similarity=0.274 Sum_probs=197.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee---
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK--- 656 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--- 656 (870)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999865 68999999997642 34457788999999999999999999999876654
Q ss_pred ---EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 657 ---ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 657 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
++||||++ ++|.+++.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 688887743 3899999999999999999999 5679999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh-cCCc-hh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS-LPRG-LT 810 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~-~~ 810 (870)
..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+....... .+.. ..
T Consensus 193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHH
Confidence 65322 233468999999999877 67899999999999999999999999763221 1222222211 1110 10
Q ss_pred hhcc--------hhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 811 EVVD--------ASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 811 ~~~~--------~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... ..+.......+. ...++..+.+++.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 000000000000 1123567899999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=335.69 Aligned_cols=260 Identities=22% Similarity=0.295 Sum_probs=192.9
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------CeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL------DFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 657 (870)
.+|++.+.||+|+||.||+|++. +|+.||||++..... ...+|++++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999975 689999999865432 234699999999999999999988532 2367
Q ss_pred EEEecCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEecccccc
Q 002892 658 LVLEFMPNGSLEKWLY---SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISK 733 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~ 733 (870)
+||||+++ ++.+.+. .....+++..+..++.||++||+||| +++|+||||||+||+++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 6666554 33456999999999999999999999 7779999999999999965 568999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---h
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG---L 809 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 809 (870)
....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ...+..++...-... +
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 7643322 2234689999999998764 789999999999999999999999976322 222333332111110 1
Q ss_pred hhhcchhhh-----cccCcchH---HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 810 TEVVDASLV-----REVQPSYA---KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 810 ~~~~~~~~~-----~~~~~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+ +.... ......+. ....+..+.+++.+||+.||++||++.|+++
T Consensus 282 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Hhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 100 00000 00000000 0122457899999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=334.73 Aligned_cols=267 Identities=19% Similarity=0.242 Sum_probs=182.8
Q ss_pred cCCCC-CCeeccccceeEEEEEec---CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeEE
Q 002892 585 DGFNE-CNLLGAGSFGSVYKGTLF---DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKAL 658 (870)
Q Consensus 585 ~~~~~-~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 658 (870)
+.|++ .++||+|+||.||+|+.. +++.||+|++..... ...+.+|++++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 458999999999999965 578999999875432 2467889999999999999999999954 678899
Q ss_pred EEecCCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee----CCCCceEE
Q 002892 659 VLEFMPNGSLEKWLYSH--------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL----DKNMTARV 726 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl 726 (870)
||||++ ++|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 5888877622 124899999999999999999999 6669999999999999 67789999
Q ss_pred eccccccccCCCCC-cccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccc--------cch
Q 002892 727 SDFGISKLLGEDDD-SVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTG--------EMS 796 (870)
Q Consensus 727 ~Dfg~a~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~--------~~~ 796 (870)
+|||++..+..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643221 122344578999999999887 45899999999999999999999999753221 112
Q ss_pred HHHHHHH-hcCCc--hhhhcc--------hhhhcccCcchHHH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 797 LKHWIKL-SLPRG--LTEVVD--------ASLVREVQPSYAKM--------DCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 797 ~~~~~~~-~~~~~--~~~~~~--------~~~~~~~~~~~~~~--------~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+..+... ..+.. +..+.. .............. .....+.+++.+||+.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2222221 11111 111100 00000000000000 01346789999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=321.91 Aligned_cols=253 Identities=23% Similarity=0.270 Sum_probs=182.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
..++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3567889999999999999999975 78999999997643 22234455556678888999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+ ++.+..+.......+++..+..++.|++.||+|||+. .|++||||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9999 5666666665556699999999999999999999942 269999999999999999999999999997653322
Q ss_pred CcccccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 740 DSVTQTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
......|++.|+|||++. ...++.++||||||+++|||++|+.||................. +....
T Consensus 180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~---- 251 (318)
T 2dyl_A 180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLP---- 251 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCCCC----
T ss_pred ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCCCC----
Confidence 223346899999999984 45688999999999999999999999975322221111111110 00000
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
....++..+.+++.+||+.||++||++.++++
T Consensus 252 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 -----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00012446889999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=332.64 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=186.5
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEecC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3445568899999999987766789999999987543 34567899999886 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-------------Cce
Q 002892 664 PNGSLEKWLYSHNYF------LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-------------MTA 724 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-------------~~~ 724 (870)
+ |+|.+++...... .++..++.++.||+.||+||| +++|+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999865321 123345789999999999999 6679999999999999754 489
Q ss_pred EEeccccccccCCCCCcc--cccccccccccCCcccccC-------CCcCcccchHhHHHHHHHHHh-CCCCCCcccccc
Q 002892 725 RVSDFGISKLLGEDDDSV--TQTMTMATIGYMAPEYASD-------GIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGE 794 (870)
Q Consensus 725 kl~Dfg~a~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~ 794 (870)
||+|||++.......... ......||+.|+|||++.+ ..++.++||||+||++|||++ |+.||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998775433221 1234579999999999865 668999999999999999999 999997532221
Q ss_pred chHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 795 MSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
..+........ . ........++..+.+++.+||+.||++||++.+|++
T Consensus 248 ---~~i~~~~~~~~--~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ---SNIIRGIFSLD--E----------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHTCCCCC--C----------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHhcCCCCcc--c----------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111111000 0 001112245668999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=325.92 Aligned_cols=273 Identities=19% Similarity=0.242 Sum_probs=190.1
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe-
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF- 655 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~- 655 (870)
.......++|++.+.||+|+||.||+|+.. +|+.||||++..... ......++++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999975 689999999865432 22456678888899999999999999865333
Q ss_pred ------eEEEEecCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-CCceE
Q 002892 656 ------KALVLEFMPNGSLEKWLY---SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-NMTAR 725 (870)
Q Consensus 656 ------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~k 725 (870)
.++||||+++ ++.+.+. .....+++..+..++.|++.|++|||. +++||+||||||+||+++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999976 5554443 244568999999999999999999993 2466999999999999997 89999
Q ss_pred EeccccccccCCCCCcccccccccccccCCcccccCCC-cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh
Q 002892 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804 (870)
Q Consensus 726 l~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 804 (870)
|+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+..+....
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~ 248 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVL 248 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHH
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHc
Confidence 99999998764332 223346899999999986654 89999999999999999999999976322 22222222211
Q ss_pred c-CCc-hhhhcchhh-----hcccCcchH------HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 805 L-PRG-LTEVVDASL-----VREVQPSYA------KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 805 ~-~~~-~~~~~~~~~-----~~~~~~~~~------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. +.. .....++.. .......+. ...++..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1 110 100000000 000000000 0113567999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=324.07 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=176.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHH-HHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECE-VLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999975 78999999997643 233344555555 677789999999999999999999999
Q ss_pred ecCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 661 EFMPNGSLEKWLYS----HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 661 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
||+++ +|.+++.. ....+++..+..++.|++.|++|||+. .||+||||||+||+++.++.+||+|||++....
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 88877763 245689999999999999999999943 169999999999999999999999999998664
Q ss_pred CCCCcccccccccccccCCcccc----cCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYA----SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......... ..+
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------------~~~ 242 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------------TQV 242 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CCC
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------------HHH
Confidence 322 22234689999999998 45678999999999999999999999997532111000 000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...... ... ......++..+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~~~-~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPP-QLS-NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCC-CCC-CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCC-CCC-CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000 000 0000123457899999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.16 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=199.4
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CC-cEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc------eeEEeeeeeeCCe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DG-TNVAIKVFNLQLERAFRSFESECEVLRNVRHRN------LIKIFSSCCNLDF 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 655 (870)
.++|++.+.||+|+||.||+|... ++ +.||+|+++... .....+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999864 34 689999997543 34567888999999997765 8999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceee----------------
Q 002892 656 KALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILL---------------- 718 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---------------- 718 (870)
.++||||+ ++++.+++... ...+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 66777777644 356899999999999999999999 7779999999999999
Q ss_pred ---CCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccc
Q 002892 719 ---DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEM 795 (870)
Q Consensus 719 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~ 795 (870)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~ 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR-E 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 56789999999999865332 22346899999999999999999999999999999999999999763221 1
Q ss_pred hHHHHHHH--hcCCchhhhc-ch----------------------hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC
Q 002892 796 SLKHWIKL--SLPRGLTEVV-DA----------------------SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM 850 (870)
Q Consensus 796 ~~~~~~~~--~~~~~~~~~~-~~----------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 850 (870)
........ ..|..+.... .. ..............++..+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 11111111 1111110000 00 00000000001123356789999999999999999
Q ss_pred CHHHHHH
Q 002892 851 CMTDVVV 857 (870)
Q Consensus 851 s~~evl~ 857 (870)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=321.88 Aligned_cols=252 Identities=20% Similarity=0.261 Sum_probs=172.6
Q ss_pred hhcCCCCCC-eeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee----CCee
Q 002892 583 ATDGFNECN-LLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN----LDFK 656 (870)
Q Consensus 583 ~~~~~~~~~-~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 656 (870)
..++|++.+ +||+|+||.||+|... +++.||+|++...... ..+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456788854 6999999999999976 6899999999754221 2223334566799999999999876 4457
Q ss_pred EEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEeccccc
Q 002892 657 ALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFGIS 732 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a 732 (870)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999998653 46999999999999999999999 567999999999999976 455999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||............ ...
T Consensus 179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----------~~~ 244 (336)
T 3fhr_A 179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM----------KRR 244 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH----------HHh
Confidence 865422 223346899999999998889999999999999999999999999753222110000 000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+....... +......++..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 245 IRLGQYGF--PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------CC--CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhcccccc--CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 00001123457889999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.39 Aligned_cols=264 Identities=20% Similarity=0.262 Sum_probs=197.9
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-----------CCceeEEeeeee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-----------HRNLIKIFSSCC 651 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 651 (870)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 478999999997543 33466788999998886 899999999987
Q ss_pred eCC----eeEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEecccCCCceeeC------
Q 002892 652 NLD----FKALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHST-PVVHCNLKPNNILLD------ 719 (870)
Q Consensus 652 ~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~------ 719 (870)
..+ ..++||||+ +++|.+++... ...+++..+..++.||+.||+||| ++ ||+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence 654 789999999 89999999864 345899999999999999999999 55 799999999999994
Q ss_pred CCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc-----
Q 002892 720 KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE----- 794 (870)
Q Consensus 720 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~----- 794 (870)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 223468999999999999999999999999999999999999997542211
Q ss_pred chHHHHHHHh--cCCchh-------hhcchh-hhccc-------------CcchHHHHHHHHHHHHHhhccCCCCCCCCC
Q 002892 795 MSLKHWIKLS--LPRGLT-------EVVDAS-LVREV-------------QPSYAKMDCLLRIMHLALGCCMDSPEQRMC 851 (870)
Q Consensus 795 ~~~~~~~~~~--~~~~~~-------~~~~~~-~~~~~-------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 851 (870)
..+....... .|..+. ..++.. ..... .....+..++..+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111111110 111000 000000 00000 000012356778999999999999999999
Q ss_pred HHHHHH
Q 002892 852 MTDVVV 857 (870)
Q Consensus 852 ~~evl~ 857 (870)
+.|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=324.68 Aligned_cols=261 Identities=21% Similarity=0.275 Sum_probs=196.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe-----
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF----- 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 655 (870)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999965 68999999986542 3345678899999999999999999999977654
Q ss_pred -eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 656 -KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 656 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
.++||||++ ++|.+++.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 588777643 3899999999999999999999 56799999999999999999999999999986
Q ss_pred cCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCC-chhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPR-GLTE 811 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~ 811 (870)
.... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ..+...... ..+. .+..
T Consensus 176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHHT
T ss_pred CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence 5322 233468999999999876 67899999999999999999999999763221 112222211 1111 0100
Q ss_pred hc-ch-------hhhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VV-DA-------SLVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~-~~-------~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+ +. .+.......+ ....++..+.+++.+|++.||++||++.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00 0000000000 01123567899999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.41 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=187.4
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..+|+..++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 346888899999999997665567899999999865432 2356799999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-----CCceEEeccccccccCC
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-----NMTARVSDFGISKLLGE 737 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~ 737 (870)
++ |+|.+++.......++..+..++.||+.||+||| +++|+||||||+||+++. ...+||+|||++.....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 96 6999999877655666677899999999999999 666999999999999953 23578999999987643
Q ss_pred CCCc-ccccccccccccCCccccc---CCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 738 DDDS-VTQTMTMATIGYMAPEYAS---DGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 738 ~~~~-~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
.... .......||+.|+|||++. ...++.++||||+||++|||++ |..||....... . ... .......
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~-~~~---~~~~~~~- 248 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--A-NIL---LGACSLD- 248 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--H-HHH---TTCCCCT-
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--H-HHH---hccCCcc-
Confidence 3221 2234457999999999997 4567889999999999999999 889986421111 0 000 0000000
Q ss_pred cchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ..........+.+++.+||+.||++||++.||++
T Consensus 249 -------~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 -------C---LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -------T---SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------c---cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0001123446789999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.36 Aligned_cols=243 Identities=23% Similarity=0.262 Sum_probs=198.0
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhH------HHHHHHHHHHHHHhcC--CCceeEEeeeee
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLER------AFRSFESECEVLRNVR--HRNLIKIFSSCC 651 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~ 651 (870)
....++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999985 47899999999765321 2245677999999996 599999999999
Q ss_pred eCCeeEEEEecCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC-CCCceEEecc
Q 002892 652 NLDFKALVLEFMPN-GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARVSDF 729 (870)
Q Consensus 652 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Df 729 (870)
..+..++||||+.+ ++|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++ .++.+||+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999999976 89999998654 4899999999999999999999 66799999999999999 7899999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG 808 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 808 (870)
|++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .......
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~--- 260 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV--- 260 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC---
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc---
Confidence 9998764322 223468999999999877665 688999999999999999999996521 1110000
Q ss_pred hhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. .. ..++..+.+++.+||+.+|++||++.|+++
T Consensus 261 ---------~--~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 ---------F--FR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---------C--CS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------c--cc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 012346889999999999999999999976
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=311.82 Aligned_cols=127 Identities=25% Similarity=0.411 Sum_probs=78.0
Q ss_pred ccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEE
Q 002892 359 LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438 (870)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 438 (870)
+++|++|++++|++++..+ +..+++|++|++++|.+++. ..+..+++|++|++++|++++. ..+..+++|+.|+
T Consensus 220 ~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~ 293 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLF 293 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEE
Confidence 3455555555555553332 55555666666666666532 3456666666777776666643 3466667777777
Q ss_pred cCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCccc
Q 002892 439 LARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493 (870)
Q Consensus 439 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 493 (870)
+++|.+++..|..|..+++|+.|+|++|++++..| +..+++|+.|++++|+++
T Consensus 294 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 77777766666667777777777777777765444 666777777777777664
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=319.24 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=189.4
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh------HHHHHHHHHHHHHHhc----CCCceeEEee
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE------RAFRSFESECEVLRNV----RHRNLIKIFS 648 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~~ 648 (870)
.....++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|++++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345567899999999999999999985 4789999999975432 1223456789999888 8999999999
Q ss_pred eeeeCCeeEEEEec-CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC-CCCceEE
Q 002892 649 SCCNLDFKALVLEF-MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARV 726 (870)
Q Consensus 649 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl 726 (870)
++...+..++|||| +++++|.+++...+ .+++..++.++.|++.||+||| +++|+||||||+||+++ .++.+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999999 78999999998654 4899999999999999999999 55699999999999999 8899999
Q ss_pred eccccccccCCCCCcccccccccccccCCcccccCCCcC-cccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc
Q 002892 727 SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIIS-PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL 805 (870)
Q Consensus 727 ~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 805 (870)
+|||++....... .....|++.|+|||++.+..+. .++||||+|+++|||++|+.||.... .....
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~-- 248 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEA-- 248 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHT--
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhh--
Confidence 9999998764322 2334689999999998776654 58999999999999999999996521 11100
Q ss_pred CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
... .. ..++..+.+++.+||+.+|++||++.|+++
T Consensus 249 ----------~~~--~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 ----------ELH--FP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----------CCC--CC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------ccC--Cc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 112346889999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=337.50 Aligned_cols=335 Identities=21% Similarity=0.223 Sum_probs=242.2
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEE
Q 002892 37 QLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHL 116 (870)
Q Consensus 37 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 116 (870)
.+.+++.|++++|.++...+..++.+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 36788999999999986666678889999999999999997777789999999999999999997777888999999999
Q ss_pred EeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeeccccc
Q 002892 117 NFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRL 196 (870)
Q Consensus 117 ~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l 196 (870)
+|++|.|++.++..|+++++|++|+|++|.+++..|..+..+++|++|+|++|.+++..
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------------------- 187 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------------------- 187 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---------------------
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---------------------
Confidence 99999999666666789999999999999999888888888888888888888887431
Q ss_pred ccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCC
Q 002892 197 TGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276 (870)
Q Consensus 197 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 276 (870)
+..+++|+.|++++|.+++ +...++|+.|++++|.++.++..
T Consensus 188 -------~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-------------------------- 229 (597)
T 3oja_B 188 -------LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP-------------------------- 229 (597)
T ss_dssp -------GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS--------------------------
T ss_pred -------hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc--------------------------
Confidence 2334556666666666552 22233455555555554432210
Q ss_pred CCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccc
Q 002892 277 DSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCL 356 (870)
Q Consensus 277 ~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~ 356 (870)
. .++|+.|++++|.+++. ..+
T Consensus 230 ----------------------------~------~~~L~~L~L~~n~l~~~-------------------------~~l 250 (597)
T 3oja_B 230 ----------------------------V------NVELTILKLQHNNLTDT-------------------------AWL 250 (597)
T ss_dssp ----------------------------C------CSCCCEEECCSSCCCCC-------------------------GGG
T ss_pred ----------------------------c------CCCCCEEECCCCCCCCC-------------------------hhh
Confidence 0 12445555555555421 224
Q ss_pred cCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCE
Q 002892 357 SSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLIT 436 (870)
Q Consensus 357 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 436 (870)
..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..++.+++|+.
T Consensus 251 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~ 328 (597)
T 3oja_B 251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328 (597)
T ss_dssp GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred ccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCE
Confidence 455677777777777777777777777788888888888774 5666777888888888888887 46777778888888
Q ss_pred EEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccC
Q 002892 437 LSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKI 496 (870)
Q Consensus 437 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 496 (870)
|+|++|.+++. | +..+++|+.|+|++|.+++..... .+..+....+.+|...|..
T Consensus 329 L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~--~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 329 LYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRA--LFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp EECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHH--HTTTCCTTTBCCCCCCCCT
T ss_pred EECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHH--HHHHHhhhccccccccCCc
Confidence 88888888754 2 667788889999999887542221 2333334444555544433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=338.95 Aligned_cols=272 Identities=22% Similarity=0.289 Sum_probs=200.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeeee------CC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCCN------LD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 654 (870)
..++|++.+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999864 6899999998754 34455778999999999999999999998755 66
Q ss_pred eeEEEEecCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc---eEEecc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN--YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT---ARVSDF 729 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 729 (870)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999998643 35899999999999999999999 567999999999999987765 999999
Q ss_pred ccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc-
Q 002892 730 GISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG- 808 (870)
Q Consensus 730 g~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 808 (870)
|.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||..... ...|........
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC----
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccc
Confidence 9998764332 22345689999999999999999999999999999999999999965211 111111000000
Q ss_pred ----hhhhcchhhh--cc-cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHHhHh
Q 002892 809 ----LTEVVDASLV--RE-VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTD-----VVVKLQKIKQ 864 (870)
Q Consensus 809 ----~~~~~~~~~~--~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e-----vl~~L~~i~~ 864 (870)
..+....... .. ..+.......+..+.+++..||..||++||++.+ ..+.++++.+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000000 00 0011111234667999999999999999999988 4555555544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=309.64 Aligned_cols=307 Identities=28% Similarity=0.393 Sum_probs=176.7
Q ss_pred ccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCcc
Q 002892 35 LGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLV 114 (870)
Q Consensus 35 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 114 (870)
+..+++|+.|++++|.++ .++. +..+++|++|++++|++++ ++. +.++++|++|++++|.++. + ..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCC
Confidence 455666666666666666 3443 5666666666666666663 333 6666666666666666652 3 2466666666
Q ss_pred EEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeeccc
Q 002892 115 HLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWAN 194 (870)
Q Consensus 115 ~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n 194 (870)
+|++++|.+++. +. +..+++|++|++++|.....++ .+..+++|++|++++|.+.
T Consensus 114 ~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~---------------------- 168 (347)
T 4fmz_A 114 ELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK---------------------- 168 (347)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCC----------------------
T ss_pred EEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcC----------------------
Confidence 666666666632 22 5666666666666664443322 2445555555555555443
Q ss_pred ccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCC
Q 002892 195 RLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSN 274 (870)
Q Consensus 195 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 274 (870)
+..+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|.++... .+..+++|++|++++|
T Consensus 169 ---~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~----------~~~~~~~L~~L~l~~n 231 (347)
T 4fmz_A 169 ---DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT----------PVANMTRLNSLKIGNN 231 (347)
T ss_dssp ---CCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCG----------GGGGCTTCCEEECCSS
T ss_pred ---Cchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCc----------hhhcCCcCCEEEccCC
Confidence 2222 5566777777777777764333 667777777777777776532 2566677777777777
Q ss_pred CCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcc
Q 002892 275 PLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPT 354 (870)
Q Consensus 275 ~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~ 354 (870)
++.+. +. +..+++|+.|++++|.+.+
T Consensus 232 ~l~~~--------------------------~~-~~~l~~L~~L~l~~n~l~~--------------------------- 257 (347)
T 4fmz_A 232 KITDL--------------------------SP-LANLSQLTWLEIGTNQISD--------------------------- 257 (347)
T ss_dssp CCCCC--------------------------GG-GTTCTTCCEEECCSSCCCC---------------------------
T ss_pred ccCCC--------------------------cc-hhcCCCCCEEECCCCccCC---------------------------
Confidence 66532 11 3444555555555555542
Q ss_pred cccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCC
Q 002892 355 CLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDL 434 (870)
Q Consensus 355 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 434 (870)
. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..|..|+++++|
T Consensus 258 --------------------~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 258 --------------------I--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp --------------------C--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred --------------------C--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 1 1233344444444444444432 235555666666666666665556666666666
Q ss_pred CEEEcCCCcccCcccccccCCCCCCeEecCCCccc
Q 002892 435 ITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 435 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 469 (870)
+.|++++|++++..| +..+++|+.|++++|.|+
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 666666666665444 666666666666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.56 Aligned_cols=233 Identities=12% Similarity=0.089 Sum_probs=185.2
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++.+++++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999975 58999999997653 34457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||++|++|.++++.. ....++.+++.|++.||+||| ++||+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 9999999999999643 366678999999999999999 6679999999999999999999998543
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
|++ .++.++|||||||++|||++|+.||......... .... .....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------------~~~~-~~~~~ 220 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------------APAE-RDTAG 220 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-------------EECC-BCTTS
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-------------HHHH-HHhcc
Confidence 333 2578999999999999999999999763221100 0000 00000
Q ss_pred cc-CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 820 EV-QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 820 ~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
.. ........++..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00 0001112345678999999999999999 9999999999987643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.97 Aligned_cols=191 Identities=34% Similarity=0.598 Sum_probs=146.4
Q ss_pred CchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCccccccc
Q 002892 305 IPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLE 384 (870)
Q Consensus 305 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 384 (870)
+|..+..+++|++|++++|.+.+.+| ..+..+++|++|+|++|++++.+|..+..++
T Consensus 117 ~p~~~~~l~~L~~L~Ls~N~l~~~~p-----------------------~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 173 (313)
T 1ogq_A 117 IPDFLSQIKTLVTLDFSYNALSGTLP-----------------------PSISSLPNLVGITFDGNRISGAIPDSYGSFS 173 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCC-----------------------GGGGGCTTCCEEECCSSCCEEECCGGGGCCC
T ss_pred CCHHHhCCCCCCEEeCCCCccCCcCC-----------------------hHHhcCCCCCeEECcCCcccCcCCHHHhhhh
Confidence 34455566666666666666664343 3345556777777777777777777777776
Q ss_pred -ccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEec
Q 002892 385 -YILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDL 463 (870)
Q Consensus 385 -~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 463 (870)
+|+.|++++|++++.+|..|..++ |++|+|++|++++..|..|..+++|+.|+|++|.+++..|. +..+++|++|+|
T Consensus 174 ~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L 251 (313)
T 1ogq_A 174 KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL 251 (313)
T ss_dssp TTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEEC
T ss_pred hcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEEC
Confidence 778888888888777777787776 88888888888877888888888888888888888766555 777888888888
Q ss_pred CCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccccccccccccCCC
Q 002892 464 SNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPP 520 (870)
Q Consensus 464 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 520 (870)
++|+|++.+|..|..+++|+.|+|++|+++|.+|....+.++....+.+|+++||.|
T Consensus 252 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred cCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence 888888888888888888888888888888888887777777777788888889877
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=341.02 Aligned_cols=242 Identities=21% Similarity=0.288 Sum_probs=195.5
Q ss_pred hcCCCCCCeeccccceeEEEEEec--CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe-----
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF--DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF----- 655 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 655 (870)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 68999999986443 3445678899999999999999999999987655
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.|+||||++|++|.+++.. .+++.+++.++.||+.||+||| ++||+||||||+||+++.+ .+||+|||++...
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999988765 4899999999999999999999 6679999999999999885 8999999999876
Q ss_pred CCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
... ....||+.|+|||++.++. +.++|||||||++|+|++|..||........ +
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~--------- 285 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P--------- 285 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C---------
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------c---------
Confidence 432 3346899999999987654 8899999999999999999888764221100 0
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHhH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-CMTDVVVKLQKIKQT 865 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~i~~~ 865 (870)
........+..+.+++.+||+.||++|| ++.++.+.+..+.+.
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0011122345688999999999999999 566677777766543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.36 Aligned_cols=130 Identities=21% Similarity=0.289 Sum_probs=74.0
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcC
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLA 440 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 440 (870)
+|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|+++
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 272 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence 4555555555555555555555555555555555555555555555566666666666665 445555556666666666
Q ss_pred CCcccCcccccccCC------CCCCeEecCCCccc--CCCCcchhhccccceeeccCCc
Q 002892 441 RNRFQDSIPDSFGSL------TSLEYLDLSNNNLS--GEIPKSFEILSHLKRLNVSHNR 491 (870)
Q Consensus 441 ~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~ls~N~ 491 (870)
+|++++..+..|..+ .+|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 273 ~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 273 TNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 666655555544432 45666666666665 4556666666667777666663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.52 Aligned_cols=130 Identities=23% Similarity=0.272 Sum_probs=72.4
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcC
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLA 440 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 440 (870)
+|++|+|++|++++..|..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|+++
T Consensus 193 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 271 (330)
T 1xku_A 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271 (330)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECC
Confidence 4555555555555555555555555555555555555444445555555555555555555 445555555556666666
Q ss_pred CCcccCcccccccC------CCCCCeEecCCCcccC--CCCcchhhccccceeeccCCc
Q 002892 441 RNRFQDSIPDSFGS------LTSLEYLDLSNNNLSG--EIPKSFEILSHLKRLNVSHNR 491 (870)
Q Consensus 441 ~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~ 491 (870)
+|+|++..+..|.. .++|+.|++++|.+.. ..|..|..+.+++.++|++|+
T Consensus 272 ~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 272 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 66665554444433 2556666777666642 455666667777777777664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=298.53 Aligned_cols=231 Identities=22% Similarity=0.299 Sum_probs=178.5
Q ss_pred hhcCCCCC-CeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHH-HhcCCCceeEEeeeeee----CCe
Q 002892 583 ATDGFNEC-NLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVL-RNVRHRNLIKIFSSCCN----LDF 655 (870)
Q Consensus 583 ~~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~ 655 (870)
..++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34567776 7899999999999986 47899999998643 3456788887 55689999999999876 677
Q ss_pred eEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEecccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHN-YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFGI 731 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~ 731 (870)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 899999999999999998653 46899999999999999999999 666999999999999998 78999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
+.... +..++.++||||+||++|||++|+.||........ ......
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~~~~~ 212 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGMKT 212 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hHHHHH
Confidence 86442 23467899999999999999999999965321110 000000
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...... ...+......++..+.+++.+||+.||++||++.|+++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 00011111234567999999999999999999999986
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.63 Aligned_cols=298 Identities=19% Similarity=0.234 Sum_probs=242.1
Q ss_pred cCCCCCCCC------CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCC
Q 002892 6 TVPPHIGNL------SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPI 79 (870)
Q Consensus 6 ~~p~~~~~l------~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 79 (870)
++|+.+... .+|+.+++++++++ .+|..+. ++|+.|++++|.+++..|..|+.+++|++|+|++|+|++..
T Consensus 18 ~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 94 (332)
T 2ft3_A 18 SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94 (332)
T ss_dssp -------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccC
Confidence 466654433 47999999999998 6787663 79999999999999777889999999999999999999888
Q ss_pred CCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccc--ccccccccc
Q 002892 80 PNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLI--GPIPTTIFN 157 (870)
Q Consensus 80 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~~~~ 157 (870)
|..++++++|++|+|++|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|.++ +..+..+..
T Consensus 95 ~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 171 (332)
T 2ft3_A 95 EKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171 (332)
T ss_dssp GGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS
T ss_pred HhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC
Confidence 889999999999999999998 6777665 89999999999999776777999999999999999996 367788888
Q ss_pred cccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccc
Q 002892 158 ISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTL 237 (870)
Q Consensus 158 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 237 (870)
+ +|+.|++++|++++ +|..+. ++|+.|++++|++++..+..+..+++|++|+|++|++++..+.+|..+++|+.|
T Consensus 172 l-~L~~L~l~~n~l~~-l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 246 (332)
T 2ft3_A 172 L-KLNYLRISEAKLTG-IPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL 246 (332)
T ss_dssp C-CCSCCBCCSSBCSS-CCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEE
T ss_pred C-ccCEEECcCCCCCc-cCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEE
Confidence 8 99999999999986 444443 789999999999998888999999999999999999998888899999999999
Q ss_pred cccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccc-----cchhhhhccccccc--ccCchhhh
Q 002892 238 NIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFS-----ASFQQFYAHECKLK--GSIPKEIG 310 (870)
Q Consensus 238 ~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~-----~~l~~l~l~~n~l~--~~~~~~l~ 310 (870)
+|++|.++.++ ..+..+++|+.|++++|+++++.+..|.... ..++.+.+.+|.+. +..|..+.
T Consensus 247 ~L~~N~l~~lp---------~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~ 317 (332)
T 2ft3_A 247 HLDNNKLSRVP---------AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317 (332)
T ss_dssp ECCSSCCCBCC---------TTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred ECCCCcCeecC---------hhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccc
Confidence 99999998654 3578899999999999999998877766542 33444555555544 34444455
Q ss_pred CccCCcEEEeeCC
Q 002892 311 NLRGLIALSLFTN 323 (870)
Q Consensus 311 ~l~~L~~L~L~~N 323 (870)
.+++|+.+++++|
T Consensus 318 ~l~~L~~l~l~~n 330 (332)
T 2ft3_A 318 CVTDRLAIQFGNY 330 (332)
T ss_dssp TBCCSTTEEC---
T ss_pred ccchhhhhhcccc
Confidence 5555555555544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=315.68 Aligned_cols=241 Identities=17% Similarity=0.166 Sum_probs=179.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCC-CceeE------------
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRH-RNLIK------------ 645 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~------------ 645 (870)
....|+..++||+|+||+||+|++ .+|+.||||++.... ....+.+.+|+.+++.++| ++...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345577888999999999999995 479999999987433 2235678999999999977 22111
Q ss_pred ---------Eeeeeee-----CCeeEEEEecCCCCCHHHHHh------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 002892 646 ---------IFSSCCN-----LDFKALVLEFMPNGSLEKWLY------SHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705 (870)
Q Consensus 646 ---------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ 705 (870)
+..++.. ....+++|+++ +++|.++++ ..+..+++..++.++.|++.||+||| +++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 1111111 12346677755 789999885 22445788899999999999999999 667
Q ss_pred cEecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccc----------cCCCcCcccchHhHHH
Q 002892 706 VVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA----------SDGIISPKCDVYSYGV 775 (870)
Q Consensus 706 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~sDvwslG~ 775 (870)
|+||||||+||+++.++.+||+|||+++..+.. .....| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998865322 334457 999999999 5667889999999999
Q ss_pred HHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 002892 776 LLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855 (870)
Q Consensus 776 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 855 (870)
++|||++|+.||......+. ....+... . .++..+.+++.+||+.+|++||++.++
T Consensus 306 il~elltg~~Pf~~~~~~~~-----------------~~~~~~~~-~------~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG-----------------SEWIFRSC-K------NIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC-----------------SGGGGSSC-C------CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHCCCCCCCcchhhh-----------------HHHHHhhc-c------cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999976322110 11111100 0 123568999999999999999998777
Q ss_pred HH
Q 002892 856 VV 857 (870)
Q Consensus 856 l~ 857 (870)
++
T Consensus 362 l~ 363 (413)
T 3dzo_A 362 ME 363 (413)
T ss_dssp TT
T ss_pred Hh
Confidence 54
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-32 Score=293.76 Aligned_cols=255 Identities=20% Similarity=0.230 Sum_probs=227.7
Q ss_pred CCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEe
Q 002892 14 LSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLD 93 (870)
Q Consensus 14 l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 93 (870)
..+|+.++++++.++ .+|..+. ++|+.|++++|.+++..+..|+.+++|++|+|++|++++..|..+.++++|++|+
T Consensus 30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 457999999999998 5776664 6899999999999977777999999999999999999988899999999999999
Q ss_pred ccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccc--cccccccccccceEEEeecccc
Q 002892 94 SRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIG--PIPTTIFNISTIIIINLVGNQL 171 (870)
Q Consensus 94 L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~l~~N~l 171 (870)
|++|+++ .+|..+. ++|++|++++|++++..+..+.++++|++|++++|++.. ..+..+.++++|++|++++|++
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 9999998 6777665 799999999999997777789999999999999999964 7788899999999999999999
Q ss_pred cccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCC
Q 002892 172 SGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSN 251 (870)
Q Consensus 172 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 251 (870)
+.. |..+ .++|+.|++++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|.++.++
T Consensus 184 ~~l-~~~~---~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp--- 256 (330)
T 1xku_A 184 TTI-PQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP--- 256 (330)
T ss_dssp CSC-CSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC---
T ss_pred ccC-Cccc---cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCC---
Confidence 854 4443 279999999999999888999999999999999999999888889999999999999999999654
Q ss_pred CCcccccccccccccceEEcCCCCCCCCCCcccccc
Q 002892 252 GEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287 (870)
Q Consensus 252 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 287 (870)
..+..+++|++|++++|+|+++.+..|...
T Consensus 257 ------~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~ 286 (330)
T 1xku_A 257 ------GGLADHKYIQVVYLHNNNISAIGSNDFCPP 286 (330)
T ss_dssp ------TTTTTCSSCCEEECCSSCCCCCCTTSSSCS
T ss_pred ------hhhccCCCcCEEECCCCcCCccChhhcCCc
Confidence 457889999999999999999877776543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=345.83 Aligned_cols=368 Identities=19% Similarity=0.190 Sum_probs=221.5
Q ss_pred CCCCCeecCCCCccccCCCcc-ccCCCCCcEEEccCCcccc----cCCccccCCCCCCEEEcCCCccccCCCCCC-CCCC
Q 002892 14 LSFLMYLDISENNFRGYLPNE-LGQLRRLKFLGFAYNDLTG----SFPSWIGVFSKLQVLSLRNNSFTGPIPNSL-FNLS 87 (870)
Q Consensus 14 l~~L~~L~ls~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~ 87 (870)
.++|++|||++|+++...... +..+++|++|++++|.+++ .++..+..+++|++|+|++|.+++..+..+ ..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 357889999999987543333 6788999999999999874 356778888999999999999875433332 2344
Q ss_pred ----CCcEEeccCCcccc----ccCcCCCCcCCccEEEeecCccceecCCccc-----CCCCCCeeecccccccccc---
Q 002892 88 ----SLVRLDSRFNSISG----NIPSKIGNLTKLVHLNFADNNLRGEIPNEIG-----NLKNLADLVLALNNLIGPI--- 151 (870)
Q Consensus 88 ----~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~-----~l~~L~~L~L~~n~l~~~~--- 151 (870)
+|++|+|++|+++. .++..+..+++|++|++++|.+++..+..+. ..++|++|++++|++++..
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 69999999999883 4577888888999999999988754443332 3567888888888887643
Q ss_pred -cccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcc-cCCCCccEEEccCCcccCC----Cc
Q 002892 152 -PTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI-TNASKLIGLDLNSNSLSGQ----IP 225 (870)
Q Consensus 152 -~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~i~~~----~~ 225 (870)
+..+..+++|++|++++|.+++..+..+.. .+ ...++|++|++++|.+++. ++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~---------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 220 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQ---------------------GLKDSPCQLEALKLESCGVTSDNCRDLC 220 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHH---------------------HHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHH---------------------HHhcCCCCceEEEccCCCCcHHHHHHHH
Confidence 555556677777777777765432222211 11 1234666777777766643 35
Q ss_pred cccccccccccccccccccccccCCCCCcccccc-cccccccceEEcCCCCCCCCCCccccccccchhhhhccccccccc
Q 002892 226 NTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSS-LTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGS 304 (870)
Q Consensus 226 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~ 304 (870)
..+..+++|++|++++|.++..... .+.+. +..+++|++|++++|++..... ..
T Consensus 221 ~~l~~~~~L~~L~Ls~n~l~~~~~~----~l~~~~~~~~~~L~~L~L~~n~l~~~~~---------------------~~ 275 (461)
T 1z7x_W 221 GIVASKASLRELALGSNKLGDVGMA----ELCPGLLHPSSRLRTLWIWECGITAKGC---------------------GD 275 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHH----HHHHHHTSTTCCCCEEECTTSCCCHHHH---------------------HH
T ss_pred HHHHhCCCccEEeccCCcCChHHHH----HHHHHHhcCCCCceEEECcCCCCCHHHH---------------------HH
Confidence 5566667777777777766542100 01111 2246677777777776653100 01
Q ss_pred CchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCC----CCccc
Q 002892 305 IPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS----IPSSF 380 (870)
Q Consensus 305 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~ 380 (870)
++..+..+++|+.|++++|.+.+..+..+...- ....++|++|+|++|.+++. ++..+
T Consensus 276 l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 337 (461)
T 1z7x_W 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETL------------------LEPGCQLESLWVKSCSFTAACCSHFSSVL 337 (461)
T ss_dssp HHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHH------------------TSTTCCCCEEECTTSCCBGGGHHHHHHHH
T ss_pred HHHHHhhCCCcceEECCCCCCchHHHHHHHHHh------------------ccCCccceeeEcCCCCCchHHHHHHHHHH
Confidence 345566677777777777777643332221110 01124667777777766643 23334
Q ss_pred ccccccceEecCCCccCCCCcccccC-----CccCCEEEccCCccCC----cccccccCCCCCCEEEcCCCccc
Q 002892 381 WSLEYILRIDLSSNSLSGSLPSDIQN-----LKVLIYLNLSRNQLSG----NIPITIGGLKDLITLSLARNRFQ 445 (870)
Q Consensus 381 ~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 445 (870)
..+++|++|++++|.+++..+..+.. .++|++|+|++|++++ .+|..+..+++|+.|++++|+++
T Consensus 338 ~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 338 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred hhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 44455555555555554332322221 3345555555555543 34444444445555555555444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=292.99 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=230.5
Q ss_pred CCCCeecCCCCcccc--CCCccccCCCCCcEEEccC-CcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcE
Q 002892 15 SFLMYLDISENNFRG--YLPNELGQLRRLKFLGFAY-NDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVR 91 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 91 (870)
.++++|+|++|++++ .+|..|..+++|++|++++ |.+++.+|..|+.+++|++|+|++|++++.+|..+.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999998 8999999999999999995 9999899999999999999999999999889999999999999
Q ss_pred EeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCC-CCCeeecccccccccccccccccccceEEEeeccc
Q 002892 92 LDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLK-NLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQ 170 (870)
Q Consensus 92 L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (870)
|+|++|++++.+|..|+.+++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..++ |++|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999989999999999999999999999999999999998 999999999999999999999997 9999999999
Q ss_pred ccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCC
Q 002892 171 LSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS 250 (870)
Q Consensus 171 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 250 (870)
+++..|..+. .+++|+.|+|++|++++..|. +..+++|++|+|++|++++.+|.+|..+++|+.|+|++|+++...+
T Consensus 209 l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip- 285 (313)
T 1ogq_A 209 LEGDASVLFG-SDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285 (313)
T ss_dssp EEECCGGGCC-TTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-
T ss_pred ccCcCCHHHh-cCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC-
Confidence 9988776664 589999999999999976665 8889999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccccceEEcCCCC-CCC
Q 002892 251 NGEWSFLSSLTNCNKLRALSLGSNP-LDS 278 (870)
Q Consensus 251 ~~~~~~~~~l~~l~~L~~L~L~~N~-l~~ 278 (870)
....+++|+.|++++|+ +.+
T Consensus 286 --------~~~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 286 --------QGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp --------CSTTGGGSCGGGTCSSSEEES
T ss_pred --------CCccccccChHHhcCCCCccC
Confidence 23778899999999998 443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-33 Score=305.95 Aligned_cols=243 Identities=18% Similarity=0.235 Sum_probs=183.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--------hHHHHHHHHHHHHHHhcC---------CCceeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--------ERAFRSFESECEVLRNVR---------HRNLIK 645 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~ 645 (870)
..++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788999999999999999997 68999999997652 223467888999988886 666666
Q ss_pred Eeeee-----------------ee-------------CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 002892 646 IFSSC-----------------CN-------------LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695 (870)
Q Consensus 646 ~~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l 695 (870)
+.+.+ .. .+..|+||||+++|++.+.+.. ..+++..+..++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 65543 32 6789999999999977666644 3489999999999999999
Q ss_pred HHHH-hcCCCCcEecccCCCceeeCCCC--------------------ceEEeccccccccCCCCCcccccccccccccC
Q 002892 696 EYLH-HSHSTPVVHCNLKPNNILLDKNM--------------------TARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754 (870)
Q Consensus 696 ~~Lh-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~ 754 (870)
+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTT
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeeccc
Confidence 9999 655 99999999999999887 8999999999876421 346999999
Q ss_pred CcccccCCCcCcccchHhHHHH-HHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHH
Q 002892 755 APEYASDGIISPKCDVYSYGVL-LMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLR 833 (870)
Q Consensus 755 aPE~~~~~~~~~~sDvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (870)
|||++.+.. +.++||||+|++ .+++++|..||... .|.... ...+.................++..
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYL----TDKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHH----HHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHH----HHhhhhhhccCcccchhhhhhcCHH
Confidence 999998766 899999998777 77888899987531 110000 0000100001111112233456788
Q ss_pred HHHHHhhccCCCCCCCCCHHHHH
Q 002892 834 IMHLALGCCMDSPEQRMCMTDVV 856 (870)
Q Consensus 834 l~~l~~~cl~~~P~~RPs~~evl 856 (870)
+.+++.+||+.| |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999966 888887
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-36 Score=341.08 Aligned_cols=365 Identities=20% Similarity=0.178 Sum_probs=217.4
Q ss_pred CCCCcEEeccCCccccccCcC-CCCcCCccEEEeecCccce----ecCCcccCCCCCCeeecccccccccccccccc-cc
Q 002892 86 LSSLVRLDSRFNSISGNIPSK-IGNLTKLVHLNFADNNLRG----EIPNEIGNLKNLADLVLALNNLIGPIPTTIFN-IS 159 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~l~~N~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~-l~ 159 (870)
+++|++|+|++|+++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|++.+..+..+.. ++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 357889999999987543333 6788899999999999884 34666778889999999999887655544443 44
Q ss_pred ----cceEEEeeccccccc----CCCcccCCCCccceeeecccccccccCCccc-----CCCCccEEEccCCcccCCC--
Q 002892 160 ----TIIIINLVGNQLSGH----RPSTMGHSLPNRQFLLLWANRLTGTIPNSIT-----NASKLIGLDLNSNSLSGQI-- 224 (870)
Q Consensus 160 ----~L~~L~l~~N~l~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~i~~~~-- 224 (870)
+|++|+|++|+++.. ++..+ ..+++|++|+|++|.+++..+..+. ..++|++|++++|++++..
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l-~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 160 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTL-RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHT-TSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHH-ccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence 588888888887742 23333 3466777777777777654333322 2456777777777776533
Q ss_pred --ccccccccccccccccccccccccCCCCCcccccccc-cccccceEEcCCCCCCCCCCccccccccchhhhhcccccc
Q 002892 225 --PNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLT-NCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301 (870)
Q Consensus 225 --~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l 301 (870)
+..+..+++|++|++++|.++..... .+...+. ..++|++|++++|.+......
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~----~l~~~l~~~~~~L~~L~L~~n~l~~~~~~------------------- 217 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINEAGVR----VLCQGLKDSPCQLEALKLESCGVTSDNCR------------------- 217 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHH----HHHHHHHHSCCCCCEEECTTSCCBTTHHH-------------------
T ss_pred HHHHHHhhCCCCCEEECcCCCcchHHHH----HHHHHHhcCCCCceEEEccCCCCcHHHHH-------------------
Confidence 44455567777777777776643210 0111111 244777777777766542100
Q ss_pred cccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCC----CC
Q 002892 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS----IP 377 (870)
Q Consensus 302 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~ 377 (870)
.++..+..+++|+.|++++|.+.+.....+. +..+..+++|++|+|++|+++.. ++
T Consensus 218 --~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 277 (461)
T 1z7x_W 218 --DLCGIVASKASLRELALGSNKLGDVGMAELC------------------PGLLHPSSRLRTLWIWECGITAKGCGDLC 277 (461)
T ss_dssp --HHHHHHHHCTTCCEEECCSSBCHHHHHHHHH------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred --HHHHHHHhCCCccEEeccCCcCChHHHHHHH------------------HHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence 2456667778888888888887643211111 01112345566666666666532 34
Q ss_pred cccccccccceEecCCCccCCCCcccccC-----CccCCEEEccCCccCCc----ccccccCCCCCCEEEcCCCcccCcc
Q 002892 378 SSFWSLEYILRIDLSSNSLSGSLPSDIQN-----LKVLIYLNLSRNQLSGN----IPITIGGLKDLITLSLARNRFQDSI 448 (870)
Q Consensus 378 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~ 448 (870)
..+..+++|++|++++|.+++..+..+.. .++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++..
T Consensus 278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 44555566666666666655333323322 14566666666666543 3344455566666666666665544
Q ss_pred cccccC-----CCCCCeEecCCCcccC----CCCcchhhccccceeeccCCcccc
Q 002892 449 PDSFGS-----LTSLEYLDLSNNNLSG----EIPKSFEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 449 p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~ 494 (870)
+..+.. .++|+.|+|++|++++ .+|..+..+++|+.|++++|++++
T Consensus 358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 433332 4566666666666654 455555556666666666666554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=274.10 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=178.1
Q ss_pred eeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccce
Q 002892 189 LLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRA 268 (870)
Q Consensus 189 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~ 268 (870)
++.+++.++ .+|..+. ++|++|+|++|+++.+.+..|.++++|++|+|++|.++.+.. .+..+..+++|++
T Consensus 12 l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~------~~~~~~~~~~L~~ 82 (306)
T 2z66_A 12 IRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC------CSQSDFGTTSLKY 82 (306)
T ss_dssp EECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE------EEHHHHSCSCCCE
T ss_pred EEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC------cccccccccccCE
Confidence 444444444 3343332 456666666666664444445666666666666666653210 1223445566666
Q ss_pred EEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCC
Q 002892 269 LSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNL 348 (870)
Q Consensus 269 L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~ 348 (870)
|++++|.+.. +|..+..+++|++|++++|++.+..+
T Consensus 83 L~Ls~n~i~~--------------------------l~~~~~~l~~L~~L~l~~n~l~~~~~------------------ 118 (306)
T 2z66_A 83 LDLSFNGVIT--------------------------MSSNFLGLEQLEHLDFQHSNLKQMSE------------------ 118 (306)
T ss_dssp EECCSCSEEE--------------------------EEEEEETCTTCCEEECTTSEEESSTT------------------
T ss_pred EECCCCcccc--------------------------ChhhcCCCCCCCEEECCCCccccccc------------------
Confidence 6666665542 23445666777777777777764322
Q ss_pred CCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCC-CCcccccCCccCCEEEccCCccCCccccc
Q 002892 349 NGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSG-SLPSDIQNLKVLIYLNLSRNQLSGNIPIT 427 (870)
Q Consensus 349 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 427 (870)
...+..+++|++|++++|++++..+..|..+++|++|++++|.+++ ..|..|..+++|++|+|++|++++..|..
T Consensus 119 ----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 194 (306)
T 2z66_A 119 ----FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 194 (306)
T ss_dssp ----TTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ----chhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHH
Confidence 1235566778888888888887778888888888888888888875 57788888888888888888888777888
Q ss_pred ccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhcc-ccceeeccCCcccccCCC
Q 002892 428 IGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILS-HLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 428 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~ 498 (870)
|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..+..++ +|+.|+|++|+|+|.++.
T Consensus 195 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp TTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred hcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence 88888888888888888877777788888888888888888888888888874 888888888888887753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=281.56 Aligned_cols=286 Identities=20% Similarity=0.228 Sum_probs=208.6
Q ss_pred ceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccc
Q 002892 161 IIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240 (870)
Q Consensus 161 L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 240 (870)
....++++|.++. +|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|+
T Consensus 33 ~~~c~~~~~~l~~-iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 33 NGICKGSSGSLNS-IPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TSEEECCSTTCSS-CCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CeEeeCCCCCccc-cccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 3345555666553 333332 466777777777776555577777777777777777777667777777777777777
Q ss_pred ccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEe
Q 002892 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSL 320 (870)
Q Consensus 241 ~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L 320 (870)
+|.++.++. ..+..+++|++|++++|++.++.+ ...+..+++|+.|++
T Consensus 109 ~n~l~~~~~--------~~~~~l~~L~~L~L~~n~l~~l~~------------------------~~~~~~l~~L~~L~l 156 (353)
T 2z80_A 109 YNYLSNLSS--------SWFKPLSSLTFLNLLGNPYKTLGE------------------------TSLFSHLTKLQILRV 156 (353)
T ss_dssp SSCCSSCCH--------HHHTTCTTCSEEECTTCCCSSSCS------------------------SCSCTTCTTCCEEEE
T ss_pred CCcCCcCCH--------hHhCCCccCCEEECCCCCCcccCc------------------------hhhhccCCCCcEEEC
Confidence 777775431 236667777777777777764321 024566778888888
Q ss_pred eCCC-ccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCC
Q 002892 321 FTND-LNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGS 399 (870)
Q Consensus 321 ~~N~-l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 399 (870)
++|+ +.... +..+..+++|++|++++|++++..|..|..+++|++|++++|.++..
T Consensus 157 ~~n~~~~~~~-----------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ 213 (353)
T 2z80_A 157 GNMDTFTKIQ-----------------------RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILL 213 (353)
T ss_dssp EESSSCCEEC-----------------------TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTH
T ss_pred CCCccccccC-----------------------HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccc
Confidence 8874 44322 34566778899999999999988889999999999999999998744
Q ss_pred CcccccCCccCCEEEccCCccCCccccccc---CCCCCCEEEcCCCcccC----cccccccCCCCCCeEecCCCcccCCC
Q 002892 400 LPSDIQNLKVLIYLNLSRNQLSGNIPITIG---GLKDLITLSLARNRFQD----SIPDSFGSLTSLEYLDLSNNNLSGEI 472 (870)
Q Consensus 400 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~ 472 (870)
.+..+..+++|+.|++++|++++..+..+. ....++.++|++|.+++ .+|..+..+++|+.|+|++|+|+ .+
T Consensus 214 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i 292 (353)
T 2z80_A 214 LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SV 292 (353)
T ss_dssp HHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CC
T ss_pred hhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-cc
Confidence 333455688999999999999876655443 46778999999999886 37788999999999999999999 55
Q ss_pred Ccc-hhhccccceeeccCCcccccCCCCCcccccc
Q 002892 473 PKS-FEILSHLKRLNVSHNRLEGKIPTNGPFRNFL 506 (870)
Q Consensus 473 p~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~ 506 (870)
|.. |..+++|+.|+|++|+++|.+|....+..|.
T Consensus 293 ~~~~~~~l~~L~~L~L~~N~~~~~~~~l~~l~~~~ 327 (353)
T 2z80_A 293 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 327 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCHHHHHHHHHHH
T ss_pred CHHHHhcCCCCCEEEeeCCCccCcCCCcHHHHHHH
Confidence 555 6899999999999999999998544444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=267.86 Aligned_cols=141 Identities=24% Similarity=0.337 Sum_probs=99.8
Q ss_pred CccccceeecCCcccCC-CCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCE
Q 002892 358 SLISLRQLHLGSNQLTS-SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLIT 436 (870)
Q Consensus 358 ~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 436 (870)
.+++|++|+|++|.+++ ..|..|..+++|+.|++++|.+++..|..|..+++|++|+|++|++++..+..|..+++|+.
T Consensus 148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 227 (306)
T 2z66_A 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227 (306)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence 34455555555555554 45566666667777777777777666677777777777777777777766667777888888
Q ss_pred EEcCCCcccCcccccccCCC-CCCeEecCCCcccCCCC--cchhhccccceeeccCCcccccCCC
Q 002892 437 LSLARNRFQDSIPDSFGSLT-SLEYLDLSNNNLSGEIP--KSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 437 L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
|+|++|.+++..|..+..++ +|+.|+|++|.+++..+ .....+...+.+.+..|.+.|..|.
T Consensus 228 L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp EECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred eECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 88888888887788888874 88888888888875432 2234456667777788888887775
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=273.89 Aligned_cols=204 Identities=20% Similarity=0.149 Sum_probs=105.8
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEee
Q 002892 40 RLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFA 119 (870)
Q Consensus 40 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 119 (870)
.....++++|.++ .+|..+. ++|++|+|++|+|++..+..+.++++|++|+|++|++++..|..|+++++|++|+++
T Consensus 32 ~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 32 RNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 3344555555555 4444332 355555555555554333345555555555555555554444445555555555555
Q ss_pred cCccceecCCcccCCCCCCeeeccccccccccc-ccccccccceEEEeecccccccCCCcccCCCCccceeeeccc-ccc
Q 002892 120 DNNLRGEIPNEIGNLKNLADLVLALNNLIGPIP-TTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWAN-RLT 197 (870)
Q Consensus 120 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n-~l~ 197 (870)
+|++++..+..+.++++|++|++++|++++..+ ..+.. +++|++|++++| .++
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~-------------------------l~~L~~L~l~~n~~~~ 163 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSH-------------------------LTKLQILRVGNMDTFT 163 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTT-------------------------CTTCCEEEEEESSSCC
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhcc-------------------------CCCCcEEECCCCcccc
Confidence 555553222234445555555555554443222 23334 444444444444 244
Q ss_pred cccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCC
Q 002892 198 GTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277 (870)
Q Consensus 198 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (870)
...+..+..+++|++|++++|++++..|..|..+++|++|++++|.++.++. ..+..+++|+.|++++|++.
T Consensus 164 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~--------~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE--------IFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHH--------HHHHHTTTEEEEEEESCBCT
T ss_pred ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchh--------hhhhhcccccEEECCCCccc
Confidence 4445566666666666666666666666666666666666666666654321 12334556666666666665
Q ss_pred CC
Q 002892 278 SI 279 (870)
Q Consensus 278 ~~ 279 (870)
+.
T Consensus 236 ~~ 237 (353)
T 2z80_A 236 TF 237 (353)
T ss_dssp TC
T ss_pred cc
Confidence 54
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=275.03 Aligned_cols=233 Identities=27% Similarity=0.338 Sum_probs=164.1
Q ss_pred CCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcccccc
Q 002892 208 SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287 (870)
Q Consensus 208 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 287 (870)
++++.|+|++|+|++..+..|.++++|++|+|++|.++.+. +..|..+++|++|+|++|++..+.
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~--------~~~~~~l~~L~~L~L~~n~l~~~~------- 128 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE--------IGAFNGLANLNTLELFDNRLTTIP------- 128 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEEC--------GGGGTTCSSCCEEECCSSCCSSCC-------
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccC--------hhhccCCccCCEEECCCCcCCeeC-------
Confidence 34455555555555444445555555555555555554432 123445555555555555554321
Q ss_pred ccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeec
Q 002892 288 SASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHL 367 (870)
Q Consensus 288 ~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~L 367 (870)
+..+..+++|+.|++++|.+....+ ..|..+++|++|+|
T Consensus 129 ------------------~~~~~~l~~L~~L~L~~N~i~~~~~-----------------------~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 129 ------------------NGAFVYLSKLKELWLRNNPIESIPS-----------------------YAFNRIPSLRRLDL 167 (440)
T ss_dssp ------------------TTTSCSCSSCCEEECCSCCCCEECT-----------------------TTTTTCTTCCEEEC
T ss_pred ------------------HhHhhccccCceeeCCCCcccccCH-----------------------HHhhhCcccCEeCC
Confidence 2234555666666666666653222 23455667777777
Q ss_pred CC-cccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccC
Q 002892 368 GS-NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD 446 (870)
Q Consensus 368 s~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 446 (870)
++ |.+....+..|.++++|+.|+|++|.++ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 245 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE
Confidence 77 4455555557888888888888888888 455 47888899999999999998888899999999999999999998
Q ss_pred cccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCC
Q 002892 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 447 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.+..
T Consensus 246 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp ECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred EChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 8888999999999999999999987778888999999999999999998864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-32 Score=316.37 Aligned_cols=130 Identities=16% Similarity=0.100 Sum_probs=53.8
Q ss_pred CCCCCcEEEccCCcccccCCccccCC--CCCCEEEcCCCc-ccc-CCCCCCCCCCCCcEEeccCCccccc----cCcCCC
Q 002892 37 QLRRLKFLGFAYNDLTGSFPSWIGVF--SKLQVLSLRNNS-FTG-PIPNSLFNLSSLVRLDSRFNSISGN----IPSKIG 108 (870)
Q Consensus 37 ~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~n~-i~~-~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~ 108 (870)
.+++|++|+|++|.+++..+..+... .+|++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 34455555555554443333333331 225555554443 110 0111112344555555555544322 111223
Q ss_pred CcCCccEEEeecCccc----eecCCcccCCCCCCeeecccccccccccccccccccceEEEee
Q 002892 109 NLTKLVHLNFADNNLR----GEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLV 167 (870)
Q Consensus 109 ~l~~L~~L~l~~N~l~----~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 167 (870)
.+++|++|++++|.++ +.++..+.++++|++|++++|.+.+ ++..+.++++|++|+++
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGG 251 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEEC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccc
Confidence 3444555555555443 1222223344445555555444442 33444444445554444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=275.17 Aligned_cols=232 Identities=25% Similarity=0.266 Sum_probs=156.1
Q ss_pred CccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccc
Q 002892 209 KLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFS 288 (870)
Q Consensus 209 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 288 (870)
++++|+|++|+|+++.+..|.++++|+.|+|++|.++.+.. ..|..+++|++|+|++|++..+.
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~--------~~~~~l~~L~~L~L~~n~l~~~~-------- 139 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEV--------GAFNGLASLNTLELFDNWLTVIP-------- 139 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT--------TTTTTCTTCCEEECCSSCCSBCC--------
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcCh--------hhccCcccCCEEECCCCcCCccC--------
Confidence 44455555555544444445555555555555554444321 23444455555555555544321
Q ss_pred cchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecC
Q 002892 289 ASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLG 368 (870)
Q Consensus 289 ~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls 368 (870)
+..+..+++|++|+|++|++....+ ..|..+++|+.|+|+
T Consensus 140 -----------------~~~~~~l~~L~~L~L~~N~l~~~~~-----------------------~~~~~l~~L~~L~l~ 179 (452)
T 3zyi_A 140 -----------------SGAFEYLSKLRELWLRNNPIESIPS-----------------------YAFNRVPSLMRLDLG 179 (452)
T ss_dssp -----------------TTTSSSCTTCCEEECCSCCCCEECT-----------------------TTTTTCTTCCEEECC
T ss_pred -----------------hhhhcccCCCCEEECCCCCcceeCH-----------------------hHHhcCCcccEEeCC
Confidence 2234455666666666666653222 234455667777777
Q ss_pred C-cccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCc
Q 002892 369 S-NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447 (870)
Q Consensus 369 ~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 447 (870)
+ |.+....+..|.++++|+.|+|++|.+++ +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++.
T Consensus 180 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (452)
T 3zyi_A 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257 (452)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred CCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence 6 44554555567777888888888888874 34 477788888888888888888888888888888888888888888
Q ss_pred ccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCC
Q 002892 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 448 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
.|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.+..
T Consensus 258 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 888888888899999998988877777788888899999999998888764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=264.47 Aligned_cols=228 Identities=20% Similarity=0.286 Sum_probs=194.7
Q ss_pred CCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEe
Q 002892 14 LSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLD 93 (870)
Q Consensus 14 l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 93 (870)
..++++|+|++|+++ .+|..+..+++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 478899999999998 68888888999999999999998 88888999999999999999998 7888899999999999
Q ss_pred ccCCccccccCcCCCC---------cCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEE
Q 002892 94 SRFNSISGNIPSKIGN---------LTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIII 164 (870)
Q Consensus 94 L~~n~i~~~~~~~~~~---------l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 164 (870)
|++|++.+.+|..++. +++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..+..+++|++|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 9998888788887765 889999999999988 778888888999999999998884 56678888889999
Q ss_pred EeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccc
Q 002892 165 NLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244 (870)
Q Consensus 165 ~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l 244 (870)
+|++|.+.+..|..+. .+++|++|+|++|++.+.+|..+.++++|++|+|++|++.+.+|+.++++++|+.+++..|.+
T Consensus 235 ~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp ECTTCTTCCBCCCCTT-CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred ECcCCcchhhhHHHhc-CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 9999888888877665 478888888888888888888888888888888888888888888888888888888887766
Q ss_pred ccc
Q 002892 245 TTE 247 (870)
Q Consensus 245 ~~~ 247 (870)
..+
T Consensus 314 ~~l 316 (328)
T 4fcg_A 314 AQL 316 (328)
T ss_dssp CC-
T ss_pred HHH
Confidence 543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=262.05 Aligned_cols=234 Identities=26% Similarity=0.296 Sum_probs=174.7
Q ss_pred CCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcccccc
Q 002892 208 SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287 (870)
Q Consensus 208 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 287 (870)
..+++|+|++|.++ .+|..+.++++|++|+|++|.++.+ +..+..+++|++|++++|++.
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~l---------p~~~~~l~~L~~L~Ls~n~l~---------- 140 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL---------PDTMQQFAGLETLTLARNPLR---------- 140 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCC---------CSCGGGGTTCSEEEEESCCCC----------
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccch---------hHHHhccCCCCEEECCCCccc----------
Confidence 34445555555554 3444444455555555555554432 123444555555555555544
Q ss_pred ccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeec
Q 002892 288 SASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHL 367 (870)
Q Consensus 288 ~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~L 367 (870)
.+|..+..+++|++|++++|++.+.+|..+... .++..+..+++|++|+|
T Consensus 141 ----------------~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~--------------~~~~~~~~l~~L~~L~L 190 (328)
T 4fcg_A 141 ----------------ALPASIASLNRLRELSIRACPELTELPEPLAST--------------DASGEHQGLVNLQSLRL 190 (328)
T ss_dssp ----------------CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE--------------C-CCCEEESTTCCEEEE
T ss_pred ----------------cCcHHHhcCcCCCEEECCCCCCccccChhHhhc--------------cchhhhccCCCCCEEEC
Confidence 234456666777777777776666666655431 12345677889999999
Q ss_pred CCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCc
Q 002892 368 GSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447 (870)
Q Consensus 368 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 447 (870)
++|+++ .+|..+..+++|+.|+|++|.+++ +|..+..+++|++|+|++|.+.+.+|..|+++++|+.|+|++|.+.+.
T Consensus 191 ~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 268 (328)
T 4fcg_A 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268 (328)
T ss_dssp EEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCB
T ss_pred cCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhh
Confidence 999998 778889999999999999999994 677899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCccc
Q 002892 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493 (870)
Q Consensus 448 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 493 (870)
+|..+.++++|+.|+|++|++.+.+|..+..+++|+.++++.|.+.
T Consensus 269 ~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999999999999999999999999999999999999988764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-31 Score=314.10 Aligned_cols=427 Identities=14% Similarity=0.087 Sum_probs=299.7
Q ss_pred CCccccCCCCCcEEEccCCcc---cccCCcccc------------CCCCCCEEEcCCCccccCCCCCCCCC--CCCcEEe
Q 002892 31 LPNELGQLRRLKFLGFAYNDL---TGSFPSWIG------------VFSKLQVLSLRNNSFTGPIPNSLFNL--SSLVRLD 93 (870)
Q Consensus 31 ~p~~~~~l~~L~~L~l~~n~l---~~~~~~~~~------------~l~~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~ 93 (870)
++..+..+++|+.|+++++.. .+.+|..++ .+++|++|+|++|.+++..+..+... .+|++|+
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~ 144 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence 444567788899999987642 123443333 68999999999999886666666653 4599999
Q ss_pred ccCCc-ccc-ccCcCCCCcCCccEEEeecCcccee----cCCcccCCCCCCeeeccccccc----ccccccccccccceE
Q 002892 94 SRFNS-ISG-NIPSKIGNLTKLVHLNFADNNLRGE----IPNEIGNLKNLADLVLALNNLI----GPIPTTIFNISTIII 163 (870)
Q Consensus 94 L~~n~-i~~-~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~ 163 (870)
|++|. ++. .++.....+++|++|+|++|.+++. ++..+..+++|++|+++.|.++ ..++..+.++++|+.
T Consensus 145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~ 224 (592)
T 3ogk_B 145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224 (592)
T ss_dssp EESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred CcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence 99987 321 1223335789999999999998755 3334567899999999999997 345566678899999
Q ss_pred EEeecccccccCCCcccCCCCccceeeecccccc---cccCCcccCCCCccEEEccCCcccCCCcccccccccccccccc
Q 002892 164 INLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLT---GTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240 (870)
Q Consensus 164 L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 240 (870)
|++++|.+.+ .+. ....+++|+.|+++..... ...+..+..+++|+.|+++++... .+|..+..+++|++|+|+
T Consensus 225 L~L~~~~~~~-l~~-~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls 301 (592)
T 3ogk_B 225 VKVGDFEILE-LVG-FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLL 301 (592)
T ss_dssp EECSSCBGGG-GHH-HHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEET
T ss_pred EeccCccHHH-HHH-HHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecC
Confidence 9999999886 333 3445799999999864433 234567788899999999987554 678888899999999999
Q ss_pred ccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEe
Q 002892 241 ANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSL 320 (870)
Q Consensus 241 ~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L 320 (870)
+|.++... +...+..+++|++|+++ |.+... .++.....+++|+.|++
T Consensus 302 ~~~l~~~~-------~~~~~~~~~~L~~L~L~-~~~~~~------------------------~l~~~~~~~~~L~~L~L 349 (592)
T 3ogk_B 302 YALLETED-------HCTLIQKCPNLEVLETR-NVIGDR------------------------GLEVLAQYCKQLKRLRI 349 (592)
T ss_dssp TCCCCHHH-------HHHHHTTCTTCCEEEEE-GGGHHH------------------------HHHHHHHHCTTCCEEEE
T ss_pred CCcCCHHH-------HHHHHHhCcCCCEEecc-CccCHH------------------------HHHHHHHhCCCCCEEEe
Confidence 99876432 22346789999999999 444321 12222344555666666
Q ss_pred e-----------CCCccccC-CchhhchhhHHHHHhc-CCCCCCCcccccC-ccccceeecC----CcccCCC-----CC
Q 002892 321 F-----------TNDLNGTI-PTTLGRLQQLQALLQR-NNLNGPIPTCLSS-LISLRQLHLG----SNQLTSS-----IP 377 (870)
Q Consensus 321 ~-----------~N~l~~~~-~~~~~~l~~L~~L~l~-n~~~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~~ 377 (870)
+ .|.+++.. +..+..+++|+.|+++ +++.+..+..+.. +++|+.|+|+ .|.+++. ++
T Consensus 350 ~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~ 429 (592)
T 3ogk_B 350 ERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVR 429 (592)
T ss_dssp ECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHH
T ss_pred ecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHH
Confidence 6 23443321 2223345555555554 4444444444544 7889999996 7788754 33
Q ss_pred cccccccccceEecCCCc--cCCCCccccc-CCccCCEEEccCCccCCc-ccccccCCCCCCEEEcCCCcccCc-ccccc
Q 002892 378 SSFWSLEYILRIDLSSNS--LSGSLPSDIQ-NLKVLIYLNLSRNQLSGN-IPITIGGLKDLITLSLARNRFQDS-IPDSF 452 (870)
Q Consensus 378 ~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~ 452 (870)
..+.++++|+.|++++|. +++..+..+. .+++|++|+|++|++++. .+..+.++++|+.|++++|.+++. ++..+
T Consensus 430 ~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 509 (592)
T 3ogk_B 430 SLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAV 509 (592)
T ss_dssp HHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHH
T ss_pred HHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHH
Confidence 346778999999998644 6654444444 488999999999999863 455668899999999999998765 34445
Q ss_pred cCCCCCCeEecCCCcccCCCCcch-hhccccceeeccCCcc
Q 002892 453 GSLTSLEYLDLSNNNLSGEIPKSF-EILSHLKRLNVSHNRL 492 (870)
Q Consensus 453 ~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l 492 (870)
..+++|+.|+|++|+++..-...+ ..++.+....+..++-
T Consensus 510 ~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~~~ 550 (592)
T 3ogk_B 510 TKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRV 550 (592)
T ss_dssp HHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC--
T ss_pred HhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCccc
Confidence 679999999999999986533333 3567777777766543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-28 Score=271.56 Aligned_cols=249 Identities=20% Similarity=0.157 Sum_probs=212.6
Q ss_pred CCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc
Q 002892 16 FLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR 95 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 95 (870)
....++.++++++ .+|..+. +++++|+|++|++++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4578899999998 5776654 689999999999998888899999999999999999998888889999999999999
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccc-cccccccccccccccceEEEeeccccccc
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALN-NLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
+|++++..+..|..+++|++|+|++|+|+...+..+.++++|++|++++| .+....+..+.++++|++|+|++|++++.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 99999666677899999999999999999777778999999999999984 45545555788899999999999999865
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 254 (870)
|. ...+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|+++.++.
T Consensus 212 -~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----- 283 (452)
T 3zyi_A 212 -PN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH----- 283 (452)
T ss_dssp -CC--CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT-----
T ss_pred -cc--ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccCh-----
Confidence 32 3457899999999999998888899999999999999999998888889999999999999999987653
Q ss_pred ccccccccccccceEEcCCCCCCC
Q 002892 255 SFLSSLTNCNKLRALSLGSNPLDS 278 (870)
Q Consensus 255 ~~~~~l~~l~~L~~L~L~~N~l~~ 278 (870)
..+..+++|+.|+|++|++..
T Consensus 284 ---~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 284 ---DLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp ---TSSTTCTTCCEEECCSSCEEC
T ss_pred ---HHhccccCCCEEEccCCCcCC
Confidence 356778899999999998753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=270.19 Aligned_cols=248 Identities=20% Similarity=0.178 Sum_probs=211.4
Q ss_pred CCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc
Q 002892 16 FLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR 95 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 95 (870)
....++.++++++ .+|..+. ++++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4678899999998 6787664 689999999999998788899999999999999999997777889999999999999
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccc-ccccccccccccccceEEEeeccccccc
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNN-LIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
+|+++...+..|..+++|++|+|++|+|+...+..|.++++|++|++++|+ +....+..|.++++|++|+|++|+++..
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 200 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence 999986666678999999999999999997777789999999999999854 4445555788899999999999999854
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 254 (870)
|. ...+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+++.++.
T Consensus 201 -~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----- 272 (440)
T 3zyj_A 201 -PN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH----- 272 (440)
T ss_dssp -CC--CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCT-----
T ss_pred -cc--cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccCh-----
Confidence 32 3457899999999999998888899999999999999999998888889999999999999999987653
Q ss_pred ccccccccccccceEEcCCCCCC
Q 002892 255 SFLSSLTNCNKLRALSLGSNPLD 277 (870)
Q Consensus 255 ~~~~~l~~l~~L~~L~L~~N~l~ 277 (870)
..+..+++|+.|+|++|++.
T Consensus 273 ---~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 273 ---DLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ---TTTSSCTTCCEEECCSSCEE
T ss_pred ---hHhccccCCCEEEcCCCCcc
Confidence 35677889999999999875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=255.00 Aligned_cols=226 Identities=20% Similarity=0.212 Sum_probs=188.1
Q ss_pred CCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
-+.++.++++++ .+|..+ .++|++|++++|.+++..+..|+.+++|++|+|++|.+++..|..+.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 367899999998 567544 56899999999999977778889999999999999999977788899999999999999
Q ss_pred Cc-cccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccC
Q 002892 97 NS-ISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHR 175 (870)
Q Consensus 97 n~-i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 175 (870)
|. ++...|..|..+++|++|++++|++++..|..+.++++|++|++++|++++..+..+..+++|++|++++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 97 77666788899999999999999999777888889999999999999998777777888888999999998888655
Q ss_pred CCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccccc
Q 002892 176 PSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246 (870)
Q Consensus 176 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 246 (870)
+..+. .+++|+.|++++|++++..|..+..+++|++|++++|++++..+..|..+++|+.|++++|.+..
T Consensus 170 ~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 170 ERAFR-GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp TTTTT-TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred HHHhc-CccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 54443 47788888888888887778888888888888888888887666778888888888888887764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=270.23 Aligned_cols=250 Identities=24% Similarity=0.212 Sum_probs=213.3
Q ss_pred CCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCccc-ccCCcccc-------CCCCCCEEEcCCCccccCCCCC
Q 002892 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLT-GSFPSWIG-------VFSKLQVLSLRNNSFTGPIPNS 82 (870)
Q Consensus 11 ~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~-~~~~~~~~-------~l~~L~~L~L~~n~i~~~~~~~ 82 (870)
++..++|++|++++|.+ .+|..+... |+.|++++|.++ ..+|..+. .+++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 56678899999999999 588877655 999999999994 46777776 7999999999999999889988
Q ss_pred C--CCCCCCcEEeccCCccccccCcCCCCc-----CCccEEEeecCccceecCCcccCCCCCCeeeccccccccc--ccc
Q 002892 83 L--FNLSSLVRLDSRFNSISGNIPSKIGNL-----TKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGP--IPT 153 (870)
Q Consensus 83 ~--~~l~~L~~L~L~~n~i~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~~~ 153 (870)
+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|+|++..|..++.+++|++|++++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 7 8999999999999999966 8888877 9999999999999988889999999999999999998764 334
Q ss_pred cc--cccccceEEEeecccccc--cCCCcccCCCCccceeeecccccccccC-CcccCCCCccEEEccCCcccCCCcccc
Q 002892 154 TI--FNISTIIIINLVGNQLSG--HRPSTMGHSLPNRQFLLLWANRLTGTIP-NSITNASKLIGLDLNSNSLSGQIPNTF 228 (870)
Q Consensus 154 ~~--~~l~~L~~L~l~~N~l~~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~ 228 (870)
.+ ..+++|++|+|++|++++ ..+..++..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 44 789999999999999984 2344444567899999999999998765 55677899999999999999 677776
Q ss_pred ccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCC
Q 002892 229 GNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDS 278 (870)
Q Consensus 229 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 278 (870)
. ++|++|+|++|+|+.++ .+..+++|++|++++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~p----------~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRNP----------SPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSCC----------CTTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCCh----------hHhhCCCCCEEeccCCCCCC
Confidence 6 89999999999998752 36788999999999999875
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-27 Score=270.03 Aligned_cols=107 Identities=29% Similarity=0.378 Sum_probs=62.7
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcC
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLA 440 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 440 (870)
+|+.|++++|.++. +|.. +++|+.|+|++|.|++ +| ..+++|+.|+|++|+|+. +|. .+++|+.|+|+
T Consensus 202 ~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls 269 (622)
T 3g06_A 202 ELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVY 269 (622)
T ss_dssp TCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred hhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCC
Confidence 45555555555552 2221 2455666666666653 34 334566666666666663 333 45666677777
Q ss_pred CCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhcc
Q 002892 441 RNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILS 480 (870)
Q Consensus 441 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 480 (870)
+|+|+ .+|..|.++++|+.|+|++|.+++.+|..+..++
T Consensus 270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 77766 4566666777777777777777666666655554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-29 Score=265.13 Aligned_cols=260 Identities=20% Similarity=0.167 Sum_probs=180.3
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
..++.++++.+.+...++..+..+++|++|++++|.+++..|..++.+++|++|+|++|++++..+ +..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 346677888888875555556677789999999999987777888889999999999999886544 888889999999
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|++++. + ..++|++|++++|++++..+.. +++|++|++++|++++..+..+..+++|++|++++|++++.
T Consensus 88 s~n~l~~l-~----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (317)
T 3o53_A 88 NNNYVQEL-L----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (317)
T ss_dssp CSSEEEEE-E----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred cCCccccc-c----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence 99988743 2 2378889999999888665543 56788888888888877777888888888888888888766
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 254 (870)
.+..+...+++|++|+|++|++++. + ....+++|++|+|++|++++. |..|..+++|+.|+|++|.++.
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~-------- 228 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-------- 228 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE--------
T ss_pred cHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccc--------
Confidence 5555544455666666666666543 2 122355555555555555532 2234444555555444444443
Q ss_pred ccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCcc-ccCCchh
Q 002892 255 SFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLN-GTIPTTL 333 (870)
Q Consensus 255 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~ 333 (870)
+|..+..+++|+.|++++|.+. +.+|..+
T Consensus 229 --------------------------------------------------l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~ 258 (317)
T 3o53_A 229 --------------------------------------------------IEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258 (317)
T ss_dssp --------------------------------------------------ECTTCCCCTTCCEEECTTCCCBHHHHHHHH
T ss_pred --------------------------------------------------hhhHhhcCCCCCEEEccCCCccCcCHHHHH
Confidence 2334455666777777777776 5667777
Q ss_pred hchhhHHHHHhc
Q 002892 334 GRLQQLQALLQR 345 (870)
Q Consensus 334 ~~l~~L~~L~l~ 345 (870)
..+++|+.+.+.
T Consensus 259 ~~~~~L~~l~l~ 270 (317)
T 3o53_A 259 SKNQRVQTVAKQ 270 (317)
T ss_dssp HTCHHHHHHHHH
T ss_pred hccccceEEECC
Confidence 777777777666
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=257.08 Aligned_cols=249 Identities=23% Similarity=0.204 Sum_probs=197.3
Q ss_pred ccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccC
Q 002892 235 STLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRG 314 (870)
Q Consensus 235 ~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~ 314 (870)
++++.+++.++.++.. ..++|++|++++|.+.+ ..+..+..+++
T Consensus 14 ~~~~c~~~~l~~ip~~-----------~~~~l~~L~l~~n~i~~-------------------------~~~~~~~~~~~ 57 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVG-----------IPAASQRIFLHGNRISH-------------------------VPAASFRACRN 57 (285)
T ss_dssp CEEECCSSCCSSCCTT-----------CCTTCSEEECTTSCCCE-------------------------ECTTTTTTCTT
T ss_pred eEEEcCcCCcccCCcC-----------CCCCceEEEeeCCcCCc-------------------------cCHHHcccCCC
Confidence 4566666666654321 12456666666666654 34455666777
Q ss_pred CcEEEeeCCCccccCCchhhchhhHHHHHhcCC--CCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecC
Q 002892 315 LIALSLFTNDLNGTIPTTLGRLQQLQALLQRNN--LNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLS 392 (870)
Q Consensus 315 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~--~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 392 (870)
|++|++++|.+.+..|..|..+++|++|++++| +....|..+..+++|++|+|++|++++..|..|..+++|++|+++
T Consensus 58 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 137 (285)
T 1ozn_A 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137 (285)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECC
Confidence 777777777777766777777777777777744 444447788899999999999999998889999999999999999
Q ss_pred CCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCC
Q 002892 393 SNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEI 472 (870)
Q Consensus 393 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 472 (870)
+|.+++..+..|..+++|++|+|++|++++..+..|.++++|+.|++++|.+++..|..|..+++|+.|+|++|++++..
T Consensus 138 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 217 (285)
T 1ozn_A 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217 (285)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCC
Confidence 99999877778999999999999999999877778999999999999999999988999999999999999999999877
Q ss_pred CcchhhccccceeeccCCcccccCCCCCccccccc-ccccccccccCCC
Q 002892 473 PKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLA-QSFLWNYALCGPP 520 (870)
Q Consensus 473 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~-~~~~~n~~~c~~~ 520 (870)
+..+..+++|+.|++++|+|+|.++... +..|.. .....+...|..|
T Consensus 218 ~~~~~~l~~L~~L~l~~N~~~c~~~~~~-~~~~l~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 218 TEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSEVPCSLP 265 (285)
T ss_dssp HHHHTTCTTCCEEECCSSCEECSGGGHH-HHHHHHHCCSEECCCBEEES
T ss_pred HHHcccCcccCEEeccCCCccCCCCcHH-HHHHHHhcccccCccccCCc
Confidence 7789999999999999999999888542 223322 2234455556555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-26 Score=267.94 Aligned_cols=268 Identities=24% Similarity=0.291 Sum_probs=220.8
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
.+++.|++++|+++ .+|..+. ++|++|++++|.++ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 46899999999999 6887776 89999999999999 6776 5789999999999998 5666 7799999999
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|+++ .+|. .+++|+.|++++|+|++ +|.. +++|++|+|++|++++ +|. .+++|+.|++++|++++.
T Consensus 109 s~N~l~-~l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~l 176 (622)
T 3g06_A 109 FSNPLT-HLPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTSL 176 (622)
T ss_dssp CSCCCC-CCCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC
T ss_pred cCCcCC-CCCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCCC
Confidence 999998 4555 56889999999999994 6654 4889999999999985 343 357899999999999864
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 254 (870)
| ..+++|+.|++++|++++ +|.. .++|+.|++++|.++. +|.. +++|+.|+|++|.|+.++
T Consensus 177 -~----~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~lp------ 237 (622)
T 3g06_A 177 -P----MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLP------ 237 (622)
T ss_dssp -C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCC------
T ss_pred -c----ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCcCC------
Confidence 3 346899999999999995 4543 4789999999999984 4443 478999999999998754
Q ss_pred ccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhh
Q 002892 255 SFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLG 334 (870)
Q Consensus 255 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 334 (870)
..+++|+.|++++|+|..+++ ...+|+.|++++|+++ .+|..+.++++|+.|+|++|.+++..|..+.
T Consensus 238 ------~~l~~L~~L~Ls~N~L~~lp~-----~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 238 ------VLPSELKELMVSGNRLTSLPM-----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp ------CCCTTCCEEECCSSCCSCCCC-----CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred ------CCCCcCcEEECCCCCCCcCCc-----ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence 345789999999999997644 3457888999999888 6788889999999999999999876666554
Q ss_pred ch
Q 002892 335 RL 336 (870)
Q Consensus 335 ~l 336 (870)
.+
T Consensus 306 ~L 307 (622)
T 3g06_A 306 EI 307 (622)
T ss_dssp HH
T ss_pred hc
Confidence 44
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-29 Score=267.49 Aligned_cols=268 Identities=19% Similarity=0.177 Sum_probs=198.1
Q ss_pred cceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccc
Q 002892 160 TIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNI 239 (870)
Q Consensus 160 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 239 (870)
+++.++++.+.+..... .+...+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ |..+++|++|++
T Consensus 11 ~l~i~~ls~~~l~~~~~-~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALA-SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp EEEEESCCTTTHHHHHH-HHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred ceeEeeccccchhhhHH-HHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 34556667776653322 333456677888888888877666777777788888888887775443 777777888888
Q ss_pred cccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEE
Q 002892 240 RANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALS 319 (870)
Q Consensus 240 ~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~ 319 (870)
++|.++.++ ..++|++|++++|++.++. + ..+++|+.|+
T Consensus 88 s~n~l~~l~-------------~~~~L~~L~l~~n~l~~~~-------------------------~---~~~~~L~~L~ 126 (317)
T 3o53_A 88 NNNYVQELL-------------VGPSIETLHAANNNISRVS-------------------------C---SRGQGKKNIY 126 (317)
T ss_dssp CSSEEEEEE-------------ECTTCCEEECCSSCCSEEE-------------------------E---CCCSSCEEEE
T ss_pred cCCcccccc-------------CCCCcCEEECCCCccCCcC-------------------------c---cccCCCCEEE
Confidence 877776532 2367777777777766431 1 1246688888
Q ss_pred eeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccc-cccccceEecCCCccCC
Q 002892 320 LFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFW-SLEYILRIDLSSNSLSG 398 (870)
Q Consensus 320 L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~ 398 (870)
+++|++++..+ ..+..+++|++|+|++|++++..+..+. .+++|+.|+|++|.+++
T Consensus 127 l~~N~l~~~~~-----------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 183 (317)
T 3o53_A 127 LANNKITMLRD-----------------------LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (317)
T ss_dssp CCSSCCCSGGG-----------------------BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCCCCCCCccc-----------------------hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc
Confidence 88888875333 3455667889999999999887777764 78899999999999985
Q ss_pred CCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCccc-CCCCcchh
Q 002892 399 SLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS-GEIPKSFE 477 (870)
Q Consensus 399 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~ 477 (870)
. |. ...+++|++|+|++|+|++. |..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.++ +.+|..+.
T Consensus 184 ~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 184 V-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (317)
T ss_dssp E-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred c-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence 4 33 33588999999999999854 445888899999999999998 46778888999999999999998 67788888
Q ss_pred hccccceeeccC-CcccccCCC
Q 002892 478 ILSHLKRLNVSH-NRLEGKIPT 498 (870)
Q Consensus 478 ~l~~L~~L~ls~-N~l~~~~p~ 498 (870)
.+++|+.|++++ +.++|..|.
T Consensus 260 ~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 260 KNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TCHHHHHHHHHHHHHHHSSSSC
T ss_pred ccccceEEECCCchhccCCchh
Confidence 899999999984 456766554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-28 Score=260.97 Aligned_cols=233 Identities=19% Similarity=0.205 Sum_probs=201.4
Q ss_pred cCCCCCCCCCCCCeecCCCCccc-cCCCcccc-------CCCCCcEEEccCCcccccCCccc--cCCCCCCEEEcCCCcc
Q 002892 6 TVPPHIGNLSFLMYLDISENNFR-GYLPNELG-------QLRRLKFLGFAYNDLTGSFPSWI--GVFSKLQVLSLRNNSF 75 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~-~~~p~~~~-------~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~n~i 75 (870)
++|+.+... |+.|+|++|+++ ..+|..+. .+++|++|++++|++++.+|..+ +.+++|++|+|++|++
T Consensus 56 ~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 133 (312)
T 1wwl_A 56 ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133 (312)
T ss_dssp CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBC
T ss_pred ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCC
Confidence 456655544 999999999994 45676665 79999999999999998899876 9999999999999999
Q ss_pred ccCCCCCCCCC-----CCCcEEeccCCccccccCcCCCCcCCccEEEeecCcccee--cCCcc--cCCCCCCeeeccccc
Q 002892 76 TGPIPNSLFNL-----SSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGE--IPNEI--GNLKNLADLVLALNN 146 (870)
Q Consensus 76 ~~~~~~~~~~l-----~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~l--~~l~~L~~L~L~~n~ 146 (870)
++. |..+..+ ++|++|+|++|++++..|..|+.+++|++|++++|++.+. .+..+ ..+++|++|+|++|+
T Consensus 134 ~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~ 212 (312)
T 1wwl_A 134 ATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212 (312)
T ss_dssp SSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSC
T ss_pred cch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCc
Confidence 966 8888887 9999999999999987789999999999999999998754 23344 889999999999999
Q ss_pred ccc---cccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCC
Q 002892 147 LIG---PIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQ 223 (870)
Q Consensus 147 l~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 223 (870)
+++ .....+.++++|++|++++|++++..|...+..+++|++|+|++|+++ .+|..+. ++|++|||++|+|++.
T Consensus 213 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN 289 (312)
T ss_dssp CCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC
T ss_pred CcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC
Confidence 983 223444578999999999999998887666667899999999999999 6787776 8999999999999976
Q ss_pred Ccccccccccccccccccccccc
Q 002892 224 IPNTFGNLRHLSTLNIRANYLTT 246 (870)
Q Consensus 224 ~~~~~~~l~~L~~L~L~~N~l~~ 246 (870)
|. +..+++|++|+|++|.++.
T Consensus 290 -p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 290 -PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -CC-TTTSCEEEEEECTTCTTTC
T ss_pred -hh-HhhCCCCCEEeccCCCCCC
Confidence 65 9999999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-28 Score=280.26 Aligned_cols=185 Identities=19% Similarity=0.108 Sum_probs=131.3
Q ss_pred eeccccceeEEEEE-ecCCcEEEEEEeechh----------hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeEEE
Q 002892 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL----------ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 592 ~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 659 (870)
..+.|+.|....++ ...|+.||+|++.+.. +...+++.+|+++++++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666665554 3358999999997542 34456799999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||++|++|.+++...+. ++.. +|+.||+.||+|+| ++|||||||||+|||++++|.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999999986653 5554 48899999999999 6779999999999999999999999999998764332
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCC
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p 786 (870)
......+||++|+|||++.+ .+..++|+||+|++.+++.++..|
T Consensus 394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22344679999999999865 457789999999999888766544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-28 Score=271.73 Aligned_cols=236 Identities=20% Similarity=0.178 Sum_probs=135.7
Q ss_pred CCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccccccccc
Q 002892 183 LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTN 262 (870)
Q Consensus 183 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~ 262 (870)
+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|+.++ .
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-------------~ 97 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-------------V 97 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-------------E
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-------------C
Confidence 3456666666666665555566666666666666666654333 556666666666666655422 1
Q ss_pred ccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHH
Q 002892 263 CNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL 342 (870)
Q Consensus 263 l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 342 (870)
.++|++|++++|.+.++. + ..+++|+.|++++|.+++..|
T Consensus 98 ~~~L~~L~L~~N~l~~~~-------------------------~---~~l~~L~~L~L~~N~l~~~~~------------ 137 (487)
T 3oja_A 98 GPSIETLHAANNNISRVS-------------------------C---SRGQGKKNIYLANNKITMLRD------------ 137 (487)
T ss_dssp CTTCCEEECCSSCCCCEE-------------------------E---CCCSSCEEEECCSSCCCSGGG------------
T ss_pred CCCcCEEECcCCcCCCCC-------------------------c---cccCCCCEEECCCCCCCCCCc------------
Confidence 245555555555554321 1 123455666666666654333
Q ss_pred HhcCCCCCCCcccccCccccceeecCCcccCCCCCcccc-cccccceEecCCCccCCCCcccccCCccCCEEEccCCccC
Q 002892 343 LQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFW-SLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421 (870)
Q Consensus 343 ~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 421 (870)
..++.+++|++|+|++|.+++..|..|. .+++|+.|+|++|.+++. | .+..+++|+.|+|++|+|+
T Consensus 138 -----------~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~ 204 (487)
T 3oja_A 138 -----------LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA 204 (487)
T ss_dssp -----------BCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC
T ss_pred -----------hhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCC
Confidence 2334445666666666666665665554 566666666666666643 2 2234666666666666666
Q ss_pred CcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCccc-CCCCcchhhccccceeecc
Q 002892 422 GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS-GEIPKSFEILSHLKRLNVS 488 (870)
Q Consensus 422 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls 488 (870)
+.+| .|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+. +.+|..+..++.|+.++++
T Consensus 205 ~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 205 FMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp EECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 4333 36666666666666666664 4555666666666666666665 4555556666666666665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=264.70 Aligned_cols=193 Identities=23% Similarity=0.172 Sum_probs=124.6
Q ss_pred CCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEee
Q 002892 40 RLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFA 119 (870)
Q Consensus 40 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 119 (870)
+|++|+|++|.+++..|..|+.+++|++|+|++|.|++..| +..+++|++|+|++|.|++..+ .++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 67777777777776666777777777777777777775444 7777777777777777773322 2677777777
Q ss_pred cCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccc
Q 002892 120 DNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGT 199 (870)
Q Consensus 120 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 199 (870)
+|.|++..+. .+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..|..+...+++|+.|+|++|.+++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 7777765543 3466777777777777777777777777777777777777665555544455556666666655543
Q ss_pred cCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccc
Q 002892 200 IPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245 (870)
Q Consensus 200 ~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 245 (870)
.+ +..+++|++|+|++|.|++..| .|..+++|+.|+|++|.++
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC
T ss_pred cc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCc
Confidence 21 2235556666666666554322 2445555555555554444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-26 Score=239.08 Aligned_cols=151 Identities=23% Similarity=0.275 Sum_probs=120.5
Q ss_pred ccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCC-CcccccCCccCCEEEccCCccCCcccccccCCCCC
Q 002892 356 LSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGS-LPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDL 434 (870)
Q Consensus 356 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 434 (870)
|..+++|++|++++|++++..+..|..+++|++|++++|.+++. +|..|.++++|++|+|++|++++..+..|..+.+|
T Consensus 96 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 175 (276)
T 2z62_A 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175 (276)
T ss_dssp TTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTC
T ss_pred hcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhc
Confidence 44556777777777777766666777888888888888888753 57888888888888888888887777777777777
Q ss_pred C----EEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCccccccc
Q 002892 435 I----TLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLA 507 (870)
Q Consensus 435 ~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~ 507 (870)
+ .|++++|.+++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|++++|+|+|.+|....+..|..
T Consensus 176 ~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~~l~~~~~ 251 (276)
T 2z62_A 176 PLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 251 (276)
T ss_dssp TTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTHHHHHHHH
T ss_pred cccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchHHHHHHHH
Confidence 6 8999999998766665554 4899999999999977777789999999999999999999987655555543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-29 Score=295.84 Aligned_cols=244 Identities=11% Similarity=0.126 Sum_probs=121.8
Q ss_pred eecCCCCccccCCCccccCCCCCcEEEccCCcccc---cCCcc------------ccCCCCCCEEEcCCCccccCCCCCC
Q 002892 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTG---SFPSW------------IGVFSKLQVLSLRNNSFTGPIPNSL 83 (870)
Q Consensus 19 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~---~~~~~------------~~~l~~L~~L~L~~n~i~~~~~~~~ 83 (870)
.++++++... ..+..+..+++|+.|++++|.... ..|.. ...+++|++|+|++|.+++..+..+
T Consensus 47 ~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l 125 (594)
T 2p1m_B 47 KVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI 125 (594)
T ss_dssp EEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred EEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHH
Confidence 4555555433 122345667888888888875221 11211 2345677777777777665444444
Q ss_pred C-CCCCCcEEeccCC-ccccc-cCcCCCCcCCccEEEeecCccceecCCccc----CCCCCCeeeccccc--ccc-cccc
Q 002892 84 F-NLSSLVRLDSRFN-SISGN-IPSKIGNLTKLVHLNFADNNLRGEIPNEIG----NLKNLADLVLALNN--LIG-PIPT 153 (870)
Q Consensus 84 ~-~l~~L~~L~L~~n-~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~----~l~~L~~L~L~~n~--l~~-~~~~ 153 (870)
. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+. .+++|++|++++|. +.. .++.
T Consensus 126 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~ 205 (594)
T 2p1m_B 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALER 205 (594)
T ss_dssp HHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHH
T ss_pred HHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHH
Confidence 3 5667777777777 44422 333334667777777777776643333332 45567777777665 211 1112
Q ss_pred cccccccceEEEeecc-cccccCCCcccCCCCccceeeec-------ccccccccCCcccCCCCccEE-EccCCcccCCC
Q 002892 154 TIFNISTIIIINLVGN-QLSGHRPSTMGHSLPNRQFLLLW-------ANRLTGTIPNSITNASKLIGL-DLNSNSLSGQI 224 (870)
Q Consensus 154 ~~~~l~~L~~L~l~~N-~l~~~~~~~~~~~l~~L~~L~L~-------~n~l~~~~~~~~~~l~~L~~L-~Ls~N~i~~~~ 224 (870)
.+.++++|++|++++| .+.+ ++..+ ..+++|+.|++. .|.+.+ ++..+.++++|+.| .+.+.... .+
T Consensus 206 l~~~~~~L~~L~L~~~~~~~~-l~~~~-~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l 281 (594)
T 2p1m_B 206 LVTRCPNLKSLKLNRAVPLEK-LATLL-QRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YL 281 (594)
T ss_dssp HHHHCTTCCEEECCTTSCHHH-HHHHH-HHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GG
T ss_pred HHHhCCCCcEEecCCCCcHHH-HHHHH-hcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hH
Confidence 2233466666666666 2222 22221 234555555532 223332 22244555555555 33332221 23
Q ss_pred ccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCC
Q 002892 225 PNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSN 274 (870)
Q Consensus 225 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 274 (870)
+..+..+++|++|+|++|.++... +...+..+++|++|++++|
T Consensus 282 ~~~~~~~~~L~~L~L~~~~l~~~~-------l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 282 PAVYSVCSRLTTLNLSYATVQSYD-------LVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp GGGHHHHTTCCEEECTTCCCCHHH-------HHHHHTTCTTCCEEEEEGG
T ss_pred HHHHHhhCCCCEEEccCCCCCHHH-------HHHHHhcCCCcCEEeCcCc
Confidence 333334555555555555543211 1112334555555555544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=232.27 Aligned_cols=222 Identities=23% Similarity=0.224 Sum_probs=127.7
Q ss_pred ecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCcc
Q 002892 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSI 99 (870)
Q Consensus 20 L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i 99 (870)
++.++.+++ .+|..+. ++|++|++++|.+++..+..+..+++|++|+|++|++++..+..+.++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 444445554 3444332 3556666666666544444555566666666666666544444556666666666666666
Q ss_pred ccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccccc-ccccccccccceEEEeecccccccCCCc
Q 002892 100 SGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGP-IPTTIFNISTIIIINLVGNQLSGHRPST 178 (870)
Q Consensus 100 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 178 (870)
++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++. +|..+.++++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 555455556666666666666666544444555666666666666665542 3555666666666666666665544433
Q ss_pred ccCCCCccc----eeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccccc
Q 002892 179 MGHSLPNRQ----FLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246 (870)
Q Consensus 179 ~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 246 (870)
+. .+++|+ .|++++|++++..+..+. ..+|++|++++|++++..+..|..+++|+.|+|++|.++.
T Consensus 169 ~~-~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 169 LR-VLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp GH-HHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred hh-hhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 32 133333 566666666644444433 3367777777777776656666777777777777777664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=231.38 Aligned_cols=215 Identities=24% Similarity=0.253 Sum_probs=179.6
Q ss_pred ccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHh
Q 002892 265 KLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQ 344 (870)
Q Consensus 265 ~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 344 (870)
..+.+++++|.++.++.. ++..++.|++++|++++..+..+..+++|++|++++|+++...
T Consensus 17 ~~~~l~~~~~~l~~ip~~----~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~--------------- 77 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSN----IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP--------------- 77 (270)
T ss_dssp TTTEEECTTSCCSSCCSC----CCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC---------------
T ss_pred CCCEEEccCCCCCccCCC----CCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC---------------
Confidence 578899999999875332 2245666677777766655566666777777777766665322
Q ss_pred cCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcc
Q 002892 345 RNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNI 424 (870)
Q Consensus 345 ~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 424 (870)
+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|+|++..
T Consensus 78 --------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 78 --------AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp --------TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred --------hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 234577889999999999999888889999999999999999999888888999999999999999999887
Q ss_pred cccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccc
Q 002892 425 PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRN 504 (870)
Q Consensus 425 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~ 504 (870)
+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.++....+.+
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~~ 229 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGIIYMAK 229 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSSSHHHHH
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCccHHHHHH
Confidence 77899999999999999999988888899999999999999999977777899999999999999999999885444555
Q ss_pred cc
Q 002892 505 FL 506 (870)
Q Consensus 505 ~~ 506 (870)
|.
T Consensus 230 ~l 231 (270)
T 2o6q_A 230 WL 231 (270)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-29 Score=293.57 Aligned_cols=437 Identities=15% Similarity=0.125 Sum_probs=297.8
Q ss_pred CCCCCCCCeecCCCCcccc---CCCc------------cccCCCCCcEEEccCCcccccCCcccc-CCCCCCEEEcCCC-
Q 002892 11 IGNLSFLMYLDISENNFRG---YLPN------------ELGQLRRLKFLGFAYNDLTGSFPSWIG-VFSKLQVLSLRNN- 73 (870)
Q Consensus 11 ~~~l~~L~~L~ls~n~l~~---~~p~------------~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n- 73 (870)
+..+++|++|++++|.... ..|. ....+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus 62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~ 141 (594)
T 2p1m_B 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE 141 (594)
T ss_dssp HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence 4567899999999985321 1221 134688999999999999877777675 6899999999999
Q ss_pred ccccC-CCCCCCCCCCCcEEeccCCccccccCcCC----CCcCCccEEEeecCc--cce-ecCCcccCCCCCCeeecccc
Q 002892 74 SFTGP-IPNSLFNLSSLVRLDSRFNSISGNIPSKI----GNLTKLVHLNFADNN--LRG-EIPNEIGNLKNLADLVLALN 145 (870)
Q Consensus 74 ~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~----~~l~~L~~L~l~~N~--l~~-~~~~~l~~l~~L~~L~L~~n 145 (870)
.++.. ++..+.++++|++|+|++|.+++..+..+ ..+++|++|++++|. +.. .++..+.++++|++|++++|
T Consensus 142 ~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 56532 33344589999999999999875444333 467899999999997 321 12222345799999999999
Q ss_pred cccccccccccccccceEEEeecc-------cccccCCCcccCCCCcccee-eecccccccccCCcccCCCCccEEEccC
Q 002892 146 NLIGPIPTTIFNISTIIIINLVGN-------QLSGHRPSTMGHSLPNRQFL-LLWANRLTGTIPNSITNASKLIGLDLNS 217 (870)
Q Consensus 146 ~l~~~~~~~~~~l~~L~~L~l~~N-------~l~~~~~~~~~~~l~~L~~L-~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 217 (870)
...+.++..+..+++|++|+++.+ .+.+..+ .+ ..+++|+.| .+.+... +.++..+..+++|++|+|++
T Consensus 222 ~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~-~l-~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~ 298 (594)
T 2p1m_B 222 VPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV-AL-SGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSY 298 (594)
T ss_dssp SCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH-HH-HTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTT
T ss_pred CcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHH-HH-hcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccC
Confidence 433347888889999999996554 3433222 23 357888888 4544433 24555666789999999999
Q ss_pred CcccCCCcc-ccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhc
Q 002892 218 NSLSGQIPN-TFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYA 296 (870)
Q Consensus 218 N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l 296 (870)
|.+++.... .+..+++|+.|++++| ++... +......+++|++|+++++.-.+ ..
T Consensus 299 ~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~-------l~~l~~~~~~L~~L~L~~~~~~g----------------~~ 354 (594)
T 2p1m_B 299 ATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAG-------LEVLASTCKDLRELRVFPSEPFV----------------ME 354 (594)
T ss_dssp CCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHH-------HHHHHHHCTTCCEEEEECSCTTC----------------SS
T ss_pred CCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHH-------HHHHHHhCCCCCEEEEecCcccc----------------cc
Confidence 997743333 3568999999999998 44311 12223458899999996532110 00
Q ss_pred ccccccccCchhh-hCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecC--C----
Q 002892 297 HECKLKGSIPKEI-GNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLG--S---- 369 (870)
Q Consensus 297 ~~n~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls--~---- 369 (870)
..+.+++.....+ ..+++|+.|.++.|.+++..+..+ ...+++|+.|+|+ +
T Consensus 355 ~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l----------------------~~~~~~L~~L~L~~~~~~~~ 412 (594)
T 2p1m_B 355 PNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI----------------------ARNRPNMTRFRLCIIEPKAP 412 (594)
T ss_dssp CSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH----------------------HHHCTTCCEEEEEESSTTCC
T ss_pred cCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH----------------------HhhCCCcceeEeecccCCCc
Confidence 0111221112222 347889999888888874322211 1235778888888 4
Q ss_pred cccCCCCC-----cccccccccceEecCCCccCCCCcccccC-CccCCEEEccCCccCCcccccc-cCCCCCCEEEcCCC
Q 002892 370 NQLTSSIP-----SSFWSLEYILRIDLSSNSLSGSLPSDIQN-LKVLIYLNLSRNQLSGNIPITI-GGLKDLITLSLARN 442 (870)
Q Consensus 370 N~l~~~~~-----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N 442 (870)
|.++.... ..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|+.|+|++|
T Consensus 413 ~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n 491 (594)
T 2p1m_B 413 DYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDC 491 (594)
T ss_dssp CTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESC
T ss_pred ccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCC
Confidence 55653221 2256778999999987 666555555554 8899999999999987666555 67899999999999
Q ss_pred cccCcccc-cccCCCCCCeEecCCCcccCCCCcch-hhccccceeeccCCcccccCC
Q 002892 443 RFQDSIPD-SFGSLTSLEYLDLSNNNLSGEIPKSF-EILSHLKRLNVSHNRLEGKIP 497 (870)
Q Consensus 443 ~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p 497 (870)
.+++.... ....+++|+.|++++|+++..-...+ ..+++|+...+..+.-....|
T Consensus 492 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~~~~~ 548 (594)
T 2p1m_B 492 PFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRP 548 (594)
T ss_dssp SCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCGGGSC
T ss_pred CCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcccccc
Confidence 99765444 44568999999999999864333334 457888877777765443333
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-25 Score=230.54 Aligned_cols=215 Identities=24% Similarity=0.178 Sum_probs=182.7
Q ss_pred cccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhH
Q 002892 260 LTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQL 339 (870)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 339 (870)
+..+++++++++++|.++.+++.. +..++.|++++|.+++..+..+..+++|+.|++++|.+++..
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~----~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~---------- 71 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDL----PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ---------- 71 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCC----CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE----------
T ss_pred ccccCCccEEECCCCCCCcCCCCC----CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCccc----------
Confidence 566788999999999998765432 246777888888887777777888888888888888776422
Q ss_pred HHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCc
Q 002892 340 QALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQ 419 (870)
Q Consensus 340 ~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 419 (870)
. ...+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..|.++++|++|+|++|+
T Consensus 72 --------------~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 72 --------------V-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp --------------C-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred --------------C-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 1 146789999999999998 678889999999999999999998878899999999999999999
Q ss_pred cCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCC
Q 002892 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTN 499 (870)
Q Consensus 420 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 499 (870)
|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.+. .
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~-~ 213 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE-I 213 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG-G
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc-c
Confidence 99888888999999999999999999877788899999999999999999 788888889999999999999999874 2
Q ss_pred Ccccccc
Q 002892 500 GPFRNFL 506 (870)
Q Consensus 500 ~~~~~~~ 506 (870)
..+..|.
T Consensus 214 ~~l~~wl 220 (290)
T 1p9a_G 214 LYFRRWL 220 (290)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 3344443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=219.65 Aligned_cols=203 Identities=21% Similarity=0.228 Sum_probs=128.3
Q ss_pred CCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc
Q 002892 16 FLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR 95 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 95 (870)
..+.+++++++++ .+|..+. ++|+.|++++|++++..+..|+.+++|++|+|++|+|++..+..+.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4567777777776 4565443 567777777777775555567777777777777777764444445667777777777
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccC
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHR 175 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 175 (870)
+|++++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|+++
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--- 170 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK--- 170 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS---
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc---
Confidence 77776544555666777777777777776555556666666666666666666555545555555555555555554
Q ss_pred CCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccccc
Q 002892 176 PSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246 (870)
Q Consensus 176 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 246 (870)
+..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 171 ----------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 171 ----------------------RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp ----------------------CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ----------------------EeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 3444445556666666666666665555556666666666666666543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=223.82 Aligned_cols=222 Identities=25% Similarity=0.285 Sum_probs=166.8
Q ss_pred CCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcccccc
Q 002892 208 SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287 (870)
Q Consensus 208 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 287 (870)
.++..+++..+.+.+. ..+..+++|+.|++++|.++.+. .+..+++|++|++++|++.++
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~~----------~l~~l~~L~~L~l~~n~l~~~-------- 78 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQ----------GIQYLPNVRYLALGGNKLHDI-------- 78 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCCT----------TGGGCTTCCEEECTTSCCCCC--------
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCccccc----------ccccCCCCcEEECCCCCCCCc--------
Confidence 3455666666666532 34566777777777777766532 456677777777777766532
Q ss_pred ccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeec
Q 002892 288 SASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHL 367 (870)
Q Consensus 288 ~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~L 367 (870)
..+..+++|++|++++|.+++..+ ..|..+++|++|+|
T Consensus 79 -------------------~~l~~l~~L~~L~L~~n~l~~~~~-----------------------~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 79 -------------------SALKELTNLTYLILTGNQLQSLPN-----------------------GVFDKLTNLKELVL 116 (272)
T ss_dssp -------------------GGGTTCTTCCEEECTTSCCCCCCT-----------------------TTTTTCTTCCEEEC
T ss_pred -------------------hhhcCCCCCCEEECCCCccCccCh-----------------------hHhcCCcCCCEEEC
Confidence 245666777777777777764333 34566678888888
Q ss_pred CCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCc
Q 002892 368 GSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447 (870)
Q Consensus 368 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 447 (870)
++|++++..+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|++++..+..|+++++|+.|++++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 88888877777888888888888888888877777788888888888888888877777788888888888888888887
Q ss_pred ccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCC
Q 002892 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 448 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
.|..|..+++|+.|+|++|.+.+. +++|+.|++++|.++|.+|.
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 197 PDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred CHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 777788888888888888888754 44688888888888888886
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-24 Score=222.54 Aligned_cols=203 Identities=22% Similarity=0.208 Sum_probs=149.9
Q ss_pred CCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCc
Q 002892 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLV 90 (870)
Q Consensus 11 ~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 90 (870)
+.++++++++++++|+++ .+|..+. ++++.|++++|.+++..+..|..+++|++|+|++|.|++. +.. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCC
Confidence 677888899999999888 5666554 6888999999988877778888888999999999988853 333 7888888
Q ss_pred EEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccc
Q 002892 91 RLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQ 170 (870)
Q Consensus 91 ~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (870)
+|+|++|+++ .+|..+..+++|++|++++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 8888888887 777788888888888888888887666778888888888888888887666667777777777777777
Q ss_pred ccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCccc
Q 002892 171 LSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLS 221 (870)
Q Consensus 171 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 221 (870)
+++..+ ..+..+++|+.|+|++|+++ .+|..+....+|+.|+|++|++.
T Consensus 160 l~~l~~-~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 160 LTELPA-GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CSCCCT-TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCccCH-HHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 764332 33334555555555555555 34444555555555555555543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-24 Score=221.73 Aligned_cols=218 Identities=19% Similarity=0.167 Sum_probs=145.5
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
..+..++++++.+.+. ..+..+++|+.|++++|.++ .++ .++.+++|++|+|++|.+++ + ..+.++++|++|+|
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEEC
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEEC
Confidence 3445566666666533 23556667777777777766 333 36667777777777777763 2 35667777777777
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|++++..+..|+.+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 77777755555567777777777777777755555667777777777777777766666666777777777777777654
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccccc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 246 (870)
.+..+ ..+++|++|++++|++++..+..+..+++|++|++++|.+.+ .+++|+.|+++.|.++.
T Consensus 173 ~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g 236 (272)
T 3rfs_A 173 PEGVF-DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSG 236 (272)
T ss_dssp CTTTT-TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGG
T ss_pred CHHHh-cCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCC
Confidence 44333 346777777777777776666667777788888888887663 34567777777777765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-25 Score=249.30 Aligned_cols=186 Identities=19% Similarity=0.220 Sum_probs=146.0
Q ss_pred CCCCeeccccceeEEEEEecCCcEEEEEEeechh--------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 588 NECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
...++||+|+||.||+|. ..++.+++|+..... ....+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 345689999999999995 457889998864321 12245689999999999999999666666677788999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++++|.+++.. +..++.|+++||+||| +++|+||||||+||+++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999875 5689999999999999 666999999999999998 99999999999774422
Q ss_pred Ccc-----cccccccccccCCcccccC--CCcCcccchHhHHHHHHHHHhCCCCCC
Q 002892 740 DSV-----TQTMTMATIGYMAPEYASD--GIISPKCDVYSYGVLLMETFTRKKPTD 788 (870)
Q Consensus 740 ~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~ 788 (870)
... ......||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 111 1234579999999999986 567888999999999999888887764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=215.60 Aligned_cols=195 Identities=14% Similarity=0.155 Sum_probs=126.7
Q ss_pred eecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCc-cccCCCCCCCCCCCCcEEeccC-
Q 002892 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNS-FTGPIPNSLFNLSSLVRLDSRF- 96 (870)
Q Consensus 19 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~- 96 (870)
.+++..++++ .+|. +. .+|++|++++|++++..+..|+.+++|++|+|++|+ +++..+..|.++++|++|++++
T Consensus 15 ~~~v~c~~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~ 90 (239)
T 2xwt_C 15 DFRVTCKDIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90 (239)
T ss_dssp TTEEEECSCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEE
T ss_pred cceeEccCcc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCC
Confidence 3333333455 4665 33 378888888888876666677778888888888886 7755555777788888888887
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCC---eeecccc-cccccccccccccccce-EEEeecccc
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLA---DLVLALN-NLIGPIPTTIFNISTII-IINLVGNQL 171 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~l~~N~l 171 (870)
|++++..+..|..+++|++|++++|++++ +|. +..+++|+ +|++++| ++++..+..|.++++|+ +|++++|++
T Consensus 91 n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 91 RNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp TTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred CCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 77775555677777888888888888774 554 66777776 7777777 77666666667777777 777777776
Q ss_pred cccCCCcccCCCCccceeeecccc-cccccCCcccCC-CCccEEEccCCccc
Q 002892 172 SGHRPSTMGHSLPNRQFLLLWANR-LTGTIPNSITNA-SKLIGLDLNSNSLS 221 (870)
Q Consensus 172 ~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l-~~L~~L~Ls~N~i~ 221 (870)
+. +|...+.. ++|+.|++++|+ +++..+..|..+ ++|++|++++|+++
T Consensus 169 ~~-i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 169 TS-VQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CE-ECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred cc-cCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 63 33322222 455555555553 554444455555 55555555555555
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.9e-26 Score=246.18 Aligned_cols=81 Identities=14% Similarity=0.078 Sum_probs=37.8
Q ss_pred ecCCCCccccCCCccccCCCCCcEEEccCCcccccCC----ccccCCC-CCCEEEcCCCccccCCCCCCCCC-----CCC
Q 002892 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFP----SWIGVFS-KLQVLSLRNNSFTGPIPNSLFNL-----SSL 89 (870)
Q Consensus 20 L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l-----~~L 89 (870)
++|+.|++++.+|..+...++|++|+|++|.+++..+ +.+..++ +|++|+|++|.|++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 3455555554444444444445555555555553333 3444444 45555555555544333333332 444
Q ss_pred cEEeccCCccc
Q 002892 90 VRLDSRFNSIS 100 (870)
Q Consensus 90 ~~L~L~~n~i~ 100 (870)
++|+|++|+++
T Consensus 83 ~~L~Ls~n~l~ 93 (362)
T 3goz_A 83 TSLNLSGNFLS 93 (362)
T ss_dssp CEEECCSSCGG
T ss_pred cEEECcCCcCC
Confidence 44444444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=237.14 Aligned_cols=263 Identities=17% Similarity=0.216 Sum_probs=139.9
Q ss_pred eeecccccccccCCcccCCCCccEEEccCCcccCCCc----ccccccc-ccccccccccccccccCCCCCcccccccccc
Q 002892 189 LLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIP----NTFGNLR-HLSTLNIRANYLTTETSSNGEWSFLSSLTNC 263 (870)
Q Consensus 189 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l 263 (870)
+.++.|++++.+|..+...++|++|||++|.+++..+ +.|..++ +|++|+|++|.++..... .+...+...
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~----~l~~~l~~~ 78 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSD----ELVQILAAI 78 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHH----HHHHHHHTS
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHH----HHHHHHhcc
Confidence 3444555555555555555556666666666665554 4555555 566666666666543210 011111222
Q ss_pred -cccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCc-cCCcEEEeeCCCccccCCchhhchhhHHH
Q 002892 264 -NKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNL-RGLIALSLFTNDLNGTIPTTLGRLQQLQA 341 (870)
Q Consensus 264 -~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 341 (870)
++|++|+|++|++.+..+..+. ..+..+ ++|++|++++|++.+..+..+..
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~---------------------~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~------ 131 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELV---------------------KTLAAIPFTITVLDLGWNDFSSKSSSEFKQ------ 131 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHH---------------------HHHHTSCTTCCEEECCSSCGGGSCHHHHHH------
T ss_pred CCCccEEECcCCcCChHHHHHHH---------------------HHHHhCCCCccEEECcCCcCCcHHHHHHHH------
Confidence 5666666666665543222111 123333 56666666666665443332211
Q ss_pred HHhcCCCCCCCcccccCc-cccceeecCCcccCCCCCcc----ccccc-ccceEecCCCccCCCCccccc----CC-ccC
Q 002892 342 LLQRNNLNGPIPTCLSSL-ISLRQLHLGSNQLTSSIPSS----FWSLE-YILRIDLSSNSLSGSLPSDIQ----NL-KVL 410 (870)
Q Consensus 342 L~l~n~~~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~----~~~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L 410 (870)
.+..+ ++|++|+|++|+++...+.. +..++ +|++|+|++|++++..+..+. .+ ++|
T Consensus 132 -------------~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L 198 (362)
T 3goz_A 132 -------------AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV 198 (362)
T ss_dssp -------------HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTC
T ss_pred -------------HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCC
Confidence 12221 35666666666666433322 23333 666666666666655544333 23 467
Q ss_pred CEEEccCCccCCc----ccccccC-CCCCCEEEcCCCcccCccc----ccccCCCCCCeEecCCCcccCCCC-------c
Q 002892 411 IYLNLSRNQLSGN----IPITIGG-LKDLITLSLARNRFQDSIP----DSFGSLTSLEYLDLSNNNLSGEIP-------K 474 (870)
Q Consensus 411 ~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p-------~ 474 (870)
++|+|++|+|++. ++..+.. .++|+.|+|++|.+++..+ ..+..+++|+.|+|++|++.+..+ .
T Consensus 199 ~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~ 278 (362)
T 3goz_A 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA 278 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHT
T ss_pred CEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHH
Confidence 7777777776642 3333433 3467777777777765433 334566777777777777543322 2
Q ss_pred chhhccccceeeccCCccccc
Q 002892 475 SFEILSHLKRLNVSHNRLEGK 495 (870)
Q Consensus 475 ~~~~l~~L~~L~ls~N~l~~~ 495 (870)
.+..+++|+.||+++|++...
T Consensus 279 ~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 279 AFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp TSTTCCEEEEECTTSCBCCGG
T ss_pred HhccCCceEEEecCCCcCCCc
Confidence 455666777777777777654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-25 Score=242.55 Aligned_cols=267 Identities=18% Similarity=0.253 Sum_probs=198.2
Q ss_pred ccCCcccCCCCccEEEccCCcccCCCcc----ccccccccccccccccccccccCC--CCCcccccccccccccceEEcC
Q 002892 199 TIPNSITNASKLIGLDLNSNSLSGQIPN----TFGNLRHLSTLNIRANYLTTETSS--NGEWSFLSSLTNCNKLRALSLG 272 (870)
Q Consensus 199 ~~~~~~~~l~~L~~L~Ls~N~i~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~~~~~l~~l~~L~~L~L~ 272 (870)
.++..+..+++|++|+|++|+|++..+. .|..+++|++|+|++|.+..+... .+...+...+..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 4566677788888888888888765443 366788888888888765543211 0001122345788999999999
Q ss_pred CCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhc-hhhHHHHHhcCCCCCC
Q 002892 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGR-LQQLQALLQRNNLNGP 351 (870)
Q Consensus 273 ~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~l~n~~~~~ 351 (870)
+|++...... .+|..+..+++|+.|+|++|.+....+..+.. +..+....+..
T Consensus 103 ~n~l~~~~~~---------------------~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~----- 156 (386)
T 2ca6_A 103 DNAFGPTAQE---------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAK----- 156 (386)
T ss_dssp SCCCCTTTHH---------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHH-----
T ss_pred CCcCCHHHHH---------------------HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcc-----
Confidence 9988752110 35667888999999999999997554444432 22222111111
Q ss_pred CcccccCccccceeecCCcccC-CCCC---cccccccccceEecCCCccCC-----CCcccccCCccCCEEEccCCccC-
Q 002892 352 IPTCLSSLISLRQLHLGSNQLT-SSIP---SSFWSLEYILRIDLSSNSLSG-----SLPSDIQNLKVLIYLNLSRNQLS- 421 (870)
Q Consensus 352 ~p~~~~~l~~L~~L~Ls~N~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~- 421 (870)
..++|++|+|++|+++ ...+ ..+..+++|+.|+|++|.++. ..|..+..+++|+.|+|++|.|+
T Consensus 157 ------~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~ 230 (386)
T 2ca6_A 157 ------NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230 (386)
T ss_dssp ------TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred ------cCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCc
Confidence 1178999999999997 3444 467788999999999999983 34558889999999999999996
Q ss_pred ---CcccccccCCCCCCEEEcCCCcccCc----ccccc--cCCCCCCeEecCCCcccC----CCCcch-hhccccceeec
Q 002892 422 ---GNIPITIGGLKDLITLSLARNRFQDS----IPDSF--GSLTSLEYLDLSNNNLSG----EIPKSF-EILSHLKRLNV 487 (870)
Q Consensus 422 ---~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~l 487 (870)
+.+|..+..+++|+.|+|++|.+++. +|..+ +.+++|+.|+|++|++++ .+|..+ ..+++|+.|++
T Consensus 231 ~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l 310 (386)
T 2ca6_A 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 310 (386)
T ss_dssp HHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEEC
T ss_pred HHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEc
Confidence 56788899999999999999999876 56666 348999999999999997 478777 66899999999
Q ss_pred cCCcccccCC
Q 002892 488 SHNRLEGKIP 497 (870)
Q Consensus 488 s~N~l~~~~p 497 (870)
++|++++..|
T Consensus 311 ~~N~l~~~~~ 320 (386)
T 2ca6_A 311 NGNRFSEEDD 320 (386)
T ss_dssp TTSBSCTTSH
T ss_pred cCCcCCcchh
Confidence 9999987665
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.2e-24 Score=225.00 Aligned_cols=226 Identities=19% Similarity=0.185 Sum_probs=158.4
Q ss_pred CCCcEEEccCCccccc----CCccccCCCCCCEEEcCCCccccCCCCCC--CCCCCCcEEeccCCccccccC----cCCC
Q 002892 39 RRLKFLGFAYNDLTGS----FPSWIGVFSKLQVLSLRNNSFTGPIPNSL--FNLSSLVRLDSRFNSISGNIP----SKIG 108 (870)
Q Consensus 39 ~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~----~~~~ 108 (870)
..++.|.+.++.++.. ++. +-.+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+.
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALR-VLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHH-HHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred cceeEEEEeCCcCCHHHHHHHHH-hcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 3467777777766521 111 1123568888888888877777776 778888888888888775443 2345
Q ss_pred CcCCccEEEeecCccceecCCcccCCCCCCeeeccccccccc--c--cccccccccceEEEeecccccccCC--CcccCC
Q 002892 109 NLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGP--I--PTTIFNISTIIIINLVGNQLSGHRP--STMGHS 182 (870)
Q Consensus 109 ~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~ 182 (870)
.+++|++|+|++|++++..+..++.+++|++|+|++|++.+. + +..+..+++|++|+|++|+++...+ ..+...
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~ 222 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA 222 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence 677888888888888777777777888888888888876542 2 2233567788888888888763221 122334
Q ss_pred CCccceeeecccccccccCCcccCC---CCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccc
Q 002892 183 LPNRQFLLLWANRLTGTIPNSITNA---SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSS 259 (870)
Q Consensus 183 l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~ 259 (870)
+++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|+|+.++ .
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~----------~ 289 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAP----------Q 289 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCC----------C
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCc----------h
Confidence 6788888888888887767777666 58888888888888 5566654 78888888888888643 2
Q ss_pred cccccccceEEcCCCCCCC
Q 002892 260 LTNCNKLRALSLGSNPLDS 278 (870)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~ 278 (870)
+..+++|+.|++++|++.+
T Consensus 290 ~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 290 PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TTSCCCCSCEECSSTTTSC
T ss_pred hhhCCCccEEECcCCCCCC
Confidence 4667888888888888865
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=213.91 Aligned_cols=190 Identities=24% Similarity=0.236 Sum_probs=158.0
Q ss_pred hhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCc
Q 002892 291 FQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSN 370 (870)
Q Consensus 291 l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N 370 (870)
.+.++++++.++ .+|..+. ++++.|++++|.+.+ ..+..|..+++|++|+|++|
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~-----------------------~~~~~~~~l~~L~~L~L~~n 69 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLAT-----------------------LSDATFRGLTKLTWLNLDYN 69 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCC-----------------------CCTTTTTTCTTCCEEECTTS
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCc-----------------------cCHhHhcCcccCCEEECCCC
Confidence 344555555555 3443333 355666666666554 33455777889999999999
Q ss_pred ccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccc
Q 002892 371 QLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD 450 (870)
Q Consensus 371 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 450 (870)
+|++..+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+.
T Consensus 70 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 149 (251)
T 3m19_A 70 QLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAG 149 (251)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred cCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHH
Confidence 99999999999999999999999999988888899999999999999999988888899999999999999999988888
Q ss_pred cccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccc
Q 002892 451 SFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFL 506 (870)
Q Consensus 451 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~ 506 (870)
.|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+|.+.....+..|.
T Consensus 150 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~ 205 (251)
T 3m19_A 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWI 205 (251)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHHH
T ss_pred HcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccccHHHHHHH
Confidence 89999999999999999998888899999999999999999999866544444443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-25 Score=244.69 Aligned_cols=134 Identities=19% Similarity=0.217 Sum_probs=101.3
Q ss_pred ccCccccceeecCCcccCC-----CCCcccccccccceEecCCCccC----CCCcccccCCccCCEEEccCCccCCc---
Q 002892 356 LSSLISLRQLHLGSNQLTS-----SIPSSFWSLEYILRIDLSSNSLS----GSLPSDIQNLKVLIYLNLSRNQLSGN--- 423 (870)
Q Consensus 356 ~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~--- 423 (870)
+..+++|++|+|++|+++. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|++|+|++|+|++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 4445677777777777762 34447777888888888888885 46778888889999999999998865
Q ss_pred -ccccc--cCCCCCCEEEcCCCcccC----cccccc-cCCCCCCeEecCCCcccCCCC--cch-hhccccceeeccC
Q 002892 424 -IPITI--GGLKDLITLSLARNRFQD----SIPDSF-GSLTSLEYLDLSNNNLSGEIP--KSF-EILSHLKRLNVSH 489 (870)
Q Consensus 424 -~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~p--~~~-~~l~~L~~L~ls~ 489 (870)
++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..+ ..+ ..+++++.+++..
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~~ 339 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 339 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchhhh
Confidence 45666 448999999999999987 477777 668999999999999997664 333 3466666666644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.5e-23 Score=208.74 Aligned_cols=203 Identities=18% Similarity=0.179 Sum_probs=174.2
Q ss_pred cCCCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCc-ccccCCccccCCCCCCEEEcCC-CccccCCCCCC
Q 002892 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYND-LTGSFPSWIGVFSKLQVLSLRN-NSFTGPIPNSL 83 (870)
Q Consensus 6 ~~p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~ 83 (870)
++|+ +. ++|++|++++|++++..+..|..+++|++|++++|+ +++..+..|..+++|++|+|++ |+|++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 5666 43 389999999999998777789999999999999997 8866677899999999999999 99997767789
Q ss_pred CCCCCCcEEeccCCccccccCcCCCCcCCcc---EEEeecC-ccceecCCcccCCCCCC-eeeccccccccccccccccc
Q 002892 84 FNLSSLVRLDSRFNSISGNIPSKIGNLTKLV---HLNFADN-NLRGEIPNEIGNLKNLA-DLVLALNNLIGPIPTTIFNI 158 (870)
Q Consensus 84 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~~~~l 158 (870)
.++++|++|++++|++++ +|. |..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++. +|...+..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~-i~~~~~~~ 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNG 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCE-ECTTTTTT
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcc-cCHhhcCC
Confidence 999999999999999994 776 88888888 9999999 99977778899999999 99999999984 45444444
Q ss_pred ccceEEEeeccc-ccccCCCcccCCC-CccceeeecccccccccCCcccCCCCccEEEccCC
Q 002892 159 STIIIINLVGNQ-LSGHRPSTMGHSL-PNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSN 218 (870)
Q Consensus 159 ~~L~~L~l~~N~-l~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 218 (870)
++|+.|++++|+ +++..+..+. .+ ++|+.|++++|++++. |.. .+++|+.|+++++
T Consensus 179 ~~L~~L~L~~n~~l~~i~~~~~~-~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLTVIDKDAFG-GVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp CEEEEEECTTCTTCCEECTTTTT-TCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCCEEEcCCCCCcccCCHHHhh-ccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 899999999995 8866555554 56 9999999999999954 443 6778999999876
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=219.95 Aligned_cols=249 Identities=18% Similarity=0.104 Sum_probs=194.2
Q ss_pred CCCCCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCC-CCCCC
Q 002892 8 PPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPN-SLFNL 86 (870)
Q Consensus 8 p~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~l 86 (870)
|+.++.... +.++.++++++ .+|..+ .+++++|+|++|+|+...+..|..+++|++|+|++|+|.+.+|. .|.++
T Consensus 3 p~~~C~C~~-~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L 78 (350)
T 4ay9_X 3 HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 78 (350)
T ss_dssp CCSSSEEET-TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSC
T ss_pred CCCccEeeC-CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcc
Confidence 555555543 67899999998 678766 46899999999999955556799999999999999998765554 67889
Q ss_pred CCCcE-EeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccc-ccccccccccccccc-cceE
Q 002892 87 SSLVR-LDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLAL-NNLIGPIPTTIFNIS-TIII 163 (870)
Q Consensus 87 ~~L~~-L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~ 163 (870)
++|.+ +.+++|+++...|..|..+++|++|++++|+|+...+..+....++..|++.+ |++....+..|..+. .++.
T Consensus 79 ~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~ 158 (350)
T 4ay9_X 79 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI 158 (350)
T ss_dssp TTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEE
T ss_pred hhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhh
Confidence 88775 66778999977788899999999999999999976666777778888888865 567666666777765 6888
Q ss_pred EEeecccccccCCCcccCCCCccceeeecc-cccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccc
Q 002892 164 INLVGNQLSGHRPSTMGHSLPNRQFLLLWA-NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRAN 242 (870)
Q Consensus 164 L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N 242 (870)
|+|++|+|+...+..+. ..+|+.|++++ |.++.+.++.|..+++|++|||++|+|+.+.+..|.++++|+.+++.
T Consensus 159 L~L~~N~i~~i~~~~f~--~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~-- 234 (350)
T 4ay9_X 159 LWLNKNGIQEIHNSAFN--GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY-- 234 (350)
T ss_dssp EECCSSCCCEECTTSST--TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--
T ss_pred hccccccccCCChhhcc--ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--
Confidence 99999999865555443 56888999874 77776556678999999999999999997766778888888777653
Q ss_pred ccccccCCCCCcccccccccccccceEEcCCC
Q 002892 243 YLTTETSSNGEWSFLSSLTNCNKLRALSLGSN 274 (870)
Q Consensus 243 ~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 274 (870)
.++.+ +.+..+++|+.++++++
T Consensus 235 ~l~~l----------P~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 235 NLKKL----------PTLEKLVALMEASLTYP 256 (350)
T ss_dssp TCCCC----------CCTTTCCSCCEEECSCH
T ss_pred CcCcC----------CCchhCcChhhCcCCCC
Confidence 34443 25677888888888754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=219.97 Aligned_cols=212 Identities=19% Similarity=0.302 Sum_probs=137.3
Q ss_pred CCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
+..+.+..+.+++.+ .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++ ++. +.++++|++|+|++
T Consensus 21 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~ 94 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSG 94 (308)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccC
Confidence 344455556655332 2455667777777777776 344 46667777777777777764 333 77777777777777
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCC
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 176 (870)
|++++ + ..+..+++|++|++++|++++ ++ .+..+++|++|++++|++++..+ +..+++|++|++++|++++..+
T Consensus 95 n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~ 168 (308)
T 1h6u_A 95 NPLKN-V-SAIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP 168 (308)
T ss_dssp CCCSC-C-GGGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred CcCCC-c-hhhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh
Confidence 77763 3 256677777777777777774 33 26777777777777777765433 6666777777777777765433
Q ss_pred CcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccc
Q 002892 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTE 247 (870)
Q Consensus 177 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 247 (870)
...+++|+.|++++|++++..+ +..+++|++|+|++|++++.. .+..+++|+.|++++|.++..
T Consensus 169 ---l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 169 ---LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp ---GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred ---hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 3346666666666666664433 667777777777777777543 267777777777777777653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=220.60 Aligned_cols=225 Identities=20% Similarity=0.157 Sum_probs=186.6
Q ss_pred CCCeecCCCCccccCCCc---cccCCCCCcEEEccCCcccccCCccc--cCCCCCCEEEcCCCccccCCC----CCCCCC
Q 002892 16 FLMYLDISENNFRGYLPN---ELGQLRRLKFLGFAYNDLTGSFPSWI--GVFSKLQVLSLRNNSFTGPIP----NSLFNL 86 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~p~---~~~~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~----~~~~~l 86 (870)
.++.|+++++.++...-. .+..+++|++|++++|.+++..|..+ +.+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467888888877532111 12345679999999999999999888 999999999999999997555 345679
Q ss_pred CCCcEEeccCCccccccCcCCCCcCCccEEEeecCcccee--c--CCcccCCCCCCeeecccccccccccc----ccccc
Q 002892 87 SSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGE--I--PNEIGNLKNLADLVLALNNLIGPIPT----TIFNI 158 (870)
Q Consensus 87 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--~~~l~~l~~L~~L~L~~n~l~~~~~~----~~~~l 158 (870)
++|++|+|++|++.+..+..|+.+++|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+.++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 9999999999999988888999999999999999998642 2 3345789999999999999973 222 35688
Q ss_pred ccceEEEeecccccccCCCcccCC--CCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccc
Q 002892 159 STIIIINLVGNQLSGHRPSTMGHS--LPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLST 236 (870)
Q Consensus 159 ~~L~~L~l~~N~l~~~~~~~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~ 236 (870)
++|++|+|++|++++..|..+... +++|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 999999999999998877766543 389999999999999 6677775 7999999999999964 43 788999999
Q ss_pred cccccccccc
Q 002892 237 LNIRANYLTT 246 (870)
Q Consensus 237 L~L~~N~l~~ 246 (870)
|+|++|+++.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999875
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-24 Score=232.54 Aligned_cols=256 Identities=18% Similarity=0.233 Sum_probs=120.3
Q ss_pred CCeecCCCCccccCCCccccCC--CCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccC-CCCCCCCCCCCcEEe
Q 002892 17 LMYLDISENNFRGYLPNELGQL--RRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGP-IPNSLFNLSSLVRLD 93 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~ 93 (870)
++.||+++|++. |..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 445555555443 2334444 4555555555555433332 33445555555555554432 334444455555555
Q ss_pred ccCCccccccCcCCCCcCCccEEEeecC-cccee-cCCcccCCCCCCeeecccc-ccccc-ccccccccc-cceEEEeec
Q 002892 94 SRFNSISGNIPSKIGNLTKLVHLNFADN-NLRGE-IPNEIGNLKNLADLVLALN-NLIGP-IPTTIFNIS-TIIIINLVG 168 (870)
Q Consensus 94 L~~n~i~~~~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~l~~ 168 (870)
|++|.+++..+..++.+++|++|++++| .+++. ++..+.++++|++|++++| ++++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 5555544444444444555555555555 34421 3333444445555555555 44432 333444444 444444444
Q ss_pred ccccccCCCcccCCCCccceeeecccccc-cccCCcccCCCCccEEEccCCc-ccCCCccccccccccccccccccc-cc
Q 002892 169 NQLSGHRPSTMGHSLPNRQFLLLWANRLT-GTIPNSITNASKLIGLDLNSNS-LSGQIPNTFGNLRHLSTLNIRANY-LT 245 (870)
Q Consensus 169 N~l~~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~-i~~~~~~~~~~l~~L~~L~L~~N~-l~ 245 (870)
|.+ .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.
T Consensus 205 ~~~-----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~ 261 (336)
T 2ast_B 205 YRK-----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 261 (336)
T ss_dssp CGG-----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred Ccc-----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCC
Confidence 421 222 2234444555555555555555 444445555555555555555553 11
Q ss_pred cccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhC
Q 002892 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGN 311 (870)
Q Consensus 246 ~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~ 311 (870)
. ..+..+..+++|+.|++++| +....+..+...+..|.++.|++++..|..+++
T Consensus 262 ~--------~~~~~l~~~~~L~~L~l~~~----i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 262 P--------ETLLELGEIPTLKTLQVFGI----VPDGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp G--------GGGGGGGGCTTCCEEECTTS----SCTTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred H--------HHHHHHhcCCCCCEEeccCc----cCHHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 1 01123445555666666555 222233333344555555666666555555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=213.74 Aligned_cols=196 Identities=21% Similarity=0.299 Sum_probs=172.6
Q ss_pred CCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCc
Q 002892 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLV 90 (870)
Q Consensus 11 ~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 90 (870)
+.++++|++|++++|+++. +| .+..+++|++|++++|.+++ ++. +..+++|++|+|++|++++ ++ .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence 4568899999999999984 55 69999999999999999994 555 9999999999999999984 44 799999999
Q ss_pred EEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccc
Q 002892 91 RLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQ 170 (870)
Q Consensus 91 ~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (870)
+|+|++|++++ ++. +..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|+
T Consensus 111 ~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence 99999999985 443 9999999999999999995444 8999999999999999986544 8899999999999999
Q ss_pred ccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCC
Q 002892 171 LSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQ 223 (870)
Q Consensus 171 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 223 (870)
+++..+ ...+++|+.|+|++|++++.. .+..+++|++|++++|++++.
T Consensus 185 l~~~~~---l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 185 ISDISP---LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCCCGG---GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred cCcChh---hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 987665 356899999999999999765 389999999999999999853
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=5e-22 Score=215.26 Aligned_cols=204 Identities=17% Similarity=0.128 Sum_probs=163.6
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccC-cCCCCcCCccE-EEee
Q 002892 42 KFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIP-SKIGNLTKLVH-LNFA 119 (870)
Q Consensus 42 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~-L~l~ 119 (870)
+.++.++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 57889999999 788766 4689999999999995555679999999999999999876665 46888988775 6677
Q ss_pred cCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeec-ccccccCCCcccCCCCccceeeeccccccc
Q 002892 120 DNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVG-NQLSGHRPSTMGHSLPNRQFLLLWANRLTG 198 (870)
Q Consensus 120 ~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 198 (870)
+|+|+...|..|..+++|++|++++|++....+..+....++..|++.+ |++....+..+......++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 8999988888999999999999999999888777888888899999976 567665555555545578888999999885
Q ss_pred ccCCcccCCCCccEEEccC-CcccCCCccccccccccccccccccccccccC
Q 002892 199 TIPNSITNASKLIGLDLNS-NSLSGQIPNTFGNLRHLSTLNIRANYLTTETS 249 (870)
Q Consensus 199 ~~~~~~~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 249 (870)
+ +.......+|++|++++ |.++.+.+++|.++++|++|+|++|+|+.++.
T Consensus 169 i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~ 219 (350)
T 4ay9_X 169 I-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219 (350)
T ss_dssp E-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred C-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh
Confidence 4 44444566788888874 67776666778888888888888888887653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.6e-24 Score=228.92 Aligned_cols=252 Identities=17% Similarity=0.234 Sum_probs=182.6
Q ss_pred CCcEEEccCCcccccCCccccCC--CCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccc-cCcCCCCcCCccEE
Q 002892 40 RLKFLGFAYNDLTGSFPSWIGVF--SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGN-IPSKIGNLTKLVHL 116 (870)
Q Consensus 40 ~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L 116 (870)
.++.+++++|.+. +..+..+ ++++.|++++|.+.+..+ .+..+++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccch-hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4778888888776 4556666 778888888888875444 456778888888888887754 66667777888888
Q ss_pred EeecCccceecCCcccCCCCCCeeecccc-cccc-cccccccccccceEEEeecc-cccccCCCcccCCCCccceeeecc
Q 002892 117 NFADNNLRGEIPNEIGNLKNLADLVLALN-NLIG-PIPTTIFNISTIIIINLVGN-QLSGHRPSTMGHSLPNRQFLLLWA 193 (870)
Q Consensus 117 ~l~~N~l~~~~~~~l~~l~~L~~L~L~~n-~l~~-~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~~l~~L~~L~L~~ 193 (870)
++++|.+++..+..++.+++|++|++++| .+++ .++..+.++++|++|++++| .++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~--------------------- 182 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT--------------------- 182 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC---------------------
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC---------------------
Confidence 88888777666777777778888888777 5554 24555666666666666666 554
Q ss_pred cccccc-cCCcccCCC-CccEEEccCCc--cc-CCCccccccccccccccccccc-cccccCCCCCcccccccccccccc
Q 002892 194 NRLTGT-IPNSITNAS-KLIGLDLNSNS--LS-GQIPNTFGNLRHLSTLNIRANY-LTTETSSNGEWSFLSSLTNCNKLR 267 (870)
Q Consensus 194 n~l~~~-~~~~~~~l~-~L~~L~Ls~N~--i~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~l~~l~~L~ 267 (870)
+. ++..+..++ +|++|++++|. ++ +.++..+..+++|+.|++++|. ++.. .+..+..+++|+
T Consensus 183 ----~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~--------~~~~l~~l~~L~ 250 (336)
T 2ast_B 183 ----EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND--------CFQEFFQLNYLQ 250 (336)
T ss_dssp ----HHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGG--------GGGGGGGCTTCC
T ss_pred ----hHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHH--------HHHHHhCCCCCC
Confidence 22 455677788 99999999994 54 3557778899999999999999 5542 245788899999
Q ss_pred eEEcCCCCCCCCCCc---cccccccchhhhhcccccccccCchhhhCc-cCCcEEEeeCCCccccCCchhhc
Q 002892 268 ALSLGSNPLDSILPP---LIGNFSASFQQFYAHECKLKGSIPKEIGNL-RGLIALSLFTNDLNGTIPTTLGR 335 (870)
Q Consensus 268 ~L~L~~N~l~~~~~~---~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~ 335 (870)
+|++++|. .+.+. .+.. ...|+.|++++| ++. ..+..+ ..|..|++++|++++..|..++.
T Consensus 251 ~L~l~~~~--~~~~~~~~~l~~-~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 251 HLSLSRCY--DIIPETLLELGE-IPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp EEECTTCT--TCCGGGGGGGGG-CTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred EeeCCCCC--CCCHHHHHHHhc-CCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 99999996 33333 3444 358999999998 432 234444 34777789999999999987764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-21 Score=201.03 Aligned_cols=180 Identities=18% Similarity=0.166 Sum_probs=107.1
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
...+++++++++++ .+|..+. ++++.|+|++|.+++..+..++.+++|++|+|++|+|++..+..+.++++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 34566777777776 4555443 46666777777666555666666666666666666666555555666666666666
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|++++..+..|..+++|++|+|++|+|++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|++
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l--- 167 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQL--- 167 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC---
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcC---
Confidence 66666654455566666666666666666644444455566666666666655544443444444444444444433
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccC
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSG 222 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 222 (870)
++..+..+..+++|++|+|++|++..
T Consensus 168 ----------------------~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 168 ----------------------QSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp ----------------------SCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred ----------------------CccCHHHHhCCCCCCEEEeeCCceeC
Confidence 33444455666666666666666653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.1e-21 Score=191.59 Aligned_cols=181 Identities=20% Similarity=0.233 Sum_probs=146.8
Q ss_pred CeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCC
Q 002892 18 MYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFN 97 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 97 (870)
+.+++++++++ .+|..+ .++|++|++++|++++..+..++.+++|++|+|++|++++..+..+..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 67888888888 466544 468999999999998666677888999999999999998655556788999999999999
Q ss_pred ccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCC
Q 002892 98 SISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPS 177 (870)
Q Consensus 98 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 177 (870)
++++..+..|..+++|++|++++|+|++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 9986666668889999999999999997777778889999999999999987777778888888888888887763
Q ss_pred cccCCCCccceeeecccccccccCCcccCCCC
Q 002892 178 TMGHSLPNRQFLLLWANRLTGTIPNSITNASK 209 (870)
Q Consensus 178 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 209 (870)
.+++|++|+++.|++++.+|..++.++.
T Consensus 163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 3456777777777777777776665544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.9e-22 Score=207.97 Aligned_cols=148 Identities=15% Similarity=0.101 Sum_probs=118.4
Q ss_pred HhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhh------------------HHHHHHHHHHHHHHhcCCCce
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE------------------RAFRSFESECEVLRNVRHRNL 643 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~ni 643 (870)
.....|.+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|++++++++|
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---
Confidence 33456667799999999999999987799999999965321 235678899999999984
Q ss_pred eEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCc
Q 002892 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMT 723 (870)
Q Consensus 644 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 723 (870)
+++.+++.. +..++||||++|++|.+ +.. .....++.|++.|++||| ++||+||||||+||+++ ++.
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTE
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCc
Confidence 555554433 55699999999999988 422 124469999999999999 66799999999999999 999
Q ss_pred eEEeccccccccCCCCCcccccccccccccCCccccc
Q 002892 724 ARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760 (870)
Q Consensus 724 ~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 760 (870)
+||+|||+|.. +..|.|||++.
T Consensus 231 vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999873 34478888774
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=196.47 Aligned_cols=159 Identities=24% Similarity=0.297 Sum_probs=138.2
Q ss_pred ccceeecCCcccCCCCC-cccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEc
Q 002892 361 SLRQLHLGSNQLTSSIP-SSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSL 439 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 439 (870)
.+++|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 56899999999998755 56899999999999999999888889999999999999999999988889999999999999
Q ss_pred CCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccc-cccccccccC
Q 002892 440 ARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQ-SFLWNYALCG 518 (870)
Q Consensus 440 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~-~~~~n~~~c~ 518 (870)
++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+|.++.. .+..|... ....+...|+
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~-~l~~~~~~~~~~~~~~~C~ 191 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLA-WLGEWLRKKRIVTGNPRCQ 191 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGH-HHHHHHHHSCCBCCCCEEE
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchH-HHHHHHHhcCccccCCccC
Confidence 999999999999999999999999999999888999999999999999999999998853 23343322 1222233566
Q ss_pred CC
Q 002892 519 PP 520 (870)
Q Consensus 519 ~~ 520 (870)
.|
T Consensus 192 ~P 193 (220)
T 2v70_A 192 KP 193 (220)
T ss_dssp ES
T ss_pred CC
Confidence 55
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=195.25 Aligned_cols=139 Identities=25% Similarity=0.320 Sum_probs=132.1
Q ss_pred cccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEc
Q 002892 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSL 439 (870)
Q Consensus 360 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 439 (870)
++|+.|+|++|+|+++.+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|+...+..|.++++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 57999999999999888889999999999999999999888999999999999999999999877778999999999999
Q ss_pred CCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCC
Q 002892 440 ARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 440 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
++|.|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.+..
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 99999999999999999999999999999988888899999999999999999998874
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=214.12 Aligned_cols=134 Identities=25% Similarity=0.337 Sum_probs=70.3
Q ss_pred CCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc
Q 002892 16 FLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR 95 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 95 (870)
+|+.|+|++|++++ +|..+ +++|++|+|++|+++ .+| +.+++|++|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 55556666665553 44433 245556666666555 444 334555555555555553 444 443 55555555
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccc
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 172 (870)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|++++ +|. +. ++|+.|+|++|+|+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE 193 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC
Confidence 555553 443 34555555555555553 333 34555555555555554 333 33 45555555555554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-20 Score=188.84 Aligned_cols=146 Identities=27% Similarity=0.270 Sum_probs=134.1
Q ss_pred cccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEc
Q 002892 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSL 439 (870)
Q Consensus 360 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 439 (870)
++|++|+|++|+|++..|..|..+++|+.|+|++|+|+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 68999999999999999999999999999999999999777778899999999999999999888888999999999999
Q ss_pred CCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccc
Q 002892 440 ARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFL 506 (870)
Q Consensus 440 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~ 506 (870)
++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+|.++....+..|.
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~l~~~~ 185 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRDIMYLRNWV 185 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGGGHHHHHHH
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcchhHHHHHHH
Confidence 999998 678899999999999999999997777889999999999999999999998544455443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-20 Score=198.25 Aligned_cols=190 Identities=22% Similarity=0.239 Sum_probs=117.3
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
..+..+.+..+.+++.. .+..+++|+.|++++|.++ .++. +..+++|++|+|++|++++. +. +.++++|++|+|
T Consensus 24 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l 97 (291)
T 1h6t_A 24 AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFL 97 (291)
T ss_dssp HHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcc-cChh-HhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEEC
Confidence 34455566667666432 3456777888888888777 4443 77778888888888888743 33 777788888888
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|++++ ++ .+..+++|++|++++|++++ + ..+..+++|+.|++++|++++. ..+..+++|++|++++|++++.
T Consensus 98 ~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~ 171 (291)
T 1h6t_A 98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 171 (291)
T ss_dssp CSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred CCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccc
Confidence 8887763 33 37777778888888877774 2 3567777777777777777653 4566666666666666666543
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCccc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLS 221 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 221 (870)
.+ ...+++|+.|++++|++++. + .+..+++|+.|++++|+++
T Consensus 172 ~~---l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 172 VP---LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp GG---GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred hh---hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence 33 22234444444444444421 1 2344444444444444443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.9e-20 Score=182.67 Aligned_cols=181 Identities=22% Similarity=0.185 Sum_probs=137.6
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecC
Q 002892 42 KFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121 (870)
Q Consensus 42 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N 121 (870)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..+.++++|++|++++|++++..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 57788888888 566554 468999999999998666666888999999999999998665666788999999999999
Q ss_pred ccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccC
Q 002892 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIP 201 (870)
Q Consensus 122 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 201 (870)
++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++++..+.. +..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~l~~N~~~~--- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV-FDRLTSLQYIWLHDNPWDC--- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT-TTTCTTCCEEECCSCCBCC---
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHH-hccCCCccEEEecCCCeec---
Confidence 998666667888899999999999888777777788888888888888887544433 3346677777777776552
Q ss_pred CcccCCCCccEEEccCCcccCCCccccccccc
Q 002892 202 NSITNASKLIGLDLNSNSLSGQIPNTFGNLRH 233 (870)
Q Consensus 202 ~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~ 233 (870)
.+++|++|+++.|++++.+|.+++.++.
T Consensus 163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 3445667777777777767766665543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-20 Score=204.21 Aligned_cols=181 Identities=23% Similarity=0.206 Sum_probs=150.6
Q ss_pred hhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCccccc-CccccceeecCCc
Q 002892 292 QQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLS-SLISLRQLHLGSN 370 (870)
Q Consensus 292 ~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~-~l~~L~~L~Ls~N 370 (870)
+.+++++++++. +|..+. +.++.|+|++|++++..+ ..+. .+++|++|+|++|
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~-----------------------~~~~~~l~~L~~L~L~~N 74 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRA-----------------------EWTPTRLTNLHSLLLSHN 74 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECT-----------------------TSSSSCCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccCh-----------------------hhhhhcccccCEEECCCC
Confidence 456666666663 454443 346677777777764333 3454 7789999999999
Q ss_pred ccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccc
Q 002892 371 QLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD 450 (870)
Q Consensus 371 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 450 (870)
+|+++.+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+.
T Consensus 75 ~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 75 HLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred cCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 99988889999999999999999999987788899999999999999999988899999999999999999999986666
Q ss_pred cc---cCCCCCCeEecCCCcccCCCCcchhhccc--cceeeccCCcccccCCC
Q 002892 451 SF---GSLTSLEYLDLSNNNLSGEIPKSFEILSH--LKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 451 ~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~ls~N~l~~~~p~ 498 (870)
.| ..+++|+.|+|++|+|++..+..|..++. |+.|+|++|+|.|.+..
T Consensus 155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 66 67999999999999999776678888887 48999999999998864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.2e-20 Score=191.99 Aligned_cols=128 Identities=28% Similarity=0.366 Sum_probs=77.5
Q ss_pred cCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCE
Q 002892 357 SSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLIT 436 (870)
Q Consensus 357 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 436 (870)
..+++|++|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++. ..++.+++|+.
T Consensus 87 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 160 (291)
T 1h6t_A 87 ANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT 160 (291)
T ss_dssp TTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred ccCCCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCE
Confidence 3445566666666666532 2255666666666666666642 3456666666666666666643 45666666666
Q ss_pred EEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccc
Q 002892 437 LSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 437 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 494 (870)
|++++|.+++..| +..+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++.
T Consensus 161 L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 161 LSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp EECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred EEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 6666666665443 6666666666666666663 33 36666666677777666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.8e-19 Score=204.91 Aligned_cols=183 Identities=23% Similarity=0.313 Sum_probs=100.0
Q ss_pred CCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecc
Q 002892 64 KLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLA 143 (870)
Q Consensus 64 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~ 143 (870)
+|+.|+|++|.|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 45555555555543 444332 44555555555554 344 224455555555555553 333 333 55555555
Q ss_pred cccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCC
Q 002892 144 LNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQ 223 (870)
Q Consensus 144 ~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 223 (870)
+|++++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|++|+|++|+|+ .
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~ 194 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-S 194 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-S
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-c
Confidence 555554 333 34555555555555554 222 24566666666666664 444 44 66777777777776 3
Q ss_pred Ccccccccccc-------ccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcc
Q 002892 224 IPNTFGNLRHL-------STLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPL 283 (870)
Q Consensus 224 ~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 283 (870)
+|. |.. +| +.|+|++|.|+.++ ..+..+++|+.|+|++|++.+..|..
T Consensus 195 lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp---------~~l~~l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 195 LPA-VPV--RNHHSEETEIFFRCRENRITHIP---------ENILSLDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp CCC-CC----------CCEEEECCSSCCCCCC---------GGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred hhh-HHH--hhhcccccceEEecCCCcceecC---------HHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence 444 443 55 77777777777543 34555777888888888877764443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.2e-20 Score=212.78 Aligned_cols=200 Identities=23% Similarity=0.242 Sum_probs=135.2
Q ss_pred CCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEe
Q 002892 14 LSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLD 93 (870)
Q Consensus 14 l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 93 (870)
+..+..++++.+.+.+..+ +..+++|+.|++++|.++ .++ .++.+++|+.|+|++|+|++..+ +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3456667777777775433 567788888888888887 444 47778888888888888875433 77888888888
Q ss_pred ccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccc
Q 002892 94 SRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSG 173 (870)
Q Consensus 94 L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 173 (870)
|++|.+++ +| .+..+++|++|+|++|+|++ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 88888873 33 67788888888888888874 3 3577778888888888877754 566677777777777777765
Q ss_pred cCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccc
Q 002892 174 HRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGN 230 (870)
Q Consensus 174 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 230 (870)
..| ...+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+.....+..
T Consensus 168 ~~~---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~ 219 (605)
T 1m9s_A 168 IVP---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSN 219 (605)
T ss_dssp CGG---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred chh---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccccccc
Confidence 544 23455666666666666542 24555666666666666665433333333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-19 Score=179.11 Aligned_cols=152 Identities=22% Similarity=0.200 Sum_probs=126.5
Q ss_pred CeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCC
Q 002892 18 MYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFN 97 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 97 (870)
+.+++++++++ .+|..+. ++|+.|++++|.+++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 67888888888 5776554 68889999999888777778888889999999999888777888888888999999999
Q ss_pred ccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccc
Q 002892 98 SISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172 (870)
Q Consensus 98 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 172 (870)
+|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 888555556788888888888888888777888888888888888888888777777888888888888888775
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=177.94 Aligned_cols=155 Identities=28% Similarity=0.356 Sum_probs=131.0
Q ss_pred cceeecCCcccCCCCCcccccccccceEecCCCccCCCCcc-cccCCccCCEEEccCCccCCcccccccCCCCCCEEEcC
Q 002892 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPS-DIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLA 440 (870)
Q Consensus 362 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 440 (870)
-+.+++++|+++ .+|..+.. +|++|++++|.+++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 378999999997 55655543 899999999999976654 48999999999999999999889999999999999999
Q ss_pred CCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCccccccc-ccccccccccCC
Q 002892 441 RNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLA-QSFLWNYALCGP 519 (870)
Q Consensus 441 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~-~~~~~n~~~c~~ 519 (870)
+|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+|.++.. .+..|.. ..+.++...|+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~-~~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch-HHHHHHHHcCCCCCCCCCCC
Confidence 99999988888999999999999999999989999999999999999999999998742 3333322 234556667876
Q ss_pred C
Q 002892 520 P 520 (870)
Q Consensus 520 ~ 520 (870)
|
T Consensus 166 P 166 (192)
T 1w8a_A 166 P 166 (192)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-19 Score=178.40 Aligned_cols=155 Identities=15% Similarity=0.145 Sum_probs=130.4
Q ss_pred CCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCC-ccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc
Q 002892 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFP-SWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR 95 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 95 (870)
-+.+++++|+++ .+|..+. ..+++|+|++|++++..+ ..|+.+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 358999999998 4776553 456899999999986644 457889999999999999987777789999999999999
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
+|++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+.+.
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 9999877777788899999999999999987788889999999999999999888888888888888888888888743
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-19 Score=193.61 Aligned_cols=175 Identities=21% Similarity=0.182 Sum_probs=92.6
Q ss_pred EEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCC-CCCCCcEEeccCCccccccCcCCCCcCCccEEEeecC
Q 002892 43 FLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121 (870)
Q Consensus 43 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N 121 (870)
.++++++.++ .+|..+. ..++.|+|++|+|++..+..+. ++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4555555555 3444332 2345555555555544444444 5555555555555555444445555555555555555
Q ss_pred ccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccC
Q 002892 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIP 201 (870)
Q Consensus 122 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 201 (870)
+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++. .+
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l-------------------------~~ 153 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRF-------------------------PV 153 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSC-------------------------CG
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCee-------------------------CH
Confidence 55544444555555555555555555544444455555555555555544421 11
Q ss_pred Ccc---cCCCCccEEEccCCcccCCCccccccccc--cccccccccccc
Q 002892 202 NSI---TNASKLIGLDLNSNSLSGQIPNTFGNLRH--LSTLNIRANYLT 245 (870)
Q Consensus 202 ~~~---~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~--L~~L~L~~N~l~ 245 (870)
..| ..+++|++|||++|+|+...+..|..++. |+.|+|++|.+.
T Consensus 154 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp GGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred HHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 122 45667777777777777655566666665 366666666665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.9e-21 Score=219.24 Aligned_cols=165 Identities=25% Similarity=0.285 Sum_probs=99.9
Q ss_pred cccCchhhhCccCCcEEE-eeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCccc
Q 002892 302 KGSIPKEIGNLRGLIALS-LFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSF 380 (870)
Q Consensus 302 ~~~~~~~l~~l~~L~~L~-L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 380 (870)
.+..|..+..+++|+.|+ ++.|.+ ..|..+.+.+|....+|. ..|+.|+|++|+|++ +|. |
T Consensus 398 ~~~~~~~l~~l~~L~~L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~-lp~-~ 459 (567)
T 1dce_A 398 LLYEKETLQYFSTLKAVDPMRAAYL-----------DDLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTV-LCH-L 459 (567)
T ss_dssp GGGHHHHHHHHHHHHHHCGGGHHHH-----------HHHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSS-CCC-G
T ss_pred ccCCHHHHHHHHhcccCcchhhccc-----------chhhhhhhhcccccccCc-----cCceEEEecCCCCCC-CcC-c
Confidence 345566666666666665 444332 344444444322222221 136677777777764 344 6
Q ss_pred ccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcc-cccccCCCCCC
Q 002892 381 WSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSI-PDSFGSLTSLE 459 (870)
Q Consensus 381 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~ 459 (870)
..+++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.. |..|+.+++|+
T Consensus 460 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~ 536 (567)
T 1dce_A 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536 (567)
T ss_dssp GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred cccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCC
Confidence 67777777777777776 566677777777777777777765 44 6667777777777777776655 66677777777
Q ss_pred eEecCCCcccCCCCcc---hhhccccceeec
Q 002892 460 YLDLSNNNLSGEIPKS---FEILSHLKRLNV 487 (870)
Q Consensus 460 ~L~L~~N~l~~~~p~~---~~~l~~L~~L~l 487 (870)
.|+|++|+|++..|.. +..+++|+.|++
T Consensus 537 ~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 537 LLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp EEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 7777777776544322 233566666653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=207.40 Aligned_cols=200 Identities=23% Similarity=0.313 Sum_probs=136.1
Q ss_pred CCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcccccc
Q 002892 208 SKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287 (870)
Q Consensus 208 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 287 (870)
..+..+.++.+.+.+.. .+..+++|+.|++++|.+..++ .+..+++|+.|+|++|+|.++
T Consensus 21 ~~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~l~----------~l~~l~~L~~L~Ls~N~l~~~-------- 80 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQ----------GIQYLPNVTKLFLNGNKLTDI-------- 80 (605)
T ss_dssp HHHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCCCT----------TGGGCTTCCEEECTTSCCCCC--------
T ss_pred HHHHHHhccCCCccccc--chhcCCCCCEEECcCCCCCCCh----------HHccCCCCCEEEeeCCCCCCC--------
Confidence 44566677777776433 3567788888888888777532 466777788888877777643
Q ss_pred ccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeec
Q 002892 288 SASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHL 367 (870)
Q Consensus 288 ~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~L 367 (870)
+. +..+++|+.|+|++|++.+ + ..+..+++|++|+|
T Consensus 81 ------------------~~-l~~l~~L~~L~Ls~N~l~~-l------------------------~~l~~l~~L~~L~L 116 (605)
T 1m9s_A 81 ------------------KP-LTNLKNLGWLFLDENKIKD-L------------------------SSLKDLKKLKSLSL 116 (605)
T ss_dssp ------------------GG-GGGCTTCCEEECCSSCCCC-C------------------------TTSTTCTTCCEEEC
T ss_pred ------------------hh-hccCCCCCEEECcCCCCCC-C------------------------hhhccCCCCCEEEe
Confidence 11 5667777778877777763 1 13556677777888
Q ss_pred CCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCc
Q 002892 368 GSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDS 447 (870)
Q Consensus 368 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 447 (870)
++|+|.+. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|.|++.
T Consensus 117 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 117 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp TTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred cCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 88877753 3577777777777777777754 567777777777777777776555 77777777777777777753
Q ss_pred ccccccCCCCCCeEecCCCcccCCCCcchhhc
Q 002892 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479 (870)
Q Consensus 448 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 479 (870)
..+..+++|+.|+|++|++++.....+..+
T Consensus 191 --~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l 220 (605)
T 1m9s_A 191 --RALAGLKNLDVLELFSQECLNKPINHQSNL 220 (605)
T ss_dssp --GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred --hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence 347777777777777777775433333333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-18 Score=175.30 Aligned_cols=153 Identities=22% Similarity=0.210 Sum_probs=122.4
Q ss_pred CCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
-+.+++++++++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|+|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 567888888887 5676553 7888888888888877788888888888888888888755555678888888888888
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccc
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSG 173 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 173 (870)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 8888666666788888888888888888 677788888888888888888887666777778888888888887764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.5e-21 Score=217.30 Aligned_cols=175 Identities=22% Similarity=0.206 Sum_probs=135.7
Q ss_pred cCchhhhCccCCcEEEeeCCC-------------ccccCCchhhchhhHHHHH-hcCCCCCCCcccccCccccceeecCC
Q 002892 304 SIPKEIGNLRGLIALSLFTND-------------LNGTIPTTLGRLQQLQALL-QRNNLNGPIPTCLSSLISLRQLHLGS 369 (870)
Q Consensus 304 ~~~~~l~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-l~n~~~~~~p~~~~~l~~L~~L~Ls~ 369 (870)
.+|..++++++|+.|++++|. +.+..|..++.+++|+.|+ ++.+ .+.+|+.+.+++
T Consensus 363 ~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n----------~~~~L~~l~l~~ 432 (567)
T 1dce_A 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA----------YLDDLRSKFLLE 432 (567)
T ss_dssp HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHH----------HHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhc----------ccchhhhhhhhc
Confidence 445666666666666664443 3344455555555555554 3321 123455555666
Q ss_pred cccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCccc
Q 002892 370 NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIP 449 (870)
Q Consensus 370 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 449 (870)
|.++...+ ..|+.|+|++|.|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|.|++ +|
T Consensus 433 n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp 502 (567)
T 1dce_A 433 NSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD 502 (567)
T ss_dssp HHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG
T ss_pred ccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc
Confidence 66653322 258999999999996 676 999999999999999999 789999999999999999999997 67
Q ss_pred ccccCCCCCCeEecCCCcccCCC-CcchhhccccceeeccCCcccccCCCC
Q 002892 450 DSFGSLTSLEYLDLSNNNLSGEI-PKSFEILSHLKRLNVSHNRLEGKIPTN 499 (870)
Q Consensus 450 ~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~ 499 (870)
.|+.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|..
T Consensus 503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp -GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred -ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 8999999999999999999877 999999999999999999999988754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=8e-19 Score=173.11 Aligned_cols=154 Identities=19% Similarity=0.248 Sum_probs=75.7
Q ss_pred cCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccE
Q 002892 36 GQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVH 115 (870)
Q Consensus 36 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 115 (870)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34445555555555555 334 3455555555555555443 1224555555555555555555444555555555555
Q ss_pred EEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCccceeeecccc
Q 002892 116 LNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANR 195 (870)
Q Consensus 116 L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~ 195 (870)
|++++|++++..+..++.+++|++|++++|+..+.++ .+..+++|++|++++|++++.. . ...+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~--~-l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR--G-IEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT--T-GGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChH--H-hccCCCCCEEEeeCcc
Confidence 5555555554444455555555555555554222233 3555555555555555554322 1 1234555566666655
Q ss_pred cc
Q 002892 196 LT 197 (870)
Q Consensus 196 l~ 197 (870)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.6e-19 Score=183.91 Aligned_cols=169 Identities=19% Similarity=0.233 Sum_probs=125.1
Q ss_pred CCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEE
Q 002892 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRL 92 (870)
Q Consensus 13 ~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 92 (870)
++.++..+++++|.+++ ++ .+..+++|+.|++++|.++ .++ .++.+++|++|+|++|+|++. +. +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEE
Confidence 56778888899999884 44 5788899999999999888 566 688889999999999999854 44 8888999999
Q ss_pred eccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccc
Q 002892 93 DSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172 (870)
Q Consensus 93 ~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 172 (870)
+|++|++++ +|.. .. ++|++|++++|+|++ ++ .+..+++|+.|++++|++++. + .+..+++|++|++++|+++
T Consensus 91 ~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 999999884 4443 33 888889999988885 33 588888888888888888754 3 5777777777777777776
Q ss_pred ccCCCcccCCCCccceeeecccccc
Q 002892 173 GHRPSTMGHSLPNRQFLLLWANRLT 197 (870)
Q Consensus 173 ~~~~~~~~~~l~~L~~L~L~~n~l~ 197 (870)
+. .....+++|+.|++++|.++
T Consensus 164 ~~---~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 164 NT---GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp BC---TTSTTCCCCCEEEEEEEEEE
T ss_pred ch---HHhccCCCCCEEeCCCCccc
Confidence 44 11223444555555555544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=170.21 Aligned_cols=155 Identities=15% Similarity=0.267 Sum_probs=129.7
Q ss_pred hhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccce
Q 002892 309 IGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388 (870)
Q Consensus 309 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 388 (870)
...+++|+.|++++|.+.. +| .+..+++|++|++++|.++. +..+..+++|++
T Consensus 40 ~~~l~~L~~L~l~~n~i~~-l~------------------------~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~ 92 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVTD-LT------------------------GIEYAHNIKDLTINNIHATN--YNPISGLSNLER 92 (197)
T ss_dssp HHHHHTCCEEEEESSCCSC-CT------------------------TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCE
T ss_pred hhhcCCccEEeccCCCccC-hH------------------------HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCE
Confidence 4677889999999998872 22 24556789999999997763 347888999999
Q ss_pred EecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCc-ccCcccccccCCCCCCeEecCCCc
Q 002892 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNR-FQDSIPDSFGSLTSLEYLDLSNNN 467 (870)
Q Consensus 389 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~ 467 (870)
|++++|.+++..|..|+.+++|++|+|++|++++..|..++.+++|+.|++++|. ++. +| .+..+++|+.|++++|+
T Consensus 93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBC
T ss_pred EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCC
Confidence 9999999998788899999999999999999998888899999999999999998 664 55 69999999999999999
Q ss_pred ccCCCCcchhhccccceeeccCCcccc
Q 002892 468 LSGEIPKSFEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 468 l~~~~p~~~~~l~~L~~L~ls~N~l~~ 494 (870)
+++ ++ .+..+++|+.|++++|++.+
T Consensus 171 i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 171 VHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 985 44 78899999999999999864
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=169.06 Aligned_cols=154 Identities=24% Similarity=0.341 Sum_probs=129.6
Q ss_pred cceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCC
Q 002892 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR 441 (870)
Q Consensus 362 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 441 (870)
-+++++++|+++ .+|..+. ++|++|+|++|+++ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 367999999999 4555443 58999999999999 6789999999999999999999998889999999999999999
Q ss_pred CcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccccc-cccccccCCC
Q 002892 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSF-LWNYALCGPP 520 (870)
Q Consensus 442 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~-~~n~~~c~~~ 520 (870)
|.|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.+.. ..+..|....+ ..+...|..|
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l-~~l~~~~~~~~~~~~~~~C~~P 166 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM-QWLSDWVKSEYKEPGIARCAGP 166 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHSSCCCSCCBEEES
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC-HHHHHHHHhccCCCCCcCcCCc
Confidence 999999889999999999999999999977777899999999999999999998874 23444443322 2223455544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.9e-18 Score=176.16 Aligned_cols=153 Identities=22% Similarity=0.348 Sum_probs=128.6
Q ss_pred hhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccc
Q 002892 308 EIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYIL 387 (870)
Q Consensus 308 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 387 (870)
.+..+++|+.|++++|.+.. + + .+..+++|++|+|++|+|++..+ +..+++|+
T Consensus 36 ~~~~l~~L~~L~l~~n~i~~-l-----------------------~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~ 88 (263)
T 1xeu_A 36 SQKELSGVQNFNGDNSNIQS-L-----------------------A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLE 88 (263)
T ss_dssp CHHHHTTCSEEECTTSCCCC-C-----------------------T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCC
T ss_pred chhhcCcCcEEECcCCCccc-c-----------------------h-HHhhCCCCCEEECCCCccCCChh--hccCCCCC
Confidence 46778888888888888873 2 2 35667889999999999997655 89999999
Q ss_pred eEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCc
Q 002892 388 RIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNN 467 (870)
Q Consensus 388 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 467 (870)
.|+|++|++++ +|. +.. ++|+.|+|++|++++. ..+..+++|+.|+|++|++++. + .+..+++|+.|+|++|+
T Consensus 89 ~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 89 ELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp EEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSC
T ss_pred EEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCc
Confidence 99999999996 443 333 8999999999999864 3589999999999999999875 4 68999999999999999
Q ss_pred ccCCCCcchhhccccceeeccCCcccccC
Q 002892 468 LSGEIPKSFEILSHLKRLNVSHNRLEGKI 496 (870)
Q Consensus 468 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 496 (870)
+++. ..+..+++|+.|++++|++++..
T Consensus 162 i~~~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 162 ITNT--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp CCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred Ccch--HHhccCCCCCEEeCCCCcccCCc
Confidence 9965 77889999999999999998763
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-17 Score=162.92 Aligned_cols=137 Identities=23% Similarity=0.315 Sum_probs=119.9
Q ss_pred ccceeecCCcccCCCCCc-ccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEc
Q 002892 361 SLRQLHLGSNQLTSSIPS-SFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSL 439 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 439 (870)
+|++|+|++|+|++..+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 799999999999977775 5899999999999999999988999999999999999999999988889999999999999
Q ss_pred CCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCC
Q 002892 440 ARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 440 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
++|+|++..|..|..+++|+.|+|++|.+++..+.. .-...++...+.++...|..|.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~-~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSST
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch-HHHHHHHHcCCCCCCCCCCCCh
Confidence 999999999999999999999999999999765532 1122345556677777777775
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-18 Score=184.59 Aligned_cols=102 Identities=18% Similarity=0.158 Sum_probs=60.5
Q ss_pred ccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCC-EEEccCCccCCcccccccCCCCCCEE
Q 002892 359 LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLI-YLNLSRNQLSGNIPITIGGLKDLITL 437 (870)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 437 (870)
+++|+.|+|++|+++.+.+.+|.++.+|+.|+|++| ++.+.+.+|.++++|+ .+++.+ .++.+.+..|.++.+|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 355666666666666555566666666666666665 5545555566666666 666655 4554555556666666666
Q ss_pred EcCCCcccCcccccccCCCCCCeEe
Q 002892 438 SLARNRFQDSIPDSFGSLTSLEYLD 462 (870)
Q Consensus 438 ~Ls~N~l~~~~p~~~~~l~~L~~L~ 462 (870)
++++|.++.+.+.+|.++++|+.|+
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 6655655555555566555555554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-19 Score=211.61 Aligned_cols=192 Identities=20% Similarity=0.214 Sum_probs=114.6
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcE-----EEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCC
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKF-----LGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSL 89 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~-----L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 89 (870)
+.++.|+|++|.+.. .|..+.....|.. ++++.|.+. ..|..+..+++|++|+|++|.|. .+|..+.++++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 567888998888874 4544433333333 334444455 56778888899999999999988 678788888999
Q ss_pred cEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecc
Q 002892 90 VRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGN 169 (870)
Q Consensus 90 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N 169 (870)
++|+|++|+|+ .+|..|+.+++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|.++++|++|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 99999999998 88888888999999999999998 77888889999999999999886 66777888889999999999
Q ss_pred cccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCC
Q 002892 170 QLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSN 218 (870)
Q Consensus 170 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 218 (870)
.|++.+|..+......+..++|++|.+++.+|. .|+.|+++.|
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n 369 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD 369 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence 888877776643223334577888888877665 3556677766
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.3e-18 Score=176.21 Aligned_cols=137 Identities=21% Similarity=0.301 Sum_probs=106.3
Q ss_pred CCCCCeeccccceeEEEEEe-cCCcE--EEEEEeechhh------------------------HHHHHHHHHHHHHHhcC
Q 002892 587 FNECNLLGAGSFGSVYKGTL-FDGTN--VAIKVFNLQLE------------------------RAFRSFESECEVLRNVR 639 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~ 639 (870)
|++.+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|++.+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 68889 99999754321 11236788999999998
Q ss_pred CCce--eEEeeeeeeCCeeEEEEecCCC-C----CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC
Q 002892 640 HRNL--IKIFSSCCNLDFKALVLEFMPN-G----SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLK 712 (870)
Q Consensus 640 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 712 (870)
|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.|++|||. +.||+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 8764 334432 356899999942 3 77776543 2344677899999999999993 2359999999
Q ss_pred CCceeeCCCCceEEecccccccc
Q 002892 713 PNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 713 ~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
|.||+++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.2e-18 Score=184.90 Aligned_cols=291 Identities=13% Similarity=0.093 Sum_probs=174.0
Q ss_pred CCccCCCCCCC--CCCCCeecCCCCccccCCCccccC-CCCCcEEEccCCccc--ccCCccccCCCCCCEEEcCCCcccc
Q 002892 3 LGGTVPPHIGN--LSFLMYLDISENNFRGYLPNELGQ-LRRLKFLGFAYNDLT--GSFPSWIGVFSKLQVLSLRNNSFTG 77 (870)
Q Consensus 3 ~~~~~p~~~~~--l~~L~~L~ls~n~l~~~~p~~~~~-l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L~~n~i~~ 77 (870)
-.|+++..+.. +.+|+.|.++++ +.......+.. +++|+.|+|++|++. ...+ +.++.++.+.+..|.|.
T Consensus 11 ~~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~---~~~~~~~~~~~~~~~I~- 85 (329)
T 3sb4_A 11 KPGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKA---GTYPNGKFYIYMANFVP- 85 (329)
T ss_dssp STTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESS---SSSGGGCCEEECTTEEC-
T ss_pred CCCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcc---ccccccccccccccccC-
Confidence 45677777665 788999999875 22111123334 788999999999988 2222 23333566777777543
Q ss_pred CCCCCCCC--------CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccc--
Q 002892 78 PIPNSLFN--------LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNL-- 147 (870)
Q Consensus 78 ~~~~~~~~--------l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l-- 147 (870)
+..|.+ +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+....+.+|..+.++..+.+..+..
T Consensus 86 --~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~ 162 (329)
T 3sb4_A 86 --AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYR 162 (329)
T ss_dssp --TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHH
T ss_pred --HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhh
Confidence 456777 99999999999 88866677899999999999999999878888898888888877765322
Q ss_pred --cccccccccccccce-EEEeecccccccCCCcc---cCCCCccceeeecccccccccCCcc-cCCCCccEEEccCCcc
Q 002892 148 --IGPIPTTIFNISTII-IINLVGNQLSGHRPSTM---GHSLPNRQFLLLWANRLTGTIPNSI-TNASKLIGLDLNSNSL 220 (870)
Q Consensus 148 --~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~i 220 (870)
......+|.++..|+ .+++....- ++..+ .....+++.+.+.++-.. .....+ ..+++|++|+|++|++
T Consensus 163 ~~~~i~~~~f~~~~~L~~~i~~~~~~~---l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i 238 (329)
T 3sb4_A 163 FKNRWEHFAFIEGEPLETTIQVGAMGK---LEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNA 238 (329)
T ss_dssp TSTTTTTSCEEESCCCEEEEEECTTCC---HHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCC
T ss_pred ccccccccccccccccceeEEecCCCc---HHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCc
Confidence 233455666677766 455543221 11111 111334444444433211 111111 1245666666666666
Q ss_pred cCCCccccccccccccccccccccccccCCCCCcccccccccccccc-eEEcCCCCCCCCCCccccccccchhhhhcccc
Q 002892 221 SGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLR-ALSLGSNPLDSILPPLIGNFSASFQQFYAHEC 299 (870)
Q Consensus 221 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n 299 (870)
+.+.+.+|.++++|+.|+|.+| ++.+.. .+|.+|.+|+ .+++.+ .+..+
T Consensus 239 ~~I~~~aF~~~~~L~~l~l~~n-i~~I~~--------~aF~~~~~L~~~l~l~~-~l~~I-------------------- 288 (329)
T 3sb4_A 239 TTIPDFTFAQKKYLLKIKLPHN-LKTIGQ--------RVFSNCGRLAGTLELPA-SVTAI-------------------- 288 (329)
T ss_dssp CEECTTTTTTCTTCCEEECCTT-CCEECT--------TTTTTCTTCCEEEEECT-TCCEE--------------------
T ss_pred ceecHhhhhCCCCCCEEECCcc-cceehH--------HHhhCChhccEEEEEcc-cceEE--------------------
Confidence 6555555666666666666665 554442 2455666666 666655 33332
Q ss_pred cccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHH
Q 002892 300 KLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQ 340 (870)
Q Consensus 300 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 340 (870)
-+.+|.++++|+.+++++|++....+.+|.++++|+
T Consensus 289 -----~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~ 324 (329)
T 3sb4_A 289 -----EFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSK 324 (329)
T ss_dssp -----CTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCC
T ss_pred -----chhhhhCCccCCEEEeCCCccCccchhhhcCCcchh
Confidence 223455555556666555655555555555555544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-18 Score=202.58 Aligned_cols=159 Identities=26% Similarity=0.287 Sum_probs=127.3
Q ss_pred CCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCcccccc
Q 002892 24 ENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNI 103 (870)
Q Consensus 24 ~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 103 (870)
.|.+. ..|+.+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+
T Consensus 210 ~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 210 ENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred cccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 33444 45788999999999999999999 78888889999999999999999 89999999999999999999999 88
Q ss_pred CcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccccccccccccccc-ceEEEeecccccccCCCcccCC
Q 002892 104 PSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIST-IIIINLVGNQLSGHRPSTMGHS 182 (870)
Q Consensus 104 ~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~~ 182 (870)
|..|+.+++|++|+|++|.|+ .+|..|+++++|+.|+|++|++++.+|..+..+.. +..|+|++|.+++..|.
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~----- 359 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH----- 359 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----
T ss_pred ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc-----
Confidence 999999999999999999998 78888999999999999999999999998877643 34589999999987765
Q ss_pred CCccceeeeccc
Q 002892 183 LPNRQFLLLWAN 194 (870)
Q Consensus 183 l~~L~~L~L~~n 194 (870)
.|..|+++.|
T Consensus 360 --~l~~l~l~~n 369 (727)
T 4b8c_D 360 --ERRFIEINTD 369 (727)
T ss_dssp --C---------
T ss_pred --ccceeEeecc
Confidence 4567777777
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=5.9e-17 Score=156.69 Aligned_cols=142 Identities=26% Similarity=0.291 Sum_probs=123.3
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcC
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLA 440 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 440 (870)
+.+.+++++|+++.. |..+. ++|+.|++++|++++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 8 ~~~~l~~~~~~l~~~-p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSV-PTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp ETTEEECCSSCCSSC-CTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCCccC-CCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 457899999999854 44332 689999999999998777788999999999999999998877889999999999999
Q ss_pred CCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCccccc
Q 002892 441 RNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNF 505 (870)
Q Consensus 441 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~ 505 (870)
+|.+++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+++|.+|....+..|
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l~~l~~~ 149 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 149 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHHHHHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCccHHHHHHH
Confidence 99999888888999999999999999999777777899999999999999999988854444444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.7e-17 Score=155.95 Aligned_cols=134 Identities=22% Similarity=0.276 Sum_probs=121.6
Q ss_pred cccceeecCCcccC-CCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEE
Q 002892 360 ISLRQLHLGSNQLT-SSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438 (870)
Q Consensus 360 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 438 (870)
++|++|+|++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 68999999999998 77888899999999999999999965 7899999999999999999987888888899999999
Q ss_pred cCCCcccCcc-cccccCCCCCCeEecCCCcccCCCC---cchhhccccceeeccCCccccc
Q 002892 439 LARNRFQDSI-PDSFGSLTSLEYLDLSNNNLSGEIP---KSFEILSHLKRLNVSHNRLEGK 495 (870)
Q Consensus 439 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~ls~N~l~~~ 495 (870)
|++|.+++.. +..+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.++..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 9999999753 3789999999999999999996555 4899999999999999998643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=5.7e-17 Score=151.93 Aligned_cols=129 Identities=21% Similarity=0.282 Sum_probs=117.7
Q ss_pred ccccceeecCCcccC-CCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEE
Q 002892 359 LISLRQLHLGSNQLT-SSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITL 437 (870)
Q Consensus 359 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 437 (870)
.++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|+.|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 478999999999998 78888999999999999999999965 789999999999999999998789888889999999
Q ss_pred EcCCCcccCc-ccccccCCCCCCeEecCCCcccCCCC---cchhhccccceeeccC
Q 002892 438 SLARNRFQDS-IPDSFGSLTSLEYLDLSNNNLSGEIP---KSFEILSHLKRLNVSH 489 (870)
Q Consensus 438 ~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~ls~ 489 (870)
++++|.+++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999974 45889999999999999999997665 5799999999999874
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3.9e-16 Score=170.73 Aligned_cols=251 Identities=12% Similarity=0.152 Sum_probs=159.6
Q ss_pred ccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCC
Q 002892 199 TIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDS 278 (870)
Q Consensus 199 ~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 278 (870)
+...+|.++ +|+.+++..| ++.+...+|.+. +|+.+.+.. .++.+.. .+|.+|++|+.+++++|.+..
T Consensus 127 I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~--------~aF~~c~~L~~l~l~~n~l~~ 194 (401)
T 4fdw_A 127 IPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKE--------DIFYYCYNLKKADLSKTKITK 194 (401)
T ss_dssp ECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECS--------STTTTCTTCCEEECTTSCCSE
T ss_pred ehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehH--------HHhhCcccCCeeecCCCcceE
Confidence 344445543 4555555544 444445555552 455555553 3443332 245555666666666555554
Q ss_pred CCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccC
Q 002892 279 ILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSS 358 (870)
Q Consensus 279 ~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~ 358 (870)
+....|. ..+|+.+.+..+ +..+...+|.++.+|+.+.+.+++...-..+|.+
T Consensus 195 I~~~aF~--------------------------~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~ 247 (401)
T 4fdw_A 195 LPASTFV--------------------------YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRE 247 (401)
T ss_dssp ECTTTTT--------------------------TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTTCCEECTTTTTT
T ss_pred echhhEe--------------------------ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCCccCcccccccc
Confidence 4333222 123444444322 3333334444444444444444443334455655
Q ss_pred ccccceeecCCcccCCCCCcccccccccceEecCCCccC-----CCCcccccCCccCCEEEccCCccCCcccccccCCCC
Q 002892 359 LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLS-----GSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKD 433 (870)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 433 (870)
.+|+.+.+ .|.++.+...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. |.++.+....|.++.+
T Consensus 248 -~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~ 324 (401)
T 4fdw_A 248 -SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRK 324 (401)
T ss_dssp -CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCS
T ss_pred -CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCC
Confidence 67888888 56677777888888889999988887765 4566788899999999998 4577677788999999
Q ss_pred CCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhcc-ccceeeccCCccc
Q 002892 434 LITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILS-HLKRLNVSHNRLE 493 (870)
Q Consensus 434 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~ 493 (870)
|+.++|..| ++.+.+.+|.++ +|+.|++++|.+....+..|.+++ .++.|++..|.+.
T Consensus 325 L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 325 VTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred ccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 999999655 666777889998 899999999988877777787774 6788888777643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.2e-16 Score=150.89 Aligned_cols=127 Identities=21% Similarity=0.308 Sum_probs=92.1
Q ss_pred CeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCC
Q 002892 18 MYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFN 97 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 97 (870)
+.+++++|+++ .+|..+. ++|++|++++|.++ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 56788888877 4665543 57778888888777 66777777777777777777777666666777777777777777
Q ss_pred ccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccc
Q 002892 98 SISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLI 148 (870)
Q Consensus 98 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~ 148 (870)
+|++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777666667777777777777777777555556667777777777776664
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.65 E-value=2e-15 Score=166.15 Aligned_cols=335 Identities=12% Similarity=0.086 Sum_probs=168.4
Q ss_pred cccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccccccccc
Q 002892 75 FTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTT 154 (870)
Q Consensus 75 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 154 (870)
++.....+|.++++|+.+.+..+ ++.+...+|.++++|+.+++.++ ++.....+|.++++|+.+.+..+ +......+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 44444456677777777777633 55444556777777777777644 45455566677777776665533 33333444
Q ss_pred ccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccc
Q 002892 155 IFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHL 234 (870)
Q Consensus 155 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L 234 (870)
|.++..+....... +......+|.++++|+.+.+.++... +...+|.++.+|
T Consensus 136 F~~~~~~~~~~~~~---------------------------~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L 187 (394)
T 4fs7_A 136 FKGCDFKEITIPEG---------------------------VTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKL 187 (394)
T ss_dssp TTTCCCSEEECCTT---------------------------CCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTC
T ss_pred eecccccccccCcc---------------------------ccccchhhhcccCCCcEEecCCccce-eccccccCCCCc
Confidence 44433222211111 11123345555566666666544322 445555666666
Q ss_pred ccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccC
Q 002892 235 STLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRG 314 (870)
Q Consensus 235 ~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~ 314 (870)
+.+.+..| ++.+.. .++..+..|+.+.+..+... + ........+
T Consensus 188 ~~i~l~~~-~~~I~~--------~~F~~~~~L~~i~~~~~~~~-i--------------------------~~~~~~~~~ 231 (394)
T 4fs7_A 188 KSIKLPRN-LKIIRD--------YCFAECILLENMEFPNSLYY-L--------------------------GDFALSKTG 231 (394)
T ss_dssp CBCCCCTT-CCEECT--------TTTTTCTTCCBCCCCTTCCE-E--------------------------CTTTTTTCC
T ss_pred eEEEcCCC-ceEeCc--------hhhccccccceeecCCCceE-e--------------------------ehhhcccCC
Confidence 66655544 333221 23445555555544433211 0 011111223
Q ss_pred CcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCC
Q 002892 315 LIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSN 394 (870)
Q Consensus 315 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 394 (870)
|+.+.+..+ +.......|..+..|+.+.+.++........|.....++.+....+.+ ....|..+.+|+.+.+.++
T Consensus 232 l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~ 307 (394)
T 4fs7_A 232 VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS 307 (394)
T ss_dssp CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT
T ss_pred CceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee---ccccccccccccccccccc
Confidence 333333221 111222222222222222222222222333445555566555554432 2345666667777766654
Q ss_pred ccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCc
Q 002892 395 SLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK 474 (870)
Q Consensus 395 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 474 (870)
++.+...+|.++++|+.++|.++ ++.+....|.++.+|+.+++..| ++.+...+|.++++|+.+++..+ ++ .+..
T Consensus 308 -i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~ 382 (394)
T 4fs7_A 308 -VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRY 382 (394)
T ss_dssp -CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGG
T ss_pred -cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehhh
Confidence 44355556667777777777543 55455566777777777777665 55555666777777777777544 33 3345
Q ss_pred chhhcccccee
Q 002892 475 SFEILSHLKRL 485 (870)
Q Consensus 475 ~~~~l~~L~~L 485 (870)
.|.+.++|+.+
T Consensus 383 ~F~~c~~L~~I 393 (394)
T 4fs7_A 383 DFEDTTKFKWI 393 (394)
T ss_dssp GBCTTCEEEEE
T ss_pred eecCCCCCcEE
Confidence 56666666543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.2e-16 Score=148.63 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=73.1
Q ss_pred CCCcEEeccCCccc-cccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEE
Q 002892 87 SSLVRLDSRFNSIS-GNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIIN 165 (870)
Q Consensus 87 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 165 (870)
++|++|++++|.++ +.+|..+..+++|++|++++|.|++. ..+..+++|++|++++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34444555555444 34444445555555555555555532 4455555555555555555544444444455555555
Q ss_pred eecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCc---ccccccccccccccccc
Q 002892 166 LVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIP---NTFGNLRHLSTLNIRAN 242 (870)
Q Consensus 166 l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~---~~~~~l~~L~~L~L~~N 242 (870)
+++|++++.. .+..+..+++|++|++++|++++..+ ..|..+++|++|++++|
T Consensus 102 Ls~N~l~~~~------------------------~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n 157 (168)
T 2ell_A 102 LSGNKLKDIS------------------------TLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157 (168)
T ss_dssp CBSSSCCSSG------------------------GGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred ccCCccCcch------------------------hHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence 5555544211 11345566667777777777765444 35667777777777777
Q ss_pred cccccc
Q 002892 243 YLTTET 248 (870)
Q Consensus 243 ~l~~~~ 248 (870)
.+..++
T Consensus 158 ~~~~~~ 163 (168)
T 2ell_A 158 EDQEAP 163 (168)
T ss_dssp TSCBCC
T ss_pred Chhhcc
Confidence 666544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-14 Score=159.40 Aligned_cols=251 Identities=12% Similarity=0.083 Sum_probs=153.1
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
..++.+.+.+ +++.....+|.+. +|+.+.+..+ ++......|.+ .+|+.+.+.. .++...+..|.++++|+.++|
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4555666543 3444445566664 5777777665 55444555555 3577777765 555455566777777777777
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|+++......|. ..+|+.+.|..+ ++.....+|.++++|+.+++..| ++.+...+|.+ .+|+.+++. |.++.
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~- 261 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN- 261 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE-
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE-
Confidence 77777644444455 467777777643 55556667777777777777654 45455555555 667777773 33443
Q ss_pred CCCcccCCCCccceeeecccccc-----cccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccC
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLT-----GTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETS 249 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 249 (870)
++...+..+++|+.+.+.+|.+. .+.+.+|.++++|+.++|. +.++.+...+|.++++|+.+.|..| ++.+..
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~ 339 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF 339 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence 23333345666777777666554 3556667777777777777 3466566667777777777777544 554432
Q ss_pred CCCCcccccccccccccceEEcCCCCCCCCCCcccccc
Q 002892 250 SNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNF 287 (870)
Q Consensus 250 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~ 287 (870)
.+|.++ +|+.+++++|.+..+.+..|.++
T Consensus 340 --------~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~ 368 (401)
T 4fdw_A 340 --------SAFNNT-GIKEVKVEGTTPPQVFEKVWYGF 368 (401)
T ss_dssp --------TSSSSS-CCCEEEECCSSCCBCCCSSCCCS
T ss_pred --------HhCCCC-CCCEEEEcCCCCcccccccccCC
Confidence 256666 77777777776665544444433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-16 Score=148.60 Aligned_cols=126 Identities=21% Similarity=0.168 Sum_probs=60.0
Q ss_pred CCCCeecCCCCccc-cCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEe
Q 002892 15 SFLMYLDISENNFR-GYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLD 93 (870)
Q Consensus 15 ~~L~~L~ls~n~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 93 (870)
++|++|++++|+++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|+|++|.|++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 44555555555554 34444455555555555555555532 4445555555555555555533444444445555555
Q ss_pred ccCCccccc-cCcCCCCcCCccEEEeecCccceecC---CcccCCCCCCeeec
Q 002892 94 SRFNSISGN-IPSKIGNLTKLVHLNFADNNLRGEIP---NEIGNLKNLADLVL 142 (870)
Q Consensus 94 L~~n~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~---~~l~~l~~L~~L~L 142 (870)
+++|++++. .+..++.+++|++|++++|.+++..+ ..+..+++|+.|++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 555554421 12344444445555555554443222 23444444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.62 E-value=8e-16 Score=147.23 Aligned_cols=118 Identities=25% Similarity=0.276 Sum_probs=93.9
Q ss_pred cceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCC
Q 002892 386 ILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSN 465 (870)
Q Consensus 386 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 465 (870)
.+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456777777777 4665553 6788888888888887788888888888888888888887777788888899999999
Q ss_pred CcccCCCCcchhhccccceeeccCCcccccCCCCCcccccc
Q 002892 466 NNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFL 506 (870)
Q Consensus 466 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~ 506 (870)
|+|++..+..|..+++|+.|+|++|+|+|.++....+..|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l~~l~~~l 128 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDILYLSRWI 128 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGGHHHHHHH
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhHHHHHHHH
Confidence 99887667778888999999999999988887544444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-15 Score=144.38 Aligned_cols=131 Identities=18% Similarity=0.136 Sum_probs=86.7
Q ss_pred CCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccC
Q 002892 17 LMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRF 96 (870)
Q Consensus 17 L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 96 (870)
.+.+++++++++ .+|..+ .++|++|++++|++++..+..++.+++|++|+|++|+|++..+..+..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 466777777776 455433 35777777777777755555667777777777777777754444567777777777777
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccccc
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGP 150 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 150 (870)
|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+.+.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 777755555566677777777777777754454556666777777776666543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.61 E-value=9e-16 Score=148.10 Aligned_cols=134 Identities=20% Similarity=0.222 Sum_probs=116.2
Q ss_pred cccCccccceeecCCcccCCCCCccccccc-ccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCC
Q 002892 355 CLSSLISLRQLHLGSNQLTSSIPSSFWSLE-YILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKD 433 (870)
Q Consensus 355 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 433 (870)
.+...++|++|+|++|+++.. |. +..+. +|+.|++++|.+++. ..|..+++|++|+|++|+|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 356678999999999999954 54 55554 999999999999965 68999999999999999999766666799999
Q ss_pred CCEEEcCCCcccCcccc--cccCCCCCCeEecCCCcccCCCCcc----hhhccccceeeccCCcccc
Q 002892 434 LITLSLARNRFQDSIPD--SFGSLTSLEYLDLSNNNLSGEIPKS----FEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 434 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~ls~N~l~~ 494 (870)
|+.|+|++|.|+. +|. .+..+++|+.|+|++|.++ .+|.. +..+++|+.||+++|....
T Consensus 90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999999999975 555 8999999999999999998 56664 8999999999999998764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-16 Score=168.79 Aligned_cols=139 Identities=11% Similarity=0.083 Sum_probs=100.3
Q ss_pred CCCCCCeeccccceeEEEEEecCCcEEEEEEeechhh----------------------HHHHHHHHHHHHHHhcCCCce
Q 002892 586 GFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLE----------------------RAFRSFESECEVLRNVRHRNL 643 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~ni 643 (870)
-|++.+.||+|++|.||+|...+|+.||||+++.... ........|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4889999999999999999988999999999753210 001112346666666654443
Q ss_pred eEEeeeeeeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-
Q 002892 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM- 722 (870)
Q Consensus 644 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~- 722 (870)
....-+.. ...++||||++|+++.++... .....++.|++.++.+|| +.|||||||||.|||+++++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence 21111111 234799999999888654321 133568899999999999 56799999999999998776
Q ss_pred ---------ceEEeccccccccC
Q 002892 723 ---------TARVSDFGISKLLG 736 (870)
Q Consensus 723 ---------~~kl~Dfg~a~~~~ 736 (870)
.+.|+||+-+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999876553
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=144.27 Aligned_cols=116 Identities=24% Similarity=0.281 Sum_probs=83.0
Q ss_pred ceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCC
Q 002892 387 LRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466 (870)
Q Consensus 387 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 466 (870)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666665 4555553 67777777777777777777777777777788877777766666777888888888888
Q ss_pred cccCCCCcchhhccccceeeccCCcccccCCCCCccccc
Q 002892 467 NLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNF 505 (870)
Q Consensus 467 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~ 505 (870)
+|++..+..|..+++|+.|+|++|+|.|.++....+..|
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~~~l~~~ 130 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYLRNW 130 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGGHHHHHH
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccccHHHHHHH
Confidence 887655556777888888888888888776644444444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.7e-14 Score=155.20 Aligned_cols=336 Identities=12% Similarity=0.024 Sum_probs=197.8
Q ss_pred ccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCc
Q 002892 26 NFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPS 105 (870)
Q Consensus 26 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 105 (870)
.++.....+|.++.+|+.+.+..+ ++......|.++++|+.++|.++ ++......|.++.+|+.+.+..+ +......
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 355455567888888888888644 66455667888888888888765 55455567888888888777755 3335556
Q ss_pred CCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCc
Q 002892 106 KIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPN 185 (870)
Q Consensus 106 ~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 185 (870)
+|..+..++.... +.+......+|.++++|+.+.+.++. ......+|.++.+|+.+++..| ++ .
T Consensus 135 aF~~~~~~~~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~-~----------- 198 (394)
T 4fs7_A 135 AFKGCDFKEITIP--EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LK-I----------- 198 (394)
T ss_dssp TTTTCCCSEEECC--TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CC-E-----------
T ss_pred eeecccccccccC--ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ce-E-----------
Confidence 6776654433332 22333456678888888888887553 4455667777777777776654 22 1
Q ss_pred cceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccc
Q 002892 186 RQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNK 265 (870)
Q Consensus 186 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~ 265 (870)
+....|.++..|+.+.+..+... +.+.+....+|+.+.+..+ ++.+. ...+..+..
T Consensus 199 -------------I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~--------~~~f~~~~~ 254 (394)
T 4fs7_A 199 -------------IRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELG--------KSVFYGCTD 254 (394)
T ss_dssp -------------ECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEEC--------SSTTTTCSS
T ss_pred -------------eCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecc--------ccccccccc
Confidence 22233444444444444433222 1111222233444443321 11111 113444555
Q ss_pred cceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhc
Q 002892 266 LRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR 345 (870)
Q Consensus 266 L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 345 (870)
|+.+.+..+... .....+.....++.+....+.+.
T Consensus 255 l~~~~~~~~~~~--------------------------i~~~~F~~~~~l~~~~~~~~~i~------------------- 289 (394)
T 4fs7_A 255 LESISIQNNKLR--------------------------IGGSLFYNCSGLKKVIYGSVIVP------------------- 289 (394)
T ss_dssp CCEEEECCTTCE--------------------------ECSCTTTTCTTCCEEEECSSEEC-------------------
T ss_pred ceeEEcCCCcce--------------------------eeccccccccccceeccCceeec-------------------
Confidence 555555443211 11223444445555544433221
Q ss_pred CCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCccc
Q 002892 346 NNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIP 425 (870)
Q Consensus 346 n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 425 (870)
...|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++++|+.+++..| ++.+..
T Consensus 290 -------~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~ 359 (394)
T 4fs7_A 290 -------EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGA 359 (394)
T ss_dssp -------TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECT
T ss_pred -------cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehH
Confidence 123455566777777554 65566777888888888888654 55456677888888888888766 665667
Q ss_pred ccccCCCCCCEEEcCCCcccCcccccccCCCCCCeE
Q 002892 426 ITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYL 461 (870)
Q Consensus 426 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 461 (870)
..|.++.+|+.+++..+ ++ ....+|.++++|+.+
T Consensus 360 ~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 360 NAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred HHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 78888888888888755 33 345678888877764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.9e-17 Score=162.00 Aligned_cols=162 Identities=23% Similarity=0.304 Sum_probs=119.2
Q ss_pred hhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccce
Q 002892 309 IGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388 (870)
Q Consensus 309 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 388 (870)
+.....++.++++.+.+.+..|. ...+|..+..+++|++|+|++|++++ +| .+..+++|+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~-----------------l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~ 74 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPP-----------------IEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRI 74 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTT-----------------CCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCE
T ss_pred HHhcccccCcchheeEeccccCc-----------------HhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCE
Confidence 44455666667777777654442 12344467777888888888888886 45 7888888888
Q ss_pred EecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCccc-ccccCCCCCCeEecCCCc
Q 002892 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIP-DSFGSLTSLEYLDLSNNN 467 (870)
Q Consensus 389 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~ 467 (870)
|++++|.++ .+|..+..+++|++|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.
T Consensus 75 L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp EEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred EECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 888888888 567777777888888888888885 44 57788888888888888875433 467888888888888888
Q ss_pred ccCCCCcc----------hhhccccceeeccCCcccc
Q 002892 468 LSGEIPKS----------FEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 468 l~~~~p~~----------~~~l~~L~~L~ls~N~l~~ 494 (870)
+++..|.. +..+++|+.|| +|+++.
T Consensus 152 l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 152 LYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred cccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 87665542 77788888776 676653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.3e-15 Score=144.13 Aligned_cols=133 Identities=16% Similarity=0.189 Sum_probs=69.5
Q ss_pred ccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCcCCcc
Q 002892 35 LGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLV 114 (870)
Q Consensus 35 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 114 (870)
+..+.+|+.|++++|+++ .+|......++|++|+|++|.|++. ..+..+++|++|+|++|+|++..+..+..+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 444555555555555555 3333222223555666666555532 4555555666666666665533223335556666
Q ss_pred EEEeecCccceecCC--cccCCCCCCeeecccccccccccc----cccccccceEEEeeccccc
Q 002892 115 HLNFADNNLRGEIPN--EIGNLKNLADLVLALNNLIGPIPT----TIFNISTIIIINLVGNQLS 172 (870)
Q Consensus 115 ~L~l~~N~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~l~~N~l~ 172 (870)
+|++++|+|+ .+|. .+..+++|+.|++++|.++. .|. .+..+++|+.||+++|.+.
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 6666666655 3333 45555566666666665552 233 2555555555555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=3e-17 Score=161.97 Aligned_cols=136 Identities=23% Similarity=0.302 Sum_probs=81.4
Q ss_pred CCCCCCCeecCCCCccccCCCc------cccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCC
Q 002892 12 GNLSFLMYLDISENNFRGYLPN------ELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFN 85 (870)
Q Consensus 12 ~~l~~L~~L~ls~n~l~~~~p~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 85 (870)
.....++.++++.+.+.+..|. .+..+++|++|++++|.+++ +| .++.+++|++|+|++|+|+ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3445666777777777666554 56666666666666666663 45 5666666666666666666 45555555
Q ss_pred CCCCcEEeccCCccccccCcCCCCcCCccEEEeecCccceecC-CcccCCCCCCeeeccccccccccc
Q 002892 86 LSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIP-NEIGNLKNLADLVLALNNLIGPIP 152 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~ 152 (870)
+++|++|+|++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 5666666666666653 33 35556666666666666663221 345556666666666666654433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=7.1e-14 Score=133.60 Aligned_cols=109 Identities=25% Similarity=0.239 Sum_probs=98.7
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcC
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLA 440 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 440 (870)
..+.+++++|+++. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 46789999999995 565553 889999999999998889999999999999999999998888889999999999999
Q ss_pred CCcccCcccccccCCCCCCeEecCCCcccCCC
Q 002892 441 RNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEI 472 (870)
Q Consensus 441 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 472 (870)
+|+|++..+..|..+++|+.|+|++|.++...
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99999888888999999999999999998543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=5.5e-14 Score=134.78 Aligned_cols=113 Identities=21% Similarity=0.205 Sum_probs=99.1
Q ss_pred cceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCC
Q 002892 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR 441 (870)
Q Consensus 362 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 441 (870)
-+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 468999999998 5566554 8999999999999988899999999999999999999987777889999999999999
Q ss_pred CcccCcccccccCCCCCCeEecCCCcccCCCCcchhh
Q 002892 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEI 478 (870)
Q Consensus 442 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 478 (870)
|+|++..+..|..+++|+.|+|++|.+. ..+..+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~~~ 126 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDIMY 126 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGGHH
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc-cccccHHH
Confidence 9999877777999999999999999998 44544333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-12 Score=141.78 Aligned_cols=336 Identities=12% Similarity=0.117 Sum_probs=170.4
Q ss_pred cccCCCCCCCCCC-CCcEEeccCCccccccCcCCCCcCCccEEEeecCc---cceecCCcccCCCCCCeeeccccccccc
Q 002892 75 FTGPIPNSLFNLS-SLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN---LRGEIPNEIGNLKNLADLVLALNNLIGP 150 (870)
Q Consensus 75 i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~---l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 150 (870)
++......|.++. .|+.+.+..+ ++.+...+|.++.+|+.+.+..|. ++.....+|..+.+|+.+.+..+ ++..
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 3433444566663 4777777644 554556677777777777777653 55455667777777777766543 4445
Q ss_pred ccccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccc
Q 002892 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGN 230 (870)
Q Consensus 151 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 230 (870)
...+|..+.+|+.+.+..+- . . +....|..+.+|+.+.+..+ +..+...+|.+
T Consensus 129 ~~~aF~~c~~L~~i~lp~~~-~-~------------------------I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~ 181 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEGV-T-S------------------------VADGMFSYCYSLHTVTLPDS-VTAIEERAFTG 181 (394)
T ss_dssp CTTTTTTCTTCCEEECCTTC-C-E------------------------ECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred hhhhhhhhccccccccccee-e-e------------------------ecccceecccccccccccce-eeEeccccccc
Confidence 55566666666666654332 1 1 22334444444554444433 22233333432
Q ss_pred ccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhh
Q 002892 231 LRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIG 310 (870)
Q Consensus 231 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~ 310 (870)
.+|+.+.+..+-.. +. ..++..+..++......+......-..+... .........+.
T Consensus 182 -~~l~~i~ip~~~~~-i~--------~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~ 239 (394)
T 4gt6_A 182 -TALTQIHIPAKVTR-IG--------TNAFSECFALSTITSDSESYPAIDNVLYEKS------------ANGDYALIRYP 239 (394)
T ss_dssp -CCCSEEEECTTCCE-EC--------TTTTTTCTTCCEEEECCSSSCBSSSCEEEEC------------TTSCEEEEECC
T ss_pred -cceeEEEECCcccc-cc--------cchhhhccccceecccccccccccceeeccc------------ccccccccccc
Confidence 33444444332111 11 1234444444444444333222110000000 00000000000
Q ss_pred CccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEe
Q 002892 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRID 390 (870)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 390 (870)
....+..+.+ | +.+...-..+|.++..|+.+.+..+..+ +...+|.+++.|+.+.
T Consensus 240 ~~~~~~~~~i---------p---------------~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~ 294 (394)
T 4gt6_A 240 SQREDPAFKI---------P---------------NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIE 294 (394)
T ss_dssp TTCCCSEEEC---------C---------------TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEE
T ss_pred cccccceEEc---------C---------------CcceEcccceeeecccccEEecccccce-ecCccccccccccccc
Confidence 1111111111 1 1111222345666667777777655443 6667777777777777
Q ss_pred cCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccC
Q 002892 391 LSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG 470 (870)
Q Consensus 391 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 470 (870)
+. +.++.+...+|.++.+|+.++|..+ ++.+....|.++.+|+.+.+..+ ++.+...+|.++++|+.+++.+|...
T Consensus 295 l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~- 370 (394)
T 4gt6_A 295 FS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ- 370 (394)
T ss_dssp CC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH-
T ss_pred CC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee-
Confidence 75 3444455667777778888877654 55556667778888888888654 55566677888888888888777543
Q ss_pred CCCcchhhccccceeeccCCcc
Q 002892 471 EIPKSFEILSHLKRLNVSHNRL 492 (870)
Q Consensus 471 ~~p~~~~~l~~L~~L~ls~N~l 492 (870)
-..+....+|+.+.+..|.+
T Consensus 371 --~~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 371 --WNAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp --HHTCBCCCCC----------
T ss_pred --hhhhhccCCCCEEEeCCCCE
Confidence 13455666777777766644
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=5.4e-13 Score=144.16 Aligned_cols=132 Identities=18% Similarity=0.123 Sum_probs=81.5
Q ss_pred eeecCCc-ccCCCCCcccccccccceEecCC-CccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCC
Q 002892 364 QLHLGSN-QLTSSIPSSFWSLEYILRIDLSS-NSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR 441 (870)
Q Consensus 364 ~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 441 (870)
.++++++ +|++ +|. +..+++|+.|+|++ |.|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 6663 455 66677777777774 777766666677777777777777777766666677777777777777
Q ss_pred CcccCcccccccCCCCCCeEecCCCcccCCCC-cchhhccccceeeccCCcccccCCC
Q 002892 442 NRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIP-KSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 442 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
|+|++..+..|..++ |+.|+|++|.+...-. ..|..+.......+..+.++|..|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 777665555555554 7777777776663221 2233333333444455566665554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=9.8e-13 Score=142.13 Aligned_cols=130 Identities=22% Similarity=0.215 Sum_probs=106.3
Q ss_pred ceEecCCC-ccCCCCcccccCCccCCEEEccC-CccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecC
Q 002892 387 LRIDLSSN-SLSGSLPSDIQNLKVLIYLNLSR-NQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLS 464 (870)
Q Consensus 387 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 464 (870)
..++++++ .|+ .+|. +..+++|+.|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 898 5787 99999999999996 99998888999999999999999999999999999999999999999
Q ss_pred CCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccc---cccccccccCCC
Q 002892 465 NNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQ---SFLWNYALCGPP 520 (870)
Q Consensus 465 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~---~~~~n~~~c~~~ 520 (870)
+|+|++..+..|..++ |+.|+|++|+|.|.+.. ..+..|... .+..+...|..|
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l-~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCAL-RWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGG-HHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCcc-HHHHHHHHhCcccccccCCCCCCC
Confidence 9999977777777776 99999999999998763 234444322 223345566544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.38 E-value=4.8e-12 Score=139.07 Aligned_cols=311 Identities=11% Similarity=0.104 Sum_probs=195.6
Q ss_pred CcCCCCcC-CccEEEeecCccceecCCcccCCCCCCeeeccccc---ccccccccccccccceEEEeecccccccCCCcc
Q 002892 104 PSKIGNLT-KLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNN---LIGPIPTTIFNISTIIIINLVGNQLSGHRPSTM 179 (870)
Q Consensus 104 ~~~~~~l~-~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 179 (870)
..+|.++. .|+.+.+..+ ++.....+|.++++|+.+.++.|. ++.+...+|.+
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~---------------------- 112 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMF---------------------- 112 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTT----------------------
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchh----------------------
Confidence 34455543 3565555433 443445555555555555555442 22222333333
Q ss_pred cCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCcccccc
Q 002892 180 GHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSS 259 (870)
Q Consensus 180 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~ 259 (870)
..+|+.+.+..+ ++.+....|..+.+|+.+.+..+. ..+...+|....+|+.+.+..+ ++.+... +
T Consensus 113 ---c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~--------a 178 (394)
T 4gt6_A 113 ---CSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEER--------A 178 (394)
T ss_dssp ---CTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTT--------T
T ss_pred ---cccceeeccCCc-cceehhhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccc--------c
Confidence 444444444433 343556778888888888887553 3366777888888888888654 4443321 2
Q ss_pred cccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhH
Q 002892 260 LTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQL 339 (870)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 339 (870)
|. ...|+.+.+..+-. . .-..++.....+.......+.........+....
T Consensus 179 F~-~~~l~~i~ip~~~~-~-------------------------i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~-- 229 (394)
T 4gt6_A 179 FT-GTALTQIHIPAKVT-R-------------------------IGTNAFSECFALSTITSDSESYPAIDNVLYEKSA-- 229 (394)
T ss_dssp TT-TCCCSEEEECTTCC-E-------------------------ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECT--
T ss_pred cc-ccceeEEEECCccc-c-------------------------cccchhhhccccceecccccccccccceeecccc--
Confidence 32 34577776654321 1 2234556666677766665554421111111100
Q ss_pred HHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCc
Q 002892 340 QALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQ 419 (870)
Q Consensus 340 ~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 419 (870)
........+.....+..+.+. +.++.+...+|.++..|+.+.+.++..+ +...+|.++++|+.+.+. +.
T Consensus 230 --------~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~ 298 (394)
T 4gt6_A 230 --------NGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SR 298 (394)
T ss_dssp --------TSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TT
T ss_pred --------cccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-Cc
Confidence 000000112222344445443 3455567789999999999999877665 677889999999999996 56
Q ss_pred cCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCccc
Q 002892 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLE 493 (870)
Q Consensus 420 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 493 (870)
++.+....|.++.+|+.+++..+ ++.+...+|.++.+|+.+.|..+ ++..-..+|.++++|+.+++.+|...
T Consensus 299 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 299 ITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred ccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 76677789999999999999875 66677889999999999999755 77566789999999999999998653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.1e-13 Score=147.60 Aligned_cols=164 Identities=20% Similarity=0.207 Sum_probs=122.8
Q ss_pred ccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCccccc-CccccceeecCCcccCCCCCccc-ccccccceE
Q 002892 312 LRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLS-SLISLRQLHLGSNQLTSSIPSSF-WSLEYILRI 389 (870)
Q Consensus 312 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L 389 (870)
++.|+.|+|++|.++......+.. .+. ..++|++|+|++|.|+......+ ..+++|+.|
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~-------------------~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L 131 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAA-------------------VLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL 131 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHH-------------------HHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEE
T ss_pred HhhCCEEEecCCCCCHHHHHHHHH-------------------HHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHh
Confidence 467889999999997433322221 112 23589999999999975444444 356789999
Q ss_pred ecCCCccCCCCcccc-----cCCccCCEEEccCCccCCc----ccccccCCCCCCEEEcCCCcccCcc----cccccCCC
Q 002892 390 DLSSNSLSGSLPSDI-----QNLKVLIYLNLSRNQLSGN----IPITIGGLKDLITLSLARNRFQDSI----PDSFGSLT 456 (870)
Q Consensus 390 ~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~ 456 (870)
+|++|.++......+ ...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++.. +..+...+
T Consensus 132 ~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~ 211 (372)
T 3un9_A 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR 211 (372)
T ss_dssp ECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred hcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence 999999975444444 2467899999999999753 3444577899999999999998643 56678888
Q ss_pred CCCeEecCCCcccCC----CCcchhhccccceeeccCCcccc
Q 002892 457 SLEYLDLSNNNLSGE----IPKSFEILSHLKRLNVSHNRLEG 494 (870)
Q Consensus 457 ~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~ 494 (870)
+|+.|+|++|.|+.. +...+...++|+.|+|++|+++.
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 999999999999853 34445567999999999999864
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=3e-14 Score=154.27 Aligned_cols=112 Identities=20% Similarity=0.142 Sum_probs=59.4
Q ss_pred cCCccEEEeecCccceecCCcccC-----CCCCCeeeccccccccccccccc-ccccceEEEeecccccccCCCccc---
Q 002892 110 LTKLVHLNFADNNLRGEIPNEIGN-----LKNLADLVLALNNLIGPIPTTIF-NISTIIIINLVGNQLSGHRPSTMG--- 180 (870)
Q Consensus 110 l~~L~~L~l~~N~l~~~~~~~l~~-----l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~--- 180 (870)
++.|++|+|++|.|+......+.. .++|++|+|++|.+++.....+. .+++|+.|+|++|.++......+.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 456788888888877443333322 25777888887777644333333 355677777777776543332221
Q ss_pred -CCCCccceeeecccccccc----cCCcccCCCCccEEEccCCccc
Q 002892 181 -HSLPNRQFLLLWANRLTGT----IPNSITNASKLIGLDLNSNSLS 221 (870)
Q Consensus 181 -~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~i~ 221 (870)
...++|+.|+|++|.|++. ++..+..+++|++|+|++|.|+
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 1234455555555554432 1222233444455555555444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=126.81 Aligned_cols=147 Identities=14% Similarity=0.087 Sum_probs=115.1
Q ss_pred HHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEE
Q 002892 580 IQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 580 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 658 (870)
+....++|++....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3455678888888999999999999744 6899999987532222345888999999884 6678889999988889999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH------------------------------------ 702 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------ 702 (870)
||||++|.++.+.+. +......++.+++++++.||...
T Consensus 88 v~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999987632 11223468889999999999711
Q ss_pred --------------------CCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 703 --------------------STPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 703 --------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
...++|||++|.||++++++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876566799998765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-09 Score=119.28 Aligned_cols=123 Identities=11% Similarity=0.062 Sum_probs=83.6
Q ss_pred ccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCC
Q 002892 354 TCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKD 433 (870)
Q Consensus 354 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 433 (870)
.+|.....|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++++|+.+.+.++.++.+....|.++.+
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~ 311 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK 311 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCC
Confidence 34555666777777655 55566677777777777777654 44355567777778888888777777666677888888
Q ss_pred CCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhcc
Q 002892 434 LITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILS 480 (870)
Q Consensus 434 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 480 (870)
|+.++|..+ ++.+...+|.++++|+.+.+..+ ++..-..+|.+..
T Consensus 312 L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 312 LSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred CCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 888888654 55566677888888888877654 5534455666553
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.12 E-value=9.7e-10 Score=120.06 Aligned_cols=133 Identities=16% Similarity=0.176 Sum_probs=102.0
Q ss_pred ccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCC
Q 002892 354 TCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKD 433 (870)
Q Consensus 354 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 433 (870)
..+....+|+.+.+..+ ++.+...+|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.+....|.++.+
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence 34555667777777554 55567778888888999888776 55466678888888999888654 55566678888899
Q ss_pred CCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCC
Q 002892 434 LITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490 (870)
Q Consensus 434 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 490 (870)
|+.+.+.++.++.+...+|.++.+|+.++|..+ ++..-..+|.++.+|+.+.+..+
T Consensus 288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 999999888888777788999999999998755 66455678888888888887654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=1.4e-10 Score=119.59 Aligned_cols=139 Identities=15% Similarity=0.079 Sum_probs=101.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc--eeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN--LIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~ 660 (870)
...++.+..+.+.|..+.||++...+|+.+++|+.... ....+..|+++++.+.+.+ +.+++++....+..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34455543333466669999998777888999997654 2245778999998886444 556888888777889999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH-------------------------------------- 702 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-------------------------------------- 702 (870)
||++|.++. ... .+ ...++.++++.++.||...
T Consensus 95 e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998884 211 11 2356778888888888532
Q ss_pred -----------------CCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 703 -----------------STPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 703 -----------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
..+++|||++|.||++++++.+.++|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667799999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.98 E-value=8.5e-11 Score=125.87 Aligned_cols=185 Identities=12% Similarity=0.116 Sum_probs=91.6
Q ss_pred ccCCCCCcEEEccCCccc---------ccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCc
Q 002892 35 LGQLRRLKFLGFAYNDLT---------GSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPS 105 (870)
Q Consensus 35 ~~~l~~L~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 105 (870)
+..+++|+.|.+..+... +.+...+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.+......
T Consensus 135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~ 211 (362)
T 2ra8_A 135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVE 211 (362)
T ss_dssp HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHH
T ss_pred hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHH
Confidence 345666777766554321 123344455566666666655211 1222 22 55666666666655432222
Q ss_pred CCC--CcCCccEEEeec--CccceecCCcccCCCCCCeeecccccccccccccc--cccccceEEEeecccccccCCCcc
Q 002892 106 KIG--NLTKLVHLNFAD--NNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTI--FNISTIIIINLVGNQLSGHRPSTM 179 (870)
Q Consensus 106 ~~~--~l~~L~~L~l~~--N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~ 179 (870)
.++ .+++|++|+|+. |...+.. . +. .+...+ ..+++|++|+|++|++.+..+..+
T Consensus 212 ~l~~~~lp~L~~L~L~~~~~~~~~~~--~----------------~~-~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 212 DILGSDLPNLEKLVLYVGVEDYGFDG--D----------------MN-VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp HHHHSBCTTCCEEEEECBCGGGTCCS--C----------------GG-GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred HHHHccCCCCcEEEEeccccccccch--h----------------HH-HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 232 455666666542 1111000 0 00 000011 124455555555555543221111
Q ss_pred c--CCCCccceeeecccccccc----cCCcccCCCCccEEEccCCcccCCCcccccc-ccccccccccccc
Q 002892 180 G--HSLPNRQFLLLWANRLTGT----IPNSITNASKLIGLDLNSNSLSGQIPNTFGN-LRHLSTLNIRANY 243 (870)
Q Consensus 180 ~--~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~-l~~L~~L~L~~N~ 243 (870)
. ..+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.|++.....+.. + ...++++.+.
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 1 1356677777777766653 3444456788999999999887544444443 2 3557888776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.92 E-value=2.5e-10 Score=122.25 Aligned_cols=138 Identities=17% Similarity=0.256 Sum_probs=82.1
Q ss_pred cCCCCcCCccEEEeecCc-cceecCCcccCCCCCCeeeccccccccccccccc--ccccceEEEeec--ccccccC----
Q 002892 105 SKIGNLTKLVHLNFADNN-LRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIF--NISTIIIINLVG--NQLSGHR---- 175 (870)
Q Consensus 105 ~~~~~l~~L~~L~l~~N~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~l~~--N~l~~~~---- 175 (870)
..+..+++|+.|+|++|. +. ++. + .+++|++|++..|.+.......+. .+++|++|+|+. |...+..
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~ 241 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred HHHhcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence 334566778888887773 22 232 3 367888888887777654444444 577888888753 2221110
Q ss_pred --CCcccCCCCccceeeecccccccccCCccc---CCCCccEEEccCCcccCCCcc----cccccccccccccccccccc
Q 002892 176 --PSTMGHSLPNRQFLLLWANRLTGTIPNSIT---NASKLIGLDLNSNSLSGQIPN----TFGNLRHLSTLNIRANYLTT 246 (870)
Q Consensus 176 --~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~Ls~N~i~~~~~~----~~~~l~~L~~L~L~~N~l~~ 246 (870)
+......+|+|++|+|++|.+++..+..+. .+++|++|+|+.|.|++..+. .+..+++|+.|+|++|.|+.
T Consensus 242 l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 111112467788888877777643332222 356777888877777654322 23456777777777777664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.3e-09 Score=113.89 Aligned_cols=143 Identities=16% Similarity=0.205 Sum_probs=106.9
Q ss_pred CCCCeeccccceeEEEEEecCCcEEEEEEee--chh-hHHHHHHHHHHHHHHhcC--CCceeEEeeeeeeC---CeeEEE
Q 002892 588 NECNLLGAGSFGSVYKGTLFDGTNVAIKVFN--LQL-ERAFRSFESECEVLRNVR--HRNLIKIFSSCCNL---DFKALV 659 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv 659 (870)
...+.++.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +..+++++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999999865 4688999876 332 122356788999999996 45578888888765 458999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH------------------------------------- 702 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------- 702 (870)
|||++|.++.+.. ...++......++.+++++|+.||...
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998774321 122678888899999999999999631
Q ss_pred ------------------CCCcEecccCCCceeeCCCCc--eEEeccccccc
Q 002892 703 ------------------STPVVHCNLKPNNILLDKNMT--ARVSDFGISKL 734 (870)
Q Consensus 703 ------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~ 734 (870)
...++|||+++.||+++.++. +.++||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256899999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.6e-09 Score=114.25 Aligned_cols=188 Identities=14% Similarity=0.157 Sum_probs=123.3
Q ss_pred CCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCc--eeEEeeeeeeCC---eeEEEEec
Q 002892 589 ECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRN--LIKIFSSCCNLD---FKALVLEF 662 (870)
Q Consensus 589 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~ 662 (870)
.++.++.|....||+.. +.+++|+.... .....+.+|+++++.+. +.. +..++......+ ..|+||||
T Consensus 24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eeEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 35679999999999863 57999986543 34467889999998883 332 344554443332 45899999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH---------------------------------------- 702 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---------------------------------------- 702 (870)
++|.++.+.... .++..+...++.++++.++.||...
T Consensus 98 i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999988754331 2677788888899999999888511
Q ss_pred ---------------CCCcEecccCCCceeeCC--CCceEEeccccccccCCCCCccccccc---cc---------cccc
Q 002892 703 ---------------STPVVHCNLKPNNILLDK--NMTARVSDFGISKLLGEDDDSVTQTMT---MA---------TIGY 753 (870)
Q Consensus 703 ---------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~---~g---------~~~y 753 (870)
...++|||++|.||++++ .+.+.++||+.+..-............ .+ ..++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 135799999999999988 456789999988653211000000000 00 0011
Q ss_pred CC-cccccCCCcCcccchHhHHHHHHHHHhCCCCC
Q 002892 754 MA-PEYASDGIISPKCDVYSYGVLLMETFTRKKPT 787 (870)
Q Consensus 754 ~a-PE~~~~~~~~~~sDvwslG~il~elltg~~p~ 787 (870)
.. |+.... .....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 221110 112368999999999999998775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.60 E-value=6e-09 Score=105.46 Aligned_cols=79 Identities=28% Similarity=0.371 Sum_probs=44.6
Q ss_pred CCccCCEEEccCCccCC--cccccccCCCCCCEEEcCCCcccCcccccccCCC--CCCeEecCCCcccCCCCc-------
Q 002892 406 NLKVLIYLNLSRNQLSG--NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLT--SLEYLDLSNNNLSGEIPK------- 474 (870)
Q Consensus 406 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~------- 474 (870)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+..|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 45566666666666665 2234455566666666666666543 2233333 666666666666654442
Q ss_pred chhhccccceee
Q 002892 475 SFEILSHLKRLN 486 (870)
Q Consensus 475 ~~~~l~~L~~L~ 486 (870)
.+..+|+|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 355666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.56 E-value=1.3e-08 Score=98.27 Aligned_cols=91 Identities=14% Similarity=0.215 Sum_probs=45.2
Q ss_pred cccCccccceeecCCc-ccCCC----CCcccccccccceEecCCCccCCC----CcccccCCccCCEEEccCCccCCc--
Q 002892 355 CLSSLISLRQLHLGSN-QLTSS----IPSSFWSLEYILRIDLSSNSLSGS----LPSDIQNLKVLIYLNLSRNQLSGN-- 423 (870)
Q Consensus 355 ~~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-- 423 (870)
.+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3455667777777777 77532 222334445566666666665431 122333344555555555555432
Q ss_pred --ccccccCCCCCCEEEc--CCCccc
Q 002892 424 --IPITIGGLKDLITLSL--ARNRFQ 445 (870)
Q Consensus 424 --~p~~~~~l~~L~~L~L--s~N~l~ 445 (870)
+...+...+.|+.|+| ++|.|.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCC
Confidence 1233333444444444 444444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.56 E-value=6.9e-09 Score=100.16 Aligned_cols=118 Identities=12% Similarity=0.117 Sum_probs=93.3
Q ss_pred CCcccccccccceEecCCC-ccCCC----CcccccCCccCCEEEccCCccCCcc----cccccCCCCCCEEEcCCCcccC
Q 002892 376 IPSSFWSLEYILRIDLSSN-SLSGS----LPSDIQNLKVLIYLNLSRNQLSGNI----PITIGGLKDLITLSLARNRFQD 446 (870)
Q Consensus 376 ~~~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~ 446 (870)
+...+...+.|++|+|++| .+... +...+...++|++|+|++|+|+... ...+...+.|+.|+|++|.|.+
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445667889999999999 88742 3456677789999999999998533 3445566899999999999986
Q ss_pred c----ccccccCCCCCCeEec--CCCcccCC----CCcchhhccccceeeccCCccc
Q 002892 447 S----IPDSFGSLTSLEYLDL--SNNNLSGE----IPKSFEILSHLKRLNVSHNRLE 493 (870)
Q Consensus 447 ~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 493 (870)
. +...+...++|++|+| ++|.|... +...+...+.|+.|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 5 4567788899999999 88999853 3345556689999999999985
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1.5e-08 Score=102.59 Aligned_cols=115 Identities=23% Similarity=0.221 Sum_probs=81.5
Q ss_pred CCCCCCCcc-cccCccccce--eecCCcccC---CCCCcccccccccceEecCCCccCC--CCcccccCCccCCEEEccC
Q 002892 346 NNLNGPIPT-CLSSLISLRQ--LHLGSNQLT---SSIPSSFWSLEYILRIDLSSNSLSG--SLPSDIQNLKVLIYLNLSR 417 (870)
Q Consensus 346 n~~~~~~p~-~~~~l~~L~~--L~Ls~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~ 417 (870)
|...+.++- .|...+.|+. ++++.|+.. ...+.....+++|+.|+|++|+|++ .+|..+..+++|+.|+|++
T Consensus 126 n~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~ 205 (267)
T 3rw6_A 126 DGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 205 (267)
T ss_dssp ETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTT
T ss_pred chhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCC
Confidence 334443332 3555666766 778888544 2222233567889999999999987 3456777899999999999
Q ss_pred CccCCcccccccCCC--CCCEEEcCCCcccCccc-------ccccCCCCCCeEe
Q 002892 418 NQLSGNIPITIGGLK--DLITLSLARNRFQDSIP-------DSFGSLTSLEYLD 462 (870)
Q Consensus 418 N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p-------~~~~~l~~L~~L~ 462 (870)
|+|++. ..+..+. +|+.|+|++|.+.+..| ..+..+++|+.||
T Consensus 206 N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 206 NELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp SCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 999865 3344444 89999999999987655 2477889999887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2.3e-06 Score=89.72 Aligned_cols=136 Identities=12% Similarity=0.076 Sum_probs=96.5
Q ss_pred CCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCC---ceeEEeeeee-eCCeeEEEEecCCC
Q 002892 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHR---NLIKIFSSCC-NLDFKALVLEFMPN 665 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 665 (870)
++.++.|....||+. |+.+++|+... ......+..|+++++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467888999999987 67899998542 23456789999999999642 3556666664 45567899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS-------------------------------------------- 701 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-------------------------------------------- 701 (870)
.++.+.... .++..+...++.++++.++.||..
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 888763221 134455555666666666666632
Q ss_pred -------------CCCCcEecccCCCceeeCC---CCce-EEeccccccc
Q 002892 702 -------------HSTPVVHCNLKPNNILLDK---NMTA-RVSDFGISKL 734 (870)
Q Consensus 702 -------------~~~~ivH~dlk~~Nill~~---~~~~-kl~Dfg~a~~ 734 (870)
....++|||+++.||+++. ++.+ .|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235699999999999987 4554 8999998763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3e-06 Score=87.42 Aligned_cols=135 Identities=17% Similarity=0.092 Sum_probs=100.1
Q ss_pred Ceeccccce-eEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCeeEEEEecCCCCC
Q 002892 591 NLLGAGSFG-SVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFKALVLEFMPNGS 667 (870)
Q Consensus 591 ~~lg~G~~g-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~ 667 (870)
+.+..|..+ .||+.... +++.+++|+.... ....+..|+..++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 456667766 58988754 5678999987644 3456788999998884 3347788888888899999999999998
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 002892 668 LEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS---------------------------------------------- 701 (870)
Q Consensus 668 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---------------------------------------------- 701 (870)
+.+...... .....+..+++..++.||..
T Consensus 107 ~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 887654321 22345667777777777731
Q ss_pred ---------CCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 702 ---------HSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 702 ---------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
....++|||+.+.||++++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01237899999999999987777899999776
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=2e-06 Score=92.72 Aligned_cols=80 Identities=9% Similarity=-0.061 Sum_probs=55.9
Q ss_pred CCee-ccccceeEEEEEec-------CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcC-C--CceeEEeeeeeeC--
Q 002892 590 CNLL-GAGSFGSVYKGTLF-------DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVR-H--RNLIKIFSSCCNL-- 653 (870)
Q Consensus 590 ~~~l-g~G~~g~v~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~-- 653 (870)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+++++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88999999988754 26789999876533 101245678888888884 3 2466777776554
Q ss_pred -CeeEEEEecCCCCCHH
Q 002892 654 -DFKALVLEFMPNGSLE 669 (870)
Q Consensus 654 -~~~~lv~e~~~~g~L~ 669 (870)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.00 E-value=6e-07 Score=83.91 Aligned_cols=85 Identities=8% Similarity=0.023 Sum_probs=62.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCc-cccCCCCCCCCC----CCCcEEeccCCc-cccccCcCCCCcC
Q 002892 38 LRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNS-FTGPIPNSLFNL----SSLVRLDSRFNS-ISGNIPSKIGNLT 111 (870)
Q Consensus 38 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l----~~L~~L~L~~n~-i~~~~~~~~~~l~ 111 (870)
-.+|+.||+++|.++..--..+..+++|++|+|++|. |++..-..++.+ ++|++|+|++|. |+...-..+.+++
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 3468888888888876666667788888888888884 665433345553 368888888874 7754445677888
Q ss_pred CccEEEeecCc
Q 002892 112 KLVHLNFADNN 122 (870)
Q Consensus 112 ~L~~L~l~~N~ 122 (870)
+|++|+++++.
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 99999998875
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.92 E-value=3.3e-06 Score=78.89 Aligned_cols=82 Identities=7% Similarity=0.097 Sum_probs=39.6
Q ss_pred CCcEEeccCCccccccCcCCCCcCCccEEEeecCc-cceecCCcccCC----CCCCeeeccccc-ccccccccccccccc
Q 002892 88 SLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNN-LRGEIPNEIGNL----KNLADLVLALNN-LIGPIPTTIFNISTI 161 (870)
Q Consensus 88 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~l~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~L 161 (870)
.|++|||+++.|+...-..+.++++|++|+|++|. |+...-..++.+ ++|++|+|++|. +++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555443333334455555555555553 443322333332 245555555542 544444444555555
Q ss_pred eEEEeecc
Q 002892 162 IIINLVGN 169 (870)
Q Consensus 162 ~~L~l~~N 169 (870)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555555
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=6.3e-05 Score=80.37 Aligned_cols=139 Identities=15% Similarity=0.118 Sum_probs=80.0
Q ss_pred CCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCC--CceeEEee------eeeeCCeeEEEEe
Q 002892 590 CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRH--RNLIKIFS------SCCNLDFKALVLE 661 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e 661 (870)
.+.++.|..+.||+....+| .+++|+..... ..+..|..+++.+.. -.+++++. +....+..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566678899999986654 59999987532 223345555554431 12333332 1234567789999
Q ss_pred cCCCCCHH--------------HHHhhc--CC-----------CCCHHHH------------------------------
Q 002892 662 FMPNGSLE--------------KWLYSH--NY-----------FLDMLER------------------------------ 684 (870)
Q Consensus 662 ~~~~g~L~--------------~~l~~~--~~-----------~~~~~~~------------------------------ 684 (870)
|++|.++. ..++.. .. ...|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 111211 00 0122211
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 685 -LNIMIDVGLALEYLHH----------SHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 685 -~~i~~~i~~~l~~Lh~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
..+..++..++++|+. .....++|||+.+.||+++.++.+.++||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666653 125679999999999999888899999999765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=3e-05 Score=84.78 Aligned_cols=75 Identities=16% Similarity=0.167 Sum_probs=49.5
Q ss_pred CCeeccccceeEEEEEec-CCcEEEEEEeechhh-------HHHHHHHHHHHHHHhcCC--C-ceeEEeeeeeeCCeeEE
Q 002892 590 CNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE-------RAFRSFESECEVLRNVRH--R-NLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l 658 (870)
.+.+|.|..+.||++... +++.++||....... ....++..|+++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 568899998653221 122456778888887732 3 34455543 3455689
Q ss_pred EEecCCCC
Q 002892 659 VLEFMPNG 666 (870)
Q Consensus 659 v~e~~~~g 666 (870)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00027 Score=73.53 Aligned_cols=138 Identities=14% Similarity=0.072 Sum_probs=92.5
Q ss_pred CCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC---CCceeEEeeeeeeCCeeEEEEecCC
Q 002892 588 NECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR---HRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
...+.++.|....+|+... +++.+++|+.... ....+..|++.++.+. ...+++++++....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456799999999999985 4778999987643 2456888999988884 3568888888887788999999999
Q ss_pred CCCHH--------H---HHhhcCC---------------------CCCHHHHHH---HHH----------------HHHH
Q 002892 665 NGSLE--------K---WLYSHNY---------------------FLDMLERLN---IMI----------------DVGL 693 (870)
Q Consensus 665 ~g~L~--------~---~l~~~~~---------------------~~~~~~~~~---i~~----------------~i~~ 693 (870)
+..+. + .++.... .-+|..... +.. +++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87642 1 1222110 124543321 111 1111
Q ss_pred H-HHHHHh-cCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 694 A-LEYLHH-SHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 694 ~-l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
. ...|.. .....++|+|+.+.|++++.++ +.++|++
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 122321 1246799999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00021 Score=74.06 Aligned_cols=79 Identities=16% Similarity=0.131 Sum_probs=58.1
Q ss_pred CCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCC---ceeEEeeeeeeCCeeEEEEec
Q 002892 586 GFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHR---NLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~ 662 (870)
+..-++.+|.|..+.||+.+..||+.|++|+...........+..|++.++.+.-. -+++++++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 44556789999999999999999999999987655433345678899999888421 24455543 234789999
Q ss_pred CCCCCH
Q 002892 663 MPNGSL 668 (870)
Q Consensus 663 ~~~g~L 668 (870)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00011 Score=65.54 Aligned_cols=68 Identities=24% Similarity=0.356 Sum_probs=48.0
Q ss_pred EEEcCCCccc-CcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccc
Q 002892 436 TLSLARNRFQ-DSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFL 506 (870)
Q Consensus 436 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~ 506 (870)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|+|.|.+-. ..|..|.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l-~~l~~wl 80 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL-VPLRAWL 80 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG-HHHHHHH
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc-HHHHHHH
Confidence 5677777775 23454332 3688888888888877777788888999999999999887763 2344443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00023 Score=78.15 Aligned_cols=78 Identities=10% Similarity=0.102 Sum_probs=49.0
Q ss_pred CCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccccccccc--ccccCCcccccCC---CcCcccchHhHHHHH
Q 002892 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA--TIGYMAPEYASDG---IISPKCDVYSYGVLL 777 (870)
Q Consensus 703 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~sDvwslG~il 777 (870)
...++|||+++.||+++.++ ++++||+.+..-.. ......... ...|.+|+..... ......++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p---~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM---GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH---HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch---HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 56799999999999998876 99999998874321 111111111 1346666654321 122345666788888
Q ss_pred HHHHhCC
Q 002892 778 METFTRK 784 (870)
Q Consensus 778 ~elltg~ 784 (870)
|+.+++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.47 E-value=3.4e-05 Score=73.54 Aligned_cols=63 Identities=19% Similarity=0.253 Sum_probs=30.3
Q ss_pred ccccceeecCCc-ccCCC----CCcccccccccceEecCCCccCCC----CcccccCCccCCEEEccCCccC
Q 002892 359 LISLRQLHLGSN-QLTSS----IPSSFWSLEYILRIDLSSNSLSGS----LPSDIQNLKVLIYLNLSRNQLS 421 (870)
Q Consensus 359 l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 421 (870)
-+.|++|+|++| +|... +.+.+..-+.|+.|+|++|+|... +.+.+..-+.|++|+|++|+|+
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 356777777764 66421 223333444555555555555421 2222333344555555555544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.47 E-value=2.8e-05 Score=74.05 Aligned_cols=114 Identities=17% Similarity=0.115 Sum_probs=83.8
Q ss_pred cccccccceEecCCC-ccCC----CCcccccCCccCCEEEccCCccCCccccc----ccCCCCCCEEEcCCCcccCc---
Q 002892 380 FWSLEYILRIDLSSN-SLSG----SLPSDIQNLKVLIYLNLSRNQLSGNIPIT----IGGLKDLITLSLARNRFQDS--- 447 (870)
Q Consensus 380 ~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~--- 447 (870)
...-+.|++|+|++| +|.. .+.+++..-+.|+.|+|++|+|....... +..-+.|+.|+|++|.|.+.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344578999999986 7763 23456677789999999999998544333 44668999999999999865
Q ss_pred -ccccccCCCCCCeEecCCCcc---cC----CCCcchhhccccceeeccCCccc
Q 002892 448 -IPDSFGSLTSLEYLDLSNNNL---SG----EIPKSFEILSHLKRLNVSHNRLE 493 (870)
Q Consensus 448 -~p~~~~~l~~L~~L~L~~N~l---~~----~~p~~~~~l~~L~~L~ls~N~l~ 493 (870)
+..++..-+.|++|+|++|.. .. .+-..+..-+.|+.|+++.|...
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 334566678899999987643 32 13345666789999999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00039 Score=72.48 Aligned_cols=131 Identities=14% Similarity=0.180 Sum_probs=77.3
Q ss_pred CCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCce-eEEeeeeeeCCeeEEEEecC-C
Q 002892 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNL-IKIFSSCCNLDFKALVLEFM-P 664 (870)
Q Consensus 587 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~ 664 (870)
+.-.+.++.|....+|+. +.+++|+........ .....|+.+++.+...++ .+++++ ..+..++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 333788999999999998 679999886542221 223567777777643222 355543 334457899999 6
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH-------------------------------------------- 700 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-------------------------------------------- 700 (870)
|.++....... ...++.++++.|+.+|.
T Consensus 92 g~~l~~~~~~~--------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 163 (301)
T 3dxq_A 92 AQTMSPEKFKT--------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR 163 (301)
T ss_dssp CEECCHHHHHH--------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred CccCCHhhHhh--------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence 65443110000 00012222222222221
Q ss_pred ------cCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 701 ------SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 701 ------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
.....++|+|+.+.||+ ..++.+.++||..+..
T Consensus 164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12345799999999999 5677889999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0016 Score=69.01 Aligned_cols=140 Identities=12% Similarity=0.071 Sum_probs=74.1
Q ss_pred CCeecccccee-EEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCC--CceeEEeeeeeeCCeeEEEEecCCCC
Q 002892 590 CNLLGAGSFGS-VYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRH--RNLIKIFSSCCNLDFKALVLEFMPNG 666 (870)
Q Consensus 590 ~~~lg~G~~g~-v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 666 (870)
.+.++.|.... +|+....+|+.+++|....... ..+..|+++++.+.. -.+.+++.+.... .+++||++++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 34566665554 6677654477888887654321 223456666666632 2345566653332 37899999877
Q ss_pred CHHHHHhhcC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHH--
Q 002892 667 SLEKWLYSHN-------------------------YFLDMLERL-------N-I------------MIDVGLALEYLH-- 699 (870)
Q Consensus 667 ~L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~Lh-- 699 (870)
++.+++.... ..++..... . + ...+...++.+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 7765443110 001111110 0 0 001112222221
Q ss_pred -hcCCCCcEecccCCCceeeCCC----CceEEeccccccc
Q 002892 700 -HSHSTPVVHCNLKPNNILLDKN----MTARVSDFGISKL 734 (870)
Q Consensus 700 -~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~ 734 (870)
......++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1124579999999999999875 6899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0016 Score=68.53 Aligned_cols=154 Identities=10% Similarity=0.089 Sum_probs=84.9
Q ss_pred hhHHHHhhcCCCC-----CCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc--eeEEeee
Q 002892 577 YLDIQQATDGFNE-----CNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN--LIKIFSS 649 (870)
Q Consensus 577 ~~~~~~~~~~~~~-----~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~ 649 (870)
..++......|.. .+.++.|....+|+....+| .+++|+..... ....+..|+.+++.+...+ +.+++..
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 3444444444443 34577788899999986655 68899987531 1133456777776664222 2333321
Q ss_pred ------eeeCCeeEEEEecCCCCCHHH--------------HHhhc--C--CC----C---CHHHHHH------------
Q 002892 650 ------CCNLDFKALVLEFMPNGSLEK--------------WLYSH--N--YF----L---DMLERLN------------ 686 (870)
Q Consensus 650 ------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~--~~----~---~~~~~~~------------ 686 (870)
....+..+++|+|++|..+.. .++.. . .. . .|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 122456789999999865310 11111 0 00 0 1222110
Q ss_pred HHHHHHHHHHHHHhc----CCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 687 IMIDVGLALEYLHHS----HSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 687 i~~~i~~~l~~Lh~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
+...+...++.+++. ...+++|+|+.+.||++++++.+.++||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 23568999999999999887666899998775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00069 Score=72.47 Aligned_cols=139 Identities=13% Similarity=0.177 Sum_probs=82.3
Q ss_pred CCeeccccceeEEEEEec--------CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc-eeEEeeeeeeCCeeEEEE
Q 002892 590 CNLLGAGSFGSVYKGTLF--------DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN-LIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 660 (870)
++.+..|-...+|+.... +++.|++|+..... .......+|.++++.+...+ ..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 467888889999999864 35789999974322 23355668999988884322 3556655432 3899
Q ss_pred ecCCCCCHHH--------------H---Hhhc----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 002892 661 EFMPNGSLEK--------------W---LYSH----NYFLD--MLERLNIMIDVGL-------------------ALEYL 698 (870)
Q Consensus 661 e~~~~g~L~~--------------~---l~~~----~~~~~--~~~~~~i~~~i~~-------------------~l~~L 698 (870)
||++|.++.. . ++.. +.... +.++.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865421 1 1111 11122 3455555544322 23333
Q ss_pred H----hc-CCCCcEecccCCCceeeCCC----CceEEecccccc
Q 002892 699 H----HS-HSTPVVHCNLKPNNILLDKN----MTARVSDFGISK 733 (870)
Q Consensus 699 h----~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~ 733 (870)
. .. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 11 23468899999999999876 789999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0031 Score=66.50 Aligned_cols=140 Identities=11% Similarity=0.075 Sum_probs=81.1
Q ss_pred CeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc--eeEEeee-----eeeCCeeEEEEecC
Q 002892 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN--LIKIFSS-----CCNLDFKALVLEFM 663 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~ 663 (870)
+.++ |....||+....+|+.+++|+...... ....+..|..+++.+.... +++++.. ....+..+.+|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 888899998777788899999864321 2245666777777774222 3444432 12245667899999
Q ss_pred CCCCHH-----H------H---Hhh--c------CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 002892 664 PNGSLE-----K------W---LYS--H------NYFLDMLER----LNI---------------MIDVGLALEYLHHS- 701 (870)
Q Consensus 664 ~~g~L~-----~------~---l~~--~------~~~~~~~~~----~~i---------------~~~i~~~l~~Lh~~- 701 (870)
+|.++. . . ++. . ....++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885431 1 1 111 0 011222111 001 11111223333221
Q ss_pred ---CCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 702 ---HSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 702 ---~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
....++|||+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 245688999999999999 4 899999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00071 Score=74.16 Aligned_cols=72 Identities=14% Similarity=0.234 Sum_probs=48.6
Q ss_pred CCeeccccceeEEEEEecC--------CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCce-eEEeeeeeeCCeeEEEE
Q 002892 590 CNLLGAGSFGSVYKGTLFD--------GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNL-IKIFSSCCNLDFKALVL 660 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 660 (870)
.+.|+.|....+|++...+ ++.+++|+...... ...+..|..+++.+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678899999999998653 57899999844211 1334568888888853333 556655432 3899
Q ss_pred ecCCCCC
Q 002892 661 EFMPNGS 667 (870)
Q Consensus 661 e~~~~g~ 667 (870)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998744
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0016 Score=57.94 Aligned_cols=37 Identities=24% Similarity=0.292 Sum_probs=21.0
Q ss_pred CCCEEEcCCCcccCcccccccCCCCCCeEecCCCccc
Q 002892 433 DLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 433 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 469 (870)
+|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555555555555555556666666666554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.76 E-value=0.016 Score=55.24 Aligned_cols=105 Identities=11% Similarity=0.029 Sum_probs=71.5
Q ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccccc
Q 002892 667 SLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTM 746 (870)
Q Consensus 667 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 746 (870)
+|.+.++..+.++++.++|.++.|.+.+|.-.-.. +.-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 79999998888999999999999999998776211 1111333457899999999998864 1110
Q ss_pred cccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCc
Q 002892 747 TMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDE 789 (870)
Q Consensus 747 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~ 789 (870)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-+.
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e 138 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE 138 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc
Confidence 0122466888763 3456788999999999999987766544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0017 Score=71.51 Aligned_cols=74 Identities=16% Similarity=0.218 Sum_probs=48.3
Q ss_pred CCeeccccceeEEEEEecC-CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCce-eEEeeeeeeCCeeEEEEecCCCCC
Q 002892 590 CNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNL-IKIFSSCCNLDFKALVLEFMPNGS 667 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~ 667 (870)
++.|+.|-...+|+....+ ++.+++|+........ .....|..+++.+...++ .++++.+. + ..||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4678899999999998764 5789999885432211 112578888888864444 45666552 2 35999998754
Q ss_pred H
Q 002892 668 L 668 (870)
Q Consensus 668 L 668 (870)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0013 Score=70.81 Aligned_cols=73 Identities=12% Similarity=0.205 Sum_probs=44.8
Q ss_pred CCeeccccceeEEEEEecC---------CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc-eeEEeeeeeeCCeeEEE
Q 002892 590 CNLLGAGSFGSVYKGTLFD---------GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN-LIKIFSSCCNLDFKALV 659 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 659 (870)
.+.++.|....+|+....+ ++.+++|+........ .....|.++++.+...+ ..++++.. . .++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4568888889999998654 2689999886543221 22356788888775333 34555443 2 3789
Q ss_pred EecCCCCC
Q 002892 660 LEFMPNGS 667 (870)
Q Consensus 660 ~e~~~~g~ 667 (870)
|||++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0079 Score=63.62 Aligned_cols=32 Identities=16% Similarity=0.335 Sum_probs=28.0
Q ss_pred CCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 703 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
...++|+|+.+.||++++++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35689999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.0067 Score=65.76 Aligned_cols=74 Identities=14% Similarity=0.284 Sum_probs=48.7
Q ss_pred CCeeccccceeEEEEEecC--------CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc-eeEEeeeeeeCCeeEEEE
Q 002892 590 CNLLGAGSFGSVYKGTLFD--------GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN-LIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 660 (870)
++.+..|-...+|+....+ ++.|++|+....... .....+|.++++.+...+ ..++++.+ . .+.||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4568888889999998653 588999997544322 122356888888774322 34555432 2 37899
Q ss_pred ecCCCCCH
Q 002892 661 EFMPNGSL 668 (870)
Q Consensus 661 e~~~~g~L 668 (870)
||++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.72 E-value=0.077 Score=57.39 Aligned_cols=29 Identities=28% Similarity=0.364 Sum_probs=24.5
Q ss_pred CcEecccCCCceee------CCCCceEEecccccc
Q 002892 705 PVVHCNLKPNNILL------DKNMTARVSDFGISK 733 (870)
Q Consensus 705 ~ivH~dlk~~Nill------~~~~~~kl~Dfg~a~ 733 (870)
.++|+|+.+.||++ +++..++++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456779999998876
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 870 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 2e-65
Identities = 64/280 (22%), Positives = 125/280 (44%), Gaps = 25/280 (8%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFS 648
+G+GSFG+VYKG +VA+K+ N+ + ++F++E VLR RH N++
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
A+V ++ SL L+ +M++ ++I ++YLH ++H
Sbjct: 72 -YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIH 127
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA---SDGIIS 765
+LK NNI L +++T ++ DFG++ + S +I +MAPE S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 766 PKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSY 825
+ DVY++G++L E T + P + + + + L L++V
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS----------- 236
Query: 826 AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
+C + L C ++R ++ ++ + ++
Sbjct: 237 ---NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-57
Identities = 61/291 (20%), Positives = 118/291 (40%), Gaps = 23/291 (7%)
Query: 593 LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN 652
+G G FG V++G G VA+K+F+ + ER++ E+E +RH N++ ++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 653 LDFKA----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS-----HS 703
+ LV ++ +GSL +L + Y + + + + + L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGYMAPEYASD 761
+ H +LK NIL+ KN T ++D G++ D++ + T YMAPE D
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 762 GI------ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK--LSLPRGLTEVV 813
I + D+Y+ G++ E R ++ + S+ V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ L + + + L + + C + R+ + L ++ Q
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (499), Expect = 3e-57
Identities = 72/306 (23%), Positives = 124/306 (40%), Gaps = 38/306 (12%)
Query: 576 SYLDIQQATDGFNEC---------NLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL- 621
++ D +A F + ++GAG FG V G L VAIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 622 ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDM 681
E+ R F SE ++ H N+I + ++ EFM NGSL+ +L ++ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 127
Query: 682 LERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741
++ + ++ + ++YL + VH +L NIL++ N+ +VSDFG+S+ L +D
Sbjct: 128 IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 742 VTQTMT---MATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798
T T I + APE + DV+SYG+++ E + + +M+ +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----DMTNQ 240
Query: 799 HWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858
I + + MDC + L L C R +V
Sbjct: 241 DVIN--------------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 859 LQKIKQ 864
L K+ +
Sbjct: 287 LDKMIR 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-57
Identities = 65/279 (23%), Positives = 115/279 (41%), Gaps = 23/279 (8%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
+G+G FG V+ G + VAIK F E EV+ + H L+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ C LV EFM +G L +L + L + +DV E + + V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV---CEGMAYLEEACV 122
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
+H +L N L+ +N +VSDFG+++ + +D + + + + +PE S S
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSS 181
Query: 767 KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826
K DV+S+GVL+ E F+ K E + + I + R +P
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDIS-------------TGFRLYKPR-- 225
Query: 827 KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
+ + C + PE R + ++ +L +I ++
Sbjct: 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 61/279 (21%), Positives = 127/279 (45%), Gaps = 25/279 (8%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI 644
+ LGAG FG V+ G T VA+K + +F +E +++ ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHHSHS 703
++++ + ++ E+M NGSL +L + + L + + L++ + + ++ +
Sbjct: 72 RLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
+H +L+ NIL+ ++ +++DFG+++L+ ED++ + I + APE + G
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823
+ K DV+S+G+LL E T + T +++ + R V+P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--------------GYRMVRP 232
Query: 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
+C + L C + PE R + L+
Sbjct: 233 D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 23/276 (8%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
LG G FG V G +VAIK+ + F E +V+ N+ H L+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ C ++ E+M NG L +L + + L + DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
+H +L N L++ +VSDFG+S+ + DD+ + + + + PE S
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 767 KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826
K D++++GVL+ E ++ K E FT + +H + + Y
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------------IAQGLRLYR 222
Query: 827 KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
++ + C + ++R ++ + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 28/285 (9%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTN-----VAIKVFNLQL-ERAFRSFESECEVLRNVRH 640
++GAG FG VYKG L + VAIK E+ F E ++ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
N+I++ ++ E+M NG+L+K+L + +L+ + ++ + + +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI---AAGMKY 125
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV-TQTMTMATIGYMAPEYA 759
+ VH +L NIL++ N+ +VSDFG+S++L +D ++ T + I + APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819
S + DV+S+G+++ E T + + +K +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA------------------IN 227
Query: 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ MDC I L + C +R D+V L K+ +
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-55
Identities = 62/271 (22%), Positives = 117/271 (43%), Gaps = 9/271 (3%)
Query: 580 IQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRS-FESECEVLRN 637
++ D F + + LGAG+ G V+K + G +A K+ +L+++ A R+ E +VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
++ + + + ++ +E M GSL++ L + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
L H ++H ++KP+NIL++ ++ DFG+S L DS+ + + T YM+PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSF-VGTRSYMSPE 173
Query: 758 YASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817
S + D++S G+ L+E + P E+ L ++ T +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQ 848
R + + I L + P +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-55
Identities = 70/280 (25%), Positives = 114/280 (40%), Gaps = 31/280 (11%)
Query: 587 FNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKI 646
+G G FG V G G VA+K ++ + ++F +E V+ +RH NL+++
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 647 FSSCCNLDFK-ALVLEFMPNGSLEKWLYSHNY-FLDMLERLNIMIDVGLALEYLHHSHST 704
+V E+M GSL +L S L L +DV A+EYL +
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 122
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII 764
VH +L N+L+ ++ A+VSDFG++K S TQ + + APE +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKF 177
Query: 765 SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824
S K DV+S+G+LL E ++ + + LK + V +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVP--------------RVEKGYKM 219
Query: 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
A C + + C R + +L+ IK
Sbjct: 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-55
Identities = 66/281 (23%), Positives = 114/281 (40%), Gaps = 29/281 (10%)
Query: 593 LGAGSFGSVYKGTLF---DGTNVAIKVFNLQLERAFR-SFESECEVLRNVRHRNLIKIFS 648
LG G+FGSV +G +VAIKV E+A E +++ + + ++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 649 SCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVH 708
C LV+E G L K+L + + ++ V + ++YL VH
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVH 132
Query: 709 CNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEYASDGIISPK 767
+L N+LL A++SDFG+SK LG DD T + + APE + S +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 768 CDVYSYGVLLMETFTR-KKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826
DV+SYGV + E + +KP +M E+ + + + +
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEV-------------------MAFIEQGKRMEC 233
Query: 827 KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
+C + L C + E R V +++ +
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 9e-54
Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 29/285 (10%)
Query: 591 NLLGAGSFGSVYKGTLFDGTN----VAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIK 645
++G G FG VY GTL D A+K N + S F +E ++++ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 646 IFSSCCNLDFKA-LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ C + +VL +M +G L ++ + + + + + + V + S
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASK 149
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGYMAPEYASDG 762
VH +L N +LD+ T +V+DFG+++ + + + T + +MA E
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822
+ K DV+S+GVLL E TR P +++ L R +Q
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLL----------QGRRLLQ 255
Query: 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
P Y C + + L C E R +++V ++ I TF+
Sbjct: 256 PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 67/282 (23%), Positives = 123/282 (43%), Gaps = 25/282 (8%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI 644
+ LG G FG V+ GT T VAIK + +F E +V++ +RH L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDML-ERLNIMIDVGLALEYLHHSHS 703
++++ + + +V E+M GSL +L L + +++ + + Y+ +
Sbjct: 76 QLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGI 763
VH +L+ NIL+ +N+ +V+DFG+++L+ ED++ + I + APE A G
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823
+ K DV+S+G+LL E T+ + R + + V+ P
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NREVLDQVERGYRMPCPP 237
Query: 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865
+C + L C PE+R + L+ +
Sbjct: 238 -----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (464), Expect = 2e-52
Identities = 63/319 (19%), Positives = 116/319 (36%), Gaps = 51/319 (15%)
Query: 576 SYLDIQQATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQLERAFRS-F 628
L ++ + +G G+FG V++ T VA+K+ + ++ F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 629 ESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---------- 678
+ E ++ + N++K+ C L+ E+M G L ++L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 679 -------------LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTAR 725
L E+L I V + YL VH +L N L+ +NM +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 726 VSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK 785
++DFG+S+ + D I +M PE + + DV++YGV+L E F+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 786 PTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDS 845
E + + ++ P +C L + +L C
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILA--------------CPE----NCPLELYNLMRLCWSKL 282
Query: 846 PEQRMCMTDVVVKLQKIKQ 864
P R + LQ++ +
Sbjct: 283 PADRPSFCSIHRILQRMCE 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 589 ECNLLGAGSFGSVYKGTLFD---GTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNL 643
E LG+G+FG+V KG VA+K+ + +E V++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+++ C + LV+E G L K+L + + + + ++ V + ++YL S+
Sbjct: 71 VRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN- 127
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYMAPEYASDG 762
VH +L N+LL A++SDFG+SK L D++ + + APE +
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP-RGLTEVVDASLVREV 821
S K DV+S+GVL+ E F+ + P RG+ +++ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRGMKGSEVTAMLEKG 226
Query: 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
+ C + L C E R V ++L+
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 8e-52
Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 25/282 (8%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNL 643
+ LG G +G VY+G VA+K F E V++ ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF-LDMLERLNIMIDVGLALEYLHHSH 702
+++ C ++ EFM G+L +L N + + L + + A+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 134
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
+H +L N L+ +N +V+DFG+S+L+ D I + APE +
Sbjct: 135 --NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822
S K DV+++GVLL E T + L + L+ +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYE--------------LLEKDY 233
Query: 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
C ++ L C +P R ++ + + Q
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 59/282 (20%), Positives = 104/282 (36%), Gaps = 31/282 (10%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHR 641
+ + +G GS+G K DG + K + E + SE +LR ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 642 NLIKIFSSCCNLDFKAL--VLEFMPNGSLEKWLYSH---NYFLDMLERLNIMIDVGLALE 696
N+++ + + L V+E+ G L + +LD L +M + LAL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 697 YLH--HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
H V+H +LKP N+ LD ++ DFG++++L D + T YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYM 181
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814
+PE + + K D++S G LL E P + L I+ R +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRRIPYRYS 239
Query: 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856
L + R + +++
Sbjct: 240 DELN-----------------EIITRMLNLKDYHRPSVEEIL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 68/287 (23%), Positives = 103/287 (35%), Gaps = 29/287 (10%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFNLQL---ERAFRSFESECEVLRN 637
LG GSFG V +G +VA+K + A F E + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
+ HRNLI+++ K +V E P GSL L H + + V + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-VTQTMTMATIGYMAP 756
L +H +L N+LL ++ DFG+ + L ++DD V Q + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
E S D + +GV L E FT + G L +D
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------IDKE 230
Query: 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863
R +P DC I ++ + C PE R + L + +
Sbjct: 231 GERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-50
Identities = 66/293 (22%), Positives = 128/293 (43%), Gaps = 29/293 (9%)
Query: 578 LDIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL-----ERAFRSFESE 631
L I + T+ F + +LG+G+FG+VYKG + +G V I V +L +A + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 632 CEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDV 691
V+ +V + ++ ++ C + L+ + MP G L ++ H + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 692 GLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATI 751
+ YL +VH +L N+L+ +++DFG++KLLG ++ I
Sbjct: 121 AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 752 GYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811
+MA E I + + DV+SYGV + E T + ++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------ISS 224
Query: 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+++ R QP C + + + + C M + R +++++ K+ +
Sbjct: 225 ILEKGE-RLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-49
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 45/297 (15%)
Query: 591 NLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQLERAFR-SFESECEVLRNV-RHRN 642
LGAG+FG V + T + VA+K+ R + SE +VL + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSH-----------------NYFLDMLERL 685
++ + +C ++ E+ G L +L LD+ + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 686 NIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQT 745
+ V + +L + +H +L NILL ++ DFG+++ + D + V +
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 746 MTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL 805
+ +MAPE + + + + DV+SYG+ L E F+ + IK
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 806 PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862
E + + C P +R +V ++K
Sbjct: 266 RMLSPE-----------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 4e-49
Identities = 49/274 (17%), Positives = 106/274 (38%), Gaps = 24/274 (8%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNL-QLERAFRSFESECEVLRNVRHRN 642
+ ++ LG G++G V VA+K+ ++ + + + E + + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
++K + + + L LE+ G L + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG 123
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
+ H ++KP N+LLD+ ++SDFG++ + ++ T+ Y+APE
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 763 -IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821
+ DV+S G++L + P D+ W + + +D++ +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--- 237
Query: 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
L +++P R+ + D+
Sbjct: 238 --------------ALLHKILVENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 8e-49
Identities = 58/280 (20%), Positives = 99/280 (35%), Gaps = 35/280 (12%)
Query: 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNL---QLERAFRSFESECEVLRNVR 639
F++ +G GSFG+VY + + VAIK + Q ++ E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
H N I+ LV+E+ + + H L +E + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
+ ++H ++K NILL + ++ DFG + ++ + T +MAPE
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVI 183
Query: 760 ---SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
+G K DV+S G+ +E RK P M
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----------------- 226
Query: 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856
+ P+ + C P+ R ++
Sbjct: 227 -AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 65/300 (21%), Positives = 120/300 (40%), Gaps = 44/300 (14%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDG---TNVAIKVFNLQLER-AFRSFESECEVLRNV-R 639
+ +++G G+FG V K + + AIK + R F E EVL +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---------------LDMLER 684
H N+I + +C + + L +E+ P+G+L +L L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 685 LNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744
L+ DV ++YL +H +L NIL+ +N A+++DFG+S+ + V +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKK 183
Query: 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS 804
TM + +MA E + + + DV+SYGVLL E + M+ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----GMTCAELYE-- 237
Query: 805 LPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
+ + ++C + L C + P +R ++V L ++ +
Sbjct: 238 ------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-48
Identities = 60/299 (20%), Positives = 112/299 (37%), Gaps = 50/299 (16%)
Query: 592 LLGAGSFGSVYKGTLFDGTN------VAIKVFNLQLERAFR-SFESECEVLRNV-RHRNL 643
+LG+G+FG V T + + VA+K+ + + + R + SE +++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHN----------------------YFLDM 681
+ + +C L+ E+ G L +L S L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 682 LERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741
+ L V +E+L VH +L N+L+ ++ DFG+++ + D +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWI 801
V + + +MAPE +GI + K DV+SYG+LL E F+ + G ++
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDANFY 277
Query: 802 KLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860
K L++ I + C +R ++ L
Sbjct: 278 K--------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-48
Identities = 58/278 (20%), Positives = 101/278 (36%), Gaps = 28/278 (10%)
Query: 592 LLGAGSFGSVYKGTLFDGTN----VAIKVFNLQLERAFRS-FESECEVLRNVRHRNLIKI 646
+G G FG V++G N VAIK + R F E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 647 FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPV 706
+ +++E G L +L Y LD+ + + AL YL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---F 129
Query: 707 VHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISP 766
VH ++ N+L+ N ++ DFG+S+ + ED + I +MAPE + +
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 767 KCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYA 826
DV+ +GV + E + + I+ + +L
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNCPPTLY-------- 239
Query: 827 KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864
L C P +R T++ +L I +
Sbjct: 240 ---------SLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 57/278 (20%), Positives = 104/278 (37%), Gaps = 28/278 (10%)
Query: 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN 642
D + LG G+FG VYK A KV + + E + E ++L + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
++K+ + + +++EF G+++ + L + + AL YLH +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA--- 759
++H +LK NIL + +++DFG+S + +MAPE
Sbjct: 131 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT--PYWMAPEVVMCE 185
Query: 760 --SDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817
D K DV+S G+ L+E + P E+ + L ++ +
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------------LLKIAKSEP 232
Query: 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
QPS + C + + R + +
Sbjct: 233 PTLAQPSRWSSNF----KDFLKKCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 56/272 (20%), Positives = 114/272 (41%), Gaps = 32/272 (11%)
Query: 593 LGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSS 649
+G GSF +VYKG VA + + + F+ E E+L+ ++H N+++ + S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 650 CCNL----DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
+ LV E M +G+L+ +L + + + + L++LH + + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH-TRTPP 134
Query: 706 VVHCNLKPNNILL-DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGII 764
++H +LK +NI + + ++ D G++ L S + + + T +MAPE +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAPEMYEEKY- 189
Query: 765 SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824
DVY++G+ ++E T + P E + P +V +
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK------ 243
Query: 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856
+ GC + ++R + D++
Sbjct: 244 -----------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 59/297 (19%), Positives = 120/297 (40%), Gaps = 37/297 (12%)
Query: 587 FNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNL-QLERAFRSFESECEVLRNVR 639
LG GSFG VY+G T VAIK N R F +E V++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---------LDMLERLNIMID 690
+++++ +++E M G L+ +L S + + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ + YL+ + VH +L N ++ ++ T ++ DFG+++ + E D +
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810
+ +M+PE DG+ + DV+S+GV+L E T + + + E L+ ++ L
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD--- 255
Query: 811 EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867
+P +C + L C +P+ R +++ +++ +
Sbjct: 256 -----------KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 7e-47
Identities = 64/277 (23%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFN---LQLERAFRSFESECEVLRNVRH 640
+ F LG G FG+VY +A+KV L+ E E+ ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
N+++++ + L+LE+ P G++ + L + F D + ++ AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH- 123
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
S V+H ++KP N+LL +++DFG S +T T+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIE 177
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH-WIKLSLPRGLTEVVDASLVR 819
+ K D++S GVL E K P + E + ++ + P +TE
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE-------- 229
Query: 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVV 856
L +P QR + +V+
Sbjct: 230 -------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-46
Identities = 57/273 (20%), Positives = 108/273 (39%), Gaps = 25/273 (9%)
Query: 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN 642
+ +G G+ G+VY + G VAI+ NLQ + +E V+R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
++ S D +V+E++ GSL + + + + ALE+LH +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLHSNQ 136
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
V+H ++K +NILL + + +++DFG + + ++ + T +MAPE +
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK 191
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822
PK D++S G++ +E + P + E L+ L +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRA---------LYLIATNGTPELQN 238
Query: 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
P C E+R ++
Sbjct: 239 PEKLSAIFR----DFLNRCLDMDVEKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 48/236 (20%), Positives = 97/236 (41%), Gaps = 9/236 (3%)
Query: 581 QQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERAFRSFESECEVLR 636
++ + F +LG GSF +V L AIK+ + E E +V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 637 NVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALE 696
+ H +K++ + + + L + NG L K++ F D ++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEI---VS 119
Query: 697 YLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
L + H ++H +LKP NILL+++M +++DFG +K+L + + T Y++P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW-IKLSLPRGLTE 811
E ++ D+++ G ++ + P + K ++ P
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (411), Expect = 1e-44
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 9/205 (4%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNL 643
D ++ LG G+FG V++ T G N A K E + E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+ + + + + ++ EFM G L + + + + E + M V L ++H ++
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 704 TPVVHCNLKPNNILL--DKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
VH +LKP NI+ ++ ++ DFG++ L T T + APE A
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 199
Query: 762 GIISPKCDVYSYGVLLMETFTRKKP 786
+ D++S GVL + P
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 66/303 (21%), Positives = 117/303 (38%), Gaps = 46/303 (15%)
Query: 585 DGFNECNLLGAGSFGSVYKGTL--------FDGTNVAIKVFNLQL-ERAFRSFESECEVL 635
D LG G+FG V T VA+K+ E+ SE E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 636 RNV-RHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYF---------------L 679
+ + +H+N+I + +C +++E+ G+L ++L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 680 DMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739
+ ++ V +EYL S +H +L N+L+ ++ +++DFG+++ + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKH 799
T + +MAPE D I + + DV+S+GVLL E FT E K
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 248
Query: 800 WIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKL 859
L++E +C + + C P QR +V L
Sbjct: 249 -----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 860 QKI 862
+I
Sbjct: 292 DRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (405), Expect = 8e-44
Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 9/205 (4%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNL 643
D ++ LG+G+FG V++ G K N + ++E ++ + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
I + + + L+LEF+ G L + + +Y + E +N M L+++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 147
Query: 704 TPVVHCNLKPNNILLDKNMTARV--SDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD 761
+VH ++KP NI+ + + V DFG++ L D+ +T AT + APE
Sbjct: 148 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR 202
Query: 762 GIISPKCDVYSYGVLLMETFTRKKP 786
+ D+++ GVL + P
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 44/304 (14%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNL-QLERAFRSFESECEVLRN 637
D LG G+FG V + F VA+K+ R+ SE ++L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 638 VRHRNLIKIFSSCCNLDFKAL--VLEFMPNGSLEKWLYSHNY---------------FLD 680
+ H + C L ++EF G+L +L S FL
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 681 MLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740
+ + V +E+L +H +L NILL + ++ DFG+++ + +D D
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW 800
V + + +MAPE D + + + DV+S+GVLL E F+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 801 IKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQ 860
+K R P Y + L C P QR +++V L
Sbjct: 250 LK-------------EGTRMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 861 KIKQ 864
+ Q
Sbjct: 293 NLLQ 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (381), Expect = 2e-41
Identities = 59/289 (20%), Positives = 118/289 (40%), Gaps = 30/289 (10%)
Query: 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVR 639
+D + +LG G V+ L +VA+KV L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 640 HRNLIKIFSSCCNLDFKA----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
H ++ ++ + +V+E++ +L +++ + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-TIGYM 754
+ H + ++H ++KP NI++ +V DFGI++ + + +SVTQT + T Y+
Sbjct: 125 NFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814
+PE A + + DVYS G +L E T + P ++ +H + +P
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP-------- 233
Query: 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-CMTDVVVKLQKI 862
PS + + L +PE R ++ L ++
Sbjct: 234 --------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 4e-40
Identities = 60/287 (20%), Positives = 103/287 (35%), Gaps = 29/287 (10%)
Query: 572 WRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQ-LERAFRSFE 629
W++ DI+ D ++ ++LG G+F V VAIK + LE S E
Sbjct: 1 WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55
Query: 630 SECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMI 689
+E VL ++H N++ + + L+++ + G L + F + ++
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114
Query: 690 DVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMA 749
V A++YLH LD++ +SDFG+SK+ ED SV T
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA-CG 171
Query: 750 TIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW-IKLSLPRG 808
T GY+APE + S D +S GV+ P + ++ + +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
Query: 809 LTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
+ + S PE+R
Sbjct: 232 YWDDISDSAK-----------------DFIRHLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (377), Expect = 6e-40
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 16/241 (6%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNL------QLERAFRSFESECEVLRN 637
+ F+ ++G G FG VY D G A+K + Q E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
++ + + D + +L+ M G L L H F + + ++ L LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE 757
+H+ VV+ +LKP NILLD++ R+SD G++ + ++ T GYMAPE
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPE 175
Query: 758 YASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
G+ D +S G +L + P + T + + L++ L +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 817 L 817
L
Sbjct: 236 L 236
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 10/198 (5%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
LG G FG V++ K ++ + E +L RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+++ ++ EF+ + + + + + L+ E ++ + V AL++L HS + H +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFD 127
Query: 711 LKPNNILLD--KNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKC 768
++P NI+ ++ T ++ +FG ++ L D + Y APE ++S
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 769 DVYSYGVLLMETFTRKKP 786
D++S G L+ + P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (364), Expect = 1e-38
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 14/232 (6%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRH 640
F LG GSFG V+ +G A+KV ++ + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
+I+++ + + ++++++ G L + +V L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEV---CLALEY 119
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
HS +++ +LKP NILLDKN +++DFG +K + + ++ T Y+APE S
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVS 174
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW-IKLSLPRGLTE 811
+ D +S+G+L+ E P + T + K +L P E
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (357), Expect = 3e-38
Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 27/243 (11%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNL---------QLERAFRSFESECEV 634
+ + +LG G V + A+K+ ++ +++ + E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 635 LRNVR-HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGL 693
LR V H N+I++ + F LV + M G L +L L E IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 121
Query: 694 ALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGY 753
+ LH + +VH +LKP NILLD +M +++DFG S L D T Y
Sbjct: 122 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175
Query: 754 MAPEYASDGI------ISPKCDVYSYGVLLMETFTRKKP---TDEMFTGEMSLKHWIKLS 804
+APE + + D++S GV++ P +M M + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 805 LPR 807
P
Sbjct: 236 SPE 238
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 16/246 (6%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFN---LQLERAFRSFESECEVL-RNVR 639
+ F +LG GSFG V+ AIK + ++ E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 640 HRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLH 699
H L +F + + V+E++ G L + S + F D+ ++ L L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYA 759
+V+ +LK +NILLDK+ +++DFG+ K D T Y+APE
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEIL 175
Query: 760 SDGIISPKCDVYSYGVLLMETFTRKKP-----TDEMFTGEMSLKHWIKLSLPRGLTEVVD 814
+ D +S+GVLL E + P +E+F + L + +++
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235
Query: 815 ASLVRE 820
VRE
Sbjct: 236 KLFVRE 241
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (353), Expect = 1e-37
Identities = 55/283 (19%), Positives = 111/283 (39%), Gaps = 18/283 (6%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRN 642
+ ++ +G G++G VYK G A+K L+ E + E +L+ ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
++K++ LV E + + L+K L L+ + + ++ + L + + H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQL---LNGIAYCH 117
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YASD 761
V+H +LKP N+L+++ +++DFG+++ G T + + Y AP+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGS 175
Query: 762 GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR-----GLTEVVDAS 816
S D++S G + E + + ++ + L P +TE+
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 817 LVREVQPSYAKMDCLLRI----MHLALGCCMDSPEQRMCMTDV 855
V L + + L P QR+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-37
Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 21/280 (7%)
Query: 591 NLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL-----ERAFRSFESECEVLRNVRHRNLI 644
+ LG G F +VYK VAIK L + R+ E ++L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 645 KIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHST 704
+ + + +LV +FM + ++ L M+ L+ L + H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMT---LQGLEYLHQH 119
Query: 705 PVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASD-GI 763
++H +LKPNN+LLD+N +++DFG++K G + T + T Y APE +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARM 177
Query: 764 ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823
D+++ G +L E R + + + L P SL V
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 824 SYAKMDCLLRI--------MHLALGCCMDSPEQRMCMTDV 855
L I + L G + +P R+ T
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 57/284 (20%), Positives = 108/284 (38%), Gaps = 18/284 (6%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHR 641
+ F + +G G++G VYK G VA+K L E + E +L+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS 701
N++K+ + LV EF+ + S + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 702 HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YAS 760
V+H +LKP N+L++ +++DFG+++ G + T + + Y APE
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILLG 176
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL--V 818
S D++S G + E TR+ + + + L P + S+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 819 REVQPSYAKMDCLLRI-------MHLALGCCMDSPEQRMCMTDV 855
+ P +A+ D + L P +R+
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 25/292 (8%)
Query: 583 ATDGFNECNLLGAGSFGSVYKGT--LFDGTNVAIKVFNLQL--ERAFRSFESECEVLR-- 636
A + +G G++G V+K G VA+K +Q E S E VLR
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 637 -NVRHRNLIKIFSSCCNLDFKA-----LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMID 690
H N++++F C LV E + + ++M
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 691 VGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMAT 750
+ L++LH VVH +LKP NIL+ + +++DFG++++ T + T
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
Query: 751 IGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLT 810
+ Y APE + D++S G + E F RK + K + LP
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 811 EVVDASLVREVQPSYAKMDCLLRIMH-------LALGCCMDSPEQRMCMTDV 855
D +L R+ S + + L L C +P +R+
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-36
Identities = 47/229 (20%), Positives = 91/229 (39%), Gaps = 9/229 (3%)
Query: 584 TDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFN-LQLERAFRSFESECEVLRNVRHR 641
+ + +G G++G V + VAIK + + + + E ++L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 642 NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYS--HNYFLDMLERLNIMIDVGLALEYLH 699
N+I I + + ++ + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 700 HSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT-MATIGYMAPEY 758
++ V+H +LKP+N+LL+ ++ DFG++++ D D +AT Y APE
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 759 ASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP 806
+ + D++S G +L E + + + L P
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (341), Expect = 5e-36
Identities = 45/281 (16%), Positives = 87/281 (30%), Gaps = 31/281 (11%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G GSFG +++GT L + VAIK + + E + + I
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+++ + SLE L + + ++ +H +V+ +
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126
Query: 711 LKPNNILLDKNMT-----ARVSDFGISKLLGEDDDSVTQTMTMA-----TIGYMAPEYAS 760
+KP+N L+ + + V DFG+ K + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW-------------IKLSLPR 807
S + D+ + G + M P + K+ + P
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246
Query: 808 GLTEVVDA--SLVREVQPSYAKMDCLLRIMHLALGCCMDSP 846
+ + +L + P Y + L + L D
Sbjct: 247 EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-36
Identities = 56/273 (20%), Positives = 103/273 (37%), Gaps = 31/273 (11%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+LG G G V + A+K+ +A R E R + ++++I
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELH---WRASQCPHIVRIVDVY 74
Query: 651 CNLDFKA----LVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTP 705
NL +V+E + G L + + E IM +G A++YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 131
Query: 706 VVHCNLKPNNILLDK---NMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
+ H ++KP N+L N +++DFG +K + + T T Y+APE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPE 188
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822
CD++S GV++ P +S ++ + +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----------YEFPN 238
Query: 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
P ++++ ++ L P QRM +T+
Sbjct: 239 PEWSEVSEEVK--MLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 53/224 (23%), Positives = 84/224 (37%), Gaps = 21/224 (9%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRS------FESECEVLRNVR--HRN 642
LLG+G FGSVY G + D VAIK + E +L+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 643 LIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
+I++ D L+LE + L + V A+ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 703 STPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEY-AS 760
V+H ++K NIL+D N ++ DFG LL + T T Y PE+
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY 183
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKP---TDEMFTGEMSLKHWI 801
V+S G+LL + P +E+ G++ + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 227
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 4e-35
Identities = 50/279 (17%), Positives = 94/279 (33%), Gaps = 29/279 (10%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
+G+GSFG +Y GT + G VAIK+ ++ + E ++ + ++ I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCN 710
+++ + SLE + + L + + +EY+H + +H +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128
Query: 711 LKPNNIL---LDKNMTARVSDFGISKLLGEDDDSVTQTMTMA-----TIGYMAPEYASDG 762
+KP+N L K + DFG++K + T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW-------------IKLSLPRGL 809
S + D+ S G +LM P + K+ + P
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 810 TEVVDASLVREVQ--PSYAKMDCLLRIMHLALGCCMDSP 846
++ P Y+ + L R + G D
Sbjct: 249 ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 287
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-34
Identities = 52/283 (18%), Positives = 96/283 (33%), Gaps = 36/283 (12%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL------ERAFRSFESECEVLRN 637
D ++ LG+G F V K G A K + + E E +L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 638 VRHRNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEY 697
++H N+I + N L+LE + G L +L + E + + L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQI---LNG 125
Query: 698 LHHSHSTPVVHCNLKPNNILLDKNMTAR----VSDFGISKLLGEDDDSVTQTMTMATIGY 753
+++ HS + H +LKP NI+L + + DFG++ + ++ T +
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 182
Query: 754 MAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHW-IKLSLPRGLTEV 812
+APE + + + D++S GV+ + P E +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 813 VDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDV 855
A + P++RM + D
Sbjct: 243 TSALAK-----------------DFIRRLLVKDPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 11/232 (4%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRH 640
+ F+ LLG G+FG V G A+K+ ++ + +E VL+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
L + + D V+E+ G L L F + ++ + L +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEI---VSALEY 120
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
HS VV+ ++K N++LDK+ +++DFG+ K D T T Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE 178
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWI-KLSLPRGLTE 811
D D + GV++ E + P + + ++ PR L+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 60/303 (19%), Positives = 116/303 (38%), Gaps = 46/303 (15%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNL 643
+ + +G G+FG V+K G VA+K ++ E + E ++L+ ++H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 644 IKIFSSCCNLDFKA--------LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
+ + C LV +F + F + E +M + L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQML---L 127
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMT--MATIGY 753
L++ H ++H ++K N+L+ ++ +++DFG+++ +S T + T+ Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 754 MAPE-YASDGIISPKCDVYSYGVLLMETFTRKKP--------------------TDEMFT 792
PE + P D++ G ++ E +TR T E++
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 793 GEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCM 852
+ + + KL L +G V L V+ YA L + P QR+
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL--------DLIDKLLVLDPAQRIDS 299
Query: 853 TDV 855
D
Sbjct: 300 DDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-34
Identities = 51/283 (18%), Positives = 112/283 (39%), Gaps = 20/283 (7%)
Query: 587 FNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNL 643
+ + +G G++G+V+K VA+K L E S E +L+ ++H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 644 IKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHS 703
+++ + LV EF + + + + + + L+ L HS
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQL---LKGLGFCHS 119
Query: 704 TPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPE-YASDG 762
V+H +LKP N+L+++N ++++FG+++ G + + T+ Y P+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK 177
Query: 763 IISPKCDVYSYGVLLMETFTRKKP------TDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
+ S D++S G + E +P D+ L +T++ D
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 817 LVREVQPSYAKMDCLLRI----MHLALGCCMDSPEQRMCMTDV 855
+ + ++ + ++ L +P QR+ +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-33
Identities = 52/288 (18%), Positives = 99/288 (34%), Gaps = 28/288 (9%)
Query: 587 FNECNLLGAGSFGSVYKGTLFD-GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIK 645
+ + ++G GSFG VY+ L D G VAIK E +++R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77
Query: 646 IFSSCC------NLDFKALVLEFMPNGSLEKWLY--SHNYFLDMLERLNIMIDVGLALEY 697
+ + + LVL+++P + L ++ M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 698 LHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAP 756
+H + H ++KP N+LLD + ++ DFG +K L + +
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192
Query: 757 EYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816
+ DV+S G +L E + + ++ L P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 817 LVREVQPSYAKMDCLLRIM---------HLALGCCMDSPEQRMCMTDV 855
E + K ++ L +P R+ +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (314), Expect = 8e-32
Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 19/223 (8%)
Query: 585 DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRH 640
D F+ LG GSFG V G + A+K+ + Q + +E +L+ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 641 RNLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH 700
L+K+ S + +V+E++ G + L F + L EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHS 159
Query: 701 SHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYAS 760
+++ +LKP N+L+D+ +V+DFG +K + ++ T +APE
Sbjct: 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIIL 211
Query: 761 DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE--MSLKHWI 801
+ D ++ GVL+ E P F + + + I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKI 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-29
Identities = 48/244 (19%), Positives = 93/244 (38%), Gaps = 32/244 (13%)
Query: 568 NRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERA 624
+T W +++ + + +G+G++G+V G VAIK E
Sbjct: 10 TKTAW------EVR---AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 625 FRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA------LVLEFMPNGSLEKWLYSHNYF 678
+ E +L+++RH N+I + + LV+ FM G+ L H
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK- 117
Query: 679 LDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738
L ++ + L Y+H + H +LKP N+ ++++ ++ DFG+++
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA--- 171
Query: 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLK 798
DS + + + D++S G ++ E T K F G L
Sbjct: 172 -DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLD 226
Query: 799 HWIK 802
+
Sbjct: 227 QLKE 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-29
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 20/230 (8%)
Query: 585 DGFNECNLLGAGSFGSVYKGTLF----DGTNVAIKVFN----LQLERAFRSFESECEVLR 636
+ F +LG G++G V+ G A+KV +Q + +E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 637 NVRHR-NLIKIFSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
++R L+ + + L+L+++ G L L F + + I VG +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH----EVQIYVGEIV 139
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMA 755
L H H +++ ++K NILLD N ++DFG+SK D+ TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMA 198
Query: 756 PEYASDGI--ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL 803
P+ G D +S GVL+ E T P FT + ++
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEI 244
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (288), Expect = 1e-28
Identities = 48/233 (20%), Positives = 100/233 (42%), Gaps = 25/233 (10%)
Query: 566 YRNRTTWRRTSYLDIQQAT------DGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFN 618
Y + T R Y D + D + LG G + V++ + + V +K+
Sbjct: 10 YTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69
Query: 619 LQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFK--ALVLEFMPNGSLEKWLYSH 675
++ + E ++L N+R N+I + + + ALV E + N ++ +
Sbjct: 70 PVKKKKIK---REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT- 125
Query: 676 NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD-KNMTARVSDFGISKL 734
L + M ++ AL+Y H ++H ++KP+N+++D ++ R+ D+G+++
Sbjct: 126 ---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 735 LGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKP 786
+ +A+ + PE D + D++S G +L RK+P
Sbjct: 180 YHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 23/220 (10%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFS 648
+G+G+ G V NVAIK + + + E +++ V H+N+I + +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 649 SCCNLDFK------ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSH 702
LV+E M + D ++ + +++LH +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSAG 139
Query: 703 STPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDG 762
++H +LKP+NI++ + T ++ DFG+++ G T + T Y APE
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM 193
Query: 763 IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK 802
D++S G ++ E K F G + W K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNK 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-27
Identities = 38/226 (16%), Positives = 86/226 (38%), Gaps = 24/226 (10%)
Query: 568 NRTTWRRTSYLDIQQATDGFNECNLLGAGSFGSVYKGT-LFDGTNVAIKVFNLQL--ERA 624
N+T W + + + + +G+G++GSV G VA+K +
Sbjct: 10 NKTIW---------EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 625 FRSFESECEVLRNVRHRNLIKIFSSC----CNLDFKALVLEFMPNGSLEKWLYSHNYFLD 680
+ E +L++++H N+I + +F + L G+ + D
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 681 MLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740
++ + L+Y+H + H +LKP+N+ ++++ ++ DFG+++ D
Sbjct: 121 D-HVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR----HTD 172
Query: 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
+ + D++S G ++ E T +
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (266), Expect = 1e-25
Identities = 42/212 (19%), Positives = 79/212 (37%), Gaps = 20/212 (9%)
Query: 592 LLGAGSFGSVYKGT-LFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSC 650
LG G F +V+ + + T+VA+K+ + + E E ++L+ V + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 651 CNLDFK---------------ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLAL 695
N K +V E + L + + ++ I + L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 696 EYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGISKLLGEDDDSVTQTMTMATIGYM 754
+Y+H ++H ++KP N+L++ + I+ L T ++ T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 755 APEYASDGIISPKCDVYSYGVLLMETFTRKKP 786
+PE D++S L+ E T
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 88/429 (20%), Positives = 149/429 (34%), Gaps = 66/429 (15%)
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
++ L + T + + +L + L + I +I + L L +NF++N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
L P + NL L D+++ N + P T + + +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRA 241
+ + I+ S L L S NL L L+I +
Sbjct: 135 NRLELSSNTIS----------DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184
Query: 242 NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
N S +S L L +L +N + I P + + + +L
Sbjct: 185 NK----------VSDISVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQL 231
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLIS 361
K + +L L L L N ++ P LS L
Sbjct: 232 KD--IGTLASLTNLTDLDLANNQISNLAP-------------------------LSGLTK 264
Query: 362 LRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421
L +L LG+NQ+++ P L + ++L+ N L S I NLK L YL L N +S
Sbjct: 265 LTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNIS 320
Query: 422 GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSH 481
P + L L L A N+ D S +LT++ +L +N +S P L+
Sbjct: 321 DISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTR 374
Query: 482 LKRLNVSHN 490
+ +L ++
Sbjct: 375 ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 5e-20
Identities = 79/396 (19%), Positives = 153/396 (38%), Gaps = 46/396 (11%)
Query: 13 NLSFLMYLDISENNFRGYLP-NELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLR 71
L+ M + + N + +L Q+ L+ + G + + L ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 72 NNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIP--- 128
NN T P L NL+ LV + N I+ P + L +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 129 ---------NEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTM 179
N I ++ L+ L G T + ++ + + + + ++
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 180 GHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNI 239
L N + L+ N+++ P I + L L LN N L T +L +L+ L++
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 240 RANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHEC 299
N ++ L+ L+ KL L LG+N + +I PL G + + + ++
Sbjct: 249 ANNQISN----------LAPLSGLTKLTELKLGANQISNI-SPLAGLTALTNLELNENQL 297
Query: 300 KLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSS 358
+ I NL+ L L+L+ N+++ P + L +LQ L N ++ + L++
Sbjct: 298 E----DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 359 LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSN 394
L ++ L G NQ++ P +L I ++ L+
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 1e-17
Identities = 68/320 (21%), Positives = 123/320 (38%), Gaps = 37/320 (11%)
Query: 203 SITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTN 262
+ + L ++ ++N L+ P NL L + + N + T +
Sbjct: 61 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118
Query: 263 CNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFT 322
N++ + N + L N + + S ++ +L+ L L+
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178
Query: 323 ----NDLNGTIPTTLGRLQQLQALLQRNN-LNGPIPTCLSSLISLRQLHLGSNQLTSSIP 377
+ + + L +L L++L+ NN ++ P + + +L +L L NQL
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--I 234
Query: 378 SSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPIT---------- 427
+ SL + +DL++N +S P + L L L L NQ+S P+
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 428 ----------IGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFE 477
I LK+L L+L N D P SLT L+ L +NN +S S
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348
Query: 478 ILSHLKRLNVSHNRLEGKIP 497
L+++ L+ HN++ P
Sbjct: 349 NLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.6 bits (156), Expect = 2e-11
Identities = 36/158 (22%), Positives = 57/158 (36%), Gaps = 28/158 (17%)
Query: 8 PPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFP----------- 56
+ +L+ L LD++ N P L L +L L N ++ P
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 57 ---------SWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
S I L L+L N+ + P + +L+ L RL N +S S +
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347
Query: 108 GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALN 145
NLT + L+ N + P + NL + L L
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 7e-06
Identities = 11/68 (16%), Positives = 27/68 (39%), Gaps = 4/68 (5%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
+ + +L+ L L + N + L L + +L +N ++ P + +++
Sbjct: 320 SDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRI 375
Query: 66 QVLSLRNN 73
L L +
Sbjct: 376 TQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 17/85 (20%), Positives = 35/85 (41%), Gaps = 6/85 (7%)
Query: 406 NLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSN 465
L + L + ++ ++ L + TL R + D L +L ++ SN
Sbjct: 20 ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 466 NNLSGEIPKSFEILSHLKRLNVSHN 490
N L+ P + L+ L + +++N
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 6e-04
Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 4/68 (5%)
Query: 430 GLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSH 489
L + + L + D++ + L + L + E L++L ++N S+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 490 NRLEGKIP 497
N+L P
Sbjct: 76 NQLTDITP 83
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 3e-18
Identities = 51/271 (18%), Positives = 101/271 (37%), Gaps = 10/271 (3%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
VP + LD+ N + L+ L L N ++ P KL
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
+ L L N L L ++ + ++ + + N +V L G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSG 140
Query: 126 EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPN 185
+K L+ + +A N+ IP + ++ ++L GN+++ +++ L N
Sbjct: 141 IENGAFQGMKKLSYIRIADTNI-TTIPQGLP--PSLTELHLDGNKITKVDAASL-KGLNN 196
Query: 186 RQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLT 245
L L N ++ S+ N L L LN+N L ++P + +++ + + N ++
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255
Query: 246 TETSSNGEWSFLSSLTNCNKLRALSLGSNPL 276
+ ++ T +SL SNP+
Sbjct: 256 --AIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.4 bits (202), Expect = 1e-17
Identities = 45/287 (15%), Positives = 92/287 (32%), Gaps = 43/287 (14%)
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
LDL +N ++ F NL++L TL + N ++ + + KL L L
Sbjct: 36 LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG--------AFAPLVKLERLYLS 87
Query: 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTT 332
N L + + + L + ++
Sbjct: 88 KNQLKELPEKMPKTL-------------------------QELRVHENEITKVRKSVFNG 122
Query: 333 LGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLS 392
L ++ ++ +G + L + + +T+ SL + L
Sbjct: 123 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLD 179
Query: 393 SNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSF 452
N ++ + ++ L L L LS N +S ++ L L L N+ +P
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGL 238
Query: 453 GSLTSLEYLDLSNNNLSGEIPKSFEI------LSHLKRLNVSHNRLE 493
++ + L NNN+S F + +++ N ++
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.2 bits (199), Expect = 3e-17
Identities = 47/218 (21%), Positives = 82/218 (37%), Gaps = 7/218 (3%)
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISL 362
+PK++ L L N + L+ L L L N ++ P + L+ L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
+L+L NQL +P LR+ + + + N +++ L + + SG
Sbjct: 82 ERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140
Query: 423 NIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHL 482
G+K L + +A +IP SL L L N ++ S + L++L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 483 KRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPP 520
+L +S N + + L + L N L P
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.0 bits (188), Expect = 7e-16
Identities = 45/266 (16%), Positives = 90/266 (33%), Gaps = 12/266 (4%)
Query: 2 SLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGV 61
+ NL L L + N P L +L+ L + N L
Sbjct: 42 KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKT 101
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
+L+V + N L N +V L + SG + KL ++ AD
Sbjct: 102 LQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
N+ IP G +L +L L N + ++ ++ + + L N +S ++ +
Sbjct: 161 NIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217
Query: 182 SLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTF------GNLRHLS 235
+ R+ L +P + + + + L++N++S N F S
Sbjct: 218 TPHLRELHLNNNK--LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 275
Query: 236 TLNIRANYLTTETSSNGEWSFLSSLT 261
+++ +N + + +
Sbjct: 276 GVSLFSNPVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.1 bits (183), Expect = 3e-15
Identities = 40/235 (17%), Positives = 78/235 (33%), Gaps = 20/235 (8%)
Query: 60 GVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFA 119
+ +L L+NN T NL +L L N IS P L KL L +
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 120 DNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTM 179
N L+ L+ L + + + + + + + + SG
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAF 146
Query: 180 GHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNI 239
+ ++ + +T TIP + L L L+ N ++ + L +L+ L +
Sbjct: 147 QG-MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202
Query: 240 RANYL---------------TTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSI 279
N + ++N L + ++ + L +N + +I
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.6 bits (174), Expect = 5e-14
Identities = 47/221 (21%), Positives = 85/221 (38%), Gaps = 7/221 (3%)
Query: 286 NFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR 345
+ K+ + NL+ L L L N ++ P L +L+ L
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 346 NNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSS--NSLSGSLPSD 403
N +P + +L++L + N++T S F L ++ ++L + SG
Sbjct: 88 KNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 145
Query: 404 IQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDL 463
Q +K L Y+ ++ ++ I G L L L N+ S L +L L L
Sbjct: 146 FQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202
Query: 464 SNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRN 504
S N++S S HL+ L++++N+L +
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.3 bits (168), Expect = 3e-13
Identities = 54/331 (16%), Positives = 108/331 (32%), Gaps = 52/331 (15%)
Query: 93 DSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIP 152
D + ++P L+ +N + + NLKNL L+L N + P
Sbjct: 19 DLGLEKVPKDLP------PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72
Query: 153 TTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIG 212
L + L L N+L +P + +
Sbjct: 73 GAFAP-------------------------LVKLERLYLSKNQLK-ELPEKMPKTLQE-- 104
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
L ++ N ++ + F L + + + N L + NG + + L+ +
Sbjct: 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR------IA 158
Query: 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTT 332
+ +I S + + K+ + L L L L N ++ +
Sbjct: 159 DTNITTIPQ----GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214
Query: 333 LGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR---- 388
L L+ L NN +P L+ ++ ++L +N +++ + F Y +
Sbjct: 215 LANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274
Query: 389 --IDLSSNSLSGS--LPSDIQNLKVLIYLNL 415
+ L SN + PS + + V + L
Sbjct: 275 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 66.2 bits (160), Expect = 3e-12
Identities = 42/247 (17%), Positives = 83/247 (33%), Gaps = 14/247 (5%)
Query: 1 MSLGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIG 60
+ P L L L +S+N + L+ L+ + S + +
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
++ L +G + + L + +I+ IP G L L+
Sbjct: 125 QMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDG 180
Query: 121 NNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMG 180
N + + L NLA L L+ N++ ++ N + ++L N+L +
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL--VKVPGGL 238
Query: 181 HSLPNRQFLLLWANRLTG------TIPNSITNASKLIGLDLNSNSLSGQ--IPNTFGNLR 232
Q + L N ++ P T + G+ L SN + P+TF +
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298
Query: 233 HLSTLNI 239
+ + +
Sbjct: 299 VRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 27/132 (20%), Positives = 44/132 (33%), Gaps = 3/132 (2%)
Query: 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSI 448
+ S L +P D+ L+L N+++ LK+L TL L N+
Sbjct: 15 VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 449 PDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQ 508
P +F L LE L LS N L K + L L+ ++ + +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131
Query: 509 SFLWNYALCGPP 520
+
Sbjct: 132 GTNPLKSSGIEN 143
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 6e-08
Identities = 33/145 (22%), Positives = 59/145 (40%), Gaps = 6/145 (4%)
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420
LR + L +P +DL +N ++ D +NLK L L L N++
Sbjct: 11 HLRVVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILS 480
S P L L L L++N+ + +P+ +L+ L + N ++ F L+
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLN 124
Query: 481 HLKRLNVSHNRLEGKIPTNGPFRNF 505
+ + + N L+ NG F+
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGM 149
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 9e-18
Identities = 22/162 (13%), Positives = 48/162 (29%), Gaps = 22/162 (13%)
Query: 591 NLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL----------ERAFRSFESECEVLRNVRH 640
L+G G +V+ +K + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 641 RNLIKI--FSSCCNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYL 698
R L K+ + ++ + +E Y + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAV------LMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 699 HHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740
+H +VH +L N+L+ + DF S +GE+
Sbjct: 120 YHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.2 bits (196), Expect = 8e-17
Identities = 50/279 (17%), Positives = 103/279 (36%), Gaps = 11/279 (3%)
Query: 197 TGTIPNSITNASKLIGLDLNSNSLSG--QIPNTFGNLRHLSTLNIRANYLTTETSSNGEW 254
G + ++ T ++ LDL+ +L IP++ NL +L+ L I N
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN-------NLVG 91
Query: 255 SFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRG 314
++ +L L + + +P + +++ L G++P I +L
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY-NALSGTLPPSISSLPN 150
Query: 315 LIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTS 374
L+ ++ N ++G IP + G +L + + + S +
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210
Query: 375 SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDL 434
S + + + + + + K L L+L N++ G +P + LK L
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 435 ITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIP 473
+L+++ N IP G+L + +NN P
Sbjct: 271 HSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.6 bits (179), Expect = 1e-14
Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 26/256 (10%)
Query: 12 GNLSFLMYLDISENNFRGY--LPNELGQLRRLKFLGFAYND-LTGSFPSWIGVFSKLQVL 68
+ LD+S N +P+ L L L FL + L G P I ++L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 69 SLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIP 128
+ + + +G IP+ L + +LV LD +N++SG +P I +L LV + F N + G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 129 NEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIIN----------------------L 166
+ G+ L + N + F + ++ +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 167 VGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPN 226
+ S N L L NR+ GT+P +T L L+++ N+L G+IP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 227 TFGNLRHLSTLNIRAN 242
GNL+ N
Sbjct: 287 -GGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 7e-14
Identities = 57/271 (21%), Positives = 103/271 (38%), Gaps = 22/271 (8%)
Query: 105 SKIGNLTKLVHLNFADNNLRG--EIPNEIGNLKNLADLVLALN-NLIGPIPTTIFNISTI 161
++ +L+ + NL IP+ + NL L L + NL+GPIP I ++ +
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 162 IIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLS 221
+ + +SG P + + N L+GT+P SI++ L+G+ + N +S
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSY-NALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 222 GQIPNTFG--------------NLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLR 267
G IP+++G L L S +S+ +
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 268 ALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNG 327
+ S + ++ G++P+ + L+ L +L++ N+L G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 328 TIPTTLGRLQQLQALLQRNNLN---GPIPTC 355
IP G LQ+ NN P+P C
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (182), Expect = 3e-15
Identities = 60/278 (21%), Positives = 97/278 (34%), Gaps = 16/278 (5%)
Query: 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGE 253
L +P I AS+ + L+ N +S +F R+L+ L + +N L ++
Sbjct: 21 QGLQ-AVPVGIPAASQR--IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 254 WSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLR 313
L + + L L L + C L+ P L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRL--------HTLHLDRCGLQELGPGLFRGLA 129
Query: 314 GLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGSNQL 372
L L L N L T L L L L N ++ L SL +L L N++
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 373 TSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLK 432
P +F L ++ + L +N+LS + L+ L YL L+ N +
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWA 248
Query: 433 DLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG 470
L + + S+P L + L+ N+L G
Sbjct: 249 WLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 62/275 (22%), Positives = 94/275 (34%), Gaps = 17/275 (6%)
Query: 54 SFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKL 113
+ P I + Q + L N + S +L L N ++ + L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 114 VHLNFADNNLRGEI-PNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172
L+ +DN + P L L L L L P ++ + + L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 173 GHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLR 232
T L N L L NR++ + L L L+ N ++ P+ F +L
Sbjct: 143 ALPDDTF-RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 233 HLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQ 292
L TL + AN L+ +L L+ L L NP A Q
Sbjct: 202 RLMTLYLFANNLS--------ALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQ 251
Query: 293 QFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNG 327
+F ++ S+P+ L G L NDL G
Sbjct: 252 KFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (163), Expect = 8e-13
Identities = 48/273 (17%), Positives = 83/273 (30%), Gaps = 16/273 (5%)
Query: 151 IPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKL 210
+P I + I L GN++S ++ L A
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 211 IGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALS 270
++ L P TF L L TL++ + L+ L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG--------LQELGPGLFRGLAALQYLY 135
Query: 271 LGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIP 330
L N L ++ + + + H ++ + L L L L N + P
Sbjct: 136 LQDNALQALPDDTFRDLG-NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 331 TTLGRLQQLQALLQRNNLNGPI-PTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRI 389
L +L L N + L+ L +L+ L L N + ++ +
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKF 253
Query: 390 DLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
SS+ + SLP + + L+ N L G
Sbjct: 254 RGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (154), Expect = 1e-11
Identities = 44/265 (16%), Positives = 71/265 (26%), Gaps = 32/265 (12%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYND--------------- 50
VP I + + N R L L N
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 51 ----------LTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSIS 100
L P+ +L L L P L++L L + N++
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 101 GNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIST 160
+L L HL N + L +L L+L N + P ++
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 161 IIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSL 220
++ + L N LS + Q+L L N + L +S+ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPL-RALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEV 260
Query: 221 SGQIPNTFGNLRHLSTLNIRANYLT 245
+P L + AN L
Sbjct: 261 PCSLPQ---RLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (145), Expect = 2e-10
Identities = 57/241 (23%), Positives = 81/241 (33%), Gaps = 3/241 (1%)
Query: 286 NFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQA--LL 343
A+ Q+ + H ++ R L L L +N L L L+ L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 344 QRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSD 403
L P L L LHL L P F L + + L N+L
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 404 IQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDL 463
++L L +L L N++S GL L L L +NR P +F L L L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 464 SNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALC-GPPRL 522
NNLS ++ L L+ L ++ N + + C P RL
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268
Query: 523 Q 523
Sbjct: 269 A 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 38/191 (19%), Positives = 60/191 (31%), Gaps = 5/191 (2%)
Query: 32 PNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVR 91
P L RL L L P + LQ L L++N+ ++ +L +L
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157
Query: 92 LDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPI 151
L N IS L L L N + P+ +L L L L NNL
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 152 PTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLI 211
+ + + + L N Q ++ + ++P +
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL-- 273
Query: 212 GLDLNSNSLSG 222
L +N L G
Sbjct: 274 -KRLAANDLQG 283
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 4e-09
Identities = 56/348 (16%), Positives = 101/348 (29%), Gaps = 36/348 (10%)
Query: 87 SSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNN 146
L+ +S ++P +L L + N+L E+P +LK+L L
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 147 LIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITN 206
L P + + + + + + + + L L +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 207 ASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKL 266
+L + N+ L L E L LT
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY-- 210
Query: 267 RALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLN 326
+ + ++ L L L L+
Sbjct: 211 --------------------ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLD 250
Query: 327 GTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYI 386
+ G + L N + I + SL +L++ +N+L +P+ LE
Sbjct: 251 VSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE-- 307
Query: 387 LRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDL 434
R+ S N L+ +P QNLK L++ N L P ++DL
Sbjct: 308 -RLIASFNHLA-EVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 9e-08
Identities = 26/108 (24%), Positives = 41/108 (37%), Gaps = 10/108 (9%)
Query: 379 SFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438
F L + N+ S + S L LN+S N+L +P L+ L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLI 310
Query: 439 LARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLN 486
+ N +P+ +L+ L + N L E P E + L R+N
Sbjct: 311 ASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 4e-07
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 46 FAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPS 105
+ N + S + L+ L++ NN +P L RL + FN ++ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPE 321
Query: 106 KIGNLTKLVHLNFADNNLRGEIPNEIGNLKNL 137
NL L+ N LR E P+ ++++L
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 9e-07
Identities = 22/81 (27%), Positives = 35/81 (43%), Gaps = 8/81 (9%)
Query: 414 NLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIP 473
N S I L L+++ N+ +P L E L S N+L+ E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVP 320
Query: 474 KSFEILSHLKRLNVSHNRLEG 494
E+ +LK+L+V +N L
Sbjct: 321 ---ELPQNLKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 19/92 (20%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 3 LGGTVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVF 62
+ L L++S N LP +L RL ++N L P
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQ-- 324
Query: 63 SKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94
L+ L + N P+ ++ L R++S
Sbjct: 325 -NLKQLHVEYNPLRE-FPDIPESVEDL-RMNS 353
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.0 bits (124), Expect = 1e-08
Identities = 34/127 (26%), Positives = 47/127 (37%), Gaps = 9/127 (7%)
Query: 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSG 422
R LHL LT L + +DLS N L P+ + L+ L L S N L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 423 NIPITIGGLKDLITLSLARNRFQD-SIPDSFGSLTSLEYLDLSNNNLSGE---IPKSFEI 478
+ L L L NR Q + S L L+L N+L E + E+
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 479 LSHLKRL 485
L + +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 3e-08
Identities = 26/121 (21%), Positives = 44/121 (36%), Gaps = 6/121 (4%)
Query: 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSI 448
+ L+ L+ ++ L ++ +L+LS N+L P + L+ L L +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQA--SDNALEN 57
Query: 449 PDSFGSLTSLEYLDLSNNNL-SGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLA 507
D +L L+ L L NN L + L LN+ N L + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 508 Q 508
Sbjct: 118 S 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 28/110 (25%), Positives = 43/110 (39%), Gaps = 5/110 (4%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
TV H+ L + +LD+S N R P L LR L+ +D + +L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEV--LQASDNALENVDGVANLPRL 67
Query: 66 QVLSLRNNSFTG-PIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLV 114
Q L L NN L + LV L+ + NS+ L +++
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 4e-04
Identities = 23/121 (19%), Positives = 42/121 (34%), Gaps = 9/121 (7%)
Query: 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGP 78
L ++ + L QL + L ++N L P+ + L+ L + S
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNAL 55
Query: 79 I-PNSLFNLSSLVRLDSRFNSI-SGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKN 136
+ + NL L L N + + + +LV LN N+L + L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 137 L 137
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 8/128 (6%)
Query: 66 QVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
+VL L + T + L L + LD N + P+ + L L L +DN L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE- 56
Query: 126 EIPNEIGNLKNLADLVLALNNLIG-PIPTTIFNISTIIIINLVGNQLSGHR--PSTMGHS 182
+ + NL L +L+L N L + + ++++NL GN L +
Sbjct: 57 -NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 183 LPNRQFLL 190
LP+ +L
Sbjct: 116 LPSVSSIL 123
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 48/191 (25%), Positives = 72/191 (37%), Gaps = 9/191 (4%)
Query: 304 SIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLR 363
++P ++ + L L N L TL +L L NL+ T L +L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL----NLDRAELTKLQVDGTLP 77
Query: 364 QLHL--GSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421
L S+ S+P +L + +D+S N L+ ++ L L L L N+L
Sbjct: 78 VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137
Query: 422 GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSH 481
P + L LSLA N + L +L+ L L N+L IPK F
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196
Query: 482 LKRLNVSHNRL 492
L + N
Sbjct: 197 LPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 6e-08
Identities = 38/219 (17%), Positives = 64/219 (29%), Gaps = 16/219 (7%)
Query: 59 IGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNF 118
+ + ++ + T +P L L N + + + T+L LN
Sbjct: 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 119 ADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPST 178
+ G L L L L+ N L + ++ S +
Sbjct: 63 --DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 179 MGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLN 238
G +L N L P +T KL L L +N+L+ L +L TL
Sbjct: 121 RGLGELQELYL--KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 239 IRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLD 277
+ N ++ + L L NP
Sbjct: 179 L---------QENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 6e-08
Identities = 36/195 (18%), Positives = 56/195 (28%), Gaps = 8/195 (4%)
Query: 48 YNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKI 107
+LT + P + +L L N +L + L +L+ +
Sbjct: 19 KRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN--LDRAELTKLQVD 73
Query: 108 GNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLV 167
G L L L+ + N L+ V N + +P + +
Sbjct: 74 GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV--SFNRLTSLPLGALRGLGELQELYL 131
Query: 168 GNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNT 227
P + P + L L N LT + L L L NSL IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 228 FGNLRHLSTLNIRAN 242
F L + N
Sbjct: 191 FFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 41/191 (21%), Positives = 56/191 (29%), Gaps = 15/191 (7%)
Query: 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANY---------- 243
LT +P + L L+ N L T L+ LN+
Sbjct: 20 RNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL 76
Query: 244 --LTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKL 301
L T S+ + L L + S + LP Q+ Y +L
Sbjct: 77 PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 302 KGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLIS 361
K P + L LSL N+L L L+ L LL + N IP
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHL 196
Query: 362 LRQLHLGSNQL 372
L L N
Sbjct: 197 LPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 41/192 (21%), Positives = 61/192 (31%), Gaps = 34/192 (17%)
Query: 6 TVPPHIGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKL 65
+PP + L +SEN + L RL L +L + + + V L
Sbjct: 24 ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL-----NLDRAELTKLQVDGTL 76
Query: 66 QVLSLRNN--------------------------SFTGPIPNSLFNLSSLVRLDSRFNSI 99
VL + T +L L L L + N +
Sbjct: 77 PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 100 SGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNIS 159
P + KL L+ A+NNL + L+NL L+L N + IP F
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ-ENSLYTIPKGFFGSH 195
Query: 160 TIIIINLVGNQL 171
+ L GN
Sbjct: 196 LLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 9/65 (13%), Positives = 21/65 (32%), Gaps = 3/65 (4%)
Query: 427 TIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLN 486
+ + + ++ + ++P L LS N L + + L +LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 487 VSHNR 491
+
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 36/180 (20%), Positives = 62/180 (34%), Gaps = 4/180 (2%)
Query: 266 LRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDL 325
L L N L + + ++ + + + + + + G L L L L N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYT---RLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQL 89
Query: 326 NGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEY 385
+ N L L L L++L+L N+L + P
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 386 ILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQ 445
+ ++ L++N+L+ + L+ L L L N L IP G L L N +
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 4/69 (5%)
Query: 351 PIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVL 410
PI S + S +++ LT+ +P + LS N L + + L
Sbjct: 2 PICEV-SKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRL 57
Query: 411 IYLNLSRNQ 419
LNL R +
Sbjct: 58 TQLNLDRAE 66
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 7e-08
Identities = 18/104 (17%), Positives = 41/104 (39%), Gaps = 3/104 (2%)
Query: 388 RIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQD- 446
+DL+ +L + + + V+ R+ + + + + + L+ + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 447 SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
++ + L+ L L LS I + S+L RLN+S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 36/286 (12%), Positives = 78/286 (27%), Gaps = 28/286 (9%)
Query: 213 LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLG 272
LDL +L P+ G L + R + L+ + +++ + L
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQP-------LAEHFSPFRVQHMDLS 54
Query: 273 SNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTT 332
++ ++ I + + Q +L I + L+ L+L +
Sbjct: 55 NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS-GFSEFAL 113
Query: 333 LGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLS 392
L L + N T +++ + + L
Sbjct: 114 QTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS-------------ETITQLNLSGYRK 160
Query: 393 SNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLAR-NRFQDSIPDS 451
+ S + ++ L + L L LSL+R
Sbjct: 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE 220
Query: 452 FGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIP 497
G + +L+ L + G + + L L ++ +
Sbjct: 221 LGEIPTLKTLQVFGIVPDGTLQL---LKEALPHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 39/262 (14%), Positives = 73/262 (27%), Gaps = 41/262 (15%)
Query: 20 LDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSW-IGVFSKLQVLSLRNNSFTG- 77
LD++ N P+ G+L + F P ++Q + L N+
Sbjct: 5 LDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 78 PIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD--NNLRGEIPNEIGNLK 135
+ L S L L +S I + + + LV LN + + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 136 NLADLV------------------------------LALNNLIGPIPTTIFNISTIIIIN 165
L +L N + T + ++ ++
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 166 LVGNQLSGHRPSTMGHSLPNRQFL-LLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQI 224
L + + + L Q L L + + L L + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 225 PNTFGNLRHLSTLNIRANYLTT 246
L H L I ++ TT
Sbjct: 242 QLLKEALPH---LQINCSHFTT 260
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 12/91 (13%), Positives = 30/91 (32%), Gaps = 10/91 (10%)
Query: 410 LIYLNLSRNQLSGN-IPITIGGLKDLITLSLARNRFQD----SIPDSFGSLTSLEYLDLS 464
+ L++ +LS + L+ + L + I + +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 465 NNNLSGEIPKSF-----EILSHLKRLNVSHN 490
+N L +++L++ +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 19/88 (21%), Positives = 29/88 (32%), Gaps = 9/88 (10%)
Query: 401 PSDIQNLKVLIYLNLSRNQLSGN----IPITIGGLKDLITLSLARNRFQDSIPDSFGS-- 454
Q VL L L+ +S + + T+ L L L+ N D+
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 455 ---LTSLEYLDLSNNNLSGEIPKSFEIL 479
LE L L + S E+ + L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 16/90 (17%), Positives = 28/90 (31%), Gaps = 9/90 (10%)
Query: 55 FPSWIGVFSKLQVLSLRNNSFTG----PIPNSLFNLSSLVRLDSRFNSISGNIPSKIG-- 108
S L+VL L + + + +L SL LD N + ++
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 109 ---NLTKLVHLNFADNNLRGEIPNEIGNLK 135
L L D E+ + + L+
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 17/73 (23%), Positives = 26/73 (35%), Gaps = 9/73 (12%)
Query: 434 LITLSLARNRFQD----SIPDSFGSLTSLEYLDLSNNNLSGEIPKSF-----EILSHLKR 484
L L LA D S+ + + SL LDLSNN L + L++
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 485 LNVSHNRLEGKIP 497
L + ++
Sbjct: 431 LVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 12/70 (17%), Positives = 24/70 (34%), Gaps = 5/70 (7%)
Query: 433 DLITLSLARNRFQDS-IPDSFGSLTSLEYLDLSNNNLSGE----IPKSFEILSHLKRLNV 487
D+ +L + D+ + L + + L + L+ I + + L LN+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 488 SHNRLEGKIP 497
N L
Sbjct: 63 RSNELGDVGV 72
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 13/90 (14%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 41 LKFLGFAYNDLTGS-FPSWIGVFSKLQVLSLRNNSFTG----PIPNSLFNLSSLVRLDSR 95
++ L +L+ + + + + + QV+ L + T I ++L +L L+ R
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRG 125
N + + + +L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 12/85 (14%), Positives = 30/85 (35%), Gaps = 5/85 (5%)
Query: 360 ISLRQLHLGSNQLTSSIPSSFWS-LEYILRIDLSSNSLSG----SLPSDIQNLKVLIYLN 414
+ ++ L + +L+ + + L+ + L L+ + S ++ L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 415 LSRNQLSGNIPITIGGLKDLITLSL 439
L N+L + + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 15/75 (20%), Positives = 24/75 (32%), Gaps = 5/75 (6%)
Query: 213 LDLNSNSLS-GQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSL 271
LD+ LS + L+ + + LT S+L L L+L
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA----RCKDISSALRVNPALAELNL 62
Query: 272 GSNPLDSILPPLIGN 286
SN L + +
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 17/85 (20%), Positives = 31/85 (36%), Gaps = 4/85 (4%)
Query: 164 INLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTG----TIPNSITNASKLIGLDLNSNS 219
+++ +LS R + + L Q + L LT I +++ L L+L SN
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 220 LSGQIPNTFGNLRHLSTLNIRANYL 244
L + + I+ L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 12/88 (13%), Positives = 25/88 (28%), Gaps = 5/88 (5%)
Query: 65 LQVLSLRNNSFTGPIPNSLF-NLSSLVRLDSRFNSISG----NIPSKIGNLTKLVHLNFA 119
+Q L ++ + L L + ++ +I S + L LN
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 120 DNNLRGEIPNEIGNLKNLADLVLALNNL 147
N L + + + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 16/81 (19%), Positives = 26/81 (32%), Gaps = 9/81 (11%)
Query: 41 LKFLGFAYNDLTG----SFPSWIGVFSKLQVLSLRNNSFTGPIPNSLF-----NLSSLVR 91
L+ L A D++ S + + L+ L L NN L L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 92 LDSRFNSISGNIPSKIGNLTK 112
L S + ++ L K
Sbjct: 431 LVLYDIYWSEEMEDRLQALEK 451
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 3e-06
Identities = 25/128 (19%), Positives = 48/128 (37%), Gaps = 6/128 (4%)
Query: 388 RIDLSSNSLSGS---LPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRF 444
R D S +L D+ + + LN + + + I + +L++L+L+ NR
Sbjct: 19 RYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRL 77
Query: 445 QD--SIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPF 502
+ +L+ L+LS N L E L+ L + N L +
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 503 RNFLAQSF 510
+ + + F
Sbjct: 138 ISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 20/107 (18%), Positives = 36/107 (33%), Gaps = 2/107 (1%)
Query: 333 LGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLT--SSIPSSFWSLEYILRID 390
L L +R+++ + ++ L L+L +N+L + S + ++
Sbjct: 38 LVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97
Query: 391 LSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITL 437
LS N L D L L L N LS + +
Sbjct: 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 3e-06
Identities = 37/207 (17%), Positives = 67/207 (32%), Gaps = 29/207 (14%)
Query: 304 SIPKEIG------NLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCL 356
++P I I +L + + T L + + +++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--I 64
Query: 357 SSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSN---------------SLSGSLP 401
L ++ +L L N+LT P + L +D + SL +
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 402 SDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYL 461
SDI L L L + IT+ + + I LT L+ L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNL 183
Query: 462 DLSNNNLSGEIPKSFEILSHLKRLNVS 488
LS N++S ++ L +L L +
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 30/194 (15%), Positives = 63/194 (32%), Gaps = 23/194 (11%)
Query: 61 VFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFAD 120
F++ +L+ S T + + L+S+ ++ + + I I L + L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 121 NNLRG---------------EIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIIN 165
N L + L +L + I + + +
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 166 LVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIP 225
+ + T+ L L L N+++ +P + +KL L L+ N +S
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--L 193
Query: 226 NTFGNLRHLSTLNI 239
L++L L +
Sbjct: 194 RALAGLKNLDVLEL 207
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.8 bits (104), Expect = 1e-05
Identities = 41/165 (24%), Positives = 64/165 (38%), Gaps = 5/165 (3%)
Query: 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDI-QNLKVLIYLNLSRNQ 419
+ L IP + + L+ N L + L L+ L L RNQ
Sbjct: 9 EGTTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 420 LSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEIL 479
L+G P G + L L N+ ++ F L L+ L+L +N +S +P SFE L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 480 SHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCG-PPRLQ 523
+ L LN++ N +S A CG P +++
Sbjct: 126 NSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVR 170
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 28/223 (12%), Positives = 70/223 (31%), Gaps = 29/223 (13%)
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
+ ++ ++ T + + +L + L + ++ + L L+ L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 122 NLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGH 181
+ P + +L + I + + + + S +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 182 SLPNRQFLLLWAN-------------RLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTF 228
+ + + + + N SKL L + N +S P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 229 GNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSL 271
+L +L ++++ N ++ +S L N + L ++L
Sbjct: 192 ASLPNLIEVHLKNNQISD----------VSPLANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 17/65 (26%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 425 PITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKR 484
+ L L TL N+ D P SL +L + L NN +S P S+L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 485 LNVSH 489
+ +++
Sbjct: 222 VTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 39/260 (15%), Positives = 79/260 (30%), Gaps = 50/260 (19%)
Query: 206 NASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNK 265
+ I + ++++ + T +L ++TL+ +TT + + N
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT----------IEGVQYLNN 64
Query: 266 LRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDL 325
L L L N + + N + + + S + +++ +L
Sbjct: 65 LIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIK-----TLDLTST 117
Query: 326 NGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEY 385
T T L L LQ L N I + + ++ L
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTT 177
Query: 386 ILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQ 445
+ N +S P + +L LI ++L NQ+S P
Sbjct: 178 LKA---DDNKISDISP--LASLPNLIEVHLKNNQISDVSP-------------------- 212
Query: 446 DSIPDSFGSLTSLEYLDLSN 465
+ ++L + L+N
Sbjct: 213 ------LANTSNLFIVTLTN 226
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 11/51 (21%), Positives = 19/51 (37%), Gaps = 3/51 (5%)
Query: 448 IPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498
D F + LD+S + E L L+ + + + K+PT
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 32/238 (13%), Positives = 65/238 (27%), Gaps = 17/238 (7%)
Query: 49 NDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIG 108
+ +T PS + L + L +++ N + I + +
Sbjct: 18 SKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 109 NLTKLV---HLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIIN 165
+ + + A+N L L+ P I ++ +++
Sbjct: 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134
Query: 166 LVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIP 225
+ ++ L L N + + ++N+L
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194
Query: 226 NTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPL 283
+ F L+I + + S L N KLRA S + LP L
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPS--------YGLENLKKLRARSTYNL---KKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 29/229 (12%), Positives = 54/229 (23%), Gaps = 26/229 (11%)
Query: 194 NRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGE 253
+++T IP+ + I L L F L + I N + ++
Sbjct: 18 SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 254 WSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAH---------------- 297
+ + L NP P + S
Sbjct: 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134
Query: 298 ---ECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPT 354
+G + L L N + Q + L NN +P
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194
Query: 355 -CLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPS 402
L + ++ S +L+ + + LP+
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 28/133 (21%), Positives = 53/133 (39%), Gaps = 4/133 (3%)
Query: 356 LSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNL 415
++ + R+L L ++ I + +L+ ID S N + L+ L L +
Sbjct: 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLV 70
Query: 416 SRNQLSGNIPITIGGLKDLITLSLARNRFQD-SIPDSFGSLTSLEYLDLSNNNLSGEIPK 474
+ N++ L DL L L N + D SL SL YL + N ++ +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 475 SFEILSHLKRLNV 487
++ + ++ V
Sbjct: 131 RLYVIYKVPQVRV 143
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 9e-04
Identities = 24/138 (17%), Positives = 43/138 (31%), Gaps = 6/138 (4%)
Query: 82 SLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLV 141
N LD R I I + L + ++F+DN +R + L+ L L+
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69
Query: 142 LALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLW---ANRLTG 198
+ N + + + + L N L SL + +L +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 199 TIPNSITNASKLIGLDLN 216
I ++ LD
Sbjct: 130 YRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.001
Identities = 19/97 (19%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 431 LKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490
L L + I + +L + +D S+N + L LK L V++N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPL--LRRLKTLLVNNN 73
Query: 491 RLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQVPPC 527
R+ L + L N +L L
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS 110
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 47/329 (14%), Positives = 90/329 (27%), Gaps = 36/329 (10%)
Query: 65 LQVLSLRNNSFTG----PIPNSLFNLSSLVRLDSRFNSISGN----IPSKIGNLTKLVHL 116
++ SL+ ++ T + L S+ + N+I + I + L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 117 NFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176
F+D L+ L +L L + T +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 177 STM--GHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLS----GQIPNTFGN 230
+ L + + + NA L + N L + TF +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 231 LRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSAS 290
R L T+ + N + E + L+ L L S + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 291 FQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNG 350
++ ++C L + + + LQ L+ LQ N +
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENI---------------GLQTLR--LQYNEIEL 287
Query: 351 PIPTCLSSLI-----SLRQLHLGSNQLTS 374
L ++I L L L N+ +
Sbjct: 288 DAVRTLKTVIDEKMPDLLFLELNGNRFSE 316
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 38/330 (11%), Positives = 84/330 (25%), Gaps = 35/330 (10%)
Query: 210 LIGLDLNSNSLSGQ----IPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNK 265
+ G L ++++ + + + + + N + TE ++ +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTE----AARWLSENIASKKD 60
Query: 266 LRALSLGSNPLDSI---LPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFT 322
L + +P + + + LI
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 323 NDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWS 382
L G Q A + R + + LR + G N+L + +
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 383 LEYIL-------------RIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIG 429
R + + L L + + + N + S + I +
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 430 GLKDLITLSLARNRFQDSIPDSFG------SLTSLEYLDLSNNNLSGEIPKS-----FEI 478
+L L L + L+ L L N + + ++ E
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 479 LSHLKRLNVSHNRLEGKIPTNGPFRNFLAQ 508
+ L L ++ NR + R +
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 12/76 (15%), Positives = 22/76 (28%), Gaps = 4/76 (5%)
Query: 446 DSIPDSFGSLTSLEYLDLSNNNLSGE----IPKSFEILSHLKRLNVSHNRLEGKIPTNGP 501
S+ S++ + LS N + E + ++ L+ S
Sbjct: 21 KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPE 80
Query: 502 FRNFLAQSFLWNYALC 517
L Q+ L L
Sbjct: 81 ALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 39/317 (12%), Positives = 84/317 (26%), Gaps = 25/317 (7%)
Query: 200 IPNSITNASKLIGLDLNSNSLSGQ----IPNTFGNLRHLSTLNIRANYLTTETSSNGEWS 255
+ + + + L+ N++ + + + + L + E
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 256 --FLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLR 313
L +L C KL + L N + +F + G P+ +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 314 GLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHL------ 367
+ P + + L +++ +
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 368 GSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPIT 427
+ L + L+ + ++ S +L +++ L L L+ LS
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 428 IG------GLKDLITLSLARNRFQDSIPDS-----FGSLTSLEYLDLSNNNLSGEIPKSF 476
+ L TL L N + + + L +L+L+ N S E
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVD 322
Query: 477 EILSHLKRLNVSHNRLE 493
EI L+
Sbjct: 323 EIREVFSTRG--RGELD 337
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 33/189 (17%), Positives = 60/189 (31%), Gaps = 19/189 (10%)
Query: 62 FSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNLTKLVHLNFADN 121
++ L + T + + +L + L + I +I + L L +NF++N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 72
Query: 122 NLRGEIP-------------NEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVG 168
L P N + L L + NL
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 169 NQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTF 228
+LS + S + L + T + N + L LD++SN +S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 229 GNLRHLSTL 237
L +L +L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 32/190 (16%), Positives = 67/190 (35%), Gaps = 21/190 (11%)
Query: 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQAL-LQRNNLNGPIPTCLSSLISLRQLHLGS 369
L + L ++ T+ + L Q+ L R + + L +L Q++ +
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 370 NQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIG 429
NQLT P + + ++ + + L + + ++ N + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 430 GLKDLITL--------------SLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKS 475
L+ L + Q + +LT+LE LD+S+N +S
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189
Query: 476 FEILSHLKRL 485
L++L+ L
Sbjct: 190 LAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 870 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.47 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.66 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.54 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.85 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.47 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.23 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.17 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.33 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=416.74 Aligned_cols=263 Identities=24% Similarity=0.433 Sum_probs=208.8
Q ss_pred HhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeech--hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQ--LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
...++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.+.+|++++++++|||||++++++.+ +..++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34578999999999999999999864 36999998654 24556789999999999999999999998754 567999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+..+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+|.......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999877777999999999999999999999 6679999999999999999999999999998775444
Q ss_pred CcccccccccccccCCcccccC---CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CCchhhhcch
Q 002892 740 DSVTQTMTMATIGYMAPEYASD---GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PRGLTEVVDA 815 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 815 (870)
.........||+.|+|||++.+ +.++.++|||||||++|||+||+.||.+..... .....+.... +....+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~~---- 233 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLSPDLSK---- 233 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCCCCGGG----
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCCCcchh----
Confidence 4444455679999999999864 358899999999999999999999997643222 1212111111 111110
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
....++..+.+++.+||+.+|++|||++||++.|+.+.+.
T Consensus 234 ----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 234 ----------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ----------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1123456799999999999999999999999999998874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=409.35 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=203.7
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMP 664 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 664 (870)
++|++.+.||+|+||+||+|.+.+++.||||+++... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999999888999999997643 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcccc
Q 002892 665 NGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQ 744 (870)
Q Consensus 665 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 744 (870)
+|+|.+++......+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+++....... ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 99999999887777999999999999999999999 56699999999999999999999999999987643322 223
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCcc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPS 824 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 824 (870)
....||+.|+|||++.++.++.++|||||||++|||+|++.|+...... ..+...+......
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~~----------------- 221 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFRL----------------- 221 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTCCC-----------------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhcCCC-----------------
Confidence 3456899999999999999999999999999999999965554332221 1111111111100
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 825 YAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 825 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++.++.+++.+||+.||++|||++||++.|+++.++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 01112345789999999999999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=404.37 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=208.5
Q ss_pred hcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999995 47999999999876655567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++||+|.+++...+ +++.++..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|..+.... .
T Consensus 99 ~~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (293)
T ss_dssp CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred cCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence 99999999887643 899999999999999999999 6679999999999999999999999999998764322 2
Q ss_pred cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 743 TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
......||+.|+|||++.++.++.++||||+||++|||++|+.||.+.... ..+........+.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~~~--------------- 235 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGTPE--------------- 235 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCSCC---------------
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCC---------------
Confidence 334457999999999999999999999999999999999999999753211 1111111111111
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+..++..+.+++.+||+.||++|||++|+++
T Consensus 236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011123456889999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=404.33 Aligned_cols=252 Identities=19% Similarity=0.310 Sum_probs=205.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999975 78999999997653 23446789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+++|+|.+++...+ .+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+|..........
T Consensus 85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999997544 4999999999999999999999 6669999999999999999999999999998775444334
Q ss_pred cccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 743 TQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+.......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-------------- 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-------------- 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS--------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------------
Confidence 4455679999999999988776 5789999999999999999999976433322222211110000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....++.++.+++.+||+.||++|||++|+++
T Consensus 227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122346789999999999999999999965
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-48 Score=409.38 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=201.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CC---cEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DG---TNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
++|++.+.||+|+||+||+|+++ ++ ..||||.+... .....+.+.+|++++++++|||||++++++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45667789999999999999865 33 25889987654 344567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++......+++.++..++.||++||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999887777999999999999999999999 5679999999999999999999999999998775433
Q ss_pred Cccc---ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcch
Q 002892 740 DSVT---QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDA 815 (870)
Q Consensus 740 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (870)
.... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.... .+...+.....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~--------- 251 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYR--------- 251 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC---------
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence 2221 223457899999999999999999999999999999998 89998763221 11111111000
Q ss_pred hhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 816 SLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
...+.+++..+.+++.+||+.+|++|||++||++.|+++.+.
T Consensus 252 --------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 --------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 001123566789999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=396.32 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=214.0
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
.++|++.+.||+|+||+||+|++++++.||||+++.... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368999999999999999999998888999999986543 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
++|++.+++......+++..+.+++.|+++||+||| ++||+||||||+||++++++.+||+|||+++....... ..
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 157 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence 999999998877777999999999999999999999 56799999999999999999999999999987654332 23
Q ss_pred ccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccC
Q 002892 744 QTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQ 822 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 822 (870)
.....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ +...+.....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~~---------------- 219 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLR---------------- 219 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCC----------------
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhCCC----------------
Confidence 344678999999999999999999999999999999998 899997643221 1111111000
Q ss_pred cchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 823 PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 823 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
...+..++.++.+++.+||+.+|++|||+.+|++.|.+|
T Consensus 220 -~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 -LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 001113345789999999999999999999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=404.95 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=207.6
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFM 663 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 663 (870)
+.|++.+.||+|+||+||+|+.. +++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999965 68999999998766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCccc
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVT 743 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 743 (870)
++|+|.+++.+.+..+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|..... ....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence 999999998876667999999999999999999999 56699999999999999999999999999975421 1122
Q ss_pred ccccccccccCCccccc-----CCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhh
Q 002892 744 QTMTMATIGYMAPEYAS-----DGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLV 818 (870)
Q Consensus 744 ~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 818 (870)
.....||+.|+|||++. ...++.++||||+||++|||++|+.||.+.... ..+..+.....+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~~~~~----------- 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKSEPPT----------- 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHSCCCC-----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCCC-----------
Confidence 33467999999999984 456889999999999999999999999763222 1122221111110
Q ss_pred cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 819 REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 819 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...+..++..+.+++.+||+.||++|||++|+++
T Consensus 235 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 -----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011123457889999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=403.80 Aligned_cols=258 Identities=22% Similarity=0.402 Sum_probs=208.7
Q ss_pred HhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
...++|++.+.||+|+||+||+|.+++++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3457899999999999999999999888999999997643 334679999999999999999999998754 56799999
Q ss_pred cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 662 FMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 662 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
|+++|+|.+++... +..+++..+.+++.||++||+||| +++|+||||||+||++++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-
Confidence 99999999988743 335899999999999999999999 5669999999999999999999999999998775332
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
........||+.|+|||++.++.++.++|||||||++|||+||+.|+....... .....+.....
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~~~~~-------------- 228 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYR-------------- 228 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCC--------------
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCC--------------
Confidence 223344568999999999999999999999999999999999766654322211 11111111000
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
...+..++.++.+++.+||+.+|++|||+++|++.|+.+-
T Consensus 229 ---~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 0011134557899999999999999999999999988753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=393.69 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=204.5
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+.. ......+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56899999999999999999975 68999999997543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|+|.+++...+. +++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|......
T Consensus 86 Ey~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred eecCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 99999999999986544 899999999999999999999 667999999999999999999999999999865432
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ......+..... ..
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~--~~----------- 223 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYKRISRVEF--TF----------- 223 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTTCC--CC-----------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCC--CC-----------
Confidence 22345799999999999999999999999999999999999999975311 111111111000 00
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+..++.++.+++.+||+.||++|||++|+++
T Consensus 224 ------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 ------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0123456889999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-48 Score=403.28 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=215.6
Q ss_pred HHHHhhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 579 DIQQATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 579 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
+.+...++|++.+.||+|+||+||+|++. +++.||||+++.... ..+++.+|++++++++|||||++++++.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34445678899999999999999999976 588999999976543 3567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 658 LVLEFMPNGSLEKWLYS-HNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
+||||+++|+|.+++.. ....+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+...
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999999975 3556899999999999999999999 5669999999999999999999999999998765
Q ss_pred CCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 737 EDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 737 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... ........|++.|+|||++.++.++.++|||||||++|||++|+.||...... ..+...+......
T Consensus 167 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~~~~~--------- 235 (287)
T d1opja_ 167 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRM--------- 235 (287)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCC---------
T ss_pred CCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHHHhcCCCC---------
Confidence 432 22334456889999999999999999999999999999999987776432221 1121211111100
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..+..++.++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 236 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 236 --------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 01113456789999999999999999999999999987543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=400.64 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=211.6
Q ss_pred cCCCCCCe-eccccceeEEEEEec---CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 585 DGFNECNL-LGAGSFGSVYKGTLF---DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 585 ~~~~~~~~-lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
++|.+.+. ||+|+||+||+|.++ ++..||||+++... ....+++.+|++++++++|||||++++++.. +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999754 35579999997543 4456789999999999999999999999865 567999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999999877777999999999999999999999 6679999999999999999999999999998775443
Q ss_pred Cc-ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 740 DS-VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 740 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.... .+...+.....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~~----------- 230 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR----------- 230 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCC-----------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-----------
Confidence 32 22334568999999999999999999999999999999998 89999764221 11111111000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
...+..++.++.+++.+||+.+|++|||+.+|.+.|+.+...+.
T Consensus 231 ------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 231 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 00112345678999999999999999999999999998876554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=398.69 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=205.1
Q ss_pred hcCCCCCCeeccccceeEEEEEecCC-----cEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDG-----TNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
.++|+..++||+|+||+||+|.+++. ..||||+++... ......+.+|++++++++|||||++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45788889999999999999986532 369999987543 344567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||++++++.+++......+++.++..++.|++.|++||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999877777999999999999999999999 56699999999999999999999999999987643
Q ss_pred CCC-cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDD-SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
... ........||+.|+|||++.++.++.++|||||||++|||++|+.|+...... ..+...+....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~----------- 230 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGF----------- 230 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC-----------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccC-----------
Confidence 322 22233456899999999999999999999999999999999977665432221 11111111100
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
. ...+..++.++.+++.+||+.+|++||++.||++.|+++.+.
T Consensus 231 -~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 -R-----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -C-----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -C-----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 0 001123456789999999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=392.47 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=193.5
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee--CCeeEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN--LDFKALV 659 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 659 (870)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... +...+.+.+|++++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999865 78999999987653 3445778999999999999999999999864 4567999
Q ss_pred EecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 660 LEFMPNGSLEKWLYS---HNYFLDMLERLNIMIDVGLALEYLHHSH--STPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
|||+++|+|.+++.+ .+..+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+|..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999873 3456999999999999999999999643 24599999999999999999999999999987
Q ss_pred cCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+.....+.
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~~~~~i~~~~~~~------- 233 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKFRR------- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCCC-------
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCCC-------
Confidence 743322 233457999999999999999999999999999999999999999753211 1111111111100
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+..++.++.+++.+||+.||++|||++|+++
T Consensus 234 -----------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01123456889999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=394.83 Aligned_cols=249 Identities=21% Similarity=0.339 Sum_probs=202.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999964 78999999997643 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||++||+|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+|..+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccCC-CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999886554 899999999999999999999 66699999999999999999999999999988754444
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..... .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~--~------------ 228 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKIIKLEY--D------------ 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHTTCC--C------------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-HHHHHHHHcCCC--C------------
Confidence 4444556799999999999999999999999999999999999999975211 111111111000 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. +...+..+.+++.+||+.||++|||+.|+.+
T Consensus 229 ~-----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 F-----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C-----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C-----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0 0112346889999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=384.61 Aligned_cols=244 Identities=22% Similarity=0.379 Sum_probs=195.1
Q ss_pred CCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee----CCeeEEEE
Q 002892 588 NECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN----LDFKALVL 660 (870)
Q Consensus 588 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 660 (870)
++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++|||||++++++.. ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999965 68899999987643 3455778999999999999999999999865 34678999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecccCCCceeeC-CCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTP--VVHCNLKPNNILLD-KNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~ 737 (870)
||+++|+|.+++.+.+ .+++..+..++.||++||+||| +++ |+||||||+||+++ +++.+||+|||+|.....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999998654 4899999999999999999999 555 99999999999996 578999999999986432
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+...... +...+....+
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~~i~~~~~----------- 230 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSGVK----------- 230 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTTTCC-----------
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHHHHHcCCC-----------
Confidence 2 2234579999999999865 589999999999999999999999975322211 1111110000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++.++.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00011112346889999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=393.02 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=201.2
Q ss_pred CeeccccceeEEEEEec---CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEecCCC
Q 002892 591 NLLGAGSFGSVYKGTLF---DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEFMPN 665 (870)
Q Consensus 591 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 665 (870)
+.||+|+||+||+|.++ .++.||||+++... ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 34689999986543 3345779999999999999999999999865 567899999999
Q ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc-cc
Q 002892 666 GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV-TQ 744 (870)
Q Consensus 666 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 744 (870)
|+|.+++..... +++..+..++.||+.||+||| +++|+||||||+||+++.++.+|++|||+|+......... ..
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999986543 899999999999999999999 5669999999999999999999999999998765433322 23
Q ss_pred cccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcccCc
Q 002892 745 TMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQP 823 (870)
Q Consensus 745 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 823 (870)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... .+...+.....
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~~----------------- 228 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER----------------- 228 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC-----------------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCCC-----------------
Confidence 34568999999999999999999999999999999998 89999763221 11111111000
Q ss_pred chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 824 SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 824 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
...+..++.++.+++.+||+.||++|||+++|.+.|+.+..+.
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 0011234567899999999999999999999999998875544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=402.64 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=208.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC-C-----cEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD-G-----TNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 654 (870)
..++|++.+.||+|+||+||+|++.. + ..||+|++.... ......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34678999999999999999998642 2 368999886543 33456788999999998 8999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccC
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN----------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLK 712 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 712 (870)
..++||||+++|+|.++++..+ ..+++..++.++.||+.||+||| +++|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence 9999999999999999998543 24889999999999999999999 6669999999
Q ss_pred CCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccc
Q 002892 713 PNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMF 791 (870)
Q Consensus 713 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~ 791 (870)
|+||+++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987655444444455678999999999999999999999999999999998 899997633
Q ss_pred cccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002892 792 TGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQK 861 (870)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 861 (870)
.. ..+...+...... ..+..++.++.+++.+||+.+|++|||++||++.|..
T Consensus 272 ~~-~~~~~~~~~~~~~-----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VD-ANFYKLIQNGFKM-----------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CS-HHHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH-HHHHHHHhcCCCC-----------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 22 2222222211110 0112345678999999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=404.85 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=206.3
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|++++++++|||||++++++.+.+..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999964 78999999997653 344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||++||+|.+++.+.+. +++..+..++.|++.||+|||+. +||+||||||+|||+++++.+||+|||+|..+..
T Consensus 84 Ey~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EcCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 99999999999986554 89999999999999999999942 3699999999999999999999999999986532
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHH--Hh---c----------
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIK--LS---L---------- 805 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~--~~---~---------- 805 (870)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......+........ .. .
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 1223457999999999999999999999999999999999999999753222111100000 00 0
Q ss_pred ----------CCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 806 ----------PRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 806 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+....+..+...... .+.......+.++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEP-PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSC-CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccC-CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000011111110000 000000112356889999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-47 Score=396.18 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=190.4
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
..+.|++.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4577999999999999999999965 68999999997654 233456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC---CCCceEEeccccccccCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD---KNMTARVSDFGISKLLGE 737 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~ 737 (870)
||++||+|.+++...+ .+++.++..++.||+.||+||| +++|+||||||+||++. +++.+||+|||+|.....
T Consensus 87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred eccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999998654 4999999999999999999999 66799999999999994 578999999999986643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ....+.....+.
T Consensus 163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~~---------- 228 (307)
T d1a06a_ 163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAEYEF---------- 228 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTCCCC----------
T ss_pred CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCCC----------
Confidence 22 2234579999999999999999999999999999999999999997532111 111111110000
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||+.||++|||++|+++
T Consensus 229 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 -----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00011123456889999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-46 Score=398.66 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=210.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3468999999999999999999964 789999999987766667789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC--CCCceEEeccccccccCCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD--KNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|++||+|.+++......+++..+..++.||+.||+||| ++||+||||||+||+++ .++.+||+|||+|..+....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999999766666999999999999999999999 66699999999999995 46889999999998774332
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...+..........
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~------------ 244 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWNM------------ 244 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCS------------
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC------------
Confidence 23345799999999999999999999999999999999999999975311 11122211111100
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||+.||++|||++|+++
T Consensus 245 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 ---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ---CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011123456889999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.7e-46 Score=397.69 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=209.8
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||+||+|... +|+.||||+++.........+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999964 7999999999876656667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeC--CCCceEEeccccccccCCCCC
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLD--KNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
++||+|.+++...+..+++.++..++.||+.||+||| ++||+||||||+|||++ .++.+||+|||+|..+....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999998877767999999999999999999999 66799999999999997 57899999999998875432
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... ..+..+.....+.
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~------------- 247 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEF------------- 247 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCC-------------
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC-------------
Confidence 233456899999999999999999999999999999999999999753211 1111111111100
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++..+.+++.+||+.||++|||+.|+++
T Consensus 248 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 --DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001123456889999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=390.38 Aligned_cols=257 Identities=24% Similarity=0.409 Sum_probs=203.0
Q ss_pred hhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
..++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 356899999999999999999999888899999997553 334679999999999999999999999854 567999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++|++..++... ...+++.+++.++.||+.||+||| +.+|+||||||+||++++++.+||+|||+|+.......
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 9999999998743 345899999999999999999999 56699999999999999999999999999987643322
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
.......||+.|+|||++..+.++.++|||||||++|||++|+.|+........ ....+......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~~~~~~-------------- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRM-------------- 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCC--------------
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCC--------------
Confidence 233445689999999999999999999999999999999997777654222211 11111111000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhH
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIK 863 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~ 863 (870)
..+..++.++.+++.+||+.||++||++++|++.|+++.
T Consensus 234 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 234 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 011234567899999999999999999999999888754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-46 Score=393.32 Aligned_cols=265 Identities=24% Similarity=0.378 Sum_probs=214.0
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSC 650 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 650 (870)
.+++...++|++.+.||+|+||+||+|+++ +++.||||+++... ....+++.+|++++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556788999999999999999999864 45789999997643 34457799999999999999999999999
Q ss_pred eeCCeeEEEEecCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 002892 651 CNLDFKALVLEFMPNGSLEKWLYSHN-----------------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVV 707 (870)
Q Consensus 651 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~iv 707 (870)
...+..+++|||+++|+|.++++... ..+++..++.++.|++.||+||| +++|+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence 99999999999999999999997432 24889999999999999999999 66699
Q ss_pred ecccCCCceeeCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCC-CC
Q 002892 708 HCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRK-KP 786 (870)
Q Consensus 708 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~-~p 786 (870)
||||||+||++++++.+||+|||+|+...........+...|++.|+|||++.+..++.++|||||||++|||++|. .|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765444444445567899999999999999999999999999999999986 46
Q ss_pred CCccccccchHHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 787 TDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
|...... .....+..... ...+..++.++.+++..||+.+|++||||.||++.|++|.+
T Consensus 243 ~~~~~~~--e~~~~v~~~~~-----------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 243 YYGMAHE--EVIYYVRDGNI-----------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTSCHH--HHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCHH--HHHHHHHcCCC-----------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 6542111 11111111000 00112345578999999999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=388.76 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=201.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC----CcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD----GTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
..++|++.+.||+|+||+||+|++.. +..||||+++... ....+.+.+|++++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 35689999999999999999998642 3568899886543 344577999999999999999999999986 46789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||+++|++.+++......+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+|+....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999998877777999999999999999999999 66699999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.. ........||+.|+|||++.++.++.++|||||||++|||++ |..||......+ +...+......
T Consensus 161 ~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~~~~--------- 228 (273)
T d1mp8a_ 161 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERL--------- 228 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCCC---------
T ss_pred Cc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC---------
Confidence 32 223334568999999999999999999999999999999998 888887643221 11111111000
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
..+..++..+.+++.+||+.||++|||+.||++.|+++.+.-
T Consensus 229 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 011234567999999999999999999999999999987653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-46 Score=391.13 Aligned_cols=245 Identities=24% Similarity=0.300 Sum_probs=200.2
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
+.|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999864 78999999987543 344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+++|++..++... ..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|.....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 999999997766544 45899999999999999999999 66699999999999999999999999999986532
Q ss_pred cccccccccccccCCcccccC---CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 741 SVTQTMTMATIGYMAPEYASD---GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
.....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.+.... ..+........+.
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~~~~---------- 233 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPA---------- 233 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCC----------
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCC----------
Confidence 223469999999999864 46899999999999999999999999753211 1111111111110
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.....++..+.+++.+||+.||++|||++|+++
T Consensus 234 -------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011123457889999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=394.67 Aligned_cols=258 Identities=24% Similarity=0.440 Sum_probs=205.6
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCc----EEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGT----NVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 658 (870)
++|++.+.||+|+||+||+|.+. +|+ +||+|.++... ....+.+.+|++++++++|||||++++++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 444 58888876433 34467899999999999999999999999764 5678
Q ss_pred EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCC
Q 002892 659 VLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGED 738 (870)
Q Consensus 659 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 738 (870)
++||+.+|+|.+++......+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999988778999999999999999999999 567999999999999999999999999999987655
Q ss_pred CCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhh
Q 002892 739 DDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASL 817 (870)
Q Consensus 739 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (870)
..........||+.|+|||++.++.++.++|||||||++|||+| |..||++.... .+...+.....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~~~----------- 231 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER----------- 231 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHTCC-----------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC-----------
Confidence 44444445568999999999999999999999999999999998 78888763222 12222211110
Q ss_pred hcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 818 VREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 818 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
...+..++..+.+++.+||+.+|++|||+.||++.|+++.+.
T Consensus 232 ------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 001123456789999999999999999999999999988653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=384.10 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=205.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh------hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL------ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDF 655 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 655 (870)
..++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3468999999999999999999964 79999999997542 1235778999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC----ceEEecccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM----TARVSDFGI 731 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~ 731 (870)
.|+||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++ .+|++|||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999998654 4999999999999999999999 66699999999999998776 499999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
|....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+......
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~~----- 234 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYE----- 234 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHTTCCC-----
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHHHHHhcCCC-----
Confidence 98764332 233456899999999999999999999999999999999999999753211 111111110000
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.+......++..+.+++.+||+.||++|||++|+++
T Consensus 235 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 ----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111233557889999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=388.36 Aligned_cols=275 Identities=21% Similarity=0.322 Sum_probs=206.8
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----eeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD----FKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 660 (870)
.+|...+.||+|+||+||+|++ +|+.||||+++..... ....+.|+..+.+++||||+++++++...+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4567788999999999999986 5889999999755332 233445666667889999999999997654 578999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS-----HSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
||+++|+|.+++++.+ ++|..+++++.|++.|++|+|.. ++++|+||||||+||++++++.+||+|||++...
T Consensus 81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999998754 89999999999999999999953 3478999999999999999999999999999877
Q ss_pred CCCCCcc--cccccccccccCCcccccCCC------cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 002892 736 GEDDDSV--TQTMTMATIGYMAPEYASDGI------ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 736 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.............. ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~--~~~~ 236 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV--PSDP 236 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS--CSSC
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc--cccc
Confidence 4433222 234567999999999987643 67799999999999999999988754322211100000 0000
Q ss_pred chh----hhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 808 GLT----EVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 808 ~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
... ...+..........+...+++..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 011 1111111122223334445677899999999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=380.57 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=198.4
Q ss_pred hcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeee-CCeeEEEEec
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCN-LDFKALVLEF 662 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 662 (870)
.++|++.+.||+|+||.||+|+++ |+.||||+++.+. ..+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 456888899999999999999975 7899999997543 34678999999999999999999999865 4567999999
Q ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 663 MPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 663 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
+++|+|.+++... ...+++..+++++.||+.|++||| +++|+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999754 335899999999999999999999 566999999999999999999999999999865322
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....+++.|+|||++.++.++.++|||||||++|||+| |+.||..... .++...+......
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~~~------------- 219 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM------------- 219 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCCC-------------
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCC-------------
Confidence 223357889999999999999999999999999999998 6777765322 2222222111100
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
. .+..++.++.+++.+||+.||++|||+.+|+++|++++.
T Consensus 220 ---~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 ---D-APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ---C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---C-CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 0 111234578899999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=384.73 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=202.0
Q ss_pred HhhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeC
Q 002892 582 QATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNL 653 (870)
Q Consensus 582 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 653 (870)
...++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 44578999999999999999999853 34689999987543 34456677888888877 689999999988654
Q ss_pred -CeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCcee
Q 002892 654 -DFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717 (870)
Q Consensus 654 -~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 717 (870)
...++||||+++|+|.++++..+ ..+++.++..++.||++||+||| +++|+||||||+||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcccee
Confidence 46899999999999999997432 34899999999999999999999 666999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCC-CCCCccccccch
Q 002892 718 LDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRK-KPTDEMFTGEMS 796 (870)
Q Consensus 718 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~-~p~~~~~~~~~~ 796 (870)
+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||...... ..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HH
Confidence 9999999999999998775544444455567999999999999999999999999999999999975 566543222 22
Q ss_pred HHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 797 LKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
+...+....... .+..++.++.+++.+||+.||++|||++||++.|+++.+.
T Consensus 246 ~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 FCRRLKEGTRMR-----------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCC-----------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 222222111110 0112345689999999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=381.93 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=198.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec--CC--cEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCee
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF--DG--TNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 656 (870)
.++|++.+.||+|+||.||+|+.+ ++ ..||||++++.. ....+++.+|++++++++||||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356899999999999999999853 22 368999986542 3445789999999999999999999999965 467
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
++||||+++|++.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999998877667999999999999999999999 5679999999999999999999999999999875
Q ss_pred CCCCcc-cccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccchHHHHHHHhcCCchhhhcc
Q 002892 737 EDDDSV-TQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVD 814 (870)
Q Consensus 737 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (870)
...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.... .....+.. .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~---~------- 230 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDK---E------- 230 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT---S-------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHh---C-------
Confidence 443322 2334457889999999999999999999999999999998 89998753211 11111110 0
Q ss_pred hhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002892 815 ASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKI 862 (870)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i 862 (870)
. .....+..++..+.+++.+||+.||++|||++||.+.|++.
T Consensus 231 -----~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 -----G-ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----C-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C-CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 00001123345789999999999999999999999988864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=384.11 Aligned_cols=248 Identities=26% Similarity=0.302 Sum_probs=205.0
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEE
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 659 (870)
.++|++.+.||+|+||.||+|+.+ +|+.||||++++.. ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999964 79999999998653 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||++||+|.+++...+. +++..+..++.|++.||+||| +++|+||||||+||+++++|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999987654 899999999999999999999 6679999999999999999999999999998653322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ..+.......... +
T Consensus 160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~~i~~~~~~-~---------- 224 (337)
T d1o6la_ 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEEIR-F---------- 224 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC-C----------
T ss_pred --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHHHHhcCCCC-C----------
Confidence 233446799999999999999999999999999999999999999976321 1111111110000 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
+..++.++.+++.+||+.||++||+ +.|+++
T Consensus 225 -------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0122446889999999999999995 777765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.3e-45 Score=379.21 Aligned_cols=262 Identities=19% Similarity=0.340 Sum_probs=203.5
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD---- 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 654 (870)
..++|++.+.||+|+||+||+|+. .+|+.||||+++... ......+.+|++++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 357899999999999999999996 479999999997543 344567999999999999999999999987644
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..|+||||++|++|.+++...+. +++.++..++.||+.||+||| ++||+||||||+||+++.++.++++|||.+..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred eEEEEEECCCCCEehhhhcccCC-CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence 47899999999999999876554 899999999999999999999 66699999999999999999999999999876
Q ss_pred cCCCCC-cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 735 LGEDDD-SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 735 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
...... ........||+.|+|||++.+..+++++||||+||++|||+||+.||......+ .......... . .
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~-~-~---- 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDP-I-P---- 233 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCC-C-C----
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCC-C-C----
Confidence 533222 223345579999999999999999999999999999999999999997532111 1111111000 0 0
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhHh
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRM-CMTDVVVKLQKIKQ 864 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~i~~ 864 (870)
+......++.++.+++.+||+.||++|| +++++++.|.+++.
T Consensus 234 ---------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 ---------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ---------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ---------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 0001112345788999999999999999 89999999988763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=379.52 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=207.8
Q ss_pred CCeeccccceeEEEEEecC----CcEEEEEEeech-hhHHHHHHHHHHHHHHhcCCCceeEEeeeeee-CCeeEEEEecC
Q 002892 590 CNLLGAGSFGSVYKGTLFD----GTNVAIKVFNLQ-LERAFRSFESECEVLRNVRHRNLIKIFSSCCN-LDFKALVLEFM 663 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 663 (870)
.++||+|+||+||+|++.+ ...||||+++.. .....+++.+|++++++++||||+++++++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998643 235899998643 34556789999999999999999999999875 56889999999
Q ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc--
Q 002892 664 PNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS-- 741 (870)
Q Consensus 664 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 741 (870)
++|+|.+++.......++..+++++.|++.||.|+| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999987777899999999999999999999 666999999999999999999999999999876443322
Q ss_pred ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhccc
Q 002892 742 VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVREV 821 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 821 (870)
.......||+.|+|||.+..+.++.++||||||+++|||+||+.||....... +...++......
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~-------------- 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRL-------------- 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC--------------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCC--------------
Confidence 22334568999999999999999999999999999999999888876532211 111211111000
Q ss_pred CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 822 QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 822 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
..+..++..+.+++.+||+.||++||++.||++.|+++.+.|.
T Consensus 254 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 254 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 0111345578999999999999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=381.69 Aligned_cols=252 Identities=19% Similarity=0.291 Sum_probs=207.2
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
..++|++.+.||+|+||+||+|... +|+.||||+++..... ...+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4678999999999999999999965 6889999999766433 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC--CceEEeccccccccCCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN--MTARVSDFGISKLLGEDD 739 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~ 739 (870)
|++||+|.+++...+..+++.++..++.||+.||+||| ++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999999877767999999999999999999999 6679999999999999854 589999999998764322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
......+|+.|+|||...+..++.++||||+||++|+|++|+.||..... ......+.......
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~------------ 222 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYTF------------ 222 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCC------------
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC------------
Confidence 23345689999999999999999999999999999999999999976321 11111111111000
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++.++.+++.+|+..||++|||++|+++
T Consensus 223 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111123456889999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=380.53 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=215.8
Q ss_pred hhcCCCCCCeeccccceeEEEEEe------cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCC
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL------FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLD 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 654 (870)
..++|++.++||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 447888999999999999999985 246789999997643 34456789999999999 6999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCcee
Q 002892 655 FKALVLEFMPNGSLEKWLYSHN-----------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 717 (870)
..++||||+++|+|.++++... ..+++..+..++.||+.|++||| +++++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence 9999999999999999998543 25899999999999999999999 566999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchH
Q 002892 718 LDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL 797 (870)
Q Consensus 718 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~ 797 (870)
++.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+.........+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999998765555555566789999999999999999999999999999999999555544323333333
Q ss_pred HHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 798 KHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
..++....+.. .+..++..+.+++.+||+.||++|||+++|+++|+++...
T Consensus 258 ~~~i~~~~~~~-----------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRML-----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCC-----------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 33332221110 0112345789999999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-44 Score=377.66 Aligned_cols=244 Identities=25% Similarity=0.323 Sum_probs=203.3
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56899999999999999999964 69999999997643 234577899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||++||++..++..... +++..+..++.||+.|++||| +++|+||||||+||+++.+|.+||+|||+|......
T Consensus 84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999998886554 788999999999999999999 778999999999999999999999999999876432
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .....+..... .
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~--~------------ 219 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAEL--R------------ 219 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCC--C------------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHHHHHcCCC--C------------
Confidence 22357999999999999999999999999999999999999999763211 11111111100 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
. +...+..+.+++.+||..||++|| +++++++
T Consensus 220 ~-----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 F-----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp C-----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C-----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0 011234688999999999999996 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-44 Score=370.90 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=203.7
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh---------hHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeC
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL---------ERAFRSFESECEVLRNVR-HRNLIKIFSSCCNL 653 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 653 (870)
++|++.+.||+|+||+||+|+. .+|+.||||++++.. +...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999996 478999999986542 223456889999999997 99999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
+..|+||||+++|+|.+++...+ .+++.++..++.||++||+||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999998655 4899999999999999999999 5669999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccC------CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASD------GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR 807 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 807 (870)
...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... .....+.......
T Consensus 159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~~~~i~~~~~~~ 234 (277)
T d1phka_ 159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNYQF 234 (277)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCC
T ss_pred EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-HHHHHHHhCCCCC
Confidence 775432 2334579999999998853 45788999999999999999999999763221 1111111111100
Q ss_pred chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+......++.++.+++.+||+.+|++|||+.||++
T Consensus 235 ---------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 235 ---------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00111134457899999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=380.83 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=207.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEecC--------CcEEEEEEeechh-hHHHHHHHHHHHHHHhc-CCCceeEEeeeeee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLFD--------GTNVAIKVFNLQL-ERAFRSFESECEVLRNV-RHRNLIKIFSSCCN 652 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 652 (870)
..++|++.+.||+|+||.||+|+... +..||||+++... ......+.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34788999999999999999998432 2479999997654 34457788899999888 79999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCcee
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHN---------------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNIL 717 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 717 (870)
++..++||||+++|+|.+++.... ..+++.++++++.||+.||+||| +++|+||||||+||+
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccccee
Confidence 999999999999999999997543 34899999999999999999999 666999999999999
Q ss_pred eCCCCceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHh-CCCCCCccccccch
Q 002892 718 LDKNMTARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFT-RKKPTDEMFTGEMS 796 (870)
Q Consensus 718 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~ 796 (870)
++.++.+||+|||++................|++.|+|||++.++.++.++|||||||++|||++ |..||..... ..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~~ 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--HH
Confidence 99999999999999987755444444555678999999999999999999999999999999998 6777765221 11
Q ss_pred HHHHHHHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 797 LKHWIKLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
+...+....... .+..++..+.+++.+||+.+|++|||+.||++.|+++.+
T Consensus 246 ~~~~i~~~~~~~-----------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLLKEGHRMD-----------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHTTCCCC-----------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC-----------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 222211111000 011234568999999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=378.23 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=203.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCc--EEEEEEeech-hhHHHHHHHHHHHHHHhc-CCCceeEEeeeeeeCCeeE
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGT--NVAIKVFNLQ-LERAFRSFESECEVLRNV-RHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 657 (870)
.+++|++.+.||+|+||+||+|+++ +|. .||||.++.. .....+.+.+|+++++++ +|||||++++++.+.+..+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 3578889999999999999999965 444 4678877543 334556799999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC
Q 002892 658 LVLEFMPNGSLEKWLYSH---------------NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM 722 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 722 (870)
+||||+++|+|.++++.. ...+++..+..++.||+.|++|+| +++|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCC
Confidence 999999999999999743 356999999999999999999999 66799999999999999999
Q ss_pred ceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCC-CCCccccccchHHHHH
Q 002892 723 TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKK-PTDEMFTGEMSLKHWI 801 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~-p~~~~~~~~~~~~~~~ 801 (870)
.+||+|||+|+..... .......||..|+|||.+.++.++.++|||||||++|||++|.. ||..... ..+...+
T Consensus 165 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--~~~~~~i 239 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKL 239 (309)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHG
T ss_pred ceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--HHHHHHH
Confidence 9999999999765322 12233468999999999999999999999999999999999765 5654211 1111111
Q ss_pred HHhcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhH
Q 002892 802 KLSLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQT 865 (870)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~ 865 (870)
. . .... ..+..++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 240 ~------------~----~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 240 P------------Q----GYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp G------------G----TCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H------------h----cCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0 0 0000 01113456799999999999999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-43 Score=380.80 Aligned_cols=248 Identities=22% Similarity=0.292 Sum_probs=197.6
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHH---HHHHHHHHHHhcCCCceeEEeeeeeeCCeeE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFR---SFESECEVLRNVRHRNLIKIFSSCCNLDFKA 657 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 657 (870)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ..... ....|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999965 69999999987543 11122 2334567777788999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCC
Q 002892 658 LVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGE 737 (870)
Q Consensus 658 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 737 (870)
+||||++||+|.+++..... +++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhccc-ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999986543 899999999999999999999 66799999999999999999999999999987643
Q ss_pred CCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchh
Q 002892 738 DDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDAS 816 (870)
Q Consensus 738 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (870)
.. .....||+.|+|||++.. ..++.++||||+||++|||+||+.||....... ............
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~~-------- 225 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMA-------- 225 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSSCC--------
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcccCC--------
Confidence 32 234579999999999865 568999999999999999999999997632221 111111111100
Q ss_pred hhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 817 LVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 817 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
. ..+..++.++.+++.+||+.||++||+ +.|+++
T Consensus 226 ----~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 ----V---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----C---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----C---CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 000122446889999999999999999 677764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=379.92 Aligned_cols=264 Identities=23% Similarity=0.385 Sum_probs=214.3
Q ss_pred HHhhcCCCCCCeeccccceeEEEEEec------CCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC
Q 002892 581 QQATDGFNECNLLGAGSFGSVYKGTLF------DGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL 653 (870)
Q Consensus 581 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 653 (870)
+...++|+..+.||+|+||+||+|.+. +++.||||+++... ......+.+|++++++++||||+++++++...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 345678899999999999999999853 35789999997543 34456789999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCce
Q 002892 654 DFKALVLEFMPNGSLEKWLYSHN---------YFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTA 724 (870)
Q Consensus 654 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 724 (870)
+..++||||+++|+|.+++...+ ..+++..+.+++.|+++||+||| +++|+||||||+|||+++++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceE
Confidence 99999999999999999987432 34789999999999999999999 5669999999999999999999
Q ss_pred EEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCC-CCCCccccccchHHHHHHH
Q 002892 725 RVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRK-KPTDEMFTGEMSLKHWIKL 803 (870)
Q Consensus 725 kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~ 803 (870)
||+|||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||+ .||..... ...+.. +.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-~~~~~~-i~- 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRF-VM- 249 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-HHHHHH-HH-
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-HHHHHH-HH-
Confidence 999999998775544444455567899999999999999999999999999999999985 66654211 111111 10
Q ss_pred hcCCchhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHh
Q 002892 804 SLPRGLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTF 866 (870)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~ 866 (870)
+... ...+..++..+.+++.+||+.+|++|||+.+|++.|++..+..
T Consensus 250 ----------~~~~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 ----------EGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp ----------TTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ----------hCCC------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1000 0011134557999999999999999999999999999876544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-44 Score=381.86 Aligned_cols=244 Identities=22% Similarity=0.243 Sum_probs=203.6
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 660 (870)
++|++++.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|++++++++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999965 79999999997543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDD 740 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 740 (870)
||+.+|+|.+++...+. +++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 99999999999986654 899999999999999999999 666999999999999999999999999999876432
Q ss_pred cccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhcc
Q 002892 741 SVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVRE 820 (870)
Q Consensus 741 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 820 (870)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.+... ......+..... .
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~-~------------- 256 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGKV-R------------- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC-C-------------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-HHHHHHHhcCCC-C-------------
Confidence 2235699999999999999999999999999999999999999975311 111111111100 0
Q ss_pred cCcchHHHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002892 821 VQPSYAKMDCLLRIMHLALGCCMDSPEQRM-----CMTDVVV 857 (870)
Q Consensus 821 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 857 (870)
.+..++..+.+++.+||+.||++|+ +++|+++
T Consensus 257 -----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0012345688999999999999994 8999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=373.04 Aligned_cols=247 Identities=26% Similarity=0.339 Sum_probs=200.7
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh---hHHHHHHHHHHHHHH-hcCCCceeEEeeeeeeCCeeEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL---ERAFRSFESECEVLR-NVRHRNLIKIFSSCCNLDFKALV 659 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 659 (870)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ......+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999965 78999999997643 233455666776665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCC
Q 002892 660 LEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDD 739 (870)
Q Consensus 660 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 739 (870)
|||+++|+|.+++...+. +++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999986554 899999999999999999999 6669999999999999999999999999998654322
Q ss_pred CcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhcchhhhc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVVDASLVR 819 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 819 (870)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ..+...+....+. .
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~~-~---------- 222 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPF-Y---------- 222 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC-C----------
T ss_pred --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCC-C----------
Confidence 233445799999999999999999999999999999999999999975321 1111111111000 0
Q ss_pred ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 002892 820 EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMT-DVVV 857 (870)
Q Consensus 820 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~ 857 (870)
+..++.++.+++.+||+.||++||++. ++++
T Consensus 223 -------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 -------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 012345688999999999999999985 6753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=374.52 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=197.6
Q ss_pred hcCCCCCC-eeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhc-CCCceeEEeeeeee----CCee
Q 002892 584 TDGFNECN-LLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNV-RHRNLIKIFSSCCN----LDFK 656 (870)
Q Consensus 584 ~~~~~~~~-~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~ 656 (870)
.++|++.+ .||+|+||+||+|+. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788775 699999999999996 47899999998653 3467789887655 89999999999865 4578
Q ss_pred EEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEeccccc
Q 002892 657 ALVLEFMPNGSLEKWLYSH-NYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFGIS 732 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a 732 (870)
|+|||||+||+|.+++... ...+++.++..++.||+.||+||| ++||+||||||+||+++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 9999999999999999865 346999999999999999999999 667999999999999975 567999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhh
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEV 812 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (870)
+...... ......||+.|+|||++.+..++.++||||+||++|+|+||+.||.+...... ...+ .....
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~-~~~i~------ 230 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGM-KTRIR------ 230 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCC------
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHH-HHHHh------
Confidence 8764432 23345799999999999999999999999999999999999999975322111 0000 00000
Q ss_pred cchhhhccc-CcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 813 VDASLVREV-QPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 813 ~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... .+......++.++.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 -----MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 011122345667999999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=369.30 Aligned_cols=268 Identities=22% Similarity=0.276 Sum_probs=201.9
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhh--HHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLE--RAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 4799999999965432 235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
|+.++.+..........+++..+..++.|++.||+||| +++||||||||+||+++.++.+||+|||.|.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence 99765444444455666999999999999999999999 6669999999999999999999999999998764332
Q ss_pred ccccccccccccCCcccccCCC-cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCc--hhhhcch--
Q 002892 742 VTQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPRG--LTEVVDA-- 815 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~-- 815 (870)
.......||+.|+|||+..... ++.++||||+||++|+|++|+.||.+.... ..+...... ..+.. +......
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhccccccccc
Confidence 2334457999999999877655 578999999999999999999999763222 222222221 11111 1111100
Q ss_pred ---hhhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 816 ---SLVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 816 ---~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.......... ........+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000 011224578899999999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=369.43 Aligned_cols=262 Identities=24% Similarity=0.284 Sum_probs=194.6
Q ss_pred CCCeeccccceeEEEEEec-CCcEEEEEEeechhhH-----HHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 589 ECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLER-----AFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 589 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
.+++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++...+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 6899999998754321 124688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
++++++..+.. .+..+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+|........
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 98877665554 4455899999999999999999999 66799999999999999999999999999987644322
Q ss_pred cccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CC--chhhhcc---h
Q 002892 743 TQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PR--GLTEVVD---A 815 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~---~ 815 (870)
......||+.|+|||++... .++.++||||+||++|||++|..||...... ..+..+..... +. .+..... .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccchhccchh
Confidence 22335689999999998654 5799999999999999999999999753221 22222222111 10 0110000 0
Q ss_pred hhhccc-Ccch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 816 SLVREV-QPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 816 ~~~~~~-~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
...... .... ........+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 0000 00122457899999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-42 Score=362.63 Aligned_cols=266 Identities=20% Similarity=0.295 Sum_probs=200.4
Q ss_pred cCCCCCCeeccccceeEEEEEecCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEec
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLEF 662 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 662 (870)
++|++.+.||+|+||+||+|++++|+.||||+++... +...+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999996643 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCcc
Q 002892 663 MPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDSV 742 (870)
Q Consensus 663 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 742 (870)
+.++.+..+.. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 97766655554 4455999999999999999999999 56699999999999999999999999999987643322
Q ss_pred cccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CC--chhhhcc----
Q 002892 743 TQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PR--GLTEVVD---- 814 (870)
Q Consensus 743 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~---- 814 (870)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+ .......... +. .+.....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhhc
Confidence 2334468999999999875 457899999999999999999999997643221 2222222111 11 1111100
Q ss_pred -hhhh-cccCc-chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 -ASLV-REVQP-SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 -~~~~-~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... ....+ .......+..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000 0001122456889999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=361.57 Aligned_cols=240 Identities=24% Similarity=0.269 Sum_probs=194.9
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhh------HHHHHHHHHHHHHHhcC--CCceeEEeeeeeeCC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLE------RAFRSFESECEVLRNVR--HRNLIKIFSSCCNLD 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 654 (870)
.++|++.+.||+|+||+||+|+.. +|+.||||++++... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999964 789999999875431 11234678999999986 899999999999999
Q ss_pred eeEEEEecCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCC-CceEEeccccc
Q 002892 655 FKALVLEFMPN-GSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKN-MTARVSDFGIS 732 (870)
Q Consensus 655 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a 732 (870)
..++||||+.+ +++.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++.+ +.+||+|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence 99999999976 67888877554 4899999999999999999999 6679999999999999854 79999999999
Q ss_pred cccCCCCCcccccccccccccCCcccccCCCc-CcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhh
Q 002892 733 KLLGEDDDSVTQTMTMATIGYMAPEYASDGII-SPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTE 811 (870)
Q Consensus 733 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 811 (870)
...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .......
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~------ 221 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV------ 221 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC------
T ss_pred eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhccc------
Confidence 865332 2234579999999999987665 577999999999999999999996521 1111000
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... .++.++.+++.+||+.||++|||++|+++
T Consensus 222 --------~~~~-----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 --------FFRQ-----RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------CCSS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCC-----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0001 12346889999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-41 Score=353.62 Aligned_cols=264 Identities=14% Similarity=0.116 Sum_probs=211.3
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRH-RNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 689999999865432 2456788999999975 899999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC-----CCceEEeccccccccC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK-----NMTARVSDFGISKLLG 736 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~ 736 (870)
|+ +++|.+++...+..+++.++..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+|+.+.
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 78999999877777999999999999999999999 777999999999999974 5789999999998764
Q ss_pred CCCCc-----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchH--HHHHHHhcCCch
Q 002892 737 EDDDS-----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSL--KHWIKLSLPRGL 809 (870)
Q Consensus 737 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~ 809 (870)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP- 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC-
Confidence 33221 12334579999999999999999999999999999999999999997643322111 11111000000
Q ss_pred hhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHhHhh
Q 002892 810 TEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQTFL 867 (870)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~~~~ 867 (870)
.......++.++.+++..|+..+|++||+++.+.+.|+++.+...
T Consensus 237 -------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 237 -------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp -------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 000111245678999999999999999999999999998876643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=363.26 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=198.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-C-CcEEEEEEeechhh--HHHHHHHHHHHHHHhc---CCCceeEEeeeeee----
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-D-GTNVAIKVFNLQLE--RAFRSFESECEVLRNV---RHRNLIKIFSSCCN---- 652 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 652 (870)
.++|++.+.||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999963 4 66799999865431 1223455677766655 79999999998853
Q ss_pred -CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccc
Q 002892 653 -LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGI 731 (870)
Q Consensus 653 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 731 (870)
....+++|||++++++..........+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 34678999999988877666666667999999999999999999999 66699999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhc-CCc--
Q 002892 732 SKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSL-PRG-- 808 (870)
Q Consensus 732 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~-- 808 (870)
+.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+........ +..
T Consensus 163 ~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 163 ARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGGG
T ss_pred hhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCchhc
Confidence 87543 22334456799999999999999999999999999999999999999976322 222222222111 110
Q ss_pred hhhh---cchhhhcccCc--chHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 809 LTEV---VDASLVREVQP--SYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 809 ~~~~---~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
+... ........... .......+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00000000000 0001122446789999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-41 Score=355.53 Aligned_cols=261 Identities=17% Similarity=0.193 Sum_probs=202.6
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc-eeEEeeeeeeCCeeEEEEe
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN-LIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 661 (870)
.++|++.+.||+|+||+||+|++. +|+.||||+....... .++..|++++++++|++ |+.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999964 6899999998765432 45788999999998765 5556666678889999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCC---CCceEEeccccccccCCC
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDK---NMTARVSDFGISKLLGED 738 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~ 738 (870)
|+ ++++.+.+......+++..+..++.|++.||+||| +++|+||||||+||+++. +..+|++|||+|+.+...
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99 56777777766667999999999999999999999 666999999999999864 457999999999877543
Q ss_pred CCc-----ccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccch--HHHHHHHhcCCchhh
Q 002892 739 DDS-----VTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMS--LKHWIKLSLPRGLTE 811 (870)
Q Consensus 739 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 811 (870)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+.....+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~---- 235 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---- 235 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----
Confidence 321 1233457999999999999999999999999999999999999999764322211 11111100000
Q ss_pred hcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhHh
Q 002892 812 VVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVKLQKIKQ 864 (870)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~i~~ 864 (870)
........++.++.+++..||+.+|++||+++++.+.|+++..
T Consensus 236 ----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 ----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000112345678999999999999999999999999888754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=357.18 Aligned_cols=270 Identities=21% Similarity=0.281 Sum_probs=197.6
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh-hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC----ee
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL-ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD----FK 656 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 656 (870)
..++|++++.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456799999999999999999985 479999999997543 444567889999999999999999999986543 23
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccC
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLG 736 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 736 (870)
+++++|+.+|+|.+++...+ +++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+|....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 45556677999999997654 899999999999999999999 5669999999999999999999999999998764
Q ss_pred CCCCc-ccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-hcCCchh--h
Q 002892 737 EDDDS-VTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-SLPRGLT--E 811 (870)
Q Consensus 737 ~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~--~ 811 (870)
..... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. ....... ..+.... .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhh
Confidence 33222 22344568999999999854 5678899999999999999999999976322111 1111111 1111000 0
Q ss_pred hcc----h---hhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 812 VVD----A---SLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 812 ~~~----~---~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
... . .........+. ......++.+++.+|++.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 00000000000 01123468899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=351.76 Aligned_cols=269 Identities=20% Similarity=0.267 Sum_probs=196.1
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee--------
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN-------- 652 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 652 (870)
.++|++++.||+|+||+||+|++. +|+.||||++.... +....++.+|++++++++|||++++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999964 79999999986543 3344678899999999999999999998754
Q ss_pred CCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccc
Q 002892 653 LDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGIS 732 (870)
Q Consensus 653 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 732 (870)
.+..++||||++++.+..+ ......+++..+..++.|++.||+||| ++||+||||||+||+++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 3467899999987766544 444455899999999999999999999 667999999999999999999999999999
Q ss_pred cccCCCCCc--ccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHh--cCC
Q 002892 733 KLLGEDDDS--VTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLS--LPR 807 (870)
Q Consensus 733 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~ 807 (870)
......... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ........... .+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhcCCCCh
Confidence 876543322 122335689999999998765 689999999999999999999999975322 11122221111 111
Q ss_pred c-hhhhcchhhhc----c------cCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 808 G-LTEVVDASLVR----E------VQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 808 ~-~~~~~~~~~~~----~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
. ........... . .............+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1 11111000000 0 0011111222446778999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=346.26 Aligned_cols=267 Identities=19% Similarity=0.242 Sum_probs=204.1
Q ss_pred cCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCCeeEEEEe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLDFKALVLE 661 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 661 (870)
++|++++.||+|+||+||+|++. +++.||||+++... .....++.+|+.+++.++||||+++++++...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 78999999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccccCCCCCc
Q 002892 662 FMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLLGEDDDS 741 (870)
Q Consensus 662 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 741 (870)
++.++++..++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|++|||.|........
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 999998888776544 4899999999999999999999 56699999999999999999999999999987754332
Q ss_pred ccccccccccccCCcccccCCC-cCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC---chhh---hcc
Q 002892 742 VTQTMTMATIGYMAPEYASDGI-ISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR---GLTE---VVD 814 (870)
Q Consensus 742 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~ 814 (870)
......+++.|+|||++.... ++.++||||+||++|||++|+.||..................+. .+.. ..+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 222345788999999987655 68999999999999999999999754322222222222211111 0110 000
Q ss_pred hh---hh-cccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 815 AS---LV-REVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 815 ~~---~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. .. ...............+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00 000000011122346889999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=357.56 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=192.4
Q ss_pred CCCCCCeeccccceeEEEEEec-CCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC------CeeEE
Q 002892 586 GFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLIKIFSSCCNL------DFKAL 658 (870)
Q Consensus 586 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 658 (870)
+|+..++||+|+||+||+|++. +|+.||||++...... ..+|++++++++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 6999999999765322 34699999999999999999998542 35789
Q ss_pred EEecCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEecccccccc
Q 002892 659 VLEFMPNGSLEKWLY--SHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLL 735 (870)
Q Consensus 659 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~ 735 (870)
||||++++....... .....+++.++..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444433 34456999999999999999999999 77899999999999999875 8999999999876
Q ss_pred CCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc---hhh
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG---LTE 811 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 811 (870)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+..+....-... +..
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhh
Confidence 43322 233468999999998765 56899999999999999999999999753221 12222221110000 000
Q ss_pred hcch----hhhc---ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 VVDA----SLVR---EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 ~~~~----~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.... .... ...........+..+.+++.+|++.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000 00000001123456889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=355.12 Aligned_cols=264 Identities=20% Similarity=0.271 Sum_probs=194.9
Q ss_pred hhcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeCC-----
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNLD----- 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 654 (870)
..++|++++.||+|+||+||+|... +|+.||||+++... +...+.+.+|++++++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999964 69999999997542 344567889999999999999999999997654
Q ss_pred -eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 655 -FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 655 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
..|+||||+ ++++..+.+..+ +++..+..++.|++.||+||| ++||+||||||+||+++.++.+|++|||.|.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecc-cccHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence 569999999 668888776543 899999999999999999999 6669999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccccCCcccccC-CCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcC--Cchh
Q 002892 734 LLGEDDDSVTQTMTMATIGYMAPEYASD-GIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLP--RGLT 810 (870)
Q Consensus 734 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 810 (870)
..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+......... ....
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHH
Confidence 76432 234568999999999876 4578999999999999999999999976322 1122222211111 0000
Q ss_pred hhc--------chhhhcccCcch--HHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 811 EVV--------DASLVREVQPSY--AKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 811 ~~~--------~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
... ............ ........+.+++.+|+..||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000000000000 001223467899999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-40 Score=349.68 Aligned_cols=260 Identities=18% Similarity=0.278 Sum_probs=196.2
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeeee--CCeeEEEE
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCN--LDFKALVL 660 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 660 (870)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .+++.+|++++++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 478999999987543 356788999999995 9999999999874 45689999
Q ss_pred ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC-ceEEeccccccccCCCC
Q 002892 661 EFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM-TARVSDFGISKLLGEDD 739 (870)
Q Consensus 661 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 739 (870)
||+++++|..+. ..+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+|++|||+|.......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999987654 34899999999999999999999 66799999999999998765 69999999998764332
Q ss_pred CcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHH-------------hc
Q 002892 740 DSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKL-------------SL 805 (870)
Q Consensus 740 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------------~~ 805 (870)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................ ..
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 23345689999999998765 47999999999999999999999987543222111111110 00
Q ss_pred CC--chhhhcchhhhc---ccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 806 PR--GLTEVVDASLVR---EVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 806 ~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
.. ............ ..........++.++.+++.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 001111000000 00011111223456889999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=348.95 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=199.7
Q ss_pred cCCCCCCeeccccceeEEEEEe----cCCcEEEEEEeechh----hHHHHHHHHHHHHHHhcCC-CceeEEeeeeeeCCe
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL----FDGTNVAIKVFNLQL----ERAFRSFESECEVLRNVRH-RNLIKIFSSCCNLDF 655 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 655 (870)
++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999984 258899999986532 2234567889999999976 899999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEecccccccc
Q 002892 656 KALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKLL 735 (870)
Q Consensus 656 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 735 (870)
.+++|||+.+|+|.+++...+. +++..+..++.|++.|++|+| +.+|+||||||+||+++.++.+||+|||+|..+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999986654 678999999999999999999 566999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccCCcccccCC--CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCchhhhc
Q 002892 736 GEDDDSVTQTMTMATIGYMAPEYASDG--IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRGLTEVV 813 (870)
Q Consensus 736 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (870)
.... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||........ .........
T Consensus 180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~-------- 249 (322)
T d1vzoa_ 180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRIL-------- 249 (322)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHH--------
T ss_pred cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcc--------
Confidence 4322 2223445789999999998764 467899999999999999999999976433222 111111110
Q ss_pred chhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002892 814 DASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMC-----MTDVVV 857 (870)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 857 (870)
.... . .+..++.++.+++.+||++||++||+ ++|+++
T Consensus 250 ----~~~~--~-~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ----KSEP--P-YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----HCCC--C-CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----cCCC--C-CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0000 0 00123557899999999999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-39 Score=345.06 Aligned_cols=262 Identities=20% Similarity=0.219 Sum_probs=191.7
Q ss_pred hcCCCCCCeeccccceeEEEEEec-CCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeee------CC
Q 002892 584 TDGFNECNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCN------LD 654 (870)
Q Consensus 584 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 654 (870)
.++|++.++||+|+||+||+|.+. +|+.||||+++... .....++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999965 69999999997543 3445678899999999999999999999864 36
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
+.|+||||+.++.+. .+. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+|++|||++..
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence 789999999765544 443 23899999999999999999999 66799999999999999999999999999886
Q ss_pred cCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCC-------
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPR------- 807 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 807 (870)
.... .......+|+.|+|||++.+..+++++||||+||++|||++|+.||.+... ..............
T Consensus 169 ~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHTT
T ss_pred cccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH-HHHHHHHHHhccCCCHHHHHH
Confidence 5432 233445689999999999999999999999999999999999999965321 11111111111000
Q ss_pred ------------------chhhhcchhhhcccCcchHHHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002892 808 ------------------GLTEVVDASLVREVQPSYAKMDCLLRIMHLALGCCMDSPEQRMCMTDVVVK 858 (870)
Q Consensus 808 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 858 (870)
.....+..... ..........+..+.+++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLF--PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGS--CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccc--cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00111111110 01112234456788999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=344.04 Aligned_cols=264 Identities=19% Similarity=0.247 Sum_probs=195.7
Q ss_pred hhcCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechh--hHHHHHHHHHHHHHHhcCCCceeEEeeeeeeC-----C
Q 002892 583 ATDGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQL--ERAFRSFESECEVLRNVRHRNLIKIFSSCCNL-----D 654 (870)
Q Consensus 583 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 654 (870)
..++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999995 479999999997543 34456788999999999999999999998633 3
Q ss_pred eeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccccccc
Q 002892 655 FKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 655 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
..+++++|+.+|+|.+++... .+++.++..++.||+.||+||| ++||+||||||+||+++.++.+|++|||.+..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence 446677788899999999654 3899999999999999999999 66799999999999999999999999999975
Q ss_pred cCCCCCcccccccccccccCCcccccCC-CcCcccchHhHHHHHHHHHhCCCCCCccccccchHHHHHHHhcCCc--hhh
Q 002892 735 LGEDDDSVTQTMTMATIGYMAPEYASDG-IISPKCDVYSYGVLLMETFTRKKPTDEMFTGEMSLKHWIKLSLPRG--LTE 811 (870)
Q Consensus 735 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 811 (870)
.. .......|++.|+|||+..+. .++.++||||+||++|+|++|+.||.+.... .............. ...
T Consensus 171 ~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 171 TD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHT
T ss_pred cC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhh
Confidence 43 223345689999999987665 4688999999999999999999999753211 11111111111100 000
Q ss_pred --------hcchhhhcccCcchH--HHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002892 812 --------VVDASLVREVQPSYA--KMDCLLRIMHLALGCCMDSPEQRMCMTDVVV 857 (870)
Q Consensus 812 --------~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 857 (870)
............... ...+...+.+++.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000010011110 0123456889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-34 Score=311.59 Aligned_cols=265 Identities=19% Similarity=0.209 Sum_probs=187.3
Q ss_pred cCCCCCCeeccccceeEEEEEe-cCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-----------CCceeEEeeeeee
Q 002892 585 DGFNECNLLGAGSFGSVYKGTL-FDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-----------HRNLIKIFSSCCN 652 (870)
Q Consensus 585 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 652 (870)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999996 479999999997653 23456778888888775 5789999988754
Q ss_pred --CCeeEEEEecCCCCCHHH--HHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCC------
Q 002892 653 --LDFKALVLEFMPNGSLEK--WLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNM------ 722 (870)
Q Consensus 653 --~~~~~lv~e~~~~g~L~~--~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~------ 722 (870)
....+++++++..+.... ........+++..+..++.|++.|++|||+ ..||+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 345566666655544332 222445568999999999999999999994 26799999999999997665
Q ss_pred ceEEeccccccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHHHHHHhCCCCCCcccccc-----chH
Q 002892 723 TARVSDFGISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLLMETFTRKKPTDEMFTGE-----MSL 797 (870)
Q Consensus 723 ~~kl~Dfg~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~-----~~~ 797 (870)
.++++|||.+...... .....||+.|+|||++....++.++||||+||++++|++|+.||....... ..+
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999999765322 234569999999999999999999999999999999999999997532111 011
Q ss_pred HHHHHH--hcCCch-------hhhcch-----hhhcccC---------cchHHHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002892 798 KHWIKL--SLPRGL-------TEVVDA-----SLVREVQ---------PSYAKMDCLLRIMHLALGCCMDSPEQRMCMTD 854 (870)
Q Consensus 798 ~~~~~~--~~~~~~-------~~~~~~-----~~~~~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 854 (870)
...... ..+... ....+. .+..... ........+..+.+++.+|+..||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111111 001100 000000 0000000 00011345678999999999999999999999
Q ss_pred HHH
Q 002892 855 VVV 857 (870)
Q Consensus 855 vl~ 857 (870)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 976
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=3e-31 Score=281.16 Aligned_cols=259 Identities=31% Similarity=0.550 Sum_probs=199.4
Q ss_pred CccEEEccCCcccCC--Cccccccccccccccccc-cccccccCCCCCcccccccccccccceEEcCCCCCCCCCCcccc
Q 002892 209 KLIGLDLNSNSLSGQ--IPNTFGNLRHLSTLNIRA-NYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIG 285 (870)
Q Consensus 209 ~L~~L~Ls~N~i~~~--~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 285 (870)
.++.|||++|.+++. +|..++++++|++|+|++ |.+++. +|..+.++++|++|+|++|++.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~--------iP~~i~~L~~L~~L~Ls~N~l~~------- 115 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP--------IPPAIAKLTQLHYLYITHTNVSG------- 115 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESC--------CCGGGGGCTTCSEEEEEEECCEE-------
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccc--------cccccccccccchhhhccccccc-------
Confidence 455566666555542 445555555555555553 444321 12234444444444444444332
Q ss_pred ccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCcccccee
Q 002892 286 NFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQL 365 (870)
Q Consensus 286 ~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L 365 (870)
..+..+..+..|+.+++++|.+.+.+ |..+..++.|+++
T Consensus 116 ------------------~~~~~~~~~~~L~~l~l~~N~~~~~~-----------------------p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 116 ------------------AIPDFLSQIKTLVTLDFSYNALSGTL-----------------------PPSISSLPNLVGI 154 (313)
T ss_dssp ------------------ECCGGGGGCTTCCEEECCSSEEESCC-----------------------CGGGGGCTTCCEE
T ss_pred ------------------cccccccchhhhcccccccccccccC-----------------------chhhccCccccee
Confidence 23344556667777777777776544 4556677889999
Q ss_pred ecCCcccCCCCCccccccccc-ceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcc
Q 002892 366 HLGSNQLTSSIPSSFWSLEYI-LRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRF 444 (870)
Q Consensus 366 ~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 444 (870)
++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+.. ..+++++|.+.+.+|..++.+++|+.+++++|.+
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l 233 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred ecccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccc
Confidence 999999999999999888776 88999999999999988888754 5799999999999999999999999999999999
Q ss_pred cCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccccccccccccCCCCcCC
Q 002892 445 QDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCGPPRLQV 524 (870)
Q Consensus 445 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~ 524 (870)
.+.+| .+..+++|+.|+|++|+|+|.+|..|..+++|+.|+|++|+|+|.+|..+.+..+....+.+|+.+||.| .
T Consensus 234 ~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p---l 309 (313)
T d1ogqa_ 234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---L 309 (313)
T ss_dssp CCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---S
T ss_pred ccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC---C
Confidence 87655 6899999999999999999999999999999999999999999999988788888888899999999988 5
Q ss_pred CCCC
Q 002892 525 PPCK 528 (870)
Q Consensus 525 ~~~~ 528 (870)
|+|.
T Consensus 310 p~c~ 313 (313)
T d1ogqa_ 310 PACT 313 (313)
T ss_dssp SCCC
T ss_pred CCCC
Confidence 6774
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=2.3e-29 Score=275.31 Aligned_cols=356 Identities=27% Similarity=0.348 Sum_probs=202.9
Q ss_pred cCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccc
Q 002892 21 DISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSIS 100 (870)
Q Consensus 21 ~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~ 100 (870)
+++.+.+++.++ ...+.+|++|++++|.|+ .+ +.++.+++|++|+|++|+|++ ++ .++++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccc
Confidence 444444443322 234455555666555555 22 234555555555555555553 22 2555555555555555554
Q ss_pred cccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCccc
Q 002892 101 GNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMG 180 (870)
Q Consensus 101 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 180 (870)
+.. .++.+++|+.|++++|.+++..+ ......+..+....|.+....+................
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~------------ 165 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV------------ 165 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESC------------
T ss_pred ccc--ccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc------------
Confidence 221 24555555555555555542221 22233344444444443322211111111111111111
Q ss_pred CCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCCccccccc
Q 002892 181 HSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSL 260 (870)
Q Consensus 181 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l 260 (870)
.....+.............|... ....+..+++++.+++++|.++.+. .+
T Consensus 166 ------------------~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~----------~~ 215 (384)
T d2omza2 166 ------------------TDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDIT----------PL 215 (384)
T ss_dssp ------------------CCCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCG----------GG
T ss_pred ------------------chhhhhccccccccccccccccc--cccccccccccceeeccCCccCCCC----------cc
Confidence 11122333444445555555443 2344556666666666666665532 23
Q ss_pred ccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHH
Q 002892 261 TNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQ 340 (870)
Q Consensus 261 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 340 (870)
..+++|++|++++|++.++ ..+..+++|+.|++++|.+++..
T Consensus 216 ~~~~~L~~L~l~~n~l~~~---------------------------~~l~~l~~L~~L~l~~n~l~~~~----------- 257 (384)
T d2omza2 216 GILTNLDELSLNGNQLKDI---------------------------GTLASLTNLTDLDLANNQISNLA----------- 257 (384)
T ss_dssp GGCTTCCEEECCSSCCCCC---------------------------GGGGGCTTCSEEECCSSCCCCCG-----------
T ss_pred cccCCCCEEECCCCCCCCc---------------------------chhhcccccchhccccCccCCCC-----------
Confidence 4456666777776665532 23555667777777777776321
Q ss_pred HHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCcc
Q 002892 341 ALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQL 420 (870)
Q Consensus 341 ~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 420 (870)
.+..+++|++|++++|++++.. .+..++.++.+++++|.+++. ..+..+++++.|++++|++
T Consensus 258 --------------~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 258 --------------PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNI 319 (384)
T ss_dssp --------------GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCC
T ss_pred --------------cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCC
Confidence 1445567788888888877543 366777788888888888742 3477778888888888888
Q ss_pred CCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCC
Q 002892 421 SGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHN 490 (870)
Q Consensus 421 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 490 (870)
++.. .+..+++|+.|++++|+|++ ++ .|+++++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 320 ~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 320 SDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 8653 37778888888888888875 33 58888888888888888886544 778888888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=6.4e-29 Score=271.77 Aligned_cols=343 Identities=23% Similarity=0.315 Sum_probs=239.8
Q ss_pred CCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcE
Q 002892 12 GNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVR 91 (870)
Q Consensus 12 ~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 91 (870)
.++.+|++|++++|+|++ + +.+..+++|++|++++|+++ .+|. ++.+++|++|++++|+|++. + .++++++|+.
T Consensus 41 ~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~ 114 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADI-T-PLANLTNLTG 114 (384)
T ss_dssp HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCE
T ss_pred HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccc-c-cccccccccc
Confidence 467889999999999984 4 46899999999999999999 4553 99999999999999999853 3 4899999999
Q ss_pred EeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccc
Q 002892 92 LDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQL 171 (870)
Q Consensus 92 L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 171 (870)
|++++|.+++..+ ......+..+....|.+....+.................. ...+.............|..
T Consensus 115 L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 187 (384)
T d2omza2 115 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKV 187 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCC
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----hhhhcccccccccccccccc
Confidence 9999999984433 4456788899999998874443333222222222222111 22233333333333333332
Q ss_pred cccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCC
Q 002892 172 SGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSN 251 (870)
Q Consensus 172 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 251 (870)
. ....+..+++++.+++++|.+++..| +...++|++|++++|.++.+
T Consensus 188 ~---------------------------~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~---- 234 (384)
T d2omza2 188 S---------------------------DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI---- 234 (384)
T ss_dssp C---------------------------CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC----
T ss_pred c---------------------------cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc----
Confidence 2 23345556666777777777765433 34556677777777766653
Q ss_pred CCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCc
Q 002892 252 GEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPT 331 (870)
Q Consensus 252 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 331 (870)
+.+..+++|+.|++++|++.+. ..+..+++|+.|++++|++.+..
T Consensus 235 ------~~l~~l~~L~~L~l~~n~l~~~---------------------------~~~~~~~~L~~L~l~~~~l~~~~-- 279 (384)
T d2omza2 235 ------GTLASLTNLTDLDLANNQISNL---------------------------APLSGLTKLTELKLGANQISNIS-- 279 (384)
T ss_dssp ------GGGGGCTTCSEEECCSSCCCCC---------------------------GGGTTCTTCSEEECCSSCCCCCG--
T ss_pred ------chhhcccccchhccccCccCCC---------------------------CcccccccCCEeeccCcccCCCC--
Confidence 2456667777777777776542 12455677778888777776321
Q ss_pred hhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCC
Q 002892 332 TLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLI 411 (870)
Q Consensus 332 ~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 411 (870)
.+..++.++.+++++|++++. ..+..+++++.|++++|++++.. .+..+++|+
T Consensus 280 -----------------------~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~ 332 (384)
T d2omza2 280 -----------------------PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQ 332 (384)
T ss_dssp -----------------------GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCC
T ss_pred -----------------------ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCC
Confidence 134456778888888888742 35777888888888888888643 377888888
Q ss_pred EEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCC
Q 002892 412 YLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466 (870)
Q Consensus 412 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 466 (870)
+|++++|+|++ ++ .|+++++|++|++++|++++..| +.++++|+.|+|++|
T Consensus 333 ~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 333 RLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp EEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred EEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 99999888875 33 58888889999999998887654 888889999999887
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=6.2e-29 Score=263.15 Aligned_cols=252 Identities=30% Similarity=0.482 Sum_probs=220.0
Q ss_pred CCCCeecCCCCcccc--CCCccccCCCCCcEEEccC-CcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcE
Q 002892 15 SFLMYLDISENNFRG--YLPNELGQLRRLKFLGFAY-NDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVR 91 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~--~~p~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 91 (870)
.++++|||++|++.+ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|+|.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 368899999999986 4789999999999999986 7899899999999999999999999999888888999999999
Q ss_pred EeccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCC-CeeecccccccccccccccccccceEEEeeccc
Q 002892 92 LDSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNL-ADLVLALNNLIGPIPTTIFNISTIIIINLVGNQ 170 (870)
Q Consensus 92 L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (870)
+++++|.+.+.+|..++.+++|+++++++|.+++.+|..+..+..+ +.++++.|++++..|..+.++..+ .+++++|.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 9999999998899999999999999999999999999999888776 789999999998888888877655 69999999
Q ss_pred ccccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCC
Q 002892 171 LSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSS 250 (870)
Q Consensus 171 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 250 (870)
..+..|..+. .+++++.+++++|.+++.++ .+..+++|++|+|++|++++.+|++|+++++|++|+|++|+++...
T Consensus 209 ~~~~~~~~~~-~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~i-- 284 (313)
T d1ogqa_ 209 LEGDASVLFG-SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-- 284 (313)
T ss_dssp EEECCGGGCC-TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC--
T ss_pred cccccccccc-cccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccC--
Confidence 9888777665 47899999999999986554 6888899999999999999999999999999999999999998522
Q ss_pred CCCcccccccccccccceEEcCCCC-CCC
Q 002892 251 NGEWSFLSSLTNCNKLRALSLGSNP-LDS 278 (870)
Q Consensus 251 ~~~~~~~~~l~~l~~L~~L~L~~N~-l~~ 278 (870)
+.+..+++|+.+++++|+ +.+
T Consensus 285 -------P~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 285 -------PQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp -------CCSTTGGGSCGGGTCSSSEEES
T ss_pred -------CCcccCCCCCHHHhCCCccccC
Confidence 245678899999999997 444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=9.6e-26 Score=237.48 Aligned_cols=85 Identities=28% Similarity=0.348 Sum_probs=42.9
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcC
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLA 440 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 440 (870)
+|+.|++++|.++...+..|..++.++.|++++|.+++..+..|.++++|++|+|++|+|+ .+|..|.++++|+.|+|+
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 250 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred ccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECC
Confidence 4555555555555444555555555555555555555444444555555555555555554 234444455555555555
Q ss_pred CCcccC
Q 002892 441 RNRFQD 446 (870)
Q Consensus 441 ~N~l~~ 446 (870)
+|+|+.
T Consensus 251 ~N~i~~ 256 (305)
T d1xkua_ 251 NNNISA 256 (305)
T ss_dssp SSCCCC
T ss_pred CCccCc
Confidence 555543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.1e-25 Score=237.07 Aligned_cols=273 Identities=21% Similarity=0.252 Sum_probs=230.9
Q ss_pred CCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc
Q 002892 16 FLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR 95 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 95 (870)
.++.+|-++++++ .+|..+. +++++|+|++|+|+...+..|..+++|++|++++|.++...|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 6778999999998 6787764 689999999999995555689999999999999999997778899999999999999
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeeccccccc--ccccccccccccceEEEeecccccc
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLI--GPIPTTIFNISTIIIINLVGNQLSG 173 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~l~~N~l~~ 173 (870)
+|+++ .+|..+ ...++.|.+++|.+.+..+..+.....++.++...|... ...+..+..+++|+.+++++|.++.
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 99998 666554 357899999999999766666777788888988887543 4556678889999999999999875
Q ss_pred cCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCCC
Q 002892 174 HRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGE 253 (870)
Q Consensus 174 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 253 (870)
. |..+ +++|+.|++++|..+...+..|..++.+++|++++|.+++..+.+|.++++|++|+|++|.|+.++
T Consensus 165 l-~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp----- 235 (305)
T d1xkua_ 165 I-PQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP----- 235 (305)
T ss_dssp C-CSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC-----
T ss_pred c-Cccc---CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccc-----
Confidence 4 3332 578999999999999999999999999999999999999888999999999999999999998754
Q ss_pred cccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCcc
Q 002892 254 WSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLN 326 (870)
Q Consensus 254 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 326 (870)
..+..+++|++|+|++|+|+.+....|.. +.....+.+|+.|+|++|.+.
T Consensus 236 ----~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~-------------------~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 236 ----GGLADHKYIQVVYLHNNNISAIGSNDFCP-------------------PGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp ----TTTTTCSSCCEEECCSSCCCCCCTTSSSC-------------------SSCCTTSCCCSEEECCSSSSC
T ss_pred ----cccccccCCCEEECCCCccCccChhhccC-------------------cchhcccCCCCEEECCCCcCc
Confidence 35788999999999999999876554432 233456778999999999885
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1e-25 Score=234.32 Aligned_cols=206 Identities=25% Similarity=0.251 Sum_probs=181.4
Q ss_pred hhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhc--CCCCCCCcccccCccccceeecCCc
Q 002892 293 QFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQR--NNLNGPIPTCLSSLISLRQLHLGSN 370 (870)
Q Consensus 293 ~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~--n~~~~~~p~~~~~l~~L~~L~Ls~N 370 (870)
.|++++|++++..+.+|.++++|+.|++++|++....+..+..+..+..+... +.+....+..|.++++|++|++++|
T Consensus 36 ~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n 115 (284)
T d1ozna_ 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115 (284)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTS
T ss_pred EEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCc
Confidence 33333333333444567888899999999999998888888888887777543 5566666788999999999999999
Q ss_pred ccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccc
Q 002892 371 QLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD 450 (870)
Q Consensus 371 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 450 (870)
.+....+..+....+|+.+++++|+++++.+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..|.
T Consensus 116 ~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~ 195 (284)
T d1ozna_ 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195 (284)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChh
Confidence 99988888999999999999999999987788999999999999999999998899999999999999999999999999
Q ss_pred cccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCC
Q 002892 451 SFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 451 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
.|.++++|++||+++|++++..|..|..+++|+.|++++|+|.|.++.
T Consensus 196 ~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred HhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 999999999999999999998889999999999999999999999874
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.7e-24 Score=225.03 Aligned_cols=225 Identities=20% Similarity=0.214 Sum_probs=173.1
Q ss_pred CeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc-C
Q 002892 18 MYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR-F 96 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~-~ 96 (870)
..++.++++++ .+|..+. +.+++|+|++|+|++..+..|..+++|++|++++|+|....+..+..+..++.++.. .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 35677788887 5676553 567888888888886666778888888888888888887777777888888887754 5
Q ss_pred CccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCC
Q 002892 97 NSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRP 176 (870)
Q Consensus 97 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 176 (870)
|.++...+..|+++++|++|++++|.+....+..+...++|+.+++++|++++..+..|..+++|++|++++|++++..+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 56665567778888888888888888876667777788888888888888887777777788888888888888876555
Q ss_pred CcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccccc
Q 002892 177 STMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTT 246 (870)
Q Consensus 177 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 246 (870)
..+ ..+++|+++++++|++++..|..|..+++|++||+++|++.+..+..|.++++|++|+|++|.+..
T Consensus 171 ~~f-~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 171 RAF-RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TTT-TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred hhh-ccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 444 357777788888887777777777777788888888888877777777777777777777777664
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.7e-24 Score=219.78 Aligned_cols=213 Identities=24% Similarity=0.194 Sum_probs=176.3
Q ss_pred cccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHH
Q 002892 262 NCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQA 341 (870)
Q Consensus 262 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 341 (870)
....+.+.+.+++.++.+ |+. ++..++.|++++|++++..+.+|.++++|++|+|++|+++.
T Consensus 8 ~~~~~~~v~C~~~~L~~i-P~~---lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-------------- 69 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTAL-PPD---LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-------------- 69 (266)
T ss_dssp CSTTCCEEECTTSCCSSC-CSC---CCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE--------------
T ss_pred ccCCCeEEEccCCCCCee-CcC---cCcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc--------------
Confidence 445566778999988875 332 23456677777777766555666777777777777776652
Q ss_pred HHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccC
Q 002892 342 LLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLS 421 (870)
Q Consensus 342 L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 421 (870)
+| .++.+++|++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++
T Consensus 70 ----------l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 70 ----------LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137 (266)
T ss_dssp ----------EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred ----------cc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc
Confidence 22 2456789999999999998 55778999999999999999999888889999999999999999999
Q ss_pred CcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCc
Q 002892 422 GNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGP 501 (870)
Q Consensus 422 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 501 (870)
...+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.|.. ..
T Consensus 138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~-~~ 215 (266)
T d1p9ag_ 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI-LY 215 (266)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG-HH
T ss_pred eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch-HH
Confidence 888888999999999999999999988899999999999999999999 8898888999999999999999998753 23
Q ss_pred ccccc
Q 002892 502 FRNFL 506 (870)
Q Consensus 502 ~~~~~ 506 (870)
|..|.
T Consensus 216 l~~wl 220 (266)
T d1p9ag_ 216 FRRWL 220 (266)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.6e-23 Score=210.87 Aligned_cols=200 Identities=22% Similarity=0.202 Sum_probs=107.1
Q ss_pred CCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEE
Q 002892 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRL 92 (870)
Q Consensus 13 ~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 92 (870)
+...+.++|.++++++ .+|..+. +++++|+|++|+|++..+..|..+++|++|+|++|+|+ .+| .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence 3445555666666666 3555443 45666666666666444455666666666666666665 233 24556666666
Q ss_pred eccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccc
Q 002892 93 DSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172 (870)
Q Consensus 93 ~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 172 (870)
+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 66666665 34555556666666666666665545555555555555555555555444444444444444444444443
Q ss_pred ccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccccccc
Q 002892 173 GHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYL 244 (870)
Q Consensus 173 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l 244 (870)
+..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+
T Consensus 162 -------------------------~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 162 -------------------------ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp -------------------------CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred -------------------------ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 333444444455555555555554 3444444444444444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.87 E-value=5.6e-20 Score=197.30 Aligned_cols=59 Identities=29% Similarity=0.380 Sum_probs=31.0
Q ss_pred CccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcccCCCCc
Q 002892 407 LKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK 474 (870)
Q Consensus 407 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 474 (870)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+. +|.. +++|+.|+|++|+|+ .+|.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc-cccc---cCCCCEEECcCCcCC-CCCc
Confidence 345566666666655 23322 3455566666666552 3332 345666666666665 4444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=3.5e-20 Score=198.90 Aligned_cols=137 Identities=22% Similarity=0.274 Sum_probs=82.9
Q ss_pred CCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEecc
Q 002892 16 FLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSR 95 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 95 (870)
+|++|||++|+++ .+|+. +++|++|++++|+|+ .+|+.+ .+|+.|++++|+++ .++. + .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--cccccccccc
Confidence 5777888888877 46643 456777788888777 666543 46777777777776 3332 1 1357777777
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccc
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 172 (870)
+|.+. .+|. ++.+++|++|++++|.+. ..+.. ...+..+.+..+... ....+..++.++.|++++|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeecccccccc-ccccc---cccccchhhcccccc--ccccccccccceeccccccccc
Confidence 77776 4553 566777777777777776 33332 234445555544432 2233444555555555555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=4.5e-22 Score=192.71 Aligned_cols=168 Identities=16% Similarity=0.149 Sum_probs=120.3
Q ss_pred CCCeeccccceeEEEEEecCCcEEEEEEeechh------------------hHHHHHHHHHHHHHHhcCCCceeEEeeee
Q 002892 589 ECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQL------------------ERAFRSFESECEVLRNVRHRNLIKIFSSC 650 (870)
Q Consensus 589 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 650 (870)
+.++||+|+||+||+|+..+|+.||||+++... .........|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 467899999999999998889999999875321 11223456788899999999998887653
Q ss_pred eeCCeeEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecccCCCceeeCCCCceEEeccc
Q 002892 651 CNLDFKALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHSHSTPVVHCNLKPNNILLDKNMTARVSDFG 730 (870)
Q Consensus 651 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 730 (870)
..+++|||+++....+ ++......++.|+++|++||| ++||+||||||+||+++++ .++++|||
T Consensus 84 ----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp ----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECC
Confidence 2379999998865432 344556779999999999999 6679999999999999865 58999999
Q ss_pred cccccCCCCCcccccccccccccCCcccccCCCcCcccchHhHHHHH
Q 002892 731 ISKLLGEDDDSVTQTMTMATIGYMAPEYASDGIISPKCDVYSYGVLL 777 (870)
Q Consensus 731 ~a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il 777 (870)
.|.....+........ +... -.|. ..+.|+.++|+||..--+
T Consensus 148 ~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 9976543221110000 0000 0111 135678899999976544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.1e-22 Score=227.33 Aligned_cols=392 Identities=20% Similarity=0.177 Sum_probs=211.5
Q ss_pred CCCeecCCCCccccCC-CccccCCCCCcEEEccCCcccc----cCCccccCCCCCCEEEcCCCccccC----CCCCCC-C
Q 002892 16 FLMYLDISENNFRGYL-PNELGQLRRLKFLGFAYNDLTG----SFPSWIGVFSKLQVLSLRNNSFTGP----IPNSLF-N 85 (870)
Q Consensus 16 ~L~~L~ls~n~l~~~~-p~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~-~ 85 (870)
+|++||+++|++++.. .+.+..+++++.|+|++|.++. .+...+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6889999999997532 3345678899999999998873 3455667888999999999988632 222332 2
Q ss_pred CCCCcEEeccCCccccc----cCcCCCCcCCccEEEeecCccceecCCccc-----CCCCCCeeeccccccccc----cc
Q 002892 86 LSSLVRLDSRFNSISGN----IPSKIGNLTKLVHLNFADNNLRGEIPNEIG-----NLKNLADLVLALNNLIGP----IP 152 (870)
Q Consensus 86 l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~-----~l~~L~~L~L~~n~l~~~----~~ 152 (870)
..+|++|+|++|+++.. ++..+..+++|++|++++|.|+......+. .......+......+... ..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35789999999988743 345677788889999988888743221111 111222233332222110 01
Q ss_pred ccccccccceEEEeecccccccCCCcccCCCCccceeeecccccccccCCcc-cCCCCccEEEccCCcccCCCc----cc
Q 002892 153 TTIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLTGTIPNSI-TNASKLIGLDLNSNSLSGQIP----NT 227 (870)
Q Consensus 153 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~i~~~~~----~~ 227 (870)
..+.....++.++++++......... ....+ ........+++..+.+..... ..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~---------------------~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 221 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRV---------------------LCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 221 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHH---------------------HHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred cccccccccccccccccccccccccc---------------------cccccccccccccccccccccccchhhhccccc
Confidence 11222344555555554432110000 00001 111234566666665542211 22
Q ss_pred cccccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCch
Q 002892 228 FGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPK 307 (870)
Q Consensus 228 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~ 307 (870)
+...+.++.+++++|.+...... ............++.+++++|.+..... +....
T Consensus 222 l~~~~~~~~l~~~~n~~~~~~~~---~~~~~~~~~~~~l~~l~l~~n~i~~~~~---------------------~~~~~ 277 (460)
T d1z7xw1 222 VASKASLRELALGSNKLGDVGMA---ELCPGLLHPSSRLRTLWIWECGITAKGC---------------------GDLCR 277 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHH---HHHHHHTSTTCCCCEEECTTSCCCHHHH---------------------HHHHH
T ss_pred ccccccccccchhhccccccccc---hhhccccccccccccccccccccccccc---------------------ccccc
Confidence 34456677777777765432100 0012234445678888888877653210 11233
Q ss_pred hhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCccc----ccc
Q 002892 308 EIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSF----WSL 383 (870)
Q Consensus 308 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~l 383 (870)
.+...+.++.+++++|.+.......+.. ......+.|+.+++++|.++......+ ...
T Consensus 278 ~l~~~~~l~~l~l~~n~i~~~~~~~l~~------------------~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~ 339 (460)
T d1z7xw1 278 VLRAKESLKELSLAGNELGDEGARLLCE------------------TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 339 (460)
T ss_dssp HHHHCTTCCEEECTTCCCHHHHHHHHHH------------------HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC
T ss_pred cccccccccccccccccccccccchhhc------------------cccccccccccccccccchhhhhhhhcccccccc
Confidence 4556677888888888776321111110 001122467778888887764433322 333
Q ss_pred cccceEecCCCccCCC----Cccccc-CCccCCEEEccCCccCCc----ccccccCCCCCCEEEcCCCcccCcccccc--
Q 002892 384 EYILRIDLSSNSLSGS----LPSDIQ-NLKVLIYLNLSRNQLSGN----IPITIGGLKDLITLSLARNRFQDSIPDSF-- 452 (870)
Q Consensus 384 ~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-- 452 (870)
++|++|+|++|++++. ++..+. ..+.|++|+|++|.|+.. ++..+..+++|++|+|++|+|++.....|
T Consensus 340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~ 419 (460)
T d1z7xw1 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419 (460)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred cchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHH
Confidence 4667777777766532 222232 344566777777766532 23334455666666666666654333222
Q ss_pred --c-CCCCCCeEecCCCcccC
Q 002892 453 --G-SLTSLEYLDLSNNNLSG 470 (870)
Q Consensus 453 --~-~l~~L~~L~L~~N~l~~ 470 (870)
. +...|+.|++++|.+..
T Consensus 420 ~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 420 SVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHTSTTCCCCEEECTTCCCCH
T ss_pred HHHhCCCccCEEECCCCCCCH
Confidence 1 22356666666666653
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.1e-22 Score=227.45 Aligned_cols=394 Identities=19% Similarity=0.179 Sum_probs=237.3
Q ss_pred CCcEEEccCCccccc-CCccccCCCCCCEEEcCCCcccc----CCCCCCCCCCCCcEEeccCCccccc----cCcCCC-C
Q 002892 40 RLKFLGFAYNDLTGS-FPSWIGVFSKLQVLSLRNNSFTG----PIPNSLFNLSSLVRLDSRFNSISGN----IPSKIG-N 109 (870)
Q Consensus 40 ~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~-~ 109 (870)
+|+.||+++|++++. +.+.+..++++++|+|++|.|+. .+...+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 578888888888753 24455667888888888888763 2233456778888888888887521 222332 2
Q ss_pred cCCccEEEeecCcccee----cCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCcccCCCCc
Q 002892 110 LTKLVHLNFADNNLRGE----IPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPSTMGHSLPN 185 (870)
Q Consensus 110 l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 185 (870)
..+|++|+|++|+|+.. ++..+..+++|++|++++|.+.......+.... ......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l--------------------~~~~~~ 142 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGL--------------------LDPQCR 142 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHH--------------------TSTTCC
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcc--------------------cccccc
Confidence 34688888888877633 344566677777777777776532222221100 000001
Q ss_pred cceeeeccccccc----ccCCcccCCCCccEEEccCCcccCCCcccc----c-cccccccccccccccccccCCCCCccc
Q 002892 186 RQFLLLWANRLTG----TIPNSITNASKLIGLDLNSNSLSGQIPNTF----G-NLRHLSTLNIRANYLTTETSSNGEWSF 256 (870)
Q Consensus 186 L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~----~-~l~~L~~L~L~~N~l~~~~~~~~~~~~ 256 (870)
..........+.. .....+.....++.++++++.+.......+ . .-.....+++..+.+..... ...
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~----~~~ 218 (460)
T d1z7xw1 143 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC----RDL 218 (460)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH----HHH
T ss_pred cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh----hcc
Confidence 1111111111110 111224455678888888887653221111 1 12234556666665543210 112
Q ss_pred ccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhch
Q 002892 257 LSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRL 336 (870)
Q Consensus 257 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 336 (870)
...+...+.++.+++++|++.... .....+........++.+++++|.+.......+
T Consensus 219 ~~~l~~~~~~~~l~~~~n~~~~~~--------------------~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~--- 275 (460)
T d1z7xw1 219 CGIVASKASLRELALGSNKLGDVG--------------------MAELCPGLLHPSSRLRTLWIWECGITAKGCGDL--- 275 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHH--------------------HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH---
T ss_pred cccccccccccccchhhccccccc--------------------cchhhcccccccccccccccccccccccccccc---
Confidence 234556777888888888653210 001122334456789999999998864221111
Q ss_pred hhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCccc-----ccccccceEecCCCccCCCCcc----cccCC
Q 002892 337 QQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSF-----WSLEYILRIDLSSNSLSGSLPS----DIQNL 407 (870)
Q Consensus 337 ~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~p~----~~~~l 407 (870)
...+...+.++.+++++|.++......+ .....|+.+++++|.++..... .+...
T Consensus 276 ----------------~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~ 339 (460)
T d1z7xw1 276 ----------------CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 339 (460)
T ss_dssp ----------------HHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC
T ss_pred ----------------cccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccc
Confidence 1223445778999999999864322222 2346799999999998754333 34456
Q ss_pred ccCCEEEccCCccCCc----cccccc-CCCCCCEEEcCCCcccCc----ccccccCCCCCCeEecCCCcccCCCCcchh-
Q 002892 408 KVLIYLNLSRNQLSGN----IPITIG-GLKDLITLSLARNRFQDS----IPDSFGSLTSLEYLDLSNNNLSGEIPKSFE- 477 (870)
Q Consensus 408 ~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~- 477 (870)
++|++|+|++|+|++. ++..+. ..+.|+.|+|++|.|++. ++..+..+++|++|||++|+|+......+.
T Consensus 340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~ 419 (460)
T d1z7xw1 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419 (460)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred cchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHH
Confidence 6899999999999753 233333 467899999999999854 445567789999999999999853333332
Q ss_pred ----hccccceeeccCCcccccC
Q 002892 478 ----ILSHLKRLNVSHNRLEGKI 496 (870)
Q Consensus 478 ----~l~~L~~L~ls~N~l~~~~ 496 (870)
....|+.|++++|.+....
T Consensus 420 ~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 420 SVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp HHTSTTCCCCEEECTTCCCCHHH
T ss_pred HHHhCCCccCEEECCCCCCCHHH
Confidence 2347999999999987533
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=3.3e-19 Score=177.83 Aligned_cols=120 Identities=27% Similarity=0.368 Sum_probs=66.1
Q ss_pred ccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEE
Q 002892 359 LISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438 (870)
Q Consensus 359 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 438 (870)
+++|+.+++++|...+. ..+...+.+..+.++++.+... ..+.++++|+.|++++|.+++.. .++++++|+.|+
T Consensus 106 l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~ 179 (227)
T d1h6ua2 106 LQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLK 179 (227)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred ccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecc
Confidence 34455555555544422 2234445555555555555432 23455566666666666665322 256666666666
Q ss_pred cCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeecc
Q 002892 439 LARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVS 488 (870)
Q Consensus 439 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 488 (870)
|++|++++. + .|+++++|++|+|++|+|++ ++ .+.++++|+.|+++
T Consensus 180 Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 180 ADDNKISDI-S-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCSSCCCCC-G-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred cCCCccCCC-h-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence 666666543 2 26666666666666666663 33 25666666666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=1.2e-19 Score=180.99 Aligned_cols=209 Identities=21% Similarity=0.308 Sum_probs=131.0
Q ss_pred CCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEE
Q 002892 13 NLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRL 92 (870)
Q Consensus 13 ~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 92 (870)
.++++..++++.+++++.. .+..+.+|+.|++++|.++ .++ .+..+++|++|++++|+|++.. .+..+++|+++
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l 90 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEE
T ss_pred HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeeccc--ccccccccccc
Confidence 3445556777777777533 4566778888888888887 453 4777888888888888887432 37777888888
Q ss_pred eccCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccc
Q 002892 93 DSRFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLS 172 (870)
Q Consensus 93 ~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 172 (870)
++++|.++ .+ ..++.+++|+.+++++|...+. ..+...+.++.+.++.+.+... ..+..+++|+.|++++|.+.
T Consensus 91 ~~~~n~~~-~i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 91 ELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp ECCSCCCS-CC-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred cccccccc-cc-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc
Confidence 88888776 33 3467777788888877776632 2355566777777777666432 23455566666666666554
Q ss_pred ccCCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccccccccccccccCCCC
Q 002892 173 GHRPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNG 252 (870)
Q Consensus 173 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 252 (870)
+.. .+.++++|++|+|++|++++. + .|+++++|++|+|++|++++++
T Consensus 165 ~~~---------------------------~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~---- 211 (227)
T d1h6ua2 165 DLT---------------------------PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS---- 211 (227)
T ss_dssp CCG---------------------------GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG----
T ss_pred cch---------------------------hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc----
Confidence 221 244555566666666665532 2 2555666666666666655432
Q ss_pred CcccccccccccccceEEcC
Q 002892 253 EWSFLSSLTNCNKLRALSLG 272 (870)
Q Consensus 253 ~~~~~~~l~~l~~L~~L~L~ 272 (870)
.+.++++|+.|+++
T Consensus 212 ------~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 212 ------PLANTSNLFIVTLT 225 (227)
T ss_dssp ------GGTTCTTCCEEEEE
T ss_pred ------ccccCCCCCEEEee
Confidence 24555666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1e-18 Score=176.43 Aligned_cols=216 Identities=17% Similarity=0.150 Sum_probs=99.8
Q ss_pred CeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCC-CCCCCCCCCCcEEecc-
Q 002892 18 MYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPI-PNSLFNLSSLVRLDSR- 95 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~- 95 (870)
+.++.++++++ .+|..+. +++++|++++|.++...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45566666665 4554442 35666666666665433445566666666666666555332 2245556666666554
Q ss_pred CCccccccCcCCCCcCCccEEEeecCccceecCC-cccCCCCCCeeecccccccccccccccccc-cceEEEeecccccc
Q 002892 96 FNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPN-EIGNLKNLADLVLALNNLIGPIPTTIFNIS-TIIIINLVGNQLSG 173 (870)
Q Consensus 96 ~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~ 173 (870)
.|.+....+..|.++++|++|++++|++....+. .+..+..+..+..+++++....+..+..++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 2445544455556666666666666655522111 122333444444444444433334444332 44444555554443
Q ss_pred cCCCcccCCCCcc-ceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccc
Q 002892 174 HRPSTMGHSLPNR-QFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLN 238 (870)
Q Consensus 174 ~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 238 (870)
..+..+ . .+++ +.+.+++|+++...+..|.++++|++|+|++|+|+.+.+..|.++++|+.|+
T Consensus 168 i~~~~~-~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~ 231 (242)
T d1xwdc1 168 IHNCAF-N-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231 (242)
T ss_dssp ECTTTT-T-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred cccccc-c-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCc
Confidence 222221 1 1222 2223344444433333344444444444444444433333344444444433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=9.2e-19 Score=169.23 Aligned_cols=158 Identities=22% Similarity=0.303 Sum_probs=119.5
Q ss_pred cccceeecCCcccCC-CCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEE
Q 002892 360 ISLRQLHLGSNQLTS-SIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438 (870)
Q Consensus 360 ~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 438 (870)
+++++|+|++|+|++ ..+..|.++++|+.|+|++|.+....+..|..+++|++|+|++|+|+.+.|..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 468888899988875 4466778888888888888888888888888888888888888888888888888888888888
Q ss_pred cCCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCcccccccccccccccccC
Q 002892 439 LARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQSFLWNYALCG 518 (870)
Q Consensus 439 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 518 (870)
|++|+|+++.|++|..+++|++|+|++|.+... .....-...++.+.++.|.++|..|.. ++...-..+..|..-|.
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~-~~~~~~~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN-CHLAWFAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS-GGGHHHHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccc-cchHHHhhhhhhhcccCCCeEeCCChh--hcCCEeeecCHhhCcCC
Confidence 888888888888888888888888888888743 333333345777788888888877752 33333334444544454
Q ss_pred CC
Q 002892 519 PP 520 (870)
Q Consensus 519 ~~ 520 (870)
.+
T Consensus 186 ~~ 187 (192)
T d1w8aa_ 186 SE 187 (192)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.3e-18 Score=175.61 Aligned_cols=222 Identities=18% Similarity=0.124 Sum_probs=179.2
Q ss_pred CcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCcccccc-CcCCCCcCCccEEEee
Q 002892 41 LKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNI-PSKIGNLTKLVHLNFA 119 (870)
Q Consensus 41 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~l~ 119 (870)
.+.++.+++.++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|..+++++++.+.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 368889999999 7887663 68999999999999655557999999999999999987554 4568899999999987
Q ss_pred c-CccceecCCcccCCCCCCeeecccccccccccc-cccccccceEEEeecccccccCCCcccCCCCccceeeecccccc
Q 002892 120 D-NNLRGEIPNEIGNLKNLADLVLALNNLIGPIPT-TIFNISTIIIINLVGNQLSGHRPSTMGHSLPNRQFLLLWANRLT 197 (870)
Q Consensus 120 ~-N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 197 (870)
. |.+....+..|.++++|++|++++|++....+. .+..+..++.+..+++.+....+..+......++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4 788878888899999999999999999754433 34456778888888888887766666655568999999999999
Q ss_pred cccCCcccCCCCccE-EEccCCcccCCCccccccccccccccccccccccccCCCCCcccccccccccccceEEcCCC
Q 002892 198 GTIPNSITNASKLIG-LDLNSNSLSGQIPNTFGNLRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSN 274 (870)
Q Consensus 198 ~~~~~~~~~l~~L~~-L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 274 (870)
...+..+ ...++++ +++++|+|+.+.++.|.++++|++|+|++|+|+.++. ..|.++++|+.+++.+.
T Consensus 167 ~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~--------~~~~~l~~L~~l~~~~l 235 (242)
T d1xwdc1 167 EIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS--------YGLENLKKLRARSTYNL 235 (242)
T ss_dssp EECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS--------SSCTTCCEEESSSEESS
T ss_pred ccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH--------HHHcCCcccccCcCCCC
Confidence 6555554 4455554 5678899997777789999999999999999998764 25788888888887653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=4.3e-19 Score=171.59 Aligned_cols=156 Identities=28% Similarity=0.359 Sum_probs=132.6
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCC-CCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEc
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSG-SLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSL 439 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 439 (870)
+.++++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|++.+..+..|..+++|+.|+|
T Consensus 9 ~~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 3468999999999 5565553 689999999999986 45677899999999999999999999999999999999999
Q ss_pred CCCcccCcccccccCCCCCCeEecCCCcccCCCCcchhhccccceeeccCCcccccCCCCCccccccc-ccccccccccC
Q 002892 440 ARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLA-QSFLWNYALCG 518 (870)
Q Consensus 440 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~-~~~~~n~~~c~ 518 (870)
++|+|+++.|.+|.++++|++|+|++|+|++..|..|..+++|++|+|++|++.|.++.. .+..+.. .....+...|+
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBC
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeC
Confidence 999999988999999999999999999999888899999999999999999999987642 2333322 23455666677
Q ss_pred CC
Q 002892 519 PP 520 (870)
Q Consensus 519 ~~ 520 (870)
.|
T Consensus 165 ~p 166 (192)
T d1w8aa_ 165 AP 166 (192)
T ss_dssp SS
T ss_pred CC
Confidence 65
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=5.9e-18 Score=164.50 Aligned_cols=142 Identities=28% Similarity=0.418 Sum_probs=95.1
Q ss_pred hhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccce
Q 002892 309 IGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388 (870)
Q Consensus 309 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 388 (870)
+..+++|++|++++|++++.. .++++++|++|++++|.+.... .+..+++|+.
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~-------------------------~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~ 110 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDIT-------------------------PLKNLTKLVDILMNNNQIADIT--PLANLTNLTG 110 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCG-------------------------GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred cccCCCcCcCccccccccCcc-------------------------cccCCccccccccccccccccc--cccccccccc
Confidence 455667777777777765311 1445567777777777776332 3667777777
Q ss_pred EecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcc
Q 002892 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNL 468 (870)
Q Consensus 389 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 468 (870)
|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++.. .++++++|+.|++++|++
T Consensus 111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKV 184 (199)
T ss_dssp EECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCC
Confidence 77777777643 346677778888888887763 2 34677778888888888777542 377778888888888887
Q ss_pred cCCCCcchhhcccccee
Q 002892 469 SGEIPKSFEILSHLKRL 485 (870)
Q Consensus 469 ~~~~p~~~~~l~~L~~L 485 (870)
++ ++ .+..+++|+.|
T Consensus 185 ~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 185 SD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CC-CG-GGGGCTTCSEE
T ss_pred CC-Cc-cccCCCCCCcC
Confidence 73 33 46677777654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.1e-17 Score=163.91 Aligned_cols=146 Identities=28% Similarity=0.355 Sum_probs=99.5
Q ss_pred hhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCCCCcccccccccce
Q 002892 309 IGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILR 388 (870)
Q Consensus 309 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 388 (870)
+..+++|++|++++|++++.. .++.+++|++|++++|+|++. | .+..+++|+.
T Consensus 64 l~~l~~L~~L~L~~n~i~~l~-------------------------~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~ 116 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLTDIK-------------------------PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKS 116 (210)
T ss_dssp GGGCTTCCEEECCSSCCCCCG-------------------------GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCE
T ss_pred HhhCCCCCEEeCCCccccCcc-------------------------ccccCcccccccccccccccc-c-cccccccccc
Confidence 455666777777777665311 134456677777777777642 3 4667777777
Q ss_pred EecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCCcc
Q 002892 389 IDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNNNL 468 (870)
Q Consensus 389 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 468 (870)
|++++|.+.. + ..+..++.++.+++++|.+++ +..+..+++|+.+++++|++++.. .++++++|+.|+|++|+|
T Consensus 117 L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 117 LSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp EECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred cccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCC
Confidence 7777777763 2 356777778888888887764 334666778888888888887543 277788888888888888
Q ss_pred cCCCCcchhhccccceeeccC
Q 002892 469 SGEIPKSFEILSHLKRLNVSH 489 (870)
Q Consensus 469 ~~~~p~~~~~l~~L~~L~ls~ 489 (870)
+ .+| .+..+++|+.|+|++
T Consensus 191 ~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 191 S-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp C-BCG-GGTTCTTCSEEEEEE
T ss_pred C-CCh-hhcCCCCCCEEEccC
Confidence 7 344 477788888888764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=7.3e-18 Score=165.27 Aligned_cols=181 Identities=23% Similarity=0.312 Sum_probs=88.0
Q ss_pred eecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCc
Q 002892 19 YLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNS 98 (870)
Q Consensus 19 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 98 (870)
..+++.+.+++.++. ..+.+|++|++++|.++ .++. +..+++|++|+|++|+|++ ++ .++.+++|++|++++|+
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~~-l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cchh-HhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccc
Confidence 344555555433321 23455566666666655 2222 4555566666666665553 22 24555555555555555
Q ss_pred cccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeecccccccCCCc
Q 002892 99 ISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGHRPST 178 (870)
Q Consensus 99 i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 178 (870)
|+ .+| .++.+++|+.|++++|.+. .+ ..+..+++|+.++++.|.+++ +..+..
T Consensus 102 i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~--------------------- 154 (210)
T d1h6ta2 102 VK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSR--------------------- 154 (210)
T ss_dssp CC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGG---------------------
T ss_pred cc-ccc-ccccccccccccccccccc-cc-ccccccccccccccccccccc--cccccc---------------------
Confidence 55 232 3555555555555555544 11 234444555555555444432 112222
Q ss_pred ccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCcccccccccccccccc
Q 002892 179 MGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTLNIR 240 (870)
Q Consensus 179 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 240 (870)
+++|+++++++|++++. + .+.++++|++|+|++|+|++ ++ .|.++++|++|+|+
T Consensus 155 ----l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 155 ----LTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp ----CTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred ----ccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 33344444444444322 1 25555666666666666653 22 35556666666554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=8.1e-18 Score=163.50 Aligned_cols=182 Identities=25% Similarity=0.353 Sum_probs=98.8
Q ss_pred CCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEec
Q 002892 15 SFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDS 94 (870)
Q Consensus 15 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 94 (870)
++...++++.+++++.++ ...+.++++|++++|.++ .++ .+..+++|++|+|++|+|++. + .++++++|++|++
T Consensus 18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l 91 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILM 91 (199)
T ss_dssp HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEEC
T ss_pred HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCc-c-cccCCcccccccc
Confidence 334455666666664332 345666777777777766 333 356666777777777766632 2 2666666666666
Q ss_pred cCCccccccCcCCCCcCCccEEEeecCccceecCCcccCCCCCCeeecccccccccccccccccccceEEEeeccccccc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADNNLRGEIPNEIGNLKNLADLVLALNNLIGPIPTTIFNISTIIIINLVGNQLSGH 174 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 174 (870)
++|.+. .++ .++.+++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++
T Consensus 92 ~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l--- 162 (199)
T d2omxa2 92 NNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQV--- 162 (199)
T ss_dssp CSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCC---
T ss_pred cccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccc---
Confidence 666665 332 356666666666666665522 235555556666655555532 1 1233334444444443333
Q ss_pred CCCcccCCCCccceeeecccccccccCCcccCCCCccEEEccCCcccCCCccccccccccccc
Q 002892 175 RPSTMGHSLPNRQFLLLWANRLTGTIPNSITNASKLIGLDLNSNSLSGQIPNTFGNLRHLSTL 237 (870)
Q Consensus 175 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 237 (870)
++. ..+.++++|++|++++|+|++ ++ .++++++|++|
T Consensus 163 ----------------------~~l--~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 163 ----------------------TDL--KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp ----------------------CCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ----------------------cCC--ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 322 125556666666666666653 22 35555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.1e-15 Score=142.04 Aligned_cols=127 Identities=22% Similarity=0.228 Sum_probs=105.4
Q ss_pred ccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCC
Q 002892 356 LSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLI 435 (870)
Q Consensus 356 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 435 (870)
+.+..++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 55667899999999999854 6777889999999999999984 4 3588899999999999999976666678899999
Q ss_pred EEEcCCCcccCccc-ccccCCCCCCeEecCCCcccCCCCc----chhhccccceee
Q 002892 436 TLSLARNRFQDSIP-DSFGSLTSLEYLDLSNNNLSGEIPK----SFEILSHLKRLN 486 (870)
Q Consensus 436 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 486 (870)
.|++++|+|+.... ..+..+++|+.|++++|.++ ..|. .+..+|+|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 99999999986432 46888999999999999997 4443 578889999877
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=4.4e-15 Score=130.83 Aligned_cols=102 Identities=33% Similarity=0.423 Sum_probs=60.7
Q ss_pred ceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCC
Q 002892 363 RQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARN 442 (870)
Q Consensus 363 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 442 (870)
|+|+|++|+|+. ++ .+..+++|++|++++|+|+ .+|..|..+++|+.|++++|+|++. | .++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 456666666662 23 3566666666666666666 3455566666666666666666632 2 3566666666666666
Q ss_pred cccCcc-cccccCCCCCCeEecCCCccc
Q 002892 443 RFQDSI-PDSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 443 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 469 (870)
+|++.. ...+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 665432 134556666666666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=4.9e-16 Score=144.35 Aligned_cols=110 Identities=18% Similarity=0.162 Sum_probs=58.6
Q ss_pred CCCCCCCCeecCCCCccccCCCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCc
Q 002892 11 IGNLSFLMYLDISENNFRGYLPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLV 90 (870)
Q Consensus 11 ~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 90 (870)
+.+...|++|||++|+|+ .+|..+..+++|+.|+|++|.|+ .++ .+..+++|++|+|++|+|+...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 445555666666666665 34444455566666666666665 332 355555666666666665532222334455555
Q ss_pred EEeccCCccccccC--cCCCCcCCccEEEeecCccc
Q 002892 91 RLDSRFNSISGNIP--SKIGNLTKLVHLNFADNNLR 124 (870)
Q Consensus 91 ~L~L~~n~i~~~~~--~~~~~l~~L~~L~l~~N~l~ 124 (870)
.|++++|+|+ .++ ..+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceecccccc-ccccccccccccccchhhcCCCccc
Confidence 5555555554 222 23455555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1e-16 Score=164.91 Aligned_cols=221 Identities=19% Similarity=0.180 Sum_probs=137.3
Q ss_pred CeecCCCCccccCCCccccCC--CCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccC-CCCCCCCCCCCcEEec
Q 002892 18 MYLDISENNFRGYLPNELGQL--RRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGP-IPNSLFNLSSLVRLDS 94 (870)
Q Consensus 18 ~~L~ls~n~l~~~~p~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L 94 (870)
+.|||+++.+. |+.+.++ ..+..+.++...+. ..........+|++|||++|.+++. +...+.++++|++|+|
T Consensus 3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCC---chHHHHHHhccceEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 46888888764 2333221 23556667766665 3333344556888888888887643 3334677888888888
Q ss_pred cCCccccccCcCCCCcCCccEEEeecC-cccee-cCCcccCCCCCCeeecccc-ccccc-ccccccc-cccceEEEeecc
Q 002892 95 RFNSISGNIPSKIGNLTKLVHLNFADN-NLRGE-IPNEIGNLKNLADLVLALN-NLIGP-IPTTIFN-ISTIIIINLVGN 169 (870)
Q Consensus 95 ~~n~i~~~~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~-l~~L~~L~l~~N 169 (870)
++|.+.+..+..++.+++|++|+++++ .++.. +...+.++++|++|+++++ ++++. +...+.. .++|+.|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~ 158 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccc
Confidence 888887666677778888888888884 55522 1222346788888888875 34321 2223333 357888888764
Q ss_pred --cccccCCCcccCCCCccceeeeccc-ccccccCCcccCCCCccEEEccCC-cccCCCcccccccccccccccccc
Q 002892 170 --QLSGHRPSTMGHSLPNRQFLLLWAN-RLTGTIPNSITNASKLIGLDLNSN-SLSGQIPNTFGNLRHLSTLNIRAN 242 (870)
Q Consensus 170 --~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N-~i~~~~~~~~~~l~~L~~L~L~~N 242 (870)
.++......+...+++|+.|++++| .+++.....+.++++|++|+|++| .|++.....++++++|+.|+++++
T Consensus 159 ~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 3433222233334566777777664 466555666666777777777774 465555555666677777777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=1.2e-14 Score=128.05 Aligned_cols=105 Identities=25% Similarity=0.319 Sum_probs=92.3
Q ss_pred ceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEecCCC
Q 002892 387 LRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDLSNN 466 (870)
Q Consensus 387 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 466 (870)
+.|+|++|+++ .++ .+.++++|++|++++|+|+ .+|..|+.+++|+.|++++|.|++. | .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 57999999999 455 5899999999999999998 4677899999999999999999864 4 4999999999999999
Q ss_pred cccCCC-CcchhhccccceeeccCCcccccC
Q 002892 467 NLSGEI-PKSFEILSHLKRLNVSHNRLEGKI 496 (870)
Q Consensus 467 ~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~ 496 (870)
+|+... ...+..+++|+.|++++|+++...
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 999543 257899999999999999998643
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=7.3e-16 Score=158.47 Aligned_cols=223 Identities=17% Similarity=0.140 Sum_probs=163.4
Q ss_pred cEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccc-cCcCCCCcCCccEEEeec
Q 002892 42 KFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGN-IPSKIGNLTKLVHLNFAD 120 (870)
Q Consensus 42 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~l~~ 120 (870)
+.||++++.+.......+-. ..+..+.+++..+.. .........+|++|||++|.+... +...+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 47899998876332222211 246678888877763 334455677999999999998744 345578899999999999
Q ss_pred CccceecCCcccCCCCCCeeecccc-cccccc-cccccccccceEEEeecc-ccccc-CCCcccCCCCccceeeeccc--
Q 002892 121 NNLRGEIPNEIGNLKNLADLVLALN-NLIGPI-PTTIFNISTIIIINLVGN-QLSGH-RPSTMGHSLPNRQFLLLWAN-- 194 (870)
Q Consensus 121 N~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~-~~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~~l~~L~~L~L~~n-- 194 (870)
|.++...+..++.+++|++|+++++ .+++.. .....++++|++|+++++ .++.. ....+....++|+.|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 9998777888999999999999995 565332 223456899999999996 45432 12223344578999999864
Q ss_pred ccccc-cCCcccCCCCccEEEccCC-cccCCCcccccccccccccccccc-ccccccCCCCCcccccccccccccceEEc
Q 002892 195 RLTGT-IPNSITNASKLIGLDLNSN-SLSGQIPNTFGNLRHLSTLNIRAN-YLTTETSSNGEWSFLSSLTNCNKLRALSL 271 (870)
Q Consensus 195 ~l~~~-~~~~~~~l~~L~~L~Ls~N-~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l~~l~~L~~L~L 271 (870)
.+++. +...+.++++|++|++++| .+++.....+.++++|++|+|++| .++.. .+..+..+++|+.|++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~--------~l~~L~~~~~L~~L~l 232 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE--------TLLELGEIPTLKTLQV 232 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGG--------GGGGGGGCTTCCEEEC
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChH--------HHHHHhcCCCCCEEee
Confidence 45433 2334467899999999987 578778888999999999999995 56542 2446788999999999
Q ss_pred CCC
Q 002892 272 GSN 274 (870)
Q Consensus 272 ~~N 274 (870)
+++
T Consensus 233 ~~~ 235 (284)
T d2astb2 233 FGI 235 (284)
T ss_dssp TTS
T ss_pred eCC
Confidence 887
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=2.7e-16 Score=167.36 Aligned_cols=264 Identities=17% Similarity=0.231 Sum_probs=176.2
Q ss_pred cCCcccCCCCccEEEccCCcccCCCc----cccccccccccccccccccccccCCC--CCcccccccccccccceEEcCC
Q 002892 200 IPNSITNASKLIGLDLNSNSLSGQIP----NTFGNLRHLSTLNIRANYLTTETSSN--GEWSFLSSLTNCNKLRALSLGS 273 (870)
Q Consensus 200 ~~~~~~~l~~L~~L~Ls~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~~~~~~l~~l~~L~~L~L~~ 273 (870)
+...+.+..+|++|+|++|.|..... ..+...++|+.|+++++......... +...+...+..+++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 34456667888888888888754332 33556788888888877654332110 0112345567788999999999
Q ss_pred CCCCCCCCccccccccchhhhhcccccccccCchhhhCccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCc
Q 002892 274 NPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIGNLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIP 353 (870)
Q Consensus 274 N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p 353 (870)
|.+...... .+...+...++|+.|++++|.+.......+. ..+..+...
T Consensus 103 n~i~~~~~~---------------------~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~-------- 151 (344)
T d2ca6a1 103 NAFGPTAQE---------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVN-------- 151 (344)
T ss_dssp CCCCTTTHH---------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHH--------
T ss_pred ccccccccc---------------------chhhhhcccccchheeccccccccccccccc--ccccccccc--------
Confidence 988653111 2334556678899999999988632222221 112222211
Q ss_pred ccccCccccceeecCCcccCCCC----CcccccccccceEecCCCccCCC-----CcccccCCccCCEEEccCCccCCc-
Q 002892 354 TCLSSLISLRQLHLGSNQLTSSI----PSSFWSLEYILRIDLSSNSLSGS-----LPSDIQNLKVLIYLNLSRNQLSGN- 423 (870)
Q Consensus 354 ~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~- 423 (870)
......+.|+.+++++|+++... ...+...+.|+.|+|++|.++.. +...+..+++|+.|+|++|.++..
T Consensus 152 ~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g 231 (344)
T d2ca6a1 152 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG 231 (344)
T ss_dssp HHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH
T ss_pred cccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccc
Confidence 11233467899999999887332 33345678899999999998742 334577788999999999998643
Q ss_pred ---ccccccCCCCCCEEEcCCCcccCccccc----ccC--CCCCCeEecCCCcccCC----CCcchh-hccccceeeccC
Q 002892 424 ---IPITIGGLKDLITLSLARNRFQDSIPDS----FGS--LTSLEYLDLSNNNLSGE----IPKSFE-ILSHLKRLNVSH 489 (870)
Q Consensus 424 ---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~--l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~ls~ 489 (870)
+...+..+++|+.|+|++|.|++..... +.. .+.|++|++++|+|+.. +...+. .+++|+.|+|++
T Consensus 232 ~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~ 311 (344)
T d2ca6a1 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311 (344)
T ss_dssp HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred cccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCC
Confidence 3455678899999999999998653333 332 36799999999998742 233332 567899999999
Q ss_pred Ccccc
Q 002892 490 NRLEG 494 (870)
Q Consensus 490 N~l~~ 494 (870)
|++..
T Consensus 312 N~~~~ 316 (344)
T d2ca6a1 312 NRFSE 316 (344)
T ss_dssp SBSCT
T ss_pred CcCCC
Confidence 99864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=1.7e-16 Score=168.82 Aligned_cols=212 Identities=18% Similarity=0.175 Sum_probs=127.1
Q ss_pred ccccccccccccccccccCCCCCcccccccccccccceEEcCCCCCCCCCCccccccccchhhhhcccccccccCchhhh
Q 002892 231 LRHLSTLNIRANYLTTETSSNGEWSFLSSLTNCNKLRALSLGSNPLDSILPPLIGNFSASFQQFYAHECKLKGSIPKEIG 310 (870)
Q Consensus 231 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~l~l~~n~l~~~~~~~l~ 310 (870)
.++|+.|+|++|.++... ...+...+..+++|+.|++++|.+.... ...+...+..+.. .....
T Consensus 92 ~~~L~~L~L~~n~i~~~~----~~~l~~~l~~~~~L~~L~l~~n~l~~~~---~~~l~~~l~~~~~---------~~~~~ 155 (344)
T d2ca6a1 92 CPKLHTVRLSDNAFGPTA----QEPLIDFLSKHTPLEHLYLHNNGLGPQA---GAKIARALQELAV---------NKKAK 155 (344)
T ss_dssp CTTCCEEECCSCCCCTTT----HHHHHHHHHHCTTCCEEECCSSCCHHHH---HHHHHHHHHHHHH---------HHHHH
T ss_pred CCCccccccccccccccc----ccchhhhhcccccchheecccccccccc---ccccccccccccc---------ccccc
Confidence 444555555555444311 1122334455666777777777654211 1111111111111 11224
Q ss_pred CccCCcEEEeeCCCccccCCchhhchhhHHHHHhcCCCCCCCcccccCccccceeecCCcccCCC-----CCcccccccc
Q 002892 311 NLRGLIALSLFTNDLNGTIPTTLGRLQQLQALLQRNNLNGPIPTCLSSLISLRQLHLGSNQLTSS-----IPSSFWSLEY 385 (870)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~ 385 (870)
..+.|+.+++++|++.......+ ...+...+.|+.|+|++|+|+.. +...+...++
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l-------------------~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~ 216 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEW-------------------AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE 216 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHH-------------------HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTT
T ss_pred cCcccceeecccccccccccccc-------------------cchhhhhhhhcccccccccccccccccchhhhhcchhh
Confidence 45678888888887753222111 12234456788888888888632 3445677888
Q ss_pred cceEecCCCccCCC----CcccccCCccCCEEEccCCccCCcccccc----c--CCCCCCEEEcCCCcccCcc----ccc
Q 002892 386 ILRIDLSSNSLSGS----LPSDIQNLKVLIYLNLSRNQLSGNIPITI----G--GLKDLITLSLARNRFQDSI----PDS 451 (870)
Q Consensus 386 L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~--~l~~L~~L~Ls~N~l~~~~----p~~ 451 (870)
|+.|+|++|.++.. +...+..+++|++|+|++|.|++.....+ . ....|+.|++++|+|+... ...
T Consensus 217 L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~ 296 (344)
T d2ca6a1 217 LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296 (344)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHH
T ss_pred hcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHH
Confidence 99999999987632 34567788899999999999986533333 2 2467999999999987542 333
Q ss_pred cc-CCCCCCeEecCCCcccCCCCcchhh
Q 002892 452 FG-SLTSLEYLDLSNNNLSGEIPKSFEI 478 (870)
Q Consensus 452 ~~-~l~~L~~L~L~~N~l~~~~p~~~~~ 478 (870)
+. ++++|+.|+|++|++. .....+..
T Consensus 297 l~~~~~~L~~L~l~~N~~~-~~~~~~~~ 323 (344)
T d2ca6a1 297 IDEKMPDLLFLELNGNRFS-EEDDVVDE 323 (344)
T ss_dssp HHHHCTTCCEEECTTSBSC-TTSHHHHH
T ss_pred HHccCCCCCEEECCCCcCC-CcchHHHH
Confidence 32 5788999999999997 34444433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=5.7e-14 Score=129.20 Aligned_cols=133 Identities=17% Similarity=0.131 Sum_probs=97.9
Q ss_pred ccceEecCCCccCCCCcccccCCccCCEEEccCC-ccCCcccccccCCCCCCEEEcCCCcccCcccccccCCCCCCeEec
Q 002892 385 YILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRN-QLSGNIPITIGGLKDLITLSLARNRFQDSIPDSFGSLTSLEYLDL 463 (870)
Q Consensus 385 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 463 (870)
..+.++++++.+. ..|..+.++++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.|.+|.++++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3455777777777 56777888888888888765 488777788899999999999999998888888999999999999
Q ss_pred CCCcccCCCCcchhhccccceeeccCCcccccCCCCCccccccccc---ccccccccCCC
Q 002892 464 SNNNLSGEIPKSFEILSHLKRLNVSHNRLEGKIPTNGPFRNFLAQS---FLWNYALCGPP 520 (870)
Q Consensus 464 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~---~~~n~~~c~~~ 520 (870)
++|+|+...+..|.. .+|+.|+|++|+|.|.+-. .++..|.... ...+...|..|
T Consensus 88 s~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C~~-~~l~~~~~~~~~~~~~~~~~C~~p 145 (156)
T d2ifga3 88 SFNALESLSWKTVQG-LSLQELVLSGNPLHCSCAL-RWLQRWEEEGLGGVPEQKLQCHGQ 145 (156)
T ss_dssp CSSCCSCCCSTTTCS-CCCCEEECCSSCCCCCGGG-HHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred cCCCCcccChhhhcc-ccccccccCCCcccCCchH-HHHHHHHHhccCccCcCCcEECcC
Confidence 999998544555554 4799999999999877732 3344443221 12344456554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.39 E-value=2.8e-15 Score=144.33 Aligned_cols=113 Identities=27% Similarity=0.336 Sum_probs=56.8
Q ss_pred CCccccCCCCCcEEEccCCcccccCCccccCCCCCCEEEcCCCccccCCCCCCCCCCCCcEEeccCCccccccCcCCCCc
Q 002892 31 LPNELGQLRRLKFLGFAYNDLTGSFPSWIGVFSKLQVLSLRNNSFTGPIPNSLFNLSSLVRLDSRFNSISGNIPSKIGNL 110 (870)
Q Consensus 31 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 110 (870)
+|..+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+. + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 4445555555666666655555 333 3555555555555555555 334333334455555555555542 2 224445
Q ss_pred CCccEEEeecCccceecC-CcccCCCCCCeeeccccccc
Q 002892 111 TKLVHLNFADNNLRGEIP-NEIGNLKNLADLVLALNNLI 148 (870)
Q Consensus 111 ~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~ 148 (870)
++|++|++++|+|+.... ..+..+++|+.|++++|.+.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 555555555555552211 23445555555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.38 E-value=4.4e-15 Score=142.98 Aligned_cols=130 Identities=25% Similarity=0.295 Sum_probs=90.8
Q ss_pred CcccccCccccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcccccccCC
Q 002892 352 IPTCLSSLISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGL 431 (870)
Q Consensus 352 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 431 (870)
++..+..+++|++|+|++|+|+.+ + .+..+++|+.|+|++|.|+ .+|..+..+++|+.|++++|+|+.. ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence 344566677888888888888744 3 4777888888888888887 4555555566788888888888743 246677
Q ss_pred CCCCEEEcCCCcccCccc-ccccCCCCCCeEecCCCcccCCCCcc----------hhhccccceee
Q 002892 432 KDLITLSLARNRFQDSIP-DSFGSLTSLEYLDLSNNNLSGEIPKS----------FEILSHLKRLN 486 (870)
Q Consensus 432 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~L~ 486 (870)
++|+.|++++|+|++... ..+..+++|+.|+|++|.+....+.. +..+|+|+.||
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 788888888888875322 45777888888888888776433322 45677777765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=7.7e-13 Score=121.49 Aligned_cols=137 Identities=17% Similarity=0.061 Sum_probs=107.8
Q ss_pred cccceeecCCcccCCCCCcccccccccceEecCCC-ccCCCCcccccCCccCCEEEccCCccCCcccccccCCCCCCEEE
Q 002892 360 ISLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSN-SLSGSLPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLS 438 (870)
Q Consensus 360 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 438 (870)
...+.++++++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+..|.++++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34567889999998 56788899999999999766 58877778899999999999999999988889999999999999
Q ss_pred cCCCcccCcccccccCCCCCCeEecCCCcccC-CCCcchhhccccceeeccCCcccccCCC
Q 002892 439 LARNRFQDSIPDSFGSLTSLEYLDLSNNNLSG-EIPKSFEILSHLKRLNVSHNRLEGKIPT 498 (870)
Q Consensus 439 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 498 (870)
|++|+|+...+..|..+ +|+.|+|++|.+.- -.-.+|..+.......+..+.++|.-|.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~ 146 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred ccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcCh
Confidence 99999996666666655 79999999999862 1122333333444555566777776653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=7.8e-10 Score=101.83 Aligned_cols=125 Identities=23% Similarity=0.167 Sum_probs=75.1
Q ss_pred ccceeecCCcccCCCCCcccccccccceEecCCCccCCCCcccccCCccCCEEEccCCccCCcc--cccccCCCCCCEEE
Q 002892 361 SLRQLHLGSNQLTSSIPSSFWSLEYILRIDLSSNSLSGSLPSDIQNLKVLIYLNLSRNQLSGNI--PITIGGLKDLITLS 438 (870)
Q Consensus 361 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~ 438 (870)
..+.|+++++... ..+..+..+..++..+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666655432 12333444444444444443 34445566778888888888887543 34466677788888
Q ss_pred cCCCcccCcccccccCCCCCCeEecCCCcccCCCCc-------chhhccccceeeccCCcc
Q 002892 439 LARNRFQDSIPDSFGSLTSLEYLDLSNNNLSGEIPK-------SFEILSHLKRLNVSHNRL 492 (870)
Q Consensus 439 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-------~~~~l~~L~~L~ls~N~l 492 (870)
|++|.|+...+-.+.....|+.|+|++|.++..... .+..+|+|+.|| |+++
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 888887765443444455677888888877754432 245677777664 5544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=2.4e-09 Score=98.40 Aligned_cols=83 Identities=28% Similarity=0.222 Sum_probs=45.7
Q ss_pred cccccccceEecCCCccCCC--CcccccCCccCCEEEccCCccCCcccccccCCCCCCEEEcCCCcccCcccc-------
Q 002892 380 FWSLEYILRIDLSSNSLSGS--LPSDIQNLKVLIYLNLSRNQLSGNIPITIGGLKDLITLSLARNRFQDSIPD------- 450 (870)
Q Consensus 380 ~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------- 450 (870)
+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+..+.+..+|+.|++++|.+......
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 34445555555555555532 123345566666666666666644333333444566677777766644332
Q ss_pred cccCCCCCCeEe
Q 002892 451 SFGSLTSLEYLD 462 (870)
Q Consensus 451 ~~~~l~~L~~L~ 462 (870)
.+..+|+|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 255677777775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=2.3e-07 Score=92.84 Aligned_cols=149 Identities=13% Similarity=0.101 Sum_probs=104.4
Q ss_pred hHHHHhhcCCCCCCeeccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcC-CCceeEEeeeeeeCCee
Q 002892 578 LDIQQATDGFNECNLLGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVR-HRNLIKIFSSCCNLDFK 656 (870)
Q Consensus 578 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 656 (870)
.++......|+..+..+.++.+.||+.. .+++.+++|+...........+.+|...+..+. +--+.+++++....+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4556666777766655555557899886 356678889886655444456778888887774 33367778888888899
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 002892 657 ALVLEFMPNGSLEKWLYSHNYFLDMLERLNIMIDVGLALEYLHHS----------------------------------- 701 (870)
Q Consensus 657 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------------------------------- 701 (870)
++||++++|.++.+...... ...+++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999988866543211 1233455666666666631
Q ss_pred ---------------------CCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 702 ---------------------HSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 702 ---------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
....++|+|+.|.||++++++.+-++||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11237899999999999987667799998775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.85 E-value=3.7e-06 Score=76.92 Aligned_cols=86 Identities=19% Similarity=0.104 Sum_probs=39.1
Q ss_pred CCccCCEEEccCCccCCccc----ccccCCCCCCEEEcCCCcccCc----ccccccCCCCCCeEecCCCcccCC------
Q 002892 406 NLKVLIYLNLSRNQLSGNIP----ITIGGLKDLITLSLARNRFQDS----IPDSFGSLTSLEYLDLSNNNLSGE------ 471 (870)
Q Consensus 406 ~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~------ 471 (870)
..+.|++|+|++|.++.... ..+...+.|+.|+|++|.+.+. +..++...++|++|+|++|++...
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~ 121 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 121 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence 33444444444444442111 1223344555555555555432 122344445566666666554421
Q ss_pred -CCcchhhccccceeeccCCc
Q 002892 472 -IPKSFEILSHLKRLNVSHNR 491 (870)
Q Consensus 472 -~p~~~~~l~~L~~L~ls~N~ 491 (870)
+...+..-+.|+.|+++++.
T Consensus 122 ~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 122 DMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHhCCCccEeeCcCCC
Confidence 12223344556666665543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=1.2e-05 Score=79.50 Aligned_cols=131 Identities=15% Similarity=0.066 Sum_probs=86.4
Q ss_pred Ceeccccc-eeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCC--CceeEEeeeeeeCCeeEEEEecCCCCC
Q 002892 591 NLLGAGSF-GSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRH--RNLIKIFSSCCNLDFKALVLEFMPNGS 667 (870)
Q Consensus 591 ~~lg~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~ 667 (870)
+.+..|.. +.||+...+++..+++|....... ..+..|+..++.+.. -.+.+++++..+.+..++||+|++|.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 35566665 578999888888899998765432 346677777777642 336677888788888899999998866
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 002892 668 LEKWLYSHNYFLDMLERLNIMIDVGLALEYLHH----------------------------------------------- 700 (870)
Q Consensus 668 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~Lh~----------------------------------------------- 700 (870)
+.+.. .+. ...+.++++.++.||.
T Consensus 93 ~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 93 LLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 53210 111 1112233333333331
Q ss_pred ----c----CCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 701 ----S----HSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 701 ----~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
. ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12347999999999999987667899998765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.75 E-value=5.5e-06 Score=75.73 Aligned_cols=112 Identities=13% Similarity=0.141 Sum_probs=83.3
Q ss_pred CccccceeecCCc-ccCCC----CCcccccccccceEecCCCccCC----CCcccccCCccCCEEEccCCccCCcc----
Q 002892 358 SLISLRQLHLGSN-QLTSS----IPSSFWSLEYILRIDLSSNSLSG----SLPSDIQNLKVLIYLNLSRNQLSGNI---- 424 (870)
Q Consensus 358 ~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~---- 424 (870)
+.++|++|+|+++ .+... +...+...+.|++|+|++|.+.. .+...+...+.|++|+|++|.|+...
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3478999999974 46532 33346667889999999999974 33345666789999999999998542
Q ss_pred cccccCCCCCCEEEcCCCcccCc-------ccccccCCCCCCeEecCCCccc
Q 002892 425 PITIGGLKDLITLSLARNRFQDS-------IPDSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 425 p~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~L~~N~l~ 469 (870)
-..+...+.|++|++++|.+... +...+...++|+.|+++.+...
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCch
Confidence 23466778999999999976532 3455666799999999887543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.47 E-value=0.00014 Score=76.19 Aligned_cols=76 Identities=17% Similarity=0.189 Sum_probs=49.3
Q ss_pred CCeeccccceeEEEEEec-CCcEEEEEEeechh-------hHHHHHHHHHHHHHHhcC-C--CceeEEeeeeeeCCeeEE
Q 002892 590 CNLLGAGSFGSVYKGTLF-DGTNVAIKVFNLQL-------ERAFRSFESECEVLRNVR-H--RNLIKIFSSCCNLDFKAL 658 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l 658 (870)
++.||.|....||+.+.. +++.|+||...... .....+...|++.++.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999865 46789999764321 112234556777777662 2 345556554 4456689
Q ss_pred EEecCCCCC
Q 002892 659 VLEFMPNGS 667 (870)
Q Consensus 659 v~e~~~~g~ 667 (870)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.23 E-value=3.6e-05 Score=70.14 Aligned_cols=63 Identities=22% Similarity=0.234 Sum_probs=28.9
Q ss_pred CCCCCCEEEcCCCcccCc----ccccccCCCCCCeEec--CCCcccC----CCCcchhhccccceeeccCCcc
Q 002892 430 GLKDLITLSLARNRFQDS----IPDSFGSLTSLEYLDL--SNNNLSG----EIPKSFEILSHLKRLNVSHNRL 492 (870)
Q Consensus 430 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l 492 (870)
..+.++.+++++|.+... +...+...++|+.++| ++|++.. .+...+...+.|+.|+++.|..
T Consensus 72 ~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 72 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred hcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 344555555555554322 2233444555554333 3444432 1223344455666666655543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.17 E-value=3e-05 Score=70.64 Aligned_cols=113 Identities=14% Similarity=0.186 Sum_probs=83.1
Q ss_pred cCccccceeecCC-cccCCC----CCcccccccccceEecCCCccCCC----CcccccCCccCCEEEccCCccCCcc---
Q 002892 357 SSLISLRQLHLGS-NQLTSS----IPSSFWSLEYILRIDLSSNSLSGS----LPSDIQNLKVLIYLNLSRNQLSGNI--- 424 (870)
Q Consensus 357 ~~l~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~--- 424 (870)
.+.++|++|+|++ +.++.. +..++...++|++|+|++|.++.. +...+...++++.+++++|.++...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4457899999997 557522 334456788999999999998743 2335667789999999999987432
Q ss_pred -cccccCCCCCCEEEc--CCCcccCc----ccccccCCCCCCeEecCCCccc
Q 002892 425 -PITIGGLKDLITLSL--ARNRFQDS----IPDSFGSLTSLEYLDLSNNNLS 469 (870)
Q Consensus 425 -p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 469 (870)
...+...++|+.++| ++|.+... +...+...++|+.|+++.|...
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 345677889987655 56777653 4556678899999999887654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.00062 Score=69.20 Aligned_cols=134 Identities=10% Similarity=0.069 Sum_probs=78.1
Q ss_pred ceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCcee--EEe-----eeeeeCCeeEEEEecCCCCCHH-
Q 002892 598 FGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNLI--KIF-----SSCCNLDFKALVLEFMPNGSLE- 669 (870)
Q Consensus 598 ~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~~~-----~~~~~~~~~~lv~e~~~~g~L~- 669 (870)
--.||+++.++|+.|++|+.+... ....++..|.+.+..+...++. ..+ ..+...+..+.+++|++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 358999999999999999987642 2345677888888877533321 111 1223456778899999874321
Q ss_pred ----HH---------Hh----h----cCCCCCH-------------------HHHHHHHHHHHHHHHHHHh----cCCCC
Q 002892 670 ----KW---------LY----S----HNYFLDM-------------------LERLNIMIDVGLALEYLHH----SHSTP 705 (870)
Q Consensus 670 ----~~---------l~----~----~~~~~~~-------------------~~~~~i~~~i~~~l~~Lh~----~~~~~ 705 (870)
.+ ++ . .+...+. .....+...+.+.++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 10 01 0 0011111 1111122222233333322 12457
Q ss_pred cEecccCCCceeeCCCCceEEeccccccc
Q 002892 706 VVHCNLKPNNILLDKNMTARVSDFGISKL 734 (870)
Q Consensus 706 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 734 (870)
++|+|+.+.||+++++ ..++||+-++.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.60 E-value=0.0035 Score=63.16 Aligned_cols=155 Identities=10% Similarity=0.013 Sum_probs=82.6
Q ss_pred chhHHHHhhcCCCCCCe-----eccccceeEEEEEecCCcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCce--eEEee
Q 002892 576 SYLDIQQATDGFNECNL-----LGAGSFGSVYKGTLFDGTNVAIKVFNLQLERAFRSFESECEVLRNVRHRNL--IKIFS 648 (870)
Q Consensus 576 ~~~~~~~~~~~~~~~~~-----lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~ 648 (870)
+..+++.....|.+.++ |..|---+.|+.+.++| .+++|++..... .+.+..|.+++..+...++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 45667777777776443 44666678899987665 599999865422 2344556666666643222 11111
Q ss_pred ------eeeeCCeeEEEEecCCCCCHH--------------HHHhhc--------CCC------------------CCHH
Q 002892 649 ------SCCNLDFKALVLEFMPNGSLE--------------KWLYSH--------NYF------------------LDML 682 (870)
Q Consensus 649 ------~~~~~~~~~lv~e~~~~g~L~--------------~~l~~~--------~~~------------------~~~~ 682 (870)
..........++.+..+.... ..++.. ... ....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 112234556677776654221 000100 000 0001
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCcEecccCCCceeeCCCCceEEecccccc
Q 002892 683 ERLNIMIDVGLALEYLHH-SHSTPVVHCNLKPNNILLDKNMTARVSDFGISK 733 (870)
Q Consensus 683 ~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 733 (870)
.....+......+...+. ....|+||+|+.+.||+++++...-++||+.++
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222222222222221 235789999999999999988877899999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.33 E-value=0.0027 Score=66.32 Aligned_cols=73 Identities=15% Similarity=0.230 Sum_probs=49.5
Q ss_pred CCeeccccceeEEEEEecC--------CcEEEEEEeechhhHHHHHHHHHHHHHHhcCCCc-eeEEeeeeeeCCeeEEEE
Q 002892 590 CNLLGAGSFGSVYKGTLFD--------GTNVAIKVFNLQLERAFRSFESECEVLRNVRHRN-LIKIFSSCCNLDFKALVL 660 (870)
Q Consensus 590 ~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 660 (870)
++.|+.|-.-.+|++...+ .+.|+++++-. ... .....+|..+++.+.-.+ ..++++++.+ +.|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678889999999998643 35678887653 222 234567888888885333 4466676542 6899
Q ss_pred ecCCCCCH
Q 002892 661 EFMPNGSL 668 (870)
Q Consensus 661 e~~~~g~L 668 (870)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|